PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jung, YS; Qian, YJ; Chen, XB				Jung, Yong-Sam; Qian, Yingjuan; Chen, Xinbin			The p73 Tumor Suppressor Is Targeted by Pirh2 RING Finger E3 Ubiquitin Ligase for the Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; P53 FAMILY; PROTEIN LIGASE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVITY; SV40-TRANSFORMED CELLS; APOPTOTIC RESPONSE; GENE-EXPRESSION; REGULATES P73; HUMAN CANCER	The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and Delta N isoforms. TAp73 has similar activity as p53 and functions as a tumor suppressor whereas Delta Np73 has both pro-and anti-survival functions. While p73 is rarely mutated in spontaneous tumors, the expression status of p73 is linked to the sensitivity of tumor cells to chemotherapy and prognosis for many types of human cancer. Thus, uncovering its regulators in tumors is of great interest. Here, we found that Pirh2, a RING finger E3 ubiquitin ligase, promotes the proteasome-dependent degradation of p73. Specifically, we showed that knockdown of Pirh2 up-regulates, whereas ectopic expression of Pirh2 down-regulates, expression of endogenous and exogenous p73. In addition, Pirh2 physically associates with and promotes TAp73 polyubiquitination both in vivo and in vitro. Moreover, we found that p73 can be degraded by both 20 S and 26 S proteasomes. Finally, we showed that Pirh2 knockdown leads to growth suppression in a TAp73-dependent manner. Taken together, our findings indicate that Pirh2 promotes the proteasomal turnover of TAp73, and thus targeting Pirh2 to restore TAp73-mediated growth suppression in p53-deficient tumors may be developed as a novel anti-cancer strategy.	[Jung, Yong-Sam; Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA123227, CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237, P30CA093373, R01CA123227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA123227 and CA081237.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Corn PG, 1999, CANCER RES, V59, P3352; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gong JG, 1999, NATURE, V399, P806; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Huang XD, 2011, HUM PATHOL, V42, P507, DOI 10.1016/j.humpath.2010.04.021; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jung YS, 2008, J BIOL CHEM, V283, P1018, DOI 10.1074/jbc.M707722200; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kawano S, 1999, BLOOD, V94, P1113; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Liu ML, 2001, LEUKEMIA RES, V25, P441, DOI 10.1016/S0145-2126(00)00148-X; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Maruyama S, 2008, MOL CELL BIOCHEM, V307, P73, DOI 10.1007/s11010-007-9586-3; Miyazaki K, 2003, BIOCHEM BIOPH RES CO, V308, P106, DOI 10.1016/S0006-291X(03)01347-0; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Prives C, 2005, MOL CELL, V19, P719, DOI 10.1016/j.molcel.2005.08.024; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Shimada M, 2009, CANCER SCI, V100, P866, DOI 10.1111/j.1349-7006.2009.01122.x; Stiewe T, 2002, CANCER RES, V62, P3598; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Sun XF, 2002, CLIN CANCER RES, V8, P165; Tokuchi Y, 1999, BRIT J CANCER, V80, P1623, DOI 10.1038/sj.bjc.6690572; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Wang ZH, 2011, CANCER SCI, V102, P909, DOI 10.1111/j.1349-7006.2011.01899.x; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika AI, 1999, CANCER RES, V59, P3257; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhu JH, 2001, ONCOGENE, V20, P4050, DOI 10.1038/sj.onc.1204516	57	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35388	35395		10.1074/jbc.M111.261537	http://dx.doi.org/10.1074/jbc.M111.261537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852228	Green Published, hybrid			2022-12-25	WOS:000295927100010
J	Kitanishi, K; Kobayashi, K; Uchida, T; Ishimori, K; Igarashi, J; Shimizu, T				Kitanishi, Kenichi; Kobayashi, Kazuo; Uchida, Takeshi; Ishimori, Koichiro; Igarashi, Jotaro; Shimizu, Toru			Identification and Functional and Spectral Characterization of a Globin-coupled Histidine Kinase from Anaeromyxobacter sp Fw109-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-DISTAL SIDE; COLI EC DOS; MYCOBACTERIUM-TUBERCULOSIS DOSS; RESONANCE RAMAN-SPECTRA; OXYGEN-SENSOR; ESCHERICHIA-COLI; LIGAND-BINDING; BACILLUS-SUBTILIS; PAS-DOMAIN; REGULATED PHOSPHODIESTERASE	Two-component signal transduction systems regulate numerous important physiological functions in bacteria. In this study we have identified, cloned, overexpressed, and characterized a dimeric full-length heme-bound (heme: protein, 1: 1 stoichiometry) globin-coupled histidine kinase (AfGcHK) from Anaeromyxobacter sp. strain Fw109-5 for the first time. The Fe(III), Fe(II)-O-2, and Fe(II)-CO complexes of the protein displayed autophosphorylation activity, whereas the Fe(II) complex had no significant activity. A H99A mutant lost heme binding ability, suggesting that this residue is the heme proximal ligand. Moreover, His-183 was proposed as the autophosphorylation site based on the finding that the H183A mutant protein was not phosphorylated. The phosphate group of autophosphorylated AfGcHK was transferred to Asp-52 and Asp-169 of a response regulator, as confirmed from site-directed mutagenesis experiments. Based on the amino acid sequences and crystal structures of other globin-coupled oxygen sensor enzymes, Tyr-45 was assumed to be the O-2 binding site at the heme distal side. The O-2 dissociation rate constant, 0.10 s(-1), was substantially increased up to 8.0 s(-1) upon Y45L mutation. The resonance Raman frequencies representing nu(Fe-O2) (559 cm(-1)) and nu(O-O) (1149 cm(-1)) of the Fe(II)-O-2 complex of Y45F mutant AfGcHK were distinct from those of the wildtype protein (nu(Fe-O2), 557 cm(-1); nu(O-O), 1141 cm(-1)), supporting the proposal that Tyr-45 is located at the distal side and forms hydrogen bonds with the oxygen molecule bound to the Fe(II) complex. Thus, we have successfully identified and characterized a novel heme-based globin-coupled oxygen sensor histidine kinase, AfGcHK, in this study.	[Kitanishi, Kenichi; Igarashi, Jotaro; Shimizu, Toru] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kobayashi, Kazuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Tohoku University; Osaka University; Hokkaido University	Shimizu, T (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	shimizu@tagen.tohoku.ac.jp	Kitanishi, Kenichi/I-3323-2014; Igarashi, Jotaro/ABC-9207-2021; Igarashi, Jotaro/B-4550-2008; Kobayashi, Kazuo/H-9279-2012; Ishimori, Koichiro/AAQ-4434-2021; Uchida, Takeshi/A-6455-2017; Ishimori, Koichiro/S-1247-2016	Kitanishi, Kenichi/0000-0002-2110-8104; Igarashi, Jotaro/0000-0002-6165-3350; Igarashi, Jotaro/0000-0002-6165-3350; Kobayashi, Kazuo/0000-0002-5586-9112; Ishimori, Koichiro/0000-0002-5868-0462; Uchida, Takeshi/0000-0001-9270-8329; Ishimori, Koichiro/0000-0002-5868-0462; Shimizu, Toru/0000-0002-3950-5554	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to T. S.) as well as a Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (to K. Kitanishi).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 2000, BIOCHEMISTRY-US, V39, P14330, DOI 10.1021/bi001681d; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2011, HANDB PORPHYR SCI, V15, P399; Inouye M, 2003, HISTIDINE KINASES SI; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito Y, 2009, FEBS LETT, V583, P2244, DOI 10.1016/j.febslet.2009.06.001; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Kobayashi K, 2010, J BIOCHEM, V148, P693, DOI 10.1093/jb/mvq103; Kramer R, 2010, BACTERIAL SIGNALING; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Mukai M, 2000, BIOCHEMISTRY-US, V39, P13810, DOI 10.1021/bi001184x; Nakajima H, 2001, J BIOL CHEM, V276, P37895; Nakamura H, 2004, P NATL ACAD SCI USA, V101, P2742, DOI 10.1073/pnas.0305795101; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; RAMSDEN J, 1989, BIOCHEMISTRY-US, V28, P3125, DOI 10.1021/bi00434a001; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; Thijs L, 2007, J BIOL CHEM, V282, P37325, DOI 10.1074/jbc.M705541200; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	66	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35522	35534		10.1074/jbc.M111.274811	http://dx.doi.org/10.1074/jbc.M111.274811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852234	Green Published, hybrid			2022-12-25	WOS:000295927100024
J	Peterson, FC; Chen, DW; Lytle, BL; Rossi, MN; Ahel, I; Denu, JM; Volkman, BF				Peterson, Francis C.; Chen, Dawei; Lytle, Betsy L.; Rossi, Marianna N.; Ahel, Ivan; Denu, John M.; Volkman, Brian F.			Orphan Macrodomain Protein (Human C6orf130) Is an O-Acyl-ADP-ribose Deacylase SOLUTION STRUCTURE AND CATALYTIC PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE/PROTEIN DEACETYLASES; LYSINE PROPIONYLATION; ARABIDOPSIS-THALIANA; HISTONE MACROH2A; DOMAIN; NMR; METABOLITE; BINDING; IDENTIFICATION; CHROMATIN	Background: Protein deacylation by sirtuins yields O-acyl-ADP-ribose molecules, which are implicated in cell signaling and metabolism. Results: Structural and functional analysis of a human orphan macrodomain protein reveals a common core structure and ability to hydrolyze O-acyl-ADP-ribose. Conclusion: Diverse macrodomains are capable of hydrolyzing O-acyl-ADP-ribose but utilize a different set of catalytic amino acids. Significance: Macrodomain-containing proteins provide a biochemical and biological link to sirtuin-dependent deacylation.	[Chen, Dawei; Denu, John M.] Univ Wisconsin Madison, Dept Biomol Chem, Madison, WI 53715 USA; [Chen, Dawei; Denu, John M.] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Volkman, Brian F.] Med Coll Wisconsin, Ctr Eukaryot Struct Genom, Milwaukee, WI 53226 USA; [Rossi, Marianna N.; Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, DNA Damage Response Grp, Manchester M20 4BX, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin; Paterson Institute for Cancer Research; University of Manchester	Denu, JM (corresponding author), 2178 Wisconsin Inst Discovery, 330 N Orchard Str, Madison, WI 53715 USA.	jmdenu@wisc.edu; bvolkman@mcw.edu	Rossi, Marianna Nicoletta/S-5083-2019; Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Rossi, Marianna Nicoletta/0000-0003-4485-7738; Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ahel, Ivan/0000-0002-9446-3756	National Institutes of Health from the NIGMS Protein Structure Initiative [U54 GM064598, P50 GM064598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, P50GM064598] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 GM064598 and P50 GM064598 from the NIGMS Protein Structure Initiative.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Anantharaman V, 2002, GENOME BIOL, P3, DOI [DOI 10.1186/GB-2002-3-5-RESEARCH0023, 10.1186/gb-2002-3-11-research0061, 10.1186/gb-2002-3-5-research0023]; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallows WC, 2009, CELL, V137, P404, DOI 10.1016/j.cell.2009.04.036; Han WD, 2011, MUTAT RES-REV MUTAT, V727, P86, DOI 10.1016/j.mrrev.2011.03.001; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Lytle BL, 2004, J BIOMOL NMR, V28, P397, DOI 10.1023/B:JNMR.0000015385.54050.19; Marina O, 2010, CANCER RES, V70, P1344, DOI 10.1158/0008-5472.CAN-09-3143; Markley J, 2009, STRUCTURAL BIOINFORM, V2, P93; Mate SE, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-20; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wang LY, 2009, J BIOMOL NMR, V44, P95, DOI 10.1007/s10858-009-9324-0; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	51	65	67	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35955	35965		10.1074/jbc.M111.276238	http://dx.doi.org/10.1074/jbc.M111.276238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849506	hybrid, Green Published			2022-12-25	WOS:000295927100069
J	Costello, DA; Lyons, A; Denieffe, S; Browne, TC; Cox, FF; Lynch, MA				Costello, Derek A.; Lyons, Anthony; Denieffe, Stephanie; Browne, Tara C.; Cox, F. Fionnuala; Lynch, Marina A.			Long Term Potentiation Is Impaired in Membrane Glycoprotein CD200-deficient Mice A ROLE FOR Toll-LIKE RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; NITRIC-OXIDE SYNTHASE; MICROGLIAL CELLS; IN-VITRO; CD200; EXPRESSION; INHIBITION; INTERLEUKIN-1-BETA; INFLAMMATION; LIGAND	The membrane glycoprotein CD200 is expressed on several cell types, including neurons, whereas expression of its receptor, CD200R, is restricted principally to cells of the myeloid lineage, including microglia. The interaction between CD200 and CD200R maintains microglia and macrophages in a quiescent state; therefore, CD200-deficient mice express an inflammatory phenotype exhibiting increased macrophage or microglial activation in models of arthritis, encephalitis, and uveoretinitis. Here, we report that lipopolysaccharide (LPS) and Pam(3)CysSerLys(4) exerted more profound effects on release of the proinflammatory cytokines, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha (TNF alpha), in glia prepared from CD200(-/-) mice compared with wild type mice. This effect is explained by the loss of CD200 on astrocytes, which modulates microglial activation. Expression of Toll-like receptors 4 and 2 (TLR4 and -2) was increased in glia prepared from CD200(-/-) mice, and the evidence indicates that microglial activation, assessed by the increased numbers of CD11b(+) cells that stained positively for both MHCII and CD40, was enhanced in CD200(-/-) mice compared with wild type mice. These neuroinflammatory changes were associated with impaired long term potentiation (LTP) in CA1 of hippocampal slices prepared from CD200(-/-) mice. One possible explanation for this is the increase in TNF alpha in hippocampal tissue prepared from CD200(-/-) mice because TNF alpha application inhibited LTP in CA1. Significantly, LPS and Pam(3)CysSerLys(4), at concentrations that did not affect LTP in wild type mice, inhibited LTP in slices prepared from CD200(-/-) mice, probably due to the accompanying increase in TLR2 and TLR4. Thus, the neuroinflammatory changes that result from CD200 deficiency have a negative impact on synaptic plasticity.	[Costello, Derek A.] Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin	Costello, DA (corresponding author), Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin 2, Ireland.	derek.costello@tcd.ie		Costello, Derek/0000-0002-5449-6166; Lynch, Marina/0000-0002-4631-0499	Science Foundation Ireland; Health Research Board, Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Ireland	This work was supported by Science Foundation Ireland and the Health Research Board, Ireland.	BARCLAY AN, 1981, IMMUNOLOGY, V44, P727; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Cowley T. R., 2010, NEUROBIOL A IN PRESS; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Deckert M, 2006, ACTA NEUROPATHOL, V111, P548, DOI 10.1007/s00401-006-0062-z; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Gorczynski RM, 2000, J IMMUNOL, V165, P4854, DOI 10.4049/jimmunol.165.9.4854; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hailer NP, 1998, BRAIN PATHOL, V8, P459; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Lotz M, 2005, J NEUROCHEM, V94, P289, DOI 10.1111/j.1471-4159.2005.03188.x; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Lyons A, 2009, BRAIN BEHAV IMMUN, V23, P1020, DOI 10.1016/j.bbi.2009.05.060; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Murray CA, 1998, J NEUROSCI, V18, P2974; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Pallasch CP, 2009, LEUKEMIA RES, V33, P460, DOI 10.1016/j.leukres.2008.08.021; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Vincent VAM, 1997, GLIA, V19, P190, DOI 10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3; Vincent VAM, 1996, GLIA, V17, P94	40	111	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34722	34732		10.1074/jbc.M111.280826	http://dx.doi.org/10.1074/jbc.M111.280826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835925	Green Published, hybrid			2022-12-25	WOS:000295406300026
J	Garcia-del Portillo, F; Calvo, E; D'Orazio, V; Graciela Pucciarelli, M				Garcia-del Portillo, Francisco; Calvo, Enrique; D'Orazio, Valentina; Graciela Pucciarelli, M.			Association of ActA to Peptidoglycan Revealed by Cell Wall Proteomics of Intracellular Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; SORTASE-B; SALMONELLA-ENTERICA; SURFACE-PROTEINS; COMPARATIVE GENOMICS; CARBON METABOLISM; STATISTICAL-MODEL; MASS-SPECTROMETRY; EPITHELIAL-CELLS; VIRULENCE	Listeria monocytogenes is a Gram-positive intracellular bacterial pathogen that colonizes the cytosol of eukaryotic cells. Recent transcriptomic studies have revealed that intracellular L. monocytogenes alter expression of genes encoding envelope components. However, no comparative global analysis of this cell wall remodeling process is yet known at the protein level. Here, we used high resolution mass spectrometry to define the cell wall proteome of L. monocytogenes growing inside epithelial cells. When compared with extracellular bacteria growing in a nutrient-rich medium, a major difference found in the proteome was the presence of the actin assembly-inducing protein ActA in peptidoglycan purified from intracellular bacteria. ActA was also identified in the peptidoglycan of extracellular bacteria growing in a chemically defined minimal medium. In this condition, ActA maintains its membrane anchoring domain and promotes efficient bacterial entry into nonphagocytic host cells. Unexpectedly, Internalin-A, which mediates entry of extracellular L. monocytogenes into eukaryotic cells, was identified at late infection times (6 h) as an abundant protein in the cell wall of intracellular bacteria. Other surface proteins covalently bound to the peptidoglycan, as Lmo0514 and Lmo2085, were detected exclusively in intracellular and extracellular bacteria, respectively. Altogether, these data provide the first insights into the changes occurring at the protein level in the L. monocytogenes cell wall as the pathogen transits from the extracellular environment to an intracytosolic lifestyle inside eukaryotic cells. Some of these changes include alterations in the relative amount and the mode of association of certain surface proteins.	[Garcia-del Portillo, Francisco; D'Orazio, Valentina; Graciela Pucciarelli, M.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Calvo, Enrique] Ctr Nacl Invest Cardiovasc, Unidad Proteo, Madrid 28029, Spain; [Graciela Pucciarelli, M.] Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid	Graciela Pucciarelli, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain.	mg.pucciarelli@uam.es	García-del Portillo, Francisco/D-2576-2009	Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316; Garcia-del Portillo, Francisco/0000-0002-4120-0530	ERA-NET Pathogenomics LISTRESS Consortium [PIM2010EPA-00714]; Spanish Ministry of Science and Innovation [BIO2010-18962]	ERA-NET Pathogenomics LISTRESS Consortium; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Grants PIM2010EPA-00714 from the ERA-NET Pathogenomics LISTRESS Consortium (to F. G.-P.) and BIO2010-18962 (to M. G. P.) from the Spanish Ministry of Science and Innovation.	Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Bonazzi M, 2009, CELL MICROBIOL, V11, P693, DOI 10.1111/j.1462-5822.2009.01293.x; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Calvo E, 2005, PROTEOMICS, V5, P433, DOI 10.1002/pmic.200400936; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chatterjee SS, 2006, INT J MED MICROBIOL, V296, P277, DOI 10.1016/j.ijmm.2005.10.001; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Donaldson JR, 2011, J PROTEOMICS, V74, P1906, DOI 10.1016/j.jprot.2011.05.008; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glaser P, 2001, SCIENCE, V294, P849; GUZMAN CA, 1995, INFECT IMMUN, V63, P3665, DOI 10.1128/IAI.63.9.3665-3673.1995; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hecker M, 2008, PROTEOMICS, V8, P4958, DOI 10.1002/pmic.200800278; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Lathrop AA, 2008, J APPL MICROBIOL, V104, P627, DOI 10.1111/j.1365-2672.2007.03574.x; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Luu PT, 1997, INT J FOOD MICROBIOL, V35, P91, DOI 10.1016/S0168-1605(96)01205-6; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NIEBUHR K, 1993, INFECT IMMUN, V61, P2793, DOI 10.1128/IAI.61.7.2793-2802.1993; Personnic N, 2010, INFECT IMMUN, V78, P1979, DOI 10.1128/IAI.01096-09; Poetsch A, 2008, PROTEOMICS, V8, P4100, DOI 10.1002/pmic.200800273; Pucciarelli M. G., 2007, LISTERIA MONOCYTOGEN, P81; Pucciarelli MG, 2005, PROTEOMICS, V5, P4808, DOI 10.1002/pmic.200402075; Pucciarelli MG, 2003, MOL MICROBIOL, V48, P573, DOI 10.1046/j.1365-2958.2003.03469.x; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; Rafelski SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/j.1365-2958.2006.05025.x; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Suarez M, 2001, CELL MICROBIOL, V3, P853, DOI 10.1046/j.1462-5822.2001.00160.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x	56	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34675	34689		10.1074/jbc.M111.230441	http://dx.doi.org/10.1074/jbc.M111.230441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846725	Green Published, hybrid			2022-12-25	WOS:000295406300022
J	Archuleta, TL; Du, YQ; English, CA; Lory, S; Lesser, C; Ohi, MD; Ohi, R; Spiller, BW				Archuleta, Tara L.; Du, Yaqing; English, Chauca A.; Lory, Stephen; Lesser, Cammie; Ohi, Melanie D.; Ohi, Ryoma; Spiller, Benjamin W.			The Chlamydia Effector Chlamydial Outer Protein N (CopN) Sequesters Tubulin and Prevents Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION TRANSLOCATOR; STATHMIN-LIKE DOMAIN; HOST-CELLS; IN-VITRO; DYNAMIC INSTABILITY; BACTERIAL INVASION; TRACHOMATIS; POLYMERIZATION; CHAPERONES; SHIGELLA	Chlamydia species are obligate intracellular pathogens that utilize a type three secretion system to manipulate host cell processes. Genetic manipulations are currently not possible in Chlamydia, necessitating study of effector proteins in heterologous expression systems and severely complicating efforts to relate molecular strategies used by Chlamydia to the biochemical activities of effector proteins. CopN is a chlamydial type three secretion effector that is essential for virulence. Heterologous expression of CopN in cells results in loss of microtubule spindles and metaphase plate formation and causes mitotic arrest. CopN is a multidomain protein with similarity to type three secretion system "plug" proteins from other organisms but has functionally diverged such that it also functions as an effector protein. Weshow that CopN binds directly to alpha beta-tubulin but not to microtubules (MTs). Furthermore, CopN inhibits tubulin polymerization by sequestering free alpha beta-tubulin, similar to one of the mechanisms utilized by stathmin. Although CopN and stathmin share no detectable sequence identity, both influence MT formation by sequestration of alpha beta-tubulin. CopN displaces stathmin from preformed stathmin-tubulin complexes, indicating that the proteins bind overlapping sites on tubulin. CopN is the first bacterial effector shown to disrupt MT formation directly. This recognition affords a mechanistic understanding of a strategy Chlamydia species use to manipulate the host cell cycle.	[Archuleta, Tara L.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Archuleta, Tara L.] Vanderbilt Univ, Div Chem & Phys Biol, Sch Med, Nashville, TN 37232 USA; [Du, Yaqing; English, Chauca A.; Ohi, Melanie D.; Ohi, Ryoma] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; [Lory, Stephen; Lesser, Cammie] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lesser, Cammie] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu			National Institutes of Health [5T90 DA022873]; National Center for Research Resources [UL1RR024975-01, DK058404]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant UL1RR024975-01 from the National Center for Research Resources and Grant DK058404 (to B. W. S.) and Grant NIH 5T90 DA022873 (to T. L. A.).	Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Balsara ZR, 2006, INFECT IMMUN, V74, P5602, DOI 10.1128/IAI.00266-06; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BULINSKI JC, 1980, ANAL BIOCHEM, V104, P432, DOI 10.1016/0003-2697(80)90095-0; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Campbell L. A., 2009, CURR PROTOC MICROBIO, V11, p11B1; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Engel J, 2004, P NATL ACAD SCI USA, V101, P9947, DOI 10.1073/pnas.0403633101; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Johnson S, 2005, CURR OPIN STRUC BIOL, V15, P700, DOI 10.1016/j.sbi.2005.10.007; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARGOLIS RL, 1978, CELL, V13, P1, DOI 10.1016/0092-8674(78)90132-0; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mukhopadhyay S, 2004, J CLIN MICROBIOL, V42, P3288, DOI 10.1128/JCM.42.7.3288-3290.2004; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Slepenkin A, 2005, J BACTERIOL, V187, P473, DOI 10.1128/JB.187.2.473-479.2005; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4	64	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33992	33998		10.1074/jbc.M111.258426	http://dx.doi.org/10.1074/jbc.M111.258426			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841198	hybrid, Green Published			2022-12-25	WOS:000295159200031
J	Delvaux, D; Murty, MRVS; Gabelica, V; Lakaye, B; Lunin, VV; Skarina, T; Onopriyenko, O; Kohn, G; Wins, P; De Pauw, E; Bettendorff, L				Delvaux, David; Murty, Mamidanna R. V. S.; Gabelica, Valerie; Lakaye, Bernard; Lunin, Vladimir V.; Skarina, Tatiana; Onopriyenko, Olena; Kohn, Gregory; Wins, Pierre; De Pauw, Edwin; Bettendorff, Lucien			A Specific Inorganic Triphosphatase from Nitrosomonas europaea STRUCTURE AND CATALYTIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST RNA TRIPHOSPHATASE; IV ADENYLYL-CYCLASE; TUNNEL METALLOENZYME SUPERFAMILY; THIAMINE TRIPHOSPHATASE; ESCHERICHIA-COLI; SOLUBLE EXOPOLYPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHORYL TRANSFER; TRYPANOSOMA-BRUCEI; PYROPHOSPHATASE	The CYTH superfamily of proteins is named after its two founding members, the CyaB adenylyl cyclase from Aeromonas hydrophila and the human 25-kDa thiamine triphosphatase. Because these proteins often form a closed beta-barrel, they are also referred to as triphosphate tunnel metalloenzymes (TTM). Functionally, they are characterized by their ability to bind triphosphorylated substrates and divalent metal ions. These proteins exist in most organisms and catalyze different reactions depending on their origin. Here we investigate structural and catalytic properties of the recombinant TTM protein from Nitrosomonas europaea (NeuTTM), a 19-kDa protein. Crystallographic data show that it crystallizes as a dimer and that, in contrast to other TTM proteins, it has an open beta-barrel structure. We demonstrate that NeuTTM is a highly specific inorganic triphosphatase, hydrolyzing tripolyphosphate (PPPi) with high catalytic efficiency in the presence of Mg2+. These data are supported by native mass spectrometry analysis showing that the enzyme binds PPPi (and Mg-PPPi) with high affinity (K-d < 1.5 mu M), whereas it has a low affinity for ATP or thiamine triphosphate. In contrast to Aeromonas and Yersinia CyaB proteins, NeuTTM has no adenylyl cyclase activity, but it shares several properties with other enzymes of the CYTH superfamily, e. g. heat stability, alkaline pH optimum, and inhibition by Ca2+ and Zn2+ ions. We suggest a catalytic mechanism involving a catalytic dyad formed by Lys-52 and Tyr-28. The present data provide the first characterization of a new type of phosphohydrolase (unrelated to pyrophosphatases or exopolyphosphatases), able to hydrolyze inorganic triphosphate with high specificity.	[Bettendorff, Lucien] Univ Liege, Unit Bioenerget & Cerebral Excitabil, GIGA Neurosci, B-4000 Liege, Belgium; [Murty, Mamidanna R. V. S.; Gabelica, Valerie; De Pauw, Edwin] Univ Liege, GIGA Syst Biol & Chem Biol, B-4000 Liege, Belgium; [Lunin, Vladimir V.; Skarina, Tatiana; Onopriyenko, Olena] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Liege; University of Liege; University of Toronto	Bettendorff, L (corresponding author), Univ Liege, Unit Bioenerget & Cerebral Excitabil, GIGA Neurosci, Ave Hop 1, B-4000 Liege, Belgium.	L.Bettendorff@ulg.ac.be	Gabelica, Valérie/E-9417-2011	Gabelica, Valérie/0000-0001-9496-0165; De Pauw, Edwin/0000-0003-3475-1315	National Institutes of Health Protein Structure Initiative (NIH) [GM074942, P50-GM62413-02]; Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique [2.4558.04, 2.4508.10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413, U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Nucleic acid sequencing was performed by Veronique Dhennin, Genotranscriptomics Platform, GIGA, University of Liege. We thank Dr. Eric Oldfield for the gift of tetrapolyphosphate and Dr. Ilca Margineanu for help with the manuscript and some experiments. We are grateful to Dr. Alexei Savchenko for the gift of the pET15b vector for the expression of NeuTTM and helpful discussion. The structure of NeuTTM was determined by the Midwest Centre for Structural Genomics as part of NIH Protein Structure Initiative Grant GM074942.; This work was supported, in whole or in part, by National Institutes of Health Protein Structure Initiative Grant P50-GM62413-02 (to Alexei Savchenko (Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, M5G 1L6, Canada). This work was also supported by Grants 2.4558.04 and 2.4508.10 from the Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique (to L. B., E. D. P., and B. L.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Baykov AA, 2000, BIOCHEMISTRY-US, V39, P11939, DOI 10.1021/bi000627u; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; BRILEY PA, 1975, BIOCHEM J, V145, P501, DOI 10.1042/bj1450501; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; EGOROV S N, 1976, Biokhimiya, V41, P1958; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Gong CL, 2002, J BIOL CHEM, V277, P15317, DOI 10.1074/jbc.M200532200; GONZALEZ MA, 1984, BIOCHEMISTRY-US, V23, P797, DOI 10.1021/bi00300a002; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hausmann S, 2003, J BIOL CHEM, V278, P30487, DOI 10.1074/jbc.M303060200; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; HILL M, 1987, METHOD ENZYMOL, V148, P132; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Issur M, 2009, NUCLEIC ACIDS RES, V37, P3714, DOI 10.1093/nar/gkp227; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Kuo CC, 2008, BIOCHEM J, V411, P467, DOI 10.1042/BJ20071278; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mato IP, 2001, J BIOL CHEM, V276, P13803, DOI 10.1074/jbc.M009017200; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Smith N, 2006, ACTA CRYSTALLOGR F, V62, P200, DOI 10.1107/S1744309106002855; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; SWITCHENKO AC, 1984, BIOCHEM BIOPH RES CO, V120, P754, DOI 10.1016/S0006-291X(84)80171-0; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; TSUTSUI K, 1986, J BIOL CHEM, V261, P2645; Weeks CM, 2005, ACTA CRYSTALLOGR A, V61, pC152, DOI 10.1107/S0108767305093554; WURST H, 1994, J BIOL CHEM, V269, P10996; Zyryanov AB, 2001, J BIOL CHEM, V276, P17629, DOI 10.1074/jbc.M100343200	55	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34023	34035		10.1074/jbc.M111.233585	http://dx.doi.org/10.1074/jbc.M111.233585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840996	Green Published, hybrid			2022-12-25	WOS:000295159200035
J	Park, K; Elias, PM; Oda, Y; Mackenzie, D; Mauro, T; Holleran, WM; Uchida, Y				Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu			Regulation of Cathelicidin Antimicrobial Peptide Expression by an Endoplasmic Reticulum (ER) Stress Signaling, Vitamin D Receptor-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; BINDING PROTEIN; C/EBP-ALPHA; 1,25-DIHYDROXYVITAMIN D-3; NEUTROPHIL DEVELOPMENT; INFLAMMATORY RESPONSE; INDUCED APOPTOSIS; GENE-EXPRESSION; IMMUNE DEFENSE; KERATINOCYTES	Vitamin D receptor (VDR)-dependent mechanisms regulate human cathelicidin antimicrobial peptide (CAMP)/LL-37 in various cell types, but CAMP expression also increases after external perturbations (such as infection, injuries, UV irradiation, and permeability barrier disruption) in parallel with induction of endoplasmic reticulum (ER) stress. We demonstrate that CAMP mRNA and protein expression increase in epithelial cells (human primary keratinocytes, HaCaT keratinocytes, and HeLa cells), but not in myeloid (U937 and HL-60) cells, following ER stress generated by two mechanistically different, pharmacological stressors, thapsigargin or tunicamycin. The mechanism for increased CAMP following exposure to ER stress involves NF-kappa B activation leading to CCAAT/enhancer-binding protein alpha (C/EBP alpha) activation via MAP kinase-mediated phosphorylation. Furthermore, both increased CAMP secretion and its proteolytic processing to LL-37 are required for antimicrobial activities occur following ER stress. In addition, topical thapsigargin also increases production of the murine homologue of CAMP in mouse epidermis. Finally and paradoxically, ER stress instead suppresses the 1,25(OH)(2) vitamin D-3-induced activation of VDR, but blockade of VDR activity does not alter ER stress-induced CAMP up-regulation. Hence, ER stress increases CAMP expression via NF-kappa B-C/EBP alpha activation, independent of VDR, illuminating a novel VDR-independent role for ER stress in stimulating innate immunity.	[Park, Kyungho; Elias, Peter M.; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA; [Oda, Yuko] Univ Calif San Francisco, Sch Med, Dept Med & Endocrinol, San Francisco, CA 94143 USA; [Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] No Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Holleran, Walter M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94131 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education; University of California System; University of California San Francisco	Uchida, Y (corresponding author), Vet Adm Med Ctr, Dermatol Serv 190, 4150 Clement St, San Francisco, CA 94121 USA.	uchiday@derm.ucsf.edu		Park, Kyungho/0000-0002-1552-9914; Uchida, Yoshikazu/0000-0002-4980-3416	Research Evaluation and Allocation Committee, University of California, San Francisco; National Institutes of Health [AR051077]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051077] Funding Source: NIH RePORTER	Research Evaluation and Allocation Committee, University of California, San Francisco(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by a Research Evaluation and Allocation Committee award from the University of California, San Francisco and National Institutes of Health Grant AR051077 (to Y. U.).	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Anand S, 2005, J INVEST DERMATOL, V125, P323, DOI 10.1111/j.0022-202X.2005.23784.x; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Buchau AS, 2009, J INVEST DERMATOL, V129, P2148, DOI 10.1038/jid.2009.49; Celli A, 2011, BRIT J DERMATOL, V164, P16, DOI 10.1111/j.1365-2133.2010.10046.x; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Elias PM, 2007, SEMIN IMMUNOPATHOL, V29, P3, DOI 10.1007/s00281-007-0060-9; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; Gira AK, 2003, J INVEST DERMATOL, V121, P1191, DOI 10.1046/j.1523-1747.2003.12535.x; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; HOLLERAN WM, 1990, J LIPID RES, V31, P1655; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Inesi G, 1998, ANN NY ACAD SCI, V853, P195, DOI 10.1111/j.1749-6632.1998.tb08267.x; Jackson SM, 1998, J LIPID RES, V39, P767; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LEE AS, 1986, J CELL PHYSIOL, V129, P277, DOI 10.1002/jcp.1041290302; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Mera K, 2010, BIOCHEM BIOPH RES CO, V397, P350, DOI 10.1016/j.bbrc.2010.05.128; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; PITTELKOW MR, 1986, MAYO CLIN PROC, V61, P771, DOI 10.1016/S0025-6196(12)64815-0; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2006, MOL NUTR FOOD RES, V50, P1006, DOI 10.1002/mnfr.200600084; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schroder JM, 2010, CURR OPIN INFECT DIS, V23, P106, DOI 10.1097/QCO.0b013e328335b004; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; Verbeek W, 1999, BLOOD, V94, P3141, DOI 10.1182/blood.V94.9.3141.421k41_3141_3150; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xie ZJ, 2002, J INVEST DERMATOL, V118, P11, DOI 10.1046/j.1523-1747.2002.01644.x; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang KZ, 2008, METHOD ENZYMOL, V442, P395, DOI 10.1016/S0076-6879(08)01420-1; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang P, 1997, J BIOL CHEM, V272, P9609	51	99	106	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34121	34130		10.1074/jbc.M111.250431	http://dx.doi.org/10.1074/jbc.M111.250431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832078	hybrid, Green Published			2022-12-25	WOS:000295159200043
J	Pinto, JR; Siegfried, JD; Parvatiyar, MS; Li, DX; Norton, N; Jones, MA; Liang, JS; Potter, JD; Hershberger, RE				Pinto, Jose Renato; Siegfried, Jill D.; Parvatiyar, Michelle S.; Li, Duanxiang; Norton, Nadine; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.; Hershberger, Ray E.			Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-C; HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; I PHOSPHORYLATION; CA2+ SENSITIVITY; TRANSGENIC MICE; G159D MUTATION; MOUSE MODEL; PHOSPHOLAMBAN; GENE	TNNC1, which encodes cardiac troponin C (cTnC), remains elusive as a dilated cardiomyopathy (DCM) gene. Here, we report the clinical, genetic, and functional characterization of four TNNC1 rare variants (Y5H, M103I, D145E, and I148V), all previously reported by us in association with DCM (Hershberger, R. E., Norton, N., Morales, A., Li, D., Siegfried, J. D., and Gonzalez-Quintana, J. (2010) Circ. Cardiovasc. Genet. 3, 155-161); in the previous study, two variants (Y5H and D145E) were identified in subjects who also carried MYH7 and MYBPC3 rare variants, respectively. Functional studies using the recombinant human mutant cTnC proteins reconstituted into porcine papillary skinned fibers showed decreased Ca2+ sensitivity of force development (Y5H and M103I). Furthermore, the cTnC mutants diminished (Y5H and I148V) or abolished (M103I) the effects of PKA phosphorylation on Ca2+ sensitivity. Only M103I decreased the troponin activation properties of the actomyosin ATPase when Ca2+ was present. CD spectroscopic studies of apo (absence of divalent cations)-, Mg2+-, and Ca2+/Mg2+-bound states indicated that all of the cTnC mutants (except I148V in the Ca2+/Mg2+ condition) decreased the alpha-helical content. These results suggest that each mutation alters the function/ability of the myofilament to bind Ca2+ as a result of modifications in cTnC structure. One variant (D145E) that was previously reported in association with hypertrophic cardiomyopathy and that produced results in vivo in this study consistent with prior hypertrophic cardiomyopathy functional studies was found associated with the MYBPC3 P910T rare variant, likely contributing to the observed DCM phenotype. We conclude that these rare variants alter the regulation of contraction in some way, and the combined clinical, molecular, genetic, and functional data reinforce the importance of TNNC1 rare variants in the pathogenesis of DCM.	[Pinto, Jose Renato] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, RMSB, Miami, FL 33136 USA; [Siegfried, Jill D.; Li, Duanxiang; Norton, Nadine; Hershberger, Ray E.] Univ Miami, Miller Sch Med, Div Cardiovasc, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Pinto, JR (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, RMSB, Rm 6104C,1600 NW 10th Ave, Miami, FL 33136 USA.	jpinto1@med.miami.edu; rhershberger@med.miami.edu	Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Pinto, Jose Renato/0000-0001-9092-4976; Hershberger, Ray/0000-0001-5683-6526; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [R01-HL58626, R01-HL42325, 1K99HL103840-01]; NHLBI [N01-HV-48194]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103840, R01HL058626, R00HL103840, R01HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01-HL58626 (to R. E. H.), R01-HL42325 (to J. D. P.), and 1K99HL103840-01 (to J. R. P.). Resequencing services were provided by the University of Washington Department of Genome Sciences under United States Federal Government Contract N01-HV-48194 from NHLBI.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Fiske CH, 1925, J BIOL CHEM, V66, P375; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; Fujino N, 2001, CLIN CARDIOL, V24, P397, DOI 10.1002/clc.4960240510; Fujino N, 2002, AM J CARDIOL, V89, P29, DOI 10.1016/S0002-9149(01)02158-0; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Ho YL, 2009, CIRC J, V73, P1691, DOI 10.1253/circj.CJ-09-0210; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Kushner JD, 2006, J CARD FAIL, V12, P422, DOI 10.1016/j.cardfail.2006.03.009; Lakdawala NK, 2010, CIRCULATION, V122, P527, DOI 10.1161/CIRCULATIONAHA.109.892240; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Parvatiyar MS, 2010, J BIOL CHEM, V285, P27785, DOI 10.1074/jbc.M110.112326; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Smith L, 1999, BIOPHYS J, V76, P400, DOI 10.1016/S0006-3495(99)77206-1; SMITH L, 1994, J BIOL CHEM, V269, P9857; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wehrens XHT, 2005, ANN NY ACAD SCI, V1047, P366, DOI 10.1196/annals.1341.032; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	49	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34404	34412		10.1074/jbc.M111.267211	http://dx.doi.org/10.1074/jbc.M111.267211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832052	Green Published, hybrid			2022-12-25	WOS:000295159200068
J	Benito, J; Shi, YX; Szymanska, B; Carol, H; Boehm, I; Lu, HB; Konoplev, S; Fang, WD; Zweidler-McKay, PA; Campana, D; Borthakur, G; Bueso-Ramos, C; Shpall, E; Thomas, DA; Jordan, CT; Kantarjian, H; Wilson, WR; Lock, R; Andreeff, M; Konopleva, M				Benito, Juliana; Shi, Yuexi; Szymanska, Barbara; Carol, Hernan; Boehm, Ingrid; Lu, Hongbo; Konoplev, Sergej; Fang, Wendy; Zweidler-McKay, Patrick A.; Campana, Dario; Borthakur, Gautam; Bueso-Ramos, Carlos; Shpall, Elizabeth; Thomas, Deborah A.; Jordan, Craig T.; Kantarjian, Hagop; Wilson, William R.; Lock, Richard; Andreeff, Michael; Konopleva, Marina			Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; ACUTE MYELOID-LEUKEMIA; BONE-MARROW MICROENVIRONMENT; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; KETO REDUCTASE 1C3; INDUCIBLE FACTOR-1-ALPHA; CANCER-TREATMENT; GENE-EXPRESSION	Recent studies indicate that interactions between leukemia cells and the bone marrow (BM) microenvironment promote leukemia cell survival and confer resistance to anti-leukemic drugs. There is evidence that BM microenvironment contains hypoxic areas that confer survival advantage to hematopoietic cells. In the present study we investigated whether hypoxia in leukemic BM contributes to the protective role of the BM microenvironment. We observed a marked expansion of hypoxic BM areas in immunodeficient mice engrafted with acute lymphoblastic leukemia (ALL) cells. Consistent with this finding, we found that hypoxia promotes chemoresistance in various ALL derived cell lines. These findings suggest to employ hypoxia-activated prodrugs to eliminate leukemia cells within hypoxic niches. Using several xenograft models, we demonstrated that administration of the hypoxia-activated dinitrobenzamide mustard, PR-104 prolonged survival and decreased leukemia burden of immune-deficient mice injected with primary acute lymphoblastic leukemia cells. Together, these findings strongly suggest that targeting hypoxia in leukemic BM is feasible and may significantly improve leukemia therapy.	[Benito, Juliana; Shi, Yuexi; Lu, Hongbo; Borthakur, Gautam; Thomas, Deborah A.; Kantarjian, Hagop; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA; [Shpall, Elizabeth; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Konoplev, Sergej; Bueso-Ramos, Carlos] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Fang, Wendy; Zweidler-McKay, Patrick A.] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Szymanska, Barbara; Carol, Hernan; Boehm, Ingrid] Univ New S Wales, Lowy Canc Res Ctr C25, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Campana, Dario] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Jordan, Craig T.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Wilson, William R.; Lock, Richard] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Children's Cancer Institute; University of New South Wales Sydney; St Jude Children's Research Hospital; University of Rochester; University of Auckland	Benito, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA.	mkonople@mdanderson.org	Carol, Hernan/F-5750-2013; Borthakur, Gautam/AAQ-4490-2021; jordan, craig/D-7666-2014	Carol, Hernan/0000-0002-9443-8032; Stacey, Ingrid/0000-0002-3032-6031; Zweidler-McKay, Patrick/0000-0001-6621-523X; jordan, craig/0000-0003-0869-3465; Lock, Richard/0000-0002-3436-9071	National Cancer Institute [NOI-CM-42216, NOI-CM-91001-03, P01 CA55164, 1R21CA153019-01, 1R01CA155056-01]; UTMDACC; Paul and Mary Haas Chair in Genetics; National Institutes of Health Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA153019, R01CA042216, R01CA155056, P01CA055164] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UTMDACC; Paul and Mary Haas Chair in Genetics; National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, NOI-CM-42216 and NOI-CM-91001-03, P01 CA55164 (to MA), 1R21CA153019-01 and 1R01CA155056-01 (MK), UTMDACC Institutional Research Grant (to MK), the Paul and Mary Haas Chair in Genetics (to MA) and National Institutes of Health Cancer Center Support Grant CA016672 (to Flow Cytometry and Cellular Imaging Facility and Research Animal Support Facility at UT MD Anderson Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ADV EXP MED BIOL, V602, P61; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Hicks KO, 2007, INT J RADIAT ONCOL, V69, P560, DOI 10.1016/j.ijrobp.2007.05.049; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Houghton PJ, 2011, PEDIATR BLOOD CANCER, V57, P443, DOI 10.1002/pbc.22921; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Jameson MB, 2010, CANCER CHEMOTH PHARM, V65, P791, DOI 10.1007/s00280-009-1188-1; Jensen PO, 2000, CELL PROLIFERAT, V33, P381, DOI 10.1046/j.1365-2184.2000.00183.x; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Reikvam Hakon, 2009, Critical Reviews in Oncogenesis, V15, P1; Schaefer C, 2008, LEUKEMIA, V22, P59, DOI 10.1038/sj.leu.2404947; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singleton RS, 2009, CANCER RES, V69, P3884, DOI 10.1158/0008-5472.CAN-08-4023; Stratford IJ, 2003, SEMIN RADIAT ONCOL, V13, P42, DOI 10.1053/srao.2003.50008; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Thompson JE, 2007, EXP HEMATOL, V35, P21, DOI 10.1016/j.exphem.2006.08.017; Tracey L, 2010, LEUKEMIA, V24, P806, DOI 10.1038/leu.2010.2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wellmann S, 2004, LEUKEMIA, V18, P926, DOI 10.1038/sj.leu.2403332; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhong H, 1999, CANCER RES, V59, P5830	53	89	94	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23108	10.1371/journal.pone.0023108	http://dx.doi.org/10.1371/journal.pone.0023108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853076	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953400027
J	Wang, XQ; Zhang, SG				Wang, Xiaoqiang; Zhang, Shuguang			Production of a Bioengineered G-Protein Coupled Receptor of Human Formyl Peptide Receptor 3	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DRUG DISCOVERY; RHODOPSIN; EXPRESSION; PURIFICATION; ANTAGONIST; ACTIVATION; MUTANTS; CXCR4; OPSIN	G-protein coupled receptors (GPCRs) participate in a wide range of vital regulations of our physiological actions. They are also of pharmaceutical importance and have become many therapeutic targets for a number of disorders and diseases. Purified GPCR-based approaches including structural study and novel biophysical and biochemical function analyses are increasingly being used in GPCR-directed drug discovery. Before these approaches become routine, however, several hurdles need to be overcome; they include overexpression, solubilization, and purification of large quantities of functional and stable receptors on a regular basis. Here we report milligram production of a human formyl peptide receptor 3 (FPR3). FPR3 comprises a functionally distinct GPCR subfamily that is involved in leukocyte chemotaxis and activation. The bioengineered FPR3 was overexpressed in stable tetracycline-inducible mammalian cell lines (HEK293S). After a systematic detergent screening, fos-choline-14 (FC-14) was selected for subsequent solubilization and purification processes. A two-step purification method, immunoaffinity using anti-rho-tag monoclonal antibody 1D4 and gel filtration, was used to purify the receptors to near homogeneity. Immunofluorescence analysis showed that expressed FPR3 was predominantly displayed on cellular membrane. Secondary structural analysis using circular dichroism showed that the purified FPR3 receptor was correctly folded with >50% alpha-helix, which is similar to other known GPCR secondary structures. Our method can readily produce milligram quantities of human FPR3, which would facilitate in developing human FPR as therapeutic drug targets.	[Wang, Xiaoqiang] China Univ Petr E China, Ctr Bioengn Biotechnol, Qingdao, Shandong, Peoples R China; [Zhang, Shuguang] MIT, Lab Mol Fabricat, Ctr Bits & Atoms, Cambridge, MA 02139 USA	China University of Petroleum; Massachusetts Institute of Technology (MIT)	Wang, XQ (corresponding author), China Univ Petr E China, Ctr Bioengn Biotechnol, Qingdao, Shandong, Peoples R China.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	China University of Petroleum (East China);  [DARPA-HR0011-09-C-0012]	China University of Petroleum (East China); 	This work is supported in part from DARPA-HR0011-09-C-0012. XW is also supported from a fellowship from China University of Petroleum (East China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Braun MC, 2001, BLOOD, V97, P3531, DOI 10.1182/blood.V97.11.3531; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; DURSTIN M, 1994, BIOCHEM BIOPH RES CO, V201, P174, DOI 10.1006/bbrc.1994.1685; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gupta R, 2004, PREDICTION N GLYCOSY; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Su SB, 1999, BLOOD, V93, P3885, DOI 10.1182/blood.V93.11.3885.411k19_3885_3892; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23076	10.1371/journal.pone.0023076	http://dx.doi.org/10.1371/journal.pone.0023076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853070	Green Published, gold			2022-12-25	WOS:000293953400024
J	Zhou, YE; O'Rourke, JP; Edwards, JS; Ness, SA				Zhou, Ye E.; O'Rourke, John P.; Edwards, Jeremy S.; Ness, Scott A.			Single Molecule Analysis of c-myb Alternative Splicing Reveals Novel Classifiers for Precursor B-ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TERMINAL TRUNCATION; GENE; CELLS; PROTEINS; DIFFERENTIATION; TRANSFORMATION; ACTIVATION; ONCOGENE; SF2/ASF	The c-Myb transcription factor, a key regulator of proliferation and differentiation in hematopoietic and other cell types, has an N-terminal DNA binding domain and a large C-terminal domain responsible for transcriptional activation, negative regulation and determining target gene specificity. Overexpression and rearrangement of the c-myb gene (MYB) has been reported in some patients with leukemias and other types of cancers, implicating activated alleles of c-myb in the development of human tumors. Alternative RNA splicing can produce variants of c-myb with qualitatively distinct transcriptional activities that may be involved in transformation and leukemogenesis. Here, by performing a detailed, single molecule assay we found that c-myb alternative RNA splicing was elevated and much more complex in leukemia samples than in cell lines or CD34+ hematopoietic progenitor cells from normal donors. The results revealed that leukemia samples express more than 60 different c-myb splice variants, most of which have multiple alternative splicing events and were not detectable by conventional microarray or PCR approaches. For example, the single molecule assay detected 21 and 22 splice variants containing the 9B and 9S exons, respectively, most of which encoded unexpected variant forms of c-Myb protein. Furthermore, the detailed analysis identified some splice variants whose expression correlated with poor survival in a small cohort of precursor B-ALL samples. Our findings indicate that single molecule assays can reveal complexities in c-myb alternative splicing that have potential as novel biomarkers and could help explain the role of c-Myb variants in the development of human leukemia.	[Zhou, Ye E.; O'Rourke, John P.; Edwards, Jeremy S.; Ness, Scott A.] Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Zhou, YE (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	ness@unm.edu	Ness, Scott/AAV-4009-2020	Ness, Scott/0000-0001-6965-8909	National Institutes of Health (NIH) [5R01CA058443, 5R01CA105257]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology [DK56465]; UNM Cancer Center [2P30CA118100]; UNM Clinical Translational Science Center [1UL1RR031977]; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA058443, R01CA105257] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UNM Cancer Center; UNM Clinical Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants 5R01CA058443 and 5R01CA105257 (to SAN). Purified CD34+ cells were provided by the Fred Hutchinson Cancer Research Center Large-Scale Cell Processing Core, supported by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology grant DK56465. Some experiments used the Keck-University of New Mexico (UNM) Genomics Resource, the microarray and gene expression shared resource supported by the UNM Cancer Center (2P30CA118100) and the UNM Clinical Translational Science Center (1UL1RR031977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; Fahl SP, 2009, J IMMUNOL, V183, P5582, DOI 10.4049/jimmunol.0901187; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; HU YL, 1991, ONCOGENE, V6, P1549; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kumar A, 2003, MOL CELL BIOL, V23, P6631, DOI 10.1128/MCB.23.18.6631-6645.2003; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mullighan CG, 2011, CLIN CANCER RES, V17, P396, DOI 10.1158/1078-0432.CCR-10-1203; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Quintana AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017362; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; SCHUUR ER, 1994, ONCOGENE, V9, P3363; SHENONG GLC, 1987, EMBO J, V6, P4035, DOI 10.1002/j.1460-2075.1987.tb02748.x; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; WESTIN EH, 1990, ONCOGENE, V5, P1117; Woo CH, 1998, J VIROL, V72, P6813, DOI 10.1128/JVI.72.8.6813-6821.1998; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	36	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22880	10.1371/journal.pone.0022880	http://dx.doi.org/10.1371/journal.pone.0022880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853052	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953400016
J	Figueiredo, J; Simoes-Correia, J; Soderberg, O; Suriano, G; Seruca, R				Figueiredo, Joana; Simoes-Correia, Joana; Soderberg, Ola; Suriano, Gianpaolo; Seruca, Raquel			ADP-Ribosylation Factor 6 Mediates E-Cadherin Recovery by Chemical Chaperones	PLOS ONE			English	Article							CELL-CELL ADHESION; DIFFUSE GASTRIC-CANCER; GERMLINE MUTATIONS; ADHERENS JUNCTIONS; PLASMA-MEMBRANE; BETA-CATENIN; I-GAMMA; ENDOCYTOSIS; PROTEIN; ARF6	E-cadherin plays a powerful tumor suppressor role. Germline E-cadherin mutations justify 30% of Hereditary Diffuse Gastric Cancer (HDGC) and missense mutations are found in 30% of these families. We found possible to restore in vitro mutant E-cadherin associated to HDGC syndrome by using Chemical Chaperones (CCs). Herein, our aim was to disclose the molecular mechanisms underlying the CCs effects in E-cadherin regulation. Using cells stably expressing WT E-cadherin or two HDGC-associated missense mutations, we show that upon DMSO treatment, not only mutant E-cadherin is restored and stabilized at the plasma membrane (PM), but also Arf6 and PIPKI gamma expressions are altered. We show that modulation of Arf6 expression partially mimics the effect of CCs, suggesting that the cellular effects observed upon CCs treatment are mediated by Arf6. Further, we show that E-cadherin expression recovery is specifically linked to Arf6 due to its role on endocytosis and recycling pathways. Finally, we demonstrated that, as DMSO, several others CCs are able to modulate the trafficking machinery through an Arf6 dependent mechanism. Interestingly, the more effective compounds in E-cadherin recovery to PM are those that simultaneously inhibit Arf6 and stimulate PIPKI gamma expression and binding to E-cadherin. Here, we present the first evidence of a direct influence of CCs in cellular trafficking machinery and we show that this effect is of crucial importance in the context of juxtamembrane E-cadherin missense mutations associated to HDGC. We propose that this influence should be taken into account when exploring the therapeutic potential of this type of chemicals in genetic diseases associated to protein-misfolding.	[Figueiredo, Joana; Simoes-Correia, Joana; Suriano, Gianpaolo; Seruca, Raquel] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Figueiredo, Joana; Seruca, Raquel] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Simoes-Correia, Joana] Ctr Ophthalmol & Vis Sci, Inst Biomed Res Light & Image, Coimbra, Portugal; [Soderberg, Ola] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Uppsala University	Figueiredo, J (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.		seruca, raquel/F-8187-2011; Söderberg, Ola/O-5130-2017; Simões Correia, Joana/C-8755-2012; Figueiredo, Joana/J-7305-2013	Söderberg, Ola/0000-0003-2883-1925; Simões Correia, Joana/0000-0003-2623-5628; Figueiredo, Joana/0000-0002-1590-1974; Seruca, Raquel/0000-0002-8851-4166	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAUOBD/64319/2006, PTDC/SAUOBD/104017/2008, SFRH/BD/43763/2008, PTDC/SAU-ONC/110294/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Fundacao para a Ciencia e Tecnologia, Portugal: PTDC/SAUOBD/64319/2006, PTDC/SAUOBD/104017/2008, SFRH/BD/43763/2008, and PTDC/SAU-ONC/110294/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Angst BD, 2001, J CELL SCI, V114, P625; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; CARNEIRO F, INT J SURG PATHOL, V18, pS33; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Karam R, 2008, ONCOGENE, V27, P4255, DOI 10.1038/onc.2008.62; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; KUMARI S, CELL RES, V20, P256; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Popov Z, 2000, BRIT J CANCER, V83, P209; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Saitoh M, 2009, BIOCHEM BIOPH RES CO, V381, P560, DOI 10.1016/j.bbrc.2009.02.098; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Simoes-Correia J, 2008, HUM MOL GENET, V17, P3566, DOI 10.1093/hmg/ddn249; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008	63	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23188	10.1371/journal.pone.0023188	http://dx.doi.org/10.1371/journal.pone.0023188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853084	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200050
J	Petersen, AM; Schjorring, S; Gerstrom, SC; Krogfelt, KA				Petersen, Andreas Munk; Schjorring, Susanne; Gerstrom, Sarah Choi; Krogfelt, Karen Angeliki			Treatment of Inflammatory Bowel Disease Associated E. coli with Ciprofloxacin and E. coli Nissle in the Streptomycin-Treated Mouse Intestine	PLOS ONE			English	Article							ESCHERICHIA-COLI; CROHNS-DISEASE; ULCERATIVE-COLITIS; STRAIN NISSLE-1917; PHYLOGENETIC GROUP; EPITHELIAL-CELLS; HIGH PREVALENCE; ILEAL MUCOSA; METAANALYSIS; MESALAZINE	Background: E. coli belonging to the phylogenetic group B2 are linked to Inflammatory Bowel Disease (IBD). Studies have shown that antimicrobials have some effect in the treatment of IBD, and it has been demonstrated that E. coli Nissle has prophylactic abilities comparable to 5-aminosalicylic acid (5-ASA) therapy in ulcerative colitis. The objective of this study was to test if ciprofloxacin and/or E. coli Nissle could eradicate IBD associated E. coli in the streptomycin-treated mouse intestine. Results: After successful colonization with the IBD associated E. coli strains in mice the introduction of E. coli Nissle did not result in eradication of either IBD associated strains or an E. coli from a healthy control, instead, co-colonization at high levels were obtained. Treatment of mice, precolonized with IBD associated E. coli, with ciprofloxacin for three days alone apparently resulted in effective eradication of tested E. coli. However, treatment of precolonized mice with a combination of ciprofloxacin for 3 days followed by E. coli Nissle surprisingly allowed one IBD associated E. coli to re-colonize the mouse intestine, but at a level 3 logs under E. coli Nissle. A prolonged treatment with ciprofloxacin for 7 days did not change this outcome. Conclusions: In the mouse model E. coli Nissle can not be used alone to eradicate IBD associated E. coli; rather, 3 days of ciprofloxacin are apparently efficient in eradicating these strains, but surprisingly, after ciprofloxacin treatment (3 or 7 days), the introduction of E. coli Nissle may support re-colonization with IBD associated E. coli.	[Petersen, Andreas Munk; Schjorring, Susanne; Gerstrom, Sarah Choi; Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Gastrointestinal & Serol Res, DK-2300 Copenhagen, Denmark; [Petersen, Andreas Munk] Hvidovre Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Petersen, AM (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Gastrointestinal & Serol Res, DK-2300 Copenhagen, Denmark.	munk@dadlnet.dk	Krogfelt, Karen Angeliki/P-2430-2018; Krogfelt, Karen Angeliki A/O-8145-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Petersen, Andreas Munk/0000-0003-0531-0553; Schjorring, Susanne/0000-0001-5575-7252				Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; COOKE EM, 1974, GUT, V15, P143, DOI 10.1136/gut.15.2.143; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kuzela L, 2001, AM J GASTROENTEROL, V96, P3216; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; Madsen KL, 2001, CLIN INVEST MED, V24, P250; Malchow HA, 1997, J CLIN GASTROENTEROL, V25, P653, DOI 10.1097/00004836-199712000-00021; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Patzer SI, 2003, MICROBIOL-SGM, V149, P2557, DOI 10.1099/mic.0.26396-0; Petersen AM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-171; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Rahimi R, 2007, DIGEST DIS SCI, V52, P2920, DOI 10.1007/s10620-007-9760-1; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9	29	5	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22823	10.1371/journal.pone.0022823	http://dx.doi.org/10.1371/journal.pone.0022823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853049	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200022
J	Stabler, S; Koyama, T; Zhao, ZG; Martinez-Ferrer, M; Allen, RH; Luka, Z; Loukachevitch, LV; Clark, PE; Wagner, C; Bhowmick, NA				Stabler, Sally; Koyama, Tatsuki; Zhao, Zhiguo; Martinez-Ferrer, Magaly; Allen, Robert H.; Luka, Zigmund; Loukachevitch, Lioudmila V.; Clark, Peter E.; Wagner, Conrad; Bhowmick, Neil A.			Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; RADICAL PROSTATECTOMY; FOLATE-DEFICIENCY; SARCOSINE; MEN; COBALAMIN; ANTIGEN; MARKER; URINE; ACID	Background: Clinical decision for primary treatment for prostate cancer is dictated by variables with insufficient specificity. Early detection of prostate cancer likely to develop rapid recurrence could support neo-adjuvant therapeutics and adjuvant options prior to frank biochemical recurrence. This study compared markers in serum and urine of patients with rapidly recurrent prostate cancer to recurrence-free patients after radical prostatectomy. Based on previous identification of urinary sarcosine as a metastatic marker, we tested whether methionine metabolites in urine and serum could serve as pre-surgical markers for aggressive disease. Methodology/Principal Findings: Urine and serum samples (n = 54 and 58, respectively), collected at the time of prostatectomy were divided into subjects who developed biochemical recurrence within 2 years and those who remained recurrence-free after 5 years. Multiple methionine metabolites were measured in urine and serum by GC-MS. The role of serum metabolites and clinical variables (biopsy Gleason grade, clinical stage, serum prostate specific antigen [PSA]) on biochemical recurrence prediction were evaluated. Urinary sarcosine and cysteine levels were significantly higher (p = 0.03 and p = 0.007 respectively) in the recurrent group. However, in serum, concentrations of homocysteine (p = 0.003), cystathionine (p = 0.007) and cysteine (p<0.001) were more abundant in the recurrent population. The inclusion of serum cysteine to a model with PSA and biopsy Gleason grade improved prediction over the clinical variables alone (p<0.001). Conclusions: Higher serum homocysteine, cystathionine, and cysteine concentrations independently predicted risk of early biochemical recurrence and aggressiveness of disease in a nested case control study. The methionine metabolites further supplemented known clinical variables to provide superior sensitivity and specificity in multivariable prediction models for rapid biochemical recurrence following prostatectomy.	[Stabler, Sally; Allen, Robert H.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Koyama, Tatsuki; Zhao, Zhiguo] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Martinez-Ferrer, Magaly] Univ Puerto Rico, Dept Surg, San Juan, PR 00936 USA; [Luka, Zigmund; Loukachevitch, Lioudmila V.; Wagner, Conrad] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Clark, Peter E.; Bhowmick, Neil A.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA; [Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Vanderbilt University; Vanderbilt University; Cedars Sinai Medical Center	Stabler, S (corresponding author), Univ Colorado, Dept Med, Aurora, CO 80045 USA.	bhowmickn@cshs.org	Clark, Peter/E-1423-2011; Bhowmick, Neil/AAA-7302-2019	Clark, Peter/0000-0002-8006-7015; Bhowmick, Neil/0000-0001-8747-5989	NCI NIH HHS [R01 CA108646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; ALLEN RH, 1993, METABOLISM, V42, P978, DOI 10.1016/0026-0495(93)90010-L; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Beam CA, 2009, J CLIN ONCOL, V27, P1087, DOI 10.1200/JCO.2008.18.3061; Blum DL, 2008, CLIN CANCER RES, V14, P7790, DOI 10.1158/1078-0432.CCR-08-1716; Cao DL, 2011, PROSTATE CANCER P D, V14, P166, DOI 10.1038/pcan.2011.2; Capitanio U, 2009, INT J UROL, V16, P526, DOI 10.1111/j.1442-2042.2009.02270.x; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Etzioni R, 2002, J NATL CANCER I, V94, P981; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HEADY JE, 1975, CANCER RES, V35, P640; Hewavitharana AK, 2010, EUR UROL, V58, pE39, DOI 10.1016/j.eururo.2010.07.031; HORNE DW, 1988, CLIN CHEM, V34, P2357; Huang YC, 2007, CLIN CANCER RES, V13, P1412, DOI 10.1158/1078-0432.CCR-06-1551; Jentzmik F, 2011, J UROLOGY, V185, P706, DOI 10.1016/j.juro.2010.09.077; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Kane CJ, 2010, UROLOGY, V76, P695, DOI 10.1016/j.urology.2009.12.073; Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013; LEVY HL, 1984, PEDIATRICS, V74, P509; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STABLER SP, 1988, J CLIN INVEST, V81, P466, DOI 10.1172/JCI113343; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Thompson KE, 2005, J UROLOGY, V174, P553, DOI 10.1097/01.ju.0000165184.72337.9d	33	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22486	10.1371/journal.pone.0022486	http://dx.doi.org/10.1371/journal.pone.0022486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853037	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200014
J	Cameron, PU; Jones, P; Gorniak, M; Dunster, K; Paul, E; Lewin, S; Woolley, I; Spelman, D				Cameron, Paul U.; Jones, Penelope; Gorniak, Malgorzata; Dunster, Kate; Paul, Eldho; Lewin, Sharon; Woolley, Ian; Spelman, Denis			Splenectomy Associated Changes in IgM Memory B Cells in an Adult Spleen Registry Cohort	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; OVERWHELMING POSTSPLENECTOMY INFECTION; SPLENIC MARGINAL ZONE; IMMUNOGLOBULIN-M; PNEUMOCOCCAL DISEASE; HIV-1 INFECTION; CHILDREN; PROPHYLAXIS; PREVENTION; RESPONSES	Asplenic patients have a lifelong risk of overwhelming post-splenectomy infection and have been reported to have low numbers of peripheral blood IgM memory B cells. The clinical value of quantitation of memory B cells as an indicator of splenic abnormality or risk of infection has been unclear. To assess changes in B cell sub-populations after splenectomy we studied patients recruited to a spleen registry (n = 591). A subset of 209 adult asplenic or hyposplenic subjects, and normal controls (n = 140) were tested for IgM memory B cells. We also determined a) changes in IgM memory B cells with time after splenectomy using the cross-sectional data from patients on the registry and b) the kinetics of changes in haematological markers associated with splenectomy(n = 45). Total B cells in splenectomy patients did not differ from controls, but memory B cells, IgM memory B cells and switched B cells were significantly (p < 0.001) reduced. The reduction was similar for different indications for splenectomy. Changes of asplenia in routine blood films including presence of Howell-Jolly bodies (HJB), occurred early (median 25 days) and splenectomy associated thrombocytosis and lymphocytosis peaked by 50 days. There was a more gradual decrease in IgM memory B cells reaching a stable level within 6 months after splenectomy. IgM memory B cells as proportion of B cells was the best discriminator between splenectomized patients and normal controls and at the optimal cut-off of 4.53, showed a true positive rate of 95% and false positive rate of 20%. In a survey of 152 registry patients stratified by IgM memory B cells around this cut-off there was no association with minor infections and no registry patients experienced OPSI during the study. Despite significant changes after splenectomy, conventional measures of IgM memory cells have limited clinical utility in this population.	[Cameron, Paul U.; Gorniak, Malgorzata; Dunster, Kate; Spelman, Denis] Alfred Hosp, Pathol Serv, Melbourne, Vic, Australia; [Cameron, Paul U.; Jones, Penelope; Lewin, Sharon; Woolley, Ian; Spelman, Denis] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cameron, Paul U.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Lewin, Sharon; Woolley, Ian] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Woolley, Ian] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia; [Lewin, Sharon] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Paul, Eldho] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University; Burnet Institute; Monash University	Cameron, PU (corresponding author), Alfred Hosp, Pathol Serv, Melbourne, Vic, Australia.	Paul.U.Cameron@monash.edu	Lewin, Sharon/Z-3297-2019	Paul, Eldho/0000-0003-1263-7255; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Woolley, Ian John/0000-0003-2928-1291	Flack foundation	Flack foundation	This work was supported by a grant from the Flack foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2002, CLIN IMMUNOL, V103, P34, DOI 10.1006/clim.2001.5197; BABIKER MA, 1986, TROP GEOGR MED, V38, P119; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Berglund LJ, 2008, PATHOLOGY, V40, P288, DOI 10.1080/00313020801911470; Bitaraes EL, 2008, J PEDIAT, V84, P316, DOI 10.1590/S0021-75572008000400006; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bouts AHM, 2004, CLIN EXP IMMUNOL, V137, P589, DOI 10.1111/j.1365-2249.2004.02571.x; Carsetti R, 2006, J INFECT DIS, V193, P1189, DOI 10.1086/501375; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Castagnola E, 2003, EUR J HAEMATOL, V71, P319, DOI 10.1034/j.1600-0609.2003.00158.x; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; de Porto APNA, 2010, EUR J CLIN MICROBIOL, V29, P1465, DOI 10.1007/s10096-010-1049-1; Denholm JT, 2010, MED J AUSTRALIA, V192, P49, DOI 10.5694/j.1326-5377.2010.tb03404.x; Di Sabatino A, 2004, Eur Rev Med Pharmacol Sci, V8, P199; Di Sabatino A, 2005, AM J GASTROENTEROL, V100, P1788, DOI 10.1111/j.1572-0241.2005.41939.x; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328; Ferry BL, 2005, CLIN EXP IMMUNOL, V140, P532, DOI 10.1111/j.1365-2249.2005.02793.x; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martinez-Gamboa L, 2009, CLIN IMMUNOL, V130, P199, DOI 10.1016/j.clim.2008.09.009; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Price VE, 2006, PEDIATR BLOOD CANCER, V46, P597, DOI 10.1002/pbc.20477; Ramachandra J, 2003, ANN ROY COLL SURG, V85, P252, DOI 10.1308/003588403766274962; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Spelman D, 2008, INTERN MED J, V38, P349, DOI 10.1111/j.1445-5994.2007.01579.x; Subramaniam K, 2009, J INFECT DIS, V200, P244, DOI 10.1086/599318; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Vodjgani M, 2007, J INVEST ALLERG CLIN, V17, P321; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Waghorn DJ, 1997, J INFECTION, V35, P289, DOI 10.1016/S0163-4453(97)93232-1; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wasserstrom H, 2008, J IMMUNOL, V181, P3684, DOI 10.4049/jimmunol.181.5.3684; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	52	70	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23164	10.1371/journal.pone.0023164	http://dx.doi.org/10.1371/journal.pone.0023164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829713	Green Published, gold			2022-12-25	WOS:000293561200053
J	Park, J; Lee, J; Choi, C				Park, Junseong; Lee, Jungsul; Choi, Chulhee			Mitochondrial Network Determines Intracellular ROS Dynamics and Sensitivity to Oxidative Stress through Switching Inter-Mitochondrial Messengers	PLOS ONE			English	Article							PERINATAL HYPOXIA-ISCHEMIA; CARDIAC MYOCYTES; SUPEROXIDE DISMUTASES; HYDROGEN-PEROXIDE; RAT-HEART; CELL; CRITICALITY; RELEASE; DEATH; MICE	Oxidative stresses caused by reactive oxygen species (ROS) can induce rapid depolarization of inner mitochondrial membrane potential and subsequent impairment of oxidative phosphorylation. Damaged mitochondria produce more ROS, especially the superoxide anion (O-2(-)) and hydrogen peroxide (H2O2), which potentiate mitochondria-driven ROS propagation, so-called ROS-induced ROS release (RIRR), via activation of an inter-mitochondria signaling network. Therefore, loss of function in only a fraction of mitochondria might eventually affect cell viability through this positive feedback loop. Since ROS are very short-lived molecules in the biological milieu, mitochondrial network dynamics, such as density, number, and spatial distribution, can affect mitochondria-driven ROS propagation. To address this issue, we developed a mathematical model using an agent-based modeling approach, and tested the effect of mitochondrial network dynamics on RIRR for mitochondria under various conditions. Simulation results show that the intracellular ROS signaling pattern, such as ROS propagation speed and oxidative stress vulnerability, are critically affected by mitochondrial network dynamics. Mitochondrial network dynamics of mitochondrial distribution, density, activity, and size can mediate inter-mitochondrial signaling under certain conditions and determine the identity of the ROS signaling pattern. We further elucidated the potential mechanism of these actions, i.e., conversion of major messenger molecules involved in ROS signaling. If the average distance between neighboring mitochondria is large or mitochondrial distribution becomes randomized, messenger molecule of the ROS signaling network can be switched from O-2(-) to H2O2. In this case, mitochondria-driven ROS propagation is efficiently blocked by introduction of excess cytosolic glutathione peroxidase 1, while introduction of cytosolic superoxide dismutase has no effect. Together, these results suggest that mitochondrial network dynamics is a major determinant for cellular responses to RIRR through changing the key messenger molecules.	[Park, Junseong; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Park, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Lee, Jungsul/A-7851-2013; Park, Junseong/C-1973-2012; Choi, Chulhee/C-1642-2011	Lee, Jungsul/0000-0002-8600-5851; Choi, Chulhee/0000-0001-5542-9136; Park, Junseong/0000-0003-0436-8614	Korea government (MEST) [2009-0080280]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study is supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST 2009-0080280) (to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Li XM, 2007, J PHARMACEUT BIOMED, V43, P364, DOI 10.1016/j.jpba.2006.06.041; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; RIBIERE C, 1992, BIOCHEM PHARMACOL, V44, P1495, DOI 10.1016/0006-2952(92)90463-S; SADOSHIMA J, 1992, P NATL ACAD SCI USA, V89, P9905, DOI 10.1073/pnas.89.20.9905; Sharma A, 2000, PHARMACOL RES, V41, P635, DOI 10.1006/phrs.1999.0631; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zaheer A, 2004, NEUROCHEM RES, V29, P1473, DOI 10.1023/B:NERE.0000029558.82943.00; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZHOU L, 1957, PLOS COMPUT BIOL, V6; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	30	137	141	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23211	10.1371/journal.pone.0023211	http://dx.doi.org/10.1371/journal.pone.0023211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829717	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200055
J	Finkelstein, A; Kunis, G; Seksenyan, A; Ronen, A; Berkutzki, T; Azoulay, D; Koronyo-Hamaoui, M; Schwartz, M				Finkelstein, Arseny; Kunis, Gilad; Seksenyan, Akop; Ronen, Ayal; Berkutzki, Tamara; Azoulay, David; Koronyo-Hamaoui, Maya; Schwartz, Michal			Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MOTOR-NEURON DEGENERATION; WILD-TYPE MICROGLIA; GROWTH-FACTOR-I; GLATIRAMER ACETATE; ALZHEIMERS-DISEASE; MOUSE MODEL	Amyotrophic lateral sclerosis (ALS) is a rapidly progressing fatal neurodegenerative disorder characterized by the selective death of motor neurons (MN) in the spinal cord, and is associated with local neuroinflammation. Circulating CD4(+) T cells are required for controlling the local detrimental inflammation in neurodegenerative diseases, and for supporting neuronal survival, including that of MN. T-cell deficiency increases neuronal loss, while boosting T cell levels reduces it. Here, we show that in the mutant superoxide dismutase 1 G93A (mSOD1) mouse model of ALS, the levels of natural killer T (NKT) cells increased dramatically, and T-cell distribution was altered both in lymphoid organs and in the spinal cord relative to wildtype mice. The most significant elevation of NKT cells was observed in the liver, concomitant with organ atrophy. Hepatic expression levels of insulin-like growth factor (IGF)-1 decreased, while the expression of IGF binding protein (IGFBP)-1 was augmented by more than 20-fold in mSOD1 mice relative to wild-type animals. Moreover, hepatic lymphocytes of pre-symptomatic mSOD1 mice were found to secrete significantly higher levels of cytokines when stimulated with an NKT ligand, ex-vivo. Immunomodulation of NKT cells using an analogue of alpha-galactosyl ceramide (alpha-GalCer), in a specific regimen, diminished the number of these cells in the periphery, and induced recruitment of T cells into the affected spinal cord, leading to a modest but significant prolongation of life span of mSOD1 mice. These results identify NKT cells as potential players in ALS, and the liver as an additional site of major pathology in this disease, thereby emphasizing that ALS is not only a non-cell autonomous, but a non-tissue autonomous disease, as well. Moreover, the results suggest potential new therapeutic targets such as the liver for immunomodulatory intervention for modifying the disease, in addition to MN-based neuroprotection and systemic treatments aimed at reducing oxidative stress.	[Finkelstein, Arseny; Kunis, Gilad; Ronen, Ayal; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Seksenyan, Akop; Azoulay, David; Koronyo-Hamaoui, Maya] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Berkutzki, Tamara] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Cedars Sinai Medical Center; Weizmann Institute of Science	Finkelstein, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	michal.schwartz@weizmann.ac.il	Azoulay, David/AAC-2495-2020; Finkelstein, Arseny/AAH-9250-2021; Koronyo-Hamaoui, Maya/AAG-2040-2021	Azoulay, David/0000-0002-3451-5737; Finkelstein, Arseny/0000-0003-1480-5670; Koronyo-Hamaoui, Maya/0000-0003-2864-8442	IsrA.L.S.; Israel Science Foundation (ISF)	IsrA.L.S.; Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by IsrA.L.S. Research Fund and Israel Science Foundation (ISF) Legacy BioMed Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Bakalash S, 2003, INVEST OPHTH VIS SCI, V44, P3374, DOI 10.1167/iovs.03-0080; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Butovsky O, 2007, EUR J NEUROSCI, V26, P413, DOI 10.1111/j.1460-9568.2007.05652.x; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DAWSON G, 1984, J NEUROSCI RES, V12, P213, DOI 10.1002/jnr.490120209; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Grajewski RS, 2008, J IMMUNOL, V181, P4791, DOI 10.4049/jimmunol.181.7.4791; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Habisch HJ, 2007, EXP NEUROL, V206, P288, DOI 10.1016/j.expneurol.2007.05.007; Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013; Halder RC, 2007, NEUROCHEM RES, V32, P257, DOI 10.1007/s11064-006-9145-4; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kong JM, 1998, J NEUROSCI, V18, P3241; KUNDU SK, 1984, BIOCHEM BIOPH RES CO, V118, P82; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Mars LT, 2008, J IMMUNOL, V181, P2321, DOI 10.4049/jimmunol.181.4.2321; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; MASUI Y, 1985, J NEUROL, V232, P15, DOI 10.1007/BF00314034; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pomie C, 2008, HUM IMMUNOL, V69, P708, DOI 10.1016/j.humimm.2008.08.288; RAPPORT MM, 1985, ANN NEUROL, V18, P60, DOI 10.1002/ana.410180111; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Ricort JM, 2004, GROWTH HORM IGF RES, V14, P277, DOI 10.1016/j.ghir.2004.02.002; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SANTODOMINGOGAR.T, 2008, HEPATOLOGY; SCHWARTZ M, NAT REV NEUROL; Schwartz M, 2008, BIODRUGS, V22, P293, DOI 10.2165/00063030-200822050-00002; Schwartz M, 2008, TRENDS PHARMACOL SCI, V29, P287, DOI 10.1016/j.tips.2008.03.006; SEKSENYAN A, J CELL MOL MED, V4, P2470; Serizawa I, 2000, EXP ANIM TOKYO, V49, P171, DOI 10.1538/expanim.49.171; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447	75	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22374	10.1371/journal.pone.0022374	http://dx.doi.org/10.1371/journal.pone.0022374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829620	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900006
J	Moutsiana, C; Field, DT; Harris, JP				Moutsiana, Christina; Field, David T.; Harris, John P.			The Neural Basis of Centre-Surround Interactions in Visual Motion Processing	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; AREA MT; SPATIAL-DISTRIBUTION; FUNCTIONAL MRI; GLOBAL-MOTION; CORTEX; MODULATION; NEURONS; MACAQUE; FMRI	Perception of a moving visual stimulus can be suppressed or enhanced by surrounding context in adjacent parts of the visual field. We studied the neural processes underlying such contextual modulation with fMRI. We selected motion selective regions of interest (ROI) in the occipital and parietal lobes with sufficiently well defined topography to preclude direct activation by the surround. BOLD signal in the ROIs was suppressed when surround motion direction matched central stimulus direction, and increased when it was opposite. With the exception of hMT+/V5, inserting a gap between the stimulus and the surround abolished surround modulation. This dissociation between hMT+/V5 and other motion selective regions prompted us to ask whether motion perception is closely linked to processing in hMT+/V5, or reflects the net activity across all motion selective cortex. The motion aftereffect (MAE) provided a measure of motion perception, and the same stimulus configurations that were used in the fMRI experiments served as adapters. Using a linear model, we found that the MAE was predicted more accurately by the BOLD signal in hMT+/V5 than it was by the BOLD signal in other motion selective regions. However, a substantial improvement in prediction accuracy could be achieved by using the net activity across all motion selective cortex as a predictor, suggesting the overall conclusion that visual motion perception depends upon the integration of activity across different areas of visual cortex.	[Moutsiana, Christina; Field, David T.; Harris, John P.] Univ Reading, Dept Psychol, Reading, Berks, England	University of Reading	Moutsiana, C (corresponding author), Univ Reading, Dept Psychol, Reading, Berks, England.	c.moutsiana@reading.ac.uk			EPSRC; University of Reading	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Reading	CM was supported by a research studentship, funded jointly by EPSRC and the University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, NEUROIMAGE, V16; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Castelo-Branco M, 2002, P NATL ACAD SCI USA, V99, P13914, DOI 10.1073/pnas.202049999; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Falkenberg HK, 2007, J EXP PSYCHOL HUMAN, V33, P257, DOI 10.1037/0096-1523.33.2.257; Harrison LM, 2007, NEUROIMAGE, V34, P1199, DOI 10.1016/j.neuroimage.2006.10.017; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; KECK MJ, 1976, VISION RES, V16, P187, DOI 10.1016/0042-6989(76)90097-3; KECK MJ, 1980, INVEST OPHTH VIS SCI, V19, P1364; Kim J, 1997, VISION RES, V37, P991, DOI 10.1016/S0042-6989(96)00254-4; Koyama S, 2005, CURR BIOL, V15, P2027, DOI 10.1016/j.cub.2005.10.069; Lappin JS, 2001, VISION RES, V41, P1631, DOI 10.1016/S0042-6989(01)00035-9; Lee CC, 1996, MAGNET RESON MED, V36, P436, DOI 10.1002/mrm.1910360316; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; LOOMIS JM, 1973, PERCEPTION, V2, P425, DOI 10.1068/p020425; McDonald JS, 2009, VISION RES, V49, P1397, DOI 10.1016/j.visres.2008.12.014; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; Nawrot M, 1996, VISION RES, V36, P1141, DOI 10.1016/0042-6989(95)00173-5; Paffen CLE, 2005, J VISION, V5, P571, DOI 10.1167/5.6.8; Paffen CLE, 2004, VISION RES, V44, P1635, DOI 10.1016/j.visres.2004.02.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SCOTT TR, 1966, J EXP PSYCHOL, V71, P806, DOI 10.1037/h0023194; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Tadin D, 2011, J NEUROSCI, V31, P1279, DOI 10.1523/JNEUROSCI.4121-10.2011; Tadin D, 2008, J VISION, V8, DOI 10.1167/8.7.9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yu C, 2001, J VISION, V1, P18, DOI 10.1167/1.1.3; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22902	10.1371/journal.pone.0022902	http://dx.doi.org/10.1371/journal.pone.0022902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799KV	21829549	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500047
J	Yu, HC; Zhao, HL; Wu, ZK; Zhang, JW				Yu, Hai-Chuan; Zhao, Hua-Lu; Wu, Zhi-Kui; Zhang, Jun-Wu			Eos Negatively Regulates Human gamma-globin Gene Transcription during Erythroid Differentiation	PLOS ONE			English	Article							HUMAN FETAL; IN-VIVO; TRANSGENIC MICE; EXPRESSION; IKAROS; GATA-1; LOCUS; CELLS; ERYTHROPOIESIS; COREPRESSORS	Background: Human globin gene expression is precisely regulated by a complicated network of transcription factors and chromatin modifying activities during development and erythropoiesis. Eos (Ikaros family zinc finger 4, IKZF4), a member of the zinc finger transcription factor Ikaros family, plays a pivotal role as a repressor of gene expression. The aim of this study was to examine the role of Eos in globin gene regulation. Methodology/Principal Findings: Western blot and quantitative real-time PCR detected a gradual decrease in Eos expression during erythroid differentiation of hemin-induced K562 cells and Epo-induced CD34+ hematopoietic stem/progenitor cells (HPCs). DNA transfection and lentivirus-mediated gene transfer demonstrated that the enforced expression of Eos significantly represses the expression of gamma-globin, but not other globin genes, in K562 cells and CD34+ HPCs. Consistent with a direct role of Eos in globin gene regulation, chromatin immunoprecipitaion and dual-luciferase reporter assays identified three discrete sites located in the DNase I hypersensitivity site 3 (HS3) of the beta-globin locus control region (LCR), the promoter regions of the G gamma- and A gamma-globin genes, as functional binding sites of Eos protein. A chromosome conformation capture (3C) assay indicated that Eos may repress the interaction between the LCR and the gamma-globin gene promoter. In addition, erythroid differentiation was inhibited by enforced expression of Eos in K562 cells and CD34+ HPCs. Conclusions/Significance: Our results demonstrate that Eos plays an important role in the transcriptional regulation of the gamma-globin gene during erythroid differentiation.	[Yu, Hai-Chuan; Zhao, Hua-Lu; Zhang, Jun-Wu] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Yu, Hai-Chuan; Zhao, Hua-Lu; Zhang, Jun-Wu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Zhi-Kui] China Acad Chinese Med Sci, Guanganmen Hosp, Mol Biol Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS	Yu, HC (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	junwu_zhang@pumc.edu.cn			National Basic Research Program of China [2010CB530406]; National Nature Science Foundation of China [30871249]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20060023031]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (2010CB530406), National Nature Science Foundation of China (30871249) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20060023031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2009, BLOOD, V114, P187, DOI 10.1182/blood-2008-07-170712; Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Caballero R, 2007, J CELL SCI, V120, P2619, DOI 10.1242/jcs.007344; Chen ZY, 2008, MOL CELL BIOL, V28, P4386, DOI 10.1128/MCB.00071-08; Cohen-Barak O, 2007, EXP HEMATOL, V35, P358, DOI 10.1016/j.exphem.2006.11.009; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; Cunningham JM, 1996, SEMIN HEMATOL, V33, P9; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Goodwin AJ, 2001, J BIOL CHEM, V276, P26883, DOI 10.1074/jbc.M008410200; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Junwu Z, 1999, Chin Med Sci J, V14, P31; Keys JR, 2008, BRIT J HAEMATOL, V141, P398, DOI 10.1111/j.1365-2141.2008.07065.x; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Liu LR, 2005, J BIOL CHEM, V280, P7452, DOI 10.1074/jbc.M411407200; Mahajan MC, 2007, J CELL BIOCHEM, V102, P801, DOI 10.1002/jcb.21507; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; RODGERS GP, 1995, BRIT J HAEMATOL, V91, P263, DOI 10.1111/j.1365-2141.1995.tb05288.x; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; SAWYER ST, 1987, METHOD ENZYMOL, V147, P340; Song CZ, 2005, BLOOD CELL MOL DIS, V34, P53, DOI 10.1016/j.bcmd.2004.08.027; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; ZHANG JW, 1990, DEV GENET, V11, P168, DOI 10.1002/dvg.1020110207; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	42	3	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22907	10.1371/journal.pone.0022907	http://dx.doi.org/10.1371/journal.pone.0022907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829552	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600065
J	Gurzov, EN; Barthson, J; Marhfour, I; Ortis, F; Naamane, N; Igoillo-Esteve, M; Gysemans, C; Mathieu, C; Kitajima, S; Marchetti, P; Orntoft, TF; Bakiri, L; Wagner, EF; Eizirik, DL				Gurzov, E. N.; Barthson, J.; Marhfour, I.; Ortis, F.; Naamane, N.; Igoillo-Esteve, M.; Gysemans, C.; Mathieu, C.; Kitajima, S.; Marchetti, P.; Orntoft, T. F.; Bakiri, L.; Wagner, E. F.; Eizirik, D. L.			Pancreatic beta-cells activate a JunB/ATF3-dependent survival pathway during inflammation	ONCOGENE			English	Article						type 1 diabetes; pancreatic beta cells; JunB; ATF3; apoptosis	ENDOPLASMIC-RETICULUM STRESS; ADAPTIVE-RESPONSE GENE; ER STRESS; APOPTOSIS; JUNB; ATF3; EXPRESSION; DEATH; CYTOKINES; MICE	Destruction of insulin-producing pancreatic beta-cells by local autoimmune inflammation is a hallmark of type 1 diabetes. Histochemical analysis of pancreases from non-obese diabetic mice indicated activation of the transcription factor JunB/AP-1 (activator protein-1) after autoimmune infiltration of the islets. In vitro studies demonstrated that the cytokines tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma induce JunB expression as a protective mechanism against apoptosis in both human and rodent beta-cells. The gene network affected was studied by microarray analysis showing that JunB regulates nearly 20% of the cytokine-modified beta-cell genes, including the transcription factor ATF3. Direct transcriptional induction of ATF3 by JunB is a key event for beta-cell survival after TNF-alpha + IFN-gamma treatment. Moreover, pharmacological upregulation of JunB/ATF3 via increased cAMP protected rodent primary beta-cells and human islet cells against pro-inflammatory mediators. These results were confirmed in genetically modified islets derived from Ubi-JunB transgenic mice. Our findings identify ATF3 as a novel downstream target of JunB in the survival mechanism of beta-cells under inflammatory stress. Oncogene (2012) 31, 1723-1732; doi:10.1038/onc.2011.353; published online 15 August 2011	[Gurzov, E. N.; Barthson, J.; Marhfour, I.; Ortis, F.; Naamane, N.; Igoillo-Esteve, M.; Eizirik, D. L.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Gysemans, C.; Mathieu, C.] Katholieke Univ Leuven, Fac Med, Lab Expt Med Endocrinol LEGENDO, Louvain, Belgium; [Kitajima, S.] Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci, Dept Biochem Genet, Tokyo, Japan; [Kitajima, S.] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Genome Struct & Regulat, Tokyo, Japan; [Marchetti, P.] Univ Pisa, Osped Cisanello, Metab Unit, Dept Endocrinol & Metab, Pisa, Italy; [Orntoft, T. F.] CMO Aros Appl Biotechnol AS, Aarhus, Denmark; [Orntoft, T. F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Bakiri, L.; Wagner, E. F.] Banco Bilbao Vizcaya Argentaria BBVA Fdn, Canc Cell Biol Programme, CNIO, Madrid, Spain	Universite Libre de Bruxelles; KU Leuven; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Pisa; Aarhus University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Gurzov, EN (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik 808,CP-618, B-1070 Brussels, Belgium.	egurzov@ulb.ac.be; deizirik@ulb.ac.be	Bakiri, Latifa/N-5780-2014; mathieu, chantal/ABD-5505-2021; Bakiri, Latifa/AAP-1674-2020; Ortis, Fernanda/M-7190-2019; Ortis, Fernanda/K-7917-2014; Marchetti, Piero/J-7439-2013	mathieu, chantal/0000-0002-4055-5233; Marchetti, Piero/0000-0003-4907-0635; Wagner, Erwin F/0000-0001-7872-0196; gysemans, conny/0000-0003-3559-6089; Ortis, Fernanda/0000-0002-9551-2839; Igoillo-Esteve, Mariana/0000-0002-3264-7912; bakiri, latifa/0000-0002-6300-2420; Gurzov, Esteban/0000-0003-4642-0273	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium; Belgium Program on Interuniversity Poles of Attraction [IUAP P6/40]; Juvenile Diabetes Research Foundation International (JDRFI) [17-2009-106]; European Union (European Community); EMBO; FWO Vlaanderen	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction; Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); European Union (European Community)(European Commission); EMBO(European Molecular Biology Organization (EMBO)); FWO Vlaanderen(FWO)	We thank MA Neef, G Vandenbroeck, M Urbain, R Makhnas, AE Musuaya and S Mertens of the Laboratory of Experimental Medicine (Universite Libre de Bruxelles, Brussels, Belgium) for excellent technical support, and Drs L Marselli and L Ladriere for help with human islet preparations. This work was supported by grants from the Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC), Fonds National de la Recherche Scientifique (FNRS) Belgium, the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40), the Juvenile Diabetes Research Foundation International (JDRFI Grant 17-2009-106) and the European Union (project Naimit, in the Framework Programme 7 of the European Community). ENG was supported by an EMBO long-term fellowship. CG and CM were supported by a postdoctoral and senior clinical scholarship from the FWO Vlaanderen, respectively.	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Bosi E, 2010, J CLIN ENDOCR METAB, V95, P2607, DOI 10.1210/jc.2009-2741; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Colli ML, 2010, HUM MOL GENET, V19, P135, DOI 10.1093/hmg/ddp474; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; PEREZALBUERNE ED, 1993, P NATL ACAD SCI USA, V90, P11960, DOI 10.1073/pnas.90.24.11960; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	40	32	32	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	13					1723	1732		10.1038/onc.2011.353	http://dx.doi.org/10.1038/onc.2011.353			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21841823				2022-12-25	WOS:000302231400010
J	Chen, W; Hoo, RLC; Konishi, M; Itoh, N; Lee, PC; Ye, HY; Lam, KSL; Xu, AM				Chen, Wei; Hoo, Ruby Lai-chong; Konishi, Morichika; Itoh, Nobuyuki; Lee, Pui-chi; Ye, Hong-ying; Lam, Karen Siu-ling; Xu, Aimin			Growth Hormone Induces Hepatic Production of Fibroblast Growth Factor 21 through a Mechanism Dependent on Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; PPAR-ALPHA ACTIVATION; INSULIN SENSITIVITY; FGF21; INHIBITION; METABOLISM; EXPRESSION; RESISTANCE; SECRETION; GLUCOSE	Fibroblast growth factor (FGF) 21 and growth hormone (GH) are metabolic hormones that play important roles in regulating glucose and lipid metabolism. Both hormones are induced in response to fasting and exert their actions on adipocytes to regulate lipolysis. However, the molecular interaction between these two hormones remains unclear. Here we demonstrate the existence of a feedback loop between GH and FGF21 on the regulation of lipolysis in adipocytes. A single bolus injection of GH into C57 mice acutely increases both mRNA and protein expression of FGF21 in the liver, thereby leading to a marked elevation of serum FGF21 concentrations. Such a stimulatory effect of GH on hepatic FGF21 production is abrogated by pretreatment of mice with the lipolysis inhibitor niacin. Direct incubation of either liver explants or human HepG2 hepatocytes with GH has no effect on FGF21 expression. On the other hand, FGF21 production in HepG2 cells is significantly induced by incubation with the conditioned medium harvested from GH-treated adipose tissue explants, which contains high concentrations of free fatty acids (FFA). Further analysis shows that FFA released by GH-induced lipolysis stimulates hepatic FGF21 expression by activation of the transcription factor PPAR alpha. In FGF21-null mice, both the magnitude and duration of GH-induced lipolysis are significantly higher than those in their wild type littermates. Taken together, these findings suggest that GH-induced hepatic FGF21 production is mediated by FFA released from adipose tissues, and elevated FGF21 in turn acts as a negative feedback signal to terminate GH-stimulated lipolysis in adipocytes.	[Chen, Wei; Hoo, Ruby Lai-chong; Lee, Pui-chi; Lam, Karen Siu-ling; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Wei] Fudan Univ, Dept Geriatr, Hua Shan Hosp, Shanghai 200040, Peoples R China; [Ye, Hong-ying] Fudan Univ, Dept Endocrinol, Hua Shan Hosp, Shanghai 200040, Peoples R China; [Hoo, Ruby Lai-chong; Lam, Karen Siu-ling; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Ageing, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Konishi, Morichika; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan	University of Hong Kong; Fudan University; Fudan University; University of Hong Kong; University of Hong Kong; Kyoto University	Lam, KSL (corresponding author), Univ Hong Kong, Dept Med, L8-40,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	ksllam@hku.hk; amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X	Research Grant Council of Hong Kong [HKU3/CRF/09]; University of Hong Kong [2011CB504004]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by the Collaborative Research Fund (HKU3/CRF/09), from the Research Grant Council of Hong Kong, seeding fund for basic research and the matching fund for the National Basic Research Program of China (Project no: 2011CB504004) from the University of Hong Kong.	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P369, DOI 10.1210/jc.2009-1730; Friend K, 1997, EUR J ENDOCRINOL, V137, P377, DOI 10.1530/eje.0.1370377; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Mai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE126, DOI 10.1152/ajpendo.00020.2010; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; MOLLER N, 1990, AM J PHYSIOL, V258, pE86, DOI 10.1152/ajpendo.1990.258.1.E86; Moller N, 2009, CLIN NUTR, V28, P597, DOI 10.1016/j.clnu.2009.08.015; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Norrelund H, 2003, J CLIN ENDOCR METAB, V88, P4371, DOI 10.1210/jc.2003-030267; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; ROSENTHAL MJ, 1988, METABOLISM, V37, P645, DOI 10.1016/0026-0495(88)90083-2; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Segerlantz M, 2003, EUR J ENDOCRINOL, V149, P511, DOI 10.1530/eje.0.1490511; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; WEITZMAN ED, 1976, ANNU REV MED, V27, P225, DOI 10.1146/annurev.me.27.020176.001301; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	40	110	118	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34559	34566		10.1074/jbc.M111.285965	http://dx.doi.org/10.1074/jbc.M111.285965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849508	Green Published, hybrid			2022-12-25	WOS:000295406300010
J	Alexandrov, AA; Boricheva, DO; Pulvermuller, F; Shtyrov, Y				Alexandrov, Alexander A.; Boricheva, Daria O.; Pulvermueller, Friedemann; Shtyrov, Yury			Strength of Word-Specific Neural Memory Traces Assessed Electrophysiologically	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; HUMAN BRAIN; SPEECH-PERCEPTION; SPOKEN WORDS; LANGUAGE; RECOGNITION; FAMILIARITY; MODEL; REPRESENTATIONS; COMPETITION	Memory traces for words are frequently conceptualized neurobiologically as networks of neurons interconnected via reciprocal links developed through associative learning in the process of language acquisition. Neurophysiological reflection of activation of such memory traces has been reported using the mismatch negativity brain potential (MMN), which demonstrates an enhanced response to meaningful words over meaningless items. This enhancement is believed to be generated by the activation of strongly intraconnected long-term memory circuits for words that can be automatically triggered by spoken linguistic input and that are absent for unfamiliar phonological stimuli. This conceptual framework critically predicts different amounts of activation depending on the strength of the word's lexical representation in the brain. The frequent use of words should lead to more strongly connected representations, whereas less frequent items would be associated with more weakly linked circuits. A word with higher frequency of occurrence in the subject's language should therefore lead to a more pronounced lexical MMN response than its low-frequency counterpart. We tested this prediction by comparing the event-related potentials elicited by low- and high-frequency words in a passive oddball paradigm; physical stimulus contrasts were kept identical. We found that, consistent with our prediction, presenting the high-frequency stimulus led to a significantly more pronounced MMN response relative to the low-frequency one, a finding that is highly similar to previously reported MMN enhancement to words over meaningless pseudowords. Furthermore, activation elicited by the higher-frequency word peaked earlier relative to low-frequency one, suggesting more rapid access to frequently used lexical entries. These results lend further support to the above view on word memory traces as strongly connected assemblies of neurons. The speed and magnitude of their activation appears to be linked to the strength of internal connections in a memory circuit, which is in turn determined by the everyday use of language elements.	[Alexandrov, Alexander A.; Boricheva, Daria O.] St Petersburg State Univ, St Petersburg, Russia; [Pulvermueller, Friedemann; Shtyrov, Yury] MRC, Cognit & Brain Sci Unit, Cambridge, England	Saint Petersburg State University	Alexandrov, AA (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	yury.shtyrov@mrc-cbu.cam.ac.uk	Aleksandrov, Aleksander/M-8465-2019; Boricheva, Daria/G-6075-2015; Shtyrov, Yury/I-3421-2013; Shtyrov, Yury/ABI-2266-2020; Aleksandrov, Aleksandr/D-5820-2013	Aleksandrov, Aleksander/0000-0002-0129-9038; Boricheva, Daria/0000-0002-3946-6647; Shtyrov, Yury/0000-0001-7203-4902; Aleksandrov, Aleksandr/0000-0002-0129-9038; pulvermuller, friedemann/0000-0003-3210-7112	University of St. Petersburg, Russia; Medical Research Council, UK [U.1055.04.014.00001.01, MC_US_A060_0043]; Russian Ministry of Education and Science [02.740.11.5148]; MRC [MC_U105597122, MC_U105580445] Funding Source: UKRI; Medical Research Council [MC_U105580445, MC_U105597122] Funding Source: researchfish	University of St. Petersburg, Russia; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the University of St. Petersburg, Russia, Medical Research Council, UK (U.1055.04.014.00001.01, MC_US_A060_0043), and Russian Ministry of Education and Science (state contract 02.740.11.5148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2002, WORDS MIND INTRO MEN; Assadollahi R, 2001, NEUROREPORT, V12, P207, DOI 10.1097/00001756-200102120-00007; Bilenko NY, 2009, J COGNITIVE NEUROSCI, V21, P960, DOI 10.1162/jocn.2009.21073; Boudelaa S, 2010, J COGNITIVE NEUROSCI, V22, P998, DOI 10.1162/jocn.2009.21273; Braitenberg V., 1992, LANGUAGE ORIGIN MULT, P89; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CONNINE CM, 1990, J EXP PSYCHOL LEARN, V16, P1084, DOI 10.1037/0278-7393.16.6.1084; Endrass T, 2004, EUR J NEUROSCI, V19, P1653, DOI 10.1111/j.1460-9568.2004.03247.x; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Garagnani M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.010.2009; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Harley T, 2008, PSYCHOL LANGUAGE DAT; Hasting AS, 2008, EUR J NEUROSCI, V27, P1561, DOI 10.1111/j.1460-9568.2008.06103.x; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Jacobsen T, 2005, J COGNITIVE NEUROSCI, V17, P1704, DOI 10.1162/089892905774589262; Jacobsen T, 2004, BRAIN LANG, V88, P54, DOI 10.1016/S0093-934X(03)00156-1; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Kujala A, 2002, NEUROSCI LETT, V331, P91, DOI 10.1016/S0304-3940(02)00843-1; MARSLENWILSON W, 1994, PSYCHOL REV, V101, P3, DOI 10.1037/0033-295X.101.1.3; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pettigrew C, 2004, APHASIOLOGY, V18, P3, DOI 10.1080/02687030344000463; Pettigrew CM, 2004, EAR HEARING, V25, P284, DOI 10.1097/01.AUD.0000130800.88987.03; Pulvermuller F, 2009, CEREB CORTEX, V19, P79, DOI 10.1093/cercor/bhn060; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Pulvermuller F, 2004, PSYCHOPHYSIOLOGY, V41, P106, DOI 10.1111/j.1469-8986.2003.00135.x; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Pulvermuller F, 2009, BRAIN LANG, V110, P81, DOI 10.1016/j.bandl.2008.12.001; Revill KP, 2008, P NATL ACAD SCI USA, V105, P13111, DOI 10.1073/pnas.0807054105; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; SHAROFF S, 2001, WORD FREQUENCY DICT; Shtyrov Y, 2000, NEUROIMAGE, V12, P657, DOI 10.1006/nimg.2000.0646; Shtyrov Y, 1998, NEUROSCI LETT, V251, P141, DOI 10.1016/S0304-3940(98)00529-1; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; SHTYROV Y, 2010, J COGNITIVE NEUROSCI, P22; Shtyrov Y, 2007, J PSYCHOPHYSIOL, V21, P176, DOI 10.1027/0269-8803.21.34.176; Shtyrov Y, 2008, CEREB CORTEX, V18, P29, DOI 10.1093/cercor/bhm028; Shtyrov Y, 2011, NEUROIMAGE, V55, P658, DOI 10.1016/j.neuroimage.2010.12.002; Sittiprapaporn W, 2003, ANN NY ACAD SCI, V999, P199, DOI 10.1196/annals.1284.029; Tamminen J, 2008, Q J EXP PSYCHOL, V61, P361, DOI 10.1080/17470210701634545; Wennekers T, 2006, J PHYSIOL-PARIS, V100, P16, DOI 10.1016/j.jphysparis.2006.09.007	53	41	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22999	10.1371/journal.pone.0022999	http://dx.doi.org/10.1371/journal.pone.0022999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827UM	21853063	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200033
J	Kumar, A; Bhandari, A; Sinha, R; Goyal, P; Grapputo, A				Kumar, Abhishek; Bhandari, Anita; Sinha, Rahul; Goyal, Pankaj; Grapputo, Alessandro			Spliceosomal Intron Insertions in Genome Compacted Ray-Finned Fishes as Evident from Phylogeny of MC Receptors, Also Supported by a Few Other GPCRs	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MELANOCORTIN RECEPTORS; FUNCTIONAL-CHARACTERIZATION; GENE REPERTOIRE; TELEOST FISH; EVOLUTION; ORIGIN; GAIN; CONSERVATION; DATABASE	Background: Insertions of spliceosomal introns are very rare events during evolution of vertebrates and the mechanisms governing creation of novel intron(s) remain obscure. Largely, gene structures of melanocortin (MC) receptors are characterized by intron-less architecture. However, recently a few exceptions have been reported in some fishes. This warrants a systematic survey of MC receptors for understanding intron insertion events during vertebrate evolution. Methodology/Principal Findings: We have compiled an extended list of MC receptors from different vertebrate genomes with variations in fishes. Notably, the closely linked MC2Rs and MC5Rs from a group of ray-finned fishes have three and one intron insertion(s), respectively, with conserved positions and intron phase. In both genes, one novel insertion was in the highly conserved DRY motif at the end of helix TM3. Further, the proto-splice site MAG up arrow R is maintained at intron insertion sites in these two genes. However, the orthologs of these receptors from zebrafish and tetrapods are intron-less, suggesting these introns are simultaneously created in selected fishes. Surprisingly, these novel introns are traceable only in four fish genomes. We found that these fish genomes are severely compacted after the separation from zebrafish. Furthermore, we also report novel intron insertions in P2Y receptors and in CHRM3. Finally, we report ultrasmall introns in MC2R genes from selected fishes. Conclusions/Significance: The current repository of MC receptors illustrates that fishes have no MC3R ortholog. MC2R, MC5R, P2Y receptors and CHRM3 have novel intron insertions only in ray-finned fishes that underwent genome compaction. These receptors share one intron at an identical position suggestive of being inserted contemporaneously. In addition to repetitive elements, genome compaction is now believed to be a new hallmark that promotes intron insertions, as it requires rapid DNA breakage and subsequent repair processes to gain back normal functionality.	[Kumar, Abhishek; Grapputo, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Abhishek] Univ Kiel, Inst Bot, Abt Bot Genet & Mol Biol, D-2300 Kiel, Germany; [Kumar, Abhishek] Univ Kiel, Bot Garten, Kiel, Germany; [Bhandari, Anita] Int Grad Sch IHI Zittau, Zittau, Germany; [Sinha, Rahul] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Goyal, Pankaj] Univ Greifswald, Univ Klinikum, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Greifswald, Germany	University of Padua; University of Kiel; University of Kiel; Technische Universitat Dresden; Cold Spring Harbor Laboratory; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kumar, A (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	abhishek.abhishekkumar@gmail.com	Grapputo, Alessandro/AAR-1252-2020; Kumar, Abhishek/A-8727-2012; Goyal, Pankaj/C-3567-2012	Grapputo, Alessandro/0000-0001-9255-4294; Kumar, Abhishek/0000-0003-4172-4059; 				Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Baron A, 2009, GEN COMP ENDOCR, V161, P13, DOI 10.1016/j.ygcen.2008.11.026; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bjenning Christina, 2004, Curr Opin Investig Drugs, V5, P1051; Bryson-Richardson RJ, 2004, GENE, V338, P15, DOI 10.1016/j.gene.2004.05.001; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; CRICK F, 1979, SCIENCE, V204, P264, DOI 10.1126/science.373120; CRICK FHC, 1978, EUR J BIOCHEM, V83, P1, DOI 10.1111/j.1432-1033.1978.tb12061.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farlow A, 2011, TRENDS GENET, V27, P1, DOI 10.1016/j.tig.2010.10.004; FIGUEROA F, 1995, P ROY SOC B-BIOL SCI, V259, P325, DOI 10.1098/rspb.1995.0048; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Force A, 1999, GENETICS, V151, P1531; Fridmanis D, 2007, MOL PHYLOGENET EVOL, V43, P864, DOI 10.1016/j.ympev.2006.11.007; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Genome 10K Community of Scientists, 2009, J Hered, V100, P659, DOI 10.1093/jhered/esp086; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GIROUX MJ, 1994, P NATL ACAD SCI USA, V91, P12150, DOI 10.1073/pnas.91.25.12150; Gregory TR, 2008, ANIMAL GENOME SIZE D; Haitina T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-101; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Iwamoto M, 1998, THEOR APPL GENET, V97, P9, DOI 10.1007/s001220050861; Iwamoto M, 1999, THEOR APPL GENET, V98, P853, DOI 10.1007/s001220051144; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kask A, 1998, BIOCHEM BIOPH RES CO, V248, P245, DOI 10.1006/bbrc.1998.8961; Klovins J, 2004, EUR J BIOCHEM, V271, P4320, DOI 10.1111/j.1432-1033.2004.04374.x; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-250; Logan DW, 2003, GENOMICS, V81, P184, DOI 10.1016/S0888-7543(02)00037-x; Logsdon JM, 1998, CURR OPIN GENET DEV, V8, P637, DOI 10.1016/S0959-437X(98)80031-2; Loh YH, 2008, MOL BIOL EVOL, V25, P526, DOI 10.1093/molbev/msm278; Losos J, 2005, PROPOSAL SEQUENCE 1; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; MARKS D, 2004, RECENT PROG HORM RES, V56, P359; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Moriyama S, 2008, ZOOL SCI, V25, P604, DOI 10.2108/zsj.25.604; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ogino K, 2010, GENE, V449, P70, DOI 10.1016/j.gene.2009.09.002; Ohno S., 1970, P1; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Ragg H, 2011, CELL MOL LIFE SCI, V68, P235, DOI 10.1007/s00018-010-0532-2; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rees JL, 1999, ANN NY ACAD SCI, V885, P134; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Ringholm A, 2002, J NEUROCHEM, V82, P6, DOI 10.1046/j.1471-4159.2002.00934.x; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; ROGERS JH, 1989, TRENDS GENET, V5, P213, DOI 10.1016/0168-9525(89)90084-X; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-251; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Schioth HB, 2001, VITAM HORM, V63, P195, DOI 10.1016/S0083-6729(01)63007-3; Schioth HB, 2005, ANN NY ACAD SCI, V1040, P460, DOI 10.1196/annals.1327.090; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Schioth HB, 2003, GENOMICS, V81, P504, DOI 10.1016/S0888-7543(03)00028-4; Schioth HB, 1996, LIFE SCI, V59, P797, DOI 10.1016/0024-3205(96)00370-0; Selz Y, 2007, GENE, V401, P114, DOI 10.1016/j.gene.2007.07.005; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Slamovits CH, 2009, MOL BIOL EVOL, V26, P1699, DOI 10.1093/molbev/msp081; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tordai H, 2004, FEBS LETT, V575, P109, DOI 10.1016/j.febslet.2004.08.045; TSUJIMOTO Y, 1979, CELL, V18, P591, DOI 10.1016/0092-8674(79)90075-8; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VASTERMARK A, 2011, EUR J PHARM; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wolfsberg Tyra G, 2010, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0105s29; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	112	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22046	10.1371/journal.pone.0022046	http://dx.doi.org/10.1371/journal.pone.0022046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850219	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000293563300003
J	Martel, CJM; Agger, EM; Poulsen, JJ; Jensen, TH; Andresen, L; Christensen, D; Nielsen, LP; Blixenkrone-Moller, M; Andersen, P; Aasted, B				Martel, Cyril Jean-Marie; Agger, Else Marie; Poulsen, Julie Juul; Jensen, Trine Hammer; Andresen, Lars; Christensen, Dennis; Nielsen, Lars Peter; Blixenkrone-Moller, Merete; Andersen, Peter; Aasted, Bent			CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS-INFECTION; MONOCLONAL-ANTIBODIES; PROTECTION; LIPOSOMES; ADJUVANT; DIMETHYLDIOCTADECYLAMMONIUM; LYMPHOCYTES; ACTIVATION; CHALLENGE	Trivalent inactivated vaccines (TIV) against influenza are given to 350 million people every year. Most of these are non-adjuvanted vaccines whose immunogenicity and protective efficacy are considered suboptimal. Commercially available non-adjuvanted TIV are known to elicit mainly a humoral immune response, whereas the induction of cell-mediated immune responses is negligible. Recently, a cationic liposomal adjuvant (dimethyldioctadecylammonium/trehalose 6,6'-dibehenate, CAF01) was developed. CAF01 has proven to enhance both humoral and cell-mediated immune responses to a number of different experimental vaccine candidates. In this study, we compared the immune responses in ferrets to a commercially available TIV with the responses to the same vaccine mixed with the CAF01 adjuvant. Two recently circulating H1N1 viruses were used as challenge to test the vaccine efficacy. CAF01 improved the immunogenicity of the vaccine, with increased influenza-specific IgA and IgG levels. Additionally, CAF01 promoted cellular-mediated immunity as indicated by interferon-gamma expressing lymphocytes, measured by flow cytometry. CAF01 also enhanced the protection conferred by the vaccine by reducing the viral load measured in nasal washes by RT-PCR. Finally, CAF01 allowed for dose-reduction and led to higher levels of protection compared to TIV adjuvanted with a squalene emulsion. The data obtained in this human-relevant challenge model supports the potential of CAF01 in future influenza vaccines.	[Martel, Cyril Jean-Marie; Poulsen, Julie Juul; Jensen, Trine Hammer; Andresen, Lars; Blixenkrone-Moller, Merete; Aasted, Bent] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark; [Agger, Else Marie; Christensen, Dennis; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Natl Influenza Lab, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut; Statens Serum Institut	Martel, CJM (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark.	PA@ssi.dk; bas@life.ku.dk	Andresen, Lars/K-1287-2012; Christensen, Dennis/C-6378-2008; Andresen, Lars/O-2271-2019	Christensen, Dennis/0000-0003-2382-8639; Andresen, Lars/0000-0002-6362-7973; Andersen, Peter/0000-0002-5869-2551	Danish Graduate School of Immunology; Danish National Advanced Technology Foundation; FluSecure; European Commission DG SANCO [2005207]; Danish Fur Breeders' Association	Danish Graduate School of Immunology; Danish National Advanced Technology Foundation; FluSecure; European Commission DG SANCO(European CommissionEuropean Commission Joint Research Centre); Danish Fur Breeders' Association	This work has been financially supported by the Danish Graduate School of Immunology, the Danish National Advanced Technology Foundation and FluSecure. FluSecure has been made possible by contributions from the European Commission DG SANCO (Contract no. 2005207) and the 10 participating members. BA has been supported by a grant from the Danish Fur Breeders' Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasted B, 2007, VET IMMUNOL IMMUNOP, V119, P27, DOI 10.1016/j.vetimm.2007.06.025; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; [Anonymous], 2005, HHS PAND INFL PLAN; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; COATES DM, 1986, J GEN VIROL, V67, P419, DOI 10.1099/0022-1317-67-3-419; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Ellebedy AH, 2010, CLIN VACCINE IMMUNOL, V17, P1998, DOI 10.1128/CVI.00247-10; *EUR MED AG, 2009, PREP EUR PUBL ASS RE, P11601; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Guo HL, 2011, J LEUKOCYTE BIOL, V89, P189, DOI 10.1189/jlb.0610319; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hehme N, 2004, VIRUS RES, V103, P163, DOI 10.1016/j.virusres.2004.02.029; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Jones T, 2009, CURR OPIN MOL THER, V11, P337; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; KORSMAN S, 2006, VACCINES, P11601; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Launay O, 2008, VACCINE, V26, P4073, DOI 10.1016/j.vaccine.2008.05.035; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Long BR, 2008, CLIN VACCINE IMMUNOL, V15, P120, DOI 10.1128/CVI.00357-07; Mann JFS, 2009, EXPERT REV VACCINES, V8, P103, DOI 10.1586/14760584.8.1.103; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Martel CJM, 2009, VET IMMUNOL IMMUNOP, V132, P109, DOI 10.1016/j.vetimm.2009.05.011; Mukherjee S, 2002, J LEUKOCYTE BIOL, V72, P921; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Orenstein WA, 2008, AM J MED, V121, pS22, DOI 10.1016/j.amjmed.2008.05.004; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; PILLET S, 2011, VACCINE IN PRESS, P11601; Pinnamaneni S, 2003, PHARMAZIE, V58, P554; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Sant AJ, 2007, EXPERT REV VACCINES, V6, P357, DOI 10.1586/14760584.6.3.357; STEBBING N, 1982, J VIROL METHODS, V5, P343, DOI 10.1016/0166-0934(82)90026-X; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Tambyah PA, 2008, RESPIROLOGY, V13, pS41, DOI 10.1111/j.1440-1843.2008.01257.x; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; *WHO, 2002, RESP CDSA, P11601; Wood JM, 2002, VACCINE, V20, pB40, DOI 10.1016/S0264-410X(02)00509-1	51	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22891	10.1371/journal.pone.0022891	http://dx.doi.org/10.1371/journal.pone.0022891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850242	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300027
J	Zhang, JE; Luo, A; Xin, HP; Zhao, J; Li, SS; Qu, LH; Ma, LG; Scholten, S; Sun, MX				Zhang, Jun-E; Luo, An; Xin, Hai-Ping; Zhao, Jing; Li, Shi-Sheng; Qu, Liang-Huan; Ma, Li-Gang; Scholten, Stefan; Sun, Meng-Xiang			Genes of Both Parental Origins Are Differentially Involved in Early Embryogenesis of a Tobacco Interspecies Hybrid	PLOS ONE			English	Article							TO-ZYGOTIC TRANSITION; SEED DEVELOPMENT; ARABIDOPSIS; EMBRYO; CHROMATIN; MAIZE	Background: In animals, early embryonic development is largely dependent on maternal transcripts synthesized during gametogenesis. However, in higher plants, the extent of maternal control over zygote development and early embryogenesis is not fully understood yet. Nothing is known about the activity of the parental genomes during seed formation of interspecies hybrids. Methodology/Principal Findings: Here, we report that an interspecies hybridization system between SR1 (Nicotiana tabacum) and Hamayan (N. rustica) has been successfully established. Based on the system we selected 58 genes that have polymorphic sites between SR1 and Hamayan, and analyzed the allele-specific expression of 28 genes in their hybrid zygotes (Hamayan x SR1). Finally the allele-specific expressions of 8 genes in hybrid zygotes were repeatedly confirmed. Among them, 4 genes were of paternal origin, 1 gene was of maternal origin and 3 genes were of biparental origin. These results revealed obvious biparental involvement and differentially contribution of parental-origin genes to zygote development in the interspecies hybrid. We further detected the expression pattern of the genes at 8-celled embryo stage found that the involvement of the parental-origin genes may change at different stages of embryogenesis. Conclusions/Significance: We reveal that genes of both parental origins are differentially involved in early embryogenesis of a tobacco interspecies hybrid and functions in a developmental stage-dependent manner. This finding may open a window to seek for the possible molecular mechanism of hybrid vigor.	[Zhang, Jun-E; Luo, An; Xin, Hai-Ping; Zhao, Jing; Li, Shi-Sheng; Qu, Liang-Huan; Ma, Li-Gang; Sun, Meng-Xiang] Wuhan Univ, Key Lab, Minist Educ Plant Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China; [Zhang, Jun-E] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Peoples R China; [Scholten, Stefan] Univ Hamburg, Bioctr Klein Flottbek Dev Biol & Biotechnol, Hamburg, Germany	Wuhan University; Jiangxi Normal University; University of Hamburg	Zhang, JE (corresponding author), Wuhan Univ, Key Lab, Minist Educ Plant Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn	Ma, Ligang/O-9603-2014	Ma, Ligang/0000-0003-3451-5291	"973" project [2007CB108700]; National Natural Science Foundation of China [30821064, 31070284]; "111" project	"973" project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" project(Ministry of Education, China - 111 Project)	The work was financially supported by "973" project (2007CB108700), the National Natural Science Foundation of China (30821064; 31070284) and "111" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroux C, 2001, FEBS LETT, V509, P11, DOI 10.1016/S0014-5793(01)03097-6; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; DAPHNE A, 2011, CELL, V145, P707; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Fu ChunMei, 1996, Acta Botanica Sinica, V38, P262; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; He Yu-Chi, 2006, Wuhan Zhiwuxue Yanjiu, V24, P6; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Newman-Smith ED, 1998, CURR OPIN GENET DEV, V8, P472, DOI 10.1016/S0959-437X(98)80120-2; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Scholten S, 2002, PLANT J, V32, P221, DOI 10.1046/j.1365-313X.2002.01418.x; Sun Meng-Xiang, 1993, Acta Botanica Sinica, V35, P893; Sun MX, 2000, SEX PLANT REPROD, V12, P267; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Xin HP, 2011, SEX PLANT REPROD, V24, P37, DOI 10.1007/s00497-010-0151-y; Zhao J, 2011, PLANT J, V65, P131, DOI 10.1111/j.1365-313X.2010.04403.x	20	6	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23153	10.1371/journal.pone.0023153	http://dx.doi.org/10.1371/journal.pone.0023153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829711	gold, Green Submitted, Green Published			2022-12-25	WOS:000293561200052
J	Pankratz, N; Dumitriu, A; Hetrick, KN; Sun, M; Latourelle, JC; Wilk, JB; Halter, C; Doheny, KF; Gusella, JF; Nichols, WC; Myers, RH; Foroud, T; DeStefano, AL				Pankratz, Nathan; Dumitriu, Alexandra; Hetrick, Kurt N.; Sun, Mei; Latourelle, Jeanne C.; Wilk, Jemma B.; Halter, Cheryl; Doheny, Kimberly F.; Gusella, James F.; Nichols, William C.; Myers, Richard H.; Foroud, Tatiana; DeStefano, Anita L.			Copy Number Variation in Familial Parkinson Disease	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; MUTATIONS; ASSOCIATION; VARIANTS; ONSET; GENES; RARE; HETEROZYGOSITY; LINKAGE; SAMPLE	Copy number variants (CNVs) are known to cause Mendelian forms of Parkinson disease (PD), most notably in SNCA and PARK2. PARK2 has a recessive mode of inheritance; however, recent evidence demonstrates that a single CNV in PARK2 (but not a single missense mutation) may increase risk for PD. We recently performed a genome-wide association study for PD that excluded individuals known to have either a LRRK2 mutation or two PARK2 mutations. Data from the Illumina370Duo arrays were re-clustered using only white individuals with high quality intensity data, and CNV calls were made using two algorithms, PennCNV and QuantiSNP. After quality assessment, the final sample included 816 cases and 856 controls. Results varied between the two CNV calling algorithms for many regions, including the PARK2 locus (genome-wide p = 0.04 for PennCNV and p = 0.13 for QuantiSNP). However, there was consistent evidence with both algorithms for two novel genes, USP32 and DOCK5 (empirical, genome-wide p-values<0.001). PARK2 CNVs tended to be larger, and all instances that were molecularly tested were validated. In contrast, the CNVs in both novel loci were smaller and failed to replicate using real-time PCR, MLPA, and gel electrophoresis. The DOCK5 variation is more akin to a VNTR than a typical CNV and the association is likely caused by artifact due to DNA source. DNA for all the cases was derived from whole blood, while the DNA for all controls was derived from lymphoblast cell lines. The USP32 locus contains many SNPs with low minor allele frequency leading to a loss of heterozygosity that may have been spuriously interpreted by the CNV calling algorithms as support for a deletion. Thus, only the CNVs within the PARK2 locus could be molecularly validated and associated with PD susceptibility.	[Pankratz, Nathan; Halter, Cheryl; Foroud, Tatiana] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Dumitriu, Alexandra; Latourelle, Jeanne C.; Wilk, Jemma B.; Myers, Richard H.; DeStefano, Anita L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hetrick, Kurt N.; Doheny, Kimberly F.] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA; [Sun, Mei; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Sun, Mei] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Nichols, William C.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH USA; [Nichols, William C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [DeStefano, Anita L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Indiana University System; Indiana University Bloomington; Boston University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Boston University	Pankratz, N (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA.	npankrat@iupui.edu	Pillay, Nischalan/F-9536-2012; Sander-Effron, Samuel/AAX-2231-2020; Litvan, Irene/X-9319-2018; Resource Center, NINDS Human Genetics/AGF-2474-2022; Goldwurm, Stefano/Q-8978-2016	Litvan, Irene/0000-0002-3485-3445; Goldwurm, Stefano/0000-0002-1651-567X; Pankratz, Nathan/0000-0001-5958-693X; Dumitriu, Alexandra/0000-0002-4467-4803; Latourelle, Jeanne/0000-0002-4218-9572; Nagle, Michael/0000-0002-4677-7582; Myers, Richard/0000-0002-8365-2674; DeStefano, Anita/0000-0002-9335-2819; Walker, Francis/0000-0002-7817-9421; Chinnery, Patrick/0000-0002-7065-6617	Robert P. & Judith N. Goldberg Foundation; Bumpus Foundation; Harvard NeuroDiscovery Center; Italian Telethon [GTB07001]; Fondazione Grigioni per il Morbo di Parkinson; National Institutes of Health [HHSN268200782096C];  [R01 NS37167];  [R01 NS036711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037167, R01NS036711] Funding Source: NIH RePORTER	Robert P. & Judith N. Goldberg Foundation; Bumpus Foundation; Harvard NeuroDiscovery Center; Italian Telethon(Fondazione Telethon); Fondazione Grigioni per il Morbo di Parkinson; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by R01 NS37167, R01 NS036711, the Robert P. & Judith N. Goldberg Foundation, the Bumpus Foundation and the Harvard NeuroDiscovery Center. This study used samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data. DNA samples contributed by the Parkinson Institute - Istituti Clinici di Perfezionamento, Milan, Italy were from the "Human genetic bank of patients affected by PD and parkinsonisms", supported by Italian Telethon grant n. GTB07001 and by the "Fondazione Grigioni per il Morbo di Parkinson". Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Karamohamed S, 2005, MOVEMENT DISORD, V20, P1188, DOI 10.1002/mds.20515; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nichols WC, 2007, NEUROLOGY, V69, P1737, DOI 10.1212/01.wnl.0000278115.50741.4e; Nichols WC, 2004, MOVEMENT DISORD, V19, P649, DOI 10.1002/mds.20097; Pankratz N, 2009, NEUROLOGY, V73, P279, DOI 10.1212/WNL.0b013e3181af7a33; Pankratz N, 2007, GENET MED, V9, P801, DOI 10.1097/GIM.0b013e31815bf97c; Pankratz N, 2006, MOVEMENT DISORD, V21, P2257, DOI 10.1002/mds.21162; Pankratz N, 2006, NEUROSCI LETT, V408, P209, DOI 10.1016/j.neulet.2006.09.003; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sun M, 2006, ARCH NEUROL-CHICAGO, V63, P826, DOI 10.1001/archneur.63.6.826; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	25	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e20988	10.1371/journal.pone.0020988	http://dx.doi.org/10.1371/journal.pone.0020988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829596	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511900001
J	Kido, T; Ou, JHJ; Lau, YFC				Kido, Tatsuo; Ou, Jing-Hsiung James; Lau, Yun-Fai Chris			The X-Linked Tumor Suppressor TSPX Interacts and Promotes Degradation of the Hepatitis B Viral Protein HBx via the Proteasome Pathway	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; LIVER-CANCER; Y-CHROMOSOME; VIRUS; GENE; GONADOBLASTOMA; EXPRESSION; UBIQUITIN; HEPATOCARCINOGENESIS	Hepatitis B virus (HBV) infection is a major risk for hepatocellular carcinoma (HCC), and it is a serious global health problem with two billion people exposed to it worldwide. HBx, an essential factor for viral replication and a putative oncoprotein encoded by the HBV genome, has been shown to promote oncogenic properties at multiple sites in HBV-infected liver cells. The expression level of HBx closely associates with the development and progression of HCC, therefore the mechanism(s) regulating the stability of HBx is important in oncogenesis of HBV-infected cells. We demonstrate that the X-linked tumor suppressor TSPX enhances the degradation of HBx through the ubiquitin-proteasome pathway. TSPX interacts with both HBx and a proteasome 19S lid subunit RPN3 via its C-terminal acidic tail. Most importantly, over-expression of RPN3 protects HBx from, and hence acts as a negative regulator for, proteasome-dependent degradation. TSPX abrogates the RPN3-depedent stabilization of HBx, suggesting that TSPX and RPN3 act competitively in regulation of HBx stability. Since mutation and/or epigenetic repression of X-located tumor suppressor gene(s) could significantly predispose males to human cancers, our data suggest that TSPX-induced HBx degradation could play key role(s) in hepatocarcinogenesis among HBV-infected HCC patients.	[Kido, Tatsuo; Lau, Yun-Fai Chris] Univ Calif San Francisco, Vet Affairs Med Ctr, Div Cell & Dev Genet, Dept Med, San Francisco, CA 94143 USA; [Ou, Jing-Hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Southern California	Kido, T (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Div Cell & Dev Genet, Dept Med, San Francisco, CA 94143 USA.	Chris.Lau@UCSF.edu	Lau, Yun-Fai C/E-4465-2014; Kido, Tatsuo/ABH-9865-2020	Lau, Yun-Fai C/0000-0002-9119-7050; Kido, Tatsuo/0000-0002-5340-5517	National Cancer Institute of the National Institutes of Health; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R21CA152589] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000865] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by a grant from the National Cancer Institute of the National Institutes of Health and a merit-reviewed grant from the Department of Veterans Affairs to Y-FCL. Y-FCL is a Research Career Scientist of the US Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Hwang GY, 2003, J CLIN MICROBIOL, V41, P5598, DOI 10.1128/JCM.41.12.5598-5603.2003; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim JH, 2008, BIOCHEM BIOPH RES CO, V366, P1036, DOI 10.1016/j.bbrc.2007.12.070; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lee CM, 1999, CANCER, V86, P1143, DOI 10.1002/(SICI)1097-0142(19991001)86:7&lt;1143::AID-CNCR7&gt;3.0.CO;2-Z; Li J, 2002, J VIROL, V76, P5875, DOI 10.1128/JVI.76.12.5875-5881.2002; Li Y, 2008, ONCOGENE, V27, P6141, DOI 10.1038/onc.2008.206; Liu Y, 2010, TRENDS GENET, V26, P260, DOI 10.1016/j.tig.2010.03.004; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Ozbun LL, 2005, BBA-GENE STRUCT EXPR, V1728, P163, DOI 10.1016/j.bbaexp.2005.02.010; PAGE DC, 1987, DEVELOPMENT, V101, P151; Park SG, 2009, CANCER LETT, V282, P229, DOI 10.1016/j.canlet.2009.03.019; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; SALO P, 1995, GENE CHROMOSOME CANC, V14, P210, DOI 10.1002/gcc.2870140309; SCULLY RE, 1970, CANCER, V25, P1340, DOI 10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Wei SJ, 2008, J MOL BIOL, V383, P693, DOI 10.1016/j.jmb.2008.08.044; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; XIAN L, 2009, MOL BIOL REP; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716	41	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22979	10.1371/journal.pone.0022979	http://dx.doi.org/10.1371/journal.pone.0022979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829568	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500061
J	Mencarelli, A; Distrutti, E; Renga, B; D'Amore, C; Cipriani, S; Palladino, G; Donini, A; Ricci, P; Fiorucci, S				Mencarelli, Andrea; Distrutti, Eleonora; Renga, Barbara; D'Amore, Claudio; Cipriani, Sabrina; Palladino, Giuseppe; Donini, Annibale; Ricci, Patrizia; Fiorucci, Stefano			Probiotics Modulate Intestinal Expression of Nuclear Receptor and Provide Counter-Regulatory Signals to Inflammation-Driven Adipose Tissue Activation	PLOS ONE			English	Article							CROHNS-DISEASE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; LIPID-METABOLISM; INNATE IMMUNITY; BOWEL-DISEASE; PLASMA LEPTIN; CREEPING FAT; GERM-FREE; VSLNUMBER-3	Background: Adipocytes from mesenteric white adipose tissue amplify the inflammatory response and participate in inflammation-driven immune dysfunction in Crohn's disease by releasing proinflammatory mediators. Peroxisome proliferator-activated receptors (PPAR)-alpha and -gamma, pregnane x receptor (PXR), farnesoid x receptor (FXR) and liver x-receptor (LXR) are ligand-activated nuclear receptor that provide counter-regulatory signals to dysregulated immunity and modulates adipose tissue. Aims: To investigate the expression and function of nuclear receptors in intestinal and adipose tissues in a rodent model of colitis and mesenteric fat from Crohn's patients and to investigate their modulation by probiotics. Methods: Colitis was induced by TNBS administration. Mice were administered vehicle or VSL#3, daily for 10 days. Abdominal fat explants obtained at surgery from five Crohn's disease patients and five patients with colon cancer were cultured with VSL#3 medium. Results: Probiotic administration attenuated development of signs and symptoms of colitis, reduced colonic expression of TNF alpha, IL-6 and IFN gamma and reserved colonic downregulation of PPAR gamma, PXR and FXR caused by TNBS. Mesenteric fat depots isolated from TNBS-treated animals had increased expression of inflammatory mediators along with PPAR gamma, FXR, leptin and adiponectin. These changes were prevented by VSL#3. Creeping fat and mesenteric adipose tissue from Crohn's patients showed a differential expression of PPAR gamma and FXR with both tissue expressing high levels of leptin. Exposure of these tissues to VSL#3 medium abrogates leptin release. Conclusions: Mesenteric adipose tissue from rodent colitis and Crohn's disease is metabolically active and shows inflammation-driven regulation of PPAR gamma, FXR and leptin. Probiotics correct the inflammation-driven metabolic dysfunction.	[Mencarelli, Andrea; Renga, Barbara; D'Amore, Claudio; Cipriani, Sabrina; Palladino, Giuseppe; Fiorucci, Stefano] Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Distrutti, Eleonora] Osped S Maria Misericordia, Azienda Osped Perugia, Perugia, Italy; [Donini, Annibale; Ricci, Patrizia] Nuova Fac Med & Chirurg St Andrea delle Fratte, Dipartimento Sci Chirurg Radiol & Odontostomatol, Perugia, Italy	University of Perugia; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Mencarelli, A (corresponding author), Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, Via Gerardo Dottori 1 S Andrea delle Fratte, I-06100 Perugia, Italy.	fiorucci@unipg.it	Palladino, Giuseppe/GOP-0198-2022; Fiorucci, Stefano/I-1251-2012; Donini, Annibale/G-2522-2011	D'Amore, Claudio/0000-0001-9217-9404; Donini, Annibale/0000-0002-8846-7208				Abdelkarim M, 2010, J BIOL CHEM, V285, P36759, DOI 10.1074/jbc.M110.166231; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Ballinger A, 1998, CLIN SCI, V94, P479, DOI 10.1042/cs0940479; Borley NR, 2000, J PATHOL, V190, P196; Boss O, 2006, EXPERT OPIN THER TAR, V10, P119, DOI 10.1517/14728222.10.1.119; Brun RP, 1997, CURR OPIN LIPIDOL, V8, P212, DOI 10.1097/00041433-199708000-00004; Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chapman TM, 2006, DRUGS, V66, P1371, DOI 10.2165/00003495-200666100-00006; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; EINARSSON K, 1977, P SOC EXP BIOL MED, V154, P319; EINARSSON K, 1973, J BIOL CHEM, V248, P3623; FAZIO VW, 1987, SURG INFLAMMATORY BO, P147; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Fiorucci S, 2010, CURR MOL MED, V10, P579; Gaudier E, 2005, J NUTR, V135, P2753; GUSTAFSSON BE, 1977, J LIPID RES, V18, P717; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Karagiannides L, 2006, P NATL ACAD SCI USA, V103, P5207, DOI 10.1073/pnas.0600821103; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lam Brian, 2010, Therap Adv Gastroenterol, V3, P121, DOI 10.1177/1756283X09359964; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; Schaffler A, 2005, GUT, V54, P742, DOI 10.1136/gut.2004.061531; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; SHEEHAN AL, 1992, BRIT J SURG, V79, P955, DOI 10.1002/bjs.1800790934; SMEDH K, 1993, BRIT J SURG, V80, P897, DOI 10.1002/bjs.1800800732; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; von der Weid PY, 2010, ALIMENT PHARM THER, V32, P697, DOI 10.1111/j.1365-2036.2010.04407.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2003, GASTROENTEROLOGY, V124, P1538, DOI 10.1016/S0016-5085(03)00345-7; Yoshinari K, 2004, J PHARMACOL EXP THER, V311, P147, DOI 10.1124/jpet.104.067066	47	66	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22978	10.1371/journal.pone.0022978	http://dx.doi.org/10.1371/journal.pone.0022978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829567	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500060
J	ten Brink, DJ; Bruun, HH				ten Brink, Dirk-Jan; Bruun, Hans Henrik			Seedling Stage Strategies as a Means of Habitat Specialization in Herbaceous Plants	PLOS ONE			English	Article							BIOMASS ALLOCATION; SHADE; RESPONSES; DROUGHT; COMMUNITIES; DIVERGENCE; PLASTICITY; EVOLUTION; DENSITY; SUN	The regeneration niche has been little investigated in studies of community assembly and plant distribution. We examined adaptive associations between seedling traits and habitat specialization. Two habitat contrasts were investigated across several evolutionary lineages of angiosperms: species specialized to forest vs. open habitats and to dry vs. wet habitats. We also tested whether effects of shade and drought vary independently or, alternatively, if shade may amplify effects on drought-stressed plants. Seedling response in terms of growth rate, height, slenderness, specific leaf area (SLA) and degree of elongation (longest internode; petiole or leaf-sheath depending on species' morphology) to light and watering treatments was assessed. We used a factorial design involving three light regimes and two watering frequencies. The open-shaded habitat contrast and the dry-wet habitat contrast were investigated using six and five pairs of congeneric species, respectively. The congeneric species pair design controlled for confounding effects of evolutionary history prior to divergence in habitat specialization. Seedling growth rate generally decreased with shade and reduced watering frequency. Plant height was generally largest at intermediate light. Specialization to shaded habitats was associated with a more conservative growth strategy, i.e. showing a more modest growth response to increasing light. Species from all habitats showed the highest relative elongation at intermediate light, except for the moist-habitat species, for which elongation increased with shade. Contrary to our expectations, species from dry habitats grew bigger than species from moist habitats in all treatments. SLA responded to the light treatment, but not to watering regime. The contrasting light and moisture conditions across habitats appear to not have selected for differences in SLA. We conclude that seedling phase strategies of resource allocation in temperate herbs contribute to their habitat specialization. Habitat-specific seedling strategies and trade-offs in response to resource availability and environmental conditions may be important to adaptive specialization.	[ten Brink, Dirk-Jan] Lund Univ, Dept Biol, Biodivers Grp, Lund, Sweden; [Bruun, Hans Henrik] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, Copenhagen, Denmark	Lund University; University of Copenhagen	ten Brink, DJ (corresponding author), Golder Associates Peru, Environm Grp, Lima, Peru.	djtenbrink@gmail.com	Bruun, Hans Henrik/C-4476-2008	Bruun, Hans Henrik/0000-0003-0674-2577	Lund University, Department of Ecology; Danish National Research Foundation	Lund University, Department of Ecology; Danish National Research Foundation(Danmarks Grundforskningsfond)	The study has been funded by Lund University, Department of Ecology. HHB thanks support of the Danish National Research Foundation to the Center for Macroecology, Evolution and Climate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P391; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; Ellenberg H, 1996, VEGETATION MITTELEUR; Ellenberg H, 1991, ZEIGERWERTE PFLANZEN, P1; Facelli Jose M., 2008, P56; Freckleton RP, 2000, FUNCT ECOL, V14, P129, DOI 10.1046/j.1365-2435.2000.00400.x; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Grime J. P., 1981, Plants and the daylight spectrum. [Smith, H. (Editor)], P159; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Haberlandt G, 1884, PHYSL PFLANZENANATOM; Hill M.O., 2004, PLANTATT ATTRIBUTES; Holmgren M, 2000, OIKOS, V90, P67, DOI 10.1034/j.1600-0706.2000.900107.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LIETH H., 1961, CANADIAN JOUR BOT, V39, P1255; Maliakal SK, 1999, INT J PLANT SCI, V160, P723, DOI 10.1086/314157; Moles AT, 2004, OIKOS, V106, P193, DOI 10.1111/j.0030-1299.2004.13101.x; Neufeld Howard S., 2003, P38; Pell, 1991, RESPONSE PLANTS MULT, P35, DOI DOI 10.1016/B978-0-08-092483-0.50007-4; PICKETT STA, 1978, ECOLOGY, V59, P1248, DOI 10.2307/1938238; Pierce S, 2007, J ECOL, V95, P698, DOI 10.1111/j.1365-2745.2007.01242.x; REES M, 1995, J ECOL, V83, P891, DOI 10.2307/2261426; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Schmitt J, 1997, PLANT CELL ENVIRON, V20, P826, DOI 10.1046/j.1365-3040.1997.d01-96.x; Schutz W, 1997, CAN J BOT, V75, P1692, DOI 10.1139/b97-883; Shipley B, 2009, PLANT TRAITS VEGETAT; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; TENBRINK DJ, HABITAT SPECIA UNPUB; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x	43	3	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23006	10.1371/journal.pone.0023006	http://dx.doi.org/10.1371/journal.pone.0023006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829576	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500067
J	Guo, J; Wang, TZ; Yang, TH; Xu, JM; Li, WT; Fridman, MD; Fisher, JT; Zhang, ST				Guo, Jun; Wang, Tingzhong; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Fridman, Michael D.; Fisher, John T.; Zhang, Shetuan			Interaction between the Cardiac Rapidly (I-Kr) and Slowly (I-Ks) Activating Delayed Rectifier Potassium Channels Revealed by Low K+-induced hERG Endocytic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; EXTRACELLULAR K+; CELL-LINES; TRAFFICKING; COMPLEX; REPOLARIZATION; ARRHYTHMIA; CURRENTS; BLOCK; IDENTIFICATION	Cardiac repolarization is controlled by the rapidly (I-Kr) and slowly (I-Ks) activating delayed rectifier potassium channels. The human ether-a-go-go-related gene (hERG) encodes I-Kr, whereas KCNQ1 and KCNE1 together encode I-Ks. Decreases in I-Kr or I-Ks cause long QT syndrome (LQTS), a cardiac disorder with a high risk of sudden death. A reduction in extracellular K+ concentration ([K+](o)) induces LQTS and selectively causes endocytic degradation of mature hERG channels from the plasma membrane. In the present study, we investigated whether I-Ks compensates for the reduced I-Kr under low K+ conditions. Our data show that when hERG and KCNQ1 were expressed separately in human embryonic kidney (HEK) cells, exposure to 0 mM K+ for 6 h completely eliminated the mature hERG channel expression but had no effect on KCNQ1. When hERG and KCNQ1 were co-expressed, KCNQ1 significantly delayed 0 mM K+-induced hERG reduction. Also, hERG degradation led to a significant reduction in KCNQ1 in 0 mM K+ conditions. An interaction between hERG and KCNQ1 was identified in hERG + KCNQ1-expressing HEK cells. Furthermore, KCNQ1 preferentially co-immunoprecipitated with mature hERG channels that are localized in the plasma membrane. Biophysical and pharmacological analyses indicate that although hERG and KCNQ1 closely interact with each other, they form distinct hERG and KCNQ1 channels. These data extend our understanding of delayed rectifier potassium channel trafficking and regulation, as well as the pathology of LQTS.	[Guo, Jun; Wang, Tingzhong; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Fridman, Michael D.; Fisher, John T.; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca	Fisher, John/E-2568-2012	Fisher, John/0000-0001-6185-5940; Wang, Tingzhong/0000-0002-6390-7967; Zhang, Shetuan/0000-0002-2297-0193	Heart and Stroke Foundation of Ontario [T 6612]; Canadian Institutes of Health Research [MOP 72911]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Ontario Grant T 6612 and Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.).	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; Funck-Brentano C, 1993, AM J CARDIOL, V72, p17B; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hayashi K, 2010, HEART RHYTHM, V7, P973, DOI 10.1016/j.hrthm.2010.03.038; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; MATSUURA H, 1987, PFLUG ARCH EUR J PHY, V410, P596, DOI 10.1007/BF00581319; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689; Odening KE, 2008, AM J PHYSIOL-HEART C, V295, pH2264, DOI 10.1152/ajpheart.00680.2008; Osteen JD, 2010, P NATL ACAD SCI USA, V107, P18751, DOI 10.1073/pnas.1014150107; Rajamani S, 2002, CIRCULATION, V105, P2830, DOI 10.1161/01.CIR.0000019513.50928.74; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhang ST, 1999, CIRC RES, V84, P989, DOI 10.1161/01.RES.84.9.989; Zhang ST, 2001, MOL PHARMACOL, V59, P1069, DOI 10.1124/mol.59.5.1069; Zhou ZF, 1999, J CARDIOVASC ELECTR, V10, P836, DOI 10.1111/j.1540-8167.1999.tb00264.x	36	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34664	34674		10.1074/jbc.M111.253351	http://dx.doi.org/10.1074/jbc.M111.253351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844197	Green Published, hybrid			2022-12-25	WOS:000295406300021
J	Appleby-Tagoe, JH; Thiel, IV; Wang, Y; Wang, YF; Mootz, HD; Liu, XQ				Appleby-Tagoe, Julia H.; Thiel, Ilka V.; Wang, Yi; Wang, Yanfei; Mootz, Henning D.; Liu, Xiang-Qin			Highly Efficient and More General cis- and trans-Splicing Inteins through Sequential Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMISYNTHETIC SPLIT INTEIN; PROTEIN LIGATION; IN-VIVO; CRYSTAL-STRUCTURE; MINI-INTEIN; DNAE INTEIN; CYCLIZATION; MODULATION; SELECTION; ELEMENTS	Inteins are internal protein sequences that post-translationally self-excise and splice together the flanking sequences, the so-called exteins. Natural and engineered inteins have been used in many practical applications. However, inteins are often inefficient or inactive when placed in a non-native host protein and may require the presence of several amino acid residues of the native exteins, which will then remain as a potential scar in the spliced protein. Thus, more general inteins that overcome these limitations are highly desirable. Here we report sequential directed evolution as a new approach to produce inteins with such properties. Random mutants of the Ssp (Synechocystis sp. PCC6803) DnaB mini-intein were inserted into the protein conferring kanamycin resistance at a site where the parent intein was inactive for splicing. The mutants selected for splicing activity were further improved by iterating the procedure for two more cycles at different positions in the same protein. The resulting improved inteins showed high activity in the positions of the first rounds of selection, in multiple new insertion sites, and in different proteins. One of these inteins, the M86 mutant, which accumulated 8 amino acid substitutions, was also biochemically characterized in an artificially split form with a chemically synthesized N-terminal intein fragment consisting of 11 amino acids. When compared with the unevolved split intein, it exhibited an similar to 60-fold increased rate in the protein trans-splicing reaction and a K-d value for the interaction of the split intein fragments improved by an order of magnitude. Implications on the intein structure-function, practical application, and evolution are discussed.	[Thiel, Ilka V.; Mootz, Henning D.] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Appleby-Tagoe, Julia H.; Wang, Yi; Wang, Yanfei; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	University of Munster; Dalhousie University	Mootz, HD (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	henning.mootz@uni-muenster.de; Paul.Liu@Dal.Ca			National Science and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research (CIHR); Deutsche Forschungsgemeinschaft (DFG) [MO1073/3-1]; German National Merit Foundation	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German National Merit Foundation	This work was supported by grants from the National Science and Engineering Research Council (NSERC) of Canada, the Canadian Institutes of Health Research (CIHR), the Deutsche Forschungsgemeinschaft (DFG Grant MO1073/3-1), and a Ph.D. stipend from the German National Merit Foundation (to I. V. T.).	Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Binschik J, 2011, ANGEW CHEM INT EDIT, V50, P3249, DOI 10.1002/anie.201007078; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Garbe D, 2010, J PEPT SCI, V16, P575, DOI 10.1002/psc.1243; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Hiraga K, 2009, J MOL BIOL, V393, P1106, DOI 10.1016/j.jmb.2009.08.074; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Sonntag T, 2011, MOL BIOSYST, V7, P2031, DOI 10.1039/c1mb05025g; Sun L, 2001, APPL ENVIRON MICROB, V67, P1025, DOI 10.1128/AEM.67.3.1025-1029.2001; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	42	74	79	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34440	34447		10.1074/jbc.M111.277350	http://dx.doi.org/10.1074/jbc.M111.277350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832069	hybrid, Green Published			2022-12-25	WOS:000295159200071
J	Baskaran, S; Chikwana, VM; Contreras, CJ; Davis, KD; Wilson, WA; DePaoli-Roach, AA; Roach, PJ; Hurley, TD				Baskaran, Sulochanadevi; Chikwana, Vimbai M.; Contreras, Christopher J.; Davis, Keri D.; Wilson, Wayne A.; DePaoli-Roach, Anna A.; Roach, Peter J.; Hurley, Thomas D.			Multiple Glycogen-binding Sites in Eukaryotic Glycogen Synthase Are Required for High Catalytic Efficiency toward Glycogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SUBCELLULAR-LOCALIZATION; LAFORA-DISEASE; DOMAIN; GLUCOSE-6-PHOSPHATE; IDENTIFICATION; ACCUMULATION; PHOSPHATASE	Glycogen synthase is a rate-limiting enzyme in the biosynthesis of glycogen and has an essential role in glucose homeostasis. The three-dimensional structures of yeast glycogen synthase (Gsy2p) complexed with maltooctaose identified four conserved maltodextrin-binding sites distributed across the surface of the enzyme. Site-1 is positioned on the N-terminal domain, site-2 and site-3 are present on the C-terminal domain, and site-4 is located in an interdomain cleft adjacent to the active site. Mutation of these surface sites decreased glycogen binding and catalytic efficiency toward glycogen. Mutations within site-1 and site-2 reduced the V-max/S-0.5 for glycogen by 40- and 70-fold, respectively. Combined mutation of site-1 and site-2 decreased the Vmax/S0.5 for glycogen by> 3000-fold. Consistent with the in vitro data, glycogen accumulation in glycogen synthase-deficient yeast cells (Delta gsy1-gsy2) transformed with the site-1, site-2, combined site-1/site-2, or site-4 mutant form of Gsy2p was decreased by up to 40-fold. In contrast to the glycogen results, the ability to utilize maltooctaose as an in vitro substrate was unaffected in the site-2 mutant, moderately affected in the site-1 mutant, and almost completely abolished in the site-4 mutant. These data show that the ability to utilize maltooctaose as a substrate can be independent of the ability to utilize glycogen. Our data support the hypothesis that site-1 and site-2 provide a "toehold mechanism," keeping glycogen synthase tightly associated with the glycogen particle, whereas site-4 is more closely associated with positioning of the nonreducing end during catalysis.	[Baskaran, Sulochanadevi; Chikwana, Vimbai M.; Contreras, Christopher J.; DePaoli-Roach, Anna A.; Roach, Peter J.; Hurley, Thomas D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Davis, Keri D.; Wilson, Wayne A.] Des Moines Univ, Dept Biochem & Nutr, Des Moines, IA 50312 USA	Indiana University System; Indiana University Bloomington	Hurley, TD (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-4019, Indianapolis, IN 46202 USA.	thurley@iupui.edu		Wilson, Wayne/0000-0003-2417-5756; HURLEY, THOMAS/0000-0002-5942-1163	United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health [R37-DK027221, R01-NS056454, R01-DK079887, R15-GM081810]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079887, T32DK064466, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Martin Schmidt (Des Moines University) for providing the anti-yeast Hsp90 polyclonal antibody. We thank the staff of the General Medical Sciences Cancer Institute Collaborative Access Team at the Advanced Photon Source at the Argonne National Laboratory. The Argonne National Laboratory is operated by the UChicago Argonne, LLC, for the United States Department of Energy Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.; This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK027221 and R01-NS056454 (to P. J. R.), R01-DK079887 (to T. D. H.), and R15-GM081810 (to W. A. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baskaran S, 2010, P NATL ACAD SCI USA, V107, P17563, DOI 10.1073/pnas.1006340107; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Diaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109; FARKAS I, 1991, J BIOL CHEM, V266, P15602; Hanashiro I, 2002, ARCH BIOCHEM BIOPHYS, V397, P286, DOI 10.1006/abbi.2001.2623; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; JOHNSON LN, 1990, J MOL BIOL, V211, P645, DOI 10.1016/0022-2836(90)90271-M; LARNER J, 1976, MOL CELL BIOCHEM, V12, P131, DOI 10.1007/BF01741711; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pederson BA, 2000, J BIOL CHEM, V275, P27753; PENG ZY, 1990, J BIOL CHEM, V265, P13871; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]	30	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33999	34006		10.1074/jbc.M111.264531	http://dx.doi.org/10.1074/jbc.M111.264531			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835915	Green Published, hybrid			2022-12-25	WOS:000295159200032
J	Motani, K; Kushiyama, H; Imamura, R; Kinoshita, T; Nishiuchi, T; Suda, T				Motani, Kou; Kushiyama, Hiroko; Imamura, Ryu; Kinoshita, Takeshi; Nishiuchi, Takumi; Suda, Takashi			Caspase-1 Protein Induces Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain (ASC)mediated Necrosis Independently of Its Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; LISTERIA-MONOCYTOGENES; MONOCYTIC CELLS; CATHEPSIN-B; ASC; INFLAMMASOME; ACTIVATION; ADAPTER; IDENTIFICATION; MACROPHAGES	The adaptor protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), connects pathogen/danger sensors such as NLRP3 and NLRC4 with caspases and is involved in inflammation and cell death. We have found that ASC activation induced caspase-8-dependent apoptosis or CA-074Me (cathepsin B inhibitor)-inhibitable necrosis depending on the cell type. Unlike necroptosis, another necrotic cell death, ASC-mediated necrosis, was neither RIP3-dependent nor necrostatin-1-inhibitable. Although acetyl-YVAD-chloromethylketone (Ac-YVAD-CMK) (caspase-1 inhibitor) did not inhibit ASC-mediated necrosis, comprehensive gene expression analyses indicated that caspase-1 expression coincided with the necrosis type. Furthermore, caspase-1 knockdown converted necrosis-type cells to apoptosis-type cells, whereas exogenous expression of either wild-type or catalytically inactive caspase-1 did the opposite. Knockdown of caspase-1, but not Ac-YVAD-CMK, suppressed the monocyte necrosis induced by Staphylococcus and Pseudomonas infection. Thus, the catalytic activity of caspase-1 is dispensable for necrosis induction. Intriguingly, a short period of caspase-1 knockdown inhibited IL-1 beta production but not necrosis, although longer knockdown suppressed both responses. Possible explanations of this phenomenon are discussed.	[Motani, Kou; Kushiyama, Hiroko; Imamura, Ryu; Kinoshita, Takeshi; Suda, Takashi] Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Nishiuchi, Takumi] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa 9200934, Japan	Kanazawa University; Kanazawa University	Suda, T (corresponding author), Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	sudat@kenroku.kanazawa-u.ac.jp	IMAMURA, Ryu/D-8433-2015; KINOSHITA, Takeshi/D-8436-2015; Nishiuchi, Takumi/F-1708-2013	Nishiuchi, Takumi/0000-0001-9429-5396	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas (cancer) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Averette KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007913; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Conway KE, 2000, CANCER RES, V60, P6236; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Fukui M, 2003, J IMMUNOL, V171, P1868, DOI 10.4049/jimmunol.171.4.1868; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hasegawa M, 2009, J IMMUNOL, V182, P7655, DOI 10.4049/jimmunol.0800448; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	40	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33963	33972		10.1074/jbc.M111.286823	http://dx.doi.org/10.1074/jbc.M111.286823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832064	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000295159200028
J	Spratley, SJ; Bastea, LI; Doppler, H; Mizuno, K; Storz, P				Spratley, Samantha J.; Bastea, Ligia I.; Doeppler, Heike; Mizuno, Kensaku; Storz, Peter			Protein Kinase D Regulates Cofilin Activity through p21-activated Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-MIGRATION; LIM-KINASE; ACTIN REORGANIZATION; PHOSPHATASE SLINGSHOT; LEADING-EDGE; PHOSPHORYLATION; ACTIVATION; INVASION; MOTILITY; DYNAMICS	Dynamic reorganization of the actin cytoskeleton at the leading edge is required for directed cell migration. Cofilin, a small actin-binding protein with F-actin severing activities, is a key enzyme initiating such actin remodeling processes. Cofilin activity is tightly regulated by phosphorylation and dephosphorylation events that are mediated by LIM kinase (LIMK) and the phosphatase slingshot (SSH), respectively. Protein kinase D (PKD) is a serine/threonine kinase that inhibits actin-driven directed cell migration by phosphorylation and inactivation of SSH. Here, we show that PKD can also regulate LIMK through direct phosphorylation and activation of its upstream kinase p21-activated kinase 4 (PAK4). Therefore, active PKD increases the net amount of phosphorylated inactive cofilin in cells through both pathways. The regulation of cofilin activity at multiple levels may explain the inhibitory effects of PKD on barbed end formation as well as on directed cell migration.	[Spratley, Samantha J.; Bastea, Ligia I.; Doeppler, Heike; Storz, Peter] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Mizuno, Kensaku] Tohoku Univ, Dept Biomol Sci, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Mayo Clinic; Tohoku University	Storz, P (corresponding author), Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Griffin Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu	Mizuno, Kensaku/G-8631-2015		National Institutes of Health [GM086438, CA140182]; Florida Department of Health [10BG11]; Ministry of Education, Culture, Science, Sports, and Technology of Japan [21370086, 22121501]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086438 and CA140182 (to P. S.). This work was also supported by Bankhead-Coley Grant 10BG11 from the Florida Department of Health (to P. S.) and by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants 21370086 and 22121501 (to K. M.).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	47	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34254	34261		10.1074/jbc.M111.259424	http://dx.doi.org/10.1074/jbc.M111.259424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832093	hybrid, Green Published			2022-12-25	WOS:000295159200055
J	Huang, XM; Auinger, P; Eberly, S; Oakes, D; Schwarzschild, M; Ascherio, A; Mailman, R; Chen, HL				Huang, Xuemei; Auinger, Peggy; Eberly, Shirley; Oakes, David; Schwarzschild, Michael; Ascherio, Alberto; Mailman, Richard; Chen, Honglei		Parkinson Study Grp DATATOP	Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; INCREASES DOPAMINE RELEASE; RAT NUCLEUS-ACCUMBENS; IN-VITRO; RISK; STATINS; COHORT; DISABILITY; MORPHINE	Background: Recent studies have suggested that higher serum cholesterol may be associated with lower occurrence of Parkinson's disease (PD). This study is to test the hypothesis that higher serum cholesterol correlates with slower PD progression. Methods: Baseline non-fasting serum total cholesterol was measured in 774 of the 800 subjects with early PD enrolled between 1987 and 1988 in the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) trial. Participants were followed for up to two years, with clinical disability requiring levodopa therapy as the primary endpoint. Hazard ratios (HRs) and 95% confidence intervals (CI) were determined for increasing serum cholesterol concentration (in quintiles) for clinical disability requiring levodopa therapy, after adjusting for confounders. At baseline, only nine subjects reported use of cholesterol-lowering agents (two with statins). Results: The overall mean cholesterol level was 216 mg/dL (range 100-355). The HR of progressing to the primary endpoint decreased with increasing serum cholesterol concentrations. Compared to the lowest quintile, the HRs (95% CI), for each higher quintile (in ascending order) are 0.83 (0.59-1.16); 0.86 (0.61-1.20); 0.84 (0.60-1.18); and 0.75 (0.52-1.09). The HR for one standard deviation (SD) increase = 0.90 [(0.80-1.01), p for trend = 0.09]. This trend was found in males (HR per SD = 0.88 [(0.77-1.00), p for trend = 0.05], but not in females [ HR = 1.03 (0.81-1.32)]. Conclusions: This secondary analysis of the DATATOP trial provides preliminary evidence that higher total serum cholesterol concentrations may be associated with a modest slower clinical progression of PD, and this preliminary finding needs confirmation from larger prospective studies.	[Huang, Xuemei; Mailman, Richard] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei; Mailman, Richard] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Auinger, Peggy] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Human Expt Therapeut, Rochester, NY 14642 USA; [Eberly, Shirley; Oakes, David] Univ Rochester, Sch Med & Dent, Dept Biostat, Rochester, NY USA; [Schwarzschild, Michael] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ascherio, Alberto] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ascherio, Alberto] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chen, Honglei] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Huang, XM (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	Xuemei@psu.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Mailman, Richard/0000-0003-1353-2738; Chen, Honglei/0000-0003-3446-7779	Parkinson's Disease Foundation; National Institutes of Health [NS060722]; Pennsylvania Tobacco Settlement Fund; National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060722] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by Parkinson's Disease Foundation, National Institutes of Health (NS060722 to XH), the Pennsylvania Tobacco Settlement Fund, and the intramural research program of the National Institute of Environmental Health Sciences (Z01-ES-101986 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Barrot M, 1999, EUR J NEUROSCI, V11, P3757, DOI 10.1046/j.1460-9568.1999.00816.x; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; de Lau LML, 2006, AM J EPIDEMIOL, V164, P998, DOI 10.1093/aje/kwj283; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee PH, 2009, MOVEMENT DISORD, V24, P752, DOI 10.1002/mds.22459; MAES M, 1994, ACTA PSYCHIAT SCAND, V90, P252, DOI 10.1111/j.1600-0447.1994.tb01589.x; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Miyake Y, 2010, J NEUROL SCI, V293, P82, DOI 10.1016/j.jns.2010.03.002; Rouge-Pont F, 2002, EUR J NEUROSCI, V16, P169, DOI 10.1046/j.1460-9568.2002.02084.x; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Stepien K, 2005, PHARMACOL REP, V57, P561; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; TANNER CM, 2002, PARKINSONS DIS MOVEM, P90; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; VASAN RS, 1992, ARCH INTERN MED, V152, P414, DOI 10.1001/archinte.152.2.414; Weiss R, 2003, CLIN THER, V25, P1490, DOI 10.1016/S0149-2918(03)80134-0; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	34	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22854	10.1371/journal.pone.0022854	http://dx.doi.org/10.1371/journal.pone.0022854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853051	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400015
J	Hayes, S; Boote, C; Kamma-Lorger, CS; Rajan, MS; Harris, J; Dooley, E; Hawksworth, N; Hiller, J; Terill, NJ; Hafezi, F; Brahma, AK; Quantock, AJ; Meek, KM				Hayes, Sally; Boote, Craig; Kamma-Lorger, Christina S.; Rajan, Madhavan S.; Harris, Jonathan; Dooley, Erin; Hawksworth, Nicholas; Hiller, Jennifer; Terill, Nick J.; Hafezi, Farhad; Brahma, Arun K.; Quantock, Andrew J.; Meek, Keith M.			Riboflavin/UVA Collagen Cross-Linking-Induced Changes in Normal and Keratoconus Corneal Stroma	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ULTRAVIOLET-A; RABBIT CORNEA; KERATECTASIA; FIBRILS; SCATTERING; HYDRATION; THERAPY; LASIK	Purpose: To determine the effect of Ultraviolet-A collagen cross-linking with hypo-osmolar and iso-osmolar riboflavin solutions on stromal collagen ultrastructure in normal and keratoconus ex vivo human corneas. Methods: Using small-angle X-ray scattering, measurements of collagen D-periodicity, fibril diameter and interfibrillar spacing were made at 1 mm intervals across six normal post-mortem corneas (two above physiological hydration (swollen) and four below (unswollen)) and two post-transplant keratoconus corneal buttons (one swollen; one unswollen), before and after hypo-osmolar cross-linking. The same parameters were measured in three other unswollen normal corneas before and after iso-osmolar cross-linking and in three pairs of swollen normal corneas, in which only the left was cross-linked (with iso-osmolar riboflavin). Results: Hypo-osmolar cross-linking resulted in an increase in corneal hydration in all corneas. In the keratoconus corneas and unswollen normal corneas, this was accompanied by an increase in collagen interfibrillar spacing (p<0.001); an increase in fibril diameter was also seen in two out of four unswollen normal corneas and one unswollen keratoconus cornea (p<0.001). Iso-osmolar cross-linking resulted in a decrease in tissue hydration in the swollen normal corneas only. Although there was no consistent treatment-induced change in hydration in the unswollen normal samples, iso-osmolar cross-linking of these corneas did result in a compaction of collagen fibrils and a reduced fibril diameter (p<0.001); these changes were not seen in the swollen normal corneas. Collagen D-periodicity was not affected by either treatment. Conclusion: The observed structural changes following Ultraviolet-A cross-linking with hypo-osmolar or iso-osmolar riboflavin solutions are more likely a consequence of treatment-induced changes in tissue hydration rather than cross-linking.	[Hayes, Sally; Boote, Craig; Kamma-Lorger, Christina S.; Harris, Jonathan; Dooley, Erin; Quantock, Andrew J.; Meek, Keith M.] Cardiff Univ, Struct Biophys Res Grp, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Rajan, Madhavan S.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Hawksworth, Nicholas] Royal Glamorgan Hosp, Llantrisant, Rhondda Cynon, England; [Hiller, Jennifer; Terill, Nick J.] Diamond Light Source, Didcot, Oxon, England; [Hafezi, Farhad] Univ Hosp Geneva, Div Ophthalmol, Geneva, Switzerland; [Brahma, Arun K.] Manchester Royal Eye Hosp, Manchester M13 9WH, Lancs, England	Cardiff University; Anglia Ruskin University; Diamond Light Source; University of Geneva; Manchester Royal Eye Hospital	Hayes, S (corresponding author), Cardiff Univ, Struct Biophys Res Grp, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.	meekkm@cf.ac.uk	Hafezi, Farhad/A-1446-2010	Hafezi, Farhad/0000-0001-8935-4558; Hayes, Sally/0000-0001-8550-0108; Bardsley, Jennifer/0000-0001-8714-942X; Boote, Craig/0000-0003-0348-6547; Rajan, Madhavan/0000-0003-2223-5364	Medical Research Council [G0600755]; Science and Technology Facilities Council [SM-194]; Royal Society; MRC [G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a 5-year Medical Research Council Grant number (G0600755) and Science and Technology Facilities Council (SM-194). Keith Meek is a Royal Society-Wolfson Research Merit Award Holder. These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Jennifer Hiller and Nick J. Terill are employees of Diamond Light Source Ltd, where the data for the study was collected. These authors were involved in data collection and provided expertise in the revision of the paper.	BLANCO T, 2008, ARVO M, V49, P3911; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Caporossi A, 2006, J CATARACT REFR SURG, V32, P837, DOI 10.1016/j.jcrs.2006.01.091; CINTRON C, 1978, J ULTRA MOL STRUCT R, V65, P13, DOI 10.1016/S0022-5320(78)90017-5; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; FRATZL P, 1993, BIOPHYS J, V64, P1210, DOI 10.1016/S0006-3495(93)81487-5; FULLWOOD NJ, 1993, J MICROSC-OXFORD, V169, P53, DOI 10.1111/j.1365-2818.1993.tb03277.x; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Hafezi F, 2009, J CATARACT REFR SURG, V35, P621, DOI 10.1016/j.jcrs.2008.10.060; Hayes S, 2008, J CATARACT REFR SURG, V34, P657, DOI 10.1016/j.jcrs.2008.02.002; HEDBYS BO, 1966, EXP EYE RES, V5, P221, DOI 10.1016/S0014-4835(66)80010-6; Huang YF, 1999, BIOPHYS J, V77, P1655, DOI 10.1016/S0006-3495(99)77013-X; KHOLHAAS M, 2006, J CATARACT REFR SURG, V32, P279; Kohlhaas M, 2005, KLIN MONATSBL AUGENH, V222, P430, DOI 10.1055/s-2005-857950; Malik NS, 1996, AGE AGEING, V25, P279, DOI 10.1093/ageing/25.4.279; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MALIK NS, 1992, INVEST OPHTH VIS SCI, V33, P895; MAROUDAS A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P285, DOI 10.1016/0304-4165(91)90133-2; MEEK KM, 1991, BIOPHYS J, V60, P467, DOI 10.1016/S0006-3495(91)82073-2; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; MEEK KM, 2008, ARVO M, V49, P3913; Salgado JP, 2011, BRIT J OPHTHALMOL, V95, P493, DOI 10.1136/bjo.2010.179424; SAYERS Z, 1982, J MOL BIOL, V160, P593, DOI 10.1016/0022-2836(82)90317-5; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, ACTA OPHTHALMOL, V87, P48, DOI 10.1111/j.1755-3768.2008.01190.x; WORTHINGTON CR, 1985, INT J BIOL MACROMOL, V7, P2, DOI 10.1016/0141-8130(85)90057-1	32	39	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22405	10.1371/journal.pone.0022405	http://dx.doi.org/10.1371/journal.pone.0022405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850225	gold, Green Published			2022-12-25	WOS:000293563300009
J	Scholten, A; Koch, KW				Scholten, Alexander; Koch, Karl-Wilhelm			Differential Calcium Signaling by Cone Specific Guanylate Cyclase-Activating Proteins from the Zebrafish Retina	PLOS ONE			English	Article							CA2+; BINDING; CALMODULIN; EXPRESSION; CLONING; DIMERIZATION; TRANSDUCIN; DIVERSITY; RETGC; GCAPS	Zebrafish express in their retina a higher number of guanylate cyclase-activating proteins (zGCAPs) than mammalians pointing to more complex guanylate cyclase signaling systems. All six zGCAP isoforms show distinct and partial overlapping expression profiles in rods and cones. We determined critical Ca2+-dependent parameters of their functional properties using purified zGCAPs after heterologous expression in E.coli. Isoforms 1-4 were strong, 5 and 7 were weak activators of membrane bound guanylate cyclase. They further displayed different Ca2+-sensitivities of guanylate cyclase activation, which is half maximal either at a free Ca2+ around 30 nM (zGCAP1, 2 and 3) or around 400 nM (zGCAP4, 5 and 7). Zebrafish GCAP isoforms showed also differences in their Ca2+/Mg2+-dependent conformational changes and in the Ca2+-dependent monomer-dimer equilibrium. Direct Ca2+-binding revealed that all zGCAPs bound at least three Ca2+. The corresponding apparent affinity constants reflect binding of Ca2+ with high (<= 100 nM), medium (0.1-5 mu M) and/or low (>= 5 mu M) affinity, but were unique for each zGCAP isoform. Our data indicate a Ca2+-sensor system in zebrafish rod and cone cells supporting a Ca2+-relay model of differential zGCAP operation in these cells.	[Scholten, Alexander; Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-2900 Oldenburg, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Ctr Interface Sci, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Scholten, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany.	karl.w.koch@uni-oldenburg.de	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044	Deutsche Forschungsgemeinschaft [KO 948/7-1, KO948/7-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to K-WK (KO 948/7-1, KO948/7-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Behnen P, 2009, J BIOL INORG CHEM, V14, P89, DOI 10.1007/s00775-008-0426-z; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Cilluffo MC, 2004, VISUAL NEUROSCI, V21, P599, DOI 10.1017/S0952523804214092; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BBA-PROTEINS PROTEOM, V1600, P111, DOI 10.1016/S1570-9639(02)00451-X; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Koch Karl-Wilhelm, 2008, P121; KOCH KW, 2006, CALCIUM BINDING PROT, V1, P3; Leung YT, 2007, J PHYSIOL-LONDON, V579, P15, DOI 10.1113/jphysiol.2006.120162; LINSE S, 1991, BIOCHEMISTRY-US, V30, P154, DOI 10.1021/bi00215a023; Linse Sara, 2002, Methods Mol Biol, V173, P15; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P3936, DOI 10.1021/bi9821263; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; PHILIPPOV PP, NEURONAL CALCIUM SEN; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Ratscho N, 2010, MOL CELL BIOCHEM, V334, P207, DOI 10.1007/s11010-009-0320-1; Ratscho N, 2009, BBA-MOL CELL RES, V1793, P1110, DOI 10.1016/j.bbamcr.2008.12.021; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106	47	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23117	10.1371/journal.pone.0023117	http://dx.doi.org/10.1371/journal.pone.0023117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829700	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900026
J	Stevens, D; Gassmann, R; Oegema, K; Desai, A				Stevens, Deanna; Gassmann, Reto; Oegema, Karen; Desai, Arshad			Uncoordinated Loss of Chromatid Cohesion Is a Common Outcome of Extended Metaphase Arrest	PLOS ONE			English	Article							SPINDLE CHECKPOINT; CHROMOSOMAL STABILITY; CENTROSOME INTEGRITY; ANAPHASE; SEPARATION; PROTEIN; KINETOCHORES; MAINTENANCE; INHIBITION; CENTROMERE	Chromosome segregation requires coordinated separation of sister chromatids following biorientation of all chromosomes on the mitotic spindle. Chromatid separation at the metaphase-to-anaphase transition is accomplished by cleavage of the cohesin complex that holds chromatids together. Here we show using live-cell imaging that extending the metaphase bioriented state using five independent perturbations (expression of non-degradable Cyclin B, expression of a Spindly point mutant that prevents spindle checkpoint silencing, depletion of the anaphase inducer Cdc20, treatment with a proteasome inhibitor, or treatment with an inhibitor of the mitotic kinesin CENP-E) leads to eventual scattering of chromosomes on the spindle. This scattering phenotype is characterized by uncoordinated loss of cohesion between some, but not all sister chromatids and subsequent spindle defects that include centriole separation. Cells with scattered chromosomes persist long-term in a mitotic state and eventually die or exit. Partial cohesion loss-associated scattering is observed in both transformed cells and in karyotypically normal human cells, albeit at lower penetrance. Suppressing microtubule dynamics reduces scattering, suggesting that cohesion at centromeres is unable to resist dynamic microtubule-dependent pulling forces on the kinetochores. Consistent with this view, strengthening cohesion by inhibiting the two pathways responsible for its removal significantly inhibits scattering. These results establish that chromosome scattering due to uncoordinated partial loss of chromatid cohesion is a common outcome following extended arrest with bioriented chromosomes in human cells. These findings have important implications for analysis of mitotic phenotypes in human cells and for development of anti-mitotic chemotherapeutic approaches in the treatment of cancer.	[Stevens, Deanna] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Stevens, D (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977	National Institutes of Health [GM074215]; National Institute for General Medical Sciences [T32 GM008666]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health to A. D. (GM074215). D. S. was supported in part by an Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences to the UCSD Genetics Training Program (T32 GM008666). K.O. and A. D. receive salary and additional support from the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban KH, 2007, DEV CELL, V13, P29, DOI 10.1016/j.devcel.2007.04.017; Bloom K, 2010, CURR BIOL, V20, pR1040, DOI 10.1016/j.cub.2010.10.055; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; GALLANT P, 1992, J CELL BIOL, V117, P213, DOI 10.1083/jcb.117.1.213; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Hardwick Kevin G, 2010, F1000 Biol Rep, V2, P55, DOI 10.3410/B2-55; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Matos I, 2009, J CELL BIOL, V186, P11, DOI 10.1083/jcb.200904153; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; QIAN X, 2008, Patent No. 0255182; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Yang S, 2008, FASEB J, V22, P1960, DOI 10.1096/fj.07-081463; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	41	64	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22969	10.1371/journal.pone.0022969	http://dx.doi.org/10.1371/journal.pone.0022969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829677	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900020
J	Vierkotten, S; Muether, PS; Fauser, S				Vierkotten, Sarah; Muether, Philipp S.; Fauser, Sascha			Overexpression of HTRA1 Leads to Ultrastructural Changes in the Elastic Layer of Bruch's Membrane via Cleavage of Extracellular Matrix Components	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; IN-VIVO; METALLOPROTEINASES-3 TIMP-3; TISSUE INHIBITOR; SERINE-PROTEASE; GENE; BINDING; DISEASE; FIBULIN-5	Variants in the chromosomal region 10q26 are strongly associated with an increased risk for age-related macular degeneration (AMD). Two potential AMD genes are located in this region: ARMS2 and HTRA1 (high-temperature requirement A1). Previous studies have suggested that polymorphisms in the promotor region of HTRA1 result in overexpression of HTRA1 protein. This study investigated the role of HTRA1 overexpression in the pathogenesis of AMD. Transgenic Htra1 mice overexpressing the murine protein in the retinal pigment epithelium (RPE) layer of the retina were generated and characterized by transmission electron microscopy, immunofluorescence staining and Western Blot analysis. The elastic layer of Bruch's membrane (BM) in the Htra1 transgenic mice was fragmented and less continuous than in wild type (WT) controls. Recombinant HTRA1 lacking the N-terminal domain cleaved various extracellular matrix (ECM) proteins. Subsequent Western Blot analysis revealed an overexpression of fibronectin fragments and a reduction of fibulin 5 and tropoelastin in the RPE/choroid layer in transgenic mice compared to WT. Fibulin 5 is essential for elastogenesis by promoting elastic fiber assembly and maturation. Taken together, our data implicate that HTRA1 overexpression leads to an altered elastogenesis in BM through fibulin 5 cleavage. It highlights the importance of ECM related proteins in the development of AMD and links HTRA1 to other AMD risk genes such as fibulin 5, fibulin 6, ARMS2 and TIMP3.	[Vierkotten, Sarah; Muether, Philipp S.; Fauser, Sascha] Univ Cologne, Ctr Ophthalmol, Cologne, Germany	University of Cologne	Vierkotten, S (corresponding author), Univ Cologne, Ctr Ophthalmol, Cologne, Germany.	sfauser@gmx.net			Novartis; Retinovit Foundation	Novartis(Novartis); Retinovit Foundation	This work was supported by grants from Novartis and the Retinovit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 1997, J MOL BIOL, V272, P226, DOI 10.1006/jmbi.1997.1244; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; CARSONS S, 1981, ARTHRITIS RHEUM, V24, P1261; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Chowers I, 2008, MOL VIS, V14, P2263; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DeAngelis MM, 2008, OPHTHALMOLOGY, V115, P1209, DOI 10.1016/j.ophtha.2007.10.032; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gu YC, 2000, BRIT J HAEMATOL, V109, P305, DOI 10.1046/j.1365-2141.2000.02011.x; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; Mendioroz M, 2010, NEUROLOGY, V75, P2033, DOI 10.1212/WNL.0b013e3181ff96ac; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9; SHIGA A, 2011, HUM MOL GENET; Sivaprasad S, 2005, INVEST OPHTH VIS SCI, V46, P3046, DOI 10.1167/iovs.04-1277; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tong Y, 2010, MOL VIS, V16, P1958; van Soest SS, 2007, MOL VIS, V13, P1608; VIDMAR SL, 1991, EUR J BIOCHEM, V201, P79, DOI 10.1111/j.1432-1033.1991.tb16258.x; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Weger M, 2007, MOL VIS, V13, P1274; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yeow KM, 2002, MATRIX BIOL, V21, P75, DOI 10.1016/S0945-053X(01)00180-9; Yu HG, 2008, INVEST OPHTH VIS SCI, V49, P2599, DOI 10.1167/iovs.07-1508; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	53	109	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22959	10.1371/journal.pone.0022959	http://dx.doi.org/10.1371/journal.pone.0022959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829675	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900018
J	Winkler, J; Kao, KC				Winkler, James; Kao, Katy C.			Transcriptional Analysis of Lactobacillus brevis to N-Butanol and Ferulic Acid Stress Responses	PLOS ONE			English	Article							P-COUMARATE DECARBOXYLASE; PHENOLIC-COMPOUNDS; ESCHERICHIA-COLI; DEGRADATION-PRODUCTS; COMPARATIVE GENOMICS; OENOCOCCUS-OENI; TOLERANCE; MEMBRANE; GROWTH; MECHANISMS	Background: The presence of anti-microbial phenolic compounds, such as the model compound ferulic acid, in biomass hydrolysates pose significant challenges to the widespread use of biomass in conjunction with whole cell biocatalysis or fermentation. Currently, these inhibitory compounds must be removed through additional downstream processing or sufficiently diluted to create environments suitable for most industrially important microbial strains. Simultaneously, product toxicity must also be overcome to allow for efficient production of next generation biofuels such as n-butanol, isopropanol, and others from these low cost feedstocks. Methodology and Principal Findings: This study explores the high ferulic acid and n-butanol tolerance in Lactobacillus brevis, a lactic acid bacterium often found in fermentation processes, by global transcriptional response analysis. The transcriptional profile of L. brevis reveals that the presence of ferulic acid triggers the expression of currently uncharacterized membrane proteins, possibly in an effort to counteract ferulic acid induced changes in membrane fluidity and ion leakage. In contrast to the ferulic acid stress response, n-butanol challenges to growing cultures primarily induce genes within the fatty acid synthesis pathway and reduced the proportion of 19: 1 cyclopropane fatty acid within the L. brevis membrane. Both inhibitors also triggered generalized stress responses. Separate attempts to alter flux through the Escherichia coli fatty acid synthesis by overexpressing acetyl-CoA carboxylase subunits and deleting cyclopropane fatty acid synthase (cfa) both failed to improve n-butanol tolerance in E. coli, indicating that additional components of the stress response are required to confer n-butanol resistance. Conclusions: Several promising routes for understanding both ferulic acid and n-butanol tolerance have been identified from L. brevis gene expression data. These insights may be used to guide further engineering of model industrial organisms to better tolerate both classes of inhibitors to enable facile production of biofuels from lignocellulosic biomass.	[Winkler, James; Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Winkler, J (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	kao.katy@mail.che.tamu.edu		Kao, Katy/0000-0002-1184-276X	United States National Science Foundation [CBET-1032487]; National Science Foundation; Texas Engineering Experiment Station	United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Texas Engineering Experiment Station	The authors gratefully acknowledge the partial financial support of the United States National Science Foundation grant CBET-1032487, the National Science Foundation Graduate Research Fellowship Program, and the Texas Engineering Experiment Station for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Campos FM, 2009, INT J FOOD MICROBIOL, V135, P144, DOI 10.1016/j.ijfoodmicro.2009.07.031; Campos FM, 2003, J APPL MICROBIOL, V94, P167, DOI 10.1046/j.1365-2672.2003.01801.x; CARTWRIGHT CP, 1986, J GEN MICROBIOL, V132, P369; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cho DH, 2009, APPL MICROBIOL BIOT, V83, P1035, DOI 10.1007/s00253-009-1925-8; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Clomburg JM, 2010, APPL MICROBIOL BIOT, V86, P419, DOI 10.1007/s00253-010-2446-1; Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006; Cullen JJ, 2003, CANCER RES, V63, P5513; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; DEGRASSI G, 1995, APPL ENVIRON MICROB, V61, P326, DOI 10.1128/AEM.61.1.326-332.1995; *DEP EN JOINT GEN, 2010, 367 ATCC DEP EN JOIN; Diez-Gonzalez F, 2004, J APPL MICROBIOL, V96, P1237, DOI 10.1111/j.1365-2672.2004.02251.x; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Ezeji T, 2007, BIOTECHNOL BIOENG, V97, P1460, DOI 10.1002/bit.21373; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Goh YJ, 2009, FRONT BIOSCI-LANDMRK, V14, P1362, DOI 10.2741/3313; GOLD RS, 1992, J IND MICROBIOL, V10, P45, DOI 10.1007/BF01583633; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Guo W, 2010, APPL BIOCHEM BIOTECH, V161, P124, DOI 10.1007/s12010-009-8857-8; HARADA T, 1976, CAN J MICROBIOL, V22, P1258, DOI 10.1139/m76-186; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6; INGRAM LO, 1976, J BACTERIOL, V125, P670, DOI 10.1128/JB.125.2.670-678.1976; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kim JH, 2009, MICROBIOL-SGM, V155, P1351, DOI 10.1099/mic.0.024653-0; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROON P, 2003, EUROPEAN J BIOCH, V267, P6740; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Liu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-36; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Lopez MJ, 2004, APPL MICROBIOL BIOT, V64, P125, DOI 10.1007/s00253-003-1401-9; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Landete JM, 2010, J IND MICROBIOL BIOT, V37, P617, DOI 10.1007/s10295-010-0709-6; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Nichols NN, 2005, APPL BIOCHEM BIOTECH, V121, P379, DOI 10.1385/ABAB:121:1-3:0379; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; Reguant C, 2000, J APPL MICROBIOL, V88, P1065, DOI 10.1046/j.1365-2672.2000.01075.x; Rodriguez H, 2008, J AGR FOOD CHEM, V56, P3068, DOI 10.1021/jf703779s; Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI 10.1016/j.ijfoodmicro.2009.03.025; Vaquero MJR, 2007, FOOD CONTROL, V18, P93, DOI 10.1016/j.foodcont.2005.08.010; Rozes N, 1998, APPL MICROBIOL BIOT, V49, P108, DOI 10.1007/s002530051145; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakai S, 2007, APPL ENVIRON MICROB, V73, P2349, DOI 10.1128/AEM.02880-06; Sambrook J, 2001, MOL CLONING LAB MANU; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Sriprapundh D, 2003, PROTEIN ENG, V16, P683, DOI 10.1093/protein/gzg082; STEAD D, 2008, J APPL MICROBIOL, V75, P135; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Wackett LP, 2008, CURR OPIN CHEM BIOL, V12, P187, DOI 10.1016/j.cbpa.2008.01.025; WHITE S, 2005, ANN REV BIOCH; WINKLER J, 2010, BIOTECHNOL LETT, P1; WOOD B, 1998, MICROBIOLOGY FERMENT, P48; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	85	40	42	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e21438	10.1371/journal.pone.0021438	http://dx.doi.org/10.1371/journal.pone.0021438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829598	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511900002
J	Marathe, A; Lewis, B; Chen, JZ; Eubank, S				Marathe, Achla; Lewis, Bryan; Chen, Jiangzhuo; Eubank, Stephen			Sensitivity of Household Transmission to Household Contact Structure and Size	PLOS ONE			English	Article							PANDEMIC INFLUENZA	Objective: Study the influence of household contact structure on the spread of an influenza-like illness. Examine whether changes to in-home care giving arrangements can significantly affect the household transmission counts. Method: We simulate two different behaviors for the symptomatic person; either s/he remains at home in contact with everyone else in the household or s/he remains at home in contact with only the primary caregiver in the household. The two different cases are referred to as full mixing and single caregiver, respectively. Results: The results show that the household's cumulative transmission count is lower in case of a single caregiver configuration than in the full mixing case. The household transmissions vary almost linearly with the household size in both single caregiver and full mixing cases. However the difference in household transmissions due to the difference in household structure grows with the household size especially in case of moderate flu. Conclusions: These results suggest that details about human behavior and household structure do matter in epidemiological models. The policy of home isolation of the sick has significant effect on the household transmission count depending upon the household size.	[Marathe, Achla; Lewis, Bryan; Chen, Jiangzhuo; Eubank, Stephen] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Marathe, Achla] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA; [Eubank, Stephen] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Marathe, A (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	amarathe@vbi.vt.edu	Eubank, Stephen/AAD-5089-2021; Eubank, Stephen/D-7497-2011	Eubank, Stephen/0000-0002-7177-309X; Chen, Jiangzhuo/0000-0002-2729-3881	National Science Foundation (NSF) [CNS-0626964, SES-0729441, OCI-0904844, CNS-0831633, CNS-0845700, CNS-1011769, OCI-1032677]; National Institutes of Health [2U01GM070694-7]; Defense Threat Reduction Agency (DTRA) [HDTRA1-0901-0017, HDTRA1-07-C-0113]; Department of Homeland Security [4112-31805]; Department of Energy [DE-SC0003957]; US Naval Surface Warfare Center [N00178-09-D-3017 DEL ORDER 13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Department of Homeland Security(United States Department of Homeland Security (DHS)); Department of Energy(United States Department of Energy (DOE)); US Naval Surface Warfare Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Science Foundation (NSF) NeTS Grant CNS-0626964, NSF HSD Grant SES-0729441, National Institutes of Health MIDAS project 2U01GM070694-7, NSF PetaApps Grant OCI-0904844, Defense Threat Reduction Agency (DTRA) R&D Grant HDTRA1-0901-0017, DTRA CNIMS Grant HDTRA1-07-C-0113, NSF NeTS CNS-0831633, Department of Homeland Security 4112-31805, Department of Energy DE-SC0003957, NSF REU Supplement CNS-0845700, US Naval Surface Warfare Center N00178-09-D-3017 DEL ORDER 13, NSF Netse CNS-1011769, and NSF SDCI OCI-1032677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barrett C, 2009, AI MAG, V31, P75; Barrett C.L., 2008, SC 2008 P 2008 ACMIE, P1, DOI DOI 10.1109/SC.2008.5214892; Bisset K., 2009, DOE SCIDAC MAG, V66, P36; Bisset K, 2009, P 23 ACM INT C SUP I, P230; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran M, 2008, P NATL ACAD SCI USA, pPMC2290797; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Taylor C, 2010, INT J INFECT DIS, V14, pE792, DOI 10.1016/j.ijid.2010.02.2267	14	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22461	10.1371/journal.pone.0022461	http://dx.doi.org/10.1371/journal.pone.0022461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829625	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511200010
J	Porto, G; Giordano, RJ; Marti, LC; Stolf, B; Pasqualini, R; Arap, W; Kalil, J; Coelho, V				Porto, Georgia; Giordano, Ricardo J.; Marti, Luciana C.; Stolf, Beatriz; Pasqualini, Renata; Arap, Wadih; Kalil, Jorge; Coelho, Veronica			Identification of Novel Immunoregulatory Molecules in Human Thymic Regulatory CD4(+)CD25(+) T Cells by Phage Display	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; IMMUNOLOGICAL SELF-TOLERANCE; AUTOIMMUNE-DISEASES; RETINOIC-ACID; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; INTERLEUKIN-11 RECEPTOR; MEDIATED TRANSCRIPTION; DENDRITIC CELLS; IMMUNE-SYSTEM	Thymic CD4(+)CD25(+) cells play an important role in immune regulation and are continuously developed in the thymus as an independent lineage. How these cells are generated, what are their multiple pathways of suppressive activity and which are their specific markers are questions that remain unanswered. To identify molecules involved in the function and development of human CD4(+)CD25(+) T regulatory cells we targeted thymic CD4(+)CD25(+) cells by peptide phage display. A phage library containing random peptides was screened ex vivo for binding to human thymic CD4(+)CD25(+) T cells. After four rounds of selection on CD4(+)CD25(+) enriched populations of thymocytes, we sequenced several phage displayed peptides and selected one with identity to the Vitamin D Receptor (VDR). We confirmed the binding of the VDR phage to active Vitamin D in vitro, as well as the higher expression of VDR in CD4(+)CD25(+) cells. We suggest that differential expression of VDR on natural Tregs may be related to the relevance of Vitamin D in function and ontogeny of these cells.	[Porto, Georgia; Stolf, Beatriz; Kalil, Jorge; Coelho, Veronica] Univ Sao Paulo, Sch Med, Inst Coracao InCor, Inst Heart, Sao Paulo, Brazil; [Porto, Georgia; Kalil, Jorge; Coelho, Veronica] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Kalil, Jorge; Coelho, Veronica] Natl Inst Sci & Technol Iii INCT, Inst Invest Immunol, Sao Paulo, Brazil; [Giordano, Ricardo J.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Marti, Luciana C.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Stolf, Beatriz] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Giordano, Ricardo J.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Texas System; UTMD Anderson Cancer Center; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo	Porto, G (corresponding author), Univ Sao Paulo, Sch Med, Inst Coracao InCor, Inst Heart, Sao Paulo, Brazil.	vecoelho@usp.br	Stolf, Beatriz S/H-7943-2012; Marti, Luciana/E-8242-2010; KALIL, JORGE/C-8029-2012; Marti, Luciana Cavalheiro/Z-2555-2019; Giordano, Ricardo/A-2074-2010; COELHO, VERONICA/D-1433-2013	Stolf, Beatriz S/0000-0001-7661-3311; Marti, Luciana/0000-0002-3890-0827; KALIL, JORGE/0000-0001-8415-4274; Marti, Luciana Cavalheiro/0000-0002-3890-0827; Giordano, Ricardo/0000-0001-8116-6771; Coelho, Veronica/0000-0002-0989-2581	FAPESP [2003/04721-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP under grant number: 2003/04721-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2002, INT IMMUNOPHARMACOL, V2, P1017, DOI 10.1016/S1567-5769(02)00049-8; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Adorini L, 2006, CURR TOP MED CHEM, V6, P1297, DOI 10.2174/156802606777864890; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Itoh M, 1999, J IMMUNOL, V162, P5317; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kang I, 2010, J IMMUNOL, V184; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Mizwicki MT, 2004, P NATL ACAD SCI USA, V101, P12876, DOI 10.1073/pnas.0403606101; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2007, CELL ADHES MIGR, V1, P142, DOI 10.4161/cam.1.3.5062; NAKAJIMA S, 1994, MOL ENDOCRINOL, V8, P159, DOI 10.1210/me.8.2.159; Nezbedova P, 2004, Endocr Regul, V38, P29; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Penna G, 2007, J BONE MINER RES, V22, pV69, DOI 10.1359/JBMR.07S217; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Tagami T, 1998, BIOCHEM BIOPH RES CO, V253, P358, DOI 10.1006/bbrc.1998.9799; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Velappan N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp809; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Yu Y, 2008, J BIOMOL SCREEN, V13, P968, DOI 10.1177/1087057108326537; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhao GS, 2010, STEROIDS, V75, P555, DOI 10.1016/j.steroids.2009.12.001; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	47	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e21702	10.1371/journal.pone.0021702	http://dx.doi.org/10.1371/journal.pone.0021702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829599	gold, Green Submitted, Green Published			2022-12-25	WOS:000293511200003
J	Sovero, M; Garcia, J; Kochel, T; Laguna-Torres, VA; Gomez, J; Chicaiza, W; Barrantes, M; Sanchez, F; Jimenez, M; Comach, G; de Rivera, IL; Arango, AE; Agudo, R; Halsey, ES				Sovero, Merly; Garcia, Josefina; Kochel, Tadeusz; Alberto Laguna-Torres, V.; Gomez, Jorge; Chicaiza, Wilson; Barrantes, Melvin; Sanchez, Felix; Jimenez, Mirna; Comach, Guillermo; Lorenzana de Rivera, Ivette; Arango, Ana E.; Agudo, Roberto; Halsey, Eric S.			Circulating Strains of Human Respiratory Syncytial Virus in Central and South America	PLOS ONE			English	Article							GROUP-A; SUBGROUP-A; GENETIC-VARIABILITY; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; ANTIGENIC DIVERSITY; G-GLYCOPROTEIN; PCR ASSAY; G-PROTEIN; INFECTION	Human respiratory syncytial virus (HRSV) is a major cause of viral lower respiratory tract infections among infants and young children. HRSV strains vary genetically and antigenically and have been classified into two broad subgroups, A and B (HRSV-A and HRSV-B, respectively). To date, little is known about the circulating strains of HRSV in Latin America. We have evaluated the genetic diversity of 96 HRSV strains by sequencing a variable region of the G protein gene of isolates collected from 2007 to 2009 in Central and South America. Our results show the presence of the two antigenic subgroups of HRSV during this period with the majority belonging to the genotype HRSV-A2.	[Sovero, Merly; Garcia, Josefina; Kochel, Tadeusz; Alberto Laguna-Torres, V.; Halsey, Eric S.] USN, Med Res Unit 6, Lima, Peru; [Gomez, Jorge] Minist Salud, Direcc Gen Epidemiol, Lima, Peru; [Chicaiza, Wilson] Hosp Vozandes, Quito, Ecuador; [Barrantes, Melvin] Hosp Solano, Buenos Aires, DF, Argentina; [Sanchez, Felix] Hosp Infantil Manuel de Jesus Rivera, Managua, Nicaragua; [Jimenez, Mirna] Hosp Nacl Metapan, Metapan, El Salvador; [Comach, Guillermo] LARDIDEV Biomed UC, Maracay, Venezuela; [Lorenzana de Rivera, Ivette] Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras; [Arango, Ana E.] Univ Antioquia, Medellin, Colombia; [Agudo, Roberto] Minist Salud, Direcc Gen Epidemiol, Cochabamba, Bolivia	Universidad Nacional Autonoma de Honduras; Universidad de Antioquia	Sovero, M (corresponding author), USN, Med Res Unit 6, Lima, Peru.	josefina.garcia@med.navy.mil	CANOS, AVELINO CORMA/A-3040-2013; Halsey, Eric/AAC-8110-2022; Gomez, Jorge/E-5258-2012	CANOS, AVELINO CORMA/0000-0002-2232-3527; Halsey, Eric/0000-0001-6291-8923; , Merly Sovero/0000-0002-4373-0295; Lorenzana, Ivette/0000-0002-8128-8602; Tripp, Ralph/0000-0002-2924-9956; Gomez, Jorge/0000-0003-1342-3507; Chicaiza-Ayala, Wilson/0000-0001-8639-698X; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301	US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS); division of the Armed Forces Health Surveillance Center [847705.82000.25GB.B0016]	US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); division of the Armed Forces Health Surveillance Center	This study was funded by the US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS), a division of the Armed Forces Health Surveillance Center, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Baumeister EG, 2003, J CLIN VIROL, V27, P44, DOI 10.1016/S1386-6532(02)00125-7; Bedoya VI, 1996, PEDIATR INFECT DIS J, V15, P1123, DOI 10.1097/00006454-199612000-00014; Boonyasuppayakorn S, 2010, INFLUENZA OTHER RESP, V4, P313, DOI 10.1111/j.1750-2659.2010.00152.x; CANE PA, 1992, VIRUS RES, V25, P15, DOI 10.1016/0168-1702(92)90096-R; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Carballal G, 2000, J MED VIROL, V61, P275, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;275::AID-JMV15&gt;3.0.CO;2-E; Casiano-Colon AE, 2003, J CLIN VIROL, V28, P169, DOI 10.1016/S1386-6532(03)00002-7; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; CRISTINA J, 1990, VIROLOGY, V174, P126, DOI 10.1016/0042-6822(90)90061-U; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Galiano MC, 2005, J MED VIROL, V77, P311, DOI 10.1002/jmv.20456; GARCIA O, 1994, J VIROL, V68, P5448; GLEZEN WP, 1990, PEDIATR ANN, V19, P535, DOI 10.3928/0090-4481-19900901-09; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Gueudin M, 2003, J VIROL METHODS, V109, P39, DOI 10.1016/S0166-0934(03)00042-9; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; KAPIKIAN AZ, 1961, AM J HYG, V74, P234, DOI 10.1093/oxfordjournals.aje.a120216; Kuypers J, 2009, TRANSPL INFECT DIS, V11, P298, DOI 10.1111/j.1399-3062.2009.00400.x; Martinello RA, 2002, J INFECT DIS, V186, P839, DOI 10.1086/342414; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Oliveira TFM, 2008, MEM I OSWALDO CRUZ, V103, P417, DOI 10.1590/S0074-02762008000500002; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; SANZ MC, 1994, VIRUS RES, V33, P203; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; STORCH GA, 1991, J INFECT DIS, V163, P858, DOI 10.1093/infdis/163.4.858; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Teng MN, 2002, J VIROL, V76, P6164, DOI 10.1128/JVI.76.12.6164-6171.2002; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Visser A, 2008, J MED VIROL, V80, P724, DOI 10.1002/jmv.21128; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; ZELAYA EAC, 1994, AM J TROP MED HYG, V51, P577, DOI 10.4269/ajtmh.1994.51.577; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09	46	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22111	10.1371/journal.pone.0022111	http://dx.doi.org/10.1371/journal.pone.0022111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829605	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511200005
J	Siebert, S; Robinson, MD; Tintori, SC; Goetz, F; Helm, RR; Smith, SA; Shaner, N; Haddock, SHD; Dunn, CW				Siebert, Stefan; Robinson, Mark D.; Tintori, Sophia C.; Goetz, Freya; Helm, Rebecca R.; Smith, Stephen A.; Shaner, Nathan; Haddock, Steven H. D.; Dunn, Casey W.			Differential Gene Expression in the Siphonophore Nanomia bijuga (Cnidaria) Assessed with Multiple Next-Generation Sequencing Workflows	PLOS ONE			English	Article							RNA-SEQ DATA; SERIAL ANALYSIS; TRANSCRIPTOME; QUANTIFICATION; ANNOTATION; BIOLOGY; BIAS	We investigated differential gene expression between functionally specialized feeding polyps and swimming medusae in the siphonophore Nanomia bijuga (Cnidaria) with a hybrid long-read/short-read sequencing strategy. We assembled a set of partial gene reference sequences from long-read data (Roche 454), and generated short-read sequences from replicated tissue samples that were mapped to the references to quantify expression. We collected and compared expression data with three short-read expression workflows that differ in sample preparation, sequencing technology, and mapping tools. These workflows were Illumina mRNA-Seq, which generates sequence reads from random locations along each transcript, and two tag-based approaches, SOLiD SAGE and Helicos DGE, which generate reads from particular tag sites. Differences in expression results across workflows were mostly due to the differential impact of missing data in the partial reference sequences. When all 454-derived gene reference sequences were considered, Illumina mRNA-Seq detected more than twice as many differentially expressed (DE) reference sequences as the tag-based workflows. This discrepancy was largely due to missing tag sites in the partial reference that led to false negatives in the tag-based workflows. When only the subset of reference sequences that unambiguously have tag sites was considered, we found broad congruence across workflows, and they all identified a similar set of DE sequences. Our results are promising in several regards for gene expression studies in non-model organisms. First, we demonstrate that a hybrid long-read/short-read sequencing strategy is an effective way to collect gene expression data when an annotated genome sequence is not available. Second, our replicated sampling indicates that expression profiles are highly consistent across field-collected animals in this case. Third, the impacts of partial reference sequences on the ability to detect DE can be mitigated through workflow choice and deeper reference sequencing.	[Siebert, Stefan; Tintori, Sophia C.; Goetz, Freya; Helm, Rebecca R.; Smith, Stephen A.; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Robinson, Mark D.] Garvan Inst Med Res, Canc Res Program, Epigenet Lab, Sydney, NSW, Australia; [Robinson, Mark D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Smith, Stephen A.] Heidelberg Inst Theoret Studies, Heidelberg, Germany; [Shaner, Nathan; Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Brown University; Garvan Institute of Medical Research; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Heidelberg Institute for Theoretical Studies; Monterey Bay Aquarium Research Institute	Siebert, S (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	stefan_siebert@brown.edu; casey_dunn@brown.edu	Smith, Stephen/AAE-8623-2019; Robinson, Mark D/A-6432-2015; Robinson, Mark D./O-2254-2019	Smith, Stephen/0000-0003-2035-9531; Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518; Shaner, Nathan/0000-0002-0148-0769; Dunn, Casey/0000-0003-0628-5150; Siebert, Stefan/0000-0001-8181-912X				Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Dunn C, 2009, CURR BIOL, V19, pR233, DOI 10.1016/j.cub.2009.02.009; Dunn CW, 2006, DEV GENES EVOL, V216, P743, DOI 10.1007/s00427-006-0101-8; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; GENIKHOVICH G, 2009, COLD SPRING HARB PRO; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Hodgins-Davis A, 2009, TRENDS ECOL EVOL, V24, P649, DOI 10.1016/j.tree.2009.06.011; Hu M, 2006, NAT PROTOC, V1, P1743, DOI 10.1038/nprot.2006.269; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; MACKIE GO, 1987, ADV MAR BIOL, V24, P97; MACKIE GO, LOWER METAZOA, P329; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	30	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22953	10.1371/journal.pone.0022953	http://dx.doi.org/10.1371/journal.pone.0022953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829563	Green Submitted, Green Published, gold			2022-12-25	WOS:000293286500056
J	Phillips, NB; Racca, J; Chen, YS; Singh, R; Jancso-Radek, A; Radek, JT; Wickramasinghe, NP; Haas, E; Weiss, MA				Phillips, Nelson B.; Racca, Joseph; Chen, Yen-Shan; Singh, Rupinder; Jancso-Radek, Agnes; Radek, James T.; Wickramasinghe, Nalinda P.; Haas, Elisha; Weiss, Michael A.			Mammalian Testis-determining Factor SRY and the Enigma of Inherited Human Sex Reversal FRUSTRATED INDUCED FIT IN A BENT PROTEIN-DNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY-GROUP BOX; HMG BOX; DETERMINING REGION; TRUE HERMAPHRODITISM; MOLECULAR-BASIS; Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; NUCLEAR-LOCALIZATION; CHROMATIN-STRUCTURE; MISSENSE MUTATIONS	Mammalian testis-determining factor SRY contains a high mobility group box, a conserved eukaryotic motif of DNA bending. Mutations in SRY cause XY gonadal dysgenesis and somatic sex reversal. Although such mutations usually arise de novo in spermatogenesis, some are inherited and so specify male development in one genetic background (the father) but not another (the daughter). Here, we describe the biophysical properties of a representative inherited mutation, V60L, within the minor wing of the L-shaped domain (box position 5). Although the stability and DNA binding properties of the mutant domain are similar to those of wildtype, studies of SRY-induced DNA bending by subnanosecond time-resolved fluorescence resonance energy transfer (FRET) revealed enhanced conformational fluctuations leading to long range variation in bend angle. H-1 NMR studies of the variant protein-DNA complex demonstrated only local perturbations near the mutation site. Because the minor wing of SRY folds on DNA binding, the inherited mutation presumably hinders induced fit. Stopped-flow FRET studies indicated that such frustrated packing leads to accelerated dissociation of the bent complex. Studies of SRY-directed transcriptional regulation in an embryonic gonadal cell line demonstrated partial activation of downstream target Sox9. Our results have demonstrated a nonlocal coupling between DNA-directed protein folding and protein-directed DNA bending. Perturbation of this coupling is associated with a genetic switch poised at the threshold of activity.	[Wickramasinghe, Nalinda P.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Haas, Elisha] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Case Western Reserve University; Bar Ilan University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Wickramasinghe, Nalinda P/F-9465-2010	Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health [GM080505]; United States/Israel Binational Foundation [98-362]; Israel Science Foundation [ISF 1464/10]; NCI, National Institutes of Health [T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States/Israel Binational Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080505 (to M. A. W.). This work was also supported in its early stages by Grant 98-362 from the United States/Israel Binational Foundation (to E. H. and M. A. W.) and by Grant ISF 1464/10 from the Israel Science Foundation (to E. H.); Supported in part by National Institutes of Health T32 CA059366 Training Grant from NCI (to C. Distelhorst) to the Clinical Oncology Research Career Development Program at Case Western Reserve University School of Medicine.	Albrecht KH, 2003, GENETICS, V164, P277; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; BEECHEM JM, 1989, BIOPHYS J, V55, P1225, DOI 10.1016/S0006-3495(89)82918-2; Benevides JM, 2000, BIOCHEMISTRY-US, V39, P537, DOI 10.1021/bi9900525; Bergstrom DE, 2000, GENESIS, V28, P111, DOI 10.1002/1526-968X(200011/12)28:3/4<111::AID-GENE40>3.0.CO;2-5; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; BRAUN A, 1993, AM J HUM GENET, V52, P578; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2005, MOL HUM REPROD, V11, P833, DOI 10.1093/molehr/gah216; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clore GM, 2002, CURR OPIN STRUC BIOL, V12, P146, DOI 10.1016/S0959-440X(02)00302-0; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; DAWSON WR, 1968, J PHYS CHEM-US, V72, P3251, DOI 10.1021/j100855a027; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Haas E, 1996, IEEE J SEL TOP QUANT, V2, P1088, DOI 10.1109/2944.577340; HADJIATHANASIOU CG, 1994, J PEDIATR-US, V125, P738, DOI 10.1016/S0022-3476(06)80172-1; HAQQ CM, 1993, P NATL ACAD SCI USA, V90, P1097, DOI 10.1073/pnas.90.3.1097; Haqq CM, 1998, PHYSIOL REV, V78, P1; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 2002, NOVART FDN SYMP, V244, P57; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; HIORT O, 1995, J PEDIATR-US, V126, P1022, DOI 10.1016/S0022-3476(95)70247-4; Isidor B, 2009, J CLIN ENDOCR METAB, V94, P3467, DOI 10.1210/jc.2009-0226; JONES DNM, 1994, STRUCTURE, V2, P609, DOI 10.1016/S0969-2126(00)00063-0; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 2001, EXS, V91, P25; KORNBERG RD, 1995, CURR OPIN CELL BIOL, V7, P371, DOI 10.1016/0955-0674(95)80092-1; KWOK C, 1995, AM J HUM GENET, V57, P1028; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.048; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Lovell-Badge R, 2010, INT J BIOCHEM CELL B, V42, P378, DOI 10.1016/j.biocel.2009.12.003; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuzawa-Watanabe Y, 2003, ONCOGENE, V22, P7900, DOI 10.1038/sj.onc.1206717; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; NAGAMINE CM, 1987, DIFFERENTIATION, V33, P214, DOI 10.1111/j.1432-0436.1987.tb01560.x; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; PALMER SJ, 1991, DEVELOPMENT, V113, P709; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; PETERS R, 1995, BIOCHEMISTRY-US, V34, P4569, DOI 10.1021/bi00014a009; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; PONTIGGIA A, 1995, GENE, V154, P277, DOI 10.1016/0378-1119(94)00853-K; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Ratner V, 2000, J MOL BIOL, V299, P1363, DOI 10.1006/jmbi.2000.3814; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Sanchez IE, 2010, P NATL ACAD SCI USA, V107, P7751, DOI 10.1073/pnas.0911734107; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; TAKETO T, 1991, DEV BIOL, V146, P386, DOI 10.1016/0012-1606(91)90240-4; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Ukiyama E, 2001, MOL ENDOCRINOL, V15, P363, DOI 10.1210/me.15.3.363; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; VILAIN E, 1993, DIFFERENTIATION, V52, P151, DOI 10.1111/j.1432-0436.1993.tb00625.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Washburn LL, 2001, GENETICS, V158, P1675; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; WEISS MA, 1995, J BIOMOL STRUCT DYN, V13, P261, DOI 10.1080/07391102.1995.10508838; Weiss MA, 2005, MOL B INT U, P159; Weiss MA, 2001, MOL ENDOCRINOL, V15, P353, DOI 10.1210/me.15.3.353; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Zheng GH, 2010, PHYS CHEM CHEM PHYS, V12, P1399, DOI 10.1039/b916183j	107	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36787	36807		10.1074/jbc.M111.260091	http://dx.doi.org/10.1074/jbc.M111.260091			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849498	Green Published, hybrid			2022-12-25	WOS:000296538300060
J	Hezroni, H; Sailaja, BS; Meshorer, E				Hezroni, Hadas; Sailaja, Badi Sri; Meshorer, Eran			Pluripotency-related, Valproic Acid (VPA)-induced Genome-wide Histone H3 Lysine 9 (H3K9) Acetylation Patterns in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; CHIP-SEQ; DIFFERENTIATION; TRANSCRIPTION; INDUCTION; STATE; METHYLATION; NUCLEAR; MODEL; MAPS	Background: Embryonic stem cell (ESC) chromatin is characterized by a unique set of histone modifications, including enrichment for H3K9ac. Recent studies suggest that HDAC inhibitors (HDACi) promote pluripotency. Results: Using H3K9ac ChIP-seq analyses and gene expression in E14 mouse ESCs before and after treatment with a low level of the HDACi valproic acid (VPA), we show that H3K9ac is enriched at gene promoters and is highly correlated with gene expression and with various genomic features, including different active histone marks and pluripotency-related transcription factors. Conclusion: This study provides insights into the genomic response of ESCs to low level HDACi, which leads to increased pluripotency. The results suggest that a mild (averaging less than 40%) but global change in the chromatin state is involved in increased pluripotency and that specific mechanisms operate selectively in bivalent genes to maintain constant H3K9ac levels. Our data support the notion that H3K9ac has an important role in ESC biology. Significance: Understanding the mechanisms that improve and support pluripotency of ESCs, such as the use of the HDAC inhibitor VPA, will promote intelligent manipulation of ESCs and expedite their use in the clinic.	[Hezroni, Hadas; Sailaja, Badi Sri; Meshorer, Eran] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	meshorer@huji.ac.il		Sailaja, Badi Sri/0000-0003-4488-738X; Meshorer, Eran/0000-0003-4777-986X	Edmond J. Safra Foundation; Israel Science Foundation [215/07, 943/09]; Israel Ministry of Health [6007]; European Union [IRG-206872, 238176]; Israel Cancer Research Foundation; Hebrew University	Edmond J. Safra Foundation; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; European Union(European Commission); Israel Cancer Research Foundation; Hebrew University	This work was supported in part by the Edmond J. Safra Foundation.; A Joseph H. and Belle R. Braun Senior Lecturer in Life Sciences, supported by Israel Science Foundation Grants 215/07 and 943/09, Israel Ministry of Health Grant 6007, European Union Grants IRG-206872 and 238176, the Israel Cancer Research Foundation, and the Internal Applicative Medical Grants of the Hebrew University. To whom correspondence should be addressed. E-mail: meshorer@huji.ac.il.	Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conigliaro A, 2008, CELL DEATH DIFFER, V15, P123, DOI 10.1038/sj.cdd.4402236; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Efroni S, 2009, CELL CYCLE, V8, P43, DOI 10.4161/cc.8.1.7216; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; HU ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou QJ, 2007, J CELL BIOCHEM, V100, P29, DOI 10.1002/jcb.20970	45	60	60	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35977	35988		10.1074/jbc.M111.266254	http://dx.doi.org/10.1074/jbc.M111.266254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849501	Green Published, hybrid			2022-12-25	WOS:000295927100071
J	Chen, JS; Song, J; Yuan, PX; Tian, QJ; Ji, YY; Ren-Patterson, R; Liu, GP; Sei, Y; Weinberger, DR				Chen, Jingshan; Song, Jian; Yuan, Peixiong; Tian, Qingjun; Ji, Yuanyuan; Ren-Patterson, Renee; Liu, Guangping; Sei, Yoshitasu; Weinberger, Daniel R.			Orientation and Cellular Distribution of Membrane-bound Catechol-O-methyltransferase in Cortical Neurons IMPLICATIONS FOR DRUG DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN EXPRESSION; DOPAMINE CLEARANCE; PREFRONTAL CORTEX; GENETIC-VARIATION; ENZYME-ACTIVITY; RAT-BRAIN; COMT; LIVER; INHIBITORS	Catechol-O-methyltransferase (COMT) is a key enzyme for inactivation and metabolism of catechols, including dopamine, norepinephrine, caffeine, and estrogens. It plays an important role in cognition, arousal, pain sensitivity, and stress reactivity in humans and in animal models. The human COMT gene is associated with a diverse spectrum of human behaviors and diseases from cognition and psychiatric disorders to chronic pain and cancer. There are two major forms of COMT proteins, membrane-bound (MB) COMT and soluble (S) COMT. MB-COMT is the main form in the brain. The cellular distribution of MB-COMT in cortical neurons remains unclear and the orientation of MB-COMT on the cellular membrane is controversial. In this study, we demonstrate that MB-COMT is located in the cell body and in axons and dendrites of rat cortical neurons. Analyses of MB-COMT orientation with computer simulation, flow cytometry and a cell surface enzyme assay reveal that the C-terminal catalytic domain of MB-COMT is in the extracellular space, which suggests that MB-COMT can inactivate synaptic and extrasynaptic dopamine on the surface of presynaptic and postsynaptic neurons. Finally, we show that the COMT inhibitor tolcapone induces cell death via the mechanism of apoptosis, and its cytotoxicity is dependent on dosage and correlated with COMT Val/Met genotypes in human lymphoblastoid cells. These results suggest that MB-COMT specific inhibitors can be developed and that tolcapone may be less hazardous at low doses and in specific genetic backgrounds.	[Chen, Jingshan; Song, Jian; Yuan, Peixiong; Tian, Qingjun; Ji, Yuanyuan; Ren-Patterson, Renee; Liu, Guangping; Sei, Yoshitasu; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Weinberger, DR (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Room 3C-103A,10 Ctr Dr,MSC 1379, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov			NIMH, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002901] Funding Source: NIH RePORTER	NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH, National Institutes of Health Intramural Research Program.	Acuna Gonzalo, 2002, Pharmacogenomics Journal, V2, P327, DOI 10.1038/sj.tpj.6500123; Akil M, 2003, J NEUROSCI, V23, P2008; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Davies NM, 2004, J PHARM PHARM SCI, V7, P332; DINGEMANSE J, 1995, CLIN PHARMACOL THER, V57, P508, DOI 10.1016/0009-9236(95)90035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Farmer John A, 2003, Curr Atheroscler Rep, V5, P96, DOI 10.1007/s11883-003-0079-x; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Goetz Christopher G., 1998, Neurology, V50, pS26; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GROSSMAN MH, 1985, J NEUROCHEM, V44, P421, DOI 10.1111/j.1471-4159.1985.tb05432.x; Haasio K, 2002, EXP TOXICOL PATHOL, V54, P9, DOI 10.1078/0940-2993-00228; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; KARHUNEN T, 1995, NEUROSCI LETT, V187, P57, DOI 10.1016/0304-3940(95)11337-V; Korlipara LVP, 2004, NEUROPHARMACOLOGY, V46, P562, DOI 10.1016/j.neuropharm.2003.10.015; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nunes T, 2009, CLIN THER, V31, P2258, DOI 10.1016/j.clinthera.2009.10.019; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Parl FF, 2009, ANN NY ACAD SCI, V1155, P68, DOI 10.1111/j.1749-6632.2008.03676.x; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Scheen AJ, 2001, DIABETES METAB, V27, P305; Sei Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010789; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Soares-Da-Silva P, 2003, PHARMACOL TOXICOL, V92, P272, DOI 10.1034/j.1600-0773.2003.920604.x; Tammimaki A, 2011, BASIC CLIN PHARMACOL, V108, P2, DOI 10.1111/j.1742-7843.2010.00647.x; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Tan Hao-Yang, 2009, Cogn Neuropsychiatry, V14, P277, DOI 10.1080/13546800903091665; Tunbridge EM, 2007, CEREB CORTEX, V17, P1206, DOI 10.1093/cercor/bhl032; Ulmanen I, 1997, EUR J BIOCHEM, V243, P452, DOI 10.1111/j.1432-1033.1997.0452a.x; ULMANEN I, 1991, EUR J BIOCHEM, V202, P1013, DOI 10.1111/j.1432-1033.1991.tb16464.x; Watkins P, 2000, NEUROLOGY, V55, pS51; Weinberger DR, 2005, CLIN THER, V27, pS8, DOI 10.1016/j.clinthera.2005.07.016; ZURCHER G, 1982, J NEUROCHEM, V38, P191, DOI 10.1111/j.1471-4159.1982.tb10871.x	44	52	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34752	34760		10.1074/jbc.M111.262790	http://dx.doi.org/10.1074/jbc.M111.262790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846718	hybrid, Green Published			2022-12-25	WOS:000295406300029
J	Lake, RJ; Basheer, A; Fan, HY				Lake, Robert J.; Basheer, Asjad; Fan, Hua-Ying			Reciprocally Regulated Chromatin Association of Cockayne Syndrome Protein B and p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; COUPLING FACTOR; CSB PROTEIN; IN-VIVO; TRANSCRIPTION; ELONGATION; BINDING; COMPLEXES	The Cockayne syndrome complementation group B (CSB) protein is an ATP-dependent chromatin remodeler with an essential function in transcription-coupled DNA repair, and mutations in the CSB gene are associated with Cockayne syndrome. The p53 tumor suppressor has been known to interact with CSB, and both proteins have been implicated in overlapping biological processes, such as DNA repair and aging. The significance of the interaction between CSB and p53 has remained unclear, however. Here, we show that the chromatin association of CSB and p53 is inversely related. Using in vitro binding and chromatin immunoprecipitation approaches, we demonstrate that CSB facilitates the sequence-independent association of p53 with chromatin when p53 concentrations are low and that this is achieved by the interaction of CSB with the C-terminal region of p53. Remarkably, p53 prevents CSB from binding to nucleosomes when p53 concentrations are elevated. Examining the enzymatic properties of CSB revealed that p53 excludes CSB from nucleosomes by occluding a nucleosome interaction surface on CSB. Together, our results suggest that the reciprocal regulation of chromatin access by CSB and p53 could be part of a mechanism by which these two proteins coordinate their activities to regulate DNA repair, cell survival, and aging.	[Lake, Robert J.; Basheer, Asjad; Fan, Hua-Ying] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Fan, HY (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 564 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	hfan@mail.med.upenn.edu			National Institutes of Health [GM 084983]; University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084983 (to H.-Y.F.). This work was also supported by the Academic Development Fund of the University of Pennsylvania.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fresht A., 1998, STRUCTURE MECH PROTE; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hogan C, 2007, MUTAT RES-FUND MOL M, V618, P41, DOI 10.1016/j.mrfmmm.2006.07.010; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KERN SE, 1991, ONCOGENE, V6, P131; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selivanova G, 1996, NUCLEIC ACIDS RES, V24, P3560, DOI 10.1093/nar/24.18.3560; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	43	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34951	34958		10.1074/jbc.M111.252643	http://dx.doi.org/10.1074/jbc.M111.252643			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852235	Green Published, hybrid			2022-12-25	WOS:000295406300049
J	Takahata, S; Yu, YX; Stillman, DJ				Takahata, Shinya; Yu, Yaxin; Stillman, David J.			Repressive Chromatin Affects Factor Binding at Yeast HO (Homothallic Switching) Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CELL-CYCLE; RNA-POLYMERASE; ASYMMETRIC ACCUMULATION; MEDIATOR COMPLEX; II ELONGATION; HISTONE H4; IN-VIVO; ACTIVATION	The yeast HO gene is tightly regulated, with multiple activators and coactivators needed to overcome repressive chromatin structures that form over this promoter. Coactivator binding is strongly interdependent, as loss of one factor sharply reduces recruitment of other factors. The Rpd3(L) histone deacetylase is recruited to HO at two distinct times during the cell cycle, first by Ash1 to the URS1 region of the promoter and then by SBF/Whi5/Stb1 to URS2. SBF itself is localized to only a subset of its potential binding sites in URS2, and this localization takes longer and is less robust than at other SBF target genes, suggesting that binding to the HO promoter is limited by chromatin structures that dynamically change as the cell cycle progresses. Ash1 only binds at the URS1 region of the promoter, but an ash1 mutation results in markedly increased binding of SBF and Rpd3(L) at URS2, some 450 bp distant from the site of Ash1 binding, suggesting these two regions of the promoter interact. An ash1 mutation also results in increased coactivator recruitment, Swi/Snf and Mediator localization in the absence of the normally required Gcn5 histone acetyltransferase, and HO expression even in the presence of a taf1 mutation affecting TFIID activity that otherwise blocks HO transcription. Ash1 therefore appears to play a central role in generating the strongly repressive environment at the HO promoter, which limits the binding of several coactivators at URS2 and TATA region.	[Takahata, Shinya; Yu, Yaxin; Stillman, David J.] Univ Utah, Dept Pathol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stillman, DJ (corresponding author), Univ Utah, Dept Pathol, Hlth Sci Ctr, 15 N Med Dr E, Salt Lake City, UT 84112 USA.	david.stillman@path.utah.edu		Stillman, David/0000-0002-5268-2416	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Bhoite LT, 2002, J BIOL CHEM, V277, P37612, DOI 10.1074/jbc.M206125200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chandarlapaty S, 1998, MOL CELL BIOL, V18, P2884, DOI 10.1128/MCB.18.5.2884; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2008, MOL CELL BIOL, V28, P6919, DOI 10.1128/MCB.00211-08; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dorland S, 2000, GENETICS, V154, P573; Eriksson P, 2004, MOL CELL BIOL, V24, P6419, DOI 10.1128/MCB.24.14.6419-6429.2004; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Liu QQ, 2011, MOL CELL BIOL, V31, P584, DOI 10.1128/MCB.00845-10; Lorch Y, 2000, MOL CELL, V6, P197, DOI 10.1016/S1097-2765(00)00021-6; McBride HJ, 2001, MOL MICROBIOL, V42, P345, DOI 10.1046/j.1365-2958.2001.02601.x; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; NASMYTH K, 1985, CELL, V42, P213, DOI 10.1016/S0092-8674(85)80117-3; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pan XW, 2000, MOL CELL BIOL, V20, P8364, DOI 10.1128/MCB.20.22.8364-8372.2000; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sidorova J, 1999, GENETICS, V151, P45; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; STILLMAN DJ, 1994, GENETICS, V136, P781; TABA MRM, 1991, GENE DEV, V5, P2000, DOI 10.1101/gad.5.11.2000; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	57	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34809	34819		10.1074/jbc.M111.281626	http://dx.doi.org/10.1074/jbc.M111.281626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840992	Green Published, hybrid			2022-12-25	WOS:000295406300035
J	Wong, KE; Kong, J; Zhang, WS; Szeto, FL; Ye, HG; Deb, DK; Brady, MJ; Li, YC				Wong, Kari E.; Kong, Juan; Zhang, Wenshuo; Szeto, Frances L.; Ye, Honggang; Deb, Dilip K.; Brady, Matthew J.; Li, Yan Chun			Targeted Expression of Human Vitamin D Receptor in Adipocytes Decreases Energy Expenditure and Induces Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; KNOCKOUT MICE; 3T3-L1 CELLS; GENE; TISSUE; THERMOGENESIS; METABOLISM; TRIACYLGLYCEROL	Our previous studies demonstrated a high fat diet-resistant lean phenotype of vitamin D receptor (VDR)-null mutant mice mainly due to increased energy expenditure, suggesting an involvement of the VDR in energy metabolism. Here, we took a transgenic approach to further define the role of VDR in adipocyte biology. We used the aP2 gene promoter to target the expression of the human (h) VDR in adipocytes in mice. In contrast to the VDR-null mice, the aP2-hVDR Tg mice developed obesity compared with the wild-type counterparts without changes in food intake. The increase in fat mass was mainly due to markedly reduced energy expenditure, which was correlated with decreased locomotive activity and reduced fatty acid beta-oxidation and lipolysis in the adipose tissue in the transgenic mice. Consistently, the expression of genes involved in the regulation of fatty acid transport, thermogenesis, and lipolysis were suppressed in the transgenic mice. Taken together, these data confirm an important role of the VDR in the regulation of energy metabolism.	[Kong, Juan; Ye, Honggang; Deb, Dilip K.; Brady, Matthew J.; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, Chicago, IL 60637 USA; [Wong, Kari E.; Zhang, Wenshuo; Szeto, Frances L.; Brady, Matthew J.; Li, Yan Chun] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Li, YC (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9-9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu		Zhang, Wenshuo/0000-0002-5124-799X	National Institutes of Health [T32DK07074, R01HL085793, 5P60DK020595-34, 5P30CA014599-36]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007074, P60DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants T32DK07074 and R01HL085793. The Diabetes Research and Training Center at the University of Chicago was supported by National Institutes of Health Grant 5P60DK020595-34. The University of Chicago Transgenic Mouse Facility was supported in part by National Institutes of Health Grant 5P30CA014599-36.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brasaemle DL, 2010, CELL METAB, V11, P173, DOI 10.1016/j.cmet.2010.02.008; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HOGAN B, 1986, MANIPULATING MOUSE E; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Vidal-Puig AJ, 2000, NAT GENET, V26, P387, DOI 10.1038/82489; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	34	134	140	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33804	33810		10.1074/jbc.M111.257568	http://dx.doi.org/10.1074/jbc.M111.257568			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840998	Green Published, hybrid			2022-12-25	WOS:000295159200011
J	Stanley, BA; Sivakumaran, V; Shi, S; McDonald, I; Lloyd, D; Watson, WH; Aon, MA; Paolocci, N				Stanley, Brian A.; Sivakumaran, Vidhya; Shi, Sa; McDonald, Iain; Lloyd, David; Watson, Walter H.; Aon, Miguel A.; Paolocci, Nazareno			Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; HYDROGEN-PEROXIDE; ANTICANCER THERAPEUTICS; REDOX ENVIRONMENT; APOPTOSIS; METABOLISM; CELL; RAT; SELENOCYSTEINE; PEROXIREDOXIN	Respiring mitochondria produce H2O2 continuously. When production exceeds scavenging, H2O2 emission occurs, endangering cell functions. The mitochondrial peroxidase peroxiredoxin-3 reduces H2O2 to water using reducing equivalents from NADPH supplied by thioredoxin-2 (Trx2) and, ultimately, thioredoxin reductase-2 (TrxR2). Here, the contribution of this mitochondrial thioredoxin system to the control of H2O2 emission was studied in isolated mitochondria and cardiomyocytes from mouse or guinea pig heart. Energization of mitochondria by the addition of glutamate/malate resulted in a 10-fold decrease in the ratio of oxidized to reduced Trx2. This shift in redox state was accompanied by an increase in NAD(P) H and was dependent on TrxR2 activity. Inhibition of TrxR2 in isolated mitochondria by auranofin resulted in increased H2O2 emission, an effect that was seen under both forward and reverse electron transport. This effect was independent of changes in NAD(P) H or membrane potential. The effects of auranofin were reproduced in cardiomyocytes; superoxide and H2O2 levels increased, but similarly, there was no effect on NAD(P) H or membrane potential. These data show that energization of mitochondria increases the antioxidant potential of the TrxR2/Trx2 system and that inhibition of TrxR2 results in increased H2O2 emission through a mechanism that is independent of changes in other redox couples.	[Stanley, Brian A.; Sivakumaran, Vidhya; Shi, Sa; Aon, Miguel A.; Paolocci, Nazareno] Johns Hopkins Univ, Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD 21205 USA; [Shi, Sa] Harbin Med Univ, Dept Pathophysiol, Harbin 150081, Peoples R China; [McDonald, Iain; Lloyd, David] Cardiff Univ, Sch Earth Sci, Cardiff CF10 3AT, S Glam, Wales; [McDonald, Iain; Lloyd, David] Cardiff Univ, Sch Biosci, Cardiff CF10 3AT, S Glam, Wales; [Watson, Walter H.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Paolocci, Nazareno] Univ Perugia, Sect Gen Pathol, Dept Clin & Expt Med, I-06122 Perugia, Italy	Johns Hopkins University; Johns Hopkins Medicine; Harbin Medical University; Cardiff University; Cardiff University; University of Louisville; University of Perugia	Aon, MA (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Div Cardiol, 720 Rutland Ave,Ross Bldg 1059, Baltimore, MD 21205 USA.	maon1@jhmi.edu	Aon, Miguel Antonio/A-6564-2008; paolocci, nazareno/A-7124-2009	Aon, Miguel Antonio/0000-0002-4355-5431; Lloyd, David/0000-0002-5656-0571; McDonald, Iain/0000-0001-9066-7244; Paolocci, Nazareno/0000-0001-7011-997X	National Institutes of Health [R01-HL091923-01]; American Heart Association [10POST414001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL091923-01 (to M. A. A. and N. P.). This work was also supported by American Heart Association Postdoctoral Fellowship 10POST414001 (to B. A. S.).	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Aon MA, 2009, INT J BIOCHEM CELL B, V41, P1940, DOI 10.1016/j.biocel.2009.02.016; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Arner E. S. J., 2000, CURRENT PROTOCOL S24, V7.4, P1; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; AYERS FC, 1986, ANAL BIOCHEM, V154, P186, DOI 10.1016/0003-2697(86)90513-0; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Di Lisa F, 2007, HEART FAIL REV, V12, P249, DOI 10.1007/s10741-007-9028-z; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Go Y. M., 2009, CURR PROTOC TOXI S41, V17.12, P1; Go YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018918; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Inarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Rackham O, 2007, BIOCHEM PHARMACOL, V74, P992, DOI 10.1016/j.bcp.2007.07.022; RADI R, 1991, J BIOL CHEM, V266, P22028; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rigobello MP, 2009, FREE RADICAL BIO MED, V47, P710, DOI 10.1016/j.freeradbiomed.2009.05.027; Rigobello MP, 2005, ARCH BIOCHEM BIOPHYS, V441, P112, DOI 10.1016/j.abb.2005.07.007; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rogers LK, 2004, TOXICOL SCI, V82, P367, DOI 10.1093/toxsci/kfh268; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Tocchetti CG, 2007, CIRC RES, V100, P96, DOI 10.1161/01.RES.0000253904.53601.c9; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vergara E, 2010, CHEMMEDCHEM, V5, P96, DOI 10.1002/cmdc.200900370; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Zhang Min, 2007, Curr Heart Fail Rep, V4, P26, DOI 10.1007/s11897-007-0022-5; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	58	147	151	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33669	33677		10.1074/jbc.M111.284612	http://dx.doi.org/10.1074/jbc.M111.284612			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832082	Green Published, hybrid			2022-12-25	WOS:000294968800083
J	Pahlevan, NM; Gharib, M				Pahlevan, Niema M.; Gharib, Morteza			Aortic Wave Dynamics and Its Influence on Left Ventricular Workload	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; FINITE-ELEMENT-ANALYSIS; FLUID-FLOWS; STRUCTURAL INTERACTIONS; ARTERIAL STIFFNESS; SMOKING; HYPERTENSION; REFLECTION; DISEASE	The pumping mechanism of the heart is pulsatile, so the heart generates pulsatile flow that enters into the compliant aorta in the form of pressure and flow waves. We hypothesized that there exists a specific heart rate at which the external left ventricular (LV) power is minimized. To test this hypothesis, we used a computational model to explore the effects of heart rate (HR) and aortic rigidity on left ventricular (LV) power requirement. While both mean and pulsatile parts of the pressure play an important role in LV power requirement elevation, at higher rigidities the effect of pulsatility becomes more dominant. For any given aortic rigidity, there exists an optimum HR that minimizes the LV power requirement at a given cardiac output. The optimum HR shifts to higher values as the aorta becomes more rigid. To conclude, there is an optimum condition for aortic waves that minimizes the LV pulsatile load and consequently the total LV workload.	[Pahlevan, Niema M.; Gharib, Morteza] CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA	California Institute of Technology	Pahlevan, NM (corresponding author), CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Pahlevan, Niema M/ABF-7268-2021; Pahlevan, Niema/AAY-4299-2020; Stefanadis, Christodoulos/ABH-2232-2020	Pahlevan, Niema/0000-0001-7498-0396; Gharib, Mohammed/0000-0001-9611-1693; Stefanadis, Christodoulos/0000-0001-5974-6454	Fletcher Jones foundation; Medtronic Corp; Charyk Family foundation	Fletcher Jones foundation; Medtronic Corp; Charyk Family foundation	This research effort has been funded by unrestricted (research topic or publication approval) gift funds from Fletcher Jones foundation, Medtronic Corp, and Charyk Family foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINA R& D I, 2009, THEOR MOD GUID, VIII; ADINA R& D I, 2009, THEOR MOD GUID, VI; Avrahami I, 2008, J FLUID MECH, V608, P139, DOI 10.1017/S0022112008002012; Bathe K.-J., 2006, FINITE ELEMENT PROCE; Bathe KJ, 1997, COMPUT STRUCT, V64, P909, DOI 10.1016/S0045-7949(97)00040-0; Bathe KJ, 1999, COMPUT STRUCT, V72, P1, DOI 10.1016/S0045-7949(99)00042-5; BATHE KJ, 1995, COMPUT STRUCT, V56, P193, DOI 10.1016/0045-7949(95)00015-9; Bathe M, 1999, J BIOMECH ENG-T ASME, V121, P361, DOI 10.1115/1.2798332; Caro C. G., 2012, MECH CIRCULATION, VSecond; Curtis SL, 2007, AM J PHYSIOL-HEART C, V293, pH557, DOI 10.1152/ajpheart.01095.2006; ELZINGA G, 1991, CIRC RES, V68, P1495, DOI 10.1161/01.RES.68.6.1495; Feldman MD, 1988, J CLIN INVESTIGATION, V82; Fung Y. C., 1997, BIOMECHANICS CIRCULA; GIANNATTASIO C, 1994, J HYPERTENS, V12, P691; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; KANNEL WB, 1994, BRIT HEART J, V72, P3; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; KOOL MJF, 1993, J AM COLL CARDIOL, V22, P1881, DOI 10.1016/0735-1097(93)90773-T; LANIADO S, 1982, CIRCULATION, V66, P226, DOI 10.1161/01.CIR.66.1.226; LASKEY WK, 1987, CIRCULATION, V75, P711, DOI 10.1161/01.CIR.75.4.711; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; Levent E, 2004, J ADOLESCENT HEALTH, V34, P339, DOI 10.1016/j.jadohealth.2003.07.012; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60; Matthys KS, 2007, J BIOMECH, V40, P11; Milnor W. R., 1989, HAEMODYNAMICS; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313; Ohte N, 2003, HEART VESSELS, V18, P136, DOI 10.1007/s00380-003-0697-9; Ooi Henry, 2008, Congest Heart Fail, V14, P31, DOI 10.1111/j.1751-7133.2008.07210.x; ORourke MF, 1996, CLIN EXP PHARMACOL P, V23, pS11, DOI 10.1111/j.1440-1681.1996.tb03035.x; Pahlevan NM, 2011, ANN BIOMED ENG, V39, P1470, DOI 10.1007/s10439-011-0246-0; Safar ME, 2006, HDB HYPERTENSION, V23; Stefanadis C, 1997, CIRCULATION, V95, P31, DOI 10.1161/01.CIR.95.1.31; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002	39	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23106	10.1371/journal.pone.0023106	http://dx.doi.org/10.1371/journal.pone.0023106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853075	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000293953400026
J	Serra, M; Correia, C; Malpique, R; Brito, C; Jensen, J; Bjorquist, P; Carrondo, MJT; Alves, PM				Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Jensen, Janne; Bjorquist, Petter; Carrondo, Manuel J. T.; Alves, Paula M.			Microencapsulation Technology: A Powerful Tool for Integrating Expansion and Cryopreservation of Human Embryonic Stem Cells	PLOS ONE			English	Article							ALGINATE-BASED MICROCAPSULES; SCALABLE CULTURE; ENCAPSULATION; DIFFERENTIATION; VIABILITY	The successful implementation of human embryonic stem cells (hESCs)-based technologies requires the production of relevant numbers of well-characterized cells and their efficient long-term storage. In this study, cells were microencapsulated in alginate to develop an integrated bioprocess for expansion and cryopreservation of pluripotent hESCs. Different three-dimensional (3D) culture strategies were evaluated and compared, specifically, microencapsulation of hESCs as: i) single cells, ii) aggregates and iii) immobilized on microcarriers. In order to establish a scalable bioprocess, hESC-microcapsules were cultured in stirred tank bioreactors. The combination of microencapsulation and microcarrier technology resulted in a highly efficient protocol for the production and storage of pluripotent hESCs. This strategy ensured high expansion ratios (an approximately twenty-fold increase in cell concentration) and high cell recovery yields (>70%) after cryopreservation. When compared with non-encapsulated cells, cell survival post-thawing demonstrated a three-fold improvement without compromising hESC characteristics. Microencapsulation also improved the culture of hESC aggregates by protecting cells from hydrodynamic shear stress, controlling aggregate size and maintaining cell pluripotency for two weeks. This work establishes that microencapsulation technology may prove a powerful tool for integrating the expansion and cryopreservation of pluripotent hESCs. The 3D culture strategy developed herein represents a significant breakthrough towards the implementation of hESCs in clinical and industrial applications.	[Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Carrondo, Manuel J. T.; Alves, Paula M.] Inst Biol Expt & Tecnol, Oeiras, Portugal; [Jensen, Janne; Bjorquist, Petter] Cellartis AB, Gotemborg, Sweden; [Carrondo, Manuel J. T.] Univ Nova Lisboa, Fac Ciencias & Tecnol, P-2825 Monte De Caparica, Portugal	Universidade Nova de Lisboa; Takara Bio Inc.; Cellartis; Universidade Nova de Lisboa	Serra, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	marques@itqb.unl.pt	Brito, Catarina/A-2389-2009; Carrondo, Manuel JT/C-8155-2011; Serra, Margarida/N-1769-2013; Malpique, Rita/M-2404-2015; Alves, Paula M/C-1070-2008	Brito, Catarina/0000-0002-8926-279X; Serra, Margarida/0000-0001-5013-6625; Malpique, Rita/0000-0002-5282-6790; Alves, Paula M/0000-0003-1445-3556; Carrondo, Manuel/0000-0002-4550-4574	FCT Portugal [PTDC/BIO/72755/2006, SFRH/BD/42176/2007]; European Commission [Clinigene: LSHB-CT-2006-018933, HYPERLAB: 223011]	FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by FCT Portugal (PTDC/BIO/72755/2006, SFRH/BD/42176/2007) and European Commission (Clinigene: LSHB-CT-2006-018933, HYPERLAB: 223011). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janne Jensen and Petter Bjorquist are employees of Cellartis AB and played a role in analysis and writing of the manuscript.	Azarin SM, 2010, BIOCHEM ENG J, V48, P378, DOI 10.1016/j.bej.2009.10.020; Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Freimark D, 2010, TRANSFUS MED HEMOTH, V37, P66, DOI 10.1159/000285777; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Hunt CJ, 2007, TRANSFUS MED HEMOTH, V34, P293, DOI 10.1159/000104458; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Jing D, 2010, CELL TRANSPLANT; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kim SJ, 2004, STEM CELLS, V22, P950, DOI 10.1634/stemcells.22-6-950; KRAWETZ R, 2009, TISSUE ENG C; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748; Malpique R, 2010, TISSUE ENG PART C-ME, V16, P965, DOI 10.1089/ten.TEC.2009.0660; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Murase N, 1997, CRYO-LETT, V18, P157; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044; Nirmalanandhan VS, 2009, J BIOMOL SCREEN, V14, P755, DOI 10.1177/1087057109336591; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Sargent CY, 2010, BIOTECHNOL BIOENG, V105, P611, DOI 10.1002/bit.22578; Schwinger C, 2002, J MICROENCAPSUL, V19, P273, DOI 10.1080/02652040110105328; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027; Tostoes RM, 2010, BIOTECHNOL IN PRESS; Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2; Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032; Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x	42	115	120	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23212	10.1371/journal.pone.0023212	http://dx.doi.org/10.1371/journal.pone.0023212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850261	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300046
J	Tsubota, T; Ohashi, Y; Tamura, K; Sato, A; Miyashita, Y				Tsubota, Tadashi; Ohashi, Yohei; Tamura, Keita; Sato, Ayana; Miyashita, Yasushi			Optogenetic Manipulation of Cerebellar Purkinje Cell Activity In Vivo	PLOS ONE			English	Article							LENTIVIRAL VECTORS; CARDIOVASCULAR CONTROL; MILLISECOND-TIMESCALE; VESTIBULAR INFLUENCES; OPTICAL TECHNOLOGIES; COMPLEX SPIKE; MOTOR CORTEX; EXPRESSION; NEURONS; BRAIN	Purkinje cells (PCs) are the sole output neurons of the cerebellar cortex. Although their anatomical connections and physiological response properties have been extensively studied, the causal role of their activity in behavioral, cognitive and autonomic functions is still unclear because PC activity cannot be selectively controlled. Here we developed a novel technique using optogenetics for selective and rapidly reversible manipulation of PC activity in vivo. We injected into rat cerebellar cortex lentiviruses expressing either the light-activated cationic channel channelrhodopsin-2 (ChR2) or light-driven chloride pump halorhodopsin (eNpHR) under the control of the PC-specific L7 promoter. Transgene expression was observed in most PCs (ChR2, 92.6%; eNpHR, 95.3%), as determined by immunohistochemical analysis. In vivo electrophysiological recordings showed that all light-responsive PCs in ChR2-transduced rats increased frequency of simple spike in response to blue laser illumination. Similarly, most light-responsive PCs (93.8%) in eNpHR-transduced rats decreased frequency of simple spike in response to orange laser illumination. We then applied these techniques to characterize the roles of rat cerebellar uvula, one of the cardiovascular regulatory regions in the cerebellum, in resting blood pressure (BP) regulation in anesthetized rats. ChR2-mediated photostimulation and eNpHR-mediated photoinhibition of the uvula had opposite effects on resting BP, inducing depressor and pressor responses, respectively. In contrast, manipulation of PC activity within the neighboring lobule VIII had no effect on BP. Blue and orange laser illumination onto PBS-injected lobule IX didn't affect BP, indicating the observed effects on BP were actually due to PC activation and inhibition. These results clearly demonstrate that the optogenetic method we developed here will provide a powerful way to elucidate a causal relationship between local PC activity and functions of the cerebellum.	[Tsubota, Tadashi; Ohashi, Yohei; Tamura, Keita; Sato, Ayana; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; [Sato, Ayana; Miyashita, Yasushi] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Tsubota, T (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Tamura, Keita/0000-0003-2697-1510; Miyashita, Yasushi/0000-0003-3496-8637	Ministry for Education, Culture, Sports, Science and Technology (MEXT) [19002010]; Japan Society for the Promotion of Science (JSPS) [235569, 195225, 211438]; Grants-in-Aid for Scientific Research [19002010] Funding Source: KAKEN	Ministry for Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for specially Promoted Research from Ministry for Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/) to Y.M. (19002010), Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT (http://www.mext.go.jp/english/) to Y.M., and Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) Research Fellowships for Young Scientists to T.T. (235569), Y.O. (195225) and K.T. (211438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BALL GG, 1974, PHYSIOL BEHAV, V13, P123, DOI 10.1016/0031-9384(74)90313-8; Barman SM, 2009, AM J PHYSIOL-REG I, V297, pR210, DOI 10.1152/ajpregu.90989.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V393, P107, DOI 10.1113/jphysiol.1987.sp016813; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V383, P537; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EKEROT CF, 1981, J PHYSIOL-LONDON, V318, P207; Frecha C, 2008, CURR GENE THER, V8, P449, DOI 10.2174/156652308786848003; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Miall RC, 1998, NAT NEUROSCI, V1, P13, DOI 10.1038/212; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; PATON JFR, 1990, J PHYSIOL-LONDON, V427, P533, DOI 10.1113/jphysiol.1990.sp018186; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; RUSSO AF, 1988, NEURON, V1, P311, DOI 10.1016/0896-6273(88)90079-7; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; THACH WT, 1967, J NEUROPHYSIOL, V30, P675, DOI 10.1152/jn.1967.30.4.675; Yates BJ, 2000, BRAIN RES BULL, V53, P3, DOI 10.1016/S0361-9230(00)00302-6; Yates BJ, 1996, ANN NY ACAD SCI, V781, P458, DOI 10.1111/j.1749-6632.1996.tb15720.x; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	51	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22400	10.1371/journal.pone.0022400	http://dx.doi.org/10.1371/journal.pone.0022400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850224	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300008
J	Berentzen, TL; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Sorensen, TIA; Overvad, K				Berentzen, Tina Landsvig; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Sorensen, Thorkild I. A.; Overvad, Kim			Changes in Waist Circumference and the Incidence of Diabetes in Middle-Aged Men and Women	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; FOOD FREQUENCY QUESTIONNAIRE; INSULIN-RESISTANCE; VISCERAL ADIPOSITY; PROSPECTIVE COHORT; HEALTH; RISK; POPULATION; DENMARK; OBESITY	Background: Waist circumference (WC) is positively associated with diabetes, but the association with changes in WC (DWC) is less clear. We investigated the association between DWC and the subsequent risk of diabetes in middle-aged men and women, and evaluated the influence from concurrent changes in body mass index (DBMI). Methodology/Principal Findings: Data on 15,577 men and 20,066 women from the Danish Diet, Cancer and Health study were analyzed. Anthropometry was assessed in 1993-97 and 1999-02. Information on diabetes was obtained from The Danish National Diabetes Register. Hazard ratios (HR) were calculated from Cox' proportional hazard models with individuals considered at risk from 1999-02 until December 31 2006. During 5.4 years of follow-up, 1,027 and 876 new cases of diabetes occurred among men and women, respectively. WC was positively associated with diabetes in both sexes also with adjustment for covariates and BMI. DWC was positively associated with diabetes in women, but not in men (HR per 5 cm change = 1.09 (1.04:1.15) in women, and 1.00 (0.94, 1.07) in men with adjustment for covariates, baseline WC, BMI and DBMI). Associations with DWC were not notably different in sub-groups stratified according to baseline WC or DBMI, or when individuals with diseases or diabetes occurring within the first years of follow-up were excluded. Conclusions/Significance: While this study confirmed that WC is positively associated with the risk of diabetes in middle-aged men and women, it surprisingly showed that changes in WC were not associated with the subsequent risk of diabetes in men, and only weakly positively associated with the risk of diabetes in women. Accordingly, these findings suggest that a reduction in WC may be a weak or insufficient or target for prevention of diabetes in middle-aged men and women.	[Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Univ Copenhagen Hosp, Inst Prevent Med, DK-2100 Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark	University of Copenhagen; Aarhus University; Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University	Berentzen, TL (corresponding author), Univ Copenhagen Hosp, Inst Prevent Med, DK-2100 Copenhagen, Denmark.	tb@ipm.regionh.dk	Jakobsen, Marianne Uhre/I-8550-2018	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921	European Commission [LSHM-CT-2005-018734]; Danish Obesity Research Centre; Danish Council for Strategic Research; Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Obesity Research Centre; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	This work was supported by the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome'' (HEPADIP; www.hepadip.org) supported by the European Commission as an Integrated Project under the 6th Framework Program (contract LSHM-CT-2005-018734), and the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk) supported by the Danish Council for Strategic Research (contract 2101-06-0005). Funding was also obtained from The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Bigaard J, 2005, J NUTR, V135, P2263; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hanley AJG, 2009, DIABETOLOGIA, V52, P2079, DOI 10.1007/s00125-009-1464-y; Harrel jF, 2002, APPL LINEAR MODELS L; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kristensen JK, 2001, DAN MED BULL, V48, P33; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Park K, 2010, OBESITY, V18, P370, DOI 10.1038/oby.2009.252; Schooling CM, 2010, DIABETOLOGIA, V53, P393, DOI 10.1007/s00125-009-1613-3; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Sorensen TIA, 2011, OBESITY FACTS, V4, P91, DOI 10.1159/000328198; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; SWINBURN BA, 1991, J CLIN INVEST, V88, P168, DOI 10.1172/JCI115274; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	33	6	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23104	10.1371/journal.pone.0023104	http://dx.doi.org/10.1371/journal.pone.0023104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829698	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200047
J	Le, L; Leluk, J				Ly Le; Leluk, Jacek			Study on Phylogenetic Relationships, Variability, and Correlated Mutations in M2 Proteins of Influenza Virus A	PLOS ONE			English	Article							A VIRUS; PROTON CHANNEL; M-GENE; MECHANISM; INHIBITION; ALGORITHM; CONSURF; BLAST	M2 channel, an influenza virus transmembrane protein, serves as an important target for antiviral drug design. There are still discordances concerning the role of some residues involved in proton transfer as well as the mechanism of inhibition by commercial drugs. The viral M2 proteins show high conservativity; about 3/4 of the positions are occupied by one residue in over 95%. Nine M2 proteins from the H3N2 strain and possibly two proteins from H2N2 strains make a phylogenic cluster closely related to 2RLF. The variability range is limited to 4 residues/position with one exception. The 2RLF protein stands out by the presence of 2 serines at the positions 19 and 50, which are in most other M2 proteins occupied by cysteines. The study of correlated mutations shows that there are several positions with significant mutational correlation that have not been described so far as functionally important. That there are 5 more residues potentially involved in the M2 mechanism of action. The original software used in this work (Consensus Constructor, SSSSg, Corm, Talana) is freely accessible as stand-alone offline applications upon request to the authors. The other software used in this work is freely available online for noncommercial purposes at public services on bioinformatics such as ExPASy or NCBI. The study on mutational variability, evolutionary relationship, and correlated mutation presented in this paper is a potential way to explain more completely the role of significant factors in proton channel action and to clarify the inhibition mechanism by specific drugs.	[Ly Le] Ho Chi Minh Int Univ, Sch Biotechnol, Ho Chi Minh City, Vietnam; [Leluk, Jacek] Univ Zielona Gora, Dept Mol Biol, Fac Biol Sci, Zielona Gora, Poland	Vietnam National University Hochiminh City; University of Zielona Gora	Le, L (corresponding author), Ho Chi Minh Int Univ, Sch Biotechnol, Ho Chi Minh City, Vietnam.	J.Leluk@wnb.uz.zgora.pl	Leluk, Jacek/G-2839-2015	Leluk, Jacek/0000-0002-4410-4317	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.99-2010.03]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	The authors wish to thank the Vietnam National Foundation for Science and Technology Development (NAFOSTED) for the funding under grant number 106.99-2010.03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fogtman A, 2005, BIOALGORITHMS MED SY, V1, P117; Forrest LR, 2000, BIOPHYS J, V78, P55, DOI 10.1016/S0006-3495(00)76572-6; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; Gajewska E, 2005, BIOALGORITHMS MED SY, V1, P121; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GORECKI A, 2005, IDENTIFICATION FREE; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Intharathep P, 2008, J MOL GRAPH MODEL, V27, P342, DOI 10.1016/j.jmgm.2008.06.002; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KUSKA J, 2010, TALANA NOVEL APPL PR; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laohpongspaisan C, 2009, J CHEM INF MODEL, V49, P847, DOI 10.1021/ci800267a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000939; Leluk J, 2001, ACTA BIOCHIM POL, V48, P21; Leluk J, 2000, BIOSYSTEMS, V56, P83, DOI 10.1016/S0303-2647(00)00074-5; Leluk J, 1998, COMPUT CHEM, V22, P123, DOI 10.1016/S0097-8485(97)00035-1; Leluk J, 2000, COMPUT CHEM, V24, P659, DOI 10.1016/S0097-8485(00)00070-X; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22970	10.1371/journal.pone.0022970	http://dx.doi.org/10.1371/journal.pone.0022970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829678	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900021
J	Sofrata, A; Santangelo, EM; Azeem, M; Borg-Karlson, AK; Gustafsson, A; Putsep, K				Sofrata, Abier; Santangelo, Ellen M.; Azeem, Muhammad; Borg-Karlson, Anna-Karin; Gustafsson, Anders; Putsep, Katrin			Benzyl Isothiocyanate, a Major Component from the Roots of Salvadora Persica Is Highly Active against Gram-Negative Bacteria	PLOS ONE			English	Article							MISWAK; PERIODONTITIS; MICROORGANISMS; METABOLISM; MYROSINASE; PRODUCTS; EXTRACTS; DEFENSE	Plants produce a number of antimicrobial substances and the roots of the shrub Salvadora persica have been demonstrated to possess antimicrobial activity. Sticks from the roots of S. persica, Miswak sticks, have been used for centuries as a traditional method of cleaning teeth. Diverging reports on the chemical nature and antimicrobial repertoire of the chewing sticks from S. persica led us to explore its antibacterial properties against a panel of pathogenic or commensal bacteria and to identify the antibacterial component/s by methodical chemical characterization. S. persica root essential oil was prepared by steam distillation and solid-phase microextraction was used to sample volatiles released from fresh root. The active compound was identified by gas chromatography-mass spectrometry and antibacterial assays. The antibacterial compound was isolated using medium-pressure liquid chromatography. Transmission electron microscopy was used to visualize the effect on bacterial cells. The main antibacterial component of both S. persica root extracts and volatiles was benzyl isothiocyanate. Root extracts as well as commercial synthetic benzyl isothiocyanate exhibited rapid and strong bactericidal effect against oral pathogens involved in periodontal disease as well as against other Gram-negative bacteria, while Gram-positive bacteria mainly displayed growth inhibition or remained unaffected. The short exposure needed to obtain bactericidal effect implies that the chewing sticks and the essential oil may have a specific role in treatment of periodontal disease in reducing Gram-negative periodontal pathogens. Our results indicate the need for further investigation into the mechanism of the specific killing of Gram-negative bacteria by S. persica root stick extracts and its active component benzyl isothiocyanate.	[Sofrata, Abier; Gustafsson, Anders] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Santangelo, Ellen M.; Azeem, Muhammad; Borg-Karlson, Anna-Karin] Royal Inst Technol, Sch Chem Sci & Engn, Dept Chem, Stockholm, Sweden; [Putsep, Katrin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet	Sofrata, A (corresponding author), Karolinska Inst, Dept Dent Med, Stockholm, Sweden.	katrin.putsep@ki.se	Azeem, Muhammad/AAX-9422-2020	Azeem, Muhammad/0000-0003-3054-700X; Sofrata, Abier H./0000-0003-4761-3042	Swedish Research Council [06XD-14653]; Swedish Medical Society; Ake Wiberg foundation; Swedish Research Council Formas; Higher Education Commission Pakistan HEC; Ministry of Health, Riyadh, Saudi Arabia	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Ake Wiberg foundation; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Higher Education Commission Pakistan HEC(Higher Education Commission of Pakistan); Ministry of Health, Riyadh, Saudi Arabia	This study was supported by the Swedish Research Council (06XD-14653 to KP), the Swedish Medical Society (to KP), the Ake Wiberg foundation (to KP), the Swedish Research Council Formas (to AKBK), Higher Education Commission Pakistan HEC (to MA), and the Ministry of Health, Riyadh, Saudi Arabia (to AS). These funding bodies had no role in study design, data collection, analysis of data, writing the manuscript or in the decision to submit this manuscript for publication.	Aires A, 2009, J APPL MICROBIOL, V106, P2086, DOI 10.1111/j.1365-2672.2009.04180.x; Al lafi T, 1995, Int Dent J, V45, P218; Al-Otaibi M, 2004, J CLIN PERIODONTOL, V31, P1048, DOI 10.1111/j.1600-051X.2004.00618.x; ALBAGIEH NH, 1994, MICROBIOS, V80, P107; ALBAGIEH NH, 1989, MICROBIOS LETT, V29, P143; Almas K, 2005, Int J Dent Hyg, V3, P18, DOI 10.1111/j.1601-5037.2004.00111.x; Almas K, 1997, BIOMED LETT, V56, P145; ALMAS K, 1999, INDIAN J DENT RES, P23; Amano A, 2010, PERIODONTOL 2000, V54, P9, DOI 10.1111/j.1600-0757.2010.00376.x; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Beevi SS, 2009, FOODBORNE PATHOG DIS, V6, P129, DOI 10.1089/fpd.2008.0166; BOMAN HG, 1974, ANN NY ACAD SCI, V235, P569, DOI 10.1111/j.1749-6632.1974.tb43291.x; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; BRIENSIMPSON NM, 2003, CURR PROTEIN PEPT SC, V4, P409; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Darmani H, 2006, Int J Dent Hyg, V4, P62, DOI 10.1111/j.1601-5037.2006.00149.x; Darout IA, 2000, ACTA ODONTOL SCAND, V58, P25, DOI 10.1080/000163500429398; Darout Ismail A., 2000, Indian Journal of Pharmacology, V32, P11; DELOUVOIS J, 1982, J ANTIMICROB CHEMOTH, V9, P253, DOI 10.1093/jac/9.4.253; Dierickx K, 2002, J CLIN PERIODONTOL, V29, P987, DOI 10.1034/j.1600-051X.2002.291103.x; Ezmirly S., 1981, J SOC CHEMIS PAKISTA, V3, P9; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Fives-Taylor P, 1995, Adv Dent Res, V9, P55; Garboui SS, 2009, J MED ENTOMOL, V46, P1415, DOI 10.1603/033.046.0623; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Haraszthy VI, 2000, J PERIODONTOL, V71, P912, DOI 10.1902/jop.2000.71.6.912; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Hyson John M Jr, 2003, J Hist Dent, V51, P73; Kassie F, 1999, MUTAGENESIS, V14, P595, DOI 10.1093/mutage/14.6.595; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh P D, 1994, Adv Dent Res, V8, P263; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Miyoshi N, 2004, CARCINOGENESIS, V25, P567, DOI 10.1093/carcin/bgh051; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sofrata A, 2007, CARIES RES, V41, P451, DOI 10.1159/000107931; Sofrata AH, 2008, J PERIODONTOL, V79, P1474, DOI [10.1902/jop.2008.070506, 10.1902/jop.2008.070506 ]; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960	45	123	124	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23045	10.1371/journal.pone.0023045	http://dx.doi.org/10.1371/journal.pone.0023045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829688	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511200033
J	Wen, S; So, Y; Singh, K; Slingerland, JM; Resnick, MB; Zhang, S; Ruiz, V; Moss, SF				Wen, S.; So, Y.; Singh, K.; Slingerland, J. M.; Resnick, M. B.; Zhang, S.; Ruiz, V.; Moss, S. F.			Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer	ONCOGENE			English	Article						gastric cancer; Helicobacter pylori; cell cycle regulation; cyclin-dependent kinase inhibitor	KINASE INHIBITOR P27(KIP1); EPITHELIAL-CELLS; PHOSPHORYLATION; EXPRESSION; APOPTOSIS; ACTIVATION; RISK; ERADICATION; PHENOTYPE; CARCINOMA	The cyclin-dependent kinase (CDK) inhibitor p27 has an important role in cell cycle regulation. Reduced expression of p27 is commonly associated with poor prognosis in many malignancies, including gastric cancer. Cytoplasmic p27 mislocalization may be an additional indicator of high-grade tumors and poor prognosis in cancer. As chronic infection by Helicobacter pylori is the most important risk factor for gastric cancer development, we evaluated the effects of H. pylori on p27 expression and localization in gastric cancer cells. Co-culture of gastric cells with H. pylori induced cytoplasmic p27 expression and reduced nuclear p27 expression in vitro. Cytoplasmic p27 expression was associated with and dependent upon phosphorylation of p27 at T157 and T198: wild-type p27 accumulated in the cytoplasm, but non-phosphorylatable mutants affecting T157 or T198 were nuclear in H. pylori-infected cells. These post-translational p27 changes were secondary to activation of cellular phosphoinositide-3 kinase (PI3K) and AKT signaling pathways, and dependent upon a functional H. pylori cag pathogenicity island. We investigated the clinical significance of cytoplasmic p27 mislocalization in 164 cases of resected gastric cancer in tissue microarrays. In 97 cases (59%), cytoplasmic p27 mislocalization was observed, and this was associated with increased mortality in multivariate analysis. These results show that H. pylori infection induces AKT/PI3K-mediated phosphorylation of p27 at T157 and T198 to cause cytoplasmic p27 mislocalization in gastric cancer, and that p27 mislocalization is an adverse prognostic feature in gastric cancer. This is the first demonstration of the translocation of a specific bacterial virulence factor that post-translationally regulates a host cell CDK inhibitor. This is of particular significance, because p27 has both tumor-suppressive and oncogenic activities, depending upon its subcellular localization. Cytoplasmic mislocalization of p27 induced by H. pylori may be an important mechanistic link between H. pylori infection and gastric carcinogenesis. Oncogene (2012) 31, 1771-1780; doi: 10.1038/onc.2011.362; published online 15 August 2011	[Wen, S.; So, Y.; Zhang, S.; Ruiz, V.; Moss, S. F.] Brown Univ, Dept Med, Div Gastroenterol, Rhode Isl Hosp, Providence, RI 02903 USA; [Wen, S.; So, Y.; Singh, K.; Resnick, M. B.; Zhang, S.; Ruiz, V.; Moss, S. F.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [Singh, K.; Resnick, M. B.] Brown Univ, Dept Pathol, Rhode Isl Hosp, Providence, RI 02903 USA; [Slingerland, J. M.] Univ Miami, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, Miami, FL USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Miami	Moss, SF (corresponding author), Brown Univ, Dept Med, Div Gastroenterol, Rhode Isl Hosp, 593 Eddy St,APC 414, Providence, RI 02903 USA.	Steven_Moss@Brown.edu	wen, sicheng/E-7676-2012; Resnick, Murray/U-2986-2019	Ruiz, Victoria/0000-0002-0121-4727; Singh, Kamaljeet/0000-0002-2506-5703	US Public Health Service [NIH R01CA111533, NIH P20RR17695]; NATIONAL CANCER INSTITUTE [R01CA111533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We appreciate the help of Virginia Hovanesian for technical assistance with confocal microscopy, and Leila Noble and Rose Tavares for immunohistochemistry. The study was funded by US Public Health Service Grants NIH R01CA111533 (to SFM) and NIH P20RR17695 (to MBR).	Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Duncan TJ, 2010, INT J GYNECOL PATHOL, V29, P8, DOI 10.1097/PGP.0b013e3181b64ec3; Eguchi H, 2004, GUT, V53, P797, DOI 10.1136/gut.2003.032144; Feakins RM, 2000, CANCER, V89, P1684, DOI 10.1002/1097-0142(20001015)89:8<1684::AID-CNCR6>3.0.CO;2-6; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hidaka T, 2009, ANTICANCER RES, V29, P597; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Jubelin G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004855; Kajihara R, 2010, BIOCHEM BIOPH RES CO, V401, P350, DOI 10.1016/j.bbrc.2010.09.051; Kim SS, 2006, MODERN PATHOL, V19, P49, DOI 10.1038/modpathol.3800476; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kuzushita N, 2005, GASTROENTEROLOGY, V129, P1544, DOI 10.1053/j.gastro.2005.07.056; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li R, 2006, J UROLOGY, V175, P528, DOI 10.1016/S0022-5347(05)00151-5; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu H, 2009, GASTROENTEROLOGY, V137, P1367, DOI 10.1053/j.gastro.2009.07.041; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Mori M, 1997, NAT MED, V3, P593, DOI 10.1038/nm0697-593; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Resnick MB, 2005, HUM PATHOL, V36, P886, DOI 10.1016/j.humpath.2005.05.019; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Shirin H, 2000, INFECT IMMUN, V68, P5321, DOI 10.1128/IAI.68.9.5321-5328.2000; Shirin H, 1999, CANCER RES, V59, P2277; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304; Yasui W, 1997, JPN J CANCER RES, V88, P625, DOI 10.1111/j.1349-7006.1997.tb00428.x	43	22	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	14					1771	1780		10.1038/onc.2011.362	http://dx.doi.org/10.1038/onc.2011.362			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21841827	Green Accepted			2022-12-25	WOS:000302785200003
J	Young, JC; Major, AT; Miyamoto, Y; Loveland, KL; Jans, DA				Young, Julia C.; Major, Andrew T.; Miyamoto, Yoichi; Loveland, Kate L.; Jans, David A.			Distinct effects of importin alpha 2 and alpha 4 on Oct3/4 localization and expression in mouse embryonic stem cells	FASEB JOURNAL			English	Article						differentiation; embryoid body; nuclear transport; importin/karyopherin	NUCLEAR-MEMBRANE; NUCLEOCYTOPLASMIC TRANSPORT; CELLULAR-DIFFERENTIATION; EARLY EMBRYOGENESIS; ES CELLS; PROTEIN; SIGNAL; SPERMATOGENESIS; PLURIPOTENCY; SUBUNITS	The cellular repertoire of importin (IMP) proteins that mediates nuclear import of transcription factors and chromatin remodeling agents is critical to processes such as differentiation and transformation. This study identifies for the first time independent roles for specific IMP alpha s in murine embryonic stem cells (mESCs), showing that mESC differentiation is accompanied by dynamic changes in the levels of transcripts encoding the IMPs, IMP alpha 3, IMP alpha 4, IMP beta 1, and IPO5. Of these, only IMP alpha 4 was maintained at higher levels in differentiating mESCs, correlating with the finding that IMP alpha 4 overexpression induced a significant decrease in Oct3/4 protein levels compared to control transfections. In parallel, IMP alpha 4 protein showed a unique and striking shift in subcellular localization from the nucleus to the cytoplasm during differentiation, which is consistent with activation of a role in nuclear import of differentiation factors. Overexpression of a dominant-negative IMP alpha 2 isoform, when assessed against adjacent untransfected or IMP alpha 2 transfected cells, led to both a significant reduction in endogenous Oct3/4 protein levels and inhibition of Oct3/4 nuclear localization, suggesting that IMP alpha 2-mediated delivery of Oct3/4 to the nucleus contributes directly to maintenance of mESC pluripotency. These findings implicate IMP alpha 2 and IMP alpha 4 in specific but distinct roles in the fate choice between pluripotency and commitment to differentiation.-Young, J. C., Major, A. T., Miyamoto, Y., Loveland, K. L., Jans, D. A. Distinct effects of importin alpha 2 and alpha 4 on Oct3/4 localization and expression in mouse embryonic stem cells. FASEB J. 25, 3958-3965 (2011). www.fasebj.org	[Young, Julia C.; Miyamoto, Yoichi; Loveland, Kate L.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Young, Julia C.; Major, Andrew T.; Miyamoto, Yoichi; Loveland, Kate L.; Jans, David A.] Monash Univ, Australian Res Council, Ctr Excellence Biotechnol & Dev, Clayton, Vic 3168, Australia; [Major, Andrew T.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Loveland, KL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3168, Australia.	kate.loveland@monash.edu	Major, Andrew T./B-8469-2016; Loveland, Kate L/X-4404-2019	Major, Andrew T./0000-0001-9036-6652; Loveland, Kate L/0000-0002-5750-8046; Young, Julia/0000-0001-7219-7824; Jans, David/0000-0001-5115-4745	Australian Research Council [348239, DPO878102]; National Health and Medical Research Council [545917, 384109, APP1002486]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work received grant support from the Australian Research Council (COE#348239 and #DPO878102) and National Health and Medical Research Council (ID#545917, ID#384109 and APP1002486). The authors acknowledge the excellent technical assistance of Chin Wong.	Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fulcher AJ, 2010, FASEB J, V24, P1454, DOI 10.1096/fj.09-136564; Geles KG, 2002, MOL BIOL CELL, V13, P3138, DOI 10.1091/mbc.E02-02-0069; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hogarth C, 2005, BIOESSAYS, V27, P1011, DOI 10.1002/bies.20289; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Li XQ, 2008, J GENET GENOMICS, V35, P723, DOI 10.1016/S1673-8527(08)60227-1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loveland K. L., 2006, EXPRESSION NUCL TRAN; Loveland KL, 2005, ANN NY ACAD SCI, V1061, P173, DOI 10.1196/annals.1336.018; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okada N, 2008, J CELL MOL MED, V12, P1863, DOI 10.1111/j.1582-4934.2008.00437.x; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trapani JA, 1998, CELL DEATH DIFFER, V5, P488, DOI 10.1038/sj.cdd.4400373; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	30	31	31	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3958	3965		10.1096/fj.10-176941	http://dx.doi.org/10.1096/fj.10-176941			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21840941	Bronze			2022-12-25	WOS:000296723100020
J	Miloslavina, Y; de Bianchi, S; Dall'Osto, L; Bassi, R; Holzwarth, AR				Miloslavina, Yuliya; de Bianchi, Silvia; Dall'Osto, Luca; Bassi, Roberto; Holzwarth, Alfred R.			Quenching in Arabidopsis thaliana Mutants Lacking Monomeric Antenna Proteins of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; CHARGE SEPARATION KINETICS; TIME-RESOLVED FLUORESCENCE; EXCITATION-ENERGY TRANSFER; PICOSECOND FLUORESCENCE; FUNCTIONAL ARCHITECTURE; PLASTOQUINONE POOL; BINDING-PROTEINS; CATION FORMATION; REACTION CENTERS	The minor light-harvesting complexes CP24, CP26, and CP29 have been proposed to play a key role in the zeaxanthin (Zx)-dependent high light-induced regulation (NPQ) of excitation energy in higher plants. To characterize the detailed roles of these minor complexes in NPQ and to determine their specific quenching effects we have studied the ultrafast fluorescence kinetics in knockout (ko) mutants koCP26, koCP29, and the double mutant koCP24/CP26. The data provide detailed insight into the quenching processes and the reorganization of the Photosystem (PS) II supercomplex under quenching conditions. All genotypes showed two NPQ quenching sites. Quenching site Q1 is formed by a light-induced functional detachment of parts of the PSII supercomplex and a pronounced quenching of the detached antenna parts. The antenna remaining bound to the PSII core was also quenched substantially in all genotypes under NPQ conditions (quenching site Q2) as compared with the dark-adapted state. The latter quenching was about equally strong in koCP26 and the koCP24/CP26 mutants as in the WT. Q2 quenching was substantially reduced, however, in koCP29 mutants suggesting a key role for CP29 in the total NPQ. The observed quenching effects in the knockout mutants are complicated by the fact that other minor antenna complexes do compensate in part for the lack of the CP24 and/or CP29 complexes. Their lack also causes some LHCII dissociation already in the dark.	[Miloslavina, Yuliya; Holzwarth, Alfred R.] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Miloslavina, Yuliya] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [de Bianchi, Silvia; Dall'Osto, Luca; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Bassi, Roberto] Forschungszentrum Julich, Inst Pflanzenwissensch 2, D-52425 Julich, Germany	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Verona; Helmholtz Association; Research Center Julich	Holzwarth, AR (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	holzwarth@mpi-muelheim.mpg.de	Holzwarth, Alfred R/G-2704-2013; Miloslavina, Yuliya/AAX-5751-2020; Holzwarth, Alfred/ABE-7424-2020	Miloslavina, Yuliya/0000-0001-6372-2420; Holzwarth, Alfred/0000-0002-9562-4873; Dall'Osto, Luca/0000-0001-9497-5156; bassi, roberto/0000-0002-4140-8446	European Union [238017]; Sonderforschungsbereich [SFB 663]; Heinrich-Heine-Universitat Dusseldorf; Max-Planck-Institutes Mulheim a.d. Ruhr	European Union(European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Heinrich-Heine-Universitat Dusseldorf; Max-Planck-Institutes Mulheim a.d. Ruhr	This work was supported by the Marie Curie Initial Training Network "HARVEST" Grant 238017 within the FP7 program of the European Union, Sonderforschungsbereich Grant SFB 663, Heinrich-Heine-Universitat Dusseldorf, and the Max-Planck-Institutes Mulheim a.d. Ruhr.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ballottari M, 2010, J BIOL CHEM, V285, P28309, DOI 10.1074/jbc.M110.124115; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dainese P., 1992, RES PHOTOSYNTHESIS, VII, P13; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEMMIGADAMS B, 1989, PLANT BIOLOGY, V8, P375; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth A. R., 2008, P141, DOI 10.1007/978-3-540-73566-3_7; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Holzwarth AR, 2005, J PHYS CHEM B, V109, P5903, DOI 10.1021/jp046299f; Holzwarth AR, 1996, BIOPHYSICAL TECHNIQU, P75, DOI DOI 10.1007/0-306-47960-5_; Horton P, 1996, NATO ADV SCI INST SE, V287, P99; Jackowski G, 1998, Z NATURFORSCH C, V53, P841; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; JOHNSON GN, 1994, PLANTA, V194, P550, DOI 10.1007/BF00714469; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Krause GH, 2003, LIGHT HARVESTING ANT, P373; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; MALKIN S, 1981, PLANT PHYSIOL, V67, P570, DOI 10.1104/pp.67.3.570; Miloslavina Y, 2006, BIOCHEMISTRY-US, V45, P2436, DOI 10.1021/bi052248c; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; MULLER MG, 1992, CHEM PHYS LETT, V199, P465, DOI 10.1016/0009-2614(92)87028-N; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Slavov C, 2008, BIOPHYS J, V94, P3601, DOI 10.1529/biophysj.107.117101; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Szczepaniak M, 2008, BBA-BIOENERGETICS, V1777, P1510, DOI 10.1016/j.bbabio.2008.09.002; Toth SZ, 2005, BBA-BIOENERGETICS, V1708, P275, DOI 10.1016/j.bbabio.2005.03.012; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X; [No title captured]	63	45	46	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36830	36840		10.1074/jbc.M111.273227	http://dx.doi.org/10.1074/jbc.M111.273227			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21844190	hybrid, Green Published			2022-12-25	WOS:000296538300063
J	Visweswaraiah, J; Lageix, S; Castilho, BA; Izotova, L; Kinzy, TG; Hinnebusch, AG; Sattlegger, E				Visweswaraiah, Jyothsna; Lageix, Sebastien; Castilho, Beatriz A.; Izotova, Lara; Kinzy, Terri Goss; Hinnebusch, Alan G.; Sattlegger, Evelyn			Evidence That Eukaryotic Translation Elongation Factor 1A (eEF1A) Binds the Gcn2 Protein C Terminus and Inhibits Gcn2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID CONTROL; EIF-2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; NUCLEOTIDE EXCHANGE; EIF2-ALPHA KINASE; STARVED CELLS; ACTIVATION; DOMAIN	The eukaryotic elongation factor 1A (eEF1A) delivers aminoacyl-tRNAs to the ribosomal A-site during protein synthesis. To ensure a continuous supply of amino acids, cells harbor the kinase Gcn2 and its effector protein Gcn1. The ultimate signal for amino acid shortage is uncharged tRNAs. We have proposed a model for sensing starvation, in which Gcn1 and Gcn2 are tethered to the ribosome, and Gcn1 is directly involved in delivering uncharged tRNAs from the A-site to Gcn2 for its subsequent activation. Gcn1 and Gcn2 are large proteins, and these proteins as well as eEF1A access the A-site, leading us to investigate whether there is a functional or physical link between these proteins. Using Saccharomyces cerevisiae cells expressing His(6)-eEF1A and affinity purification, we found that eEF1A co-eluted with Gcn2. Furthermore, Gcn2 co-immunoprecipitated with eEF1A, suggesting that they reside in the same complex. The purified GST-tagged Gcn2 C-terminal domain (CTD) was sufficient for precipitating eEF1A from whole cell extracts generated from gcn2 Delta cells, independently of ribosomes. Purified GST-Gcn2-CTD and purified His(6)-eEF1A interacted with each other, and this was largely independent of the Lys residues in Gcn2-CTD known to be required for tRNA binding and ribosome association. Interestingly, Gcn2-eEF1A interaction was diminished in amino acid-starved cells and by uncharged tRNAs in vitro, suggesting that eEF1A functions as a Gcn2 inhibitor. Consistent with this possibility, purified eEF1A reduced the ability of Gcn2 to phosphorylate its substrate, eIF2 alpha, but did not diminish Gcn2 autophosphorylation. These findings implicate eEF1A in the intricate regulation of Gcn2 and amino acid homeostasis.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Albany 0745, New Zealand; [Lageix, Sebastien; Hinnebusch, Alan G.; Sattlegger, Evelyn] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Izotova, Lara; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Massey University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidade Federal de Sao Paulo (UNIFESP); Rutgers State University New Brunswick; Rutgers State University Medical Center	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, POB 102 904, Albany 0745, New Zealand.	e.sattlegger@massey.ac.nz	Castilho, Beatriz A/C-2503-2012	Castilho, Beatriz A/0000-0003-4509-5237; Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health; Fundacao de Apoio a Pesquisa no Estado de Sao Paulo; Marsden Fund Council; Massey University; Royal Society of New Zealand [MAU0607];  [RO1 GM57483]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Apoio a Pesquisa no Estado de Sao Paulo; Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; Royal Society of New Zealand(Royal Society of New Zealand); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (to A.G.H.) and by Grant RO1 GM57483 (to T.G.K.). This work was also supported by a grant from Fundacao de Apoio a Pesquisa no Estado de Sao Paulo (to B.A.C.), The Marsden Fund Council from Government funding, administered by the Royal Society of New Zealand (MAU0607), and a Massey University Technician Award and Research Fund (to E.S.).	ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grallert B, 2007, CELL CYCLE, V6, P2768, DOI 10.4161/cc.6.22.4933; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; LAROSSA RA, 1984, J BIOL CHEM, V259, P8753; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MURCHIE MJ, 1978, BIOCHIM BIOPHYS ACTA, V520, P233, DOI 10.1016/0005-2787(78)90024-2; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Petrushenko ZM, 1997, FEBS LETT, V407, P13, DOI 10.1016/S0014-5793(97)00242-1; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Sambrook J., 2002, MOL CLONING LAB MANU; Sasse C, 2008, FUNGAL GENET BIOL, V45, P693, DOI 10.1016/j.fgb.2007.12.008; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E, 1998, J BIOL CHEM, V273, P20404, DOI 10.1074/jbc.273.32.20404; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; Taylor D. R., 2007, MONOGRAPH SERIES, V48, P59; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Visweswaraiah J., 2011, NAT PROTOC EXCHANGE, DOI [10.1038/protex.2011.2112, DOI 10.1038/PROTEX.2011.2112]; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	42	33	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36568	36579		10.1074/jbc.M111.248898	http://dx.doi.org/10.1074/jbc.M111.248898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849502	hybrid, Green Published			2022-12-25	WOS:000296538300041
J	Popoff, V; Langer, JD; Reckmann, I; Hellwig, A; Kahn, RA; Brugger, B; Wieland, FT				Popoff, Vincent; Langer, Julian D.; Reckmann, Ingeborg; Hellwig, Andrea; Kahn, Richard A.; Bruegger, Britta; Wieland, Felix T.			Several ADP-ribosylation Factor (Arf) Isoforms Support COPI Vesicle Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; COATED TRANSPORT VESICLES; EARLY SECRETORY PATHWAY; AP-3 ADAPTER COMPLEX; CLASS-II ARFS; GOLGI MEMBRANES; FUNCTIONAL-CHARACTERIZATION; BINDING-PROTEINS; APPENDAGE DOMAIN; MAMMALIAN-CELLS	Newly synthesized proteins and lipids are transported in vesicular carriers along the secretory pathway. Arfs (ADP-ribosylation factors), a family of highly conserved GTPases within the Ras superfamily, control recruitment of molecular coats to membranes, the initial step of coated vesicle biogenesis. Arf1 and coatomer constitute the minimal cytosolic machinery leading to COPI vesicle formation from Golgi membranes. Although some functional redundancies have been suggested, other Arf isoforms have been poorly analyzed in this context. In this study, we found that Arf1, Arf4, and Arf5, but not Arf3 and Arf6, associate with COPI vesicles generated in vitro from Golgi membranes and purified cytosol. Using recombinant myristoylated proteins, we show that Arf1, Arf4, and Arf5 each support COPI vesicle formation individually. Unexpectedly, we found that Arf3 could also mediate vesicle biogenesis. However, Arf3 was excluded from the vesicle fraction in the presence of the other isoforms, highlighting a functional competition between the different Arf members.	[Popoff, Vincent; Reckmann, Ingeborg; Bruegger, Britta; Wieland, Felix T.] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Univ Heidelberg, Dept Neurobiol IZN, D-69120 Heidelberg, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society; Emory University	Popoff, V (corresponding author), Univ Heidelberg, Biochem Ctr BZH, INF 364, D-69120 Heidelberg, Germany.	vincent.popoff@bzh.uni-heidelberg.de	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Langer, Julian David/0000-0002-5190-577X	German Research Council [SFB 638, A10]; European Union; Max Planck Gesellschaft; FEBS	German Research Council(German Research Foundation (DFG)); European Union(European Commission); Max Planck Gesellschaft(Max Planck Society); FEBS	This work was supported by the German Research Council, SFB 638, A10, the ESFRI-INSTRUCT program of the European Union, and the Max Planck Gesellschaft.; Supported by a FEBS long-term fellowship. To whom correspondence should be addressed. E-mail: vincent.popoff@bzh.uni-heidelberg.de.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Gaschet J, 1999, J BIOL CHEM, V274, P20040, DOI 10.1074/jbc.274.28.20040; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hoffman GR, 2003, MOL CELL, V12, P615, DOI 10.1016/j.molcel.2003.08.002; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Hui N, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P46; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lay D, 2005, J BIOL CHEM, V280, P34489, DOI 10.1074/jbc.M503497200; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Liang JO, 1997, J BIOL CHEM, V272, P4141, DOI 10.1074/jbc.272.7.4141; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Randazzo PA, 1997, BIOCHEM J, V324, P413, DOI 10.1042/bj3240413; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Sun Z, 2007, TRAFFIC, V8, P582, DOI 10.1111/j.1600-0854.2007.00554.x; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; TSAI SC, 1991, J BIOL CHEM, V266, P8213; TSUCHIYA M, 1989, BIOCHEMISTRY-US, V28, P9668, DOI 10.1021/bi00451a019; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; Yu WY, 2009, J MOL BIOL, V386, P903, DOI 10.1016/j.jmb.2008.12.083; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	62	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35634	35642		10.1074/jbc.M111.261800	http://dx.doi.org/10.1074/jbc.M111.261800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844198	Green Published, hybrid			2022-12-25	WOS:000295927100035
J	Bidwell, P; Blackwell, DJ; Hou, ZJ; Zima, AV; Robia, SL				Bidwell, Philip; Blackwell, Daniel J.; Hou, Zhanjia; Zima, Aleksey V.; Robia, Seth L.			Phospholamban Binds with Differential Affinity to Calcium Pump Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SODIUM-POTASSIUM PUMP; RESONANCE ENERGY-TRANSFER; PROTEIN-KINASE-A; CA2+ PUMP; CRYSTAL-STRUCTURE; CROSS-LINKING; FUNCTIONAL INTERACTIONS; DILATED CARDIOMYOPATHY; PHYSICAL INTERACTIONS	To investigate the mechanism of regulation of sarco-endo-plasmic reticulum Ca2+-ATPase (SERCA) by phospholamban (PLB), we expressed Cerulean-SERCA and yellow fluorescent protein (YFP)-PLB in adult rabbit ventricular myocytes using adenovirus vectors. SERCA and PLB were localized in the sarcoplasmic reticulum and were mobile over multiple sarcomeres on a timescale of tens of seconds. We also observed robust fluorescence resonance energy transfer (FRET) from Cerulean-SERCA to YFP-PLB. Electrical pacing of cardiac myocytes elicited cytoplasmic Ca2+ elevations, but these increases in Ca2+ produced only modest changes in SERCA-PLB FRET. The data suggest that the regulatory complex is not disrupted by elevations of cytosolic calcium during cardiac contraction (systole). This conclusion was also supported by parallel experiments in heterologous cells, which showed that FRET was reduced but not abolished by calcium. Thapsigargin also elicited a small decrease in PLB-SERCA binding affinity. We propose that PLB is not displaced from SERCA by high calcium during systole, and relief of functional inhibition does not require dissociation of the regulatory complex. The observed modest reduction in the affinity of the PLB-SERCA complex with Ca2+ or thapsigargin suggests that the binding interface is altered by SERCA conformational changes. The results are consistent with multiple modes of PLB binding or alternative binding sites.	[Bidwell, Philip; Blackwell, Daniel J.; Hou, Zhanjia; Zima, Aleksey V.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 102-5689,2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu		Bidwell, Philip/0000-0001-5045-4535	National Institutes of Health [HL092321, EB006061]; McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092321 and EB006061 (to S. L. R.). This work was also supported by the McCormick Foundation.	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Autry J. M., 2011, J BIOL CHEM IN PRESS; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; Chen Z., 2011, BIOCH J IN PRESS; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; INESI G, 1988, METHOD ENZYMOL, V157, P154; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Lalli MJ, 2001, CIRC RES, V89, P160; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; O'Donnell JM, 2009, J MOL CELL CARDIOL, V47, P614, DOI 10.1016/j.yjmcc.2009.08.031; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	49	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35044	35050		10.1074/jbc.M111.266759	http://dx.doi.org/10.1074/jbc.M111.266759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832088	Green Published, hybrid			2022-12-25	WOS:000295406300057
J	Chakraborty, DC; Mukherjee, G; Banerjee, P; Banerjee, KK; Biswas, T				Chakraborty, Deep Chandan; Mukherjee, Gayatri; Banerjee, Pallavi; Banerjee, Kalyan K.; Biswas, Tapas			Hemolysin Induces Toll-like Receptor (TLR)-independent Apoptosis and Multiple TLR-associated Parallel Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE HEMOLYSIN; DENDRITIC CELLS; RECOGNITION; EXPRESSION; DISTINCT; TOXIN; PORE; COOPERATION; PNEUMOLYSIN; INFECTION	Vibrio cholerae hemolysin (HlyA) displays bipartite property while supervising macrophages (M Phi). The pore-forming toxin causes profound apoptosis within 3h of exposure and in parallel supports activation of the defying M Phi. HlyA-induced apoptosis of M Phi remains steady for 24 h, is Toll-like receptor (TLR)-independent, and is driven by caspase-9 and caspase-7, thus involving the mitochondrial or intrinsic pathway. Cell activation is carried forward by time dependent up-regulation of varying TLRs. The promiscuous TLR association of HlyA prompted investigation, which revealed the beta-prism lectin domain of HlyA simulated TLR4 up-regulation by jacalin, a plant lectin homologue besides expressing CD86 and type I cytokines TNF-alpha and IL-12. However, HlyA cytolytic protein domain up-regulated TLR2, which controlled CD40 for continuity of cell activation. Expression of TOLLIP before TLR2 and TLR6 abrogated TLR4, CD40, and CD86. We show that the transient expression of TOLLIP leading to curbing of activation-associated capabilities is a plausible feedback mechanism of M Phi to deploy TLR2 and prolong activation involving CD40 to encounter the HlyA cytolysin domain.	[Chakraborty, Deep Chandan; Mukherjee, Gayatri; Banerjee, Pallavi; Biswas, Tapas] Natl Inst Cholera & Enter Dis, Div Immunol, Kolkata 700010, W Bengal, India; [Banerjee, Kalyan K.] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata 700010, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Biswas, T (corresponding author), Natl Inst Cholera & Enter Dis, Div Immunol, P-33,CIT Rd, Kolkata 700010, W Bengal, India.	shigellaporin@yahoo.com						Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Blaecke A, 2002, CYTOMETRY, V48, P71, DOI 10.1002/cyto.10115; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; CHEN YJ, 1994, MICROB PATHOGENESIS, V17, P203, DOI 10.1006/mpat.1994.1066; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Epelman S, 2004, J IMMUNOL, V173, P2031, DOI 10.4049/jimmunol.173.3.2031; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mukherjee G, 2008, MOL IMMUNOL, V45, P266, DOI 10.1016/j.molimm.2007.04.024; Nelson KL, 1999, CELL MICROBIOL, V1, P69, DOI 10.1046/j.1462-5822.1999.00009.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Ray A, 2005, IMMUNOLOGY, V114, P94, DOI 10.1111/j.1365-2567.2004.02002.x; Ray A, 2003, IMMUNOL LETT, V89, P143, DOI 10.1016/S0165-2478(03)00135-4; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; VanGool SW, 1996, IMMUNOL REV, V153, P47; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003	36	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34542	34551		10.1074/jbc.M111.241851	http://dx.doi.org/10.1074/jbc.M111.241851			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846723	hybrid, Green Published			2022-12-25	WOS:000295406300008
J	Gur, M; Kahn, R; Karbat, I; Regev, N; Wang, JT; Catterall, WA; Gordon, D; Gurevitz, M				Gur, Maya; Kahn, Roy; Karbat, Izhar; Regev, Noa; Wang, Jinti; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Elucidation of the Molecular Basis of Selective Recognition Uncovers the Interaction Site for the Core Domain of Scorpion alpha-Toxins on Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-ANEMONE TOXIN; VOLTAGE SENSOR; RAT-BRAIN; MEMBRANE-PROTEIN; RECEPTOR SITE-3; INACTIVATION; MODULATION; BINDING; INSECT; SUBUNIT	Neurotoxin receptor site-3 at voltage-gated Na+ channels is recognized by various peptide toxin inhibitors of channel inactivation. Despite extensive studies of the effects of these toxins, their mode of interaction with the channel remained to be described at the molecular level. To identify channel constituents that interact with the toxins, we exploited the opposing preferences of Lqh alpha IT and Lqh2 scorpion alpha-toxins for insect and mammalian brain Na+ channels. Construction of the DIV/S1-S2, DIV/S3-S4, DI/S5-SS1, and DI/SS2-S6 external loops of the rat brain rNa(v)1.2a channel (highly sensitive to Lqh2) in the background of the Drosophila DmNa(v)1 channel (highly sensitive to Lqh alpha IT), and examination of toxin activity on the channel chimera expressed in Xenopus oocytes revealed a substantial decrease in Lqh alpha IT effect, whereas Lqh2 was as effective as at rNa(v)1.2a. Further substitutions of individual loops and specific residues followed by examination of gain or loss in Lqh2 and Lqh alpha IT activities highlighted the importance of DI/S5-S6 (pore module) and the C-terminal region of DIV/S3 (gating module) of rNa(v)1.2a for Lqh2 action and selectivity. In contrast, a single substitution of Glu-1613 to Asp at DIV/S3-S4 converted rNa(v)1.2a to high sensitivity toward Lqh alpha IT. Comparison of depolarization-driven dissociation of Lqh2 and mutant derivatives off their binding site at rNa(v)1.2a mutant channels has suggested that the toxin core domain interacts with the gating module of DIV. These results constitute the first step in better understanding of the way scorpion alpha-toxins interact with voltage-gated Na+-channels at the molecular level.	[Wang, Jinti; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Gur, Maya; Kahn, Roy; Karbat, Izhar; Regev, Noa; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.			Regev, Noa/0000-0002-5865-4774	National Institutes of Health [1U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-4313-10]; Israeli Science Foundation [107/08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1U01 NS058039-01 (to W. A. C. and M. G.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-4313-10 (to M. G. and D. G.) and by Israeli Science Foundation Grant 107/08 (to M. G. and D. G.).	Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chen H, 2001, J GEN PHYSIOL, V117, P505, DOI 10.1085/jgp.117.6.505; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; Featherstone DE, 1996, BIOPHYS J, V71, P3098, DOI 10.1016/S0006-3495(96)79504-8; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Gilles N, 2002, EUR J BIOCHEM, V269, P1500, DOI 10.1046/j.1432-1033.2002.02799.x; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Gordon D., 2004, NEUROTOX 03 NEUROTOX, P59; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Leipold E, 2004, MOL PHARMACOL, V65, P685, DOI 10.1124/mol.65.3.685; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Moran Y, 2007, BIOCHEM J, V406, P41, DOI 10.1042/BJ20070233; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; STRICHARTZ GR, 1986, J GEN PHYSIOL, V88, P413, DOI 10.1085/jgp.88.3.413; TEJEDOR FJ, 1990, CELL MOL NEUROBIOL, V10, P257, DOI 10.1007/BF00734578; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Wang JT, 2011, BIOPHYS J, V100, P422; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yang YC, 2003, J NEUROSCI, V23, P4922; Yu FH, 2003, J NEUROSCI, V23, P7577; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	43	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35209	35217		10.1074/jbc.M111.259507	http://dx.doi.org/10.1074/jbc.M111.259507			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832067	Green Published, hybrid			2022-12-25	WOS:000295406300073
J	Toei, M; Toei, S; Forgac, M				Toei, Masashi; Toei, Satoko; Forgac, Michael			Definition of Membrane Topology and Identification of Residues Important for Transport in Subunit a of the Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; MEDIATED CROSS-LINKING; AQUEOUS ACCESS CHANNELS; BREAST-CANCER CELLS; H+-ATPASE; ESCHERICHIA-COLI; PROTON TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE SEGMENTS; 100-KDA SUBUNIT	Subunit a of the vacuolar H+-ATPases plays an important role in proton transport. This membrane-integral 100-kDa subunit is thought to form or contribute to proton-conducting hemi-channels that allow protons to gain access to and leave buried carboxyl groups on the proteolipid subunits (c, c', and c") during proton translocation. We previously demonstrated that subunit a contains a large N-terminal cytoplasmic domain followed by a C-terminal domain containing eight transmembrane (TM) helices. TM7 contains a buried arginine residue (Arg-735) that is essential for proton transport and is located on a helical face that interacts with the proteolipid ring. To further define the topology of the C-terminal domain, the accessibility of 30 unique cysteine residues to the membrane-permeant reagent N-ethylmaleimide and the membrane-impermeant reagent polyethyleneglycol maleimide was determined. The results further define the borders of transmembrane segments in subunit a. To identify additional buried polar and charged residues important in proton transport, 25 sites were individually mutated to hydrophobic amino acids, and the effect on proton transport was determined. These and previous results identify a set of residues important for proton transport located on the cytoplasmic half of TM7 and TM8 and the lumenal half of TM3, TM4, and TM7. Based upon these data, we propose a tentative model in which the cytoplasmic hemi-channel is located at the interface of TM7 and TM8 of subunit a and the proteolipid ring, whereas the lumenal hemi-channel is located within subunit a at the interface of TM3, TM4, and TM7.	[Forgac, Michael] Tufts Univ, Sch Med, Dept Mol Physiol & Phamacol, Boston, MA 02111 USA; Tufts Univ, Grad Program Cell & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Phamacol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Northeast Affiliate of the American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Affiliate of the American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.). This work was also supported by a Postdoctoral Fellowship from the Northeast Affiliate of the American Heart Association (to M. T.).	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	43	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35176	35186		10.1074/jbc.M111.273409	http://dx.doi.org/10.1074/jbc.M111.273409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832060	Green Published, hybrid			2022-12-25	WOS:000295406300070
J	Golubkov, VS; Chernov, AV; Strongin, AY				Golubkov, Vladislav S.; Chernov, Andrei V.; Strongin, Alex Y.			Intradomain Cleavage of Inhibitory Prodomain Is Essential to Protumorigenic Function of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; BASEMENT-MEMBRANE; TISSUE INHIBITOR; EPITHELIAL-CELLS; FURIN CLEAVAGE; CANCER; ACTIVATION; PROTEIN; TUMORIGENICITY; EMBRYOGENESIS	Invasive cancers use pericellular proteolysis to breach the extracellular matrix and basement membrane barriers and invade the surrounding tissue. Proinvasive membrane type-1 matrix metalloproteinase (MT1-MMP) is the primary mediator of proteolytic events on the cancer cell surface. MT1-MMP is synthesized as a zymogen. The latency of MT1-MMP is maintained by its N-terminal inhibitory prodomain. In the course of MT1-MMP activation, the (RRKR111)-R-108 down arrow Y-112 prodomain sequence is processed by furin. The intact prodomain released by furin alone, however, is a potent inhibitor of the emerging MT1-MMP enzyme. Evidence suggests that the prodomain undergoes intradomain cleavage at the PGD down arrow L-50 site followed by the release of the degraded prodomain by furin cleavage that finalizes the two-step activation event. These cleavages, only if combined, cause the activation of MT1-MMP. The significance of the intradomain cleavage in the protumorigenic program of MT1-MMP, however, remained unidentified. To identify this important parameter, in our current study, we used the cells that expressed the wild-type prodomain-based fluorescent biosensor and the mutant biosensor with the inactivated PGD down arrow L-50 cleavage site (L50D mutant) and also the cells with the enforced expression of the wild-type and L50D mutant MT1-MMP. Using cell-based tests, orthotopic breast cancer xenografts in mice, and genome-wide transcriptional profiling of cultured cells and tumor xenografts, we demonstrated that the intradomain cleavage of the PGD down arrow L-50 sequence of the prodomain is essential for the protumorigenic function of MT1-MMP. Our results emphasize the importance of the intradomain cleavages resulting in the inactivation of the respective inhibitory prodomains not only for MT1-MMP but also for other MMP family members.	[Golubkov, Vladislav S.; Chernov, Andrei V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; 	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A. Y. S.).	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934	36	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34215	34223		10.1074/jbc.M111.264036	http://dx.doi.org/10.1074/jbc.M111.264036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832072	hybrid, Green Published			2022-12-25	WOS:000295159200051
J	Satapathy, AK; Kulczyk, AW; Ghosh, S; van Oijen, AM; Richardson, CC				Satapathy, Ajit K.; Kulczyk, Arkadiusz W.; Ghosh, Sharmistha; van Oijen, Antoine M.; Richardson, Charles C.			Coupling dTTP Hydrolysis with DNA Unwinding by the DNA Helicase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 4 PROTEIN; DEOXYRIBONUCLEIC-ACID; REPLICATION-FORK; NUCLEOTIDE HYDROLYSIS; STERIC EXCLUSION; RING HELICASE; STRANDED-DNA; DUPLEX DNA; PRIMASE; MECHANISM	The DNA helicase encoded by gene 4 of bacteriophage T7 assembles on single-stranded DNA as a hexamer of six identical subunits with the DNA passing through the center of the toroid. The helicase couples the hydrolysis of dTTP to unidirectional translocation on single-stranded DNA and the unwinding of duplex DNA. Phe(523), positioned in a beta-hairpin loop at the subunit interface, plays a key role in coupling the hydrolysis of dTTP to DNA unwinding. Replacement of Phe(523) with alanine or valine abolishes the ability of the helicase to unwind DNA or allow T7 polymerase to mediate strand-displacement synthesis on duplex DNA. In vivo complementation studies reveal a requirement for a hydrophobic residue with long side chains at this position. In a crystal structure of T7 helicase, when a nucleotide is bound at a subunit interface, Phe(523) is buried within the interface. However, in the unbound state, it is more exposed on the outer surface of the helicase. This structural difference suggests that the beta-hairpin bearing the Phe(523) may undergo a conformational change during nucleotide hydrolysis. We postulate that upon hydrolysis of dTTP, Phe(523) moves from within the subunit interface to a more exposed position where it contacts the displaced complementary strand and facilitates unwinding.	[Satapathy, Ajit K.; Kulczyk, Arkadiusz W.; Ghosh, Sharmistha; van Oijen, Antoine M.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161	National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Satapathy AK, 2011, J BIOL CHEM, V286, P23113, DOI 10.1074/jbc.M111.218651; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	41	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34468	34478		10.1074/jbc.M111.283796	http://dx.doi.org/10.1074/jbc.M111.283796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840995	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000295159200074
J	Filosto, S; Khan, EM; Tognon, E; Becker, C; Ashfaq, M; Ravid, T; Goldkorn, T				Filosto, Simone; Khan, Elaine M.; Tognon, Emiliana; Becker, Cathleen; Ashfaq, Majid; Ravid, Tommer; Goldkorn, Tzipora			EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-INDEPENDENT ACTIVATION; PULMONARY CELL APOPTOSIS; LUNG-CANCER; EPITHELIAL-CELLS; PERINUCLEAR TRAFFICKING; REVERSIBLE INACTIVATION; TYROSINE PHOSPHATASES; KINASE INHIBITORS; SIGNALING NETWORK	Crystallographic studies have offered understanding of how receptor tyrosine kinases from the ErbB family are regulated by their growth factor ligands. A conformational change of the EGFR (ErbB1) was shown to occur upon ligand binding, where a solely ligand-mediated mode of dimerization/activation was documented. However, this dogma of dimerization/activation was revolutionized by the discovery of constitutively active ligand-independent EGFR mutants. In addition, other ligand-independent activation mechanisms may occur. We have shown that oxidative stress (ox-stress), induced by hydrogen peroxide or cigarette smoke, activates EGFR differently than its ligand, EGF, thereby inducing aberrant phosphorylation and impaired trafficking and degradation of EGFR. Here we demonstrate that ox-stress activation of EGFR is ligand-independent, does not induce "classical" receptor dimerization and is not inhibited by the tyrosine kinase inhibitor AG1478. Thus, an unprecedented, apparently activated, state is found for EGFR under ox-stress. Furthermore, this activation mechanism is temperature-dependent, suggesting the simultaneous involvement of membrane structure. We propose that ceramide increase under ox-stress disrupts cholesterol-enriched rafts leading to EGFR re-localization into the rigid, ceramide-enriched rafts. This increase in ceramide also supports EGFR aberrant trafficking to a peri-nuclear region. Therefore, the EGFR unprecedented and activated conformation could be sustained by simultaneous alterations in membrane structure under ox-stress.	[Filosto, Simone; Khan, Elaine M.; Tognon, Emiliana; Becker, Cathleen; Ashfaq, Majid; Ravid, Tommer; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA	University of California System; University of California Davis	Filosto, S (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu		Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-Related Disease Research Program (TRDRP) [17RT-0131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program (TRDRP)(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-71871 and HL-66189 to T. G.) and from the Tobacco-Related Disease Research Program (TRDRP) (17RT-0131 to T. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KA, 2010, CELL PHYSIOL BIOCHEM, V26, P57, DOI 10.1159/000315106; Bublil EM, 2010, FASEB J; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Cai Z, 2010, SEMIN CELL DEV BIOL; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; COCHET C, 1988, J BIOL CHEM, V263, P3290; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; FILOSTO S, AM J RESP C IN PRESS; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goldkorn T, 1998, J CELL SCI, V111, P3209; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Harris LN, 2001, CLIN CANCER RES, V7, P1497; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ise N, 2010, BIOCHEM BIOPH RES CO, V394, P685, DOI 10.1016/j.bbrc.2010.03.052; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lambert S, 2006, J INVEST DERMATOL, V126, P954, DOI 10.1038/sj.jid.5700168; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Lieu C, 2010, CLIN COLORECTAL CANC, V9, P89, DOI 10.3816/CCC.2010.n.012; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Megha, 2007, BBA-BIOMEMBRANES, V1768, P2205, DOI 10.1016/j.bbamem.2007.05.007; Ni CY, 2003, J BIOL CHEM, V278, P4561, DOI 10.1074/jbc.M210504200; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache Irina, 2006, Proc Am Thorac Soc, V3, P510, DOI 10.1513/pats.200603-071MS; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; RAVID T, 2002, J BIOL CHEM, V12, P12; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; REUTER S, 2010, FREE RADIC BIOL MED; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Sot J, 2008, FEBS LETT, V582, P3230, DOI 10.1016/j.febslet.2008.08.016; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yang CH, 2008, LUNG CANCER, V60, pS23, DOI 10.1016/S0169-5002(08)70102-8; Yang Y, 2010, EUR RESPIR J, V36, P417, DOI 10.1183/09031936.00095609; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	69	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23240	10.1371/journal.pone.0023240	http://dx.doi.org/10.1371/journal.pone.0023240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853092	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200055
J	Laczi, M; Torok, J; Rosivall, B; Hegyi, G				Laczi, Miklos; Toeroek, Janos; Rosivall, Balazs; Hegyi, Gergely			Integration of Spectral Reflectance across the Plumage: Implications for Mating Patterns	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; MULTIPLE SEXUAL SIGNALS; FEMALE MATE CHOICE; CONDITION-DEPENDENCE; INFORMATION-CONTENT; COLOR VARIATION; ULTRAVIOLET COLORATION; REPRODUCTIVE SUCCESS; NORTHERN CARDINALS; PIED FLYCATCHERS	Background: In complex sexual signaling systems such as plumage color, developmental or genetic links may occur among seemingly distinct traits. However, the interrelations of such traits and the functional significance of their integration rarely have been examined. Methodology/Principal Findings: We investigated the parallel variation of two reflectance descriptors (brightness and UV chroma) across depigmented and melanized plumage areas of collared flycatchers (Ficedula albicollis), and the possible role of integrated color signals in mate acquisition. We found moderate integration in brightness and UV chroma across the plumage, with similar correlation structures in the two sexes despite the strong sexual dichromatism. Patterns of parallel color change across the plumage were largely unrelated to ornamental white patch sizes, but they all showed strong assortative mating between the sexes. Comparing different types of assortative mating patterns for individual spectral variables suggested a distinct role for plumage-level color axes in mate acquisition. Conclusions/Significance: Our results indicate that the plumage-level, parallel variation of coloration might play a role in mate acquisition. This study underlines the importance of considering potential developmental and functional integration among apparently different ornaments in studies of sexual selection.	[Laczi, Miklos; Toeroek, Janos; Rosivall, Balazs; Hegyi, Gergely] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary	Eotvos Lorand University	Laczi, M (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	laczi.miklos@gmail.com	Torok, Janos/C-6144-2008; Rosivall, Balázs/T-1057-2017; Laczi, Miklós/AAE-5892-2020; Hegyi, Gergely/AAG-4988-2021	Torok, Janos/0000-0002-4799-5522; Rosivall, Balázs/0000-0002-0732-1160; Laczi, Miklós/0000-0001-9235-2553; Hegyi, Gergely/0000-0002-4906-3550	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [PD72117, PD75481, K75618]; Bolyai Janos fellowship; Pilis Park Forestry; Erdok a Kozjoert Alapitvany	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos fellowship(Hungarian Academy of Sciences); Pilis Park Forestry; Erdok a Kozjoert Alapitvany	The research was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, http://www.otka.hu/) grants PD72117, PD75481 and K75618 to G. H., B. R. and J.T., respectively; a Bolyai Janos fellowship (www.mta.hu) to G. H.; the Pilis Park Forestry (http://www.parkerdo.hu/); and the Erdok a Kozjoert Alapitvany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Badyaev Alexander V., 2006, P349; Badyaev AV, 2004, EVOL ECOL RES, V6, P975; Badyaev AV, 2001, AM NAT, V158, P221, DOI 10.1086/321325; Ballentine B, 2003, CONDOR, V105, P593, DOI 10.1650/7234; BALMFORD A, 1992, BEHAV ECOL SOCIOBIOL, V31, P107, DOI 10.1007/BF00166343; Bitton PP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1543, DOI 10.1007/s00265-008-0583-7; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Bonato M, 2009, ANIM BEHAV, V77, P1033, DOI 10.1016/j.anbehav.2009.02.008; BONSER RHC, 1995, CONDOR, V97, P590, DOI 10.2307/1369048; Bridge ES, 2005, J AVIAN BIOL, V36, P18, DOI 10.1111/j.0908-8857.2005.03470.x; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Budden AE, 2009, J AVIAN BIOL, V40, P18, DOI 10.1111/j.1600-048X.2008.04344.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cramp S, BIRDS W PALEARCTIC, VVII; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Doucet SM, 2003, J AVIAN BIOL, V34, P237, DOI 10.1034/j.1600-048X.2003.03113.x; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Flury B, 1988, COMMON PRINCIPAL COM; Galvan I, 2010, IBIS, V152, P359; Galvan I, 2009, P ROY SOC B-BIOL SCI, V276, P3089, DOI 10.1098/rspb.2009.0774; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Garamszegi LZ, 2004, BIRD STUDY, V51, P270, DOI 10.1080/00063650409461363; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Gotmark F, 1997, BEHAV ECOL SOCIOBIOL, V40, P41, DOI 10.1007/s002650050314; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Griggio M, 2011, BEHAV ECOL SOCIOBIOL, V65, P655, DOI 10.1007/s00265-010-1067-0; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Hanssen SA, 2006, ANIM BEHAV, V71, P337, DOI 10.1016/j.anbehav.2005.04.021; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hegyi G, 2002, J EVOLUTION BIOL, V15, P710, DOI 10.1046/j.1420-9101.2002.00449.x; Hegyi G, 2008, NATURWISSENSCHAFTEN, V95, P993, DOI 10.1007/s00114-008-0408-6; Hegyi G, 2008, EVOL ECOL RES, V10, P559; Hegyi G, 2008, ANIM BEHAV, V75, P977, DOI 10.1016/j.anbehav.2007.08.009; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Hegyi G, 2007, BEHAV ECOL, V18, P1116, DOI 10.1093/beheco/arm085; Hegyi G, 2007, EVOL ECOL RES, V9, P905; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jawor JM, 2004, ETHOLOGY, V110, P113, DOI 10.1111/j.1439-0310.2003.00962.x; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; JOHNSTONE RA, 1995, J THEOR BIOL, V177, P87, DOI 10.1016/S0022-5193(05)80006-2; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Kose M, 1999, BEHAV ECOL SOCIOBIOL, V45, P430, DOI 10.1007/s002650050581; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lehtonen PK, 2009, ANIM BEHAV, V77, P1103, DOI 10.1016/j.anbehav.2009.01.014; Loyau A, 2005, BEHAV ECOL SOCIOBIOL, V58, P552, DOI 10.1007/s00265-005-0958-y; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; Macedonia JM, 2004, J HERPETOL, V38, P340, DOI 10.1670/183-03A; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; Moller AP, 2002, BEHAV ECOL, V13, P248, DOI 10.1093/beheco/13.2.248; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Perrier G, 2002, BEHAV ECOL, V13, P728, DOI 10.1093/beheco/13.6.728; Peters A, 2006, BEHAV ECOL SOCIOBIOL, V59, P666, DOI 10.1007/s00265-005-0095-7; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Prum RO, 2009, J R SOC INTERFACE, V6, pS253, DOI 10.1098/rsif.2008.0466.focus; Prum RO, 2006, BIRD COLORATION, V1, P295; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; Reudink MW, 2009, ANIM BEHAV, V77, P495, DOI 10.1016/j.anbehav.2008.11.005; Riesz J., 2007, THESIS U QUEENSLAND; Rosivall B, 2009, ANIM BEHAV, V77, P611, DOI 10.1016/j.anbehav.2008.11.009; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Shawkey MD, 2005, BIOL J LINN SOC, V84, P259, DOI 10.1111/j.1095-8312.2005.00428.x; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 2002, ANIM BEHAV, V63, P97, DOI 10.1006/anbe.2001.1870; Silva N, 2008, BEHAV ECOL SOCIOBIOL, V62, P1969, DOI 10.1007/s00265-008-0628-y; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; SLAGSVOLD T, 1995, ANIM BEHAV, V50, P1109, DOI 10.1016/0003-3472(95)80110-3; SORENSON LG, 1994, BEHAV ECOL SOCIOBIOL, V35, P389, DOI 10.1007/s002650050111; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Svensson L., 1992, IDENTIFICATION GUIDE; Szigeti B, 2007, J AVIAN BIOL, V38, P105, DOI 10.1111/j.2007.0908-8857.03769.x; Torok J, 2003, BEHAV ECOL, V14, P382, DOI 10.1093/beheco/14.3.382; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Vincent S. E., 2008, Journal of Orthoptera Research, V17, P219, DOI 10.1665/1082-6467-17.2.219; Woodcock EA, 2005, ETHOLOGY, V111, P891, DOI 10.1111/j.1439-0310.2005.01120.x; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	111	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23201	10.1371/journal.pone.0023201	http://dx.doi.org/10.1371/journal.pone.0023201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853088	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000295454200052
J	Martiniere, A; Macia, JL; Bagnolini, G; Jridi, C; Bak, A; Blanc, S; Drucker, M				Martiniere, Alexandre; Macia, Jean-Luc; Bagnolini, Guillaume; Jridi, Chiraz; Bak, Aurelie; Blanc, Stephane; Drucker, Martin			VAPA, an Innovative "Virus-Acquisition Phenotyping Assay" Opens New Horizons in Research into the Vector-Transmission of Plant Viruses	PLOS ONE			English	Article							CAULIFLOWER-MOSAIC-VIRUS; APHID TRANSMISSION; TRANSMITTED VIRUSES; INCLUSION-BODIES; HELPER COMPONENT; YELLOWS VIRUS; POTYVIRUS; INOCULATION; SALIVATION; PROTEIN	Host-to-host transmission-a key step in plant virus infection cycles-is ensured predominantly by vectors, especially aphids and related insects. A deeper understanding of the mechanisms of virus acquisition, which is critical to vector-transmission, might help to design future virus control strategies, because any newly discovered molecular or cellular process is a potential target for hampering viral spread within host populations. With this aim in mind, an aphid membrane-feeding assay was developed where aphids transmitted two non-circulative viruses [ cauliflower mosaic virus (CaMV) and turnip mosaic virus] from infected protoplasts. In this assay, virus acquisition occurs exclusively from living cells. Most interestingly, we also show that CaMV is less efficiently transmitted by aphids in the presence of oryzalin-a microtubule-depolymerising drug. The example presented here demonstrates that our technically simple "virus-acquisition phenotyping assay" (VAPA) provides a first opportunity to implement correlative studies relating the physiological state of infected plant cells to vector-transmission efficiency.	[Martiniere, Alexandre; Macia, Jean-Luc; Bagnolini, Guillaume; Jridi, Chiraz; Bak, Aurelie; Blanc, Stephane; Drucker, Martin] INRA, Equipe CaGeTE, UMR BGPI, F-34060 Montpellier, France	INRAE	Drucker, M (corresponding author), INRA, Equipe CaGeTE, UMR BGPI, F-34060 Montpellier, France.	drucker@supagro.inra.fr	Drucker, Martin/S-6832-2019; Blanc, Stéphane/F-5873-2011; Martiniere, Alexandre/ABE-1857-2021	Blanc, Stéphane/0000-0002-3412-0989; Drucker, Martin/0000-0002-9765-1189	Agence Nationale Recherche [BLAN07-2-192768]	Agence Nationale Recherche(French National Research Agency (ANR))	This work was funded by a grant from Agence Nationale Recherche, BLAN07-2-192768, awarded to SB (www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANC S, 1993, VIROLOGY, V197, P283, DOI 10.1006/viro.1993.1589; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Bruyere A, 1997, VIROLOGY, V230, P323, DOI 10.1006/viro.1997.8476; DELSENY M, 1983, PLASMID, V9, P31, DOI 10.1016/0147-619X(83)90029-X; Drucker M, 2002, P NATL ACAD SCI USA, V99, P2422, DOI 10.1073/pnas.042587799; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hoh F, 2010, J VIROL, V84, P4706, DOI 10.1128/JVI.02662-09; Khelifa M, 2007, J GEN VIROL, V88, P2872, DOI 10.1099/vir.0.83009-0; MARKHAM PG, 1987, ANN APPL BIOL, V111, P571, DOI 10.1111/j.1744-7348.1987.tb02015.x; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; Martiniere A, 2009, PLANT J, V58, P135, DOI 10.1111/j.1365-313X.2008.03768.x; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Palacios I, 2002, J GEN VIROL, V83, P3163, DOI 10.1099/0022-1317-83-12-3163; Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0; SAKO N, 1981, VIROLOGY, V112, P762, DOI 10.1016/0042-6822(81)90322-6; Sanchez F, 1998, VIRUS RES, V55, P207, DOI 10.1016/S0168-1702(98)00049-5; THORNBURY DW, 1985, VIROLOGY, V144, P260, DOI 10.1016/0042-6822(85)90322-8; Tian TY, 1999, J GEN VIROL, V80, P1111, DOI 10.1099/0022-1317-80-5-1111; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Uzest M, 2007, P NATL ACAD SCI USA, V104, P17959, DOI 10.1073/pnas.0706608104; Uzest M, 2010, ARTHROPOD STRUCT DEV, V39, P221, DOI 10.1016/j.asd.2010.02.005; van HOOF H. A., 1954, TIJDSCHR PLANTENZIEKTEN, V60, P267; Wang RY, 1998, J GEN VIROL, V79, P1519, DOI 10.1099/0022-1317-79-6-1519; Wang RY, 1996, J GEN VIROL, V77, P3145, DOI 10.1099/0022-1317-77-12-3145; Watson MA, 1939, PROC R SOC SER B-BIO, V127, P543, DOI 10.1098/rspb.1939.0039; WIDHOLM JM, 1972, STAIN TECHNOL, V47, P189, DOI 10.3109/10520297209116483	27	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23241	10.1371/journal.pone.0023241	http://dx.doi.org/10.1371/journal.pone.0023241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853093	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200056
J	Villegas-Amtmann, S; Simmons, SE; Kuhn, CE; Huckstadt, LA; Costa, DP				Villegas-Amtmann, Stella; Simmons, Samantha E.; Kuhn, Carey E.; Huckstadt, Luis A.; Costa, Daniel P.			Latitudinal Range Influences the Seasonal Variation in the Foraging Behavior of Marine Top Predators	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; DIVING BEHAVIOR; ZALOPHUS-CALIFORNIANUS; TEMPORAL VARIATION; STABLE-ISOTOPES; LIFE-HISTORY; LION; ECOLOGY; ENERGETICS; CARBON	Non-migratory resident species should be capable of modifying their foraging behavior to accommodate changes in prey abundance and availability associated with a changing environment. Populations that are better adapted to change will have higher foraging success and greater potential for survival in the face of climate change. We studied two species of resident central place foragers from temperate and equatorial regions with differing population trends and prey availability associated to season, the California sea lion (Zalophus californianus) (CSL) whose population is increasing and the endangered Galapagos sea lion (Zalophus wollebaeki) (GSL) whose population is declining. To determine their response to environmental change, we studied and compared their diving behavior using time-depth recorders and satellite location tags and their diet by measuring C and N isotope ratios during a warm and a cold season. Based on latitudinal differences in oceanographic productivity, we hypothesized that the seasonal variation in foraging behavior would differ for these two species. CSL exhibited greater seasonal variability in their foraging behavior as seen in changes to their diving behavior, foraging areas and diet between seasons. Conversely, GSL did not change their diving behavior between seasons, presenting three foraging strategies (shallow, deep and bottom divers) during both. GSL exhibited greater dive and foraging effort than CSL. We suggest that during the warm and less productive season a greater range of foraging behaviors in CSL was associated with greater competition for prey, which relaxed during the cold season when resource availability was greater. GSL foraging specialization suggests that resources are limited throughout the year due to lower primary production and lower seasonal variation in productivity compared to CSL. These latitudinal differences influence their foraging success, pup survival and population growth reflected in contrasting population trends in which CSL are more successful and potentially more resilient to climate change.	[Villegas-Amtmann, Stella; Simmons, Samantha E.; Kuhn, Carey E.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Huckstadt, Luis A.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Villegas-Amtmann, S (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	stella.villegas@gmail.com	Huckstadt, Luis/A-5838-2018; Huckstadt, Luis A./J-8532-2019; Costa, Daniel/E-2616-2013	Huckstadt, Luis/0000-0002-2453-7350; Huckstadt, Luis A./0000-0002-2453-7350; Simmons, Samantha/0000-0003-0326-6990; Kuhn, Carey/0000-0002-6835-9744; Costa, Daniel/0000-0002-0233-5782	Sloan Foundation; Packard Foundation; Moore Foundation; Office of Naval Research; UC MEXUS; CONACYT; NSF Office of Polar Programs; CRS (Center for Remote Sensing); Ecology and Evolutionary Biology Department at UCSC	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Office of Naval Research(Office of Naval Research); UC MEXUS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF Office of Polar Programs(National Science Foundation (NSF)); CRS (Center for Remote Sensing); Ecology and Evolutionary Biology Department at UCSC	This work was part of the TOPP (Tagging of Pacific Predators) Program supported by the Sloan, Packard and Moore Foundations, the Office of Naval Research, UC MEXUS, CONACYT, NSF Office of Polar Programs, CRS (Center for Remote Sensing) and the Ecology and Evolutionary Biology Department at UCSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; AURIOLES D, 2008, ZALOPHUS CALIFORNIAN; Aurioles D., 2008, ZALOPHUS WOLLEBAEKI; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2000, J EXP BIOL, V203, P3655; COSTA DP, 2006, POTENTIAL INFLUENCES, P344; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darwin C., 1859, ORIGIN SPECIES MEANS; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Farina JM, 2003, J ANIM ECOL, V72, P873, DOI 10.1046/j.1365-2656.2003.00760.x; FELDKAMP SD, 1989, CAN J ZOOL, V67, P872, DOI 10.1139/z89-129; FELDMAN GC, 1986, PATTERNS PHYTOPLANKT, P77; Ferguson SH, 2006, OECOLOGIA, V150, P318, DOI 10.1007/s00442-006-0489-x; Gales NJ, 1997, CAN J ZOOL, V75, P1695, DOI 10.1139/z97-796; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Garcia-Rodriguez FJ, 2004, FISH B-NOAA, V102, P47; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Halsey LG, 2006, FUNCT ECOL, V20, P889, DOI 10.1111/j.1365-2435.2006.01170.x; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hockey PAR, 2003, OSTRICH, V74, P110, DOI 10.2989/00306520309485376; Huckstadt LA, 2007, J EXP MAR BIOL ECOL, V347, P123, DOI 10.1016/j.jembe.2007.03.014; Johnson CN, 1998, J ANIM ECOL, V67, P689, DOI 10.1046/j.1365-2656.1998.00232.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KOOYMAN GL, 1986, DIVING BEHAV GALAPAG, P209; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; KUHN CE, 2006, MEASURING FEEDING RA; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; Mattlin RH, 1998, CAN J ZOOL, V76, P350, DOI 10.1139/cjz-76-2-350; McGarigal K., 2000, MULTIVARIATE STAT WI; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Orians G.H., 1979, P155; PAK H, 1973, J GEOPHYS RES, V78, P7845, DOI 10.1029/JC078i033p07845; Sakamoto CM, 1998, DEEP-SEA RES PT II, V45, P1055, DOI 10.1016/S0967-0645(98)00013-7; Salazar S., 2002, RESERVA MARINA GALAP, P267; SALAZAR SK, 2005, VARIACION TEMPORAL E; SALAZARALDAS D, 2007, ECOLOGIA ALIMENTARIA; SCHOOLEY RL, 1994, J MAMMAL, V75, P466, DOI 10.2307/1382569; Szteren D, 2006, LOW WAKE FI, P369; Tanaka H, 2006, ZOOL SCI, V23, P991, DOI 10.2108/zsj.23.991; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tracy CR, 2007, COPEIA, P901; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2010, FUNCT ECOL, V24, P785, DOI 10.1111/j.1365-2435.2009.01685.x; ZEITZSCHEL B, 1969, MAR BIOL, V3, P201, DOI 10.1007/BF00360952	53	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23166	10.1371/journal.pone.0023166	http://dx.doi.org/10.1371/journal.pone.0023166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853081	Green Published, gold			2022-12-25	WOS:000295454200048
J	Kishida, KT; Sandberg, SG; Lohrenz, T; Comair, YG; Saez, I; Phillips, PEM; Montague, PR				Kishida, Kenneth T.; Sandberg, Stefan G.; Lohrenz, Terry; Comair, Youssef G.; Saez, Ignacio; Phillips, Paul E. M.; Montague, P. Read			Sub-Second Dopamine Detection in Human Striatum	PLOS ONE			English	Article							REAL-TIME MEASUREMENT; FREELY MOVING RATS; NEURONS ENCODE; BEHAVING RATS; HUMAN-BRAIN; REWARD; COCAINE; VOLTAMMETRY; ANIMALS; NUCLEUS	Fast-scan cyclic voltammetry at carbon fiber microelectrodes allows rapid (sub-second) measurements of dopamine release in behaving animals. Herein, we report the modification of existing technology and demonstrate the feasibility of making sub-second measurements of dopamine release in the caudate nucleus of a human subject during brain surgery. First, we describe the modification of our electrodes that allow for measurements to be made in a human brain. Next, we demonstrate in vitro and in vivo, that our modified electrodes can measure stimulated dopamine release in a rat brain equivalently to previously determined rodent electrodes. Finally, we demonstrate acute measurements of dopamine release in the caudate of a human patient during DBS electrode implantation surgery. The data generated are highly amenable for future work investigating the relationship between dopamine levels and important decision variables in human decision-making tasks.	[Kishida, Kenneth T.; Saez, Ignacio; Montague, P. Read] Virginia Tech Caril Res Inst, Human Neuroimaging Lab, Roanoke, VA USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lohrenz, Terry] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Comair, Youssef G.] Amer Univ Beirut, Dept Surg, Div Neurosurg, Lebanon, NH USA; [Montague, P. Read] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Montague, P. Read] UCL, Wellcome Trust Ctr Neuroimaging, London WC1E 6BT, England; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; American University of Beirut; Virginia Polytechnic Institute & State University; University of London; University College London; University of Washington; University of Washington Seattle	Kishida, KT (corresponding author), Virginia Tech Caril Res Inst, Human Neuroimaging Lab, Roanoke, VA USA.	pemp@uw.edu; read@vt.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Saez, Ignacio/0000-0003-0651-2069	NIH [DA024140, DA11723, T32-NS43124]; Parkinson's Disease Foundation; Brown Foundation; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723, R21DA024140] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; Brown Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH DA024140 (PRM & PEMP), DA11723 (PRM), T32-NS43124 (KTK), the Parkinson's Disease Foundation (SGS), the Brown Foundation (PRM), and the Wellcome Trust Principal Research Fellowship (PRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Garris PA, 1997, J NEUROCHEM, V68, P152; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Kiyatkin EA, 2000, NEUROSCIENCE, V98, P729, DOI 10.1016/S0306-4522(00)00168-8; Kramer R., 1998, CHEMOMETRIC TECHNIQU; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; REBEC GV, 1993, J NEUROSCI METH, V47, P53, DOI 10.1016/0165-0270(93)90021-I; Volkow ND, 1996, J NUCL MED, V37, P1242; WICKENS J, 1990, J NEURAL TRANSM-GEN, V80, P9, DOI 10.1007/BF01245020; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342	21	69	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23291	10.1371/journal.pone.0023291	http://dx.doi.org/10.1371/journal.pone.0023291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829726	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200063
J	Rimsza, LM; Unger, JM; Tome, ME; LeBlanc, ML				Rimsza, Lisa M.; Unger, Joseph M.; Tome, Margaret E.; LeBlanc, Michael L.			A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma	PLOS ONE			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR; SURVIVAL; PREDICTION; BURKITTS; FAMILY; MODEL; BCL-6; TRANSCRIPTION; SEROTONIN	Background: Gene expression profiling yields quantitative data on gene expression used to create prognostic models that accurately predict patient outcome in diffuse large B cell lymphoma (DLBCL). Often, data are analyzed with genes classified by whether they fall above or below the median expression level. We sought to determine whether examining multiple cut-points might be a more powerful technique to investigate the association of gene expression with outcome. Methodology/Principal Findings: We explored gene expression profiling data using variable cut-point analysis for 36 genes with reported prognostic value in DLBCL. We plotted two-group survival logrank test statistics against corresponding cut-points of the gene expression levels and smooth estimates of the hazard ratio of death versus gene expression levels. To facilitate comparisons we also standardized the expression of each of the genes by the fraction of patients that would be identified by any cut-point. A multiple comparison adjusted permutation p-value identified 3 different patterns of significance: 1) genes with significant cut-point points below the median, whose loss is associated with poor outcome (e.g. HLA-DR); 2) genes with significant cut-points above the median, whose over-expression is associated with poor outcome (e.g. CCND2); and 3) genes with significant cut-points on either side of the median, (e.g. extracellular molecules such as FN1). Conclusions/Significance: Variable cut-point analysis with permutation p-value calculation can be used to identify significant genes that would not otherwise be identified with median cut-points and may suggest biological patterns of gene effects.	[Rimsza, Lisa M.; Tome, Margaret E.] Univ Arizona, Dept Pathol, Tucson, AZ 85721 USA; [Unger, Joseph M.; LeBlanc, Michael L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	University of Arizona; Fred Hutchinson Cancer Center	Rimsza, LM (corresponding author), Univ Arizona, Dept Pathol, Tucson, AZ 85721 USA.	lrimsza@email.arizona.edu	Unger, Joseph/O-7457-2019		NIH [R01 CA90998]; American Cancer Society [RSG0605501LIB]; NATIONAL CANCER INSTITUTE [R01CA090998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by NIH grant R01 CA90998 (PI LeBlanc) and American Cancer Society grant RSG0605501LIB (PI Rimsza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ST, 2010, BLOOD, V115, P4447, DOI 10.1182/blood-2009-06-229872; Akasaka T, 2000, J CLIN ONCOL, V18, P510, DOI 10.1200/JCO.2000.18.3.510; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Barnett ME, 2007, CELL SIGNAL, V19, P1820, DOI 10.1016/j.cellsig.2007.05.014; Becker KG, 1997, GENOMICS, V41, P502, DOI 10.1006/geno.1997.4678; Bialik S, 2010, CURR OPIN CELL BIOL, V22, P199, DOI 10.1016/j.ceb.2009.11.004; Bowman AW, 2000, BIOMETRICS, V56, P563, DOI 10.1111/j.0006-341X.2000.00563.x; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chang KC, 2007, CLIN CANCER RES, V13, P6666, DOI 10.1158/1078-0432.CCR-07-0504; Chiles TC, 2004, J IMMUNOL, V173, P2901, DOI 10.4049/jimmunol.173.5.2901; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; COX DR, 1972, J R STAT SOC B, V34, P187; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; Gadad SS, 2010, BIOCHEMISTRY-US, V49, P1355, DOI 10.1021/bi9021632; GENTLEMAN R, 1991, BIOMETRICS, V47, P1283, DOI 10.2307/2532386; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hastie T., 2009, UNSUPERVISED LEARNIN; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Iqbal J, 2003, BLOOD, V102, p884A; KARTTUNEN T, 1989, J HISTOCHEM CYTOCHEM, V37, P279, DOI 10.1177/37.3.2918219; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; LEBLANC M, 1995, CAN J STAT, V23, P109, DOI 10.2307/3315439; LEBLANC M, 2005, HDB STAT CLIN ONCOLO, P365; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; LIST AF, 1993, LEUKEMIA, V7, P398; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lu XQ, 2007, BLOOD, V110, P4268, DOI 10.1182/blood-2007-04-087775; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; MILLER TP, 1994, BLOOD, V83, P1460, DOI 10.1182/blood.V83.6.1460.1460; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pan ZG, 2007, BRIT J HAEMATOL, V137, P578, DOI 10.1111/j.1365-2141.2007.06597.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paterson MA, 2007, BIOCHEM J, V405, P489, DOI 10.1042/BJ20070174; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pienkowska-Grela B, 2005, CANCER GENET CYTOGEN, V156, P114, DOI 10.1016/j.cancergencyto.2004.04.009; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Roberts RG, 1998, HUM MOL GENET, V7, P589, DOI 10.1093/hmg/7.4.589; Roberts RA, 2007, LAB INVEST, V87, P979, DOI 10.1038/labinvest.3700665; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; RYBSKI JA, 1991, LEUKEMIA LYMPHOMA, V6, P31, DOI 10.3109/10428199109064876; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; SLEEPER LA, 1990, J AM STAT ASSOC, V85, P941, DOI 10.2307/2289591; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tome ME, 2005, BLOOD, V106, P3594, DOI 10.1182/blood-2005-02-0487; Vicaut E, 2000, ANN MED, V32, P187, DOI 10.3109/07853890008998826; Vitolo U, 1998, ANN ONCOL, V9, P55, DOI 10.1023/A:1008201729596; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71	75	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22267	10.1371/journal.pone.0022267	http://dx.doi.org/10.1371/journal.pone.0022267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829609	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200010
J	Balaguer, L; Arroyo-Garcia, R; Jimenez, P; Jimenez, MD; Villegas, L; Cordero, I; de Casas, RR; Fernandez-Delgado, R; Ron, ME; Manrique, E; Vargas, P; Cano, E; Pueyo, JJ; Aronson, J				Balaguer, Luis; Arroyo-Garcia, Rosa; Jimenez, Percy; Dolores Jimenez, Maria; Villegas, Luis; Cordero, Irene; de Casas, Rafael Rubio; Fernandez-Delgado, Raul; Eugenia Ron, Maria; Manrique, Esteban; Vargas, Pablo; Cano, Emilio; Pueyo, Jose J.; Aronson, James			Forest Restoration in a Fog Oasis: Evidence Indicates Need for Cultural Awareness in Constructing the Reference	PLOS ONE			English	Article							PERMUTATION TESTS; GENETIC DIVERSITY; WATER-USE; TREE; CONSERVATION; POLLINATION; POPULATIONS; ADAPTATION; FABACEAE; ECOLOGY	Background: In the Peruvian Coastal Desert, an archipelago of fog oases, locally called lomas, are centers of biodiversity and of past human activity. Fog interception by a tree canopy, dominated by the legume tree tara (Caesalpinia spinosa), enables the occurrence in the Atiquipa lomas (southern Peru) of an environmental island with a diverse flora and high productivity. Although this forest provides essential services to the local population, it has suffered 90% anthropogenic reduction in area. Restoration efforts are now getting under way, including discussion as to the most appropriate reference ecosystem to use. Methodology/Principal Findings: Genetic diversity of tara was studied in the Atiquipa population and over a wide geographical and ecological range. Neither exclusive plastid haplotypes to loma formations nor clear geographical structuring of the genetic diversity was found. Photosynthetic performance and growth of seedlings naturally recruited in remnant patches of loma forest were compared with those of seedlings recruited or planted in the adjacent deforested area. Despite the greater water and nitrogen availability under tree canopy, growth of forest seedlings did not differ from that of those recruited into the deforested area, and was lower than that of planted seedlings. Tara seedlings exhibited tight stomatal control of photosynthesis, and a structural photoprotection by leaflet closure. These drought-avoiding mechanisms did not optimize seedling performance under the conditions produced by forest interception of fog moisture. Conclusions/Significance: Both weak geographic partitioning of genetic variation and lack of physiological specialization of seedlings to the forest water regime strongly suggest that tara was introduced to lomas by humans. Therefore, the most diverse fragment of lomas is the result of landscape management and resource use by pre-Columbian cultures. We argue that an appropriate reference ecosystem for ecological restoration of lomas should include sustainable agroforestry practices that emulate the outcomes of ancient uses.	[Balaguer, Luis; Cordero, Irene; Eugenia Ron, Maria] Univ Complutense Madrid, Dept Biol Vegetal 1, Madrid, Spain; [Arroyo-Garcia, Rosa; Fernandez-Delgado, Raul] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain; [Jimenez, Percy; Villegas, Luis] Univ Nacl San Agustin, IRECA, Arequipa, Peru; [Dolores Jimenez, Maria] Univ Complutense Madrid, Dept Interuniv Ecol, Madrid, Spain; [Cordero, Irene; Manrique, Esteban; Pueyo, Jose J.] CSIC, Inst Ciencias Agr, Madrid, Spain; [de Casas, Rafael Rubio] Natl Evolutionary Synth Ctr NESCent, Durham, NC USA; [Vargas, Pablo; Cano, Emilio] CSIC, Real Jardin Bot Madrid, Madrid, Spain; [Aronson, James] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Aronson, James] Missouri Bot Garden, St Louis, MO USA	Complutense University of Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Nacional de San Agustin de Arequipa; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); The National Evolutionary Synthesis Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Missouri Botanical Gardens	Balaguer, L (corresponding author), Univ Complutense Madrid, Dept Biol Vegetal 1, Madrid, Spain.	balaguer@bio.ucm.es	Arenas, Maria Dolores/AAB-7002-2020; Fernández-Delgado, Raúl/S-6617-2019; Jimenez, María Dolores/R-4762-2016; de Casas, Rafael Rubio/AAA-6912-2019; Cordero, Irene/H-8171-2019; Manrique, Esteban/C-3163-2017; Pueyo, José J./D-8993-2016	Fernández-Delgado, Raúl/0000-0001-7411-9010; Jimenez, María Dolores/0000-0002-2982-3743; de Casas, Rafael Rubio/0000-0003-4276-4968; Manrique, Esteban/0000-0002-6565-0704; Pueyo, José J./0000-0003-0337-4078; Cordero, Irene/0000-0002-6249-8348; Arroyo-Garcia, R/0000-0002-0597-1282	Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA) [BIOCON 05-102/06]; Comunidad de Madrid [REMEDINAL-2, S2009/AMB-1783]	Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA); Comunidad de Madrid(Comunidad de Madrid)	This research was funded by the Biodiversity Conservation Programme of the Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA, project BIOCON 05-102/06). The authors are also indebted to the Comunidad de Madrid (project REMEDINAL-2, S2009/AMB-1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Aronson J., 1990, Desert Plants, V10, P65; ARONSON J, 1995, RESTOR ECOL, V3, P1, DOI 10.1111/j.1526-100X.1995.tb00069.x; Aronson J., 1990, DESERT PLANTS, V10, P79; BARREIRO RPA, 1931, RELACION VIAJE HECHO; Borges LA, 2009, FLORA, V204, P111, DOI 10.1016/j.flora.2008.01.003; CANZIANI J, 2007, CUAD ARQUITECT CIUD, V5, P1; Chepstow-Lusty A, 2000, AMBIO, V29, P322, DOI 10.1639/0044-7447(2000)029[0322:IALFTP]2.0.CO;2; Chung SM, 2003, THEOR APPL GENET, V107, P757, DOI 10.1007/s00122-003-1311-3; *CIZA, 1989, APR NIEBL COST ZON A; Cobo B., 1956, HIST NUEVO MUNDO; CONRAD GW, 1981, AM ANTIQUITY, V46, P3, DOI 10.2307/279981; D'Orangeville L, 2008, FOREST ECOL MANAG, V255, P1637, DOI 10.1016/j.foreco.2007.11.023; De la Cruz Lapa P, 2004, REV I INVEST FIGMMG, V7, P64; DEESPINOSA AV, 1992, CRONICAS AM, V68, P695; Dillon M. O., 2005, MONOGRAPHS SYSTEMATI, V104, P131; Dillon M.O., 2003, EL NINO PERU BIOL CU, P1; Egan D., 2001, HIST ECOLOGY HDB RES; Esteban R, 2009, PHOTOSYNTH RES, V101, P77, DOI 10.1007/s11120-009-9468-5; Eynard C, 2002, J ARID ENVIRON, V51, P79, DOI 10.1006/jare.2001.0923; Ferreyra R., 1983, Anales del Jardin Botanico de Madrid, V40, P241; FERREYRA R, 1986, GRAN GEOGRAFIA PERU, V2, P1; Fraker ME, 2008, ACTA OECOL, V33, P66, DOI 10.1016/j.actao.2007.09.001; Gebrekirstos A, 2006, FOREST ECOL MANAG, V229, P259, DOI 10.1016/j.foreco.2006.04.029; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hasse P, 2000, J ARID ENVIRON, V46, P79, DOI 10.1006/jare.2000.0657; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Huertas ML, 2007, SYST BOT, V32, P157, DOI 10.1600/036364407780360157; INRENA, 1995, MAP EC PER; Keefer DK, 1998, SCIENCE, V281, P1833, DOI 10.1126/science.281.5384.1833; Kherad-Pajouh S, 2010, COMPUT STAT DATA AN, V54, P1881, DOI 10.1016/j.csda.2010.02.015; KVIST LP, 2006, PLANTAS PSICOACTIVAS, P294; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linares E., 1990, PREHISTORIA AREQUIPA, VII; Lira CF, 2003, MOL ECOL, V12, P3219, DOI 10.1046/j.1365-294X.2003.01991.x; Loveless MD, 2003, ECOL STU AN, V159, P9; Martorell C, 2007, OECOLOGIA, V151, P561, DOI 10.1007/s00442-006-0614-x; Masuda S., 1985, ANDEAN ECOLOGY CIVIL, P233; Meister J, 2005, BOT J LINN SOC, V148, P437, DOI 10.1111/j.1095-8339.2005.00421.x; Miller AJ, 2006, MOL ECOL, V15, P1467, DOI 10.1111/j.1365-294X.2006.02834.x; Murra John, 1985, ANDEAN ECOLOGY CIVIL, P3; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Parker KC, 2010, MOL ECOL, V19, P1622, DOI 10.1111/j.1365-294X.2010.04593.x; PEFAUR JE, 1982, VEGETATIO, V49, P163, DOI 10.1007/BF00123840; Pinto R, 2006, J ARID ENVIRON, V65, P543, DOI 10.1016/j.jaridenv.2005.08.015; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; POTVIN C, 1990, ECOLOGY, V71, P1389, DOI 10.2307/1938276; R Development Core Team, 2009, R FDN STAT COMP; Raez Luna E., 2016, AMBIENTE RECURSOS NA; Romao RL, 2000, GENET RESOUR CROP EV, V47, P207, DOI 10.1023/A:1008723706557; Rossini S., 2006, LAGASCALIA, V26, P119; Rostworowski Maria, 1981, RECURSOS NATURALES R; Sandquist DR, 2007, AM J BOT, V94, P1459, DOI 10.3732/ajb.94.9.1459; Schneider S, 2000, ARLEQUIN VER 2 00 SO; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; SER, 2022, US; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Simonin KA, 2009, PLANT CELL ENVIRON, V32, P882, DOI 10.1111/j.1365-3040.2009.01967.x; Simpson B.B., 2003, ADV LEGUME SYSTEMATI, P123; Smith S, 2003, CONSERV GENET, V4, P289, DOI 10.1023/A:1024077315820; Teketay D, 1996, FOREST ECOL MANAG, V80, P209, DOI 10.1016/0378-1127(95)03616-4; TORRES J, 2007, CLIMATE LAND DEGRADA, P501; TOWLE M, 2007, ETHNOBOTANY PRECOLUM; Villagran C., 2004, HIST NATURAL PARQUE, P3; VILLANUEVA C, 2007, TARA ORO VERDE INCAS; Villar-Salvador P, 2004, FOREST ECOL MANAG, V196, P257, DOI 10.1016/j.foreco.2004.02.061; Vittoz P, 2001, J VEG SCI, V12, P417, DOI 10.2307/3236856; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wheeler B, 2010, LMPERM PERMUTATION T; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004; ZIMMERER KS, 1991, ECON BOT, V45, P176, DOI 10.1007/BF02862046	76	15	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23004	10.1371/journal.pone.0023004	http://dx.doi.org/10.1371/journal.pone.0023004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829680	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000293511900022
J	Cocozza, S; Akhtar, MM; Miele, G; Monticelli, A				Cocozza, Sergio; Akhtar, Most. Mauluda; Miele, Gennaro; Monticelli, Antonella			CpG Islands Undermethylation in Human Genomic Regions under Selective Pressure	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; CELLS; EPIGENETICS; SEQUENCE; EXPRESSION; ANIMALS; CULTURE	DNA methylation at CpG islands (CGIs) is one of the most intensively studied epigenetic mechanisms. It is fundamental for cellular differentiation and control of transcriptional potential. DNA methylation is involved also in several processes that are central to evolutionary biology, including phenotypic plasticity and evolvability. In this study, we explored the relationship between CpG islands methylation and signatures of selective pressure in Homo Sapiens, using a computational biology approach. By analyzing methylation data of 25 cell lines from the Encyclopedia of DNA Elements (ENCODE) Consortium, we compared the DNA methylation of CpG islands in genomic regions under selective pressure with the methylation of CpG islands in the remaining part of the genome. To define genomic regions under selective pressure, we used three different methods, each oriented to provide distinct information about selective events. Independently of the method and of the cell type used, we found evidences of undermethylation of CGIs in human genomic regions under selective pressure. Additionally, by analyzing SNP frequency in CpG islands, we demonstrated that CpG islands in regions under selective pressure show lower genetic variation. Our findings suggest that the CpG islands in regions under selective pressure seem to be somehow more "protected" from methylation when compared with other regions of the genome.	[Cocozza, Sergio; Akhtar, Most. Mauluda; Miele, Gennaro] Univ Napoli Federico II Univ Salerno, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy; [Cocozza, Sergio; Akhtar, Most. Mauluda] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy; [Miele, Gennaro] Univ Naples Federico 2, Dipartimento Sci Fis, Naples, Italy; [Miele, Gennaro] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Monticelli, Antonella] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Cocozza, S (corresponding author), Univ Napoli Federico II Univ Salerno, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	cocozza@unina.it	Miele, Gennaro/AAG-6782-2020; Cocozza, Sergio/F-6488-2010; Miele, Gennaro/F-3628-2010	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578	University "Federico II", Naples	University "Federico II", Naples	This work was supported by Institutional funds by University "Federico II", Naples. MMA is a recipient of a fellowship by Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Duthie SJ, 2011, P NUTR SOC, V70, P47, DOI 10.1017/S0029665110003952; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Han L, 2007, CANCER BIOL THER, V6, P1284; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Johnson LJ, 2010, HEREDITY, V105, P113, DOI 10.1038/hdy.2010.25; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; PELIZZOLA M, 2010, FEBS LETT; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; R Development Core Team, 2009, R FDN STAT COMP; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Tomso DJ, 2003, J MOL BIOL, V327, P303, DOI 10.1016/S0022-2836(03)00120-7; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23156	10.1371/journal.pone.0023156	http://dx.doi.org/10.1371/journal.pone.0023156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829712	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900030
J	Weinkopff, T; Lammie, P				Weinkopff, Tiffany; Lammie, Patrick			Lack of Evidence for the Direct Activation of Endothelial Cells by Adult Female and Microfilarial Excretory-Secretory Products	PLOS ONE			English	Article							HUMAN LYMPHATIC FILARIASIS; BRUGIA-MALAYI INFECTION; BANCROFTIAN FILARIASIS; NUDE-MICE; IMMUNE-RECONSTITUTION; PATHOLOGY; PAHANGI; HISTOPATHOLOGY; ABNORMALITIES; CHILDREN	Lymphangiectasia (dilation of the lymphatic vessel (LV)) is pathognomonic for lymphatic filariasis. In both infected humans and animal models of infection, lymphangiectasia is not restricted to the site of the worm nest, but is found along the infected vessel. These observations argue that soluble products secreted by the worm could be mediating this effect by activating the lymphatic endothelial cells (LEC) lining the vessel. We tested the ability of filarial Excretory-Secretory products to activate LECs, but were unable to detect a direct effect of the Excretory-Secretory products on the activation of LEC as assessed by a variety of approaches including cellular proliferation, cell surface molecule expression and cytokine and growth factor production (although other mediators used as positive controls did induce these effects). Collectively, these results do not support the hypothesis that Excretory-Secretory products directly activate LECs.	[Weinkopff, Tiffany] Univ Georgia, Dept Cell Biol, Athens, GA 30602 USA; [Lammie, Patrick] Ctr Dis Control & Prevent, Atlanta, GA USA	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	Weinkopff, T (corresponding author), Univ Georgia, Dept Cell Biol, Athens, GA 30602 USA.	tiffany.weinkopff@unil.ch		Weinkopff, Tiffany/0000-0002-5239-2486	Center for Tropical and Emerging Infectious Diseases [T32 AI 060546]; Centers for Disease Control and Prevention's Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	Center for Tropical and Emerging Infectious Diseases; Centers for Disease Control and Prevention's Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by a training grant to the Center for Tropical and Emerging Infectious Diseases (T32 AI 060546) with additional support from the Centers for Disease Control and Prevention's Emerging Infectious Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753; Bennuru S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000688; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BUCK AA, 1991, HUNTERS TROPICAL MED, P711; CASE T, 1991, LYMPHOLOGY, V24, P174; Dreyer G, 2000, T ROY SOC TROP MED H, V94, P594, DOI 10.1016/S0035-9203(00)90200-1; Dreyer G, 2000, PARASITOL TODAY, V16, P544, DOI 10.1016/S0169-4758(00)01778-6; Figueredo-Silva J, 2002, ANN TROP MED PARASIT, V96, P531, DOI 10.1179/000349802125001348; FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927; FREEDMAN DO, 1995, J INFECT DIS, V171, P997, DOI 10.1093/infdis/171.4.997; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hu Xueqing, 2006, Lymphatic Research and Biology, V4, P191, DOI 10.1089/lrb.2006.4403; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nutman TB, 2001, PARASITE IMMUNOL, V23, P389, DOI 10.1046/j.1365-3024.2001.00399.x; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Rao UR, 1996, J PARASITOL, V82, P550, DOI 10.2307/3283779; Sawa Y, 2007, J HISTOCHEM CYTOCHEM, V55, P721, DOI 10.1369/jhc.6A7171.2007; Shenoy RK, 2009, ANN TROP MED PARASIT, V103, P235, DOI 10.1179/136485909X398249; Shenoy R. K., 2008, Journal of Communicable Diseases, V40, P91; Shin JW, 2008, BLOOD, V112, P2318, DOI 10.1182/blood-2008-05-156331; VICKERY AC, 1983, J PARASITOL, V69, P478, DOI 10.2307/3281358; VICKERY AC, 1991, ACTA TROP, V49, P45, DOI 10.1016/0001-706X(91)90029-J; VICKERY AC, 1985, ACTA TROP, V42, P353; VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924; VONLICHTENBERG F, 1957, J MT SINAI HOSP, V24, P983	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22282	10.1371/journal.pone.0022282	http://dx.doi.org/10.1371/journal.pone.0022282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829611	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900004
J	Stover, NA; Dixon, TA; Cavalcanti, ARO				Stover, Nicholas A.; Dixon, Thomas A.; Cavalcanti, Andre R. O.			Multiple Independent Fusions of Glucose-6-Phosphate Dehydrogenase with Enzymes in the Pentose Phosphate Pathway	PLOS ONE			English	Article							HEXOSE 6-PHOSPHATE DEHYDROGENASE; HEXOSE-6-PHOSPHATE DEHYDROGENASE; BIFUNCTIONAL ENZYME; SEQUENCE ALIGNMENT; GENOME-SEQUENCE; GENE FUSION; 6-PHOSPHOGLUCONOLACTONASE; CRYPTOSPORIDIUM; EVOLUTIONARY; DEHYDROGENASE-6-PHOSPHOGLUCONOLACTONASE	Fusions of the first two enzymes in the pentose phosphate pathway, glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconolactonase (6PGL), have been previously described in two distant clades, chordates and species of the malarial parasite Plasmodium. We have analyzed genome and expressed sequence data from a variety of organisms to identify the origins of these gene fusion events. Based on the orientation of the domains and range of species in which homologs can be found, the fusions appear to have occurred independently, near the base of the metazoan and apicomplexan lineages. Only one of the two metazoan paralogs of G6PD is fused, showing that the fusion occurred after a duplication event, which we have traced back to an ancestor of choanoflagellates and metazoans. The Plasmodium genes are known to contain a functionally important insertion that is not seen in the other apicomplexan fusions, highlighting this as a unique characteristic of this group. Surprisingly, our search revealed two additional fusion events, one that combined 6PGL and G6PD in an ancestor of the protozoan parasites Trichomonas and Giardia, and another fusing G6PD with phosphogluconate dehydrogenase (6PGD) in a species of diatoms. This study extends the range of species known to contain fusions in the pentose phosphate pathway to many new medically and economically important organisms.	[Stover, Nicholas A.] Bradley Univ, Dept Biol, Peoria, IL 61625 USA; [Dixon, Thomas A.] Pomona Coll, Dept Chem, Claremont, CA 91711 USA; [Cavalcanti, Andre R. O.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA	Bradley University; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Stover, NA (corresponding author), Bradley Univ, Dept Biol, Peoria, IL 61625 USA.	aroc@pomona.edu	Cavalcanti, Andre RO/H-9777-2013	Cavalcanti, Andre RO/0000-0001-8708-6932	National Science Foundation [0920697]; Direct For Biological Sciences [0920697] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by National Science Foundation Award Number 0920697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; BEUTLER E, 1967, J BIOL CHEM, V242, P5289; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Clarke JL, 2003, MOL BIOCHEM PARASIT, V127, P1, DOI 10.1016/S0166-6851(02)00298-0; Clarke JL, 2003, ARCH BIOCHEM BIOPHYS, V415, P229, DOI 10.1016/S0003-9861(03)00229-7; Clarke JL, 2001, EUR J BIOCHEM, V268, P2013, DOI 10.1046/j.1432-1327.2001.02078.x; Collard F, 1999, FEBS LETT, V459, P223, DOI 10.1016/S0014-5793(99)01247-8; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MATSUOKA N, 1980, COMP BIOCHEM PHYS B, V65, P191, DOI 10.1016/0305-0491(80)90002-4; MATSUOKA N, 1983, COMP BIOCHEM PHYS B, V76, P811, DOI 10.1016/0305-0491(83)90397-8; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; MOCHIZUKI Y, 1976, COMP BIOCHEM PHYS B, V54, P489, DOI 10.1016/0305-0491(76)90127-9; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Okuda S, 2006, NUCLEIC ACIDS RES, V34, pD358, DOI 10.1093/nar/gkj037; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; SHAW CR, 1968, ANN NY ACAD SCI, V151, P149, DOI 10.1111/j.1749-6632.1968.tb11884.x; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; STEGEMAN JJ, 1971, BIOCHEM GENET, V5, P579, DOI 10.1007/BF00485675; TAN SG, 1976, HUM HERED, V26, P113, DOI 10.1159/000152791; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; YAMAUCHI T, 1973, BIOCHEM GENET, V10, P121, DOI 10.1007/BF00485760; Zhu G, 2000, INT J SYST EVOL MICR, V50, P1673, DOI 10.1099/00207713-50-4-1673	51	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22269	10.1371/journal.pone.0022269	http://dx.doi.org/10.1371/journal.pone.0022269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829610	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511200006
J	Li, HH; Wang, YQ; Ding, L; Zheng, SJJ				Li, Haihua; Wang, Yongqiang; Ding, Lin; Zheng, Shijun J.			Staphylococcus sciuri Exfoliative Toxin C (ExhC) is a Necrosis-Inducer for Mammalian Cells	PLOS ONE			English	Article							HYICUS SUBSP HYICUS; MOLECULAR CHARACTERIZATION; EXUDATIVE EPIDERMITIS; SKIN; PIGS; STRAINS; CLONING	Staphylococcus sciuri (S. sciuri) is a rare pathogen in humans, but it can cause a wide array of human infections. Recently a S. sciuri isolate (HBXX06) was reported to cause fatal exudative epidermitis (EE) in piglets and thus considered as a potential zoonotic agent. To investigate the pathogenicity of this bacterium, we cloned exfoliative toxin C (ExhC), a major toxin of the S. sciuri isolate and performed functional analysis of the recombinant ExhC-his (rExhC) protein using in vitro cell cultures and newborn mice as models. We found that rExhC could induce necrosis in multiple cell lines and peritoneal macrophages as well as skin lesions in newborn mice, and that the rExhC-induced necrosis in cells or skin lesions in newborn mice could be completely abolished if amino acids 79-128 of rExhC were deleted or blocked with a monoclonal antibody (3E4), indicating aa 79-128 portion as an essential necrosis-inducing domain. This information contributes to further understandings of the mechanisms underlying S. sciuri infection.	[Li, Haihua] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Li, HH (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	sjzheng@cau.edu.cn			National Natural Science Foundation of China [30725026, 31072117]; National Basic Research Program of China [2006CB504303]; National High-tech Program of China [2006AA10A208-1-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (#30725026 and 31072117 to SJ Zheng), National Basic Research Program of China (#2006CB504303 to SJ Zheng) and National High-tech Program of China (#2006AA10A208-1-1 to SJ Zheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens P, 2004, J BACTERIOL, V186, P1833, DOI 10.1128/JB.186.6.1833-1837.2004; Andresen LO, 1997, MICROB PATHOGENESIS, V22, P113, DOI 10.1006/mpat.1996.0097; Andresen LO, 1998, FEMS IMMUNOL MED MIC, V20, P301, DOI 10.1111/j.1574-695X.1998.tb01140.x; Andresen LO, 2005, VET REC, V157, P376, DOI 10.1136/vr.157.13.376; Andresen LO, 2005, VET MICROBIOL, V105, P291, DOI 10.1016/j.vetmic.2004.12.006; ANDRESEN LO, 1993, MICROB PATHOGENESIS, V15, P217, DOI 10.1006/mpat.1993.1072; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Fudaba Y, 2005, MICROB PATHOGENESIS, V39, P171, DOI 10.1016/j.micpath.2005.08.003; Hedin G, 1998, EUR J CLIN MICROBIOL, V17, P673, DOI 10.1007/s100960050157; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Kanbar T, 2008, J VET SCI, V9, P327, DOI 10.4142/jvs.2008.9.3.327; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Koh Eun-Mi, 2009, Immune Netw, V9, P203, DOI 10.4110/in.2009.9.5.203; Ladhani S, 2001, CLIN MICROBIOL INFEC, V7, P301, DOI 10.1046/j.1198-743x.2001.00258.x; Ladhani S, 1999, CLIN MICROBIOL REV, V12, P224, DOI 10.1128/CMR.12.2.224; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Nishifuji K, 2005, VET DERMATOL, V16, P315, DOI 10.1111/j.1365-3164.2005.00474.x; OKADA K, 1987, J GEN MICROBIOL, V133, P2279; POUTREL B, 1984, AM J VET RES, V45, P2084; Rahman MT, 2005, MICROB DRUG RESIST, V11, P205, DOI 10.1089/mdr.2005.11.205; Sato H, 2000, J BACTERIOL, V182, P4096, DOI 10.1128/JB.182.14.4096-4100.2000; SATO H, 1991, VET MICROBIOL, V27, P263, DOI 10.1016/0378-1135(91)90153-7; SATO H, 1991, VET MICROBIOL, V28, P157, DOI 10.1016/0378-1135(91)90090-3; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; Smith JG, 2007, CLIN VACCINE IMMUNOL, V14, P527, DOI 10.1128/CVI.00435-06; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Stepanovic S, 2002, SCAND J INFECT DIS, V34, P685, DOI 10.1080/00365540110076949; Stepanovic S, 2001, VET MICROBIOL, V82, P177, DOI 10.1016/S0378-1135(01)00377-7; Stepanovic S, 2001, FEMS MICROBIOL LETT, V199, P47, DOI 10.1016/S0378-1097(01)00150-1; TAKEUCHI S, 1987, VET MICROBIOL, V14, P47, DOI 10.1016/0378-1135(87)90051-4; Wallet F, 2000, SCAND J INFECT DIS, V32, P697, DOI 10.1080/003655400459667	36	49	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23145	10.1371/journal.pone.0023145	http://dx.doi.org/10.1371/journal.pone.0023145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829591	Green Submitted, Green Published, gold			2022-12-25	WOS:000293286500078
J	Wichmann, J; Andersen, Z; Ketzel, M; Ellermann, T; Loft, S				Wichmann, Janine; Andersen, Zorana; Ketzel, Matthias; Ellermann, Thomas; Loft, Steffen			Apparent Temperature and Cause-Specific Emergency Hospital Admissions in Greater Copenhagen, Denmark	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSES; AIR-POLLUTION; EUROPEAN CITIES; CARDIOVASCULAR-DISEASES; MORTALITY; WEATHER; HEALTH; COLD; SELECTION; WAVES	One of the key climate change factors, temperature, has potentially grave implications for human health. We report the first attempt to investigate the association between the daily 3-hour maximum apparent temperature (Tapp(max)) and respiratory (RD), cardiovascular (CVD), and cerebrovascular (CBD) emergency hospital admissions in Copenhagen, controlling for air pollution. The study period covered 1 January 2002231 December 2006, stratified in warm and cold periods. A case-crossover design was applied. Susceptibility (effect modification) by age, sex, and socio-economic status was investigated. For an IQR (8 degrees C) increase in the 5-day cumulative average of Tapp(max), a 7% (95% CI: 1%, 13%) increase in the RD admission rate was observed in the warm period whereas an inverse association was found with CVD (-8%, -5% CI: -13%, -4%), and none with CBD. There was no association between the 5-day cumulative average of Tapp(max) during the cold period and any of the cause-specific admissions, except in some susceptible groups: a negative association for RD in the oldest age group and a positive association for CVD in men and the second highest SES group. In conclusion, an increase in Tapp(max) is associated with a slight increase in RD and decrease in CVD admissions during the warmer months.	[Wichmann, Janine; Loft, Steffen] Univ Copenhagen, Environm Hlth Sect, Copenhagen, Denmark; [Andersen, Zorana] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Ketzel, Matthias; Ellermann, Thomas] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark	University of Copenhagen; Danish Cancer Society; Aarhus University	Wichmann, J (corresponding author), Univ Copenhagen, Environm Hlth Sect, Copenhagen, Denmark.	jawic@sund.ku.dk	Andersen, Zorana Jovanovic/P-4983-2014; Ketzel, Matthias/K-4246-2015	Andersen, Zorana Jovanovic/0000-0003-4138-9828; Ketzel, Matthias/0000-0001-9519-1935; Loft, Steffen/0000-0001-9552-8518	Danish National Board of Health; Danish Research Councils; Danish Environmental Protection Agency	Danish National Board of Health; Danish Research Councils(Det Frie Forskningsrad (DFF)); Danish Environmental Protection Agency	This work was commissioned and partially funded by the Danish National Board of Health and the Danish Research Councils. The Danish Environmental Protection Agency is funding the air pollution and meteorological measurements as part of the Danish Air Quality Monitoring Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Andersen ZJ, 2007, J EXPO SCI ENV EPID, V17, P625, DOI 10.1038/sj.jes.7500546; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Ellermann T, 2011, 836 AARH U NAT ENV R; Falagas ME, 2010, ENFERM INFEC MICR CL, V28, P716, DOI 10.1016/j.eimc.2009.11.013; *FORSKN FOR SUNDH, DAN HLTH REV REG COM; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; HEI (Health Effects Institute), 2003, REV AN TIM SER STUD; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; Lee JT, 2000, ENVIRON HEALTH PERSP, V108, P1107, DOI 10.2307/3434821; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Matthies FB., 2008, HEAT HLTH ACTION PLA; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; Metzger KB, 2004, EPIDEMIOLOGY, V15, P46, DOI 10.1097/01.EDE.0000101748.28283.97; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Nafstad P, 2001, EUR J EPIDEMIOL, V17, P621, DOI 10.1023/A:1015547012242; Nayha S, 2007, INT J CIRCUMPOL HEAL, V66, P418; Nayha Simo, 2005, Int J Circumpolar Health, V64, P451; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; WHO (World Health Organization), 2004, MET TIM SER STUD PAN; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; World Health Organization, AIR QUAL GUID GLOB U; *WORLD MET ORG, UN ENV PROGR	33	55	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22904	10.1371/journal.pone.0022904	http://dx.doi.org/10.1371/journal.pone.0022904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829550	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500048
J	Xu, J; Wang, B; Xu, Y; Sun, L; Tian, W; Shukla, D; Barod, R; Grillari, J; Grillari-Voglauer, R; Maxwell, PH; Esteban, MA				Xu, J.; Wang, B.; Xu, Y.; Sun, L.; Tian, W.; Shukla, D.; Barod, R.; Grillari, J.; Grillari-Voglauer, R.; Maxwell, P. H.; Esteban, M. A.			Epigenetic regulation of HIF-1 alpha in renal cancer cells involves HIF-1 alpha/2 alpha binding to a reverse hypoxia-response element	ONCOGENE			English	Article						von Hippel-Lindau tumor suppressor gene; hypoxia-inducible factor; renal cancer; epigenetics; histone modifications	TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR-I; HISTONE DEMETHYLASES; C-MYC; EXPRESSION; VHL; HIF; CARCINOMA; ALPHA; GENE	Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene underlies the majority of sporadic clear cell renal cell carcinomas (CCRCCs) and is also responsible for the hereditary VHL cancer syndrome. VHL loss of function results in constitutive stabilization of hypoxia-inducible factors (HIF-1 alpha and HIF-2 alpha) due to insufficient proteolysis in the presence of oxygen. This activates multiple genes relevant to tumorigenesis, allowing cells to acquire further mutations and undergo malignant transformation. However, the specific role of each HIF-alpha subunit in CCRCC tumorigenesis is not yet well understood. The current paradigm supports that in the first stages of CCRCC formation the stabilization of HIF-1 alpha is dominant and this limits proliferation, but later on HIF-2 alpha increases and this induces a more aggressive cell behavior. Understanding how this transition happens is highly relevant, as it may provide novel ways to treat these cancers. Here, we show that VHL inactivation in CCRCC cells results in HIF-1 alpha/2 alpha-dependent down-regulation of HIF-1 alpha mRNA through direct binding of either subunit to a reverse hypoxia-response element in the HIF-1 alpha proximal promoter. This binding activates a series of repressive histone modification marks including histone 3 lysine 27 trimethylation (H3K27me3) to make the changes stable, and if overturned reduces CCRCC cell proliferation due to excessive HIF-1 alpha expression level. Our findings thus help understand how HIF-alpha subunits influence each other and also reinforce the idea that epigenetic mechanisms are a key step of CCRCC progression. Oncogene (2012) 31, 1065-1072; doi:10.1038/onc.2011.305; published online 15 August 2011	[Xu, J.; Wang, B.; Xu, Y.; Sun, L.; Tian, W.; Esteban, M. A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Shukla, D.; Barod, R.; Maxwell, P. H.] UCL, Rayne Inst, Ctr Cell Signaling & Mol Genet, London, England; [Grillari, J.; Grillari-Voglauer, R.] Univ Nat Resources & Life Sci, Dept Biotechnol Aging & Immortalizat Res, Vienna, Austria	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of London; King's College London; University College London; University of Natural Resources & Life Sciences, Vienna	Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	estebanb@gibh.org	Grillari, Johannes/B-2967-2011; Maxwell, Patrick H/C-5557-2008	Grillari, Johannes/0000-0001-5474-6332; Maxwell, Patrick H/0000-0002-0338-2679; Tian, Weihua/0000-0003-2357-3947; Xu, Yan/0000-0001-5653-291X	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences [KSCX2-YW-R-244]; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences(Chinese Academy of Sciences); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by start-up funding from the Guangzhou Institutes of Biomedicine and Health and the Chinese Academy of Sciences Grant KSCX2-YW-R-244 to MAE. We thank Dr Duanqing Pei for his constant support.	Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koslowski M, 2011, ONCOGENE, V30, P876, DOI 10.1038/onc.2010.481; Kothari S, 2003, ONCOGENE, V22, P4734, DOI 10.1038/sj.onc.1206666; Lee KJ, 2010, BBA-MOL CELL RES, V1803, P608, DOI 10.1016/j.bbamcr.2010.01.004; Lin Q, 2011, MOL CANC RES, DOI 10.115811541-7786. MCR-11-0053; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 2002, CANCER RES, V62, P1158; Menrad H, 2010, HEPATOLOGY, V51, P2183, DOI 10.1002/hep.23597; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	39	27	28	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	8					1065	1072		10.1038/onc.2011.305	http://dx.doi.org/10.1038/onc.2011.305			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21841824				2022-12-25	WOS:000300709700012
J	Vida, G; Pena, G; Kanashiro, A; Thompson-Bonilla, MD; Palange, D; Deitch, EA; Ulloa, L				Vida, Gergely; Pena, Geber; Kanashiro, Alexandre; Thompson-Bonilla, Maria del Rocio; Palange, David; Deitch, Edwin A.; Ulloa, Luis			beta 2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system	FASEB JOURNAL			English	Article						sepsis; septic shock; parasympathetic nervous system; vagus nerve; inflammation; cytokine	CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TUMOR-NECROSIS-FACTOR; NICOTINIC ACETYLCHOLINE-RECEPTOR; SEPTIC SHOCK; VAGUS NERVE; HOST RESPONSE; SEVERE SEPSIS; PROTEIN; STIMULATION; MODULATION	The nervous system is classically organized into sympathetic and parasympathetic systems acting in opposition to maintain physiological homeostasis. Here, we report that both systems converge in the activation of beta 2-adrenoceptors of splenic regulatory lymphocytes to control systemic inflammation. Vagus nerve stimulation fails to control serum TNF levels in either beta 2-knockout or lymphocyte-deficient nude mice. Unlike typical suppressor CD25(+) cells, the transfer of CD4(+)CD25(-) regulatory lymphocytes reestablishes the anti-inflammatory potential of the vagus nerve and beta 2-agonists to control inflammation in both beta 2-knockout and nude mice. beta 2-Agonists inhibit cytokine production in splenocytes (IC50 similar to 1 mu M) and prevent systemic inflammation in wild-type but not in beta 2-knockout mice. beta 2-Agonists rescue wild-type mice from established polymicrobial peritonitis in a clinically relevant time frame. Regulatory lymphocytes reestablish the anti-inflammatory potential of beta 2-agonists to control systemic inflammation, organ damage, and lethal endotoxic shock in beta 2-knockout mice. These results indicate that beta 2-adrenoceptors in regulatory lymphocytes are critical for the anti-inflammatory potential of the parasympathetic vagus nerve, and they represent a potential pharmacological target for sepsis. Vida, G., Pena, G., Kanashiro, A., del Rocio Thompson-Bonilla, M., Palange, D., Deitch, E. A., Ulloa, L. beta 2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J. 25, 4476-4485 (2011). www.fasebj.org	[Vida, Gergely; Pena, Geber; Kanashiro, Alexandre; Thompson-Bonilla, Maria del Rocio; Palange, David; Deitch, Edwin A.; Ulloa, Luis] Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Immun & Infect, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ulloa, L (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Immun & Infect, Dept Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	mail@luisulloa.com	Ulloa, Luis/AAE-8751-2019; pena, Geber/AAD-5890-2019; Kanashiro, Alexandre/AAX-3823-2020; Kanashiro, Alexandre/C-9435-2012	Ulloa, Luis/0000-0002-7702-7549; Kanashiro, Alexandre/0000-0003-0367-7503; Kanashiro, Alexandre/0000-0003-0367-7503	Hungarian Rosztoczy Foundation; Brazilian Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Mexican National Council for Science and Technology (CONACyT); Department of Surgery of the New Jersey Medical School; U.S. National Institutes of Health [RO1-GM084125]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084125] Funding Source: NIH RePORTER	Hungarian Rosztoczy Foundation; Brazilian Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Department of Surgery of the New Jersey Medical School; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Brian Kobilka (Stanford University, Stanford, CA, USA) for his collaboration with the beta 2KO mice. G.V. was supported by the Hungarian Rosztoczy Foundation, A.K. was supported by the Brazilian Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and M.R.T. was supported by the Mexican National Council for Science and Technology (CONACyT). L.U. is supported by the faculty program of the Department of Surgery of the New Jersey Medical School, and the U.S. National Institutes of Health (RO1-GM084125).	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2007, JAMA-J AM MED ASSOC, V298, P456, DOI 10.1001/jama.298.4.456; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cai BL, 2009, J CELL MOL MED, V13, P3774, DOI 10.1111/j.1582-4934.2008.00550.x; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Crandall M, 2009, MOL MED, V15, P263, DOI 10.2119/molmed.2009.00029; Crassous PA, 2007, CURR TOP MED CHEM, V7, P187, DOI 10.2174/156802607779318190; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; de Montmollin E, 2009, CRIT CARE, V13, DOI 10.1186/cc8026; Eijkelkamp N, 2004, J NEUROIMMUNOL, V150, P3, DOI 10.1016/j.jneuroim.2004.01.001; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Felten S Y, 1998, Adv Pharmacol, V42, P583; FLOOD JF, 1987, SCIENCE, V236, P832, DOI 10.1126/science.3576201; Hasko G, 1998, J NEUROIMMUNOL, V88, P57, DOI 10.1016/S0165-5728(98)00073-3; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Javed U, 2009, CARDIOL REV, V17, P287, DOI 10.1097/CRD.0b013e3181bdf63e; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; LEVINE JD, 1988, P NATL ACAD SCI USA, V85, P4553, DOI 10.1073/pnas.85.12.4553; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Nakada TA, 2010, AM J RESP CRIT CARE, V181, P143, DOI 10.1164/rccm.200903-0332OC; Nakamura A, 2004, J AM SOC NEPHROL, V15, P316, DOI 10.1097/01.ASN.0000111247.76908.59; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; O'Mahony C, 2009, AM J PHYSIOL-REG I, V297, pR1118, DOI 10.1152/ajpregu.90904.2008; Oberbeck R, 2009, CURR MED CHEM, V16, P1082, DOI 10.2174/092986709787581770; Ortega VE, 2010, CURR OPIN PHARMACOL, V10, P246, DOI 10.1016/j.coph.2010.04.009; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Sanders VM, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P63; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Straub RH, 1998, IMMUNOL TODAY, V19, P409, DOI 10.1016/S0167-5699(98)01297-3; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	57	107	121	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4476	4485		10.1096/fj.11-191007	http://dx.doi.org/10.1096/fj.11-191007			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21840939	Green Published			2022-12-25	WOS:000298138100038
J	Lubos, E; Kelly, NJ; Oldebeken, SR; Leopold, JA; Zhang, YY; Loscalzo, J; Handy, DE				Lubos, Edith; Kelly, Neil J.; Oldebeken, Scott R.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.			Glutathione Peroxidase-1 Deficiency Augments Proinflammatory Cytokine-induced Redox Signaling and Human Endothelial Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; DUAL-SPECIFICITY PHOSPHATASES; OXIDATIVE STRESS MEASUREMENTS; ADHESION MOLECULE-1 GENE; FREE-RADICAL FORMATION; TNF-ALPHA; HYDROGEN-PEROXIDE; TRANSCRIPTIONAL REGULATION	Glutathione peroxidase-1 (GPx-1) is a crucial antioxidant enzyme, the deficiency of which promotes atherogenesis. Accordingly, we examined the mechanisms by which GPx-1 deficiency enhances endothelial cell activation and inflammation. In human microvascular endothelial cells, we found that GPx-1 deficiency augments intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by redox-dependent mechanisms that involve NF kappa B. Suppression of GPx-1 enhanced TNF-alpha-induced ROS production and ICAM-1 expression, whereas overexpression of GPx-1 attenuated these TNF-alpha-mediated responses. GPx-1 deficiency prolonged TNF-alpha-induced I kappa B alpha degradation and activation of ERK1/2 and JNK. JNK or NF kappa B inhibition attenuated TNF-alpha induction of ICAM-1 and VCAM-1 expression in GPx-1-deficient and control cells, whereas ERK1/2 inhibition attenuated only VCAM-1 expression. To analyze further signaling pathways involved in GPx-1-mediated protection from TNF-alpha-induced ROS, we performed microarray analysis of human microvascular endothelial cells treated with TNF-alpha in the presence and absence of GPx-1. Among the genes whose expression changed significantly, dual specificity phosphatase 4 (DUSP4), encoding an antagonist of MAPK signaling, was down-regulated by GPx-1 suppression. Targeted DUSP4 knockdown enhanced TNF-alpha-mediated ERK1/2 pathway activation and resulted in increased adhesion molecule expression, indicating that GPx-1 deficiency may augment TNF-alpha-mediated events, in part, by regulating DUSP4.	[Lubos, Edith; Kelly, Neil J.; Oldebeken, Scott R.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Handy, DE (corresponding author), HMS NRB 0630,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527	National Institutes of Health [HL 58976, HL 61795, HV 28178, HL 81587, HL 48743]; NHLBI; Deutsche Forschungsgemeinschaft [LU 1452/1-1, LU 1452/2-1]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061795, P01HL081587, R01HL058976, R01HL105301, P01HL048743, R37HL061795, R01HL028178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 58976, HL 61795, HV 28178, HL 81587, and HL 48743 from the NHLBI and Deutsche Forschungsgemeinschaft Grants LU 1452/1-1 and LU 1452/2-1.	Ahmad M, 1998, J BIOL CHEM, V273, P4616, DOI 10.1074/jbc.273.8.4616; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cao C, 2003, J BIOL CHEM, V278, P39609, DOI 10.1074/jbc.M305770200; Chrissobolis S, 2008, HYPERTENSION, V51, P872, DOI 10.1161/HYPERTENSIONAHA.107.103572; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; D'Alessio P, 1998, FREE RADICAL BIO MED, V24, P979, DOI 10.1016/S0891-5849(97)00396-1; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Espinola-Klein C, 2007, AM J CARDIOL, V99, P808, DOI 10.1016/j.amjcard.2006.10.041; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Montes-Sanchez Delina, 2009, BMC Chemical Biology, V9, P7, DOI 10.1186/1472-6769-9-7; Murakami T, 2000, J Atheroscler Thromb, V7, P39; Murias Marek, 2005, Journal of Pharmacological and Toxicological Methods, V52, P302, DOI 10.1016/j.vascn.2005.03.002; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Wagner AH, 2009, ARTERIOSCL THROM VAS, V29, P1894, DOI 10.1161/ATVBAHA.109.194738; Weisbrot-Lefkowitz M, 1998, MOL BRAIN RES, V53, P333, DOI 10.1016/S0169-328X(97)00313-6; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yoshida T, 1997, CIRCULATION, V96, P216; Zhang YF, 2005, CIRC RES, V96, P831, DOI 10.1161/01.RES.0000164401.21929.CF; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	57	50	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35407	35417		10.1074/jbc.M110.205708	http://dx.doi.org/10.1074/jbc.M110.205708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852236	hybrid, Green Published			2022-12-25	WOS:000295927100012
J	Yasui, N; Kitago, Y; Beppu, A; Kohno, T; Morishita, S; Gomi, H; Nagae, M; Hattori, M; Takagi, J				Yasui, Norihisa; Kitago, Yu; Beppu, Ayako; Kohno, Takao; Morishita, Shunsuke; Gomi, Hiroki; Nagae, Masamichi; Hattori, Mitsuharu; Takagi, Junichi			Functional Importance of Covalent Homodimer of Reelin Protein Linked via Its Central Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; VLDL RECEPTOR; IN-VIVO; BINDING; FRAGMENT; NEURONS; RECOGNITION; DISRUPTION; DOMAIN; BRAIN	Reelin is a 3461-residue secreted glycoprotein that plays a critical role in brain development through its action on target neurons. Although it is known that functional reelin protein exists as multimer formed by interchain disulfide bond(s) as well as through non-covalent interactions, the chemical nature of the multimer assembly has been elusive. In the present study, we identified, among 122 cysteines present in full-length reelin, the single critical cysteine residue (Cys(2101)) responsible for the covalent multimerization. C2101A mutant reelin failed to assemble into disulfide-bonded multimers, whereas it still exhibited non-covalently associated high molecular weight oligomeric states in solution. Detailed analysis of tryptic fragments produced from the purified reelin proteins revealed that the minimum unit of the multimer is a homodimeric reelin linked via Cys(2101) present in the central region and that this cysteine does not connect to the N-terminal region of reelin, which had been postulated as the primary oligomerization domain. A surface plasmon resonance binding assay confirmed that C2101A mutant reelin retained binding capability toward two neuronal receptors apolipoprotein E receptor 2 and very low density lipoprotein receptor. However, it failed to show signaling activity in the assay using the cultured neurons. These results indicate that an intact higher order architecture of reelin multimer maintained by both Cys(2101)-mediated homodimerization and other non-covalent association present elsewhere in the reelin primary structure are essential for exerting its full biological activity.	[Yasui, Norihisa; Kitago, Yu; Beppu, Ayako; Nagae, Masamichi; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; [Kohno, Takao; Morishita, Shunsuke; Gomi, Hiroki; Hattori, Mitsuharu] Nagoya City Univ, Dept Biomed Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Aichi 4678603, Japan	Osaka University; Nagoya City University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takagi@protein.osaka-u.ac.jp	Yasui, Norihisa/V-8252-2019; Hattori, Mitsuharu/F-3859-2010	Yasui, Norihisa/0000-0001-7117-3070; Hattori, Mitsuharu/0000-0002-0503-4969; Nagae, Masamichi/0000-0002-5470-3807; Kohno, Takao/0000-0003-2557-4281; Kitago, Yu/0000-0003-2325-6917	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20770084]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), a grant-in-aid for scientific research on innovative areas from MEXT, a Protein 3000 Project grant from MEXT, and Grant-in-aid for Young Scientists (B) 20770084 (to N. Y.) from MEXT.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2003, CEREB CORTEX, V13, P627, DOI 10.1093/cercor/13.6.627; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; Miyata T, 1997, J NEUROSCI, V17, P3599; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nagae M, 2008, ACTA CRYSTALLOGR D, V64, P1138, DOI 10.1107/S0907444908028308; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Nogi T, 2008, PROTEIN SCI, V17, P2120, DOI 10.1110/ps.038299.108; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Tabata S, 2010, J PROTEOMICS, V73, P1777, DOI 10.1016/j.jprot.2010.05.012; Takagi Junichi, 2008, P57, DOI 10.1007/978-0-387-76761-1_5; Tan KM, 2008, J MOL BIOL, V381, P1213, DOI 10.1016/j.jmb.2008.06.045; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	39	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35247	35256		10.1074/jbc.M111.242719	http://dx.doi.org/10.1074/jbc.M111.242719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844191	Green Published, hybrid			2022-12-25	WOS:000295406300077
J	Benson, MA; Fu, ZJ; Kim, JJP; Baldwin, MR				Benson, Marc A.; Fu, Zhuji; Kim, Jung-Ja P.; Baldwin, Michael R.			Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CC-DOMAIN; BOTULINUM NEUROTOXIN; TETANUS TOXIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; SEROTYPE-F; BINDING; RECEPTOR; CRYSTALLOGRAPHY; SV2	Botulinum neurotoxins (BoNTs) and tetanus neurotoxin are the causative agents of the paralytic diseases botulism and tetanus, respectively. The potency of the clostridial neurotoxins (CNTs) relies primarily on their highly specific binding to nerve terminals and cleavage of SNARE proteins. Although individual CNTs utilize distinct proteins for entry, they share common ganglioside co-receptors. Here, we report the crystal structure of the BoNT/F receptor-binding domain in complex with the sugar moiety of ganglioside GD1a. GD1a binds in a shallow groove formed by the conserved peptide motif E ... H ... SXWY ... G, with additional stabilizing interactions provided by two arginine residues. Comparative analysis of BoNT/F with other CNTs revealed several differences in the interactions of each toxin with ganglioside. Notably, exchange of BoNT/F His-1241 with the corresponding lysine residue of BoNT/E resulted in increased affinity for GD1a and conferred the ability to bind ganglioside GM1a. Conversely, BoNT/E was not able to bind GM1a, demonstrating a discrete mechanism of ganglioside recognition. These findings provide a structural basis for ganglioside binding among the CNTs and show that individual toxins utilize unique ganglioside recognition strategies.	[Benson, Marc A.; Baldwin, Michael R.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Missouri System; University of Missouri Columbia; Medical College of Wisconsin	Baldwin, MR (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, M618 Med Sci Bldg, Columbia, MO 65212 USA.	baldwinmr@missouri.edu		Benson, Marc/0000-0002-7189-1133	Consortium for Functional Glycomics [GM62116]; National Institutes of Health, NIAID [U54 AI057153]; NINDS [R00 NS061763]; Great Lakes Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	Consortium for Functional Glycomics; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The GD1a analog (compound Te303) utilized in this study was provided by Consortium for Functional Glycomics Grant GM62116. We thank the staff at Advanced Photon Source beamline SBC 19ID for excellent assistance in data collection and Dr. Joseph T. Barbieri for helpful suggestions during the preparation of this manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057153 from NIAID (to J.-J. P. K.) and Grant R00 NS061763 from NINDS (to M. R. B.). This work was also supported by grants from the Great Lakes Regional Center of Excellence.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1989, BIOCHEM J, V259, P47, DOI 10.1042/bj2590047; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; OCHANDA JO, 1986, J BIOCHEM-TOKYO, V100, P27, DOI 10.1093/oxfordjournals.jbchem.a121702; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SIMPSON LL, 1971, J NEUROCHEM, V18, P1341, DOI 10.1111/j.1471-4159.1971.tb00235.x; SIMPSON LL, 1971, J NEUROCHEM, V18, P1761, DOI 10.1111/j.1471-4159.1971.tb03751.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VANHEYNINGEN W, 1961, J GEN MICROBIOL, V24, P107, DOI 10.1099/00221287-24-1-107; VANHEYNINGEN W, 1961, BRIT J EXP PATHOL, V42, P397; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	41	43	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34015	34022		10.1074/jbc.M111.272054	http://dx.doi.org/10.1074/jbc.M111.272054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21849494	Green Published, hybrid			2022-12-25	WOS:000295159200034
J	Geng, YF; Hsu, JJ; Lu, JX; Ting, TC; Miyazaki, M; Demer, LL; Tintut, Y				Geng, Yifan; Hsu, Jeffrey J.; Lu, Jinxiu; Ting, Tabitha C.; Miyazaki, Makoto; Demer, Linda L.; Tintut, Yin			Role of Cellular Cholesterol Metabolism in Vascular Cell Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CHRONIC KIDNEY-DISEASE; IN-VITRO; MATRIX VESICLES; DEFICIENT MICE; RENAL-FAILURE; LDL RECEPTOR; MECHANISMS; ATHEROSCLEROSIS; PHOSPHATE	Vascular calcification impairs vessel compliance and increases the risk of cardiovascular events. We found previously that liver X receptor agonists, which regulate intracellular cholesterol homeostasis, augment PKA agonist-or high phosphate-induced osteogenic differentiation of vascular smooth muscle cells. Because cholesterol is an integral component of the matrix vesicles that nucleate calcium mineral, we examined the role of cellular cholesterol metabolism in vascular cell mineralization. The results showed that vascular smooth muscle cells isolated from LDL receptor null (Ldlr(-/-))mice, which have impaired cholesterol uptake, had lower levels of intracellular cholesterol and less osteogenic differentiation, as indicated by alkaline phosphatase activity and matrix mineralization, compared with WT cells. PKA activation with forskolin acutely induced genes that promote cholesterol uptake (LDL receptor) and biosynthesis (HMG-CoA reductase). In WT cells, inhibition of cholesterol uptake by lipoprotein-deficient serum attenuated forskolin-induced matrix mineralization, which was partially reversed by the addition of cell-permeable cholesterol. Prolonged activation of both uptake and biosynthesis pathways by cotreatment with a liver X receptor agonist further augmented forskolin-induced matrix mineralization. Inhibition of either cholesterol uptake, using Ldlr(-/-) cells, or of cholesterol biosynthesis, using mevastatin-treated WT cells, failed to inhibit matrix mineralization due to up-regulation of the respective compensatory pathway. Inhibition of both pathways simultaneously using mevastatintreated Ldlr(-/-) cells did inhibit forskolin-induced matrix mineralization. Altogether, the results suggest that up-regulation of cholesterol metabolism is essential for matrix mineralization by vascular cells.	[Tintut, Yin] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90095 USA; [Lu, Jinxiu; Demer, Linda L.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Demer, Linda L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Ting, Tabitha C.; Miyazaki, Makoto] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Tintut, Y (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, A2-237,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ytintut@mednet.ucla.edu	Hsu, Jeff/AAW-3115-2020; Demer, Linda L/I-5770-2013	Hsu, Jeff/0000-0002-9971-5916; Demer, Linda L/0000-0002-9618-6895; Ting, Tabitha/0000-0001-5206-9243	National Institutes of Health [DK081346, DK081346-S1, HL081202]; NIGMS Initiative for Maximizing Student Development [R25GM083333]; American Heart Association [10BGIA458005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202, R21HL109628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076009, R01DK081346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Initiative for Maximizing Student Development; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081346 and DK081346-S1 (to Y. T.) and HL081202 (to L. L. D.) and NIGMS Initiative for Maximizing Student Development Grant R25GM083333 (to T. C. T.). This work was also supported by American Heart Association Grant 10BGIA458005 (to M. M.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Hsu JJ, 2008, CURR DRUG TARGETS, V9, P224; Hsu JJ, 2009, FEBS LETT, V583, P1344, DOI 10.1016/j.febslet.2009.03.039; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kizu A, 2004, J CELL BIOCHEM, V93, P1011, DOI 10.1002/jcb.20207; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; PERESS NS, 1974, CALC TISS RES, V14, P275, DOI 10.1007/BF02060301; Rattazzi M, 2005, ARTERIOSCL THROM VAS, V25, P1420, DOI 10.1161/01.ATV.0000166600.58468.1b; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Sawada N, 2007, BONE, V41, P52, DOI 10.1016/j.bone.2007.02.030; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Ting TC, 2011, J BIOL CHEM, V286, P23938, DOI 10.1074/jbc.M111.237065; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	28	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33701	33706		10.1074/jbc.M111.269639	http://dx.doi.org/10.1074/jbc.M111.269639			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21835914	Green Published, hybrid			2022-12-25	WOS:000294968800086
J	Kasprowicz, VO; Mitchell, JE; Chetty, S; Govender, P; Huang, KHG; Fletcher, HA; Webster, DP; Brown, S; Kasmar, A; Millington, K; Day, CL; Mkhwanazi, N; McClurg, C; Chonco, F; Lalvani, A; Walker, BD; Ndung'u, T; Klenerman, P				Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Huang, Kuan-Hsiang Gary; Fletcher, Helen A.; Webster, Daniel P.; Brown, Sebastian; Kasmar, Anne; Millington, Kerry; Day, Cheryl L.; Mkhwanazi, Nompumelelo; McClurg, Cheryl; Chonco, Fundisiwe; Lalvani, Ajit; Walker, Bruce D.; Ndung'u, Thumbi; Klenerman, Paul			A Molecular Assay for Sensitive Detection of Pathogen-Specific T-Cells	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; DIAGNOSIS; IP-10; TOOLS; EXPRESSION; CHILDREN; DISEASE	Here we describe the development and validation of a highly sensitive assay of antigen-specific IFN-gamma production using real time quantitative PCR (qPCR) for two reporters monokine-induced by IFN-gamma (MIG) and the IFN-gamma inducible protein-10 (IP10). We developed and validated the assay and applied it to the detection of CMV, HIV and Mycobacterium tuberculosis (MTB) specific responses, in a cohort of HIV co-infected patients. We compared the sensitivity of this assay to that of the ex vivo RD1 (ESAT-6 and CFP-10)-specific IFN-gamma Elispot assay. We observed a clear quantitative correlation between the two assays (P<0.001). Our assay proved to be a sensitive assay for the detection of MTB-specific T cells, could be performed on whole blood samples of fingerprick (50 uL) volumes, and was not affected by HIV-mediated immunosuppression. This assay platform is potentially of utility in diagnosis of infection in this and other clinical settings.	[Kasprowicz, Victoria O.; Mitchell, Jessica E.; McClurg, Cheryl; Walker, Bruce D.; Ndung'u, Thumbi] Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Boston, MA 02215 USA; [Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; McClurg, Cheryl] Nelson R Mandela Sch Med, Kwazulu Natal Res Inst TB & HIV, Durban, South Africa; [Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Day, Cheryl L.; Mkhwanazi, Nompumelelo; McClurg, Cheryl; Chonco, Fundisiwe; Walker, Bruce D.; Ndung'u, Thumbi] Nelson R Mandela Sch Med, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Fletcher, Helen A.] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England; [Huang, Kuan-Hsiang Gary; Webster, Daniel P.; Brown, Sebastian; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford Biomed Res Ctr, Oxford, England; [Huang, Kuan-Hsiang Gary; Webster, Daniel P.; Brown, Sebastian; Klenerman, Paul] Univ Oxford, James Martin Sch 21st Century, Oxford, England; [Kasmar, Anne] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Millington, Kerry; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Res Unit, Dept Resp Med, Natl Heart & Lung Inst, London, England	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; University of Oxford; Jenner Institute; University of Oxford; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Imperial College London	Kasprowicz, VO (corresponding author), Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Boston, MA 02215 USA.	vkasprowicz@partners.org	Fletcher, Helen/D-1470-2011; Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Day, Cheryl L/0000-0002-6497-4846; Ndung'u, Thumbi/0000-0003-2962-3992; klenerman, paul/0000-0003-4307-9161; Lalvani, Ajit/0000-0002-2396-246X; Fletcher, Helen/0000-0002-0435-1006; Brown, Sebastian/0000-0002-0627-880X	Howard Hughes Medical Institute; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Wellcome Trust; James Martin School for 21st Century (Oxford); NIHR (Oxford); MRC; National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID]) [1U19AI082630-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, P30AI060354, K08AI089858] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Wellcome Trust(Wellcome TrustEuropean Commission); James Martin School for 21st Century (Oxford); NIHR (Oxford)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the Howard Hughes Medical Institute, the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), the Wellcome Trust, the James Martin School for 21st Century (Oxford), the NIHR Biomedical Research Centre Programme (Oxford), the MRC, and the National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID] 1U19AI082630-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berthoud TK, 2009, VACCINE, V28, P21, DOI 10.1016/j.vaccine.2009.09.132; Brice GT, 2001, J IMMUNOL METHODS, V257, P55, DOI 10.1016/S0022-1759(01)00446-X; Campion S, 2011, EUR J IMMUNOL, V41, P255, DOI 10.1002/eji.201040296; Dunachie SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012557; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fisher RA, 2009, TRANSPL INFECT DIS, V11, P195, DOI 10.1111/j.1399-3062.2009.00372.x; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Trojan A, 2007, J CLIN VIROL, V40, P80, DOI 10.1016/j.jcv.2007.04.022; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	20	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e20606	10.1371/journal.pone.0020606	http://dx.doi.org/10.1371/journal.pone.0020606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853018	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400003
J	Ebrahimi, M; Lakizadeh, A; Agha-Golzadeh, P; Ebrahimie, E; Ebrahimi, M				Ebrahimi, Mansour; Lakizadeh, Amir; Agha-Golzadeh, Parisa; Ebrahimie, Esmaeil; Ebrahimi, Mahdi			Prediction of Thermostability from Amino Acid Attributes by Combination of Clustering with Attribute Weighting: A New Vista in Engineering Enzymes	PLOS ONE			English	Article							THERMAL-STABILITY; 3-ISOPROPYLMALATE DEHYDROGENASE; PROTEIN STABILITY; STRUCTURAL BASIS; EXPRESSION; XYLANASE; FEATURES; PATTERNS; DISCRIMINATION; STABILIZATION	The engineering of thermostable enzymes is receiving increased attention. The paper, detergent, and biofuel industries, in particular, seek to use environmentally friendly enzymes instead of toxic chlorine chemicals. Enzymes typically function at temperatures below 60 degrees C and denature if exposed to higher temperatures. In contrast, a small portion of enzymes can withstand higher temperatures as a result of various structural adaptations. Understanding the protein attributes that are involved in this adaptation is the first step toward engineering thermostable enzymes. We employed various supervised and unsupervised machine learning algorithms as well as attribute weighting approaches to find amino acid composition attributes that contribute to enzyme thermostability. Specifically, we compared two groups of enzymes: mesostable and thermostable enzymes. Furthermore, a combination of attribute weighting with supervised and unsupervised clustering algorithms was used for prediction and modelling of protein thermostability from amino acid composition properties. Mining a large number of protein sequences (2090) through a variety of machine learning algorithms, which were based on the analysis of more than 800 amino acid attributes, increased the accuracy of this study. Moreover, these models were successful in predicting thermostability from the primary structure of proteins. The results showed that expectation maximization clustering in combination with uncertainly and correlation attribute weighting algorithms can effectively (100%) classify thermostable and mesostable proteins. Seventy per cent of the weighting methods selected Gln content and frequency of hydrophilic residues as the most important protein attributes. On the dipeptide level, the frequency of Asn-Glu was the key factor in distinguishing mesostable from thermostable enzymes. This study demonstrates the feasibility of predicting thermostability irrespective of sequence similarity and will serve as a basis for engineering thermostable enzymes in the laboratory.	[Ebrahimi, Mansour] Univ Qom, Dept Biol, Qom, Iran; [Ebrahimi, Mansour; Lakizadeh, Amir] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Lakizadeh, Amir] Univ Qom, Dept Comp Sci, Qom, Iran; [Agha-Golzadeh, Parisa; Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Ebrahimi, Mahdi] Max Planck Inst Informat, Saarbrucken, Germany	Shiraz University; Max Planck Society	Ebrahimi, M (corresponding author), Univ Qom, Dept Biol, Qom, Iran.	mebrahimi14@gmail.com	Ebrahimi, Mahdi/A-5042-2012; ebrahimi, mansour/D-9950-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimi, Mahdi/0000-0002-3827-7369; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Aghagolzadeh, Parisa/0000-0002-1519-5790; lakizadeh, amir/0000-0001-9870-3676	Bioinformatics Research Group	Bioinformatics Research Group	The work has been supported by Bioinformatics Research Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Akanuma S, 1997, FEBS LETT, V410, P141, DOI 10.1016/S0014-5793(97)00540-1; Asada Y, 2009, CHEM-BIOL INTERACT, V178, P117, DOI 10.1016/j.cbi.2008.09.018; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; ASHRAFI E, 2011, BIOINFORMAT IN PRESS; BALASUBRAMANIAN D, 2007, C P IEEE ENG MED BIO, P2134; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bendova-Biedermannova L, 2008, PROTEINS, V72, P402, DOI 10.1002/prot.21938; Berens S, 1996, ANTON LEEUW INT J G, V69, P235, DOI 10.1007/BF00399612; Bijanzadeh E, 2010, AUST J CROP SCI, V4, P402; Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; Borovskii Genadii B, 2002, BMC Plant Biol, V2, P5, DOI 10.1186/1471-2229-2-5; Chantasingh D, 2006, PROTEIN EXPRES PURIF, V46, P143, DOI 10.1016/j.pep.2005.09.013; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Dancey D, 2007, IEEE T SYST MAN CY B, V37, P794, DOI 10.1109/TSMCB.2007.895334; De Bruyne Veronique, 2007, V382, P373, DOI 10.1007/978-1-59745-304-2_23; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; EBRAHIMIE E, 2010, J CELL MOL RES, V2, P15; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Fisher J, 2010, BRIEF FUNCT GENOMICS, V9, P79, DOI 10.1093/bfgp/elp054; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Georis J, 2000, PROTEIN SCI, V9, P466; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Gromiha MM, 2002, BIOPOLYMERS, V64, P210, DOI 10.1002/bip.10125; Gromiha MM, 2001, BIOPHYS CHEM, V91, P71, DOI 10.1016/S0301-4622(01)00154-5; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; Heider D, 2009, TECHNOL CANCER RES T, V8, P333, DOI 10.1177/153303460900800503; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; Lin Y, 2008, BIOINFORMATICS, V24, P2665, DOI 10.1093/bioinformatics/btn509; MASUI A, 1994, APPL ENVIRON MICROB, V60, P3579, DOI 10.1128/AEM.60.10.3579-3584.1994; McLachlan Geoffrey J., 2008, V453, P423, DOI 10.1007/978-1-60327-429-6_22; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Paloheimo M, 2007, APPL ENVIRON MICROB, V73, P3215, DOI 10.1128/AEM.02967-06; Rustici G. R., 2008, CURR PROTOC BIOINFOR; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Sparks ME, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-381; THAI KM, 2009, MOL DIVERS; Valavanis IK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-453; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493; Yang Hao-Meng, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P6; Yang ZR, 2010, METHODS MOL BIOL, V609, P197, DOI 10.1007/978-1-60327-241-4_12; Ye XF, 2009, PHARMACOEPIDEM DR S, V18, P154, DOI 10.1002/pds.1695; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0	54	44	46	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23146	10.1371/journal.pone.0023146	http://dx.doi.org/10.1371/journal.pone.0023146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853079	Green Published, gold			2022-12-25	WOS:000295454200046
J	Santer, RD; Hebets, EA				Santer, Roger D.; Hebets, Eileen A.			Evidence for Air Movement Signals in the Agonistic Behaviour of a Nocturnal Arachnid (Order Amblypygi)	PLOS ONE			English	Article							AFRICAN CAVE CRICKET; ESCAPE BEHAVIOR; FORELEGS WHIPS; SPIDER; HAIRS; TRICHOBOTHRIA; MORPHOLOGY; COURTSHIP; FEMALE	Many arthropods possess filiform hair sensilla (termed trichobothria in arachnids), which are extremely sensitive detectors of medium particle displacement. Electrophysiological evidence in some taxa suggests that these sensilla can detect air particle displacements resulting from intraspecific communication signals. However, it has not yet been shown for any species that the air particle displacements detected by the filiform hairs are themselves perceived as a 'signal' (i.e. that individuals make behavioural decisions based upon the responses of these organs to the displays of conspecifics). We investigate the agonistic behaviour of the whip spider Phrynus marginemaculatus and the role of its trichobothria in receiving agonistic signals. Whip spiders have extremely elongated 'antenniform' first legs, which they vibrate close to their opponents during agonistic interactions, inducing air movements that excite their opponents' trichobothria. We find that ablation of the trichobothria causes significant increases in: (I) contest duration, and (II) the probability of contest escalation past aggressive displays to physical fighting. Therefore, in the absence of air movement-sensitive sensilla, contest assessment is impaired. This suggests that whip spiders exploit true air movement signals during agonistic interactions, and that these are received by the trichobothria. Furthermore, these results indicate that, in whip spiders, such signals help mitigate the cost of agonistic interaction.	[Santer, Roger D.; Hebets, Eileen A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Santer, Roger D.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Nebraska System; University of Nebraska Lincoln; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Santer, RD (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	rds5@aber.ac.uk	/AAH-5543-2019		Searle Foundation	Searle Foundation	Dr. Hebets was awarded a Searle Foundation Scholars Program Grant (http://www.searlescholars.net/go.php?id = 5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth FG, 1999, PHILOS T R SOC B, V354, P183, DOI 10.1098/rstb.1999.0370; Barth FG, 2000, NATURWISSENSCHAFTEN, V87, P51, DOI 10.1007/s001140050010; BECK L, 1974, Zeitschrift fuer Tierpsychologie, V35, P173; Briers R., 2003, MANTEL XLA VBA ADD I; CAMHI JM, 1978, J COMP PHYSIOL, V128, P203, DOI 10.1007/BF00656853; Draud M, 2004, BEHAV ECOL, V15, P102, DOI 10.1093/beheco/arg081; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fowler-Finn KD, 2006, J ARACHNOL, V34, P62, DOI 10.1636/S04-104.1; GORNER P, 1969, Z VERGL PHYSIOL, V64, P301, DOI 10.1007/BF00340548; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2002, CAN J ZOOL, V80, P286, DOI 10.1139/z02-006; HEIDELBACH J, 1991, NATURWISSENSCHAFTEN, V78, P277, DOI 10.1007/BF01134358; Heidelbach J, 1997, ETHOLOGY, V103, P827; HERGENRODER R, 1983, J COMP PHYSIOL, V152, P347, DOI 10.1007/BF00606240; IGELMUND P, 1987, J MORPHOL, V193, P75, DOI 10.1002/jmor.1051930108; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P75, DOI 10.1007/BF00217105; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Logue DM, 2010, P ROY SOC B-BIOL SCI, V277, P2571, DOI 10.1098/rspb.2010.0421; Lowry R, 2011, VASSAR STATS WEBSITE; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rundus AS, 2010, BEHAV ECOL, V21, P701, DOI 10.1093/beheco/arq042; Santer RD, 2008, P ROY SOC B-BIOL SCI, V275, P363, DOI 10.1098/rspb.2007.1466; TAUTZ J, 1978, BEHAV ECOL SOCIOBIOL, V4, P101, DOI 10.1007/BF00302564; Tinbergen, 1951, STUDY INSTINCT; WEYGOLDT P, 1969, Z MORPHOL TIERE, V64, P338, DOI 10.1007/BF00298640; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Weygoldt P., 1995, NEWSLETTER BRIT ARAC, V74, P6, DOI DOI 10.1636/ST07-139.1	29	14	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22473	10.1371/journal.pone.0022473	http://dx.doi.org/10.1371/journal.pone.0022473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853035	Green Published, gold			2022-12-25	WOS:000295454200012
J	Yukitake, H; Kimura, H; Suzuki, H; Tajima, Y; Sato, Y; Imaeda, T; Kajino, M; Takizawa, M				Yukitake, Hiroshi; Kimura, Haruhide; Suzuki, Hirobumi; Tajima, Yasukazu; Sato, Yoshimi; Imaeda, Toshihiro; Kajino, Masahiro; Takizawa, Masayuki			BTZO-15, an ARE-Activator, Ameliorates DSS- and TNBS-Induced Colitis in Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; OXIDATIVE STRESS; RESPONSE ELEMENT; HEME OXYGENASE-1; GENE-EXPRESSION; MICE; MECHANISMS; MODELS; TARGET	Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders that are primarily represented by ulcerative colitis and Crohn's disease. The etiology of IBD is not well understood; however, oxidative stress is considered a potential etiological and/or triggering factor for IBD. We have recently reported the identification of BTZO-1, an activator of antioxidant response element (ARE)-mediated gene expression, which protects cardiomyocytes from oxidative stress-induced insults. Here we describe the potential of BTZO-15, an active BTZO-1 derivative for ARE-activation with a favorable ADME-Tox profile, for the treatment of IBD. BTZO-15 induced expression of heme oxygenase-1 (HO-1), an ARE-regulated cytoprotective protein, and inhibited NO-induced cell death in IEC-18 cells. Large intestine shortening, rectum weight gain, diarrhea, intestinal bleeding, and an increase in rectal myeloperoxidase (MPO) activity were observed in a dextran sulfate sodium (DSS)-induced colitis rat model. Oral administration of BTZO-15 induced HO-1 expression in the rectum and attenuated DSS-induced changes. Furthermore BTZO-15 reduced the ulcerated area and rectal MPO activity in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rats without affecting rectal TNF-alpha levels. These results suggest that BTZO-15 is a promising compound for a novel IBD therapeutic drug with ARE activation properties.	[Yukitake, Hiroshi; Kimura, Haruhide; Suzuki, Hirobumi; Tajima, Yasukazu; Sato, Yoshimi; Imaeda, Toshihiro; Takizawa, Masayuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Kajino, Masahiro] Takeda Pharmaceut Co Ltd, Chem Mfg & Controls, Osaka, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Yukitake, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	kimura_haruhide@takeda.co.jp			Takeda Pharmaceutical Company Limited.	Takeda Pharmaceutical Company Limited.(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. All authors were employees of Takeda Pharmaceutical Company Limited and were paid as such, therefore Takeda Pharmaceutical Company Limited had a role in the study design, data collection and analysis, and decision to publish.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Arafa HMM, 2009, FOOD CHEM TOXICOL, V47, P1311, DOI 10.1016/j.fct.2009.03.003; Blonski W, 2007, INFLAMM BOWEL DIS, V13, P769, DOI 10.1002/ibd.20027; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Clapper ML, 1999, ALIMENT PHARM THER, V13, P389; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dryden Gerald W Jr, 2005, Curr Gastroenterol Rep, V7, P308, DOI 10.1007/s11894-005-0024-y; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Hara H, 2003, MOL BRAIN RES, V119, P125, DOI 10.1016/j.molbrainres.2003.08.021; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kimura H, 2010, CHEM BIOL, V17, P1282, DOI 10.1016/j.chembiol.2010.10.011; Kimura H, 2010, CHEM BIOL, V17, P18, DOI 10.1016/j.chembiol.2009.12.012; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishihira J, 2009, CURR PHARM DESIGN, V15, P2104, DOI 10.2174/138161209788489113; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Rosenberg LN, 2010, EXPERT OPIN DRUG SAF, V9, P573, DOI 10.1517/14740331003639412; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Varga C, 2007, EUR J PHARMACOL, V561, P164, DOI 10.1016/j.ejphar.2006.12.022; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xu CT, 2004, WORLD J GASTROENTERO, V10, P2311; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23256	10.1371/journal.pone.0023256	http://dx.doi.org/10.1371/journal.pone.0023256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853095	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200057
J	He, QL; Shen, Y; Wang, MX; Huang, MR; Yang, RZ; Zhu, SJ; Wang, LS; Xu, YJ; Wu, RL				He, Qiuling; Shen, Ye; Wang, Mingxiu; Huang, Minren; Yang, Ruizhen; Zhu, Shuijin; Wang, Liangsheng; Xu, Yanjun; Wu, Rongling			Natural Variation in Petal Color in Lycoris longituba Revealed by Anthocyanin Components	PLOS ONE			English	Article							FLOWERS; COPIGMENTATION; BIOSYNTHESIS; CONVERGENCE; CULTIVARS; PIGMENTS	Lycoris longituba is one of the species belonging to the Amaryllidaceae family. Despite its limited distribution, endemic to central eastern China, this species displays an exceptionally wide diversity of flower colors from purple, red, orange, to yellow, in nature. We study the natural variation of floral color in L. longituba by testing the components of water-soluble vacuolar pigments - anthocyanins - in its petals using high-performance liquid chromatography coupled with photodiode array detection and electrospray ionization mass spectrometry. Four anthocyanins were identified, cyanidin-3-sophoroside (Cy3So), cyanidin-3-xylosylglucoside (Cy3XyGlc), cyanidin-3-sambubioside (Cy3Sa), and pelargonidin-3-xylosylglucoside (Pg3XyGlc), which occur at various amounts in L. longituba petals of different colors. A multivariate analysis was used to explore the relationship between pigments and flower color. Anthocyanins have been thought to play a major role in acting as a UV screen that protects the plant's DNA from sunlight damage and attracting insects for the purpose of pollination. Thus, knowledge about the content and type of anthocyanins determining the petal coloration of Lycoris longituba will help to study the adaptive evolution of flowers and provide useful information for the ornamental breeding of this species.	[He, Qiuling; Shen, Ye; Wang, Mingxiu; Huang, Minren] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Peoples R China; [He, Qiuling; Zhu, Shuijin] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruizhen; Wang, Liangsheng] Chinese Acad Sci, Beijing Bot Garden, Inst Bot, Beijing, Peoples R China; [Xu, Yanjun] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China	Nanjing Forestry University; Zhejiang University; Chinese Academy of Sciences; Institute of Botany, CAS; China Agricultural University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	He, QL (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Peoples R China.	mrhuang@njfu.edu.cn; wanglsh@ibcas.ac.cn; rwu@hes.hmc.psu.edu			Graduate Research Innovation Project of Jiangsu Province; Excellent Doctoral Thesis Foundation of Nanjing Forestry University; Beijing Forestry University	Graduate Research Innovation Project of Jiangsu Province; Excellent Doctoral Thesis Foundation of Nanjing Forestry University; Beijing Forestry University	This research was supported by the Graduate Research Innovation Project of Jiangsu Province, the Excellent Doctoral Thesis Foundation of Nanjing Forestry University, and the Changjiang Scholars Award and the "One-thousand Person Plan'' Award at Beijing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISUMI K, 1970, YAMAGUCHI DAIGAKU NO, V21, P65; ARISUMI K, 1971, YAMAGUCHI DAIGAKU NO, V22, P171; ASEN S, 1971, PHYTOCHEMISTRY, V10, P171, DOI 10.1016/S0031-9422(00)90266-8; BARRITT BH, 1973, J CHROMATOGR, V75, P151, DOI 10.1016/S0021-9673(01)83429-4; Berg A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1528; Buchert J, 2005, J SCI FOOD AGR, V85, P2548, DOI 10.1002/jsfa.2284; Byamukama R, 2006, SCI HORTIC-AMSTERDAM, V109, P262, DOI 10.1016/j.scienta.2006.05.007; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; de Ancos B, 1999, Z LEBENSM UNTERS F A, V208, P33, DOI 10.1007/s002170050371; Deng CL, 2006, J GENET, V85, P205, DOI 10.1007/BF02935332; GONNET JF, 1992, J HORTIC SCI, V67, P663, DOI 10.1080/00221589.1992.11516297; Gonnet JF, 1998, FOOD CHEM, V63, P409, DOI 10.1016/S0308-8146(98)00053-3; Hada H, 2003, PLANT CELL ENVIRON, V26, P1691, DOI 10.1046/j.1365-3040.2003.01087.x; He QL, 2009, MOL ECOL RESOUR, V9, P278, DOI 10.1111/j.1755-0998.2008.02322.x; Hoch WA, 2001, TREE PHYSIOL, V21, P1; HRAZDINA G, 1988, BIOCHIM BIOPHYS ACTA, V955, P301, DOI 10.1016/0167-4838(88)90208-7; HU SY, 1976, ARNOLDIA, V35, P264; Kamffer Z, 2010, J AGR FOOD CHEM, V58, P6578, DOI 10.1021/jf1004308; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; NIEUWHOF M, 1989, NETH J AGR SCI, V37, P365; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; STEYN WJ, 2009, SPRINGER SCI BUSINES, P85; Stintzing FC, 2003, EUR FOOD RES TECHNOL, V216, P303, DOI 10.1007/s00217-002-0657-0; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036; Wang LS, 2001, J PLANT RES, V114, P213, DOI 10.1007/PL00013985; White SA, 2005, J PLANT NUTR, V28, P1767, DOI 10.1080/01904160500250896; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; [No title captured]	33	47	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22098	10.1371/journal.pone.0022098	http://dx.doi.org/10.1371/journal.pone.0022098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829604	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200006
J	Zhang, HW; Li, J; Zhang, XS; Wang, Y; Qiu, WJ; Ye, J; Han, LS; Gao, XL; Gu, XF				Zhang, Huiwen; Li, Jing; Zhang, Xinshun; Wang, Yu; Qiu, Wenjuan; Ye, Jun; Han, Lianshu; Gao, Xiaolan; Gu, Xuefan			Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G > A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic Splicing	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-II; IDURONATE-2-SULFATASE GENE; MPS-II; MUTATION ANALYSIS; STRUCTURAL-ANALYSIS; JAPANESE PATIENTS; MOLECULAR-BASIS; DISEASE; DIAGNOSIS; MILD	Background: Hunter syndrome (mucopolysaccharidosis type II, MPS II) is a rare disease inherited in an X-linked autosomal recessive pattern. It is the prevailing form of the mucopolysaccharidoses in China. Here we investigated mutations of IDS (iduronate 2-sulfatase) gene in 38 unrelated Chinese patients, one of which is a female. Methods: Peripheral leucocytes were collected from the patients and the IDS gene was amplified to looking for the variations. For a female patient, the X chromosome status was analyzed by androgen receptor X-inactivation assay and the mutation impact on RNA level was further performed by reverse transcription polymerase chain reaction. Results: We discovered that point mutations constituted the major form while mutations in codon p.R468 defined the largest number of patients in our cohort. Consistent with data from other ethnic groups, exons 9 and 3 had comparatively more mutations, while exon 2 had quite a few mutations unique to Chinese patients. Of the 30 different mutations identified, only 9 were novel: one was a premature termination mutation, i.e., c.196C > T (p.Gln66X); three were missense mutations, i.e., c.200T > C (p.Leu67Pro), c.215T > C (p.Leu72Pro), c.389C > T (p.Thr130Ile); one was a small deletion, i.e., c.1104_1122del19 (p.Ser369ArgfsX16); and one was a deletion that spanned both exons 8 and 9 deletion leading to gross structural changes in the IDS gene. In addition, a synonymous mutation c.879G > A (p.Gln293Gln) was identified in a female Hunter disease patient, which resulted in loss of the original splicing site, activated a cryptic splicing site upstream, leading to a 28 bp deletion and a premature termination at p. Tyr285GlufsX47. Together with concurrent skewed X-inactivation this was believed to facilitate the development of Hunter disease in this girl. Conclusions: In conclusion, the molecular analysis of IDS gene in Chinese patients confirmed the Hunter disease diagnosis and expanded the mutation and clinical spectrum of this devastating disorder.	[Zhang, Huiwen; Li, Jing; Zhang, Xinshun; Wang, Yu; Qiu, Wenjuan; Ye, Jun; Han, Lianshu; Gao, Xiaolan; Gu, Xuefan] Shanghai Jiao Tong Univ, Sch Med,Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, HW (corresponding author), Shanghai Jiao Tong Univ, Sch Med,Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	huiwenzhang@yahoo.com; guxuefan@online.sh.cn			Shanghai Rising Star Program [09QA1404700]; National Natural Science Foundation of China [30801257]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Shanghai Rising Star Program (09QA1404700) and National Natural Science Foundation of China (30801257) to H. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2006, J INHERIT METAB DIS, V29, P743, DOI 10.1007/s10545-006-0403-z; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; BONDESON ML, 1995, EUR J HUM GENET, V3, P219; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Coelho JC, 1997, EUR J PEDIATR, V156, P650, DOI 10.1007/s004310050685; Crotty Paul L., 1992, Human Molecular Genetics, V1, P755, DOI 10.1093/hmg/1.9.755; Filocamo M, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1169; Froissart R, 2002, ACTA PAEDIATR, V91, P82, DOI 10.1080/080352502762457996; Froissart R, 1998, CLIN GENET, V53, P362; Goldenfum SL, 1996, HUM MUTAT, V7, P76, DOI 10.1002/(SICI)1098-1004(1996)7:1<76::AID-HUMU14>3.3.CO;2-T; Gort L, 1998, J INHERIT METAB DIS, V21, P655, DOI 10.1023/A:1005432600871; HOPWOOD JJ, 1993, HUM MUTAT, V2, P435, DOI 10.1002/humu.1380020603; Isogai K, 1998, J INHERIT METAB DIS, V21, P60, DOI 10.1023/A:1005363414792; Karsten SL, 1997, GENOMICS, V43, P123, DOI 10.1006/geno.1997.4811; Kato T, 2005, J HUM GENET, V50, P395, DOI 10.1007/s10038-005-0266-4; KEERATICHAMROEN S, 2008, J INHERIT METAB DIS; Kim CH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9128; Kloska A, 2010, CLIN GENET; Li PN, 1999, J MED GENET, V36, P21; Lin HY, 2009, AM J MED GENET A, V149A, P960, DOI 10.1002/ajmg.a.32781; Lin SP, 2006, CLIN CHIM ACTA, V369, P29, DOI 10.1016/j.cca.2006.01.001; Lualdi S, 2005, HUM MUTAT, V25, P491, DOI 10.1002/humu.20165; Lualdi S, 2010, HUM MUTAT, V31, pE1261, DOI 10.1002/humu.21208; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Nelson J, 2003, AM J MED GENET A, V123A, P310, DOI 10.1002/ajmg.a.20314; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Rathmann M, 1996, AM J HUM GENET, V59, P1202; SCHAAP T, 1980, HUM GENET, V56, P221, DOI 10.1007/BF00295699; Sohn YB, 2010, AM J MED GENET A, V152A, P3129, DOI 10.1002/ajmg.a.33589; Sukegawa K, 1998, CLIN GENET, V53, P96; Sukegawa-Hayasaka K, 2006, J INHERIT METAB DIS, V29, P755, DOI 10.1007/s10545-006-0440-7; Vafiadaki E, 1998, ARCH DIS CHILD, V79, P237, DOI 10.1136/adc.79.3.237; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; YANO S, 2010, CLIN GENET; YATZIV S, 1977, CLIN GENET, V11, P319; Zhang Hui-Wen, 2009, Zhonghua Er Ke Za Zhi, V47, P276	36	30	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22951	10.1371/journal.pone.0022951	http://dx.doi.org/10.1371/journal.pone.0022951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829674	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200040
J	Huang, CT; Lin, HC; Chang, SC; Lee, WC				Huang, Ching-Tzu; Lin, Horng-Chyuan; Chang, Shi-Chuan; Lee, Wei-Chen			Pre-Operative Risk Factors Predict Post-Operative Respiratory Failure after Liver Transplantation	PLOS ONE			English	Article							ADSORBENT RECIRCULATING SYSTEM; INTENSIVE-CARE-UNIT; CHILD-TURCOTTE-PUGH; PULMONARY COMPLICATIONS; TRACHEAL EXTUBATION; HEPATIC-FAILURE; MELD SCORE; SURVIVAL; SURGERY; DISEASE	Objective: Post-operative pulmonary complications significantly affect patient survival rates, but there is still no conclusive evidence regarding the effect of post-operative respiratory failure after liver transplantation on patient prognosis. This study aimed to predict the risk factors for post-operative respiratory failure (PRF) after liver transplantation and the impact on short-term survival rates. Design: The retrospective observational cohort study was conducted in a twelve-bed adult surgical intensive care unit in northern Taiwan. The medical records of 147 liver transplant patients were reviewed from September 2002 to July 2007. Sixty-two experienced post-operative respiratory failure while the remaining 85 patients did not. Measurements and Main Results: Gender, age, etiology, disease history, pre-operative ventilator use, molecular adsorbent re-circulating system (MARS) use, source of organ transplantation, model for end-stage liver disease score (MELD) and Child-Turcotte-Pugh score calculated immediately before surgery were assessed for the two groups. The length of the intensive care unit stay, admission duration, and mortality within 30 days, 3 months, and 1 year were also evaluated. Using a logistic regression model, post-operative respiratory failure correlated with diabetes mellitus prior to liver transplantation, pre-operative impaired renal function, pre-operative ventilator use, pre-operative MARS use and deceased donor source of organ transplantation (p<0.05). Once liver transplant patients developed PRF, their length of ICU stay and admission duration were prolonged, significantly increasing their mortality and morbidity (p<0.001). Conclusions: The predictive pre-operative risk factors significantly influenced the occurrence of post-operative respiratory failure after liver transplantation.	[Huang, Ching-Tzu; Lin, Horng-Chyuan] Chang Gung Mem Hosp, Dept Resp Therapy, Tao Yuan, Taiwan; [Huang, Ching-Tzu; Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Lin, Horng-Chyuan] Chang Gung Mem Hosp, Dept Thorac Med, Tao Yuan, Taiwan; [Lin, Horng-Chyuan] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Lee, Wei-Chen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, CT (corresponding author), Chang Gung Mem Hosp, Dept Resp Therapy, Tao Yuan, Taiwan.	lin53424@ms13.hinet.net; weichen@cgmh.org.tw						Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BALIGA P, 1992, SURGERY, V112, P704; Biancofiore G, 2001, LIVER TRANSPLANT, V7, P777, DOI 10.1053/jlts.2001.23785; Bilbao I, 2003, CLIN TRANSPLANT, V17, P401, DOI 10.1034/j.1399-0012.2003.00068.x; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; Doria C, 2006, DIGEST DIS SCI, V51, P47, DOI 10.1007/s10620-006-3115-1; Farnsworth N, 2004, AM J SURG, V188, P580, DOI 10.1016/j.amjsurg.2004.07.034; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Findlay JY, 2002, LIVER TRANSPLANT, V8, P670, DOI 10.1053/jlts.2002.34678; Fukuhara T, 2010, J GASTROEN HEPATOL, V25, P978, DOI 10.1111/j.1440-1746.2009.06162.x; Ghobrial RM, 2002, ANN SURG, V236, P315, DOI 10.1097/00000658-200209000-00008; Glanemann M, 2001, J CLIN ANESTH, V13, P377, DOI 10.1016/S0952-8180(01)00290-2; Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x; Glanemann M, 2007, SWISS MED WKLY, V137, P187; Golfieri R, 2000, EUR RADIOL, V10, P1169, DOI 10.1007/s003309900268; Gonzalez E, 2006, Rev Esp Anestesiol Reanim, V53, P75; Habib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721; Kotloff RM, 2005, CLIN CHEST MED, V26, P623, DOI 10.1016/j.ccm.2005.06.011; Kuiper JW, 2005, CRIT CARE MED, V33, P1408, DOI 10.1097/01.CCM.0000165808.30416.EF; Macedo FIB, 2010, EXP CLIN TRANSPLANT, V8, P202; Maluf DG, 2006, TRANSPLANTATION, V82, P1653, DOI 10.1097/01.tp.0000250571.41361.21; Mandell MS, 2007, LIVER TRANSPLANT, V13, P1557, DOI 10.1002/lt.21263; Mandell MS, 2002, LIVER TRANSPLANT, V8, P676, DOI 10.1053/jlts.2002.34379; Menon KVN, 2004, AM J TRANSPLANT, V4, P819, DOI 10.1111/j.1600-6143.2004.00433.x; MEYERS JR, 1975, ARCH SURG-CHICAGO, V110, P576; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; PREETI JR, 2001, HEPATOLOGY, V34, P889; Rodriguez-Ariza A, 2008, REV ESP ENFERM DIG, V100, P129, DOI 10.4321/s1130-01082008000300002; Saab S, 2003, LIVER TRANSPLANT, V9, P473, DOI 10.1053/jlts.2003.50090; Saliba F, 2006, CRIT CARE, V10, DOI 10.1186/cc4825; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; SVENSSON LG, 1991, J VASC SURG, V14, P271; Wong CS, 2010, LIVER TRANSPLANT, V16, P138, DOI 10.1002/lt.21969; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013	34	48	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22689	10.1371/journal.pone.0022689	http://dx.doi.org/10.1371/journal.pone.0022689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829646	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511200019
J	Volkmer, B; Heinemann, M				Volkmer, Benjamin; Heinemann, Matthias			Condition-Dependent Cell Volume and Concentration of Escherichia coli to Facilitate Data Conversion for Systems Biology Modeling	PLOS ONE			English	Article							FLOW-CYTOMETRY; GROWTH-RATE; BACTERIA; SIZE; METABOLOMICS; DIMENSIONS; CULTURES; FLUXES	Systems biology modeling typically requires quantitative experimental data such as intracellular concentrations or copy numbers per cell. In order to convert population-averaging omics measurement data to intracellular concentrations or cellular copy numbers, the total cell volume and number of cells in a sample need to be known. Unfortunately, even for the often studied model bacterium Escherichia coli this information is hardly available and furthermore, certain measures (e. g. cell volume) are also dependent on the growth condition. In this work, we have determined these basic data for E. coli cells when grown in 22 different conditions so that respective data conversions can be done correctly. First, we determine growth-rate dependent cell volumes. Second, we show that in a 1 ml E. coli sample at an optical density (600 nm) of 1 the total cell volume is around 3.6 mu l for all conditions tested. Third, we demonstrate that the cell number in a sample can be determined on the basis of the sample's optical density and the cells' growth rate. The data presented will allow for conversion of E. coli measurement data normalized to optical density into volumetric cellular concentrations and copy numbers per cell - two important parameters for systems biology model development.	[Volkmer, Benjamin; Heinemann, Matthias] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Volkmer, Benjamin] Life Sci Zurich PhD Program Syst Biol Complex Dis, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Volkmer, B (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	m.heinemann@rug.nl	Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Volkmer, Benjamin/0000-0002-9945-9772	ETH Zurich	ETH Zurich(ETH Zurich)	ETH Zurich (INIT program project "Single cell metabolomics"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bouvier T, 2001, CYTOMETRY, V44, P188, DOI 10.1002/1097-0320(20010701)44:3<188::AID-CYTO1111>3.0.CO;2-C; BOYE E, 1983, J GEN MICROBIOL, V129, P973; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHURCHWARD G, 1981, J BACTERIOL, V145, P1232, DOI 10.1128/JB.145.3.1232-1238.1981; Fagerbakke KM, 1999, CAN J MICROBIOL, V45, P304, DOI 10.1139/cjm-45-4-304; Gonzalez O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000799; GROSSMAN N, 1982, J BACTERIOL, V152, P35; HELDAL M, 1985, APPL ENVIRON MICROB, V50, P1251, DOI 10.1128/AEM.50.5.1251-1257.1985; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; KUBITSCHEK HE, 1969, BIOPHYS J, V9, P792, DOI 10.1016/S0006-3495(69)86418-0; Lee SY, 2009, SYSTEMS BIOLOGY AND BIOTECHNOLOGY OF ESCHERICHIA COLI, P441, DOI 10.1007/978-1-4020-9394-4_20; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; PIERUCCI O, 1978, J BACTERIOL, V135, P559, DOI 10.1128/JB.135.2.559-574.1978; Reshes G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046001; SARDONINI CA, 1987, BIOTECHNOL BIOENG, V29, P469, DOI 10.1002/bit.260290410; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441; Usuda Y, 2010, J BIOTECHNOL, V147, P17, DOI 10.1016/j.jbiotec.2010.02.018; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	32	207	209	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23126	10.1371/journal.pone.0023126	http://dx.doi.org/10.1371/journal.pone.0023126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829590	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500077
J	Andres, E; Martinez, N; Planas, A				Andres, Eduardo; Martinez, Nuria; Planas, Antoni			Expression and Characterization of a Mycoplasma genitalium Glycosyltransferase in Membrane Glycolipid Biosynthesis POTENTIAL TARGET AGAINST MYCOPLASMA INFECTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHOLEPLASMA-LAIDLAWII; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; MONOGALACTOSYLDIACYLGLYCEROL SYNTHASE; STAPHYLOCOCCUS-AUREUS; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; LIPID GLYCOSYLTRANSFERASE; ARABIDOPSIS-THALIANA; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; PHASE-EQUILIBRIA	Mycoplasmas contain glycoglycerolipids in their plasma membrane as key structural components involved in bilayer properties and stability. A membrane-associated glycosyltransferase (GT), GT MG517, has been identified in Mycoplasma genitalium, which sequentially produces monoglycosyl- and diglycosyldiacylglycerols. When recombinantly expressed in Escherichia coli, the enzyme was functional in vivo and yielded membrane glycolipids from which Glc beta 1,6Glc beta DAG was identified as the main product. A chaperone co-expression system and extraction with CHAPS detergent afforded soluble protein that was purified by affinity chromatography. GT MG517 transfers glucosyl and galactosyl residues from UDP-Glc and UDPGal to dioleoylglycerol (DOG) acceptor to form the corresponding beta-glycosyl-DOG, which then acts as acceptor to give beta-diglycosyl-DOG products. The enzyme (GT2 family) follows Michaelis-Menten kinetics. k(cat) is about 5-fold higher for UDP-Gal with either DOG or monoglucosyldioleoylglycerol acceptors, but it shows better binding for UDP-Glc than UDP-Gal, as reflected by the lower Km, which results in similar k(cat)/K-m values for both donors. Although sequentially adding glycosyl residues with beta-1,6 connectivity, the first glycosyltransferase activity (to DOG) is about 1 order of magnitude higher than the second (to monoglucosyldioleoylglycerol). Because the ratio between the non-bilayer-forming monoglycosyldiacylglycerols and the bilayer-prone diglycosyldiacylglycerols contributes to regulate the properties of the plasma membrane, both synthase activities are probably regulated. Dioleoylphosphatidylglycerol (anionic phospholipid) activates the enzyme, k(cat) linearly increasing with dioleoylphosphatidylglycerol concentration. GT MG517 is shown to be encoded by an essential gene, and the addition of GT inhibitors results in cell growth inhibition. It is proposed that glycolipid synthases are potential targets for drug discovery against infections by mycoplasmas.	[Andres, Eduardo; Martinez, Nuria; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Dept Bioengn, Biochem Lab, Barcelona 08017, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Planas, A (corresponding author), Via Augusta 390, Barcelona 08017, Spain.	antoni.planas@iqs.edu	PLANAS, ANTONI/I-4803-2015	PLANAS, ANTONI/0000-0001-7073-3320	Ministerio de Ciencia e Innovacion (MICINN), Spain [BIO2007-67904-C02-02, BFU2010-22209-C02-02]; Institut Quimic de Sarria; MICINN	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institut Quimic de Sarria; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by Ministerio de Ciencia e Innovacion (MICINN), Spain, Grants BIO2007-67904-C02-02 and BFU2010-22209-C02-02.; Recipient of a predoctoral fellowship from the Institut Quimic de Sarria.; Recipient of a predoctoral fellowship from MICINN.	ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Andersson AS, 1996, BIOCHEMISTRY-US, V35, P11119, DOI 10.1021/bi960561w; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Burgos R, 2007, J BACTERIOL, V189, P7014, DOI 10.1128/JB.00975-07; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DAHLQVIST A, 1992, BIOCHIM BIOPHYS ACTA, V1105, P131, DOI 10.1016/0005-2736(92)90171-H; DAHLQVIST A, 1995, BIOCHEMISTRY-US, V34, P13381, DOI 10.1021/bi00041a015; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; HORNER PJ, 1993, LANCET, V342, P582, DOI 10.1016/0140-6736(93)91411-E; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Jorasch P, 2000, EUR J BIOCHEM, V267, P3770, DOI 10.1046/j.1432-1327.2000.01414.x; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; LINDBLOM G, 1993, J BIOL CHEM, V268, P16198; Marechal E, 2000, BIOCHEM SOC T, V28, P732, DOI 10.1042/BST0280732; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; OSTERBERG F, 1995, BBA-LIPID LIPID MET, V1257, P18, DOI 10.1016/0005-2760(95)00042-B; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; TRULLY JG, 1975, MOL DIAGNOSTIC PROCE, V1, P33; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Vikstrom S, 2000, J BIOL CHEM, V275, P9296, DOI 10.1074/jbc.275.13.9296; WIESLANDER A, 1977, BIOCHIM BIOPHYS ACTA, V466, P336, DOI 10.1016/0005-2736(77)90229-2; WIESLANDER A, 1980, BIOCHEMISTRY-US, V19, P3650, DOI 10.1021/bi00557a002; Yamaryo Y, 2006, FEBS LETT, V580, P4086, DOI 10.1016/j.febslet.2006.06.050; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZWEIG C, 1972, HDB CHROMATOGRAPHY, V2, P107	53	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35367	35379		10.1074/jbc.M110.214148	http://dx.doi.org/10.1074/jbc.M110.214148			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21835921	Green Published, hybrid			2022-12-25	WOS:000295927100008
J	Bromley, KM; Kiss, AS; Lokappa, SB; Lakshminarayanan, R; Fan, DM; Ndao, M; Evans, JS; Moradian-Oldak, J				Bromley, Keith M.; Kiss, Andrew S.; Lokappa, Sowmya Bekshe; Lakshminarayanan, Rajamani; Fan, Daming; Ndao, Moise; Evans, John Spencer; Moradian-Oldak, Janet			Dissecting Amelogenin Protein Nanospheres CHARACTERIZATION OF METASTABLE OLIGOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC LIGHT-SCATTERING; INTRINSICALLY DISORDERED PROTEIN; BOVINE SERUM-ALBUMIN; RECOMBINANT AMELOGENIN; PORCINE AMELOGENIN; ENAMEL PROTEIN; PRION PROTEIN; CROSS-LINKING; IN-VITRO; DIFFUSION	Amelogenin self-assembles to form an extracellular protein matrix, which serves as a template for the continuously growing enamel apatite crystals. To gain further insight into the molecular mechanism of amelogenin nanosphere formation, we manipulated the interactions between amelogenin monomers by altering pH, temperature, and protein concentration to create isolated metastable amelogenin oligomers. Recombinant porcine amelogenins (rP172 and rP148) and three different mutants containing only a single tryptophan (Trp(161), Trp(45), and Trp(25)) were used. Dynamic light scattering and fluorescence studies demonstrated that oligomers were metastable and in constant equilibrium with monomers. Stable oligomers with an average hydrodynamic radius (R-H) of 7.5 nm were observed at pH 5.5 between 4 and 10 mg.ml(-1). We did not find any evidence of a significant increase in folding upon self-association of the monomers into oligomers, indicating that they are disordered. Fluorescence experiments with single tryptophan amelogenins revealed that upon oligomerization the C terminus of amelogenin (around residue Trp161) is exposed at the surface of the oligomers, whereas the N-terminal region around Trp25 and Trp45 is involved in protein-protein interaction. The truncated rP148 formed similar but smaller oligomers, suggesting that the C terminus is not critical for amelogenin oligomerization. We propose a model for nanosphere formation via oligomers, and we predict that nanospheres will break up to form oligomers in mildly acidic environments via histidine protonation. We further suggest that oligomeric structures might be functional components during maturation of enamel apatite.	[Bromley, Keith M.; Kiss, Andrew S.; Lokappa, Sowmya Bekshe; Lakshminarayanan, Rajamani; Fan, Daming; Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Ndao, Moise; Evans, John Spencer] NYU, Chem Phys Lab, New York, NY 10010 USA	University of Southern California; New York University	Moradian-Oldak, J (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Evans, John Spencer/AAD-2396-2019; Rajamani, Lakshminarayanan/AAG-5541-2019	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818	National Institutes of Health from the NIDCR [DE-13414, DE-020099, DE-015644]; United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-03ER46099]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414, R01DE020099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015644] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-13414, DE-020099, and DE-015644 from the NIDCR (to J. M.-O.). This work was also supported by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-FG02-03ER46099 (to J. S. E.). Portions of this work represent contribution number 61 from the Laboratory for Chemical Physics, New York University.	Aichmayer B, 2005, J STRUCT BIOL, V151, P239, DOI 10.1016/j.jsb.2005.06.007; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bouropoulos N, 2003, CALCIFIED TISSUE INT, V72, P599, DOI 10.1007/s00223-002-1099-1; BROIDE ML, 1991, P NATL ACAD SCI USA, V88, P5660, DOI 10.1073/pnas.88.13.5660; Brookes SJ, 2006, EUR J ORAL SCI, V114, P280, DOI 10.1111/j.1600-0722.2006.00311.x; Buchko GW, 2008, BIOCHEMISTRY-US, V47, P13215, DOI 10.1021/bi8018288; Cho KR, 2011, J AM CHEM SOC, V133, P8586, DOI 10.1021/ja1117446; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; DOHERTY P, 1974, J CHEM PHYS, V61, P5426, DOI 10.1063/1.1681898; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Everett D.H., 1988, BASIC PRINCIPLES COL, DOI [10.1039/9781847550200, DOI 10.1039/9781847550200]; Fan DM, 2009, J STRUCT BIOL, V166, P88, DOI 10.1016/j.jsb.2009.01.003; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 2000, DEV FUNCTION EVOLUTI, P37, DOI DOI 10.1017/CBO9780511542626.004; Gokarn YR, 2009, PROTEIN SCI, V18, P169, DOI 10.1002/pro.20; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Iijima M, 2010, CRYST GROWTH DES, V10, P4815, DOI 10.1021/cg100696r; Klug A, 1999, PHILOS T ROY SOC B, V354, P531, DOI 10.1098/rstb.1999.0404; Konev S. V., 1978, Journal of Applied Spectroscopy, V29, P785, DOI 10.1007/BF00618625; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Lee AC, 2009, J CHEM INF MODEL, V49, P2013, DOI 10.1021/ci900209w; LIMEBACK H, 1990, ARCH ORAL BIOL, V35, P459, DOI 10.1016/0003-9969(90)90209-S; Lowenstam H. A., 1989, BIOMINERALISATION, P182; Mechanic G., 1971, TOOTH ENAMEL, P88; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC, P106; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NEAL DG, 1984, J CHEM PHYS, V80, P3469, DOI 10.1063/1.447103; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1997, J BONE MINER RES, V12, P221, DOI 10.1359/jbmr.1997.12.2.221; Pecora R., 1985, DYNAMIC LIGHT SCATTE, P363; PIAZZA R, 1993, J PHYS-CONDENS MAT, V5, pB173, DOI 10.1088/0953-8984/5/34B/021; Pusey P.N., 1972, J PHYS PARIS     SC1, V33, P1, DOI 10.1051/jphyscol:1972129; RAJ T, 1974, BIOCHEMISTRY-US, V13, P3336, DOI 10.1021/bi00713a024; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; SCHURR JM, 1986, ANNU REV PHYS CHEM, V37, P271; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith C E, 1996, Adv Dent Res, V10, P159; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Sun Z, 2006, EUR J ORAL SCI, V114, P59, DOI 10.1111/j.1600-0722.2006.00296.x; Tarasevich BJ, 2009, J PHYS CHEM B, V113, P1833, DOI 10.1021/jp804548x; THOMAS JC, 1984, BIOCHEMISTRY-US, V23, P5407, DOI 10.1021/bi00318a005; Uskokovic V, 2010, J DENT RES, V89, P149, DOI 10.1177/0022034509354455; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; Wang XQ, 2004, PROTEIN SCI, V13, P810, DOI 10.1110/ps.03367304; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Zhang H, 2010, ARCH ORAL BIOL, V55, P417, DOI 10.1016/j.archoralbio.2010.03.009	56	48	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34643	34653		10.1074/jbc.M111.250928	http://dx.doi.org/10.1074/jbc.M111.250928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840988	Green Published, hybrid			2022-12-25	WOS:000295406300019
J	Chartron, JW; Gonzalez, GM; Clemons, WM				Chartron, Justin W.; Gonzalez, Grecia M.; Clemons, William M., Jr.			A Structural Model of the Sgt2 Protein and Its Interactions with Chaperones and the Get4/Get5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH TETRATRICOPEPTIDE REPEAT; TAIL-ANCHORED PROTEINS; MEMBRANE-PROTEINS; BINDING; IDENTIFICATION; HSC70; COCHAPERONE; RECOGNITION; LANDSCAPE; INSERTION	The insertion of tail-anchored transmembrane (TA) proteins into the appropriate membrane is a post-translational event that requires stabilization of the transmembrane domain and targeting to the proper destination. Sgt2 is a heat-shock protein cognate (HSC) co-chaperone that preferentially binds endoplasmic reticulum-destined TA proteins and directs them to the GET pathway via Get4 and Get5. Here, we present the crystal structure from a fungal Sgt2 homolog of the tetratrico-repeat (TPR) domain and part of the linker that connects to the C-terminal domain. The linker extends into the two-carboxylate clamp of the TPR domain from a symmetry-related molecule mimicking the binding to HSCs. Based on this structure, we provide biochemical evidence that the Sgt2 TPR domain has the ability to directly bind multiple HSC family members. The structure allows us to propose features involved in this lower specificity relative to other TPR containing co-chaperones. We further show that a dimer of Sgt2 binds a single Get5 and use small angle x-ray scattering to characterize the domain arrangement of Sgt2 in solution. These results allow us to present a structural model of the Sgt2-Get4/Get5-HSC complex.	[Chartron, Justin W.; Gonzalez, Grecia M.; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), M-C 114-96,1200 E Calif Blvd, Pasadena, CA 91104 USA.	clemons@caltech.edu	Chartron, Justin/L-9096-2019; Clemons, William M/D-1026-2009	Chartron, Justin/0000-0003-1734-3424; Clemons, William M/0000-0002-0021-889X	National Institutes of Health [R01GM097572]; Searle Scholar program; Burroughs-Wellcome Fund Career Award for the Biological Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; Burroughs-Wellcome Fund Career Award for the Biological Sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM097572 (to W. M. C.).; Supported by the Searle Scholar program and a Burroughs-Wellcome Fund Career Award for the Biological Sciences. To whom correspondence should be addressed: M/C 114-96, 1200 E. California Blvd., Pasadena, CA 91104. Tel.: 626-395-1796; E-mail: clemons@caltech.edu.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Abell BM, 2011, PLANT CELL REP, V30, P137, DOI 10.1007/s00299-010-0925-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angeletti PC, 2002, CELL STRESS CHAPERON, V7, P258, DOI 10.1379/1466-1268(2002)007<0258:SGRPVP>2.0.CO;2; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2010, FEBS LETT, V584, P1509, DOI 10.1016/j.febslet.2010.02.070; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fielding BC, 2006, BIOCHEM BIOPH RES CO, V343, P1201, DOI 10.1016/j.bbrc.2006.03.091; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Kajander T, 2009, J BIOL CHEM, V284, P25364, DOI 10.1074/jbc.M109.033894; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; KRIECHBAUMER V, 2011, PROTOPLASMA IN PRESS; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tobaben S, 2003, J BIOL CHEM, V278, P38376, DOI 10.1074/jbc.M301558200; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang HX, 2003, BIOCHEM BIOPH RES CO, V311, P877, DOI 10.1016/j.bbrc.2003.10.080; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	62	50	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34325	34334		10.1074/jbc.M111.277798	http://dx.doi.org/10.1074/jbc.M111.277798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832041	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-25	WOS:000295159200061
J	Domes, K; Ding, J; Lemke, T; Blaich, A; Wegener, JW; Brandmayr, J; Moosmang, S; Hofmann, F				Domes, Katrin; Ding, Jie; Lemke, Toni; Blaich, Anne; Wegener, Joerg W.; Brandmayr, Julia; Moosmang, Sven; Hofmann, Franz			Truncation of Murine Ca(v)1.2 at Asp-1904 Results in Heart Failure after Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL CA(V)1.2; CALMODULIN KINASE-II; CA2+ CHANNEL; CA2+-DEPENDENT INACTIVATION; DEPENDENT FACILITATION; CARBOXYL-TERMINUS; C-TERMINUS; ALPHA(1C); PHOSPHORYLATION; SUBUNIT	The carboxyl-terminal intracellular tail of the L-type Ca2+ channel Ca(V)1.2 modulates various aspects of channel activity. For example, deletion of the carboxyl-terminal sequence at Ser-1905 increased Ca(V)1.2 currents in an expression model. To verify this finding in an animal model, we inserted three stop codons at the corresponding Asp-1904 in the murine Ca(V)1.2 gene. Mice homozygous for the Stop mutation (Stop/Stop mice) were born at a Mendelian ratio but died after birth. Stop/Stop hearts showed reduced beating frequencies and contractions. Surprisingly, Stop/Stop cardiomyocytes displayed reduced I-Ba and a minor expression of the Ca(V)1.2(Stop) protein. In contrast, expression of the Ca(V)1.2(Stop) protein was normal in pooled smooth muscle samples from Stop/Stop embryos. As the Ca(V)1.2 channel exists in a cardiac and smooth muscle splice variant, HK1 and LK1, respectively, we analyzed the consequences of the deletion of the carboxyl terminus in the respective splice variant using the rabbit Ca(V)1.2 clone expressed in HEK293 cells. HEK293 cells transfected with the HK1(Stop) channel showed a reduced I-Ba and Ca(V)1.2 expression. Treatment with proteasome inhibitors increased the expression of HK1(Stop) protein and I-Ba in HEK293 cells and in Stop/Stop cardiomyocytes indicating that truncation of Ca(V)1.2 containing the cardiac exon 1a amino terminus results in proteasomal degradation of the translated protein. In contrast, HEK293 cells transfected with the LK1(Stop) channel had normal I-Ba and Ca(V)1.2 expression. These findings indicate that absence of the carboxyl-terminal tail differentially determines the fate of the cardiac and smooth muscle splice variant of the Ca(V)1.2 channel in the mouse.	[Hofmann, Franz] Tech Univ Munich, FOR 923, Inst Pharmakol & Toxikol, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, FOR 923, Inst Pharmakol & Toxikol, Forschergrp 923, Biedersteiner Str 29, D-80802 Munich, Germany.	Franz.Hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; BIEL M, 1991, EUR J BIOCHEM, V200, P81, DOI 10.1111/j.1432-1033.1991.tb21051.x; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hamilton S. L., 2005, SCI STKE; Hu H, 1998, MOL PHARMACOL, V53, P902; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Kobrinsky E, 2004, BIOPHYS J, V87, P844, DOI 10.1529/biophysj.104.041152; Langwieser N, 2010, J NEUROSCI, V30, P8367, DOI 10.1523/JNEUROSCI.4164-08.2010; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wegener JW, 2006, FASEB J, V20, P1260, DOI 10.1096/fj.05-5292fje; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; WEI XY, 1994, J BIOL CHEM, V269, P1635; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	41	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33863	33871		10.1074/jbc.M111.252312	http://dx.doi.org/10.1074/jbc.M111.252312			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832054	hybrid, Green Published			2022-12-25	WOS:000295159200018
J	Imai, A; Yoshie, S; Ishibashi, K; Haga-Tsujimura, M; Nashida, T; Shimomura, H; Fukuda, M				Imai, Akane; Yoshie, Sumio; Ishibashi, Koutaro; Haga-Tsujimura, Maiko; Nashida, Tomoko; Shimomura, Hiromi; Fukuda, Mitsunori			EPI64 Protein Functions as a Physiological GTPase-activating Protein for Rab27 Protein and Regulates Amylase Release in Rat Parotid Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL PLASMA-MEMBRANE; BINDING PROTEINS; PC12 CELLS; RAB35; DOMAIN; SECRETION; EFFECTOR; IDENTIFICATION; STIMULATION; SALIVARY	Rab27, a small GTPase, is generally recognized as an important regulator of secretion that interacts with Rab27-specific effectors to regulate events in a wide variety of cells, including endocrine and exocrine cells. However, the mechanisms governing the spatio-temporal regulation of GTPase activity of Rab27 are not firmly established, and no GTPase-activating protein (GAP) specific for Rab27 has been identified in secretory cells. We previously showed that expression of EPI64, a Tre-2/Bub2/Cdc16 (TBC)-domain-containing protein, in melanocytes inactivates endogenous Rab27A on melanosomes (Itoh, T., and Fukuda, M. (2006) J. Biol. Chem. 281, 31823-31831), but the EPI64 role in secretory cells has never been investigated. In this study, we investigated the effect of EPI64 on Rab27 in isoproterenol (IPR)-stimulated amylase release from rat parotid acinar cells. Subcellular fractionation and immunohistochemical analyses indicated that EPI64 was enriched on the apical plasma membrane of parotid acinar cells. We found that an antibody against the TBC/Rab-GAP domain of EPI64 inhibited the reduction in levels of the endogenous GTP-Rab27 in streptolysin-O-permeabilized parotid acinar cells and suppressed amylase release in a dose-dependent manner. We also found that the levels of EPI64 mRNA and EPI64 protein increased after IPR stimulation, and that treatment with actinomycin D or anti-sense-EPI64 oligonucleotides suppressed the increase of EPI64 mRNA/EPI64 protein and the amount of amylase released. Our findings indicated that EPI64 acted as a physiological Rab27-GAP that enhanced GTPase activity of Rab27 in response to IPR stimulation, and that this activity is required for IPR-induced amylase release.	[Imai, Akane; Nashida, Tomoko; Shimomura, Hiromi] Nippon Dent Univ, Dept Biochem, Sch Life Dent Niigata, Chuo Ku, Niigata 9518580, Japan; [Yoshie, Sumio; Haga-Tsujimura, Maiko] Nippon Dent Univ, Dept Histol, Sch Life Dent Niigata, Chuo Ku, Niigata 9518580, Japan; [Ishibashi, Koutaro; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Nippon Dental University; Nippon Dental University; Tohoku University	Imai, A (corresponding author), Nippon Dent Univ, Dept Biochem, Sch Life Dent Niigata, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	imaiak@ngt.ndu.ac.jp; nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Nippon Dental University [NDUF-10-03, 11-10]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Dental University(Nippon Dental University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to A. I. and M. F.), by a Research Promotion Grant (NDUF-10-03 and 11-10; to A. I.) from The Nippon Dental University, and by a grant from the Global Center of Excellence (GCOE) Program (Basic & Translational Research Center for Global Brain Science) from MEXT of Japan (to M. F.). Supported was also provided by the Japan Society for the Promotion of Science (to K. I.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BUTCHER FR, 1975, BIOCHIM BIOPHYS ACTA, V392, P82, DOI 10.1016/0304-4165(75)90168-3; Castle D, 1998, CRIT REV ORAL BIOL M, V9, P4, DOI 10.1177/10454411980090010301; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fujita-Yoshigaki J, 1998, CELL SIGNAL, V10, P371, DOI 10.1016/S0898-6568(97)00178-2; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Imai A, 2003, ARCH ORAL BIOL, V48, P597, DOI 10.1016/S0003-9969(03)00116-X; Imai A, 2006, ARCH BIOCHEM BIOPHYS, V455, P127, DOI 10.1016/j.abb.2006.09.021; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Imai A, 2009, ARCH ORAL BIOL, V54, P361, DOI 10.1016/j.archoralbio.2008.12.007; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; PAUL E, 1992, J MEMBRANE BIOL, V127, P129; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TAKUMA T, 1988, J BIOCHEM-TOKYO, V103, P95, DOI 10.1093/oxfordjournals.jbchem.a122247; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Yu E, 2008, P NATL ACAD SCI USA, V105, P16003, DOI 10.1073/pnas.0804825105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	51	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33854	33862		10.1074/jbc.M111.281394	http://dx.doi.org/10.1074/jbc.M111.281394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832089	Green Published, hybrid			2022-12-25	WOS:000295159200017
J	Lin, AP; Anderson, SL; Minard, KI; McAlister-Henn, L				Lin, An-Ping; Anderson, Sondra L.; Minard, Karyl I.; McAlister-Henn, Lee			Effects of Excess Succinate and Retrograde Control of Metabolite Accumulation in Yeast Tricarboxylic Cycle Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ISOCITRATE DEHYDROGENASE; MALATE-DEHYDROGENASE; FUMARATE HYDRATASE; GENE-EXPRESSION; RENAL-CANCER; KREBS CYCLE; MITOCHONDRIAL; MUTATIONS; IDENTIFICATION	Cellular and mitochondrial metabolite levels were measured in yeast TCA cycle mutants (sdh2 Delta or fum1 Delta) lacking succinate dehydrogenase or fumarase activities. Cellular levels of succinate relative to parental strain levels were found to be elevated similar to 8-fold in the sdh2 Delta mutant and similar to 4-fold in the fum1 Delta mutant, and there was a preferential increase in mitochondrial levels in these mutant strains. The sdh2 Delta and fum1 Delta strains also exhibited 3-4-fold increases in expression of Cit2, the cytosolic form of citrate synthase that functions in the glyoxylate pathway. Co-disruption of the SFC1 gene encoding the mitochondrial succinate/fumarate transporter resulted in higher relative mitochondrial levels of succinate and in substantial reductions of Cit2 expression in sdh2 Delta sfc1 Delta and fum1 Delta sfc1 Delta strains as compared with sdh2 Delta and fum1 Delta strains, suggesting that aberrant transport of succinate out of mitochondria mediated by Sfc1 is related to the increased expression of Cit2 in sdh2 Delta and fum1 Delta strains. A defect (rtg1 Delta) in the yeast retrograde response pathway, which controls expression of several mitochondrial proteins and Cit2, eliminated expression of Cit2 and reduced expression of NAD-specific isocitrate dehydrogenase (Idh) and aconitase (Aco1) in parental, sdh2 Delta, and fum1 Delta strains. Concomitantly, co-disruption of the RTG1 gene reduced the cellular levels of succinate in the sdh2 Delta and fum1 Delta strains, of fumarate in the fum1 Delta strain, and citrate in an idh Delta strain. Thus, the retrograde response is necessary for maintenance of normal flux through the TCA and glyoxylate cycles in the parental strain and for metabolite accumulation in TCA cycle mutants.	[Lin, An-Ping; Anderson, Sondra L.; Minard, Karyl I.; McAlister-Henn, Lee] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	McAlister-Henn, L (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	henn@uthscsa.edu			National Institutes of Health [GM051265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM051265.	Alam NA, 2003, HUM MOL GENET, V12, P1241, DOI 10.1093/hmg/ddg148; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P333, DOI 10.1016/S1389-1723(99)80041-3; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; DAUM G, 1982, J BIOL CHEM, V257, P3028; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; FOX TD, 1991, METHOD ENZYMOL, V194, P149; GOTHAM SM, 1988, ANAL BIOCHEM, V173, P353, DOI 10.1016/0003-2697(88)90199-6; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; Hu G, 2006, J BIOL CHEM, V281, P16935, DOI 10.1074/jbc.M512281200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; Kirchman PA, 1999, GENETICS, V152, P179; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin AP, 2008, ARCH BIOCHEM BIOPHYS, V474, P205, DOI 10.1016/j.abb.2008.03.005; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Maniatis T., 1982, MOL CLONING LAB MANU; McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422; McCammon MT, 1996, GENETICS, V144, P57; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Raab AM, 2010, METAB ENG, V12, P518, DOI 10.1016/j.ymben.2010.08.005; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Srinivasan V, 2010, AGING CELL, V9, P933, DOI 10.1111/j.1474-9726.2010.00622.x; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; THOMPSON LM, 1988, BIOCHEMISTRY-US, V27, P8393, DOI 10.1021/bi00422a015; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	47	14	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33737	33746		10.1074/jbc.M111.266890	http://dx.doi.org/10.1074/jbc.M111.266890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841001	Green Published, hybrid			2022-12-25	WOS:000295159200004
J	Dutheil, S; Lacour, M; Tighilet, B				Dutheil, Sophie; Lacour, Michel; Tighilet, Brahim			Neurogenic Potential of the Vestibular Nuclei and Behavioural Recovery Time Course in the Adult Cat Are Governed by the Nature of the Vestibular Damage	PLOS ONE			English	Article							UNILATERAL LABYRINTHECTOMY; HIPPOCAMPAL NEUROGENESIS; STEREOLOGICAL METHODS; MOLECULAR-MECHANISMS; GABAERGIC CONTROL; INJURED BRAIN; TOTAL NUMBER; GUINEA-PIG; STEM-CELL; NEURONS	Functional and reactive neurogenesis and astrogenesis are observed in deafferented vestibular nuclei after unilateral vestibular nerve section in adult cats. The newborn cells survive up to one month and contribute actively to the successful recovery of posturo-locomotor functions. This study investigates whether the nature of vestibular deafferentation has an incidence on the neurogenic potential of the vestibular nuclei, and on the time course of behavioural recovery. Three animal models that mimic different vestibular pathologies were used: unilateral and permanent suppression of vestibular input by unilateral vestibular neurectomy (UVN), or by unilateral labyrinthectomy (UL, the mechanical destruction of peripheral vestibular receptors), or unilateral and reversible blockade of vestibular nerve input using tetrodotoxin (TTX). Neurogenesis and astrogenesis were revealed in the vestibular nuclei using bromodeoxyuridine (BrdU) as a newborn cell marker, while glial fibrillary acidic protein (GFAP) and glutamate decarboxylase 67 (GAD67) were used to identify astrocytes and GABAergic neurons, respectively. Spontaneous nystagmus and posturo-locomotor tests (static and dynamic balance performance) were carried out to quantify the behavioural recovery process. Results showed that the nature of vestibular loss determined the cellular plastic events occurring in the vestibular nuclei and affected the time course of behavioural recovery. Interestingly, the deafferented vestibular nuclei express neurogenic potential after acute and total vestibular loss only (UVN), while non-structural plastic processes are involved when the vestibular deafferentation is less drastic (UL, TTX). This is the first experimental evidence that the vestibular complex in the brainstem can become neurogenic under specific injury. These new data are of interest for understanding the factors favouring the expression of functional neurogenesis in adult mammals in a brain repair perspective, and are of clinical relevance in vestibular pathology.	[Dutheil, Sophie; Lacour, Michel; Tighilet, Brahim] Univ Aix Marseille 1, Dept Neurosci, UMR Neurosci Integrat & Adaptat 6149, CNRS Pole Comportement Cerveau Cognit 3C,Ctr St C, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Dutheil, S (corresponding author), Univ Aix Marseille 1, Dept Neurosci, UMR Neurosci Integrat & Adaptat 6149, CNRS Pole Comportement Cerveau Cognit 3C,Ctr St C, Marseille, France.	brahim.tighilet@univ-provence.fr		Dutheil, Sophie/0000-0002-2031-482X	Ministere de l'enseignement superieur et de la recherche; CNRS (UMR Universite de Provence/CNRS) [6149]	Ministere de l'enseignement superieur et de la recherche; CNRS (UMR Universite de Provence/CNRS)	This study was supported by grants from the "Ministere de l'enseignement superieur et de la recherche" and CNRS (UMR Universite de Provence/CNRS No 6149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campos-Torres A, 2005, NEUROSCIENCE, V130, P853, DOI 10.1016/j.neuroscience.2004.08.052; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Christensen JR, 2007, ANAT REC, V290, P330, DOI 10.1002/ar.20504; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Darlington CL, 2000, PROG NEUROBIOL, V62, P313, DOI 10.1016/S0301-0082(00)00002-2; DIERINGER N, 1995, PROG NEUROBIOL, V46, P97, DOI 10.1016/0301-0082(94)00063-N; Dutheil S, 2009, NEUROSCIENCE, V164, P1444, DOI 10.1016/j.neuroscience.2009.09.048; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Flohr H, 1985, Rev Oculomot Res, V1, P269; Gacek Richard R., 1998, Auris Nasus Larynx, V25, P193, DOI 10.1016/S0385-8146(98)00015-7; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Gliddon CM, 2005, J PHARMACOL EXP THER, V313, P1126, DOI 10.1124/jpet.104.082172; Gliddon CM, 2005, PROG NEUROBIOL, V75, P53, DOI 10.1016/j.pneurobio.2004.11.001; Guilding C, 2005, NEUROREPORT, V16, P1415, DOI 10.1097/01.wnr.0000176519.42218.a6; Him A, 2001, BRAIN RES, V908, P58, DOI 10.1016/S0006-8993(01)02600-2; HOWARD CV, 2005, UNBIAISED STEREOLOGY; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; LACOUR M, 1976, BRAIN RES, V113, P255, DOI 10.1016/0006-8993(76)90940-9; Lacour M, 2006, CURR MED RES OPIN, V22, P1651, DOI 10.1185/030079906X115694; Lacour M, 2010, RESTOR NEUROL NEUROS, V28, P19, DOI 10.3233/RNN-2010-0509; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Liberge M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-91; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paterson JM, 2006, J PHYSIOL-LONDON, V575, P777, DOI 10.1113/jphysiol.2006.112409; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; REDON C, 2010, J CLIN PHARM; RIS L, 1995, J NEUROPHYSIOL, V74, P2087, DOI 10.1152/jn.1995.74.5.2087; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Saxon DW, 2001, NEUROREPORT, V12, P3051, DOI 10.1097/00001756-200110080-00014; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tighilet B, 2009, NEUROSCIENCE, V160, P716, DOI 10.1016/j.neuroscience.2009.02.070; TIGHILET B, 1995, J VESTIBUL RES-EQUIL, V5, P187; Tighilet B, 2001, EUR J NEUROSCI, V13, P2255, DOI 10.1046/j.0953-816x.2001.01622.x; Tighilet B, 2007, EUR J NEUROSCI, V25, P47, DOI 10.1111/j.1460-9568.2006.05267.x; Tighilet B, 2006, J PHYSIOL-LONDON, V573, P723, DOI 10.1113/jphysiol.2006.107805; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; XERRI C, 1980, ACTA OTO-LARYNGOL, V90, P414, DOI 10.3109/00016488009131743; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zennou-Azogui Y, 1993, Acta Otolaryngol Suppl, V509, P1; Zheng YW, 2010, NEUROSCI LETT, V468, P85, DOI 10.1016/j.neulet.2009.10.070	60	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22262	10.1371/journal.pone.0022262	http://dx.doi.org/10.1371/journal.pone.0022262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853029	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400005
J	Shin, A; Joo, J; Bak, J; Yang, HR; Kim, J; Park, S; Nam, BH				Shin, Aesun; Joo, Jungnam; Bak, Jeongin; Yang, Hye-Ryung; Kim, Jeongseon; Park, Sohee; Nam, Byung-Ho			Site-Specific Risk Factors for Colorectal Cancer in a Korean Population	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; BODY-MASS-INDEX; ALCOHOL-CONSUMPTION; RECTAL-CANCER; METABOLIC SYNDROME; POOLED ANALYSIS; JAPANESE MEN; COLON-CANCER; COHORT; METAANALYSIS	We investigated the association of colorectal cancer risk factors with different colorectal cancer subsites to assess etiological differences for cancers of the proximal colon, distal colon, and rectum. Included in this study were 869,725 men and 395,501 women who participated in a health examination provided by the Korean National Health System between 1996 and 1997. During up to 7 years of follow-up, 4,144 incident colorectal cancer cases were detected (3,051 men and 1,093 women). Greater height was associated with elevated risk for distal colon cancer and rectal cancer in both men and women. Family history of cancer was associated with higher risk for cancers of the proximal colon in men and distal colon in both men and women. Frequent alcohol consumption and consuming high amounts of alcohol were associated with elevated risk for distal colon cancer in men and higher risk for rectal cancer in women. Frequent meat consumption was associated with risk for proximal colon cancer in men and for rectal cancer in women. Our findings suggest that risk factors for colorectal cancer are different by subsites of colon and rectum, as well as by sex.	[Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Joo, Jungnam; Bak, Jeongin; Yang, Hye-Ryung; Park, Sohee; Nam, Byung-Ho] Natl Canc Ctr, Canc Biostat Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Shin, A (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea.	byunghonam@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center, Korea [0810190-3]	National Cancer Center, Korea	This work was supported by the National Cancer Center, Korea (grant No. 0810190-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Akhter M, 2007, EUR J CANCER, V43, P383, DOI 10.1016/j.ejca.2006.09.020; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; DELEON MP, 1989, CANCER RES, V49, P4344; GOLDBOHM RA, 1994, CANCER CAUSE CONTROL, V5, P95, DOI 10.1007/BF01830255; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; *KOR MIN HLTH WELF, 2008, ANN REP CANC INC; Lagakos S. W., 1978, APPLIED STATISTICS, V27, P235, DOI DOI 10.2307/2347158; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; MCMICHAEL AJ, 1985, JNCI-J NATL CANCER I, V75, P185; Mizoue T, 2008, AM J EPIDEMIOL, V167, P1397, DOI 10.1093/aje/kwn073; NOMURA AMY, 1991, J NATL CANCER I, V83, P1403, DOI 10.1093/jnci/83.19.1403; Otani T, 2005, CANCER CAUSE CONTROL, V16, P839, DOI 10.1007/s10552-005-4573-z; PARK S, 2009, CANC RES TREAT, V14, pS11; Pedersen A, 2003, GUT, V52, P861, DOI 10.1136/gut.52.6.861; Pelucchi C, 2010, EUR J CANCER, V46, P1866, DOI 10.1016/j.ejca.2010.03.010; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sharpe CR, 2002, CANCER CAUSE CONTROL, V13, P483, DOI 10.1023/A:1015700415808; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Sturmer T, 2006, CANCER EPIDEM BIOMAR, V15, P2391, DOI 10.1158/1055-9965.EPI-06-0391; Sung J, 2009, AM J EPIDEMIOL, V170, P53, DOI 10.1093/aje/kwp088; Trevisan M, 2001, CANCER EPIDEM BIOMAR, V10, P937; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; 2001, JAMA, V285, P2486	36	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23196	10.1371/journal.pone.0023196	http://dx.doi.org/10.1371/journal.pone.0023196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853085	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200051
J	Suarez-Morales, E				Suarez-Morales, Eduardo			Diversity of the Monstrilloida (Crustacea: Copepoda)	PLOS ONE			English	Review							SARS CRUSTACEA; CARIBBEAN SEA; CYMBASOMA; REDESCRIPTION; RECORD; MEXICO; REEF; CALIFORNIA; NORWAY; BRAZIL	Monstrilloid copepods are protelean parasites of different groups of marine benthic invertebrates. Only their first naupliar, preadult, and adult phases are planktonic. Monstrilloids are currently represented by more than 115 nominal species contained in four genera. Its taxonomic knowledge has been hampered by nomenclatural and descriptive problems derived from their peculiar ontogeny and poor definitions of taxa. One of the most important difficulties is that of matching males to females. The only reliable methods to link the sexes of a species are the confirmation of particular apomorphies shared by both sexes, finding both sexes in the same host or as a pre-copulatory male-female pair in the plankton, or by the use of molecular markers. A general overview of the morphology of the group and its life cycle is provided herein. Recently, upgraded descriptive standards have been established and the relevance of redescribing taxa based on type and museum specimens has been demonstrated. The rate of species description per decade has had several peaks between 1840 and 2010: (19711980, 1991-2000, 2001-2010), each related to the activity of a few researchers. An analysis of the world distribution of published records of the Monstrilloida revealed that the Northeast Atlantic is the best studied region (45% of all records), followed by the Northwestern Atlantic (17%); the least surveyed areas include regions of the southern hemisphere (less than 3%). The Northeast Atlantic region harbors the highest number of known species (32 nominal species), followed by the Caribbean Sea/Gulf of Mexico (24), the Mediterranean/Black Sea (19), Indonesia-Malaysia-Philippines region (17), Japanese waters (17), and the Brazil-Argentina area (16). Other than these generalized patterns, little can be concluded concerning the biogeography of the group. Many species records are doubtful or improbable, and purportedly cosmopolitan nominal species are being revealed as species complexes yet to be studied.	Colegio Frontera Sur Unidad Chetumal, Chetmal, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Suarez-Morales, E (corresponding author), Colegio Frontera Sur Unidad Chetumal, Chetmal, Quintana Roo, Mexico.	esuarez@ecosur.mx			ES-M's institution; El Colegio de la Frontera Sur	ES-M's institution; El Colegio de la Frontera Sur	Funding was provided by ES-M's institution, El Colegio de la Frontera Sur through the author's personal institutional project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancalana F, 2007, BRAZ J OCEANOGR, V55, P83, DOI 10.1590/S1679-87592007000200002; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Caullery Maurice, 1914, Bulletin Scientifique de la France et de la Belgique ser 7, V48; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Dana JD., 1849, AM J SCI ARTS, V8, P276; Davis C.C., 1984, P67; DAVIS CHARLES C., 1949, TRANS AMER MICROSC SOC, V68, P245, DOI 10.2307/3223221; DIAS CO, 2007, BIOTA NEOTROP, V7, P281; DIAS CO, 2005, BIOTA NEOTROPICA, V5; Dias Cristina de Oliveira, 2007, Pan-American Journal of Aquatic Sciences, V2, P270; FOSSHAGEN A, 1970, SARSIA, V42, P33; GIARD A, 1895, CR HEBD ACAD SCI, V120, P937; GIARD A, 1896, CR HEBD ACAD SCI, V123, P836; Giesbrecht W, 1893, FAUNA FLORA GOLF, V19, P1, DOI DOI 10.5962/BHL.TITLE.913; Grygier MJ, 2008, ZOOL J LINN SOC-LOND, V152, P459, DOI 10.1111/j.1096-3642.2007.00381.x; Grygier Mark J., 1995, Galaxea, V12, P1; GRYGIER MJ, 1995, J CRUSTACEAN BIOL, V15, P703, DOI 10.2307/1548820; GRYGIER MJ, 1993, SARSIA, V78, P235, DOI 10.1080/00364827.1993.10413537; GRYGIER MJ, 1994, HYDROBIOLOGIA, V293, P23; HARTMAN O, 1964, ZOOL ANZ, V167, P325; Ho JS, 2003, J CRUSTACEAN BIOL, V23, P582, DOI 10.1651/C-2391; Huys R, 1991, COPEPOD EVOLUTION; Huys R, 2007, MOL PHYLOGENET EVOL, V43, P368, DOI 10.1016/j.ympev.2007.02.004; Isaac M.J., 1975, Fiches Ident Zooplancton, V144-145, P1; KROYER, 1842, VOYAGES COMMISSION S, P41; Leite NR, 2010, AN ACAD BRAS CIENC, V82, P577, DOI 10.1590/S0001-37652010000300005; MALAQUIN A, 1901, ARCH ZOOLOGIE EXPT G, V9, P81; MARIN V, 1985, J PLANKTON RES, V7, P961, DOI 10.1093/plankt/7.6.961; MCALICE BJ, 1985, J CRUSTACEAN BIOL, V5, P627, DOI 10.2307/1548240; PARK TS, 1967, T AM MICROSC SOC, V86, P144, DOI 10.2307/3224681; Pelseneer Paul, 1914, Bulletin Scientifique de la France et de la Belgique ser 7, V48; RAMIREZ F C, 1971, Physis (Buenos Aires), V30, P377; RAZOULS C, 1994, ANN I OCEANOGR PARIS, V70, P3; Razouls C, 1996, ANN I OCEANOGR PARIS, V72, P5; RAZOULS C, DIVERSITE REPARTITIO; SALE PF, 1976, MAR BIOL, V34, P59, DOI 10.1007/BF00390788; Sars G. O., 1921, ACCOUNT CRUSTACEA NO, V8; Suarez-Morales E, 1997, B MAR SCI, V61, P539; Suarez-Morales E, 2000, SARSIA, V85, P203, DOI 10.1080/00364827.2000.10414573; Suarez-Morales E., 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V71, P53; Suarez-Morales E, 2006, HELGOLAND MAR RES, V60, P171, DOI 10.1007/s10152-005-0018-z; Suarez-Morales E., 2000, Beaufortia, V50, P139; Suarez-Morales E, 2004, ZOOL STUD, V43, P292; Suarez-Morales E, 2004, ARCTIC, V57, P37; Suarez-Morales E, 1999, P BIOL SOC WASH, V112, P189; Suarez-Morales E, 2001, CRUSTACEANA, V74, P689, DOI 10.1163/156854001750377966; Suarez-Morales E, 2001, J NAT HIST, V35, P1433, DOI 10.1080/002229301317067629; Suarez-Morales E, 2001, CAH BIOL MAR, V42, P243; Suarez-Morales E, 2000, J MAR BIOL ASSOC UK, V80, P1031, DOI 10.1017/S002531540000309X; Suarez-Morales E., 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V70, P107; Suarez-Morales E, 2007, ZOOTAXA, P25; Suarez-Morales E, 2006, ZOOL ANZ, V245, P95, DOI 10.1016/j.jcz.2006.05.002; Suarez-Morales E, 2010, ZOOTAXA, P55; Suarez-Morales Eduardo, 2001, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V72, P9; Suarez-Morales E, 2010, J MAR BIOL ASSOC UK, V90, P953, DOI 10.1017/S0025315409991391; SUAREZMORALES E, 1993, HYDROBIOLOGIA, V271, P45, DOI 10.1007/BF00005694; SUAREZMORALES E, 1990, UNIV CIENC, V7, P57; Walter TC, 2010, WORLD COPEPODA DATAB	58	27	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22915	10.1371/journal.pone.0022915	http://dx.doi.org/10.1371/journal.pone.0022915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853055	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200026
J	Zhang, X; He, JF; Li, LH; Zhu, XL; Ke, CW; Ni, HZ; Hou, NM; Zhong, HJ; Wu, J				Zhang, Xin; He, Jianfeng; Li, Linghui; Zhu, Xiaolan; Ke, Changwen; Ni, Hanzhong; Hou, Nianmei; Zhong, Haojie; Wu, Jie			Serologic Survey of the Pandemic H1N1 2009 Virus in Guangdong Province, China: A Cross Sectional Study	PLOS ONE			English	Article							HOUSEHOLD TRANSMISSION; INFLUENZA-VIRUS	Background: Relying on surveillance of clinical cases limits the ability to understand the full impact and severity of an epidemic, which urges a deep insight into the serological evidence of infection and transmission feature of pandemic H1N1 2009 (pH1N1) virus in Guangdong province. Methods: In this cross-sectional serological survey, serum samples were collected by multi-stage stratified random sampling in Jan 2010. Antibody titers were measured by hemagglutination inhibition (HI) assay. Age-specific and region-specific prevalence were calculated based on the results of HI assay (positive, HI titer >= 1:40). Results: A total of 4,319 serum samples had been collected from subjects without vaccination with pH1N1 vaccine. The seroprevalence was 22.82% (985/4,319). By contrast, there was a marked spatial heterogeneity in prevalence. The seroprevalence was 27.3% in large city, 21.4% in medium cities, higher than that of 20.2% in rural areas. The seroprevalence was highest in 11-20 age group (32.8%), however, in those above 60 years of age group, which was 12.6%, lower than other age groups. On the other hand, antibody titers to pH1N1 virus were highest in school children, which were followed by a gradual decrease in adult. However, in the elderly groups from cities, especially from large city, the antibody titer to pH1N1 increased significantly and reached a much higher level. Conclusion: Our results showed that the prevalence for pH1N1 was correlated with age and population density. Preexisting antibody may have protected the very old from pH1N1 infection, while original antigenic sin and immunosenescence may have contributed to greater severity once infected. These should be considered when studying the pathogenesis and transmission of influenza virus and formulating strategies on vaccination and treatment.	[Zhang, Xin; He, Jianfeng; Li, Linghui; Zhu, Xiaolan; Ke, Changwen; Ni, Hanzhong; Hou, Nianmei; Zhong, Haojie; Wu, Jie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China		Zhang, X (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	zhangxinhui16@163.com			national transfer payments funding for the pandemic H1N1 serologic survey	national transfer payments funding for the pandemic H1N1 serologic survey	This study was supported by the national transfer payments funding for the pandemic H1N1 serologic survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; CHAN M, 2009, WHO WORLD NOW START; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Collins SD, 1931, PUBLIC HEALTH REP, V46, P1909, DOI 10.2307/4580139; Committee for Proprietary Medicinal Products [CPMP], 1997, CPMPBWP21496, P1; DANUTA MS, 2011, JID, V203, P158; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jianfeng H, 2010, S CHINA J PREV MED, V36, P4; JIN HK, 2009, J IMMUNOL, V183, P3294; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; LINGHUI L, 2010, S CHINA J PREV MED, V36, P17; McSweeny Kirsten, 2007, N Z Med J, V120, pU2579; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pebody R, 2011, VACCINE, V29, P2613, DOI 10.1016/j.vaccine.2011.01.046; PHYLLIS JL, 2004, NAT IMMUNOL, V5, P133; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SHUANG L, 2009, MECH AGEING, V130, P538; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; *WHO, 2009, PANDEMIC A H1N1 UPDA, V59; World Health Organization, 2002, WHO MAN AN INFL DIAG	26	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23034	10.1371/journal.pone.0023034	http://dx.doi.org/10.1371/journal.pone.0023034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853064	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200035
J	Deibler, M; Spatz, JP; Kemkemer, R				Deibler, Martin; Spatz, Joachim P.; Kemkemer, Ralf			Actin Fusion Proteins Alter the Dynamics of Mechanically Induced Cytoskeleton Rearrangement	PLOS ONE			English	Article							CELL MECHANICS; CYCLIC STRETCH; STRESS FIBER; REORIENTATION; MODEL; REORGANIZATION; ORIENTATION; FORCE	Mechanical forces can regulate various functions in living cells. The cytoskeleton is a crucial element for the transduction of forces in cell-internal signals and subsequent biological responses. Accordingly, many studies in cellular biomechanics have been focused on the role of the contractile acto-myosin system in such processes. A widely used method to observe the dynamic actin network in living cells is the transgenic expression of fluorescent proteins fused to actin. However, adverse effects of GFP-actin fusion proteins on cell spreading, migration and cell adhesion strength have been reported. These shortcomings were shown to be partly overcome by fusions of actin binding peptides to fluorescent proteins. Nevertheless, it is not understood whether direct labeling by actin fusion proteins or indirect labeling via these chimaeras alters biomechanical responses of cells and the cytoskeleton to forces. We investigated the dynamic reorganization of actin stress fibers in cells under cyclic mechanical loading by transiently expressing either egfp-Lifeact or eyfp-actin in rat embryonic fibroblasts and observing them by means of live cell microscopy. Our results demonstrate that mechanically-induced actin stress fiber reorganization exhibits very different kinetics in EYFP-actin cells and EGFP-Lifeact cells, the latter showing a remarkable agreement with the reorganization kinetics of non-transfected cells under the same experimental conditions.	[Deibler, Martin; Spatz, Joachim P.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Deibler, Martin; Spatz, Joachim P.] Univ Heidelberg, Dept Biophys Chem, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Deibler, M (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	ralf.kemkemer@is.mpg.de	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	Bundesministerium fur Bildung und Forschung (BMBF); Max Planck Society (MPG)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society)	Parts of the study were financially supported by the Bundesministerium fur Bildung und Forschung (BMBF project Systec MSC). The Max Planck Society (MPG) is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmed WW, 2010, ACTA BIOMATER, V6, P2979, DOI 10.1016/j.actbio.2010.02.035; Aizawa H, 1997, CELL STRUCT FUNCT, V22, P335, DOI 10.1247/csf.22.335; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Feng ZQ, 2005, BIOMATERIALS, V26, P5348, DOI 10.1016/j.biomaterials.2005.01.069; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Forster B, 2004, MICROSC RES TECHNIQ, V65, P33, DOI 10.1002/jemt.20092; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Geiger RC, 2006, GENE THER, V13, P725, DOI 10.1038/sj.gt.3302693; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katoh K, 2008, VASC HEALTH RISK MAN, V4, P1273, DOI 10.2147/VHRM.S3933; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Neidlinger-Wilke C, 2002, J ORTHOPAED RES, V20, P953, DOI 10.1016/S0736-0266(02)00024-4; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5	25	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22941	10.1371/journal.pone.0022941	http://dx.doi.org/10.1371/journal.pone.0022941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850245	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300030
J	Lipinska, U; Hermans, K; Meulemans, L; Dumitrescu, O; Badiou, C; Duchateau, L; Haesebrouck, F; Etienne, J; Lina, G				Lipinska, Urszula; Hermans, Katleen; Meulemans, Lieve; Dumitrescu, Oana; Badiou, Cedric; Duchateau, Luc; Haesebrouck, Freddy; Etienne, Jerome; Lina, Gerard			Panton-Valentine Leukocidin Does Play a Role in the Early Stage of Staphylococcus aureus Skin Infections: A Rabbit Model	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; VIRULENCE DETERMINANT; CUTANEOUS INFECTIONS; STRAINS; USA300; INFLAMMATION; LEUCOCIDIN; PNEUMONIA; DISEASE; TOXINS	Despite epidemiological data linking necrotizing skin infections with the production of Panton-Valentine leukocidin (PVL), the contribution of this toxin to the virulence of S. aureus has been highly discussed as a result of inconclusive results of in vivo studies. However, the majority of these results originate from experiments using mice, an animal species which neutrophils - the major target cells for PVL - are highly insensitive to the action of this leukocidin. In contrast, the rabbit neutrophils have been shown to be as sensitive to PVL action as human cells, making the rabbit a better experimental animal to explore the PVL role. In this study we examined whether PVL contributes to S. aureus pathogenicity by means of a rabbit skin infection model. The rabbits were injected intradermally with 10(8) cfu of either a PVL positive community-associated methicillin-resistant S. aureus isolate, its isogenic PVL knockout or a PVL complemented knockout strain, and the development of skin lesions was observed. While all strains induced skin infection, the wild type strain produced larger lesions and a higher degree of skin necrosis compared to the PVL knockout strain in the first week after the infection. The PVL expression in the rabbits was indirectly confirmed by a raise in the serum titer of anti-LukS-PV antibodies observed only in the rabbits infected with PVL positive strains. These results indicate that the rabbit model is more suitable for studying the role of PVL in staphylococcal diseases than other animal models. Further, they support the epidemiological link between PVL producing S. aureus strains and necrotizing skin infections.	[Lipinska, Urszula; Hermans, Katleen; Meulemans, Lieve; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Physiol & Biometry, Merelbeke, Belgium; [Dumitrescu, Oana; Badiou, Cedric; Etienne, Jerome; Lina, Gerard] Univ Lyon 1, Ctr Natl Reference Staphylocoques, F-69365 Lyon, France; [Dumitrescu, Oana; Badiou, Cedric; Etienne, Jerome; Lina, Gerard] INSERM, IFR128, U851, F-69008 Lyon, France; [Dumitrescu, Oana; Etienne, Jerome; Lina, Gerard] Hosp Civils Lyon, Lyon, France	Ghent University; Ghent University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Lipinska, U (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	urszula.lipinska@ugent.be	Haesebrouck, Freddy/M-3857-2014; Lina, Gerard J/L-9352-2014; Dumitrescu, Oana/C-6222-2013; ETIENNE, Jerome/C-5471-2014	Haesebrouck, Freddy/0000-0002-1709-933X; Dumitrescu, Oana/0000-0001-8193-1437; ETIENNE, Jerome/0000-0002-3348-3315; Lina, Gerard/0000-0002-9236-7998	Ghent University [01J.055.06]; European Community [EC 222718]; Pfizer; bioMerieux; Novartis	Ghent University(Ghent University); European Community(European Commission); Pfizer(Pfizer); bioMerieux; Novartis(Novartis)	This research was funded by the Special Research Fund of Ghent University (01J.055.06), the grant European Community (EC 222718), Pfizer, bioMerieux and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Croze M, 2009, CLIN MICROBIOL INFEC, V15, P144, DOI 10.1111/j.1469-0691.2008.02650.x; des Horts TB, 2010, INFECT IMMUN, V78, P260, DOI 10.1128/IAI.00843-09; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; GLADSTONE GP, 1957, BRIT J EXP PATHOL, V38, P123; HARCOURTBROWN F, 2002, TXB RABBIT MED, P52; Hermans K, 1999, VET MICROBIOL, V67, P37, DOI 10.1016/S0378-1135(99)00028-0; Hermans K, 2003, VET MICROBIOL, V91, P57, DOI 10.1016/S0378-1135(02)00260-2; Hongo I, 2009, J INFECT DIS, V200, P715, DOI 10.1086/605332; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1994, ZBL BAKT S, V24, P284; Szmigielski S, 1998, ZBL BAKT-INT J MED M, V288, P383; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Vancraeynest D, 2007, VET MICROBIOL, V121, P368, DOI 10.1016/j.vetmic.2006.12.011; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; WOODIN AM, 1959, BIOCHEM J, V73, P225, DOI 10.1042/bj0730225	30	71	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22864	10.1371/journal.pone.0022864	http://dx.doi.org/10.1371/journal.pone.0022864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850240	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300025
J	Werth, BB; Bashir, M; Chang, L; Werth, VP				Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.			Ultraviolet Irradiation Induces the Accumulation of Chondroitin Sulfate, but Not Other Glycosaminoglycans, in Human Skin	PLOS ONE			English	Article							DERMATAN SULFATE; HYALURONIC-ACID; HAIRLESS MOUSE; KAPPA-B; UVB; SERGLYCIN; INTERLEUKIN-1-BETA; TRANSLOCATION; INFLAMMATION; ACTIVATION	Ultraviolet (UV) light alters cutaneous structure and function. Prior work has shown loss of dermal hyaluronan after UV-irradiation of human skin, yet UV exposure increases total glycosaminoglycan (GAG) content in mouse models. To more fully describe UV-induced alterations to cutaneous GAG content, we subjected human volunteers to intermediate-term (5 doses/week for 4 weeks) or single-dose UV exposure. Total dermal uronyl-containing GAGs increased substantially with each of these regimens. We found that UV exposure substantially increased dermal content of chondroitin sulfate (CS), but not hyaluronan, heparan sulfate, or dermatan sulfate. UV induced the accumulation of both the 4-sulfated (C4S) and 6-sulfated (C6S) isoforms of CS, but in distinct distributions. Next, we examined several CS proteoglycan core proteins and found a significant accumulation of dermal and endothelial serglycin, but not of decorin or versican, after UV exposure. To examine regulation in vitro, we found that UVB in combination with IL-1 alpha, a cytokine upregulated by UV radiation, induced serglycin mRNA in cultured dermal fibroblasts, but did not induce the chondroitin sulfate synthases. Overall, our data indicate that intermediate-term and single-dose UVB exposure induces specific GAGs and proteoglycan core proteins in human skin in vivo. These molecules have important biologic functions and contribute to the cutaneous response to UV.	[Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.] Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA; [Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania	Werth, BB (corresponding author), Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA.	werth@mail.med.upenn.edu			Department of Veterans Affairs Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development	Department of Veterans Affairs Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs)	This material is based upon work supported in part by a Merit Review Grant from the Department of Veterans Affairs Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Bassleer CT, 1998, OSTEOARTHR CARTILAGE, V6, P196, DOI 10.1053/joca.1998.0112; Bernstein EF, 1996, BRIT J DERMATOL, V135, P255, DOI 10.1111/j.1365-2133.1996.tb01156.x; BERNSTEIN EF, 1995, LAB INVEST, V72, P662; Bernstein EF, 1996, CLIN DERMATOL, V14, P143, DOI 10.1016/0738-081X(95)00149-A; Campo GM, 2008, OSTEOARTHR CARTILAGE, V16, P1474, DOI 10.1016/j.joca.2008.04.002; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; Ikeda M, 2009, BIOCHEM BIOPH RES CO, V390, P1221, DOI 10.1016/j.bbrc.2009.10.125; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jomphe C, 2008, BASIC CLIN PHARMACOL, V102, P59, DOI 10.1111/j.1742-7843.2007.00158.x; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KLIGMAN LH, 1989, J AM ACAD DERMATOL, V21, P623, DOI 10.1016/S0190-9622(89)70229-2; KLIGMAN LH, 1985, J INVEST DERMATOL, V84, P272, DOI 10.1111/1523-1747.ep12265353; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Koshiishi I, 1999, BBA-GEN SUBJECTS, V1428, P327, DOI 10.1016/S0304-4165(99)00081-1; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; MARGELIN D, 1993, PHOTOCHEM PHOTOBIOL, V58, P211, DOI 10.1111/j.1751-1097.1993.tb09551.x; MENTER JM, 1983, PHOTOCHEM PHOTOBIOL, V38, P481, DOI 10.1111/j.1751-1097.1983.tb03371.x; Monfort J, 2008, ANN RHEUM DIS, V67, P735, DOI 10.1136/ard.2006.068882; Nabatian N, J INVEST DE IN PRESS; Pauloin T, 2009, MOL VIS, V15, P577; Rachmilewitz J, 1998, BLOOD, V92, P223, DOI 10.1182/blood.V92.1.223.413k15_223_229; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Toida T, 2006, ADV PHARMACOL, V53, P403, DOI 10.1016/S1054-3589(05)53019-9; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x; Werth VP, 1999, J INVEST DERMATOL, V113, P196, DOI 10.1046/j.1523-1747.1999.00681.x; Werth VP, 1997, J INVEST DERMATOL, V108, P290, DOI 10.1111/1523-1747.ep12286462; WILLEN MD, 1991, J INVEST DERMATOL, V96, P968, DOI 10.1111/1523-1747.ep12476335; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zhang L, 2010, CONNECT TISSUE RES, V51, P230, DOI 10.3109/03008200903288902	39	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e14830	10.1371/journal.pone.0014830	http://dx.doi.org/10.1371/journal.pone.0014830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829593	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200002
J	Newman, AM; Cooper, JB				Newman, Aaron M.; Cooper, James B.			Global Analysis of Proline-Rich Tandem Repeat Proteins Reveals Broad Phylogenetic Diversity in Plant Secretomes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELL-WALL; GENE FAMILY; HYDROXYPROLINE; IDENTIFICATION; EXPRESSION; EXTENSIN; GLYCOPROTEIN; GROWTH; DIVERSIFICATION	Cell walls, constructed by precisely choreographed changes in the plant secretome, play critical roles in plant cell physiology and development. Along with structural polysaccharides, secreted proline-rich Tandem Repeat Proteins (TRPs) are important for cell wall function, yet the evolutionary diversity of these structural TRPs remains virtually unexplored. Using a systems-level computational approach to analyze taxonomically diverse plant sequence data, we identified 31 distinct Pro-rich TRP classes targeted for secretion. This analysis expands upon the known phylogenetic diversity of extensins, the most widely studied class of wall structural proteins, and demonstrates that extensins evolved before plant vascularization. Our results also show that most Pro-rich TRP classes have unexpectedly restricted evolutionary distributions, revealing considerable differences in plant secretome signatures that define unexplored diversity.	[Newman, Aaron M.; Cooper, James B.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cooper, James B.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Newman, AM (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA.	jcooper@lifesci.ucsb.edu	Newman, Aaron M/ABE-1620-2021	Newman, Aaron M/0000-0002-1857-8172	University of California, Santa Barbara (UCSB)	University of California, Santa Barbara (UCSB)(University of California System)	This work was partially supported by a University of California, Santa Barbara (UCSB) Dissertation Fellowship awarded to Dr. Newman. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Brewin NJ, 2004, CRIT REV PLANT SCI, V23, P293, DOI 10.1080/07352680490480734; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; COOPER JB, 1994, PLANT PHYSIOL, V104, P747, DOI 10.1104/pp.104.2.747; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Creighton T. E., 1993, PROTEINS STRUCTURES; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; DOUGALL DK, 1960, PLANT PHYSIOL, V35, P396, DOI 10.1104/pp.35.3.396; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EPSTEIN L, 1984, PHYTOCHEMISTRY, V23, P1241, DOI 10.1016/S0031-9422(00)80433-1; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; JOHNSON KL, 2003, PLANT CELL WALL, V8, P111; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KIELISZEWSKI M, 1987, PLANT PHYSIOL, V85, P823, DOI 10.1104/pp.85.3.823; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Quackenbush J, 2000, NUCLEIC ACIDS RES, V28, P141, DOI 10.1093/nar/28.1.141; RASHID A, 2011, THESIS U ALBERTA CAN; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STIEFEL V, 1990, PLANT CELL, V2, P785, DOI 10.1105/tpc.2.8.785; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas P, 2003, PLANT CELL ENVIRON, V26, P1497, DOI 10.1046/j.1365-3040.2003.01071.x; Uchida K, 1998, PLANT J, V15, P813, DOI 10.1046/j.1365-313X.1998.00264.x; VANHOLST GJ, 1984, PLANT PHYSIOL, V74, P247, DOI 10.1104/pp.74.2.247; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang XL, 2008, J EXP BOT, V59, P4045, DOI 10.1093/jxb/ern245	62	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23167	10.1371/journal.pone.0023167	http://dx.doi.org/10.1371/journal.pone.0023167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829715	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511900032
J	van Mourik, MSM; Groenwold, RHH; van der Sprenkel, JWB; van Solinge, WW; Troelstra, A; Bonten, MJM				van Mourik, Maaike S. M.; Groenwold, Rolf H. H.; van der Sprenkel, Jan Willem Berkelbach; van Solinge, Wouter W.; Troelstra, Annet; Bonten, Marc J. M.			Automated Detection of External Ventricular and Lumbar Drain-Related Meningitis Using Laboratory and Microbiology Results and Medication Data	PLOS ONE			English	Article							CEREBROSPINAL-FLUID INFECTION; SURGICAL SITE INFECTIONS; BLOOD-STREAM INFECTIONS; NOSOCOMIAL INFECTION; INTRAVENTRICULAR HEMORRHAGE; BACTERIAL-MENINGITIS; SERUM PROCALCITONIN; SURVEILLANCE SYSTEM; EARLY-DIAGNOSIS; VALIDATION	Objective: Monitoring of healthcare-associated infection rates is important for infection control and hospital benchmarking. However, manual surveillance is time-consuming and susceptible to error. The aim was, therefore, to develop a prediction model to retrospectively detect drain-related meningitis (DRM), a frequently occurring nosocomial infection, using routinely collected data from a clinical data warehouse. Methods: As part of the hospital infection control program, all patients receiving an external ventricular (EVD) or lumbar drain (ELD) (2004 to 2009; n = 742) had been evaluated for the development of DRM through chart review and standardized diagnostic criteria by infection control staff; this was the reference standard. Children, patients dying <24 hours after drain insertion or with <1 day follow-up and patients with infection at the time of insertion or multiple simultaneous drains were excluded. Logistic regression was used to develop a model predicting the occurrence of DRM. Missing data were imputed using multiple imputation. Bootstrapping was applied to increase generalizability. Results: 537 patients remained after application of exclusion criteria, of which 82 developed DRM (13.5/1000 days at risk). The automated model to detect DRM included the number of drains placed, drain type, blood leukocyte count, C-reactive protein, cerebrospinal fluid leukocyte count and culture result, number of antibiotics started during admission, and empiric antibiotic therapy. Discriminatory power of this model was excellent (area under the ROC curve 0.97). The model achieved 98.8% sensitivity (95% CI 88.0% to 99.9%) and specificity of 87.9% (84.6% to 90.8%). Positive and negative predictive values were 56.9% (50.8% to 67.9%) and 99.9% (98.6% to 99.9%), respectively. Predicted yearly infection rates concurred with observed infection rates. Conclusion: A prediction model based on multi-source data stored in a clinical data warehouse could accurately quantify rates of DRM. Automated detection using this statistical approach is feasible and could be applied to other nosocomial infections.	[van Mourik, Maaike S. M.; Troelstra, Annet; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Groenwold, Rolf H. H.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Sprenkel, Jan Willem Berkelbach] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [van Solinge, Wouter W.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Mourik, MSM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	m.s.m.vanmourik-2@umcutrecht.nl		Van Solinge, Wouter/0000-0003-2867-2581; Groenwold, Rolf/0000-0001-9238-6999; van Mourik, Maaike/0000-0003-2465-4132	Alexandre Suerman stipendium	Alexandre Suerman stipendium	MSMvM was supported by an Alexandre Suerman stipendium provided by the University Medical Centre Utrecht. The remaining authors did not receive funding for participation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini C, 2007, INFECT CONT HOSP EP, V28, P1030, DOI 10.1086/519861; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; Bolon MK, 2009, CLIN INFECT DIS, V48, P1223, DOI 10.1086/597584; Brossette SE, 2006, AM J CLIN PATHOL, V125, P34, DOI 10.1309/502AUPR8VE67MBDE; ECDC, 2008, ANN EP REP COMM DIS; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Ehrenkranz NJ, 1995, INFECT CONT HOSP EP, V16, P697; Gastmeier P, 1998, INFECT CONT HOSP EP, V19, P668; Graham PL, 2004, AM J INFECT CONTROL, V32, P232, DOI 10.1016/j.ajic.2003.07.008; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-20; Klompas M, 2009, CLIN INFECT DIS, V48, P1268, DOI 10.1086/597591; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Platt R, 2002, EMERG INFECT DIS, V8, P1433, DOI 10.3201/eid0812.020039; Pokorny L, 2006, INFECT CONT HOSP EP, V27, P500, DOI 10.1086/502685; Rubin DB, 2004, MULTIPLE IMPUTATION; Rubin Michael A, 2008, AMIA Annu Symp Proc, P631; Sands K, 1999, J INFECT DIS, V179, P434, DOI 10.1086/314586; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Sundbarg G, 1988, Br J Neurosurg, V2, P485, DOI 10.3109/02688698809029603; ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Trick WE, 2008, AM J INFECT CONTROL, V36, pS75, DOI 10.1016/j.ajic.2007.07.004; van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Woeltje KF, 2008, INFECT CONT HOSP EP, V29, P842, DOI 10.1086/590261; Wong GK, 2008, J CLIN NEUROSCI, V15, P654, DOI 10.1016/j.jocn.2007.03.011; Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572	38	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22846	10.1371/journal.pone.0022846	http://dx.doi.org/10.1371/journal.pone.0022846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829659	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511900016
J	LaBreche, HG; Meadows, SK; Nevins, JR; Chute, JP				LaBreche, Heather G.; Meadows, Sarah K.; Nevins, Joseph R.; Chute, John P.			Peripheral Blood Signatures of Lead Exposure	PLOS ONE			English	Article							LIVER-CELL PROLIFERATION; SET ENRICHMENT ANALYSIS; HUMAN BREAST-CANCER; GENE-EXPRESSION; PROTEIN; TOXICITY; PATHWAY; INHIBITION; APOPTOSIS; PROFILES	Background: Current evidence indicates that even low-level lead (Pb) exposure can have detrimental effects, especially in children. We tested the hypothesis that Pb exposure alters gene expression patterns in peripheral blood cells and that these changes reflect dose-specific alterations in the activity of particular pathways. Methodology/Principal Finding: Using Affymetrix Mouse Genome 430 2.0 arrays, we examined gene expression changes in the peripheral blood of female Balb/c mice following exposure to per os lead acetate trihydrate or plain drinking water for two weeks and after a two-week recovery period. Data sets were RMA-normalized and dose-specific signatures were generated using established methods of supervised classification and binary regression. Pathway activity was analyzed using the ScoreSignatures module from GenePattern. Conclusions/Significance: The low-level Pb signature was 93% sensitive and 100% specific in classifying samples a leave-one-out crossvalidation. The high-level Pb signature demonstrated 100% sensitivity and specificity in the leave-one-out crossvalidation. These two signatures exhibited dose-specificity in their ability to predict Pb exposure and had little overlap in terms of constituent genes. The signatures also seemed to reflect current levels of Pb exposure rather than past exposure. Finally, the two doses showed differential activation of cellular pathways. Low-level Pb exposure increased activity of the interferon-gamma pathway, whereas high-level Pb exposure increased activity of the E2F1 pathway.	[LaBreche, Heather G.; Nevins, Joseph R.; Chute, John P.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; [LaBreche, Heather G.; Nevins, Joseph R.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [LaBreche, Heather G.] Duke Univ, Program Genet & Genom, Durham, NC USA; [Meadows, Sarah K.; Chute, John P.] Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC USA; [Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	LaBreche, HG (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA.	hgl@duke.edu			NIH/NIAID, Centers for Medical Countermeasures Against Radiation [U19-A1067798]	NIH/NIAID, Centers for Medical Countermeasures Against Radiation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the authors was provided by NIH/NIAID grant U19-A1067798 from the Centers for Medical Countermeasures Against Radiation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FS, 2002, J NEUROSCI RES, V67, P174, DOI 10.1002/jnr.10091; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BELLINGER D, 1994, PEDIATR ANN, V23, P600, DOI 10.3928/0090-4481-19941101-08; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bouton CMLS, 2001, TOXICOL APPL PHARM, V176, P34, DOI 10.1006/taap.2001.9274; CHOIE DD, 1974, LAB INVEST, V30, P647; COLUMBANO A, 1990, CARCINOGENESIS, V11, P771, DOI 10.1093/carcin/11.5.771; DAMSTRA T, 1977, Environmental Health Perspectives, V19, P297, DOI 10.2307/3428488; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fischer Anna Barbara, 2001, Arhiv za Higijenu Rada i Toksikologiju, V52, P333; FU H, 1995, OCCUP ENVIRON MED, V52, P73, DOI 10.1136/oem.52.2.73; FUJIWARA Y, 1995, TOXICOLOGY, V98, P105, DOI 10.1016/0300-483X(94)02984-3; Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; HARTWIG A, 1994, ENVIRON HEALTH PERSP, V102, P45, DOI 10.2307/3431762; Heo Y, 2007, TOXICOL SCI, V96, P92, DOI 10.1093/toxsci/kfl182; Hirsch HVB, 2010, PHYSIOL BEHAV, V99, P254, DOI 10.1016/j.physbeh.2009.09.014; HITZFELD B, 1989, BIOL TRACE ELEM RES, V21, P87, DOI 10.1007/BF02917240; Hossain MA, 2000, J BIOL CHEM, V275, P27874; IARC, 1987, IARC MON EV CARC R S, V7, P1, DOI DOI 10.1002/14356007.A04; Iavicoli I, 2006, TOXICOL APPL PHARM, V210, P94, DOI 10.1016/j.taap.2005.09.016; Iavicoli I, 2002, TOXICOL LETT, V129, P143, DOI 10.1016/S0378-4274(01)00525-2; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Jayapal M, 2010, INT J BIOCHEM CELL B, V42, P230, DOI 10.1016/j.biocel.2009.10.007; Johnson FM, 1998, MUTAT RES-REV MUTAT, V410, P123, DOI 10.1016/S1383-5742(97)00032-X; Kasten-Jolly J, 2010, TOXICOL APPL PHARM, V247, P105, DOI 10.1016/j.taap.2010.06.003; LEDDACOLUMBANO GM, 1983, AM J PATHOL, V113, P315; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu JY, 1997, BIOCHEM MOL BIOL INT, V43, P355; LOCKITCH G, 1993, CLIN BIOCHEM, V26, P371, DOI 10.1016/0009-9120(93)90113-K; Loikkanen J, 2003, TOXICOL LETT, V144, P235, DOI 10.1016/S0378-4274(03)00220-0; Lu HL, 2001, J NEUROCHEM, V78, P590, DOI 10.1046/j.1471-4159.2001.00434.x; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Oberto A, 1996, J PHARMACOL EXP THER, V279, P435; Orphanides G, 2003, TOXICOL LETT, V140, P145, DOI 10.1016/S0378-4274(02)00500-3; Qian YC, 2003, NEUROCHEM RES, V28, P153, DOI 10.1023/A:1021664632393; Razani-Boroujerdi S, 1999, J PHARMACOL EXP THER, V288, P714; ROY NK, 1992, MUTAT RES, V298, P97, DOI 10.1016/0165-1218(92)90034-W; Ruden DM, 2009, NEUROTOXICOLOGY, V30, P898, DOI 10.1016/j.neuro.2009.08.011; SILBERGELD EK, 1990, ENVIRON HEALTH PERSP, V89, P49, DOI 10.2307/3430896; Steenland K, 2000, AM J IND MED, V38, P295, DOI 10.1002/1097-0274(200009)38:3<295::AID-AJIM8>3.3.CO;2-C; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; *US DEP HHS, 2007, BOOK INT MAN BLOOD L; *US DEP HHS, 2007, TOX BOOK TOX PROF LE; Waters MD, 2003, MUTAT RES-REV MUTAT, V544, P415, DOI 10.1016/j.mrrev.2003.06.014; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; 2006, IARC MONOGR EVAL CAR, V87, P1; 2003, BOOK REPORT CARCINOG	52	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23043	10.1371/journal.pone.0023043	http://dx.doi.org/10.1371/journal.pone.0023043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829687	gold, Green Submitted, Green Published			2022-12-25	WOS:000293511200032
J	Harrison, BJ; Pujol, J; Contreras-Rodriguez, O; Soriano-Mas, C; Lopez-Sola, M; Deus, J; Ortiz, H; Blanco-Hinojo, L; Alonso, P; Hernandez-Ribas, R; Cardoner, N; Menchon, JM				Harrison, Ben J.; Pujol, Jesus; Contreras-Rodriguez, Oren; Soriano-Mas, Carles; Lopez-Sola, Marina; Deus, Joan; Ortiz, Hector; Blanco-Hinojo, Laura; Alonso, Pino; Hernandez-Ribas, Rosa; Cardoner, Narcis; Menchon, Jose M.			Task-Induced Deactivation from Rest Extends beyond the Default Mode Brain Network	PLOS ONE			English	Article							WORKING-MEMORY; PAIN INTENSITY; CORTEX; PATTERNS; AMYGDALA; SPECIALIZATION; INSULA; SYSTEM; MINDS; STATE	Activity decreases, or deactivations, of midline and parietal cortical brain regions are routinely observed in human functional neuroimaging studies that compare periods of task-based cognitive performance with passive states, such as rest. It is now widely held that such task-induced deactivations index a highly organized 'default-mode network' (DMN): a large-scale brain system whose discovery has had broad implications in the study of human brain function and behavior. In this work, we show that common task-induced deactivations from rest also occur outside of the DMN as a function of increased task demand. Fifty healthy adult subjects performed two distinct functional magnetic resonance imaging tasks that were designed to reliably map deactivations from a resting baseline. As primary findings, increases in task demand consistently modulated the regional anatomy of DMN deactivation. At high levels of task demand, robust deactivation was observed in non-DMN regions, most notably, the posterior insular cortex. Deactivation of this region was directly implicated in a performance-based analysis of experienced task difficulty. Together, these findings suggest that task-induced deactivations from rest are not limited to the DMN and extend to brain regions typically associated with integrative sensory and interoceptive processes.	[Harrison, Ben J.; Pujol, Jesus; Contreras-Rodriguez, Oren; Soriano-Mas, Carles; Lopez-Sola, Marina; Deus, Joan; Ortiz, Hector; Blanco-Hinojo, Laura] Hosp del Mar, CRC Mar, Inst Alta Tecnol PRBB, Barcelona, Spain; [Harrison, Ben J.] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Harrison, Ben J.] Melbourne Hlth, Melbourne, Vic, Australia; [Soriano-Mas, Carles] Fundacio Inst Municipal Invest Med IMIM, Barcelona, Spain; [Deus, Joan] Autonomous Univ Barcelona, Dept Clin & Hlth Psychol, Barcelona, Spain; [Lopez-Sola, Marina; Alonso, Pino; Hernandez-Ribas, Rosa; Cardoner, Narcis; Menchon, Jose M.] Univ Barcelona, CIBERSAM, Bellvitge Univ Hosp ICS, Neurosci Grp IDIBELL,Dept Psychiat, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Melbourne; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Harrison, BJ (corresponding author), Hosp del Mar, CRC Mar, Inst Alta Tecnol PRBB, Barcelona, Spain.	habj@unimelb.edu.au	Cardoner, Narcis/AAD-5449-2022; Harrison, Ben J/I-2940-2014; Soriano-Mas, Carles/E-4028-2019; Cardoner, Narcis/H-8436-2015; Yela, Joan Deus/F-3652-2011; Alonso, Pino/AAI-3439-2020; Menchon, Jose/A-5242-2009	Cardoner, Narcis/0000-0001-9633-0888; Soriano-Mas, Carles/0000-0003-4574-6597; LOPEZ SOLA, MARINA/0000-0002-5517-2665; Harrison, Ben/0000-0002-2226-2074; HERNANDEZ-RIBAS, ROSA/0000-0002-0084-6976; Alonso, Pino/0000-0002-5779-9111; Menchon, Jose/0000-0002-6231-6524	Fondo de Investigacion Sanitaria (FIS) [PI050884]; Ministry of Education and Science of Spain [SAF2007-62376]; National Health and Medical Research Council of Australia (NHMRC) [628509]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Ministry of Education and Science of Spain(Spanish Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the Fondo de Investigacion Sanitaria (FIS, I.D. PI050884) and Ministry of Education and Science of Spain ( I. D. SAF2007-62376). BJH is supported by a National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Award (I.D. 628509). JD and ML-S are members of the Research Group SGR-1450 of the Agency of University and Research Funding Management of the Catalan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CARDONER N, 2011, WORLD J BIO IN PRESS; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Ebisch SJH, 2010, HUM BRAIN MAPP; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Gentili C, 2009, BRAIN RES BULL, V79, P409, DOI 10.1016/j.brainresbull.2009.02.002; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; GULDIN WO, 1984, J COMP NEUROL, V229, P393, DOI 10.1002/cne.902290309; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Harrison BJ, 2007, SCHIZOPHR RES, V91, P82, DOI 10.1016/j.schres.2006.12.027; Hutchinson M, 1999, MAGN RESON IMAGING, V17, P1427, DOI 10.1016/S0730-725X(99)00093-4; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kurth F, 2010, CEREB CORTEX, V20, P1448, DOI 10.1093/cercor/bhp208; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pujol J, 2009, PSYCHOL MED, V39, P1177, DOI 10.1017/S003329170800500X; Pujol J, 2008, HUM BRAIN MAPP, V29, P910, DOI 10.1002/hbm.20436; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Timmermann L, 2001, J NEUROPHYSIOL, V86, P1499, DOI 10.1152/jn.2001.86.3.1499; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	51	64	64	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22964	10.1371/journal.pone.0022964	http://dx.doi.org/10.1371/journal.pone.0022964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829564	Green Published, gold			2022-12-25	WOS:000293286500057
J	Yang, Z; Zhang, LL; Zhang, Y; Zhang, T; Feng, YY; Lu, XX; Lan, WX; Wang, JF; Wu, HM; Cao, CY; Wang, XN				Yang, Zhong; Zhang, Linlin; Zhang, Yan; Zhang, Ting; Feng, Yanye; Lu, Xiuxiu; Lan, Wenxian; Wang, Jufang; Wu, Houming; Cao, Chunyang; Wang, Xiaoning			Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-Denaturing and Refolding Method	PLOS ONE			English	Article							CATALYTIC DOMAIN; EXPRESSION; SOLUBILIZATION; PURIFICATION; AGGREGATION; REPRESSION; MMP-12; GENES	The production of recombinant proteins in a large scale is important for protein functional and structural studies, particularly by using Escherichia coli over-expression systems; however, approximate 70% of recombinant proteins are over-expressed as insoluble inclusion bodies. Here we presented an efficient method for generating soluble proteins from inclusion bodies by using two steps of denaturation and one step of refolding. We first demonstrated the advantages of this method over a conventional procedure with one denaturation step and one refolding step using three proteins with different folding properties. The refolded proteins were found to be active using in vitro tests and a bioassay. We then tested the general applicability of this method by analyzing 88 proteins from human and other organisms, all of which were expressed as inclusion bodies. We found that about 76% of these proteins were refolded with an average of >75% yield of soluble proteins. This "two-step-denaturing and refolding" (2DR) method is simple, highly efficient and generally applicable; it can be utilized to obtain active recombinant proteins for both basic research and industrial purposes.	[Yang, Zhong; Feng, Yanye; Wang, Xiaoning] Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhang, Linlin; Zhang, Yan; Lu, Xiuxiu; Lan, Wenxian; Wu, Houming; Cao, Chunyang] Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China; [Yang, Zhong; Zhang, Linlin; Zhang, Ting; Feng, Yanye] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Biotechnol, Shanghai 200237, Peoples R China; [Wang, Jufang; Wang, Xiaoning] S China Univ Sci & Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; East China University of Science & Technology	Yang, Z (corresponding author), Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China.	ccao@mail.sioc.ac.cn; xnwang88@gmail.com	Wang, Jufang/AAH-8068-2019; yang, zhong/E-9993-2012; Zhang, Yan/V-8007-2019	Zhang, Yan/0000-0003-2189-0244	Ministry of Science and Technology of the People's Republic of China [2009CB918600]; National Scientific Fundation Committee [20872169, 20921091]; Science and Technology Commission of Shanghai Municipality [08PJ1411700]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Scientific Fundation Committee; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the Ministry of Science and Technology of the People's Republic of China (No. 2009CB918600), the National Scientific Fundation Committee (No. 20872169 and 20921091), and the Pujiang Talents Awards from Science and Technology Commission of Shanghai Municipality (No. 08PJ1411700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabrita Lisa D, 2004, Biotechnol Annu Rev, V10, P31, DOI 10.1016/S1387-2656(04)10002-1; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; FINK LA, 1998, FOLD DES, V3, P9; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Luo W X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P578; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Mujacic M, 2004, PROTEIN EXPRESSION TECHNOLOGIES: CURRENT STATUS AND FUTURE TRENDS, P85; Nagarajan R, 2006, BIOCHEMISTRY-US, V45, P5775, DOI 10.1021/bi060133i; Park HI, 2000, J BIOL CHEM, V275, P20540, DOI 10.1074/jbc.M002349200; Parkar AA, 2000, PROTEIN EXPRES PURIF, V20, P152, DOI 10.1006/prep.2000.1280; RICHARD R, 2009, METHOD ENZYMOL, V463, P259; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; Wang QR, 2005, PROTEIN EXPRES PURIF, V39, P131, DOI 10.1016/j.pep.2004.09.017; WANG XN, 2008, Patent No. 101220079; WANG XN, 1998, Patent No. 1169998; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443; Zhang Ting, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2156; Zhang T, 2009, ACTA BIOCH BIOPH SIN, V41, P1044, DOI 10.1093/abbs/gmp098; Zheng XH, 2007, PROTEIN EXPRES PURIF, V56, P160, DOI 10.1016/j.pep.2007.05.005	30	59	75	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22981	10.1371/journal.pone.0022981	http://dx.doi.org/10.1371/journal.pone.0022981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829569	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500062
J	Wang, F; Chan, CH; Chen, K; Guan, X; Lin, HK; Tong, Q				Wang, F.; Chan, C-H; Chen, K.; Guan, X.; Lin, H-K; Tong, Q.			Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation	ONCOGENE			English	Article						sirtuin; E3 ubiquitin ligase; Forkhead transcription factor; ubiquitination; acetylation; proteasomal degradation	TRANSCRIPTION FACTOR AFX; FORKHEAD TRANSCRIPTION; OXIDATIVE-STRESS; LIFE-SPAN; PROMOTES TUMORIGENESIS; NUCLEAR TRANSLOCATION; CELL-SURVIVAL; E3 LIGASE; CANCER; PHOSPHORYLATION	Sirtuin deacetylases and FOXO (Forkhead box, class O) transcription factors have important roles in many biological pathways, including cancer development. SIRT1 and SIRT2 deacetylate FOXO factors to regulate FOXO function. Because acetylation and ubiquitination both modify the epsilon-amino group of lysine residues, we investigated whether FOXO3 deacetylation by SIRT1 or SIRT2 facilitates FOXO3 ubiquitination and subsequent proteasomal degradation. We found that SIRT1 and SIRT2 promote FOXO3 poly-ubiquitination and degradation. Proteasome-inhibitor treatment prevented sirtuin-induced FOXO3 degradation, indicating that this process is proteasome dependent. In addition, we demonstrated that E3 ubiquitin ligase subunit Skp2 binds preferentially to deacetylated FOXO3. Overexpression of Skp2 caused poly-ubiquitination of FOXO3 and degradation, whereas knockdown of Skp2 increased the amount of FOXO3 protein. We also present evidence that SCF-Skp2 ubiquitinates FOXO3 directly in vitro. Furthermore, mutating four known acetylated lysine residues (K242, K259, K290 and K569) of FOXO3 into arginines to mimic deacetylated FOXO3 resulted in enhanced Skp2 binding but with inhibition of FOXO3 ubiquitination; this suggests that some or all of these four lysine residues are likely the sites for ubiquitination. In the livers of mice deficient in SIRT1, we detected increased expression of FOXO3, indicating SIRT1 regulates FOXO3 protein levels in vivo. Furthermore, we found that the elevation of SIRT1 and Skp2 expression in malignant PC3 and DU145 prostate cells is responsible for the downregulation of FOXO3 protein levels in these cells. Taken together, our data support the notion that deacetylation of FOXO3 by SIRT1 or SIRT2 facilitates Skp2-mediated FOXO3 poly-ubiquitination and proteasomal degradation. Oncogene (2012) 31, 1546-1557; doi:10.1038/onc.2011.347; published online 15 August 2011	[Wang, F.; Chen, K.; Guan, X.; Tong, Q.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Chan, C-H; Lin, H-K] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Tong, Q (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA.	qtong@bcm.tmc.edu	高, 雨莉/HGU-8187-2022		Ellison Medical Foundation/American Federation for Aging Research; US Department of Agriculture [6250-51000-055]; NIH [DK075978]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075978] Funding Source: NIH RePORTER	Ellison Medical Foundation/American Federation for Aging Research(Lawrence Ellison Foundation); US Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Xinhua Feng for providing HA-ubiquitin expression plasmid and Dr Jianping Jin for providing HeLa cells stably transfected with His-Biotin-Ubiquitin. We thank Dr Steven I Reed for providing pcDNA-hSkp1, pcDNA-Cul1, pcDNA-Roc1 constructs, and Dr Anne Brunet for providing pECE-FOXO3-M2 wild-type and K242R, K259R, K290R, K569R individual mutants and 4KR mutants, Dr Tony Kouzarides for providing pcDNA-SIRT1, Dr Junjie Chen for providing pcDNA-SIRT1-H363Y plasmid and Dr Boudewijn MT Burgering for providing 6X DBE-Luc construct. We thank Dr Frederic Alt for providing SIRT1 knockout mice. FW was supported by the Ellison Medical Foundation/American Federation for Aging Research senior postdoctoral fellowship. This work was also supported by the US Department of Agriculture grant (6250-51000-055) and NIH (DK075978) to QT.	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fukuoka M, 2003, INT J MOL MED, V12, P503; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Sung JY, 2010, CANCER SCI, V101, P1738, DOI 10.1111/j.1349-7006.2010.01573.x; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Verdin E, 2007, MOL CELL, V28, P354, DOI 10.1016/j.molcel.2007.10.013; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	66	141	146	0	35	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1546	1557		10.1038/onc.2011.347	http://dx.doi.org/10.1038/onc.2011.347			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21841822				2022-12-25	WOS:000302132000007
J	Ge, X; Chen, C; Hui, XY; Wang, Y; Lam, KSL; Xu, AM				Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Wang, Yu; Lam, Karen S. L.; Xu, Aimin			Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; BETA-KLOTHO; INSULIN SENSITIVITY; METABOLIC-ACTIVITY; GENE-EXPRESSION; PPAR-ALPHA; KINASE; OBESITY; FGF-21; PHOSPHORYLATION	Fibroblast growth factor 21 (FGF21) is a liver-secreted endocrine factor with multiple beneficial effects on obesity-related disorders. It enhances glucose uptake by inducing the expression of glucose transporter-1 (GLUT1) in adipocytes. Here we investigated the signaling pathways that mediate FGF21-induced GLUT1 expression and glucose uptake in vitro and in animals. Quantitative real-time PCR and a luciferase reporter assay showed that FGF21 induced GLUT1 expression through transcriptional activation. The truncation of the GLUT1 promoter from -3145 to -3105 bp, which contains two highly conserved serum response element (SRE) and E-Twenty Six (ETS) binding motif, dramatically decreased FGF21-induced promoter activity of the GLUT1 gene. A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1) were recruited to the GLUT1 promoter upon FGF21 stimulation. The siRNA-mediated knockdown of either SRF or Elk-1 resulted in a marked attenuation in FGF21-induced GLUT1 expression and glucose uptake in adipocytes. In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of Elk-1 at Ser(383) and SRF at Ser(103) and also led to the recruitment of Elk-1 and SRF to the GLUT1 promoter in epididymal fats. By contrast, such effects of in vivo FGF21 administration were blunted in high fat diet-induced obese mice. In conclusion, FGF21 induces GLUT1 expression and glucose uptake through sequential activation of ERK1/2 and SRF/Elk-1, which in turn triggers the transcriptional activation of GLUT1 in adipocytes. The impairment in this signaling pathway may contribute to FGF21 resistance in obese mice.	[Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Wang, Yu; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013; HUI, Xiaoyan Hannah/M-5175-2019	Xu, Aimin/0000-0002-0668-033X; HUI, Xiaoyan Hannah/0000-0002-7525-5812; wang, yu/0000-0001-8697-2940	Research Grant Council of Hong Kong [HKU3/09C]; University of Hong Kong	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by Collaborative Research Fund (HKU3/09C) from the Research Grant Council of Hong Kong, Seeding fund for basic research, and matching funding for national 973 projects from the University of Hong Kong (to A. X.).	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Latinkic BV, 1996, NUCLEIC ACIDS RES, V24, P1345, DOI 10.1093/nar/24.7.1345; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olefsky JM, 1999, J BIOL CHEM, V274, P1863, DOI 10.1074/jbc.274.4.1863; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; TODAKA M, 1994, J BIOL CHEM, V269, P29265; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Xu AM, 2004, FEBS LETT, V572, P129, DOI 10.1016/j.febslet.2004.07.020; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	45	111	122	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34533	34541		10.1074/jbc.M111.248591	http://dx.doi.org/10.1074/jbc.M111.248591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846717	Green Published, hybrid			2022-12-25	WOS:000295406300007
J	Dennis, AT; Nassal, D; Deschenes, I; Thomas, D; Ficker, E				Dennis, Adrienne T.; Nassal, Drew; Deschenes, Isabelle; Thomas, Dierk; Ficker, Eckhard			Antidepressant-induced Ubiquitination and Degradation of the Cardiac Potassium Channel hERG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; K+ CHANNEL; PROTEIN TRAFFICKING; I-KR; DESIPRAMINE; MECHANISMS; INHIBITION; KV1.5; BLOCK; DISRUPTION	The most common cause for adverse cardiac events by antidepressants is acquired long QT syndrome (acLQTS), which produces electrocardiographic abnormalities that have been associated with syncope, torsade de pointes arrhythmias, and sudden cardiac death. acLQTS is often caused by direct block of the cardiac potassium current IKr/hERG, which is crucial for terminal repolarization in human heart. Importantly, desipramine belongs to a group of tricyclic antidepressant compounds that can simultaneously block hERG and inhibit its surface expression. Although up to 40% of all hERG blockers exert combined hERG block and trafficking inhibition, few of these compounds have been fully characterized at the cellular level. Here, we have studied in detail how desipramine inhibits hERG surface expression. We find a previously unrecognized combination of two entirely different mechanisms; desipramine increases hERG endocytosis and degradation as a consequence of drug-induced channel ubiquitination and simultaneously inhibits hERG forward trafficking from the endoplasmic reticulum. This unique combination of cellular effects in conjunction with acute channel block may explain why tricyclic antidepressants as a compound class are notorious for their association with arrhythmias and sudden cardiac death. Taken together, we describe the first example of drug-induced channel ubiquitination and degradation. Our data are directly relevant to the cardiac safety of not only tricyclic antidepressants but also other therapeutic compounds that exert multiple effects on hERG, as hERG trafficking and degradation phenotypes may go undetected in most preclinical safety assays designed to screen for acLQTS.	[Dennis, Adrienne T.; Nassal, Drew; Deschenes, Isabelle; Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Nassal, Drew; Deschenes, Isabelle] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Thomas, Dierk] Med Univ Hosp Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Ruprecht Karls University Heidelberg	Ficker, E (corresponding author), MetroHlth Med Ctr, Rammelkamp Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	eficker@metrohealth.org	Thomas, Dierk/V-3940-2017; Thomas, Dierk/ABA-4706-2021	Thomas, Dierk/0000-0002-5687-7843	National Institutes of Health [T32HL105338, 1R01HL096962]; Deutsche Forschungsgemeinschaft; ADUMED foundation; German Heart Foundation/German Foundation of Heart Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096962, T32HL105338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ADUMED foundation; German Heart Foundation/German Foundation of Heart Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32HL105338 (to D. N.) and 1R01HL096962 (to I. D.). This work was also supported in part by research grants from the Deutsche Forschungsgemeinschaft (FRONTIERS program, the ADUMED foundation, and the German Heart Foundation/German Foundation of Heart Research (all to D. T.).	ALDERTON HR, 1995, CAN J PSYCHIAT, V40, P325; APODACA G, 1994, J BIOL CHEM, V269, P19005; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Carter WP, 2003, INT J EAT DISORDER, V34, pS74, DOI 10.1002/eat.10207; CASAZZA F, 1986, Giornale Italiano di Cardiologia, V16, P1058; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Christian AE, 1997, J LIPID RES, V38, P2264; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cordes JS, 2005, BRIT J PHARMACOL, V145, P15, DOI 10.1038/sj.bjp.0706140; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; HONEGGER UE, 1983, J PHARMACOL EXP THER, V225, P436; Hong HK, 2010, BIOCHEM BIOPH RES CO, V394, P536, DOI 10.1016/j.bbrc.2010.03.010; HURSTING MJ, 1992, CLIN CHEM, V38, P2468; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kiesecker C, 2006, N-S ARCH PHARMACOL, V373, P212, DOI 10.1007/s00210-006-0068-z; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; LEONARD HL, 1995, J AM ACAD CHILD PSY, V34, P1460, DOI 10.1097/00004583-199511000-00012; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Obers S, 2010, N-S ARCH PHARMACOL, V381, P385, DOI 10.1007/s00210-010-0496-7; Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; PROZIALECK WC, 1982, J PHARMACOL EXP THER, V222, P509; Pull Charles B, 2008, Neuropsychiatr Dis Treat, V4, P779; Rajamani S, 2006, BRIT J PHARMACOL, V149, P481, DOI 10.1038/sj.bjp.0706892; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shenoy SK, 2011, CURR TOP MEMBR, V67, P51, DOI 10.1016/B978-0-12-384921-2.00003-3; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Staudacher I, 2011, N-S ARCH PHARMACOL, V383, P119, DOI 10.1007/s00210-010-0583-9; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Swanson JR, 1997, J FORENSIC SCI, V42, P335; Takemasa H, 2008, BRIT J PHARMACOL, V153, P439, DOI 10.1038/sj.bjp.0707537; Teschemacher AG, 1999, BRIT J PHARMACOL, V128, P479, DOI 10.1038/sj.bjp.0702800; Varley C K, 2001, Paediatr Drugs, V3, P613, DOI 10.2165/00128072-200103080-00006; Waslick BD, 1999, J AM ACAD CHILD PSY, V38, P179, DOI 10.1097/00004583-199902000-00017; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Witchel HJ, 2003, J CLIN PSYCHOPHARM, V23, P58, DOI 10.1097/00004714-200302000-00010; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005	54	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34413	34425		10.1074/jbc.M111.254367	http://dx.doi.org/10.1074/jbc.M111.254367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832094	Green Published, hybrid			2022-12-25	WOS:000295159200069
J	Chen, Z; Chen, X; Luo, YC				Chen, Zhi; Chen, Xiang; Luo, Yan-Cheng			Technical Modifications of Double-J Stenting for Retroperitoneal Laparoscopic Dismembered Pyeloplasty in Children under 5 Years Old	PLOS ONE			English	Article							ANTEGRADE; EXPERIENCE	Both antegrade stenting and retrograde stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children have many disadvantages. In this work, we tried using an alternative technique of modified antegrade (MAG) double-J stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children under 5 years old, analyzed our results using the conventional antegrade (CAG) and the MAG techniques of stent insertion for this procedure, and reported our experience with these techniques. Between December 2002 and July 2010, 77 children under 5 years old with ureteropelvic junction obstruction underwent retroperitoneal laparoscopic dismembered pyeloplasty. CAG and MAG double-J stenting were attempted, in the first 36 cases (mean age 27.1 months) and the following 41 cases (mean age 25.4 months), respectively. The stents were removed 4-6 weeks later via cystoscopy. Follow-up studies were performed with ultrasonography and intravenous urography at 3 and 12 months postoperatively. The results showed that successful stent placement without malpositioning was achieved in 31 of 36 (86%) and all 41 (100%) cases, in the CAG and MAG groups, respectively. The common factor of unsuccessful stent was the inability to across the ureterovesical junction. The mean stent insertion time was 10 min 54 s and 12 min 46 s in the CAG and MAG groups, respectively. The mean operating time was 176 min and 185 min in the CAG and MAG groups, respectively. No stent malpositioning occurred in the MAG group; in the CAG group, two children had a malpositioned stent in the distal ureter and one child presented with a severe hematuria. Twelve months follow-up showed no new onset of hydroureteronephrosis and hydronephrosis. Thus we concluded that the MAG double-J stenting seems more reliable than CAG stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children under 5 years old, with greater success and lower complication rates.	[Chen, Zhi; Chen, Xiang; Luo, Yan-Cheng] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University	Chen, X (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	cxiang1007@126.com						Andreoni C, 2005, BJU INT, V96, P1139, DOI 10.1111/j.1464-410X.2005.05813.x; Arumainayagam N, 2008, J ENDOUROL, V22, P671, DOI 10.1089/end.2007.0210; Bauer JJ, 1999, J UROLOGY, V162, P692, DOI 10.1097/00005392-199909010-00016; Calvert RC, 2008, SURG ENDOSC, V22, P411, DOI 10.1007/s00464-007-9436-0; Chandrasekharam VVSS, 2005, UROLOGY, V66, P1301, DOI 10.1016/j.urology.2005.06.132; Davenport K, 2005, EUR UROL, V48, P973, DOI 10.1016/j.eururo.2005.08.004; Egan S C, 2001, Tech Urol, V7, P276; El-Shazly MA, 2007, J ENDOUROL, V21, P673, DOI 10.1089/end.2007.9952; Gaitonde K, 2008, J ENDOUROL, V22, P1199, DOI 10.1089/end.2008.0078; Inagaki T, 2005, BJU INT, V95, P102, DOI 10.1111/j.1464-410X.2005.05208.x; Jarrett TW, 2002, J UROLOGY, V167, P1253, DOI 10.1016/S0022-5347(05)65276-7; KAVOUSSI LR, 1993, J UROLOGY, V150, P1891, DOI 10.1016/S0022-5347(17)35926-8; Klingler HC, 2003, EUR UROL, V44, P340, DOI 10.1016/S0302-2838(03)00297-5; Lopez-Pujals A, 2004, J ENDOUROL, V18, P756, DOI 10.1089/end.2004.18.756; Mandhani A, 2004, J UROLOGY, V171, P1440, DOI 10.1097/01.ju.0000116546.06765.d1; Minervini A, 2009, SURG ENDOSC, V23, P1831, DOI 10.1007/s00464-008-0272-7; Moon DA, 2006, UROLOGY, V67, P932, DOI 10.1016/j.urology.2005.11.024; Notley R G, 1973, Br J Urol, V45, P464, DOI 10.1111/j.1464-410X.1973.tb06804.x; O'Reilly PH, 2001, BJU INT, V87, P287, DOI 10.1046/j.1464-410x.2001.00108.x; Rodrigues H, 2002, INT BRAZ J UROL, V28; Rodrigues Henrique, 2002, Int Braz J Urol, V28, P439; Siqueira TM, 2002, UROLOGY, V60, P973, DOI 10.1016/S0090-4295(02)02072-1; Wu ZH, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.03.067; Yurkanin JP, 2004, J ENDOUROL, V18, P765, DOI 10.1089/0892779042360616; Zhang X, 2005, UROLOGY, V66, P514, DOI 10.1016/j.urology.2005.04.007	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23073	10.1371/journal.pone.0023073	http://dx.doi.org/10.1371/journal.pone.0023073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853069	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400023
J	Bartosova, J; Komarkova, M; Dubcova, J; Bartos, L; Pluhacek, J				Bartosova, Jitka; Komarkova, Martina; Dubcova, Jana; Bartos, Ludek; Pluhacek, Jan			Concurrent Lactation and Pregnancy: Pregnant Domestic Horse Mares Do Not Increase Mother-Offspring Conflict during Intensive Lactation	PLOS ONE			English	Article							ZEBRA EQUUS-BURCHELLI; REPRODUCTIVE SUCCESS; SOCIAL-ORGANIZATION; SUCKLING BEHAVIOR; MILK INTAKE; CABALLUS; AGGRESSION; RABBITS; HERD	Lactation is the most energy demanding part of parental care in mammals, so parent-offspring conflict arises over milk provided by the mother. In some species females commonly become pregnant shortly after parturition of previous young. This further intensifies mother-offspring conflict due to concurrent pregnancy and lactation. In equids it has been well established that pregnant females wean their foals earlier than non-pregnant ones. Intensified mother-offspring conflict was presumed to associate with pregnancy also during the period of intensive lactation, i.e., before the weaning process starts. We investigated the effect of pregnancy on suckling behaviour characteristics as indicators of mother-offspring conflict in domestic horses. Contrary to expectation, here we provide evidence of a decreased mother-offspring conflict related to pregnancy in lactating females during first two trimesters of pregnancy. Pregnant mares provided longer suckling bouts and did not reject or terminate suckling of their foals more often than non-pregnant mares. Our results suggest that pregnant mares cope with parallel investment into a nursed foal and a foetus through enhancing nursing behaviour in early stages of pregnancy before the initially low requirements of the foetus increase. They compensate their suckling foal with the perspective of its early weaning due to ongoing pregnancy.	[Bartosova, Jitka; Komarkova, Martina; Dubcova, Jana; Bartos, Ludek; Pluhacek, Jan] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Komarkova, Martina] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Czech Research Institute of Animal Science; Charles University Prague	Bartosova, J (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	bartosova.jitka@vuzv.cz	Bartosova, Jitka/A-4908-2019; Pluhacek, Jan/F-1151-2019; Bartosova, Jitka/U-7255-2019	Bartosova, Jitka/0000-0002-4675-3310; , Jan/0000-0002-0864-4332; Komarkova, Martina/0000-0003-4645-3083	Ministry of Agriculture of the Czech Republic [MZe0002701404, QH92265]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The project was supported by the Ministry of Agriculture of the Czech Republic (Project Nos. MZe0002701404 and QH92265, http://eagri.cz/public/web/en/mze/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2001, REPRODUCTION, V121, P513, DOI 10.1530/rep.0.1210513; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BARBER JA, 1994, APPL ANIM BEHAV SCI, V41, P161, DOI 10.1016/0168-1591(94)90021-3; BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; BECKER CD, 1990, ANIM BEHAV, V40, P1111, DOI 10.1016/S0003-3472(05)80177-0; Berger J., 1986, WILD HORSES GREAT BA; Cameron EZ, 1998, ANIM BEHAV, V56, P521, DOI 10.1006/anbe.1998.0793; Cameron EZ, 1999, ANIM BEHAV, V57, P673, DOI 10.1006/anbe.1998.0997; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Crowell-Davis SL, 2007, HORM BEHAV, V52, P12, DOI 10.1016/j.yhbeh.2007.03.020; Crowell-Davis SL, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P126; CROWELLDAVIS SL, 1985, APPL ANIM BEHAV SCI, V14, P11, DOI 10.1016/0168-1591(85)90034-6; Davies Morel MCG, 2008, EQUINE REPROD PHYSL, V3rd; DUNCAN P, 1984, ANIM BEHAV, V32, P255, DOI 10.1016/S0003-3472(84)80345-0; Gonzalez-Mariscal G, 2009, WORLD RABBIT SCI, V17, P145; Heitor F, 2008, APPL ANIM BEHAV SCI, V113, P189, DOI 10.1016/j.applanim.2007.11.005; KLINGEL H, 1975, J REPROD FERTIL, P7; National Research Council Comittee on Nutrient Requirements of Horses, 2007, NUTR REQ HORS; PARTRIDGE GG, 1986, BRIT J NUTR, V56, P199, DOI 10.1079/BJN19860100; PENZHORN BL, 1984, Z TIERPSYCHOL, V64, P97; Pluhacek J, 2010, J ANIM SCI, V88, P131, DOI 10.2527/jas.2009-1982; Pluhacek J, 2007, APPL ANIM BEHAV SCI, V105, P192, DOI 10.1016/j.applanim.2006.05.019; Pluhacek J, 2006, APPL ANIM BEHAV SCI, V99, P315, DOI 10.1016/j.applanim.2005.11.003; Pluhacek J, 2010, APPL ANIM BEHAV SCI, V122, P127, DOI 10.1016/j.applanim.2009.11.009; Rehling A, 2008, ETHOLOGY, V114, P318, DOI 10.1111/j.1439-0310.2007.01465.x; RUTBERG AT, 1990, ANIM BEHAV, V40, P322, DOI 10.1016/S0003-3472(05)80927-3; TRIVERS RL, 1974, AM ZOOL, V14, P249; Tyler S.J., 1972, Animal Behav Monogr, V5, P85	29	10	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22068	10.1371/journal.pone.0022068	http://dx.doi.org/10.1371/journal.pone.0022068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853024	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200005
J	Hu, JM; Liu, XL; Hughes, D; Esteva, FJ; Liu, BL; Chandra, J; Li, SL				Hu, Jiemiao; Liu, Xinli; Hughes, Dennis; Esteva, Francisco J.; Liu, Bolin; Chandra, Joya; Li, Shulin			Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; ACUTE MYELOID-LEUKEMIA; TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODIES; GENE AMPLIFICATION; APOPTOSIS; EXPRESSION; MECHANISMS; LYMPHOMA	Tumor-targeted antibody therapy is one of the safest biological therapeutics for cancer patients, but it is often ineffective at inducing direct tumor cell death and is ineffective against resistant tumor cells. Currently, the antitumor efficacy of antibody therapy is primarily achieved by inducing indirect tumor cell death, such as antibody-dependent cell cytotoxicity. Our study reveals that Herceptin conjugates, if generated via the crosslinker EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride), are capable of engendering human epidermal growth factor receptor 2 (Her2) positive tumor cells death. Using a high-performance liquid chromatography (HPLC) system, three peaks with estimated molecular weights of antibody monomer, dimer, and trimer were isolated. Both Herceptin trimer and dimer separated by HPLC induced significant levels of necrotic tumor cell death, although the trimer was more effective than the dimer. Notably, the Herceptin trimer also induced Herceptin-resistant tumor cell death. Surprisingly different from the known cell death mechanism that often results from antibody treatment, the Herceptin trimer elicited effective and direct tumor cell death via a novel mechanism: programmed cell necrosis. In Her2-positive cells, inhibition of necrosis pathways significantly reversed Herceptin trimer-induced cell death. In summary, the Herceptin trimer reported herein harbors great potential for overcoming tumor cell resistance to Herceptin treatment.	[Hu, Jiemiao; Hughes, Dennis; Chandra, Joya; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Liu, Bolin] Univ Colorado Denver Sch Med, Dept Pathol, Aurora, CO USA	University of Texas System; UTMD Anderson Cancer Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA.	sli4@mdanderson.org	Li, Shulin/D-6478-2011; Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715; Esteva, Francisco J./0000-0003-2437-3920; Liu, Bolin/0000-0003-0150-8650	National Institutes of Health [R01CA120895-3S]; NATIONAL CANCER INSTITUTE [R01CA120895, P30CA016672, R01CA149501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (grant R01CA120895-3S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadori S, 2005, LEUKEMIA, V19, P1768, DOI 10.1038/sj.leu.2403901; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein Stephanie, 2002, Hum Antibodies, V11, P107; FENDLY BM, 1990, J BIOL RESP MODIF, V9, P449; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Ghetie MA, 1997, P NATL ACAD SCI USA, V94, P7509, DOI 10.1073/pnas.94.14.7509; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Hughes DPM, 2004, CANCER RES, V64, P2047, DOI 10.1158/0008-5472.CAN-03-3096; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; ISHIGAMI T, 1992, J IMMUNOL, V148, P360; Kumar R, 2007, CLIN CANCER RES, V13, P4657, DOI 10.1158/1078-0432.CCR-07-1401; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Lee S, 2002, CANCER RES, V62, P5703; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Okada N, 2005, MICROBIOL IMMUNOL, V49, P447, DOI 10.1111/j.1348-0421.2005.tb03749.x; Pandolfi PP, 2004, NEW ENGL J MED, V351, P2337, DOI 10.1056/NEJMcibr043143; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Press MF, 2008, CLIN CANCER RES, V14, P7861, DOI 10.1158/1078-0432.CCR-08-1056; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; WOLFF EA, 1993, CANCER RES, V53, P2560	38	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23270	10.1371/journal.pone.0023270	http://dx.doi.org/10.1371/journal.pone.0023270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853100	Green Submitted, gold, Green Published			2022-12-25	WOS:000295454200060
J	Januchowski-Hartley, FA; Graham, NAJ; Feary, DA; Morove, T; Cinner, JE				Januchowski-Hartley, Fraser A.; Graham, Nicholas A. J.; Feary, David A.; Morove, Tau; Cinner, Joshua E.			Fear of Fishers: Human Predation Explains Behavioral Changes in Coral Reef Fishes	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; KILLIFISH FUNDULUS-DIAPHANUS; TAKE MARINE RESERVES; PAPUA-NEW-GUINEA; ANTIPREDATOR BEHAVIOR; POECILIA-RETICULATA; ESCAPE RESPONSE; FORAGING BEHAVIOR; PREY CHOICE; RISK	Prey flight decisions in response to predation risk are increasingly being considered in conservation and management decisions in the terrestrial realm, but are rarely considered in marine systems. This field-based study investigated how the behavioral response of coral reef fish families varied along a gradient of subsistence fishing pressure in Papua New Guinea. Specifically, we examined how fishing pressure was related to pre-flight behavior and flight initiation distance (FID), and whether FID was influenced by body size (centimeters total length), group size (including both con-and hetero-specific individuals), or life-history phase. Fishing pressure was positively associated with higher FID, but only in families that were primarily targeted by spear guns. Among these families, there were variable responses in FID; some families showed increased FID monotonically with fishing pressure, while others showed increased FID only at the highest levels of fishing pressure. Body size was more significant in varying FID at higher levels of fishing pressure. Although family-level differences in pre-flight behavior were reported, such behavior showed low concordance with fishing pressure. FID shows promise as a tool by which compliance and effectiveness of management of reef fisheries can be assessed.	[Januchowski-Hartley, Fraser A.; Graham, Nicholas A. J.; Cinner, Joshua E.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Feary, David A.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Morove, Tau] Papua New Guinea Marine Program, Wildlife Conservat Soc, Kavieng, New Ireland Pro, Guinea	James Cook University; University of Technology Sydney	Januchowski-Hartley, FA (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	f.a.hartley@gmail.com	Cinner, Joshua e/E-8966-2011; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua/AAA-6823-2021; Januchowski-Hartley, Fraser A./H-8904-2019	Cinner, Joshua e/0000-0003-2675-9317; Graham, Nicholas AJ/0000-0002-0304-7467; Januchowski-Hartley, Fraser A./0000-0003-2468-8199	Australian Research Council; National Geographic grant [8506-382 08]; James Cook University; David and Lucille Packard Foundation [2009-33893]	Australian Research Council(Australian Research Council); National Geographic grant(National Geographic Society); James Cook University; David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This study was funded by the Australian Research Council and a National Geographic grant (#8506-382 08). Fraser Januchowski-Hartley is supported by a James Cook University International Postgraduate Studentship and Tau Morove by the David and Lucille Packard Foundation (Grant # 2009-33893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; BELLMAN KL, 1983, SCIENCE, V221, P779, DOI 10.1126/science.221.4612.779; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; Botham MS, 2008, ECOLOGY, V89, P3174, DOI 10.1890/07-0490.1; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; CARRIER G, 1981, J SOC OCEANISTES, V37, P205; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Choat JH, 1996, MAR ECOL PROG SER, V145, P33, DOI 10.3354/meps145033; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Connell SD, 1998, AUST J ECOL, V23, P579, DOI 10.1111/j.1442-9993.1998.tb00768.x; Cooper WE, 1999, CAN J ZOOL, V77, P671; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2009, AMPHIBIA-REPTILIA, V30, P99, DOI 10.1163/156853809787392720; de Boer HY, 2004, WILDLIFE BIOL, V10, P35, DOI 10.2981/wlb.2004.007; Domenici P, 2002, MAR FRESHW BEHAV PHY, V35, P87, DOI 10.1080/10236240290025635; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; ELGAR MA, 1981, ANIM BEHAV, V29, P868, DOI 10.1016/S0003-3472(81)80022-X; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; GILES N, 1984, ANIM BEHAV, V32, P264, DOI 10.1016/S0003-3472(84)80346-2; Gill AB, 2003, J FISH BIOL, V63, P105, DOI 10.1111/j.1095-8649.2003.00214.x; GILL AB, 1994, ANIM BEHAV, V47, P921, DOI 10.1006/anbe.1994.1124; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; GODIN JGJ, 1986, CAN J ZOOL, V64, P1675, DOI 10.1139/z86-251; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Higgins RM, 2008, J NAT CONSERV, V16, P222, DOI 10.1016/j.jnc.2008.09.001; HUGHES RN, 1999, 6 DIET SELECTION BEH; HUNTINGFORD FA, 1989, BEHAV PROCESS, V19, P181, DOI 10.1016/0376-6357(89)90040-5; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Kaly U., 2005, SMALL SCALE FISHERIE; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; KRAUSE J, 1994, ETHOLOGY, V98, P128; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LICHT T, 1989, ETHOLOGY, V82, P238; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; MAGURRAN AE, 1990, ANIM BEHAV, V39, P834, DOI 10.1016/S0003-3472(05)80947-9; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McGill BJ, 2006, EVOL ECOL RES, V8, P691; NFA, 2007, REV FISH MAR RES NEW; PARRISH JD, 1987, TROPICAL SNAPPERS GR, P405; PITCHER TJ, 1986, J FISH BIOL, V28, P439, DOI 10.1111/j.1095-8649.1986.tb05181.x; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; SHPIGEL M, 1991, J FISH BIOL, V38, P887, DOI 10.1111/j.1095-8649.1991.tb03628.x; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Thiel D, 2007, J WILDLIFE MANAGE, V71, P1784, DOI 10.2193/2006-268; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Warner RR, 1998, J FISH BIOL, V53, P82, DOI 10.1111/j.1095-8649.1998.tb01019.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	64	89	91	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22761	10.1371/journal.pone.0022761	http://dx.doi.org/10.1371/journal.pone.0022761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853046	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000295454200019
J	Chen, M; Forrester, JV; Xu, HP				Chen, Mei; Forrester, John V.; Xu, Heping			Dysregulation in Retinal Para-Inflammation and Age-Related Retinal Degeneration in CCL2 or CCR2 Deficient Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; FACTOR-H POLYMORPHISM; COMPLEMENT FACTOR-B; MACULAR DEGENERATION; SUBRETINAL MICROGLIA; ACCUMULATION; MIGRATION; CELLS; MODEL; MAINTENANCE	We have shown previously that a para-inflammatory response exists at the retinal/choroidal interface in the aging eye; and this response plays an important role in maintaining retinal homeostasis under chronic stress conditions. We hypothesized that dysregulation of the para-inflammatory response may result in an overt pro-inflammatory response inducing retinal degeneration. In this study, we examined this hypothesis in mice deficient in chemokine CCL2 or its cognate receptor CCR2. CCL2- or CCR2-deficient mice developed retinal degenerative changes with age, characterized as retinal pigment epithelial (RPE) cell and photoreceptor cell death. Retinal cell death was associated with significantly more subretinal microglial accumulation and increased complement activation. In addition, monocytes from CCL2- or CCR2-deficient mice had reduced capacity for phagocytosis and chemotaxis, expressed less IL-10 but more iNOS, IL-12 and TNF-alpha when compared to monocytes from WT mice. Complement activation at the site of RPE cell death resulted in C3b/C3d but not C5b-9 deposition, indicating only partial activation of the complement pathway. Our results suggest that altered monocyte functions may convert the protective para-inflammatory response into an overtly harmful inflammation at the retina/choroidal interface in CCL2- or CCR2-deficient mice, leading to RPE and photoreceptor degeneration. These data support a concept whereby a protective para-inflammatory response relies upon a normally functioning innate immune system. If the innate immune system is deficient chronic stress may tip the balance towards an overt inflammatory response causing cell/tissue damage.	[Chen, Mei; Xu, Heping] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Forrester, John V.] Univ Aberdeen, Aberdeen, Scotland	Queens University Belfast; University of Aberdeen	Chen, M (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	heping.xu@qub.ac.uk	Xu, Heping/A-4430-2008	Xu, Heping/0000-0003-4000-931X	Tait family; RS McDonald Trust; NHS Endowment [09/31]; University of Aberdeen Development	Tait family; RS McDonald Trust; NHS Endowment; University of Aberdeen Development	This project was supported by the University of Aberdeen Development, through funds received from the Tait family, the RS McDonald Trust, and NHS Endowment (09/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; Chan-Ling T, 2007, MICROCIRCULATION, V14, P63, DOI 10.1080/10739680601073451; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2010, EUR J IMMUNOL, V40, P2870, DOI 10.1002/eji.201040323; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; Despriet DDG, 2008, INVEST OPHTH VIS SCI, V49, P364, DOI 10.1167/iovs.07-0656; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hughes MS, 2006, OPHTHAL SURG LAS IM, V37, P446, DOI 10.3928/15428877-20061101-01; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Kaushik S, 2008, AM J CLIN NUTR, V88, P1104, DOI 10.1093/ajcn/88.4.1104; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; LUTZ MB, 1999, J IMMUNOL METHODS, P22377; Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Read RW, 2006, EXP EYE RES, V82, P389, DOI 10.1016/j.exer.2005.07.011; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; XU H, 2002, EXP EYE RES, P74403; XU H, 2004, J LEUKOCYTE BIOL, P75224; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	45	79	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22818	10.1371/journal.pone.0022818	http://dx.doi.org/10.1371/journal.pone.0022818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850237	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300022
J	Kim, KH; Kim, EY; Kim, Y; Kim, E; Lee, HS; Yoon, SY; Lee, KA				Kim, Kyeoung-Hwa; Kim, Eun-Young; Kim, Yuna; Kim, Eunju; Lee, Hyun-Seo; Yoon, Sook-Young; Lee, Kyung-Ah			Gas6 Downregulation Impaired Cytoplasmic Maturation and Pronuclear Formation Independent to the MPF Activity	PLOS ONE			English	Article							PROMOTING FACTOR MPF; IN-VITRO MATURATION; MEIOTIC MATURATION; MOUSE OOCYTES; CELL-CYCLE; CA2+ OSCILLATIONS; BOVINE OOCYTES; SELECTIVE DEGRADATION; CYTOSTATIC FACTOR; GERMINAL VESICLE	Previously, we found that the growth arrest-specific gene 6 (Gas6) is more highly expressed in germinal vesicle (GV) oocytes than in metaphase II (MII) oocytes using annealing control primer (ACP)-PCR technology. The current study was undertaken to investigate the role of Gas6 in oocyte maturation and fertilization using RNA interference (RNAi). Interestingly, despite the specific and marked decrease in Gas6 mRNA and protein expression in GVs after Gas6 RNAi, nuclear maturation including spindle structures and chromosome segregation was not affected. The only discernible effect induced by Gas6 RNAi was a change in maturation promoting factor (MPF) activity. After parthenogenetic activation, Gas6 RNAi-treated oocytes at the MII stage had not developed further and arrested at MII (90.0%). After stimulation with Sr2+, Gas6-silenced MII oocytes had markedly reduced Ca2+ oscillation and exhibited no exocytosis of cortical granules. In these oocytes, sperm penetration occurred during fertilization but not pronucleus (PN) formation. By roscovitine and colcemid treatment, we found that the Gas6 knockdown affected cytoplasmic maturation directly, independent to the changed MPF activity. These results strongly suggest that 1) the Gas6 signaling itself is important to the cytoplasmic maturation, but not nuclear maturation, and 2) the decreased Gas6 expression and decreased MPF activity separately or mutually influence sperm head decondensation and PN formation.	[Kim, Kyeoung-Hwa; Kim, Eun-Young; Kim, Yuna; Kim, Eunju; Lee, Hyun-Seo; Yoon, Sook-Young; Lee, Kyung-Ah] CHA Univ, CHA Gen Hosp, CHA Res Inst, Dept Biomed Sci,Coll Life Sci,Fertil Ctr, Seoul, South Korea	Pochon Cha University	Kim, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Res Inst, Dept Biomed Sci,Coll Life Sci,Fertil Ctr, Seoul, South Korea.	leeka@ovary.co.kr			Korean government [R01-2007-000-20451-0]; Ministry of Education, Science and Technology [2009-0093821]	Korean government(Korean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (No. R01-2007-000-20451-0) and the Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2001, FRONT BIOSCI, V6, pD792, DOI 10.2741/Abbott; Ajduk A, 2008, REPRODUCTION, V136, P741, DOI 10.1530/REP-08-0271; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Collas P, 1997, J BIOL CHEM, V272, P21274, DOI 10.1074/jbc.272.34.21274; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; CROSBY IM, 1984, J EXP ZOOL, V229, P459, DOI 10.1002/jez.1402290313; Deng MQ, 2000, BIOL REPROD, V62, P873, DOI 10.1095/biolreprod62.4.873; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; DUCIBELLA T, 1990, DEV BIOL, V137, P46, DOI 10.1016/0012-1606(90)90006-5; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; Eppig JJ, 2000, BIOL REPROD, V63, P1014, DOI 10.1095/biolreprod63.4.1014; Evans JP, 2002, HUM REPROD UPDATE, V8, P297, DOI 10.1093/humupd/8.4.297; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Fulka J, 1998, MOL HUM REPROD, V4, P41, DOI 10.1093/molehr/4.1.41; Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2; Goruppi S, 1996, ONCOGENE, V12, P471; Gosden RG, 2002, MOL CELL ENDOCRINOL, V186, P149, DOI 10.1016/S0303-7207(01)00683-9; Goudet G, 1998, MOL HUM REPROD, V4, P563, DOI 10.1093/molehr/4.6.563; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; HAMPL A, 1995, MOL REPROD DEV, V40, P9, DOI 10.1002/mrd.1080400103; Hegele-Hartung C, 1999, BIOL REPROD, V61, P1362, DOI 10.1095/biolreprod61.5.1362; JONES KT, 1995, DEVELOPMENT, V121, P3259; Jones KT, 1998, INT J DEV BIOL, V42, P1; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lee HS, 2010, FASEB J, V24, P2314, DOI 10.1096/fj.09-147314; LEE SH, 1988, DEVELOPMENT, V102, P595; Lequarre AS, 2004, BIOL REPROD, V71, P425, DOI 10.1095/biolreprod.103.026724; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; McLay DW, 2002, DEV BIOL, V241, P195, DOI 10.1006/dbio.2001.0499; McLay DW, 1997, DEV BIOL, V186, P73, DOI 10.1006/dbio.1997.8581; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nasr-Esfahani MH, 2007, REPROD BIOMED ONLINE, V14, P422, DOI 10.1016/S1472-6483(10)60888-7; Nganvongpanit K, 2006, REPRODUCTION, V131, P861, DOI 10.1530/rep.1.01040; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Swain JE, 2008, HUM REPROD UPDATE, V14, P431, DOI 10.1093/humupd/dmn025; SZYBEK K, 1972, J ENDOCRINOL, V54, P527, DOI 10.1677/joe.0.0540527; Tgarashi H, 2007, DEV BIOL, V312, P321, DOI 10.1016/j.ydbio.2007.09.028; THIBAULT C, 1977, J REPROD FERTIL, V51, P1; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wolfe BA, 1996, J REPROD FERTIL, V106, P135, DOI 10.1530/jrf.0.1060135; Wu XQ, 2006, ACTA PHARMACOL SIN, V27, P1353, DOI 10.1111/j.1745-7254.2006.00407.x; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037; YOSHIMURA Y, 1987, FERTIL STERIL, V47, P22	68	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23304	10.1371/journal.pone.0023304	http://dx.doi.org/10.1371/journal.pone.0023304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850267	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300052
J	Ardura, A; Planes, S; Garcia-Vazquez, E				Ardura, Alba; Planes, Serge; Garcia-Vazquez, Eva			Beyond Biodiversity: Fish Metagenomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MARINE; CONSERVATION; DIVERSITY; DEPLETION; SELECTION; ECOSYSTEM; REGION	Biodiversity and intra-specific genetic diversity are interrelated and determine the potential of a community to survive and evolve. Both are considered together in Prokaryote communities treated as metagenomes or ensembles of functional variants beyond species limits. Many factors alter biodiversity in higher Eukaryote communities, and human exploitation can be one of the most important for some groups of plants and animals. For example, fisheries can modify both biodiversity and genetic diversity (intra specific). Intra-specific diversity can be drastically altered by overfishing. Intense fishing pressure on one stock may imply extinction of some genetic variants and subsequent loss of intra-specific diversity. The objective of this study was to apply a metagenome approach to fish communities and explore its value for rapid evaluation of biodiversity and genetic diversity at community level. Here we have applied the metagenome approach employing the Barcoding target gene COI as a model sequence in catch from four very different fish assemblages exploited by fisheries: freshwater communities from the Amazon River and northern Spanish rivers, and marine communities from the Cantabric and Mediterranean seas. Treating all sequences obtained from each regional catch as a biological unit (exploited community) we found that metagenomic diversity indices of the Amazonian catch sample here examined were lower than expected. Reduced diversity could be explained, at least partially, by overexploitation of the fish community that had been independently estimated by other methods. We propose using a metagenome approach for estimating diversity in Eukaryote communities and early evaluating genetic variation losses at multi-species level.	[Ardura, Alba; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Planes, Serge] Univ Perpignan, CNRS, EPHE, URA 1453, F-66025 Perpignan, France; [Planes, Serge] EPHE Ctr Rech Insulaire, CNRS, USR 3278, Papetoai, Moorea, France; [Planes, Serge] Observ Environm CRIOBE BP, Papetoai, Moorea, France	University of Oviedo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Ardura, A (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Spain.	alarguti@hotmail.com	PLANES, Serge/ABF-1360-2021; Garcia-Vazquez, Eva/Y-7293-2019	Garcia-Vazquez, Eva/0000-0002-8429-838X; Ardura Gutierrez, Alba/0000-0003-2598-6534; PLANES, Serge/0000-0002-5689-5371	Spanish AECI (Agencia Espanola de Cooperacion Internacional) [D/023514/09]; FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia) [IB09-0023]	Spanish AECI (Agencia Espanola de Cooperacion Internacional); FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia)(Principality of Asturias)	This study has been funded by the Spanish AECI (Agencia Espanola de Cooperacion Internacional) Project D/023514/09 and the FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia) IB09-0023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Brown CJ, 2008, MAR ECOL PROG SER, V369, P257, DOI 10.3354/meps07601; Carr MH, 2003, ECOL APPL, V13, pS90; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Garcia A, 2009, FISH PHYSIOL BIOCHEM, V35, P53, DOI 10.1007/s10695-008-9212-7; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kennedy J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-27; Langridge G, 2009, NAT REV MICROBIOL, V7, P552, DOI 10.1038/nrmicro2188; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Singh B, 2008, ANAEROBE, V14, P138, DOI 10.1016/j.anaerobe.2008.03.002; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang SZ, 2002, CONSERV GENET, V3, P321, DOI 10.1023/A:1019925910992; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	37	18	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22592	10.1371/journal.pone.0022592	http://dx.doi.org/10.1371/journal.pone.0022592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829636	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200024
J	Pe'er, G; Henle, K; Dislich, C; Frank, K				Pe'er, Guy; Henle, Klaus; Dislich, Claudia; Frank, Karin			Breaking Functional Connectivity into Components: A Novel Approach Using an Individual-Based Model, and First Outcomes	PLOS ONE			English	Article							ATLANTIC FOREST; LANDSCAPE CONNECTIVITY; DISPERSAL BEHAVIOR; FRAGMENTED LANDSCAPES; MATRIX HETEROGENEITY; PATCH CONNECTIVITY; BUTTERFLY MOVEMENT; SPATIAL STRUCTURE; PERCEPTUAL RANGE; UNDERSTORY BIRDS	Landscape connectivity is a key factor determining the viability of populations in fragmented landscapes. Predicting 'functional connectivity', namely whether a patch or a landscape functions as connected from the perspective of a focal species, poses various challenges. First, empirical data on the movement behaviour of species is often scarce. Second, animal-landscape interactions are bound to yield complex patterns. Lastly, functional connectivity involves various components that are rarely assessed separately. We introduce the spatially explicit, individual-based model FunCon as means to distinguish between components of functional connectivity and to assess how each of them affects the sensitivity of species and communities to landscape structures. We then present the results of exploratory simulations over six landscapes of different fragmentation levels and across a range of hypothetical bird species that differ in their response to habitat edges. i) Our results demonstrate that estimations of functional connectivity depend not only on the response of species to edges (avoidance versus penetration into the matrix), the movement mode investigated (home range movements versus dispersal), and the way in which the matrix is being crossed (random walk versus gap crossing), but also on the choice of connectivity measure (in this case, the model output examined). ii) We further show a strong effect of the mortality scenario applied, indicating that movement decisions that do not fully match the mortality risks are likely to reduce connectivity and enhance sensitivity to fragmentation. iii) Despite these complexities, some consistent patterns emerged. For instance, the ranking order of landscapes in terms of functional connectivity was mostly consistent across the entire range of hypothetical species, indicating that simple landscape indices can potentially serve as valuable surrogates for functional connectivity. Yet such simplifications must be carefully evaluated in terms of the components of functional connectivity they actually predict.	[Pe'er, Guy; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Pe'er, Guy; Dislich, Claudia; Frank, Karin] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Pe'er, Guy] Univ Aegean, Dept Environm Studies, Biodivers Conservat Lab, Mitilini, Greece	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Aegean	Pe'er, G (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	guy.peer@ufz.de	Frank, Karin/D-6490-2015; Wrbka, Thomas/A-5699-2010; Henle, Klaus/I-6837-2013	Frank, Karin/0000-0002-2769-0692; Wrbka, Thomas/0000-0002-1451-9108; Henle, Klaus/0000-0002-6647-5362	German Federal Ministry of Education and Research (BMBF) [01 LB 0202 A1]; EU [226852]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	The work was conducted within GP's postdoctoral position at the Department of Ecological Modelling, as part of the BioCAPSP project "Biodiversity Conservation in Fragmented Landscapes at the Atlantic Plateau of Sao Paulo'' (funded by the German Federal Ministry of Education and Research (BMBF), project number 01 LB 0202 A1) and its onward development and application occurs within the EU FP7 Large-scale integrating project "SCALES'' (grant number 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awade M, 2008, AUSTRAL ECOL, V33, P863, DOI 10.1111/j.1442-9993.2008.01857.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Baldi A, 2005, FOLIA ZOOL, V54, P285; Baniya CB, 2009, PLANT ECOL, V201, P383, DOI 10.1007/s11258-008-9473-3; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; Beltran JW, 2010, ORNITOL NEOTROP, V21, P409; Boscolo D, 2009, LANDSCAPE ECOL, V24, P907, DOI 10.1007/s10980-009-9370-8; Bowers MA, 1999, LANDSCAPE ECOL, V14, P381, DOI 10.1023/A:1008014426117; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Bronstein I. N., 2007, HDB MATH; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cantrell RS, 2007, B MATH BIOL, V69, P2339, DOI 10.1007/s11538-007-9222-0; Crone EE, 2008, ECOLOGY, V89, P2061, DOI 10.1890/07-1173.1; Crooks K. R., 2006, CONNECTIVITY CONSERV; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Delgado MD, 2009, BEHAV ECOL SOCIOBIOL, V64, P35, DOI 10.1007/s00265-009-0815-5; Delibes M, 2009, ANIM CONSERV, V12, P400, DOI 10.1111/j.1469-1795.2009.00263.x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Desrochers A, 2000, OIKOS, V91, P376, DOI 10.1034/j.1600-0706.2000.910218.x; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Doak DF, 1995, CONSERV BIOL, V9, P1370, DOI 10.1046/j.1523-1739.1995.09061370.x; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; FERRER M, 1993, IBIS, V135, P132, DOI 10.1111/j.1474-919X.1993.tb02824.x; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gagne C, 2007, FOREST ECOL MANAG, V252, P191, DOI 10.1016/j.foreco.2007.06.039; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V., 2005, INDIVIDUAL BASED MOD; Grimm V, 2008, ECOLOGICAL MODELS, V3, P1959; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruber B, 2008, OECOLOGIA, V154, P679, DOI 10.1007/s00442-007-0866-0; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Hansbauer MM, 2006, J ORNITHOL, V147, P178; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hansbauer MM, 2008, BIOL CONSERV, V141, P782, DOI 10.1016/j.biocon.2008.01.002; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski Ilkka, 2001, P283; HANSSON L, 1991, BIOL J LINN SOC, V42, P89, DOI 10.1111/j.1095-8312.1991.tb00553.x; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Henle K, 2004, BIODIVERS CONSERV, V13, P1, DOI 10.1023/B:BIOC.0000004311.04226.29; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hinsley SA, 2000, LANDSCAPE ECOL, V15, P765, DOI 10.1023/A:1008149403852; Hovestadt T, 2000, OIKOS, V90, P612, DOI 10.1034/j.1600-0706.2000.900320.x; Kark S, 2007, ENCY BIODIVERSITY, DOI DOI 10.1016/B978-012226865-6/00573-0; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; King AW, 2002, ECOL MODEL, V147, P23, DOI 10.1016/S0304-3800(01)00400-8; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Kuefler D, 2006, ECOGRAPHY, V29, P549, DOI 10.1111/j.0906-7590.2006.04574.x; Kunin WE, 2000, AM NAT, V156, P560, DOI 10.1086/303408; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P134, DOI 10.1016/S0169-5347(00)01838-3; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Li YK, 2010, INT J PRIMATOL, V31, P609, DOI 10.1007/s10764-010-9416-4; Lookingbill TR, 2010, ECOL APPL, V20, P427, DOI 10.1890/09-0073.1; Luhrs ML, 2009, ANIM COGN, V12, P599, DOI 10.1007/s10071-009-0219-y; Macdonald DW, 2003, J BIOGEOGR, V30, P607, DOI 10.1046/j.1365-2699.2003.00874.x; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Manolis JC, 2002, AUK, V119, P955, DOI 10.1642/0004-8038(2002)119[0955:EEONSO]2.0.CO;2; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Mazerolle MJ, 2005, CAN J ZOOL, V83, P455, DOI 10.1139/Z05-032; McGarigal K, 2001, FRAGSTATS SPATIAL PA; Morales JM, 2002, ECOLOGY, V83, P2240; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Palmer SCF, 2011, METHODS ECOL EVOL, V2, P258, DOI 10.1111/j.2041-210X.2010.00073.x; Pe'er G, 2004, ANIM BEHAV, V68, P825, DOI 10.1016/j.anbehav.2004.02.006; Pe'er G, DIVERSITY D IN PRESS; Pe'er G, 2008, ECOL MODEL, V213, P73, DOI 10.1016/j.ecolmodel.2007.11.020; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Reif J, 2006, J ORNITHOL, V147, P236; Revilla E, 2004, AM NAT, V164, pE130, DOI 10.1086/424767; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Riitters K, 2009, LANDSCAPE ECOL, V24, P699, DOI 10.1007/s10980-009-9344-x; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schumaker NH, 1996, ECOLOGY, V77, P1210, DOI 10.2307/2265590; Semlitsch RD, 2007, CONSERV BIOL, V21, P159, DOI 10.1111/j.1523-1739.2006.00571.x; Stevens VM, 2008, CONSERV BIOL, V22, P1194, DOI 10.1111/j.1523-1739.2008.00990.x; Storch D, 2006, J ORNITHOL, V147, P33; Szemethy L, 2003, ACTA THERIOL, V48, P547, DOI 10.1007/BF03192500; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Turchin Peter, 1998; Turcotte Y, 2003, OIKOS, V100, P614, DOI 10.1034/j.1600-0706.2003.12234.x; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Visconti P, 2009, DIVERS DISTRIB, V15, P602, DOI 10.1111/j.1472-4642.2009.00564.x; Vogt P, 2009, ECOL INDIC, V9, P64, DOI 10.1016/j.ecolind.2008.01.011; Watts K, 2010, ECOL INDIC, V10, P552, DOI 10.1016/j.ecolind.2009.07.009; Wiegand K, 2002, CONSERV BIOL, V16, P117, DOI 10.1046/j.1523-1739.2002.99552.x; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; With KA, 1999, ECOLOGY, V80, P1340, DOI 10.1890/0012-9658(1999)080[1340:MRTPSI]2.0.CO;2; Zetterberg A, 2010, LANDSCAPE URBAN PLAN, V95, P181, DOI 10.1016/j.landurbplan.2010.01.002; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878; Zurita GA, 2006, FOREST ECOL MANAG, V235, P164, DOI 10.1016/j.foreco.2006.08.009; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4; Zurita GA, 2009, FOREST ECOL MANAG, V257, P271, DOI 10.1016/j.foreco.2008.08.032	120	53	54	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22355	10.1371/journal.pone.0022355	http://dx.doi.org/10.1371/journal.pone.0022355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829617	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200008
J	Zakiewicz, IM; van Dongen, YC; Leergaard, TB; Bjaalie, JG				Zakiewicz, Izabela M.; van Dongen, Yvette C.; Leergaard, Trygve B.; Bjaalie, Jan G.			Workflow and Atlas System for Brain-Wide Mapping of Axonal Connectivity in Rat	PLOS ONE			English	Article							ARCHITECTURE MANAGEMENT-SYSTEM; PRIMARY SOMATOSENSORY CORTEX; SOMATIC SENSORY CORTEX; CEREBRAL-CORTEX; LATERAL LEMNISCUS; BARREL CORTEX; MOUSE-BRAIN; CORTICOSTRIATAL PROJECTIONS; SOMATOTOPIC ORGANIZATION; CORTICOPONTINE NEURONS	Detailed knowledge about the anatomical organization of axonal connections is important for understanding normal functions of brain systems and disease-related dysfunctions. Such connectivity data are typically generated in neuroanatomical tract-tracing experiments in which specific axonal connections are visualized in histological sections. Since journal publications typically only accommodate restricted data descriptions and example images, literature search is a cumbersome way to retrieve overviews of brain connectivity. To explore more efficient ways of mapping, analyzing, and sharing detailed axonal connectivity data from the rodent brain, we have implemented a workflow for data production and developed an atlas system tailored for online presentation of axonal tracing data. The system is available online through the Rodent Brain WorkBench (www.rbwb.org; Whole Brain Connectivity Atlas) and holds experimental metadata and high-resolution images of histological sections from experiments in which axonal tracers were injected in the primary somatosensory cortex. We here present the workflow and the data system, and exemplify how the online image repository can be used to map different aspects of the brain-wide connectivity of the rat primary somatosensory cortex, including not only presence of connections but also morphology, densities, and spatial organization. The accuracy of the approach is validated by comparing results generated with our system with findings reported in previous publications. The present study is a contribution to a systematic mapping of rodent brain connections and represents a starting point for further large-scale mapping efforts.	[Zakiewicz, Izabela M.; van Dongen, Yvette C.; Leergaard, Trygve B.; Bjaalie, Jan G.] Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway	University of Oslo	Zakiewicz, IM (corresponding author), Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway.	j.g.bjaalie@medisin.uio.no	Bjaalie, Jan G. G./AAW-6445-2021	Bjaalie, Jan G. G./0000-0001-7899-906X; Leergaard, Trygve B./0000-0001-5965-8470	Research Council of Norway; EMBIO/MLS@UiO	Research Council of Norway(Research Council of Norway); EMBIO/MLS@UiO	This research was funded by the Research Council of Norway and EMBIO/MLS@UiO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Bello M, 2005, LECT NOTES COMPUT SC, V3749, P254; Bjaalie JG, 2005, NEUROSCIENCE, V136, P681, DOI 10.1016/j.neuroscience.2005.06.036; BJAALIE JG, 2005, DATABASING BRAIN, P350; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Boline J, 2008, FRONT NEUROSCI-SWITZ, V2, P100, DOI 10.3389/neuro.01.012.2008; Bota M, 2005, NEUROINFORMATICS, V3, P15, DOI 10.1385/NI:3:1:015; BOTA M, 2008, 1 INCF WORKSH NEUR N; Bota M, 2007, J COMP NEUROL, V500, P807, DOI 10.1002/cne.21209; Bota M, 2006, NEUROINFORMATICS, V4, P275, DOI 10.1385/NI:4:4:275; Boy J, 2006, NEUROIMAGE, V33, P449, DOI 10.1016/j.neuroimage.2006.05.055; Brodal P, 1997, PROG BRAIN RES, V114, P227; Brown LL, 1998, J COMP NEUROL, V392, P468; Bug William, 2008, AMIA Annu Symp Proc, P1220; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; Carson J, 2010, METHODS, V50, P85, DOI 10.1016/j.ymeth.2009.08.005; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Crasto Chiquito J, 2007, Methods Mol Biol, V401, P3, DOI 10.1007/978-1-59745-520-6_1; DONOGHUE JP, 1981, J COMP NEUROL, V201, P1, DOI 10.1002/cne.902010102; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Fletcher M, 2008, NEURAL NETWORKS, V21, P1076, DOI 10.1016/j.neunet.2008.06.009; Gardner D, 2001, J AM MED INFORM ASSN, V8, P17, DOI 10.1136/jamia.2001.0080017; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Gibson F., 2009, MINIMUM INFORM NEURO; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HAWRYLYCZ M, 2009, INCF DIGITAL ADASING; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Hoffer ZS, 2005, J COMP NEUROL, V488, P82, DOI 10.1002/cne.20579; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kennedy DN, 2010, NEUROINFORMATICS, V8, P61, DOI 10.1007/s12021-010-9070-1; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kotter R, 2004, NEUROINFORMATICS, V2, P127; LANCIEGO JL, 1994, NEUROSCIENCE PROTOCO; Lee SK, 2004, NEUROIMAGE, V22, P1826, DOI 10.1016/j.neuroimage.2004.04.028; Leergaard TB, 2000, J COMP NEUROL, V422, P246, DOI 10.1002/(SICI)1096-9861(20000626)422:2<246::AID-CNE7>3.0.CO;2-R; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Leergaard TB, 2003, ANAT EMBRYOL, V206, P149, DOI 10.1007/s00429-002-0272-7; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MacKenzie-Graham A, 2003, NEUROINFORMATICS, V1, P397, DOI 10.1385/NI:1:4:397; Malmierca MS, 1998, J NEUROSCI, V18, P10603; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Merchan MA, 1996, J COMP NEUROL, V372, P245; MERCHAN MA, 1994, J COMP NEUROL, V342, P259, DOI 10.1002/cne.903420209; MIHAILOFF GA, 1985, J COMP NEUROL, V237, P251, DOI 10.1002/cne.902370209; Moene IA, 2007, NEUROINFORMATICS, V5, P35, DOI 10.1385/NI:5:1:35; Nadkarni Prakash, 2007, Methods Mol Biol, V401, P37, DOI 10.1007/978-1-59745-520-6_3; Oberti D, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00024; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; OVERBY SE, 1989, EXP BRAIN RES, V77, P653; Paxinos G., 2004, J CHEM INF MODEL, V5th; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penfield W, 1950, CEREBRAL CORTEX MAN; Petrovicky P, 1972, Folia Morphol (Praha), V20, P161; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Reiner A, 2006, NEUROANATOMICAL TRACT-TRACING 3: MOLECULES, NEURONS, AND SYSTEMS, P304; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SCHWARZ C, 1995, J NEUROSCI, V15, P3475; Staiger JF, 2009, BRAIN STRUCT FUNCT, V214, P1, DOI 10.1007/s00429-009-0225-5; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Vassbo K, 1999, J COMP NEUROL, V406, P109, DOI 10.1002/(SICI)1096-9861(19990329)406:1<109::AID-CNE7>3.0.CO;2-U; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WIESENDANGER R, 1982, J COMP NEUROL, V208, P227, DOI 10.1002/cne.902080303; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5; WISE SP, 1977, BRAIN RES, V133, P223, DOI 10.1016/0006-8993(77)90760-0; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wouterlood FG, 2008, J NEUROSCI METH, V171, P296, DOI 10.1016/j.jneumeth.2008.03.014	82	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22669	10.1371/journal.pone.0022669	http://dx.doi.org/10.1371/journal.pone.0022669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829640	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200015
J	Zhang, YH; Larsen, CA; Stadler, HS; Ames, JB				Zhang, Yonghong; Larsen, Christine A.; Stadler, H. Scott; Ames, James B.			Structural Basis for Sequence Specific DNA Binding and Protein Dimerization of HOXA13	PLOS ONE			English	Article							FOOT-GENITAL SYNDROME; POLYALANINE EXPANSION; LIGHT-SCATTERING; NMR STRUCTURES; HOMEODOMAIN; COMPLEX; DOMAIN; EXPRESSION; ASSIGNMENTS; HEXAPEPTIDE	The homeobox gene (HOXA13) codes for a transcription factor protein that binds to AT-rich DNA sequences and controls expression of genes during embryonic morphogenesis. Here we present the NMR structure of HOXA13 homeodomain (A13DBD) bound to an 11-mer DNA duplex. A13DBD forms a dimer that binds to DNA with a dissociation constant of 7.5 nM. The A13DBD/DNA complex has a molar mass of 35 kDa consistent with two molecules of DNA bound at both ends of the A13DBD dimer. A13DBD contains an N-terminal arm (residues 324 - 329) that binds in the DNA minor groove, and a C-terminal helix (residues 362 - 382) that contacts the ATAA nucleotide sequence in the major groove. The N370 side-chain forms hydrogen bonds with the purine base of A5* (base paired with T5). Side-chain methyl groups of V373 form hydrophobic contacts with the pyrimidine methyl groups of T5, T6* and T7*, responsible for recognition of TAA in the DNA core. I366 makes similar methyl contacts with T3* and T4*. Mutants (I366A, N370A and V373G) all have decreased DNA binding and transcriptional activity. Exposed protein residues (R337, K343, and F344) make intermolecular contacts at the protein dimer interface. The mutation F344A weakens protein dimerization and lowers transcriptional activity by 76%. We conclude that the non-conserved residue, V373 is critical for structurally recognizing TAA in the major groove, and that HOXA13 dimerization is required to activate transcription of target genes.	[Zhang, Yonghong; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Larsen, Christine A.; Stadler, H. Scott] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Larsen, Christine A.; Stadler, H. Scott] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA	University of California System; University of California Davis; Oregon Health & Science University	Zhang, YH (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			NIH [5R01EY012347, 5R01CA131458-03]; Shriners Hospitals for Children [85800]; Basic Research Training in Embryonic Development Award [5T32HD049309-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049309] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA131458] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; Basic Research Training in Embryonic Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants 5R01EY012347 (J.B.A.) and 5R01CA131458-03 (HSS) from the NIH; Shriners Hospitals for Children Grant Award Number 85800 (HSS) and a Basic Research Training in Embryonic Development Award 5T32HD049309-05 (CAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Innis Jeffrey W, 2002, Hum Mutat, V19, P573; Innis JW, 2004, HUM MOL GENET, V13, P2841, DOI 10.1093/hmg/ddh306; Jorgensen EM, 2010, FERTIL STERIL, V94, P1235, DOI 10.1016/j.fertnstert.2009.05.057; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Knosp WM, 2007, J BIOL CHEM, V282, P6843, DOI 10.1074/jbc.M610775200; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Longo A, 2007, BIOCHEMISTRY-US, V46, P2948, DOI 10.1021/bi060969l; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Parker L, 2011, Foot Ankle Surg, V17, pe28, DOI 10.1016/j.fas.2010.12.003; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shanmugam K, 1997, J BIOL CHEM, V272, P19081, DOI 10.1074/jbc.272.30.19081; Shaut CA, 2007, DEV DYNAM, V236, P951, DOI 10.1002/dvdy.21077; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; TREISMAN J, 1989, CELL, V59, P553; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; Utsch B, 2007, AM J MED GENET A, V143A, P3161, DOI 10.1002/ajmg.a.31967; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Zhang YH, 2010, BIOMOL NMR ASSIGN, V4, P97, DOI 10.1007/s12104-010-9216-y; Zhang YH, 2009, BIOMOL NMR ASSIGN, V3, P199, DOI 10.1007/s12104-009-9174-4; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	53	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23069	10.1371/journal.pone.0023069	http://dx.doi.org/10.1371/journal.pone.0023069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829694	gold, Green Published			2022-12-25	WOS:000293511200038
J	Romero-Romero, ML; Ingles-Prieto, A; Ibarra-Molero, B; Sanchez-Ruiz, JM				Luisa Romero-Romero, M.; Ingles-Prieto, Alvaro; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.			Highly Anomalous Energetics of Protein Cold Denaturation Linked to Folding-Unfolding Kinetics	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CHARGE INTERACTIONS; LOW-TEMPERATURE; HEAT; STABILITY; BARRIERS; STATE; COOPERATIVITY; TRANSITIONS; DEPENDENCE	Despite several careful experimental analyses, it is not yet clear whether protein cold-denaturation is just a "mirror image" of heat denaturation or whether it shows unique structural and energetic features. Here we report that, for a well-characterized small protein, heat denaturation and cold denaturation show dramatically different experimental energetic patterns. Specifically, while heat denaturation is endothermic, the cold transition (studied in the folding direction) occurs with negligible heat effect, in a manner seemingly akin to a gradual, second-order-like transition. We show that this highly anomalous energetics is actually an apparent effect associated to a large folding/unfolding free energy barrier and that it ultimately reflects kinetic stability, a naturally-selected trait in many protein systems. Kinetics thus emerges as an important factor linked to differential features of cold denaturation. We speculate that kinetic stabilization against cold denaturation may play a role in cold adaptation of psychrophilic organisms. Furthermore, we suggest that folding-unfolding kinetics should be taken into account when analyzing in vitro cold-denaturation experiments, in particular those carried out in the absence of destabilizing conditions.	[Luisa Romero-Romero, M.; Ingles-Prieto, Alvaro; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain	University of Granada	Romero-Romero, ML (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain.	sanchezr@ugr.es	Ingles-Prieto, Alvaro/A-4365-2017; Romero Romero, Maria Luisa/B-2136-2019; Sanchez-Ruiz, Jose/H-2849-2015	Ingles-Prieto, Alvaro/0000-0002-5409-8571; Romero Romero, Maria Luisa/0000-0003-3397-6758; Sanchez-Ruiz, Jose/0000-0002-9056-3928	Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER ("Fondo Europeo de DEsarrollo Regional")	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER ("Fondo Europeo de DEsarrollo Regional")(European Commission)	This work was supported by FEDER ("Fondo Europeo de DEsarrollo Regional") funds and Grants BIO2009-09562 and CSD2009-00088 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; ANDOVER M, 2010, J AM CHEM SOC, V132, P16240; ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715; Ascolese E, 2008, CHEM PHYS LETT, V467, P150, DOI 10.1016/j.cplett.2008.10.078; Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; DELPINO IMP, 1992, BIOCHEMISTRY-US, V31, P11196, DOI 10.1021/bi00160a033; Dyer RB, 2005, BIOCHEMISTRY-US, V44, P10406, DOI 10.1021/bi050698z; FREIRE E, 1992, BIOCHEMISTRY-US, V31, P250, DOI 10.1021/bi00116a034; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Georgescu RE, 2001, EUR J BIOCHEM, V268, P1477, DOI 10.1046/j.1432-1327.2001.02014.x; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; GRIKO YV, 1994, BIOPHYS J, V67, P356, DOI 10.1016/S0006-3495(94)80488-6; GRIKO YV, 1989, FEBS LETT, V244, P276, DOI 10.1016/0014-5793(89)80544-7; GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017; GRIKO YV, 1988, P NATL ACAD SCI USA, V85, P3343, DOI 10.1073/pnas.85.10.3343; GRIKO YV, 1994, J MOL BIOL, V235, P1318, DOI 10.1006/jmbi.1994.1085; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Huang GWS, 1996, BIOCHEMISTRY-US, V35, P6173, DOI 10.1021/bi960250l; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Ibarra-Molero B, 1999, BBA-PROTEIN STRUCT M, V1429, P384, DOI 10.1016/S0167-4838(98)00252-0; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Lazar KL, 2010, MABS-AUSTIN, V2, P42, DOI 10.4161/mabs.2.1.10787; Li Y, 2007, J MOL BIOL, V368, P256, DOI 10.1016/j.jmb.2007.02.011; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Molski MA, 2010, J AM CHEM SOC, V132, P3658, DOI 10.1021/ja910903c; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; Pometun MS, 2006, J AM CHEM SOC, V128, P10652, DOI 10.1021/ja0628654; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Rodriguez-Larrea D, 2006, BIOPHYS J, V91, pL48, DOI 10.1529/biophysj.106.087932; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rodriguez-Larrea D, 2010, BIOCHEM J, V429, P243, DOI 10.1042/BJ20100386; Sadqi M, 2009, P NATL ACAD SCI USA, V106, P4127, DOI 10.1073/pnas.0812108106; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636; Shan B, 2010, J AM CHEM SOC, V132, P4669, DOI 10.1021/ja908104s; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Todgham AE, 2007, J COMP PHYSIOL B, V177, P857, DOI 10.1007/s00360-007-0183-2; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Whitten ST, 2006, BIOCHEMISTRY-US, V45, P10163, DOI 10.1021/bi060855+; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang WY, 2005, PHILOS T R SOC A, V363, P565, DOI 10.1098/rsta.2004.1508	54	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23050	10.1371/journal.pone.0023050	http://dx.doi.org/10.1371/journal.pone.0023050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829584	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500071
J	Takai, A; Marusawa, H; Minaki, Y; Watanabe, T; Nakase, H; Kinoshita, K; Tsujimoto, G; Chiba, T				Takai, A.; Marusawa, H.; Minaki, Y.; Watanabe, T.; Nakase, H.; Kinoshita, K.; Tsujimoto, G.; Chiba, T.			Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation	ONCOGENE			English	Article						AID; colitis-associated cancer; colonic inflammation; IL-10(-/-) mouse	HELICOBACTER-PYLORI INFECTION; ULCERATIVE-COLITIS; BOWEL-DISEASE; INTERLEUKIN-10-DEFICIENT MICE; DNA DEMETHYLATION; COLORECTAL-CANCER; HUMAN HEPATOCYTES; LAMINA PROPRIA; P53 MUTATIONS; CELLS	Inflammatory bowel disease (IBD) is an important etiologic factor in the development of colorectal cancer. However, the mechanism underlying carcinogenesis through chronic inflammation is still unknown. Activation-induced cytidine deaminase (AID) is induced by the inflammation and involved in various human carcinogenesis via its mutagenic activity. In the current study, we investigated whether the inflammation/AID axis plays an integral role in the development of colitis-associated cancers. Inflammation in the cecum was more severe than that in other colonic regions, and endogenous AID expression was enhanced most prominently in the inflamed cecal mucosa of interleukin (IL)-10(-/-) mice. Blockade of tumor necrosis factor (TNF)-alpha and IL-12 significantly suppressed AID expression. Although proinflammatory cytokine expression was comparable between IL-10(-/-) AID(+/+) and IL-10(-/-) AID(-/-) mice, sequencing analyses revealed a significantly lower incidence of somatic mutations in Trp53 gene in the colonic mucosa of IL-10(-/-) AID(-/-) than IL-10(-/-) AID(+/+) mice. Colon cancers spontaneously developed in the cecum in 6 of 22 (27.2%) IL-10(-/-) AID(+/+) mice. In contrast, none of the IL-10(-/-) AID(-/-) mice developed cancers except only one case of neoplasia in the distal colon. These findings suggest that the proinflammatory cytokine-induced aberrant production of AID links colonic inflammation to an enhanced genetic susceptibility to oncogenic mutagenesis. Targeting AID could be a novel strategy to prevent colitis-associated colon carcinogenesis irrespective of ongoing colonic inflammation. Oncogene (2012) 31, 1733-1742; doi:10.1038/onc.2011.352; published online 15 August 2011	[Marusawa, H.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Kinoshita, K.] Shiga Med Ctr Res Inst, Moriyama, Japan; [Tsujimoto, G.] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Marusawa, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	maru@kuhp.kyoto-u.ac.jp	Nakase, Hiroshi/AAZ-4425-2020; Watanabe, Tomohiro/ABA-4712-2021	Marusawa, Hiroyuki/0000-0002-4286-2712	Ministry of Education, Culture, Sports, Science; Ministry of Health, Labor, and Welfare, Japan; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [23390196, 21229009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Keiichiro Suzuki and Dr Tasuku Honjo for critical reading of this manuscript, and Dr Masamichi Muramatsu for providing information of siRNA for AID. This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science; a grant-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare, Japan; and a research grant of the Princess Takamatsu Cancer Research Fund.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Chiba T, 2006, J GASTROENTEROL, V41, P1, DOI 10.1007/s00535-005-1743-4; Chiba T, 2009, J MOL MED-JMM, V87, P1023, DOI 10.1007/s00109-009-0527-3; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Holzmann K, 1998, INT J CANCER, V76, P1; Hussain SP, 2000, CANCER RES, V60, P3333; Ikeda K, 2007, ANN INTERN MED, V146, P649, DOI 10.7326/0003-4819-146-9-200705010-00008; Inoue S, 2009, CLIN EXP IMMUNOL, V156, P172, DOI 10.1111/j.1365-2249.2008.03872.x; KERN SE, 1994, GASTROENTEROLOGY, V107, P420, DOI 10.1016/0016-5085(94)90167-8; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lashner BA, 1999, AM J GASTROENTEROL, V94, P456, DOI 10.1016/S0002-9270(98)00758-8; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakatani T, 2004, J BIOL CHEM, V279, P16356, DOI 10.1074/jbc.M311740200; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; REDSTON MS, 1995, GASTROENTEROLOGY, V108, P383, DOI 10.1016/0016-5085(95)90064-0; Sturlan S, 2001, CARCINOGENESIS, V22, P665, DOI 10.1093/carcin/22.4.665; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; YIN J, 1993, GASTROENTEROLOGY, V104, P1633, DOI 10.1016/0016-5085(93)90639-T	44	35	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	13					1733	1742		10.1038/onc.2011.352	http://dx.doi.org/10.1038/onc.2011.352			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21841819	Green Published			2022-12-25	WOS:000302231400011
J	Ge, YJ; Yoon, MS; Chen, J				Ge, Yejing; Yoon, Mee-Sup; Chen, Jie			Raptor and Rheb Negatively Regulate Skeletal Myogenesis through Suppression of Insulin Receptor Substrate 1 (IRS1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; MAMMALIAN TARGET; MYOBLAST DIFFERENTIATION; SIGNALING PATHWAYS; C2C12 MYOGENESIS; MUSCLE-CELLS; IGF-II; MTOR; GROWTH; PHOSPHORYLATION	The mammalian target of rapamycin (mTOR) is essential for skeletal myogenesis through controlling distinct cellular pathways. The importance of the canonical mTOR complex 1 signaling components, including raptor, S6K1, and Rheb, had been suggested in muscle maintenance, growth, and metabolism. However, the role of those components in myogenic differentiation is not entirely clear. In this study we have investigated the functions of raptor, S6K1, and Rheb in the differentiation of C2C12 mouse myoblasts. We find that although mTOR knockdown severely impairs myogenic differentiation as expected, the knockdown of raptor, as well as Rheb, enhances differentiation. Consistent with a negative role for these proteins in myogenesis, overexpression of raptor or Rheb inhibits C2C12 differentiation. On the other hand, neither knockdown nor overexpression of S6K1 has any effect. Moreover, the enhanced differentiation elicited by raptor or Rheb knockdown is accompanied by increased Akt activation, elevated IRS1 protein levels, and decreased Ser-307 (human Ser-312) phosphorylation on IRS1. Finally, IRS1 knockdown eliminated the enhancement in differentiation elicited by raptor or Rheb knockdown, suggesting that IRS1 is a critical mediator of the myogenic functions of raptor and Rheb. In conclusion, the Rheb-mTOR/raptor pathway negatively regulates myogenic differentiation by suppressing IRS1-PI3K-Akt signaling. These findings underscore the versatility of mTOR signaling in biological regulations and implicate the existence of novel mTOR complexes and/or signaling mechanism in skeletal myogenesis.	[Ge, Yejing; Yoon, Mee-Sup; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), 601 S Goodwin Ave B107, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant AR048914 (to J. C.) from the National Institutes of Health.	Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35675	35682		10.1074/jbc.M111.262881	http://dx.doi.org/10.1074/jbc.M111.262881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852229	hybrid, Green Published			2022-12-25	WOS:000295927100039
J	Enomoto, T; Ohashi, K; Shibata, R; Higuchi, A; Maruyama, S; Izumiya, Y; Walsh, K; Murohara, T; Ouchi, N				Enomoto, Takashi; Ohashi, Koji; Shibata, Rei; Higuchi, Akiko; Maruyama, Sonomi; Izumiya, Yasuhiro; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESE MICE; EXPRESSION; INFLAMMATION; DISEASE; KINASE; MUSCLE; ACRP30/ADIPONECTIN	Obesity is a major risk factor for the development of insulin resistance and type 2 diabetes. Adipose tissue secretes various bioactive molecules, referred to as adipokines, whose dysregulation can mediate changes in glucose homeostasis and inflammatory responses. Here, we identify C1qdc2/CTRP12 as an insulin-sensitizing adipokine that is abundantly expressed by fat tissues and designate this adipokine as adipolin (adipose-derived insulin-sensitizing factor). Adipolin expression in adipose tissue and plasma was reduced in rodent models of obesity. Adipolin expression was also decreased in cultured 3T3-L1 adipocytes by treatment with inducers of endoplasmic reticulum stress and inflammation. Systemic administration of adipolin ameliorated glucose intolerance and insulin resistance in diet-induced obese mice. Adipolin administration also reduced macrophage accumulation and proinflammatory gene expression in the adipose tissue of obese mice. Conditioned medium from adipolin-expressing cells diminished the expression of proinflammatory cytokines in response to stimulation with LPS or TNF alpha in cultured macrophages. These data suggest that adipolin functions as an anti-inflammatory adipokine that exerts beneficial actions on glucose metabolism. Therefore, adipolin represents a new target molecule for the treatment of insulin resistance and diabetes.	[Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Takashi; Shibata, Rei; Maruyama, Sonomi; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Higuchi, Akiko; Izumiya, Yasuhiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Unit, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Nagoya University; Nagoya University; Boston University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013	National Institutes of Health [P01HL081587]; ministry of Education; Suzuken Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation; Japan Heart Foundation/Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ministry of Education; Suzuken Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL081587 (to K. W.). This work was also supported by a grant-in-aid for scientific research from the ministry of Education and grants from the Suzuken Memorial Foundation, the Japan Research Foundation for Clinical Pharmacology, and the Uehara Memorial Foundation (to N. O.) and by a grant-in-aid for young scientists (B) from the ministry of Education, the Uehara Memorial Foundation, and the Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2011 (to R. S.).	Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Siegrist-Kaiser CA, 1997, J CLIN INVEST, V100, P2858, DOI 10.1172/JCI119834; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6	33	99	108	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34552	34558		10.1074/jbc.M111.277319	http://dx.doi.org/10.1074/jbc.M111.277319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849507	Green Published, hybrid			2022-12-25	WOS:000295406300009
J	Favaro, LCD; de Melo, FL; Aguilar-Vildoso, CI; Araujo, WL				de Lima Favaro, Leia Cecilia; de Melo, Fernando Lucas; Aguilar-Vildoso, Carlos Ivan; Araujo, Welington Luiz			Polyphasic Analysis of Intraspecific Diversity in Epicoccum nigrum Warrants Reclassification into Separate Species	PLOS ONE			English	Article							POSTHARVEST BROWN-ROT; FUSARIUM-OXYSPORUM; VEGETATIVE COMPATIBILITY; NATURAL-POPULATIONS; GENETIC-VARIATION; PHOMA-EPICOCCINA; AFLP; PHYLOGENY; PCR; IDENTIFICATION	Background: Epicoccum nigrum Link (syn. E. purpurascens Ehrenb. ex Schlecht) is a saprophytic ascomycete distributed worldwide which colonizes a myriad of substrates. This fungus has been known as a biological control agent for plant pathogens and produces a variety of secondary metabolites with important biological activities as well as biotechnological application. E. nigrum produces darkly pigmented muriform conidia on short conidiophores on sporodochia and is a genotypically and phenotypically highly variable species. Since different isolates identified as E. nigrum have been evaluated as biological control agents and used for biocompound production, it is highly desirable that this species name refers to only one lineage. However, according to morphological and genetic variation, E. nigrum present two genotypes that may comprise more than one species. Methodology/Principal Findings: We report the application of combined molecular (ITS and beta-tubulin gene sequence analysis, PCR-RFLP and AFLP techniques), morphometric, physiological, genetic compatibility and recombination analysis to study the taxonomic relationships within an endophytic population that has been identified as E. nigrum. This combined analysis established two genotypes showing morphological, physiological and genetic divergence as well as genetic incompatibility characterized by colony inhibition, strongly indicating that these genotypes correspond to different species. Genotype 1 corresponds to E. nigrum while genotype 2 represents a new species, referred to in this study as Epicoccum sp. Conclusions/Significance: This research contributes to the knowledge of the Epicoccum genus and asserts that the classification of E. nigrum as a single variable species should be reassessed. In fact, based on the polyphasic approach we suggest the occurrence of cryptic species within E. nigrum and also that many of the sequences deposited as E. nigrum in GenBank and culture collection of microbial strains should be reclassified, including the reference strain CBS 161.73 sequenced in this work. In addition, this study provides valuable tools for differentiation of Epicoccum species.	[de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Empraba Agroenergia, Brasilia, DF, Brazil; [de Melo, Fernando Lucas] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Aguilar-Vildoso, Carlos Ivan] Brazilian Agr Res Corp, Empraba Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil; [Araujo, Welington Luiz] Univ Mogi das Cruzes, Lab Mol Biol & Microbial Ecol, NIB, Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Mogi das Cruzes	Favaro, LCD (corresponding author), Brazilian Agr Res Corp, Empraba Agroenergia, Brasilia, DF, Brazil.	welingtonluiz@umc.br	DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Melo, Fernando Lucas/U-6535-2017; Araújo, Welington/G-4905-2012	DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Melo, Fernando Lucas/0000-0002-9591-0239; Araújo, Welington/0000-0002-2120-8172	FAPESP (State of Sao Paulo Research Foundation) [2002/14143-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	FAPESP (State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP (State of Sao Paulo Research Foundation) (Grant 2002/14143-3). The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral fellowship to LCLF (Graduate Program in Plant Genetics and Breeding, "Luiz de Queiroz" College of Agriculture, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateff A, 2003, PLANTA MED, V69, P831, DOI 10.1055/s-2003-43209; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; APPEL DJ, 1995, EXP MYCOL, V19, P120, DOI 10.1006/emyc.1995.1014; Arenal F, 2004, MYCOTAXON, V89, P465; Arenal F, 2000, MYCOL RES, V104, P301, DOI 10.1017/S0953756299001537; Arenal F, 2002, J APPL MICROBIOL, V93, P36, DOI 10.1046/j.1365-2672.2002.01654.x; Arenal F, 1999, J APPL MICROBIOL, V87, P898, DOI 10.1046/j.1365-2672.1999.00946.x; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Aveskamp MM, 2009, MYCOLOGIA, V101, P363, DOI 10.3852/08-199; Baayen RP, 2000, PHYTOPATHOLOGY, V90, P891, DOI 10.1094/PHYTO.2000.90.8.891; BAMFORD PHILIP C., 1961, TRANS BRIT MYCOL SOC, V44, P354; BAUTE MA, 1978, J ANTIBIOT, V31, P1099, DOI 10.7164/antibiotics.31.1099; Bell PJL, 2003, J AM CHEM SOC, V125, P9304, DOI 10.1021/ja035496+; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bruns TD, 2001, MYCOLOGIA S, V52; BRUTON BD, 1993, PLANT DIS, V77, P1060, DOI 10.1094/PD-77-1060; Favaro LCD, 2007, MYCOL RES, V111, P93, DOI 10.1016/j.mycres.2006.08.008; Coghlan DR, 2005, ORG LETT, V7, P2401, DOI 10.1021/ol050665b; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Craven KD, 2008, EUKARYOT CELL, V7, P675, DOI 10.1128/EC.00423-07; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; De Cal A, 2009, J APPL MICROBIOL, V106, P592, DOI 10.1111/j.1365-2672.2008.04030.x; De Gruyter J, 2009, MYCOL RES, V113, P508, DOI 10.1016/j.mycres.2009.01.002; Douhan GW, 2008, MOL ECOL, V17, P2276, DOI 10.1111/j.1365-294X.2008.03753.x; Douhan GW, 2007, CURR GENET, V52, P191, DOI 10.1007/s00294-007-0150-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS DH, 1978, T BRIT MYCOL SOC, V70, P170, DOI 10.1016/S0007-1536(78)80195-8; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; FREDERICK CB, 1981, BIOCHEMISTRY-US, V20, P2432, DOI 10.1021/bi00512a010; Garcia RA, 2002, MOL ECOL, V11, P355, DOI 10.1046/j.0962-1083.2001.01456.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goloboff P, 2008, CLADISTICS, V24, P91; Guo HJ, 2009, J NAT PROD, V72, P2115, DOI 10.1021/np900654a; HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395; Hashem M., 2004, Archives of Phytopathology and Plant Protection, V37, P283, DOI 10.1080/03235400310001612955; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC; IKAWA M, 1978, J ANTIBIOT, V31, P159, DOI 10.7164/antibiotics.31.159; Immanuel VY, 1996, WINBOOT PROGRAM PERF; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Jo YK, 2008, PHYTOPATHOLOGY, V98, P108, DOI 10.1094/PHYTO-98-1-0108; Kanai A, 2007, CHEM PHARM BULL, V55, P495, DOI 10.1248/cpb.55.495; Wangun HVK, 2007, ORG BIOMOL CHEM, V5, P1702, DOI 10.1039/b702378b; KILPATRICK JA, 1981, T BRIT MYCOL SOC, V77, P497, DOI 10.1016/S0007-1536(81)80097-6; Koopman WJM, 2008, AM J BOT, V95, P353, DOI 10.3732/ajb.95.3.353; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kueck Ulrich, 2009, Fungal Biology Reviews, V23, P86, DOI 10.1016/j.fbr.2009.10.004; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Mari M, 2007, J SCI FOOD AGR, V87, P1271, DOI 10.1002/jsfa.2839; Milgroom MG, 2009, FUNGAL GENET BIOL, V46, P849, DOI 10.1016/j.fgb.2009.07.007; Mims CW, 2005, CAN J BOT, V83, P1354, DOI 10.1139/b05-137; Mishra PK, 2002, FEMS MICROBIOL LETT, V215, P291, DOI 10.1111/j.1574-6968.2002.tb11405.x; Moy M, 2000, SYMBIOSIS, V28, P291; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Murillo C, 2009, MYCOL RES, V113, P405, DOI 10.1016/j.mycres.2008.09.003; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pazoutova Sylvie, 2003, Czech Mycology, V54, P155; Pieckenstain FL, 2001, MYCOL RES, V105, P77, DOI 10.1017/S0953756200003129; Pimentel G, 2000, PHYTOPATHOLOGY, V90, P376, DOI 10.1094/PHYTO.2000.90.4.376; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Promputtha I, 2010, FUNGAL DIVERS, V41, P89, DOI 10.1007/s13225-010-0024-6; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Romao AS, 2007, MICOLOGIA AVANCOS CO, P150; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossman AY, 2008, PLANT DIS, V92, P1376, DOI 10.1094/PDIS-92-10-1376; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; SCHOL-SCHWARZ M. BEATRICE, 1959, TRANS BRIT MYCOL SOC, V42, P149; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Shu YZ, 1997, BIOORG MED CHEM LETT, V7, P2295, DOI 10.1016/S0960-894X(97)00407-1; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wangun HVK, 2008, EUR J ORG CHEM, V2008, P3781, DOI 10.1002/ejoc.200800447; Wangun HVK, 2007, J NAT PROD, V70, P1800, DOI 10.1021/np070245q; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u	93	33	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e14828	10.1371/journal.pone.0014828	http://dx.doi.org/10.1371/journal.pone.0014828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853017	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400002
J	Rojo, DR; Prough, DS; Falduto, MT; Boone, DR; Micci, MA; Kahrig, KM; Crookshanks, JM; Jimenez, A; Uchida, T; Cowart, JC; Hawkins, BE; Avila, M; DeWitt, DS; Hellmich, HL				Rojo, Daniel R.; Prough, Donald S.; Falduto, Michael T.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Jimenez, Arnaldo; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.			Influence of Stochastic Gene Expression on the Cell Survival Rheostat after Traumatic Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; MOLECULAR NETWORKS; MOUSE MODEL; HEAD-INJURY; DISEASE; DEATH; NEURONS	Experimental evidence suggests that random, spontaneous (stochastic) fluctuations in gene expression have important biological consequences, including determination of cell fate and phenotypic variation within isogenic populations. We propose that fluctuations in gene expression represent a valuable tool to explore therapeutic strategies for patients who have suffered traumatic brain injury (TBI), for which there is no effective drug therapy. We have studied the effects of TBI on the hippocampus because TBI survivors commonly suffer cognitive problems that are associated with hippocampal damage. In our previous studies we separated dying and surviving hippocampal neurons by laser capture microdissection and observed unexplainable variations in post-TBI gene expression, even though dying and surviving neurons were adjacent and morphologically identical. We hypothesized that, in hippocampal neurons that subsequently are subjected to TBI, randomly increased pre-TBI expression of genes that are associated with neuroprotection predisposes neurons to survival; conversely, randomly decreased expression of these genes predisposes neurons to death. Thus, to identify genes that are associated with endogenous neuroprotection, we performed a comparative, high-resolution transcriptome analysis of dying and surviving hippocampal neurons in rats subjected to TBI. We found that surviving hippocampal neurons express a distinct molecular signature - increased expression of networks of genes that are associated with regeneration, cellular reprogramming, development, and synaptic plasticity. In dying neurons we found decreased expression of genes in those networks. Based on these data, we propose a hypothetical model in which hippocampal neuronal survival is determined by a rheostat that adds injury-induced genomic signals to expression of pro-survival genes, which pre-TBI varies randomly and spontaneously from neuron to neuron. We suggest that pharmacotherapeutic strategies that co-activate multiple survival signals and enhance self-repair mechanisms have the potential to shift the cell survival rheostat to favor survival and therefore improve functional outcome after TBI.	[Rojo, Daniel R.; Prough, Donald S.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.] GenUs BioSyst, Northbrook, IL USA; [Jimenez, Arnaldo] Vel Lab Res, Missouri City, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Rojo, DR (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013; Hawkins, Bridget/H-4933-2015	Prough, Donald S/0000-0001-7994-532X; Hawkins, Bridget/0000-0002-1887-3657	National Institutes of Health [RO1 NS052532]; Moody Foundation; Department of Anesthesiology, University of Texas Medical Branch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moody Foundation; Department of Anesthesiology, University of Texas Medical Branch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health, RO1 NS052532 (to H.L.H), by a grant from the Moody Foundation and the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Benekareddy M, 2008, SYNAPSE, V62, P590, DOI 10.1002/syn.20529; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontan- Lozano A, 2008, MOL NEUROBIOL, V27; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Paizanis E, 2007, NEUROCHEM RES, V32, P1762, DOI 10.1007/s11064-007-9330-0; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Papa L, 2009, CRIT CARE MED; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; SAS Institute Inc, 2004, SAS STAT US GUID VER; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seo SY, 2004, J BIOL CHEM, V279, P42240, DOI 10.1074/jbc.M406775200; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weinreb O, 2009, NEUROTHERAPEUTICS, V6, P163, DOI 10.1016/j.nurt.2008.10.030; Winship IR, 2008, J NEUROSCI, V28, P6592, DOI 10.1523/JNEUROSCI.0622-08.2008; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	86	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23111	10.1371/journal.pone.0023111	http://dx.doi.org/10.1371/journal.pone.0023111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853077	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400028
J	Kokolo, MB; Fergusson, DA; Cameron, DW				Kokolo, Madzouka B.; Fergusson, Dean A.; Cameron, D. William			HIV Pre-Exposure Prophylaxis (PrEP)-A Quantitative Ethics Appraisal	PLOS ONE			English	Article							PREVENTION; TRIAL; TRANSMISSION; AFRICA; IMPACT	Background: There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents. Methods: We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported. Results: On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average). Discussion: Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.	[Kokolo, Madzouka B.; Fergusson, Dean A.; Cameron, D. William] Ottawa Hosp, Res Inst, Clin Epidemiol Programme, Ottawa, ON, Canada; [Fergusson, Dean A.; Cameron, D. William] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Kokolo, MB (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Programme, Ottawa, ON, Canada.	mkokolo@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Fergusson, Dean/0000-0002-3389-2485	University of Ottawa; Ontario Ministry of Health/Ontario HIV Treatment Network; Ottawa Hospital Research Institute	University of Ottawa; Ontario Ministry of Health/Ontario HIV Treatment Network(Ministry of Health and Long-Term Care, Ontario); Ottawa Hospital Research Institute	This study started as a graduate thesis project and, as such, a thesis proposal required initial approval by the University of Ottawa, from which MK received a scholarship. DWC is supported as a Career Scientist of the Ontario Ministry of Health/Ontario HIV Treatment Network. However, he received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; This study started as a graduate thesis project by Madzouka Kokolo, who received a scholarship from the University of Ottawa and a fellow stipend from the Ottawa Hospital Research Institute. These do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other funding was specifically received for this study.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Anton P, 2009, 2 SITE PHASE 1 PARTI, V1; Anton P, 2010, NCT00984971; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL; AVAC, 2008, ANT RES PREP TRIALS; Celum C, 2008, NCT00557245; Celum CL, 2007, PARALLEL COMP TENOFO, V3. 0; Center for Disease Control and Prevention (CDC), 2007, Q A CDCS CLIN STUD P; Center for Disease Control and Prevention (CDC), 2009, STAT BOTSW TDF2 STUD; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chillag K, 2007, NCT00131677; Chirenje Z, 2009, NCT00705679; Chirenje Z, 2008, PHASE 2B SAFETY EFFE, V1. 0; Choopanya K, 2008, NCT00119106; Choopanya K, 2007, STUDY SAFETY EFFICAC, V7; DAIDS Regulatory Affairs Board, 2004, INF CONS FORM HOP WO, V1; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; . Family Health International ( FHI), 2008, ENR CONS FORM, V1. 0; Family Health International (FHI), 2004, ENR CONS FORM, V2; Global Campaign for Microbicides, 2006, RES RASH LESS CAM PR; Global Campaign for Microbicides Global, PREV PREV TRIAL FAIL; Grant R, 2008, CHEMOPROPHYLAXIS HIV, V4; Grant R, 2008, SAMPLE CONSENT ENROL, V4. 0; Grant R, 2010, SAMPLE CONSENT ENROL, V4. 0; Grant R, 2009, NCT00458393; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf L, 2007, PHASE 2 EXTENDED SAF, V1. 6; Grosskurth H, 2009, NCT00931346; Hendrix C, 2007, PHASE 2 ADHERENCE PH, V1. 0; Hendrix C, 2008, NCT00592124; HIV Prevention Treatment Network, 2010, 066 HPTN; HIV Prevention Treatment Network, 2010, BEH ASP PREP COUNS I; HIV Vaccines and Microbicides Resource Tracking Working Group, 2000, PREP; Hoffman I, 2006, NCT00122512; Hosek S, 2010, NCT01033942; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jackson JB, 2003, AIDS, V17, P547, DOI 10.1097/00002030-200303070-00010; [Joint United Nations Programme for HIV/ AIDS (UNAIDS) World Health Organization (WHO)], 2007, ETH COND BIOM HIV PR; Karim QB, 2006, AIDS, V20, pW1, DOI 10.1097/01.aids.0000218573.29930.67; Kokolo M, 2009, CAN J INFECT DIS SB, V20; Lagakos SW, 2008, METHODOLOGICAL CHALL; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Mutua G, 2010, NCT00971230; Networking for Ethics on Biomedical Research in Africa ( NEBRA), 2006, NEBRA AN ENQ RAPP FI; New HIV Vaccines and Microbicides Advocacy Society (NHVMAS), 2009, OR TEN CONTR; Nyika A, 2009, J MED ETHICS, V35, P189, DOI 10.1136/jme.2008.025189; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; Page-Shafer K, 2004, STUDY DAILY ORAL TEN, V1; Page-Shafer K, 2008, NCT00078182; Paxton L, 2007, NCT00448669; Perrey C, 2009, DEV WORLD BIOETH, V9, P88, DOI 10.1111/j.1471-8847.2008.00229.x; Peterson L, 2006, NCT00122486; Peterson L, 2007, PHASE 2 STUDY TENOFO, V3.5; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Smith D, STUDY SAFETY EFFICAC, V2. 0; Smith D, 2007, NCT00111150; Smith Stephen M, 2004, Retrovirology, V1, P16, DOI 10.1186/1742-4690-1-16; Thigpen M, 2008, STUDY SAFETY EFFICAC, V3. 1; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; Van Damme L, 2009, NCT00625404; Van Damme L, PHASE 3 MULTICENTER, V1. 0; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wendler D. D., 2008, OXFORD TXB CLIN RES, P123; *WORLD MED ASS, 2000, DECL HELS ETH PRINC	65	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22497	10.1371/journal.pone.0022497	http://dx.doi.org/10.1371/journal.pone.0022497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850229	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300013
J	Korhonen, JJ; Wang, JJ; Soininen, J				Korhonen, Jenni J.; Wang, Jianjun; Soininen, Janne			Productivity-Diversity Relationships in Lake Plankton Communities	PLOS ONE			English	Article							SPECIES RICHNESS; MICROBIAL DIVERSITY; ZOOPLANKTON DIVERSITY; BIODIVERSITY; PATTERNS; STABILITY; PHYTOPLANKTON; HETEROGENEITY; CONSEQUENCES; ENVIRONMENTS	One of the most intriguing environmental gradients connected with variation in diversity is ecosystem productivity. The role of diversity in ecosystems is pivotal, because species richness can be both a cause and a consequence of primary production. However, the mechanisms behind the varying productivity-diversity relationships (PDR) remain poorly understood. Moreover, large-scale studies on PDR across taxa are urgently needed. Here, we examined the relationships between resource supply and phyto-, bacterio-, and zooplankton richness in 100 small boreal lakes. We studied the PDR locally within the drainage systems and regionally across the systems. Second, we studied the relationships between resource availability, species richness, biomass and resource ratio (N:P) in phytoplankton communities using Structural Equation Modeling (SEM) for testing the multivariate hypothesis of PDR. At the local scale, the PDR showed variable patterns ranging from positive linear and unimodal to negative linear relationships for all planktonic groups. At the regional scale, PDRs were significantly linear and positive for phyto- and zooplankton. Phytoplankton richness and the amount of chlorophyll a showed a positive linear relationship indicating that communities consisting of higher number of species were able to produce higher levels of biomass. According to the SEM, phytoplankton biomass was largely related to resource availability, yet there was a pathway via community richness. Finally, we found that species richness at all trophic levels was correlated with several environmental factors, and was also related to richness at the other trophic levels. This study showed that the PDRs in freshwaters show scale-dependency. We also documented that the PDR complies with the multivariate model showing that plant biomass is not mirroring merely the resource availability, but is also influenced by richness. This highlights the need for conserving diversity in order to maintain ecosystem processes in freshwaters.	[Korhonen, Jenni J.; Soininen, Janne] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Wang, Jianjun] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China	University of Helsinki; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Korhonen, JJ (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	jenni.j.korhonen@helsinki.fi	Soininen, Janne/A-4205-2008	Soininen, Janne/0000-0002-8583-3137; Wang, Jianjun/0000-0001-7039-7136	University of Helsinki [2157010]; Academy of Finland [126718]	University of Helsinki; Academy of Finland(Academy of Finland)	This study was supported by grants from University of Helsinki (www.helsinki.fi/yliopisto, grant no. 2157010) and Academy of Finland (http://www.aka.fi/en-GB/A/, grant no. 126718). No additional external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P739, DOI 10.1139/cjfas-56-5-739; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gamfeldt L, 2008, INT REV HYDROBIOL, V93, P550, DOI 10.1002/iroh.200711022; Grace JB., 2015, STRUCTURAL EQUATION; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; Hessen DO, 2006, ECOLOGY, V87, P433, DOI 10.1890/05-0352; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2001, OECOLOGIA, V126, P114, DOI 10.1007/s004420000492; Horner-Devine MC, 2003, ECOL LETT, V6, P613; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; KINZIG AP, 2001, MONOGRAPHS POPULATIO, V33; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOREAU M, BIODIVERSITY ECOSYST; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Naeem S., 2009, BIODIVERSITY ECOSYST; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Partel M, 2007, J ECOL, V95, P90, DOI 10.1111/j.1365-2745.2006.01185.x; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ptacnik R, 2010, P ROY SOC B-BIOL SCI, V277, P3755, DOI 10.1098/rspb.2010.1158; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rosenzweig Michael L., 1993, P52; Shurin JB, 2007, ECOL LETT, V10, P127, DOI 10.1111/j.1461-0248.2006.01009.x; Shurin JB, 2010, ECOL LETT, V13, P453, DOI 10.1111/j.1461-0248.2009.01438.x; Smith VH, 2007, FEMS MICROBIOL ECOL, V62, P181, DOI 10.1111/j.1574-6941.2007.00381.x; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; Soininen J, 2011, LIMNOL OCEANOGR, V56, P508, DOI 10.4319/lo.2011.56.2.0508; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	65	52	60	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22041	10.1371/journal.pone.0022041	http://dx.doi.org/10.1371/journal.pone.0022041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850218	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300002
J	van Hemert, FJ; van de Klundert, MAA; Lukashov, VV; Kootstra, NA; Berkhout, B; Zaaijer, HL				van Hemert, Formijn J.; van de Klundert, Maarten A. A.; Lukashov, Vladimir V.; Kootstra, Neeltje A.; Berkhout, Ben; Zaaijer, Hans L.			Protein X of Hepatitis B Virus: Origin and Structure Similarity with the Central Domain of DNA Glycosylase	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR FUNCTIONS; CRYSTAL-STRUCTURE; DOCKING; EVOLUTION; INFECTION; INTERACTS; PROGRAM; HBXIP; GENE	Orthohepadnavirus (mammalian hosts) and avihepadnavirus (avian hosts) constitute the family of Hepadnaviridae and differ by their capability and inability for expression of protein X, respectively. Origin and functions of X are unclear. The evolutionary analysis at issue of X indicates that present strains of orthohepadnavirus started to diverge about 25,000 years ago, simultaneously with the onset of avihepadnavirus diversification. These evolutionary events were preceded by a much longer period during which orthohepadnavirus developed a functional protein X while avihepadnavirus evolved without X. An in silico generated 3D-model of orthohepadnaviral X protein displayed considerable similarity to the tertiary structure of DNA glycosylases (key enzymes of base excision DNA repair pathways). Similarity is confined to the central domain of MUG proteins with the typical DNA-binding facilities but without the capability of DNA glycosylase enzymatic activity. The hypothetical translation product of a vestigial X reading frame in the genome of duck hepadnavirus could also been folded into a DNA glycosylase-like 3D-structure. In conclusion, the most recent common ancestor of ortho-and avihepadnavirus carried an X sequence with orthology to the central domain of DNA glycosylase.	[van Hemert, Formijn J.; Lukashov, Vladimir V.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [van de Klundert, Maarten A. A.; Kootstra, Neeltje A.; Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Immunol,Ctr Infect & Immun Amsterdam CIN, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Hemert, FJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands.	f.j.vanhemert@amc.uva.nl; v.lukashov@amc.uva.nl	van de Klundert, Maarten/AAD-6207-2019	van de Klundert, Maarten/0000-0001-6407-9481; Kootstra, Neeltje A./0000-0001-9429-7754				Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; DELIUS H, 1983, J VIROL, V47, P337, DOI 10.1128/JVI.47.2.337-343.1983; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kortemme T, 2004, SCI STKE, V2004, P1; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lin B, 2000, INTERVIROLOGY, V43, P185, DOI 10.1159/000025037; Lin-Marq N, 2001, VIROLOGY, V287, P266, DOI 10.1006/viro.2001.1036; Ocama Ponsiano, 2005, Am J Med, V118, P1413, DOI 10.1016/j.amjmed.2005.06.021; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Park SG, 2003, EUR J BIOCHEM, V270, P2929, DOI 10.1046/j.1432-1033.2003.03650.x; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadri I, 1996, J BIOL CHEM, V271, P15443, DOI 10.1074/jbc.271.26.15443; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Hemert FJ, 2008, VIROLOGY, V370, P362, DOI 10.1016/j.virol.2007.08.036; van Hemert FJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-146; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23392	10.1371/journal.pone.0023392	http://dx.doi.org/10.1371/journal.pone.0023392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850270	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300055
J	Joshi, NN; Kale, MD; Hake, SS; Kannan, S				Joshi, Narendra N.; Kale, Mithila D.; Hake, Sujata S.; Kannan, Sadhana			Transforming Growth Factor beta Signaling Pathway Associated Gene Polymorphisms May Explain Lower Breast Cancer Risk in Western Indian Women	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; TGFBR1 POLYMORPHISMS; TGFBR1-ASTERISK-6A; SUSCEPTIBILITY; VARIANT; POPULATION; RESPONSES; DISEASE; PREDICT; GENOME	Transforming growth factor beta 1 (TGFB1) T29C and TGF beta receptor type 1 (TGFBR1) 6A/9A polymorphisms have been implicated in the modulation of risk for breast cancer in Caucasian women. We analyzed these polymorphisms and combinations of their genotypes, in pre menopausal breast cancer patients (N = 182) and healthy women (N = 236) from western India as well as in breast cancer patients and healthy women from the Parsi community (N = 48 & 171, respectively). Western Indian women were characterized by a higher frequency of TGFB1*C allele of the TGF beta T29C polymorphism (0.48 vs 0.44) and a significantly lower frequency of TGFBR1*6A allele of the TGFBR1 6A/9A polymorphism (0.02 vs 0.068, p<0.01) as compared to healthy Parsi women. A strong protective effect of TGFB1*29C allele was seen in younger western Indian women (<40 yrs; OR = 0.45, 95% CI 0.25-0.81). Compared to healthy women, the strikingly higher frequencies of low or intermediate TGF beta signalers in patients suggested a strong influence of the combination of these genotypes on the risk for breast cancer in Parsi women (for intermediate signalers, OR = 4.47 95% CI 1.01-19.69). The frequency of low signalers in Parsi healthy women, while comparable to that reported in Europeans and Americans, was three times higher than that in healthy women from western India (10.6% vs 3.3%, p<0.01). These observations, in conjunction with the low incidence rate of breast cancer in Indian women compared to White women, raise a possibility that the higher frequency of TGFB1*29C allele and lower frequency of TGFBR1*6A allele may represent important genetic determinants that together contribute to a lower risk of breast cancer in western Indian women.	[Joshi, Narendra N.; Kale, Mithila D.; Hake, Sujata S.] Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Canc Res Inst, Kharghar, Navi Mumbai, India; [Kannan, Sadhana] Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Clin Res Ctr, Epidemiol & Clin Trials Unit, Kharghar, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Joshi, NN (corresponding author), Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Canc Res Inst, Kharghar, Navi Mumbai, India.	njoshi@actrec.gov.in			Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR/1317/Med/09/213/98]; Lady Tata Memorial Trust; Women's Cancer Initiative (TMC); ACTREC, TMC	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Lady Tata Memorial Trust; Women's Cancer Initiative (TMC); ACTREC, TMC	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR/1317/Med/09/213/98), The Lady Tata Memorial Trust, Women's Cancer Initiative (TMC), and Annual Scientific Fund, ACTREC, TMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blackwell CC, 2005, J LEUKOCYTE BIOL, V78, P1242, DOI 10.1189/jlb.0505253; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Chandalia M, 2003, J CLIN ENDOCR METAB, V88, P3773, DOI 10.1210/jc.2003-030301; Colleran G, 2010, BREAST CANCER RES TR, V119, P437, DOI 10.1007/s10549-009-0395-0; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Cox DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-175; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Dunning AM, 2003, CANCER RES, V63, P2610; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Fischbacher CM, 2003, ARTERIOSCL THROM VAS, V23, P703, DOI 10.1161/01.ATV.0000060449.70345.8E; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hishida Asahi, 2003, Breast Cancer, V10, P63, DOI 10.1007/BF02967627; Hu YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-169; Kakarala M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-191; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kaur G, 2007, TISSUE ANTIGENS, V69, P113, DOI 10.1111/j.1399-0039.2006.00740.x; Khalilzadeh O, 2010, CLIN EXP MED, V10, P123, DOI 10.1007/s10238-009-0078-5; Krippl P, 2003, CANCER LETT, V201, P181, DOI 10.1016/S0304-3835(03)00468-3; Kulkarni S, 2008, IMMUNOGENETICS, V60, P121, DOI 10.1007/s00251-008-0279-1; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P412; Le Souef PN, 2000, LANCET, V356, P242; Liao RY, 2010, MOL BIOL REP, V37, P3227, DOI 10.1007/s11033-009-9906-7; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma X, 2010, J CERAM PROCESS RES, V11, P392; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; NANAVUTTY P, 1997, PARSIS; Notani PN, 2001, CURR SCI INDIA, V81, P465; Papadopoulou E, 2008, NEOPLASMA, V55, P229; Pasche B, 1999, CANCER RES, V59, P5678; Pasche B, 2005, JAMA-J AM MED ASSOC, V294, P1634, DOI 10.1001/jama.294.13.1634; Pasche B, 1998, CANCER RES, V58, P2727; Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Qiu LX, 2010, BREAST CANCER RES TR, V123, P563, DOI 10.1007/s10549-010-0781-7; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rajkumar T, 2008, BREAST CANCER RES TR, V112, P81, DOI 10.1007/s10549-007-9821-3; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sastry PSRK, 2003, MED HYPOTHESES, V60, P573, DOI 10.1016/S0306-9877(03)00030-6; Schirmer MA, 2009, PHARMACOGENET GENOM, V19, P249, DOI 10.1097/FPC.0b013e32831cb5a7; Taherkhani H, 2009, INT J IMMUNOGENET, V36, P345, DOI 10.1111/j.1744-313X.2009.00873.x; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Yeole Balkrishna B, 2003, Asian Pac J Cancer Prev, V4, P51; Yeole Balkrishna Bhika, 2001, Asian Pac J Cancer Prev, V2, P293; You W, 2007, J THORAC ONCOL, V2, P657, DOI 10.1097/JTO.0b013e318070ccd7; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e21866	10.1371/journal.pone.0021866	http://dx.doi.org/10.1371/journal.pone.0021866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829601	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200004
J	Johansson, MA; Sjogren, YM; Persson, JO; Nilsson, C; Sverremark-Ekstrom, E				Johansson, Maria A.; Sjogren, Ylva M.; Persson, Jan-Olov; Nilsson, Caroline; Sverremark-Ekstrom, Eva			Early Colonization with a Group of Lactobacilli Decreases the Risk for Allergy at Five Years of Age Despite Allergic Heredity	PLOS ONE			English	Article							EARLY INTESTINAL COLONIZATION; GUT MICROBIOTA COMPOSITION; PLACEBO-CONTROLLED TRIAL; HOST IMMUNE-SYSTEM; FECAL MICROBIOTA; HEALTHY INFANTS; ATOPIC ECZEMA; PROBIOTICS; RESPONSES; CHILDREN	Background: Microbial deprivation early in life can potentially influence immune mediated disease development such as allergy. The aims of this study were to investigate the influence of parental allergy on the infant gut colonization and associations between infant gut microbiota and allergic disease at five years of age. Methods and Findings: Fecal samples were collected from 58 infants, with allergic or non-allergic parents respectively, at one and two weeks as well as at one, two and twelve months of life. DNA was extracted from the fecal samples and Real time PCR, using species-specific primers, was used for detection of Bifidobacterium (B.) adolescentis, B. breve, B. bifidum, Clostridium (C.) difficile, a group of Lactobacilli (Lactobacillus (L.) casei, L. paracasei and L. rhamnosus) as well as Staphylococcus (S.) aureus. Infants with non-allergic parents were more frequently colonized by Lactobacilli compared to infants with allergic parents (p = 0.014). However, non-allergic five-year olds acquired Lactobacilli more frequently during their first weeks of life, than their allergic counterparts, irrespectively of parental allergy (p = 0.009, p = 0.028). Further the non-allergic children were colonized with Lactobacilli on more occasions during the first two months of life (p = 0.038). Also, significantly more non-allergic children were colonized with B. bifidum at one week of age than the children allergic at five years (p = 0.048). Conclusion: In this study we show that heredity for allergy has an impact on the gut microbiota in infants but also that early Lactobacilli (L. casei, L. paracasei, L. rhamnosus) colonization seems to decrease the risk for allergy at five years of age despite allergic heredity.	[Johansson, Maria A.; Sjogren, Ylva M.; Sverremark-Ekstrom, Eva] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Persson, Jan-Olov] Stockholm Univ, Div Math Stat, Dept Math, S-10691 Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden	Stockholm University; Stockholm University; Karolinska Institutet; Karolinska Institutet	Johansson, MA (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	maria.johansson@imun.su.se; eva.sverremark@imun.su.se	Sverremark-Ekström, Eva/A-2305-2016; Nilsson, Caroline/AAF-9663-2022; Nilsson, Caroline/AFK-2402-2022	Sverremark-Ekström, Eva/0000-0001-6271-8681; 	Swedish Research Council [57X-15160-05-2, 57X-15160-07-3]; Ekhaga Foundation; Cancer and Allergy Foundation; Mjolkdroppen Foundation; Magnus Bergvall Foundation; Konsul Th C Bergh foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ekhaga Foundation; Cancer and Allergy Foundation; Mjolkdroppen Foundation; Magnus Bergvall Foundation; Konsul Th C Bergh foundation	This work was supported by the Swedish Research Council (grants 57X-15160-05-2 and 57X-15160-07-3) and the Ekhaga Foundation, the Cancer and Allergy Foundation, the Mjolkdroppen Foundation, the Magnus Bergvall Foundation, and the Konsul Th C Bergh foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bottcher MF, 2003, CLIN EXP ALLERGY, V33, P295, DOI 10.1046/j.1365-2222.2003.01562.x; Bottcher MF, 2002, CLIN EXP ALLERGY, V32, P1293, DOI 10.1046/j.1365-2222.2002.01470.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dong P, 2010, EARLY HUM DEV, V86, P51, DOI 10.1016/j.earlhumdev.2010.01.002; Edelman SM, 2008, CURR OPIN GASTROEN, V24, P720, DOI 10.1097/MOG.0b013e32830c4355; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Karlsson H, 2002, INFECT IMMUN, V70, P6688, DOI 10.1128/IAI.70.12.6688-6696.2002; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Martino DJ, 2008, CLIN EXP ALLERGY, V38, P69, DOI 10.1111/j.1365-2222.2007.02856.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2010, MICROBIOL-SGM, V156, P3298, DOI 10.1099/mic.0.042069-0; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011	37	103	111	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23031	10.1371/journal.pone.0023031	http://dx.doi.org/10.1371/journal.pone.0023031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829685	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511200031
J	Yilmaz, S; Sancar, A; Kemp, MG				Yilmaz, Secil; Sancar, Aziz; Kemp, Michael G.			Multiple ATR-Chk1 Pathway Proteins Preferentially Associate with Checkpoint-Inducing DNA Substrates	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; XENOPUS EGG EXTRACTS; ATR-ATRIP COMPLEX; DAMAGE CHECKPOINT; HUMAN CLASPIN; BINDING PROTEIN; FISSION YEAST; GROUP-A; REPLICATION; ACTIVATION	The ATR-Chk1 DNA damage checkpoint pathway is a critical regulator of the cellular response to DNA damage and replication stress in human cells. The variety of environmental, chemotherapeutic, and carcinogenic agents that activate this signal transduction pathway do so primarily through the formation of bulky adducts in DNA and subsequent effects on DNA replication fork progression. Because there are many protein-protein and protein-DNA interactions proposed to be involved in activation and/or maintenance of ATR-Chk1 signaling in vivo, we systematically analyzed the association of a number of ATR-Chk1 pathway proteins with relevant checkpoint-inducing DNA structures in vitro. These DNA substrates included single-stranded DNA, branched DNA, and bulky adduct-containing DNA. We found that many checkpoint proteins show a preference for single-stranded, branched, and bulky adduct-containing DNA in comparison to undamaged, double-stranded DNA. We additionally found that the association of checkpoint proteins with bulky DNA damage relative to undamaged DNA was strongly influenced by the ionic strength of the binding reaction. Interestingly, among the checkpoint proteins analyzed the checkpoint mediator proteins Tipin and Claspin showed the greatest differential affinity for checkpoint-inducing DNA structures. We conclude that the association and accumulation of multiple checkpoint proteins with DNA structures	[Yilmaz, Secil; Sancar, Aziz; Kemp, Michael G.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Yilmaz, S (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	michael_kemp@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Yilmaz, Secil/A-9051-2016	Kemp, Michael G./0000-0001-8203-0745; 	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM32833 to Aziz Sancar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bomgarden RD, 2004, J BIOL CHEM, V279, P13346, DOI 10.1074/jbc.M311098200; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Choi JH, 2009, NUCL ACIDS RES; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang M, 2010, MOL CELL, V39, P259, DOI 10.1016/j.molcel.2010.07.005; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Sercin O, 2011, CELL CYCLE, V10, P1599, DOI 10.4161/cc.10.10.15562; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22986	10.1371/journal.pone.0022986	http://dx.doi.org/10.1371/journal.pone.0022986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829571	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500064
J	Eliyahu, E; Shtraizent, N; He, XX; Chen, DN; Shalgi, R; Schuchman, EH				Eliyahu, Efrat; Shtraizent, Nataly; He, Xingxuan; Chen, Dafna; Shalgi, Ruth; Schuchman, Edward H.			Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BREAST-CANCER; DISEASE; ASSAY; MICE	Autoproteolytic cleavage of the inactive acid ceramidase (AC) precursor into the active heterodimer exposes a free cysteine residue, leading us to study whether AC could be regulated by one or more members of the cystatin family. Co-expression of the full-length AC and cystatin SA (cysSA) cDNAs led to significant reduction of AC activity in the transfected cells. Expression of cysSA also inhibited endogenous AC activity in cells and increased ceramide. Conversely, cysSA siRNA expression led to elevated AC activity and reduction in ceramide. The effects of cysSA siRNA expression could be reversed by the addition of recombinant cysSA into the culture media. These results were consistent with detection of a physical interaction between AC and cysSA, assessed by co-immunoprecipitation and nickel-nitrilotriacetic acid affinity chromatography, and further supported by co-localization of the endogenous proteins using confocal microscopy. In vitro kinetic analysis of purified, recombinant AC and cysSA confirmed the transfection results and suggested a non-competitive type of inhibition with a K-i in the low micromolar range. Processing of the AC precursor into the active form was not affected by cysSA expression, suggesting that it likely inhibits AC by allosteric interference. Computer modeling and expression studies identified several potential inhibitory domains in cysSA, including a small "AC-like" domain (identical to the AC cleavage site, TICT). Small peptides, synthesized with combinations of this and a "cystatin-like" domain (QXVXG), exhibited significant AC inhibition as well. Such peptide-based AC inhibitors could potentially be used to regulate AC activity in cancer cells that are known to overexpress this enzyme alone and in combination with conventional anti-cancer drugs.	[Eliyahu, Efrat; Shtraizent, Nataly; He, Xingxuan; Chen, Dafna; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Shtraizent, Nataly; Shalgi, Ruth] Tel Aviv Univ, Dept Dev & Cell Biol, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Icahn School of Medicine at Mount Sinai; Tel Aviv University; Sackler Faculty of Medicine	Schuchman, EH (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, Room 14-20A, New York, NY 10029 USA.	Edward.Schuchman@mssm.edu			National Institutes of Health [2 R01 DK54830]; Binational Science Foundation [2009212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 DK54830. This work was also supported by Binational Science Foundation Grant 2009212. N. S., E. E., X. H., and E. H. S. are inventors on AC-related patent applications, which if licensed could generate royalties for them and the Mount Sinai School of Medicine.	AZUMA N, 1994, ARCH BIOCHEM BIOPHYS, V311, P354, DOI 10.1006/abbi.1994.1248; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Feldman AS, 2009, CLIN CANCER RES, V15, P1024, DOI 10.1158/1078-0432.CCR-08-1143; HALL A, 1993, BIOCHEM J, V291, P123, DOI 10.1042/bj2910123; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; He XX, 2001, ANAL BIOCHEM, V293, P204, DOI 10.1006/abio.2001.5108; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Saitoh E, 1998, ARCH BIOCHEM BIOPHYS, V352, P199, DOI 10.1006/abbi.1997.0609; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Usova TA, 2003, B EXP BIOL MED+, V135, P81, DOI 10.1023/A:1023462316317; van Lijnschoten G, 2000, PEDIATR DEVEL PATHOL, V3, P597, DOI 10.1007/s100240010107; Veena MS, 2008, GENE CHROMOSOME CANC, V47, P740, DOI 10.1002/gcc.20576; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030	23	13	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35624	35633		10.1074/jbc.M111.260372	http://dx.doi.org/10.1074/jbc.M111.260372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21846728	hybrid, Green Published			2022-12-25	WOS:000295927100034
J	Astudillo, AM; Perez-Chacon, G; Meana, C; Balgoma, D; Pol, A; del Pozo, MA; Balboa, MA; Balsinde, J				Astudillo, Alma M.; Perez-Chacon, Gema; Meana, Clara; Balgoma, David; Pol, Albert; del Pozo, Miguel A.; Balboa, Maria A.; Balsinde, Jesus			Altered Arachidonate Distribution in Macrophages from Caveolin-1 Null Mice Leading to Reduced Eicosanoid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); MOUSE PERITONEAL-MACROPHAGES; PLATELET-ACTIVATING-FACTOR; FATTY-ACID INCORPORATION; DIET-INDUCED OBESITY; PROTEIN-KINASE-C; P388D(1) MACROPHAGES; U937 CELLS; PLASMA-MEMBRANE; STIMULATED MACROPHAGES	In this work we have studied the effect of caveolin-1 deficiency on the mechanisms that regulate free arachidonic acid (AA) availability. The results presented here demonstrate that macrophages from caveolin-1-deficient mice exhibit elevated fatty acid incorporation and remodeling and a constitutively increased CoA-independent transacylase activity. Mass spectrometry-based lipidomic analyses reveal stable alterations in the profile of AA distribution among phospholipids, manifested by reduced levels of AA in choline glycerophospholipids but elevated levels in ethanolamine glycerophospholipids and phosphatidylinositol. Furthermore, macrophages from caveolin-1 null mice show decreased AA mobilization and prostaglandin E-2 and LTB4 production upon cell stimulation. Collectively, these results provide insight into the role of caveolin-1 in AA homeostasis and suggest an important role for this protein in the eicosanoid biosynthetic response.	[Astudillo, Alma M.; Perez-Chacon, Gema; Meana, Clara; Balgoma, David; Balboa, Maria A.; Balsinde, Jesus] Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Astudillo, Alma M.; Meana, Clara; Balboa, Maria A.; Balsinde, Jesus] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain; [Pol, Albert] Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; [del Pozo, Miguel A.] Ctr Nacl Invest Cardiovasc, Dept Biol Vasc & Inflamac, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Balsinde, J (corresponding author), Univ Valladolid, Sch Med, Calle Sanz & Fores 3, Valladolid 47003, Spain.	jbalsinde@ibgm.uva.es	del Pozo, Miguel Angel/L-2861-2014; Perez-Chacon, Gema/H-5954-2015; Meana, Clara/AAN-4887-2020; Balboa, María A./V-9493-2018; Balgoma, David/ABG-9548-2020; Pol, Albert/M-1865-2014; Balsinde, Jesús/C-7833-2018	del Pozo, Miguel Angel/0000-0001-9077-391X; Perez-Chacon, Gema/0000-0002-2081-0882; Balboa, María A./0000-0002-2130-5298; Pol, Albert/0000-0002-1750-1085; Balsinde, Jesús/0000-0002-4157-6714; Balgoma Hernando, David/0000-0001-6463-4502; ASTUDILLO DEL VALLE, ALMA MARIA/0000-0002-9966-7950; Meana, Clara/0000-0003-3580-6058	Spanish Ministry of Science and Innovation [BFU2010-18826, SAF2010-18831]; Regional Government of Castile and Leon, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Castile and Leon, Spain	This work was supported by the Spanish Ministry of Science and Innovation Grants BFU2010-18826 and SAF2010-18831.; Supported by a predoctoral fellowship from the Regional Government of Castile and Leon, Spain.	Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Balboa MA, 2003, J IMMUNOL, V170, P5276, DOI 10.4049/jimmunol.170.10.5276; Balboa MA, 2008, FEBS J, V275, P1915, DOI 10.1111/j.1742-4658.2008.06350.x; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Balgoma D, 2010, BIOCHIMIE, V92, P645, DOI 10.1016/j.biochi.2009.11.010; Balgoma D, 2010, J IMMUNOL, V184, P3857, DOI 10.4049/jimmunol.0902883; Balgoma D, 2008, FEBS J, V275, P6180, DOI 10.1111/j.1742-4658.2008.06742.x; Balsinde J, 1996, EUR J BIOCHEM, V235, P480, DOI 10.1111/j.1432-1033.1996.00480.x; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; BALSINDE J, 1994, BBA-LIPID LIPID MET, V1210, P195, DOI 10.1016/0005-2760(94)90121-X; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; BALSINDE J, 1992, BIOCHIM BIOPHYS ACTA, V1136, P75, DOI 10.1016/0167-4889(92)90087-R; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; BALSINDE J, 1990, J IMMUNOL, V144, P4298; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; BALSINDE J, 1994, EUR J BIOCHEM, V221, P1013, DOI 10.1111/j.1432-1033.1994.tb18818.x; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boilard E, 2001, J BIOL CHEM, V276, P17568, DOI 10.1074/jbc.M006152200; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; DIEZ E, 1987, BIOCHIM BIOPHYS ACTA, V921, P82, DOI 10.1016/0005-2760(87)90173-1; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; FONTEH AN, 1992, J IMMUNOL, V148, P1784; FONTEH AN, 1993, J IMMUNOL, V150, P563; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Heimer S, 2008, BIOCHEM BIOPH RES CO, V367, P826, DOI 10.1016/j.bbrc.2008.01.010; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; KAEVER V, 1988, PROSTAGLANDINS, V35, P885, DOI 10.1016/0090-6980(88)90114-1; KAYGANICH KA, 1992, ANAL CHEM, V64, P2965, DOI 10.1021/ac00047a015; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kiss AL, 1997, EUR J CELL BIOL, V73, P19; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Murphy R. C, 2002, MASS SPECTROMETRY PH; NIETO ML, 1991, J BIOL CHEM, V266, P18699; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; SCOTT WA, 1982, J EXP MED, V155, P1148, DOI 10.1084/jem.155.4.1148; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Surette ME, 1999, CARCINOGENESIS, V20, P757, DOI 10.1093/carcin/20.5.757; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Trimboli AJ, 1999, CANCER RES, V59, P6171; VENABLE ME, 1991, J BIOL CHEM, V266, P18691; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yan SR, 1996, FEBS LETT, V380, P198	71	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35299	35307		10.1074/jbc.M111.277137	http://dx.doi.org/10.1074/jbc.M111.277137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852231	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000295406300083
J	Win, S; Than, TA; Han, D; Petrovic, LM; Kaplowitz, N				Win, Sanda; Tin Aung Than; Han, Derick; Petrovic, Lydia M.; Kaplowitz, Neil			c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEPATOCYTE APOPTOSIS; SIGNAL-TRANSDUCTION PATHWAY; REACTIVE OXYGEN; JNK ACTIVATION; MOUSE HEPATOCYTES; DNA-DAMAGE; CELL-DEATH; HEPATOTOXICITY; RELEASE; PHOSPHORYLATION	Sustained JNK activation plays a critical role in hepatotoxicity by acetaminophen or GalN/TNF-alpha. To address the importance of JNK translocation to mitochondria that accompanies sustained activation in these models, we assessed the importance of the expression of a potential initial target of JNK in the outer membrane of mitochondria, namely Sab (SH3 domain-binding protein that preferentially associates with Btk), also known as Sh3bp5 (SH3 domain-binding protein 5). Silencing the expression of Sab in the liver using adenoviral shRNA inhibited sustained JNK activation and mitochondrial targeting of JNK and the upstream MKK4 (MAPK kinase 4), accompanied by striking protection against liver injury in vivo and in cultured hepatocytes in both toxicity models. We conclude that mitochondrial Sab may serve as a platform for the MAPK pathway enzymes and that the interaction of stress-activated JNK with Sab is required for sustained JNK activation and toxicity.	[Win, Sanda; Tin Aung Than; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, USC Res Ctr Liver Dis, Div Gastrointestinal & Liver Dis, Los Angeles, CA 90089 USA; [Petrovic, Lydia M.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, USC Res Ctr Liver Dis, Div Gastrointestinal & Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [R01 DK067215];  [DK067215];  [AA016911]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK067215 (to N. K.), a training supplement to Grant DK067215 to promote reentry into research careers (to S. W.), and K01 Award AA016911 (to D. H.).	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bradham CA, 1997, HEPATOLOGY, V25, P1128, DOI 10.1002/hep.510250514; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Court NW, 2004, BIOCHEM BIOPH RES CO, V319, P130, DOI 10.1016/j.bbrc.2004.04.148; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Getachew Y, 2010, BIOCHEM PHARMACOL, V79, P1363, DOI 10.1016/j.bcp.2009.12.019; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D., 2010, HDB EXP PHARM, V196, P267, DOI DOI 10.1007/978-3-642-00663-0_10; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Osawa Y, 2001, J CELL PHYSIOL, V187, P374, DOI 10.1002/jcp.1088; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Shinohara M, 2010, J BIOL CHEM, V285, P8244, DOI 10.1074/jbc.M109.054999; Than TA, 2011, J BIOL CHEM, V286, P22047, DOI 10.1074/jbc.M111.240481; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	39	129	135	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35071	35078		10.1074/jbc.M111.276089	http://dx.doi.org/10.1074/jbc.M111.276089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844199	hybrid, Green Published			2022-12-25	WOS:000295406300060
J	Gates, DP; Coonrod, LA; Berglund, JA				Gates, Devika P.; Coonrod, Leslie A.; Berglund, J. Andrew			Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SECONDARY STRUCTURE PREDICTION; SINGLE NUCLEOTIDE RESOLUTION; EXPANDED-REPEAT TRANSCRIPTS; PRIMER EXTENSION SHAPE; TRACT BINDING-PROTEIN; DISTANT BRANCH-POINTS; MYOTONIC-DYSTROPHY; MAMMALIAN INTRONS; CHLORIDE CHANNEL	Muscleblind-like 1 (MBNL1) is a splicing factor whose improper cellular localization is a central component of myotonic dystrophy. In myotonic dystrophy, the lack of properly localized MBNL1 leads to missplicing of many pre-mRNAs. One of these events is the aberrant inclusion of exon 5 within the MBNL1 pre-mRNA. The region of the MBNL1 gene that includes exon 5 and flanking intronic sequence is highly conserved in vertebrate genomes. The 3'-end of intron 4 is non-canonical in that it contains a predicted branch point that is 141 nucleotides from the 3'-splice site and an AAG 3'-splice site. Using a minigene that includes exon 4, intron 4, exon 5, intron 5, and exon 6 of MBNL1, we showed that MBNL1 regulates inclusion of exon 5. Mapping of the intron 4 branch point confirmed that branching occurs primarily at the predicted distant branch point. Structure probing and footprinting revealed that the highly conserved region between the branch point and 3'-splice site is primarily unstructured and that MBNL1 binds within this region of the pre-mRNA. Deletion of the MBNL1 response element eliminated MBNL1 splicing regulation and led to complete inclusion of exon 5, which is consistent with the suppressive effect of MBNL1 on splicing.	[Berglund, J. Andrew] Univ Oregon, Inst Mol Biol 1229, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Berglund, JA (corresponding author), Univ Oregon, Inst Mol Biol 1229, Dept Chem, Eugene, OR 97403 USA.	aberglund@molbio.uoregon.edu	Berglund, Andrew/AAS-1065-2021		National Institutes of Health [AR053903, GM-07759]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR053903 (to J. A. B.) and Training Grant GM-07759 (to D. P. G.).	Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Gooding C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r1; Grossman JS, 1998, RNA, V4, P613, DOI 10.1017/S1355838298971448; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Murray JI, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r97; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Sathirapongsasuti JF, 2011, NUCLEIC ACIDS RES, V39, P1967, DOI 10.1093/nar/gkq949; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Tran H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194928; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	44	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34224	34233		10.1074/jbc.M111.236547	http://dx.doi.org/10.1074/jbc.M111.236547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832083	Green Published, hybrid			2022-12-25	WOS:000295159200052
J	Drozdov, I; Svejda, B; Gustafsson, BI; Mane, S; Pfragner, R; Kidd, M; Modlin, IM				Drozdov, Ignat; Svejda, Bernhard; Gustafsson, Bjorn I.; Mane, Shrikant; Pfragner, Roswitha; Kidd, Mark; Modlin, Irvin M.			Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; FUNCTIONAL-CHARACTERIZATION; CHROMOGRANIN-A; CELL-LINE; KRJ-I; EXPRESSION; TUMOR; TRANSCRIPTION; MICROARRAY; PHOSPHORYLATION	Small intestinal (SI) neuroendocrine tumors (NET) are increasing in incidence, however little is known about their biology. High throughput techniques such as inference of gene regulatory networks from microarray experiments can objectively define signaling machinery in this disease. Genome-wide co-expression analysis was used to infer gene relevance network in SI-NETs. The network was confirmed to be non-random, scale-free, and highly modular. Functional analysis of gene co-expression modules revealed processes including 'Nervous system development', 'Immune response', and 'Cell-cycle'. Importantly, gene network topology and differential expression analysis identified over-expression of the GPCR signaling regulators, the cAMP synthetase, ADCY2, and the protein kinase A, PRKAR1A. Seven CREB response element (CRE) transcripts associated with proliferation and secretion: BEX1, BICD1, CHGB, CPE, GABRB3, SCG2 and SCG3 as well as ADCY2 and PRKAR1A were measured in an independent SI dataset (n = 10 NETs; n = 8 normal preparations). All were up-regulated (p<0.035) with the exception of SCG3 which was not differently expressed. Forskolin (a direct cAMP activator, 10(-5) M) significantly stimulated transcription of pCREB and 3/7 CREB targets, isoproterenol (a selective beta-adrenergic receptor agonist and cAMP activator, 10(-5) M) stimulated pCREB and 4/7 targets while BIM-53061 (a dopamine D-2 and Serotonin [5-HT2] receptor agonist, 10(-6) M) stimulated 100% of targets as well as pCREB; CRE transcription correlated with the levels of cAMP accumulation and PKA activity; BIM-53061 stimulated the highest levels of cAMP and PKA (2.8-fold and 2.5-fold vs. 1.8-2-fold for isoproterenol and forskolin). Gene network inference and graph topology analysis in SI NETs suggests that SI NETs express neural GPCRs that activate different CRE targets associated with proliferation and secretion. In vitro studies, in a model NET cell system, confirmed that transcriptional effects are signaled through the cAMP/PKA/pCREB signaling pathway and that a SI NET cell line was most sensitive to a D-2 and 5-HT2 receptor agonist BIM-53061.	[Drozdov, Ignat] Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, James Black Ctr, London WC2R 2LS, England; [Drozdov, Ignat] Kings Coll London, Ctr Bioinformat, Sch Phys Sci & Engn, London WC2R 2LS, England; [Svejda, Bernhard; Kidd, Mark; Modlin, Irvin M.] Yale Univ, Sch Med, Gastrointestinal Pathobiol Res Grp, New Haven, CT USA; [Gustafsson, Bjorn I.] St Olavs Hosp, Dept Gastroenterol, Trondheim, Norway; [Gustafsson, Bjorn I.] NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Mane, Shrikant] Yale Univ, Keck Affymetrix Facil, Sch Med, New Haven, CT USA; [Pfragner, Roswitha] Med Univ Graz, Inst Pathophysiol & Immunol, Ctr Mol Med, Graz, Austria	University of London; King's College London; University of London; King's College London; Yale University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Yale University; Medical University of Graz	Drozdov, I (corresponding author), Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, James Black Ctr, London WC2R 2LS, England.	mark.kidd@yale.edu; imodlin@optonline.net		Drozdov, Ignat/0000-0001-6727-4688	British Heart Foundation (BHF); National Institutes of Health [CA097050, DK080871]; NATIONAL CANCER INSTITUTE [R01CA097050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	British Heart Foundation (BHF)(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Parts of this work were supported by the British Heart Foundation (BHF) through a PhD studentship for ID, and by the National Institutes of Health: CA097050 (IMM) and DK080871 (MK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; BARBER DL, 1986, AM J PHYSIOL, V250, pG385, DOI 10.1152/ajpgi.1986.250.3.G385; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Boushey Robin P, 2002, Curr Treat Options Oncol, V3, P319, DOI 10.1007/s11864-002-0031-2; CETIN Y, 1994, P NATL ACAD SCI USA, V91, P2935, DOI 10.1073/pnas.91.8.2935; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; DeRisi J, 1996, NAT GENET, V14, P457; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P4934, DOI 10.1002/cncr.24533; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Faure C, 2010, GASTROENTEROLOGY, V139, P249, DOI 10.1053/j.gastro.2010.03.032; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; Florio T, 2008, FRONT BIOSCI-LANDMRK, V13, P822, DOI 10.2741/2722; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gustafsson BI, 2008, CURR OPIN ONCOL, V20, P1, DOI 10.1097/CCO.0b013e3282f1c595; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JIN L, 1993, J CLIN ENDOCR METAB, V76, P728, DOI 10.1210/jc.76.3.728; Kidd M, 2006, AM J PHYSIOL-GASTR L, V291, pG778, DOI 10.1152/ajpgi.00552.2005; Kidd M, 2006, ANN SURG ONCOL, V13, P253, DOI 10.1245/ASO.2006.12.011; Kidd M, 2006, ANN SURG, V243, P273, DOI 10.1097/01.sla.0000197734.28551.0f; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kidd M, 2007, CANCER-AM CANCER SOC, V109, P2420, DOI 10.1002/cncr.22725; Kidd M, 2007, J MOL ENDOCRINOL, V38, P181, DOI 10.1677/jme.1.02037; Kimura N, 2002, ENDOCR PATHOL, V13, P117, DOI 10.1385/EP:13:2:117; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Mahapatra NR, 2006, J NEUROCHEM, V99, P119, DOI 10.1111/j.1471-4159.2006.04128.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Modlin IM, 2007, AM J GASTROENTEROL, V102, P1464, DOI 10.1111/j.1572-0241.2007.01185.x; Modlin IM, 2006, J CLIN ENDOCR METAB, V91, P2340, DOI 10.1210/jc.2006-0110; Modlin IM, 2006, CLIN GASTROENTEROL H, V4, P526, DOI 10.1016/j.cgh.2005.12.008; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; National Cancer Institute's, SURV EP END RES SEER; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pfragner R, 1996, INT J ONCOL, V8, P513; Pigazzi M, 2007, HAEMATOLOGICA, V92, P1435, DOI 10.3324/haematol.11122; R Core Team, 2021, R LANG ENV STAT COMP; Rodien P, 2003, ANN ENDOCRINOL-PARIS, V64, P12; Rolph MS, 2006, PHARMACOL THERAPEUT, V109, P284, DOI 10.1016/j.pharmthera.2005.08.009; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sutton R, 2003, ENDOCR-RELAT CANCER, V10, P469, DOI 10.1677/erc.0.0100469; Svejda B, 2010, CANCER-AM CANCER SOC, V116, P2902, DOI 10.1002/cncr.25049; Taniwaki M, 2006, INT J ONCOL, V29, P567; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thomson ABR, 2001, DIGEST DIS SCI, V46, P2588, DOI 10.1023/A:1012746622735; van der Hiel B, 2003, EUR J ENDOCRINOL, V149, P479, DOI 10.1530/eje.0.1490479; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; WATERMAN M, 1985, SCIENCE, V229, P267, DOI 10.1126/science.2990047; Welford SM, 1998, NUCLEIC ACIDS RES, V26, P3059, DOI 10.1093/nar/26.12.3059; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	70	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22457	10.1371/journal.pone.0022457	http://dx.doi.org/10.1371/journal.pone.0022457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853033	Green Published, gold			2022-12-25	WOS:000293953400008
J	Wu, ZLL				Wu, Zhengliang L.			Phosphatase-Coupled Universal Kinase Assay and Kinetics for First-Order-Rate Coupling Reaction	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE KINASE; BETA-CELL GLUCOKINASE; EXPRESSION; CD39L2; KINOME; IDENTIFICATION	Kinases use adenosine-5'-triphosphate (ATP) as the donor substrate and generate adenosine-5'-diphosphate (ADP) as a product. An ADP-based phosphatase-coupled kinase assay is described here. In this assay, CD39L2, a nucleotidase, is added into a kinase reaction to hydrolyze ADP to AMP and phosphate. The phosphate is subsequently detected using malachite green phosphate-detection reagents. As ADP hydrolysis by CD39L2 displays a first-order rate constant, relatively simple equations are derived to calculate the coupling rate and the lagging time of the coupling reaction, allowing one to obtain kinase kinetic parameters without the completion of the coupling reaction. ATP inhibition of CD39L2-catalyzed ADP hydrolysis is also determined for correction of the kinetic data. As examples, human glucokinase, P. chrysogenum APS kinase and human ERK1, kinases specific for sugar, nucleotide and protein respectively, are assayed. To assess the compatibility of the method for high-throughput assays, Z' factors >0.5 are also obtained for the three kinases.	R&D Syst Inc, Minneapolis, MN 55413 USA		Wu, ZLL (corresponding author), R&D Syst Inc, Minneapolis, MN 55413 USA.	leon.wu@rndsystems.com		Wu, Zhengliang/0000-0002-0700-0906				Anderson SN, 2004, J BIOMOL SCREEN, V9, P112, DOI 10.1177/1087057103260592; Brooijmans N, 2010, PROTEIN SCI, V19, P763, DOI 10.1002/pro.355; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chadwick BP, 1998, GENOMICS, V50, P357, DOI 10.1006/geno.1998.5317; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; GRANET RA, 1987, ANAL BIOCHEM, V163, P458, DOI 10.1016/0003-2697(87)90248-X; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; Ivanenkov VV, 2003, BIOCHEMISTRY-US, V42, P11726, DOI 10.1021/bi035137r; Jia Yong, 2008, Curr Drug Discov Technol, V5, P59, DOI 10.2174/157016308783769414; Kleman-Leyer KM, 2009, ASSAY DRUG DEV TECHN, V7, P56, DOI 10.1089/adt.2008.175; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; LANGE AJ, 1991, BIOCHEM J, V277, P159, DOI 10.1042/bj2770159; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning Gerard, 2005, WormBook, P1; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; McDonald OB, 1999, ANAL BIOCHEM, V268, P318, DOI 10.1006/abio.1998.3030; Milanesi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S20; RENOSTO F, 1989, J BIOL CHEM, V264, P9433; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STORER AC, 1974, BIOCHEM J, V141, P205, DOI 10.1042/bj1410205; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; von Ahsen O, 2005, CHEMBIOCHEM, V6, P481, DOI 10.1002/cbic.200400211; WEI YF, 1990, ANAL BIOCHEM, V190, P188, DOI 10.1016/0003-2697(90)90179-D; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; XU LZ, 1995, J BIOL CHEM, V270, P9939, DOI 10.1074/jbc.270.17.9939; Yeung G, 2000, BIOCHEMISTRY-US, V39, P12916, DOI 10.1021/bi000959z; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	37	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23172	10.1371/journal.pone.0023172	http://dx.doi.org/10.1371/journal.pone.0023172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853082	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400029
J	Hioe, CE; Tuen, M; Vasiliver-Shamis, G; Alvarez, Y; Prins, KC; Banerjee, S; Nadas, A; Cho, MW; Dustin, ML; Kachlany, SC				Hioe, Catarina E.; Tuen, Michael; Vasiliver-Shamis, Gaia; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika; Nadas, Arthur; Cho, Michael W.; Dustin, Michael L.; Kachlany, Scott C.			HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSE FORMATION; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; TARGET-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; NEUTRALIZATION; ADHESION; VIREMIA	The cellular adhesion molecule LFA-1 and its ICAM-1 ligand play an important role in promoting HIV-1 infectivity and transmission. These molecules are present on the envelope of HIV-1 virions and are integral components of the HIV virological synapse. However, cellular activation is required to convert LFA-1 to the active conformation that has high affinity binding for ICAM-1. This study evaluates whether such activation can be induced by HIV itself. The data show that HIV-1 gp120 was sufficient to trigger LFA-1 activation in fully quiescent naive CD4 T cells in a CD4-dependent manner, and these CD4 T cells became more susceptible to killing by LtxA, a bacterial leukotoxin that preferentially targets leukocytes expressing high levels of the active LFA-1. Moreover, virus p24-expressing CD4 T cells in the peripheral blood of HIV-infected subjects were found to have higher levels of surface LFA-1, and LtxA treatment led to significant reduction of the viral DNA burden. These results demonstrate for the first time the ability of HIV to directly induce LFA-1 activation on CD4 T cells. Although LFA-1 activation may enhance HIV infectivity and transmission, it also renders the cells more susceptible to an LFA-1-targeting bacterial toxin, which may be harnessed as a novel therapeutic strategy to deplete virus reservoir in HIV-infected individuals.	[Hioe, Catarina E.; Tuen, Michael; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika] New York Univ Sch Med, Dept Pathol, New York, NY 10016 USA; [Hioe, Catarina E.; Tuen, Michael; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Vasiliver-Shamis, Gaia; Prins, Kathleen C.; Dustin, Michael L.] New York Univ Sch Med, Program Mol Pathogenesis, Marty & Helen Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY USA; [Nadas, Arthur] New York Univ Sch Med, Dept Environm Med, New York, NY USA; [Cho, Michael W.] Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA USA; [Kachlany, Scott C.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; [Kachlany, Scott C.] Actinobac Biomed Inc, N Brunswick, NJ USA	New York University; New York University; New York University; Iowa State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hioe, CE (corresponding author), New York Univ Sch Med, Dept Pathol, Manhattan Campus, New York, NY 10016 USA.	catarina.hioe@nyumc.org	Banerjee, Sagarika/AAR-2682-2020; Dustin, Michael/AAM-4611-2020	Banerjee, Sagarika/0000-0002-4549-3342; Cho, Michael/0000-0003-0522-345X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI71815, AI71815S, DE16133, AI080606, AI044931, AI080192, P01-AI074286, AI085958, AI1007647]; United States Department of Veterans Affairs, New York University Center for AIDS Research [AI-27742]; Training Program in TB and HIV Prevention and Treatment [D43 TWO1409]; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931, R01AI044931, R21AI080606, R21AI071815, P01AI074286, P01AI080192, P30AI027742, F31AI085958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs, New York University Center for AIDS Research(US Department of Veterans Affairs); Training Program in TB and HIV Prevention and Treatment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health grants AI71815 and AI71815S (CEH), DE16133 and AI080606 (SCK), AI044931 and AI080192 (MLD), P01-AI074286 (MWC), AI085958 (YA), AI1007647 (KCP), as well as a Merit Review Award and the Research Enhancement Award Program of the United States Department of Veterans Affairs, New York University Center for AIDS Research (AI-27742), and the Training Program in TB and HIV Prevention and Treatment (D43 TWO1409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achkar JM, 2000, J ACQ IMMUN DEF SYND, V24, P203; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bastiani L, 1997, J VIROL, V71, P3444, DOI 10.1128/JVI.71.5.3444-3450.1997; Brennan TP, 2009, J VIROL, V83, P8470, DOI 10.1128/JVI.02568-08; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; CAPOBIANCHI MR, 1994, J INFECT DIS, V169, P886, DOI 10.1093/infdis/169.4.886; Cho MW, 2001, J VIROL, V75, P2224, DOI 10.1128/JVI.75.5.2224-2234.2001; Cicala C, 2006, VIROLOGY, V345, P105, DOI 10.1016/j.virol.2005.09.052; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Di Mascio M, 2004, J VIROL, V78, P10566, DOI 10.1128/JVI.78.19.10566-10573.2004; Diaz R, 2006, MICROB PATHOGENESIS, V40, P48, DOI 10.1016/j.micpath.2005.10.005; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Fortin JF, 2000, VIROLOGY, V268, P493, DOI 10.1006/viro.2000.0190; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; Fortin JF, 1999, VIROLOGY, V257, P228, DOI 10.1006/viro.1999.9687; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Hioe CE, 1999, AIDS RES HUM RETROV, V15, P523, DOI 10.1089/088922299311042; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jones LE, 2007, JAIDS-J ACQ IMM DEF, V45, P483, DOI 10.1097/QAI.0b013e3180654836; Kachlany SC, 2010, LEUKEMIA RES, V34, P777, DOI 10.1016/j.leukres.2009.08.022; Kaur G, 2007, VIROLOGY, V369, P214, DOI 10.1016/j.virol.2007.07.031; Kennedy PE, 2006, J LEUKOCYTE BIOL, V80, P1175, DOI 10.1189/jlb.0306139; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Korman BD, 2009, ARCH DERMATOL, V145, P937, DOI 10.1001/archdermatol.2009.175; Losier M, 2003, CLIN IMMUNOL, V108, P111, DOI 10.1016/S1521-6616(03)00093-7; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Pessler F, 2004, GENES IMMUN, V5, P158, DOI 10.1038/sj.gene.6364047; Pincus SH, 2003, AIDS RES HUM RETROV, V19, P901, DOI 10.1089/088922203322493076; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STENDERUP K, 2011, J INVEST DE IN PRESS, P11601; Tardif MR, 2009, ANTIMICROB AGENTS CH, V53, P4656, DOI 10.1128/AAC.00117-09; Vasiliver-Shamis G, 2008, J VIROL, V82, P9445, DOI 10.1128/JVI.00835-08; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09	50	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23202	10.1371/journal.pone.0023202	http://dx.doi.org/10.1371/journal.pone.0023202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850260	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300045
J	Watabe, S; Sakamoto, Y; Morikawa, M; Okada, R; Miura, T; Ito, E				Watabe, Satoshi; Sakamoto, Yuki; Morikawa, Mika; Okada, Ryuichi; Miura, Toshiaki; Ito, Etsuro			Highly Sensitive Determination of Hydrogen Peroxide and Glucose by Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							FLUOROMETRIC-DETERMINATION; HORSERADISH-PEROXIDASE; QUANTIFICATION; AMPLIFICATION; OXIDATION; TYROSINE; OXIDASE; WATER	Background: Because H2O2 is generated by various oxidase-catalyzed reactions, a highly sensitive determination method of H2O2 is applicable to measurements of low levels of various oxidases and their substrates such as glucose, lactate, glutamate, urate, xanthine, choline, cholesterol and NADPH. We propose herein a new, highly sensitive method for the measurement of H2O2 and glucose using fluorescence correlation spectroscopy (FCS). Methodology/Principal Findings: FCS has the advantage of allowing us to determine the number of fluorescent molecules. FCS measures the fluctuations in fluorescence intensity caused by fluorescent probe movement in a small light cavity with a defined volume generated by confocal illumination. We thus developed a highly sensitive determination system of H2O2 by FCS, where horseradish peroxidase (HRP) catalyzes the formation of a covalent bond between fluorescent molecules and proteins in the presence of H2O2. Our developed system gave a linear calibration curve for H2O2 in the range of 28 to 300 nM with the detection limit of 8 nM. In addition, by coupling with glucose oxidase (GOD)-catalyzed reaction, the method allows to measure glucose in the range of 80 nM to 1.5 mu M with detection limit of 24 nM. The method was applicable to the assay of glucose in blood plasma. The mean concentration of glucose in normal human blood plasma was determined to be 4.9 mM. Conclusions/Significance: In comparison with commercial available methods, the detection limit and the minimum value of determination for glucose are at least 2 orders of magnitude more sensitive in our system. Such a highly sensitive method leads the fact that only a very small amount of plasma (20 nL) is needed for the determination of glucose concentration in blood plasma.	[Watabe, Satoshi] BL Co Ltd, Shizuoka, Japan; [Sakamoto, Yuki; Morikawa, Mika; Okada, Ryuichi; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan; [Miura, Toshiaki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 060, Japan	Tokushima Bunri University; Hokkaido University	Watabe, S (corresponding author), BL Co Ltd, Shizuoka, Japan.	eito@kph.bunri-u.ac.jp			Ministry of Economy, Trade, and Industry of Japan; Hokkaido Bureau of Economy, Trade, and Industry; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Economy, Trade, and Industry of Japan; Hokkaido Bureau of Economy, Trade, and Industry; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly funded by a research grant of the "New Regional Consortium Research and Development Project" from the Ministry of Economy, Trade, and Industry of Japan and the Hokkaido Bureau of Economy, Trade, and Industry, and a research grant of the "Knowledge Cluster Initiative (2009)" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Satoshi Watabe is an employee of BL Co. Ltd. and contributed to all aspects of the study.	BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Boren Suzanne Austin, 2010, J Diabetes Sci Technol, V4, P84; DELAHARPE J, 1985, J IMMUNOL METHODS, V78, P323, DOI 10.1016/0022-1759(85)90089-4; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Hu YF, 2008, LUMINESCENCE, V23, P338, DOI 10.1002/bio.1042; HWANG H, 1985, ANAL CHIM ACTA, V170, P347, DOI 10.1016/S0003-2670(00)81761-4; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Kotzian P, 2005, ANAL LETT, V38, P1099, DOI 10.1081/AL-200057205; Luo W, 2010, TALANTA, V81, P901, DOI 10.1016/j.talanta.2010.01.035; Nagaraja P, 2009, ANAL BIOCHEM, V395, P231, DOI 10.1016/j.ab.2009.07.053; Nomura Y, 2007, CURR PHARM BIOTECHNO, V8, P286, DOI 10.2174/138920107782109958; Ohye H, 2010, EXP BIOL MED, V235, P424, DOI 10.1258/ebm.2009.009241; PRAVDA M, 1995, ELECTROANAL, V7, P619, DOI 10.1002/elan.1140070704; Serrano J, 2009, BIOCHEM BIOPH RES CO, V388, P443, DOI 10.1016/j.bbrc.2009.08.041; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Tang B, 2006, SPECTROCHIM ACTA A, V63, P609, DOI 10.1016/j.saa.2005.06.008; Tonyushkina Ksenia, 2009, J Diabetes Sci Technol, V3, P971; Tortora G. J., 2006, PRINCIPLES ANATOMY P; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; ZAITSU K, 1980, ANAL BIOCHEM, V109, P109, DOI 10.1016/0003-2697(80)90017-2; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	21	17	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22955	10.1371/journal.pone.0022955	http://dx.doi.org/10.1371/journal.pone.0022955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850246	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300031
J	Pieper, D; Schirmer, S; Prechtel, AT; Kehlenbach, RH; Hauber, J; Chemnitz, J				Pieper, Dorothea; Schirmer, Susann; Prechtel, Alexander T.; Kehlenbach, Ralph H.; Hauber, Joachim; Chemnitz, Jan			Functional Characterization of the HuR:CD83 mRNA Interaction	PLOS ONE			English	Article							REV TRANS-ACTIVATOR; HUR LIGAND APRIL; AU-RICH ELEMENTS; NUCLEAR EXPORT; DENDRITIC CELLS; LEPTOMYCIN B; GENE-EXPRESSION; IN-VITRO; CD83; BINDING	Maturation of dendritic cells (DC) is characterized by expression of CD83, a surface protein that appears to be necessary for the effective activation of naive T-cells and T-helper cells by DC. Lately it was shown that CD83 expression is regulated on the posttranscriptional level by interaction of the shuttle protein HuR with a novel posttranscriptional regulatory RNA element (PRE), which is located in the coding region of the CD83 transcript. Interestingly, this interaction commits the CD83 mRNA to efficient nuclear export via the CRM1 pathway. To date, however, the structural basis of this interaction, which potentially involves three distinct RNA recognition motifs (RRM1-3) in HuR and a complex three-pronged RNA stem-loop element in CD83 mRNA, has not been investigated in detail. In the present work we analyzed this interaction in vitro and in vivo using various HuR- and CD83 mRNA mutants. We are able to demonstrate that both, RRM1 and RRM2 are crucial for binding, whereas RRM3 as well as the HuR hinge region contributed only marginally to this protein: RNA interaction. Furthermore, mutation of uridine rich patches within the PRE did not disturb HuR:CD83 mRNA complex formation while, in contrast, the deletion of specific PRE subfragments from the CD83 mRNA prevented HuR binding in vitro and in vivo. Interestingly, the observed inhibition of HuR binding to CD83 mRNA does not lead to a nuclear trapping of the transcript but rather redirected this transcript from the CRM1-towards the NXF1/TAP-specific nuclear export pathway. Thus, the presence of a functional PRE permits nucleocytoplasmic trafficking of the CD83 transcript via the CRM1 pathway.	[Pieper, Dorothea; Schirmer, Susann; Prechtel, Alexander T.; Hauber, Joachim; Chemnitz, Jan] Leibniz Inst Expt Virol, Dept Cell Biol & Virol, Heinrich Pette Inst, Hamburg, Germany; [Kehlenbach, Ralph H.] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Gottingen, Germany	Heinrich Pette Institute; University of Gottingen	Pieper, D (corresponding author), Leibniz Inst Expt Virol, Dept Cell Biol & Virol, Heinrich Pette Inst, Hamburg, Germany.	jan.chemnitz@hpi.uni-hamburg.de		Kehlenbach, Ralph/0000-0003-4920-9916	Wilhelm Sander-Stiftung [1003.033.1]; Deutsche Forschungsgemeinschaft [CH668/1-1]; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free and Hanseatic City of Hamburg; Federal Ministry of Health	This work received financial support from the Wilhelm Sander-Stiftung (grant 1003.033.1) and from the Deutsche Forschungsgemeinschaft (grant CH668/1-1). The Heinrich Pette Institute is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Berchtold S, 2002, IMMUNOBIOLOGY, V205, P231, DOI 10.1078/0171-2985-00128; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Browne SK, 2006, J IMMUNOL, V177, P8612, DOI 10.4049/jimmunol.177.12.8612; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chemnitz J, 2010, IMMUNOBIOLOGY, V215, P370, DOI 10.1016/j.imbio.2009.05.008; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heger P, 1999, ONCOGENE, V18, P4080, DOI 10.1038/sj.onc.1202762; Higashino F, 2005, J CELL BIOL, V170, P15, DOI 10.1083/jcb.200405112; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kimura T, 2004, J CELL SCI, V117, P2259, DOI 10.1242/jcs.01076; Kimura T, 2010, MED MOL MORPHOL, V43, P145, DOI 10.1007/s00795-010-0492-5; KING PH, 1994, J NEUROSCI, V14, P1943; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2002, INT ARCH ALLERGY IMM, V129, P113, DOI 10.1159/000065883; Lewis T, 1998, J BIOL CHEM, V273, P13781, DOI 10.1074/jbc.273.22.13781; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Prazma CM, 2008, IMMUNOL LETT, V115, P1, DOI 10.1016/j.imlet.2007.10.001; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Prechtel AT, 2006, J BIOL CHEM, V281, P10912, DOI 10.1074/jbc.M510306200; Rosorius O, 1999, BIOTECHNIQUES, V27, P350, DOI 10.2144/99272rr02; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Strom AC, 2001, GENOME BIOL, V2; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Tsai NP, 2010, J CELL BIOL, V188, P325, DOI 10.1083/jcb.200910083; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; ZHOU LJ, 1992, J IMMUNOL, V149, P735; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	69	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23290	10.1371/journal.pone.0023290	http://dx.doi.org/10.1371/journal.pone.0023290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829725	gold, Green Submitted, Green Published			2022-12-25	WOS:000293561200062
J	Wu, DZ; Qiu, L; Xu, LL; Ye, LZ; Chen, MX; Sun, DF; Chen, ZH; Zhang, HT; Jin, XL; Dai, F; Zhang, GP				Wu, Dezhi; Qiu, Long; Xu, Lulu; Ye, Lingzhen; Chen, Mingxian; Sun, Dongfa; Chen, Zhonghua; Zhang, Haitao; Jin, Xiaoli; Dai, Fei; Zhang, Guoping			Genetic Variation of HvCBF Genes and Their Association with Salinity Tolerance in Tibetan Annual Wild Barley	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SALT TOLERANCE; LOW-TEMPERATURE; POPULATION-STRUCTURE; DIVERSITY ANALYSIS; EXPRESSION; TRANSCRIPTION; DROUGHT; STRESS; RICE	The evaluation of both the genetic variation and the identification of salinity tolerant accessions of Tibetan annual wild barley (hereafter referred to as Tibetan barley) (Hordeum vulgare L. ssp. Spontaneum and H. vulgare L. ssp. agriocrithum) are essential for discovering and exploiting novel alleles involved in salinity tolerance. In this study, we examined tissue dry biomass and the Na+ and K+ contents of 188 Tibetan barley accessions in response to salt stress. We investigated the genetic variation of transcription factors HvCBF1, HvCBF3 and HvCBF4 within these accessions, conducting association analysis between these three genes and the respective genotypic salt tolerance. Salt stress significantly reduced shoot and root dry weight by 27.6% to 73.1% in the Tibetan barley lines. HvCBF1, HvCBF3 and HvCBF4 showed diverse sequence variation in amplicon as evident by the identification of single nucleotide polymorphisms (SNPs) and 3, 8 and 13 haplotypes, respectively. Furthermore, the decay of Linkage disequilibrium (LD) of chromosome 5 was 8.9 cM (r(2) < 0.1). Marker bpb-4891 and haplotype 13 (Ps 610) of the HvCBF4 gene were significantly (P < 0.05) and highly significantly (P < 0.001) associated with salt tolerance. However, HvCBF1 and HvCBF3 genes were not associated with salinity tolerance. The accessions from haplotype 13 of the HvCBF4 gene showed high salinity tolerance, maintaining significantly lower Na+/K+ ratios and higher dry weight. It is thus proposed that these Tibetan barley accessions could be of value for enhancing salinity tolerance in cultivated barley.	[Wu, Dezhi; Qiu, Long; Xu, Lulu; Ye, Lingzhen; Chen, Mingxian; Zhang, Haitao; Jin, Xiaoli; Dai, Fei; Zhang, Guoping] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci, Wuhan, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Nat Sci, Ctr Plants & Environm, Richmond, NSW, Australia	Zhejiang University; Huazhong Agricultural University; Western Sydney University	Wu, DZ (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	wu, dezhi/C-2735-2011; Dai, Fei/F-6512-2010; Chen, Zhong-Hua/B-8927-2008; Wu, Dezhi/AAO-9316-2020	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dezhi/0000-0002-7900-0542	China Natural Science Foundation [30630047, 30828023]; National major science and technology of GMO cultivation [20092X08009-076B]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National major science and technology of GMO cultivation	The project was supported by China Natural Science Foundation (30630047, 30828023) and National major science and technology of GMO cultivation (20092X08009-076B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Dai F, 2010, J AGR FOOD CHEM, V58, P11821, DOI 10.1021/jf1029948; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; FAO, 2005, GLOB NETW INT SOIL M; Feng Zong-Yun, 2006, Acta Genetica Sinica, V33, P917, DOI 10.1016/S0379-4172(06)60126-1; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fricano A, 2009, THEOR APPL GENET, V119, P1335, DOI 10.1007/s00122-009-1138-7; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Garris AJ, 2003, GENETICS, V165, P759; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; HACK B, 2000, TEXT ANAL PRACTICE, P26; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Huang JC, 2000, BIOTECHNIQUES, V28, P432, DOI 10.2144/00283bm08; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jabnoune M, 2009, PLANT PHYSIOL, V150, P1955, DOI 10.1104/pp.109.138008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; McKhann HI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-105; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355; Munns R, 2002, PLANT SOIL, V247, P93, DOI 10.1023/A:1021119414799; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Oh SJ, 2007, PLANT BIOTECHNOL J, V5, P646, DOI 10.1111/j.1467-7652.2007.00272.x; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wang AH, 2009, CR BIOL, V332, P393, DOI 10.1016/j.crvi.2008.11.007; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG QF, 1994, GENOME, V37, P631, DOI 10.1139/g94-090; ZHANG QF, 1992, THEOR APPL GENET, V84, P682, DOI 10.1007/BF00224168; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	63	61	66	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22938	10.1371/journal.pone.0022938	http://dx.doi.org/10.1371/journal.pone.0022938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829562	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600068
J	Pagac, M; de la Mora, HV; Duperrex, C; Roubaty, C; Vionnet, C; Conzelmann, A				Pagac, Martin; de la Mora, Hector Vazquez; Duperrex, Cecile; Roubaty, Carole; Vionnet, Christine; Conzelmann, Andreas			Topology of 1-Acyl-sn-glycerol-3-phosphate Acyltransferases SLC1 and ALE1 and Related Membrane-bound O-Acyltransferases (MBOATs) of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; ENDOPLASMIC-RETICULUM; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASES; STEROL ESTERIFICATION; PHOSPHATIDIC-ACID; YEAST; IDENTIFICATION; ENCODES; PHOSPHATIDYLCHOLINE; ACCESSIBILITY	In yeast, phosphatidic acid, the biosynthetic precursor for all glycerophospholipids and triacylglycerols, is made de novo by the 1-acyl-sn-glycerol-3-phosphate acyltransferases Ale1p and Slc1p. Ale1p belongs to the membrane-bound O-acyl-transferase (MBOAT) family, which contains many enzymes acylating lipids but also others that acylate secretory proteins residing in the lumen of the ER. A histidine present in a very short loop between two predicted transmembrane domains is the only residue that is conserved throughout the MBOAT gene family. The yeast MBOAT proteins of known function comprise Ale1p, the ergosterol acyltransferases Are1p and Are2p, and Gup1p, the last of which acylates lysophosphatidylinositol moieties of GPI anchors on ER lumenal GPI proteins. C-terminal topology reporters added to truncated versions of Gup1p yield a topology predicting a lumenal location of its uniquely conserved histidine 447 residue. The same approach shows that Ale1p and Are2p also have the uniquely conserved histidine residing in the ER lumen. Because these data raised the possibility that phosphatidic acid could be made in the lumen of the ER, we further investigated the topology of the second yeast 1-acyl-sn-glycerol-3-phosphate acyltransferase, Slc1p. The location of C-terminal topology reporters, microsomal assays probing the protease sensitivity of inserted tags, and the accessibility of natural or artificially inserted cysteines to membrane-impermeant alkylating agents all indicate that the most conserved motif containing the presumed active site histidine of Slc1p is oriented toward the ER lumen, whereas other conserved motifs are cytosolic. The implications of these findings are discussed.	[Pagac, Martin; de la Mora, Hector Vazquez; Duperrex, Cecile; Roubaty, Carole; Vionnet, Christine; Conzelmann, Andreas] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Fribourg	Conzelmann, A (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch			Swiss National Science Foundation [31-67188.01, CRSI33_125232/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31-67188.01 and CRSI33_125232/1.	Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; Alberts B., 2008, MOL BIOL CELL, P743; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; BELL RM, 1981, J LIPID RES, V22, P391; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bleve G, 2005, BIOCHEM J, V390, P145, DOI 10.1042/BJ20042045; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Cassel M, 2008, J MOL BIOL, V381, P860, DOI 10.1016/j.jmb.2008.06.039; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; COLEMAN R, 1978, J CELL BIOL, V76, P245, DOI 10.1083/jcb.76.1.245; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Kihara A, 2003, GENES CELLS, V8, P525, DOI 10.1046/j.1365-2443.2003.00653.x; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Schmidt JA, 2010, BIOCHEM BIOPH RES CO, V397, P661, DOI 10.1016/j.bbrc.2010.05.149; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Slabas AR, 2002, J BIOL CHEM, V277, P43918, DOI 10.1074/jbc.M206429200; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	61	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36438	36447		10.1074/jbc.M111.256511	http://dx.doi.org/10.1074/jbc.M111.256511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849510	Green Published, hybrid			2022-12-25	WOS:000296538300029
J	Huang, Z; Hoffmann, FW; Norton, RL; Hashimoto, AC; Hoffmann, PR				Huang, Zhi; Hoffmann, Fukun W.; Norton, Robert L.; Hashimoto, Ann C.; Hoffmann, Peter R.			Selenoprotein K Is a Novel Target of m-Calpain, and Cleavage Is Regulated by Toll-like Receptor-induced Calpastatin in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ACTIVATION; MEMBRANE; COMPLEXES; CALCIUM; PROTEIN; SITE	Calpains are proteolytic enzymes that modulate cellular function through cleavage of targets, thereby modifying their actions. An important role is emerging for calpains in regulating inflammation and immune responses, although specific mechanisms by which this occurs have not been clearly defined. In this study, we identify a novel target of calpain, selenoprotein K (SelK), which is an endoplasmic reticulum transmembrane protein important for Ca2+ flux in immune cells. Calpain-mediated cleavage of SelK was detected in myeloid cells (macrophages, neutrophils, and dendritic cells) but not in lymphoid cells (B and T cells). Both m- and mu-calpain were capable of cleaving immunoprecipitated SelK, but m-calpain was the predominant isoform expressed in mouse immune cells. Consistent with these results, specific inhibitors were used to show that only m-calpain cleaved SelK in macrophages. The cleavage site in SelK was identified between Arg(81) and Gly(82) and the resulting truncated SelK was shown to lack selenocysteine, the amino acid that defines selenoproteins. Resting macrophages predominantly expressed cleaved SelK and, when activated through different Toll-like receptors (TLRs), SelK cleavage was inhibited. We found that decreased calpain cleavage was due to TLR-induced up-regulation of the endogenous inhibitor, calpastatin. TLR-induced calpastatin expression not only inhibited SelK cleavage, but cleavage of another calpain target, talin. Moreover, the expression of the calpain isoforms and calpastatin in macrophages were different from T and B cells. Overall, our findings identify SelK as a novel calpain target and reveal dynamic changes in the calpain/calpastatin system during TLR-induced activation of macrophages.	[Huang, Zhi; Hoffmann, Fukun W.; Norton, Robert L.; Hashimoto, Ann C.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Huang, Zhi] Jinan Univ, Dept Biotechnol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China	University of Hawaii System; Jinan University	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	peterh@pbrc.hawaii.edu			National Institutes of Health [R21AT004844, R01AI089999]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported, in whole or in part, by National Institutes of Health Grants R21AT004844 and R01AI089999.	BROWN N, 1993, FEBS LETT, V322, P65, DOI 10.1016/0014-5793(93)81112-D; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; duVerle David, 2010, V22, P202; Fettucciari K, 2011, CELL MICROBIOL, V13, P859, DOI 10.1111/j.1462-5822.2011.01584.x; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hendry L, 2004, EUR J BIOCHEM, V271, P4613, DOI 10.1111/j.1432-1033.2004.04424.x; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee FYI, 2005, J BIOL CHEM, V280, P29929, DOI 10.1074/jbc.M414600200; Letavernier E, 2011, EUR J IMMUNOL, V41, P473, DOI 10.1002/eji.201040437; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Samanta K, 2007, BBA-GEN SUBJECTS, V1770, P1297, DOI 10.1016/j.bbagen.2007.06.010; Samanta K, 2010, J BIOCHEM, V147, P765, DOI 10.1093/jb/mvq009; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Ueda Y, 2002, MOL CELL PROTEOMICS, V1, P357, DOI 10.1074/mcp.M200007-MCP200; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Zhang GQ, 2011, LAB INVEST, V91, P106, DOI 10.1038/labinvest.2010.135	36	44	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34830	34838		10.1074/jbc.M111.265520	http://dx.doi.org/10.1074/jbc.M111.265520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849499	hybrid, Green Published			2022-12-25	WOS:000295406300037
J	Lusher, SJ; Raaijmakers, HCA; Vu-Pham, D; Dechering, K; Lam, TW; Brown, AR; Hamilton, NM; Nimz, O; Bosch, R; McGuire, R; Oubrie, A; de Vlieg, J				Lusher, Scott J.; Raaijmakers, Hans C. A.; Vu-Pham, Diep; Dechering, Koen; Lam, Tsang Wai; Brown, Angus R.; Hamilton, Niall M.; Nimz, Olaf; Bosch, Rolien; McGuire, Ross; Oubrie, Arthur; de Vlieg, Jacob			Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAINS; MINERALOCORTICOID RECEPTOR; B ISOFORMS; CHO-CELLS; IN-VITRO; (ANTI)PROGESTAGENS; TRANSACTIVATION; HYPERTENSION; PROGESTINS; ASOPRISNIL	The progesterone receptor is able to bind to a large number and variety of ligands that elicit a broad range of transcriptional responses ranging from full agonism to full antagonism and numerous mixed profiles inbetween. We describe here two new progesterone receptor ligand binding domain x-ray structures bound to compounds from a structurally related but functionally divergent series, which show different binding modes corresponding to their agonistic or antagonistic nature. In addition, we present a third progesterone receptor ligand binding domain dimer bound to an agonist in monomer A and an antagonist in monomer B, which display binding modes in agreement with the earlier observation that agonists and antagonists from this series adopt different binding modes.	[Lusher, Scott J.; Raaijmakers, Hans C. A.; Bosch, Rolien; McGuire, Ross; Oubrie, Arthur; de Vlieg, Jacob] MSD, DMPK, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands; [Vu-Pham, Diep; Dechering, Koen; Lam, Tsang Wai] MSD, DMPK, Dept Mol Pharmacol, NL-5340 BH Oss, Netherlands; [Brown, Angus R.; Hamilton, Niall M.; Nimz, Olaf] MSD, Dept Chem, Newhouse ML1 5SH, Lancs, England; [de Vlieg, Jacob] Radboud Univ Nijmegen, Computat Drug Discovery Grp, NL-6525 HP Nijmegen, Netherlands	Merck & Company; Merck & Company; Merck & Company; Radboud University Nijmegen	Lusher, SJ (corresponding author), MSD, DMPK, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands.	scott.lusher@merck.com	McGuire, Ross/P-8855-2015	McGuire, Ross/0000-0003-3404-6456; Oubrie, Arthur/0000-0001-6765-9246; raaijmakers, hans/0000-0002-2567-7363				Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2473, DOI [10.1517/14656566.9.14.2473, 10.1517/14656566.9.14.2473 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2459, DOI [10.1517/14656566.9.14.2459, 10.1517/14656566.9.14.2459 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2487, DOI [10.1517/14656566.9.14.2487, 10.1517/14656566.9.14.2487 ]; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Brown AR, 2011, BIOORG MED CHEM LETT, V21, P137, DOI 10.1016/j.bmcl.2010.11.054; Chabbert-Buffet N, 2005, HUM REPROD UPDATE, V11, P293, DOI 10.1093/humupd/dmi002; DeManno D, 2003, STEROIDS, V68, P1019, DOI 10.1016/j.steroids.2003.09.008; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; Jones DG, 2005, BIOORG MED CHEM LETT, V15, P3203, DOI 10.1016/j.bmcl.2005.05.001; Kallander LS, 2010, BIOORG MED CHEM LETT, V20, P371, DOI 10.1016/j.bmcl.2009.10.092; KEIGHTLEY DD, 1979, EUR J CANCER, V15, P785, DOI 10.1016/0014-2964(79)90154-3; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Schoonen WGEJ, 1998, J STEROID BIOCHEM, V64, P157, DOI 10.1016/S0960-0760(97)00161-1; Schoonen WGEJ, 2000, J STEROID BIOCHEM, V74, P109, DOI 10.1016/S0960-0760(00)00094-7; Spitz IM, 2003, STEROIDS, V68, P981, DOI 10.1016/j.steroids.2003.08.007; Spitz IM, 2000, STEROIDS, V65, P807, DOI 10.1016/S0039-128X(00)00194-X; Thompson SK, 2009, BIOORG MED CHEM LETT, V19, P4777, DOI 10.1016/j.bmcl.2009.06.055; Washburn DG, 2009, BIOORG MED CHEM LETT, V19, P4664, DOI 10.1016/j.bmcl.2009.06.081; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005; Zhang ZM, 2005, J BIOL CHEM, V280, P28468, DOI 10.1074/jbc.M504144200	39	25	28	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35079	35086		10.1074/jbc.M111.273029	http://dx.doi.org/10.1074/jbc.M111.273029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849509	hybrid, Green Published			2022-12-25	WOS:000295406300061
J	Tomikawa, J; Shimokawa, H; Uesaka, M; Yamamoto, N; Mori, Y; Tsukamura, H; Maeda, K; Imamura, T				Tomikawa, Junko; Shimokawa, Hiroko; Uesaka, Masahiro; Yamamoto, Naoki; Mori, Yuji; Tsukamura, Hiroko; Maeda, Kei-ichiro; Imamura, Takuya			Single-stranded Noncoding RNAs Mediate Local Epigenetic Alterations at Gene Promoters in Rat Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; GROWTH-FACTOR; INTERMEDIATE-FILAMENTS; HISTONE MODIFICATION; PC12 CELLS; CPG ISLAND; EXPRESSION; DEMETHYLATION; CHROMATIN	Agrowing number of noncoding RNAs (ncRNAs) are thought to be involved in sequence-specific alterations of epigenetic processes, mostly causing gene repression. In this study, promoterassociated ncRNAs (pancRNAs > 200 nucleotides in size) that were endogenously generated from the sense strand at Map2b, antisense strand at Nefl, and both strands at Vim were investigated regarding their epigenetic potential as positive or negative regulators in rat pheochromocytoma (PC12) and fibroblast (normal rat kidney) cell lines. The respective antisense pancRNAs were associated with several active chromatin marks at the Nefl and Vim promoters. Forced expression of fragments expressing the antisense pancRNAs caused sequence-specific DNA demethylation, whereas a decrease of expression induced methylation of the same sequences. In contrast, perturbing the expression of the two sense pancRNAs did not change the DNA methylation status. These results suggest that a fraction of naturally occurring ncRNAs acts in cis as a single-stranded form and that the transcriptional orientation of pancRNA is important for the establishment of sequence-specific epigenetic modifications consistent with open chromatin structure.	[Tomikawa, Junko; Shimokawa, Hiroko; Mori, Yuji; Tsukamura, Hiroko; Imamura, Takuya] Natl Inst Basic Biol, Div Behav Biol, Okazaki, Aichi 4448585, Japan; [Tomikawa, Junko; Shimokawa, Hiroko; Tsukamura, Hiroko; Maeda, Kei-ichiro] Nagoya Univ, Grad Sch Bioagr Sci, Lab Reprod Sci, Nagoya, Aichi 4648601, Japan; [Uesaka, Masahiro; Yamamoto, Naoki; Imamura, Takuya] Kyoto Univ, Lab Biodivers, Global COE Program, Div Biol Sci,Grad Sch Sci,Sakyo Ku, Kyoto 6068502, Japan; [Mori, Yuji] Univ Tokyo, Lab Vet Ethol, Bunkyo Ku, Tokyo 1138657, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Kyoto University; University of Tokyo	Imamura, T (corresponding author), Natl Inst Basic Biol, Div Behav Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	imamura@gcoe.biol.sci.kyoto-u.ac.jp	Tsukamura, Hiroko/AAC-5632-2022	IMAMURA, TAKUYA/0000-0002-1825-2084; Uesaka, Masahiro/0000-0002-2927-4860; Tomikawa, Junko/0000-0002-6149-1400	Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [17052028];  [18770008];  [A06]; Grants-in-Aid for Scientific Research [21688021] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid 17052028, 18770008, if double-stranded structures were formed between RNA/DNA 19040029, and 21688021 (to T.I.) and by Global COE program A06 to Kyoto University from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; Deng J, 1999, MOL BRAIN RES, V71, P23, DOI 10.1016/S0169-328X(99)00147-3; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Imamura T, 2011, HORM BEHAV, V59, P345, DOI 10.1016/j.yhbeh.2010.05.018; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; KIMELMAN D, 1989, CELL, V59, P687, DOI 10.1016/0092-8674(89)90015-9; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEE VMY, 1984, J NEUROSCI, V4, P1705; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; OSBORN M, 1982, CELL, V31, P303, DOI 10.1016/0092-8674(82)90122-2; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; TENG KK, 1993, J NEUROSCI, V13, P3124; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107	50	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34788	34799		10.1074/jbc.M111.275750	http://dx.doi.org/10.1074/jbc.M111.275750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844201	Green Published, hybrid			2022-12-25	WOS:000295406300033
J	Bercovich, Z; Snapir, Z; Keren-Paz, A; Kahana, C				Bercovich, Zippi; Snapir, Zohar; Keren-Paz, Alona; Kahana, Chaim			Antizyme Affects Cell Proliferation and Viability Solely through Regulating Cellular Polyamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; PROTEASOMAL DEGRADATION; REQUIRES INTERACTION; IN-VITRO; GROWTH; EXPRESSION; PROTEIN; DNA; ACCUMULATION; MUTAGENESIS	Antizymes are key regulators of cellular polyamine metabolism that negatively regulate cell proliferation and are therefore regarded as tumor suppressors. Although the regulation of antizyme (Az) synthesis by polyamines and the ability of Az to regulate cellular polyamine levels suggest the centrality of polyamine metabolism to its antiproliferative function, recent studies have suggested that antizymes might also regulate cell proliferation by targeting to degradation proteins that do not belong to the cellular polyamine metabolic pathway. Using a co-degradation assay, we show here that, although they efficiently stimulated the degradation of ornithine decarboxylase (ODC), Az1 and Az2 did not affect or had a negligible effect on the degradation of cyclin D1, Aurora-A, and a p73 variant lacking the N-terminal transactivation domain whose degradation was reported recently to be stimulated by Az1. Furthermore, we demonstrate that, although Az1 and Az2 could not be constitutively expressed in transfected cells, they could be stably expressed in cells that express trypanosome ODC, a form of ODC that does not bind Az and therefore maintains a constant level of cellular polyamines. Taken together, our results clearly demonstrate that Az1 and Az2 affect cell proliferation and viability solely by modulating cellular polyamine metabolism.	[Bercovich, Zippi; Snapir, Zohar; Keren-Paz, Alona; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel	Weizmann Institute of Science	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			Israel Academy of Science and Humanities	Israel Academy of Science and Humanities	This work was supported by grants from the Israel Academy of Science and Humanities.	Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fong LYY, 2003, CANCER RES, V63, P3945; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; HE Y, 1994, BIOCHEM BIOPH RES CO, V203, P608, DOI 10.1006/bbrc.1994.2226; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Koike C, 1999, CANCER RES, V59, P6109; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; MAMROUDKIDRON E, 1994, EUR J BIOCHEM, V226, P547, DOI 10.1111/j.1432-1033.1994.tb20079.x; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Murai N, 2009, J CELL BIOCHEM, V108, P1012, DOI 10.1002/jcb.22334; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 2000, BIOCHEM BIOPH RES CO, V267, P1, DOI 10.1006/bbrc.1999.1706; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; TOBIAS KE, 1995, CELL GROWTH DIFFER, V6, P1279; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; Wang TW, 2003, FRONT BIOSCI, V8, pD1109, DOI 10.2741/1057	38	18	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33778	33783		10.1074/jbc.M111.270637	http://dx.doi.org/10.1074/jbc.M111.270637			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832059	Green Published, hybrid			2022-12-25	WOS:000295159200008
J	Borah, S; Shivarathri, R; Kaur, R				Borah, Sapan; Shivarathri, Raju; Kaur, Rupinder			The Rho1 GTPase-activating Protein CgBem2 Is Required for Survival of Azole Stress in Candida glabrata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE PATHWAY; ENDOPLASMIC-RETICULUM STRESS; CELL-CYCLE REGULATOR; SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS INHIBITORS; MULTIDRUG-RESISTANCE; TRANSPORTER GENE; DRUG-RESISTANCE; BINDING PROTEIN; DISK DIFFUSION	Invasive fungal infections are common clinical complications of neonates, critically ill, and immunocompromised patients worldwide. Candida species are the leading cause of disseminated fungal infections, with Candida albicans being the most prevalent species. Candida glabrata, the second/third most common cause of candidemia, shows reduced susceptibility to a widely used antifungal drug fluconazole. Here, we present findings from a screen of 9134 C. glabrata Tn7 insertion mutants for altered survival profiles in the presence of fluconazole. We have identified two components of RNA polymerase II mediator complex, three players of Rho GTPase-mediated signaling cascade, and two proteins implicated in actin cytoskeleton biogenesis and ergosterol biosynthesis that are required to sustain viability during fluconazole stress. We show that exposure to fluconazole leads to activation of the protein kinase C (PKC)-mediated cell wall integrity pathway in C. glabrata. Our data demonstrate that disruption of a RhoGAP (GTPase activating protein) domain-containing protein, CgBem2, results in bud-emergence defects, azole susceptibility, and constitutive activation of CgRho1-regulated CgPkc1 signaling cascade and cell wall-related phenotypes. The viability loss of Cgbem2 Delta mutant upon fluconazole treatment could be partially rescued by the PKC inhibitor staurosporine. Additionally, we present evidence that CgBEM2 is required for the transcriptional activation of genes encoding multidrug efflux pumps in response to fluconazole exposure. Last, we report that Hsp90 inhibitor geldanamycin renders fluconazole a fungicidal drug in C. glabrata.	[Borah, Sapan; Shivarathri, Raju; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa,5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	rkaur@cdfd.org.in	Shivrathri, Raju/AHC-0076-2022; Borah, Sapan/AAT-1105-2021	Borah, Sapan/0000-0002-9383-9854	Department of Biotechnology, Government of India [BT/BI/12/040/2005]; Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India	This work was supported in part by Innovative Young Biotechnologist Award BT/BI/12/040/2005 from the Department of Biotechnology, Government of India and by core funds of Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India. \ Recipient of a Senior Research Fellowship from Department of Biotechnology, Government of India.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Berila N, 2009, INT J ANTIMICROB AG, V33, P574, DOI 10.1016/j.ijantimicag.2008.11.011; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Castano I, 2003, GENOME RES, V13, P905, DOI 10.1101/gr.848203; Cid VJ, 1998, MICROBIOL-SGM, V144, P25, DOI 10.1099/00221287-144-1-25; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; GRANT SM, 1990, DRUGS, V39, P877, DOI 10.2165/00003495-199039060-00006; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hazen KC, 2003, J CLIN MICROBIOL, V41, P5623, DOI 10.1128/JCM.41.12.5623-5632.2003; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jain P, 2003, ANTIMICROB AGENTS CH, V47, P3195, DOI 10.1128/AAC.47.10.3195-3201.2003; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Messer SA, 2006, J CLIN MICROBIOL, V44, P1782, DOI 10.1128/JCM.44.5.1782-1787.2006; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Wada S, 2005, J BIOL CHEM, V280, P94, DOI 10.1074/jbc.M408252200; WANG TT, 1995, MOL BIOL CELL, V6, P1011, DOI 10.1091/mbc.6.8.1011; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71	54	35	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34311	34324		10.1074/jbc.M111.264671	http://dx.doi.org/10.1074/jbc.M111.264671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832071	Green Published, hybrid			2022-12-25	WOS:000295159200060
J	Su, LH; Pan, YJ; Huang, YC; Cho, CC; Chen, CW; Huang, SW; Chuang, SF; Sun, CH				Su, Li-Hsin; Pan, Yu-Jiao; Huang, Yu-Chang; Cho, Chao-Cheng; Chen, Chia-Wei; Huang, Shao-Wei; Chuang, Sheng-Fung; Sun, Chin-Hung			A Novel E2F-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA-BINDING PROTEIN; MESSENGER-RNA DECAY; CELL-CYCLE; E2F FAMILY; PRIMITIVE EUKARYOTE; POLYMERASE-II; EXPRESSION; DNA; ENCYSTATION; PROMOTER	Giardia lamblia differentiates into resistant walled cysts for survival outside the host and transmission. During encystation, synthesis of cyst wall proteins is coordinately induced. The E2F family of transcription factors in higher eukaryotes is involved in cell cycle progression and cell differentiation. We asked whether Giardia has E2F-like genes and whether they influence gene expression during Giardia encystation. Blast searches of the Giardia genome database identified one gene (e2f1) encoding a putative E2F protein with two putative DNA-binding domains. We found that the e2f1 gene expression levels increased significantly during encystation. Epitope-tagged E2F1 was found to localize to nuclei. Recombinant E2F1 specifically bound to the thymidine kinase and cwp1-3 gene promoters. E2F1 contains several key residues for DNA binding, and mutation analysis revealed that its binding sequence is similar to those of the known E2F family proteins. The E2F1-binding sequences were positive cis-acting elements of the thymidine kinase and cwp1 promoters. We also found that E2F1 transactivated the thymidine kinase and cwp1 promoters through its binding sequences in vivo. Interestingly, E2F1 overexpression resulted in a significant increase of the levels of CWP1 protein, cwp1-3 gene mRNA, and cyst formation. We also found E2F1 can interact with Myb2, a transcription factor that coordinate up-regulates the cwp1-3 genes during encystation. Our results suggest that E2F family has been conserved during evolution and that E2F1 is an important transcription factor in regulation of the Giardia cwp genes, which are key to Giardia differentiation into cysts.	[Su, Li-Hsin; Pan, Yu-Jiao; Huang, Yu-Chang; Cho, Chao-Cheng; Chen, Chia-Wei; Huang, Shao-Wei; Chuang, Sheng-Fung; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council (NSC) [98-2320-B-002-018-MY2, 99-2320-B-002-017-MY3, 100-2325-B-002-039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research in National Taiwan University Hospital; National Taiwan University	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research in National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by the National Science Council Grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002-039, National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan, and in part by the Department of Medical Research in National Taiwan University Hospital and the Aim for the Top University Program of National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; BUCK V, 1995, ONCOGENE, V11, P31; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chaboute ME, 2000, PLANT CELL, V12, P1987, DOI 10.1105/tpc.12.10.1987; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chen YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003609; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DeGregori J, 2006, CURR MOL MED, V6, P739; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kosugi S, 2002, J BIOL CHEM, V277, P16553, DOI 10.1074/jbc.M200913200; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Lavia P, 1999, BIOESSAYS, V21, P221; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nip J, 2001, ONCOGENE, V20, P910, DOI 10.1038/sj.onc.1204171; Page BD, 2001, MOL CELL, V7, P451, DOI 10.1016/S1097-2765(01)00193-9; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Ramirez-Parra E, 1999, NUCLEIC ACIDS RES, V27, P3527, DOI 10.1093/nar/27.17.3527; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Schaefer JB, 2004, CELL, V117, P849, DOI 10.1016/j.cell.2004.06.008; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stevens C, 2003, CELL CYCLE, V2, P435, DOI 10.4161/cc.2.5.462; Stevens R, 2002, J BIOL CHEM, V277, P32978, DOI 10.1074/jbc.M205125200; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Suzuki M, 1998, ONCOGENE, V17, P853, DOI 10.1038/sj.onc.1202163; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Vlieghe K, 2003, J CELL SCI, V116, P4249, DOI 10.1242/jcs.00715; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; Wang YT, 2010, J BIOL CHEM, V285, P32213, DOI 10.1074/jbc.M110.156620; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	86	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34101	34120		10.1074/jbc.M111.280206	http://dx.doi.org/10.1074/jbc.M111.280206			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835923	hybrid, Green Published			2022-12-25	WOS:000295159200042
J	Ahmad, A; Dong, YZ; Cao, XF				Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng			Characterization of the PRMT Gene Family in Rice Reveals Conservation of Arginine Methylation	PLOS ONE			English	Article							HISTONE METHYLATION; FLOWERING TIME; PROTEIN; METHYLTRANSFERASE; IDENTIFICATION; RNA; COACTIVATOR; SUBSTRATE; ENZYME; EXPRESSION	Post-translational methylation of arginine residues profoundly affects the structure and functions of protein and, hence, implicated in a myriad of essential cellular processes such as signal transduction, mRNA splicing and transcriptional regulation. Protein arginine methyltransferases (PRMTs), the enzymes catalyzing arginine methylation have been extensively studied in animals, yeast and, to some extent, in model plant Arabidopsis thaliana. Eight genes coding for the PRMTs were identified in Oryza sativa, previously. Here, we report that these genes show distinct expression patterns in various parts of the plant. In vivo targeting experiment demonstrated that GFP-tagged OsPRMT1, OsPRMT5 and OsPRMT10 were localized to both the cytoplasm and nucleus, whereas OsPRMT6a and OsPRMT6b were predominantly localized to the nucleus. OsPRMT1, OsPRMT4, OsPRMT5, OsPRMT6a, OsPRMT6b and OsPRMT10 exhibited in vitro arginine methyltransferase activity against myelin basic protein, glycine-arginine-rich domain of fibrillarin and calf thymus core histones. Furthermore, they depicted specificities for the arginine residues in histones H3 and H4 and were classified into type I and Type II PRMTs, based on the formation of type of dimethylarginine in the substrate proteins. The two homologs of OsPRMT6 showed direct interaction in vitro and further titrating different amounts of these proteins in the methyltransferase assay revealed that OsPRMT6a inhibits the methyltransferase activity of OsPRMT6b, probably, by the formation of heterodimer. The identification and characterization of PRMTs in rice suggests the conservation of arginine methylation in monocots and hold promise for gaining further insight into regulation of plant development.	[Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ahmad, Ayaz] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ahmad, A (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China.	xfcao@genetics.ac.cn	Ahmad, Ayaz/GVT-1025-2022	Ahmad, Ayaz/0000-0003-3555-4735	Higher Education Commission of Pakistan; National Basic Research Program of China [2011CB915400, 2009CB941500]; National Natural Science Foundation of China [30930048, 30621001]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The first author would like to cordially thank the Higher Education Commission of Pakistan for awarding him a scholarship for this study. This work was supported by National Basic Research Program of China (grant nos. 2011CB915400, 2009CB941500), by National Natural Science Foundation of China (grant nos. 30930048 and 30621001) to X.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, MOL PLANT, V3, P719, DOI 10.1093/mp/ssq026; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Choi S, 2008, BBA-GEN SUBJECTS, V1780, P1062, DOI 10.1016/j.bbagen.2008.05.010; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kzhyshkowska J, 2004, BIOCHEM J, V383, P259, DOI 10.1042/BJ20040210; Kzhyshkowska J, 2001, BIOCHEM J, V358, P305, DOI 10.1042/0264-6021:3580305; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marques CJ, 2010, FERTIL STERIL, V94, P585, DOI 10.1016/j.fertnstert.2009.02.051; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Niu LF, 2008, PLANT PHYSIOL, V148, P490, DOI 10.1104/pp.108.124727; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Scebba F, 2007, PLANT J, V52, P210, DOI 10.1111/j.1365-313X.2007.03238.x; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yan D, 2007, BIOCHEM J, V408, P113, DOI 10.1042/BJ20070786; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356	54	19	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22664	10.1371/journal.pone.0022664	http://dx.doi.org/10.1371/journal.pone.0022664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853042	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400010
J	Everson, CA; Szabo, A				Everson, Carol A.; Szabo, Aniko			Repeated Exposure to Severely Limited Sleep Results in Distinctive and Persistent Physiological Imbalances in Rats	PLOS ONE			English	Article							STARVATION-INDUCED CHANGES; GLUCOSE-METABOLISM; LEPTIN LEVELS; PLASMA-CORTICOSTERONE; INFLAMMATORY MARKERS; RECOVERY SLEEP; NORMAL HUMANS; DEPRIVATION; RESTRICTION; DURATION	Chronic sleep disruption in laboratory rats leads to increased energy expenditure, connective tissue abnormalities, and increased weights of major organs relative to body weight. Here we report on expanded findings and the extent to which abnormalities become long-lasting, potentially permanent changes to health status after apparent recuperation from chronic sleep disruption. Rats were exposed 6 times to long periods of disrupted sleep or control conditions during 10 weeks to produce adaptations and then were permitted nearly 4 months of undisturbed sleep. Measurements were made in tissues from these groups and in preserved tissue from the experimental and control groups of an antecedent study that lacked a lengthy recuperation period. Cycles of sleep restriction resulted in energy deficiency marked by a progressive course of hyperphagia and major (15%) weight loss. Analyses of tissue composition in chronically sleep-restricted rats indicated that protein and lipid amounts in internal organs were largely spared, while adipose tissue depots appeared depleted. This suggests high metabolic demands may have preserved the size of the vital organs relative to expectations of severe energy deficiency alone. Low plasma corticosterone and leptin concentrations appear to reflect low substrate availability and diminished adiposity. After nearly 4 months of recuperation, sleep-restricted rats were consuming 20% more food and 35% more water than did comparison control rats, despite normalized weight, normalized adipocytes, and elevated plasma leptin concentrations. Plasma cholesterol levels in recuperated sleep-restricted rats were diminished relative to those of controls. The chronically increased intake of nutriments and water, along with altered negative feedback regulation and substrate use, indicate that internal processes are modified long after a severe period of prolonged and insufficient sleep has ended.	[Everson, Carol A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Szabo, Aniko] Med Coll Wisconsin, Dept Populat Hlth, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Everson, CA (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	ceverson@mcw.edu	Szabo, Aniko/F-9656-2012	Szabo, Aniko/0000-0002-8129-0614	National Heart, Lung, and Blood Institute [HL-086447, HL-080744]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov) Grants HL-086447 and HL-080744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; AX A, 1961, ARCH GEN PSYCHIAT, V4, P55; BARNETT SA, 1965, BIOL REV, V40, P5, DOI 10.1111/j.1469-185X.1965.tb00794.x; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; BERGMANN BM, 1989, SLEEP, V12, P31, DOI 10.1093/sleep/12.1.31; BJORKMAN O, 1985, J CLIN INVEST, V76, P87, DOI 10.1172/JCI111982; BONNET MH, 1991, J APPL PHYSIOL, V71, P1112, DOI 10.1152/jappl.1991.71.3.1112; Born J, 1997, J IMMUNOL, V158, P4454; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BOYNE R, 1966, J PHYSIOL-LONDON, V183, P570, DOI 10.1113/jphysiol.1966.sp007884; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chaput JP, 2007, OBESITY, V15, P253, DOI 10.1038/oby.2007.512; Convertino VA., 1987, CAN J SPORT SCI S, V12; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Duarte FO, 2008, NUTRITION, V24, P177, DOI 10.1016/j.nut.2007.10.012; Eiland MM, 2002, BRAIN RES, V945, P1, DOI 10.1016/S0006-8993(02)02448-4; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; EVERSON CA, 1994, J NEUROSCI, V14, P6769; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Everson CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE85, DOI 10.1152/ajpendo.00558.2001; EVERSON CA, 1989, SLEEP, V12, P60; EVERSON CA, 1995, ENDOCRINOLOGY, V136, P1426, DOI 10.1210/en.136.4.1426; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; EVERSON CA, 1993, AM J PHYSIOL, V264, pR376, DOI 10.1152/ajpregu.1993.264.2.R376; Everson CA, 2005, AM J PHYSIOL-REG I, V288, P274; Everson CA, 2009, AM J PHYSIOL-REG I, V297, pR1430, DOI 10.1152/ajpregu.00230.2009; Everson CA, 2008, AM J PHYSIOL-REG I, V295, pR2067, DOI 10.1152/ajpregu.90623.2008; Ferrell C.L., 1988, J ANIM SCI S3, V66, P23, DOI DOI 10.1093/ANSCI/66.SUPPLEMENT_3.23; FERY F, 1990, AM J PHYSIOL, V259, pE770, DOI 10.1152/ajpendo.1990.259.6.E770; FIORICA V, 1968, J APPL PHYSIOL, V24, P167, DOI 10.1152/jappl.1968.24.2.167; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Goodman MN, 1980, AM J PHYSIOL-ENDOC M, V239, P269; Goodman MN, 1984, AM J PHYSIOL, V246, P383; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Guyton AC, 2006, ENERGENTICS METABOLI, P881; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Harlan Laboratories, 2010, HSD SPRAG DAWL; HARRIS RBS, 1984, J NUTR, V114, P1143, DOI 10.1093/jn/114.6.1143; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Heiser P, 2000, EUR ARCH PSY CLIN N, V250, P16, DOI 10.1007/PL00007534; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Hu J, 2003, BRAIN BEHAV IMMUN, V17, P498, DOI 10.1016/j.bbi.2003.03.001; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Irwin MR, 2010, BRAIN BEHAV IMMUN, V24, P54, DOI 10.1016/j.bbi.2009.06.001; Johansen PB, 2000, GROWTH HORM IGF RES, V10, P342, DOI 10.1054/ghir.2000.0173; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Johnson DE, 2007, J NUTR, V137, P698, DOI 10.1093/jn/137.3.698; JOHNSON LC, 1965, PSYCHOSOM MED, V27, P415, DOI 10.1097/00006842-196509000-00003; Johnson LC, 1974, 193 AGARDOGRAPH NTIS; Jones S, 2008, J NEUROCHEM, V105, P46, DOI 10.1111/j.1471-4159.2007.05089.x; JORIS I, 1983, AM J PATHOL, V113, P341; KEENAN KP, 1994, TOXICOL PATHOL, V22, P300, DOI 10.1177/019262339402200308; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Koban M, 2008, SLEEP, V31, P927; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; KOLLAR EJ, 1966, PSYCHOSOM MED, V28, P101, DOI 10.1097/00006842-196603000-00002; KOLLAR EJ, 1969, AM J PSYCHIAT, V126, P488, DOI 10.1176/ajp.126.4.488; Laurberg P, 2005, HORM METAB RES, V37, P545, DOI 10.1055/s-2005-870420; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P1252, DOI 10.1139/y86-211; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Magee CA, 2008, PUBLIC HEALTH, V122, P1373, DOI 10.1016/j.puhe.2008.05.010; MCCAY CM, 1989, NUTRITION, V5, P155; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mistlberger RE, 2002, J BIOL RHYTHM, V17, P227, DOI 10.1177/07430402017003006; MITEV Y, 1993, BRAIN RES BULL, V30, P7, DOI 10.1016/0361-9230(93)90033-8; MOLDOFSKY H, 1989, FASEB J, V3, P1972, DOI 10.1096/fasebj.3.8.2785942; Mosoni L, 1996, J NUTR, V126, P516, DOI 10.1093/jn/126.2.516; Naito H K, 1984, Lab Res Methods Biol Med, V10, P1; NAITOH P, 1990, OCCUP MED, V5, P209; NAITOH P, 1971, BIOL PSYCHIAT, V3, P309; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Nedeltcheva AV, 2009, AM J CLIN NUTR, V89, P126, DOI 10.3945/ajcn.2008.26574; OBERMEYER W, 1991, SLEEP, V14, P285, DOI 10.1093/sleep/14.4.285; Ozturk L, 1999, Sleep Res Online, V2, P107; Palma BD, 2009, BRAZ J MED BIOL RES, V42, P299, DOI 10.1590/S0100-879X2009000300012; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; PILCHER JJ, 1990, SLEEP, V13, P218, DOI 10.1093/sleep/13.3.218; PILCHER JJ, 1991, SLEEP, V14, P201; POPPER DA, 1985, AM J PHYSIOL, V249, pG161, DOI 10.1152/ajpgi.1985.249.2.G161; RADOMSKI MW, 1992, AVIAT SPACE ENVIR MD, V63, P101; Ramsey JJ, 2006, J NUTR, V136, p1958S, DOI 10.1093/jn/136.7.1958S; RECHTSCHAFFEN A, 1995, BEHAV BRAIN RES, V69, P55, DOI 10.1016/0166-4328(95)00020-T; Rowlands DS, 2009, METABOLISM, V58, P1161, DOI 10.1016/j.metabol.2009.03.016; RUBIN RT, 1969, PSYCHOSOM MED, V31, P68, DOI 10.1097/00006842-196901000-00007; SAINZ RD, 1986, J NUTR, V116, P1529, DOI 10.1093/jn/116.8.1529; SALINPASCUAL RJ, 1988, SLEEP, V11, P362, DOI 10.1093/sleep/11.4.362; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmid SM, 2007, J CLIN ENDOCR METAB, V92, P3044, DOI 10.1210/jc.2006-2788; Sgoifo A, 2006, PSYCHONEUROENDOCRINO, V31, P197, DOI 10.1016/j.psyneuen.2005.06.009; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; SNYDER F, 1969, Biological Psychiatry, V1, P271; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; SWANER JC, 1975, AM J PHYSIOL, V229, P365, DOI 10.1152/ajplegacy.1975.229.2.365; SZYMUSIAK R, 1981, PHYSIOL BEHAV, V26, P687, DOI 10.1016/0031-9384(81)90145-1; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Theorell-Haglow J, 2010, SLEEP, V33, P593; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas ML, 2007, AVIAT SPACE ENVIR MD, V78, pB144; TOBLER I, 1983, NEUROSCI LETT, V35, P297, DOI 10.1016/0304-3940(83)90333-6; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TOWNSEND WF, 1981, GUT, V22, P953, DOI 10.1136/gut.22.11.953; Turner N, 2006, CURR OPIN CLIN NUTR, V9, P691, DOI 10.1097/01.mco.0000247474.56908.79; TYLER DB, 1946, P SOC EXP BIOL MED, V62, P38; Van Cauter E., 1997, MONOGR CLIN NEUROSCI, V15, P144, DOI [10.1159/000061553, DOI 10.1159/000061553]; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Dijk G, 2008, EUR J PHARMACOL, V585, P137, DOI 10.1016/j.ejphar.2007.11.079; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; VANHAASTEREN GAC, 1995, J ENDOCRINOL, V145, P143, DOI 10.1677/joe.0.1450143; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; VOGEL GW, 1975, ARCH GEN PSYCHIAT, V32, P749; VONDRA K, 1986, EUR J APPL PHYSIOL, V55, P83, DOI 10.1007/BF00422899; Webb WB, 1979, FUNCTIONS SLEEP, P19; Weiss A, 2010, SLEEP, V33, P1201, DOI 10.1093/sleep/33.9.1201; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WOODWARD CJH, 1991, BRIT J NUTR, V66, P117, DOI 10.1079/BJN19910015; WU JC, 1991, SLEEP, V14, P155; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	138	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22987	10.1371/journal.pone.0022987	http://dx.doi.org/10.1371/journal.pone.0022987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853062	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400022
J	Boutte, AM; McDonald, WH; Shyr, Y; Yang, L; Lin, PC				Boutte, Angela M.; McDonald, W. Hayes; Shyr, Yu; Yang, Li; Lin, P. Charles			Characterization of the MDSC Proteome Associated with Metastatic Murine Mammary Tumors Using Label-Free Mass Spectrometry and Shotgun Proteomics	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MYELOID CELLS; SUPPRESSOR-CELLS; BREAST-CANCER; TISSUE TRANSGLUTAMINASE; PEPTIDE IDENTIFICATION; TRANSFORMED-CELLS; CATHEPSIN-B; IN-VIVO; EXPRESSION	Expansion of Gr-1+/CD11b+ myeloid derived suppressor cells (MDSCs) is governed by the presence of increasingly metastatic, malignant primary tumors. Metastasis, not the primary tumor, is often the cause of mortality. This study sought to fully characterize the MDSC proteome in response to metastatic and non-metastatic mammary tumors using label-free mass spectrometry shotgun proteomics in a mouse model with tumor cell lines, 67NR and 4T1, derived from the same tumor. 67NR cells form only primary mammary tumors, whereas 4T1 cells readily metastasize to the lungs, lymph nodes, and blood. Overall analysis identified a total of 2825 protein groups with a 0.78% false discovery rate. Of the 2814 true identifications, 43 proteins were exclusive to the 67NR group, 153 were exclusive to the 4T1 group, and 2618 were shared. Among the shared cohort, 26 proteins were increased and 31 were decreased in the metastatic 4T1 cohort compared to non-metastatic 67NR controls after filtering. MDSCs selectively express proteins involved in the c-glutamyl transferase, glutathione synthase pathways, CREB transcription factor signaling, and other pathways involved in platelet aggregation, as well as lipid and amino acid metabolism, in response to highly metastatic 4T1 tumors. Cell cycle regulation dominated protein pathways and ontological groups of the 67NR non-metastatic group. Not only does this study provide a starting point to identify potential biomarkers of metastasis expressed by MDSCs; it identifies critical pathways that are unique to non-metastatic and metastatic conditions. Therapeutic interventions aimed at these pathways in MDSC may offer a new route to control malignancy and metastasis.	[Boutte, Angela M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37240 USA; [McDonald, W. Hayes] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Yang, Li; Lin, P. Charles] NIH, Ctr Canc Res, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boutte, AM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37240 USA.	angela.boutte@alumni.vanderbilt.edu; p.lin@nih.gov	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NIH [1F32CA136118, UL1 RR 024975, CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [R01CA108856, ZIABC011390, F32CA136118] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from NIH (1F32CA136118 and UL1 RR 024975) to AMB and NIH (CA108856, NS45888 and AR053718) to PCL. No additional external funding was received for this study. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrethsen J, 2010, MOL CELL PROTEOMICS, V9, P988, DOI 10.1074/mcp.M900546-MCP200; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Asano T, 2008, J SURG RES, V146, P32, DOI 10.1016/j.jss.2007.02.011; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BAUVOIS B, 1995, CELL GROWTH DIFFER, V6, P1163; Boutte AM, 2011, FASEB J, V25, P2626, DOI 10.1096/fj.10-180604; Chen YC, 2005, CANCER RES, V65, P331; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chung FY, 2006, AM J SURG PATHOL, V30, P969, DOI 10.1097/00000478-200608000-00006; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; EISMAN R, 1990, BLOOD, V76, P336; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kirov Stefan A., 2007, V408, P19, DOI 10.1007/978-1-59745-547-3_2; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; MOORE JC, 1990, BRIT J HAEMATOL, V74, P457, DOI 10.1111/j.1365-2141.1990.tb06335.x; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; NIERODZIK ML, 1991, J CLIN INVEST, V87, P229, DOI 10.1172/JCI114976; NOZAKI H, 1987, Tokai Journal of Experimental and Clinical Medicine, V12, P223; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sandoval Salemiz, 2009, Adv Hematol, V2009, P634292, DOI 10.1155/2009/634292; Saydam O, 2010, J PROTEOME RES, V9, P485, DOI 10.1021/pr900834h; Seth Late R K, 2003, Indian J Med Sci, V57, P350; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tazi KA, 2009, HEPATOL RES, V39, P706, DOI 10.1111/j.1872-034X.2009.00498.x; Terraube V, 2007, THROMB RES, V120, pS64, DOI 10.1016/S0049-3848(07)70132-9; Trotter MJ, 2003, J CUTAN MED SURG, V7, P136, DOI 10.1007/s10227-002-0164-8; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Venkatesha S, 2006, MOL CANCER RES, V4, P821, DOI 10.1158/1541-7786.MCR-06-0110; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	63	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22446	10.1371/journal.pone.0022446	http://dx.doi.org/10.1371/journal.pone.0022446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853032	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200010
J	Cho, Y; McQuade, T; Zhang, HB; Zhang, JK; Chan, FKM				Cho, YoungSik; McQuade, Thomas; Zhang, Haibing; Zhang, Jianke; Chan, Francis Ka-Ming			RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; DOMAIN KINASE RIP; PROGRAMMED NECROSIS; TNF-ALPHA; INDUCED APOPTOSIS; L929 CELLS; DEATH; NECROPTOSIS; IDENTIFICATION; MECHANISMS	Background: Programmed necrosis/necroptosis is an emerging form of cell death that plays important roles in mammalian development and the immune system. The pro-necrotic kinases in the receptor interacting protein (RIP) family are crucial mediators of programmed necrosis. Recent advances in necrosis research have been greatly aided by the identification of chemical inhibitors that block programmed necrosis. Necrostatin-1 (Nec-1) and its derivatives were previously shown to target the pro-necrotic kinase RIP1/RIPK1. The protective effect conferred by Nec-1 and its derivatives in many experimental model systems was often attributed to the inhibition of RIP1 function. Methodology/Principal Findings: We compared the effect of Nec-1 and siRNA-mediated silencing of RIP1 in the murine fibrosarcoma cell line L929. Treatment of L929 cells with the pan-caspase inhibitor zVAD-fmk or exogenous TNF induces necrosis. Strikingly, we found that siRNA-mediated silencing of RIP1 inhibited zVAD-fmk induced necrosis, but not TNF-induced necrosis. TNF-induced cell death in RIP1 knocked down L929 cells was inhibited by Nec-1, but not the caspase inhibitor zVAD-fmk. We found that PKA-C1 expression, but not Jnk or Erk activation, was moderately inhibited by Nec-1. Moreover, we found that Nec-1 inhibits proximal T cell receptor signaling independent of RIP1, leading to inhibition of T cell proliferation. Conclusions/Significance: Our results reveal that besides RIP1, Nec-1 also targets other factors crucial for necrosis induction in L929 cells. In addition, high doses of Nec-1 inhibit other signal transduction pathways such as that for T cell receptor activation. These results highlight the importance to independently validate results obtained using Nec-1 with other approaches such as siRNA-mediated gene silencing. We propose that some of the previous published results obtained using Nec-1 should be re-evaluated in light of our findings.	[Cho, YoungSik; McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Program Immunol & Virol, Worcester, MA 01605 USA; [Zhang, Haibing; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, UMass Diabet & Endocrinol Res Ctr, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Cho, Y (corresponding author), Keimyung Univ, Coll Pharm, Taegu, South Korea.	Francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Zhang, Jianke/0000-0002-5822-2226	National Institutes of Health [AI088502, AI083497, DK32520, AI076788]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088502, R01AI083497, R03AI076788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (AI088502, AI083497, and DK32520 to F. K. C. and AI076788 to J.Z.). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Cho Y, 2011, ADV EXP MED BIOL, V691, P589, DOI 10.1007/978-1-4419-6612-4_62; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Trichonas G, 2010, P NATL ACAD SCI US; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; YOU Z, 2008, J CEREB BLOOD FLOW M; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, RIP3 ENERGY METABOLI; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	36	75	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23209	10.1371/journal.pone.0023209	http://dx.doi.org/10.1371/journal.pone.0023209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853090	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200053
J	Salathe, RM; Schmid-Hempel, P				Salathe, Rahel M.; Schmid-Hempel, Paul			The Genotypic Structure of a Multi-Host Bumblebee Parasite Suggests a Role for Ecological Niche Overlap	PLOS ONE			English	Article							GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; PLASMODIUM-FALCIPARUM; POPULATION STRUCTURES; EVOLUTIONARY ECOLOGY; HOST HETEROGENEITY; TRYPANOSOMA-CRUZI; CRITHIDIA-BOMBI; RARE ALLELES; PATHOGEN	The genotypic structure of parasite populations is an important determinant of ecological and evolutionary dynamics of host-parasite interactions with consequences for pest management and disease control. Genotypic structure is especially interesting where multiple hosts co-exist and share parasites. We here analyze the natural genotypic distribution of Crithidia bombi, a trypanosomatid parasite of bumblebees (Bombus spp.), in two ecologically different habitats over a time period of three years. Using an algorithm to reconstruct genotypes in cases of multiple infections, and combining these with directly identified genotypes from single infections, we find a striking diversity of infection for both data sets, with almost all multilocus genotypes being unique, and are inferring that around half of the total infections are resulting from multiple strains. Our analyses further suggest a mixture of clonality and sexuality in natural populations of this parasite species. Finally, we ask whether parasite genotypes are associated with host species (the phylogenetic hypothesis) or whether ecological factors (niche overlap in flower choice) shape the distribution of parasite genotypes (the ecological hypothesis). Redundancy analysis demonstrates that in the region with relatively high parasite prevalence, both host species identity and niche overlap are equally important factors shaping the distribution of parasite strains, whereas in the region with lower parasite prevalence, niche overlap more strongly contributes to the distribution observed. Overall, our study underlines the importance of ecological factors in shaping the natural dynamics of host-parasite systems.	[Salathe, Rahel M.; Schmid-Hempel, Paul] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Salathe, Rahel M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	ETH Zurich; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Salathe, RM (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	rms55@psu.edu			Swiss NSF [3100A0-116057]; Australian ARC [DP0209447]; Genetic Diversity Centre of ETH Zurich (GDC); CCES	Swiss NSF(Swiss National Science Foundation (SNSF)); Australian ARC; Genetic Diversity Centre of ETH Zurich (GDC); CCES	The study was supported by Swiss NSF (grant nr. 3100A0-116057) and Australian ARC (grant nr. DP0209447). It was also supported by the Genetic Diversity Centre of ETH Zurich (GDC) and CCES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Babiker H. A., 1996, Annals of Tropical Medicine and Parasitology, V90, P410; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Belkhir K, 1998, 9060 CNRS UPR U MONT; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; BRIAN AD, 1957, J ANIM ECOL, V26, P71, DOI 10.2307/1782; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Cuervo P, 2002, MEM I OSWALDO CRUZ, V97, P877, DOI 10.1590/S0074-02762002000600023; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Durrer Stephan, 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V258, P299, DOI 10.1098/rspb.1994.0176; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLOGENETIC INFEREN; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2000, OIKOS, V91, P485, DOI 10.1034/j.1600-0706.2000.910309.x; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hamilton R, 2005, P ROY SOC B-BIOL SCI, V272, P1647, DOI 10.1098/rspb.2005.3134; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hess AE, 1991, BESTIMMUNGSSCHLUSSEL; HIDE G, 1994, PARASITOLOGY, V109, P95, DOI 10.1017/S0031182000077805; INOUYE DW, 1980, OECOLOGIA, V45, P197, DOI 10.1007/BF00346460; Ivey CT, 2001, INT J PLANT SCI, V162, P1327, DOI 10.1086/323476; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Ladd C, 2001, CROAT MED J, V42, P244; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Lythgoe KA, 2002, AM NAT, V159, P519, DOI 10.1086/339462; MacLeod A, 2005, MOL BIOCHEM PARASIT, V143, P12, DOI 10.1016/j.molbiopara.2005.04.009; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mortera J, 2003, THEOR POPUL BIOL, V63, P191, DOI 10.1016/S0040-5809(03)00006-6; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SCHMIDHEMPEL P, 1993, BEHAV ECOL SOCIOBIOL, V33, P319, DOI 10.1007/BF00172930; Seppala O, 2009, P ROY SOC B-BIOL SCI, V276, P691, DOI 10.1098/rspb.2008.1229; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Takezaki N, 1996, GENETICS, V144, P389; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thiele EA, 2008, INT J PARASITOL, V38, P389, DOI 10.1016/j.ijpara.2007.07.011; Tibayrenc M, 2005, TRENDS MICROBIOL, V13, P575, DOI 10.1016/j.tim.2005.09.004; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Tibayrenc M, 1999, MICROBES INFECT, V1, P465, DOI 10.1016/S1286-4579(99)80050-1; Tibayrenc M, 1999, ANNU REV GENET, V33, P449, DOI 10.1146/annurev.genet.33.1.449; Wakelin Derek, 1997, P30; Wilfert L, 2007, MOL ECOL, V16, P1327, DOI 10.1111/j.1365-294X.2007.03234.x	67	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22054	10.1371/journal.pone.0022054	http://dx.doi.org/10.1371/journal.pone.0022054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853023	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200004
J	Yang, CJ; Kim, SH; Bianco, NR; Robbins, PD				Yang, Chenjie; Kim, Seon-Hee; Bianco, Nicole R.; Robbins, Paul D.			Tumor-Derived Exosomes Confer Antigen-Specific Immunosuppression in a Murine Delayed-Type Hypersensitivity Model	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; MEMBRANE-VESICLES; DENDRITIC CELLS; VIRAL IL-10; TGF-BETA; T-CELLS; EXPERIMENTAL ARTHRITIS; SUPPRESS INFLAMMATION; EFFICIENT INDUCTION; ANTITUMOR RESPONSE	Exosomes are endosome-derived small membrane vesicles that are secreted by most cell types including tumor cells. Tumor-derived exosomes usually contain tumor antigens and have been used as a source of tumor antigens to stimulate anti-tumor immune responses. However, many reports also suggest that tumor-derived exosomes can facilitate tumor immune evasion through different mechanisms, most of which are antigen-independent. In the present study we used a mouse model of delayed-type hypersensitivity (DTH) and demonstrated that local administration of tumor-derived exosomes carrying the model antigen chicken ovalbumin (OVA) resulted in the suppression of DTH response in an antigen-specific manner. Analysis of exosome trafficking demonstrated that following local injection, tumor-derived exosomes were internalized by CD11c+ cells and transported to the draining LN. Exosome-mediated DTH suppression is associated with increased mRNA levels of TGF-beta 1 and IL-4 in the draining LN. The tumor-derived exosomes examined were also found to inhibit DC maturation. Taken together, our results suggest a role for tumor-derived exosomes in inducing tumor antigen-specific immunosuppression, possibly by modulating the function of APCs.	[Yang, Chenjie; Kim, Seon-Hee; Bianco, Nicole R.; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, CJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu			DOD [17-03-1-0488, 17-03-0412, U01 NS058451, P30 AG024827, R21 AG033907]; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033907, P30AG024827] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by DOD grants 17-03-1-0488 and 17-03-0412 and U01 NS058451, P30 AG024827, and R21 AG033907 grants from the National Institutes of Health to PDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Cone RE, 2007, IMMUNOLOGY, V120, P112, DOI 10.1111/j.1365-2567.2006.02486.x; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Dai SM, 2006, J MOL MED, V84, P1067, DOI 10.1007/s00109-006-0102-0; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Denzer K, 2000, J CELL SCI, V113, P3365; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Ghivizzani SC, 1998, P NATL ACAD SCI USA, V95, P4613, DOI 10.1073/pnas.95.8.4613; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Jacysyn JF, 2003, IMMUNOL CELL BIOL, V81, P424, DOI 10.1046/j.1440-1711.2003.01194.x; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Lechman ER, 2003, GENE THER, V10, P2029, DOI 10.1038/sj.gt.3302109; Lechman ER, 1999, J IMMUNOL, V163, P2202; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MEADE R, 1992, J IMMUNOL, V149, P521; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Ostman S, 2005, IMMUNOLOGY, V116, P464, DOI 10.1111/j.1365-2567.2005.02245.x; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Rock KL, 1996, J IMMUNOL, V156, P3721; Sack U, 1999, J AUTOIMMUN, V13, P335, DOI 10.1006/jaut.1999.0328; Seder RA, 1998, J IMMUNOL, V160, P5719; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Whalen JD, 2001, MOL THER, V4, P543, DOI 10.1006/mthe.2001.0492; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Xiu FM, 2007, J MOL MED, V85, P511, DOI 10.1007/s00109-006-0154-1; Yang YS, 2007, J CANCER RES CLIN, V133, P389, DOI 10.1007/s00432-006-0184-7; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zhang Y, 2010, INT J ONCOL, V36, P133, DOI 10.3892/ijo_00000484; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	57	75	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22517	10.1371/journal.pone.0022517	http://dx.doi.org/10.1371/journal.pone.0022517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829629	Green Published, gold, Green Accepted			2022-12-25	WOS:000293511900009
J	Hakze-van der Honing, RW; van Coillie, E; Antonis, AFG; van der Poel, WHM				Hakze-van der Honing, Renate W.; van Coillie, Els; Antonis, Adriaan F. G.; van der Poel, Wim H. M.			First Isolation of Hepatitis E Virus Genotype 4 in Europe through Swine Surveillance in the Netherlands and Belgium	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; UNITED-STATES; RT-PCR; PREVALENCE; HEV; EPIDEMIOLOGY; TRANSMISSION; ANTIBODIES; SEQUENCES; HUMANS	Hepatitis E virus (HEV) genotypes 3 and 4 are a cause of human hepatitis and swine are considered the main reservoir. To study the HEV prevalence and characterize circulating HEV strains, fecal samples from swine in the Netherlands and Belgium were tested by RT-PCR. HEV prevalence in swine was 7-15%. The Dutch strains were characterized as genotype 3, subgroups 3a, 3c and 3f, closely related to sequences found in humans and swine earlier. The HEV strains found in Belgium belonged to genotypes 3f and 4b. The HEV genotype 4 strain was the first ever reported in swine in Europe and an experimental infection in pigs was performed to isolate the virus. The genotype 4 strain readily infected piglets and caused fever and virus shedding. Since HEV4 infections have been reported to run a more severe clinical course in humans this observation may have public health implications.	[Hakze-van der Honing, Renate W.; Antonis, Adriaan F. G.; van der Poel, Wim H. M.] Univ Wageningen & Res Ctr, Lelystad, Netherlands; [van Coillie, Els] Inst Agr & Fisheries Res ILVO, Melle, Belgium; [van der Poel, Wim H. M.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	Wageningen University & Research; Institute For Agricultural & Fisheries Research; University of Liverpool	Hakze-van der Honing, RW (corresponding author), Univ Wageningen & Res Ctr, Lelystad, Netherlands.	wim.vanderpoel@wur.nl			Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre	Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre	This study was commissioned by the Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre internal research program "Kennisbasis''. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Bouwknegt M, 2008, EPIDEMIOL INFECT, V136, P567, DOI 10.1017/S0950268807008941; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Drobeniuc J, 2001, J INFECT DIS, V184, P1594, DOI 10.1086/324566; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Gyarmati P, 2007, J VIROL METHODS, V146, P226, DOI 10.1016/j.jviromet.2007.07.014; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Meng XJ, 2003, CURR TOP MICROBIOL, V278, P185; Olsen BR, 2006, SCAND J INFECT DIS, V38, P55, DOI 10.1080/00365540500321470; Rutjes SA, 2007, J VIROL METHODS, V143, P112, DOI 10.1016/j.jviromet.2007.01.030; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Schlauder GG, 1999, J MED VIROL, V57, P243, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;243::AID-JMV6&gt;3.0.CO;2-R; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Widdowson MA, 2003, CLIN INFECT DIS, V36, P29, DOI 10.1086/345439; Widen F, 2010, EPIDEMIOL INFECT, V14, P1; Withers MR, 2002, AM J TROP MED HYG, V66, P384, DOI 10.4269/ajtmh.2002.66.384; Worm HC, 2002, MICROBES INFECT, V4, P657, DOI 10.1016/S1286-4579(02)01584-8	34	95	99	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22673	10.1371/journal.pone.0022673	http://dx.doi.org/10.1371/journal.pone.0022673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829641	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511200016
J	Hong, YD; Xing, XR; Li, SJ; Bi, HL; Yang, CH; Zhao, F; Liu, Y; Ao, X; Chang, AK; Wu, HJ				Hong, Yongde; Xing, Xinrong; Li, Shujing; Bi, Hailian; Yang, Chunhua; Zhao, Feng; Liu, Ying; Ao, Xiang; Chang, Alan K.; Wu, Huijian			SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; TUMOR-SUPPRESSOR; MOLECULAR CLOCK; E-BOX; STRA13; SUMO; HYPOXIA; LOOP; PROMOTES; UBIQUITIN	Differentiated embryo-chondrocyte expressed gene 1 (DEC1, also known as sharp2, stra13, or BHLHB2) is a mammalian basic helix-loop-helix protein that is involved in many aspects of gene regulation through acting as a transcription factor. Changes in DEC1 expression levels have been implicated in the development of cancers. Using COS-7 cell, we showed that DEC1 can be modified by the small ubiquitin-like modifiers, SUMO1, 2 and 3. Two major SUMOylation sites (K(159) and K(279)) were identified in the C-terminal domain of DEC1. Substitution of either K(159) or K(279) with arginine reduced DEC1 SUMOylation, but substitution of both K(159) and K(279) abolished SUMOylation, and more protein appeared to be retained in the cytoplasm compared to wild-type DEC1. The expression of DEC1 was up-regulated after serum starvation as previously reported, but at the same time, serum starvation also led to more SUMOylation of DEC1. In MCF-7 cells SUMOylation also stabilized DEC1 through inhibiting its ubiquitination. Moreover, SUMOylation of DEC1 promoted its repression of CLOCK/BMAL1-mediated transcriptional activity through recruitment of histone deacetylase1. These findings suggested that posttranslational modification of DEC1 in the form of SUMOylation may serve as a key factor that regulates the function of DEC1 in vivo.	[Hong, Yongde; Xing, Xinrong; Li, Shujing; Bi, Hailian; Yang, Chunhua; Zhao, Feng; Liu, Ying; Ao, Xiang; Chang, Alan K.; Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Dalian University of Technology	Hong, YD (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	wuhj@dlut.edu.cn	Liu, Ying/ABF-6380-2021	Liu, Ying/0000-0003-1699-9309; Zhao, Feng/0000-0002-7959-0394	National Natural Science Foundation of China [30771221]; Ministry of Science and Technology of China [2011CB504201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (30771221 to H.W.) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default106.htm) and grants (973 Program 2011CB504201 to H.W.) from the Ministry of Science and Technology of China (http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Currie MJ, 2004, J CLIN PATHOL, V57, P829, DOI 10.1136/jcp.2003.015644; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kohler M, 1999, EXP NEPHROL, V7, P290; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li YX, 2004, BIOCHEM J, V382, P895, DOI 10.1042/BJ20040592; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Teramoto M, 2001, J BIOCHEM-TOKYO, V129, P391, DOI 10.1093/oxfordjournals.jbchem.a002869; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yagita K, 2000, GENE DEV, V14, P1353; Yamada K, 2005, FEBS LETT, V579, P1509, DOI 10.1016/j.febslet.2005.01.060; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Yunokawa M, 2007, ONCOL REP, V17, P871; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	51	34	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23046	10.1371/journal.pone.0023046	http://dx.doi.org/10.1371/journal.pone.0023046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829689	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200034
J	Uebanso, T; Taketani, Y; Yamamoto, H; Amo, K; Ominami, H; Arai, H; Takei, Y; Masuda, M; Tanimura, A; Harada, N; Yamanaka-Okumura, H; Takeda, E				Uebanso, Takashi; Taketani, Yutaka; Yamamoto, Hironori; Amo, Kikuko; Ominami, Hirokazu; Arai, Hidekazu; Takei, Yuichiro; Masuda, Masashi; Tanimura, Ayako; Harada, Nagakatsu; Yamanaka-Okumura, Hisami; Takeda, Eiji			Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-21; ELEMENT-BINDING PROTEIN; PPAR-ALPHA; METABOLIC REGULATOR; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ANOREXIA-NERVOSA; CARBOHYDRATE; FIBROBLAST-GROWTH-FACTOR-21; CHREBP	Fibroblast growth factor 21 (FGF21) has recently emerged as a metabolic hormone involved in regulating glucose and lipid metabolism in mouse, but the regulatory mechanisms and actions of FGF21 in humans remain unclear. Here we have investigated the regulatory mechanisms of the human FGF21 gene at the transcriptional level. A deletion study of the human FGF21 promoter (-1672 to +230 bp) revealed two fasting signals, including peroxisome proliferator-activated receptor alpha (PPAR alpha) and glucagon signals, that independently induced human FGF21 gene transcription in mouse primary hepatocytes. In addition, two feeding signals, glucose and xylitol, also dose-dependently induced human FGF21 gene transcription and mRNA expression in both human HepG2 cells and mouse primary hepatocytes. FGF21 protein expression and secretion were also induced by high glucose stimulation. The human FGF21 promoter (-1672 to +230 bp) was found to have a carbohydrate-responsive element at -380 to -366 bp, which is distinct from the PPAR response element (PPRE). Knock-down of the carbohydrate response element binding protein by RNAi diminished glucose-induced human FGF21 transcription. Moreover, we found that a region from -555 to -443 bp of the human FGF21 promoter region exerts an important role in the activation of basic transcription. In conclusion, human FGF21 gene expression is paradoxically and independently regulated by both fasting and feeding signals. These regulatory mechanisms suggest that human FGF21 is increased with nutritional crisis, including starvation and overfeeding.	[Uebanso, Takashi; Taketani, Yutaka; Yamamoto, Hironori; Amo, Kikuko; Ominami, Hirokazu; Takei, Yuichiro; Masuda, Masashi; Tanimura, Ayako; Yamanaka-Okumura, Hisami; Takeda, Eiji] Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Uebanso, Takashi] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst, Tokyo, Japan; [Arai, Hidekazu] Univ Shizuoka, Sch Food & Nutr Sci, Lab Clin Nutr Management, Shizuoka 4228526, Japan; [Harada, Nagakatsu] Univ Tokushima, Dept Nutr & Metab, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	Tokushima University; National Center for Global Health & Medicine - Japan; University of Shizuoka; Tokushima University	Uebanso, T (corresponding author), Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	taketani@nutr.med.tokushima-u.ac.jp	Yamamoto, Hironori/E-3902-2015; Arai, Hidekazu/R-6636-2019	Arai, Hidekazu/0000-0001-8491-021X; Masuda, Masashi/0000-0003-3762-2770	Ministry of Education, Culture, Sports, Science, and Technology in Japan [19680030, 18790567, 22890244, 18300232, 22300237]; University of Tokushima, Tokushima, Japan; Grants-in-Aid for Scientific Research [22680053] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokushima, Tokushima, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research for Young Scientists (19680030, 18790567); for Research Activity Start-up (22890244) and for Scientific Research (B) (18300232, 22300237) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; the 21st Century COE program "Human Nutritional Science and Stress Control"; and the Initiatives for Attractive Education in Graduate School from the University of Tokushima, Tokushima, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P369, DOI 10.1210/jc.2009-1730; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mizuha Y, 2007, BIOFACTORS, V30, P105, DOI 10.1002/biof.5520300204; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	22	68	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22976	10.1371/journal.pone.0022976	http://dx.doi.org/10.1371/journal.pone.0022976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829679	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200029
J	Deswal, S; Schulze, AK; Hofer, T; Schamel, WWA				Deswal, Sumit; Schulze, Anna K.; Hoefer, Thomas; Schamel, Wolfgang W. A.			Quantitative Analysis of Protein Phosphorylations and Interactions by Multi-Colour IP-FCM as an Input for Kinetic Modelling of Signalling Networks	PLOS ONE			English	Article							CELL ANTIGEN-RECEPTOR; TYROSINE KINASE ZAP-70; BEAD ARRAY; T-CELLS; ACTIVATION; SENSITIVITY; STOICHIOMETRY; RECOGNITION; DOMAINS; BIOLOGY	Background: To understand complex biological signalling mechanisms, mathematical modelling of signal transduction pathways has been applied successfully in last few years. However, precise quantitative measurements of signal transduction events such as activation-dependent phosphorylation of proteins, remains one bottleneck to this success. Methodology/Principal Findings: We use multi-colour immunoprecipitation measured by flow cytometry (IP-FCM) for studying signal transduction events to unrivalled precision. In this method, antibody-coupled latex beads capture the protein of interest from cellular lysates and are then stained with differently fluorescent-labelled antibodies to quantify the amount of the immunoprecipitated protein, of an interaction partner and of phosphorylation sites. The fluorescence signals are measured by FCM. Combining this procedure with beads containing defined amounts of a fluorophore allows retrieving absolute numbers of stained proteins, and not only relative values. Using IP-FCM we derived multidimensional data on the membrane-proximal T-cell antigen receptor (TCR-CD3) signalling network, including the recruitment of the kinase ZAP70 to the TCR-CD3 and subsequent ZAP70 activation by phosphorylation in the murine T-cell hybridoma and primary murine T cells. Counter-intuitively, these data showed that cell stimulation by pervanadate led to a transient decrease of the phospho-ZAP70/ZAP70 ratio at the TCR. A mechanistic mathematical model of the underlying processes demonstrated that an initial massive recruitment of non-phosphorylated ZAP70 was responsible for this behaviour. Further, the model predicted a temporal order of multisite phosphorylation of ZAP70 (with Y319 phosphorylation preceding phosphorylation at Y493) that we subsequently verified experimentally. Conclusions/Significance: The quantitative data sets generated by IP-FCM are one order of magnitude more precise than Western blot data. This accuracy allowed us to gain unequalled insight into the dynamics of the TCR-CD3-ZAP70 signalling network.	[Deswal, Sumit; Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Deswal, Sumit; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Biol, Freiburg, Germany; [Deswal, Sumit] Spemann Grad Sch Biol & Med, Freiburg, Germany; [Schulze, Anna K.; Hoefer, Thomas] German Canc Res Ctr, Res Grp Modeling Biol Syst, D-6900 Heidelberg, Germany; [Schulze, Anna K.; Hoefer, Thomas] BioQuant Ctr, Heidelberg, Germany; [Schamel, Wolfgang W. A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Schamel, Wolfgang W. A.] Univ Med Ctr Freiburg, CCI, Freiburg, Germany	Max Planck Society; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg	Deswal, S (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	schamel@immunbio.mpg.de	Höfer, Thomas/G-5665-2013	Höfer, Thomas/0000-0003-3560-8780	European Union [FP7/2007-2013]; Deutsche-Forschungsgemeinschaft [EXC294]; Bundesministerium fur Bildung und Forschung; SGBM (Spemann Graduate School of Biology and Medicine) [GSC-4]	European Union(European Commission); Deutsche-Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); SGBM (Spemann Graduate School of Biology and Medicine)	This work was funded by the European Union through grant FP7/2007-2013 (SYBILLA, to WWAS and TH, www.sybilla-t-cell.de), the Deutsche-Forschungsgemeinschaft through EXC294 (to WWAS, www.bioss.uni-freiburg.de) and the Bundesministerium fur Bildung und Forschung through FORSYS (to WWAS and TH, www.forsys.net/joomla). SD was funded by SGBM (Spemann Graduate School of Biology and Medicine, GSC-4, www.sgbm.uni-freiburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Bridgeman JS, 2010, CYTOM PART A, V77A, P338, DOI 10.1002/cyto.a.20840; BRONSTEIN I, 1992, BIOTECHNIQUES, V12, P748; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Deswal S, 2010, IMMUNOL LETT, V130, P51, DOI 10.1016/j.imlet.2009.12.012; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Khan IH, 2006, MOL CELL PROTEOMICS, V5, P758, DOI 10.1074/mcp.T500032-MCP200; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Lund-Johansen F, 2000, CYTOMETRY, V39, P250, DOI 10.1002/(SICI)1097-0320(20000401)39:4<250::AID-CYTO2>3.0.CO;2-S; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; OSHEA JJ, 1991, P NATL ACAD SCI USA, V88, P1741, DOI 10.1073/pnas.88.5.1741; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schilling M, 2005, IEE P SYST BIOL, V152, P193, DOI 10.1049/ip-syb:20050044; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Schrum Adam G, 2009, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0509s87; SCHRUM AG, 2007, SCI STKE, pL2; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Weissenhorn W, 1996, EUR J BIOCHEM, V238, P440, DOI 10.1111/j.1432-1033.1996.0440z.x; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wu WW, 2009, MOL CELL PROTEOMICS, V8, P245, DOI 10.1074/mcp.M800171-MCP200	45	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22928	10.1371/journal.pone.0022928	http://dx.doi.org/10.1371/journal.pone.0022928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829558	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500054
J	Pulido, MR; Diaz-Ruiz, A; Jimenez-Gomez, Y; Garcia-Navarro, S; Gracia-Navarro, F; Tinahones, F; Lopez-Miranda, J; Fruhbeck, G; Vazquez-Martinez, R; Malagon, MM				Pulido, Marina R.; Diaz-Ruiz, Alberto; Jimenez-Gomez, Yolanda; Garcia-Navarro, Socorro; Gracia-Navarro, Francisco; Tinahones, Francisco; Lopez-Miranda, Jose; Fruehbeck, Gema; Vazquez-Martinez, Rafael; Malagon, Maria M.			Rab18 Dynamics in Adipocytes in Relation to Lipogenesis, Lipolysis and Obesity	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; LIPID DROPLETS; HORMONAL-REGULATION; PROTEIN; EXPRESSION; TISSUE; EXOCYTOSIS; STORAGE; DIFFERENTIATION; ADIPOGENESIS	Lipid droplets (LDs) are organelles that coordinate lipid storage and mobilization, both processes being especially important in cells specialized in managing fat, the adipocytes. Proteomic analyses of LDs have consistently identified the small GTPase Rab18 as a component of the LD coat. However, the specific contribution of Rab18 to adipocyte function remains to be elucidated. Herein, we have analyzed Rab18 expression, intracellular localization and function in relation to the metabolic status of adipocytes. We show that Rab18 production increases during adipogenic differentiation of 3T3-L1 cells. In addition, our data show that insulin induces, via phosphatidylinositol 3-kinase (PI3K), the recruitment of Rab18 to the surface of LDs. Furthermore, Rab18 overexpression increased basal lipogenesis and Rab18 silencing impaired the lipogenic response to insulin, thereby suggesting that this GTPase promotes fat accumulation in adipocytes. On the other hand, studies of the beta-adrenergic receptor agonist isoproterenol confirmed and extended previous evidence for the participation of Rab18 in lipolysis. Together, our data support the view that Rab18 is a common mediator of lipolysis and lipogenesis and suggests that the endoplasmic reticulum (ER) is the link that enables Rab18 action on these two processes. Finally, we describe, for the first time, the presence of Rab18 in human adipose tissue, wherein the expression of this GTPase exhibits sex-and depot-specific differences and is correlated to obesity. Taken together, these findings indicate that Rab18 is involved in insulin-mediated lipogenesis, as well as in beta-adrenergic-induced lipolysis, likely facilitating interaction of LDs with ER membranes and the exchange of lipids between these compartments. A role for Rab18 in the regulation of adipocyte biology under both normal and pathological conditions is proposed.	[Pulido, Marina R.; Diaz-Ruiz, Alberto; Jimenez-Gomez, Yolanda; Garcia-Navarro, Socorro; Gracia-Navarro, Francisco; Vazquez-Martinez, Rafael; Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Pulido, Marina R.; Diaz-Ruiz, Alberto; Jimenez-Gomez, Yolanda; Garcia-Navarro, Socorro; Tinahones, Francisco; Lopez-Miranda, Jose; Fruehbeck, Gema; Vazquez-Martinez, Rafael; Malagon, Maria M.] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Pulido, Marina R.; Diaz-Ruiz, Alberto; Jimenez-Gomez, Yolanda; Garcia-Navarro, Socorro; Gracia-Navarro, Francisco; Lopez-Miranda, Jose; Vazquez-Martinez, Rafael; Malagon, Maria M.] Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain; [Tinahones, Francisco] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Lopez-Miranda, Jose] Hosp Univ Reina Sofia, Lipids & Atherosclerosis Unit, Cordoba, Spain; [Fruehbeck, Gema] Univ Navarra, Metab Res Lab, E-31080 Pamplona, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Virgen de la Victoria; Hospital Universitario Reina Sofia - Cordoba; University of Navarra	Pulido, MR (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.	bc2vamar@uco.es; bc1mapom@uco.es	Lopez-Miranda, Jose/Y-8306-2019; Jiménez-Gómez, Yolanda/Y-3742-2018; Malagon, Maria M/L-5386-2014; Pulido, Marina/J-3176-2018; Vazquez-Martinez, Rafael/G-1243-2016; Tinahones, Francisco José/AAB-2882-2020	Lopez-Miranda, Jose/0000-0002-8844-0718; Jiménez-Gómez, Yolanda/0000-0002-1607-2717; Malagon, Maria M/0000-0002-2419-2727; Tinahones, Francisco J/0000-0001-6871-4403; Pulido, Marina Rosa/0000-0003-1633-4294; Gracia Navarro, Francisco/0000-0003-2128-4228; Diaz-Ruiz, Alberto/0000-0002-0488-4216	Ministerio de Ciencia e Innovacion (MICINN) [BFU2007-60180, BFU2010-17116, AGL2009-12270, FPU AP2005-3348, FPI BES-2005-7405, HF2007-0002]; Junta de Andalucia [BIO-139], CTS-03039]; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); Instituto de Salud Carlos III, Spain	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This work has been supported by Ministerio de Ciencia e Innovacion (MICINN)/FEDER (BFU2007-60180, BFU2010-17116, AGL2009-12270, FPU AP2005-3348, FPI BES-2005-7405, and Accion Integrada HF2007-0002), Junta de Andalucia (BIO-139; CTS-03039), and CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; BALDINI G, 1995, P NATL ACAD SCI USA, V92, P4284, DOI 10.1073/pnas.92.10.4284; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Berndt J, 2008, EXP CLIN ENDOCR DIAB, V116, P203, DOI 10.1055/s-2007-993148; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; DELPOZO CH, 2010, OBES SURG; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fruhbeck Gema, 2008, V456, P1, DOI 10.1007/978-1-59745-245-8_1; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Genuth S, 2003, DIABETES CARE, V26, P3160; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; LAFONTAN M, 2009, PROG LIPID RES; LAI E, 1981, J BIOL CHEM, V256, P2866; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; LUTCKE A, 1994, J CELL SCI, V107, P3437; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shibata H, 1997, J BIOL CHEM, V272, P14542, DOI 10.1074/jbc.272.23.14542; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Vazquez-Martinez R, 2007, TRAFFIC, V8, P867, DOI 10.1111/j.1600-0854.2007.00570.x; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	64	83	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22931	10.1371/journal.pone.0022931	http://dx.doi.org/10.1371/journal.pone.0022931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829560	Green Published, gold			2022-12-25	WOS:000293284600066
J	Samarakoon, R; Chitnis, SS; Higgins, SP; Higgins, CE; Krepinsky, JC; Higgins, PJ				Samarakoon, Rohan; Chitnis, Subhanir S.; Higgins, Stephen P.; Higgins, Craig E.; Krepinsky, Joan C.; Higgins, Paul J.			Redox-Induced Src Kinase and Caveolin-1 Signaling in TGF-beta 1-Initiated SMAD2/3 Activation and PAI-1 Expression	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; TGF-BETA; NEOINTIMA FORMATION; INHIBITOR; PHOSPHATASE; DEFICIENCY; PATHWAYS; EVENTS; MODEL	Background: Plasminogen activator inhibitor-1 (PAI-1), a major regulator of the plasmin-based pericellular proteolytic cascade, is significantly increased in human arterial plaques contributing to vessel fibrosis, arteriosclerosis and thrombosis, particularly in the context of elevated tissue TGF-beta 1. Identification of molecular events underlying to PAI-1 induction in response to TGF-beta 1 may yield novel targets for the therapy of cardiovascular disease. Principal Findings: Reactive oxygen species are generated within 5 minutes after addition of TGF-beta 1 to quiescent vascular smooth muscle cells (VSMCs) resulting in pp60(c-src) activation and PAI-1 expression. TGF-beta 1-stimulated Src kinase signaling sustained the duration (but not the initiation) of SMAD3 phosphorylation in VSMC by reducing the levels of PPM1A, a recently identified C-terminal SMAD2/3 phosphatase, thereby maintaining SMAD2/3 in an active state with retention of PAI-1 transcription. The markedly increased PPM1A levels in triple Src kinase (c-Src, Yes, Fyn)-null fibroblasts are consistent with reductions in both SMAD3 phosphorylation and PAI-1 expression in response to TGF-beta 1 compared to wild-type cells. Activation of the Rho-ROCK pathway was mediated by Src kinases and required for PAI-1 induction in TGF-beta 1-stimulated VSMCs. Inhibition of Rho-ROCK signaling blocked the TGF-beta 1-mediated decrease in nuclear PPM1A content and effectively attenuated PAI-1 expression. TGF-beta 1-induced PAI-1 expression was undetectable in caveolin-1-null cells, correlating with the reduced Rho-GTP loading and SMAD2/3 phosphorylation evident in TGF-beta 1-treated caveolin-1-deficient cells relative to their wild-type counterparts. Src kinases, moreover, were critical upstream effectors of caveolin-1(Y14) phosphoryation and initiation of downstream signaling. Conclusions: TGF-beta 1-initiated Src-dependent caveolin-1(Y14) phosphorylation is a critical event in Rho-ROCK-mediated suppression of nuclear PPM1A levels maintaining, thereby, SMAD2/3-dependent transcription of the PAI-1 gene.	[Samarakoon, Rohan; Chitnis, Subhanir S.; Higgins, Stephen P.; Higgins, Craig E.; Higgins, Paul J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Krepinsky, Joan C.] McMaster Univ, Div Nephrol, Hamilton, ON, Canada	Albany Medical College; McMaster University	Samarakoon, R (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	higginp@mail.amc.edu			National Institutes of Health (NIH) [GM057242]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant GM057242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DeYoung MB, 2001, CIRCULATION, V104, P1972, DOI 10.1161/hc4101.097110; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kaikita K, 2001, CIRCULATION, V104, P839, DOI 10.1161/hc3301.092803; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Mayoral R, 2010, J BIOL CHEM, V285, P3633, DOI 10.1074/jbc.M109.072900; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Otsuka G, 2006, ARTERIOSCL THROM VAS, V26, P737, DOI 10.1161/01.ATV.0000201087.23877.e1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peng FF, 2008, AM J PHYSIOL-RENAL, V295, pF153, DOI 10.1152/ajprenal.00419.2007; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Smith LH, 2006, BLOOD, V107, P132, DOI 10.1182/blood-2005-07-2681; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Vaughan DE, 2006, ARTERIOSCL THROM VAS, V26, P679, DOI 10.1161/01.ATV.0000209949.86606.c2; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhu YH, 2001, CIRCULATION, V103, P3105, DOI 10.1161/01.CIR.103.25.3105	41	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22896	10.1371/journal.pone.0022896	http://dx.doi.org/10.1371/journal.pone.0022896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829547	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600063
J	Eppinga, RD; Krueger, EW; Weller, SG; Zhang, L; Cao, H; McNiven, MA				Eppinga, R. D.; Krueger, E. W.; Weller, S. G.; Zhang, L.; Cao, H.; McNiven, M. A.			Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma	ONCOGENE			English	Article						dynamin 2 (Dyn2); pancreatic ductal adenocarcinoma (PDAC); cell migration; invasion; metastasis; Src	ACTIN-BINDING PROTEIN; FOCAL ADHESION; TYROSINE PHOSPHORYLATION; CELL-MIGRATION; SRC; ENDOCYTOSIS; CANCER; CYTOSKELETON; ACTIVATION; INHIBITORS	Pancreatic ductal tumors invade local parenchyma and metastasize to distant organs. Src-mediated tyrosine kinase signaling pathways promote pancreatic ductal adenocarcinoma (PDAC) metastasis, though the molecular mechanisms supporting this invasive process are poorly understood and represent important and novel therapeutic targets. The large GTPase Dynamin 2 (Dyn2), a Src-kinase substrate, regulates membrane-cytoskeletal dynamics although it is yet to be defined if it contributes to tumor cell migration and invasion. Therefore, the goal of this study was to test if Dyn2 is upregulated in human pancreatic tumors and to define its role in cell migration and metastatic invasion using in vitro assays and nude mouse models. Histological analysis showed that 81% of 85 patients had elevated Dyn2 in PDAC. To test if Dyn2 overexpression alters metastatic properties of human pancreatic tumor cells, stable clones of BxPC-3 cells overexpressing either wild-type Dyn2 or a phosphorylation-deficient mutant Dyn2Y(231/597) F known to attenuate Dyn2 function, were generated and analyzed. Importantly, tumor cells overexpressing Dyn2 protruded lamellipodia at twice the rate, migrated faster (180%) and farther (2.5-fold greater distance) on glass and through transwell chambers (2-3-fold more cells through the filter) compared with cells expressing Dyn2Y(231/597) F or vector alone. Further, depletion of Dyn2 and dynamin inhibitors Myristyl trimethyl ammonium bromides and Dynasore significantly reduced cell migration, wound healing and invasion in transwell assays compared with controls. To test the metastatic potential conferred by increased Dyn2 expression, the BxPC-3 cell lines were implanted orthotopically into the pancreas of nude mice. Cells expressing Dyn2-green fluorescent protein exhibited a threefold increase in large distal tumors compared with cells expressing Dyn2Y(231/597) F or vector alone. Finally, histological analysis revealed that Dyn2 is upregulated in 60% of human metastatic pancreatic tumors. These findings are the first to implicate dynamin in any neoplastic condition and to directly demonstrate a role for this mechanoenzyme in invasive cell migration. Oncogene (2012) 31, 1228-1241; doi:10.1038/onc.2011.329; published online 15 August 2011	[Eppinga, R. D.; Krueger, E. W.; Weller, S. G.; Cao, H.; McNiven, M. A.] Mayo Clin, Dept Biochem & Mol Biol, Ctr Digest Dis, Rochester, MN 55905 USA; [Zhang, L.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Ctr Digest Dis, 200 1st St SW,Guggenheim 1637, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu			National Institutes of Health NCI [R01-CA104125, T32-DK007198]; Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK) [P30DK084567]; Mayo Clinic SPORE in Pancreatic Cancer [P50 CA 102701]; Lustgarten Foundation for Pancreatic Cancer Research; Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE [R01CA104125, P50CA102701, P20CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, T32DK007198] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic SPORE in Pancreatic Cancer; Lustgarten Foundation for Pancreatic Cancer Research; Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for support from the National Institutes of Health NCI R01-CA104125 (MAM), T32-DK007198 (RDE), the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), the Mayo Clinic SPORE in Pancreatic Cancer (P50 CA 102701), the Lustgarten Foundation for Pancreatic Cancer Research and the Fraternal Order of the Eagles.	Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Alves F, 2001, PANCREAS, V23, P227, DOI 10.1097/00006676-200110000-00002; Bloomston M, 2006, DIGEST SURG, V23, P74, DOI 10.1159/000093497; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Dancer J, 2007, ONCOL REP, V18, P151; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Hakam A, 2003, DIGEST DIS SCI, V48, P1972, DOI 10.1023/A:1026122421369; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hasegawa K, 2006, CLIN CANCER RES, V12, P6170, DOI 10.1158/1078-0432.CCR-06-0992; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim Y, 2005, J NEUROSCI, V25, P9515, DOI 10.1523/JNEUROSCI.1643-05.2005; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mihaljevic AL, 2010, LANGENBECK ARCH SURG, V395, P295, DOI 10.1007/s00423-010-0622-5; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Thybusch-Bernhardt A, 2001, Int J Surg Investig, V2, P393; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yoo JY, 2005, BIOCHEM BIOPH RES CO, V328, P424, DOI 10.1016/j.bbrc.2004.12.179	63	45	45	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	10					1228	1241		10.1038/onc.2011.329	http://dx.doi.org/10.1038/onc.2011.329			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21841817	Green Accepted			2022-12-25	WOS:000301344600003
J	Hao, H; Tummala, P; Guzman, E; Mali, RS; Gregorski, J; Swaroop, A; Mitton, KP				Hao, Hong; Tummala, Padmaja; Guzman, Eduardo; Mali, Raghuveer S.; Gregorski, Janina; Swaroop, Anand; Mitton, Kenneth P.			The Transcription Factor Neural Retina Leucine Zipper (NRL) Controls Photoreceptor-specific Expression of Myocyte Enhancer Factor Mef2c from an Alternative Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; SEVERE MENTAL-RETARDATION; IN-VIVO; GENE-EXPRESSION; ROD PHOTORECEPTORS; DIFFERENTIATION FACTOR; CONE PHOTORECEPTORS; HISTONE ACETYLATION; HORMONE-RECEPTOR; RHODOPSIN GENE	Neural retina leucine zipper (NRL) is an essential transcription factor for cell fate specification and functional maintenance of rod photoreceptors in the mammalian retina. In the Nrl(-/-) mouse retina, photoreceptor precursors fail to produce rods and generate functional cone photoreceptors that predominantly express S-opsin. Previous global expression analysis using microarrays revealed dramatically reduced expression of myocyte enhancer factor Mef2c in the adult Nrl(-/-) retina. We undertook this study to examine the biological relevance of Mef2c expression in retinal rod photoreceptors. Bioinformatics analysis, rapid analysis of cDNA ends (5'-RACE), and reverse transcription coupled with qPCR using splice site-specific oligonucleotides suggested that Mef2c is expressed in the mature retina from an alternative promoter. Chromatin immunoprecipitation (ChIP) studies showed the association of active RNA polymerase II and acetylated histone H3 just upstream of Mef2c exon 4, providing additional evidence for the utilization of an alternative promoter in the retina. In concordance, we observed the binding of NRL to a putative NRL-response element (NRE) at this location by ChIP-seq and electrophoretic mobility shift assays. NRL also activated the Mef2c alternative promoter in vitro and in vivo. Notably, MEF2C could support Rhodopsin promoter activity in rod photoreceptors. We conclude that Mef2c expression from an alternative promoter in the retina is regulated by NRL. Our studies also implicate MEF2C as a transcriptional regulator of homeostasis in rod photoreceptor cells.	[Tummala, Padmaja; Guzman, Eduardo; Mali, Raghuveer S.; Mitton, Kenneth P.] Oakland Univ, Eye Res Inst, Control Gene Express Lab, Rochester, MI 48309 USA; [Hao, Hong; Gregorski, Janina; Swaroop, Anand] NIH, Neurobiol Neurodegenerat & Repair Lab, NEI, Bethesda, MD 20892 USA	Oakland University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Mitton, KP (corresponding author), Oakland Univ, Eye Res Inst, Control Gene Express Lab, Rm 412,Dodge Hall, Rochester, MI 48309 USA.	mitton@oakland.edu	Tummala, Padmaja/AAT-5157-2021; mitton, kenneth/Y-1974-2019	mitton, kenneth/0000-0002-4751-7440; Swaroop, Anand/0000-0002-1975-1141; TUMMALA, PADMAJA/0000-0003-4841-8599	National Institutes of Health [EY14626, EY14803]; NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000451, ZIAEY000450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY14626 (to K. P. M.), EY14803 (Oakland University Eye Research Institute), and the intramural program of the NEI, National Institutes of Health.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; DeAngelis MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P369; Feng J., 2011, CURR PROTOC BIOINFOR, V34, P2141; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanda A, 2007, HUM MUTAT, V28, P589, DOI 10.1002/humu.20488; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mali RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-87; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARUYAMA K, 1994, GENE, V138, P171; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tummala P, 2010, MOL VIS, V16, P252; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	67	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34893	34902		10.1074/jbc.M111.271072	http://dx.doi.org/10.1074/jbc.M111.271072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849497	Green Published, hybrid			2022-12-25	WOS:000295406300043
J	Zhou, G; Marathe, GK; Willard, B; McIntyre, TM				Zhou, Gang; Marathe, Gopal K.; Willard, Belinda; McIntyre, Thomas M.			Intracellular Erythrocyte Platelet-activating Factor Acetylhydrolase I Inactivates Aspirin in Blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A(2); PAF-AH; PROSTAGLANDIN SYNTHESIS; ACETYLSALICYLIC-ACID; ESTERASE-ACTIVITY; HYDROLYSIS; CYCLOOXYGENASE; PURIFICATION; INHIBITION; BIOLOGY	Aspirin (acetylsalicylic acid) prophylaxis suppresses major adverse cardiovascular events, but its rapid turnover limits inhibition of platelet cyclooxygenase activity and thrombosis. Despite its importance, the identity of the enzyme(s) that hydrolyzes the acetyl residue of circulating aspirin, which must be an existing enzyme, remains unknown. We find that circulating aspirin was extensively hydrolyzed within erythrocytes, and chromatography indicated these cells contained a single hydrolytic activity. Purification by over 1400-fold and sequencing identified the PAFAH1B2 and PAFAH1B3 subunits of type I platelet-activating factor (PAF) acetylhydrolase, a phospholipase A(2) with selectivity for acetyl residues of PAF, as a candidate for aspirin acetylhydrolase. Western blotting showed that catalytic PAFAH1B2 and PAFAH1B3 subunits of the type I enzyme co-migrated with purified erythrocyte aspirin hydrolytic activity. Recombinant PAFAH1B2, but not its family member plasma PAF acetylhydrolase, hydrolyzed aspirin, and PAF competitively inhibited aspirin hydrolysis by purified or recombinant erythrocyte enzymes. Aspirin was hydrolyzed by HEK cells transfected with PAFAH1B2 or PAFAH1B3, and the competitive type I PAF acetylhydrolase inhibitor NaF reduced erythrocyte hydrolysis of aspirin. Exposing aspirin to erythrocytes blocked its ability to inhibit thromboxane A2 synthesis and platelet aggregation. Not all individuals or populations are equally protected by aspirin prophylaxis, the phenomenon of aspirin resistance, and erythrocyte hydrolysis of aspirin varied 3-fold among individuals, which correlated with PAFAH1B2 and not PAFAH1B3. We conclude that intracellular type I PAF acetylhydrolase is the major aspirin hydrolase of human blood.	[Zhou, Gang; Marathe, Gopal K.; Willard, Belinda; McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org		Marathe, Gopal/0000-0002-0025-6677	National Institutes of Health [P50 HL081011]; NIH/National Center for Research Resources [RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HL081011, and service support from the Case Western Reserve University/Cleveland Clinic CTSA UL1 Grant RR024989 from the NIH/National Center for Research Resources.	Adebayo GI, 2007, EUR J INTERN MED, V18, P299, DOI 10.1016/j.ejim.2006.12.004; AKOPOV SS, 1992, J CLIN PHARMACOL, V32, P133, DOI 10.1002/j.1552-4604.1992.tb03817.x; ALI B, 1983, J PHARMACOL EXP THER, V226, P589; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Bigler J, 2001, CANCER RES, V61, P3566; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Chen JW, 2007, J LIPID RES, V48, P2365, DOI 10.1194/jlr.M700325-JLR200; COSTELLO PB, 1982, ARTHRITIS RHEUM, V25, P550, DOI 10.1002/art.1780250509; COSTELLO PB, 1984, ARTHRITIS RHEUM, V27, P422, DOI 10.1002/art.1780270409; COSTELLO PB, 1983, ARTHRITIS RHEUM, V26, P541, DOI 10.1002/art.1780260414; Fitzgerald Desmond J, 2007, Hematology Am Soc Hematol Educ Program, P114; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Gresner P, 2006, BBA-GEN SUBJECTS, V1760, P207, DOI 10.1016/j.bbagen.2005.11.018; HATTORI M, 1993, J BIOL CHEM, V268, P18748; HATTORI M, 1994, J BIOL CHEM, V269, P23150; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Ho YS, 1999, PROTEIN ENG, V12, P693, DOI 10.1093/protein/12.8.693; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Karasawa K, 2005, J BIOCHEM, V138, P509, DOI 10.1093/jb/mvi144; Koizumi H, 2003, J BIOL CHEM, V278, P12489, DOI 10.1074/jbc.M211836200; Kotani K, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-50; LEVY G, 1965, ANESTH ANAL CURR RES, V44, P837; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Maree A. O., 2007, NAT CLIN PRACT CARD, V4, pE2; Maree Andrew O, 2007, Nat Clin Pract Cardiovasc Med, V4, pE2, DOI 10.1038/ncpcardio0834; Masson P, 1998, BBA-PROTEIN STRUCT M, V1387, P41, DOI 10.1016/S0167-4838(98)00104-6; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; MENTLEIN R, 1984, BIOCHEM PHARMACOL, V33, P1243, DOI 10.1016/0006-2952(84)90176-X; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; OBRIEN JR, 1968, LANCET, V1, P779; OHSAKO M, 1993, BIOL PHARM BULL, V16, P154; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; PUCHE E, 1993, ACTA ANAESTH SCAND, V37, P20, DOI 10.1111/j.1399-6576.1993.tb03590.x; REILLY IAG, 1988, DRUGS, V35, P154, DOI 10.2165/00003495-198835020-00005; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; ROWLAND M, 1972, J PHARM SCI-US, V61, P379, DOI 10.1002/jps.2600610312; Samanta U, 2008, J BIOL CHEM, V283, P31617, DOI 10.1074/jbc.M804750200; Santanam N, 2007, ATHEROSCLEROSIS, V191, P272, DOI 10.1016/j.atherosclerosis.2006.05.027; SEYMOUR RA, 1984, BRIT J CLIN PHARMACO, V17, P697, DOI 10.1111/j.1365-2125.1984.tb02406.x; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; STAFFORINI DM, 1993, J BIOL CHEM, V268, P3857; STAFFORINI DM, 1991, METHOD ENZYMOL, V197, P411; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WILLIAMS FM, 1987, EUR J CLIN PHARMACOL, V33, P387, DOI 10.1007/BF00637635; Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147; Yoshida H, 1996, AM J HEMATOL, V53, P158, DOI 10.1002/(SICI)1096-8652(199611)53:3<158::AID-AJH2>3.3.CO;2-8; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200	58	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34820	34829		10.1074/jbc.M111.267161	http://dx.doi.org/10.1074/jbc.M111.267161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844189	Green Published, hybrid			2022-12-25	WOS:000295406300036
J	Fedeles, BI; Zhu, AY; Young, KS; Hillier, SM; Proffitt, KD; Essigmann, JM; Croy, RG				Fedeles, Bogdan I.; Zhu, Angela Y.; Young, Kellie S.; Hillier, Shawn M.; Proffitt, Kyle D.; Essigmann, John M.; Croy, Robert G.			Chemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CANCER CELLS; MITOCHONDRIAL DYSFUNCTION; APOPTOSIS; CYTOTOXICITY; DECREASES; THERAPY; VIVO	The antitumor agent 11 beta (CAS 865070-37-7), consisting of a DNA-damaging aniline mustard linked to an androgen receptor (AR) ligand, is known to form covalent DNA adducts and to induce apoptosis potently in AR-positive prostate cancer cells in vitro; it also strongly prevents growth of LNCaP xenografts in mice. The present study describes the unexpectedly strong activity of 11 beta against the AR-negative HeLa cells, both in cell culture and tumor xenografts, and uncovers a new mechanism of action that likely explains this activity. Cellular fractionation experiments indicated that mitochondria are the major intracellular sink for 11 beta; flow cytometry studies showed that 11 beta exposure rapidly induced oxidative stress, mitochondria being an important source of reactive oxygen species (ROS). Additionally, 11 beta inhibited oxygen consumption both in intact HeLa cells and in isolated mitochondria. Specifically, 11 beta blocked uncoupled oxygen consumption when mitochondria were incubated with complex I substrates, but it had no effect on oxygen consumption driven by substrates acting downstream of complex I in the mitochondrial electron transport chain. Moreover, 11 beta enhanced ROS generation in isolated mitochondria, suggesting that complex I inhibition is responsible for ROS production. At the cellular level, the presence of antioxidants (N-acetylcysteine or vitamin E) significantly reduced the toxicity of 11 beta, implicating ROS production as an important contributor to cytotoxicity. Collectively, our findings establish complex I inhibition and ROS generation as a new mechanism of action for 11 beta, which supplements conventional DNA adduct formation to promote cancer cell death.	[Essigmann, John M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Essigmann, JM (corresponding author), MIT, Dept Biol Engn, Bldg 56,Rm 669,77 Massachusetts Ave, Cambridge, MA 02139 USA.	jessig@mit.edu; rgcroy@mit.edu		Fedeles, Bogdan/0000-0001-5252-826X; Zhu, Angela/0000-0002-3010-8464	National Institutes of Health [R01 CA077743]; Department of Defense [DAMD17-98-1-8520]; NATIONAL CANCER INSTITUTE [R01CA077743, R01CA086061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 CA077743. This work was also supported by Department of Defense Prostate Cancer Research Program Award DAMD17-98-1-8520.	COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fang J, 2008, INT J CANCER, V122, P1135, DOI 10.1002/ijc.22982; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hillier SM, 2006, MOL CANCER THER, V5, P977, DOI 10.1158/1535-7163.MCT-05-0464; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Kapiszewska M, 2007, TOXICOL IN VITRO, V21, P1020, DOI 10.1016/j.tiv.2007.03.005; Laurent A, 2005, CANCER RES, V65, P948; Le SB, 2007, J BIOL CHEM, V282, P8860, DOI 10.1074/jbc.M611777200; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Marquis JC, 2005, CHEM BIOL, V12, P779, DOI 10.1016/j.chembiol.2005.05.009; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NELSONREES WA, 1980, CYTOGENET CELL GENET, V27, P216, DOI 10.1159/000131490; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; PETRONILLI V, 1986, EUR J BIOCHEM, V155, P423, DOI 10.1111/j.1432-1033.1986.tb09508.x; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Ravid A, 1999, CANCER RES, V59, P862; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; WEISS MJ, 1987, P NATL ACAD SCI USA, V84, P5444, DOI 10.1073/pnas.84.15.5444	31	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33910	33920		10.1074/jbc.M111.278390	http://dx.doi.org/10.1074/jbc.M111.278390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832047	Green Published, hybrid			2022-12-25	WOS:000295159200023
J	Brokx, SJ; Wernimont, AK; Dong, AP; Wasney, GA; Lin, YH; Lew, J; Vedadi, M; Lee, WH; Hui, R				Brokx, Stephen J.; Wernimont, Amy K.; Dong, Aiping; Wasney, Gregory A.; Lin, Yu-Hui; Lew, Jocelyne; Vedadi, Masoud; Lee, Wen Hwa; Hui, Raymond			Characterization of 14-3-3 Proteins from Cryptosporidium parvum	PLOS ONE			English	Article							AUTOMATED STRUCTURE SOLUTION; C-TERMINAL TAIL; STRUCTURAL BASIS; SUBCELLULAR-LOCALIZATION; DENSITY MODIFICATION; APICOMPLEXAN; BINDING; PHOSPHORYLATION; SPECIFICITY; REGULATORS	The parasite Cryptosporidium parvum has three 14-3-3 proteins: Cp14 epsilon, Cp14a and Cp14b, with only Cp14 epsilon similar to human 14-3-3 proteins in sequence, peptide-binding properties and structure. Structurally, Cp14a features the classical 14-3-3 dimer but with a uniquely wide pocket and a disoriented RRY triad potentially incapable of binding phosphopeptides. The Cp14b protein deviates from the norm significantly: (i) In one subunit, the phosphorylated C-terminal tail is bound in the binding groove like a phosphopeptide. This supports our binding study indicating this protein was stabilized by a peptide mimicking its last six residues. (ii) The other subunit has eight helices instead of nine, with alpha A and alpha B forming a single helix and occluding the peptide-binding cleft. (iii) The protein forms a degenerate dimer with the two binding grooves divided and facing opposite directions. These features conspire to block and disrupt the bicameral substrate-binding pocket, suggesting a possible tripartite auto-regulation mechanism that has not been observed previously.	[Brokx, Stephen J.; Wernimont, Amy K.; Dong, Aiping; Wasney, Gregory A.; Lin, Yu-Hui; Lew, Jocelyne; Vedadi, Masoud; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford, England	University of Toronto; Structural Genomics Consortium; University of Oxford	Brokx, SJ (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	Raymond.hui@utoronto.ca	Lee, Wen Hwa/G-1250-2013; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trus	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trus(Wellcome Trust)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca), the Canadian Foundation for Innovation (http://www.innovation.ca), Genome Canada (http://www.genomecanada.ca) through the Ontario Genomics Institute (http://www.ontariogenomics.ca), GlaxoSmithKline (http://www.gsk.com), the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com), the Ontario Innovation Trust (http://www.oit.on.ca), the Ontario Ministry for Research and Innovation (http://www.mri.gov.on.ca), Merck & Co., Inc. (http://www.merck.com), the Novartis Research Foundation (http://www.novartis.com), the Petrus and Augusta Hedlund's Foundation (http://www.hedlundsstiftelse.se), the Swedish Agency for Innovation Systems (http://www.vinnova.se/en), the Swedish Foundation for Strategic Research (http://www.stratresearch.se/en) and the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assossou O, 2003, FEMS MICROBIOL LETT, V224, P161, DOI 10.1016/S0378-1097(03)00479-8; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Chen XM, 2004, INFECT IMMUN, V72, P6806, DOI 10.1128/IAI.72.12.6806-6816.2004; Clark RM, 2002, WATER RES, V36, P3141, DOI 10.1016/S0043-1354(02)00006-4; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Murshudov GN, 1996, J BIOL CHEM, V271, P8863, DOI 10.1074/jbc.271.15.8863; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Ricci Karen A, 2006, Nature, V444 Suppl 1, P29; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Siles-Lucas M, 2003, VACCINE, V21, P431, DOI 10.1016/S0264-410X(02)00517-0; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e14827	10.1371/journal.pone.0014827	http://dx.doi.org/10.1371/journal.pone.0014827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853016	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400001
J	Mamenko, M; Zaika, O; Jin, M; O'Neil, RG; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg; Jin, Min; O'Neil, Roger G.; Pochynyuk, Oleh			Purinergic Activation of Ca2+-Permeable TRPV4 Channels Is Essential for Mechano-Sensitivity in the Aldosterone-Sensitive Distal Nephron	PLOS ONE			English	Article							CORTICAL COLLECTING DUCT; EPITHELIAL SODIUM-CHANNEL; DEPENDENT K+ SECRETION; P2 RECEPTORS; INTERCALATED CELLS; WATER REABSORPTION; CONNECTING TUBULE; PRINCIPAL CELLS; NA+ CHANNEL; FLOW	Mechanical forces are known to induce increases of [Ca2+](i) in the aldosterone-sensitive distal nephron (ASDN) cells to regulate epithelial transport. At the same time, mechanical stress stimulates ATP release from ASDN cells. In this study, we combined ratiometric Fura-2 based monitoring of [Ca2+](i) in freshly isolated split-opened ASDN with targeted deletion of P2Y2 and TRPV4 in mice to probe a role for purinergic signaling in mediating mechano-sensitive responses in ASDN cells. ATP application causes a reproducible transient Ca2+ peak followed by a sustained plateau. Individual cells of the cortical collecting duct (CCD) and the connecting tubule (CNT) respond to purinergic stimulation with comparative elevations of [Ca2+](i). Furthermore, ATP-induced Ca2+-responses are nearly identical in both principal (AQP2-positive) and intercalated (AQP2-negative) cells as was confirmed using immunohistochemistry in split-opened ASDN. UTP application produces elevations of [Ca2+](i) similar to that observed with ATP suggesting a dominant role of P2Y2-like receptors in generation of [Ca2+](i) response. Indeed, genetic deletion of P2Y2 receptors decreases the magnitude of ATP-induced and UTP-induced Ca2+ responses by more than 70% and 90%, respectively. Both intracellular and extracellular sources of Ca2+ appeared to contribute to the generation of ATP-induced Ca2+ response in ASDN cells. Importantly, flow-and hypotonic-induced Ca2+ elevations are markedly blunted in P2Y2 -/- mice. We further demonstrated that activation of mechano-sensitive TRPV4 channel plays a major role in the sustained [Ca2+](i) elevation during purinergic stimulation. Consistent with this, ATP-induced Ca2+ plateau are dramatically attenuated in TRV4 -/- mice. Inhibition of TRPC channels with 10 mu M BTP2 also decreased ATP-induced Ca2+ plateau whilst to a lower degree than that observed with TRPV4 inhibition/genetic deletion. We conclude that stimulation of purinergic signaling by mechanical stimuli leads to activation of TRPV4 and, to a lesser extent, TRPCs channels, and this is an important component of mechano-sensitive response of the ASDN.	[Mamenko, Mykola; Zaika, Oleg; Jin, Min; O'Neil, Roger G.; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Mamenko, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715	American Heart Association [SDG2230391]; American Society of Nephrology; National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases [RO1-DK-70950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the American Heart Association SDG2230391 (awarded to Dr. Pochynyuk), the Carl W. Gottschalk Research Scholar of the American Society of Nephrology (awarded to Dr. Pochynyuk), and National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1-DK-70950 (awarded to Dr. O'Neil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Deetjen P, 2000, J AM SOC NEPHROL, V11, P1798, DOI 10.1681/ASN.V11101798; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liu W, 2005, AM J PHYSIOL-RENAL, V289, pF978, DOI 10.1152/ajprenal.00260.2004; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Palmer LG, 2007, CURR OPIN NEPHROL HY, V16, P477, DOI 10.1097/MNH.0b013e32820ac850; POCHYNYUK O, 2010, FASEB J; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Praetorius HA, 2009, ACTA PHYSIOL, V197, P241, DOI 10.1111/j.1748-1716.2009.02002.x; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Schild L, 1996, NEPHROLOGIE, V17, P395; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Stockand JD, 2010, J AM SOC NEPHROL, V21, P1903, DOI 10.1681/ASN.2010040377; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Welch BD, 2003, AM J PHYSIOL-RENAL, V285, pF711, DOI 10.1152/ajprenal.00096.2003; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Zhang Y, 2008, AM J PHYSIOL-RENAL, V295, pF1715, DOI 10.1152/ajprenal.90311.2008	48	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22824	10.1371/journal.pone.0022824	http://dx.doi.org/10.1371/journal.pone.0022824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850238	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300023
J	Baker, J; Alcantara, A; Ruan, XM				Baker, Jack; Alcantara, Adelamar; Ruan, Xiaomin			A Stochastic Version of the Brass PF Ratio Adjustment of Age-Specific Fertility Schedules	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; POPULATION; TESTS; MODEL; IMMIGRATION	Estimates of age-specific fertility rates based on survey data are known to suffer down-bias associated with incomplete reporting. Previously, William Brass (1964, 1965, 1968) proposed a series of adjustments of such data to reflect more appropriate levels of fertility through comparison with data on children-ever-born by age, a measure of cohort-specific cumulative fertility. His now widely-used Parity/Fertility or PF ratio method makes a number of strong assumptions, which have been the focus of an extended discussion in the literature on indirect estimation. However, while it is clear that the measures used in making adjusted age-specific fertility estimates with this method are captured with statistical uncertainty, little discussion of the nature of this uncertainty around PF-ratio based estimates of fertility has been entertained in the literature. Since both age-specific risk of childbearing and cumulative parity (children ever born) are measured with statistical uncertainty, an unknown credibility interval must surround every PF ratio-based estimate. Using the standard approach, this is unknown, limiting the ability to make statistical comparisons of fertility between groups or to understand stochasticity in population dynamics. This paper makes use of approaches applied to similar problems in engineering, the natural sciences, and decision analysis-often discussed under the title of uncertainty analysis or stochastic modeling-to characterize this uncertainty and to present a new method for making PF ratio-based fertility estimates with 95 percent uncertainty intervals. The implications for demographic analysis, between-group comparisons of fertility, and the field of statistical demography are explored.	[Baker, Jack; Alcantara, Adelamar; Ruan, Xiaomin] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Baker, J (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	kali@unm.edu			State of New Mexico	State of New Mexico	Funding for this research was provided by the State of New Mexico as part of an ongoing appropriation by the legislature to UNM's Census Data Dissemination and Demographic Analysis project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, DEMOGRAPHY TROPICAL; Arriaga E.E., 1994, POPULATION ANAL MICR; Barnard G., 1963, J R STAT SOC B, V25, P294; BARNTHOUSE LW, 1990, ENVIRON TOXICOL CHEM, V9, P297, DOI 10.1002/etc.5620090306; BESAG J, 1989, BIOMETRIKA, V76, P633; Brass W, 1965, WPCWP409 UN; Brass W, 1964, ECN14CAS7 UN; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell W, 1998, ECOL APPL, V8, P1226, DOI 10.2307/2640975; CERONE P, 1987, DEMOGRAPHY, V24, P431, DOI 10.2307/2061308; COALE AJ, 1974, POPUL INDEX, V40, P185, DOI 10.2307/2733910; Cox D.C., 1981, RISK ANAL, V1, P251, DOI DOI 10.1111/J.1539-6924.1981.TB01425.X; Devroye L., 1986, NONUNIFORM RANDOM VA; DOLL JD, 1986, SCIENCE, V234, P1356, DOI 10.1126/science.234.4782.1356; DONG WM, 1987, COMPUT STRUCT, V26, P415, DOI 10.1016/0045-7949(87)90041-1; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; FEENEY G, 1983, POP STUD-J DEMOG, V37, P75, DOI 10.1080/00324728.1983.10405925; FISHMAN GS, 1986, MONTE CARLO CONCEPTS; Gardiner C. W., 1983, HDB STOCHASTIC METHO; George M.V., 2004, METHODS MAT DEMOGRAP, V2nd, P561; GOODMAN D, 1984, REP INT WHALING COMM, V6, P161; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Hogan H, 2008, APPLIED DEMOGRAPHY IN THE 21ST CENTURY, P13, DOI 10.1007/978-1-4020-8329-7_2; HORNBERGER GM, 1981, J ENVIRON MANAGE, V12, P7; JOCKEL KH, 1986, ANN STAT, V14, P336, DOI 10.1214/aos/1176349860; Jonzen N, 2010, J ANIM ECOL, V79, P109, DOI 10.1111/j.1365-2656.2009.01601.x; KALOS MH, 1986, MONTE CARLOS METHODS; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; KULKARNI VG, 2005, INTRO MODELING ANAL; LEE D, 1969, Yonsei Medical Journal, V10, P65; LEE RD, 1994, J AM STAT ASSOC, V89, P1175, DOI 10.2307/2290980; LINSTROM J, 2010, BMC ECOLOGY, V10, P4; Little R. J. A., 1987, STAT ANAL MISSING DA; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MITRA S, 1983, DEMOGRAPHY, V20, P111, DOI 10.2307/2060905; MTURI A, 2001, P WORKSH PROSP FERT; Powell RA, 1996, CONSERV BIOL, V10, P224, DOI 10.1046/j.1523-1739.1996.10010224.x; RAGEN TJ, 1995, MAR MAMMAL SCI, V11, P275, DOI 10.1111/j.1748-7692.1995.tb00285.x; RAMBERG JS, 1979, TECHNOMETRICS, V21, P201, DOI 10.2307/1268517; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Sacks J., 1989, STAT SCIREV J I MATH, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Samuels ML, 1998, STAT LIFE SCI; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SHYROCK H, 1980, METHODS MATERIALS DE, V2; Siegel, 2004, METHODS MAT DEMOGRAP; SMITH JE, 1993, MANAGE SCI, V39, P340, DOI 10.1287/mnsc.39.3.340; Sobol I., 1994, PRIMER MONTE CARLO M; Swanson DA., 2004, METHODS MAT DEMOGRAP, P523; *UN, 1983, UNM MAX X TECHN IND; WACHTER K, 2006, ESSENTIAL DEMO UNPUB; Wilson E. O., 1971, PRIMER POPULATION BI; YIMAMU E, 1990, INT STAT REV, V58, P191, DOI 10.2307/1403803	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23222	10.1371/journal.pone.0023222	http://dx.doi.org/10.1371/journal.pone.0023222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829718	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200056
J	Eklof, JS; van der Heide, T; Donadi, S; van der Zee, EM; O'Hara, R; Eriksson, BK				Eklof, Johan S.; van der Heide, Tjisse; Donadi, Serena; van der Zee, Els M.; O'Hara, Robert; Eriksson, Britas Klemens			Habitat-Mediated Facilitation and Counteracting Ecosystem Engineering Interactively Influence Ecosystem Responses to Disturbance	PLOS ONE			English	Article							SEAGRASS ZOSTERA-NOLTII; DUTCH WADDEN SEA; BRENT GEESE; COMMUNITY STRUCTURE; SEDIMENT STABILITY; ARENICOLA-MARINA; SCALE; ECOLOGY; ORGANISMS; BEDS	Recovery of an ecosystem following disturbance can be severely hampered or even shift altogether when a point disturbance exceeds a certain spatial threshold. Such scale-dependent dynamics may be caused by preemptive competition, but may also result from diminished self-facilitation due to weakened ecosystem engineering. Moreover, disturbance can facilitate colonization by engineering species that alter abiotic conditions in ways that exacerbate stress on the original species. Consequently, establishment of such counteracting engineers might reduce the spatial threshold for the disturbance, by effectively slowing recovery and increasing the risk for ecosystem shifts to alternative states. We tested these predictions in an intertidal mudflat characterized by a two-state mosaic of hummocks (humps exposed during low tide) dominated by the sediment-stabilizing seagrass Zostera noltii) and hollows (low-tide waterlogged depressions dominated by the bioturbating lugworm Arenicola marina). In contrast to expectations, seagrass recolonized both natural and experimental clearings via lateral expansion and seemed unaffected by both clearing size and lugworm addition. Near the end of the growth season, however, an additional disturbance (most likely waterfowl grazing and/or strong hydrodynamics) selectively impacted recolonizing seagrass in the largest (1 m(2)) clearings (regardless of lugworm addition), and in those medium (0.25 m(2)) clearings where lugworms had been added nearly five months earlier. Further analyses showed that the risk for the disturbance increased with hollow size, with a threshold of 0.24 m(2). Hollows of that size were caused by seagrass removal alone in the largest clearings, and by a weaker seagrass removal effect exacerbated by lugworm bioturbation in the medium clearings. Consequently, a sufficiently large disturbance increased the vulnerability of recolonizing seagrass to additional disturbance by weakening seagrass engineering effects (sediment stabilization). Meanwhile, the counteracting ecosystem engineering (lugworm bioturbation) reduced that threshold size. Therefore, scale-dependent interactions between habitat-mediated facilitation, competition and disturbance seem to maintain the spatial two-state mosaic in this ecosystem.	[Eklof, Johan S.; Donadi, Serena; Eriksson, Britas Klemens] Univ Groningen, Dept Marine Benth Ecol & Evolut, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Heide, Tjisse] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Zee, Els M.] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Zee, Els M.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands; [O'Hara, Robert] Biodivers & Climate Res Ctr, Frankfurt, Germany	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Eklof, JS (corresponding author), Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden.	johane@ecology.su.se	O'Hara, Bob/A-7499-2008; Eriksson, Britas Klemens/D-8601-2015; Donadi, Serena/I-5092-2019; Eklöf, Johan S/C-7722-2017; Eklöf, Johan/B-3099-2012; van der Heide, Tjisse/M-3000-2013	O'Hara, Bob/0000-0001-9737-3724; Eriksson, Britas Klemens/0000-0003-4752-922X; Donadi, Serena/0000-0002-8920-9630; Eklöf, Johan S/0000-0001-6936-0926; 	FORMAS [2008-839]; Netherlands Organization for Research (NWO)	FORMAS(Swedish Research Council Formas); Netherlands Organization for Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The study was financed by FORMAS (grant no. 2008-839), and by the ZKO project "Wadden engine: A human-driven regime shift through the loss of ecosystem engineers'' from The Netherlands Organization for Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarado JL, 2001, MAR ECOL PROG SER, V224, P93, DOI 10.3354/meps224093; Berkenbusch K, 2003, NEW ZEAL J ECOL, V27, P67; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bustamante-Sanchez MA, 2011, J ECOL, V99, P288, DOI 10.1111/j.1365-2745.2010.01737.x; Clements F.E., 1916, PLANT SUCCESSION ANA; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; CRAN, 2010, R LANG ENV STAT COMP; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; Eriksson BK, 2010, ECOSYSTEMS, V13, P752, DOI 10.1007/s10021-010-9352-3; FLACH EC, 1992, NETH J SEA RES, V30, P81, DOI 10.1016/0077-7579(92)90048-J; Folkard AM, 2005, LIMNOL OCEANOGR, V50, P1592, DOI 10.4319/lo.2005.50.5.1592; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fox AD, 1996, BIRD STUDY, V43, P257, DOI 10.1080/00063659609461018; Ganter B, 2000, HELGOLAND MAR RES, V54, P63, DOI 10.1007/s101520050003; Goldenheim W, 2008, OECOLOGIA, V158, P473, DOI 10.1007/s00442-008-1157-0; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; JACOBS RPWM, 1981, AQUAT BOT, V10, P241, DOI 10.1016/0304-3770(81)90026-7; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kuhnert J, 2010, J EXP MAR BIOL ECOL, V387, P36, DOI 10.1016/j.jembe.2010.03.001; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; Maltese A, 2007, J HYDRAUL ENG, V133, P750, DOI 10.1061/(ASCE)0733-9429(2007)133:7(750); Montserrat F, 2011, J SEA RES, V65, P170, DOI 10.1016/j.seares.2010.09.003; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Petraitis PS, 2009, OECOLOGIA, V161, P139, DOI 10.1007/s00442-009-1350-9; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; PHILIPPART CJM, 1994, MAR ECOL PROG SER, V111, P251, DOI 10.3354/meps111251; PHILIPPART CJM, 1995, AQUAT BOT, V49, P255, DOI 10.1016/0304-3770(94)00431-K; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; Reise K, 2002, J SEA RES, V48, P127, DOI 10.1016/S1385-1101(02)00150-8; REISE K, 1983, MAR BIOL, V74, P327, DOI 10.1007/BF00403459; RHOADS D C, 1970, Journal of Marine Research, V28, P150; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Siebert T, 2007, J EXP MAR BIOL ECOL, V340, P11, DOI 10.1016/j.jembe.2006.08.007; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stewart AM, 2007, COMMUN SOIL SCI PLAN, V38, P895, DOI 10.1080/00103620701277718; SUCHANEK TH, 1983, J MAR RES, V41, P281, DOI 10.1357/002224083788520216; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Tinkler E, 2009, J ZOOL, V278, P313, DOI 10.1111/j.1469-7998.2009.00578.x; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van Wesenbeeck BK, 2007, OIKOS, V116, P742, DOI [10.1111/j.2007.0030-1299.15485.x, 10.1111/j.0030-1299.2007.15485.x]; Vermaat JE, 1996, AQUAT BOT, V52, P259, DOI 10.1016/0304-3770(95)00510-2; Wernberg T, 2006, EUR J PHYCOL, V41, P105, DOI 10.1080/09670260500505524; WOODIN SA, 1978, ECOLOGY, V59, P274, DOI 10.2307/1936373	51	22	22	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23229	10.1371/journal.pone.0023229	http://dx.doi.org/10.1371/journal.pone.0023229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829719	Green Submitted, Green Published, gold			2022-12-25	WOS:000293561200057
J	Guo, T; Wang, WP; Zhang, H; Liu, YA; Chen, P; Ma, KT; Zhou, CY				Guo, Ting; Wang, Weiping; Zhang, Hui; Liu, Yinan; Chen, Ping; Ma, Kangtao; Zhou, Chunyan			ISL1 Promotes Pancreatic Islet Cell Proliferation	PLOS ONE			English	Article							HOMEOBOX GENE ISL-1; BETA-CELLS; ENDOCRINE PANCREAS; BINDING-PROTEIN; EXPRESSION; TRANSCRIPTION; DOMAIN; ADULT; HOMEODOMAIN; P53	Background: Islet 1 (ISL1), a LIM-homeodomain transcription factor is essential for promoting pancreatic islets proliferation and maintaining endocrine cells survival in embryonic and postnatal pancreatic islets. However, how ISL1 exerts the role in adult islets is, to date, not clear. Methodology/Principal Findings: Our results show that ISL1 expression was up-regulated at the mRNA level both in cultured pancreatic cells undergoing glucose oxidase stimulation as well in type 1 and type 2 diabetes mouse models. The knockdown of ISL1 expression increased the apoptosis level of HIT-T15 pancreatic islet cells. Using HIT-T15 and primary adult islet cells as cell models, we show that ISL1 promoted adult pancreatic islet cell proliferation with increased c-Myc and CyclinD1 transcription, while knockdown of ISL1 increased the proportion of cells in G(1) phase and decreased the proportion of cells in G(2)/M and S phases. Further investigation shows that ISL1 activated both c-Myc and CyclinD1 transcription through direct binding on their promoters. Conclusions/Significance: ISL1 promoted adult pancreatic islet cell proliferation and probably by activating c-Myc and CyclinD1 transcription through direct binding on their promoters. Our findings extend the knowledge about the crucial role of ISL1 in maintaining mature islet cells homeostasis. Our results also provide insights into the new regulation relationships between ISL1 and other growth factors.	[Guo, Ting; Wang, Weiping; Zhang, Hui; Liu, Yinan; Chen, Ping; Ma, Kangtao; Zhou, Chunyan] Peking Univ, Minist Educ China, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Mol Cardiovasc Sc, Beijing 100871, Peoples R China	Ministry of Education, China; Peking University	Guo, T (corresponding author), Peking Univ, Minist Educ China, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Mol Cardiovasc Sc, Beijing 100871, Peoples R China.	chunyanzhou@bjmu.edu.cn			National Natural Science Foundation of China [30871253, 90919022, 81071675]; 111 Project of China [B07001]; Specialized Research Fund for the Doctoral Program of Higher Education [20060001107, 20070001798]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of China(Ministry of Education, China - 111 Project); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (30871253, 90919022, and 81071675), the 111 Project of China (B07001), and the Specialized Research Fund for the Doctoral Program of Higher Education (20060001107, 20070001798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Beger C, 1998, DIABETES, V47, P559, DOI 10.2337/diabetes.47.4.559; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; DONG JL, 1991, MOL ENDOCRINOL, V5, P1633, DOI 10.1210/mend-5-11-1633; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hashimoto T, 2005, J BIOL CHEM, V280, P1893, DOI 10.1074/jbc.M410759200; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Oren M, 2002, BIOCHEM PHARMACOL, V64, P865, DOI 10.1016/S0006-2952(02)01149-8; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peng SY, 2005, BBA-GENE STRUCT EXPR, V1731, P154, DOI 10.1016/j.bbaexp.2005.08.013; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Shi Y, 2009, BIOCHEM BIOPH RES CO, V388, P506, DOI 10.1016/j.bbrc.2009.08.017; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008; Zhang H, 2009, J MOL BIOL, V392, P566, DOI 10.1016/j.jmb.2009.07.036	27	63	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22387	10.1371/journal.pone.0022387	http://dx.doi.org/10.1371/journal.pone.0022387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829621	gold, Green Submitted, Green Published			2022-12-25	WOS:000293561200017
J	Fechner, P; Damdimopoulou, P; Gauglitz, G				Fechner, Peter; Damdimopoulou, Pauliina; Gauglitz, Guenter			Biosensors Paving the Way to Understanding the Interaction between Cadmium and the Estrogen Receptor Alpha	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER CELL; ZINC-FINGER; POSTTRANSLATIONAL MODIFICATIONS; IN-VIVO; ACTIVATION; PHOSPHORYLATION; METALLOESTROGEN; REPLACEMENT; BINDING	Cadmium is a toxic heavy metal ubiquitously present in the environment and subsequently in the human diet. Cadmium has been proposed to disrupt the endocrine system, targeting in particular the estrogen signaling pathway already at environmentally relevant concentrations. Thus far, the reports on the binding affinity of cadmium towards human estrogen receptor alpha (hER alpha) have been contradicting, as have been the reports on the in vivo estrogenicity of cadmium. Hence, the mode of interaction between cadmium and the receptor remains unclear. Here, we investigated the interaction between cadmium and hER alpha on a molecular level by applying a novel, label-free biosensor technique based on reflectometric interference spectroscopy (RIfS). We studied the binding of cadmium to hER alpha, and the conformation of the receptor following cadmium treatment. Our data reveals that cadmium interacts with the ligand binding domain (LBD) of the ER alpha and affects the conformation of the receptor. However, the binding event, as well as the induced conformation change, greatly depends on the accessibility of the cysteine tails in the LBD. As the LBD cysteine residues have been reported as targets of post-translational modifications in vivo, we present a hypothesis according to which different cellular pools of ER alpha respond to cadmium differently. Our proposed theory could help to explain some of the previously contradicting results regarding estrogen-like activity of cadmium.	[Fechner, Peter; Gauglitz, Guenter] Univ Tubingen, Inst Phys & Theoret Chem, D-7400 Tubingen, Germany; [Damdimopoulou, Pauliina] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Eberhard Karls University of Tubingen; Karolinska Institutet	Fechner, P (corresponding author), Univ Tubingen, Inst Phys & Theoret Chem, Morgenstelle 8, D-7400 Tubingen, Germany.	guenter.gauglitz@ipc.uni-tuebingen.de		Damdimopoulou, Pauliina/0000-0001-8458-0855	European Union [FOOD-CT-2004-506319]; Swedish Research Council	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We kindly acknowledge financial support by the European Union project CASCADE Network of Excellence FOOD-CT-2004-506319 and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; ALI I, 2010, ENV HLTH PERSPECT; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Asano K, 2004, ANAL SCI, V20, P611, DOI 10.2116/analsci.20.611; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Choe SY, 2003, SCI TOTAL ENVIRON, V312, P15, DOI 10.1016/S0048-9697(03)00190-6; Denier X, 2009, TOXICOL IN VITRO, V23, P569, DOI 10.1016/j.tiv.2009.01.006; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.243r; FECHNER P, 2011, ANAL BIOANAL CHEM; Fechner P, 2010, TRAC-TREND ANAL CHEM, V29, P297, DOI 10.1016/j.trac.2009.12.009; Fechner P, 2009, ANAL BIOANAL CHEM, V393, P1579, DOI 10.1007/s00216-008-2480-3; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Hofer N, 2009, TOXICOL LETT, V191, P123, DOI 10.1016/j.toxlet.2009.08.014; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V58; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Le Guevel R, 2000, BIOL REPROD, V63, P259, DOI 10.1095/biolreprod63.1.259; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pillet S, 2006, TOXICOL SCI, V92, P423, DOI 10.1093/toxsci/kfl005; PREDKI PF, 1992, J BIOL CHEM, V267, P5842; PREDKI PF, 1994, ENVIRON HEALTH PERSP, V102, P195, DOI 10.2307/3431786; Rider CV, 2009, ENVIRON TOXICOL CHEM, V28, P2175, DOI 10.1897/09-018.1; Schmitt HM, 1997, BIOSENS BIOELECTRON, V12, P809, DOI 10.1016/S0956-5663(97)00046-8; SIEWIT CL, 2010, MOL ENDOCRINOL; Silva E, 2006, TOXICOL APPL PHARM, V216, P20, DOI 10.1016/j.taap.2006.04.002; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Usami M, 2002, J STEROID BIOCHEM, V81, P47, DOI 10.1016/S0960-0760(02)00046-8; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Zang Y, 2009, TOXICOL LETT, V184, P134, DOI 10.1016/j.toxlet.2008.10.032; Zhang WC, 2007, TOXICOLOGY, V241, P84, DOI 10.1016/j.tox.2007.08.089	44	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23048	10.1371/journal.pone.0023048	http://dx.doi.org/10.1371/journal.pone.0023048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829690	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511900023
J	Sideri, TC; Koloteva-Levine, N; Tuite, MF; Grant, CM				Sideri, Theodora C.; Koloteva-Levine, Nadejda; Tuite, Mick F.; Grant, Chris M.			Methionine Oxidation of Sup35 Protein Induces Formation of the [PSI+] Prion in a Yeast Peroxiredoxin Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO FORMATION; SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; ALZHEIMERS-DISEASE; HUMAN BRAIN; AGGREGATION; STRESS; SYSTEM; PROPAGATION; ELIMINATION	The frequency with which the yeast [PSI+] prion form of Sup35 arises de novo is controlled by a number of genetic and environmental factors. We have previously shown that in cells lacking the antioxidant peroxiredoxin proteins Tsa1 and Tsa2, the frequency of de novo formation of [PSI+] is greatly elevated. We show here that Tsa1/Tsa2 also function to suppress the formation of the [PIN+] prion form of Rnq1. However, although oxidative stress increases the de novo formation of both [PIN+] and [PSI+], it does not overcome the requirement of cells being [PIN+] to form the [PSI+] prion. We use an anti-methionine sulfoxide antibody to show that methionine oxidation is elevated in Sup35 during oxidative stress conditions. Abrogating Sup35 methionine oxidation by overexpressing methionine sulfoxide reductase (MSRA) prevents [PSI+] formation, indicating that Sup35 oxidation may underlie the switch from a soluble to an aggregated form of Sup35. In contrast, we were unable to detect methionine oxidation of Rnq1, and MSRA overexpression did not affect [PIN+] formation in a tsa1 tsa2 mutant. The molecular basis of how yeast and mammalian prions form infectious amyloid-like structures de novo is poorly understood. Our data suggest a causal link between Sup35 protein oxidation and de novo [PSI+] prion formation.	[Sideri, Theodora C.; Grant, Chris M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Koloteva-Levine, Nadejda; Tuite, Mick F.] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of Manchester; University of Kent	Grant, CM (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	chris.grant@manchester.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X; Sideri, Theodora/0000-0002-5674-0804; Grant, Chris/0000-0002-0616-6576	Wellcome Trust; Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by funding from the Wellcome Trust.; Supported by funding from the Biotechnology and Biological Sciences Research Council.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Boutte AM, 2006, FASEB J, V20, P1473, DOI 10.1096/fj.06-5920com; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; Dean RT, 1997, BIOCHEM J, V324, P1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Du ZQ, 2010, MOL CELL BIOL, V30, P4644, DOI 10.1128/MCB.00225-10; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Iraqui I, 2008, CANCER RES, V68, P1055, DOI 10.1158/0008-5472.CAN-07-2683; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Oien DB, 2009, J MOL NEUROSCI, V39, P323, DOI 10.1007/s12031-009-9274-8; Oien DB, 2009, ARCH BIOCHEM BIOPHYS, V485, P35, DOI 10.1016/j.abb.2009.01.020; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Ripaud L, 2003, EMBO J, V22, P5251, DOI 10.1093/emboj/cdg488; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tuite M, 2008, BIOCHEM SOC T, V36, P1083, DOI 10.1042/BST0361083; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077	53	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38924	38931		10.1074/jbc.M111.272419	http://dx.doi.org/10.1074/jbc.M111.272419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21832086	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000296759800011
J	Forfar, R; Lu, ZL				Forfar, Rachel; Lu, Zhi-Liang			Role of the Transmembrane Domain 4/Extracellular Loop 2 Junction of the Human Gonadotropin-releasing Hormone Receptor in Ligand Binding and Receptor Conformational Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; 2ND EXTRACELLULAR LOOP; GNRH RECEPTOR; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; IN-VITRO; ANTAGONIST; ACTIVATION; MUTATIONS; AGONIST	Recent crystal structures of G protein-coupled receptors (GPCRs) show the remarkable structural diversity of extracellular loop 2 (ECL2), implying its potential role in ligand binding and ligand-induced receptor conformational selectivity. Here we have applied molecular modeling and mutagenesis studies to the TM4/ECL2 junction (residues Pro(174(4.59))-Met(180(4.66))) of the human gonadotropin-releasing hormone (GnRH) receptor, which uniquely has one functional type of receptor but two endogenous ligands in humans. We suggest that the above residues assume an alpha-helical extension of TM4 in which the side chains of Gln(174(4.60)) and Phe(178(4.64)) face toward the central ligand binding pocket to make H-bond and aromatic contacts with pGlu(1) and Trp(3) of both GnRH I and GnRH II, respectively.The interaction between the side chains of Phe(178(4.64)) of the receptor and Trp(3) of the GnRHs was supported by reciprocal mutations of the interacting residues. Interestingly, alanine mutations of Leu(175(4.61)), Ile(177(4.63)), and Met(180(4.66)) decreased mutant receptor affinity for GnRH I but, in contrast, increased affinity for GnRH II. This suggests that these residues make intramolecular or intermolecular contacts with residues of transmembrane (TM) domain 3, TM5, or the phospholipid bilayer, which couple the ligand structure to specific receptor conformational switches. The marked decrease in signaling efficacy of I177A and F178A also indicates that IIe(177(4.63)) and Phe(178(4.64)) are important in stabilizing receptor-active conformations. These findings suggest that the TM4/ECL2 junction is crucial for peptide ligand binding and, consequently, for ligand-induced receptor conformational selection.	[Lu, Zhi-Liang] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Xian 215123, Jiangsu Provinc, Peoples R China; [Forfar, Rachel] MRC Technol, London NW7 1AD, England	Xi'an Jiaotong-Liverpool University	Lu, ZL (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, 111 Renai Rd, Xian 215123, Jiangsu Provinc, Peoples R China.	zhiliang.lu@xjtlu.edu.cn		Lu, Zhiliang/0000-0002-3442-1415	Medical Research Council, United Kingdom [U1276.00.005.00001.01]; MRC [MC_U127685846] Funding Source: UKRI; Medical Research Council [MC_U127685846] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Programme Grant U1276.00.005.00001.01 from the Medical Research Council, United Kingdom.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chauvin S, 2000, MOL PHARMACOL, V57, P625, DOI 10.1124/mol.57.3.625; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coetsee M., 2006, BIOSCIENCE 2006 GLAS; Coetsee M, 2008, BIOCHEMISTRY-US, V47, P10305, DOI 10.1021/bi800911z; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; DEGHENGHI R, 1993, BIOMED PHARMACOTHER, V47, P107, DOI 10.1016/0753-3322(93)90299-Z; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Grundker C, 2001, ENDOCRINOLOGY, V142, P2369, DOI 10.1210/en.142.6.2369; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; IMAI A, 1987, METHOD ENZYMOL, V141, P100; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Javitch JA, 2000, BIOCHEMISTRY-US, V39, P12190, DOI 10.1021/bi001069m; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lu Z. L., 2010, 92 ANN M END SOC SAN, P3; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Lu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; Mamputha S, 2007, MOL ENDOCRINOL, V21, P281, DOI 10.1210/me.2006-0150; Millar R, 1995, METH NEUROSCI, P145; Millar RP, 2008, FRONT NEUROENDOCRIN, V29, P17, DOI 10.1016/j.yfrne.2007.06.002; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Stewart AJ, 2008, MOL PHARMACOL, V73, P75, DOI 10.1124/mol.107.040816; Storjohann L, 2008, BIOCHEMISTRY-US, V47, P9198, DOI 10.1021/bi8005016; Tucci FC, 2005, J MED CHEM, V48, P1169, DOI 10.1021/jm049218c; Ulloa-Aguirre A, 1998, ENDOCRINOLOGY, V139, P2472, DOI 10.1210/en.139.5.2472; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34617	34626		10.1074/jbc.M111.240341	http://dx.doi.org/10.1074/jbc.M111.240341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832286	Green Published, hybrid			2022-12-25	WOS:000295406300016
J	Steenblock, ER; Fadel, T; Labowsky, M; Pober, JS; Fahmy, TM				Steenblock, Erin R.; Fadel, Tarek; Labowsky, Michael; Pober, Jordan S.; Fahmy, Tarek M.			An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOSOMAL INTERLEUKIN-2; SECONDARY EXPANSION; ANTITUMOR-ACTIVITY; MEMORY; DEATH; PROTEINS; INSIGHTS; SIGNALS; MODEL	Artificial antigen-presenting cells (aAPCs) are an emerging technology to induce therapeutic cellular immunity without the need for autologous antigen-presenting cells (APCs). To fully replace natural APCs, an optimized aAPC must present antigen (signal 1), provide costimulation (signal 2), and release cytokine (signal 3). Here we demonstrate that the spatial and temporal characteristics of paracrine release of IL-2 from biodegradable polymer aAPCs (now termed paAPCs) can significantly alter the balance in the activation and proliferation of CD8+ and CD4+ T cells. Paracrine delivery of IL-2 upon T cell contact with paAPCs induces significant IL-2 accumulation in the synaptic contact region. This accumulation increases CD25 (the inducible IL-2 R alpha chain) on responding T cells and increases proliferation of CD8+ T cells in vitro to levels 10 times that observed with equivalent amounts of bulk IL-2. These CD8+ T cell responses critically depend upon close contact of T cells and the paAPCs and require sustained release of low levels of IL-2. The same conditions promote activation-induced cell death in CD4+ T cells. These findings provide insight into the response of T cell subsets to paracrine IL-2.	[Steenblock, Erin R.; Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; [Fadel, Tarek; Fahmy, Tarek M.] Yale Univ, Dept Chem Engn, New Haven, CT 06511 USA; [Labowsky, Michael] Ansama Res LLC, Wayne, NJ USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA	Yale University; Yale University; Yale University	Fahmy, TM (corresponding author), 55 Prospect St,MEC 412, New Haven, CT 06511 USA.	Tarek.Fahmy@yale.edu	Fadel, Tarek/GQQ-2682-2022	Fadel, Tarek/0000-0002-8416-5157	National Institutes of Health Autoimmunity Center of Excellence [HL051015]; United States Department of Homeland Security; National Science Foundation [0747577]	National Institutes of Health Autoimmunity Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Homeland Security(United States Department of Homeland Security (DHS)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Institutes of Health Autoimmunity Center of Excellence pilot award (to T. M. F.) and Grant HL051015 (to J. S. P.). This work was also supported by a United States Department of Homeland Security predoctoral fellowship (to E. S.) and National Science Foundation Career Award 0747577 (to T. M. F.).	Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Blachere NE, 2006, J IMMUNOL, V176, P7288, DOI 10.4049/jimmunol.176.12.7288; CARLSSON R, 1985, CELL IMMUNOL, V96, P175, DOI 10.1016/0008-8749(85)90349-1; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025; Fakhrai H, 1997, J IMMUNOTHER, V20, P437, DOI 10.1097/00002371-199711000-00003; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Ganusov VV, 2007, J IMMUNOL, V179, P950, DOI 10.4049/jimmunol.179.2.950; Gillies SD, 2011, CLIN CANCER RES, V17, P3673, DOI 10.1158/1078-0432.CCR-10-2921; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Hu PS, 2003, BLOOD, V101, P4853, DOI 10.1182/blood-2002-10-3089; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kanaoka E, 2002, J CONTROL RELEASE, V82, P183, DOI 10.1016/S0168-3659(02)00083-4; Kaufman HL, 2002, VACCINE, V20, P1862, DOI 10.1016/S0264-410X(02)00032-4; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Labowsky M, 2000, ANAL CHIM ACTA, V406, P105, DOI 10.1016/S0003-2670(99)00595-4; Labowsky M, 2010, RAPID COMMUN MASS SP, V24, P3079, DOI 10.1002/rcm.4738; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Neville ME, 2001, CYTOKINE, V16, P239, DOI 10.1006/cyto.2001.0963; Neville ME, 2000, CYTOKINE, V12, P1691, DOI 10.1006/cyto.2000.0769; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Park J., 2011, J CONTROL RELEASE; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shrikant P, 2002, J IMMUNOL, V169, P1753, DOI 10.4049/jimmunol.169.4.1753; Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11; Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P451, DOI [10.1517/14712590902849216 , 10.1517/14712590902849216]; TEPPLER H, 1993, J EXP MED, V177, P483, DOI 10.1084/jem.177.2.483; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6	42	84	92	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34883	34892		10.1074/jbc.M111.276329	http://dx.doi.org/10.1074/jbc.M111.276329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849500	hybrid, Green Published			2022-12-25	WOS:000295406300042
J	Nunziante, M; Ackermann, K; Dietrich, K; Wolf, H; Gadtke, L; Gilch, S; Vorberg, I; Groschup, M; Schatzl, HM				Nunziante, Max; Ackermann, Kerstin; Dietrich, Kim; Wolf, Hanna; Gaedtke, Lars; Gilch, Sabine; Vorberg, Ina; Groschup, Martin; Schaetzl, Hermann M.			Proteasomal Dysfunction and Endoplasmic Reticulum Stress Enhance Trafficking of Prion Protein Aggregates through the Secretory Pathway and Increase Accumulation of Pathologic Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED CELLS; NEURODEGENERATIVE DISEASES; QUALITY-CONTROL; CULTURED-CELLS; CELLULAR PRION; RETROGRADE TRANSPORT; TRANSMEMBRANE FORM; MOLECULAR-BASIS; NEURONAL CELLS; SCRAPIE PRIONS	A conformational change of the cellular prion protein (PrPc) underlies formation of PrPSc, which is closely associated with pathogenesis and transmission of prion diseases. The precise conformational prerequisites and the cellular environment necessary for this post-translational process remain to be completely elucidated. At steady state, glycosylated PrPc is found primarily at the cell surface, whereas a minor fraction of the population is disposed of by the ER-associated degradation-proteasome pathway. However, chronic ER stress conditions and proteasomal dysfunctions lead to accumulation of aggregation-prone PrP molecules in the cytosol and to neurodegeneration. In this study, we challenged different cell lines by inducing ER stress or inhibiting proteasomal activity and analyzed the subsequent repercussion on PrP metabolism, focusing on PrP in the secretory pathway. Both events led to enhanced detection of PrP aggregates and a significant increase of PrPSc in persistently prion-infected cells, which could be reversed by overexpression of proteins of the cellular quality control. Remarkably, upon proteasomal impairment, an increased fraction of misfolded, fully glycosylated PrP molecules traveled through the secretory pathway and reached the plasma membrane. These findings suggest a novel pathway that possibly provides additional substrate and template necessary for prion formation when protein clearance by the proteasome is impaired.	[Schaetzl, Hermann M.] Univ Wyoming, Dept Vet Sci, MICRO Mol Biol, UW Shipping, Laramie, WY 82071 USA; [Gilch, Sabine; Schaetzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Nunziante, Max; Ackermann, Kerstin; Dietrich, Kim; Wolf, Hanna; Gaedtke, Lars; Gilch, Sabine; Vorberg, Ina; Schaetzl, Hermann M.] Tech Univ Munich, Inst Virol, Prion Res Grp, D-81675 Munich, Germany; [Groschup, Martin] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, D-17493 Greifswald, Riems, Germany	University of Wyoming; University of Wyoming; Technical University of Munich; Friedrich Loeffler Institute	Schatzl, HM (corresponding author), Univ Wyoming, Dept Vet Sci, MICRO Mol Biol, UW Shipping, 16th & Gibbons St, Laramie, WY 82071 USA.	hschatzl@uwyo.edu	Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [Scha594/7-1, SFB-596, A8]; Alberta Prion Research Institute, Alberta, Canada [20080238, 20090122]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alberta Prion Research Institute, Alberta, Canada	This work was also supported by Deutsche Forschungsgemeinschaft Scha594/7-1, SFB-596 (Project A8), and Alberta Prion Research Institute, Alberta, Canada (Projects 20080238 and 20090122).	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Schatzl HM, 1997, J VIROL, V71, P8821; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	76	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33942	33953		10.1074/jbc.M111.272617	http://dx.doi.org/10.1074/jbc.M111.272617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835918	hybrid, Green Published			2022-12-25	WOS:000295159200026
J	Benam, KH; Kok, WL; McMichael, AJ; Ho, LP				Benam, Kambez Hajipouran; Kok, Wai Ling; McMichael, Andrew J.; Ho, Ling-Pei			Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; NATURAL-KILLER-CELLS; I-LIKE MOLECULE; NK-T-CELLS; CUTTING EDGE; ANTIGEN PRESENTATION; MONONUCLEAR-CELLS; CRYSTAL-STRUCTURE; B-CELLS; EXPRESSION	CD1d is a MHC I like molecule which presents glycolipid to natural killer T (NKT) cells, a group of cells with diverse but critical immune regulatory functions in the immune system. These cells are required for optimal defence against bacterial, viral, protozoan, and fungal infections, and control of immune-pathology and autoimmune diseases. CD1d is expressed on antigen presenting cells but also found on some non-haematopoietic cells. However, it has not been observed on bronchial epithelium, a site of active host defence in the lungs. Here, we identify for the first time, CD1D mRNA variants and CD1d protein expression on human bronchial epithelial cells, describe six alternatively spliced transcripts of this gene in these cells; and show that these variants are specific to epithelial cells. These findings provide the basis for investigations into a role for CD1d in lung mucosal immunity.	[Benam, Kambez Hajipouran; Kok, Wai Ling; McMichael, Andrew J.; Ho, Ling-Pei] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England	University of Oxford	Benam, KH (corresponding author), Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	Ling-pei.ho@imm.ox.ac.uk	Benam, Kambez/AAF-1750-2021; Ho, Ling-Pei/AAL-4776-2021	Benam, Kambez/0000-0001-9117-3959; Ho, Ling Pei/0000-0001-8319-301X	Medical Research Council (UK); Medical Research Council [G0600371] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68] Funding Source: researchfish; MRC [G0600371] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Amano M, 1998, J IMMUNOL, V161, P1710; Bainbridge D, 2001, TRENDS IMMUNOL, V22, P548, DOI 10.1016/S1471-4906(01)02031-2; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Bonish B, 2000, J IMMUNOL, V165, P4076, DOI 10.4049/jimmunol.165.7.4076; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; FUJII T, 1994, J IMMUNOL, V153, P5516; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Jenkinson HJ, 1999, IMMUNOLOGY, V96, P649; Jin N, 2007, J IMMUNOL, V179, P2961, DOI 10.4049/jimmunol.179.5.2961; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kojo S, 2000, BIOCHEM BIOPH RES CO, V276, P107, DOI 10.1006/bbrc.2000.3450; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; MOREAU P, 1995, HUM IMMUNOL, V43, P231, DOI 10.1016/0198-8859(95)00009-S; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Nickoloff BJ, 1999, ARCH DERMATOL, V135, P546, DOI 10.1001/archderm.135.5.546; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; PISON U, 1994, EUR J CLIN INVEST, V24, P586, DOI 10.1111/j.1365-2362.1994.tb01110.x; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Tsuneyama K, 1998, HEPATOLOGY, V28, P620, DOI 10.1002/hep.510280303; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; WOOLFSON A, 1994, P NATL ACAD SCI USA, V91, P6683, DOI 10.1073/pnas.91.14.6683; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zidi I, 2010, J PHYSIOL BIOCHEM, V66, P39, DOI 10.1007/s13105-010-0005-y	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22726	10.1371/journal.pone.0022726	http://dx.doi.org/10.1371/journal.pone.0022726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853044	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400011
J	Seto, WK; Lee, CF; Lai, CL; Ip, PPC; Fong, DYT; Fung, J; Wong, DKH; Yuen, MF				Seto, Wai-Kay; Lee, Chun-Fan; Lai, Ching-Lung; Ip, Philip P. C.; Fong, Daniel Yee-Tak; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung			A New Model Using Routinely Available Clinical Parameters to Predict Significant Liver Fibrosis in Chronic Hepatitis B	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; BIOPSY; CIRRHOSIS; IDENTIFICATION; INFLAMMATION; ALGORITHM; DISEASE; RISK	Objective: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routinely available clinical parameters. Methods: 237 treatment-naive CHB patients [58.4% hepatitis B e antigen (HBeAg)-positive] who had undergone liver biopsy were randomly divided into two cohorts: training group (n = 108) and validation group (n = 129). Liver histology was assessed for fibrosis. All common demographics, viral serology, viral load and liver biochemistry were analyzed. Results: Based on 12 available clinical parameters (age, sex, HBeAg status, HBV DNA, platelet, albumin, bilirubin, ALT, AST, ALP, GGT and AFP), a model to predict significant liver fibrosis (Ishak fibrosis score >= 3) was derived using the five best parameters (age, ALP, AST, AFP and platelet). Using the formula log(index+1) = 0.025+0.0031(age)+0.1483 log(ALP)+0.004 log(AST)+0.0908 log(AFP+1)-0.028 log(platelet), the PAPAS (Platelet/Age/Phosphatase/AFP/AST) index predicts significant ibrosis with an area under the receiving operating characteristics (AUROC) curve of 0.776 [0.797 for patients with ALT <2xupper limit of normal (ULN)] The negative predictive value to exclude significant fibrosis was 88.4%. This predictive power is superior to other non-invasive models using common parameters, including the AST/platelet/GGT/AFP (APGA) index, AST/platelet ratio index (APRI), and the FIB-4 index (AUROC of 0.757, 0.708 and 0.723 respectively). Using the PAPAS index, 67.5% of liver biopsies for patients being considered for treatment with ALT <2xULN could be avoided. Conclusion: The PAPAS index can predict and exclude significant fibrosis, and may reduce the need for liver biopsy in CHB patients.	[Seto, Wai-Kay; Lai, Ching-Lung; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lee, Chun-Fan] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore; [Lee, Chun-Fan] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Ip, Philip P. C.] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Dept Nursing Studies, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Singapore Clinical Research Institute; National University of Singapore; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Fung, James/AAG-4832-2020; Wong, Danny/S-6230-2019; Fong, Daniel YT/C-4269-2009; SETO, Wai-Kay/H-4452-2012; Wong, Danny/H-6819-2016	Ip, Philip/0000-0002-0493-9838; Fong, Daniel YT/0000-0001-7365-9146; SETO, Wai-Kay/0000-0002-9012-313X; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436				ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Edirisooriya G, 1995, STEPWISE REGRESSION; Fleisher AS, 2008, NEUROLOGY, V70, P191, DOI 10.1212/01.wnl.0000287091.57376.65; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Freed MN, 1991, HDB STAT PROCEDURES; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Guo W, 2009, GENET EPIDEMIOL, V33, P308, DOI 10.1002/gepi.20382; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KAMIMOTO Y, 1985, HEPATOLOGY, V5, P367, DOI 10.1002/hep.1840050305; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Parkman HP, 2010, GASTROENTEROLOGY, V138, pS; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Welge P, 1990, 3 REASONS WHY STEPWI; Wong GLH, 2010, ALIMENT PHARM THER, V31, P1095, DOI 10.1111/j.1365-2036.2010.04276.x; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960	48	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23077	10.1371/journal.pone.0023077	http://dx.doi.org/10.1371/journal.pone.0023077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853071	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953400025
J	Agatha, S				Agatha, Sabine			Global Diversity of Aloricate Oligotrichea (Protista, Ciliophora, Spirotricha) in Marine and Brackish Sea Water	PLOS ONE			English	Review							HALTERIA-GRANDINELLA MULLER; N. SP CILIOPHORA; CILIATES CILIOPHORA; COMMUNITY STRUCTURE; MOLECULAR EVIDENCE; COASTAL WATERS; GEOGRAPHIC-DISTRIBUTION; PHYLOGENETIC POSITION; HETEROSIGMA-AKASHIWO; GENETIC-DIVERGENCE	Oligotrichids and choreotrichids are ciliate taxa contributing to the multi-step microbial food web and episodically dominating the marine microzooplankton. The global diversity and distribution of aloricate Oligotrichea are unknown. Here, the geographic ranges of the 141 accepted species and their synonyms in marine and brackish sea water are analyzed, using hundreds of taxonomical and ecological studies; the quality of the records is simultaneously evaluated. The aloricate Oligotrichea match the moderate endemicity model, i.e., the majority (94) of morphospecies has a wide, occasionally cosmopolitan distribution, while 47 morphospecies show biogeographic patterns: they are restricted to single geographic regions and probably include 12 endemic morphospecies. These endemics are found in the Antarctic, North Pacific, and Black Sea, whereas the "flagship" species Strombidinopsis cercionis is confined to the Caribbean Sea. Concerning genera, again several geographic patterns are recognizable. The species richness is distinctly lower in the southern hemisphere than in the northern, ranging from nine morphospecies in the South Pacific to 95 in the North Atlantic; however, this pattern is probably caused by undersampling. Since the loss of species might affect higher trophical levels substantially, the aloricate Oligotrichea should not any longer be ignored in conservation issues. The ecophysiological diversity is considerably larger than the morphological, and even tops the richness of SSrRNA and ITS haplotypes, indicating that probably more than 83-89% of the diversity in aloricate Oligotrichea are unknown. The huge challenge to discover all these species can only be managed by combining the expertises of morphological taxonomists, molecular biologists, ecologists, and physiologists.	Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	Salzburg University	Agatha, S (corresponding author), Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria.	sabine.agatha@sbg.ac.at	Agatha, Sabine/AAB-4836-2022	Agatha, Sabine/0000-0003-3083-9782	Austrian Science Foundation (FWF) [P20461-B17]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Foundation (FWF; Project P20461-B17), which had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Agatha S, 1997, ARCH PROTISTENKD, V148, P445, DOI 10.1016/S0003-9365(97)80021-8; Agatha S, 2005, EUR J PROTISTOL, V41, P65, DOI 10.1016/j.ejop.2004.09.005; Agatha S, 2004, ACTA PROTOZOOL, V43, P201; Agatha S, 2004, ZOOLOGY, V107, P153, DOI 10.1016/j.zool.2004.02.003; Agatha S, 2004, J EUKARYOT MICROBIOL, V51, P267, DOI 10.1111/j.1550-7408.2004.tb00567.x; Agatha S, 2001, PATRIMOINES NATURELS, V50, P42; Agatha S, 2007, EUR J PROTISTOL, V43, P37, DOI 10.1016/j.ejop.2006.10.001; Agatha S, 2011, EUR J PROTISTOL, V47, P51, DOI 10.1016/j.ejop.2010.09.001; Agatha S, 2009, EUR J PROTISTOL, V45, P51, DOI 10.1016/j.ejop.2008.07.004; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Awerinzew S, 1901, T IMP S PETERB OBSHC, V31, P1; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN, P263; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; BELVISO S, 1990, LIMNOL OCEANOGR, V35, P1810, DOI 10.4319/lo.1990.35.8.1810; Benton MJ, 2001, TRENDS ECOL EVOL, V16, P405, DOI 10.1016/S0169-5347(01)02149-8; BLACKBOURN DJ, 1973, J PROTOZOOL, V20, P286, DOI 10.1111/j.1550-7408.1973.tb00877.x; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Bouchet Philippe, 2006, P31; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Caron DA, 2009, AQUAT MICROB ECOL, V57, P227, DOI 10.3354/ame01352; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Chao A, 2006, OIKOS, V114, P479, DOI 10.1111/j.2006.0030-1299.14814.x; Christaki U, 1996, MAR ECOL PROG SER, V141, P119, DOI 10.3354/meps141119; Christaki U, 1998, LIMNOL OCEANOGR, V43, P458, DOI 10.4319/lo.1998.43.3.0458; Claessens M, 2010, MAR BIOL, V157, P483, DOI 10.1007/s00227-009-1334-7; Claessens M, 2008, AQUAT MICROB ECOL, V53, P181, DOI 10.3354/ame01243; Claparede E, 1859, MEM I NATN GENEV, V6, P261; Clough J, 2005, AQUAT MICROB ECOL, V39, P121, DOI 10.3354/ame039121; Song Weibo, 2003, Bulletin of Zoological Nomenclature, V60, P48; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Cotterill FPD, 2008, BIODIVERS CONSERV, V17, P427, DOI 10.1007/s10531-007-9261-8; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; DALE T, 1987, J PLANKTON RES, V9, P871, DOI 10.1093/plankt/9.5.871; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; de Fromentel E, 1874, ETUDES MICROZOAIRES, pi; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Doherty M, 2010, ENVIRON MICROBIOL, V12, P886, DOI 10.1111/j.1462-2920.2009.02133.x; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2009, J BIOGEOGR, V36, P887, DOI 10.1111/j.1365-2699.2008.02046.x; Dolan JR, 2006, HYDROBIOLOGIA, V555, P143, DOI 10.1007/s10750-005-1112-6; Dolan JR, 1997, MAR GEOL, V139, P109, DOI 10.1016/S0025-3227(96)00106-5; DUJARDIN F, 1841, HIST NATURELLE ZOOPH; EDWARDS ES, 1995, J PLANKTON RES, V17, P771, DOI 10.1093/plankt/17.4.771; FAURE-FREMIET E, 1970, Protistologica, V6, P207; FAURE-FREMIET E., 1950, BULL BIOL FRANCE BELGIQUE, V84, P35; FAURE-FREMIET E., 1948, BULL BIOL FRANCE ET BELGIQUE, V82, P3; Faure-Fremiet E., 1910, BULL SCI FR BELG, V45, P27; FAUREFREMIET E, 1948, J ANIM ECOL, V17, P127, DOI 10.2307/1474; Fenchel T., 1986, Progress in Protistology, V1, P65; Fenchel T, 1987, BERLIN BROCK SPRINGE, pi; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fileman ES, 2002, J MAR BIOL ASSOC UK, V82, P359, DOI 10.1017/S0025315402005593; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; FOISSNER W, 1987, ARCH PROTISTENKD, V133, P219, DOI 10.1016/S0003-9365(87)80054-4; Foissner W., 2007, JPN J PROTOZOOL, V40, P1; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Foissner W, 2007, EUR J PROTISTOL, V43, P295, DOI 10.1016/j.ejop.2007.06.001; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Foissner Wilhelm, 2002, Bulletin of Zoological Nomenclature, V59, P165; Foissner Wilhelm, 2002, Denisia, V5, P1; Fox JW, 2006, COMMUNITY ECOL, V7, P143, DOI 10.1556/ComEc.7.2006.2.2; Gao S, 2009, SYST BIODIVERS, V7, P347, DOI 10.1017/S1477200009990077; Gao S, 2009, SYST BIODIVERS, V7, P235, DOI 10.1017/S1477200009002989; Gismervik I, 2005, AQUAT MICROB ECOL, V40, P163, DOI 10.3354/ame040163; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Graham SL, 2010, AQUAT MICROB ECOL, V59, P111, DOI 10.3354/ame01391; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Helbig AJ, 2005, HEREDITY, V95, P113, DOI 10.1038/sj.hdy.6800679; Heyman RP, 1983, COMP ATLAS ZOOPLANKT, P186; Hillebrand H, 2001, OECOLOGIA, V126, P114, DOI 10.1007/s004420000492; Holzer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026232; Hubbell S.P., 2001, MG POP BIOL, V32; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ichinomiya M, 2004, AQUAT MICROB ECOL, V37, P305, DOI 10.3354/ame037305; Jeong HJ, 2007, MAR ECOL PROG SER, V349, P199, DOI 10.3354/meps07094; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P69, DOI 10.1111/j.1550-7408.1999.tb04586.x; Jeong HJ, 2004, J EUKARYOT MICROBIOL, V51, P451, DOI 10.1111/j.1550-7408.2004.tb00393.x; Johnson MD, 2003, LIMNOL OCEANOGR, V48, P238, DOI 10.4319/lo.2003.48.1.0238; JONSSON PR, 1986, MAR ECOL PROG SER, V33, P265, DOI 10.3354/meps033265; JONSSON PR, 1994, J EXP MAR BIOL ECOL, V175, P77, DOI 10.1016/0022-0981(94)90177-5; JONSSON PR, 1989, MAR ECOL PROG SER, V52, P39, DOI 10.3354/meps052039; Kahl A., 1932, Tierwelt Deutschlands Jena, V25, P399; Kahl A., 1935, Dahl Die Tierwelt Deutschlands, V30, P651; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kato Satoshi, 1993, Fisheries Oceanography, V2, P166, DOI 10.1111/j.1365-2419.1993.tb00132.x; Katz LA, 2005, AQUAT MICROB ECOL, V41, P55, DOI 10.3354/ame041055; Kent W.S., 1881, MANUAL INFUSORIA INC, VII; Kettle AJ, 2006, CAN J FISH AQUAT SCI, V63, P90, DOI 10.1139/F05-198; Kim JS, 2005, J EUKARYOT MICROBIOL, V52, P514, DOI 10.1111/j.1550-7408.2005.00062.x; Kim YO, 2002, J EUKARYOT MICROBIOL, V49, P338, DOI 10.1111/j.1550-7408.2002.tb00380.x; Kim YO, 1997, MAR BIOL, V128, P207, DOI 10.1007/s002270050084; KIM YO, 1995, AQUAT MICROB ECOL, V9, P149, DOI 10.3354/ame009149; Kim YO, 2010, J EUKARYOT MICROBIOL, V57, P48, DOI 10.1111/j.1550-7408.2009.00446.x; Kim YO, 2008, AQUAT MICROB ECOL, V53, P173, DOI 10.3354/ame01241; Knapp S, 2002, NATURE, V419, P559, DOI 10.1038/419559a; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Laval-Peuto M., 1986, MAR MICROB FD WEBS, V1, P81; Laval-Peuto M, 1985, J PROTOZOOL, V32, p40A; Laval-Peuto M, 1983, EUROP C CILIATE BIOL, V5; LAVALPEUTO M, 1986, BIOSYSTEMS, V19, P137, DOI 10.1016/0303-2647(86)90026-2; LAZARUS D, 1983, PALEOBIOLOGY, V9, P327, DOI 10.1017/S0094837300007806; Li You-Xing, 2009, Open Paleontology Journal, V2, P10; Lowe CD, 2001, BR ECOL SOC B, V32, P24; Luo W, 2009, HYDROBIOLOGIA, V636, P233, DOI 10.1007/s10750-009-9953-z; LYNN DH, 1988, J MAR BIOL ASSOC UK, V68, P639, DOI 10.1017/S0025315400028770; Maeda M., 1985, BULL OCEAN RES INST, V19, P1, DOI [10.15625/2615-9023/15888, DOI 10.15625/2615-9023/15888]; Maeda M., 1986, B OCEAN RES I U TOKY, V21, P1, DOI [10.1007/978-3-319-23534-9_1, DOI 10.1007/978-3-319-23534-9_1]; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McManus GB, 2010, J EUKARYOT MICROBIOL, V57, P369, DOI 10.1111/j.1550-7408.2010.00485.x; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; Modeo L, 2003, J EUKARYOT MICROBIOL, V50, P175, DOI 10.1111/j.1550-7408.2003.tb00114.x; Modeo L, 2001, J EUKARYOT MICROBIOL, V48, P95, DOI 10.1111/j.1550-7408.2001.tb00420.x; Modigh M, 2005, J PLANKTON RES, V27, P845, DOI 10.1093/plankt/fbi053; Montagnes David J.S., 1998, British Ecological Society Bulletin, V29, P25; Montagnes DJS, 1996, MAR ECOL PROG SER, V130, P241, DOI 10.3354/meps130241; Montagnes DJS, 2002, J EUKARYOT MICROBIOL, V49, P329, DOI 10.1111/j.1550-7408.2002.tb00379.x; Montagnes DJS, 2002, AQUAT MICROB ECOL, V28, P55, DOI 10.3354/ame028055; Montagnes DJS, 1998, J EUKARYOT MICROBIOL, V45, P502, DOI 10.1111/j.1550-7408.1998.tb05108.x; Montagnes DJS, 1999, MAR BIOL, V134, P167, DOI 10.1007/s002270050535; Montresor M, 2003, POLAR BIOL, V26, P186, DOI 10.1007/s00300-002-0473-9; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Muller H, 2002, AQUAT MICROB ECOL, V29, P181, DOI 10.3354/ame029181; MULLER OF, 1773, VERMIUM TERRESTRIUM, P135; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Pearson PN, 1997, J GEOL SOC LONDON, V154, P295, DOI 10.1144/gsjgs.154.2.0295; PETZ W, 1992, J PROTOZOOL, V39, P159, DOI 10.1111/j.1550-7408.1992.tb01296.x; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pierce RW, 1997, MAR ECOL PROG SER, V149, P295, DOI 10.3354/meps149295; PIERCE RW, 1993, MAR ECOL PROG SER, V94, P11, DOI 10.3354/meps094011; Pine-Alloul Bemadette, 2007, P203, DOI 10.1007/978-1-4020-6216-2_8; Pitta P, 2000, MAR ECOL PROG SER, V194, P269, DOI 10.3354/meps194269; Ptacnik R, 2010, ADV ECOL RES, V43, P1, DOI 10.1016/S0065-2504(10)43001-9; RASSOULZADEGAN F, 1988, HYDROBIOLOGIA, V159, P75, DOI 10.1007/BF00007369; REID PC, 1987, MAR BIOL, V95, P221, DOI 10.1007/BF00409009; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rosetta CH, 2003, HARMFUL ALGAE, V2, P109, DOI 10.1016/S1568-9883(03)00019-2; Rubino F, 2002, MAR ECOL-P S Z N I, V23, P329, DOI 10.1111/j.1439-0485.2002.tb00031.x; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Secretariat of the Convention on Biological Diversity, 2008, CBD TECHN SER, P105; Secretariat of the Convention on Biological Diversity (CBD), 2005, HDB CONV BIOL DIV IN; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Shin MK, 2000, EUR J PROTISTOL, V36, P293, DOI 10.1016/S0932-4739(00)80005-X; Simon N, 2009, CR BIOL, V332, P159, DOI 10.1016/j.crvi.2008.09.009; Sitran R, 2009, J PLANKTON RES, V31, P153, DOI 10.1093/plankt/fbn111; Snoeyenbos-West OLO, 2002, INT J SYST EVOL MICR, V52, P1901, DOI 10.1099/00207713-52-5-1901; Song W, 1994, ANTARCT RES CHIN ED, V6, P53; Stoecker D.K., 1988, MAR MICROB FOOD WEBS, V3, P79; STOECKER DK, 1990, MAR BIOL, V107, P491, DOI 10.1007/BF01313434; STOECKER DK, 1988, MAR BIOL, V99, P415, DOI 10.1007/BF02112135; STOECKER DK, 1987, ANN NY ACAD SCI, V503, P562, DOI 10.1111/j.1749-6632.1987.tb40646.x; STOECKER DK, 1987, NATURE, V326, P790, DOI 10.1038/326790a0; Strom SL, 1998, J PLANKTON RES, V20, P831, DOI 10.1093/plankt/20.5.831; STROM SL, 1993, PROG OCEANOGR, V32, P185, DOI 10.1016/0079-6611(93)90013-4; Struder-Kypke MC, 2003, J ZOOL, V260, P87, DOI 10.1017/S0952836903003546; Strueder-Kypke Michaela C., 2008, Denisia, V23, P417; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tsai SF, 2008, J EUKARYOT MICROBIOL, V55, P567, DOI 10.1111/j.1550-7408.2008.00364.x; Tyler PA, 1996, HYDROBIOLOGIA, V336, P127, DOI 10.1007/BF00010826; Verity PG, 1986, MAR ECOL PROG SER, V29, P195; Weisse T, 2006, J PLANKTON RES, V28, P55, DOI 10.1093/plankt/fbi100; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; Weisse T, 2008, J EUKARYOT MICROBIOL, V55, P257, DOI 10.1111/j.1550-7408.2008.00330.x; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Xu Dapeng, 2008, Denisia, V23, P273; Xu DP, 2006, ZOOTAXA, P33; ZEITZSCHEL B, 1982, ANN I OCEANOGR PARIS, V58, P91; Zeitzschel B., 1990, P139; Zeitzschel B, 1969, METEOR FORSCHUNGSE D, V4, P47; ZEITZSCHEL BERNT, 1966, VEROEFFENTLICHUNGEN INST MEERESFORSCH BREMERHAVEN, V2, P293; Zhang QQ, 2010, CHIN J OCEANOL LIMN, V28, P769, DOI 10.1007/s00343-010-9096-0	192	74	78	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22466	10.1371/journal.pone.0022466	http://dx.doi.org/10.1371/journal.pone.0022466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853034	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200011
J	Van Spall, HGC; Atzema, C; Schull, MJ; Newton, GE; Mak, S; Chong, A; Tu, JV; Stukel, TA; Lee, DS				Van Spall, Harriette G. C.; Atzema, Clare; Schull, Michael J.; Newton, Gary E.; Mak, Susanna; Chong, Alice; Tu, Jack V.; Stukel, Therese A.; Lee, Douglas S.			Prediction of Emergent Heart Failure Death by Semi-Quantitative Triage Risk Stratification	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; LIFE EXPECTANCY; UNITED-STATES; MODEL; DISCORDANCE; VALIDATION; PHYSICIANS; MORTALITY; ADMISSION; JUDGMENT	Objectives: Generic triage risk assessments are widely used in the emergency department (ED), but have not been validated for prediction of short-term risk among patients with acute heart failure (HF). Our objective was to evaluate the Canadian Triage Acuity Scale (CTAS) for prediction of early death among HF patients. Methods: We included patients presenting with HF to an ED in Ontario from Apr 2003 to Mar 2007. We used the National Ambulatory Care Reporting System and vital statistics databases to examine care and outcomes. Results: Among 68,380 patients (76 +/- 12 years, 49.4% men), early mortality was stratified with death rates of 9.9%, 1.9%, 0.9%, and 0.5% at 1-day, and 17.2%, 5.9%, 3.8%, and 2.5% at 7-days, for CTAS 1, 2, 3, and 4-5, respectively. Compared to lower acuity (CTAS 4-5) patients, adjusted odds ratios (aOR) for 1-day death were 1.32 (95% CI; 0.93-1.88; p = 0.12) for CTAS 3, 2.41 (95% CI; 1.71-3.40; p < 0.001) for CTAS 2, and highest for CTAS 1: 9.06 (95% CI; 6.28-13.06; p < 0.001). Predictors of triage-critical (CTAS 1) status included oxygen saturation <90% (aOR 5.92, 95% CI; 3.09-11.81; p < 0.001), respiratory rate >24 breaths/minute (aOR 1.96, 95% CI; 1.05-3.67; p = 0.034), and arrival by paramedic (aOR 3.52, 95% CI; 1.70-8.02; p = 0.001). While age/sex-adjusted CTAS score provided good discrimination for ED (c-statistic = 0.817) and 1-day (c-statistic = 0.724) death, mortality prediction was improved further after accounting for cardiac and non-cardiac comorbidities (c-statistics 0.882 and 0.810, respectively; both p < 0.001). Conclusions: A semi-quantitative triage acuity scale assigned at ED presentation and based largely on respiratory factors predicted emergent death among HF patients.	[Van Spall, Harriette G. C.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Van Spall, Harriette G. C.] McMaster Univ, Hamilton, ON, Canada; [Atzema, Clare; Chong, Alice; Tu, Jack V.; Stukel, Therese A.; Lee, Douglas S.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Atzema, Clare; Schull, Michael J.; Tu, Jack V.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Newton, Gary E.; Mak, Susanna] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Newton, Gary E.; Mak, Susanna; Lee, Douglas S.] Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada; [Newton, Gary E.; Mak, Susanna; Lee, Douglas S.] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	McMaster University; Population Health Research Institute; McMaster University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Van Spall, HGC (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.	dlee@ices.on.ca	Schull, Michael J/A-7955-2013; Mak, Susanna/C-4617-2015	Schull, Michael J/0000-0002-1318-6364; Atzema, Clare/0000-0002-7236-5522; Mak, Susanna/0000-0003-2193-602X; Tu, Jack/0000-0003-0111-722X; Van Spall, Harriette Gillian Christine/0000-0002-8370-4569; Lee, Douglas/0000-0001-7078-745X; Stukel, Therese/0000-0002-2951-1360	Ontario Ministry of Health and Long Term Care; Canadian Institutes of Health Research (CIHR) [MOP 114937]; Canada Research Chair in Health Services Research award	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research award	The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health and Long Term Care. The opinions, results and conclusions are those of the authors and no endorsement by the Ministry of Health and Long-Term Care or by the Institute for Clinical Evaluative Sciences is intended or should be inferred. This research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR MOP 114937), a Canadian Institutes of Health Research clinician-scientist award to DL, and a Canada Research Chair in Health Services Research award to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Allen LA, 2008, JAMA-J AM MED ASSOC, V299, P2533, DOI 10.1001/jama.299.21.2533; Arnold JMO, 2007, CAN J CARDIOL, V23, P21, DOI 10.1016/S0828-282X(07)70211-8; Auble TE, 2005, ACAD EMERG MED, V12, P514, DOI 10.1197/j.aem.2004.11.026; Auble TE, 2007, ANN EMERG MED, V50, P127, DOI 10.1016/j.annemergmed.2007.02.017; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Hugli O, 2005, AM J CARDIOL, V96, P1537, DOI 10.1016/j.amjcard.2005.07.064; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KLEINMUNTZ B, 1990, PSYCHOL BULL, V107, P296, DOI 10.1037/0033-2909.107.3.296; Ko DT, 2008, AM HEART J, V155, P324, DOI 10.1016/j.ahj.2007.08.036; Lee DS, 2010, CIRC-HEART FAIL, V3, P228, DOI 10.1161/CIRCHEARTFAILURE.109.885285; Lee DS, 2009, CIRC-HEART FAIL, V2, P616, DOI 10.1161/CIRCHEARTFAILURE.109.869743; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Rector TS, 2006, J CARD FAIL, V12, P276, DOI 10.1016/j.cardfail.2006.02.004; Scott IA, 2007, MED J AUSTRALIA, V187, P153, DOI 10.5694/j.1326-5377.2007.tb01173.x; Seymann G, 2008, J EMERG MED, V34, P261, DOI 10.1016/j.jemermed.2007.05.050; Smith WR, 2002, CHEST, V121, P1610, DOI 10.1378/chest.121.5.1610; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; World Health Organization, 1992, INT STAT CLASS DIS R; Yamokoski LM, 2007, J CARD FAIL, V13, P8, DOI 10.1016/j.cardfail.2006.10.002; Yan AT, 2009, ARCH INTERN MED, V169, P372, DOI 10.1001/archinternmed.2008.563	27	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23065	10.1371/journal.pone.0023065	http://dx.doi.org/10.1371/journal.pone.0023065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853068	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200040
J	Liu, B; Yan, SW; Gao, XF				Liu, Bo; Yan, Shiwei; Gao, Xingfa			Noise Amplification in Human Tumor Suppression following Gamma Irradiation	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCE; P53-MDM2 FEEDBACK LOOP; STOCHASTIC RESONANCE; NETWORK MOTIFS; TIME-DELAY; P53 PULSES; DYNAMICS; OSCILLATIONS; MODEL; BISTABILITY	The influence of noise on oscillatory motion is a subject of permanent interest, both for fundamental and practical reasons. Cells respond properly to external stimuli by using noisy systems. We have clarified the effect of intrinsic noise on the dynamics in the human cancer cells following gamma irradiation. It is shown that the large amplification and increasing mutual information with delay are due to coherence resonance. Furthermore, frequency domain analysis is used to study the mechanisms.	[Liu, Bo; Yan, Shiwei] Beijing Normal Univ, Key Lab Beam Technol & Mat Modificat, Minist Educ, Coll Nucl Sci & Technol, Beijing 100875, Peoples R China; [Liu, Bo; Gao, Xingfa] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Yan, Shiwei] Beijing Radiat Ctr, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Liu, B (corresponding author), Beijing Normal Univ, Key Lab Beam Technol & Mat Modificat, Minist Educ, Coll Nucl Sci & Technol, Beijing 100875, Peoples R China.	yansw@bnu.edu.cn	Gao, Xingfa/E-5691-2010	Gao, Xingfa/0000-0002-1636-6336	National Natural Science Foundation of China [10975019]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China [MOP2006138]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	SY acknowledges support from the National Natural Science Foundation of China under Grant No. 10975019, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China under Grant No. MOP2006138, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2009, J THEOR BIOL, V258, P561, DOI 10.1016/j.jtbi.2009.02.005; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Bulsara AR, 1996, PHYS REV E, V54, pR2185, DOI 10.1103/PhysRevE.54.R2185; Cai XD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710253; Cai XD, 2009, J COMPUT BIOL, V16, P917, DOI 10.1089/cmb.2008.0231; Carrillo O, 2004, EUROPHYS LETT, V65, P452, DOI 10.1209/epl/i2003-10105-4; Cover TM, 1991, ELEMENTS INFORM THEO; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GANG H, 1993, PHYS REV LETT, V71, P807, DOI 10.1103/PhysRevLett.71.807; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Gosak M, 2007, BIOPHYS CHEM, V128, P210, DOI 10.1016/j.bpc.2007.04.007; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kim S, 1999, PHYS REV LETT, V82, P1620, DOI 10.1103/PhysRevLett.82.1620; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Longtin A, 1997, PHYS REV E, V55, P868, DOI 10.1103/PhysRevE.55.868; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mihalas GI, 2000, J BIOL SYST, V8, P21, DOI 10.1142/S0218339000000031; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Munakata T, 2006, EUR PHYS J B, V53, P239, DOI [10.1140/epjb/e2006-00363-x, 10.1140/epjh/e2006-00363-x]; Munakata T, 2005, J PHYS SOC JPN, V74, P2094, DOI 10.1143/JPSJ.74.2094; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; NICOLIS C, 1981, TELLUS, V33, P225, DOI 10.1111/j.2153-3490.1981.tb01746.x; Ohira T, 1999, PHYS REV LETT, V82, P2811, DOI 10.1103/PhysRevLett.82.2811; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/252; Perc M, 2005, CHEM PHYS LETT, V410, P49, DOI 10.1016/j.cplett.2005.05.042; Perc M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066205; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; RAPPEL WJ, 1994, PHYS REV E, V50, P3249, DOI 10.1103/PhysRevE.50.3249; RISKEN H, 1989, FOKKERPLANK EQUATION; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; SIGETI D, 1989, J STAT PHYS, V54, P1217, DOI 10.1007/BF01044713; Stegemann G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016221; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Suzuki T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S52; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Tiana G, 2002, EUR PHYS J B, V29, P135, DOI 10.1140/epjb/e2002-00271-1; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tyson JJ, 2004, NAT GENET, V36, P113, DOI 10.1038/ng0204-113; Tyson JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100060; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yan SW, 2007, J BIOL SYST, V15, P123, DOI 10.1142/S0218339007002167; Yan SW, 2006, PHYSICA D, V220, P157, DOI 10.1016/j.physd.2006.07.004; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	78	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22487	10.1371/journal.pone.0022487	http://dx.doi.org/10.1371/journal.pone.0022487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850227	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300011
J	Wohl, SG; Schmeer, CW; Friese, T; Witte, OW; Isenmann, S				Wohl, Stefanie G.; Schmeer, Christian W.; Friese, Thomas; Witte, Otto W.; Isenmann, Stefan			In Situ Dividing and Phagocytosing Retinal Microglia Express Nestin, Vimentin, and NG2 In Vivo	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; POSTNATAL RAT RETINA; MULLER GLIAL-CELLS; ADULT-MOUSE EYE; OPTIC-NERVE; GANGLION-CELLS; PROGENITOR CELLS; CILIARY BODY; NEURAL PROGENITORS	Background: Following injury, microglia become activated with subsets expressing nestin as well as other neural markers. Moreover, cerebral microglia can give rise to neurons in vitro. In a previous study, we analysed the proliferation potential and nestin re-expression of retinal macroglial cells such as astrocytes and Muller cells after optic nerve (ON) lesion. However, we were unable to identify the majority of proliferative nestin(+) cells. Thus, the present study evaluates expression of nestin and other neural markers in quiescent and proliferating microglia in naive retina and following ON transection in adult rats in vivo. Methodology/Principal Findings: For analysis of cell proliferation and cells fates, rats received BrdU injections. Microglia in retinal sections or isolated cells were characterized using immunofluorescence labeling with markers for microglia (e. g., Iba1, CD11b), cell proliferation, and neural cells (e. g., nestin, vimentin, NG2, GFAP, Doublecortin etc.). Cellular analyses were performed using confocal laser scanning microscopy. In the naive adult rat retina, about 60% of resting ramified microglia expressed nestin. After ON transection, numbers of nestin(+) microglia peaked to a maximum at 7 days, primarily due to in situ cell proliferation of exclusively nestin(+) microglia. After 8 weeks, microglia numbers re-attained control levels, but 20% were still BrdU(+) and nestin(+), although no further local cell proliferation occurred. In addition, nestin(+) microglia co-expressed vimentin and NG2, but not GFAP or neuronal markers. Fourteen days after injury and following retrograde labeling of retinal ganglion cells (RGCs) with Fluorogold (FG), nestin(+)NG2(+) microglia were positive for the dye indicating an active involvement of a proliferating cell population in phagocytosing apoptotic retinal neurons. Conclusions/Significance: The current study provides evidence that in adult rat retina, a specific resident population of microglia expresses proteins of immature neural cells that are involved in injury-induced cell proliferation and phagocytosis while transdifferentiation was not observed.	[Wohl, Stefanie G.; Schmeer, Christian W.; Friese, Thomas; Witte, Otto W.; Isenmann, Stefan] Jena Univ Hosp, Hans Berger Clin Neurol, Jena, Germany; [Isenmann, Stefan] HELIOS Klinikum Wuppertal, Dept Neurol, Wuppertal, Germany; [Wohl, Stefanie G.; Isenmann, Stefan] Univ Witten Herdecke, Witten, Germany	Friedrich Schiller University of Jena; Helios Kliniken; Witten Herdecke University	Wohl, SG (corresponding author), Jena Univ Hosp, Hans Berger Clin Neurol, Jena, Germany.	stefanie.wohl@med.uni-jena.de	Wohl, Stefanie/I-1590-2019; Isenmann, Stefan/AAJ-3788-2020; Witte, Otto/P-4127-2018	Wohl, Stefanie/0000-0003-2559-7678; Witte, Otto/0000-0003-2101-4105; Schmeer, Christian/0000-0002-2289-0126	Bundesministerium fur Bildung und Forschung (BMBF); Interdisciplinary Centre for Clinical Research Jena (IZKF); UWH (University of Witten/Herdecke)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Clinical Research Jena (IZKF); UWH (University of Witten/Herdecke)	This study was supported by the Bundesministerium fur Bildung und Forschung (BMBF), and the Interdisciplinary Centre for Clinical Research Jena (IZKF). In addition, SW was supported by a UWH scholarship (University of Witten/Herdecke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Alliot F, 1999, J NEUROSCI RES, V58, P367; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bodeutsch N, 2000, GLIA, V32, P91, DOI 10.1002/1098-1136(200010)32:1<91::AID-GLIA90>3.0.CO;2-X; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; COSTA MR, 2010, BRAIN RES REV; Daniel C, 2008, LAB INVEST, V88, P387, DOI 10.1038/labinvest.2008.5; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Engelhardt M, 2004, EXP EYE RES, V78, P1025, DOI 10.1016/j.exer.2003.12.002; Fiedorowicz A, 2008, GLIA, V56, P209, DOI 10.1002/glia.20605; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Garcia-Valenzuela E, 1999, J NEUROBIOL, V40, P55, DOI 10.1002/(SICI)1097-4695(199907)40:1<55::AID-NEU5>3.0.CO;2-E; Garcia-Valenzuela E, 2005, MOL VIS, V11, P225; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; GRAEBER MB, 1988, J NEUROCYTOL, V17, P573, DOI 10.1007/BF01189811; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Ha Y, 2003, ACTA NEUROCHIR, V145, P483, DOI 10.1007/s00701-003-0023-4; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hou B, 2004, INVEST OPHTH VIS SCI, V45, P662, DOI 10.1167/iovs.03-0281; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; KREUTZBERG GW, 1995, ARZNEIMITTEL-FORSCH, V45-1, P357; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Matsuda S, 2008, BIOCHEM BIOPH RES CO, V368, P971, DOI 10.1016/j.bbrc.2008.02.038; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; McMenamin PG, 1999, BRIT J OPHTHALMOL, V83, P598, DOI 10.1136/bjo.83.5.598; MCMENAMIN PG, 1994, INVEST OPHTH VIS SCI, V35, P3234; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nickerson PEB, 2007, INVEST OPHTH VIS SCI, V48, P5266, DOI 10.1167/iovs.07-0167; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; PERRY VH, 1990, J NEUROCYTOL, V19, P265, DOI 10.1007/BF01217304; Pouly S, 1999, GLIA, V27, P259, DOI 10.1002/(SICI)1098-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rao NA, 2003, INVEST OPHTH VIS SCI, V44, P22, DOI 10.1167/iovs.02-0199; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; SIRKO S, 2010, STEM CELLS; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Takamori Y, 2009, BRAIN RES, V1270, P10, DOI 10.1016/j.brainres.2009.03.014; THANOS S, 1991, EUR J NEUROSCI, V3, P1189, DOI 10.1111/j.1460-9568.1991.tb00054.x; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Wiese C, 2006, STEM CELLS, V24, P2085, DOI 10.1634/stemcells.2006-0008; Wirenfeldt M, 2011, HISTOL HISTOPATHOL, V26, P519, DOI 10.14670/HH-26.519; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537; Wohl SG, 2009, EXP NEUROL, V219, P175, DOI 10.1016/j.expneurol.2009.05.008; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Wu D, 2005, BRAIN RES, V1051, P183, DOI 10.1016/j.brainres.2005.05.054; Xu HX, 2007, INVEST OPHTH VIS SCI, V48, P1674, DOI 10.1167/iovs.06-1034; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713; ZHU L, 2010, NEUROSCIENCE	99	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22408	10.1371/journal.pone.0022408	http://dx.doi.org/10.1371/journal.pone.0022408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850226	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300010
J	Plucinski, MM; Starfield, R; Almeida, RPP				Plucinski, Mateusz M.; Starfield, Richard; Almeida, Rodrigo P. P.			Inferring Social Network Structure from Bacterial Sequence Data	PLOS ONE			English	Article							POPULATION; EVOLUTION; VIRUS; IDENTIFICATION; TRANSMISSION; VIRULENCE; DYNAMICS; OUTBREAK; SPREAD; CLONES	Using DNA sequence data from pathogens to infer transmission networks has traditionally been done in the context of epidemics and outbreaks. Sequence data could analogously be applied to cases of ubiquitous commensal bacteria; however, instead of inferring chains of transmission to track the spread of a pathogen, sequence data for bacteria circulating in an endemic equilibrium could be used to infer information about host contact networks. Here, we show-using simulated data-that multilocus DNA sequence data, based on multilocus sequence typing schemes (MLST), from isolates of commensal bacteria can be used to infer both local and global properties of the contact networks of the populations being sampled. Specifically, for MLST data simulated from small-world networks, the small world parameter controlling the degree of structure in the contact network can robustly be estimated. Moreover, we show that pairwise distances in the network-degrees of separation-correlate with genetic distances between isolates, so that how far apart two individuals in the network are can be inferred from MLST analysis of their commensal bacteria. This result has important consequences, and we show an example from epidemiology: how this result could be used to test for infectious origins of diseases of unknown etiology.	[Plucinski, Mateusz M.; Starfield, Richard; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Plucinski, Mateusz M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Plucinski, MM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mateusz@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo/0000-0003-2888-9617; Plucinski, Mateusz/0000-0002-7322-4625	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	MMP was funded by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; Buckee CO, 2010, INFECTIOUS DISEASE INFORMATICS, P167, DOI 10.1007/978-1-4419-1327-2_8; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Spada E, 2004, J CLIN MICROBIOL, V42, P4230, DOI 10.1128/JCM.42.9.4230-4236.2004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	19	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22685	10.1371/journal.pone.0022685	http://dx.doi.org/10.1371/journal.pone.0022685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829645	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200018
J	Porceddu, A; Camiolo, S				Porceddu, Andrea; Camiolo, Salvatore			Spatial Analyses of Mono, Di and Trinucleotide Trends in Plant Genes	PLOS ONE			English	Article							CODON USAGE; EUKARYOTIC GENOMES; ISOCHORES; HETEROGENEITY; TRANSCRIPTION; SEQUENCES; EVOLUTION; BIAS	Genomic DNA sequences display compositional heterogeneity on many scales. In this paper we analyzed tendencies and anomalies in the occurence of mono, di and trinucleotides in structural regions of plant genes. Representation of these trends as a function of position along genic sequences highlighted compositional features peculiar of either monocots or eudicots that were remarkably uniform within these two evolutionary clades. The most evident of these features appeared in the form of gradient of base content along the direction of transcription. The robustness of such a representation was validated in sequences sub-datasets generated considering structural and compositional features such as total length of cds, overall GC content and genic orientation in the genome. Piecewise regression analyses indicated that the gradients could be conveniently approximated to a two segmented model where a first region featuring a steep slope is followed by a second segment fitting a milder variation. In general, monocots species showed steeper segments than eudicots. The guanine gradient was the most distinctive feature between the two evolutionary clades, being moderately increasing in eudicots and firmly decreasing in monocots. Single gene investigation revealed that a high proportion of genes show compositional trends compatible with a segmented model suggesting that these features are essential attributes of gene organization. Dinucleotide and trinucleotide biases were referred to expectation based on a random union of the component elements. The average bias at dinucleotide level identified a significant undererpresentation of some dinucleotide and the overrepresention of others. The bias at trinucleotide level was on average low. Finally, the analysis of bryophyte coding sequences showed mononucleotide, dinucleotide and trinucleotide compositional trends resembling those of higher plants. This finding suggested that the emergenge of compositional bias is an ancient event in evolution which was already present at the time of land conquest by green plants.	[Porceddu, Andrea; Camiolo, Salvatore] Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr, I-07100 Sassari, Italy	University of Sassari	Porceddu, A (corresponding author), Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr, I-07100 Sassari, Italy.	aporceddu@uniss.it		Camiolo, Salvatore/0000-0002-8874-9993	University of Sassari	University of Sassari	University of Sassari - PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BULMER M, 1991, GENETICS, V129, P897; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Clay O, 1996, MOL PHYLOGENET EVOL, V5, P2, DOI 10.1006/mpev.1996.0002; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; De Amicis F, 2000, NUCLEIC ACIDS RES, V28, P3339, DOI 10.1093/nar/28.17.3339; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; FILIPSKI J, 1987, FEBS LETT, V217, P184, DOI 10.1016/0014-5793(87)80660-9; Fujimori S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-26; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Niimura Y, 2003, NUCLEIC ACIDS RES, V31, P5195, DOI 10.1093/nar/gkg701; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; ROSEWILSON LJ, 2007, BMC EVOL BIOL, V7, P66; Ryan S.E, 2007, TUTORIAL PIECEWISE R, DOI [10.2737/rmrs-gtr-189, DOI 10.2737/RMRS-GTR-189]; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Wong GKS, 2002, GENOME RES, V12, P851, DOI 10.1101/gr.189102; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; 2010, NATURE, V463, P763, DOI DOI 10.1038/NATURE08747	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22855	10.1371/journal.pone.0022855	http://dx.doi.org/10.1371/journal.pone.0022855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829660	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200022
J	Zhao, XX; Ogunwobi, OO; Liu, C				Zhao, Xiangxuan; Ogunwobi, Olorunseun O.; Liu, Chen			Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							FAMILY INHIBITOR; DOWN-REGULATION; MESSENGER-RNA; LUNG-CANCER; IN-VITRO; YM155; ERK; EXPRESSION; ABT-263; LIVER	Our study aims to study the therapeutic effects of a novel Bcl-2 inhibitor, ABT-263, on hepatocellular carcinoma (HCC) and to provide primary preclinical data for future clinical trial with ABT-263. In this study we showed that Bcl-xL and survivin were up-regulated in HCC cell lines and human liver cancer tissues. Clinic used ABT-263 single treatment had no apoptotic effects on HCC cells whereas higher doses of ABT-263 did. Interestingly, the combination treatment of ABT-263 with survivin inhibitor YM-155 could result in significant apoptosis in HCC cells. Survivin inhibition through gene silencing significantly enhanced ABT-263 to induce apoptosis in HCC cells. We found that low dose of ABT-263 single treatment resulted in ERK activation and survivin up-regulation, which might be involved in the resistance of HCC cells to ABT-263 since blockade of ERK activation sensitized ABT-263-induced apoptosis. Importantly, ABT-263 and YM-155 combination treatment had no apoptotic effects on normal human hepatocytes. Taken together, these data suggest the combination treatment of Bcl-2 inhibitor and survivin inhibition may have a great potential for liver cancer therapy.	[Zhao, Xiangxuan; Ogunwobi, Olorunseun O.; Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Zhao, XX (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	liu@pathology.ufl.edu	Ogunwobi, Olorunseun/F-3172-2010	Ogunwobi, Olorunseun/0000-0003-3388-2137	National Institutes of Health [R01CA133086]; University of Florida; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant R01CA133086 to CL. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Feng Deyun, 1999, Hunan Yike Daxue Xuebao, V24, P325; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fiorentino M, 1999, DIAGN MOL PATHOL, V8, P189, DOI 10.1097/00019606-199912000-00004; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gandhi L, 2011, J CLIN ONCOL, V2010, P6208; Garcia EJ, 2002, APPL IMMUNOHISTO M M, V10, P210, DOI 10.1097/00022744-200209000-00004; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Guo XZ, 2002, WORLD J GASTROENTERO, V8, P1059, DOI 10.3748/wjg.v8.i6.1059; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosseinimehr SJ, 2004, J RADIAT RES, V45, P557, DOI 10.1269/jrr.45.557; Ito T, 2000, HEPATOLOGY, V31, P1080, DOI 10.1053/he.2000.6496; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Kita A, 2011, LEUK RES S, VS0145-2126, P00561; Kita Aya, 2010, Folia Pharmacologica Japonica, V136, P198; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; Li L, 2008, CANCER LETT, V272, P61, DOI 10.1016/j.canlet.2008.06.033; Mamori S, 2007, WORLD J GASTROENTERO, V13, P5306, DOI 10.3748/wjg.v13.i40.5306; Montorsi M, 2007, HEPATO-GASTROENTEROL, V54, P2040; Nair HK, 2004, CLIN DIAGN LAB IMMUN, V11, P63, DOI 10.1128/CDLI.11.1.63-69.2004; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Peroukides S, 2010, HISTOL HISTOPATHOL, V25, P299, DOI 10.14670/HH-25.299; Ravazoula P, 2002, ANTICANCER RES, V22, P1799; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wang Q, 2011, CANC LETT S, VS0304-3835, P00566; Yan Ge, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P712; Yang Y, 2011, MED ONCOL, V28, P796, DOI 10.1007/s12032-010-9519-y; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	37	40	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e21980	10.1371/journal.pone.0021980	http://dx.doi.org/10.1371/journal.pone.0021980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829603	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200004
J	Minocha, N; Kumar, D; Rajanala, K; Saha, S				Minocha, Neha; Kumar, Devanand; Rajanala, Kalpana; Saha, Swati			Characterization of Leishmania donovani MCM4: Expression Patterns and Interaction with PCNA	PLOS ONE			English	Article							DNA-POLYMERASE-ALPHA; REPLICATION INITIATION PROTEINS; PARASITE PLASMODIUM-FALCIPARUM; RECOGNITION COMPLEX SUBUNIT-1; XENOPUS EGG EXTRACTS; S-PHASE PROGRESSION; SACCHAROMYCES-CEREVISIAE; ORIGIN RECOGNITION; CELL-CYCLE; PREREPLICATION COMPLEX	Events leading to origin firing and fork elongation in eukaryotes involve several proteins which are mostly conserved across the various eukaryotic species. Nuclear DNA replication in trypanosomatids has thus far remained a largely uninvestigated area. While several eukaryotic replication protein orthologs have been annotated, many are missing, suggesting that novel replication mechanisms may apply in this group of organisms. Here, we characterize the expression of Leishmania donovani MCM4, and find that while it broadly resembles other eukaryotes, noteworthy differences exist. MCM4 is constitutively nuclear, signifying that, unlike what is seen in S. cerevisiae, varying subcellular localization of MCM4 is not a mode of replication regulation in Leishmania. Overexpression of MCM4 in Leishmania promastigotes causes progress through S phase faster than usual, implicating a role for MCM4 in the modulation of cell cycle progression. We find for the first time in eukaryotes, an interaction between any of the proteins of the MCM2-7 (MCM4) and PCNA. MCM4 colocalizes with PCNA in S phase cells, in keeping with the MCM2-7 complex being involved not only in replication initiation, but fork elongation as well. Analysis of a LdMCM4 mutant indicates that MCM4 interacts with PCNA via the PIP box motif of MCM4 - perhaps as an integral component of the MCM2-7 complex, although we have no direct evidence that MCM4 harboring a PIP box mutation can still functionally associate with the other members of the MCM2-7 complex-and the PIP box motif is important for cell survival and viability. In Leishmania, MCM4 may possibly help in recruiting PCNA to chromatin, a role assigned to MCM10 in other eukaryotes.	[Minocha, Neha; Kumar, Devanand; Saha, Swati] Univ Delhi S Campus, Dept Microbiol, New Delhi, India; [Rajanala, Kalpana] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Minocha, N (corresponding author), Univ Delhi S Campus, Dept Microbiol, New Delhi, India.	ss5gp@yahoo.co.in			Council of Scientific and Industrial Research (CSIR), India [37/1341/08]; Department of Biotechnology (DBT), India [BT/PR11029/BRB/10/629/200837/1341/08]; University of Delhi; DBT	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi); DBT(Department of Biotechnology (DBT) India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), India (Grant No:37/1341/08); the Department of Biotechnology (DBT), India (Grant No: BT/PR11029/BRB/10/629/200837/1341/08); and the University Research Fund from University of Delhi. N.M. is a University Grants Commission Senior Research Fellow. D. K. is a Senior Research Fellow supported from the DBT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Brand N, 2007, MOL GENET GENOMICS, V278, P623, DOI 10.1007/s00438-007-0278-1; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donti TR, 2009, EMBO J, V28, P223, DOI 10.1038/emboj.2008.282; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Gupta A, 2008, MOL MICROBIOL, V69, P646, DOI 10.1111/j.1365-2958.2008.06316.x; Gupta A, 2006, FEMS MICROBIOL LETT, V261, P12, DOI 10.1111/j.1574-6968.2006.00324.x; Gupta A, 2009, EUKARYOT CELL, V8, P1341, DOI 10.1128/EC.00170-09; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Homesley L, 2000, GENE DEV, V14, P913; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Krude T, 1996, J CELL SCI, V109, P309; Kumar D, 2009, MICROBIOL-SGM, V155, P3748, DOI 10.1099/mic.0.033217-0; Kumar D, 2008, BIOCHEM BIOPH RES CO, V375, P74, DOI 10.1016/j.bbrc.2008.07.125; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Mehra P, 2005, BIOCHEM BIOPH RES CO, V337, P955, DOI 10.1016/j.bbrc.2005.09.131; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; MINOCHA N, 2011, J EUKARYOT MICROBIOL, DOI DOI 10.1111/J.1550-7408.2011.00539X; Mohammad MM, 2007, EMBO J, V26, P5048, DOI 10.1038/sj.emboj.7601919; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morrison TL, 2005, MOL BIOL CELL, V16, P2624, DOI 10.1091/mbc.E05-02-0107; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SINHA P, 1986, J MOL BIOL, V192, P805, DOI 10.1016/0022-2836(86)90030-6; THOMMES P, 1992, NUCLEIC ACIDS RES, V20, P1069, DOI 10.1093/nar/20.5.1069; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	60	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23107	10.1371/journal.pone.0023107	http://dx.doi.org/10.1371/journal.pone.0023107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829589	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500076
J	Khameneh, HJ; Isa, SABM; Min, L; Nih, FW; Ruedl, C				Khameneh, Hanif Javanmard; Isa, Siti Aminah Bte Mohammad; Min, Lin; Nih, Fam Wee; Ruedl, Christiane			GM-CSF Signalling Boosts Dramatically IL-1Production	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; GENE-EXPRESSION; MICE DEFICIENT; BETA SUBUNIT; IN-VIVO; ACTIVATION; RECEPTOR	CSF is mostly known for its capacity to promote bone marrow progenitor differentiation, to mobilize and mature myeloid cells as well as to enhance host immune responses. However the molecular actions of GM-CSF are still poorly characterized. Here we describe a new surprising facet of this "old" growth factor as a key regulator involved in IL-1 beta secretion. We found that IL-1 beta release, a pivotal component of the triggered innate system, is heavily dependent on the signaling induced by GM-CSF in such an extent that in its absence IL-1 beta is only weakly secreted. GM-CSF synergizes with LPS for IL-1 beta secretion mainly at the level of pro-IL-1 beta production via strengthening the NF-kappa B signaling. In addition, we show that expression of Rab39a, a GTPase required for caspase-1 dependent IL-1 beta secretion is greatly augmented by LPS and GMCSF co-stimulation suggesting a potential GM-CSF contribution in enhancing IL-1 beta exocytosis. The role of GM-CSF in regulating IL-1 beta secretion is extended also in vivo, since GM-CSF R-/- mice are more resistant to LPS-mediated septic shock. These results identify GM-CSF as a key regulator of IL-1 beta production and indicate GM-CSF as a previously underestimated target for therapeutic intervention.	[Khameneh, Hanif Javanmard; Isa, Siti Aminah Bte Mohammad; Min, Lin; Nih, Fam Wee; Ruedl, Christiane] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Khameneh, HJ (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	Ruedl@ntu.edu.sg	Khameneh, Hanif Javanmard/L-5679-2019; Ruedl, christiane/A-2219-2011	Khameneh, Hanif Javanmard/0000-0002-1737-0388; Ruedl, christiane/0000-0002-5599-6541	Academic Research Fund Tier1	Academic Research Fund Tier1	This work was supported by an Academic Research Fund Tier1 grant to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 1997, J IMMUNOL, V159, P1412; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Beinart Garth, 2005, Clin Prostate Cancer, V4, P55, DOI 10.3816/CGC.2005.n.013; Bergamini A, 2000, IMMUNOLOGY, V101, P254, DOI 10.1046/j.1365-2567.2000.00117.x; BURGESS AW, 1980, BLOOD, V56, P947; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Evans TG, 2000, CLIN NEPHROL, V54, P138; Fernandez MC, 1996, J LEUKOCYTE BIOL, V59, P598, DOI 10.1002/jlb.59.4.598; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hartoonian C, 2009, CYTOKINE, V46, P43, DOI 10.1016/j.cyto.2008.12.007; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meads MB, 2010, J IMMUNOL, V185, P1606, DOI 10.4049/jimmunol.0902026; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Nakamura T, 2002, J BIOL CHEM, V277, P6254, DOI 10.1074/jbc.M109878200; Osiecki K, 2005, AIDS RES HUM RETROV, V21, P125, DOI 10.1089/aid.2005.21.125; Parker SE, 2001, GENE THER, V8, P1011, DOI 10.1038/sj.gt.3301491; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SMITH RJ, 1990, INFLAMMATION, V14, P83, DOI 10.1007/BF00914032; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TIEGS G, 1994, J CLIN INVEST, V93, P2616, DOI 10.1172/JCI117274; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5	40	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23025	10.1371/journal.pone.0023025	http://dx.doi.org/10.1371/journal.pone.0023025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829580	Green Submitted, Green Published, gold			2022-12-25	WOS:000293284600072
J	Roldan, M; Macias-Gonzalez, M; Garcia, R; Tinahones, FJ; Martin, M				Roldan, Mar; Macias-Gonzalez, Manuel; Garcia, Regina; Tinahones, Francisco J.; Martin, Miguel			Obesity short-circuits stemness gene network in human adipose multipotent stem cells	FASEB JOURNAL			English	Article						multilineage differentiation; Wnt; Notch; Sonic Hedgehog; microRNAs	ADIPOCYTE DIFFERENTIATION; WNT; EXPRESSION; INSULIN; TISSUE; OSTEOBLASTOGENESIS; PROLIFERATION; PREADIPOCYTES; ADIPOGENESIS; INHIBITION	The discovery of adipose multipotent stem cells has provided new insights to explore cellular mechanisms involved in adipose tissue function. In the present work, we aimed to evaluate how the adipogenic environment influences the stemness of the resident multipotent stem cells. To achieve this goal, human omental multipotent stem cells (hO-MSCs) were isolated, expanded, and characterized in both healthy lean and morbidly obese individuals. We observed decreased cell proliferation, premature senescence, and increased cytokine secretion associated with increasing body mass index of the patients. Consistent with the latter finding, the hO-MSCs derived from patients with morbid obesity lose their multilineage differentiation capacity associated with a dysregulation in the Wnt, Notch, and Sonic Hedgehog signaling pathways. Moreover, microRNAs involved in the regulation of stemness, cell differentiation, and senescence were also up-regulated in obese individuals. Altogether, our data show that obesity causes a general short circuit in the stemness gene network of hO-MSCs.-Roldan, M., Macias-Gonzalez, M., Garcia, R., Tinahones, F. J., Martin, M. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 25, 4111-4126 (2011). www.fasebj.org	[Roldan, Mar; Macias-Gonzalez, Manuel; Garcia, Regina; Martin, Miguel] Hosp Univ Virgen de la Victoria, Fdn Inst Mediterraneo Avance Biotecnol & Invest S, Malaga, Spain; [Garcia, Regina] Hosp Univ Virgen de la Victoria, Serv Hematol, Malaga, Spain; [Tinahones, Francisco J.] Hosp Univ Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Roldan, Mar; Martin, Miguel] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain; [Macias-Gonzalez, Manuel; Tinahones, Francisco J.] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Martin, M (corresponding author), CABIMER, Andalusian Ctr Mol Biol & Regenerat Med, Dept Stem Cells, Edificio CABIMER,Avda Amer Vespucio S-N,Parque Ci, Seville 41092, Spain.	miguel.martin@cabimer.es	Duarte, Graziela Biude Silva/Q-7728-2016; Tinahones, Francisco José/AAB-2882-2020; MACIAS-GONZALEZ, MANUEL/E-7584-2016	MACIAS-GONZALEZ, MANUEL/0000-0002-6475-4704; Tinahones, Francisco J/0000-0001-6871-4403	Consejeria de Salud-Junta de Andalucia [PI-0253, PI-0020, P08-CTS-04369]; Spanish Ministry of Science and Innovation (MICINN) [RYC-2006-001013]; Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria (ISCIII-FIS) [PI070953, PS09/00997]	Consejeria de Salud-Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria (ISCIII-FIS)	The authors thank Dr. Jose Maria Perez-Pomares, Dr. Javier Garcia-Castro, and Dr. Rene Rodriguez for valuable scientific input to this work, and Dr. Jose Rivas (Hospital Universitario Virgen de la Victoria, Malaga, Spain) for providing the adipose tissue biopsies. This work was funded by the Consejeria de Salud-Junta de Andalucia, grants PI-0253 (to M.M.), PI-0020 (to M.M. and M.M.-G.), and P08-CTS-04369 (to F.J.T.); the Spanish Ministry of Science and Innovation (MICINN), grant RYC-2006-001013 (to M.M.); and the Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria (ISCIII-FIS), grants PI070953 (to M.M.-G.) and PS09/00997 (to F.J.T.). The authors declare no conflicts of interest.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baglioni S, 2009, FASEB J, V23, P3494, DOI 10.1096/fj.08-126946; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; de la Fuente R, 2004, EXP CELL RES, V297, P313, DOI 10.1016/j.yexcr.2004.02.026; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Zaatari M, 2007, BRIT J CANCER, V96, P1855, DOI 10.1038/sj.bjc.6603782; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Harp JB, 2004, CURR OPIN LIPIDOL, V15, P303, DOI 10.1097/00041433-200406000-00010; Hellingman C. A., 2009, TISSUE ENG PART A, V17, P1157; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim SH, 2009, BIOCHEM BIOPH RES CO, V386, P532, DOI 10.1016/j.bbrc.2009.06.071; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shockley KR, 2007, PPAR RES, V2007, DOI 10.1155/2007/81219; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Vujovic S, 2007, CELL PROLIFERAT, V40, P185, DOI 10.1111/j.1365-2184.2007.00426.x; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	86	88	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4111	4126		10.1096/fj.10-171439	http://dx.doi.org/10.1096/fj.10-171439			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21846837				2022-12-25	WOS:000298138100006
J	Perdiguero, EG; Galaup, A; Durand, M; Teillon, J; Philippe, J; Valenzuela, DM; Murphy, AJ; Yancopoulos, GD; Thurston, G; Germain, S				Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Thurston, Gavin; Germain, Stephane			Alteration of Developmental and Pathological Retinal Angiogenesis in angptl4-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR MORPHOGENESIS; MOLECULAR REGULATION; BLOOD-VESSELS; HYPOXIA; EXPRESSION; ANGIOPOIETIN-LIKE-4; PERMEABILITY; CAVEOLIN-1; MOUSE	Proper vessel maturation, remodeling of endothelial junctions, and recruitment of perivascular cells is crucial for establishing and maintaining vessel functions. In proliferative retinopathies, hypoxia-induced angiogenesis is associated with disruption of the vascular barrier, edema, and vision loss. Therefore, identifying factors that regulate vascular maturation is critical to target pathological angiogenesis. Given the conflicting role of angiopoietin-like-4 (ANGPTL4) reported in the current literature using gain of function systems both in vitro and in vivo, the goal of this study was to characterize angiogenesis, focusing on perinatal retinal vascularization and pathological circumstances in angpl4-deficient mice. We report altered organization of endothelial junctions and pericyte coverage, both leading to impaired angiogenesis and increased vascular leakage that were eventually caught up, suggesting a delay in vessel maturation. In a model of oxygen-induced retinopathy, pathological neovascularization, which results from tissue hypoxia, was also strongly inhibited in angptl4-deficient mice. This study therefore shows that ANGPTL4 tunes endothelial cell junction organization and pericyte coverage and controls vascular permeability and angiogenesis, both during development and in pathological conditions.	[Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] Coll France, CIRB, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] CNRS, Unite Mixte Rech 7241, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] Inst Sante & Rech Med, U1050, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Germain, Stephane] MEMOLIFE Lab Excellence, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Germain, Stephane] Paris Sci Lettre Res Univ, F-75005 Paris, France; [Teillon, Jeremie] Coll France, Plate Forme Imagerie Ctr Interdisciplinaire Rech, F-75005 Paris, France; [Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Germain, Stephane] Univ Paris 06, Ecole Doctorale Physiol & Physiopathol 394, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Regeneron; UDICE-French Research Universities; Sorbonne Universite	Germain, S (corresponding author), Coll France, CIRB, F-75005 Paris, France.	stephane.germain@college-de-france.fr	Germain, Stephane/E-2301-2016; Perdiguero, Elisa Gomez/U-2120-2018	Germain, Stephane/0000-0001-5992-1275; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Teillon, Jeremie/0000-0002-5335-6153; Murphy, Andrew/0000-0003-4152-4081; Thurston, Gavin/0000-0002-4105-5919	Institut de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-06-JCJC-0160]; Ligue Nationale contre le Cancer; Fondation de France [R09045JJ]	Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France)	This work was supported in part by Institut de la Sante et de la Recherche Medicale, Agence Nationale de la Recherche Grant ANR-06-JCJC-0160, the Ligue Nationale contre le Cancer, Fondation de France Grant R09045JJ, and an Attache Temporaire d'Enseignement et de Recherche position from the College de France (to E. G. P.).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; DeWever J, 2007, AM J PATHOL, V171, P1619, DOI 10.2353/ajpath.2007.060968; Feng YX, 2009, CELL PHYSIOL BIOCHEM, V23, P277, DOI 10.1159/000218174; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Greenberg JI, 2009, EXPERT OPIN BIOL TH, V9, P1347, DOI 10.1517/14712590903208883; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Ito Y, 2003, CANCER RES, V63, P6651; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Kubota Y, 2009, TRENDS CARDIOVAS MED, V19, P38, DOI 10.1016/j.tcm.2009.04.004; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Miki K, 2009, OPHTHALMOLOGY, V116, P1748, DOI 10.1016/j.ophtha.2009.05.020; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nakajima M, 2001, INVEST OPHTH VIS SCI, V42, P2110; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; PEER J, 1995, LAB INVEST, V72, P638; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Razani B, 2001, J BIOL CHEM, V276, P38121; SAGATIES MJ, 1987, INVEST OPHTH VIS SCI, V28, P2000; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Verine J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010421; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137	45	59	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36841	36851		10.1074/jbc.M111.220061	http://dx.doi.org/10.1074/jbc.M111.220061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832056	hybrid, Green Published			2022-12-25	WOS:000296538300064
J	Rusconi, L; Kilstrup-Nielsen, C; Landsberger, N				Rusconi, Laura; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Extrasynaptic N-Methyl-D-aspartate (NMDA) Receptor Stimulation Induces Cytoplasmic Translocation of the CDKL5 Kinase and Its Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; CREB SHUTOFF; CELL-DEATH; GENE; EXPRESSION; DISORDERS; CALCIUM; PATHWAY	Mutations in the X-linked gene cyclin-dependent kinase-like 5 (CDKL5) have been found in patients with epileptic encephalopathy characterized by early onset intractable epilepsy, including infantile spasms and other types of seizures, severe developmental delay, and often the development of Rett syndrome-like features. Despite its clear involvement in proper brain development, CDKL5 functions are still far from being understood. In this study, we analyzed the subcellular localization of the endogenous kinase in primary murine hippocampal neurons. CDKL5 was localized both in nucleus and cytoplasm and, conversely to proliferating cells, did not undergo constitutive shuttling between these compartments. Nevertheless, glutamate stimulation was able to induce the exit of the kinase from the nucleus and its subsequent accumulation in the perinuclear cytoplasm. Moreover, we found that sustained glutamate stimulation promoted CDKL5 proteasomal degradation. Both events were mediated by the specific activation of extrasynaptic pool of N-methyl-D-aspartate receptors. Proteasomal degradation was also induced by withdrawal of neurotrophic factors and hydrogen peroxide treatment, two different paradigms of cell death. Altogether, our results indicate that both subcellular localization and expression of CDKL5 are modulated by the activation of extrasynaptic N-methyl-D-aspartate receptors and suggest regulation of CDKL5 by cell death pathways.	[Rusconi, Laura; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Biomed Informat & Commun Sci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Ist Sci San Raffaele, San Raffaele Rett Res Ctr, Div Neurosci, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Dept Biomed Informat & Commun Sci, Lab Genet & Epigenet Control Gene Express, Via Alberto da Giussano 12, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Kilstrup-Nielsen, Charlotte/A-6348-2014	Landsberger, Nicoletta/0000-0003-0820-3155; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077	Fondazione Cariplo [2010-0724]; Telethon [GGP10032]; Le Jeune Foundation;  [FP7-PEOPLE-ITN-2008]	Fondazione Cariplo(Fondazione Cariplo); Telethon(Fondazione Telethon); Le Jeune Foundation; 	This work was supported by Fondazione Cariplo (Grant 2010-0724 to N.L.), Telethon (Grant GGP10032 to N.L.), FP7-PEOPLE-ITN-2008 (to C.K.-N.), and Le Jeune Foundation (to C.K.-N.).	Artuso R, 2010, BRAIN DEV-JPN, V32, P17, DOI 10.1016/j.braindev.2009.02.004; Baptista MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010139; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Mei D, 2010, EPILEPSIA, V51, P647, DOI 10.1111/j.1528-1167.2009.02308.x; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Sierra-Paredes German, 2007, CNS & Neurological Disorders-Drug Targets, V6, P288; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021	24	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36550	36558		10.1074/jbc.M111.235630	http://dx.doi.org/10.1074/jbc.M111.235630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832092	Green Published, hybrid			2022-12-25	WOS:000296538300039
J	Terme, JM; Sese, B; Millan-Arino, L; Mayor, R; Belmonte, JCI; Barrero, MJ; Jordan, A				Terme, Jean-Michel; Sese, Borja; Millan-Arino, Lluis; Mayor, Regina; Izpisua Belmonte, Juan Carlos; Jose Barrero, Maria; Jordan, Albert			Histone H1 Variants Are Differentially Expressed and Incorporated into Chromatin during Differentiation and Reprogramming to Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; LINKER HISTONE; GENE-EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; DYNAMICS; SUBTYPES; MOUSE; LINES; FIBROBLASTS	There are seven linker histone variants in human somatic cells (H1.0 to H1.5 and H1X), and their prevalence varies as a function of cell type and differentiation stage, suggesting that the different variants may have distinct roles. We have revisited this notion by using new methodologies to study pluripotency and differentiation, including the in vitro differentiation of human embryonic stem (ES) and teratocarcinoma cells and the reprogramming of keratinocytes to induced pluripotent stem cells. Our results show that pluripotent cells (PCs) have decreased levels of H1.0 and increased levels of H1.1, H1.3, and H1.5 compared with differentiated cells. PCs have a more diverse repertoire of H1 variants, whereas in differentiated cells, H1.0 expression represents similar to 80% of the H1 transcripts. In agreement with their prevalent expression in ES cells, the regulatory regions of H1.3 and H1.5 genes were found to be occupied by pluripotency factors. Moreover, the H1.0 gene promoter contains bivalent domains (H3K4me2 and H3K27me3) in PCs, suggesting that this variant is likely to have an important role during differentiation. Indeed, the knockdown of H1.0 in human ES did not affect self-renewal but impaired differentiation. Accordingly, H1.0 was recruited to the regulatory regions of differentiation and pluripotency genes during differentiation, confirming that this histone variant plays a critical role in the regulation of these genes. Thus, histone H1 variant expression is controlled by a variety of mechanisms that produce distinct but consistent H1 repertoires in pluripotent and differentiated cells that appear critical to maintain the functionality of such cells.	[Sese, Borja; Izpisua Belmonte, Juan Carlos; Jose Barrero, Maria] Ctr Regenerat Med Barcelona, E-08003 Barcelona, Spain; [Terme, Jean-Michel; Millan-Arino, Lluis; Mayor, Regina; Jordan, Albert] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Salk Institute	Barrero, MJ (corresponding author), Ctr Regenerat Med Barcelona, Doctor Aiguader 88, E-08003 Barcelona, Spain.	mjbarrero@cmrb.eu; albert.jordan@ibmb.csic.es	Barrero, Maria J./Q-1785-2017; jordan, albert/ABC-8229-2020; jordan, albert/K-4678-2014	Barrero, Maria J./0000-0002-5990-7040; jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Sese, Borja/0000-0001-8554-897X	Ministerio de Ciencia e Innovacion of Spain (MICINN); Fondo Europeo Desarrollo Regional [200820I090, BFU2008-00359/BMC, RYC-2007-01510, SAF2009-08588]; Generalitat de Catalunya [2009-SGR-1222]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Centro Investigacion Biomedica en Red de Bioingenieria; Fundacion Cellex; Fondation pour la Recherche Medicale; Consejo Superior de Investigaciones Cientificas-MICINN; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo Desarrollo Regional; Generalitat de Catalunya(Generalitat de Catalunya); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Centro Investigacion Biomedica en Red de Bioingenieria; Fundacion Cellex(Foundation CELLEX); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Consejo Superior de Investigaciones Cientificas-MICINN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (MICINN); Fondo Europeo Desarrollo Regional Grants 200820I090 and BFU2008-00359/BMC (to A. J.) and RYC-2007-01510 and SAF2009-08588 (to M. J. B.); and Generalitat de Catalunya Grant 2009-SGR-1222 (to A. J.). Work at the laboratory of J. C. I. B. is supported by grants from the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, MICINN, Centro Investigacion Biomedica en Red de Bioingenieria, and Fundacion Cellex.; Recipient of a fellowship from the Fondation pour la Recherche Medicale and a JAE-Doc contract from Consejo Superior de Investigaciones Cientificas-MICINN.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Franke K, 1998, BBA-GENE STRUCT EXPR, V1398, P232, DOI 10.1016/S0167-4781(98)00062-1; Fu G, 2003, BIOL REPROD, V68, P1569, DOI 10.1095/biolreprod.102.012336; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; HELLIGER W, 1992, BIOCHEM J, V288, P747, DOI 10.1042/bj2880747; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Kratzmeier M, 1999, BIOCHEM J, V337, P319, DOI 10.1042/0264-6021:3370319; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Meergans T, 1997, DNA CELL BIOL, V16, P1041, DOI 10.1089/dna.1997.16.1041; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Parseghian MH, 2001, J CELL BIOCHEM, V83, P643, DOI 10.1002/jcb.1224; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Shahhoseini M, 2010, FEBS LETT, V584, P4661, DOI 10.1016/j.febslet.2010.10.041; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wood C, 2009, FEBS J, V276, P4109, DOI 10.1111/j.1742-4658.2009.07079.x; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103	41	73	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35347	35357		10.1074/jbc.M111.281923	http://dx.doi.org/10.1074/jbc.M111.281923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852237	Green Published, hybrid			2022-12-25	WOS:000295927100006
J	Goyal, R; Salahudeen, AA; Jansen, M				Goyal, Raman; Salahudeen, Ahmed Abdullah; Jansen, Michaela			Engineering a Prokaryotic Cys-loop Receptor with a Third Functional Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; ANESTHETIC BINDING-SITE; LARGE CYTOPLASMIC LOOP; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; GABA(A) RECEPTORS; LIGAND-BINDING; 5-HYDROXYTRYPTAMINE TYPE-3; MAMMALIAN-CELLS	Prokaryotic members of the Cys-loop receptor ligand-gated ion channel superfamily were recently identified. Previously, Cys-loop receptors were only known from multicellular organisms (metazoans). Contrary to the metazoan Cys-loop receptors, the prokaryotic ones consist of an extracellular (ECD) and a transmembrane domain (TMD), lacking the large intracellular domain (ICD) present in metazoa (between transmembrane segments M3 and M4). Using a chimera approach, we added the 115-amino acid ICD from mammalian serotonin type 3A receptors (5-HT3A) to the prokaryotic proton-activated Gloeobacter violaceus ligand-gated ion channel (GLIC). We created 12 GLIC-5-HT3A-ICD chimeras by replacing a variable number of amino acids in the short GLIC M3M4 linker with the entire 5-HT3A-ICD. Two-electrode voltage clamp recordings after expression in Xenopus laevis oocytes showed that only two chimeras were functional and produced currents upon acidification. The pH(50) was comparable with wild-type GLIC. 5-HT3A receptor expression can be inhibited by the chaperone protein RIC-3. We have shown previously that the 5-HT3A-ICD is required for the attenuation of 5-HT-induced currents when RIC-3 is co-expressed with 5-HT3A receptors in X. laevis oocytes. Expression of both functional 5-HT3A chimeras was inhibited by RIC-3 co-expression, indicating appropriate folding of the 5-HT3A-ICD in the chimeras. Our results indicate that the ICD can be considered a separate domain that can be removed from or added to the ECD and TMD while maintaining the overall structure and function of the ECD and TMD.	[Goyal, Raman; Salahudeen, Ahmed Abdullah; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Salahudeen, Ahmed Abdullah] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Summer Res Program, Lubbock, TX 79430 USA; [Goyal, Raman; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Sch Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA.	michaela.jansen@ttuhsc.edu	Goyal, Raman/AAG-8507-2019	Jansen, Michaela/0000-0003-1325-9700	National Institutes of Health [NS059841]; South Plains Foundation (SPF); Texas Tech University Health Sciences Center (TTUHSC) School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS059841, K99NS059841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Plains Foundation (SPF); Texas Tech University Health Sciences Center (TTUHSC) School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059841 (to M. J.). This work was also supported by grants from the South Plains Foundation (SPF) (to M. J.) and the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Student Summer Research Program (to A. A. S.).	Akk G, 2000, J PHYSIOL-LONDON, V527, P405, DOI 10.1111/j.1469-7793.2000.t01-2-00405.x; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Belelli D, 1995, MOL PHARMACOL, V48, P1054; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Castelan F, 2007, J NEUROCHEM, V100, P406, DOI 10.1111/j.1471-4159.2006.04202.x; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; Ilegems E, 2004, J BIOL CHEM, V279, P53346, DOI 10.1074/jbc.M407467200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Kottwitz D, 2004, PROTEIN EXPRES PURIF, V38, P237, DOI 10.1016/j.pep.2004.07.017; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li M, 2002, BIOPHYS J, V83, P206, DOI 10.1016/S0006-3495(02)75162-X; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Peters JA, 2004, BIOCHEM SOC T, V32, P547, DOI 10.1042/BST0320547; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Tasneem A, 2005, GENOME BIOL, V6; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Valor LM, 2002, BIOCHEMISTRY-US, V41, P7931, DOI 10.1021/bi025831r; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	68	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34635	34642		10.1074/jbc.M111.269647	http://dx.doi.org/10.1074/jbc.M111.269647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844195	Green Published, hybrid			2022-12-25	WOS:000295406300018
J	Otomo, T; Higaki, K; Nanba, E; Ozono, K; Sakai, N				Otomo, Takanobu; Higaki, Katsumi; Nanba, Eiji; Ozono, Keiichi; Sakai, Norio			Lysosomal Storage Causes Cellular Dysfunction in Mucolipidosis II Skin Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-REPLACEMENT; ENDOCYTIC PATHWAY; PH; MEMBRANES; THERAPY; SUBUNIT; DISEASE; IV	Mucolipidosis II (ML-II) is a fatal inherited metabolic disease caused by deficiency of GlcNAc-phosphotransferase, which plays a role in generating the mannose 6-phosphate recognition marker on lysosomal enzymes. In ML-II, many lysosomal acid hydrolases are mistargeted out of cells, and lysosomes become filled with undigested substrates, which explains inclusion cell disease as an alternative name for this disease. In this study, we revealed various cellular phenotypes in ML-II skin fibroblasts. We quantitated phospholipid and cholesterol within cells and showed similar to 2-fold accumulation in ML-II as compared with normal cells. Lysosomal pH of ML-II cells was higher than that of normal cells (5.29 +/- 0.08 versus 4.79 +/- 0.10, p < 0.001). The proliferated lysosomes in ML-II cells were accumulated similar to 3-fold in amount as compared with normal cells. Intracellular logistics including endocytosis and mannose 6-phosphate receptor recycling were impaired in ML-II cells. To confirm whether these ML-II cellular phenotypes derive from deficient lysosomal acid hydrolases within lysosomes, we performed supplementation of lysosomal enzymes using a partially purified total enzyme mixture, which was derived from the conditioned culture medium of normal skin fibroblasts after NH4Cl treatment. This supplementation corrected all of the previously described ML-II phenotypes. In addition, the autophagic and mitochondrial impairment that we have previously reported improved, and inclusion bodies disappeared on electron micrography following total lysosomal enzyme supplementation. Our results indicate that various cellular phenotypes in ML-II are caused by the deficiency of many lysosomal enzymes and massive accumulation of undigested substrates.	[Otomo, Takanobu; Ozono, Keiichi; Sakai, Norio] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Higaki, Katsumi; Nanba, Eiji] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Tottori 6838503, Japan	Osaka University; Tottori University	Otomo, T (corresponding author), 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	otomo@ped.med.osaka-u.ac.jp	Otomo, Takanobu/AAD-3586-2019		Ministry of Education, Culture, Science, Sports and Technology of Japan [20790728, 18390299, 21659257, 21591322]; Ministry of Health, Labour and Welfare of Japan [H20-Kokoro-022]	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of Japan (Grants 20790728, 18390299, 21659257, and 21591322) and the Ministry of Health, Labour and Welfare of Japan (Grant H20-Kokoro-022 and a grant for Research for Intractable Diseases).	Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Boonen M, 2011, MOL BIOL CELL, V22, P1135, DOI 10.1091/mbc.E10-07-0584; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BROWN JA, 1985, J CELL BIOL, V100, P1894, DOI 10.1083/jcb.100.6.1894; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kawashima I, 2007, CLIN CHIM ACTA, V378, P142, DOI 10.1016/j.cca.2006.11.019; Kobayashi H, 2011, MOL GENET METAB, V102, P170, DOI 10.1016/j.ymgme.2010.09.014; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kogot-Levin A, 2009, PEDIATR RES, V65, P686, DOI 10.1203/PDR.0b013e3181a1681a; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Otomo T, 2009, MOL GENET METAB, V98, P393, DOI 10.1016/j.ymgme.2009.07.002; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2010, J INHERIT METAB DIS, V33, P373, DOI 10.1007/s10545-010-9047-0; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Storch Stephan, 2005, P17; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L	33	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35283	35290		10.1074/jbc.M111.267930	http://dx.doi.org/10.1074/jbc.M111.267930			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846724	Green Published, hybrid			2022-12-25	WOS:000295406300081
J	Pless, SA; Leung, AWY; Galpin, JD; Ahern, CA				Pless, Stephan A.; Leung, Ada W. Y.; Galpin, Jason D.; Ahern, Christopher A.			Contributions of Conserved Residues at the Gating Interface of Glycine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTION; TRANSMEMBRANE DOMAIN INTERFACE; CYS-LOOP RECEPTORS; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; COUPLING AGONIST BINDING; SIGNATURE DISULFIDE LOOP; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CONFORMATIONAL-CHANGES	Glycine receptors (GlyRs) are chloride channels that mediate fast inhibitory neurotransmission and are members of the pentameric ligand-gated ion channel (pLGIC) family. The interface between the ligand binding domain and the transmembrane domain of pLGICs has been proposed to be crucial for channel gating and is lined by a number of charged and aromatic side chains that are highly conserved among different pLGICs. However, little is known about specific interactions between these residues that are likely to be important for gating in alpha 1 GlyRs. Here we use the introduction of cysteine pairs and the in vivo nonsense suppression method to incorporate unnatural amino acids to probe the electrostatic and hydrophobic contributions of five highly conserved side chains near the interface, Glu-53, Phe-145, Asp-148, Phe-187, and Arg-218. Our results suggest a salt bridge between Asp-148 in loop 7 and Arg-218 in the pre-M1 domain that is crucial for channel gating. We further propose that Phe-145 and Phe-187 play important roles in stabilizing this interaction by providing a hydrophobic environment. In contrast to the equivalent residues in loop 2 of other pLGICs, the negative charge at Glu-53 alpha 1 GlyRs is not crucial for normal channel function. These findings help decipher the GlyR gating pathway and show that distinct residue interaction patterns exist in different pLGICs. Furthermore, a salt bridge between Asp-148 and Arg-218 would provide a possible mechanistic explanation for the pathophysiologically relevant hyperekplexia, or startle disease, mutant Arg-2183 -> Gln.	Univ British Columbia, Dept Anesthesiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pharmacol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Therapeut, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Pless, SA (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	spless@mail.ubc.ca		Ahern, Christopher/0000-0002-7975-2744; Pless, Stephan/0000-0001-6654-114X; Leung, Ada/0000-0002-8018-1248; Galpin, Jason/0000-0003-1923-5312	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by Canadian Institutes of Health Research Grant 56858, the Heart and Stroke Foundation of Canada, the Michael Smith Foundation for Health Research (to C. A. A.), and a postdoctoral fellowship by the Heart and Stroke Foundation of Canada (to S. A. P.).	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; Aldea M, 2010, J NEUROCHEM, V113, P1036, DOI 10.1111/j.1471-4159.2010.06665.x; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2010, J NEUROCHEM, V115, P1245, DOI 10.1111/j.1471-4159.2010.07021.x; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; De Saint Jan D, 2001, J PHYSL, V535, P741; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Elmslie FV, 1996, J MED GENET, V33, P435, DOI 10.1136/jmg.33.5.435; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Limapichat W, 2010, J BIOL CHEM, V285, P8976, DOI 10.1074/jbc.M109.060939; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Pless SA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1351; Pless SA, 2011, MOL PHARMACOL, V79, P742, DOI 10.1124/mol.110.069583; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Santarelli VP, 2007, J BIOL CHEM, V282, P8044, DOI 10.1074/jbc.M611334200; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Vicente-Agullo F, 2001, BIOCHEMISTRY-US, V40, P8300, DOI 10.1021/bi010087g; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	63	22	22	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35129	35136		10.1074/jbc.M111.269027	http://dx.doi.org/10.1074/jbc.M111.269027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835920	Green Published, hybrid			2022-12-25	WOS:000295406300066
J	Medler, S; Al Husini, N; Raghunayakula, S; Mukundan, B; Aldea, A; Ansari, A				Medler, Scott; Al Husini, Nadra; Raghunayakula, Sarita; Mukundan, Banupriya; Aldea, Ashley; Ansari, Athar			Evidence for a Complex of Transcription Factor IIB (TFIIB) with Poly(A) Polymerase and Cleavage Factor 1 Subunits Required for Gene Looping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE SELECTION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL DOMAINS; PROTEIN COMPLEXES; BINDING PROTEIN; YEAST TFIIB; IN-VIVO; RNA; INITIATION; TERMINATION	Gene looping, defined as the interaction of the promoter and the terminator regions of a gene during transcription, requires transcription factor IIB (TFIIB). We have earlier demonstrated association of TFIIB with the distal ends of a gene in an activator-dependent manner (El Kaderi, B., Medler, S., Raghunayakula, S., and Ansari, A. (2009) J. Biol. Chem. 284, 25015-25025). The presence of TFIIB at the 3' end of a gene required its interaction with cleavage factor 1 (CF1) 3' end processing complex subunit Rna15. Here, employing affinity chromatography and glycerol gradient centrifugation, we show that TFIIB associates with poly(A) polymerase and the entire CF1 complex in yeast cells. The factors required for general transcription such as TATA-binding protein, RNA polymerase II, and TFIIH are not a component of the TFIIB complex. This holo-TFIIB complex was resistant to MNase digestion. The complex was observed only in the looping-competent strains, but not in the looping-defective sua7-1 strain. The requirement of Rna15 in gene looping has been demonstrated earlier. Here we provide evidence that poly(A) polymerase (Pap1) as well as CF1 subunits Rna14 and Pcf11 are also required for loop formation of MET16 and INO1 genes. Accordingly, cross-linking of TFIIB to the 3' end of genes was abolished in the mutants of Pap1, Rna14, and Pcf11. We further show that in sua7-1 cells, where holo-TFIIB complex is not formed, the kinetics of activated transcription is altered. These results suggest that a complex of TFIIB, CF1 subunits, and Pap1 exists in yeast cells. Furthermore, TFIIB interaction with the CF1 complex and Pap1 is crucial for gene looping and transcriptional regulation.	[Medler, Scott; Al Husini, Nadra; Raghunayakula, Sarita; Mukundan, Banupriya; Aldea, Ashley; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation (NSF) [MCB1020911]; Dept. of Biological Sciences (Wayne State University)	National Science Foundation (NSF)(National Science Foundation (NSF)); Dept. of Biological Sciences (Wayne State University)	This work was supported by National Science Foundation (NSF) Grant MCB1020911.; Supported by an enhancement graduate research assistantship from the Dept. of Biological Sciences (Wayne State University).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Auty R, 2004, J BIOL CHEM, V279, P49973, DOI 10.1074/jbc.M409849200; BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chew BS, 2007, BIOCHEM J, V406, P265, DOI 10.1042/BJ20070441; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Papantonis A, 2010, CURR OPIN CELL BIOL, V22, P271, DOI 10.1016/j.ceb.2010.03.004; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh BN, 2009, METHODS, V48, P361, DOI 10.1016/j.ymeth.2009.02.018; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; TSCHOCHNER H, 1992, P NATL ACAD SCI USA, V89, P11292, DOI 10.1073/pnas.89.23.11292; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu WH, 1999, P NATL ACAD SCI USA, V96, P2764, DOI 10.1073/pnas.96.6.2764; Zhang DY, 2000, NUCLEIC ACIDS RES, V28, P1913, DOI 10.1093/nar/28.9.1913	43	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33709	33718		10.1074/jbc.M110.193870	http://dx.doi.org/10.1074/jbc.M110.193870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835917	hybrid, Green Published			2022-12-25	WOS:000295159200001
J	Torres-Bacete, J; Sinha, PK; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Matsuno-Yagi, Akemi; Yagi, Takao			Structural Contribution of C-terminal Segments of NuoL (ND5) and NuoM (ND4) Subunits of Complex I from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; CONSERVED CHARGED RESIDUES; DNA-ENCODED SUBUNITS; PARACOCCUS-DENITRIFICANS; MEMBRANE DOMAIN; UBIQUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; PERIPHERAL SUBUNITS; RESPIRATORY-CHAIN	The proton-translocating NADH-quinone oxidoreductase (complex I/NDH-1) is a multisubunit enzymatic complex. It has a characteristic L-shaped form with two domains, a hydrophilic peripheral domain and a hydrophobic membrane domain. The membrane domain contains three antiporter-like subunits (NuoL, NuoM, and NuoN, Escherichia coli naming) that are considered to be involved in the proton translocation. Deletion of either NuoL or NuoM resulted in an incomplete assembly of NDH-1 and a total loss of the NADH-quinone oxidoreductase activity. We have truncated the C terminus segments of NuoM and NuoL by introducing STOP codons at different locations using site-directed mutagenesis of chromosomal DNA. Our results suggest an important structural role for the C-terminal segments of both subunits. The data further advocate that the elimination of the last transmembrane helix (TM14) of NuoM and the TM16 (at least C-terminal seven residues) or together with the HL helix and the TM15 of the NuoL subunit lead to reduced stability of the membrane arm and therefore of the whole NDH-1 complex. A region of NuoL critical for stability of NDH-1 architecture has been discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health, USPHS [R01GM033712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM033712 from USPHS (to T. Y. and A. M.-Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; Dupuis A, 1997, FEMS MICROBIOL LETT, V148, P107, DOI 10.1016/S0378-1097(97)00023-2; Dupuis A, 1998, MOL MICROBIOL, V28, P531, DOI 10.1046/j.1365-2958.1998.00814.x; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Ghelli A, 1997, J BIOCHEM, V121, P746; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LEONARD K, 1987, J MOL BIOL, V194, P277, DOI 10.1016/0022-2836(87)90375-5; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Moparthi VK, 2011, BBA-BIOENERGETICS, V1807, P427, DOI 10.1016/j.bbabio.2011.01.005; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Morino M, 2008, J BACTERIOL, V190, P4162, DOI 10.1128/JB.00294-08; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Sinha P.K, 2009, CURR TOP BIOCH RES, V11, P79; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	53	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34007	34014		10.1074/jbc.M111.260968	http://dx.doi.org/10.1074/jbc.M111.260968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835926	Green Published, hybrid			2022-12-25	WOS:000295159200033
J	Fragkos, M; Beard, P				Fragkos, Michalis; Beard, Peter			Mitotic Catastrophe Occurs in the Absence of Apoptosis in p53-Null Cells with a Defective G1 Checkpoint	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TUMOR-CELLS; ADENOASSOCIATED VIRUS; INK4A/ARF LOCUS; CYCLE CONTROL; DEATH; AUTOPHAGY; CASPASES; PATHWAY; ARREST	Cell death occurring during mitosis, or mitotic catastrophe, often takes place in conjunction with apoptosis, but the conditions in which mitotic catastrophe may exhibit features of programmed cell death are still unclear. In the work presented here, we studied mitotic cell death by making use of a UV-inactivated parvovirus (adeno-associated virus; AAV) that has been shown to induce a DNA damage response and subsequent death of p53-defective cells in mitosis, without affecting the integrity of the host genome. Osteosarcoma cells (U2OSp53DD) that are deficient in p53 and lack the G1 cell cycle checkpoint respond to AAV infection through a transient G2 arrest. We found that the infected U2OSp53DD cells died through mitotic catastrophe with no signs of chromosome condensation or DNA fragmentation. Moreover, cell death was independent of caspases, apoptosis-inducing factor (AIF), autophagy and necroptosis. These findings were confirmed by time-lapse microscopy of cellular morphology following AAV infection. The assays used readily revealed apoptosis in other cell types when it was indeed occurring. Taken together the results indicate that in the absence of the G1 checkpoint, mitotic catastrophe occurs in these p53-null cells predominantly as a result of mechanical disruption induced by centrosome overduplication, and not as a consequence of a suicide signal.	[Fragkos, Michalis; Beard, Peter] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Fragkos, M (corresponding author), CNRS, Inst Human Genet, Montpellier, France.	peter.beard@epfl.ch	Fragkos, Michalis/GQQ-1030-2022	Fragkos, Michalis/0000-0003-2721-4327	Swiss National Science Foundation [31003A 124980]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation grant number 31003A 124980, www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CW, 2000, RADIAT RES, V154, P473, DOI 10.1667/0033-7587(2000)154[0473:HTFTMG]2.0.CO;2; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEGTEREV A, 2008, CHEM BIOL, V5, P313; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; DOU QP, 1995, P NATL ACAD SCI USA, V92, P9019, DOI 10.1073/pnas.92.20.9019; Emanuele S, 2004, EUR J CANCER, V40, P1441, DOI 10.1016/j.ejca.2004.01.039; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fragkos M, 2008, J VIROL, V82, P7379, DOI 10.1128/JVI.00358-08; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang HM, 2008, CANCER RES, V68, P3724, DOI 10.1158/0008-5472.CAN-08-0479; Ingemarsdotter C, 2010, VIROLOGY, V400, P271, DOI 10.1016/j.virol.2010.02.003; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jin Y, 2005, CELL RES, V15, P695, DOI 10.1038/sj.cr.7290339; Jordan MA, 1996, CANCER RES, V56, P816; Jurvansuu J, 2005, J VIROL, V79, P569, DOI 10.1128/JVI.79.1.569-580.2005; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kim JS, 2000, ONCOGENE, V19, P6082, DOI 10.1038/sj.onc.1204008; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lock RB, 1996, CANCER RES, V56, P4006; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Meier P, 2007, MOL CELL, V28, P746, DOI 10.1016/j.molcel.2007.11.016; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Xie Q, 2004, J VIROL METHODS, V122, P17, DOI 10.1016/j.jviromet.2004.07.007; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	53	44	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22946	10.1371/journal.pone.0022946	http://dx.doi.org/10.1371/journal.pone.0022946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853057	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200029
J	Beal, J; Lu, T; Weiss, R				Beal, Jacob; Lu, Ting; Weiss, Ron			Automatic Compilation from High-Level Biologically-Oriented Programming Language to Genetic Regulatory Networks	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; EXPRESSION	Background: The field of synthetic biology promises to revolutionize our ability to engineer biological systems, providing important benefits for a variety of applications. Recent advances in DNA synthesis and automated DNA assembly technologies suggest that it is now possible to construct synthetic systems of significant complexity. However, while a variety of novel genetic devices and small engineered gene networks have been successfully demonstrated, the regulatory complexity of synthetic systems that have been reported recently has somewhat plateaued due to a variety of factors, including the complexity of biology itself and the lag in our ability to design and optimize sophisticated biological circuitry. Methodology/Principal Findings: To address the gap between DNA synthesis and circuit design capabilities, we present a platform that enables synthetic biologists to express desired behavior using a convenient high-level biologically-oriented programming language, Proto. The high level specification is compiled, using a regulatory motif based mechanism, to a gene network, optimized, and then converted to a computational simulation for numerical verification. Through several example programs we illustrate the automated process of biological system design with our platform, and show that our compiler optimizations can yield significant reductions in the number of genes (similar to 50%) and latency of the optimized engineered gene networks. Conclusions/Significance: Our platform provides a convenient and accessible tool for the automated design of sophisticated synthetic biological systems, bridging an important gap between DNA synthesis and circuit design capabilities. Our platform is user-friendly and features biologically relevant compiler optimizations, providing an important foundation for the development of sophisticated biological systems.	[Beal, Jacob] BBN Technol, Cambridge, MA 02138 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Elect Engn, Cambridge, MA 02139 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Comp Engn, Cambridge, MA 02139 USA	Raytheon Technologies; Raytheon BBN Technologies; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Beal, J (corresponding author), BBN Technol, Cambridge, MA 02138 USA.	jakebeal@bbn.com		Beal, Jacob/0000-0002-1663-5102	NIH [7R01GM74712-5]; DARPA [HR0011-10-C-0168]; NSF [0968682]; BBN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); BBN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01: "Engineering Synthetic Multicellular Systems" (Grant # 7R01GM74712-5) (http://nih.gov). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially sponsored by DARPA under contract HR0011-10-C-0168, and by an NSF CAREER award 0968682; the views and conclusions contained in this document are those of the authors and not DARPA or the U.S. Government. Jacob Beal is an employee of BBN Technologies and his work on this manuscript submission was partially internally funded by BBN. The funder, BBN Technologies, therefore played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. BBN Technologies operates on a university-like Primary Investigator model, where the dominant product is scientific research results. As a PI, Dr. Beal organizes his own research program and funds it through external grants and contracts, typically with government funding agencies. This study aids BBN Technologies financially in the same way that it would aid a university: publication of high-quality work certified by ones' scientific peers aids in securing funding for future research.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Alon U, 2007, INTRO SYSTEMS BIOL D; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; BACHRACH J, 2007, IEEE SASO 2007; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Batt G, 2007, BIOINFORMATICS, V23, P2415, DOI 10.1093/bioinformatics/btm362; Beal J, 2006, IEEE INTELL SYST, V21, P10, DOI 10.1109/MIS.2006.29; BEAL J, 2010, 45 AS C SIGN SYST CO; BEAL J, 2008, SPAT COMP WORKSH; *BERK SOFTW 2009 I, 2009, EUG; BRAUN D, 2005, IEEE INT C AC SPEECH; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; CZAR M, 2009, NUCL ACIDS RES, V37; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Finney A, 2006, SYSTEM MODELING CELL; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garny A, 2008, PHILOS T R SOC A, V366, P3017, DOI 10.1098/rsta.2008.0094; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Katz R. H., 1994, CONT LOGIC DESIGN; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kittleson JT, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-10; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lu T, 2004, SYSTEMS BIOL, V1, P121, DOI 10.1049/sb:20045016; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lu T, 2007, P NATL ACAD SCI USA, V104, P18982, DOI 10.1073/pnas.0706115104; Lu T, 2006, BIOPHYS J, V91, P84, DOI 10.1529/biophysj.105.074914; Lu T, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036006; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Mirschel S, 2009, BIOINFORMATICS, V25, P687, DOI 10.1093/bioinformatics/btp029; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shetty R.P., 2008, J BIOL ENG, V2; Smith LP, 2009, BIOINFORMATICS, V25, P2452, DOI 10.1093/bioinformatics/btp401; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; SUBRAMANIAN S, 2007, THESIS PRINCETON U; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; YAMAN F, 2011, 3 INT WORKSH BIOD AU; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	53	75	75	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22490	10.1371/journal.pone.0022490	http://dx.doi.org/10.1371/journal.pone.0022490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850228	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300012
J	Hess, J; Goldman, N				Hess, Jaqueline; Goldman, Nick			Addressing Inter-Gene Heterogeneity in Maximum Likelihood Phylogenomic Analysis: Yeasts Revisited	PLOS ONE			English	Article							MODEL SELECTION; SEQUENCE EVOLUTION; NUCLEOTIDE SUBSTITUTION; INFORMATION CRITERION; PROTEIN EVOLUTION; CUG CODON; SCALE; TREES; PHYLOGENETICS; INFERENCE	Phylogenomic approaches to the resolution of inter-species relationships have become well established in recent years. Often these involve concatenation of many orthologous genes found in the respective genomes followed by analysis using standard phylogenetic models. Genome-scale data promise increased resolution by minimising sampling error, yet are associated with well-known but often inappropriately addressed caveats arising through data heterogeneity and model violation. These can lead to the reconstruction of highly-supported but incorrect topologies. With the aim of obtaining a species tree for 18 species within the ascomycetous yeasts, we have investigated the use of appropriate evolutionary models to address inter-gene heterogeneities and the scalability and validity of supermatrix analysis as the phylogenetic problem becomes more difficult and the number of genes analysed approaches truly phylogenomic dimensions. We have extended a widely-known early phylogenomic study of yeasts by adding additional species to increase diversity and augmenting the number of genes under analysis. We have investigated sophisticated maximum likelihood analyses, considering not only a concatenated version of the data but also partitioned models where each gene constitutes a partition and parameters are free to vary between the different partitions (thereby accounting for variation in the evolutionary processes at different loci). We find considerable increases in likelihood using these complex models, arguing for the need for appropriate models when analyzing phylogenomic data. Using these methods, we were able to reconstruct a well-supported tree for 18 ascomycetous yeasts spanning about 250 million years of evolution.	[Hess, Jaqueline] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hess, Jaqueline; Goldman, Nick] EMBL European Bioinformat Inst, Hinxton, England	Harvard University; European Molecular Biology Laboratory (EMBL)	Hess, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	jhess@oeb.harvard.edu		Goldman, Nick/0000-0001-8486-2211; Hess, Jaqueline/0000-0003-3281-5434	Biotechnology and Biological Sciences Research Council; AstraZeneca; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome TrustEuropean Commission)	JH was supported by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) CASE studentship with AstraZeneca (www.astrazeneca.com) and was a member of Clare Hall College, Univeristy of Cambridge. NG is supported by the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOFKIN L, 2005, THESIS U CAMBRIDGE; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delsuc F, 2003, SCIENCE, V301, P1482; Diezmann S, 2004, J CLIN MICROBIOL, V42, P5624, DOI 10.1128/JCM.42.12.5624-5635.2004; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HESS J, 2011, THESIS U CAMBRIDGE; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; JUKES T H, 1969, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Le SQ, 2010, SYST BIOL, V59, P277, DOI 10.1093/sysbio/syq002; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ren FR, 2009, GENE, V441, P119, DOI 10.1016/j.gene.2008.04.002; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas Antonis, 2008, V422, P1, DOI 10.1007/978-1-59745-581-7_1; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sugita T, 1999, J GEN APPL MICROBIOL, V45, P193, DOI 10.2323/jgam.45.193; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; UZZELL T, 1971, SCIENCE, V172, P1089, DOI 10.1126/science.172.3988.1089; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2003, BIOINFORMATICS, V19, P1556, DOI 10.1093/bioinformatics/btg188; Whelan S, 2008, MOL BIOL EVOL, V25, P1683, DOI 10.1093/molbev/msn119; Whelan S, 2007, SYSTEMATIC BIOL, V56, P727, DOI 10.1080/10635150701611134; Wu Q, 2008, FEMS YEAST RES, V8, P641, DOI 10.1111/j.1567-1364.2008.00362.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2009, PAML PHYLOGENETIC AN; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	69	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22783	10.1371/journal.pone.0022783	http://dx.doi.org/10.1371/journal.pone.0022783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850235	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300020
J	Hussain, F; Morton, PE; Snippe, M; Sullivan, J; Farmer, C; Martin-Fernandez, ML; Parsons, M; Santis, G				Hussain, Fawziyah; Morton, Penny E.; Snippe, Marjolein; Sullivan, Janis; Farmer, Charlotte; Martin-Fernandez, Marisa L.; Parsons, Maddy; Santis, George			CAR Modulates E-Cadherin Dynamics in the Presence of Adenovirus Type 5	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; CELL-CELL ADHESION; RECEPTOR CAR; TIGHT JUNCTION; IMMUNOGLOBULIN SUPERFAMILY; ADHERENS JUNCTIONS; IN-VIVO; COXSACKIE; PROTEIN; BINDING	Adenovirus (Ad) serotype 5 (Ad5) fiber competitively binds to the coxsackievirus and Ad receptor (CAR) to attach Ad5 to target cells and also disrupts cell junctions and facilitates virus escape at a late stage in Ad5 infection. Here we demonstrate that paracellular permeability in MCF7 and CAR overexpressing MCF7 (FLCARMCF7) cells is increased within minutes following the addition of Ad5 to cells. This is brought about, at least in part, by altering the molecular dynamics of E-cadherin, a key component of the cell-cell adhesion complex. We also demonstrate that the increase in E-cadherin mobility is constitutively altered by the presence of CAR at FLCARMCF7 cell junctions. As increased paracellular permeability was observed early after the addition of Ad5 to cells, we postulate that this may represent a mechanism by which Ad5 could disrupt cell junctions to facilitate further access to its cell receptors.	[Hussain, Fawziyah; Morton, Penny E.; Snippe, Marjolein; Sullivan, Janis; Farmer, Charlotte; Santis, George] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Martin-Fernandez, Marisa L.] Sci & Technol Facil Council, Rutherford Appleton Lab, Oxford, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; King's College London	Hussain, F (corresponding author), Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England.	george.santis@kcl.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; martin-fernandez, marisa/0000-0001-5496-6300	Medical Research Council UK; Biotechnology and Biological Sciences Research Council UK; Royal Society of Medicine UK; National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London; Biotechnology and Biological Sciences Research Council [BB/G006911/1] Funding Source: researchfish; BBSRC [BB/G006911/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society of Medicine UK(Royal Society of London); National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Medical Research Council UK, Biotechnology and Biological Sciences Research Council UK, Royal Society of Medicine UK, and the National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Aurrand-Lions MA, 2000, CURR TOP MICROBIOL, V251, P91; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BYERS SW, 1995, J CELL SCI, V108, P2053; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cohen CJ, 2001, J BIOL CHEM, V276, P25392, DOI 10.1074/jbc.M009531200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Davis B, 2004, MOL THER, V10, P500, DOI 10.1016/j.ymthe.2004.05.032; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Honda M, 2000, GENE THER, V7, P978, DOI 10.1038/sj.gt.3301203; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kirby I, 1999, J VIROL, V73, P9508, DOI 10.1128/JVI.73.11.9508-9514.1999; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Nasdala I, 2002, J BIOL CHEM, V277, P16294, DOI 10.1074/jbc.M111999200; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Serrels A, 2009, CANCER RES, V69, P2714, DOI 10.1158/0008-5472.CAN-08-4308; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Veena MS, 2009, LAB INVEST, V89, P875, DOI 10.1038/labinvest.2009.56; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23056	10.1371/journal.pone.0023056	http://dx.doi.org/10.1371/journal.pone.0023056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850251	Green Submitted, gold, Green Published			2022-12-25	WOS:000293563300036
J	Chen, WT; Hayward, C; Wright, AF; Hicks, AA; Vitart, V; Knott, S; Wild, SH; Pramstaller, PP; Wilson, JF; Rudan, I; Porteous, DJ				Chen, Wanting; Hayward, Caroline; Wright, Alan F.; Hicks, Andrew A.; Vitart, Veronique; Knott, Sara; Wild, Sarah H.; Pramstaller, Peter P.; Wilson, James F.; Rudan, Igor; Porteous, David J.			Copy Number Variation across European Populations	PLOS ONE			English	Article							RECENT SEGMENTAL DUPLICATIONS; ASSOCIATION; GENE; DELETIONS; IDENTIFICATION; POLYMORPHISM; NUCLEOTIDE; EXPRESSION; DIVERSITY; EVOLUTION	Genome analysis provides a powerful approach to test for evidence of genetic variation within and between geographical regions and local populations. Copy number variants which comprise insertions, deletions and duplications of genomic sequence provide one such convenient and informative source. Here, we investigate copy number variants from genome wide scans of single nucleotide polymorphisms in three European population isolates, the island of Vis in Croatia, the islands of Orkney in Scotland and the South Tyrol in Italy. We show that whereas the overall copy number variant frequencies are similar between populations, their distribution is highly specific to the population of origin, a finding which is supported by evidence for increased kinship correlation for specific copy number variants within populations.	[Chen, Wanting; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Ctr Mol Med,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Hayward, Caroline; Wright, Alan F.; Vitart, Veronique] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Knott, Sara] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Wild, Sarah H.; Wilson, James F.; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia	University of Edinburgh; University of Edinburgh; European Academy of Bozen-Bolzano; University of Lubeck; University of Edinburgh; University of Edinburgh; Krankenhaus Bozen; University of Lubeck; University of Split	Chen, WT (corresponding author), Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Ctr Mol Med,Inst Genet & Mol Med, Crewe Rd S, Edinburgh, Midlothian, Scotland.	david.porteous@ed.ac.uk	Porteous, David/AAA-3446-2021; Rudan, Igor/I-1467-2012; Hayward, Caroline/M-8818-2016; Knott, Sara A/H-2466-2013; Porteous, David J/C-7289-2013; Wilson, James F/A-5704-2009; Pramstaller, Peter P/C-2357-2008; Hicks, Andrew Anthony/E-9518-2017; chen, want/GRX-0662-2022	Porteous, David/0000-0003-1249-6106; Rudan, Igor/0000-0001-6993-6884; Hayward, Caroline/0000-0002-9405-9550; Knott, Sara A/0000-0002-4568-2928; Porteous, David J/0000-0003-1249-6106; Wilson, James F/0000-0001-5751-9178; Hicks, Andrew Anthony/0000-0001-6320-0411; Pramstaller, Peter P/0000-0002-9831-8302	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Office of the Scottish Government; Royal Society; European Union [LSHG-CT-2006-018947]; Medical Research Council (UK); Wellcome Trust; Republic of Croatia Ministry of Science, Education and Sports [108-1080315-0302]; P.R. [196-1962766-2751]; Scottish Executive Health Department, Chief Scientist Office [CZB/4/285]; MRC [MC_PC_U127561128, MC_U127561128] Funding Source: UKRI; Medical Research Council [G0700704B, MC_PC_U127561128, MC_U127561128] Funding Source: researchfish; Chief Scientist Office [CZB/4/710, CZD/16/6/2] Funding Source: researchfish	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Office of the Scottish Government; Royal Society(Royal Society of London); European Union(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Republic of Croatia Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); P.R.; Scottish Executive Health Department, Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The MICROS study in South Tyrol was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. ORCADES was supported by the Chief Scientist Office of the Scottish Government(http://www.cso.scot.nhs.uk/), the Royal Society (http://royalsociety.org/) and the European Union framework program 6 EUROSPAN project (http://cordis.europa.eu/fp6/dc/index.cfm?fuseaction=UserSite.FP6HomePage contract no. LSHG-CT-2006-018947) (I.R., H.C., J.F.W.). VIS study research was funded by grants from the Medical Research Council (UK)(http://www.mrc.ac.uk/index.htm), the Wellcome Trust (http://www.wellcome.ac.uk/), Republic of Croatia Ministry of Science, Education and Sports grants to I.R. (108-1080315-0302), P.R. (196-1962766-2751). It is now components of the EU Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) (A.F.W.) W. Chen's PhD study was supported by Generation Scotland project which was funded by a project grant from the Scottish Executive Health Department, Chief Scientist Office (CZB/4/285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2008, CYTOGENET GENOME RES, V123, P234, DOI 10.1159/000184713; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cowell JK, 2009, METHODS MOL BIOL, V556, P47, DOI 10.1007/978-1-60327-192-9_5; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cronin S, 2008, HUM MOL GENET, V17, P3392, DOI 10.1093/hmg/ddn233; Cutler G, 2008, CYTOGENET GENOME RES, V123, P297, DOI 10.1159/000184721; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Franke L, 2008, AM J HUM GENET, V82, P1316, DOI 10.1016/j.ajhg.2008.05.008; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kamatani Y, 2008, J HUM GENET, V53, P64, DOI 10.1007/s10038-007-0219-1; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Mascalzoni D, 2010, EUR J HUM GENET, V18, P296, DOI 10.1038/ejhg.2009.155; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peltonen L, 2000, HUM HERED, V50, P66, DOI 10.1159/000022892; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pielberg G, 2002, GENETICS, V160, P305; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; Vitart V, 2010, INVEST OPHTH VIS SCI, V51, P737, DOI 10.1167/iovs.09-3720; WANG J, 2008, CYTOGENET GENOME RES, V123, P322; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Winchester L, 2008, CYTOGENET GENOME RES, V123, P322, DOI 10.1159/000184724; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Yang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004474; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	50	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23087	10.1371/journal.pone.0023087	http://dx.doi.org/10.1371/journal.pone.0023087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829696	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200046
J	Schonecker, B; Freimanis, T; Sorensen, IV				Schonecker, Bryan; Freimanis, Tonny; Sorensen, Irene Vejgaard			Diabetes in Danish Bank Voles (M. glareolus): Survivorship, Influence on Weight, and Evaluation of Polydipsia as a Screening Tool for Hyperglycaemia	PLOS ONE			English	Article							LJUNGAN VIRUS; MYODES-GLAREOLUS; CLETHRIONOMYS-GLAREOLUS; LEW.1AR1/ZTM-IDDM RAT; PANCREATIC-ISLETS; LIFE-EXPECTANCY; STOOL SAMPLES; ANIMAL-MODELS; WILD-CAUGHT; TYPE-1	Background: Previous studies have concluded that the development of polydipsia (PD, a daily water intake >= 21 ml) among captive Danish bank voles, is associated with the development of a type 1 diabetes (T1D), based on findings of hyperglycaemia, glucosuria, ketonuria/-emia, lipemia, destroyed beta cells, and presence of autoantibodies against GAD65, IA-2, and insulin. Aim and Methods: We retrospectively analysed data from two separate colonies of Danish bank voles in order to 1) estimate survivorship after onset of PD, 2) evaluate whether the weight of PD voles differed from non-PD voles, and, 3), evaluate a state of PD as a practical and non-invasive tool to screen for voles with a high probability of hypeglycaemia. In addition, we discuss regional differences related to the development of diabetes in Scandinavian bank voles and the relevance of the Ljungan virus as proposed etiological agent. Results: We found that median survival after onset of PD is at least 91 days (lower/upper quartiles = 57/134 days) with a maximum recording of at least 404 days survivorship. The development of PD did not influence the weight of Danish bank voles. The measures of accuracy when using PD as predictor of hyperglycaemia, i.e. sensitivity, specificity, positive predictive value, and negative predictive value, equalled 69%, 97%, 89%, and 89%, respectively. Conclusion: The relatively long survival of Danish PD bank voles suggests potentials for this model in future studies of the long-term complications of diabetes, of which some observations are mentioned. Data also indicates that diabetes in Danish bank is not associated with a higher body weight. Finally, the method of using measurements of daily water intake to screen for voles with a high probability of hyperglycaemia constitutes a considerable refinement when compared to the usual, invasive, methods.	[Schonecker, Bryan; Freimanis, Tonny] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Sorensen, Irene Vejgaard] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Schonecker, B (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	bryan@clethrionomys.info			Danish Research Council; Apodemus AB; Swedish company (Apodemus AB)	Danish Research Council(Det Frie Forskningsrad (DFF)); Apodemus AB; Swedish company (Apodemus AB)	This study was in part supported by donations from the Danish Research Council and Apodemus AB, neither of which had any influence on either study, analysis, interpretations, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was in part supported by donations from a private Swedish company (Apodemus AB), which have had no influence on either the study, analysis, interpretations, decision to publish, or preparation of the manuscript. The donations were used to pay a minor part of the expenses to keep the colony (rent, food and woodcutting). However, Bo Niklasson (CEO and co-owner of Apodemus AB) assisted Schonecker on one single occasion where Niklasson performed the actual orbital bleedings on 128 Danish bank voles, which then were analysed for blood glucose by Schonecker. Neither the brief funding from Apodemus AB, nor this one-time assistance, does in any way alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The authors have declared that no further potential competing interests exist.	Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; BENNETT PH, 1983, ANNU REV MED, V34, P295, DOI 10.1146/annurev.me.34.020183.001455; Blixt M, 2007, GEN COMP ENDOCR, V154, P41, DOI 10.1016/j.ygcen.2007.06.019; Blixt M, 2010, J ENDOCRINOL, V206, P47, DOI 10.1677/JOE-10-0074; Blixt M, 2009, MOL CELL ENDOCRINOL, V305, P1, DOI 10.1016/j.mce.2009.02.010; Boettler T, 2010, INT IMMUNOPHARMACOL, V10, P1491, DOI 10.1016/j.intimp.2010.07.008; Bollyky J, 2008, MT SINAI J MED, V75, P385, DOI 10.1002/msj.20054; Bonifacio E, 2001, DIABETES, V50, P2451, DOI 10.2337/diabetes.50.11.2451; Burner TW, 2009, CURR OPIN RHEUMATOL, V21, P50, DOI 10.1097/BOR.0b013e32831bc0c4; BUSCHARD K, 2003, HDB LAB ANIMAL SCI A, P157; Cebioglu Melanie, 2008, Infectious Disorders - Drug Targets, V8, P76; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Cooper JJ, 1996, ANIM WELFARE, V5, P245; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Deedwania Prakash, 2008, Expert Rev Cardiovasc Ther, V6, P127, DOI 10.1586/14779072.6.1.127; Donmez FY, 2008, ACTA RADIOL, V49, P673, DOI 10.1080/02841850802105269; Ekstrom JO, 2007, VIRUS RES, V130, P129, DOI 10.1016/j.virusres.2007.06.004; ENGEL L, 1998, PRACTICAL DIABETES I, V15, P15, DOI DOI 10.1002/pdi.1960150110; Flores JE, 2008, MOL IMAGING BIOL, V10, P192, DOI 10.1007/s11307-008-0137-4; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Freimanis Tonny, 2003, Int J Exp Diabesity Res, V4, P21; FURDELL EL, 2009, FATAL THIRST DIABETE, P194; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Hageman Ida, 1994, P103; Hauffe HC, 2010, J WILDLIFE DIS, V46, P262, DOI 10.7589/0090-3558-46.1.262; Holmberg R, 2009, MICROBIOL IMMUNOL, V53, P567, DOI 10.1111/j.1348-0421.2009.00160.x; In't Veld P, 2009, DIABETES, V58, P1257, DOI 10.2337/db09-0345; Intagliata Nicolas, 2007, Curr Gastroenterol Rep, V9, P270, DOI 10.1007/s11894-007-0030-3; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jorns A, 2004, VIRCHOWS ARCH, V444, P183, DOI 10.1007/s00428-003-0956-2; KAWANO K, 1991, DIABETES, V40, P1375, DOI 10.2337/diabetes.40.11.1375; KEEN H, 1982, CLIN ENDOCRINOL META, V11, P279, DOI 10.1016/S0300-595X(82)80017-0; KOLB H, 1987, DIABETES METAB REV, V3, P751, DOI 10.1002/dmr.5610030308; Komeda K, 1998, ENDOCR J, V45, P737, DOI 10.1507/endocrj.45.737; Krous HF, 2010, BIRTH DEFECTS RES A, V88, P947, DOI 10.1002/bdra.20728; Leal J, 2009, EUR HEART J, V30, P834, DOI 10.1093/eurheartj/ehn567; LEITER EH, 1987, AM J PATHOL, V128, P380; Lenzen S, 2001, DIABETOLOGIA, V44, P1189, DOI 10.1007/s001250100625; Lernmark A, 2004, AUTOIMMUNITY, V37, P341, DOI 10.1080/08916930410001726012; Leslie RDG, 2004, DIABETES, V53, P3033, DOI 10.2337/diabetes.53.12.3033; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; LORENZEN T, 1994, DIABETOLOGIA, V37, P321, DOI 10.1007/BF00398061; Makino S, 1980, Jikken Dobutsu, V29, P1; Maria H, 2005, J CLIN VIROL, V33, P158, DOI 10.1016/j.jcv.2004.12.009; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mathews CE, 2005, PEDIATR DIABETES, V6, P165, DOI 10.1111/j.1399-543X.2005.00123.x; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; MORDES JP, 1987, DIABETES METAB REV, V3, P725, DOI 10.1002/dmr.5610030307; NAKHOODA AF, 1977, DIABETES, V26, P100, DOI 10.2337/diabetes.26.2.100; NAKHOODA AF, 1978, DIABETOLOGIA, V14, P199, DOI 10.1007/BF00429781; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nemirov K, 2010, J GEN VIROL, V91, P1262, DOI 10.1099/vir.0.016618-0; Niklasson B, 2003, ANN NY ACAD SCI, V1005, P170, DOI 10.1196/annals.1288.020; Niklasson B, 1998, EMERG INFECT DIS, V4, P187, DOI 10.3201/eid0402.980206; Niklasson B, 1999, VIROLOGY, V255, P86, DOI 10.1006/viro.1998.9557; NIKLASSON B, Patent No. 1432990; NIKLASSON B, Patent No. 7560609; Niklasson B, 2006, OECOLOGIA, V150, P1, DOI 10.1007/s00442-006-0493-1; Niklasson Bo, 2003, Int J Exp Diabesity Res, V4, P35; Niklasson B, 2009, BIRTH DEFECTS RES A, V85, P542, DOI 10.1002/bdra.20568; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Odberg F.O., 1978, P 1 WORLD C ETH APPL, V1, P475; ODBERG FO, 1987, BEHAV PROCESS, V14, P155, DOI 10.1016/0376-6357(87)90042-8; Ojetti V, 2009, EUR REV MED PHARMACO, V13, P419; Ostman J, 2008, J INTERN MED, V263, P386, DOI 10.1111/j.1365-2796.2007.01896.x; PORTH CM, 1998, PATHOPHYSIOLOGY CONC, P815; Roep BO, 2007, ANN NY ACAD SCI, V1103, P1, DOI 10.1196/annals.1394.018; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; ROZA AM, 1992, AM J SURG, V163, P417, DOI 10.1016/0002-9610(92)90044-R; Schoenecker B, 2000, APPL ANIM BEHAV SCI, V68, P339, DOI 10.1016/S0168-1591(00)00114-3; Schoenecker B, 2000, APPL ANIM BEHAV SCI, V68, P349, DOI 10.1016/S0168-1591(00)00108-8; Schonecker B, 2009, APPL ANIM BEHAV SCI, V121, P55, DOI 10.1016/j.applanim.2009.08.003; Shier D, 2010, HOLES HUMAN ANATOMY, P482; Sima AAF, 2006, ANN NY ACAD SCI, V1084, P235, DOI 10.1196/annals.1372.004; SORENSEN G, 1986, STRESS MEDICINE, V2, P103; TANIGUCHI H, 2007, ANIMAL MODELS DIABET, P41; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tapia G, 2010, DIABETES CARE, V33, P1069, DOI 10.2337/dc09-1951; Thrower SL, 2009, DIABETES OBES METAB, V11, P931, DOI 10.1111/j.1463-1326.2009.01064.x; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Zhao Y, 2010, J DIABETES COMPLICAT, V24, P9, DOI 10.1016/j.jdiacomp.2008.09.001; YSI 2700 SELECT BIOC	90	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22893	10.1371/journal.pone.0022893	http://dx.doi.org/10.1371/journal.pone.0022893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829666	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200037
J	Yu, L; Lu, JB				Yu, Lin; Lu, Jianbo			Does Landscape Fragmentation Influence Sex Ratio of Dioecious Plants? A Case Study of Pistacia chinensis in the Thousand-Island Lake Region of China	PLOS ONE			English	Article							HABITAT FRAGMENTATION; RESOURCE-ALLOCATION; PATERNITY ANALYSIS; POLLEN DISPERSAL; POPULATION-SIZE; POLLINATOR; PATTERNS; ECOSYSTEM; CONSEQUENCES; DENSITY	The Thousand-Island Lake region in Zhejiang Province, China is a highly fragmented landscape with a clear point-in-time of fragmentation as a result of flooding to form the reservoir. Islands in the artificial lake were surveyed to examine how population sex ratio of a dioecious plant specie Pistacia chinensis B. was affected by landscape fragmentation. A natural population on the mainland near the lake was also surveyed for comparison. Population size, sex ratio and diameter at breast height (DBH) of individuals were measured over 2 years. More than 1,500 individuals, distributed in 31 populations, were studied. Soil nitrogen in the different populations was measured to identify the relationship between sex ratio and micro-environmental conditions. In accordance with the results of many other reports on biased sex ratio in relation to environmental gradient, we found that poor soil nitrogen areas fostered male-biased populations. In addition, the degree of sex ratio bias increased with decreasing population size and population connectivity. The biased sex ratios were only found in younger individuals (less than 50 years old) in small populations, while a stable 1:1 sex ratio was found in the large population on the mainland. We concluded that the effects of landscape fragmentation on the dioecious population sex ratio were mainly achieved in relation to changing soil nitrogen conditions in patches and pollen limitation within and among populations. Large populations could maintain a more suitable environment in terms of nutrient conditions and pollen flow, subsequently maintaining a stable sex ratio in dioecious plant populations. Both micro-environmental factors and spatial structure should be considered in fragmented landscape for the conservation of dioecious plant species.	[Yu, Lin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Jianbo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University	Yu, L (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	jianbo.lu63@gmail.com			National Natural Science Foundation of China [30570320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (30570320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1988, ECOLOGY, V69, P962, DOI 10.2307/1941251; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Banuelos MJ, 2004, EVOL ECOL RES, V6, P397; Bertiller MB, 2002, BIODIVERS CONSERV, V11, P69, DOI 10.1023/A:1014084024145; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Cairns J, 1997, INT J SUST DEV WORLD, V4, P153, DOI 10.1080/13504509709469951; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; DANELL K, 1991, OIKOS, V62, P145, DOI 10.2307/3545259; DANELL K, 1985, OIKOS, V44, P82, DOI 10.2307/3544047; de Jong TJ, 2004, PLANT BIOLOGY, V6, P616, DOI 10.1055/s-2004-821177; ELMQVIST T, 1988, OIKOS, V51, P259, DOI 10.2307/3565306; Espirito-Santo MM, 2003, ANN BOT-LONDON, V91, P13, DOI 10.1093/aob/mcg001; Fisher R.A., 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; GEHRING JL, 1993, INT J PLANT SCI, V154, P152, DOI 10.1086/297100; GIBSON DJ, 1994, J VEG SCI, V5, P337, DOI 10.2307/3235857; HANCOCK JF, 1980, EVOLUTION, V34, P762, DOI 10.1111/j.1558-5646.1980.tb04015.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hilfiker K, 2004, CAN J BOT, V82, P219, DOI [10.1139/B03-136, 10.1139/b03-136]; [侯新村 HOU Xincun], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P3524; Iszkulo G, 2009, PLANT ECOL, V200, P229, DOI 10.1007/s11258-008-9447-5; KOLMAN WA, 1960, AM NAT, V94, P373, DOI 10.1086/282139; KORPELAINEN H, 1992, OECOLOGIA, V89, P133, DOI 10.1007/BF00319025; KRISCHIK VA, 1990, OECOLOGIA, V83, P176, DOI 10.1007/BF00317749; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; LEIGH EG, 1970, AM NAT, V104, P205, DOI 10.1086/282650; Li CY, 2005, PLANT SCI, V168, P1365, DOI 10.1016/j.plantsci.2005.02.001; Lian CL, 2001, HEREDITY, V87, P88, DOI 10.1046/j.1365-2540.2001.00913.x; Liu Q, 1999, J HENAN FORESTRY SCI, V19, P2; Massei G, 2006, ACTA OECOL, V29, P135, DOI 10.1016/j.actao.2005.08.004; Mustajarvi K, 2001, J ECOL, V89, P80, DOI 10.1046/j.1365-2745.2001.00521.x; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oster M, 2007, ECOSCIENCE, V14, P387, DOI 10.2980/1195-6860(2007)14[387:SRMPLI]2.0.CO;2; OYAMA K, 2005, PLANT SPEC BIOL, V3, P27; POPP JW, 1988, AM J BOT, V75, P1732, DOI 10.2307/2444688; Portela R, 2001, ECOL MODEL, V143, P115, DOI 10.1016/S0304-3800(01)00359-3; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; RENNER SS, 1998, EFFECTS HABITAT FRAG, P339; Retuerto R, 2000, FUNCT ECOL, V14, P529, DOI 10.1046/j.1365-2435.2000.t01-1-00454.x; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sawyer NW, 1998, RHODORA, V100, P1; Schuster WSF, 2000, HEREDITY, V84, P348, DOI 10.1046/j.1365-2540.2000.00684.x; Seifert, 2000, AUSTR GEOGRAPHICAL S, V38, P263, DOI [https://doi.org/10.1111/1467-8470.00115, DOI 10.1111/1467-8470.00115]; Stehlik I, 2008, P NATL ACAD SCI USA, V105, P10847, DOI 10.1073/pnas.0801964105; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Sun Q, 2008, BIODIVERSITY SCI, V51, P1099; [孙雀 SUN Que], 2009, [生态学报, Acta Ecologica Sinica], V29, P2195; Taylor DR, 1999, EVOLUTION, V53, P1028, DOI 10.1111/j.1558-5646.1999.tb04518.x; THOMAS SC, 1993, ECOLOGY, V74, P1529, DOI 10.2307/1940080; VASILIAUSKAS SA, 1992, ECOLOGY, V73, P622, DOI 10.2307/1940768; Wang K, 2001, FOR SCI, V70, P259; WILLSON MF, 1983, OIKOS, V41, P27, DOI 10.2307/3544342; Zohary M., 1952, Palestine Journal of Botany (Jerusalem Series), V5, P187	61	29	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22903	10.1371/journal.pone.0022903	http://dx.doi.org/10.1371/journal.pone.0022903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829667	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200038
J	de Almeida, LA; Carvalho, NB; Oliveira, FS; Lacerda, TLS; Vasconcelos, AC; Nogueira, L; Bafica, A; Silva, AM; Oliveira, SC				de Almeida, Leonardo A.; Carvalho, Natalia B.; Oliveira, Fernanda S.; Lacerda, Thais L. S.; Vasconcelos, Anilton C.; Nogueira, Lucas; Bafica, Andre; Silva, Aristobolo M.; Oliveira, Sergio C.			MyD88 and STING Signaling Pathways Are Required for IRF3-Mediated IFN-beta Induction in Response to Brucella abortus Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; DENDRITIC CELL MATURATION; I INTERFERON-PRODUCTION; RIG-I; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; GAMMA-INTERFERON; MICE LACKING; RNA; ALPHA/BETA	Type I interferons (IFNs) are cytokines that orchestrate diverse immune responses to viral and bacterial infections. Although typically considered to be most important molecules in response to viruses, type I IFNs are also induced by most, if not all, bacterial pathogens. In this study, we addressed the role of type I IFN signaling during Brucella abortus infection, a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Herein, we have shown that B. abortus induced IFN-beta in macrophages and splenocytes. Further, IFN-beta induction by Brucella was mediated by IRF3 signaling pathway and activates IFN-stimulated genes via STAT1 phosphorylation. In addition, IFN-beta expression induced by Brucella is independent of TLRs and TRIF signaling but MyD88-dependent, a pathway not yet described for Gram-negative bacteria. Furthermore, we have identified Brucella DNA as the major bacterial component to induce IFN-beta and our study revealed that this molecule operates through a mechanism dependent on RNA polymerase III to be sensed probably by an unknown receptor via the adaptor molecule STING. Finally, we have demonstrated that IFN-alpha beta R KO mice are more resistant to infection suggesting that type I IFN signaling is detrimental to host control of Brucella. This resistance phenotype is accompanied by increased IFN-gamma and NO production by IFN-alpha beta Rho R KO spleen cells and reduced apoptosis.	[de Almeida, Leonardo A.; Carvalho, Natalia B.; Oliveira, Fernanda S.; Lacerda, Thais L. S.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Vasconcelos, Anilton C.] Univ Fed Minas Gerais, Dept Pathol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Silva, Aristobolo M.] Univ Fed Minas Gerais, Dept Morphol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Nogueira, Lucas; Bafica, Andre] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Santa Catarina (UFSC)	de Almeida, LA (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil.	scozeus@icb.ufmg.br	Vasconcelos, Anilton ACV/L-9861-2014; Bafica, Andre/ABF-5986-2020; Silva, Aristóbolo/AAA-2239-2021; de+Lima+Nogueira, Lucas/AAD-3447-2020; de Almeida, Leonardo A/G-2482-2012; Silva, Aristobolo/CAF-4874-2022; Carvalho, Natalia/H-3977-2015; Oliveira, Sergio Costa/AAG-5408-2021	Vasconcelos, Anilton ACV/0000-0001-6202-580X; Bafica, Andre/0000-0002-5148-600X; Silva, Aristóbolo/0000-0001-7473-7433; de+Lima+Nogueira, Lucas/0000-0003-3907-777X; de Almeida, Leonardo A/0000-0003-1886-5080; Carvalho, Natalia/0000-0003-2586-7877; Oliveira, Sergio Costa/0000-0003-4062-5577	Brazilian Council of Science and Technology (CNPq); CNPq/ANPCyT [490528/2008-2]; Research Foundation of the State of Minas Gerais (FAPEMIG); Brazilian Agency for Development of Graduate Courses (CAPES/PNPD); CNPq/MAPA; CNPq/REPENSA; National Institute of Science and Technology on Vaccines (INCTV)	Brazilian Council of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/ANPCyT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Agency for Development of Graduate Courses (CAPES/PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/MAPA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/REPENSA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology on Vaccines (INCTV)	This work was supported by the Brazilian Council of Science and Technology (CNPq), CNPq/ANPCyT (# 490528/2008-2), Research Foundation of the State of Minas Gerais (FAPEMIG), Brazilian Agency for Development of Graduate Courses (CAPES/PNPD), CNPq/MAPA, CNPq/REPENSA and National Institute of Science and Technology on Vaccines (INCTV) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; den Hartigh AB, 2008, J BACTERIOL, V190, P4427, DOI 10.1128/JB.00406-08; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; Golding B, 2001, MICROBES INFECT, V3, P43, DOI 10.1016/S1286-4579(00)01350-2; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Oliveira SC, 2008, MICROBES INFECT, V10, P1005, DOI 10.1016/j.micinf.2008.07.005; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	57	57	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23135	10.1371/journal.pone.0023135	http://dx.doi.org/10.1371/journal.pone.0023135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829705	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900028
J	Westreich, D; Cole, SR; Nagar, S; Maskew, M; van der Horst, C; Sanne, I				Westreich, Daniel; Cole, Stephen R.; Nagar, Shashi; Maskew, Mhairi; van der Horst, Charles; Sanne, Ian			Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; DISEASE PROGRESSION; PROSPECTIVE COHORT; CLINICAL-TRIALS; HIV-INFECTION; VIRAL LOAD; WOMEN; SURVIVAL	Background: Although women of reproductive age are the largest group of HIV-infected individuals in sub-Saharan Africa, little is known about the impact of pregnancy on response to highly active antiretroviral therapy (HAART) in that setting. We examined the effect of incident pregnancy after HAART initiation on virologic response to HAART. Methods and Findings: We evaluated a prospective clinical cohort of adult women who initiated HAART in Johannesburg, South Africa between 1 April 2004 and 30 September 2009, and followed up until an event, death, transfer, drop-out, or administrative end of follow-up on 31 March 2010. Women over age 45 and women who were pregnant at HAART initiation were excluded from the study; final sample size for analysis was 5,494 women. Main exposure was incident pregnancy, experienced by 541 women; main outcome was virologic failure, defined as a failure to suppress virus to <= 400 copies/ml by six months or virologic rebound >400 copies/ml thereafter. We calculated adjusted hazard ratios using marginal structural Cox proportional hazards models and weighted lifetable analysis to calculate adjusted five-year risk differences. The weighted hazard ratio for the effect of pregnancy on time to virologic failure was 1.34 (95% confidence limit [CL] 1.02, 1.78). Sensitivity analyses generally confirmed these main results. Conclusions: Incident pregnancy after HAART initiation was associated with modest increases in both relative and absolute risks of virologic failure, although uncontrolled confounding cannot be ruled out. Nonetheless, these results reinforce that family planning is an essential part of care for HIV-positive women in sub-Saharan Africa. More work is needed to confirm these findings and to explore specific etiologic pathways by which such effects may operate.	[Westreich, Daniel] Duke Univ, Dept Obstet & Gynecol, Duke Global Hlth Inst, Durham, NC 27710 USA; [Westreich, Daniel; Cole, Stephen R.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Nagar, Shashi; Maskew, Mhairi; Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa; [Nagar, Shashi; Maskew, Mhairi; Sanne, Ian] Right Care, Johannesburg, South Africa; [van der Horst, Charles] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Westreich, D (corresponding author), Duke Univ, Dept Obstet & Gynecol, Duke Global Hlth Inst, Durham, NC 27710 USA.	daniel.westreich@duke.edu	Sanne, Ian/ABH-2231-2020	Westreich, Daniel/0000-0003-3069-1650; MASKEW, MHAIRI/0000-0003-4238-0200	National and Gauteng Department of Health; United States Agency for International Development to Right to Care and the Institution [674-A-00-08-00007-00]; National Institutes of Health, Eunice Kennedy Shriver NICHD [K99-HD-06-3961, 4R00-HD-06-3961-02]; National Institute of Allergy and Infectious Diseases [P30-AI-50410]; University of North Carolina Center for AIDS Research; University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health; GlaxoSmithKline for examining IV zanamavir for influenza; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD063961] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD063961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National and Gauteng Department of Health; United States Agency for International Development to Right to Care and the Institution(United States Agency for International Development (USAID)); National Institutes of Health, Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health; GlaxoSmithKline for examining IV zanamavir for influenza; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical activities of the Helen Joseph Hospital are supported by the National and Gauteng Department of Health and the United States President's Emergency Plan for AIDS Relief in a grant by United States Agency for International Development to Right to Care and the Institution (674-A-00-08-00007-00). The research activities of this publication are supported by the National Institutes of Health in a grant from the Eunice Kennedy Shriver NICHD K99-HD-06-3961 and 4R00-HD-06-3961-02, and National Institute of Allergy and Infectious Diseases P30-AI-50410 to the University of North Carolina Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DW received an unrestricted educational training grant from the University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health from 2006-2008. CvdH has conducted research studies funded by GlaxoSmithKline for examining IV zanamavir for influenza. All other authors have declared that no competing interests exist. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.	AWEEKA F, 2007, 14 C RETR OPP INF LO; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Burns DN, 1998, AM J OBSTET GYNECOL, V178, P355, DOI 10.1016/S0002-9378(98)80025-2; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Keiser O, 2008, AIDS, V22, P2323, DOI 10.1097/QAD.0b013e3283189bf1; Kumar RM, 1997, J REPROD MED, V42, P429; MacCarthy S, 2009, AIDS BEHAV; Melekhin VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006961; Minkoff H, 2003, AM J OBSTET GYNECOL, V189, P552, DOI 10.1067/S0002-9378(03)00467-8; Mirochnick M, 2004, CLIN PHARMACOKINET, V43, P1071, DOI 10.2165/00003088-200443150-00002; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Petersen ML, 2006, JAIDS-J ACQ IMM DEF, V43, pS96, DOI 10.1097/01.qai.0000248344.95135.8d; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roustit M, 2008, BRIT J CLIN PHARMACO, V66, P179, DOI 10.1111/j.1365-2125.2008.03220.x; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Sha BE, 2011, HIV CLIN TRIALS, V12, P9, DOI 10.1310/hct1201-9; Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90; Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; *UNAIDS WHO, 2007, AIDS EP UPD 2007; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; Watts DH, 2009, INFECT DIS OBSTET GY, V2009; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Westreich D, 2010, AM J EPIDEMIOL, V171, P674, DOI 10.1093/aje/kwp436; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; *WHO, 2006, ANT DRUGS PREV MOTH; Zhang MJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-82	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22778	10.1371/journal.pone.0022778	http://dx.doi.org/10.1371/journal.pone.0022778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829650	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900013
J	Huwiler, A; Bourquin, F; Kotelevets, N; Pastukhov, O; Capitani, G; Grutter, MG; Zangemeister-Wittke, U				Huwiler, Andrea; Bourquin, Florence; Kotelevets, Nataliya; Pastukhov, Oleksandr; Capitani, Guido; Gruetter, Markus G.; Zangemeister-Wittke, Uwe			A Prokaryotic S1P Lyase Degrades Extracellular S1P In Vitro and In Vivo: Implication for Treating Hyperproliferative Disorders	PLOS ONE			English	Article							MESANGIAL CELL-PROLIFERATION; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE LYASE; FUNCTIONAL EXPRESSION; ENDOTHELIAL-CELLS; KINASE PATHWAY; CANCER; GROWTH; RECEPTOR; ANGIOGENESIS	Sphingosine-1-phosphate (S1P) regulates a broad spectrum of fundamental cellular processes like proliferation, death, migration and cytokine production. Therefore, elevated levels of S1P may be causal to various pathologic conditions including cancer, fibrosis, inflammation, autoimmune diseases and aberrant angiogenesis. Here we report that S1P lyase from the prokaryote Symbiobacterium thermophilum (StSPL) degrades extracellular S1P in vitro and in blood. Moreover, we investigated its effect on cellular responses typical of fibrosis, cancer and aberrant angiogenesis using renal mesangial cells, endothelial cells, breast (MCF-7) and colon (HCT 116) carcinoma cells as disease models. In all cell types, wild-type StSPL, but not an inactive mutant, disrupted MAPK phosphorylation stimulated by exogenous S1P. Functionally, disruption of S1P receptor signaling by S1P depletion inhibited proliferation and expression of connective tissue growth factor in mesangial cells, proliferation, migration and VEGF expression in carcinoma cells, and proliferation and migration of endothelial cells. Upon intravenous injection of StSPL in mice, plasma S1P levels rapidly declined by 70% within 1 h and then recovered to normal 6 h after injection. Using the chicken chorioallantoic membrane model we further demonstrate that also under in vivo conditions StSPL, but not the inactive mutant, inhibited tumor cell-induced angiogenesis as an S1P-dependent process. Our data demonstrate that recombinant StSPL is active under extracellular conditions and holds promise as a new enzyme therapeutic for diseases associated with increased levels of S1P and S1P receptor signaling.	[Huwiler, Andrea; Kotelevets, Nataliya; Pastukhov, Oleksandr; Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Bourquin, Florence; Gruetter, Markus G.; Zangemeister-Wittke, Uwe] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Capitani, Guido] Paul Scherrer Inst, Villigen, Switzerland	University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Huwiler, A (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	uwe.zangemeister@pki.unibe.ch			Wilhelm Sander-Stiftung; Krebsliga of the Kanton Bern	Wilhelm Sander-Stiftung; Krebsliga of the Kanton Bern	This work was supported by the Wilhelm Sander-Stiftung (www.sanst.de) and the Krebsliga of the Kanton Bern (www.bernischekrebsliga.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Claus RA, 2009, CURR MED CHEM, V16, P1978, DOI 10.2174/092986709788682182; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; HUWILER A, 1994, BRIT J PHARMACOL, V113, P1455, DOI 10.1111/j.1476-5381.1994.tb17160.x; Huwiler A, 2007, CRIT REV ONCOL HEMAT, V63, P150, DOI 10.1016/j.critrevonc.2007.04.010; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Kim MR, 2009, MOL CANCER THER, V8, P2163, DOI 10.1158/1535-7163.MCT-08-1061; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Leong WI, 2010, BIOCHIMIE, V92, P716, DOI 10.1016/j.biochi.2010.02.014; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Randriamboavonjy V, 2009, BASIC RES CARDIOL, V104, P333, DOI 10.1007/s00395-008-0769-1; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; SATTLER KJ, 2010, BASIC RES CARDIOL; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Schwalm S, 2008, BIOCHEM BIOPH RES CO, V368, P1020, DOI 10.1016/j.bbrc.2008.01.132; Shimamura K, 2004, EUR J PHARMACOL, V486, P141, DOI 10.1016/j.ejphar.2003.12.022; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yonesu K, 2009, BIOCHEM PHARMACOL, V77, P1011, DOI 10.1016/j.bcp.2008.12.007; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	56	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22436	10.1371/journal.pone.0022436	http://dx.doi.org/10.1371/journal.pone.0022436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829623	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200009
J	Koshino, H; Minamoto, T; Ikeda, T; Osaka, M; Otsuka, Y; Osaka, N				Koshino, Hideya; Minamoto, Takehiro; Ikeda, Takashi; Osaka, Mariko; Otsuka, Yuki; Osaka, Naoyuki			Anterior Medial Prefrontal Cortex Exhibits Activation during Task Preparation but Deactivation during Task Execution	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONSCIOUS RESTING STATE; BLOOD-FLOW CHANGES; TOP-DOWN CONTROL; WORKING-MEMORY; HUMAN BRAIN; FRONTOPOLAR CORTEX; DEFAULT NETWORK; EPISODIC MEMORY; HUMAN COGNITION	Background: The anterior prefrontal cortex (PFC) exhibits activation during some cognitive tasks, including episodic memory, reasoning, attention, multitasking, task sets, decision making, mentalizing, and processing of self-referenced information. However, the medial part of anterior PFC is part of the default mode network (DMN), which shows deactivation during various goal-directed cognitive tasks compared to a resting baseline. One possible factor for this pattern is that activity in the anterior medial PFC (MPFC) is affected by dynamic allocation of attentional resources depending on task demands. We investigated this possibility using an event related fMRI with a face working memory task. Methodology/Principal Findings: Sixteen students participated in a single fMRI session. They were asked to form a task set to remember the faces (Face memory condition) or to ignore them (No face memory condition), then they were given 6 seconds of preparation period before the onset of the face stimuli. During this 6-second period, four single digits were presented one at a time at the center of the display, and participants were asked to add them and to remember the final answer. When participants formed a task set to remember faces, the anterior MPFC exhibited activation during a task preparation period but deactivation during a task execution period within a single trial. Conclusions/Significance: The results suggest that the anterior MPFC plays a role in task set formation but is not involved in execution of the face working memory task. Therefore, when attentional resources are allocated to other brain regions during task execution, the anterior MPFC shows deactivation. The results suggest that activation and deactivation in the anterior MPFC are affected by dynamic allocation of processing resources across different phases of processing.	[Koshino, Hideya] Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA; [Minamoto, Takehiro; Otsuka, Yuki; Osaka, Naoyuki] Kyoto Univ, Dept Psychol, Kyoto, Japan; [Ikeda, Takashi; Osaka, Mariko] Osaka Univ, Dept Human Sci, Osaka, Japan	California State University System; California State University San Bernardino; Kyoto University; Osaka University	Koshino, H (corresponding author), Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA.	hkoshino@csusb.edu		Koshino, Hideya/0000-0001-6889-1856	Japan Society of promotion Science [20113136]; Grants-in-Aid for Scientific Research [23800034] Funding Source: KAKEN	Japan Society of promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society of promotion Science #20113136 (N.O., M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Bengtsson SL, 2009, CEREB CORTEX, V19, P1929, DOI 10.1093/cercor/bhn222; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1292, DOI 10.1016/S0028-3932(00)00026-9; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; MacLeod AK, 1998, NEUROIMAGE, V7, P41, DOI 10.1006/nimg.1997.0308; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Matsuyoshi D, 2010, NEUROPSYCHOLOGIA, V48, P3094, DOI 10.1016/j.neuropsychologia.2010.06.021; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Minamoto T, 2010, BRAIN RES, V1335, P63, DOI 10.1016/j.brainres.2010.03.088; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pessoa L, 2003, J NEUROSCI, V23, P3990; Pollmann S, 2000, J COGNITIVE NEUROSCI, V12, P480, DOI 10.1162/089892900562156; Pollmann S, 2001, NEUROIMAGE, V14, pS118, DOI 10.1006/nimg.2001.0837; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Rowe JB, 2007, J NEUROSCI, V27, P13303, DOI 10.1523/JNEUROSCI.2349-07.2007; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Velanova K, 2003, J NEUROSCI, V23, P8460; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zysset S, 2003, NEUROSCI LETT, V335, P183, DOI 10.1016/S0304-3940(02)01196-5	86	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22909	10.1371/journal.pone.0022909	http://dx.doi.org/10.1371/journal.pone.0022909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LA	21829668	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200025
J	Gomez-Hurtado, I; Santacruz, A; Peiro, G; Zapater, P; Gutierrez, A; Perez-Mateo, M; Sanz, Y; Frances, R				Gomez-Hurtado, Isabel; Santacruz, Arlette; Peiro, Gloria; Zapater, Pedro; Gutierrez, Ana; Perez-Mateo, Miguel; Sanz, Yolanda; Frances, Ruben			Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis	PLOS ONE			English	Article							GROUP-SPECIFIC PRIMERS; PREDOMINANT BACTERIA; HEMORRHAGIC-SHOCK; SEMINESTED PCR; IDENTIFICATION; LACTOBACILLUS; CIRRHOSIS; RATS; INHIBITION; DIVERSITY	Background: Gut is the major source of endogenous bacteria causing infections in advanced cirrhosis. Intestinal barrier dysfunction has been described in cirrhosis and account for an increased bacterial translocation rate. Hypothesis and Aims: We hypothesize that microbiota composition may be affected and change along with the induction of experimental cirrhosis, affecting the inflammatory response. Animals and Methods: Progressive liver damage was induced in Balb/c mice by weight-controlled oral administration of carbon tetrachloride. Laparotomies were performed at weeks 6, 10, 13 and 16 in a subgroup of treated mice (n = 6/week) and control animals (n = 4/week). Liver tissue specimens, mesenteric lymph nodes, intestinal content and blood were collected at laparotomies. Fibrosis grade, pro-fibrogenic genes expression, gut bacterial composition, bacterial translocation, host's specific butyrate-receptor GPR-43 and serum cytokine levels were measured. Results: Expression of pro-fibrogenic markers was significantly increased compared with control animals and correlated with the accumulated dose of carbon tetrachloride. Bacterial translocation episodes were less frequent in control mice than in treated animals. Gram-positive anaerobic Clostridia spp count was decreased in treated mice compared with control animals and with other gut common bacterial species, altering the aerobic/anaerobic ratio. This fact was associated with a decreased gene expression of GPR43 in neutrophils of treated mice and inversely correlated with TNF-alpha and IL-6 up-regulation in serum of treated mice along the study protocol. This pro-inflammatory scenario favoured blood bacterial translocation in treated animals, showing the highest bacterial translocation rate and aerobic/anaerobic ratio at the same weeks. Conclusions: Gut microbiota alterations are associated with the development of an inflammatory environment, fibrosis progression and bacterial translocation in carbon tetrachloride-treated mice.	[Gomez-Hurtado, Isabel; Zapater, Pedro; Gutierrez, Ana; Perez-Mateo, Miguel; Frances, Ruben] Hosp Gen Univ, Unidad Hepat, Alicante, Spain; [Gomez-Hurtado, Isabel; Zapater, Pedro; Frances, Ruben] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Santacruz, Arlette; Sanz, Yolanda] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Peiro, Gloria] Hosp Gen Univ, Unidad Invest, Alicante, Spain	General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); General University Hospital of Alicante	Gomez-Hurtado, I (corresponding author), Hosp Gen Univ, Unidad Hepat, Alicante, Spain.	frances_rub@gva.es	Zapater, Pedro/H-7277-2017; Francés, Rubén/V-4120-2019; Gomez-Hurtado, Isabel/AAA-5815-2019; Sanz, Yolanda/H-5498-2012; Gutiérrez, Ana/V-5129-2019; Zapater, Pedro/H-8450-2019	Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Gomez-Hurtado, Isabel/0000-0003-4305-9427; Sanz, Yolanda/0000-0002-1615-1976; Gutiérrez, Ana/0000-0002-5460-4139; Zapater, Pedro/0000-0001-7927-858X; Santacruz, Arlette/0000-0001-5580-3108	Instituto de Salud Carlos III, Madrid, Spain [CP05/0005, PI10/0340]; Ministry of Science and Innovation, Spain [CSD2007-00063]; Conselleria de Sanitat, Generalitat Valenciana, Spain [AP-026/09, AP-124/09]; Fundacion FCVI-HGUA, Alicante, Spain [C-5]; CONACYT (Mexico)	Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Sanitat, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Fundacion FCVI-HGUA, Alicante, Spain; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work has been supported by grants CP05/0005 and PI10/0340 from the Instituto de Salud Carlos III, Madrid, Spain; AGL2008-01440/ALI and Consolider Fun-C-Food CSD2007-00063 from the Ministry of Science and Innovation, Spain; AP-026/09 and AP-124/09 from Conselleria de Sanitat, Generalitat Valenciana, Spain; and C-5 from Fundacion FCVI-HGUA, Alicante, Spain. The scholarship from CONACYT (Mexico) to A. Santacruz is fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BERG RD, 1992, J MED, V23, P217; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chakrabarti P, 2009, INDIAN J MED RES, V129, P182; DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185; DUBOS R, 1965, J EXP MED, V122, P67, DOI 10.1084/jem.122.1.67; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; Garcia-Tsao G, 2001, J HEPATOL, V34, P150, DOI 10.1016/S0168-8278(00)00006-4; Goldman G, 2001, EUR J SURG, V167, P299; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Guarner C, 1997, J HEPATOL, V26, P1372, DOI 10.1016/S0168-8278(97)80474-6; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hecht GA, 2009, GASTROENTEROLOGY, V136, P1849, DOI 10.1053/j.gastro.2009.03.057; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Inamura T, 2003, IMMUNOL LETT, V90, P3, DOI 10.1016/j.imlet.2003.05.002; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Klampfer L, 2003, MOL CANCER RES, V1, P855; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luhrs H, 2001, INT J COLORECTAL DIS, V16, P195, DOI 10.1007/s003840100295; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Martineau F, 2001, J CLIN MICROBIOL, V39, P2541, DOI 10.1128/JCM.39.7.2541-2547.2001; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; RUSELERVANEMBDEN JGH, 1995, SCAND J GASTROENTERO, V30, P675, DOI 10.3109/00365529509096312; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shimizu T, 2001, SHOCK, V16, P59, DOI 10.1097/00024382-200116010-00011; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Theron J, 2001, WATER RES, V35, P869, DOI 10.1016/S0043-1354(00)00348-1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632	41	89	95	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23037	10.1371/journal.pone.0023037	http://dx.doi.org/10.1371/journal.pone.0023037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829583	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500070
J	Hu, LL; Huang, T; Cai, YD; Chou, KC				Hu, Le-Le; Huang, Tao; Cai, Yu-Dong; Chou, Kuo-Chen			Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; HUMAN URINARY PROTEOME; SUBCELLULAR-LOCALIZATION; SIGNAL PEPTIDES; ENZYME-KINETICS; INTERACTION MAP; LIBRARY BEADS; GRAPHIC RULES; DATABASE; CANCER	Determining the body fluids where secreted proteins can be secreted into is important for protein function annotation and disease biomarker discovery. In this study, we developed a network-based method to predict which kind of body fluids human proteins can be secreted into. For a newly constructed benchmark dataset that consists of 529 human-secreted proteins, the prediction accuracy for the most possible body fluid location predicted by our method via the jackknife test was 79.02%, significantly higher than the success rate by a random guess (29.36%). The likelihood that the predicted body fluids of the first four orders contain all the true body fluids where the proteins can be secreted into is 62.94%. Our method was further demonstrated with two independent datasets: one contains 57 proteins that can be secreted into blood; while the other contains 61 proteins that can be secreted into plasma/serum and were possible biomarkers associated with various cancers. For the 57 proteins in first dataset, 55 were correctly predicted as blood-secrete proteins. For the 61 proteins in the second dataset, 58 were predicted to be most possible in plasma/serum. These encouraging results indicate that the network-based prediction method is quite promising. It is anticipated that the method will benefit the relevant areas for both basic research and drug development.	[Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Fudan University	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979				Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buckhaults P, 2001, CANCER RES, V61, P6996; Cai YD, 2004, BIOCHEM BIOPH RES CO, V323, P425, DOI 10.1016/j.bbrc.2004.08.113; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang X, 2007, ANAL CHEM, V79, P5785, DOI 10.1021/ac070611a; Gilbert D, 2005, BRIEF BIOINFORM, V6, P194, DOI 10.1093/bib/6.2.194; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Huang LJ, 2006, LUNG CANCER, V54, P87, DOI 10.1016/j.lungcan.2006.06.011; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SJ, 2009, NUCLEIC ACIDS RES, V37, pD907, DOI 10.1093/nar/gkn849; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sennels L, 2007, J PROTEOME RES, V6, P4055, DOI 10.1021/pr070339l; Shin CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-28; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun W, 2005, PROTEOMICS, V5, P4994, DOI 10.1002/pmic.200401334; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Vilar S, 2009, J THEOR BIOL, V261, P449, DOI 10.1016/j.jtbi.2009.07.031; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang YC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-53; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; XIAO X, 2011, J THEOR BIOL, DOI DOI 10.1016/J.JTBI.2011.1006.1005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169	65	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22989	10.1371/journal.pone.0022989	http://dx.doi.org/10.1371/journal.pone.0022989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829572	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500065
J	El-Armouche, A; Wittkopper, K; Fuller, W; Howie, J; Shattock, MJ; Pavlovic, D				El-Armouche, Ali; Wittkoepper, Katrin; Fuller, William; Howie, Jacqueline; Shattock, Michael J.; Pavlovic, Davor			Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase	FASEB JOURNAL			English	Article						sodium pump; FXYD1; beta-adrenergic signaling; heart failure	PROTEIN PHOSPHATASE-1; HEART-FAILURE; NA+ CONCENTRATION; PUMP FUNCTION; PHOSPHORYLATION; CONTRACTILITY; EXPRESSION; MYOCYTES; ACTIVATION; SERINE-68	Cardiac Na/K-ATPase (NKA) is regulated by its accessory protein phospholemman (PLM). Whereas kinase-induced PLM phosphorylation has been shown to mediate NKA stimulation, the role of endogenous phosphatases is presently unknown. We investigated the role of protein phosphatase-1 (PP-1) on PLM phosphorylation and NKA activity in rat cardiomyocytes and failing human hearts. Incubation of rat cardiomyocytes with the chemical PP-1/PP-2A inhibitor okadaic acid or the specific PP-1-inhibitor peptide (I-1ct) identified PLM phosphorylation at Ser-68 as the main substrate for PP-1. Moreover, myocytes adenovirally overexpressing PP-1 inhibitor-1 protein (I-1,Ad-I-1/eGFP) showed a 70% increase in PLM Ser-68 phosphorylation and 65% increase in NKA current, compared with enhanced green fluorescence protein (eGFP)-infected controls (Ad-eGFP), using Western blotting and voltage clamping, respectively. Notably, in left ventricular myocardium from patients with heart failure, PLM Ser-68 phosphorylation was similar to 50% lower (n=7) than in nonfailing controls (n=7). We provide the first physiological and biochemical evidence that PLM phosphorylation and cardiac Na/K-ATPase activity are negatively regulated by PP-1 and that this regulatory mechanism could be counteracted by I-1. This novel mechanism is markedly perturbed in failing hearts favoring PLM dephosphorylation and NKA deactivation and thus may contribute to maladaptive hypertrophy and arrhythmogenesis via chronically higher intracellular Na and Ca concentrations.-El-Armouche, A., Wittkopper, K., Fuller, W., Howie, J., Shattock, M. J., Pavlovic, D. Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase. FASEB J. 25, 4467-4475 (2011). www.fasebj.org	[El-Armouche, Ali; Wittkoepper, Katrin] Univ Med Ctr Gottingen, Ctr Heart, Dept Pharmacol, Gottingen, Germany; [Fuller, William; Howie, Jacqueline] Univ Dundee, Ctr Cardiovasc & Lung Biol, Dundee, Scotland; [Shattock, Michael J.; Pavlovic, Davor] Kings Coll London, Div Cardiovasc, London SE1 7EH, England	University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Dundee; University of London; King's College London	Shattock, MJ (corresponding author), Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England.	michael.shattock@kcl.ac.uk	El-Armouche, Ali/H-3161-2018	El-Armouche, Ali/0000-0003-2514-9429; Pavlovic, Davor/0000-0002-3171-3551; Fuller, William/0000-0002-5883-4433; Shattock, Michael/0000-0001-6242-7585	British Heart Foundation; Medical Research Council; Deutsche Forschungsgemeinschaft; German Heart Foundation; MRC [G0700903] Funding Source: UKRI; British Heart Foundation [RG/07/001/22628] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Heart Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	The authors thank Shiney Reiji for expert help with the isolation of the myocytes and Susanne Lutz for technical advice for adenovirus generation. This work was supported by grants from the British Heart Foundation, the Medical Research Council, the Deutsche Forschungsgemeinschaft, and the German Heart Foundation. The authors have no conflicts of interest to disclose.	ALLEN PD, 1992, BASIC RES CARDIOL, V87, P87; Baartscheer A, 2003, CARDIOVASC RES, V57, P1015, DOI 10.1016/S0008-6363(02)00809-X; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bers DM, 2009, TRENDS CARDIOVAS MED, V19, P111, DOI 10.1016/j.tcm.2009.07.001; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Carr AN, 2001, J PHYSIOL-LONDON, V534, P357, DOI 10.1111/j.1469-7793.2001.00357.x; Despa S, 2002, CIRCULATION, V105, P2543, DOI 10.1161/01.CIR.0000016701.85760.97; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; El-Armouche A, 2004, CARDIOVASC RES, V61, P87, DOI 10.1016/j.cardiores.2003.11.005; El-Armouche A, 2003, FASEB J, V17, P437, DOI 10.1096/fj.02-0057fje; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; El-Armouche A, 2006, BIOCHEM BIOPH RES CO, V346, P700, DOI 10.1016/j.bbrc.2006.05.182; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; LEE CO, 1982, BIOPHYS J, V40, P185, DOI 10.1016/S0006-3495(82)84474-3; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicklin S A, 1999, Methods Mol Med, V30, P271, DOI 10.1385/1-59259-247-3:271; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Pavlovic D, 2010, EXP PHYSIOL, V95, P518, DOI 10.1113/expphysiol.2009.052126; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; SCHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376, DOI 10.1016/0165-6147(92)90116-N; Schwinger RHG, 1999, CIRCULATION, V99, P2105, DOI 10.1161/01.CIR.99.16.2105; Semb SO, 1998, J MOL CELL CARDIOL, V30, P1311; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; Verdonck F, 2003, CARDIOVASC RES, V57, P1035, DOI 10.1016/S0008-6363(02)00734-4; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wittkopper K, 2010, BASIC RES CARDIOL, V105, P569, DOI 10.1007/s00395-010-0107-2; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237	47	29	30	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4467	4475		10.1096/fj.11-184903	http://dx.doi.org/10.1096/fj.11-184903			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21849407				2022-12-25	WOS:000298138100037
J	Vivarini, AD; Pereira, RDS; Teixeira, KLD; Calegari-Silva, TC; Bellio, M; Laurenti, MD; Corbett, CEP; Gomes, CMD; Soares, RP; Silva, AM; Silveira, FT; Lopes, UG				Vivarini, Aislan de Carvalho; Santos Pereira, Renata de Meirelles; Dias Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; Bellio, Maria; Laurenti, Marcia Dalastra; Pereira Corbett, Carlos Eduardo; de Castro Gomes, Claudia Maria; Soares, Rodrigo Pedro; Silva, Aristobolo Mendes; Silveira, Fernando Tobias; Lopes, Ulisses Gazos			Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2	FASEB JOURNAL			English	Article						interferon-1; Toll-like receptor 2; SOD1	PROTOZOAN PARASITE LEISHMANIA; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; VIRAL-INFECTION; I INTERFERON; RECEPTOR 2; IFN-BETA; LIPOPHOSPHOGLYCAN; MACROPHAGES; ACTIVATION	We investigated the type I interferon (IFN-1)/PKR axis in the outcome of the Leishmania (Leishmania) amazonensis infection, along with the underlying mechanisms that trigger and sustain this signaling pathway. Reporter assays of cell extracts from RAW-264.7 macrophages infected with L. (L.) amazonensis or HEK-293T cells cotransfected with TLR2 and PKR promoter constructions were employed. Primary macrophages of TLR2-knockout (KO) or IFNR-KO mice were infected, and the levels of PKR, IFN-1, and superoxide dismutase 1 (SOD1) transcript levels were investigated and compared. Immunohistochemical analysis of human biopsy lesions was evaluated for IFN-1 and PKR-positive cells. Leishmania infection increased the expression of PKR and IFN-beta on induction of PKR-promoter activity. The observed effects required the engagement of TLR2. TLR2-KO macrophages expressed low IFN-beta and PKR levels postinfection with a reduced parasite load. We also revealed the requirement of PKR signaling for Leishmania-induced IFN-1 expression, responsible for sustaining PKR expression and enhancing infection. Moreover, during infection, SOD1 transcripts increased and were also enhanced when IFN-1 was added to the cultures. Remarkably, SOD1 expression was abrogated in infected, dominant-negative PKR-expressing cells. Finally, lesions of patients with anergic diffuse cutaneous leishmaniasis exhibited higher levels of PKR/IFN1-expressing cells compared to those with single cutaneous leishmaniasis. In summary, we demonstrated the mechanisms and relevance of the IFN-1/PKR axis in the Leishmania infection.-De Carvalho Vivarini, A., Pereira, R. M. S., Dias Teixeira, K. L., Calegari-Silva, T. C., Bellio, M., Laurenti, M. D., Corbett, C. E. P., de Castro Gomes, C. M., Soares, R. P., Mendes Silva, A., Silveira, F. T., Lopes, U. G. Human cutaneous leish-maniasis: interferon-dependent expression of double-stranded RNA-kinase (PKR) via TLR2. FASEB J. 25, 4162-4173 (2011). www.fasebj.org	[Lopes, Ulisses Gazos] Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol,CCS, BR-21940902 Rio De Janeiro, Brazil; [Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21940902 Rio De Janeiro, Brazil; [Laurenti, Marcia Dalastra; Pereira Corbett, Carlos Eduardo; de Castro Gomes, Claudia Maria] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, Brazil; [Soares, Rodrigo Pedro] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Silva, Aristobolo Mendes] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genes Inflamatorios, Belo Horizonte, MG, Brazil; [Silveira, Fernando Tobias] Minist Saude, Inst Evandro Chagas, Lab Leishmaniose, Belem, Para, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Instituto Evandro Chagas	Lopes, UG (corresponding author), Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol,CCS, Av Carlos Chagas Filho S-N, BR-21940902 Rio De Janeiro, Brazil.	lopesu@biof.ufrj.br	Pereira, Renata/V-6194-2019; Corbett, Carlos E P/R-7090-2018; Silva, Aristobolo/CAF-4874-2022; Silva, Aristóbolo/AAA-2239-2021; Lopes, Ulisses/N-4416-2013; Silveira, Fernando Tobias/AAE-5767-2021; Vivarini, Áislan/G-3249-2015; Lopes, Ulisses Gazos/T-6634-2019; Bellio, Maria/N-8525-2018; Dias Teixeira, Karina/J-4918-2017; Laurenti, Marcia Dalastra/C-4734-2012	Silva, Aristóbolo/0000-0001-7473-7433; Silveira, Fernando Tobias/0000-0002-0412-6060; Vivarini, Áislan/0000-0002-2629-257X; Bellio, Maria/0000-0002-3360-2740; Dias Teixeira, Karina/0000-0002-6115-6768; Calegari Silva, Teresa Cristina/0000-0002-1656-3460; Pereira, Renata/0000-0002-7719-8356; Pereira Corbett, Carlos Eduardo/0000-0003-1587-3085	Instituto Nacional de Ciencia e Tecnologia-Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-IMPeTAM); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Instituto Nacional de Ciencia e Tecnologia-Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-IMPeTAM); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors especially thank Paulo Cordeiro for his technical assistance. The authors are most grateful to Dr. Charles Samuel (University of California, Santa Barbara, CA, USA) for providing the PKR-promoter constructs used in this study. The authors are in debt to Dr. Marcelo Torres Bozza (Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil) for providing the IFNRA-KO mice and Judy Grevan and James Scott-Browne (La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA) for editing the manuscript. This work was supported by the Instituto Nacional de Ciencia e Tecnologia-Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-IMPeTAM), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP).	Akuffo H, 1997, J INFECT DIS, V175, P737, DOI 10.1093/infdis/175.3.737; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bonfim G., 1996, EXP PARASITOL, V84, P188; Brittingham A, 1996, PARASITOL TODAY, V12, P444, DOI 10.1016/0169-4758(96)10067-3; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Chai Y, 2011, MOL BIOL REP, V38, P139, DOI 10.1007/s11033-010-0087-1; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Giorgione JR, 1996, P NATL ACAD SCI USA, V93, P11634, DOI 10.1073/pnas.93.21.11634; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Khouri R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014394; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Kuhen KL, 1999, VIROLOGY, V254, P182, DOI 10.1006/viro.1998.9536; Lykens JE, 2010, J IMMUNOL, V184, P877, DOI 10.4049/jimmunol.0902346; Mattner J, 2004, J IMMUNOL, V172, P7574, DOI 10.4049/jimmunol.172.12.7574; Mattner J, 2000, EUR J IMMUNOL, V30, P2257, DOI 10.1002/1521-4141(2000)30:8&lt;2257::AID-IMMU2257&gt;3.0.CO;2-U; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Schriefer A, 2008, CURR OPIN INFECT DIS, V21, P483, DOI 10.1097/QCO.0b013e32830d0ee8; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Shankar AH, 1996, EXP PARASITOL, V84, P136, DOI 10.1006/expr.1996.0099; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x; Silveira FT, 1998, PARASITE IMMUNOL, V20, P19, DOI 10.1046/j.1365-3024.1998.00126.x; Soares RPP, 2002, MOL BIOCHEM PARASIT, V121, P213, DOI 10.1016/S0166-6851(02)00033-6; Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772; Vargas-Inchaustegui DA, 2009, INFECT IMMUN, V77, P2948, DOI 10.1128/IAI.00154-09; Ward SV, 2002, VIROLOGY, V296, P136, DOI 10.1006/viro.2002.1356; *WHO, 2010, LEISHM BURD DIS; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179	45	46	47	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4162	4173		10.1096/fj.11-185165	http://dx.doi.org/10.1096/fj.11-185165			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21846836				2022-12-25	WOS:000298138100010
J	Dames, SA; Junemann, A; Sass, HJ; Schonichen, A; Stopschinski, BE; Grzesiek, S; Faix, J; Geyer, M				Dames, Sonja A.; Junemann, Alexander; Sass, Hans J.; Schoenichen, Andre; Stopschinski, Barbara E.; Grzesiek, Stephan; Faix, Jan; Geyer, Matthias			Structure, Dynamics, Lipid Binding, and Physiological Relevance of the Putative GTPase-binding Domain of Dictyostelium Formin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; 3-DIMENSIONAL STRUCTURE; PROTEIN STRUCTURES; DIPOLAR COUPLINGS; CLEAVAGE FURROW; RAS-BINDING; FH1 DOMAIN; NMR; PHAGOCYTOSIS; ACTIVATION	Dictyostelium Formin C (ForC) is involved in the regulation of local actin cytoskeleton reorganization (e.g. during cellular adhesion or migration). ForC contains formin homology 2 and 3 (FH2 and -3) domains and an N-terminal putative GTPase-binding domain (GBD) but lacks a canonical FH1 region. To better understand the role of the GBD, its structure, dynamics, lipid-binding properties, and cellular functions were analyzed by NMR and CD spectroscopy and by in vivo fluorescence microscopy. Moreover, the program CS-Rosetta was tested for the structure prediction based on chemical shift data only. The ForC GBD adopts an ubiquitin-like alpha/beta-roll fold with an unusually long loop between beta-strands 1 and 2. Based on the lipid-binding data, the presence of DPC micelles induces the formation of alpha-helical secondary structure and a rearrangement of the tertiary structure. Lipid-binding studies with a mutant protein and a peptide suggest that the beta 1-beta 2 loop is not relevant for these conformational changes. Whereas small amounts of negatively charged phosphoinositides (1,2-dioctanoyl-sn-glycero-3(phosphoinositol 4,5-bisphosphate) and 1,2-dihexanoyl-sn-glycero-3-(phosphoinositol 3,4,5-trisphosphate)) lower the micelle concentration necessary to induce the observed spectral changes, other negatively charged phospholipids (1,2-dihexanoyl-sn-glycero-3-(phospho-L-serine) and 1,2-dihexanoyl-snglycero-3-phospho-(1'-rac-glycerol)) had no such effect. Interestingly, bicelles and micelles composed of diacylphospho-cholines had no effect on the GBD structure. Our data suggest a model in which part of the large positively charged surface area of the GBD mediates localization to specific membrane patches, thereby regulating interactions with signaling proteins. Our cellular localization studies show that both the GBD and the FH3 domain are required for ForC targeting to cell-cell contacts and early phagocytic cups and macropinosomes.	[Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, D-85747 Garching, Germany; [Junemann, Alexander; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany; [Sass, Hans J.; Grzesiek, Stephan] Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland; [Schoenichen, Andre; Stopschinski, Barbara E.; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Technical University of Munich; Hannover Medical School; University of Basel; Max Planck Society	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Geyer, Matthias/0000-0002-7718-5002; Dames, Sonja/0000-0001-7495-6943; Grzesiek, Stephan/0000-0003-1998-4225; Junemann, Alexander/0000-0002-0048-5410	German Research Foundation [DA 1195/3-1, FA 330-6-1, GE 976/4-2]; Swiss National Science Foundation [31-109712]	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by German Research Foundation Grants DA 1195/3-1 (to S. A. D.), FA 330-6-1 (to J. F.), and GE 976/4-2 (to M. G.) and Swiss National Science Foundation Grant 31-109712 (to S. G.).	Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; BRUNE D, 1993, P NATL ACAD SCI USA, V90, P3835, DOI 10.1073/pnas.90.9.3835; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154; Dames SA, 2011, BIOMOL NMR ASSIGN, V5, P47, DOI 10.1007/s12104-010-9264-3; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dames Sonja A, 2008, J Biol Chem, V283, P23485, DOI 10.1074/jbc.M708335200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dumontier M, 2000, J CELL SCI, V113, P2253; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kessin RH, 2000, NATURE, V408, P917, DOI 10.1038/35050184; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Morris Andrew J., 1999, Trends in Pharmacological Sciences, V20, P393, DOI 10.1016/S0165-6147(99)01390-5; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rivero F, 1999, MOL BIOL CELL, V10, P1205, DOI 10.1091/mbc.10.4.1205; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rupper A, 2001, J CELL SCI, V114, P2449; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Somesh BP, 2006, EUKARYOT CELL, V5, P1648, DOI 10.1128/EC.00221-06; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Xian WJ, 2002, J MOL BIOL, V322, P755, DOI 10.1016/S0022-2836(02)00841-0; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006	72	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36907	36920		10.1074/jbc.M111.225052	http://dx.doi.org/10.1074/jbc.M111.225052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846933	hybrid, Green Published			2022-12-25	WOS:000296538300070
J	Park, H; Lee, JH; Gouin, E; Cossart, P; Izard, T				Park, HaJeung; Lee, Jun Hyuck; Gouin, Edith; Cossart, Pascale; Izard, Tina			The Rickettsia Surface Cell Antigen 4 Applies Mimicry to Bind to and Activate Vinculin.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; MOUNTAIN-SPOTTED-FEVER; TALIN ROD; ARP2/3 COMPLEX; MICROFILAMENT BUNDLES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DIFFRACTION DATA; MAMMALIAN-CELLS; CHICKEN GIZZARD	Pathogenic Rickettsia species cause high morbidity and mortality, especially R. prowazekii, the causative agent of typhus. Like many intracellular pathogens, Rickettsia exploit the cytoskeleton to enter and spread within the host cell. Here we report that the cell surface antigen sca4 of Rickettsia co-localizes with vinculin in cells at sites of focal adhesions in sca4-transfected cells and that sca4 binds to and activates vinculin through two vinculin binding sites (VBSs) that are conserved across all Rickettsia. Remarkably, this occurs through molecular mimicry of the vinculin-talin interaction that is also seen with the IpaA invasin of the intracellular pathogen Shigella, where binding of these VBSs to the vinculin seven-helix bundle head domain (Vh1) displaces intramolecular interactions with the vinculin tail domain that normally clamp vinculin in an inactive state. Finally, the vinculin.sca4-VBS crystal structures reveal that vinculin adopts a new conformation when bound to the C-terminal VBS of sca4. Collectively, our data define the mechanism by which sca4 activates vinculin and interacts with the actin cytoskeleton, and they suggest important roles for vinculin in Rickettsia pathogenesis.	[Park, HaJeung; Lee, Jun Hyuck; Izard, Tina] Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA; [Gouin, Edith; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Gouin, Edith; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Gouin, Edith; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France	Scripps Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Izard, T (corresponding author), Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA.	mkernick@scripps.edu			National Institutes of Health; state of Florida; Stanford Synchrotron Radiation Laboratory for synchrotron	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Florida; Stanford Synchrotron Radiation Laboratory for synchrotron	Supported by grants from the National Institutes of Health and by startup funds to Scripps Florida from the state of Florida. To whom correspondence should be addressed. Tel.: 561-228-3220; Fax: 561-228-3068; E-mail: mkernick@scripps.edu.; We are indebted to our colleagues at Scripps Florida, John L. Cleveland for discussions and critical review of the manuscript, Erumbi S. Rangarajan for fruitful discussions, and Philippe R. Bois and Zhen Wu for sequencing. We are grateful to the staff at Stanford Synchrotron Radiation Laboratory for synchrotron support.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; HAND WL, 1970, ARCH INTERN MED, V125, P879, DOI 10.1001/archinte.125.5.879; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Park H, 2011, J BIOL CHEM, V286, P23214, DOI 10.1074/jbc.M110.184283; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; SMART OS, 2008, ANN M AM CRYST ASS K; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Nhieu GT, 2007, EMBO J, V26, P4588; VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X; Vonrhein C, 2008, ACTA CRYSTALLOGR A, V64, pC78, DOI 10.1107/S010876730809750X; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042	52	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35096	35103		10.1074/jbc.M111.263855	http://dx.doi.org/10.1074/jbc.M111.263855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841197	Green Published, hybrid			2022-12-25	WOS:000295406300063
J	Aittaleb, M; Nishimura, A; Linder, ME; Tesmer, JJG				Aittaleb, Mohamed; Nishimura, Akiyuki; Linder, Maurine E.; Tesmer, John J. G.			Plasma Membrane Association of p63 Rho Guanine Nucleotide Exchange Factor (p63RhoGEF) Is Mediated by Palmitoylation and Is Required for Basal Activity in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PDZ-RHOGEF; G-PROTEINS; P115 RHOGEF; PH DOMAINS; G-ALPHA(13); RECEPTORS; MOTIF; LARG; TRIO	Activation of G protein-coupled receptors at the cell surface leads to the activation or inhibition of intracellular effector enzymes, which include various Rho guanine nucleotide exchange factors (RhoGEFs). RhoGEFs activate small molecular weight GTPases at the plasma membrane (PM). Many of the known G protein-coupled receptor-regulated RhoGEFs are found in the cytoplasm of unstimulated cells, and PM recruitment is a critical aspect of their regulation. In contrast, p63RhoGEF, a G alpha(q)-regulated RhoGEF, appears to be constitutively localized to the PM. The objective of this study was to determine the molecular basis for the localization of p63RhoGEF and the impact of its subcellular localization on its regulation by G alpha(q). Herein, we show that the pleckstrin homology domain of p63RhoGEF is not involved in its PM targeting. Instead, a conserved string of cysteines (Cys-23/25/26) at the N terminus of the enzyme is palmitoylated and required for membrane localization and full basal activity in cells. Conversion of these residues to serine relocates p63RhoGEF from the PM to the cytoplasm, diminishes its basal activity, and eliminates palmitoylation. The activity of palmitoylation-deficient p63RhoGEF can be rescued by targeting to the PM by fusion with tandem phospholipase C-delta 1 pleckstrin homology domains or by co-expression with wild-type G alpha(q) but not with palmitoylation-deficient G alpha(q). Our data suggest that p63RhoGEF is regulated chiefly through allosteric control by G alpha(q), as opposed to other known G alpha-regulated RhoGEFs, which are instead sequestered in the cytoplasm, perhaps because of their high basal activity.	[Aittaleb, Mohamed; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nishimura, Akiyuki; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Cornell University; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL071818, HL086865, GM051466, DK20572, GM078850-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071818 and HL086865 (to J. J. G. T.) and GM051466 (to M. E. L.). This research used the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by National Institutes of Health Grant DK20572.; Supported in part by National Institutes of Health Grant GM078850-S1.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Crouthamel M, 2010, MOL PHARMACOL, V78, P767, DOI 10.1124/mol.110.066340; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Hajicek N, 2011, J BIOL CHEM, V286, P20625, DOI 10.1074/jbc.M110.201392; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Steenhuis P, 2010, TRAFFIC, V11, P987, DOI 10.1111/j.1600-0854.2010.01073.x; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Suzuki N, 2009, NEUROSIGNALS, V17, P55, DOI 10.1159/000186690; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001	51	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34448	34456		10.1074/jbc.M111.273342	http://dx.doi.org/10.1074/jbc.M111.273342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832057	Green Published, hybrid			2022-12-25	WOS:000295159200072
J	Isaji, M; Lenartowska, M; Noguchi, T; Frank, DJ; Miller, KG				Isaji, Mamiko; Lenartowska, Marta; Noguchi, Tatsuhiko; Frank, Deborah J.; Miller, Kathryn G.			Myosin VI Regulates Actin Structure Specialization through Conserved Cargo-Binding Domain Sites	PLOS ONE			English	Article							DROSOPHILA SPERMATID INDIVIDUALIZATION; COCHLEAR HAIR-CELLS; UNCONVENTIONAL MYOSIN; MEDIATED ENDOCYTOSIS; GOLGI-COMPLEX; PROTEIN; MOTOR; MEMBRANE; SPERMATOGENESIS; LOCALIZATION	Actin structures are often stable, remaining unchanged in organization for the lifetime of a differentiated cell. Little is known about stable actin structure formation, organization, or maintenance. During Drosophila spermatid individualization, long-lived actin cones mediate cellular remodeling. Myosin VI is necessary for building the dense meshwork at the cones' fronts. We test several ideas for myosin VI's mechanism of action using domain deletions or site-specific mutations of myosin VI. The head (motor) and globular tail (cargo-binding) domains were both needed for localization at the cone front and dense meshwork formation. Several conserved partner-binding sites in the globular tail previously identified in vertebrate myosin VI were critical for function in cones. Localization and promotion of proper actin organization were separable properties of myosin VI. A vertebrate myosin VI was able to localize and function, indicating that functional properties are conserved. Our data eliminate several models for myosin VI's mechanism of action and suggest its role is controlling organization and action of actin assembly regulators through interactions at conserved sites. The Drosophila orthologues of interaction partners previously identified for vertebrate myosin VI are likely not required, indicating novel partners mediate this effect. These data demonstrate that generating an organized and functional actin structure in this cell requires multiple activities coordinated by myosin VI.	[Isaji, Mamiko; Frank, Deborah J.; Miller, Kathryn G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Lenartowska, Marta] Nicholas Copernicus Univ, Fac Biol & Earth Sci, Inst Gen & Mol Biol, Dev Biol Lab, Torun, Poland; [Noguchi, Tatsuhiko] RIKEN Kobe, Lab Morphogenet Signaling, Ctr Dev Biol, Kobe, Hyogo, Japan	Washington University (WUSTL); Nicolaus Copernicus University; RIKEN	Isaji, M (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	miller@wustl.edu	Lenartowska, Marta/G-5203-2014; Lenartowska, Marta/S-4545-2019	Lenartowska, Marta/0000-0002-5886-2493; Lenartowska, Marta/0000-0002-5886-2493	National Institutes of Health [GM-60494]; Polish Ministry of Science and Higher Education [NN303 816240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM-60494 (to K.G.M.), http://www.nih.gov/; and Polish Ministry of Science and Higher Education grant NN303 816240 (to M.L.), http://www.nauka.gov.pl/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Breshears LM, 2007, CURR BIOL, V17, pR915, DOI 10.1016/j.cub.2007.09.003; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Djiane A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011228; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Fabian L, 2010, MOL BIOL CELL, V21, P1546, DOI 10.1091/mbc.E09-07-0582; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Finan D, 2011, P NATL ACAD SCI USA, V108, P5566, DOI 10.1073/pnas.1101415108; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lin HP, 2007, DEV BIOL, V311, P423, DOI 10.1016/j.ydbio.2007.08.043; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Millo H, 2004, MECH DEVELOP, V121, P1335, DOI 10.1016/j.mod.2004.06.007; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Noguchi T, 2006, MOL BIOL CELL, V17, P2559, DOI 10.1091/mbc.E06-01-0031; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; Noguchi T, 2009, MOL BIOL CELL, V20, P358, DOI 10.1091/mbc.E08-07-0776; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Rogat AD, 2002, J CELL SCI, V115, P4855, DOI 10.1242/jcs.00149; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Sweeney HL, 2010, CELL, V141, P573, DOI 10.1016/j.cell.2010.04.028; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V127, P492, DOI 10.1007/BF00306868; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22755	10.1371/journal.pone.0022755	http://dx.doi.org/10.1371/journal.pone.0022755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853045	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400012
J	Ortiz, T; Poch, J; Santos, JM; Requena, C; Martinez, AM; Ortiz-Teran, L; Turrero, A; Barcia, J; Nogales, R; Calvo, A; Martinez, JM; Cordoba, JL; Pascual-Leone, A				Ortiz, Tomas; Poch, Joaquin; Santos, Juan M.; Requena, Carmen; Martinez, Ana M.; Ortiz-Teran, Laura; Turrero, Agustin; Barcia, Juan; Nogales, Ramon; Calvo, Agustin; Martinez, Jose M.; Cordoba, Jose L.; Pascual-Leone, Alvaro			Recruitment of Occipital Cortex during Sensory Substitution Training Linked to Subjective Experience of Seeing in People with Blindness	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; VISUAL-CORTEX; CONGENITALLY BLIND; EFFECTIVE CONNECTIVITY; ACTIVATION PATTERNS; CORTICAL ACTIVITY; HUMAN BRAIN; HUMANS; PERCEPTION; TACTILE	Over three months of intensive training with a tactile stimulation device, 18 blind and 10 blindfolded seeing subjects improved in their ability to identify geometric figures by touch. Seven blind subjects spontaneously reported 'visual qualia', the subjective sensation of seeing flashes of light congruent with tactile stimuli. In the latter subjects tactile stimulation evoked activation of occipital cortex on electroencephalography (EEG). None of the blind subjects who failed to experience visual qualia, despite identical tactile stimulation training, showed EEG recruitment of occipital cortex. None of the blindfolded seeing humans reported visual-like sensations during tactile stimulation. These findings support the notion that the conscious experience of seeing is linked to the activation of occipital brain regions in people with blindness. Moreover, the findings indicate that provision of visual information can be achieved through non-visual sensory modalities which may help to minimize the disability of blind individuals, affording them some degree of object recognition and navigation aid.	[Ortiz, Tomas; Santos, Juan M.; Martinez, Ana M.; Ortiz-Teran, Laura] Univ Complutense, Fac Med, Dept Psychiat, E-28040 Madrid, Spain; [Poch, Joaquin] Hosp Clin Univ San Carlos, Dept Ear Nose & Throat ENT, Madrid, Spain; [Santos, Juan M.] Spanish Res Network Mental Hlth, CIBERSAM Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Requena, Carmen] Univ Leon, Dept Psychol, E-24071 Leon, Spain; [Ortiz-Teran, Laura] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Turrero, Agustin] Univ Complutense, Fac Med, Dept Stat, E-28040 Madrid, Spain; [Barcia, Juan] Hosp Clin Univ San Carlos, Dept Neurosurg, Madrid, Spain; [Nogales, Ramon; Calvo, Agustin; Martinez, Jose M.; Cordoba, Jose L.] Univ Complutense, Fac Med, Vis Tactile Project, E-28040 Madrid, Spain; [Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat,Dept N, Boston, MA 02215 USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttman Neurorehabil, E-08193 Barcelona, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad de Leon; Harvard University; Massachusetts General Hospital; Complutense University of Madrid; Complutense University of Madrid; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona	Ortiz, T (corresponding author), Univ Complutense, Fac Med, Dept Psychiat, E-28040 Madrid, Spain.	tortiz@med.ucm.es	Requena, Carmen/ABG-6994-2020; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Requena, Carmen MC/J-6849-2014	Requena, Carmen/0000-0003-2427-8608; Pascual-Leone, Alvaro/0000-0001-8975-0382; Requena, Carmen MC/0000-0003-2427-8608; Barcia Albacar, Juan Antonio/0000-0001-6562-4568	Fundacion Esther Koplowitz [EK-4131306]; Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain) [IMADE-4131307]	Fundacion Esther Koplowitz; Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain)	This research has been made possible through grants from the Fundacion Esther Koplowitz (grant #EK-4131306) and Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain) (grant #IMADE-4131307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; De Santis L, 2007, NEUROIMAGE, V37, P890, DOI 10.1016/j.neuroimage.2007.05.052; De Santis L, 2007, CEREB CORTEX, V17, P9, DOI 10.1093/cercor/bhj119; De Volder AG, 1999, BRAIN RES, V826, P128, DOI 10.1016/S0006-8993(99)01275-5; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Hotting K, 2003, EXP BRAIN RES, V148, P26, DOI 10.1007/s00221-002-1261-z; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Llinas R R, 1998, Adv Neurol, V77, P95; Lucan JN, 2010, HUM BRAIN MAPP, V31, P1813, DOI 10.1002/hbm.20983; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Merabet LB, 2004, J NEURO-OPHTHALMOL, V24, P109, DOI 10.1097/00041327-200406000-00003; Murray MM, 2009, BRAIN COGNITION, V69, P47, DOI 10.1016/j.bandc.2008.05.004; Noppeney U, 2007, NEUROSCI BIOBEHAV R, V31, P1169, DOI 10.1016/j.neubiorev.2007.04.012; Ortiz T, 2010, REV NEUROLOGIA, V50, pS19; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pedroarena C, 1997, P NATL ACAD SCI USA, V94, P724, DOI 10.1073/pnas.94.2.724; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; Poirier C, 2007, NEUROSCI BIOBEHAV R, V31, P1064, DOI 10.1016/j.neubiorev.2007.05.010; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sehatpour P, 2008, P NATL ACAD SCI USA, V105, P4399, DOI 10.1073/pnas.0708418105; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; UHL F, 1991, NEUROSCI LETT, V124, P256, DOI 10.1016/0304-3940(91)90107-5; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x	58	43	43	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23264	10.1371/journal.pone.0023264	http://dx.doi.org/10.1371/journal.pone.0023264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853098	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000295454200059
J	Creevey, CJ; Doerks, T; Fitzpatrick, DA; Raes, J; Bork, P				Creevey, Christopher J.; Doerks, Tobias; Fitzpatrick, David A.; Raes, Jeroen; Bork, Peer			Universally Distributed Single-Copy Genes Indicate a Constant Rate of Horizontal Transfer	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; LATERAL TRANSFER; EVOLUTION; TREE; BARRIERS; BACTERIA; GENOMES; LIFE; RECONSTRUCTION	Single copy genes, universally distributed across the three domains of life and encoding mostly ancient parts of the translation machinery, are thought to be only rarely subjected to horizontal gene transfer (HGT). Indeed it has been proposed to have occurred in only a few genes and implies a rare, probably not advantageous event in which an ortholog displaces the original gene and has to function in a foreign context (orthologous gene displacement, OGD). Here, we have utilised an automatic method to identify HGT based on a conservative statistical approach capable of robustly assigning both donors and acceptors. Applied to 40 universally single copy genes we found that as many as 68 HGTs (implying OGDs) have occurred in these genes with a rate of 1.7 per family since the last universal common ancestor (LUCA). We examined a number of factors that have been claimed to be fundamental to HGT in general and tested their validity in the subset of universally distributed single copy genes. We found that differing functional constraints impact rates of OGD and the more evolutionarily distant the donor and acceptor, the less likely an OGD is to occur. Furthermore, species with larger genomes are more likely to be subjected to OGD. Most importantly, regardless of the trends above, the number of OGDs increases linearly with time, indicating a neutral, constant rate. This suggests that levels of HGT above this rate may be indicative of positively selected transfers that may allow niche adaptation or bestow other benefits to the recipient organism.	[Creevey, Christopher J.] TEAGASC, Anim & Biosci Res Dept, Dunsany, Meath, Ireland; [Doerks, Tobias; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Fitzpatrick, David A.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Raes, Jeroen] Vrije Univ Brussel, VIB Dept Mol & Cellular Interact, Brussels, Belgium	Teagasc; European Molecular Biology Laboratory (EMBL); Maynooth University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Creevey, CJ (corresponding author), TEAGASC, Anim & Biosci Res Dept, Dunsany, Meath, Ireland.	bork@embl.de	raes, jeroen/D-7835-2018; Bork, Peer/F-1813-2013; Creevey, Christopher James/A-1836-2013	raes, jeroen/0000-0002-1337-041X; Bork, Peer/0000-0002-2627-833X; Creevey, Christopher James/0000-0001-7183-1555; Fitzpatrick, David/0000-0001-7345-6998	EU [HEALTH-F4-2007-201052]; Science Foundation Ireland (SFI) [07/SK/B1236A]	EU(European Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland)	This project was funded under the EU 7th Framework Programme (number: HEALTH-F4-2007-201052). CJC is funded under the Science Foundation Ireland (SFI) Stokes Lecturer Scheme (number: 07/SK/B1236A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapteste E, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-34; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Bull JJ, 2007, MOL BIOL EVOL, V24, P900, DOI 10.1093/molbev/msm006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Copley SD, 2002, GENOME BIOL, V3; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fall S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001055; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fox J, 2002, COX PROPORTIONAL HAZ; Friedrich MW, 2002, J BACTERIOL, V184, P278, DOI 10.1128/JB.184.1.278-289.2002; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haggerty LS, 2009, PHILOS T R SOC B, V364, P2209, DOI 10.1098/rstb.2009.0042; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kunin V, 2003, BIOINFORMATICS, V19, P1412, DOI 10.1093/bioinformatics/btg174; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Makarova KS, 1999, GENOME RES, V9, P608; Medrano-Soto A, 2004, MOL BIOL EVOL, V21, P1884, DOI 10.1093/molbev/msh202; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Raymond J, 2003, PHILOS T R SOC B, V358, P223, DOI 10.1098/rstb.2002.1181; Sanderson MJ, 2003, MOL BIOL EVOL, V20, P1036, DOI 10.1093/molbev/msg115; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SNEL B, 2005, ANN REV MICROBIOL, P11601; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wellner A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r156	44	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22099	10.1371/journal.pone.0022099	http://dx.doi.org/10.1371/journal.pone.0022099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850220	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000293563300004
J	Davis, FM; Kenny, PA; Soo, ETL; van Denderen, BJW; Thompson, EW; Cabot, PJ; Parat, MO; Roberts-Thomson, SJ; Monteith, GR				Davis, Felicity M.; Kenny, Paraic A.; Soo, Eliza T-L; van Denderen, Bryce J. W.; Thompson, Erik W.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Remodeling of Purinergic Receptor-Mediated Ca2+ Signaling as a Consequence of EGF-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; SMOOTH-MUSCLE; ACTIVATED RECEPTOR-2; EXTRACELLULAR ATP; PROSTATE-CANCER; P2X(5) RECEPTOR; CARCINOMA CELLS; P2 RECEPTORS; METASTASIS; MIGRATION	Background: The microenvironment plays a pivotal role in tumor cell proliferation, survival and migration. Invasive cancer cells face a new set of environmental challenges as they breach the basement membrane and colonize distant organs during the process of metastasis. Phenotypic switching, such as that which occurs during epithelial-mesenchymal transition (EMT), may be associated with a remodeling of cell surface receptors and thus altered responses to signals from the tumor microenvironment. Methodology/Principal Findings: We assessed changes in intracellular Ca2+ in cells loaded with Fluo-4 AM using a fluorometric imaging plate reader (FLIPRTETRA) and observed significant changes in the potency of ATP (EC50 0.175 mu M (-EGF) versus 1.731 mu M (+EGF), P < 0.05), and the nature of the ATP-induced Ca2+ transient, corresponding with a 10-fold increase in the mesenchymal marker vimentin (P < 0.05). We observed no change in the sensitivity to PAR2-mediated Ca2+ signaling, indicating that these alterations are not simply a consequence of changes in global Ca2+ homeostasis. To determine whether changes in ATP-mediated Ca2+ signaling are preceded by alterations in the transcriptional profile of purinergic receptors, we analyzed the expression of a panel of P2X ionotropic and P2Y metabotropic purinergic receptors using real-time RT-PCR and found significant and specific alterations in the suite of ATP-activated purinergic receptors during EGF-induced EMT in breast cancer cells. Our studies are the first to show that P2X(5) ionotropic receptors are enriched in the mesenchymal phenotype and that silencing of P2X(5) leads to a significant reduction (25%, P < 0.05) in EGF-induced vimentin protein expression. Conclusions: The acquisition of a new suite of cell surface purinergic receptors is a feature of EGF-mediated EMT in MDA-MB-468 breast cancer cells. Such changes may impart advantageous phenotypic traits and represent a novel mechanism for the targeting of cancer metastasis.	[Davis, Felicity M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Soo, Eliza T-L; van Denderen, Bryce J. W.; Thompson, Erik W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Soo, Eliza T-L; Thompson, Erik W.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [van Denderen, Bryce J. W.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	University of Queensland; Yeshiva University; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	gregm@uq.edu.au	Davis, Felicity M/P-1387-2016; Parat, Marie-Odile/G-4410-2010; Cabot, Peter John/B-2424-2013; Thompson, Erik/GPK-2067-2022; Roberts-Thomson, Sarah J/B-4282-2011; Thompson, Erik W/A-1425-2009; Monteith, Gregory/B-1626-2008; Roberts-Thomson, Sarah/W-5676-2019; van Denderen, Bryce/AAW-5454-2021	Davis, Felicity M/0000-0001-9112-118X; Parat, Marie-Odile/0000-0003-4895-7381; Cabot, Peter John/0000-0003-1778-3753; Thompson, Erik/0000-0002-9723-4924; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Thompson, Erik W/0000-0002-9723-4924; Monteith, Gregory/0000-0002-4345-530X; Roberts-Thomson, Sarah/0000-0001-8202-5786; 	National Health and Medical Research Council (NHMRC) [569645]; Susan G. Komen for the Cure [KG100888]; Cancer Australia - National Breast Cancer Foundation [628720]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Cancer Australia - National Breast Cancer Foundation	This work was partially supported by the National Health and Medical Research Council (NHMRC) (569645) and an NHMRC Biomedical Postgraduate Research Scholarship to FD, www.nhmrc.gov.au. PK was supported by Susan G. Komen for the Cure (KG100888), www.komen.org. ET was funded by Cancer Australia - National Breast Cancer Foundation (628720), www.nbcf.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bohm SK, 1996, BIOCHEM J, V314, P1009; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Briand P, 1996, CANCER RES, V56, P2039; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gilles C, 1999, J CELL SCI, V112, P4615; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Khakh BS, 2001, PHARMACOL REV, V53, P107; Leinonen P, 2007, CELL COMMUN ADHES, V14, P125, DOI 10.1080/15419060701557065; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; NEYLON CB, 1994, CIRC RES, V75, P733, DOI 10.1161/01.RES.75.4.733; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Price JT, 1999, CANCER RES, V59, P5475; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V499, P40, DOI 10.1016/j.abb.2010.05.001; Shabbir M, 2008, BJU INT, V101, P352, DOI 10.1111/j.1464-410X.2007.07293.x; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Suzuki M, 2006, AM J PATHOL, V169, P673, DOI 10.2353/ajpath.2006.060053; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	54	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23464	10.1371/journal.pone.0023464	http://dx.doi.org/10.1371/journal.pone.0023464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850275	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300060
J	Kelly, H; Peck, HA; Laurie, KL; Wu, P; Nishiura, H; Cowling, BJ				Kelly, Heath; Peck, Heidi A.; Laurie, Karen L.; Wu, Peng; Nishiura, Hiroshi; Cowling, Benjamin J.			The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination	PLOS ONE			English	Article							ANTIBODY-RESPONSE; HEMAGGLUTINATION INHIBITION; HOSPITAL STAFF; PREGNANT-WOMEN; RISK-FACTORS; ATTACK RATE; VIRUS; PREVALENCE; SEROCONVERSION; CHILDREN	Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were needed to guide vaccination policies and inform other control measures. Serological studies are the most reliable way to measure influenza infection independent of symptoms. We reviewed all published serological studies that estimated the cumulative incidence of infection with pandemic influenza H1N1 2009 prior to the initiation of population-based vaccination against the pandemic strain. Methodology and Principal Findings: We searched for studies that estimated the cumulative incidence of pandemic influenza infection in the wider community. We excluded studies that did not include both pre- and post-pandemic serological sampling and studies that included response to vaccination. We identified 47 potentially eligible studies and included 12 of them in the review. Where there had been a significant first wave, the cumulative incidence of pandemic influenza infection was reported in the range 16%-28% in pre-school aged children, 34%-43% in school aged children and 12%-15% in young adults. Only 2%-3% of older adults were infected. The proportion of the entire population infected ranged from 11%-18%. We re-estimated the cumulative incidence to account for the small proportion of infections that may not have been detected by serology, and performed direct age-standardisation to the study population. For those countries where it could be calculated, this suggested a population cumulative incidence in the range 11%-21%. Conclusions and Significance: Around the world, the cumulative incidence of infection (which is higher than the cumulative incidence of clinical disease) was below that anticipated prior to the pandemic. Serological studies need to be routine in order to be sufficiently timely to provide support for decisions about vaccination.	[Kelly, Heath; Peck, Heidi A.; Laurie, Karen L.] WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia; [Wu, Peng; Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Hong Kong; Japan Science & Technology Agency (JST)	Kelly, H (corresponding author), WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia.	heath.kelly@mh.org.au	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537; Wu, Peng/0000-0003-1157-9401; Laurie, Karen/0000-0001-5186-8342	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2010, EUROSURVEILLANCE, V15; AHO M, 2010, EURO SURVEILL, V15; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; *AUSTR BUR STAT, 2010, AUSTR DEM STAT SEP 2; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CENS STAT DEP HON, 2011, STAT TABL TABL 002 P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M, 2009, WORLD NOW START INFL; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chang SC, 2010, CLIN INFECT DIS, V51, P1465, DOI 10.1086/657406; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Chen MIC, 2010, EMERG INFECT DIS, V16, P1554, DOI 10.3201/eid1610.100516; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; *DEP STAT SING, 2010, YB STAT SING 2010 3; Department of Health, 2007, PAND FLU NAT FRAM RE; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Flahault A, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1140; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; GREENBAUM JA, 2009, P NATL ACAD SCI 1118; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; *HLTH PROT AG UK, 2010, SER PROGR SAMPL COLL; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Ikonen N, 2010, EURO SURVEILL, V15; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jiang T, 2010, CLIN INFECT DIS, V50, P285, DOI 10.1086/649552; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Lee VJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-164; LEE VJ, 2011, AM J EPIDEM IN PRESS; Liu WT, 2010, CLIN INFECT DIS, V51, P251, DOI 10.1086/653680; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *MIN HLTH FAM WELF, 2009, SECT A POP VIT STAT; Moghadami M, 2010, IRAN J IMMUNOL, V7, P39, DOI IJIv7i1A5; Nishiura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017908; *OFF NAT STAT UK, 2011, VIT STAT POP HLTH RE; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; *STAT NORW, 2010, POP AG COUNT; *STAT NZ, 2010, NAT POP EST JUN 2010; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Tian LL, 2011, PREV MED, V52, P71, DOI 10.1016/j.ypmed.2010.10.006; Tsai T.F., 2010, EURO SURVEILL, V15; WHO, 2009, GLOB INFL PROGR PAND; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Wilson N, 2009, EUROSURVEILLANCE, V14; Wiwanitkit V, 2010, IRAN J IMMUNOL, V7, P130, DOI IJIv7i2A9; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang P, 2011, INT J INFECT DIS, V15, pE151, DOI 10.1016/j.ijid.2010.11.001; Zhang RQ, 2011, SCAND J INFECT DIS, V43, P216, DOI 10.3109/00365548.2010.539258; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	69	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e21828	10.1371/journal.pone.0021828	http://dx.doi.org/10.1371/journal.pone.0021828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850217	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300001
J	Lin, YT; Chern, YJ; Shen, CKJ; Wen, HL; Chang, YC; Li, H; Cheng, TH; Hsieh-Li, HM				Lin, Yuan-Ta; Chern, Yijuang; Shen, Che-Kun James; Wen, Hsin-Lan; Chang, Ya-Chin; Li, Hung; Cheng, Tzu-Hao; Hsieh-Li, Hsiu Mei			Human Mesenchymal Stem Cells Prolong Survival and Ameliorate Motor Deficit through Trophic Support in Huntington's Disease Mouse Models	PLOS ONE			English	Article							MARROW STROMAL CELLS; FETAL STRIATAL TRANSPLANTATION; BONE-MARROW; NEURAL TRANSPLANTATION; EXCITOTOXIC LESION; QUINOLINIC ACID; RAT STRIATUM; ADULT BRAIN; STROKE; EXPRESSION	We investigated the therapeutic potential of human bone marrow-derived mesenchymal stem cells (hBM-MSCs) in Huntington's disease (HD) mouse models. Ten weeks after intrastriatal injection of quinolinic acid (QA), mice that received hBM-MSC transplantation showed a significant reduction in motor function impairment and increased survival rate. Transplanted hBM-MSCs were capable of survival, and inducing neural proliferation and differentiation in the QA-lesioned striatum. In addition, the transplanted hBM-MSCs induced microglia, neuroblasts and bone marrow-derived cells to migrate into the QA-lesioned region. Similar results were obtained in R6/2-J2, a genetically-modified animal model of HD, except for the improvement of motor function. After hBM-MSC transplantation, the transplanted hBM-MSCs may integrate with the host cells and increase the levels of laminin, Von Willebrand Factor (VWF), stromal cell-derived factor-1 (SDF-1), and the SDF-1 receptor Cxcr4. The p-Erk1/2 expression was increased while Bax and caspase-3 levels were decreased after hBM-MSC transplantation suggesting that the reduced level of apoptosis after hBM-MSC transplantation was of benefit to the QA-lesioned mice. Our data suggest that hBM-MSCs have neural differentiation improvement potential, neurotrophic support capability and an anti-apoptotic effect, and may be a feasible candidate for HD therapy.	[Lin, Yuan-Ta; Li, Hung; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Lin, Yuan-Ta; Shen, Che-Kun James; Wen, Hsin-Lan; Li, Hung] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Ya-Chin; Hsieh-Li, Hsiu Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan Normal University	Lin, YT (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	hmhsieh@ntnu.edu.tw	chern, yijuang/S-7013-2018	chern, yijuang/0000-0002-5842-5429	Academia Sinica [AS-94-TP-B17, AS-97-TP-B02]; National Science Council [NSC 97-2320-B-003-003-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica Grants AS-94-TP-B17, AS-97-TP-B02, and National Science Council Grant NSC 97-2320-B-003-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Alberti E, 2009, MED SCI MONITOR, V15, pBR47; Amann B, 2009, CELL TRANSPLANT, V18, P371, DOI 10.3727/096368909788534942; Amin EM, 2008, NEUROL RES, V30, P1086, DOI 10.1179/174313208X327955; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BJORKLUND A, 1993, NATURE, V362, P414, DOI 10.1038/362414a0; Capetian P, 2009, NEUROSCIENCE, V160, P661, DOI 10.1016/j.neuroscience.2009.02.035; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chindewa Rattiya, 2008, Journal of the Medical Association of Thailand, V91, P208; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Cicchetti F, 2009, P NATL ACAD SCI USA, V106, P12483, DOI 10.1073/pnas.0904239106; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; Edalatmanesh MA, 2010, NEUROL RES, V32, P166, DOI 10.1179/174313209X409025; Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.04.014; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gaura V, 2004, BRAIN, V127, P65, DOI 10.1093/brain/awh003; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Hauser RA, 2002, NEUROLOGY, V58, P687, DOI 10.1212/WNL.58.5.687; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hernandez-Lopez C, 2008, IMMUNOL LETT, V120, P72, DOI 10.1016/j.imlet.2008.07.006; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Keene CD, 2007, NEUROLOGY, V68, P2093, DOI 10.1212/01.wnl.0000264504.14301.f5; Keene CD, 2009, ACTA NEUROPATHOL, V117, P329, DOI 10.1007/s00401-008-0465-0; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Kordower JH, 1997, J COMP NEUROL, V387, P96, DOI 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krystkowiak P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000166; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lee ST, 2008, J NEUROCHEM, V104, P1190, DOI 10.1111/j.1471-4159.2007.05044.x; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Lescaudron L, 2003, INT J NEUROSCI, V113, P945, DOI 10.1080/00207450390207759; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Marco S, 2002, EXP NEUROL, V174, P243, DOI 10.1006/exnr.2001.7859; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2000, BIOCHEM SOC T, V28, P341, DOI 10.1042/0300-5127:0280341; Ramaswamy S, 2007, CELL TRANSPLANT, V16, P301, DOI 10.3727/000000007783464687; Reuter I, 2008, J NEUROL NEUROSUR PS, V79, P948, DOI 10.1136/jnnp.2007.142380; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Sadan O, 2008, STEM CELLS, V26, P2542, DOI 10.1634/stemcells.2008-0240; SANBERG PR, 1984, CRC CR REV CL NEUROB, V1, P1; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Snyder BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009347; STRAUSS S, 1994, NEUROSCI LETT, V168, P193, DOI 10.1016/0304-3940(94)90448-0; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tanabe S, 1997, J IMMUNOL, V159, P905; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x; Zand L, 2005, NEUROREPORT, V16, P129, DOI 10.1097/00001756-200502080-00011; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	70	74	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22924	10.1371/journal.pone.0022924	http://dx.doi.org/10.1371/journal.pone.0022924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850243	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300028
J	Peter, H; Ylla, I; Gudasz, C; Romani, AM; Sabater, S; Tranvik, LJ				Peter, Hannes; Ylla, Irene; Gudasz, Cristian; Romani, Anna M.; Sabater, Sergi; Tranvik, Lars J.			Multifunctionality and Diversity in Bacterial Biofilms	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; SPECIES RICHNESS; FRESH-WATER; BIODIVERSITY; REDUNDANCY; SELECTION; INCREASE	Bacteria are highly diverse and drive a bulk of ecosystem processes. Analysis of relationships between diversity and single specific ecosystem processes neglects the possibility that different species perform multiple functions at the same time. The degradation of dissolved organic carbon (DOC) followed by respiration is a key bacterial function that is modulated by the availability of DOC and the capability to produce extracellular enzymes. In freshwater ecosystems, biofilms are metabolic hotspots and major sites of DOC degradation. We manipulated the diversity of biofilm forming communities which were fed with DOC differing in availability. We characterized community composition using molecular fingerprinting (T-RFLP) and measured functioning as oxygen consumption rates, the conversion of DOC in the medium, bacterial abundance and the activities of five specific enzymes. Based on assays of the extracellular enzyme activity, we calculated how the likelihood of sustaining multiple functions was affected by reduced diversity. Carbon source and biofilm age were strong drivers of community functioning, and we demonstrate how the likelihood of sustaining multifunctionality decreases with decreasing diversity.	[Peter, Hannes; Gudasz, Cristian; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Ylla, Irene; Romani, Anna M.; Sabater, Sergi] Univ Girona, Inst Aquat Ecol, Dept Environm Sci, Girona, Spain; [Sabater, Sergi] Catalan Inst Water Res ICRA, Girona, Spain	Uppsala University; Universitat de Girona; Institut Catala de Recerca de l'Aigua (ICRA)	Peter, H (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	hannes.peter@ebc.uu.se	Romaní, Anna M/L-7572-2014; Sabater, Sergi/A-7549-2008; Tranvik, Lars J/H-2222-2011	Romaní, Anna M/0000-0001-5183-8231; Sabater, Sergi/0000-0003-3730-0261; Tranvik, Lars J./0000-0003-3509-8266	Malmens Stiftelse; Swedish Research Council; Generalitat de Catalunya	Malmens Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	The study was financially supported by grants from the Malmens Stiftelse to HP, the Swedish Research Council to LJT, and from the Generalitat de Catalunya (beques per estades de recerca fora de Catalunya) to IY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Arnosti C., 2003, AQUATIC ECOSYSTEMS I, P315; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bastviken D, 2004, LIMNOL OCEANOGR, V49, P109, DOI 10.4319/lo.2004.49.1.0109; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHROST RJ, 1990, ERGEB LIMNOL, V34, P93; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fischer H, 2006, ARCH HYDROBIOL, V166, P79, DOI 10.1127/0003-9136/2006/0166-0079; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He JZ, 2009, J SOIL SEDIMENT, V9, P547, DOI 10.1007/s11368-009-0120-y; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; KAPLAN LA, 1995, WATER RES, V29, P2696, DOI 10.1016/0043-1354(95)00135-8; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MEYER JL, 1994, MICROBIAL ECOL, V28, P195, DOI 10.1007/BF00166808; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Perdue E.M., 2009, ENCY INLAND WATERS, P806, DOI 10.1016/B978-012370626-3.00114-9; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Romani AM, 1999, AQUAT SCI, V61, P122, DOI 10.1007/s000270050057; Singer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009988; Sinsabaugh R.L., 2003, AQUATIC ECOSYSTEMS I; SINSABAUGH RL, 1994, J N AM BENTHOL SOC, V13, P160, DOI 10.2307/1467235; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Szabo KE, 2007, AQUAT MICROB ECOL, V47, P1, DOI 10.3354/ame047001; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	44	82	86	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23225	10.1371/journal.pone.0023225	http://dx.doi.org/10.1371/journal.pone.0023225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850263	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300048
J	Dubois, CL; Shih, HP; Seymour, PA; Patel, NA; Behrmann, JM; Ngo, V; Sander, M				Dubois, Claire L.; Hung Ping Shih; Seymour, Philip A.; Patel, Nisha A.; Behrmann, James M.; Ngo, Victoria; Sander, Maike			Sox9-Haploinsufficiency Causes Glucose Intolerance in Mice	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; TRANSCRIPTION FACTOR; PANCREAS DEVELOPMENT; INSULIN GENE; DIABETES-MELLITUS; PROGENITOR CELLS; GLUCOKINASE GENE; SOX9 EXPRESSION; MUTATIONS; MOUSE	The HMG box transcription factor Sox9 plays a critical role in progenitor cell expansion during pancreas organogenesis and is required for proper endocrine cell development in the embryo. Based on in vitro studies it has been suggested that Sox9 controls expression of a network of important developmental regulators, including Tcf2/MODY5, Hnf6, and Foxa2, in pancreatic progenitor cells. Here, we sought to: 1) determine whether Sox9 regulates this transcriptional network in vivo and 2) investigate whether reduced Sox9 gene dosage leads to impaired glucose homeostasis in adult mice. Employing two genetic models of temporally-controlled Sox9 inactivation in pancreatic progenitor cells, we demonstrate that contrary to in vitro findings, Sox9 is not required for Tcf2, Hnf6, or Foxa2 expression in vivo. Moreover, our analysis revealed a novel role for Sox9 in maintaining the expression of Pdx1/MODY4, which is an important transcriptional regulator of beta-cell development. We further show that reduced beta-cell mass in Sox9-haploinsufficient mice leads to glucose intolerance during adulthood. Sox9-haploinsufficient mice displayed 50% reduced beta-cell mass at birth, which recovered partially via a compensatory increase in beta-cell proliferation early postnatally. Endocrine islets from mice with reduced Sox9 gene dosage exhibited normal glucose stimulated insulin secretion. Our findings show Sox9 plays an important role in endocrine development by maintaining Ngn3 and Pdx1 expression. Glucose intolerance in Sox9-haploinsufficient mice suggests that mutations in Sox9 could play a role in diabetes in humans.	[Dubois, Claire L.; Hung Ping Shih; Seymour, Philip A.; Patel, Nisha A.; Behrmann, James M.; Ngo, Victoria; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dubois, CL (corresponding author), Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA.	masander@ucsd.edu	; Sander, Maike/N-6615-2016	Seymour, Philip/0000-0001-5782-6020; Sander, Maike/0000-0001-5308-7785	NIH/NIDDK [RO1 DK078803, RO1 DK68471]; JDRF; CIRM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068471, R01DK078803] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH/NIDDK (RO1 DK078803 and RO1 DK68471) to M.S., by postdoctoral fellowships from the JDRF to P.A.S. and H.P.S., and a graduate student fellowship from the CIRM to C.L.D and N.A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Badea TC, 2003, J NEUROSCI, V23, P2314; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Edghill EL, 2006, DIABETIC MED, V23, P1301, DOI 10.1111/j.1464-5491.2006.01999.x; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kilic G, 2006, DEV DYNAM, V235, P1659, DOI 10.1002/dvdy.20729; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Mayer C, 2008, METABOLISM, V57, P416, DOI 10.1016/j.metabol.2007.11.001; Nyqvist D, 2005, J ENDOCRINOL, V186, P333, DOI 10.1677/joe.1.06204; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Piper K, 2002, MECH DEVELOP, V116, P223, DOI 10.1016/S0925-4773(02)00145-4; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Stoffers DA, 1997, TRENDS ENDOCRIN MET, V8, P145, DOI 10.1016/S1043-2760(97)00008-8; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	45	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23131	10.1371/journal.pone.0023131	http://dx.doi.org/10.1371/journal.pone.0023131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829703	Green Submitted, Green Published			2022-12-25	WOS:000293511900027
J	Antunes, LCS; Imperi, F; Carattoli, A; Visca, P				Antunes, Luisa C. S.; Imperi, Francesco; Carattoli, Alessandra; Visca, Paolo			Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; PATHOGENESIS; VIRULENCE; IDENTIFICATION; OUTBREAK; SURFACES; SURVIVAL; MUTANTS; STRAINS	Background: Acinetobacter baumannii is an emerging bacterial pathogen that causes a broad array of infections, particularly in hospitalized patients. Many studies have focused on the epidemiology and antibiotic resistance of A. baumannii, but little is currently known with respect to its virulence potential. Methodology/Principal Findings: The aim of this work was to analyze a number of virulence-related traits of four A. baumannii strains of different origin and clinical impact for which complete genome sequences were available, in order to tentatively identify novel determinants of A. baumannii pathogenicity. Clinical strains showed comparable virulence in the Galleria mellonella model of infection, irrespective of their status as outbreak or sporadic strains, whereas a non-human isolate was avirulent. A combined approach of genomic and phenotypic analyses led to the identification of several virulence factors, including exoproducts with hemolytic, phospholipase, protease and iron-chelating activities, as well as a number of multifactorial phenotypes, such as biofilm formation, surface motility and stress resistance, which were differentially expressed and could play a role in A. baumannii pathogenicity. Conclusion/Significance: This work provides evidence of the multifactorial nature of A. baumannii virulence. While A. baumannii clinical isolates could represent a selected population of strains adapted to infect the human host, subpopulations of highly genotypically and phenotypically diverse A. baumannii strains may exist outside the hospital environment, whose relevance and distribution deserve further investigation.	[Antunes, Luisa C. S.; Imperi, Francesco; Visca, Paolo] Univ Roma Tre, Dept Biol, Rome, Italy; [Carattoli, Alessandra] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Roma Tre University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Antunes, LCS (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	visca@uniroma3.it	Imperi, Francesco/AAA-3671-2021; Carattoli, Alessandra/A-1324-2009; Visca, Paolo/G-8977-2014	Carattoli, Alessandra/0000-0002-6120-6526; Visca, Paolo/0000-0002-6128-7039	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/43420/2008]	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	The study was supported by a PhD fellowship to L.C.S.A. from the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) (grant SFRH/BD/43420/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, RES MICROBIOL, V162, P279, DOI 10.1016/j.resmic.2010.10.010; Arnow LE, 1937, J BIOL CHEM, V118, P531; BERKA RM, 1981, INFECT IMMUN, V34, P1071, DOI 10.1128/IAI.34.3.1071-1074.1981; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Cevahir N, 2008, J MICROBIOL IMMUNOL, V41, P513; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; GILLAM AH, 1981, ANAL CHEM, V53, P841, DOI 10.1021/ac00229a023; HUNT DE, 1969, APPL MICROBIOL, V17, P329, DOI 10.1128/AEM.17.2.329-330.1969; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Imperi F, 2011, IUBMB LIFE IN PRESS, V63, pxxx; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merritt JH, 2005, CURR PROTOC MICROBIO; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; OHMAN DE, 1980, INFECT IMMUN, V28, P899; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; PHILLIPS PK, 1984, J CLIN PATHOL, V37, P329, DOI 10.1136/jcp.37.3.329; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VISCA P, 1992, EPIDEMIOL INFECT, V108, P323, DOI 10.1017/S0950268800049797; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/BF00301846; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	46	159	163	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22674	10.1371/journal.pone.0022674	http://dx.doi.org/10.1371/journal.pone.0022674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829642	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200017
J	Gullo, D; Latina, A; Frasca, F; Le Moli, R; Pellegriti, G; Vigneri, R				Gullo, Damiano; Latina, Adele; Frasca, Francesco; Le Moli, Rosario; Pellegriti, Gabriella; Vigneri, Riccardo			Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients	PLOS ONE			English	Article							THYROXINE PLUS TRIIODOTHYRONINE; HORMONE REPLACEMENT THERAPY; PRIMARY HYPOTHYROIDISM; TISSUE HYPOTHYROIDISM; COMBINATION THERAPY; THYROID-HORMONES; COMMON VARIATION; DOUBLE-BLIND; BIOCHEMISTRY; THYROTROPIN	Context: Levothyroxine monotherapy is the treatment of choice for hypothyroid patients because peripheral T4 to T3 conversion is believed to account for the overall tissue requirement for thyroid hormones. However, there are indirect evidences that this may not be the case in all patients. Objective: To evaluate in a large series of athyreotic patients whether levothyroxine monotherapy can normalize serum thyroid hormones and thyroid-pituitary feedback. Design: Retrospective study. Setting: Academic hospital. Patients: 1,811 athyreotic patients with normal TSH levels under levothyroxine monotherapy and 3,875 euthyroid controls. Measurements: TSH, FT4 and FT3 concentrations by immunoassays. Results: FT4 levels were significantly higher and FT3 levels were significantly lower (p < 0.001 in both cases) in levothyroxine-treated athyreotic patients than in matched euthyroid controls. Among the levothyroxine-treated patients 15.2% had lower serum FT3 and 7.2% had higher serum FT4 compared to euthyroid controls. A wide range of FT3/FT4 ratios indicated a major heterogeneity in the peripheral T3 production capacity in different individuals. The correlation between thyroid hormones and serum TSH levels indicated an abnormal feedback mechanism in levothyroxine-treated patients. Conclusions: Athyreotic patients have a highly heterogeneous T3 production capacity from orally administered levothyroxine. More than 20% of these patients, despite normal TSH levels, do not maintain FT3 or FT4 values in the reference range, reflecting the inadequacy of peripheral deiodination to compensate for the absent T3 secretion. The long-term effects of chronic tissue exposure to abnormal T3/T4 ratio are unknown but a sensitive marker of target organ response to thyroid hormones (serum TSH) suggests that this condition causes an abnormal pituitary response. A more physiological treatment than levothyroxine monotherapy may be required in some hypothyroid patients.	[Gullo, Damiano; Latina, Adele; Frasca, Francesco; Le Moli, Rosario; Pellegriti, Gabriella; Vigneri, Riccardo] Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrine Unit,Dept Clin & Mol Biomed, Catania, Italy	Presidio Ospedaliero Garibaldi-Nesima; University of Catania	Gullo, D (corresponding author), Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrine Unit,Dept Clin & Mol Biomed, Catania, Italy.	damiano.gullo@poste.it	Gullo, Damiano/GNP-5649-2022; Pellegriti, Gabriella/J-7923-2012; Pellegriti, Gabriella/CAH-1780-2022; Frasca, Francesco/J-1332-2018; Vigneri, Riccardo/M-3968-2017	Pellegriti, Gabriella/0000-0001-6102-379X; Pellegriti, Gabriella/0000-0001-6102-379X; Frasca, Francesco/0000-0002-5556-3201; Vigneri, Riccardo/0000-0002-4401-3140; Gullo, Damiano/0000-0002-4034-6378	University of Catania; AIRC (Associazione Italiana Ricerca Cancro)	University of Catania; AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro)	This study has been sponsored by the University of Catania and was supported also by a grant from AIRC (Associazione Italiana Ricerca Cancro) to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA BM, 2010, F1000 MED REP   0511, P485; Alevizaki M, 2005, WIEN KLIN WOCHENSCHR, V117, P636, DOI 10.1007/s00508-005-0421-0; Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Cooper DS, 2008, JAMA-J AM MED ASSOC, V299, P817, DOI 10.1001/jama.299.7.817; Davey R, 1997, CLIN CHEM, V43, P2143; Dayan CM, 2009, NAT REV ENDOCRINOL, V5, P211, DOI 10.1038/nrendo.2009.19; de Jong FJ, 2007, J CLIN ENDOCR METAB, V92, P636, DOI 10.1210/jc.2006-1331; EscobarMorreale HF, 1995, J CLIN INVEST, V96, P2828, DOI 10.1172/JCI118353; Fadeyev Valentin V, 2005, Hormones (Athens), V4, P101; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Hennemann G, 2004, THYROID, V14, P271, DOI 10.1089/105072504323030924; Iverson Jennifer F, 2008, Endocr Pract, V14, P550; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; Kohrle J, 2005, ENDOCR REV, V26, P944, DOI 10.1210/er.2001-0034; Kratzsch J, 2005, CLIN CHEM, V51, P1480, DOI 10.1373/clinchem.2004.047399; Ma C, 2009, NUCL MED COMMUN, V30, P586, DOI 10.1097/MNM.0b013e32832c79e0; Meier C, 2003, BRIT MED J, V326, P311, DOI 10.1136/bmj.326.7384.311; Nygaard B, 2009, EUR J ENDOCRINOL, V161, P895, DOI 10.1530/EJE-09-0542; Panicker V, 2008, J CLIN ENDOCR METAB, V93, P3075, DOI 10.1210/jc.2008-0397; Panicker V, 2009, J CLIN ENDOCR METAB, V94, P1623, DOI 10.1210/jc.2008-1301; Regalbuto C, 2010, J ENDOCRINOL INVEST, V33, P300, DOI [10.1007/BF03346590, 10.3275/6715]; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; VISSER TJ, 1990, TRENDS ENDOCRIN MET, V1, P211, DOI 10.1016/1043-2760(90)90055-8; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Woeber KA, 2002, J ENDOCRINOL INVEST, V25, P106, DOI 10.1007/BF03343972; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	30	176	183	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22552	10.1371/journal.pone.0022552	http://dx.doi.org/10.1371/journal.pone.0022552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829633	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200012
J	Ren, YX; Liu, B; Feng, YX; Shu, L; Cao, XJ; Karaplis, A; Goltzman, D; Miao, DS				Ren, Yongxin; Liu, Bo; Feng, Yuxu; Shu, Lei; Cao, Xiaojian; Karaplis, Andrew; Goltzman, David; Miao, Dengshun			Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)	PLOS ONE			English	Article							PARATHYROID-HORMONE 1-34; BONE-MINERAL DENSITY; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN-D 1-ALPHA-HYDROXYLASE; PRIMARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; SKELETAL; OSTEOPOROSIS; CALCIUM; MICE	Background: Although the capacity of exogenous PTH1-34 to enhance the rate of bone repair is well established in animal models, our understanding of the mechanism(s) whereby PTH induces an anabolic response during skeletal repair remains limited. Furthermore it is unknown whether endogenous PTH is required for fracture healing and how the absence of endogenous PTH would influence the fracture-healing capacity of exogenous PTH. Methodology/Principal Findings: Closed mid-diaphyseal femur fractures were created and stabilized with an intramedullary pin in 8-week-old wild-type and Pth null (Pth(-/-)) mice. Mice received daily injections of vehicle or of PTH1-34 (80 mu g/kg) for 1-4 weeks post-fracture, and callus tissue properties were analyzed at 1, 2 and 4 weeks post-fracture. Cartilaginous callus areas were reduced at 1 week post-fracture, but were increased at 2 weeks post-fracture in vehicle-treated and PTH-treated Pth(-/-) mice compared to vehicle-treated and PTH-treated wild-type mice respectively. The mineralized callus areas, bony callus areas, osteoblast number and activity, osteoclast number and surface in callus tissues were all reduced in vehicle-treated and PTH-treated Pth(-/-) mice compared to vehicle-treated and PTH-treated wild-type mice, but were increased in PTH-treated wild-type and Pth(-/-) mice compared to vehicle-treated wild-type and Pth(-/-) mice. Conclusions/Significance: Absence of endogenous PTH1-84 impedes bone fracture healing. Exogenous PTH1-34 can act in the absence of endogenous PTH but callus formation, including accelerated endochondral bone formation and callus remodeling as well as mechanical strength of the bone are greater when endogenous PTH is present. Results of this study suggest a complementary role for endogenous PTH1-84 and exogenous PTH1-34 in accelerating fracture healing.	[Ren, Yongxin; Liu, Bo; Feng, Yuxu; Cao, Xiaojian] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Peoples R China; [Liu, Bo] Liyang Peoples Hosp, Dept Orthopaed, Changzhou, Peoples R China; [Ren, Yongxin; Feng, Yuxu; Shu, Lei; Miao, Dengshun] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China; [Karaplis, Andrew; Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University	Ren, YX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Natural Science Foundation of China [30901528, 30830103]; Kidney Foundation of Canada; Canadian Institutes for Health Research, Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kidney Foundation of Canada; Canadian Institutes for Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China to YX Ren (No. 30901528) and D Miao (No. 30830103), the Kidney Foundation of Canada to A Karaplis, and the Canadian Institutes for Health Research, Canada to D Goltzman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Andreassen TT, 1999, J BONE MINER RES, V14, P960, DOI 10.1359/jbmr.1999.14.6.960; Fukuhara H, 1989, Nihon Seikeigeka Gakkai Zasshi, V63, P100; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hodsman AB, 2003, J CLIN ENDOCR METAB, V88, P5212, DOI 10.1210/jc.2003-030768; Holzer G, 1999, CLIN ORTHOP RELAT R, P258, DOI 10.1097/00003086-199909000-00033; Jahng JS, 2000, ORTHOPEDICS, V23, P1089; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kim H W, 1999, Iowa Orthop J, V19, P71; LAW WM, 1984, J CLIN ENDOCR METAB, V59, P394, DOI 10.1210/jcem-59-3-394; Liu H, 2009, J ENDOCRINOL, V203, P203, DOI 10.1677/JOE-09-0247; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Miao DS, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-16; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; Nakazawa T, 2005, BONE, V37, P711, DOI 10.1016/j.bone.2005.06.013; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; PARISIEN M, 1990, J CLIN ENDOCR METAB, V70, P930, DOI 10.1210/jcem-70-4-930; Schmidmaier G, 2004, EUR J TRAUMA, V30, P35; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Sun W, 2010, DEVELOPMENT, V137, P985, DOI 10.1242/dev.045898; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Zhou H, 2001, J BONE MINER RES, V16, P1300, DOI 10.1359/jbmr.2001.16.7.1300	27	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23060	10.1371/journal.pone.0023060	http://dx.doi.org/10.1371/journal.pone.0023060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829585	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500072
J	Roselli, F; Livrea, P; Almeida, OFX				Roselli, Francesco; Livrea, Paolo; Almeida, Osborne F. X.			CDK5 Is Essential for Soluble Amyloid beta-Induced Degradation of GKAP and Remodeling of the Synaptic Actin Cytoskeleton	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; DENDRITIC SPINES; LIGHT-CHAIN; PROTEIN; PHOSPHORYLATION; PEPTIDE; FAMILY; PSD-95	The early stages of Alzheimer's disease are marked by synaptic dysfunction and loss. This process results from the disassembly and degradation of synaptic components, in particular of scaffolding proteins that compose the post-synaptic density (PSD), namely PSD95, Homer and Shank. Here we investigated in rat frontal cortex dissociated culture the mechanisms involved in the downregulation of GKAP (SAPAP1), which links the PSD95 complex to the Shank complex and cytoskeletal structures within the PSD. We show that A beta causes the rapid loss of GKAP from synapses through a pathway that critically requires cdk5 activity, and is set in motion by NMDAR activity and Ca2+ influx. We show that GKAP is a direct substrate of cdk5 and that its phosphorylation results in polyubiquitination and proteasomal degradation of GKAP and remodeling (collapse) of the synaptic actin cytoskeleton; the latter effect is abolished in neurons expressing GKAP mutants that are resistant to phosphorylation by cdk5. Given that cdk5 also regulates degradation of PSD95, these results underscore the central position of cdk5 in mediating A beta-induced PSD disassembly and synapse loss.	[Roselli, Francesco; Almeida, Osborne F. X.] Max Planck Inst Psychiat, Neuroadaptat Grp, D-80804 Munich, Germany; [Roselli, Francesco; Livrea, Paolo] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy	Max Planck Society; Universita degli Studi di Bari Aldo Moro	Roselli, F (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	Francesco.Roselli@fmi.ch; osa@mpipsykl.mpg.de	Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019; roselli, francesco/G-6701-2013	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899; Livrea, Paolo/0000-0001-7410-3860	Max Planck Institute of Psychiatry; University of Bari	Max Planck Institute of Psychiatry(Max Planck Society); University of Bari	FR was supported by a Max Planck Institute of Psychiatry fellowship and by the University of Bari PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAO F, 2011, NEUROBIOL AGING; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bongiorno-Borbone L, 2005, BIOCHEM BIOPH RES CO, V337, P641, DOI 10.1016/j.bbrc.2005.09.099; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Cambon K, 2003, NEUROSCIENCE, V122, P183, DOI 10.1016/S0306-4522(03)00597-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Edbauer D, 2009, MOL CELL PROTEOMICS, V8, P681, DOI 10.1074/mcp.M800233-MCP200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Futter M, 2005, P NATL ACAD SCI USA, V102, P3489, DOI 10.1073/pnas.0409802102; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirao K, 2000, GENES CELLS, V5, P203, DOI 10.1046/j.1365-2443.2000.00318.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Humbert S, 2000, J CELL SCI, V113, P975; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Prediger RDS, 2007, BEHAV BRAIN RES, V177, P205, DOI 10.1016/j.bbr.2006.11.032; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tirard M, 2004, J MOL ENDOCRINOL, V32, P825, DOI 10.1677/jme.0.0320825; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463	79	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23097	10.1371/journal.pone.0023097	http://dx.doi.org/10.1371/journal.pone.0023097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829588	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500075
J	Zhang, R; Pan, YT; He, SM; Lam, M; Brayer, GD; Elbein, AD; Withers, SG				Zhang, Ran; Pan, Yuan T.; He, Shouming; Lam, Michael; Brayer, Gary D.; Elbein, Alan D.; Withers, Stephen G.			Mechanistic Analysis of Trehalose Synthase from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIMELOBACTER SP R48; SACCHAROMYCES-CEREVISIAE; GLYCOSYL FLUORIDES; ALPHA-GLYCOSIDASES; ESCHERICHIA-COLI; CORD FACTOR; ENZYME; CLONING; TUBERCULOSIS; PURIFICATION	Trehalose synthase (TreS) catalyzes the reversible interconversion of maltose and trehalose and has been shown recently to function primarily in the mobilization of trehalose as a glycogen precursor. Consequently, the mechanism of this intriguing isomerase is of both academic and potential pharmacological interest. TreS catalyzes the hydrolytic cleavage of alpha-aryl glucosides as well as alpha-glucosyl fluoride, thereby allowing facile, continuous assays. Reaction of TreS with 5-fluoroglycosyl fluorides results in the trapping of a covalent glycosyl-enzyme intermediate consistent with TreS being a member of the retaining glycoside hydrolase family 13 enzyme family, thus likely following a two-step, double displacement mechanism. This trapped intermediate was subjected to protease digestion followed by LC-MS/MS analysis, and Asp(230) was thereby identified as the catalytic nucleophile. The isomerization reaction was shown to be an intramolecular process by demonstration of the inability of TreS to incorporate isotope-labeled exogenous glucose into maltose or trehalose consistent with previous studies on other TreS enzymes. The absence of a secondary deuterium kinetic isotope effect and the general independence of k(cat) upon leaving group ability both point to a rate-determining conformational change, likely the opening and closing of the enzyme active site.	[Zhang, Ran; He, Shouming; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Lam, Michael; Brayer, Gary D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z1, Canada; [Pan, Yuan T.; Elbein, Alan D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of British Columbia; University of British Columbia; University of Arkansas System; University of Arkansas Medical Sciences	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; BERVEN LA, 1986, CARBOHYD RES, V156, P282, DOI 10.1016/S0008-6215(00)90123-X; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Chen HM, 2007, CHEMBIOCHEM, V8, P719, DOI 10.1002/cbic.200700021; Chen YS, 2006, J AGR FOOD CHEM, V54, P7098, DOI 10.1021/jf060828q; Cielo CBC, 2010, ACTA CRYSTALLOGR F, V66, P397, DOI 10.1107/S1744309110006354; CLEGG JS, 1961, NATURE, V192, P1077, DOI 10.1038/1921077b0; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; ELBEIN AD, 2003, GLYCOBIOLOGY, V13, P27; GARCES E, 1969, BIOCHEMISTRY-US, V8, P633, DOI 10.1021/bi00830a026; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Higashiyama T, 2002, PURE APPL CHEM, V74, P1263, DOI 10.1351/pac200274071263; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kato M, 2000, BIOSCI BIOTECH BIOCH, V64, P319, DOI 10.1271/bbb.64.319; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; Kobayashi M., 2003, Journal of Applied Glycoscience, V50, P1; Koh S, 1998, BIOTECHNOL LETT, V20, P757, DOI 10.1023/A:1005342921339; Koh S, 2003, CARBOHYD RES, V338, P1339, DOI 10.1016/S0008-6215(03)00172-1; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; MARUTA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1829, DOI 10.1271/bbb.59.1829; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Nakada T, 1995, BIOSCI BIOTECH BIOCH, V59, P2215, DOI 10.1271/bbb.59.2215; Nakada T, 1995, BIOSCI BIOTECH BIOCH, V59, P2210, DOI 10.1271/bbb.59.2210; Nishimoto T, 1996, BIOSCI BIOTECH BIOCH, V60, P640, DOI 10.1271/bbb.60.640; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189, DOI 10.1271/bbb.59.2189; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Pan YT, 2004, EUR J BIOCHEM, V271, P4259, DOI 10.1111/j.1432-1033.2004.04365.x; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Rhimi M, 2008, BIOLOGIA, V63, P1020, DOI 10.2478/s11756-008-0166-0; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; TEWARI YB, 1991, BIOPHYS CHEM, V40, P59, DOI 10.1016/0301-4622(91)85029-P; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Tsusaki K, 1996, BBA-GEN SUBJECTS, V1290, P1, DOI 10.1016/0304-4165(96)00023-2; Tsusaki K, 1997, BBA-GEN SUBJECTS, V1334, P28, DOI 10.1016/S0304-4165(96)00103-1; Vocadlo DJ, 2002, BIOCHEMISTRY-US, V41, P9727, DOI 10.1021/bi020077v; Wang JH, 2007, J AGR FOOD CHEM, V55, P1256, DOI 10.1021/jf062355t; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yue M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-34; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2003, BIOCHEMISTRY-US, V42, P7195, DOI 10.1021/bi034329j; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang R, 2008, J ORG CHEM, V73, P3070, DOI 10.1021/jo702565q; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p; Zhu YM, 2010, EXTREMOPHILES, V14, P1, DOI 10.1007/s00792-009-0281-z	57	30	36	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35601	35609		10.1074/jbc.M111.280362	http://dx.doi.org/10.1074/jbc.M111.280362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21840994	Green Published, hybrid			2022-12-25	WOS:000295927100032
J	Dick, JM; Shock, EL				Dick, Jeffrey M.; Shock, Everett L.			Calculation of the Relative Chemical Stabilities of Proteins as a Function of Temperature and Redox Chemistry in a Hot Spring	PLOS ONE			English	Article							PARTIAL MOLAL PROPERTIES; YELLOWSTONE-NATIONAL-PARK; AMINO-ACID-COMPOSITION; THERMODYNAMIC PROPERTIES; HIGH-PRESSURES; TRANSPORT-PROPERTIES; HYDROTHERMAL ECOSYSTEMS; UNFOLDED PROTEINS; SOFTWARE PACKAGE; MICROBIAL MATS	Uncovering the chemical and physical links between natural environments and microbial communities is becoming increasingly amenable owing to geochemical observations and metagenomic sequencing. At the hot spring known as Bison Pool in Yellowstone National Park, the cooling of the water in the outflow channel is associated with an increase in oxidation potential estimated from multiple field-based measurements. Representative groups of proteins whose sequences were derived from metagenomic data also exhibit an increase in average oxidation state of carbon in the protein molecules with distance from the hot-spring source. The energetic requirements of reactions to form selected proteins used in the model were computed using amino-acid group additivity for the standard molal thermodynamic properties of the proteins, and the relative chemical stabilities of the proteins were investigated by varying temperature, pH and oxidation state, expressed as activity of dissolved hydrogen. The relative stabilities of the proteins were found to track the locations of the sampling sites when the calculations included a function for hydrogen activity that increases with temperature and is higher, or more reducing, than values consistent with measurements of dissolved oxygen, sulfide and oxidation-reduction potential in the field. These findings imply that spatial patterns in the amino acid compositions of proteins can be linked, through energetics of overall chemical reactions representing the formation of the proteins, to the environmental conditions at this hot spring, even if microbial cells maintain considerably different internal conditions. Further applications of the thermodynamic calculations are possible for other natural microbial ecosystems.	[Dick, Jeffrey M.; Shock, Everett L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Shock, Everett L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Dick, JM (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	jmdick@asu.edu	Dick, Jeffrey M/K-1619-2013	Dick, Jeffrey M/0000-0002-0687-5890; Shock, Everett/0000-0002-4283-0163	National Science Foundation [EAR-0847616]; Directorate For Geosciences [0826588] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under grant EAR-0847616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti C, 2007, NATURE, V445, P47, DOI 10.1038/nature05450; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Amend JP, 1998, SCIENCE, V281, P1659, DOI 10.1126/science.281.5383.1659; Amend JP, 2000, BIOPHYS CHEM, V84, P105, DOI 10.1016/S0301-4622(00)00116-2; Bard A. J., 1985, STANDARD POTENTIALS; Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Bowers TS, 1984, EQUILIBRIUM ACTIVITY, P397; Boyd ES, 2010, ISME J, P1; Buvet R, 1983, E MAJORANA INT SCI S, V11, P15; CALVERT JG, 1990, PURE APPL CHEM, V62, P2167, DOI 10.1351/pac199062112167; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; Curtis RA, 1998, BIOTECHNOL BIOENG, V57, P11, DOI 10.1002/(SICI)1097-0290(19980105)57:1<11::AID-BIT2>3.0.CO;2-Y; de Vendittis E, 2008, J THEOR BIOL, V250, P156, DOI 10.1016/j.jtbi.2007.09.006; Dick JM, 2006, BIOGEOSCIENCES, V3, P311, DOI 10.5194/bg-3-311-2006; Dick JM, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-10; Donder Th. De, 1927, AFFINITE; Drever J. I., 1988, GEOCHEMISTRY NATURAL; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Engel T., 2006, THERMODYNAMICS STAT; Erol A, 2002, EXTREMOPHILES, V6, P351, DOI 10.1007/s00792-001-0264-1; Haar L, 1984, NBS NRC STEAM TABLES; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; Hendrickson JB, 1970, ORGANIC CHEM; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Huber R, 1998, APPL ENVIRON MICROB, V64, P3576; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; International Union of Pure and Applied Chemistry, IUPAC COMP CHEM TERM; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; JOHNSON JW, 1991, AM J SCI, V291, P541, DOI 10.2475/ajs.291.6.541; Kroll JH, 2011, NATURE CHEM, P948; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaRowe DE, 2011, GEOCHIM COSMOCHIM AC, V75, P2030, DOI 10.1016/j.gca.2011.01.020; LYNCH JM, 1979, MICROBIAL ECOLOGY CO; Mallick P, 2002, P NATL ACAD SCI USA, V99, P9679, DOI 10.1073/pnas.142310499; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Masiello CA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000534; McCollom TM, 2005, GEOBIOLOGY, V3, P135, DOI 10.1111/j.1472-4669.2005.00045.x; McDonald JH, 2001, MOL BIOL EVOL, V18, P741, DOI 10.1093/oxfordjournals.molbev.a003856; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer- Dombard DR, 2011, ENV MICROBI IN PRESS; Nakashima H, 2003, J BIOCHEM, V133, P507, DOI 10.1093/jb/mvg067; NELSON PG, 1986, J CHEM EDUC, V63, P852, DOI 10.1021/ed063p852; Oijerholm J, 2009, J ELECTROCHEM SOC, V156, pP56, DOI 10.1149/1.3056125; Pfeil W., 1998, PROTEIN STABILITY FO; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RUFFROBERTS AL, 1994, APPL ENVIRON MICROB, V60, P697, DOI 10.1128/AEM.60.2.697-704.1994; Schulte MD, 2001, GEOCHIM COSMOCHIM AC, V65, P3919, DOI 10.1016/S0016-7037(01)00717-7; SENGERS JMHL, 1983, J PHYS CHEM REF DATA, V12, P1, DOI 10.1063/1.555676; Shock E, 2010, GEOFLUIDS, V10, P161, DOI 10.1111/j.1468-8123.2010.00277.x; SHOCK EL, 1992, J CHEM SOC FARADAY T, V88, P803, DOI 10.1039/ft9928800803; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; SHOCK EL, 1989, GEOCHIM COSMOCHIM AC, V53, P2157, DOI 10.1016/0016-7037(89)90341-4; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Swayer D.T., 1974, EXPT ELECTROCHEMISTR; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	67	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22782	10.1371/journal.pone.0022782	http://dx.doi.org/10.1371/journal.pone.0022782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853048	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400013
J	Geiser, V; Cahir-McFarland, E; Kieff, E				Geiser, Vicki; Cahir-McFarland, Ellen; Kieff, Elliott			Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells	PLOS ONE			English	Article							ORAL HAIRY LEUKOPLAKIA; NF-KAPPA-B; GROWTH TRANSFORMATION; IN-VIVO; SV40 TC-II(KAPPA-B); ACTIVATED CD40; INFECTION; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION	Epstein Barr Virus (EBV) replicates in oral epithelial cells and gains entry to B-lymphocytes. In B-lymphocytes, EBV expresses a restricted subset of genes, the Latency III program, which converts B-lymphocytes to proliferating lymphoblasts. Latent Membrane Protein 1 (LMP1) and the other Latency III associated proteins are also expressed during virus replication. LMP1 is essential for virus replication and egress from Akata Burkitt Lymphoma cells, but a role in epithelial cell replication has not been established. Therefore, we have investigated whether LMP1 enhances EBV replication and egress from HEK293 cells, a model epithelial cell line used for EBV recombinant molecular genetics. We compared wild type (wt) and LMP1-deleted (LMP1 Delta) EBV bacterial artificial chromosome (BAC) based virus replication and egress from HEK293. Following EBV immediate early Zta protein induction of EBV replication in HEK293 cells, similar levels of EBV proteins were expressed in wt-and LMP1 Delta-infected HEK293 cells. LMP1 deletion did not impair EBV replication associated DNA replication, DNA encapsidation, or mature virus release. Indeed, virus from LMP1 Delta-infected HEK293 cells was as infectious as EBV from wt EBV infected HEK cells. Trans-complementation with LMP1 reduced Rta expression and subsequent virus production. These data indicate that LMP1 is not required for EBV replication and egress from HEK293 cells.	[Geiser, Vicki] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Geiser, V (corresponding author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	ekieff@rics.bwh.harvard.edu			National Institutes of Health [CA085180]; NATIONAL CANCER INSTITUTE [R01CA085180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Public Health Service grant CA085180. VG is a fellow of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2005, J VIROL, V79, P4415, DOI 10.1128/JVI.79.7.4415-4424.2005; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Chang Y, 2004, J VIROL, V78, P13028, DOI 10.1128/JVI.78.23.13028-13036.2004; Chen A, 2005, J VIROL, V79, P4506, DOI 10.1128/JVI.79.7.4506-4509.2005; Chen A, 2006, J VIROL, V80, P10139, DOI 10.1128/JVI.00854-06; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Dirmeier U, 2003, CANCER RES, V63, P2982; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; HUEN DS, 1995, ONCOGENE, V10, P549; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; KANNO M, 1989, EMBO J, V8, P4205, DOI 10.1002/j.1460-2075.1989.tb08606.x; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KISHIMOTO T, 1977, CLIN EXP IMMUNOL, V30, P62; Kutok JL, 2004, J VIROL, V78, P3455, DOI 10.1128/JVI.78.7.3455-3461.2004; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lu CC, 2006, VIROLOGY, V345, P358, DOI 10.1016/j.virol.2005.09.064; MACCHI M, 1989, EMBO J, V8, P4215, DOI 10.1002/j.1460-2075.1989.tb08607.x; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; PARKER BD, 1990, VIROLOGY, V179, P339, DOI 10.1016/0042-6822(90)90302-8; Pich D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn273; Rickinson AB, 2006, FIELDS VIROLOGY, P2511; Seifi A, 2011, VIROLOGY, V410, P17, DOI 10.1016/j.virol.2010.10.023; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Walling DM, 2004, J INFECT DIS, V190, P396, DOI 10.1086/422039; WANG D, 1988, J VIROL, V62, P2337, DOI 10.1128/JVI.62.7.2337-2346.1988; Webster-Cyriaque J, 1998, VIROLOGY, V248, P53, DOI 10.1006/viro.1998.9268; Webster-Cyriaque J, 2000, J VIROL, V74, P7610, DOI 10.1128/JVI.74.16.7610-7618.2000; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; ZimberStrobl U, 1996, EMBO J, V15, P7070, DOI 10.1002/j.1460-2075.1996.tb01098.x	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22929	10.1371/journal.pone.0022929	http://dx.doi.org/10.1371/journal.pone.0022929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853056	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400018
J	Auvert, B; Mahiane, GS; Lissouba, P; Moreau, T				Auvert, Bertran; Mahiane, Guy Severin; Lissouba, Pascale; Moreau, Thierry			Statistical Power and Estimation of Incidence Rate Ratios Obtained from BED Incidence Testing for Evaluating HIV Interventions among Young People	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTION; RISK	Background: The objectives of this study were to determine the capacity of BED incidence testing to a) estimate the effect of a HIV prevention intervention and b) provide adequate statistical power, when used among young people from sub-Saharan African settings with high HIV incidence rates. Methods: Firstly, after having elaborated plausible scenarios based on empirical data and the characteristics of the BED HIV-1 Capture EIA (BED) assay, we conducted statistical calculations to determine the BED theoretical power and HIV incidence rate ratio (IRR) associated with an intervention when using BED incidence testing. Secondly, we simulated a cross-sectional study conducted in a population among whom an HIV intervention was rolled out. Simulated data were analyzed using a log-linear Poisson model to recalculate the IRR and its confidence interval, and estimate the BED practical power. Calculations were conducted with and without corrections for misclassifications. Results: Calculations showed that BED incidence testing can yield a BED theoretical power of 75% or more of the power that can be obtained in a classical cohort study conducted over a duration equal to the BED window period. Statistical analyses using simulated populations showed that the effect of a prevention intervention can be estimated with precision using classical statistical analysis of BED incidence testing data, even with an imprecise knowledge of the characteristics of the BED assay. The BED practical power was lower but of the same magnitude as the BED theoretical power. Conclusions: BED incidence testing can be applied to reasonably small samples to achieve good statistical power when used among young people to estimate IRR.	[Auvert, Bertran; Lissouba, Pascale] CESP INSERM UVSQ UMRS 1018, Villejuif, France; [Auvert, Bertran] Univ Versailles St Quentin, Versailles, France; [Auvert, Bertran] Hop Ambroise Pare, Assistance Publ Hop Paris, Boulogne, France; [Auvert, Bertran] IUF, Paris, France; [Mahiane, Guy Severin] Univ Stellenbosch, SACEMA, Stellenbosh, South Africa; [Moreau, Thierry] CESP INSERM Paris 11 UMRS 1018, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Stellenbosch University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Auvert, B (corresponding author), CESP INSERM UVSQ UMRS 1018, Villejuif, France.	bertran.auvert@uvsq.fr	Lissouba, Pascale/ABB-8815-2021	Lissouba, Pascale/0000-0002-4751-6894	Agence Nationale de Recherches sur le Sida et les hepatites virales (France) [ANRS-1265, ANRS-12126]; SACEMA; Stellenbosch University (South Africa); INSERM (France); University of Versailles - Saint-Quentin (France)	Agence Nationale de Recherches sur le Sida et les hepatites virales (France)(ANRS); SACEMA; Stellenbosch University (South Africa); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Versailles - Saint-Quentin (France)	Supported by ANRS-1265 and ANRS-12126, Agence Nationale de Recherches sur le Sida et les hepatites virales (France), SACEMA, Stellenbosch University (South Africa), INSERM (France) and the University of Versailles - Saint-Quentin (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAXIMA COMPUTER ALGE; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; Braunstein SL, 2009, AIDS REV, V11, P140; Brookmeyer R, 2009, J ACQ IMMUN DEF SYND, V54, P406; Fiamma A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-137; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; HOLFORD TR, 1980, BIOMETRICS, V36, P299, DOI 10.2307/2529982; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Team RDC, 2005, R LANG ENV STAT COMP; UNAIDS Reference Group on Estimates MaP, 2006, STAT US BED ASS EST; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21149	10.1371/journal.pone.0021149	http://dx.doi.org/10.1371/journal.pone.0021149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853019	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200001
J	Gray, LK; Hamann, A				Gray, Laura K.; Hamann, Andreas			Strategies for Reforestation under Uncertain Future Climates: Guidelines for Alberta, Canada	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; POPULATION DIFFERENTIATION; FOREST TREES; GROWTH; CONSERVATION; IMPACTS; DIEBACK	Background: Commercial forestry programs normally use locally collected seed for reforestation under the assumption that tree populations are optimally adapted to local environments. However, in western Canada this assumption is no longer valid because of climate trends that have occurred over the last several decades. The objective of this study is to show how we can arrive at reforestation recommendations with alternative species and genotypes that are viable under a majority of climate change scenarios. Methodology/Principal Findings: In a case study for commercially important tree species of Alberta, we use an ecosystem-based bioclimate envelope modeling approach for western North America to project habitat for locally adapted populations of tree species using multi-model climate projections for the 2020s, 2050s and 2080s. We find that genotypes of species that are adapted to drier climatic conditions will be the preferred planting stock over much of the boreal forest that is commercially managed. Interestingly, no alternative species that are currently not present in Alberta can be recommended with any confidence. Finally, we observe large uncertainties in projections of suitable habitat that make reforestation planning beyond the 2050s difficult for most species. Conclusion/Significance: More than 50,000 hectares of forests are commercially planted every year in Alberta. Choosing alternative planting stock, suitable for expected future climates, could therefore offer an effective climate change adaptation strategy at little additional cost. Habitat projections for locally adapted tree populations under observed climate change conform well to projections for the 2020s, which suggests that it is a safe strategy to change current reforestation practices and adapt to new climatic realities through assisted migration prescriptions.	[Gray, Laura K.; Hamann, Andreas] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Gray, LK (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	lkgray@gmail.com		Hamann, Andreas/0000-0003-2046-4550; Gray, Laura/0000-0003-0477-2705	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 349100-06]; Alberta Forest Research Institute; Alberta-Pacific Forest Industries; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Forest Research Institute; Alberta-Pacific Forest Industries; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC)/Industry Collaborative Development Grant CRDPJ 349100-06. Government funders included the NSERC and the Alberta Forest Research Institute. Industry co-sponsors included Alberta-Pacific Forest Industries, Ainsworth Engineered Canada LP, Daishowa-Marubeni International Ltd., Western Boreal Aspen Corporation, and Weyerhaeuser Company Ltd.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; AH received a research grant and LKG received a graduate student stipend that was co-funded by the commercial companies listed in the financial disclosure. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bechtold W.A., 2005, ENHANCED FOREST INVE, P85, DOI [10.2737/SRS-GTR-80, DOI 10.2737/SRS-GTR-80]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; EPA, 2007, EC MAPS GIS RES; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; *FLOR N AM ED COMM, 1993, FLOR N AM MEX; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; *GOV ALB, 2008, EC SIT INF SYST ESIS; Gray LK, 2011, ECOL APPL, V21, P1591, DOI 10.1890/10-1054.1; GRAY LK, 2011, THESIS U ALBERTA; Hamann A, 2005, CAN J FOREST RES, V35, P2553, DOI [10.1139/x05-181, 10.1139/X05-181]; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hogg EH, 1997, AGR FOREST METEOROL, V84, P115, DOI 10.1016/S0168-1923(96)02380-5; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mbogga M., 2010, COMPREHENSIVE SET IN; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; MEIDINGER D, 1991, SPECIAL REPORT RES B, V6; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; NRC, 2006, NAT REG SUBR ALB; R Core Team, 2021, R LANG ENV STAT COMP; Rweyongeza DM, 2010, SILVAE GENET, V59, P158, DOI 10.1515/sg-2010-0019; Rweyongeza DM, 2007, CAN J BOT, V85, P545, DOI 10.1139/B07-053; Selby CJ, 1996, NATL ECOLOGICAL FRAM; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; *SRD, 2005, STAND TREE IMPR ALB; SRD, 2009, ALB FOR GEN RES MAN; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Ying CC, 2006, FOREST ECOL MANAG, V227, P1, DOI 10.1016/j.foreco.2006.02.028	38	60	61	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22977	10.1371/journal.pone.0022977	http://dx.doi.org/10.1371/journal.pone.0022977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853061	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200031
J	Harvey, BK; Airavaara, M; Hinzman, J; Wires, EM; Chiocco, MJ; Howard, DB; Shen, H; Gerhardt, G; Hoffer, BJ; Wang, Y				Harvey, Brandon K.; Airavaara, Mikko; Hinzman, Jason; Wires, Emily M.; Chiocco, Matthew J.; Howard, Douglas B.; Shen, Hui; Gerhardt, Greg; Hoffer, Barry J.; Wang, Yun			Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; NMDA RECEPTOR; UP-REGULATION; ASPARTATE; DAMAGE; NEUROPROTECTION; INDUCTION; TOLERANCE; ELEVATION; BLOCKADE	Following the onset of an ischemic brain injury, the excitatory neurotransmitter glutamate is released. The excitotoxic effects of glutamate are a major contributor to the pathogenesis of a stroke. The aim of this study was to examine if overexpression of a glutamate transporter (GLT-1) reduces ischemic brain injury in a rat model of stroke. We generated an adeno-associated viral (AAV) vector expressing the rat GLT-1 cDNA (AAV-GLT1). Functional expression of AAV-GLT1 was confirmed by increased glutamate clearance rate in non-stroke rat brain as measured by in vivo amperometry. AAV-GLT1 was injected into future cortical region of infarction 3 weeks prior to 60 min middle cerebral artery occlusion (MCAo). Tissue damage was assessed at one and two days after MCAo using TUNEL and TTC staining, respectively. Behavioral testing was performed at 2, 8 and 14 days post-stroke. Animals receiving AAV-GLT1, compared to AAV-GFP, showed significant decreases in the duration and magnitude of extracellular glutamate, measured by microdialysis, during the 60 minute MCAo. A significant reduction in brain infarction and DNA fragmentation was observed in the region of AAV-GLT1 injection. Animals that received AAV-GLT1 showed significant improvement in behavioral recovery following stroke compared to the AAV-GFP group. We demonstrate that focal overexpression of the glutamate transporter, GLT-1, significantly reduces ischemia-induced glutamate overflow, decreases cell death and improves behavioral recovery. These data further support the role of glutamate in the pathogenesis of ischemic damage in brain and demonstrate that targeted gene delivery to decrease the ischemia-induced glutamate overflow reduces the cellular and behavioral deficits caused by stroke.	[Harvey, Brandon K.; Airavaara, Mikko; Wires, Emily M.; Chiocco, Matthew J.; Howard, Douglas B.; Shen, Hui; Hoffer, Barry J.; Wang, Yun] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA; [Hinzman, Jason; Gerhardt, Greg] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Ctr Microelectrode Technol, Lexington, KY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Kentucky	Harvey, BK (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA.	bharvey@mail.nih.gov	Harvey, Brandon Keith/AAY-4080-2021; Harvey, Brandon K/A-5559-2010	Harvey, Brandon Keith/0000-0002-4036-1383; Howard, Doug/0000-0002-4163-5956; Airavaara, Mikko/0000-0002-2026-1609	National Institute on Drug Abuse;  [F31NS067899];  [DA017186]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS067899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, ZIADA000461, R01DA017186, ZIADA000443, ZIADA000429, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Intramural Program of the National Institute on Drug Abuse. In addition, support was received from F31NS067899 (Jason Hinzman) and DA017186 (Greg Gerhardt). Because Greg Gerhardt is an owner of Quanteon, LLC, where the microelectrodes were purchased, it could be considered a funder, although no money was received from Quanteon, LLC. Microelectrodes were purchased from Quanteon, LLC because it is the only company that makes this type of multielectrode for in vivo amperometry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Baker DA, 2003, ANN NY ACAD SCI, V1003, P349, DOI 10.1196/annals.1300.023; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Behar TN, 1999, J NEUROSCI, V19, P4449; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chu K, 2006, STROKE, V37, P730; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Garber K, 2007, NAT BIOTECHNOL, V25, P837, DOI 10.1038/nbt0807-838; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Lin SZ, 1996, STROKE, V27, P747, DOI 10.1161/01.STR.27.4.747; Lowery RL, 2009, DEV NEUROBIOL, V69, P674, DOI 10.1002/dneu.20735; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Wang Y, 2003, J NEUROSCI, V23, P7958; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zhou FC, 1996, J NEUROSCI, V16, P6965	35	76	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22135	10.1371/journal.pone.0022135	http://dx.doi.org/10.1371/journal.pone.0022135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853027	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200008
J	Marais, GAB; Forrest, A; Kamau, E; Kafer, J; Daubin, V; Charlesworth, D				Marais, Gabriel A. B.; Forrest, Alan; Kamau, Esther; Kaefer, Jos; Daubin, Vincent; Charlesworth, Deborah			Multiple Nuclear Gene Phylogenetic Analysis of the Evolution of Dioecy and Sex Chromosomes in the Genus Silene	PLOS ONE			English	Article							Y-CHROMOSOME; PLANT SILENE; CHLOROPLAST DNA; RETICULATE EVOLUTION; SUBSTITUTION RATES; BREEDING SYSTEM; CARYOPHYLLACEAE; LATIFOLIA; SELECTION; MODEL	In the plant genus Silene, separate sexes and sex chromosomes are believed to have evolved twice. Silene species that are wholly or largely hermaphroditic are assumed to represent the ancestral state from which dioecy evolved. This assumption is important for choice of outgroup species for inferring the genetic and chromosomal changes involved in the evolution of dioecy, but is mainly based on data from a single locus (ITS). To establish the order of events more clearly, and inform outgroup choice, we therefore carried out (i) multi-nuclear-gene phylogenetic analyses of 14 Silene species (including 7 hermaphrodite or gynodioecious species), representing species from both Silene clades with dioecious members, plus a more distantly related outgroup, and (ii) a BayesTraits character analysis of the evolution of dioecy. We confirm two origins of dioecy within this genus in agreement with recent work on comparing sex chromosomes from both clades with dioecious species. We conclude that sex chromosomes evolved after the origin of Silene and within a clade that includes only S. latifolia and its closest relatives. We estimate that sex chromosomes emerged soon after the split with the ancestor of S. viscosa, the probable closest non-dioecious S. latifolia relative among the species included in our study.	[Marais, Gabriel A. B.; Kaefer, Jos; Daubin, Vincent] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Forrest, Alan; Kamau, Esther; Charlesworth, Deborah] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Edinburgh	Marais, GAB (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	gabriel.marais@univ-lyon1.fr	Käfer, Jos/AAR-1547-2021; Käfer, Jos/E-7714-2017	Käfer, Jos/0000-0002-0561-8008; Käfer, Jos/0000-0002-0561-8008; Daubin, Vincent/0000-0001-8269-9430; Forrest, Alan/0000-0003-2752-4819	Natural Environment Research Council (United Kingdom); Agence National de la Recherche [ANR-08-JCJC-0109]; BBSRC [BB/E020909/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020909/1] Funding Source: researchfish	Natural Environment Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Agence National de la Recherche(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DC, AF and EK acknowledge support from Natural Environment Research Council (United Kingdom), and GM and JK from Agence National de la Recherche (grant number ANR-08-JCJC-0109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov I, 2001, MOL BIOL EVOL, V18, P2162, DOI 10.1093/oxfordjournals.molbev.a003762; Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; Bergero R, UNPUB; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B., 1999, SEX DETERMINATION PL, P25; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Criscuolo A, 2006, SYST BIOL, V55, P740, DOI 10.1080/10635150600969872; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Darwin C, 1877, EFFECTS CROSS SELF F; Desfeux C, 1996, CR ACAD SCI III-VIE, V319, P351; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Dorken ME, 2004, P ROY SOC B-BIOL SCI, V271, P213, DOI 10.1098/rspb.2003.2580; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Eggens F, 2007, AM J BOT, V94, P210, DOI 10.3732/ajb.94.2.210; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Filatov DA, 2002, MOL BIOL EVOL, V19, P898, DOI 10.1093/oxfordjournals.molbev.a004147; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Frajman B, 2007, MOL PHYLOGENET EVOL, V43, P140, DOI 10.1016/j.ympev.2006.11.003; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heilbuth JC, 2000, AM NAT, V156, P221, DOI 10.1086/303389; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jurgens A, 2002, SEX PLANT REPROD, V14, P279, DOI 10.1007/s00497-001-0124-2; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Laporte V, 2005, J EVOLUTION BIOL, V18, P337, DOI 10.1111/j.1420-9101.2004.00833.x; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Li GL, 2008, SYST BIOL, V57, P647, DOI 10.1080/10635150802203898; Liden M, 2000, NORD J BOT, V20, P513, DOI 10.1111/j.1756-1051.2000.tb01595.x; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Mabberley DJ, 1997, PLANT BOOK; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Matsunaga S, 2002, GENOME, V45, P745, DOI 10.1139/G02-026; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Mrackova M, 2008, GENETICS, V179, P1129, DOI 10.1534/genetics.107.085670; Muir G, 2007, GENETICS, V177, P1239, DOI 10.1534/genetics.107.071969; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; OXELMAN B, 1995, TAXON, V44, P525, DOI 10.2307/1223498; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu S, 2010, P ROY SOC B-BIOL SCI, V277, P3283, DOI 10.1098/rspb.2010.0606; Rannala B, 2003, GENETICS, V164, P1645; Rautenberg A, 2010, MOL PHYLOGENET EVOL, V57, P978, DOI 10.1016/j.ympev.2010.08.003; Rautenberg A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-299; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Renner SS, 2001, SYST BIOL, V50, P700, DOI 10.1080/106351501753328820; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Touzet P, 2009, GENETICS, V181, P631, DOI 10.1534/genetics.108.092411; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zluvova J, 2005, EVOL DEV, V7, P327, DOI 10.1111/j.1525-142X.2005.05038.x	75	27	27	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21915	10.1371/journal.pone.0021915	http://dx.doi.org/10.1371/journal.pone.0021915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853022	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200003
J	Chander, H; Halpern, M; Resnick-Silverman, L; Manfredi, JJ; Germain, D				Chander, Harish; Halpern, Max; Resnick-Silverman, Lois; Manfredi, James J.; Germain, Doris			Skp2B Overexpression Alters a Prohibitin-p53 Axis and the Transcription of PAPP-A, the Protease of Insulin-Like Growth Factor Binding Protein 4	PLOS ONE			English	Article							GENE-EXPRESSION; MUTANT P53; EARLY RECURRENCE; GADD45 GENE; WILD-TYPE; GAIN; IGF; ACTIVATION; MECHANISM; CHAPERONE	Background: We previously reported that the degradation of prohibitin by the SCFSkp2B ubiquitin ligase results in a defect in the activity of p53. We also reported that MMTV-Skp2B transgenic mice develop mammary gland tumors that are characterized by an increased proteolytic cleavage of the insulin-like growth factor binding protein 4 (IGFBP-4), an inhibitor of IGF signaling. However, whether a link exists between a defect in p53 activity and proteolysis of IGFBP-4 was not established. Methods and Results: We analyzed the levels of pregnancy-associated plasma protein A (PAPP-A), the protease of IGFBP-4, in MMTV-Skp2B transgenic mice and found that PAPP-A levels are elevated. Further, we found a p53 binding site in intron 1 of the PAPP-A gene and that both wild type and mutant p53 bind to this site. However, binding of wild type p53 results in the transcriptional repression of PAPP-A, while binding of mutant p53 results in the transcriptional activation of PAPP-A. Since MMTV-Skp2B mice express wild type p53 and yet show elevated levels of PAPP-A, at first, these observations appeared contradictory. However, further analysis revealed that the defect in p53 activity in Skp2B overexpressing cells does not only abolish the activity of wild type of p53 but actually mimics that of mutant p53. Our results suggest that in absence of prohibitin, the half-life of p53 is increased and like mutant p53, the conformation of p53 is denatured. Conclusions: These observations revealed a novel function of prohibitin as a chaperone of p53. Further, they suggest that binding of denatured p53 in intron 1 causes an enhancer effect and increases the transcription of PAPP-A. Therefore, these findings indicate that the defect in p53 function and the increased proteolysis of IGFBP-4, we had observed, represent two components of the same pathway, which contributes to the oncogenic function of Skp2B.	[Chander, Harish; Halpern, Max; Germain, Doris] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA; [Resnick-Silverman, Lois; Manfredi, James J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chander, H (corresponding author), Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA.	doris.germain@mssm.edu			NIH [CA109482, CA086001]; NATIONAL CANCER INSTITUTE [R01CA086001, R01CA109482] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by an NIH RO1 grant # CA109482 to D.G. and by an NIH R01 grant # CA086001 to J.M. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Bulut I, 2009, AM J MED SCI, V337, P241, DOI 10.1097/MAJ.0b013e31818967a3; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Chander H, 2010, EMBO REP, V11, P220, DOI 10.1038/embor.2010.2; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Janus F, 1999, MOL CELL BIOL, V19, P2155; Kobayashi S, 2008, BREAST CANCER-TOKYO, V15, P153, DOI 10.1007/s12282-008-0034-3; KUHAJDA FP, 1985, AM J PATHOL, V121, P342; KUHAJDA FP, 1985, LAB INVEST, V53, P101; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshman E, 2002, BREAST CANCER RES, V4, P231, DOI 10.1186/bcr535; Mussi P, 2006, P NATL ACAD SCI USA, V103, P16716, DOI 10.1073/pnas.0607768103; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tanaka Y, 2004, INT J CANCER, V109, P336, DOI 10.1002/ijc.11700; Umanskaya K, 2007, MOL CELL BIOL, V27, P7615, DOI 10.1128/MCB.01239-07; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Yang XL, 1999, ONCOGENE, V18, P4546, DOI 10.1038/sj.onc.1202843; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724	35	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22456	10.1371/journal.pone.0022456	http://dx.doi.org/10.1371/journal.pone.0022456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829624	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200019
J	Yip, WK; Cheng, ASL; Zhu, RX; Lung, RWM; Tsang, DPF; Lau, SSK; Chen, YC; Sung, JG; Lai, PBS; Ng, EKO; Yu, J; Wong, N; To, KF; Wong, VWS; Sung, JJY; Chan, HLY				Yip, Wing-Kit; Cheng, Alfred Sze-Lok; Zhu, Ranxu; Lung, Raymond Wai-Ming; Tsang, Daisy Pui-Fong; Lau, Suki Shuk-Kei; Chen, Yangchao; Sung, Jonathan Gabriel; Lai, Paul Bo-San; Enders Kai-On Ng; Yu, Jun; Wong, Nathalie; To, Ka-Fai; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen			Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development	PLOS ONE			English	Article							VIRUS-X PROTEIN; HEPATITIS-B; UP-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; DOWN-REGULATION; INCREASED RISK; LIVER-CANCER; EXPRESSION; GROWTH	Background: The biological pathways and functional properties by which misexpressed microRNAs (miRNAs) contribute to liver carcinogenesis have been intensively investigated. However, little is known about the upstream mechanisms that deregulate miRNA expressions in this process. In hepatocellular carcinoma (HCC), hepatitis B virus (HBV) X protein (HBx), a transcriptional trans-activator, is frequently expressed in truncated form without carboxyl-terminus but its role in miRNA expression and HCC development is unclear. Methods: Human non-tumorigenic hepatocytes were infected with lentivirus-expressing full-length and carboxyl-terminal truncated HBx (Ct-HBx) for cell growth assay and miRNA profiling. Chromatin immunoprecipitation microarray was performed to identify the miRNA promoters directly associated with HBx. Direct transcriptional control was verified by luciferase reporter assay. The differential miRNA expressions were further validated in a cohort of HBV-associated HCC tissues using real-time PCR. Results: Hepatocytes expressing Ct-HBx grew significantly faster than the full-length HBx counterparts. Ct-HBx decreased while full-length HBx increased the expression of a set of miRNAs with growth-suppressive functions. Interestingly, Ct-HBx bound to and inhibited the transcriptional activity of some of these miRNA promoters. Notably, some of the examined repressed-miRNAs (miR-26a, -29c, -146a and -190) were also significantly down-regulated in a subset of HCC tissues with carboxyl-terminal HBx truncation compared to their matching non-tumor tissues, highlighting the clinical relevance of our data. Conclusion: Our results suggest that Ct-HBx directly regulates miRNA transcription and in turn promotes hepatocellular proliferation, thus revealing a viral contribution of miRNA deregulation during hepatocarcinogenesis.	[Yip, Wing-Kit; Cheng, Alfred Sze-Lok; Zhu, Ranxu; Tsang, Daisy Pui-Fong; Lau, Suki Shuk-Kei; Sung, Jonathan Gabriel; Lai, Paul Bo-San; Enders Kai-On Ng; Yu, Jun; To, Ka-Fai; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China; [Yip, Wing-Kit; Zhu, Ranxu; Tsang, Daisy Pui-Fong; Chen, Yangchao; Sung, Jonathan Gabriel; Yu, Jun; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Lung, Raymond Wai-Ming; Wong, Nathalie; To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China; [Lai, Paul Bo-San] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Yip, WK (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.	alfredcheng@cuhk.edu.hk	Chen, Yangchao/AAG-2127-2019; Ng, Enders/T-3881-2019; Cheng, Alfred SL/C-3327-2014; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015; Wong, Vincent WS/K-3864-2014; Ng, Enders K.O./F-2787-2010; LUNG, Raymond Wai-ming/D-1274-2014; Lai, Paul BS/K-8556-2015; Raymond, Lung/G-3200-2011; Sung, Jonathan/ABB-9563-2021; Chan, Henry Lik-Yuen/B-9636-2008	Chen, Yangchao/0000-0002-0249-3414; Ng, Enders/0000-0002-6955-0030; Cheng, Alfred SL/0000-0003-2345-6951; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Wong, Vincent WS/0000-0003-2215-9410; Ng, Enders K.O./0000-0002-6955-0030; LUNG, Raymond Wai-ming/0000-0002-0813-7429; Lai, Paul BS/0000-0002-9469-6728; Raymond, Lung/0000-0002-0813-7429; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Ng, Enders Kai-on/0000-0002-5293-3529	Hong Kong Government [08070332, 09080042]; Research Grants Council [09/060/GRF, 462309]; Collaborative Research Fund [CUHK04/CRF/08]	Hong Kong Government; Research Grants Council(Hong Kong Research Grants Council); Collaborative Research Fund	This work was supported by grants from the Hong Kong Government Research Fund for the Control of Infectious Diseases (08070332) to AS-LC, JJ-YS and HL-YC; (09080042) to AS-LC and JJ-YS; from the Research Grants Council General Research Fund (09/060/GRF and 462309) to AS-LC and JJ-YS; and from the Collaborative Research Fund (CUHK04/CRF/08) to AS-LC, NW and K-FT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1990, JPN J CANCER RES, V81, P1265, DOI 10.1111/j.1349-7006.1990.tb02689.x; Bock CT, 2008, INTERVIROLOGY, V51, P432, DOI 10.1159/000209672; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Brown JJ, 2000, HEPATOLOGY, V31, P173, DOI 10.1002/hep.510310126; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chan HLY, 2006, SEMIN LIVER DIS, V26, P153, DOI 10.1055/s-2006-939753; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Cheng ASL, 2008, BIOCHEM BIOPH RES CO, V374, P175, DOI 10.1016/j.bbrc.2008.06.098; Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cheng ASL, 2004, MODERN PATHOL, V17, P1169, DOI 10.1038/modpathol.3800196; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Cheng B, 2010, LIVER INT, V30, P319, DOI 10.1111/j.1478-3231.2009.02167.x; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; Fabbri M, 2008, CURR OPIN INVEST DR, V9, P583; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feitelson MA, 1997, AM J PATHOL, V150, P1141; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Iavarone M, 2003, J HEPATOL, V39, P253, DOI 10.1016/S0168-8278(03)00217-4; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lee ATC, 2005, J BIOL CHEM, V280, P33525, DOI 10.1074/jbc.M506628200; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; MA YL, 2010, J CELL MOL IN PRESS; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Su JM, 2007, HEPATOLOGY, V46, P402, DOI 10.1002/hep.21675; Sung JJY, 2008, J VIROL, V82, P3604, DOI 10.1128/JVI.01197-07; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Tu H, 2001, CANCER RES, V61, P7803; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893	68	64	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22888	10.1371/journal.pone.0022888	http://dx.doi.org/10.1371/journal.pone.0022888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829663	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200034
J	Wan, NK; Yao, Z; Finkbeiner, WE; Verkman, AS				Wan Namkung; Yao, Zhen; Finkbeiner, Walter E.; Verkman, A. S.			Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction	FASEB JOURNAL			English	Article						CaCC; cystic fibrosis; dry mouth; intestinal motility; drug discovery	CA2+-ACTIVATED CL-CHANNELS; CYSTIC-FIBROSIS; INTERSTITIAL-CELLS; FLUID SECRETION; ACINAR-CELLS; GLAND-CELLS; IN-VITRO; INHIBITORS; EXPRESSION; THERAPY	TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of similar to 110,000 compounds revealed compounds that activated TMEM16A CaCC conductance without increasing cytoplasmic Ca2+. By patch-clamp, N-aroylaminothiazole "activators" (E-act) strongly increased Cl- current at 0 Ca2+, whereas tetrazolylbenzamide "potentiators" (Fact) were not active at 0 Ca2+ but reduced the EC50 for Ca2+-dependent TMEM16A activation. Of 682 analogs tested, the most potent activator (E-act) and potentiator (F-act) produced large and more sustained CaCC Cl- currents than general agonists of Ca2+ signaling, with EC50 3-6 mu M and Cl- conductance comparable to that induced transiently by Ca2+-elevating purinergic agonists. Analogs of activators were identified that fully inhibited TMEM16A Cl- conductance, providing further evidence for direct TMEM16A binding. The TMEM16A activators increased CaCC conductance in human salivary and airway submucosal gland epithelial cells, and IL-4 treated bronchial cells, and stimulated submucosal gland secretion in human bronchi and smooth muscle contraction in mouse intestine. Small-molecule, TMEM16A-targeted activators may be useful for drug therapy of cystic fibrosis, dry mouth, and gastrointestinal hypomotility disorders, and for pharmacological dissection of TMEM16A function.-Namkung, W., Yao, Z., Finkbeiner, W. E., Verkman, A. S. Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. FASEB J. 25, 4048-4062 (2011). www.fasebj.org	[Wan Namkung; Yao, Zhen; Verkman, A. S.] Univ Calif San Francisco, Dept Med & Physiol, San Francisco, CA 94143 USA; [Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med & Physiol, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			NIH [DK72517, HL73856, DK35124, DK86125, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, RC1DK086125, P30DK072517, R37DK035124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Dennis W. Nielson (Department of Pediatrics, University of California, San Francisco) and Dr. Jae-Woo Lee (Department of Anesthesia and Perioperative Care, University of California, San Francisco) for human airway tissues. This work was supported by NIH grants DK72517, HL73856, DK35124, DK86125, EB00415, and EY13574 and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.	Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cheng JF, 2006, J MED CHEM, V49, P1517, DOI 10.1021/jm050109n; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; DiMauro EF, 2006, J MED CHEM, V49, P5671, DOI 10.1021/jm0605482; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Finkbeiner WE, 2010, IN VITRO CELL DEV-AN, V46, P450, DOI 10.1007/s11626-009-9262-x; Fischer H, 2010, AM J PHYSIOL-LUNG C, V299, pL585, DOI 10.1152/ajplung.00421.2009; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P760, DOI 10.1111/j.1365-2982.2011.01729.x; KAWAMATSU Y, 1981, EUR J MED CHEM, V16, P355; Kellerman D, 2008, PULM PHARMACOL THER, V21, P600, DOI 10.1016/j.pupt.2007.12.003; Lee K, 2010, EUR J MED CHEM, V45, P5420, DOI 10.1016/j.ejmech.2010.09.002; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Levin MH, 2006, J BIOL CHEM, V281, P25803, DOI 10.1074/jbc.M604332200; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Mokale SN, 2010, EUR J MED CHEM, V45, P3096, DOI 10.1016/j.ejmech.2010.03.043; Munchhof MJ, 2009, BIOORG MED CHEM LETT, V19, P1428, DOI 10.1016/j.bmcl.2009.01.032; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Satoh A, 2009, BIOORG MED CHEM LETT, V19, P5464, DOI 10.1016/j.bmcl.2009.07.097; Scheiff AB, 2010, BIOORGAN MED CHEM, V18, P2195, DOI 10.1016/j.bmc.2010.01.072; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shipps GW, 2005, BIOORG MED CHEM LETT, V15, P115, DOI 10.1016/j.bmcl.2004.10.024; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; Stadelmann B, 2010, J ANTIMICROB CHEMOTH, V65, P512, DOI 10.1093/jac/dkp490; Steiner I, 2008, N-S ARCH PHARMACOL, V378, P323, DOI 10.1007/s00210-008-0293-8; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; White April F, 2006, Med Chem, V2, P499, DOI 10.2174/157340606778250180; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	46	142	148	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					4048	4062		10.1096/fj.11-191627	http://dx.doi.org/10.1096/fj.11-191627			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21836025	Green Published			2022-12-25	WOS:000296723100028
J	Huang, HQ; Huang, SF; Yu, YC; Yuan, SC; Li, R; Wang, X; Zhao, HC; Yu, YH; Li, J; Yang, MY; Xu, LQ; Chen, SW; Xu, AL				Huang, Huiqing; Huang, Shengfeng; Yu, Yingcai; Yuan, Shaochun; Li, Rui; Wang, Xin; Zhao, Hongchen; Yu, Yanhong; Li, Jun; Yang, Manyi; Xu, Liqun; Chen, Shangwu; Xu, Anlong			Functional Characterization of a Ficolin-mediated Complement Pathway in Amphioxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; IMMUNE GENE REPERTOIRE; BRANCHIOSTOMA-BELCHERI; FIBRINOGEN-LIKE; PROTEIN; ORIGIN; SYSTEM; INSIGHTS; CLONING; C1Q	The ficolin-mediated complement pathway plays an important role in vertebrate immunity, but it is not clear whether this pathway exists in invertebrates. Here we identified homologs of ficolin pathway components from the cephalochordate amphioxus and investigated whether they had been co-opted into a functional ficolin pathway. Four of these homologs, ficolin FCN1, serine protease MASP1 and MASP3, and complement component C3, were highly expressed in mucosal tissues and gonads, and were significantly up-regulated following bacterial infection. Recombinant FCN1 could induce hemagglutination, discriminate among sugar components, and specifically recognize and aggregate several bacteria (especially Gram-positive strains) without showing bactericidal activity. This suggested that FCN1 is a dedicated pattern-recognition receptor. Recombinant serine protease MASP1/3 formed complexes with recombinant FCN1 and facilitated the activation of native C3 protein in amphioxus humoral fluid, in which C3 acted as an immune effector. We conclude that amphioxus have developed a functional ficolin-complement pathway. Because ficolin pathway components have not been reported in non-chordate species, our findings supported the idea that this pathway may represent a chordate-specific innovation in the evolution of the complement system.	[Huang, Huiqing; Huang, Shengfeng; Yu, Yingcai; Yuan, Shaochun; Li, Rui; Wang, Xin; Zhao, Hongchen; Li, Jun; Yang, Manyi; Xu, Liqun; Chen, Shangwu; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Dept Biochem,Natl Engn Res Ctr S China Sea Marine, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Yanhong] Jinan Univ, Inst Reprod Immunol, Guangzhou 510632, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University	Xu, AL (corresponding author), Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Dept Biochem,Natl Engn Res Ctr S China Sea Marine, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Yuan, Shaochun/GQB-5134-2022	Yu, Yanhong/0000-0002-1652-201X; Huang, Shengfeng/0000-0002-0968-1370	National Basic Research Program (973) [2007CB815800, 2011CB946101]; State High-Tech Development Project (863) [2008AA092603]; Ministry of Science and Technology of China [2007DFA30840]; Ministry of Education [0107]; National Natural Science Foundation of China [30901103, 30730089]; Commission of Science and Technology of Guangdong Province and Guangzhou City; Sun Yet-sen University Science Foundation	National Basic Research Program (973)(National Basic Research Program of China); State High-Tech Development Project (863)(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Commission of Science and Technology of Guangdong Province and Guangzhou City; Sun Yet-sen University Science Foundation	This work was supported by Projects 2007CB815800 and 2011CB946101 of the National Basic Research Program (973), Project 2008AA092603 of the State High-Tech Development Project (863), and 2007DFA30840 (International S&T Cooperation Program) from the Ministry of Science and Technology of China; Key Project (0107) from the Ministry of Education; Key Project (30901103) and Project (30730089) from the National Natural Science Foundation of China; and projects from the Commission of Science and Technology of Guangdong Province and Guangzhou City and from Sun Yet-sen University Science Foundation.	Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Endo Y, 2003, J IMMUNOL, V170, P4701, DOI 10.4049/jimmunol.170.9.4701; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019; Fan CX, 2007, INT J BIOCHEM CELL B, V39, P450, DOI 10.1016/j.biocel.2006.09.013; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; ICHIJO H, 1993, J BIOL CHEM, V268, P14505; ICHIJO H, 1991, J BIOL CHEM, V266, P22459; Kadirvelraj R, 2006, P NATL ACAD SCI USA, V103, P8149, DOI 10.1073/pnas.0602815103; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schlapbach LJ, 2009, CLIN EXP IMMUNOL, V157, P83, DOI 10.1111/j.1365-2249.2009.03957.x; Sekine H, 2001, J IMMUNOL, V167, P4504, DOI 10.4049/jimmunol.167.8.4504; Smith LC, 1998, J IMMUNOL, V161, P6784; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Takahashi M, 2006, J IMMUNOL, V176, P4861, DOI 10.4049/jimmunol.176.8.4861; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207; Zhang XL, 2008, ADV EXP MED BIOL, V632, P105, DOI 10.1007/978-0-387-78952-1_9; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	51	28	34	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36739	36748		10.1074/jbc.M111.245944	http://dx.doi.org/10.1074/jbc.M111.245944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832079	Green Published, hybrid			2022-12-25	WOS:000296538300056
J	Wurie, HR; Buckett, L; Zammit, VA				Wurie, Haja R.; Buckett, Linda; Zammit, Victor A.			Evidence That Diacylglycerol Acyltransferase 1 (DGAT1) Has Dual Membrane Topology in the Endoplasmic Reticulum of HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; RAT-LIVER MICROSOMES; TRIACYLGLYCEROL SYNTHESIS; CARNITINE ACYLTRANSFERASES; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; ACYL-COA; SECRETION; OVERT; IDENTIFICATION	Triacylglycerol (TAG) synthesis and secretion are important functions of the liver that have major impacts on health, as over-accumulation of TAG within the liver (steatosis) or hypersecretion of TAG within very low density lipoproteins (VLDL) both have deleterious metabolic consequences. Two diacylglycerol acyltransferases (DGATs 1 and 2) can catalyze the final step in the synthesis of TAG from diacylglycerol, which has been suggested to play an important role in the transfer of the glyceride moiety across the endoplasmic reticular membrane for (re)synthesis of TAG on the lumenal aspect of the endoplasmic reticular (ER) membrane (Owen, M., Corstorphine, C. C., and Zammit, V. A. (1997) Biochem. J. 323, 17-21). Recent topographical studies suggested that the oligomeric enzyme DGAT1 is exclusively lumen facing (latent) in the ER membrane. By contrast, in the present study, using two specific inhibitors of human DGAT1, we present evidence that DGAT1 has a dual topology within the ER of HepG2 cells, with approximately equal DGAT1 activities exposed on the cytosolic and lumenal aspects of the ER membrane. This was confirmed by the observation of the loss of both overt (partial) and latent (total) DGAT activity in microsomes prepared from livers of Dgat1(-/-) mice. Conformational differences between DGAT1 molecules having the different topologies were indicated by the markedly disparate sensitivities of the overt DGAT1 to one of the inhibitors. These data suggest that DGAT1 belongs to the family of oligomeric membrane proteins that adopt a dual membrane topology.	[Wurie, Haja R.; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Buckett, Linda] Astra Zeneca Pharmaceut, Macclesfield SK10 4TF, Cheshire, England	University of Warwick; AstraZeneca	Zammit, VA (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	v.a.zammit@warwick.ac.uk		Wurie, Haja Ramatulai/0000-0002-2500-3393	UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering; Astra Zeneca Ltd.	UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering; Astra Zeneca Ltd.(AstraZeneca)	Supported by a UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering studentship in association with Astra Zeneca Ltd.	Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; ADELI K, 1994, J BIOL CHEM, V269, P9166; BELL RM, 1981, J LIPID RES, V22, P391; BOON MR, 1988, BIOCHEM J, V249, P645, DOI 10.1042/bj2490645; Broadway NM, 1999, ADV EXP MED BIOL, V466, P59; BROADWAY NM, 1995, BIOCHEM J, V310, P989, DOI 10.1042/bj3100989; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gotto Jr. A. M., 1998, Am J Cardiol, V82, p22Q; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Kolbusz MA, 2010, J MOL BIOL, V402, P127, DOI 10.1016/j.jmb.2010.07.019; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lankester DL, 1998, J LIPID RES, V39, P1889; Levy D, 1996, Essays Biochem, V31, P49; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Owen Mark, 1997, Biochemical Society Transactions, V25, p21S; Owen MR, 1997, BIOCHEM J, V323, P17, DOI 10.1042/bj3230017; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Waterman IJ, 2002, DIABETES, V51, P1708, DOI 10.2337/diabetes.51.6.1708; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; YANG LY, 1995, J LIPID RES, V36, P125; Zammit VA, 2001, J NUTR, V131, P2074, DOI 10.1093/jn/131.8.2074; Zammit VA, 2008, PHARMACOL THERAPEUT, V118, P295, DOI 10.1016/j.pharmthera.2008.03.010	33	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36238	36247		10.1074/jbc.M111.251900	http://dx.doi.org/10.1074/jbc.M111.251900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846726	Green Published, hybrid			2022-12-25	WOS:000296538300008
J	Ilias, A; Liliom, K; Greiderer-Kleinlercher, B; Reitinger, S; Lepperdinger, G				Ilias, Attila; Liliom, Karoly; Greiderer-Kleinlercher, Brigitte; Reitinger, Stephan; Lepperdinger, Guenter			Unbinding of Hyaluronan Accelerates the Enzymatic Activity of Bee Hyaluronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE TESTICULAR HYALURONIDASE; BINDING DOMAIN; LINK MODULE; PROTEIN; EXPRESSION; ACID; RECEPTOR; SURFACE; GROWTH; VENOM	Hyaluronan (HA), a polymeric glycosaminoglycan ubiquitously present in higher animals, is hydrolyzed by hyaluronidases (HAases). Here, we used bee HAase as a model enzyme to study the HA-HAase interaction. Located in close proximity to the active center, a bulky surface loop, which appears to obstruct one end of the substrate binding groove, was found to be functionally involved in HA turnover. To better understand kinetic changes in substrate interaction, binding of high molecular weight HA to catalytically inactive HAase was monitored by means of quartz crystal microbalance technology. Replacement of the delimiting loop by a tetrapeptide interconnection increased the affinity for HA up to 100-fold, with a K-D below 1 nM being the highest affinity among HA-binding proteins surveyed so far. The experimental data of HA-HAase interaction were further validated showing best fit to the theoretically proposed sequential two-site model. Besides the one, which had been shown previously in course of x-ray structure determination, a previously unrecognized binding site works in conjunction with an unbinding loop that facilitates liberation of hydrolyzed HA.	[Ilias, Attila; Greiderer-Kleinlercher, Brigitte; Reitinger, Stephan; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Liliom, Karoly] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary	Austrian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Lepperdinger, G (corresponding author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	guenter.lepperdinger@oeaw.ac.at	Liliom, Karoly/A-6563-2011; Iliás, Attila/I-7072-2017	Liliom, Karoly/0000-0002-7177-6872; Iliás, Attila/0000-0003-3196-0795; Lepperdinger, Gunter/0000-0002-4265-4489	Marie-Curie International Reintegration; Austrian Research Agency; Tyrolean Future Fund; European Commission	Marie-Curie International Reintegration(European Commission); Austrian Research Agency; Tyrolean Future Fund; European Commission(European CommissionEuropean Commission Joint Research Centre)	Recipient of a Marie-Curie International Reintegration grant.; Supported by research funds from by the Austrian Research Agency, the Tyrolean Future Fund, and the European Commission 7th framework program. To whom correspondence should be addressed: Extracellular Matrix Research, Institute for Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, Innsbruck A-6020, Austria. Tel.: 43-512-583919-40; Fax: 43-512-583919-8; E-mail: guenter.lepperdinger@oeaw.ac.at.	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BANERJI S, 2005, STRUCTURE CD44 HYALU, V2, P625; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BRUCKENSTEIN S, 1985, ELECTROCHIM ACTA, V30, P1295, DOI 10.1016/0013-4686(85)85005-2; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; CRAMER JA, 1994, BBA-GEN SUBJECTS, V1200, P315, DOI 10.1016/0304-4165(94)90173-2; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De Crescenzo G, 2000, BIOCHEMISTRY-US, V39, P9466, DOI 10.1021/bi992987r; DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303; Deschrevel B, 2008, MATRIX BIOL, V27, P475, DOI 10.1016/j.matbio.2008.01.007; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2010, GLYCOBIOLOGY, V20, P991, DOI 10.1093/glycob/cwq057; Hascall V, 2009, ESSENTIALS GLYCOBIOL, P219; Hess R, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000194; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jumel K, 2002, CARBOHYD POLYM, V48, P241, DOI 10.1016/S0144-8617(01)00242-9; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MARKOVICHOUSLEY Z, 2002, STRUCTURAL EVIDENCE, P19; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OGSTON AG, 1966, J BIOL CHEM, V241, P17; Rees SG, 2002, BIOCHEM BIOPH RES CO, V292, P727, DOI 10.1006/bbrc.2002.6699; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Reitinger S, 2008, PROTEIN EXPRES PURIF, V57, P226, DOI 10.1016/j.pep.2007.10.001; Reitinger S, 2009, J BIOL CHEM, V284, P19173, DOI 10.1074/jbc.C109.004358; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; SHAW M, 1977, BIOPHYS J, V17, P47, DOI 10.1016/S0006-3495(77)85626-9; Shen BJ, 2003, J PHARMACEUT BIOMED, V31, P83, DOI 10.1016/S0731-7085(02)00606-4; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Vincent J.-C., 2003, Journal of Biological Physics and Chemistry, V3, P35; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	49	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35699	35707		10.1074/jbc.M111.263731	http://dx.doi.org/10.1074/jbc.M111.263731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21840987	hybrid, Green Published			2022-12-25	WOS:000295927100042
J	Jilkova, A; Rezacova, P; Lepsik, M; Horn, M; Vachova, J; Fanfrlik, J; Brynda, J; McKerrow, JH; Caffrey, CR; Mares, M				Jilkova, Adela; Rezacova, Pavlina; Lepsik, Martin; Horn, Martin; Vachova, Jana; Fanfrlik, Jindrich; Brynda, Jiri; McKerrow, James H.; Caffrey, Conor R.; Mares, Michael			Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; RAY CRYSTAL-STRUCTURE; H-BONDING CORRECTION; OCCLUDING LOOP; SUBSTRATE-SPECIFICITY; SELECTIVE INHIBITORS; RNA INTERFERENCE; VINYL SULFONES; POTENT; IDENTIFICATION	Schistosomiasis caused by a parasitic blood fluke of the genus Schistosoma afflicts over 200 million people worldwide. Schistosoma mansoni cathepsin B1 (SmCB1) is a gut-associated peptidase that digests host blood proteins as a source of nutrients. It is under investigation as a drug target. To further this goal, we report three crystal structures of SmCB1 complexed with peptidomimetic inhibitors as follows: the epoxide CA074 at 1.3 angstrom resolution and the vinyl sulfones K11017 and K11777 at 1.8 and 2.5 angstrom resolutions, respectively. Interactions of the inhibitors with the subsites of the active-site cleft were evaluated by quantum chemical calculations. These data and inhibition profiling with a panel of vinyl sulfone derivatives identify key binding interactions and provide insight into the specificity of SmCB1 inhibition. Furthermore, hydrolysis profiling of SmCB1 using synthetic peptides and the natural substrate hemoglobin revealed that carboxydipeptidase activity predominates over endopeptidolysis, thereby demonstrating the contribution of the occluding loop that restricts access to the active-site cleft. Critically, the severity of phenotypes induced in the parasite by vinyl sulfone inhibitors correlated with enzyme inhibition, providing support that SmCB1 is a valuable drug target. The present structure and inhibitor interaction data provide a footing for the rational design of anti-schistosomal inhibitors.	[Jilkova, Adela; Rezacova, Pavlina; Lepsik, Martin; Horn, Martin; Vachova, Jana; Fanfrlik, Jindrich; Brynda, Jiri; Mares, Michael] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic; [Jilkova, Adela] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 12843, Czech Republic; [Rezacova, Pavlina; Brynda, Jiri] Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Struct, Prague 16610, Czech Republic; [McKerrow, James H.; Caffrey, Conor R.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [McKerrow, James H.; Caffrey, Conor R.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mares, M (corresponding author), Flemingovo 2, Prague 16610, Czech Republic.	mares@uochb.cas.cz	Lepšík, Martin/X-8603-2019; Rezacova, Pavlina/G-3600-2014; Brynda, Jiri/G-2760-2014; Lepsik, Martin/C-6614-2012; Mares, Michael/B-2413-2009; Jilkova, Adela/G-5809-2014; Horn, Martin/A-8701-2008	Lepšík, Martin/0000-0003-2607-8132; Rezacova, Pavlina/0000-0001-9626-346X; Brynda, Jiri/0000-0003-3675-6769; Lepsik, Martin/0000-0003-2607-8132; Mares, Michael/0000-0002-0847-5022; Jilkova, Adela/0000-0002-3158-9626; Horn, Martin/0000-0001-9110-2018; Fanfrlik, Jindrich/0000-0002-1257-1201	Grant Agency of the Czech Republic [203/09/1585, P208/11/0295]; Academy of Sciences of the Czech Republic; Sandler Center for Drug Discovery; Ministry of Education, Youth and Sports of the Czech Repulic [OC09007]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357];  [Z40550506];  [Z50520514]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Sandler Center for Drug Discovery; Ministry of Education, Youth and Sports of the Czech Repulic; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; 	This work was supported, in whole or in part, by Grant 203/09/1585 from the Grant Agency of the Czech Republic, Institutional Research Projects Z40550506 and Z50520514, the Academy of Sciences of the Czech Republic, and by the Sandler Center for Drug Discovery. Additional support was by Grant P208/11/0295 (to M. L. and J. F.) from the Grant Agency of the Czech Republic and by Grant OC09007 (to M. M.) from the Ministry of Education, Youth and Sports of the Czech Repulic. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; [Anonymous], 2008, AMBER 10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Bromme D, 1996, BIOCHEM J, V315, P85; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Caffrey CR, 1997, PARASITOL RES, V83, P37, DOI 10.1007/s004360050204; Caffrey CR, 2002, MOL BIOCHEM PARASIT, V121, P49, DOI 10.1016/S0166-6851(02)00022-1; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Caffrey CR, 1997, PARASITOL RES, V83, P632, DOI 10.1007/s004360050310; Caffrey CR, 2000, FEBS LETT, V466, P244, DOI 10.1016/S0014-5793(99)01798-6; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Chen YT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000825; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Dvorak J, 2005, INT J PARASITOL, V35, P895, DOI 10.1016/j.ijpara.2005.02.018; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Greenspan PD, 2001, J MED CHEM, V44, P4524, DOI 10.1021/jm010206q; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HASNAIN S, 1993, J BIOL CHEM, V268, P235; Horn M, 2011, ACS CHEM BIOL, V6, P609, DOI 10.1021/cb100411v; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Jaishankar P, 2008, BIOORG MED CHEM LETT, V18, P624, DOI 10.1016/j.bmcl.2007.11.070; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Krissinel E., 2005, DETECTION PROTEIN AS, P163; Krupa JC, 2002, BIOCHEM J, V361, P613, DOI 10.1042/0264-6021:3610613; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Masa M, 2006, BIOCHEMISTRY-US, V45, P15474, DOI 10.1021/bi0614986; McCarthy E, 2004, INT J PARASITOL, V34, P703, DOI 10.1016/j.ijpara.2004.01.008; McKerrow JH, 2009, MEM I OSWALDO CRUZ, V104, P263, DOI 10.1590/S0074-02762009000900034; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Olson JE, 1999, BIOORGAN MED CHEM, V7, P633, DOI 10.1016/S0968-0896(99)00004-8; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Ranjit N, 2008, MOL BIOCHEM PARASIT, V160, P90, DOI 10.1016/j.molbiopara.2008.04.008; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Roush WR, 2001, BIOORG MED CHEM LETT, V11, P2759, DOI 10.1016/S0960-894X(01)00566-2; Roush WR, 1998, J AM CHEM SOC, V120, P10994, DOI 10.1021/ja981792o; Sajid M, 2003, MOL BIOCHEM PARASIT, V131, P65, DOI 10.1016/S0166-6851(03)00194-4; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scheidt KA, 1998, BIOORGAN MED CHEM, V6, P2477, DOI 10.1016/S0968-0896(98)80022-9; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Sorgine MHF, 2000, J BIOL CHEM, V275, P28659, DOI 10.1074/jbc.M005675200; Sripa J, 2010, CELL MICROBIOL, V12, P781, DOI 10.1111/j.1462-5822.2010.01433.x; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; TURK D, 1995, BIOCHEMISTRY-US, V34, P4791, DOI 10.1021/bi00014a037; UTZINGER J, 2011, ACTA TROP IN PRESS; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Watanabe D, 2006, J MOL BIOL, V362, P979, DOI 10.1016/j.jmb.2006.07.070; Williamson AL, 2004, J BIOL CHEM, V279, P35950, DOI 10.1074/jbc.M405842200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamamoto A, 2000, J BIOCHEM-TOKYO, V127, P635, DOI 10.1093/oxfordjournals.jbchem.a022651	75	57	57	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35770	35781		10.1074/jbc.M111.271304	http://dx.doi.org/10.1074/jbc.M111.271304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832058	Green Published, hybrid			2022-12-25	WOS:000295927100050
J	Saletta, F; Rahmanto, YS; Siafakas, AR; Richardson, DR				Saletta, Federica; Rahmanto, Yohan Suryo; Siafakas, Aritee R.; Richardson, Des R.			Cellular Iron Depletion and the Mechanisms Involved in the Iron-dependent Regulation of the Growth Arrest and DNA Damage Family of Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; PYRIDOXAL ISONICOTINOYL HYDRAZONE; MESSENGER-RNA; NF-Y; ANTITUMOR-ACTIVITY; MOLECULAR TARGETS; GADD45 PROMOTER; CYCLE ARREST; EXPRESSION; CHELATORS	Iron plays a crucial part in proliferation while iron deficiency results in G(1)/S arrest, DNA damage, and apoptosis. However, the precise role of iron in cell cycle control remains unclear. We showed that iron depletion using the iron chelators, desferrioxamine (DFO), or 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone (311), increased the mRNA levels of the growth arrest and DNA damage 45 alpha gene, GADD45 alpha (Darnell, G. and Richardson, D. R. (1999) Blood 94, 781-792). In this study, we examined the effect of iron depletion on up-regulating GADD family members involved in growth control, including cell cycle arrest, apoptosis, and DNA repair, making them therapeutic targets for tumor suppression. We showed the GADD family members were up-regulated by cellular iron depletion. Further, upregulation of GADD45 alpha after iron deprivation was independent of hypoxia-inducible factor-1 alpha (HIF-1 alpha), octamer-1 (Oct-1), p53 and early growth response 1 (Egr1). We then analyzed the regulatory elements responsible for iron depletion-mediated regulation of GADD45 alpha and identified the specific transcription factor/s involved. This region was within -117 bp and -81 bp relative to the start codon where the consensus sequences of three transcription factors are located: the CCAAT-binding factor/nuclear factor-Y (NF-Y), the stabilizing molecule v-MYB and the enhancer, CCAAT enhancer-binding protein (CEBP alpha). Mutation analysis, shRNA studies, Western blotting, and electrophoretic mobility shift assays led to the identification of NF-Y in the transcriptional up-regulation of GADD45 alpha after iron depletion. Furthermore, like GADD45 alpha, NF-YA was upregulated after iron chelation and down-regulated by iron supplementation. These results are important for understanding the mechanisms of iron depletion-mediated cell cycle arrest, DNA damage repair, and apoptosis.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Suryo Rahmanto, Yohan/K-8043-2018	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Espedido, Aritee Rosemary/0000-0002-8059-1757; Richardson, Des/0000-0002-5506-3274; Saletta, Federica/0000-0003-0598-3504	Cancer Institute NSW (CINSW) [07/RSA/1-22, 08/ECF/1-36]; University of Sydney; National Health and Medical Research Council of Australia	Cancer Institute NSW (CINSW); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Cancer Institute NSW (CINSW) Research Scholar Award (07/RSA/1-22) and University of Sydney PhD Scholarship and University Post-Graduate Award (to F. S.), a CINSW Early Career Fellowship (08/ECF/1-36) (to Y. S. R.), and a National Health and Medical Research Council of Australia Senior Principal Research Fellowship and Project Grants (to D. R. R.).	Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Campanero MR, 2008, ONCOGENE, V27, P1263, DOI 10.1038/sj.onc.1210735; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Fanzo JC, 2001, AM J PHYSIOL-CELL PH, V281, pC751, DOI 10.1152/ajpcell.2001.281.3.C751; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Khan QA, 1997, CARCINOGENESIS, V18, P2313, DOI 10.1093/carcin/18.12.2313; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Liang SX, 2003, CARCINOGENESIS, V24, P1601, DOI 10.1093/carcin/bgg116; Martinez E, 2010, CELL CYCLE, V9, P642, DOI 10.4161/cc.9.4.10828; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PRICE BD, 1992, CANCER RES, V52, P3814; Radomska HS, 1999, BLOOD, V94, P3772, DOI 10.1182/blood.V94.11.3772.423k19_3772_3780; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Richardson DR, 1999, J BIOL INORG CHEM, V4, P266, DOI 10.1007/s007750050312; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Takahashi S, 2001, CANCER RES, V61, P1187; Tardito S, 2009, CURR MED CHEM, V16, P1325, DOI 10.2174/092986709787846532; Turner J, 2005, BLOOD, V106, P3191, DOI 10.1182/blood-2005-03-1263; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zerbini LF, 2005, CLIN CANCER RES, V11, P6409, DOI 10.1158/1078-0432.CCR-05-1475; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang YD, 2009, MOL CARCINOGEN, V48, P454, DOI 10.1002/mc.20483	46	31	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35396	35406		10.1074/jbc.M111.273060	http://dx.doi.org/10.1074/jbc.M111.273060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852233	hybrid, Green Published			2022-12-25	WOS:000295927100011
J	Dunschede, B; Bals, T; Funke, S; Schunemann, D				Duenschede, Beatrix; Bals, Thomas; Funke, Silke; Schuenemann, Danja			Interaction Studies between the Chloroplast Signal Recognition Particle Subunit cpSRP43 and the Full-length Translocase Alb3 Reveal a Membrane-embedded Binding Region in Alb3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID MEMBRANES; FUNCTIONAL INTERACTION; YIDC; INSERTION; HOMOLOG; COMPLEX; INTEGRATION; SUBSTRATE; COMPONENT; SECA	Posttranslational targeting of the light-harvesting chlorophyll a, b-binding proteins depends on the function of the chloroplast signal recognition particle, its receptor cpFtsY, and the translocase Alb3. The thylakoid membrane protein Alb3 of Arabidopsis chloroplasts belongs to the evolutionarily conserved YidC/Oxa1/Alb3 protein family; the members of this family facilitate the insertion, folding, and assembly of membrane proteins in bacteria, mitochondria, and chloroplasts. Here, we analyzed the interaction sites of full-length Alb3 with the cpSRP pathway component cpSRP43 by using in vitro and in vivo studies. Bimolecular fluorescence complementation and Alb3 proteoliposome studies showed that the interaction of cpSRP43 is dependent on a binding domain in the C terminus of Alb3 as well as an additional membrane-embedded binding site in the fifth transmembrane domain (TMD5) of Alb3. The C-terminal binding domain was mapped to residues 374-388, and the binding domain within TMD5 was mapped to residues 314-318 located close to the luminal end of TMD5. A direct binding between cpSRP43 and these binding motifs was shown by pepspot analysis. Further studies using blue-native gel electrophoresis revealed that full-length Alb3 is able to form dimers. This finding and the identification of a membrane-embedded cpSRP43 binding site in Alb3 support a model in which cpSRP43 inserts into a dimeric Alb3 translocation pore during cpSRP-dependent delivery of light-harvesting chlorophyll a, b-binding proteins.	[Duenschede, Beatrix; Bals, Thomas; Funke, Silke; Schuenemann, Danja] Ruhr Univ Bochum, D-44780 Bochum, Germany	Ruhr University Bochum	Schunemann, D (corresponding author), Univ Str 150, D-44780 Bochum, Germany.	Danja.Schuenemann@rub.de		Schuenemann, Danja/0000-0001-8894-7685	Deutsche Forschungsgemeinschaft [SCHU 1163/5-1]; Ruhr-University Research School; Germany Excellence Initiative [DFG GSC 98/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr-University Research School; Germany Excellence Initiative	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU 1163/5-1 and by the Ruhr-University Research School funded by Germany Excellence Initiative Grant DFG GSC 98/1.	Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; HOFFMAN NE, 1994, PLANT PHYSIOL, V105, P295, DOI 10.1104/pp.105.1.295; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Randelj Olga, 2007, V390, P417; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; YANG C, 2005, CELL BIOL TECHNIQUES, P300; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	37	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35187	35195		10.1074/jbc.M111.250746	http://dx.doi.org/10.1074/jbc.M111.250746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832051	Green Published, hybrid			2022-12-25	WOS:000295406300071
J	Emmer, KL; Waxman, EA; Covy, JP; Giasson, BI				Emmer, Kristel L.; Waxman, Elisa A.; Covy, Jason P.; Giasson, Benoit I.			E46K Human alpha-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NONMOTOR SYMPTOMS; PRECURSOR PROTEIN; SUBSTANTIA-NIGRA; ANIMAL-MODELS; MOUSE MODELS; MUTATION; AGGREGATION; GENE	Synucleinopathies are a group of neurodegenerative disorders associated with the formation of aberrant amyloid inclusions composed of the normally soluble presynaptic protein alpha-synuclein (alpha-syn). Parkinson disease is the most well known of these disorders because it bears alpha-syn pathological inclusions known as Lewy bodies (LBs). Mutations in the gene for alpha-syn, including the E46K missense mutation, are sufficient to cause Parkinson disease as well as other synucleinopathies like dementia with LBs. Herein, we describe transgenic mice expressing E46K human alpha-syn in CNS neurons that develop detrimental age-dependent motor impairments. These animals accumulate age-dependent intracytoplasmic neuronal alpha-syn inclusions that parallel disease and recapitulate the biochemical, histological, and morphological properties of LBs. Surprisingly, the morphology of alpha-syn inclusions in E46K human alpha-syn transgenic mice more closely resemble LBs than the previously described transgenic mice (line M83) that express neuronal A53T human alpha-syn. E46K human alpha-syn mice also develop abundant neuronal tau inclusions that resemble neurofibrillary tangles. Subsequent studies on the ability of E46K alpha-syn to induce tau inclusions in cellular models suggest that both direct and indirect mechanisms of protein aggregation are probably involved in the formation of the tau inclusions observed here in vivo. Re-evaluation of presymptomatic transgenic mice expressing A53T human alpha-syn reveals that the formation of alpha-syn inclusions in mice must be synchronized; however, inclusion formation is diffuse within affected areas of the neuroaxis such that there was no clustering of inclusions. Collectively, these findings provide insights in the mechanisms of formation of these aberrant proteinaceous inclusions and support the notion that alpha-syn aggregates are involved in the pathogenesis of human diseases.	[Giasson, Benoit I.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Giasson, BI (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk,125 John Morgan Bldg, Philadelphia, PA 19104 USA.	giassonb@mail.med.upenn.edu		Emmer, Kristel/0000-0002-9353-1622; Waxman, Elisa/0000-0003-4562-7969	National Institutes of Health (NIH), NIA [AG09215, T32 AG00255]; NIH, NINDS [NS053488]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255, P01AG009215] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIA, Grant AG09215 and NIH, NINDS, Grant NS053488.; Supported by NIH, NIA, Training Grant T32 AG00255. Present address: Neurobiology Division, Medical Diagnostic Laboratories, Hamilton, NJ 08690.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Athanassiadou A, 1999, AM J HUM GENET, V65, P555, DOI 10.1086/302486; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Baba M, 1998, AM J PATHOL, V152, P879; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; CORNFORD ME, 1995, BRAIN COGNITION, V28, P321, DOI 10.1006/brcg.1995.1261; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2003, ACTA NEUROPATHOL, V106, P243, DOI 10.1007/s00401-003-0726-x; Giasson BI, 2001, EXP NEUROL, V172, P354, DOI 10.1006/exnr.2001.7805; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Hutton M, 2001, TRENDS MOL MED, V7, P467, DOI 10.1016/S1471-4914(01)02123-2; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Markopoulou K, 1999, ANN NEUROL, V46, P374, DOI 10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30; Papadimitriou A, 1999, NEUROLOGY, V52, P651, DOI 10.1212/WNL.52.3.651; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; SIMUNI T, 2000, NEURODEGENERATIVE DE, P193; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; TeclemariamMesbah R, 1997, J HISTOCHEM CYTOCHEM, V45, P619, DOI 10.1177/002215549704500414; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	91	87	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35104	35118		10.1074/jbc.M111.247965	http://dx.doi.org/10.1074/jbc.M111.247965			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846727	Green Published, hybrid			2022-12-25	WOS:000295406300064
J	Lai, SJ; O'Callaghan, B; Zoghbi, HY; Orr, HT				Lai, Shaojuan; O'Callaghan, Brennon; Zoghbi, Huda Y.; Orr, Harry T.			14-3-3 Binding to Ataxin-1(ATXN1) Regulates Its Dephosphorylation at Ser-776 and Transport to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE-INDUCED DISEASE; MEDIATES NEURODEGENERATION; PROTEIN PHOSPHATASES; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; INHIBITORS; EXPANSION; REPEAT; DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is a lethal neurodegenerative disorder caused by expansion of a polyglutamine tract in ATXN1. A prominent site of pathology in SCA1 is cerebellar Purkinje neurons where mutant ATXN1 must enter the nucleus to cause disease. In SCA1, phosphorylation of ATXN1 at Ser-776 modulates disease. Interestingly, Ser-776 is located within a region of ATXN1 that harbors several functional motifs including binding sites for 14-3-3, and splicing factors RBM17 and U2AF65. The interaction of ATXN1 with these proteins is thought to be regulated by the phosphorylation status of Ser-776. In addition, Ser-776 is adjacent to the NLS in ATXN1. Although pS776-ATXN1 is enriched in nuclear extracts of cerebellar cells, the vast majority of 14-3-3 is in the cytoplasmic fraction. We found that dephosphorylation of cytoplasmic pS776-ATXN1 is blocked by virtue of it being in a complex with 14-3-3. In addition, data suggest that binding of 14-3-3 to cytoplasmic ATXN1 impeded its transport to the nucleus, suggesting that 14-3-3 must disassociate from ATXN1 for transport of ATXN1 to the nucleus. Consistent with this hypothesis is the observation that once in the nucleus pS776 is able to be dephosphorylated. Evidence is presented that PP2A is the pS776-ATXN1 phosphatase in the mammalian cerebellum. In the nucleus, we propose that dephosphorylation of pS776-ATXN1 by PP2A regulates the interaction of ATXN1 with the splicing factors RBM17 and U2AF65.	[Lai, Shaojuan; O'Callaghan, Brennon; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Lai, Shaojuan; Orr, Harry T.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [O'Callaghan, Brennon; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, 2101 6th St SE, Minneapolis, MN 55455 USA.	orrxx002@umn.edu	Lai, Shaojuan/O-5477-2014	Lai, Shaojuan/0000-0002-7721-1266; Zoghbi, Huda/0000-0002-0700-3349; O'Callaghan, Brennon L/0000-0002-0800-5856; Orr, Harry/0000-0001-6118-741X	National Institutes of Health/NINDS [NS045667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045667] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health/NINDS Grant NS045667.	Carlson KM, 2009, J NEUROGENET, V23, P313, DOI 10.1080/01677060802399976; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; HASHIKAWA T, 1995, NEUROSCI RES, V22, P133, DOI 10.1016/0168-0102(95)00886-X; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Rossie S, 2006, BRAIN RES, V1111, P1, DOI 10.1016/j.brainres.2006.06.106; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Strack S, 1998, J COMP NEUROL, V392, P515; Swingle Mark, 2007, V365, P23; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Tzivion G., 2011, BIOCH BIOPH IN PRESS; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	36	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34606	34616		10.1074/jbc.M111.238527	http://dx.doi.org/10.1074/jbc.M111.238527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835928	hybrid, Green Published			2022-12-25	WOS:000295406300015
J	Pemberton, S; Madiona, K; Pieri, L; Kabani, M; Bousset, L; Melki, R				Pemberton, Samantha; Madiona, Karine; Pieri, Laura; Kabani, Mehdi; Bousset, Luc; Melki, Ronald			Hsc70 Protein Interaction with Soluble and Fibrillar alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES; HSP70; AGGREGATION; TOXICITY; TRANSMISSION; COMPLEX; BRAIN; DEATH	The aggregation of alpha-synuclein (alpha-Syn), the primary component of Lewy bodies, into high molecular weight assemblies is strongly associated with Parkinson disease. This event is believed to result from a conformational change within native alpha-Syn. Molecular chaperones exert critical housekeeping functions in vivo including refolding, maintaining in a soluble state, and/or pacifying protein aggregates. The influence of the stress-induced heat shock protein 70 (Hsp70) on alpha-Syn aggregation has been notably investigated. The constitutively expressed chaperone Hsc70 acts as an antiaggregation barrier before cellsare overwhelmed with alpha-Syn aggregates and Hsp70 expression induced. Here, we investigate the interaction between Hsc70 and alpha-Syn, the consequences of this interaction, and the role of nucleotides and co-chaperones Hdj1 and Hdj2 as modulators. We show that Hsc70 sequesters soluble alpha-Syn in an assembly incompetent complex in the absence of ATP. The affinity of Hsc70 for soluble alpha-Syn diminishes upon addition of ATP alone or together with its co-chaperones Hdj1 or Hdj2 allowing faster binding and release of client proteins thus abolishing alpha-Syn assembly inhibition by Hsc70. We show that Hsc70 binds alpha-Syn fibrils with a 5-fold tighter affinity compared with soluble alpha-Syn. This suggests that Hsc70 preferentially interacts with high molecular weight alpha-Syn assemblies in vivo. Hsc70 binding certainly has an impact on the physicochemical properties of alpha-Syn assemblies. We show a reduced cellular toxicity of alpha-Syn fibrils coated with Hsc70 compared with "naked" fibrils. Hsc70 may therefore significantly affect the cellular propagation of alpha-Syn aggregates and their spread throughout the central nervous system in Parkinson disease.	[Pemberton, Samantha; Madiona, Karine; Pieri, Laura; Kabani, Mehdi; Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394; bousset, luc/0000-0002-0433-4337	French Ministry of Education, Research and Technology; Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche [ANR-08-NEUR-001-01]; Human Frontier Science Program; Era-Net Neuron	French Ministry of Education, Research and Technology; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontier Science Program(Human Frontier Science Program); Era-Net Neuron	This work was supported by the French Ministry of Education, Research and Technology, the Centre National de la Recherche Scientifique (CNRS), the Era-Net Neuron, Agence Nationale pour la Recherche Grant ANR-08-NEUR-001-01, and the Human Frontier Science Program.	BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chirico WJ, 1998, BIOCHEMISTRY-US, V37, P13862, DOI 10.1021/bi980597j; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; HALFMANN R, 2008, J VIS EXP, V17; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107	41	84	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34690	34699		10.1074/jbc.M111.261321	http://dx.doi.org/10.1074/jbc.M111.261321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832061	Green Published, hybrid			2022-12-25	WOS:000295406300023
J	Saeed, M; Sheff, D; Kohen, A				Saeed, Muhammad; Sheff, David; Kohen, Amnon			Novel Positron Emission Tomography Tracer Distinguishes Normal from Cancerous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR IMAGING TECHNOLOGIES; THYMIDYLATE SYNTHASE; ESOPHAGEAL CANCER; ESCHERICHIA-COLI; F-18-FLT PET; LUNG-CANCER; PROLIFERATION; EXPRESSION; TUMOR; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE	Development of tumor-specific probes for imaging by positron emission tomography has broad implications in clinical oncology, such as diagnosis, staging, and monitoring therapeutic responses in patients, as well as in biomedical research. Thymidylate synthase (TSase)-based de novo biosynthesis of DNA is an important target for drug development. Increased DNA replication in proliferating cancerous cells requires TSase activity, which catalyzes the reductive methylation of dUMP to dTMP using (R)-N-5,N-10-methylene-5,6,7,8-tetrahydrofolate (MTHF) as a cofactor. In principle, radiolabeled MTHF can be used as a substrate for this reaction to identify rapidly dividing cells. In this proof-of-principle study, actively growing (log phase) breast cancer (MCF7, MDA-MB-231, and hTERT-HME1), normal breast (human mammary epithelial and MCF10A), colon cancer (HT-29), and normal colon (FHC) cells were incubated with [C-14]MTHF in culture medium from 30 min to 2 h, and uptake of radiotracer was measured. Cancerous cell lines incorporated significantly more radioactivity than their normal counterparts. The uptake of radioactively labeled MTHF depended upon a combination of cell doubling time, folate receptor status, S phase percentage, and TSase expression in the cells. These findings suggest that the recently synthesized [C-11]MTHF may serve as a new positron emission tomography tracer for cancer imaging.	[Saeed, Muhammad; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Sheff, David] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu			Institute of Clinical and Translational Science; University of Iowa	Institute of Clinical and Translational Science; University of Iowa	This work was supported by a pilot grant from the Institute of Clinical and Translational Science and a Biological Science Funding Program grant from the University of Iowa.	Agrawal N, 2004, ANAL BIOCHEM, V328, P44, DOI 10.1016/j.ab.2004.01.029; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P1998, DOI 10.1021/bi036124g; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Bouchelouche K, 2009, CURR OPIN ONCOL, V21, P469, DOI 10.1097/CCO.0b013e32832d56e4; Bradbury MS, 2008, J NUCL MED, V49, P422, DOI 10.2967/jnumed.107.047092; Buck AK, 2005, EUR J NUCL MED MOL I, V32, P525, DOI 10.1007/s00259-004-1706-7; Changchien LM, 2000, PROTEIN EXPRES PURIF, V19, P265, DOI 10.1006/prep.2000.1245; Chao KSC, 2006, SEMIN ONCOL, V33, pS59, DOI 10.1053/j.seminoncol.2006.10.011; Drzezga A, 2009, BEHAV NEUROL, V21, P101, DOI [10.3233/BEN-2009-0228, 10.1155/2009/276026]; Hayat M. A., 2008, CANC IMAGING, V1; Hayat MA, 2008, CANC IMAGING, V2; Honer M, 2010, TRANSL ONCOL, V3, P264, DOI 10.1593/tlo.10127; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Hooker JM, 2008, ANGEW CHEM INT EDIT, V47, P5989, DOI 10.1002/anie.200800991; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kiss-Laszlo Zsuzsanna, 2006, Magy Onkol, V50, P33; Lindebjerg J, 2006, APPL IMMUNOHISTO M M, V14, P37, DOI 10.1097/01.pai.0000154057.41274.6b; Lodge MA, 2008, J NUCL MED, V49, P1620, DOI 10.2967/jnumed.108.052076; McEwan AJ, 2008, J NUCL MED, V49, p37N; Miele E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-52; MURPHY M, 1976, BIOCHEM BIOPH RES CO, V71, P1017, DOI 10.1016/0006-291X(76)90756-7; Nair VS, 2009, J THORAC ONCOL, V4, P1473, DOI 10.1097/JTO.0b013e3181bccbc6; Pelosi E, 2007, EJSO-EUR J SURG ONC, V33, P1, DOI 10.1016/j.ejso.2006.10.020; Perrone A, 2008, J NUCL MED, V49, p25N; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Phelps ME, 2000, J NUCL MED, V41, P661; Saga T, 2006, CLIN NUCL MED, V31, P774, DOI 10.1097/01.rlu.0000246820.14892.d2; Sajjad M, 2002, APPL RADIAT ISOTOPES, V57, P607, DOI 10.1016/S0969-8043(02)00175-6; Shields AF, 2005, EUR J NUCL MED MOL I, V32, P1269, DOI 10.1007/s00259-005-1813-0; Shimoda M, 2009, PATHOBIOLOGY, V76, P193, DOI 10.1159/000218335; Song WS, 2009, NUCL MED COMMUN, V30, P462, DOI 10.1097/MNM.0b013e32832aa7ce; Timmers HJLM, 2009, J CLIN ENDOCR METAB, V94, P4757, DOI 10.1210/jc.2009-1248; Troost EGC, 2007, J NUCL MED, V48, P726, DOI 10.2967/jnumed.106.037473; Ullrich RT, 2009, J NUCL MED, V50, P1962, DOI 10.2967/jnumed.109.065904; van der Meel R, 2010, DRUG DISCOV TODAY, V15, P102, DOI 10.1016/j.drudis.2009.12.003; van Waarde A, 2008, CURR PHARM DESIGN, V14, P3326; van Westreenen HL, 2005, J NUCL MED, V46, P400; Verlinde PHCJ, 2009, J AGR FOOD CHEM, V57, P6803, DOI 10.1021/jf900832g; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Yasumatsu R, 2009, CHEMOTHERAPY, V55, P36, DOI 10.1159/000175465; Yoshida Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-7; Yu Z, 2005, HISTOL HISTOPATHOL, V20, P871, DOI 10.14670/HH-20.871; Zhang XS, 2008, NUCL MED COMMUN, V29, P1052, DOI 10.1097/MNM.0b013e328310af34	45	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33872	33878		10.1074/jbc.M111.275446	http://dx.doi.org/10.1074/jbc.M111.275446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832075	Green Published, hybrid			2022-12-25	WOS:000295159200019
J	Furtbauer, I; Heistermann, M; Schulke, O; Ostner, J				Fuertbauer, Ines; Heistermann, Michael; Schuelke, Oliver; Ostner, Julia			Concealed Fertility and Extended Female Sexuality in a Non-Human Primate (Macaca assamensis)	PLOS ONE			English	Article							OVARIAN CYCLE PHASE; MATE CHOICE; COPULATION CALLS; MULTIPLE MALES; MACAQUES; EVOLUTION; PATERNITY; PROMISCUITY; SWELLINGS; BEHAVIOR	In numerous primates living in mixed-sex groups, females display probabilistic cues of fertility to simultaneously concentrate paternity to dominant males while diluting it amongst others as a means to reduce the risk of infanticide and to increase male care for offspring. A few species, however, lack these cues and potentially conceal fertility from males; yet, to date, little is known about mating patterns and their underlying proximate mechanisms in such species. Here, we investigated mating activity and sexual consortships relative to female reproductive state in wild Assamese macaques (Macaca assamensis), a species where females lack prominent anogenital swellings and copulation calls. During two mating seasons (2837 contact hours) we recorded sexual and social behaviors, sexual consortships, and collected 1178 fecal samples (n = 15 females) which were analyzed for progestogen concentrations to assess female reproductive state and to determine the timing of ovulation and conception. Although mostly conceiving in their first ovarian cycle, females were sexually receptive throughout the entire 4-month mating season, and within-cycle mating frequencies were not increased during fertile phases. Dominant males did not monopolize fertile matings, and consortships by high-ranking males lasted for long periods, which were not exclusively linked to female fertile phases. Furthermore, females copulated promiscuously but not randomly, i.e. for almost every female, matings were concentrated to a certain male, irrespective of male rank. Collectively, we demonstrate that fertility is undisclosed to males. The extreme extended female sexuality facilitated by concealed fertility may allow females to create differentiated mating relationships within a promiscuous mating system. Our study provides important new insight into the plasticity of female sexuality in non-human primates.	[Fuertbauer, Ines; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany; [Fuertbauer, Ines; Heistermann, Michael] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Fuertbauer, Ines; Schuelke, Oliver; Ostner, Julia] Max Planck Inst Evolutionary Anthropol, Integrat Primate Socioecol Grp, Leipzig, Germany	University of Gottingen; Deutsches Primatenzentrum (DPZ); Max Planck Society	Furtbauer, I (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany.	ifuertb@uni-goettingen.de		Furtbauer, Ines/0000-0003-1404-6280	Max Planck Society for the Advancement of Science; German Initiative of Excellence	Max Planck Society for the Advancement of Science(Max Planck Society); German Initiative of Excellence	The study was supported by funds from the Max Planck Society for the Advancement of Science to Julia Ostner used to conduct the experiments and from the German Initiative of Excellence to Georg August University Gottingen for data analyses and writing of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDELMAN SJ, 1987, AM NAT, V129, P785, DOI 10.1086/284675; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BEHBOODI E, 1991, J MED PRIMATOL, V20, P229; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Borries C., 2002, Natural History Bulletin of the Siam Society, V50, P75; Brauch K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1453, DOI 10.1007/s00265-008-0575-7; Brauch K, 2007, HORM BEHAV, V52, P375, DOI 10.1016/j.yhbeh.2007.06.001; BURT A, 1992, FOLIA PRIMATOL, V58, P1, DOI 10.1159/000156600; BUSSE CD, 1985, AM ZOOL, V25, P873; Carosi M, 1999, HORM BEHAV, V36, P252, DOI 10.1006/hbeh.1999.1545; Clarke Parry, 2009, P42; Connor R. C., 2009, SEXUAL COERCION PRIM; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emery MA, 2003, BEHAV ECOL SOCIOBIOL, V54, P340, DOI 10.1007/s00265-003-0648-6; Engelhardt A, 2004, ANIM BEHAV, V67, P915, DOI 10.1016/j.anbehav.2003.09.006; Furtbauer I, 2010, INT J PRIMATOL, V31, P501, DOI 10.1007/s10764-010-9409-3; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Heape W, 1900, Q J MICROSC SCI, V44, P1; HEISTERMANN M, 1993, J REPROD FERTIL, V99, P243; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; Heistermann M, 2008, AM J PRIMATOL, V70, P44, DOI 10.1002/ajp.20455; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; Hoelzer G. A., 1996, P3; Hrdy S.B., 1987, P370; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Li Jin-Hua, 2005, Acta Zoologica Sinica, V51, P365; Cerda-Molina AL, 2006, INT J PRIMATOL, V27, P791, DOI 10.1007/s10764-006-9045-0; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; Maestripieri D, 2005, BEHAV ECOL, V16, P106, DOI 10.1093/beheco/arh120; MANSON JH, 1992, ANIM BEHAV, V44, P405, DOI 10.1016/0003-3472(92)90051-A; Manson JH, 1997, CURR ANTHROPOL, V38, P353, DOI 10.1086/204623; MARSON J, 1989, J REPROD FERTIL, V85, P43; Matsubara M, 2004, INT J PRIMATOL, V25, P901, DOI 10.1023/B:IJOP.0000029128.00559.91; MCCARTHY MM, 2002, BEHAV ENDOCRINOLOGY, P117; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Muller MN, 2011, BEHAV ECOL SOCIOBIOL, V65, P921, DOI 10.1007/s00265-010-1093-y; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; O'Neill AC, 2004, AM J PHYS ANTHROPOL, V125, P352, DOI 10.1002/ajpa.20024; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Ostner J, 2006, AM J PRIMATOL, V68, P701, DOI 10.1002/ajp.20260; Ostner J, 2011, HORM BEHAV, V59, P105, DOI 10.1016/j.yhbeh.2010.10.017; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; R Core Team, 2022, R LANG ENV STAT COMP; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P695, DOI 10.1006/anbe.2000.1630; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Semple S, 2002, AM J PRIMATOL, V56, P43, DOI 10.1002/ajp.1062; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Setchell JM, 2010, J EVOLUTION BIOL, V23, P136, DOI 10.1111/j.1420-9101.2009.01880.x; SHIDELER SE, 1993, BIOL REPROD, V48, P1290, DOI 10.1095/biolreprod48.6.1290; SMALL MF, 1988, CURR ANTHROPOL, V29, P81, DOI 10.1086/203615; SMALL MF, 1990, AM J PRIMATOL, V20, P267, DOI 10.1002/ajp.1350200403; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; Soltis J, 2002, EVOL ANTHROPOL, V11, P187, DOI 10.1002/evan.10025; Soltis J, 1999, AM J PRIMATOL, V47, P263, DOI 10.1002/(SICI)1098-2345(1999)47:4<263::AID-AJP1>3.0.CO;2-F; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; Taub D.M., 1980, P287; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; VAN HOOF J. A. R. A. M., 1967, P7; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik C.P., 2000, INFANTICIDE MALES IT; van Schaik Carel P., 1999, P204, DOI 10.1017/CBO9780511542466.011; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; Van Schaik CP, 2000, PRIMATE MALES, P34; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Ziegler T, 2000, AM J PRIMATOL, V51, P119, DOI 10.1002/(SICI)1098-2345(200006)51:2<119::AID-AJP2>3.0.CO;2-O; Zinner D, 2000, AM J PRIMATOL, V52, P157, DOI 10.1002/1098-2345(200012)52:4<157::AID-AJP1>3.0.CO;2-L	86	33	34	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23105	10.1371/journal.pone.0023105	http://dx.doi.org/10.1371/journal.pone.0023105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853074	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200043
J	McDonald, AT				McDonald, Andrew T.			A Subadult Specimen of Rubeosaurus ovatus (Dinosauria: Ceratopsidae), with Observations on Other Ceratopsids from the Two Medicine Formation	PLOS ONE			English	Article							JUDITH RIVER FORMATION; PHYLOGENETIC ANALYSIS; OLDMAN-FORMATION; NORTH-AMERICA; MONTANA; ALBERTA; ORNITHISCHIA; AVACERATOPS; SYSTEMATICS; ONTOGENY	Background: Centrosaurine ceratopsids are well known from the middle Campanian Upper Two Medicine Formation of Montana. Four taxa have been named: Brachyceratops montanensis, Rubeosaurus ovatus, Einiosaurus procurvicornis, and Achelousaurus horneri. Rubeosaurus has been historically the most enigmatic of these taxa; only two specimens, the holotype caudal parietal bar and a referred incomplete skull, have been assigned to Rubeosaurus. Methodology/Principal Findings: A revised interpretation of the parietal processes of USNM 14765, the partial skeleton of a subadult centrosaurine formerly referred to Brachyceratops, indicates that it shares a P5 spike with the holotype of Rubeosaurus ovatus and should therefore be referred to that taxon. Brachyceratops is considered a nomen dubium. Conclusions/Significance: USNM 14765 provides additional anatomical information for Rubeosaurus ovatus. These new data are incorporated into a recent phylogenetic analysis of centrosaurine relationships; Rubeosaurus appears as the sister taxon of a clade composed of Einiosaurus, Achelousaurus, and Pachyrhinosaurus.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Department of Earth and Environmental Science, University of Pennsylvania	Department of Earth and Environmental Science, University of Pennsylvania	The author's research was facilitated by travel funds from the Department of Earth and Environmental Science, University of Pennsylvania (http://www.sas.upenn.edu/earth/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Currie Philip J., 2008, P1; Dodson P., 1990, P231, DOI 10.1017/CBO9780511608377.020; DODSON P, 1986, P ACAD NAT SCI PHILA, V138, P305; FARKE AA, ACTA PALAEO IN PRESS; Gilmore, 1917, US GEOLOGICAL SURVEY, V103, P1; Gilmore C. W., 1914, Smithsonian Institution Miscellaneous Collection, V63; GILMORE CHARLES W., 1930, PROC U S NATION MUS, V77, P1; GILMORE CHARLES W., 1939, PROC V S NATION MUS, V87, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2008, NEWSL STRATIGR, V43, P5, DOI 10.1127/0078-0421/2008/0043-0005; Kirkland James I., 2010, P117; Lambe L. M., 1913, Ottawa Naturalist, V27; LAMBE LM, 1915, B NATL MUSEUM CANADA, V24, P1; LAMBE LM, 1904, OTTAWA NATURALIST, V18, P81; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; LUND E, 2010, J VERTEBRATE PALE S3, V30, pA125; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; McDonald Andrew T., 2010, P156; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Ryan M, 2009, J VERTEBR PALEONTOL, V29, p174A; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; STERNBERG C. M., 1950, NATION MUS CANADA MUS BULL, V118, P109; Tumarkin-Deratzian Allison R., 2010, P251; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5	34	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22710	10.1371/journal.pone.0022710	http://dx.doi.org/10.1371/journal.pone.0022710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853043	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200018
J	Michelfelder, S; Varadi, K; Raupp, C; Hunger, A; Korbelin, J; Pahrmann, C; Schrepfer, S; Muller, OJ; Kleinschmidt, JA; Trepel, M				Michelfelder, Stefan; Varadi, Karl; Raupp, Christina; Hunger, Agnes; Koerbelin, Jakob; Pahrmann, Christiane; Schrepfer, Sonja; Mueller, Oliver J.; Kleinschmidt, Juergen A.; Trepel, Martin			Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; VIRAL VECTORS; LIVER TRANSDUCTION; PHAGE DISPLAY; THERAPY; LIBRARIES; DELIVERY; TROPISM; SEROTYPE-8; SELECTION	Efficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient than AAV2 for gene transfer to certain tissues in vivo. Consequently, re-targeting of these serotypes by ligand insertion could be a promising approach but has not been explored so far. Here, we generated AAV8 and -9 vectors displaying peptides in the threefold spike capsid domain. These peptides had been selected from peptide libraries displayed on capsids of AAV serotype 2 to optimize systemic gene delivery to murine lung tissue and to breast cancer tissue in PymT transgenic mice (PymT). Such peptide insertions at position 590 of the AAV8 capsid and position 589 of the AAV9 capsid changed the transduction properties of both serotypes. However, both peptides inserted in AAV8 did not result in the same changes of tissue tropism as they did in AAV2. While the AAV2 peptides selected on murine lung tissue did not alter tropism of serotypes 8 and -9, insertion of the AAV2-derived peptide selected on breast cancer tissue augmented tumor gene delivery in both serotypes. Further, this peptide mediated a strong but unspecific in vivo gene transfer for AAV8 and abrogated transduction of various control tissues for AAV9. Our findings indicate that peptide insertion into defined sites of AAV8 and -9 capsids can change and improve their efficiency and specificity compared to their wild type variants and to AAV2, making these insertion sites attractive for the generation of novel targeted vectors in these serotypes.	[Michelfelder, Stefan; Hunger, Agnes; Koerbelin, Jakob; Trepel, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hubertus Wald Canc Ctr, Hamburg, Germany; [Pahrmann, Christiane; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Transplant & Stem Cell Immunobiol Lab, Hamburg, Germany; [Varadi, Karl; Mueller, Oliver J.] Univ Med Ctr Heidelberg, Heidelberg, Germany; [Raupp, Christina; Kleinschmidt, Juergen A.] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Michelfelder, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hubertus Wald Canc Ctr, Hamburg, Germany.	m.trepel@uke.de	Müller, Oliver J./H-4739-2016; Körbelin, Jakob/ABG-2863-2020; Müller, Oliver/AAA-4399-2021	Körbelin, Jakob/0000-0002-5435-7182; Müller, Oliver/0000-0001-8223-2638; Michelfelder, Stefan/0000-0001-8678-1546	Deutsche Forschungsgemeinschaft [TR448/5-3, Mu1654/3-2, KL 516/8-2]; Wilhelm-Sander Stiftung [2005.114.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de (grants TR448/5-3 to MT, Mu1654/3-2 to OJM and JAK, and KL 516/8-2 to JAK), as well as the Wilhelm-Sander Stiftung, http://www.wilhelm-sander-stiftung.de (grant 2005.114.1), to MT and JAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Boutin S, 2010, HUM GENE THER; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; GRIMM D, 2008, J VIROL; Huttner NA, 2003, GENE THER, V10, P2139, DOI 10.1038/sj.gt.3302123; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Koerber JT, 2008, MOL THER, V16, P1703, DOI 10.1038/mt.2008.167; Koerber JT, 2007, HUM GENE THER, V18, P367, DOI 10.1089/hum.2006.139; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Manfredsson FP, 2009, MOL THER, V17, P403, DOI 10.1038/mt.2009.15; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Park K, 2008, FRONT BIOSCI-LANDMRK, V13, P2653, DOI 10.2741/2872; Perabo L, 2003, MOL THER, V8, P151, DOI 10.1016/S1525-0016(03)00123-0; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Shen X, 2007, MOL THER, V15, P1955, DOI 10.1038/sj.mt.6300293; Shi WF, 2003, MOL THER, V7, P515, DOI 10.1016/S1525-0016(03)00042-X; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Waterkamp DA, 2006, J GENE MED, V8, P1307, DOI 10.1002/jgm.967; White K, 2008, GENE THER, V15, P443, DOI 10.1038/sj.gt.3303077; White SJ, 2004, CIRCULATION, V109, P513, DOI 10.1161/01.CIR.0000109697.68832.5D; Work LM, 2006, MOL THER, V13, P683, DOI 10.1016/j.ymthe.2005.11.013; Work LM, 2004, MOL THER, V9, P198, DOI 10.1016/j.ymthe.2003.11.006; Wright JF, 2008, GENE THER, V15, P840, DOI 10.1038/gt.2008.65; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; YING Y, 2010, GENE THER; YU CY, 2009, GENE THER, P11601; ZINCARELLI C, 2008, MOL THER	50	32	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23101	10.1371/journal.pone.0023101	http://dx.doi.org/10.1371/journal.pone.0023101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850255	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300040
J	Sheldon, AL; Zhang, JM; Fei, H; Levitan, IB				Sheldon, Amanda L.; Zhang, Jiaming; Fei, Hong; Levitan, Irwin B.			SLOB, a SLOWPOKE Channel Binding Protein, Regulates Insulin Pathway Signaling and Metabolism in Drosophila	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; DEPENDENT POTASSIUM CHANNEL; FEEDING-BEHAVIOR; LOCOMOTOR-ACTIVITY; SCHNEIDER CELLS; AMINO-ACIDS; FAT-BODY; GROWTH; RECEPTOR; GENE	There is ample evidence that ion channel modulation by accessory proteins within a macromolecular complex can regulate channel activity and thereby impact neuronal excitability. However, the downstream consequences of ion channel modulation remain largely undetermined. The Drosophila melanogaster large conductance calcium-activated potassium channel SLOWPOKE (SLO) undergoes modulation via its binding partner SLO-binding protein (SLOB). Regulation of SLO by SLOB influences the voltage dependence of SLO activation and modulates synaptic transmission. SLO and SLOB are expressed especially prominently in median neurosecretory cells (mNSCs) in the pars intercerebralis (PI) region of the brain; these cells also express and secrete Drosophila insulin like peptides (dILPs). Previously, we found that flies lacking SLOB exhibit increased resistance to starvation, and we reasoned that SLOB may regulate aspects of insulin signaling and metabolism. Here we investigate the role of SLOB in metabolism and find that slob null flies exhibit changes in energy storage and insulin pathway signaling. In addition, slob null flies have decreased levels of dilp3 and increased levels of takeout, a gene known to be involved in feeding and metabolism. Targeted expression of SLOB to mNSCs rescues these alterations in gene expression, as well as the metabolic phenotypes. Analysis of fly lines mutant for both slob and slo indicate that the effect of SLOB on metabolism and gene expression is via SLO. We propose that modulation of SLO by SLOB regulates neurotransmission in mNSCs, influencing downstream insulin pathway signaling and metabolism.	[Sheldon, Amanda L.; Zhang, Jiaming; Fei, Hong; Levitan, Irwin B.] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University	Sheldon, AL (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.	Irwin.Levitan@Jefferson.edu	Zhang, Jiaming/GSD-8224-2022		U.S. National Institutes of Health	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant to IBL from the U.S. National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Atkinson NS, 2000, J NEUROSCI, V20, P2988; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Engel JE, 1998, J NEUROSCI, V18, P2254; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; GHO M, 1992, J EXP BIOL, V170, P93; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Jaramillo AM, 2006, J NEUROPHYSIOL, V95, P1957, DOI 10.1152/jn.00427.2005; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kim SE, 2004, CELL SIGNAL, V16, P1309, DOI 10.1016/j.cellsig.2004.04.004; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Klowden M. J., 2002, PHYSL SYSTEMS INSECT; Kreneisz O, 2010, NEUROREPORT, V21, P1116, DOI 10.1097/WNR.0b013e3283409200; Kwon HB, 2002, J BIOL CHEM, V277, P14853, DOI 10.1074/jbc.M110366200; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Ma HF, 2011, J GEN PHYSIOL, V137, P225, DOI 10.1085/jgp.201010439; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Proks P, 2006, CURR PHARM DESIGN, V12, P485, DOI 10.2174/138161206775474431; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Shahidullah M, 2009, J NEUROSCI, V29, P13328, DOI 10.1523/JNEUROSCI.3024-09.2009; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; Wang J, 1999, J Neurosci, V19, pRC4; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Zeng HY, 2005, J GEN PHYSIOL, V125, P631, DOI 10.1085/jgp.200509252; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zinke I, 1999, DEVELOPMENT, V126, P5275	64	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23343	10.1371/journal.pone.0023343	http://dx.doi.org/10.1371/journal.pone.0023343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850269	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300054
J	Halsey, LG; Jones, TT; Jones, DR; Liebsch, N; Booth, DT				Halsey, Lewis G.; Jones, T. Todd; Jones, David R.; Liebsch, Nikolai; Booth, David T.			Measuring Energy Expenditure in Sub-Adult and Hatchling Sea Turtles via Accelerometry	PLOS ONE			English	Article							DOUBLY LABELED WATER; DIVING GREAT CORMORANTS; JUVENILE GREEN TURTLES; CHELONIA-MYDAS L.; HEART-RATE; OXYGEN-CONSUMPTION; METABOLIC-RATE; CARDIOVASCULAR ADJUSTMENTS; DERMOCHELYS-CORIACEA; LOGGERHEAD TURTLES	Measuring the metabolic of sea turtles is fundamental to understanding their ecology yet the presently available methods are limited. Accelerometry is a relatively new technique for estimating metabolic rate that has shown promise with a number of species but its utility with air-breathing divers is not yet established. The present study undertakes laboratory experiments to investigate whether rate of oxygen uptake (<(V)over dot>o(2)) at the surface in active sub-adult green turtles Chelonia mydas and hatchling loggerhead turtles Caretta caretta correlates with overall dynamic body acceleration (ODBA), a derivative of acceleration used as a proxy for metabolic rate. Six green turtles (25-44 kg) and two loggerhead turtles (20 g) were instrumented with tri-axial acceleration logging devices and placed singly into a respirometry chamber. The green turtles were able to submerge freely within a 1.5 m deep tank and the loggerhead turtles were tethered in water 16 cm deep so that they swam at the surface. A significant prediction equation for mean <(V)over dot>o(2) over an hour in a green turtle from measures of ODBA and mean flipper length (R-2 = 0.56) returned a mean estimate error across turtles of 8.0%. The range of temperatures used in the green turtle experiments (22-30 degrees C) had only a small effect on <(V)over dot>o(2). A <(V)over dot>o(2)-ODBA equation for the loggerhead hatchling data was also significant (R-2 = 0.67). Together these data indicate the potential of the accelerometry technique for estimating energy expenditure in sea turtles, which may have important applications in sea turtle diving ecology, and also in conservation such as assessing turtle survival times when trapped underwater in fishing nets.	[Halsey, Lewis G.] Roehampton Univ, Dept Life Sci, London, England; [Jones, T. Todd] Univ Hawaii Manoa, NOAA, Kewalo Res Facil, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Jones, David R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Liebsch, Nikolai] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Booth, David T.] Univ Queensland, Sch Biol Sci, Physiol Ecol Grp, St Lucia, Qld, Australia	Roehampton University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; University of British Columbia; University of Queensland; University of Queensland	Halsey, LG (corresponding author), Roehampton Univ, Dept Life Sci, London, England.	l.halsey@roehampton.ac.uk	Booth, David T./A-7184-2012; Halsey, Lewis/B-8498-2011	Booth, David T./0000-0002-3801-0488; Halsey, Lewis/0000-0002-0786-7585	NSERC; Percy Sladen Memorial Fund; Linnaean Society of London	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Percy Sladen Memorial Fund; Linnaean Society of London	This project was partly funded by an NSERC Discovery Grant to Professor Dave Jones, and partly funded by the Percy Sladen Memorial Fund, care of The Linnaean Society of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Booth DT, 2009, J EXP BIOL, V212, P50, DOI 10.1242/jeb.019778; BOYD IL, 1995, FUNCT ECOL, V9, P151, DOI 10.2307/2390559; Brand SJ, 1999, MAR FRESHWATER RES, V50, P145, DOI 10.1071/MF98033; BUTLER PJ, 1984, J COMP PHYSIOL, V154, P167, DOI 10.1007/BF00684141; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; DAVENPORT J, 1982, J ZOOL, V198, P399; deLeeuw JJ, 1996, CAN J ZOOL, V74, P2131, DOI 10.1139/z96-242; Enstipp MR, 2006, J EXP BIOL, V209, P845, DOI 10.1242/jeb.02064; Epperly S, 2002, 490 NOAA NMFSSEFSC U; Fahlman A, 2008, J EXP BIOL, V211, P3573, DOI 10.1242/jeb.023655; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; Fedak M.A., 1986, DIVING ANIMALS MAN, P11; Fossette S, J EXPT BIOL IN PRESS, V213; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Green J, 2005, CAN J ZOOL, V83, P445, DOI 10.1139/Z05-035; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Green JA, 2001, J EXP BIOL, V204, P673; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Gremillet D, 1998, FUNCT ECOL, V12, P386, DOI 10.1046/j.1365-2435.1998.00199.x; Gremillet D, 2005, J AVIAN BIOL, V36, P57, DOI 10.1111/j.0908-8857.2005.03331.x; Halsey LG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P230, DOI 10.1086/658636; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2007, ZOOLOGY, V110, P81, DOI 10.1016/j.zool.2006.09.001; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Halsey LG, 2005, PHYSIOL BIOCHEM ZOOL, V78, P273, DOI 10.1086/427053; Hays GC, 2001, J EXP BIOL, V204, P4093; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2000, ANIM BEHAV, V59, P577, DOI 10.1006/anbe.1999.1326; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hochscheid S, 2003, J EXP MAR BIOL ECOL, V297, P123, DOI 10.1016/j.jembe.2003.07.004; Jones TT, 2007, COMP BIOCHEM PHYS A, V147, P313, DOI 10.1016/j.cbpa.2006.09.013; Jones TT, 2009, J EXP BIOL, V212, P2635, DOI 10.1242/jeb.029330; Kooyman G. L., 1989, DIVERSE DIVERS; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; LUTCAVAGE ME, 1991, J EXP MAR BIOL ECOL, V147, P287, DOI 10.1016/0022-0981(91)90187-2; Lutcavage Molly E., 1997, P277; LUTZ PL, 1985, COPEIA, P671, DOI 10.2307/1444761; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Payne N, 2010, J ANIMAL ECOLOGY ONL; Richman SE, 2008, J COMP PHYSIOL B, V178, P321, DOI 10.1007/s00360-007-0225-9; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; SATO K, 1994, MAR BIOL, V118, P343, DOI 10.1007/BF00349802; SHELTON G, 1982, J EXP BIOL, V100, P245; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Southwood AL, 2006, CAN J ZOOL, V84, P125, DOI 10.1139/Z05-185; Southwood AL, 2003, J EXP BIOL, V206, P4521, DOI 10.1242/jeb.00689; Southwood AL, 1999, J EXP BIOL, V202, P1115; STANDORA EA, 1982, J THERM BIOL, V7, P159, DOI 10.1016/0306-4565(82)90006-7; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Wallace BP, 2005, J EXP BIOL, V208, P3873, DOI 10.1242/jeb.01860; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	59	34	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22311	10.1371/journal.pone.0022311	http://dx.doi.org/10.1371/journal.pone.0022311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829613	gold, Green Published			2022-12-25	WOS:000293561200012
J	Kiok, K; Sun, H; Clancy, H; Bose, S; Kluz, T; Wu, F; Costa, M				Kiok, Kathrin; Sun, Hong; Clancy, Hailey; Bose, Sutapa; Kluz, Thomas; Wu, Fen; Costa, Max			Liprin-alpha 4 Is Required for Nickel Induced Receptor Protein Tyrosine Phosphatase-Leukocyte Antigen Related Receptor F (RPTP-LAR) Activity	PLOS ONE			English	Article							CELL-LINE; MAINTENANCE; BINDING; SYSTEM; ALPHA; GRIP; A549	Liprin-alpha 4 was strongly induced following nickel (II) chloride exposure in a variety of cell types including BEAS-2B, A549, BEP2D and BL41 cells. Liprin-alpha 4, a member of the Liprin alpha family, has seven isoforms but only three of these variants were detected in BEAS-2B cells (004, 201 and 202). The level of Liprin-alpha 4 variants 201 and 004 were highly increased in BEAS-2B cells in response to nickel. We showed that Liprin-alpha 4 bound directly to the cytoplasmic region of RPTP-LAR (receptor protein tyrosine phosphatase-leukocyte antigen-related receptor F). The cytoplasmic region of RPTP-LAR contains two phosphatase domains but only the first domain shows activity. The second domain interacts with other proteins. The phosphatase activity was increased both following nickel treatment and also in the presence of nickel ions in cell extracts. Liprin-alpha 4 knock-down lines with decreased expression of Liprin-alpha 4 variants 004 and 201 exhibited greater nickel toxicity compared to controls. The RPTP-LAR phosphatase activity was only slightly increased in a Liprin-alpha 4 knock-down line. Liprin-alpha 4 appeared necessary for the nickel induced tyrosine phosphatase activity. The presence of Liprin-alpha 4 and nickel increased tyrosine phosphatase activity that reduced the global levels of tyrosine phosphorylation in the cell.	[Kiok, Kathrin; Sun, Hong; Clancy, Hailey; Bose, Sutapa; Kluz, Thomas; Wu, Fen; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA	New York University	Kiok, K (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.	Max.Costa@nyumc.org	Wu, Fen/G-1569-2010; costa, max/H-1754-2012	BOSE, SUTAPA/0000-0002-6569-4643	National Institutes of Environmental Health Sciences [ES000260, ES010344, ES014454, ES005512]; National Cancer Institute [CA16087]; National Center for Research Resources [RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014454, R01ES005512, P42ES010344, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers ES000260, ES010344, ES014454, ES005512 from the National Institutes of Environmental Health Sciences and from grant number CA16087 from National Cancer Institute and RR029893 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran R, 2002, NEURON, V34, P1, DOI 10.1016/S0896-6273(02)00649-9; Busch W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-65; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Davidson TL, 2006, MOL CARCINOGEN, V45, P479, DOI 10.1002/mc.20176; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; KO J, 2003, J NEUROSCIENCE, V23; Lewis JB, 2006, BIOMATERIALS, V27, P5348, DOI 10.1016/j.biomaterials.2006.06.007; LI Q, 2006, EFFECTS 12 METAL ION; MAPARA MY, 1995, EUR J IMMUNOL, V25, P2506, DOI 10.1002/eji.1830250915; Mattauch S, 2010, EXP CELL RES, V316, P2883, DOI 10.1016/j.yexcr.2010.06.022; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Piche B, 2010, CELL MOL LIFE SCI, V67, P1987, DOI 10.1007/s00018-010-0312-z; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; REDDEL RR, 1988, CANCER RES, V48, P1904; Salnikow K, 2000, CANCER RES, V60, P38; Serra-Pages C, 2005, BIOCHEMISTRY-US, V44, P15715, DOI 10.1021/bi051434f; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; SHIN H, 2003, J BIOL CHEM, V278; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; TEMPEST PR, 1986, CARCINOGENESIS, V7, P2051, DOI 10.1093/carcin/7.12.2051; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Ying WT, 2003, PROTEOMICS, V3, P64, DOI 10.1002/pmic.200390010	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22764	10.1371/journal.pone.0022764	http://dx.doi.org/10.1371/journal.pone.0022764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829649	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200029
J	Hostager, BS; Kashiwada, M; Colgan, JD; Rothman, PB				Hostager, Bruce S.; Kashiwada, Masaki; Colgan, John D.; Rothman, Paul B.			HOIL-1L Interacting Protein (HOIP) Is Essential for CD40 Signaling	PLOS ONE			English	Article							CHAIN ASSEMBLY COMPLEX; KAPPA-B ACTIVATION; MONOCLONAL-ANTIBODY; T-CELLS; NEMO; LYMPHOCYTES; EXPRESSION; INDUCTION; MECHANISM; APOPTOSIS	CD40 is a cell surface receptor important in the activation of antigen-presenting cells during immune responses. In macrophages and dendritic cells, engagement of CD40 by its ligand CD154 provides signals critical for anti-microbial and T cell-mediated immune responses, respectively. In B cells, CD40 signaling has a major role in regulating cell proliferation, antibody production, and memory B cell development. CD40 engagement results in the formation of a receptor-associated complex that mediates activation of NF-kappa B, stress-activated protein kinases, and other signaling molecules. However, the mechanisms that link CD40 to these signaling events have been only partially characterized. Known components of the CD40 signaling complex include members of the TNF receptor-associated factor (TRAF) family of proteins. We previously showed that the TRAF family member TRAF2 mediates recruitment of HOIL-1L-interacting protein (HOIP) to the cytoplasmic domain of CD40, suggesting that HOIP has a role in the CD40 signaling pathway. To determine the role of HOIP in CD40 signaling, we used somatic cell gene targeting to generate mouse B cell lines deficient in HOIP. We found that the CD40-induced upregulation of CD80 and activation of germline immunoglobulin epsilon transcription were defective in HOIP-deficient cells. We also found that the CD40-mediated activation of NF-kappa B and c-Jun kinase was impaired. Recruitment of I kappa B kinase proteins to the CD40 signaling complex was undetectable in HOIP-deficient cells, potentially explaining the defect in NF-kappa B activation. Restoration of HOIP expression reversed the defects in cellular activation and signaling. These results reveal HOIP as a key component of the CD40 signaling pathway.	[Hostager, Bruce S.; Kashiwada, Masaki; Colgan, John D.; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Hostager, BS (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	bruce-hostager@uiowa.edu		Colgan, John/0000-0001-9273-2644	National Institute of Health [R01AI054821, R01AI077516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054821, R01AI067489, R01AI077516] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institute of Health grants R01AI054821 (P.B.R) and R01AI077516 (P.B.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hostager BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011380; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; KIM KJ, 1979, J IMMUNOL, V122, P549; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; MCKEAN DJ, 1983, J IMMUNOL, V131, P2726; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; SILKE J, CELL DEATH DIFFER, V17, P35; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wiedemann P, 1996, J BIOL CHEM, V271, P29915, DOI 10.1074/jbc.271.47.29915; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2008, CYTOKINE GROWTH F R, V19, P199, DOI 10.1016/j.cytogfr.2008.04.002	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23061	10.1371/journal.pone.0023061	http://dx.doi.org/10.1371/journal.pone.0023061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829693	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511200037
J	Gregg, B; Dzierszinski, F; Tait, E; Jordan, KA; Hunter, CA; Roos, DS				Gregg, Beth; Dzierszinski, Florence; Tait, Elia; Jordan, Kimberly A.; Hunter, Christopher A.; Roos, David S.			Subcellular Antigen Location Influences T-Cell Activation during Acute Infection with Toxoplasma gondii	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE; DENDRITIC CELLS; BONE-MARROW; MICE; RESPONSES; COMPLEX; MACROPHAGES; RESISTANCE; EXPRESSION; INDUCTION	Effective control of the intracellular protozoan parasite Toxoplasma gondii depends on the activation of antigen-specific CD8(+) T-cells that manage acute disease and prevent recrudescence during chronic infection. T-cell activation in turn, requires presentation of parasite antigens by MHC-I molecules on the surface of antigen presenting cells. CD8(+) T-cell epitopes have been defined for several T. gondii proteins, but it is unclear how these antigens enter into the presentation pathway. We have exploited the well-characterized model antigen ovalbumin (OVA) to investigate the ability of parasite proteins to enter the MHC-I presentation pathway, by engineering recombinant expression in various organelles. CD8(+) T-cell activation was assayed using 'B3Z' reporter cells in vitro, or adoptively-transferred OVA-specific 'OT-I' CD8(+) T-cells in vivo. As expected, OVA secreted into the parasitophorous vacuole strongly stimulated antigen-presenting cells. Lower levels of activation were observed using glycophosphatidyl inositol (GPI) anchored OVA associated with (or shed from) the parasite surface. Little CD8(+) T-cell activation was detected using parasites expressing intracellular OVA in the cytosol, mitochondrion, or inner membrane complex (IMC). These results indicate that effective presentation of parasite proteins to CD8(+) T-cells is a consequence of active protein secretion by T. gondii and escape from the parasitophorous vacuole, rather than degradation of phagocytosed parasites or parasite products.	[Gregg, Beth; Dzierszinski, Florence; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tait, Elia; Jordan, Kimberly A.; Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Gregg, B (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	droos@sas.upenn.edu		Roos, David Siker/0000-0001-6725-4089; Tait Wojno, Elia/0000-0003-2822-296X	National Institutes of Health (NIH) [AI28724, AI071302, AI 42334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028724, R01AI071302, R37AI028724, R01AI042334] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI28724, AI071302, and AI 42334 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertholet S, 2005, INFECT IMMUN, V73, P6620, DOI 10.1128/IAI.73.10.6620-6628.2005; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Caamano J, 1999, J IMMUNOL, V163, P4453; DENKERS EY, 1993, J IMMUNOL, V150, P517; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Garg N, 1997, J IMMUNOL, V158, P3293; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KASPER LH, 1992, J IMMUNOL, V148, P1493; KHAN IA, 1991, J IMMUNOL, V147, P3501; KHAN IA, 1988, J IMMUNOL, V141, P3600; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kwok LY, 2003, J IMMUNOL, V170, P1949, DOI 10.4049/jimmunol.170.4.1949; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; PARKER SJ, 1991, CLIN EXP IMMUNOL, V84, P207, DOI 10.1111/j.1365-2249.1991.tb08150.x; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pepper M, 2004, INFECT IMMUN, V72, P7240, DOI 10.1128/IAI.72.12.7240-7246.2004; REYNOLDS M, 1998, BIOCH EVOLUTION ANTI; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Seeber F, 1998, J CELL SCI, V111, P23; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; SUZUKI Y, 1988, J IMMUNOL, V140, P3943; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tu L, 2009, EUR J IMMUNOL, V39, P3385, DOI 10.1002/eji.200839117; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	50	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22936	10.1371/journal.pone.0022936	http://dx.doi.org/10.1371/journal.pone.0022936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829561	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600067
J	Carrascosa, C; Obula, RG; Missiaglia, E; Lehr, HA; Delorenzi, M; Frattini, M; Ruegg, C; Mariotti, A				Carrascosa, C.; Obula, R. G.; Missiaglia, E.; Lehr, H-A; Delorenzi, M.; Frattini, M.; Rueegg, C.; Mariotti, A.			MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells	ONCOGENE			English	Article						MFG-E8; mammary tumorigenesis; neoplastic transformation; cyclin D; N-cadherin	MILK-FAT GLOBULE; BREAST-CANCER; N-CADHERIN; PREOPERATIVE CHEMOTHERAPY; MONOCLONAL-ANTIBODIES; ESTROGEN-RECEPTOR; APOPTOTIC CELLS; TUMOR; CARCINOMA; PROTEIN	Milk fat globule-EGF factor 8 (MFG-E8) is a glycoprotein highly expressed in breast cancer that contributes to tumor progression through largely undefined mechanisms. By analyzing publicly available gene expression profiles of breast carcinomas, we found that MFG-E8 is highly expressed in primary and metastatic breast carcinomas, associated with absent estrogen receptor expression. Immunohistochemistry analysis of breast cancer biopsies revealed that MFG-E8 is expressed on the cell membrane as well as in the cytoplasm and nucleus. We also show that increased expression of MFG-E8 in mammary carcinoma cells increases their tumorigenicity in immunodeficient mice, and conversely, its downregulation reduces their in vivo growth. Moreover, expression of MFG-E8 in immortalized mammary epithelial cells promotes their growth and branching in three-dimensional collagen matrices and induces the expression of cyclins D1/D3 and N-cadherin. A mutant protein unable to bind integrins can in part exert these effects, indicating that MFG-E8 function is only partially dependent on integrin activation. We conclude that MFG-E8-dependent signaling stimulates cell proliferation and the acquisition of mesenchymal properties and contributes to mammary carcinoma development. Oncogene (2012) 31, 1521-1532; doi:10.1038/onc.2011.356; published online 15 August 2011	[Carrascosa, C.; Mariotti, A.] Univ Lausanne, Div Expt Oncol, Ctr Pluridisciplinaire Oncol, Lausanne Canc Ctr, CH-1066 Epalinges, Switzerland; [Missiaglia, E.; Delorenzi, M.] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Lehr, H-A] CHUV, Inst Pathol, Lausanne, Switzerland; [Delorenzi, M.; Mariotti, A.] Univ Lausanne, Dept Format & Rech, CHUV, Lausanne, Switzerland; [Frattini, M.] Inst Pathol, Lab Mol Diagnost, Locarno, Switzerland; [Rueegg, C.] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg	Mariotti, A (corresponding author), Univ Lausanne, Div Expt Oncol, Ctr Pluridisciplinaire Oncol, Lausanne Canc Ctr, 155 Ch Boveresses,Room D203, CH-1066 Epalinges, Switzerland.	Agnese.Mariotti@unil.ch		missiaglia, edoardo/0000-0001-9221-0117; Mariotti, Agnese/0000-0002-3704-7908	MEDIC Foundation	MEDIC Foundation	This work was supported by a grant from the MEDIC Foundation to AM. We thank J-C Stehle and J Horlbeck of the UNIL Mouse Pathology facility for help with immunohistochemistry, F Botta for help in obtaining the breast carcinoma biopsies, C Brisken for reagents and T Petrova for discussions and support.	Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; CERIANI RL, 1982, P NATL ACAD SCI-BIOL, V79, P5420, DOI 10.1073/pnas.79.17.5420; CERIANI RL, 1977, P NATL ACAD SCI USA, V74, P582, DOI 10.1073/pnas.74.2.582; CERIANI RL, 1987, CANCER RES, V47, P532; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; LAROCCA D, 1991, CANCER RES, V51, P4994; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Lincoln DW, 2003, BREAST CANCER RES TR, V78, P167, DOI 10.1023/A:1022904624054; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Peintinger F, 2007, CLIN CANCER RES, V13, P4078, DOI 10.1158/1078-0432.CCR-06-2600; PETERSON JA, 1990, HYBRIDOMA, V9, P221, DOI 10.1089/hyb.1990.9.221; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Yang CW, 2011, CANCER RES, V71, P937, DOI 10.1158/0008-5472.CAN-10-1471; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	40	32	35	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	12					1521	1532		10.1038/onc.2011.356	http://dx.doi.org/10.1038/onc.2011.356			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21841820	Green Submitted			2022-12-25	WOS:000302132000005
J	Gammelsaeter, R; Coppola, T; Marcaggi, P; Storm-Mathisen, J; Chaudhry, FA; Attwell, D; Regazzi, R; Gundersen, V				Gammelsaeter, Runhild; Coppola, Thierry; Marcaggi, Paikan; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Attwell, David; Regazzi, Romano; Gundersen, Vidar			A Role for Glutamate Transporters in the Regulation of Insulin Secretion	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; EXOGENOUS D-ASPARTATE; RAT-BRAIN; VESICULAR GLUTAMATE; DIFFERENTIAL EXPRESSION; NERVE-ENDINGS; AMINO-ACIDS; EXOCYTOSIS; ISLETS; IMMUNOCYTOCHEMISTRY	In the brain, glutamate is an extracellular transmitter that mediates cell-to-cell communication. Prior to synaptic release it is pumped into vesicles by vesicular glutamate transporters (VGLUTs). To inactivate glutamate receptor responses after release, glutamate is taken up into glial cells or neurons by excitatory amino acid transporters (EAATs). In the pancreatic islets of Langerhans, glutamate is proposed to act as an intracellular messenger, regulating insulin secretion from beta-cells, but the mechanisms involved are unknown. By immunogold cytochemistry we show that insulin containing secretory granules express VGLUT3. Despite the fact that they have a VGLUT, the levels of glutamate in these granules are low, indicating the presence of a protein that can transport glutamate out of the granules. Surprisingly, in beta-cells the glutamate transporter EAAT2 is located, not in the plasma membrane as it is in brain cells, but exclusively in insulin-containing secretory granules, together with VGLUT3. In EAAT2 knock out mice, the content of glutamate in secretory granules is higher than in wild type mice. These data imply a glutamate cycle in which glutamate is carried into the granules by VGLUT3 and carried out by EAAT2. Perturbing this cycle by knocking down EAAT2 expression with a small interfering RNA, or by over-expressing EAAT2 or a VGLUT in insulin granules, significantly reduced the rate of granule exocytosis. Simulations of granule energetics suggest that VGLUT3 and EAAT2 may regulate the pH and membrane potential of the granules and thereby regulate insulin secretion. These data suggest that insulin secretion from beta-cells is modulated by the flux of glutamate through the secretory granules.	[Gammelsaeter, Runhild; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Gundersen, Vidar] Univ Oslo, Dept Anat, Oslo, Norway; [Gammelsaeter, Runhild; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Gundersen, Vidar] Univ Oslo, CMBN, Oslo, Norway; [Coppola, Thierry] Univ Nice, Inst Pharmacol Mol & Cellulaire, Nice, France; [Marcaggi, Paikan; Attwell, David] UCL, Dept Physiol, London, England; [Regazzi, Romano] Univ Lausanne, Dept Biol Cellulaire & Morphol, Lausanne, Switzerland; [Chaudhry, Farrukh A.] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Gundersen, Vidar] Univ Oslo, Rikshosp, Dept Neurol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; UDICE-French Research Universities; Universite Cote d'Azur; University of London; University College London; University of Lausanne; University of Oslo; University of Oslo; National Hospital Norway	Gammelsaeter, R (corresponding author), Univ Oslo, Dept Anat, Oslo, Norway.	vidar.gundersen@medisin.uio.no	Attwell, David/ABE-6750-2020; Marcaggi, Païkan/P-5855-2016; Marcaggi, Païkan/GYU-1658-2022; Coppola, Thierry/I-5036-2016	Marcaggi, Païkan/0000-0003-3575-8340; Coppola, Thierry/0000-0003-1018-722X; Regazzi, Romano/0000-0002-9773-2915; Storm-Mathisen, Jon/0000-0002-2930-3262	Medical Faculty, University of Oslo; Norwegian Research Council; Norwegian Diabetes Association; EU (DECG) [QLG3-CT-2001-2004]; Wellcome Trust [017948, 075232]	Medical Faculty, University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Diabetes Association; EU (DECG)(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by grants from the Medical Faculty, University of Oslo, the Norwegian Research Council, the Norwegian Diabetes Association, the EU (DECG,QLG3-CT-2001-2004), and the Wellcome Trust (grants 017948 and 075232 to D. Attwell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; Barg S, 2001, J CELL SCI, V114, P2145; Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO;2-C; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; Gundersen V, 1998, J NEUROSCI, V18, P6059; GUNDERSEN V, 1995, J NEUROSCI, V15, P4417; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MANFRAS BJ, 1994, BBA-BIOMEMBRANES, V1195, P185, DOI 10.1016/0005-2736(94)90026-4; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; OTTERSEN OP, 1987, EXP BRAIN RES, V69, P167; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thirion S, 1999, P NATL ACAD SCI USA, V96, P3206, DOI 10.1073/pnas.96.6.3206; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Weiss L, 1988, CELL TISSUE BIOL TXB	48	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22960	10.1371/journal.pone.0022960	http://dx.doi.org/10.1371/journal.pone.0022960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853059	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400020
J	Kawada, H; Dida, GO; Ohashi, K; Komagata, O; Kasai, S; Tomita, T; Sonye, G; Maekawa, Y; Mwatele, C; Njenga, SM; Mwandawiro, C; Minakawa, N; Takagi, M				Kawada, Hitoshi; Dida, Gabriel O.; Ohashi, Kazunori; Komagata, Osamu; Kasai, Shinji; Tomita, Takashi; Sonye, George; Maekawa, Yoshihide; Mwatele, Cassian; Njenga, Sammy M.; Mwandawiro, Charles; Minakawa, Noboru; Takagi, Masahiro			Multimodal Pyrethroid Resistance in Malaria Vectors, Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus s.s. in Western Kenya	PLOS ONE			English	Article							DIPTERA-CULICIDAE; INSECTICIDE RESISTANCE; NYANZA PROVINCE; ALLELE; NETS; SUSCEPTIBILITY; POPULATIONS; COVERAGE; BEHAVIOR; DDT	Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus s.s. are the most important species for malaria transmission. Pyrethroid resistance of these vector mosquitoes is one of the main obstacles against effective vector control. The objective of the present study was to monitor the pyrethroid susceptibility in the 3 major malaria vectors in a highly malaria endemic area in western Kenya and to elucidate the mechanisms of pyrethroid resistance in these species. Gembe East and West, Mbita Division, and 4 main western islands in the Suba district of the Nyanza province in western Kenya were used as the study area. Larval and adult collection and bioassay were conducted, as well as the detection of point mutation in the voltage-gated sodium channel (1014L) by using direct DNA sequencing. A high level of pyrethroid resistance caused by the high frequency of point mutations (L1014S) was detected in An. gambiae s.s. In contrast, P450-related pyrethroid resistance seemed to be widespread in both An. arabiensis and An. funestus s.s. Not a single L1014S mutation was detected in these 2 species. A lack of cross-resistance between DDT and permethrin was also found in An. arabiensis and An. funestus s.s., while An. gambiae s.s. was resistant to both insecticides. It is noteworthy that the above species in the same area are found to be resistant to pyrethroids by their unique resistance mechanisms. Furthermore, it is interesting that 2 different resistance mechanisms have developed in the 2 sibling species in the same area individually. The cross resistance between permethrin and DDT in An. gambiae s.s. may be attributed to the high frequency of kdr mutation, which might be selected by the frequent exposure to ITNs. Similarly, the metabolic pyrethroid resistance in An. arabiensis and An. funestus s.s. is thought to develop without strong selection by DDT.	[Kawada, Hitoshi; Maekawa, Yoshihide; Minakawa, Noboru; Takagi, Masahiro] Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med, Nagasaki 852, Japan; [Minakawa, Noboru] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Dida, Gabriel O.] Maseno Univ, Sch Publ Hlth, Kisumu, Kenya; [Dida, Gabriel O.; Sonye, George] Springs Hope, Mbita, Kenya; [Ohashi, Kazunori] Sumitomo Chem Co Ltd, Agr Chem Res Lab, Takarazuka, Hyogo, Japan; [Komagata, Osamu; Kasai, Shinji; Tomita, Takashi] Natl Inst Infect Dis, Tokyo, Japan; [Mwatele, Cassian; Njenga, Sammy M.] Eastern & So Africa Ctr Int Parasite Control, Nairobi, Kenya; [Mwandawiro, Charles] Kenya Govt Med Res Ctr, Nairobi, Kenya	Nagasaki University; Nagasaki University; Maseno University; Sumitomo Chem Co Ltd; National Institute of Infectious Diseases (NIID); Kenya Medical Research Institute	Kawada, H (corresponding author), Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med, Nagasaki 852, Japan.	vergiss@nagasaki-u.ac.jp	Komagata, Osamu/J-2771-2013	Komagata, Osamu/0000-0002-8175-6402; , Noboru/0000-0003-3664-9605; O Dida, Gabriel/0000-0003-2442-0352; Njenga, Sammy/0000-0001-6309-476X	Nagasaki University; Sumitomo Chemical Co., Ltd.	Nagasaki University; Sumitomo Chemical Co., Ltd.(Sumitomo Chem Co Ltd)	This study was funded by Nagasaki University and Sumitomo Chemical Co., Ltd. for the creation of field and semi-field bioassay systems for insecticide delivering technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; BERTRAM DS, 1969, T ROY SOC TROP MED H, V63, P125, DOI 10.1016/0035-9203(69)90093-5; Bliss CI, 1934, P NATL ACAD SCI USA, V79, P38; BRUCECHWATT LJ, 1985, ESSENTIAL MALARIOLOG, P452; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Futami K, 2010, MAL J IN PRESS; Gillies M, 1987, ANOPHELINAE AFRICA S; Gouagna L C, 2003, East Afr Med J, V80, P627; HEMINGWAY J, 1983, T ROY SOC TROP MED H, V77, P477, DOI 10.1016/0035-9203(83)90118-9; Hougard JM, 2002, J MED ENTOMOL, V39, P526, DOI 10.1603/0022-2585-39.3.526; Kamau L, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1101; Kawada H., 2009, ACS S BOOK, V1014; Kawada H., 2009, PLOS NEGLECT TROP D, V3; Kawada Hitoshi, 1993, Japanese Journal of Sanitary Zoology, V44, P349; Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Muriu SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-43; Mzilahowa T, 2008, MED VET ENTOMOL, V22, P258, DOI 10.1111/j.1365-2915.2008.00736.x; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nazni W A, 2005, Trop Biomed, V22, P63; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Okara RM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-69; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service MW, 1993, MOSQUITO ECOLOGY FIE, V1993, P210, DOI [10.1007/978-94-015-8113-4_3, DOI 10.1007/978-94-015-8113-4_3]; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Wacira DG, 2007, TROP MED INT HEALTH, V12, P140, DOI 10.1111/j.1365-3156.2006.01759.x; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Zaim M., 2007, GLOBAL INSECTICIDE U	44	69	73	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22574	10.1371/journal.pone.0022574	http://dx.doi.org/10.1371/journal.pone.0022574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853038	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400009
J	Zuo, L; Youtz, DJ; Wold, LE				Zuo, Li; Youtz, Dane J.; Wold, Loren E.			Particulate Matter Exposure Exacerbates High Glucose-Induced Cardiomyocyte Dysfunction through ROS Generation	PLOS ONE			English	Article							REACTIVE OXYGEN; AIR-POLLUTION; NADPH OXIDASE; VENTRICULAR MYOCYTES; OXIDATIVE STRESS; DIABETIC CARDIOMYOPATHY; ULTRAFINE PARTICLES; HOSPITAL ADMISSIONS; ELECTRON-TRANSPORT; HEART	Diabetes mellitus and fine particulate matter from diesel exhaust (DEP) are both important contributors to the development of cardiovascular disease (CVD). Diabetes mellitus is a progressive disease with a high mortality rate in patients suffering from CVD, resulting in diabetic cardiomyopathy. Elevated DEP levels in the air are attributed to the development of various CVDs, presumably since fine DEP (<2.5 mu m in diameter) can be inhaled and gain access to the circulatory system. However, mechanisms defining how DEP affects diabetic or control cardiomyocyte function remain poorly understood. The purpose of the present study was to evaluate cardiomyocyte function and reactive oxygen species (ROS) generation in isolated rat ventricular myocytes exposed overnight to fine DEP (0.1 mu g/ml), and/or high glucose (HG, 25.5 mM). Our hypothesis was that DEP exposure exacerbates contractile dysfunction via ROS generation in cardiomyocytes exposed to HG. Ventricular myocytes were isolated from male adult Sprague-Dawley rats cultured overnight and sarcomeric contractile properties were evaluated, including: peak shortening normalized to baseline (PS), time-to-90% shortening (TPS90), time-to-90% relengthening (TR90) and maximal velocities of shortening/relengthening (+/- dL/dt), using an IonOptix field-stimulator system. ROS generation was determined using hydroethidine/ethidium confocal microscopy. We found that DEP exposure significantly increased TR90, decreased PS and +/- dL/dt, and enhanced intracellular ROS generation in myocytes exposed to HG. Further studies indicated that co-culture with antioxidants (0.25 mM Tiron and 0.5 mM N-Acetyl-L-cysteine) completely restored contractile function in DEP, HG and HG+DEP-treated myocytes. ROS generation was blocked in HG-treated cells with mitochondrial inhibition, while ROS generation was blocked in DEP-treated cells with NADPH oxidase inhibition. Our results suggest that DEP exacerbates myocardial dysfunction in isolated cardiomyocytes exposed to HG-containing media, which is potentially mediated by various ROS generation pathways.	[Zuo, Li; Youtz, Dane J.; Wold, Loren E.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Zuo, Li; Wold, Loren E.] Ohio State Univ Coll Med, Dept Pediat, Columbus, OH USA; [Wold, Loren E.] Ohio State Univ Coll Med, Dept Physiol & Cell Biol, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zuo, L (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA.	Loren.Wold@nationwidechildrens.org	Wold, Loren E/E-4320-2011		American Heart Association [0835298N]; Research Institute at Nationwide Children's Hospital; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019923] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by an American Heart Association Scientific Development Grant to Dr. Loren E. Wold (No. 0835298N) as well as funds from the Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, AGING-US, V2, P1012, DOI 10.18632/aging.100261; AlMehdi AB, 1997, AM J PHYSIOL-LUNG C, V272, pL294, DOI 10.1152/ajplung.1997.272.2.L294; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Clanton TL, 1999, P SOC EXP BIOL MED, V222, P253, DOI 10.1046/j.1525-1373.1999.d01-142.x; Costa VM, 2009, TOXICOLOGY, V260, P84, DOI 10.1016/j.tox.2009.03.012; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dominici F, 2003, AM J EPIDEMIOL, V157, P1055, DOI 10.1093/aje/kwg087; Donaldson K, 2001, INT J HYG ENVIR HEAL, V203, P411, DOI 10.1078/1438-4639-00059; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; Godenschwege T, 2009, GENETICS, V183, P175, DOI 10.1534/genetics.109.103515; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Mo YQ, 2009, TOXICOL APPL PHARM, V236, P183, DOI 10.1016/j.taap.2009.01.017; MohazzabH KM, 1997, CIRCULATION, V96, P614; Monforton C, 2006, AM J PUBLIC HEALTH, V96, P271, DOI 10.2105/AJPH.2005.064410; Nethery D, 1999, J APPL PHYSIOL, V87, P792, DOI 10.1152/jappl.1999.87.2.792; Pani G, 2010, AGING-US, V2, P514, DOI 10.18632/aging.100182; Pope CA, 2008, AM J CARDIOL, V102, P1230, DOI 10.1016/j.amjcard.2008.06.044; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Ren J, 1997, AM J PHYSIOL-HEART C, V272, pH148, DOI 10.1152/ajpheart.1997.272.1.H148; Ren J, 1999, DIABETES, V48, P2059, DOI 10.2337/diabetes.48.10.2059; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; Ren Jun, 1997, Circulation, V96, pI314; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Schaffer SW, 1997, MOL CELL BIOCHEM, V176, P219, DOI 10.1023/A:1006801128850; Schaffer SW, 1997, CARDIOVASC RES, V34, P129, DOI 10.1016/S0008-6363(97)00020-5; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Simkhovich BZ, 2007, BASIC RES CARDIOL, V102, P467, DOI 10.1007/s00395-007-0681-0; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Sunyer J, 2003, EUR HEART J, V24, P752, DOI 10.1016/S0195-668X(02)00808-4; SYROVY I, 1992, GEN PHYSIOL BIOPHYS, V11, P301; Vinciguerra M, 2010, AGING-US, V2, P43; Wang Jianxun, 2006, Review of Diabetic Studies, V3, P108, DOI 10.1900/RDS.2006.3.108; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Wold LE, 2001, J MOL CELL CARDIOL, V33, P1719, DOI 10.1006/jmcc.2001.1431; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031; Zuo L, 2003, ANTIOXID REDOX SIGN, V5, P667, DOI 10.1089/152308603770310347; Zuo L, 2002, METHOD ENZYMOL, V352, P307; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058; Zuo L, 2009, J PHARMACOL EXP THER, V329, P515, DOI 10.1124/jpet.108.143479	53	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23116	10.1371/journal.pone.0023116	http://dx.doi.org/10.1371/journal.pone.0023116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850256	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300041
J	Kim, CS; Keum, SJ; Jang, SK				Kim, Chon Saeng; Keum, Sun Ju; Jang, Sung Key			Generation of a Cell Culture-Adapted Hepatitis C Virus with Longer Half Life at Physiological Temperature	PLOS ONE			English	Article							INFECTION IN-VITRO; ION-CHANNEL; P7 PROTEIN; COMPENSATORY MUTATIONS; ENVELOPE GLYCOPROTEIN; CORE PROTEIN; LOCALIZATION; BINDING; REPLICATION; POLYPEPTIDE	Background: We previously reported infectious HCV clones that contain the convenient reporters, green fluorescent protein (GFP) and Renilla luciferase (Rluc), in the NS5a-coding sequence. Although these viruses were useful in monitoring viral proliferation and screening of anti-HCV drugs, the infectivity and yield of the viruses were low. Methodology/Principal Findings: In order to obtain a highly efficient HCV cultivation system, we transfected Huh7.5.1 cells [1] with JFH 5a-GFP RNA and then cultivated cells for 20 days. We found a highly infectious HCV clone containing two cell culture-adapted mutations. Two cell culture-adapted mutations which were responsible for the increased viral infectivity were located in E2 and p7 protein coding regions. The viral titer of the variant was similar to 100-fold higher than that of the parental virus. The mutation in the E2 protein increased the viability of virus at 37 degrees C by acquiring prolonged interaction capability with a HCV receptor CD81. The wild-type and p7-mutated virus had a half-life of similar to 2.5 to 3 hours at 37 degrees C. In contrast, the half-life of viruses, which contained E2 mutation singly and combination with the p7 mutation, was 5 to 6 hours at 37 degrees C. The mutation in the p7 protein, either singly or in combination with the E2 mutation, enhanced infectious virus production about 10-50-fold by facilitating an early step of virion production. Conclusion/Significance: The mutation in the E2 protein generated by the culture system increases virion viability at 37 degrees C. The adaptive mutation in the p7 protein facilitates an earlier stage of virus production, such as virus assembly and/or morphogenesis. These reporter-containing HCV viruses harboring adaptive mutations are useful in investigations of the viral life cycle and for developing anti-viral agents against HCV.	[Kim, Chon Saeng; Keum, Sun Ju; Jang, Sung Key] Pohang Univ Sci & Technol, Mol Virol Lab, POSTECH Biotech Ctr, Dept Life Sci, Pohang, Kyungbuk, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Kyungbuk, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, CS (corresponding author), Pohang Univ Sci & Technol, Mol Virol Lab, POSTECH Biotech Ctr, Dept Life Sci, Pohang, Kyungbuk, South Korea.	sungkey@postech.ac.kr	Jang, Sung K/P-1230-2017		MEST [FPR08B1-220]; NRF [20100028447, 2010-0019706, 2010-0018167]; Korea government (MEST) [R31-2009-000-10105-0]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported in part by a grant FPR08B1-220 of the 21C Frontier Functional Proteomics Project from MEST, NRF NCRC grant (no. 20100028447), NRF BRL grant (no. 2010-0019706), Bio R&D program through the NRF grant (no. 2010-0018167) and WCU program through the NRF grant (no. R31-2009-000-10105-0) funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bartenschlager R, 2001, ANTIVIR RES, V52, P1, DOI 10.1016/S0166-3542(01)00164-4; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Heathcote J, 2005, J VIRAL HEPATITIS, V12, P223, DOI 10.1111/j.1365-2893.2005.00600.x; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kim CS, 2007, J VIROL, V81, P8814, DOI 10.1128/JVI.02824-06; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Layden TJ, 2000, SEMIN LIVER DIS, V20, P173, DOI 10.1055/s-2000-9940; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	39	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22808	10.1371/journal.pone.0022808	http://dx.doi.org/10.1371/journal.pone.0022808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829654	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200032
J	Iguchi, N; Ohkuri, T; Slack, JP; Zhong, P; Huang, LQ				Iguchi, Naoko; Ohkuri, Tadahiro; Slack, Jay P.; Zhong, Ping; Huang, Liquan			Sarco/Endoplasmic Reticulum Ca2+-ATPases (SERCA) Contribute to GPCR-Mediated Taste Perception	PLOS ONE			English	Article							MAMMALIAN TASTE; RECEPTOR-CELLS; UMAMI TASTE; SWEET TASTE; SIGNAL-TRANSDUCTION; TRANSIENT RECEPTOR; CALCIUM LEVELS; MICE LACKING; ACID TASTE; MOUSE	The sense of taste is important for providing animals with valuable information about the qualities of food, such as nutritional or harmful nature. Mammals, including humans, can recognize at least five primary taste qualities: sweet, umami (savory), bitter, sour, and salty. Recent studies have identified molecules and mechanisms underlying the initial steps of tastant-triggered molecular events in taste bud cells, particularly the requirement of increased cytosolic free Ca2+ concentration ([Ca2+](c)) for normal taste signal transduction and transmission. Little, however, is known about the mechanisms controlling the removal of elevated [Ca2+](c) from the cytosol of taste receptor cells (TRCs) and how the disruption of these mechanisms affects taste perception. To investigate the molecular mechanism of Ca2+ clearance in TRCs, we sought the molecules involved in [Ca2+](c) regulation using a single-taste-cell transcriptome approach. We found that Serca3, a member of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) family that sequesters cytosolic Ca2+ into endoplasmic reticulum, is exclusively expressed in sweet/umami/bitter TRCs, which rely on intracellular Ca2+ release for signaling. Serca3-knockout (KO) mice displayed significantly increased aversive behavioral responses and greater gustatory nerve responses to bitter taste substances but not to sweet or umami taste substances. Further studies showed that Serca2 was mainly expressed in the T1R3-expressing sweet and umami TRCs, suggesting that the loss of function of Serca3 was possibly compensated by Serca2 in these TRCs in the mutant mice. Our data demonstrate that the SERCA family members play an important role in the Ca2+ clearance in TRCs and that mutation of these proteins may alter bitter and perhaps sweet and umami taste perception.	[Iguchi, Naoko; Ohkuri, Tadahiro; Huang, Liquan] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Slack, Jay P.; Zhong, Ping] Givaudan Flavors Corp, Cincinnati, OH USA	Monell Chemical Senses Center; Givaudan SA	Iguchi, N (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	lhuang@monell.org		Huang, Liquan/0000-0003-3400-0685; Iguchi, Nao/0000-0001-6244-7404	Givaudan Flavors Corporation; National Institutes of Health/National Institute on Deafness and Other Communication Disorders [DC007487]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007487] Funding Source: NIH RePORTER	Givaudan Flavors Corporation; National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was in part supported by Givaudan Flavors Corporation (http://www.givaudan.com/) and by grants from National Institutes of Health/National Institute on Deafness and Other Communication Disorders (DC007487 to L.H.)(http://www.nidcd.nih.gov/) and from the National Science Foundation (DBJ-0216310 to N. Rawson)(http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Bobe R, 2005, PLATELETS, V16, P133, DOI 10.1080/09537100400016847; BURK SE, 1989, J BIOL CHEM, V264, P18561; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Hacker K, 2008, J NEUROPHYSIOL, V100, P2177, DOI 10.1152/jn.90534.2008; Hennings JK, 2008, J NEUROCHEM, V106, P2249, DOI 10.1111/j.1471-4159.2008.05563.x; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Laskowski AI, 2009, J PHYSIOL-LONDON, V587, P4077, DOI 10.1113/jphysiol.2009.173567; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu LH, 1997, J BIOL CHEM, V272, P30538, DOI 10.1074/jbc.272.48.30538; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Medler KF, 2010, CHEM SENSES, V35, P753, DOI 10.1093/chemse/bjq082; Medler KF, 2003, J NEUROSCI, V23, P2608; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 1999, J NEUROPHYSIOL, V82, P2657, DOI 10.1152/jn.1999.82.5.2657; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Seta Y, 2007, HISTOCHEM CELL BIOL, V127, P415, DOI 10.1007/s00418-006-0257-3; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Szebenyi SA, 2010, J NEUROPHYSIOL, V104, P529, DOI 10.1152/jn.00118.2010; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Weaver DL, 1999, METH MOL B, V97, P601, DOI 10.1385/1-59259-270-8:601; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	62	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23165	10.1371/journal.pone.0023165	http://dx.doi.org/10.1371/journal.pone.0023165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829714	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900031
J	Shi, FT; Cheung, AP; Huang, HF; Leung, PCK				Shi, Feng-Tao; Cheung, Anthony P.; Huang, He-Feng; Leung, Peter C. K.			Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells	PLOS ONE			English	Article							ACTIVIN-BINDING PROTEIN; POLYCYSTIC-OVARY-SYNDROME; IN-VITRO; PROGESTERONE PRODUCTION; HEPARAN-SULFATE; PITUITARY-CELLS; MENSTRUAL-CYCLE; HOMOLOG GDF-9B; FACTOR-BETA; EXPRESSION	Background: We have demonstrated that growth differentiation factor 9 (GDF9) enhances activin A-induced inhibin beta(B)-subunit mRNA levels in human granulosa-lutein (hGL) cells by regulating receptors and key intracellular components of the activin signaling pathway. However, we could not exclude its effects on follistatin (FST) and follistatin-like 3 (FSTL3), well recognized extracellular inhibitors of activin A. Methodology: hGL cells from women undergoing in vitro fertilization (IVF) treatment were cultured with and without siRNA transfection of FST, FSTL3 or GDF9 and then treated with GDF9, activin A, FST, FSTL3 or combinations. FST, FSTL3 and inhibin beta(B)-subunit mRNA, and FST, FSTL3 and inhibin B protein levels were assessed with real-time RT-PCR and ELISA, respectively. Data were log transformed before ANOVA followed by Tukey's test. Principal Findings: GDF9 suppressed basal FST and FSTL3 mRNA and protein levels in a time-and dose-dependent manner and inhibited activin A-induced FST and FSTL3 mRNA and protein expression, effects attenuated by BMPR2 extracellular domain (BMPR2 ECD), a GDF9 antagonist. After GDF9 siRNA transfection, basal and activin A-induced FST and FSTL3 mRNA and protein levels increased, but changes were reversed by adding GDF9. Reduced endogenous FST or FSTL3 expression with corresponding siRNA transfection augmented activin A-induced inhibin beta(B)-subunit mRNA levels as well as inhibin B levels (P values all <0.05). Furthermore, the enhancing effects of GDF9 in activin A-induced inhibin beta(B)-subunit mRNA and inhibin B production were attenuated by adding FST. Conclusion: GDF9 decreases basal and activin A-induced FST and FSTL3 expression, and this explains, in part, its enhancing effects on activin A-induced inhibin beta(B)-subunit mRNA expression and inhibin B production in hGL cells.	[Shi, Feng-Tao; Cheung, Anthony P.; Leung, Peter C. K.] Univ British Columbia, Dept Obstet & Gynaecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Huang, He-Feng] Zhejiang Univ, Sch Med, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China	Child & Family Research Institute; University of British Columbia; Zhejiang University	Shi, FT (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	peleung@interchange.ubc.ca	Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020; Huang, He-Feng/AAN-7985-2020	Huang, He-Feng/0000-0003-4344-8019; Leung, Peter/0000-0003-3152-3800; Cheung, Anthony P/0000-0002-3266-494X	Canadian Institutes of Health Research; NSFC; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSFC(National Natural Science Foundation of China (NSFC)); Child and Family Research Institute	This study was supported by an operating grant from the Canadian Institutes of Health Research to P. C. K. L. and a grant from the CIHR and NSFC Joint Health Research Initiative ( to P. C. K. L. and H.-F.H.). P. C. K. L. is a recipient of a Distinguished Scientist Award of the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; CATALDO NA, 1994, J CLIN ENDOCR METAB, V79, P272, DOI 10.1210/jc.79.1.272; DEMURA R, 1993, J CLIN ENDOCR METAB, V76, P1080, DOI 10.1210/jc.76.4.1080; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Eldar-Geva T, 2001, HUM REPROD, V16, P2552, DOI 10.1093/humrep/16.12.2552; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Hashimoto O, 1997, J BIOL CHEM, V272, P13835, DOI 10.1074/jbc.272.21.13835; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; HUTCHINSON LA, 1987, BIOCHEM BIOPH RES CO, V146, P1405, DOI 10.1016/0006-291X(87)90806-0; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Jaatinen R, 1999, MOL CELL ENDOCRINOL, V156, P189, DOI 10.1016/S0303-7207(99)00100-8; Jardin F, 2011, BRIT J HAEMATOL, V153, P413, DOI 10.1111/j.1365-2141.2010.08556.x; KOGAWA K, 1991, ENDOCRINOLOGY, V128, P1434, DOI 10.1210/endo-128-3-1434; Liu ZH, 1996, ENDOCR J, V43, P321, DOI 10.1507/endocrj.43.321; Magill C, 1987, PROG BRAIN RES <D>, V71, P391; McConnell DS, 1998, J CLIN ENDOCR METAB, V83, P851, DOI 10.1210/jc.83.3.851; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; MICHEL U, 1990, BIOCHEM BIOPH RES CO, V173, P401, DOI 10.1016/S0006-291X(05)81072-1; MIRO F, 1991, ENDOCRINOLOGY, V129, P3388, DOI 10.1210/endo-129-6-3388; Myers M, 2008, J ENDOCRINOL, V199, P201, DOI 10.1677/JOE-08-0302; Myers M, 2007, ENDOCRINOLOGY, V148, P3730, DOI 10.1210/en.2007-0244; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Saito S, 2005, ENDOCRINOLOGY, V146, P5052, DOI 10.1210/en.2005-0833; Schneyer AL, 1996, ENDOCRINOLOGY, V137, P240, DOI 10.1210/en.137.1.240; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Shi FT, 2010, J CLIN ENDOCR METAB, V95, pE172, DOI 10.1210/jc.2010-0477; Shi FT, 2009, J CLIN ENDOCR METAB, V94, P5108, DOI 10.1210/jc.2009-1047; Shi FT, 2009, ENDOCRINOLOGY, V150, P3540, DOI 10.1210/en.2009-0267; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Shintani Y, 1997, ENDOCRINOLOGY, V138, P2544, DOI 10.1210/en.138.6.2544; SHUKOVSKI L, 1990, ENDOCRINOLOGY, V126, P2222, DOI 10.1210/endo-126-4-2222; Sidis Y, 2002, ENDOCRINOLOGY, V143, P1613, DOI 10.1210/en.143.5.1613; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; SUGINO K, 1993, J BIOL CHEM, V268, P15579; SUMITOMO S, 1995, BIOCHEM BIOPH RES CO, V208, P1, DOI 10.1006/bbrc.1995.1297; TANO M, 1995, MOL CELL ENDOCRINOL, V109, P167, DOI 10.1016/0303-7207(95)03499-W; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Thadhani R, 2010, DIABETES CARE, V33, P664, DOI 10.2337/dc09-1745; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Urbanek M, 2000, J CLIN ENDOCR METAB, V85, P4455, DOI 10.1210/jc.85.12.4455; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Welt CK, 2004, SEMIN REPROD MED, V 22, P187, DOI 10.1055/s-2004-831894	54	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22866	10.1371/journal.pone.0022866	http://dx.doi.org/10.1371/journal.pone.0022866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829661	gold, Green Submitted, Green Published			2022-12-25	WOS:000293511200023
J	Stieren, ES; El Ayadi, A; Xiao, Y; Siller, E; Landsverk, ML; Oberhauser, AF; Barral, JM; Boehning, D				Stieren, Emily S.; El Ayadi, Amina; Xiao, Yao; Siller, Efrain; Landsverk, Megan L.; Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren			Ubiquilin-1 Is a Molecular Chaperone for the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; A-BETA; ENDOPLASMIC-RETICULUM; NUTRIENT STARVATION; UBQLN1 POLYMORPHISM; GENETIC ASSOCIATION; AGGRESOME FORMATION; CITRATE SYNTHASE; GAMMA-SECRETASE	Alzheimer disease (AD) is associated with extracellular deposition of proteolytic fragments of amyloid precursor protein (APP). Although mutations in APP and proteases that mediate its processing are known to result in familial, early onset forms of AD, the mechanisms underlying the more common sporadic, yet genetically complex forms of the disease are still unclear. Four single-nucleotide polymorphisms within the ubiquilin-1 gene have been shown to be genetically associated with AD, implicating its gene product in the pathogenesis of late onset AD. However, genetic linkage between ubiquilin-1 and AD has not been confirmed in studies examining different populations. Here we show that regardless of genotype, ubiquilin-1 protein levels are significantly decreased in late onset AD patient brains, suggesting that diminished ubiquilin function may be a common denominator in AD progression. Our interrogation of putative ubiquilin-1 activities based on sequence similarities to proteins involved in cellular quality control showed that ubiquilin-1 can be biochemically defined as a bona fide molecular chaperone and that this activity is capable of preventing the aggregation of amyloid precursor protein both in vitro and in live neurons. Furthermore, we show that reduced activity of ubiquilin-1 results in augmented production of pathogenic amyloid precursor protein fragments as well as increased neuronal death. Our results support the notion that ubiquilin-1 chaperone activity is necessary to regulate the production of APP and its fragments and that diminished ubiquilin-1 levels may contribute to AD pathogenesis.	[Stieren, Emily S.; El Ayadi, Amina; Xiao, Yao; Siller, Efrain; Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Landsverk, Megan L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Barral, JM (corresponding author), Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77550 USA.	jmbarral@utmb.edu; dfboehni@utmb.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; El Ayadi, Amina/0000-0002-3657-0633	National Institutes of Health [R21AG031948, F30AG030878, UL1RR029876, P30-AG-024832, P50AG05128]; Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005128, P30AG024832, R21AG031948, F30AG030878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AG031948 (to J. M. B. and D. B.) and F30AG030878 (to E. S. S.). J. M. B. is a scholar in the Translational Research Scholar Program and a member of the University of Texas Medical Branch Claude E. Pepper Older Americans Independence Center (supported by NIH Grants UL1RR029876 and P30-AG-024832, respectively). This work was also supported by funds from the Jean C. and William D. Willis Neuroscience Research Endowment (to E. S. S.). Cortical tissue samples were obtained from the Joseph and Kathleen Bryan Alzheimer's Disease Research Center (Duke University Medical Center), which is funded by National Institutes of Health Grant P50AG05128.	Arias-Vasquez A, 2007, NEUROSCI LETT, V424, P1, DOI 10.1016/j.neulet.2007.07.015; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bensemain F, 2006, NEUROBIOL DIS, V22, P691, DOI 10.1016/j.nbd.2006.01.007; Bergemalm D, 2006, J NEUROSCI, V26, P4147, DOI 10.1523/JNEUROSCI.5461-05.2006; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Cao F, 2001, BBA-MOL BASIS DIS, V1537, P158, DOI 10.1016/S0925-4439(01)00068-0; Chuo LJ, 2010, NEUROSCI LETT, V475, P108, DOI 10.1016/j.neulet.2010.03.061; Ciuculescu ED, 2005, CHEM-EUR J, V11, P903, DOI 10.1002/chem.200400786; De Strooper B, 2000, J CELL SCI, V113, P1857; Feng PH, 2004, MOL CELL BIOL, V24, P3938, DOI 10.1128/MCB.24.9.3938-3948.2004; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Golan MP, 2008, DEMENT GERIATR COGN, V25, P366, DOI 10.1159/000121006; Gosal WS, 2006, PROTEIN PEPTIDE LETT, V13, P261, DOI 10.2174/092986606775338498; Haapasalo A, 2010, BIOCHEM SOC T, V38, P150, DOI 10.1042/BST0380150; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hulette CM, 1997, ARCH PATHOL LAB MED, V121, P615; Hwang GW, 2005, MOL PHARMACOL, V68, P1074, DOI 10.1124/mol.105.013516; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lee MH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.83; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Massey LK, 2005, BIOCHEM J, V391, P513, DOI 10.1042/BJ20050491; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Slifer MA, 2006, AM J MED GENET B, V141B, P208, DOI 10.1002/ajmg.b.30298; Slifer MA, 2005, NEW ENGL J MED, V352, P2752; Smemo S, 2006, ANN NEUROL, V59, P21, DOI 10.1002/ana.20673; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tonoki A, 2011, GENES CELLS, V16, P557, DOI 10.1111/j.1365-2443.2011.01505.x; Volz J, 1998, J CHROMATOGR A, V800, P29, DOI 10.1016/S0021-9673(97)00877-7; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200	64	74	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35689	35698		10.1074/jbc.M111.243147	http://dx.doi.org/10.1074/jbc.M111.243147			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852239	hybrid, Green Published			2022-12-25	WOS:000295927100041
J	Awai, T; Ochi, A; Ihsanawati; Sengoku, T; Hirata, A; Bessho, Y; Yokoyama, S; Hori, H				Awai, Takako; Ochi, Anna; Ihsanawati; Sengoku, Toru; Hirata, Akira; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Hori, Hiroyuki			Substrate tRNA Recognition Mechanism of a Multisite-specific tRNA Methyltransferase, Aquifex aeolicus Trm1, Based on the X-ray Crystal Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PYROCOCCUS-FURIOSUS; BINDING; ACID; GENE; TRNA(M(2)(2)G(26))DIMETHYLTRANSFERASE; IDENTIFICATION; GUANOSINE-26; BIOSYNTHESIS; PURIFICATION	Archaeal and eukaryotic tRNA (N-2,N-2-guanine)-dimethyltransferase (Trm1) produces N-2,N-2-dimethylguanine at position 26 in tRNA. In contrast, Trm1 from Aquifex aeolicus, a hyper-thermophilic eubacterium, modifies G27 as well as G26. Here, a gel mobility shift assay revealed that the T-arm in tRNA is the binding site of A. aeolicus Trm1. To address the multisite specificity, we performed an x-ray crystal structure study. The overall structure of A. aeolicus Trm1 is similar to that of archaeal Trm1, although there is a zinc-cysteine cluster in the C-terminal domain of A. aeolicus Trm1. The N-terminal domain is a typical catalytic domain of S-adenosyl-L-methionine-dependent methyltransferases. On the basis of the crystal structure and amino acid sequence alignment, we prepared 30 mutant Trm1 proteins. These mutant proteins clarified residues important for S-adenosyl-L-methionine binding and enabled us to propose a hypothetical reaction mechanism. Furthermore, the tRNA-binding site was also elucidated by methyl transfer assay and gel mobility shift assay. The electrostatic potential surface models of A. aeolicus and archaeal Trm1 proteins demonstrated that the distribution of positive charges differs between the two proteins. We constructed a tRNA-docking model, in which the T-arm structure was placed onto the large area of positive charge, which is the expected tRNA-binding site, of A. aeolicus Trm1. In this model, the target G26 base can be placed near the catalytic pocket; however, the nucleotide at position 27 gains closer access to the pocket. Thus, this docking model introduces a rational explanation of the multisite specificity of A. aeolicus Trm1.	[Awai, Takako; Ochi, Anna; Hirata, Akira; Hori, Hiroyuki] Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ihsanawati; Sengoku, Toru; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Hori, Hiroyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama Inst, Tsurumi Ku, Kanagawa 2300045, Japan; [Bessho, Yoshitaka; Yokoyama, Shigeyuki] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; RIKEN; RIKEN; University of Tokyo; Ehime University	Hori, H (corresponding author), Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Bessho, Yoshitaka/K-7702-2012; Hori, Hiroyuki/AAB-3911-2021; Yokoyama, Shigeyuki/N-6911-2015; Sengoku, Toru/E-4304-2013	Bessho, Yoshitaka/0000-0001-9297-7473; Yokoyama, Shigeyuki/0000-0003-3133-7338; Sengoku, Toru/0000-0001-9461-8714	Ministry of Education, Science, Sports, and Culture of Japan [20034041, 19350087, 2350081, 21603018]; Grants-in-Aid for Scientific Research [23350081] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Science Research on Priority Areas 20034041 (to H. H.), Grants-in-aid for Science Research 19350087 and 2350081 (to H. H.) and 21603018 (to Y. B.), and the National Project on Targeted Proteins Research Program for Science Research from the Ministry of Education, Science, Sports, and Culture of Japan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; ARENA F, 1978, NUCLEIC ACIDS RES, V5, P4523, DOI 10.1093/nar/5.12.4523; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujnicki JM, 2002, J MOL MICROB BIOTECH, V4, P405; Constantinesco F, 1999, NUCLEIC ACIDS RES, V27, P1308, DOI 10.1093/nar/27.5.1308; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Constantinesco F, 1998, NUCLEIC ACIDS RES, V26, P3753, DOI 10.1093/nar/26.16.3753; CORTESE R, 1974, J BIOL CHEM, V249, P1103; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; EDQVIST J, 1994, BIOCHEMISTRY-US, V33, P9546, DOI 10.1021/bi00198a021; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GARCIA GA, 1998, MODIFICATION EDITING, P135; GARCIA GR, 1998, MODIFICATION EDITING, P555; GLICK JM, 1978, BIOCHIM BIOPHYS ACTA, V518, P158, DOI 10.1016/0005-2787(78)90125-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Guelorget A, 2010, NUCLEIC ACIDS RES, V38, P6206, DOI 10.1093/nar/gkq381; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KUCHINO Y, 1970, BIOCHEM BIOPH RES CO, V40, P306, DOI 10.1016/0006-291X(70)91010-7; Liu JM, 1998, NUCLEIC ACIDS RES, V26, P5102, DOI 10.1093/nar/26.22.5102; Liu JM, 1999, GENE, V226, P73, DOI 10.1016/S0378-1119(98)00550-2; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Michel SLJ, 2002, CHEM BIOL, V9, P667, DOI 10.1016/S1074-5521(02)00160-6; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Niederberger C, 1999, FEBS LETT, V464, P67, DOI 10.1016/S0014-5793(99)01679-8; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Ohtsuki T, 2002, NUCLEIC ACIDS RES, V30, P5444, DOI 10.1093/nar/gkf679; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS JH, 1967, J MOL BIOL, V26, P509, DOI 10.1016/0022-2836(67)90318-X; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; REINHART MP, 1986, NUCLEIC ACIDS RES, V14, P1131, DOI 10.1093/nar/14.3.1131; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sharpe BK, 2002, STRUCTURE, V10, P639, DOI 10.1016/S0969-2126(02)00757-8; STANGE N, 1987, EMBO J, V6, P2811, DOI 10.1002/j.1460-2075.1987.tb02577.x; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VEDEL M, 1981, FEBS LETT, V128, P87, DOI 10.1016/0014-5793(81)81086-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35236	35246		10.1074/jbc.M111.253641	http://dx.doi.org/10.1074/jbc.M111.253641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844194	Green Published, hybrid			2022-12-25	WOS:000295406300076
J	Osawa, Y; Kanamori, H; Seki, E; Hoshi, M; Ohtaki, H; Yasuda, Y; Ito, H; Suetsugu, A; Nagaki, M; Moriwaki, H; Saito, K; Seishima, M				Osawa, Yosuke; Kanamori, Hiromitsu; Seki, Ekihiro; Hoshi, Masato; Ohtaki, Hirofumi; Yasuda, Yoichi; Ito, Hiroyasu; Suetsugu, Atsushi; Nagaki, Masahito; Moriwaki, Hisataka; Saito, Kuniaki; Seishima, Mitsuru			L-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PROTEIN-SYNTHESIS; OXIDATIVE STRESS; RAT-LIVER; LIPID-METABOLISM; AMINO-ACID; SEROTONIN; MICE; LEUCINE; MTOR	Nonalcoholic fatty liver disease is one of the most common liver diseases. L-Tryptophan and its metabolite serotonin are involved in hepatic lipid metabolism and inflammation. However, it is unclear whether L-tryptophan promotes hepatic steatosis. To explore this issue, we examined the role of L-tryptophan in mouse hepatic steatosis by using a high fat and high fructose diet (HFHFD) model. L-Tryptophan treatment in combination with an HFHFD exacerbated hepatic steatosis, expression of HNE-modified proteins, hydroxyproline content, and serum alanine aminotransaminase levels, whereas L-tryptophan alone did not result in these effects. We also found that L-tryptophan treatment increases serum serotonin levels. The introduction of adenoviral aromatic amino acid decarboxylase, which stimulates the serotonin synthesis from L-tryptophan, aggravated hepatic steatosis induced by the HFHFD. The fatty acid-induced accumulation of lipid was further increased by serotonin treatment in cultured hepatocytes. These results suggest that L-tryptophan increases the sensitivity to hepatic steatosis through serotonin production. Furthermore, L-tryptophan treatment, adenoviral AADC introduction, and serotonin treatment induced phosphorylation of the mammalian target of rapamycin (mTOR), and a potent mTOR inhibitor rapamycin attenuated hepatocyte lipid accumulation induced by fatty acid with serotonin. These results suggest the importance of mTOR activation for the exacerbation of hepatic steatosis. In conclusion, L-tryptophan exacerbates hepatic steatosis induced by HFHFD through serotonin-mediated activation of mTOR.	[Osawa, Yosuke; Kanamori, Hiromitsu; Hoshi, Masato; Ohtaki, Hirofumi; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Osawa, Yosuke; Yasuda, Yoichi; Suetsugu, Atsushi; Nagaki, Masahito; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Saito, Kuniaki] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto 6068507, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto 6068507, Japan	Gifu University; Gifu University; University of California System; University of California San Diego; Kyoto University; Kyoto University	Osawa, Y (corresponding author), 1-1 Yanagido, Gifu 5011194, Japan.	osawa-gif@umin.ac.jp	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085	Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790657, 23790787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020172] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20390167] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants from the Takeda Science Foundation, Mitsubishi Pharma Research Foundation and by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 21790657 and 23790787.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Drakos Elias, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000586; FACER P, 1979, HISTOCHEM J, V11, P117, DOI 10.1007/BF01041271; FEARS R, 1980, BRIT J NUTR, V43, P349, DOI 10.1079/BJN19800097; Feksa LR, 2006, NEUROCHEM INT, V49, P87, DOI 10.1016/j.neuint.2006.01.001; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Forrest CM, 2004, FREE RADICAL RES, V38, P1167, DOI 10.1080/10715760400011437; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; HIRATA Y, 1967, BIOCHIM BIOPHYS ACTA, V144, P233; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kubovcakova L, 2004, NEUROSCIENCE, V126, P375, DOI 10.1016/j.neuroscience.2004.04.005; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; MATTHIES DL, 1993, J NUTR, V123, P852, DOI 10.1093/jn/123.5.852; Nocito A, 2007, GASTROENTEROLOGY, V133, P608, DOI 10.1053/j.gastro.2007.05.019; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; Sainio EL, 1996, AMINO ACIDS, V10, P21, DOI 10.1007/BF00806091; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; TRULSON ME, 1986, J NUTR, V116, P1109, DOI 10.1093/jn/116.6.1109; Wilson FA, 2011, AMINO ACIDS, V40, P157, DOI 10.1007/s00726-010-0629-9; Yu PL, 1999, J COMP NEUROL, V411, P654, DOI 10.1002/(SICI)1096-9861(19990906)411:4<654::AID-CNE9>3.0.CO;2-H; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	42	53	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34800	34808		10.1074/jbc.M111.235473	http://dx.doi.org/10.1074/jbc.M111.235473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841000	hybrid, Green Published			2022-12-25	WOS:000295406300034
J	Witkowski, A; Thweatt, J; Smith, S				Witkowski, Andrzej; Thweatt, Jennifer; Smith, Stuart			Mammalian ACSF3 Protein Is a Malonyl-CoA Synthetase That Supplies the Chain Extender Units for Mitochondrial Fatty Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A-SYNTHETASE; MOLECULAR-CLONING; CARRIER PROTEIN; RAT-BRAIN; CARBOXYLASE; BIOSYNTHESIS; METABOLISM; EXPRESSION; SEQUENCE; SYNTHASE	The objective of this study was to identify a source of intramitochondrial malonyl-CoA that could be used for de novo fatty acid synthesis in mammalian mitochondria. Because mammalian mitochondria lack an acetyl-CoA carboxylase capable of generating malonyl-CoA inside mitochondria, the possibility that malonate could act as a precursor was investigated. Although malonyl-CoA synthetases have not been identified previously in animals, interrogation of animal protein sequence databases identified candidates that exhibited sequence similarity to known prokaryotic forms. The human candidate protein ACSF3, which has a predicted N-terminal mitochondrial targeting sequence, was cloned, expressed, and characterized as a 65-kDa acyl-CoA synthetase with extremely high specificity for malonate and methylmalonate. An arginine residue implicated in malonate binding by prokaryotic malonyl-CoA synthetases was found to be positionally conserved in animal ACSF3 enzymes and essential for activity. Subcellular fractionation experiments with HEK293T cells confirmed that human ACSF3 is located exclusively in mitochondria, and RNA interference experiments verified that this enzyme is responsible for most, if not all, of the malonyl-CoA synthetase activity in the mitochondria of these cells. In conclusion, unlike fungi, which have an intramitochondrial acetyl-CoA carboxylase, animals require an alternative source of mitochondrial malonyl-CoA; the mitochondrial ACSF3 enzyme is capable of filling this role by utilizing free malonic acid as substrate.	[Witkowski, Andrzej; Thweatt, Jennifer; Smith, Stuart] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Smith, S (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	ssmith@chori.org		Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [GM069717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM069717.	ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Fernandez-Gomez FJ, 2005, BRIT J PHARMACOL, V144, P528, DOI 10.1038/sj.bjp.0706069; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; JANG SH, 1989, J BIOL CHEM, V264, P3500; Jung JW, 2000, PROTEIN SCI, V9, P1294, DOI 10.1110/ps.9.7.1294; KIM YS, 1991, BIOCHEM J, V273, P511, DOI 10.1042/bj2730511; KIM YS, 1985, J BIOL CHEM, V260, P5098; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; KOEPPEN AH, 1974, BIOCHEMISTRY-US, V13, P3589, DOI 10.1021/bi00714a029; LOPEZCASILLAS F, 1988, P NATL ACAD SCI USA, V85, P5784, DOI 10.1073/pnas.85.16.5784; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MENON GKK, 1960, J BIOL CHEM, V235, P3393; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MITZEN EJ, 1984, J NEUROCHEM, V43, P499, DOI 10.1111/j.1471-4159.1984.tb00927.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PATTEE HE, 1965, BOT GAZ, V126, P179, DOI 10.1086/336316; SAINTMACARY M, 1980, BIOCHEM BIOPH RES CO, V96, P457, DOI 10.1016/0006-291X(80)91236-X; SCHOOLWERTH AC, 1985, ANNU REV PHYSIOL, V47, P143; SINGH I, 1983, J LIPID RES, V24, P662; Stokes AH, 2001, J NEUROSCI RES, V64, P43, DOI 10.1002/jnr.1052; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Widmer J, 1996, BIOCHEM J, V316, P915, DOI 10.1042/bj3160915; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	39	42	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33729	33736		10.1074/jbc.M111.291591	http://dx.doi.org/10.1074/jbc.M111.291591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21846720	Green Published, hybrid			2022-12-25	WOS:000295159200003
J	Wu, JJ; Zhang, YS; Frilot, N; Kim, JI; Kim, WJ; Daaka, Y				Wu, Juanjuan; Zhang, Yushan; Frilot, Nicole; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia			Prostaglandin E-2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; PROMOTES INVASION; PROTEIN-KINASE; KIDNEY CANCER; TUMOR-GROWTH; RAP1GAP; EXPRESSION; CYCLOOXYGENASE-2; BREAST; PHOSPHORYLATION	Prognosis for patients with early stage kidney cancer has improved, but the treatment options for patients with locally advanced disease and metastasis remain few. Understanding the molecular mechanisms that regulate invasion and metastasis is critical for developing successful therapies to treat these patients. Proinflammatory prostaglandin E-2 plays an important role in cancer initiation and progression via activation of cognate EP receptors that belong to the superfamily of G protein-coupled receptors. Here we report that prostaglandin E-2 promotes renal cancer cell invasion through a signal transduction pathway that encompasses EP4 and small GTPase Rap. Inactivation of Rap signaling with Rap1GAP, like inhibition of EP4 signaling with ligand antagonist or knockdown with shRNA, reduces the kidney cancer cell invasion. Human kidney cells evidence increased EP4 and decreased Rap1GAP expression levels in the malignant compared with benign samples. These results support the idea that targeted inhibition of EP4 signaling and restoration of Rap1GAP expression constitute a new strategy to control kidney cancer progression.	[Wu, Juanjuan; Frilot, Nicole; Daaka, Yehia] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Zhang, Yushan; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia] Univ Florida, Coll Med, Dept Urol, Gainesville, FL 32610 USA; [Zhang, Yushan; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia] Univ Florida, Coll Med, Prostate Dis Ctr, Gainesville, FL 32610 USA	University System of Georgia; Augusta University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Daaka, Y (corresponding author), CGRC, Rm 462,2033 Mowry Rd, Gainesville, FL 32610 USA.	ydaaka@ufl.edu		Kim, Jae/0000-0003-1668-3910	National Institutes of Health Public Health Service, NCI [CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA129155 from the NCI.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Asano T, 2002, CLIN CANCER RES, V8, P1157; Atkins MB, 2004, CLIN CANCER RES, V10, p6342S, DOI 10.1158/1078-0432.CCR-040029; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; BASTIEN L, 1994, J BIOL CHEM, V269, P11873; Belldegrun AS, 2008, CANCER-AM CANCER SOC, V113, P2457, DOI 10.1002/cncr.23851; Bisignani GJ, 1999, J UROLOGY, V162, P2186, DOI 10.1016/S0022-5347(05)68157-8; Biswas S, 2009, NAT REV CLIN ONCOL, V6, P478, DOI 10.1038/nrclinonc.2009.91; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kadhim SA, 1997, CANCER RES, V57, P4803; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Lanas A, 2006, ANN MED, V38, P415, DOI 10.1080/07853890600925843; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429; Mungan MU, 2006, EUR UROL, V50, P92, DOI 10.1016/j.eururo.2005.12.039; Murai M, 2004, CURR OPIN UROL, V14, P229, DOI 10.1097/01.mou.0000135078.04721.f5; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomura T, 2007, J UROLOGY, V178, P292, DOI 10.1016/j.juro.2007.03.007; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; POLAKIS P, 1992, J BIOL CHEM, V267, P10780; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Schlesinger-Raab A, 2008, EUR J CANCER, V44, P2485, DOI 10.1016/j.ejca.2008.07.039; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; SONNENBURG WK, 1990, J BIOL CHEM, V265, P8479; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tawfik OW, 2007, ARCH PATHOL LAB MED, V131, P261; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Young AN, 2006, UROLOGY, V67, P873, DOI 10.1016/j.urology.2005.11.042; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	64	40	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33954	33962		10.1074/jbc.M110.187344	http://dx.doi.org/10.1074/jbc.M110.187344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832044	Green Published, hybrid			2022-12-25	WOS:000295159200027
J	Henk, DA; Fisher, MC				Henk, Daniel A.; Fisher, Matthew C.			Genetic Diversity, Recombination, and Divergence in Animal Associated Penicillium dipodomyis	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; TERVERTICILLATE PENICILLIA; SEXUAL REPRODUCTION; CHEEK POUCHES; ASPERGILLUS; IDENTIFICATION; CHRYSOGENUM; SPECIATION; DISCOVERY; EVOLUTION	Penicillium dipodomyis is thought to be an exclusively asexual fungus associated with Kangaroo Rats, Dipodomys species, and is unique among Penicillium species in growing at 37 degrees C but producing no known toxins. Lack of recombination within P. dipodomyis would result in limited adaptive flexibility but possibly enhance local adaptation and host selection via maintenance of favourable genotypes. Here, analysis of DNA sequence data from five protein-coding genes shows that recombination occurs within P. dipodomyis on a small spatial scale. Furthermore, detection of mating-type alleles supports outcrossing and a sexual cycle in P. dipodomyis. P. dipodomyis was a weaker competitor in in vitro assays with other Penicillium species found in association with Kanagaroo rats. Bayesian species level analysis suggests that the P. dipodomyis lineage diverged from closely related species also found in cheek pouches of Kangaroo Rats and their stored seeds about 11 million years ago, a similar divergence time as Dipodomys from its sister rodent taxa.	[Henk, Daniel A.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Henk, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	d.henk@imperial.ac.uk	Fisher, Matthew/B-9094-2011	Fisher, Matthew/0000-0002-1862-6402	Leverhulme Trust [F/07/058/AJ]; Wellcome Trust [084616/A/08/Z]	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants to Dr. Matthew Fisher's lab at Imperial College London from the Leverhulme Trust [F/07/058/AJ] (http://www.leverhulme.ac.uk/) and the Wellcome Trust [084616/A/08/Z] (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MD, 2009, MICROSC RES TECHNIQ, V72, P482, DOI 10.1002/jemt.20695; Banke S, 1997, MYCOL RES, V101, P617, DOI 10.1017/S0953756296003048; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eagle C, 2009, MATING TYPE GENES SE, P371; Frisvad JC, 2004, STUD MYCOL, P1; FRISVAD JC, 1987, CAN J BOT, V65, P765, DOI 10.1139/b87-102; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Hafner JC, 2007, J MAMMAL, V88, P1129, DOI 10.1644/06-MAMM-A-413R1.1; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hoff B, 2008, EUKARYOT CELL, V7, P465, DOI 10.1128/EC.00430-07; Houbraken J, 2008, APPL ENVIRON MICROB, V74, P1613, DOI 10.1128/AEM.01761-07; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maddison WPDRM, 2002, MACCLADE VER 4 0 COM; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Poggeler S, 2002, CURR GENET, V42, P153, DOI 10.1007/s00294-002-0338-3; REICHMAN OJ, 1986, ANIM BEHAV, V34, P221, DOI 10.1016/0003-3472(86)90026-6; REICHMAN OJ, 1985, ANIM BEHAV, V33, P726, DOI 10.1016/S0003-3472(85)80003-8; Scazzocchio C, 2006, TRENDS GENET, V22, P521, DOI 10.1016/j.tig.2006.08.004; Scott J, 2004, MYCOLOGIA, V96, P1095, DOI 10.2307/3762092; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; WICKLOW DT, 1988, MYCOLOGIA, V80, P750, DOI 10.2307/3807732	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22883	10.1371/journal.pone.0022883	http://dx.doi.org/10.1371/journal.pone.0022883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850241	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300026
J	Schimpl, M; Lederer, C; Daumer, M				Schimpl, Michaela; Lederer, Christian; Daumer, Martin			Development and Validation of a New Method to Measure Walking Speed in Free-Living Environments Using the Actibelt (R) Platform	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; STATISTICAL-METHODS; ASSESSING AGREEMENT; ENERGY-EXPENDITURE; ACTIVITY MONITOR; RELIABILITY; DISABILITY; VALIDITY; PARAMETERS; ADULTS	Walking speed is a fundamental indicator for human well-being. In a clinical setting, walking speed is typically measured by means of walking tests using different protocols. However, walking speed obtained in this way is unlikely to be representative of the conditions in a free-living environment. Recently, mobile accelerometry has opened up the possibility to extract walking speed from long-time observations in free-living individuals, but the validity of these measurements needs to be determined. In this investigation, we have developed algorithms for walking speed prediction based on 3D accelerometry data (actibelt (R)) and created a framework using a standardized data set with gold standard annotations to facilitate the validation and comparison of these algorithms. For this purpose 17 healthy subjects operated a newly developed mobile gold standard while walking/running on an indoor track. Subsequently, the validity of 12 candidate algorithms for walking speed prediction ranging from well-known simple approaches like combining step length with frequency to more sophisticated algorithms such as linear and non-linear models was assessed using statistical measures. As a result, a novel algorithm employing support vector regression was found to perform best with a concordance correlation coefficient of 0.93 (95% CI 0.92-0.94) and a coverage probability CP1 of 0.46 (95% CI 0.12-0.70) for a deviation of 0.1 m/s (CP2 0.78, CP3 0.94) when compared to the mobile gold standard while walking indoors. A smaller outdoor experiment confirmed those results with even better coverage probability. We conclude that walking speed thus obtained has the potential to help establish walking speed in free-living environments as a patient-oriented outcome measure.	[Schimpl, Michaela; Daumer, Martin] Trium Anal Online GmbH, Munich, Germany; [Schimpl, Michaela; Lederer, Christian; Daumer, Martin] Sylvia Lawry Ctr Multiple Sclerosis Res eV, Human Mot Inst, Munich, Germany		Schimpl, M (corresponding author), Trium Anal Online GmbH, Munich, Germany.	daumer@slcmsr.org			German Ministry for Education and Research (BMBF) [01GI0920]; EU [NETSIM (215820-2), VPHOP (FP7-223865)]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This work was supported by grants from the German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Boyd LA, 1997, GAIT POSTURE, V5, P165, DOI DOI 10.1016/S0966-6362(97)83397-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Czabke A, 2009, AMBIENT ASSISTED LIV; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Dimitriadou E, 2010, E1071 TU WIEN; Dobkin BH, 2011, STROKE; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Foster R, 2008, P I MECH ENG P-J SPO, V222, P53, DOI 10.1243/17543371JSET3; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Graham SE, 2004, J EXPO ANAL ENV EPID, V14, P23, DOI 10.1038/sj.jea.7500293; Hoogervorst ELJ, 2003, J NEUROL NEUROSUR PS, V74, P439, DOI 10.1136/jnnp.74.4.439; Lin L, 2002, J AM STAT ASSOC, V97, P257, DOI 10.1198/016214502753479392; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; R Core Team, 2021, R LANG ENV STAT COMP; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Salzman SH, 2009, CHEST, V135, P1345, DOI 10.1378/chest.07-1682; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Scheermesser Mandy, 2008, 2008 Second International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth), P205, DOI 10.1109/PCTHEALTH.2008.4571071; Schimpl M, 2011, PLOS ONE IN PRESS; Sekiya N, 1998, GAIT POSTURE, V7, P225, DOI 10.1016/S0966-6362(98)00009-5; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vaney C, 1996, CLIN REHABIL, V10, P216, DOI DOI 10.1177/026921559601000306; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Yeoh WS, 2008, IEEE ENG MED BIO, P5184, DOI 10.1109/IEMBS.2008.4650382; Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	39	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23080	10.1371/journal.pone.0023080	http://dx.doi.org/10.1371/journal.pone.0023080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850254	Green Submitted, gold, Green Published			2022-12-25	WOS:000293563300039
J	Scyphers, SB; Powers, SP; Heck, KL; Byron, D				Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.; Byron, Dorothy			Oyster Reefs as Natural Breakwaters Mitigate Shoreline Loss and Facilitate Fisheries	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; RELATIVE IMPORTANCE; ECOSYSTEM SERVICES; CHESAPEAKE BAY; HABITAT; RESTORATION; ESTUARINE; FISH; CONSERVATION; PREDATION	Shorelines at the interface of marine, estuarine and terrestrial biomes are among the most degraded and threatened habitats in the coastal zone because of their sensitivity to sea level rise, storms and increased human utilization. Previous efforts to protect shorelines have largely involved constructing bulkheads and seawalls which can detrimentally affect nearshore habitats. Recently, efforts have shifted towards "living shoreline" approaches that include biogenic breakwater reefs. Our study experimentally tested the efficacy of breakwater reefs constructed of oyster shell for protecting eroding coastal shorelines and their effect on nearshore fish and shellfish communities. Along two different stretches of eroding shoreline, we created replicated pairs of subtidal breakwater reefs and established unaltered reference areas as controls. At both sites we measured shoreline and bathymetric change and quantified oyster recruitment, fish and mobile macro-invertebrate abundances. Breakwater reef treatments mitigated shoreline retreat by more than 40% at one site, but overall vegetation retreat and erosion rates were high across all treatments and at both sites. Oyster settlement and subsequent survival were observed at both sites, with mean adult densities reaching more than eighty oysters m 22 at one site. We found the corridor between intertidal marsh and oyster reef breakwaters supported higher abundances and different communities of fishes than control plots without oyster reef habitat. Among the fishes and mobile invertebrates that appeared to be strongly enhanced were several economically-important species. Blue crabs (Callinectes sapidus) were the most clearly enhanced (+297%) by the presence of breakwater reefs, while red drum (Sciaenops ocellatus) (+108%), spotted seatrout (Cynoscion nebulosus) (+88%) and flounder (Paralichthys sp.) (+79%) also benefited. Although the vertical relief of the breakwater reefs was reduced over the course of our study and this compromised the shoreline protection capacity, the observed habitat value demonstrates ecological justification for future, more robust shoreline protection projects.	[Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.; Byron, Dorothy] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Scyphers, SB (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	sscyphers@disl.org		Powers, Sean/0000-0002-4770-9944; Byron, Dorothy/0000-0002-0274-5220	National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama; Northern Gulf Institute	National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama; Northern Gulf Institute	Funding for this project was provided by the National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama's Oyster Restoration Program and the Northern Gulf Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bilkovic DM, 2008, MAR ECOL PROG SER, V358, P27, DOI 10.3354/meps07279; Bostrom C, 1999, OECOLOGIA, V120, P162, DOI 10.1007/s004420050845; Brumbaugh R. D., 2008, BASINS COASTS NEWS, V2, P8; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2000, OECOLOGIA, V122, P98, DOI 10.1007/PL00008841; Chambers J.R., 1991, STEMMING TIDE COASTA; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coen LD, 1998, AM FISH S S, V22, P438; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CRAN, 2010, R LANG ENV STAT COMP; DAME RF, 1981, MAR ECOL PROG SER, V5, P115, DOI 10.3354/meps005115; Douglass S.L., 1999, SHORE BEACH, V67, P19; GARTON D, 1980, BIOL BULL, V158, P49, DOI 10.2307/1540757; Geraldi NR, 2009, MAR ECOL PROG SER, V389, P171, DOI 10.3354/meps08224; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; GRABOWSKI JH, 2007, ECOSYSTEM ENG, V4; Gregalis KC, 2008, J SHELLFISH RES, V27, P1163, DOI 10.2983/0730-8000-27.5.1163; Gunter G., 1967, P621; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jordan SJ, 2009, ECOL SOC, V14; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; KIM CK, 2010, J GEOPHYS RES, V115, P1; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Mann R, 2007, J SHELLFISH RES, V26, P905, DOI 10.2983/0730-8000(2007)26[905:WORGIT]2.0.CO;2; Meyer DL, 1997, RESTOR ECOL, V5, P93, DOI 10.1046/j.1526-100X.1997.09710.x; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; Minton MD, 1998, AM FISH S S, V22, P405; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moksnes PO, 2006, MAR ECOL PROG SER, V308, P165, DOI 10.3354/meps308165; National Research Council (NRC), 2007, MITIGATING SHORE ERO; ORTH RJ, 1977, ECOLOGY MARINE BENTH, P281; Peterson CH, 2003, MAR ECOL PROG SER, V264, P297, DOI 10.3354/meps264297; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Pilkey O. H., 1988, J COASTAL RES, VSI4, P41, DOI DOI 10.2112/JCOASTRES-D-14A-00011.1; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Roland RM, 2005, J COASTAL RES, V21, P453, DOI 10.2112/03-0079.1; Ronnback P, 1999, ECOL ECON, V29, P235, DOI 10.1016/S0921-8009(99)00016-6; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; ROZAS LP, 1987, MAR ECOL PROG SER, V38, P101, DOI 10.3354/meps038101; SCHROEDER WW, 1985, MISSISSIPPI ALABAMA, P102; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; THAYER GW, 2003, NOAA COASTAL OCEAN P, V23; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Vitousek P., 1997, SCIENCE, V277; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; WITTMAN J, 1985, NEW ENGLAND ECOLOGIC, V55, P421	58	208	216	18	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22396	10.1371/journal.pone.0022396	http://dx.doi.org/10.1371/journal.pone.0022396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850223	gold, Green Published			2022-12-25	WOS:000293563300007
J	Swaty, R; Blankenship, K; Hagen, S; Fargione, J; Smith, J; Patton, J				Swaty, Randy; Blankenship, Kori; Hagen, Sarah; Fargione, Joseph; Smith, Jim; Patton, Jeannie			Accounting for Ecosystem Alteration Doubles Estimates of Conservation Risk in the Conterminous United States	PLOS ONE			English	Article							SPECIES RICHNESS; HISTORICAL RANGE; FIRE; BIODIVERSITY; SIMULATION; MANAGEMENT; DIVERSITY; DYNAMICS; USA; COMMUNITIES	Previous national and global conservation assessments have relied on habitat conversion data to quantify conservation risk. However, in addition to habitat conversion to crop production or urban uses, ecosystem alteration (e.g., from logging, conversion to plantations, biological invasion, or fire suppression) is a large source of conservation risk. We add data quantifying ecosystem alteration on unconverted lands to arrive at a more accurate depiction of conservation risk for the conterminous United States. We quantify ecosystem alteration using a recent national assessment based on remote sensing of current vegetation compared with modeled reference natural vegetation conditions. Highly altered (but not converted) ecosystems comprise 23% of the conterminous United States, such that the number of critically endangered ecoregions in the United States is 156% higher than when calculated using habitat conversion data alone. Increased attention to natural resource management will be essential to address widespread ecosystem alteration and reduce conservation risk.	[Swaty, Randy] Nature Conservancy, Marquette, MI 49855 USA; [Blankenship, Kori] Nature Conservancy, Bend, OR USA; [Hagen, Sarah; Fargione, Joseph] Nature Conservancy, Minneapolis, MN USA; [Smith, Jim] Nature Conservancy, Jacksonville, FL USA; [Patton, Jeannie] Nature Conservancy, Boulder, CO USA	Nature Conservancy; Nature Conservancy; Nature Conservancy	Swaty, R (corresponding author), Nature Conservancy, Marquette, MI 49855 USA.	rswaty@tnc.org		Fargione, Joseph/0000-0002-0636-5380	TNC-LANDFIRE [10-CA-11132543-054]; U.S. Forest Service and Dept. of the Interior	TNC-LANDFIRE; U.S. Forest Service and Dept. of the Interior	This work was funded by the TNC-LANDFIRE Cooperative Agreement 10-CA-11132543-054 with the U.S. Forest Service and Dept. of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; [Anonymous], 2009, NATURESERVE CONS STA; BAILEY RG, 1983, ENVIRON MANAGE, V7, P365, DOI 10.1007/BF01866919; BAILEY RG, 1989, ENVIRON CONSERV, V16, P307, DOI 10.1017/S0376892900009711; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; Brooks ML, 2006, J ARID ENVIRON, V67, P100, DOI 10.1016/j.jaridenv.2006.09.021; Carey AB, 2000, ECOL APPL, V10, P248, DOI 10.1890/1051-0761(2000)010[0248:EONFMS]2.0.CO;2; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cleland D. T, 2007, WO76 USDA FOR SERV, VWO-76; Dinerstein E., 1995, CONSERVATION ASSESSM; Donovan GH, 2007, FRONT ECOL ENVIRON, V5, P73, DOI 10.1890/1540-9295(2007)5[73:BCWYWF]2.0.CO;2; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Groves C., 2000, DESIGNING GEOGRAPHY; Guyette RP, 2002, ECOSYSTEMS, V5, P472, DOI 10.1007/s10021-002-0115-7; Hann WJ, 2001, INT J WILDLAND FIRE, V10, P389, DOI 10.1071/WF01037; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurteau M, 2009, FRONT ECOL ENVIRON, V7, P409, DOI 10.1890/080049; Joern A, 2005, ECOLOGY, V86, P861, DOI 10.1890/04-0135; Keane RE, 2002, ECOL MODEL, V151, P29, DOI 10.1016/S0304-3800(01)00470-7; Knick ST, 2011, STUD AVIAN BIOL, P1; *LANDFIRE, 2009, LANDFIRE 1 0 0 VEG D; *LANDFIRE, 2007, LANDFIRE 1 1 0 FIR R; *LANDFIRE, 2009, LANDFIRE NAT W MIL O; *LANDFIRE, 2010, LANDFIRE NAT E MIL O; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Nicholson E, 2009, CONSERV BIOL, V23, P259, DOI 10.1111/j.1523-1739.2008.01158.x; Nonaka E, 2005, ECOL APPL, V15, P1727, DOI 10.1890/04-0902; Noss RF, 2006, RESTOR ECOL, V14, P4, DOI 10.1111/j.1526-100X.2006.00099.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NOSS RF, 1995, NATL BIOL SERV, P1; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Pratt S, 2006, LANDFIRE PROTOTYPE P, P277; Rodriguez JP, 2007, BIODIVERS CONSERV, V16, P183, DOI 10.1007/s10531-006-9102-1; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Shang BZ, 2004, ECOL MODEL, V180, P89, DOI 10.1016/j.ecolmodel.2004.01.020; Smith JE, 2002, CAN J BOT, V80, P186, DOI [10.1139/b02-003, 10.1139/B02-003]; Spies TA, 2007, ECOL APPL, V17, P48, DOI 10.1890/1051-0761(2007)017[0048:PEOFPO]2.0.CO;2; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Sullivan TP, 2001, J APPL ECOL, V38, P1234, DOI 10.1046/j.0021-8901.2001.00674.x; TEMPLETON AR, 2001, ECOLOGICAL APPL, V18, P1212; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; WDPA, 2009, WORLD DAT PROT AR AN; WIEDINMYER C, 2010, ENVIRON SCI TECHNOL, V44, P1962; YANG J, 2008, ECOLOGICAL APPLICATI, V18, DOI DOI 10.1016/J.RSE.2004.08.016; Zavaleta Erika, 2000, P261	47	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23002	10.1371/journal.pone.0023002	http://dx.doi.org/10.1371/journal.pone.0023002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850248	Green Published, gold			2022-12-25	WOS:000293563300033
J	Agwale, SM; Forbi, JC; Notka, F; Wrin, T; Wild, J; Wagner, R; Wolf, H				Agwale, Simon M.; Forbi, Joseph C.; Notka, Frank; Wrin, Terri; Wild, Jens; Wagner, Ralf; Wolf, Hans			Broad Antibody Mediated Cross-Neutralization and Preclinical Immunogenicity of New Codon-Optimized HIV-1 Clade CRF02_AG and G Primary Isolates	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTION-DRUG USERS; VACCINE; DNA; INFECTION; STRAINS; TRIAL; USAGE; PREVALENCE; EXPRESSION	Creation of an effective vaccine for HIV has been an elusive goal of the scientific community for almost 30 years. Neutralizing antibodies are assumed to be pivotal to the success of a prophylactic vaccine but previous attempts to make an immunogen capable of generating neutralizing antibodies to primary "street strain'' isolates have resulted in responses of very limited breadth and potency. The objective of the study was to determine the breadth and strength of neutralizing antibodies against autologous and heterologous primary isolates in a cohort of HIV-1 infected Nigerians and to characterize envelopes from subjects with particularly broad or strong immune responses for possible use as vaccine candidates in regions predominated by HIV-1 CRF02_AG and G subtypes. Envelope vectors from a panel of primary Nigerian isolates were constructed and tested with plasma/sera from the same cohort using the PhenoSense HIV neutralizing antibody assay (Monogram Biosciences Inc, USA) to assess the breadth and potency of neutralizing antibodies. The immediate goal of this study was realized by the recognition of three broadly cross-neutralizing sera: (NG2-clade CRF02_AG, NG3-clade CRF02_AG and NG9-clade G). Based on these findings, envelope gp140 sequences from NG2 and NG9, complemented with a gag sequence (Clade G) and consensus tat (CRF02_AG and G) antigens have been codon-optimized, synthesized, cloned and evaluated in BALB/c mice. The intramuscular administration of these plasmid DNA constructs, followed by two booster DNA immunizations, induced substantial specific humoral response against all constructs and strong cellular responses against the gag and tat constructs. These preclinical findings provide a framework for the design of candidate vaccine for use in regions where the HIV-1 epidemic is driven by clades CRF02_AG and G.	[Agwale, Simon M.; Forbi, Joseph C.] Innovat Biotech, Clin Virol Lab, Keffi Abuja, Nigeria; [Agwale, Simon M.; Forbi, Joseph C.] Innovat Biotech, Frederick Innovat Technol Ctr, Frederick, MD USA; [Notka, Frank; Wagner, Ralf] GeneArt AG, Regensburg, Germany; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA; [Wild, Jens; Wagner, Ralf; Wolf, Hans] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany	University of Regensburg	Agwale, SM (corresponding author), Innovat Biotech, Clin Virol Lab, Keffi Abuja, Nigeria.	sagwale@innovativebiotechng.com		Wild, Jens/0000-0001-9880-7897				Agwale SM, 2006, AIDS RES HUM RETROV, V22, P22, DOI 10.1089/aid.2006.22.22; Agwale SM, 2002, P NATL ACAD SCI USA, V99, P10037, DOI 10.1073/pnas.152313899; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Andre S, 1998, J VIROL, V72, P1497; Bojak A, 2002, DRUG DISCOV TODAY, V7, P36, DOI 10.1016/S1359-6446(01)02081-5; Bojak A, 2002, INTERVIROLOGY, V45, P275, DOI 10.1159/000067919; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Carr JK, 2001, VIROLOGY, V286, P168, DOI 10.1006/viro.2001.0976; CARROW EW, 1991, AIDS RES HUM RETROV, V7, P831, DOI 10.1089/aid.1991.7.831; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frost SDW, 2008, CURR OPIN HIV AIDS, V3, P45, DOI 10.1097/COH.0b013e3282f310ae; GIACCONE G, 1992, CANCER RES, V52, pS2732; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haigwood N L, 1998, AIDS, V12 Suppl A, pS121; Haigwood Nancy L, 2003, AIDS, V17 Suppl 4, pS67, DOI 10.1097/00002030-200317004-00008; Kent SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000331; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Schultz AM, 2001, AIDS, V15, pS147, DOI 10.1097/00002030-200100005-00018; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Taiwo OO, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-19; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; *UNAIDS, 2007, REP GLOB HIV AIDS EP, P18; *UNAIDS, 2009, LARG EV HIV VACC TRI; VOGEL T, 1994, J IMMUNOL, V153, P1895; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wayne C Koff, 2010, N Engl J Med, V363, pe7, DOI 10.1056/NEJMp1007629; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23233	10.1371/journal.pone.0023233	http://dx.doi.org/10.1371/journal.pone.0023233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829720	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200058
J	Anderson, DJ; Durieux, JK; Song, K; Alvarado, R; Jackson, PK; Hatzivassiliou, G; Ludlam, MJC				Anderson, Daniel J.; Durieux, Jenni K.; Song, Kyung; Alvarado, Ryan; Jackson, Peter K.; Hatzivassiliou, Georgia; Ludlam, Mary J. C.			Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics	PLOS ONE			English	Article							RAS ACTIVATION; LIVING CELLS; HUMAN CANCER; NUCLEAR TRANSLOCATION; C-RAF; B-RAF; KINASE; GROWTH; BRAF; PHOSPHORYLATION	Oncogenic mutations in the mitogen activated protein kinase (MAPK) pathway are prevalent in human tumors, making this pathway a target of drug development efforts. Recently, ATP-competitive Raf inhibitors were shown to cause MAPK pathway activation via Raf kinase priming in wild-type BRaf cells and tumors, highlighting the need for a thorough understanding of signaling in the context of small molecule kinase inhibitors. Here, we present critical improvements in cell-line engineering and image analysis coupled with automated image acquisition that allow for the simultaneous identification of cellular localization of multiple MAPK pathway components (KRas, CRaf, Mek1 and Erk2). We use these assays in a systematic study of the effect of small molecule inhibitors across the MAPK cascade either as single agents or in combination. Both Raf inhibitor priming as well as the release from negative feedback induced by Mek and Erk inhibitors cause translocation of CRaf to the plasma membrane via mechanisms that are additive in pathway activation. Analysis of Erk activation and sub-cellular localization upon inhibitor treatments reveals differential inhibition and activation with the Raf inhibitors AZD628 and GDC0879 respectively. Since both single agent and combination studies of Raf and Mek inhibitors are currently in the clinic, our assays provide valuable insight into their effects on MAPK signaling in live cells.	[Anderson, Daniel J.; Durieux, Jenni K.; Jackson, Peter K.; Ludlam, Mary J. C.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA; [Song, Kyung; Alvarado, Ryan; Hatzivassiliou, Georgia] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Anderson, DJ (corresponding author), Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA.	anderson.daniel@gene.com		Anderson, Daniel/0000-0002-3249-2439; Jackson, Peter/0000-0002-1742-2539	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The studies in this manuscript were fully funded by Genentech, Inc. All authors are employees of Genentech, Inc. The funder, Genentech, Inc., approved the manuscript for public disclosure, however studies were conducted in an academic fashion, independently from Genentech's financial interests.	Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bivona TG, 2006, METHOD ENZYMOL, V407, P128, DOI 10.1016/S0076-6879(05)07012-6; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; BOS JL, 1989, CANCER RES, V49, P4682; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Flaherty K, 2009, J CLIN ONCOL, V27; Gonzalez-Perez Vanessa, 2010, J Mol Signal, V5, P2, DOI 10.1186/1750-2187-5-2; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hibino K, 2009, BIOPHYS J, V97, P1277, DOI 10.1016/j.bpj.2009.05.048; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Kupzig S, 2006, METHOD ENZYMOL, V407, P64, DOI 10.1016/S0076-6879(05)07007-2; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Martinez-botella, 2006, PYRROLE INHIBITORS E; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rosen LS, 2008, J CLIN ONCOLOGY; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2009, ONCOLOGY JOC, P3513; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22607	10.1371/journal.pone.0022607	http://dx.doi.org/10.1371/journal.pone.0022607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829637	Green Submitted, Green Published, gold			2022-12-25	WOS:000293561200025
J	Margus, T; Remm, M; Tenson, T				Margus, Tonu; Remm, Maido; Tenson, Tanel			A Computational Study of Elongation Factor G (EFG) Duplicated Genes: Diverged Nature Underlying the Innovation on the Same Structural Template	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RECYCLING FACTOR; TUF GENES; SEQUENCE; RIBOSOME; EVOLUTION; GTPASES; PROTEINS	Background: Elongation factor G (EFG) is a core translational protein that catalyzes the elongation and recycling phases of translation. A more complex picture of EFG's evolution and function than previously accepted is emerging from analyzes of heterogeneous EFG family members. Whereas the gene duplication is postulated to be a prominent factor creating functional novelty, the striking divergence between EFG paralogs can be interpreted in terms of innovation in gene function. Methodology/Principal Findings: We present a computational study of the EFG protein family to cover the role of gene duplication in the evolution of protein function. Using phylogenetic methods, genome context conservation and insertion/deletion (indel) analysis we demonstrate that the EFG gene copies form four subfamilies: EFG I, spdEFG1, spdEFG2, and EFG II. These ancient gene families differ by their indispensability, degree of divergence and number of indels. We show the distribution of EFG subfamilies and describe evidences for lateral gene transfer and recent duplications. Extended studies of the EFG II subfamily concern its diverged nature. Remarkably, EFG II appears to be a widely distributed and a much-diversified subfamily whose subdivisions correlate with phylum or class borders. The EFG II subfamily specific characteristics are low conservation of the GTPase domain, domains II and III; absence of the trGTPase specific G2 consensus motif "RGITI''; and twelve conserved positions common to the whole subfamily. The EFG II specific functional changes could be related to changes in the properties of nucleotide binding and hydrolysis and strengthened ionic interactions between EFG II and the ribosome, particularly between parts of the decoding site and loop I of domain IV. Conclusions/Significance: Our work, for the first time, comprehensively identifies and describes EFG subfamilies and improves our understanding of the function and evolution of EFG duplicated genes.	[Margus, Tonu; Remm, Maido] Univ Tartu, Dept Bioinformat, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Margus, Tonu; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu; Estonian Biocentre; University of Tartu	Margus, T (corresponding author), Univ Tartu, Dept Bioinformat, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	tonu.margus@ut.ee	Remm, Maido/L-9072-2019; Tenson, Tanel/I-6431-2015	Remm, Maido/0000-0003-3966-8422; Tenson, Tanel/0000-0002-0260-3601; Margus, Tonu/0000-0003-4966-1291	Estonian Ministry of Education and Research [SF0180026s09, SF0180166s08]; EU through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); EU through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology	This work was funded by grants SF0180026s09 and SF0180166s08 from the Estonian Ministry of Education and Research and by the EU through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; Aevarsson A, 1995, J MOL EVOL, V41, P1096; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; ATKINSON GC, 2010, MOL BIOL EVOL; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; De Vendittis E, 1999, EUR J BIOCHEM, V262, P600, DOI 10.1046/j.1432-1327.1999.00428.x; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J, PHYLIP PHYLOGENY INF; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HAMEL E, 1972, J BIOL CHEM, V247, P805; Hauryliuk V, 2008, BIOPHYS J, V95, P1704, DOI 10.1529/biophysj.107.127290; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes T, 2007, J MOL EVOL, V65, P574, DOI 10.1007/s00239-007-9041-9; Inagaki Y, 2002, CURR BIOL, V12, P772, DOI 10.1016/S0960-9822(02)00816-3; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JASKUNAS SR, 1977, J BIOL CHEM, V252, P7323; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kovtun A A, 2006, Mol Biol (Mosk), V40, P850; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lathe WC, 2001, FEBS LETT, V502, P113, DOI 10.1016/S0014-5793(01)02639-4; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LILJAS A, STRUCTURAL ASPECTS P; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 1999, FEBS LETT, V452, P155, DOI 10.1016/S0014-5793(99)00635-3; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; *NCBI, 2008, BACT SEQ DAT; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; PESTKA S, 1968, P NATL ACAD SCI USA, V61, P726, DOI 10.1073/pnas.61.2.726; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; RHEINBERGER HJ, 1983, P NATL ACAD SCI-BIOL, V80, P4213, DOI 10.1073/pnas.80.14.4213; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Seshadri A, 2009, TUBERCULOSIS, V89, P453, DOI 10.1016/j.tube.2009.06.003; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUEMATSU T, 2010, MOL MICROBIOL; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	71	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22789	10.1371/journal.pone.0022789	http://dx.doi.org/10.1371/journal.pone.0022789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829651	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200030
J	Regier, JC; Zwick, A				Regier, Jerome C.; Zwick, Andreas			Sources of Signal in 62 Protein-Coding Nuclear Genes for Higher-Level Phylogenetics of Arthropods	PLOS ONE			English	Article							BASE-COMPOSITIONAL HETEROGENEITY; NUCLEOTIDE COMPOSITION; AMINO-ACID; MITOCHONDRIAL; INFERENCE; EVOLUTION; BIAS; SUPPORT; TREE; ACCURACY	Background: This study aims to investigate the strength of various sources of phylogenetic information that led to recent seemingly robust conclusions about higher-level arthropod phylogeny and to assess the role of excluding or downweighting synonymous change for arriving at those conclusions. Methodology/Principal Findings: The current study analyzes DNA sequences from 68 gene segments of 62 distinct protein-coding nuclear genes for 80 species. Gene segments analyzed individually support numerous nodes recovered in combined-gene analyses, but few of the higher-level nodes of greatest current interest. However, neither is there support for conflicting alternatives to these higher-level nodes. Gene segments with higher rates of nonsynonymous change tend to be more informative overall, but those with lower rates tend to provide stronger support for deeper nodes. Higher-level nodes with bootstrap values in the 80% - 99% range for the complete data matrix are markedly more sensitive to substantial drops in their bootstrap percentages after character subsampling than those with 100% bootstrap, suggesting that these nodes are likely not to have been strongly supported with many fewer data than in the full matrix. Data set partitioning of total data by (mostly) synonymous and (mostly) nonsynonymous change improves overall node support, but the result remains much inferior to analysis of (unpartitioned) nonsynonymous change alone. Clusters of genes with similar nonsynonymous rate properties (e. g., faster vs. slower) show some distinct patterns of node support but few conflicts. Synonymous change is shown to contribute little, if any, phylogenetic signal to the support of higher-level nodes, but it does contribute nonphylogenetic signal, probably through its underlying heterogeneous nucleotide composition. Analysis of seemingly conservative indels does not prove useful. Conclusions: Generating a robust molecular higher-level phylogeny of Arthropoda is currently possible with large amounts of data and an exclusive reliance on nonsynonymous change.	[Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Regier, Jerome C.; Zwick, Andreas] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Stuttgart, Germany	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park	Regier, JC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	regier@umd.edu; andreas.zwick@smns-bw.de	Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752	National Science Foundation, U.S.A. [1042845, 0120635]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	National Science Foundation, U.S.A.(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from the National Science Foundation, U.S.A. (grant numbers 1042845 and 0120635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu M, 2008, MOL BIOL EVOL, V25, P2521, DOI 10.1093/molbev/msn224; Aleshin VV, 2009, MOL BIOL+, V43, P804, DOI 10.1134/S0026893309050124; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Belinky F, 2010, MOL BIOL EVOL, V27, P441, DOI 10.1093/molbev/msp263; Bjorklund M, 1999, CLADISTICS, V15, P191, DOI 10.1111/j.1096-0031.1999.tb00261.x; Brenneis G, 2008, EVOL DEV, V10, P717, DOI 10.1111/j.1525-142X.2008.00285.x; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; CHO S, 2011, SYST BIOL IN PRESS; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Conant GC, 2001, MOL BIOL EVOL, V18, P1024, DOI 10.1093/oxfordjournals.molbev.a003874; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Davalos LA, 2008, GENOMICS, V91, P433, DOI 10.1016/j.ygeno.2008.01.006; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; Delsuc F, 2003, SCIENCE, V301, P1482; Dietz L, 2011, MOL PHYLOGENET EVOL, V58, P553, DOI 10.1016/j.ympev.2010.12.016; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Fanenbruck M, 2004, P NATL ACAD SCI USA, V101, P3868, DOI 10.1073/pnas.0306212101; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Gowri-Shankar V, 2006, MOL BIOL EVOL, V23, P352, DOI 10.1093/molbev/msj040; Gruber KF, 2007, SYST BIOL, V56, P83, DOI 10.1080/10635150601182939; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Herbeck JT, 2005, MOL BIOL EVOL, V22, P520, DOI 10.1093/molbev/msi036; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; Inagaki Y, 2006, MOL PHYLOGENET EVOL, V40, P428, DOI 10.1016/j.ympev.2006.03.020; Inagaki Y, 2009, MOL BIOL EVOL, V26, P1171, DOI 10.1093/molbev/msp036; Jayaswal V, 2007, SYSTEMATIC BIOL, V56, P155, DOI 10.1080/10635150701247921; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Kallersjo M, 1999, CLADISTICS, V15, P91; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Koenemann S, 2010, ARTHROPOD STRUCT DEV, V39, P88, DOI 10.1016/j.asd.2009.10.003; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; PHILIPPE H, 2009, P ROY SOC LOND B BIO, V267, P1213; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P610, DOI 10.1093/molbev/msg067; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Tarrio R, 2001, MOL BIOL EVOL, V18, P1464, DOI 10.1093/oxfordjournals.molbev.a003932; Tarrio R, 2000, MOL PHYLOGENET EVOL, V16, P344, DOI 10.1006/mpev.2000.0813; Taylor DJ, 2004, MOL BIOL EVOL, V21, P1534, DOI 10.1093/molbev/msh156; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Whelan S, 2008, MOL BIOL EVOL, V25, P1683, DOI 10.1093/molbev/msn119; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; ZWICK A, 2010, SYST ENTOMO IN PRESS; Zwickl D., 2006, GARLI GENETIC ALGORI	90	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23408	10.1371/journal.pone.0023408	http://dx.doi.org/10.1371/journal.pone.0023408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829732	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200069
J	Oliveira, DC; de Lencastre, H				Oliveira, Duarte C.; de Lencastre, Herminia			Methicillin-Resistance in Staphylococcus aureus Is Not Affected by the Overexpression in Trans of the mecA Gene Repressor: A Surprising Observation	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE DETERMINATION; MULTIPLEX PCR STRATEGY; TRANSCRIPTIONAL REGULATION; ANTIBIOTIC-RESISTANCE; BETA-LACTAMASE; EXPRESSION; CHROMOSOME; EVOLUTION; STRAINS; REGION	Methicillin-resistant Staphylococcus aureus (MRSA) is intrinsically cross-resistant to virtually all beta-lactam antibiotics. The central determinant for the MRSA phenotype is the mecA gene, whose transcriptional control may be mediated by a repressor (mecI) and a sensor/inducer (mecR1). The mecI-mecR1-mediated induction of mecA takes several hours rendering the strains phenotypically susceptible in spite of the presence of the resistance gene. Therefore, it has been proposed that the full resistance to beta-lactams observed in many contemporary clinical MRSA strains requires a non-functional mecI-mecR1 regulatory system. The mecA gene is embedded in a large chromosomal cassette (the SCCmec element) for which several structural types have been described. Some epidemic MRSA clones, typically expressing full beta-lactam resistance, carry SCCmec elements that contain an intact mecI-mecR1 locus (e.g. SCCmec types II and III). We have addressed this apparent contradiction by first sequencing the mecI coding region and mecA promoter sequences in a collection of prototype MRSA strains characterized by different SCCmec types. A conserved non-sense mutation within mecI was detected in all SCCmec type III strains tested, presumably responsible for a non-functional truncated MecI protein and, therefore, explaining the full resistance phenotype. In SCCmec type II strains no conserved mutations were found. We next transformed a collection of prototype MRSA epidemic strains with a recombinant plasmid overexpressing a wild-type copy of mecI. Surprisingly, for the great majority of the strains no significant alterations in the phenotypic expression of beta-lactam resistance could be detected. These findings were confirmed and further explored, challenging the currently accepted mechanism of mecA transcriptional control. Our observations suggest the existence of yet unidentified additional determinants involved in the transcriptional control of mecA gene and point to a revision of the mecA regulatory mechanism in contemporary MRSA strains.	[Oliveira, Duarte C.; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Oliveira, Duarte C.; de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Rockefeller University	Oliveira, DC (corresponding author), Univ Nova Lisboa, Dept Life Sci, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Caparica, Portugal.	dco@fct.unl.pt	Oliveira, Duarte/B-4097-2008	Oliveira, Duarte/0000-0002-9591-1039; /0000-0001-6816-8932	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [POCI/BIA-MIC/60320/2004, PTDC/BIA-MIC/64071/2006]; European Commission [223031]; U.S. Public Health Service [RO1AI045738]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045738] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partial support for this study was provided by Projects POCI/BIA-MIC/60320/2004 and PTDC/BIA-MIC/64071/2006 from Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, awarded to D. C. Oliveira; Project TROCAR, contract number 223031 from the European Commission awarded to H. de Lencastre; and grant RO1AI045738 from the U.S. Public Health Service awarded to A. Tomasz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; Archer GL, 2001, SCIENCE, V291, P1915, DOI 10.1126/science.1059671; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; COHEN S, 1968, J BACTERIOL, V95, P1368, DOI 10.1128/JB.95.4.1368-1374.1968; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dickinson TM, 2000, ANTIMICROB AGENTS CH, V44, P1616, DOI 10.1128/AAC.44.6.1616-1623.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; HIRAMATSU K, 1992, FEBS LETT, V298, P133, DOI 10.1016/0014-5793(92)80039-J; HURLIMANNDALEL RL, 1992, ANTIMICROB AGENTS CH, V36, P2617, DOI 10.1128/AAC.36.12.2617; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Kobayashi N, 1998, ANTIMICROB AGENTS CH, V42, P717, DOI 10.1128/AAC.42.3.717; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; Pinho MG, 1998, J BACTERIOL, V180, P6077; Rosato AE, 2003, J BACTERIOL, V185, P3446, DOI 10.1128/JB.185.11.3446-3452.2003; Rosato AE, 2003, ANTIMICROB AGENTS CH, V47, P1460, DOI 10.1128/AAC.47.4.1460-1463.2003; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; Shukla SK, 2004, ANTIMICROB AGENTS CH, V48, P3080, DOI 10.1128/AAC.48.8.3080-3085.2004; SONG MD, 1987, FEBS LETT, V221, P167, DOI 10.1016/0014-5793(87)80373-3; SUZUKI E, 1993, ANTIMICROB AGENTS CH, V37, P1219, DOI 10.1128/AAC.37.6.1219; Weller TMA, 1999, J ANTIMICROB CHEMOTH, V43, P15, DOI 10.1093/jac/43.1.15; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	43	38	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23287	10.1371/journal.pone.0023287	http://dx.doi.org/10.1371/journal.pone.0023287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829724	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511900033
J	Sharafieh, R; Lemire, Y; Powell, S; O'Rourke, J; Cone, RE				Sharafieh, Roshanak; Lemire, Yen; Powell, Sabrina; O'Rourke, James; Cone, Robert E.			Immune Amplification of Murine CD8(+) Suppressor T Cells Induced via An Immune-Privileged Site: Quantifying Suppressor T Cells Functionally	PLOS ONE			English	Article							TGF-BETA; INDUCTION; EYE; HYPERSENSITIVITY; GENERATION; TOLERANCE; RESPONSES; ANTIGEN; CD4(+); ACAID	Background: CD8(+) suppressor T cells exert antigen-specific suppression of the expression of hypersensitivity by activated T cells. Therefore, CD8(+) suppressor T cells serve a major regulatory role for the control of active immunity. Accordingly, the number and/or activity of CD8(+) suppressor T cells should be influenced by an immune response to the antigen. To test this hypothesis we used an adoptive transfer assay that measures the suppression of the expression of delayed-type hypersensitivity (DTH) by CD8(+) suppressor T cells to quantify the antigen-specific suppression of DTH by these suppressor T cells. Methods: Suppressor T cells were induced in the spleens of mice by the injection of antigen into the anterior chamber of an eye. Following this injection, the mice were immunized by the same antigen injected into the anterior chamber. Spleen cells recovered from these mice (AC-SPL cells) were titrated in an adoptive transfer assay to determine the number of AC-SPL cells required to effect a 50% reduction of antigen-induced swelling (Sw50) in the footpad of immunized mice challenged by antigen. Results: Suppression of the expression of DTH is proportional to the number of AC-SPL cells injected into the site challenged by antigen. The number of AC-SPL cells required for a 50% reduction in DTH-induced swelling is reduced by injecting a cell population enriched for CD8(+) AC-SPL cells. Immunizing the mice receiving intracameral antigen to the same antigen decreases the RSw50 of AC-SPL cells required to inhibit the expression of DTH. Conclusions: The results provide the first quantitative demonstration that the numbers of antigen-specific splenic CD8(+) suppressor T cells are specifically amplified by antigen during an immune response.	[Sharafieh, Roshanak; Lemire, Yen; Powell, Sabrina; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	University of Connecticut	Sharafieh, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA.	Cone@UCHC.EDU			United States Public Health Service [EY 017237, EY 017289]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017289, R03EY017237] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by United States Public Health Service grants EY 017237 and EY 017289 and the Connecticut Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Bhowmick S, 2009, J LEUKOCYTE BIOL, V86, P1275, DOI 10.1189/jlb.0209107; Cantor H, 2004, NAT IMMUNOL, V5, P347, DOI 10.1038/ni0404-347; Cone RE, 2010, OPHTHALMOL EYE DIS, V2, P57, DOI 10.4137/OED.S6113; Cone RE, 2009, INT IMMUNOL, V21, P567, DOI 10.1093/intimm/dxp023; Cone RE, 2009, IMMUNOL CELL BIOL, V87, P241, DOI 10.1038/icb.2008.102; Cone RE, 2007, IMMUNOLOGY, V120, P112, DOI 10.1111/j.1365-2567.2006.02486.x; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; HAO H, 2008, BMC IMMUNOL, V9, P53; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Jiang H, 2004, ADV IMMUNOL, V83, P253; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; Jiang LQ, 2009, GRAEF ARCH CLIN EXP, V247, P87, DOI 10.1007/s00417-008-0947-8; Kapp JA, 2006, INT IMMUNOL, V18, P1549, DOI 10.1093/intimm/dxl088; Keino H, 2006, INVEST OPHTH VIS SCI, V47, P1047, DOI 10.1167/iovs.05-0110; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Li X, 2006, IMMUNOLOGY, V117, P566, DOI 10.1111/j.1365-2567.2006.02333.x; LI X, 2006, IMMUNOLOGY, V113, P44; MARCHAL G, 1982, J IMMUNOL, V129, P954; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Tang XL, 2007, J IMMUNOL, V178, P6043, DOI 10.4049/jimmunol.178.10.6043; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; WILBANKS GA, 1991, J IMMUNOL, V146, P3018; WILBANKS GA, 1990, REG IMMUNOL, V4, P130	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22496	10.1371/journal.pone.0022496	http://dx.doi.org/10.1371/journal.pone.0022496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829628	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511900008
J	Yang, CH; Cheng, CH; Chen, GD; Liao, WH; Chen, YC; Huang, KY; Hwang, PP; Hwang, SPL; Huang, CJ				Yang, Chung-Hsiang; Cheng, Chia-Hsiung; Chen, Gen-Der; Liao, Wei-Hao; Chen, Yi-Chung; Huang, Kai-Yun; Hwang, Pung-Pung; Hwang, Sheng-Ping L.; Huang, Chang-Jen			Zona Pellucida Domain-Containing Protein beta-Tectorin is Crucial for Zebrafish Proper Inner Ear Development	PLOS ONE			English	Article							HEARING IMPAIRMENT; MOLECULAR-CLONING; MATRIX PROTEINS; ALPHA-TECTORIN; MESSENGER-RNA; EXPRESSION; GENE; MOUSE; FERTILIZATION; MUTATIONS	Background: The zona pellucida (ZP) domain is part of many extracellular proteins with diverse functions from structural components to receptors. The mammalian beta-tectorin is a protein of 336 amino acid residues containing a single ZP domain and a putative signal peptide at the N-terminus of the protein. It is 1 component of a gel-like structure called the tectorial membrane which is involved in transforming sound waves into neuronal signals and is important for normal auditory function. beta-Tectorin is specifically expressed in the mammalian and avian inner ear. Methodology/Principal Findings: We identified and cloned the gene encoding zebrafish beta-tectorin. Through whole-mount in situ hybridization, we demonstrated that beta-tectorin messenger RNA was expressed in the otic placode and specialized sensory patch of the inner ear during zebrafish embryonic stages. Morpholino knockdown of zebrafish beta-tectorin affected the position and number of otoliths in the ears of morphants. Finally, swimming behaviors of beta-tectorin morphants were abnormal since the development of the inner ear was compromised. Conclusions/Significance: Our results reveal that zebrafish beta-tectorin is specifically expressed in the zebrafish inner ear, and is important for regulating the development of the zebrafish inner ear. Lack of zebrafish beta-tectorin caused severe defects in inner ear formation of otoliths and function.	[Yang, Chung-Hsiang; Huang, Kai-Yun; Huang, Chang-Jen] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Yang, Chung-Hsiang; Cheng, Chia-Hsiung; Chen, Gen-Der; Liao, Wei-Hao; Chen, Yi-Chung; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hwang, Pung-Pung; Hwang, Sheng-Ping L.] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yang, CH (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan.	cjibc@gate.sinica.edu.tw	hwang, pp/A-3641-2011; Hwang, Pung-Pung/AEQ-4633-2022; Cheng, Chia-Hsiung/A-6044-2019; Hwang, Sheng-Ping/F-2882-2014; Hwang, Pung-Pung/AAH-1538-2022	Cheng, Chia-Hsiung/0000-0003-0307-9650; Chen, Yi-Chun/0000-0002-2237-9416	Academia Sinica [AS-99-TP-B08]; National Science Council, Taipei, Taiwan [97-2313-B-001-002-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (AS-99-TP-B08) from Academia Sinica and a grant (97-2313-B-001-002-MY3) from National Science Council, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen YC, 2009, DEV DYNAM, V238, P746, DOI 10.1002/dvdy.21877; Coutinho P, 1999, HEARING RES, V130, P62, DOI 10.1016/S0378-5955(98)00213-5; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Granato M, 1996, DEVELOPMENT, V123, P399; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Kwak SJ, 2006, DEV DYNAM, V235, P3026, DOI 10.1002/dvdy.20961; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Meyers JR, 2003, J NEUROSCI, V23, P4054; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; Rau A, 1999, J COMP NEUROL, V405, P271; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Tanimoto M, 2011, J NEUROSCI, V31, P3784, DOI 10.1523/JNEUROSCI.5554-10.2011; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073	29	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23078	10.1371/journal.pone.0023078	http://dx.doi.org/10.1371/journal.pone.0023078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829695	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511900024
J	Jenkins, HE; Zignol, M; Cohen, T				Jenkins, Helen E.; Zignol, Matteo; Cohen, Ted			Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994-2009	PLOS ONE			English	Article							EARLY BACTERICIDAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; METAANALYSIS; COUNTRIES	Background: Quantifying isoniazid resistant (INH-R) tuberculosis (TB) is important because isoniazid resistance reduces the probability of treatment success, may facilitate the spread of multidrug resistance, and may reduce the effectiveness of isoniazid preventive therapy (IPT). Methodology/Principal Findings: We used data reported to the World Health Organization between 1994-2009 to estimate the INH-R burden among new and retreatment TB cases. We assessed geographical and temporal variation in INHR and reported levels in high HIV prevalence countries ($2%) to understand implications for IPT. 131 settings reported INHR data since 1994. A single global estimate of the percentage of incident TB cases with INH-R was deemed inappropriate due to particularly high levels in the Eastern European region where 44.9% (95% CI: 34.0%, 55.8%) of incident TB cases had INH-R. In all other regions combined, 13.9% (95% CI: 12.6%, 15.2%) of incident cases had INH-R with the lowest regional levels seen in West/Central Europe and Africa. Where trend data existed, we found examples of rising and falling burdens of INH-R. 40% of high HIV prevalence countries reported national data on INH-R and 7.3% (95% CI: 5.5%, 9.1%) of cases in these settings had INH-R. Conclusions/Significance: Outside the Eastern European region, one in seven incident TB cases has INH-R, while this rises to nearly half within Eastern Europe. Many countries cannot assess trends in INH-R and the scarcity of data from high HIV prevalence areas limits insight into the implications for IPT. Further research is required to understand reasons for the observed time trends and to determine the effects of INH-R for control of TB.	[Jenkins, Helen E.; Cohen, Ted] Brigham & Womens Hosp, Boston, MA 02115 USA; [Jenkins, Helen E.] Harvard Univ, Sch Med, Boston, MA USA; [Zignol, Matteo] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Jenkins, HE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jenkins.helen@gmail.com	Cohen, Ted/G-8101-2011; Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Jenkins, Helen/0000-0003-4749-1591; Cohen, Ted/0000-0002-8091-7198	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Award Number U54GM088558 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe G, 2011, J MICROBIOL METH, V84, P155, DOI 10.1016/j.mimet.2010.11.014; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Falzon D, 2008, EURO SURVEILL, V13; Hafner R, 1997, AM J RESP CRIT CARE, V156, P918, DOI 10.1164/ajrccm.156.3.9612016; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Leimane V, 2006, Euro Surveill, V11, P29, DOI 10.2807/esm.11.03.00610-en; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Organization WH, 1997, WHOTB97229; RIEDER HL, 2002, INTERVENTIONS TUBERC; SAMANDARI T, 2009, 40 UN WORLD LUNG C; Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; UNAIDS, 2010, UNAIDS REP GLOB AIDS; *WHO, 2010, MULT EXT DRUG RES M; *WHO, 2009, GUID DRUG RES SURV T; *WHO, 2000, WHOGDSTB2000278; *WHO, 2008, WHOHTMTB2008394; WHO, 2010, GLOB TUB CONTR 2010; *WHO, WHO PORT TUB TB SCRE; World Health Organization, 2010, GUID INT CAS FIND IS	28	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22927	10.1371/journal.pone.0022927	http://dx.doi.org/10.1371/journal.pone.0022927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829557	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500053
J	Brigotti, M; Carnicelli, D; Arfilli, V; Rocchi, L; Ricci, F; Pagliaro, P; Tazzari, PL; Vara, AG; Amelia, M; Manoli, F; Monti, S				Brigotti, Maurizio; Carnicelli, Domenica; Arfilli, Valentina; Rocchi, Laura; Ricci, Francesca; Pagliaro, Pasqualepaolo; Tazzari, Pier Luigi; Vara, Antonio Gonzalez; Amelia, Matteo; Manoli, Francesco; Monti, Sandra			Change in Conformation with Reduction of alpha-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ESCHERICHIA-COLI O157-H7; RICIN A-CHAIN; HUMAN ENDOTHELIAL-CELLS; SHIGELLA-DYSENTERIAE; PROTEINS; SITE; CHILDREN; RECEPTOR	Shiga toxins (Stx) play an important role in the pathogenesis of hemolytic uremic syndrome, a life-threatening renal sequela of human intestinal infection caused by specific Escherichia coli strains. Stx target a restricted subset of human endothelial cells that possess the globotriaosylceramide receptor, like that in renal glomeruli. The toxins, composed of five B chains and a single enzymatic A chain, by removing adenines from ribosomes and DNA, trigger apoptosis and the production of pro-inflammatory cytokines in target cells. Because bacteria are confined to the gut, the toxins move to the kidney through the circulation. Polymorphonuclear leukocytes (PMN) have been indicated as the carriers that "piggyback" shuttle toxins to the kidney. However, there is no consensus on this topic, because not all laboratories have been able to reproduce the Stx/PMN interaction. Here, we demonstrate that conformational changes of Shiga toxin 1, with reduction of alpha-helix content and exposition to solvent of hydrophobic tryptophan residues, cause a loss of PMN binding activity. The partially unfolded toxin was found to express both enzymatic and globotriaosylceramide binding activities being fully active in intoxicating human endothelial cells; this suggests the presence of a distinct PMN-binding domain. By reviewing functional and structural data, we suggest that A chain moieties close to Trp-203 are recognized by PMN. Our findings could help explain the conflicting results regarding Stx/PMN interactions, especially as the groups reporting positive results obtained Stx by single-step affinity chromatography, which could have preserved the correct folding of Stx with respect to more complicated multi-step purification methods.	[Brigotti, Maurizio; Carnicelli, Domenica; Arfilli, Valentina; Rocchi, Laura] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy; [Ricci, Francesca; Pagliaro, Pasqualepaolo; Tazzari, Pier Luigi] Osped S Orsola Malpighi, Serv Immunoematol & Trasfus, Bologna, Italy; [Vara, Antonio Gonzalez] Univ Bologna, Dipartimento Chim Ind & Mat, I-40136 Bologna, Italy; [Amelia, Matteo] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; [Manoli, Francesco; Monti, Sandra] CNR, Ist Sintesi Organ & Fotoreattivita, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Brigotti, M (corresponding author), Via San Giacomo 14, I-40126 Bologna, Italy.	maurizio.brigotti@unibo.it	Monti, Sandra/B-9272-2009; Brigotti, Maurizio/AAB-9007-2022; TAZZARI, PIER LUIGI/HGC-8394-2022; Manoli, Francesco/E-5981-2014	Brigotti, Maurizio/0000-0001-7429-744X; TAZZARI, PIER LUIGI/0000-0002-8789-657X; Manoli, Francesco/0000-0003-2734-1625; Ricci, Francesca/0000-0003-4387-1415	University of Bologna; Centro per la Cura e lo Studio della Sindrome Emolitico Uremica	University of Bologna; Centro per la Cura e lo Studio della Sindrome Emolitico Uremica	This work is supported by the University of Bologna (RFO funds to M. B.) and Centro per la Cura e lo Studio della Sindrome Emolitico Uremica.	Arfilli V, 2010, BIOCHEM J, V432, P173, DOI 10.1042/BJ20100455; Barbieri L, 1998, MOL MICROBIOL, V29, P661, DOI 10.1046/j.1365-2958.1998.00911.x; Beechem J. M., 1988, FLUORESCENCE SPECTRO; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Brigotti M, 1998, NUCLEIC ACIDS RES, V26, P4306, DOI 10.1093/nar/26.18.4306; Brigotti M, 2006, J CLIN MICROBIOL, V44, P313, DOI 10.1128/JCM.44.2.313-317.2006; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; Brigotti M, 2008, J LEUKOCYTE BIOL, V84, P1019, DOI 10.1189/jlb.0308157; Brigotti M, 2007, INFECT IMMUN, V75, P2201, DOI 10.1128/IAI.01707-06; Brigotti M, 2011, PEDIATR INFECT DIS J, V30, P486, DOI 10.1097/INF.0b013e3182074d22; Brigotti M, 2010, J LEUKOCYTE BIOL, V88, P201, DOI 10.1189/jlb.0709475; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fernandez GC, 2005, PEDIATR NEPHROL, V20, P1306, DOI 10.1007/s00467-005-1906-9; Flagler MJ, 2007, INFECT IMMUN, V75, P760, DOI 10.1128/IAI.01594-06; Fraser ME, 2006, ACTA CRYSTALLOGR F, V62, P627, DOI 10.1107/S1744309106021968; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; GARRED O, 1995, J BIOL CHEM, V270, P10817; Geelen JM, 2007, NEPHROL DIAL TRANSPL, V22, P749, DOI 10.1093/ndt/gfl688; Griener TP, 2007, J MED MICROBIOL, V56, P1423, DOI 10.1099/jmm.0.47282-0; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hoffmann P, 2010, RAPID COMMUN MASS SP, V24, P2295, DOI 10.1002/rcm.4636; JEMAL C, 1995, J BACTERIOL, V177, P3128, DOI 10.1128/jb.177.11.3128-3132.1995; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; Lakowicz, 2006, PRINCIPLES FLUORESCE; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PETRONINI PG, 1987, EXP CELL RES, V172, P450, DOI 10.1016/0014-4827(87)90403-4; RYD M, 1989, FEBS LETT, V258, P320, DOI 10.1016/0014-5793(89)81684-9; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STROCKBINE NA, 1988, J BACTERIOL, V170, P1116, DOI 10.1128/jb.170.3.1116-1122.1988; SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2; Tazzari PL, 2004, CYTOM PART B-CLIN CY, V61B, P40, DOI 10.1002/cyto.b.20022; te Loo DMWM, 2000, BLOOD, V95, P3396, DOI 10.1182/blood.V95.11.3396.011k19_3396_3402; TROMPETER RS, 1983, ARCH DIS CHILD, V58, P101, DOI 10.1136/adc.58.2.101; vanSetten PA, 1996, BLOOD, V88, P174, DOI 10.1182/blood.V88.1.174.bloodjournal881174; Yan XJ, 1998, PROTEINS, V31, P33, DOI 10.1002/(SICI)1097-0134(19980401)31:1<33::AID-PROT4>3.0.CO;2-I	44	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34514	34521		10.1074/jbc.M111.255414	http://dx.doi.org/10.1074/jbc.M111.255414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832076	Green Published, hybrid			2022-12-25	WOS:000295406300005
J	Chi, SS; Cao, H; Wang, Y; McNiven, MA				Chi, Susan; Cao, Hong; Wang, Yu; McNiven, Mark A.			Recycling of the Epidermal Growth Factor Receptor Is Mediated by a Novel Form of the Clathrin Adaptor Protein Eps15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; COATED PITS; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE; MYOSIN VB; EARLY ENDOSOMES; INTERNALIZATION; TRAFFICKING; TRANSPORT; TRANSFERRIN	Levels of the epidermal growth factor receptor (EGFR) at the cell surface are tightly regulated by a complex endocytic machinery. Following internalization, EGFR is either recycled back to the cell surface or transported to the late endosome/lysosome for degradation. Currently, the molecular machinery that regulates this sorting pathway is only partially defined. Eps15 (EGFR pathway substrate 15) is an endocytic adaptor protein that is well known to support clathrin-mediated internalization of EGFR at the plasma membrane. Using RT-PCR, we have identified a novel short form of Eps15 (Eps15S) from rat liver that lacks the 111 C-terminal amino acids present in the traditional Eps15 form. The goal of this study was to define the functional role of the novel Eps15S form in EGFR trafficking. Overexpression of a mutant form of Eps15S (Eps15S Delta EH2/EH3) did not block EGFR internalization but reduced its recycling to the cell surface. After knockdown of all Eps15 forms, re-expression of Eps15S significantly reduced EGFR degradation while promoting recycling back to the cell surface. In contrast, re-expression of Eps15 did not potentiate receptor recycling. Furthermore, overexpression of the mutant Eps15S substantially reduced cell proliferation, linking EGFR recycling to downstream mitogenic effects. Finally, we found that Eps15S is localized to the Rab11-positive recycling endosome that is disrupted in cells expressing the Eps15S mutant, leading to an accumulation of the EGFR in early endosomes. These findings suggest that distinct forms of Eps15 direct EGFR to either the late endosome/lysosome for degradation (Eps15) or to the recycling endosome for transit back to the cell surface (Eps15S).	[McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Guggenheim 1637,200 1st St SW, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu			Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [R01 DK44650, P30DK84567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044650, P30DK084567] Funding Source: NIH RePORTER	Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grants R01 DK44650 (to M. A. M.) and P30DK84567 from the Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Carbone R, 1997, CANCER RES, V57, P5498; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Iannolo G, 1997, CANCER RES, V57, P240; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001	51	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35196	35208		10.1074/jbc.M111.247577	http://dx.doi.org/10.1074/jbc.M111.247577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832070	Green Published, hybrid			2022-12-25	WOS:000295406300072
J	Fulkerson, Z; Wu, T; Sunkara, M; Vander Kooi, C; Morris, AJ; Smyth, SS				Fulkerson, Zachary; Wu, Tao; Sunkara, Manjula; Vander Kooi, Craig; Morris, Andrew J.; Smyth, Susan S.			Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHOLIPASE-D; ACTIVATION; RECEPTORS; LPA; LIPOPROTEIN; INHIBITOR; PROMOTES; PLASMA; ENZYME; ROLES	Autotaxin (ATX) is a secreted lysophospholipase D that generates the bioactive lipid mediator lysophosphatidic acid (LPA). We and others have reported that ATX binds to integrins, but the function of ATX-integrin interactions is unknown. The recently reported crystal structure of ATX suggests a role for the solvent-exposed surface of the N-terminal tandem somatomedin B-like domains in binding to platelet integrin alpha IIb beta(3). The opposite face of the somatomedin B-like domain interacts with the catalytic phosphodiesterase (PDE) domain to form a hydrophobic channel through which lysophospholipid substrates enter and leave the active site. Based on this structure, we hypothesize that integrin-bound ATX can access cell surface substrates and deliver LPA to cell surface receptors. To test this hypothesis, we investigated the integrin selectivity and signaling pathways that promote ATX binding to platelets. We report that both platelet beta 1 and beta 3 integrins interact in an activation-dependent manner with ATX via the SMB2 domain. ATX increases thrombin-stimulated LPA production by washed platelets similar to 10-fold. When incubated under conditions to promote integrin activation, ATX generates LPA from CHO cellsprimed with bee venom phospholipase A(2), and ATX-mediated LPA production is enhanced more than 2-fold by CHO cell overexpression of integrin beta(3). The effects of ATX on platelet and cell-associated LPA production, but not hydrolysis of small molecule or detergent-solubilized substrates, are attenuated by point mutations in the SMB2 that impair integrin binding. Integrin binding therefore localizes ATX activity to the cell surface, providing a mechanism to generate LPA in the vicinity of its receptors.	[Fulkerson, Zachary; Wu, Tao; Sunkara, Manjula; Morris, Andrew J.; Smyth, Susan S.] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA; [Vander Kooi, Craig] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, 900 S Limestone St,326 CTW Bldg, Lexington, KY 40536 USA.	SusanSmyth@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929	National Institutes of Health [GM050388, RR026884, HL078663, GM094155, P20RR021954, F30 HL099272]; Lexington Veterans Affairs Medical Center; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026884, P20RR021954, S10RR024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078663, F30HL099272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388, R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lexington Veterans Affairs Medical Center; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM050388 and RR026884 (to A. J. M.), HL078663 (to S. S. S.), GM094155 (to C. V. K.), and P20RR021954 and F30 HL099272 (to Z. F.). This work was also supported by the resources and use of the facilities at the Lexington Veterans Affairs Medical Center.; Supported by an American Heart Association postdoctoral fellowship.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bolen AL, 2011, J LIPID RES, V52, P958, DOI 10.1194/jlr.M013326; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COLLER BS, 1993, J CLIN INVEST, V92, P2796, DOI 10.1172/JCI116899; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Fox MA, 2003, MOL CELL NEUROSCI, V23, P507, DOI 10.1016/S1044-7431(03)00073-3; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Panetti TS, 2004, J THROMB HAEMOST, V2, P1645, DOI 10.1111/j.1538-7836.2004.00902.x; Perrin-Cocon L, 2004, EUR J IMMUNOL, V34, P2293, DOI 10.1002/eji.200324797; Rizza C, 1999, LAB INVEST, V79, P1227; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Tabchy A, 2011, NAT STRUCT MOL BIOL, V18, P117, DOI 10.1038/nsmb0211-117; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	35	103	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34654	34663		10.1074/jbc.M111.276725	http://dx.doi.org/10.1074/jbc.M111.276725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832043	Green Published, hybrid			2022-12-25	WOS:000295406300020
J	Redelinghuys, P; Antonopoulos, A; Liu, Y; Campanero-Rhodes, MA; McKenzie, E; Haslam, SM; Dell, A; Feizi, T; Crocker, PR				Redelinghuys, Pierre; Antonopoulos, Aristotelis; Liu, Yan; Campanero-Rhodes, Maria A.; McKenzie, Emma; Haslam, Stuart M.; Dell, Anne; Feizi, Ten; Crocker, Paul R.			Early Murine T-lymphocyte Activation Is Accompanied by a Switch from N-Glycolyl- to N-Acetyl-neuraminic Acid and Generation of Ligands for Siglec-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES SHP-1; O-GLYCAN BIOSYNTHESIS; SURFACE SIALIC ACIDS; IMMUNE-SYSTEM; DIFFERENTIAL GLYCOSYLATION; NEOGLYCOLIPID TECHNOLOGY; GLYCOLYLNEURAMINIC ACID; LINKED OLIGOSACCHARIDES; HUMAN-EVOLUTION; CELL-DEATH	It is well established that murine T-lymphocyte activation is accompanied by major changes in cell-surface sialylation, potentially influencing interactions with sialic acid-binding immunoglobulin-like lectins (siglecs). In the present study, we analyzed early activation of murine CD4+ and CD8+ T-lymphocytes at 24 h. We observed a striking and selective up-regulation in the binding of a recombinant soluble form of siglec-E, an inhibitory siglec, which is expressed on several myeloid cell types including antigen-presenting dendritic cells. In contrast, much lower levels of T cell binding were observed with other siglecs, including sialoadhesin, CD22, and siglec-F and the plant lectins Maackia amurensis leukoagglutinin and Sambucus nigra agglutinin. By mass spectrometry, the sialic acid content of 24-h-activated CD4+ and CD8+ T-lymphocytes exhibited an increased proportion of N-acetyl-neuraminic acid (NeuAc) to N-glycolyl-neuraminic acid (NeuGc) in N-glycans. Reduced levels of NeuGc on the surface of activated T cells were demonstrated using an antibody specific for NeuGc and the expression levels of the gene encoding NeuAc-to NeuGc-converting enzyme, CMP-NeuAc hydroxylase, were also reduced. Siglec-E bound a wide range of sialylated structures in glycan arrays, had a preference for NeuAc versus NeuGc-terminated sequences and could recognize a set of sialoglycoproteins that included CD45, in lysates from activated T-lymphocytes. Collectively, these results show that early in T cell activation, glycan remodelling involves a switch from NeuGc- to NeuAc-terminating oligosaccharides on cell surface glycoproteins. This is associated with a strong up-regulation of siglec-E ligands, which may be important in promoting cellular interactions between early activated T-lymphocytes and myeloid cells expressing this inhibitory receptor.	[Crocker, Paul R.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; [Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Liu, Yan; Campanero-Rhodes, Maria A.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, Harrow HA1 3UJ, Middx, England	University of Dundee; Imperial College London; Imperial College London	Crocker, PR (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bioctr, Wellcome Trust Bldg,Dow St, Dundee DD1 5EH, Scotland.	p.r.crocker@dundee.ac.uk	Liu, Yan/D-9117-2013; RASOR, Scotland/A-3274-2011; Campanero-Rhodes, María Asunción/M-3158-2014	Campanero-Rhodes, María Asunción/0000-0002-3373-0064; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Crocker, Paul/0000-0001-6230-0293; Dell, Anne/0000-0003-1380-2347; McKenzie, Emma/0000-0002-4355-317X	Biotechnology and Biological Sciences Research Council [BBF0083091]; Engineering and Physical Sciences Research Council [BB/C511572/1, EP/G037604/1]; Wellcome Trust [WT081882MA]; Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics [GM 62116]; MRC; RCUK Basic Technology Initiative Glycoarrays [GRS/79268]; Biotechnology and Biological Sciences Research Council [BB/C511572/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK Basic Technology Initiative Glycoarrays; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council through the Radical Solutions for Researching the Proteome (RASOR) Project BB/C511572/1, and the Wellcome Trust (WT081882MA). This work was also supported in part by funding from the Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics (GM 62116) and the Biotechnology and Biological Sciences Research Council (BBSRC) Grant number BBF0083091 (to A. D. and S. M. H.), the MRC and the RCUK Basic Technology Initiative Glycoarrays (GRS/79268) and EPSRC Translational Grant (EP/G037604/1) (EP/G037604/1) (to T. F.).	Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bi SG, 2009, BBA-GEN SUBJECTS, V1790, P1599, DOI 10.1016/j.bbagen.2009.07.027; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Galustian C, 1997, BIOCHEM BIOPH RES CO, V240, P748, DOI 10.1006/bbrc.1997.7737; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Haslam SM, 2008, IMMUNOL CELL BIOL, V86, P564, DOI 10.1038/icb.2008.54; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PILLER F, 1988, J BIOL CHEM, V263, P15146; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ramya TNC, 2010, MOL CELL PROTEOMICS, V9, P1339, DOI 10.1074/mcp.M900461-MCP200; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; Stoll MS, 2009, P BEILST S GLYC BIOI, P123; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	57	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34522	34532		10.1074/jbc.M111.243410	http://dx.doi.org/10.1074/jbc.M111.243410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835922	Green Published, hybrid			2022-12-25	WOS:000295406300006
J	Chai, XY; Wu, S; Murray, TK; Kinley, R; Cella, CV; Sims, H; Buckner, N; Hanmer, J; Davies, P; O'Neill, MJ; Hutton, ML; Citron, M				Chai, Xiyun; Wu, Su; Murray, Tracey K.; Kinley, Robert; Cella, Claire V.; Sims, Helen; Buckner, Nicola; Hanmer, Jenna; Davies, Peter; O'Neill, Michael J.; Hutton, Michael L.; Citron, Martin			Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGLE MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CEREBROSPINAL-FLUID; P301L TAU; PROTEIN; MICE; IMMUNOTHERAPY; TAUOPATHY; FILAMENTS	The microtubule-associated protein Tau plays a critical role in the pathogenesis of Alzheimer disease and several related disorders (tauopathies). In the disease Tau aggregates and becomes hyperphosphorylated forming paired helical and straight filaments, which can further condense into higher order neurofibrillary tangles in neurons. The development of this pathology is consistently associated with progressive neuronal loss and cognitive decline. The identification of tractable therapeutic targets in this pathway has been challenging, and consequently very few clinical studies addressing Tau pathology are underway. Recent active immunization studies have raised the possibility of modulating Tau pathology by activating the immune system. Here we report for the first time on passive immunotherapy for Tau in two well established transgenic models of Tau pathogenesis. We show that peripheral administration of two antibodies against pathological Tau forms significantly reduces biochemical Tau pathology in the JNPL3 mouse model. We further demonstrate that peripheral administration of the same antibodies in the more rapidly progressive P301S tauopathy model not only reduces Tau pathology quantitated by biochemical assays and immunohistochemistry, but also significantly delays the onset of motor function decline and weight loss. This is accompanied by a reduction in neurospheroids, providing direct evidence of reduced neurodegeneration. Thus, passive immunotherapy is effective at preventing the buildup of intracellular Tau pathology, neurospheroids, and associated symptoms, although the exact mechanism remains uncertain. Tau immunotherapy should therefore be considered as a therapeutic approach for the treatment of Alzheimer disease and other tauopathies.	[Citron, Martin] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Murray, Tracey K.; Kinley, Robert; Cella, Claire V.; Sims, Helen; Buckner, Nicola; Hanmer, Jenna; O'Neill, Michael J.; Hutton, Michael L.] Eli Lilly & Co, Lilly Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Davies, Peter] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Davies, Peter] Feinstein Inst, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA	Eli Lilly; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine; Northwell Health	Citron, M (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.	citronma@lilly.com	Hanmer, Jenna Mary/ABB-4884-2021	Hanmer, Jenna Mary/0000-0002-7652-6098; Buckner, Nikki/0000-0003-2842-9928; Davies, Peter/0000-0002-8015-1997	NATIONAL INSTITUTE ON AGING [R37AG022102] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG022102, R37 AG022102] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2006, J ALZHEIMERS DIS, V9, P195; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; THOMPSON EJ, 1990, ANN CLIN BIOCHEM, V27, P425, DOI 10.1177/000456329002700503; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Yamamori H, 2007, NEUROSCI LETT, V418, P186, DOI 10.1016/j.neulet.2007.03.022	26	261	285	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34457	34467		10.1074/jbc.M111.229633	http://dx.doi.org/10.1074/jbc.M111.229633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841002	Green Published, hybrid			2022-12-25	WOS:000295159200073
J	Choi, YH; Lee, SN; Aoyagi, H; Yamasaki, Y; Yoo, JY; Park, B; Shin, DM; Yoon, HG; Yoon, JH				Choi, Yeon Ho; Lee, Sang-Nam; Aoyagi, Hiroki; Yamasaki, Yasundo; Yoo, Jung-Yoon; Park, Boryung; Shin, Dong Min; Yoon, Ho-Geun; Yoon, Joo-Heon			The Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase/Ribosomal S6 Protein Kinase 1 Cascade Phosphorylates cAMP Response Element-binding Protein to Induce MUC5B Gene Expression via D-Prostanoid Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN D-2 RECEPTOR; 11P15 MUCIN GENES; MOLECULAR-CLONING; ALLERGIC INFLAMMATION; RETINOIC-ACID; MAST-CELLS; D SYNTHASE; CREB; TRANSCRIPTION; MECHANISM	Mucus hypersecretion is a prominent feature of respiratory diseases, and MUC5B is a major airway mucin. Mucin gene expression can be affected by inflammatory mediators, including prostaglandin (PG) D-2, an inflammatory mediator synthesized by hematopoietic PGD synthase (H-PGDS). PGD(2) binds to either D-prostanoid receptor (DP1) or chemoattractant receptor homologous molecule expressed on T-helper type 2 cells (CRTH2). We investigated the mechanisms by which PGD(2) induces MUC5B gene expression in airway epithelial cells. Western blot analysis showed that H-PGDS was highly expressed in nasal polyps. Similar results were obtained for PGD2 expression. In addition, we could clearly detect the expressions of both H-PGDS and DP1 in nasal epithelial cells but not CRTH2. We demonstrated that PGD(2) increased MUC5B gene expression in normal human nasal epithelial cells as well as in NCI-H292 cells in vitro. S5751, a DP1 antagonist, inhibited PGD(2)-induced MUC5B expression, whereas a CRTH2 antagonist (OC0459) did not. These data suggest that PGD(2) induced MUC5B expression via DP1. Pretreatment with extracellular signal-regulated kinase (ERK) inhibitor (PD98059) blocked both PGD(2)-induced ERK mitogen-activated protein kinase (MAPK) activation and MUC5B expression. Proximity ligation assays showed direct interaction between RSK1 and cAMP response element-binding protein (CREB). Stimulation with PGD2 caused an increase in intracellular cAMP levels, whereas intracellular Ca2+ did not have such an effect. PGD2-induced MUC5B mRNA levels were regulated by CREB via direct interaction with two cAMP-response element sites (-921/-914 and -900/-893). Finally, we demonstrated that PGD(2) can induce MUC5B overproduction via ERK MAPK/RSK1/CREB signaling and that DP1 receptor may have suppressive effects in controlling MUC5B overproduction in the airway.	[Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Choi, Yeon Ho; Lee, Sang-Nam; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul 120752, South Korea; [Choi, Yeon Ho; Yoo, Jung-Yoon; Yoon, Ho-Geun; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul 120752, South Korea; [Choi, Yeon Ho; Lee, Sang-Nam; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea; [Park, Boryung; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul 120752, South Korea; [Yoo, Jung-Yoon; Yoon, Ho-Geun] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Aoyagi, Hiroki; Yamasaki, Yasundo] TAIHO Pharmaceut Co Ltd, Drug Discovery & Dev, Saitama 3578527, Japan	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Taiho Pharmaceutical	Yoon, JH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, 134 Shinchon Dong, Seoul 120752, South Korea.	jhyoon@yuhs.ac	rchnds, rchnds/D-7595-2016; Yoon, Joo-Heon/E-5781-2016	Shin, Dong Min/0000-0001-6042-0435; Yoon, Joo-Heon/0000-0003-2404-7156; Yoo, Jung-Yoon/0000-0001-9366-3863; Yoon, Ho-Geun Yoon/0000-0003-2718-3372	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2011-0001168]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2011-0001168).	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arimura A, 2001, J PHARMACOL EXP THER, V298, P411; Armer RE, 2005, J MED CHEM, V48, P6174, DOI 10.1021/jm050519b; Binker MG, 2009, BIOCHEM BIOPH RES CO, V386, P124, DOI 10.1016/j.bbrc.2009.05.136; Blodorn B, 1996, NEUROSCI LETT, V209, P117, DOI 10.1016/0304-3940(96)12614-8; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Borchers MT, 1999, AM J PHYSIOL-LUNG C, V276, pL549, DOI 10.1152/ajplung.1999.276.4.L549; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Chen YY, 2007, J IMMUNOL, V179, P2766, DOI 10.4049/jimmunol.179.5.2766; Choi HJ, 2009, AM J RESP CELL MOL, V40, P168, DOI 10.1165/rcmb.2007-0377OC; Choi KC, 2008, BIOCHEM J, V411, P19, DOI 10.1042/BJ20071393; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chung WC, 2009, J IMMUNOL, V182, P2349, DOI 10.4049/jimmunol.0713637; Enss ML, 1997, PROSTAG LEUKOTR ESS, V56, P93, DOI 10.1016/S0952-3278(97)90503-2; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hatoum OA, 2005, ARTERIOSCL THROM VAS, V25, P2355, DOI 10.1161/01.ATV.0000184757.50141.8d; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; Isakson BE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-105; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Keates AC, 1997, BIOCHEM J, V324, P295, DOI 10.1042/bj3240295; Kim HJ, 2010, AM J RESP CELL MOL, V43, P349, DOI 10.1165/rcmb.2009-0205OC; Kim JH, 2010, AM J OPHTHALMOL, V149, P45, DOI 10.1016/j.ajo.2009.07.030; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; LEWIS RA, 1982, J IMMUNOL, V129, P1627; MAROM Z, 1984, PROSTAGLANDINS, V28, P79, DOI 10.1016/0090-6980(84)90115-1; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McNamara N, 2004, FASEB J, V18, P1770, DOI 10.1096/fj.04-1964fje; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Murray PD, 2009, GLIA, V57, P828, DOI 10.1002/glia.20809; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; Nantel F, 2004, PROSTAG OTH LIPID M, V73, P87, DOI 10.1016/j.prostaglandins.2003.12.002; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; URADE Y, 1989, J IMMUNOL, V143, P2982; URADE Y, 1990, J BIOL CHEM, V265, P371; van de Bovenkamp JHB, 1998, BIOCHEM BIOPH RES CO, V245, P853, DOI 10.1006/bbrc.1998.8535; Van Hecken A, 2007, EUR J CLIN PHARMACOL, V63, P135, DOI 10.1007/s00228-006-0211-2; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Voynow Judith A, 2002, Paediatr Respir Rev, V3, P98, DOI 10.1016/S1526-0550(02)00007-0; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu DYC, 2007, AM J PATHOL, V170, P20, DOI 10.2353/ajpath.2007.060452; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasui K, 2008, EUR J PHARMACOL, V578, P286, DOI 10.1016/j.ejphar.2007.09.014; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2002, DIFFERENTIATION, V70, P77, DOI 10.1046/j.1432-0436.2002.700202.x; Yuta A, 1997, AM J PHYSIOL-LUNG C, V273, pL1203, DOI 10.1152/ajplung.1997.273.6.L1203	62	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34199	34214		10.1074/jbc.M111.247684	http://dx.doi.org/10.1074/jbc.M111.247684			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832046	Green Published, hybrid			2022-12-25	WOS:000295159200050
J	Ma, BY; Nussinov, R				Ma, Buyong; Nussinov, Ruth			Polymorphic Triple beta-Sheet Structures Contribute to Amide Hydrogen/Deuterium (H/D) Exchange Protection in the Alzheimer Amyloid beta 42 Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; A-BETA; MOLECULAR-DYNAMICS; FIBRIL FORMATION; EXPERIMENTAL CONSTRAINTS; SECONDARY STRUCTURE; SOLVENT PROTECTION; PRION PROTEIN; WILD-TYPE; OLIGOMERS	Characterization of the polymorphic structural range of A beta oligomers is important to the understanding of the mechanisms of toxicity. Yet for highly polymorphic ensembles, experimental structural elucidation is difficult. Here, we use a combination of NMR solvent protection experiments and computational structural screening to identify major species in the amyloid conformational ensemble. We examined the polymorphic pentamer and fibril seeds of A beta 42 and its mutants and compared the theoretical backbone amide protection obtained from simulations with experimental hydrogen/deuterium (H/D) exchange protection ratio. Weobserved that highly flexible pentamers do not share structural similarities with fibril seed oligomers, except the turn regions. We found that a novel amyloid structural motif of a triple beta-sheet, with the N-terminal residues interacting with the core (Lys(17)-Glu(22)) beta-sheet region, correlates with H/D exchange protection. The triple beta-sheet A beta 42 oligomer has a minimal exposure of hydrophobic residues and is further stabilized by the E22Q (Dutch) mutation in Alzheimer disease. The experimental H/D exchange solvent protection ratio implies that triple beta-sheet fibrils and globulomers could coexist in the A beta 42 ensemble, pointing to a broad heterogeneous aggregate population. Our results suggest that an approach that combines computational modeling with NMR protection data can be a useful strategy for obtaining clues to the preferred conformational species of the assemblies in solution and help in alleviating experimental difficulties and consequently possible errors in the exchange data for A beta 42 fibrils.	[Ma, Buyong; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Bldg 469,Rm 151, Frederick, MD 21702 USA.	mabuyong@mail.nih.gov	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	National Institutes of Health, NCI [HHSN261200800001E]; NCI, CCR; NATIONAL CANCER INSTITUTE [ZIABC010440, ZIABC010441] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, CCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from the NCI and by the Intramural Research Program NCI, CCR.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Blinov N, 2010, BIOPHYS J, V98, P282, DOI 10.1016/j.bpj.2009.09.062; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demeester N, 2001, EUR J NEUROSCI, V13, P2015, DOI 10.1046/j.0953-816x.2001.01579.x; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Paparcone R, 2010, BIOCHEMISTRY-US, V49, P8967, DOI 10.1021/bi100953t; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sabate R, 2010, J MOL BIOL, V404, P337, DOI 10.1016/j.jmb.2010.09.052; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shen Y, 2010, PROTEIN SCI, V19, P349, DOI 10.1002/pro.303; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yun SJ, 2007, BIOPHYS J, V92, P4064, DOI 10.1529/biophysj.106.097766; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	45	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34244	34253		10.1074/jbc.M111.241141	http://dx.doi.org/10.1074/jbc.M111.241141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832091	hybrid, Green Published			2022-12-25	WOS:000295159200054
J	Ahmed, AA; Mooar, PA; Kleiner, M; Torg, JS; Miyamoto, CT				Ahmed, Awad A.; Mooar, Pekka A.; Kleiner, Matthew; Torg, Joseph S.; Miyamoto, Curtis T.			Hypertensive Patients Show Delayed Wound Healing following Total Hip Arthroplasty	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; BLOOD-PRESSURE; PREVENTION; INFECTION; REPLACEMENT; ENOXAPARIN; THROMBOSIS; EFFICACY; DRAINAGE	Background: Prolonged wound-discharge following total hip arthroplasty (THA) is associated with an increased risk of infection. However, the potential role of hypertension in prolonging the duration of wound healing in this population has not yet been investigated. The aim of the present study was to compare healing in this population that has not yet been investigated. The aim of the present study was to compare hypertensive and normotensive THA patients in terms of the length of time required to achieve a dry wound and the length of stay in the hospital. Methods: One hundred and twenty primary THA patients were evaluated. Pre-operative clinical history and physical examination revealed that 29 were hypertensive and 91 were normotensive. The two groups were statistically matched using optimal propensity score matching. The outcomes of interest were the number of days until a dry wound was observed and the duration of hospital stay. Results: The average systolic blood pressures were 150.1 mmHg and 120.3 mmHg for the hypertensive and normotensive groups, respectively. The mean number of days until the wound was dry was 3.79 for the hypertensive group and 2.03 for the normotensive group. Hypertensive patients required more days for their wounds to dry than normotensive patients (odds ratio = 1.65, p<0.05). No significant difference in the duration of hospital stay was found between the two groups. Conclusions: Hypertensive patients had a higher risk of prolonged wound discharge after THA than their normotensive counterparts. Patients with prolonged wound drainage are at greater risk for infection. Clinicians should pay particular attention to infection-prevention strategies in hypertensive THA patients.	[Ahmed, Awad A.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Mooar, Pekka A.; Kleiner, Matthew; Torg, Joseph S.] Temple Univ Hosp & Med Sch, Dept Orthopaed & Sports Med, Philadelphia, PA 19140 USA; [Miyamoto, Curtis T.] Temple Univ Hosp & Med Sch, Dept Radiat Oncol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ahmed, AA (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.	awad.ahmed@temple.edu	ahmed, awad/K-4914-2019	ahmed, awad/0000-0002-9710-779X	John Lachman Research Fund	John Lachman Research Fund	Funding for this study was provided by the John Lachman Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HLTH US 2009 SPECIAL; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Chen J, 2002, HYPERTENSION, V40, P810, DOI 10.1161/01.HYP.0000039962.68332.59; CHOONARA IA, 1988, BRIT J CLIN PHARMACO, V25, P1; CLAGETT GP, 1992, CHEST, V102, pS391, DOI 10.1378/chest.102.4_Supplement.391S; Colwell CW, 2010, J BONE JOINT SURG AM, V92A, P527, DOI 10.2106/JBJS.I.00047; Colwell CW, 1999, J BONE JOINT SURG AM, V81A, P932, DOI 10.2106/00004623-199907000-00005; COLWELL CW, 1994, J BONE JOINT SURG AM, V76A, P3, DOI 10.2106/00004623-199401000-00002; Cordero-Ampuero J, 2010, CLIN ORTHOP RELAT R, V468, P3268, DOI 10.1007/s11999-010-1411-8; ERIKSSON BI, 1991, THROMB RES, V62, P55, DOI 10.1016/0049-3848(91)90668-M; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; HALL MJ, 2010, 29 NAT HLTH STAT; Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016; Hirsh J, 1998, CHEST, V114, p489S, DOI 10.1378/chest.114.5_Supplement.489S; Imai K, 2008, LOGIT LOGISTIC REGRE; Jain NB, 2005, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000156479.97488.a2; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Lai K, 2007, J ARTHROPLASTY, V22, P651, DOI 10.1016/j.arth.2006.09.002; LAVIE CJ, 1988, AM HEART J, V116, P1146, DOI 10.1016/0002-8703(88)90179-2; Lubbeke A, 2007, ARTHRIT RHEUM-ARTHR, V57, P327, DOI 10.1002/art.22542; Murray DW, 1996, J BONE JOINT SURG BR, V78B, P863, DOI 10.1302/0301-620X78B6.6714; Patel VP, 2007, J BONE JOINT SURG AM, V89A, P33, DOI 10.2106/JBJS.F.00163; Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Spencer A P, 2000, Curr Treat Options Cardiovasc Med, V2, P1, DOI 10.1007/s11936-000-0001-6; Steiner M, 1999, NUTR REV, V57, P306, DOI 10.1111/j.1753-4887.1999.tb06903.x; Stuart EA, 2008, DEV PSYCHOL, V44, P395, DOI 10.1037/0012-1649.44.2.395; SURIN VV, 1983, J BONE JOINT SURG BR, V65, P412, DOI 10.1302/0301-620X.65B4.6874711; Weiss A P, 1993, J Arthroplasty, V8, P285, DOI 10.1016/S0883-5403(06)80091-4	34	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23224	10.1371/journal.pone.0023224	http://dx.doi.org/10.1371/journal.pone.0023224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853091	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953400033
J	Erlandsson, L; Rosenstierne, MW; McLoughlin, K; Jaing, C; Fomsgaard, A				Erlandsson, Lena; Rosenstierne, Maiken W.; McLoughlin, Kevin; Jaing, Crystal; Fomsgaard, Anders			The Microbial Detection Array Combined with Random Phi29-Amplification Used as a Diagnostic Tool for Virus Detection in Clinical Samples	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; MULTIPLE DISPLACEMENT AMPLIFICATION; ROLLING-CIRCLE AMPLIFICATION; POLYMERASE CHAIN-REACTION; PHI-29 DNA-POLYMERASE; REAL-TIME PCR; HUMAN CORONAVIRUS; MICROARRAY; IDENTIFICATION; HYBRIDIZATION	A common technique used for sensitive and specific diagnostic virus detection in clinical samples is PCR that can identify one or several viruses in one assay. However, a diagnostic microarray containing probes for all human pathogens could replace hundreds of individual PCR-reactions and remove the need for a clear clinical hypothesis regarding a suspected pathogen. We have established such a diagnostic platform for random amplification and subsequent microarray identification of viral pathogens in clinical samples. We show that Phi29 polymerase-amplification of a diverse set of clinical samples generates enough viral material for successful identification by the Microbial Detection Array, demonstrating the potential of the microarray technique for broad-spectrum pathogen detection. We conclude that this method detects both DNA and RNA virus, present in the same sample, as well as differentiates between different virus subtypes. We propose this assay for diagnostic analysis of viruses in clinical samples.	[Erlandsson, Lena; Rosenstierne, Maiken W.; Fomsgaard, Anders] Statens Serum Inst, Dept Virol, Virus Res & Dev, DK-2300 Copenhagen, Denmark; [McLoughlin, Kevin; Jaing, Crystal] Lawrence Livermore Natl Lab, Livermore, CA USA	Statens Serum Institut; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Erlandsson, L (corresponding author), Statens Serum Inst, Dept Virol, Virus Res & Dev, DK-2300 Copenhagen, Denmark.	lao@ssi.dk		Fomsgaard, Anders/0000-0003-4304-0603; Erlandsson, Lena/0000-0003-4350-5909; McLoughlin, Kevin/0000-0001-9651-4951; Jaing, Crystal/0000-0001-9933-3005; Tripp, Ralph/0000-0002-2924-9956	Lawrence Livermore National Laboratory under the U.S. Department of Energy [LLNL02-SI-008, DE-AC52-07NA27344]	Lawrence Livermore National Laboratory under the U.S. Department of Energy	The project was supported by the Laboratory Directed Research and Development Program at the Lawrence Livermore National Laboratory [Project LLNL02-SI-008 under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 to CJ, KM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Clem AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-65; Compston LI, 2008, J VIROL METHODS, V151, P47, DOI 10.1016/j.jviromet.2008.03.023; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163; Jasmine F, 2008, CANCER EPIDEM BIOMAR, V17, P3499, DOI 10.1158/1055-9965.EPI-08-0482; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Oh T, 2004, J CLIN MICROBIOL, V42, P3272, DOI 10.1128/JCM.42.7.3272-3280.2004; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schollkopf C, 2008, INT J CANCER, V122, P1885, DOI 10.1002/ijc.23416; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; VOSBERG HP, 1989, HUM GENET, V83, P1, DOI 10.1007/BF00274139; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wolf S, 2010, APPL ENVIRON MICROB, V76, P1388, DOI 10.1128/AEM.02249-09; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007	33	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22631	10.1371/journal.pone.0022631	http://dx.doi.org/10.1371/journal.pone.0022631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853040	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200016
J	Lirman, D; Schopmeyer, S; Manzello, D; Gramer, LJ; Precht, WF; Muller-Karger, F; Banks, K; Barnes, B; Bartels, E; Bourque, A; Byrne, J; Donahue, S; Duquesnel, J; Fisher, L; Gilliam, D; Hendee, J; Johnson, M; Maxwell, K; McDevitt, E; Monty, J; Rueda, D; Ruzicka, R; Thanner, S				Lirman, Diego; Schopmeyer, Stephanie; Manzello, Derek; Gramer, Lewis J.; Precht, William F.; Muller-Karger, Frank; Banks, Kenneth; Barnes, Brian; Bartels, Erich; Bourque, Amanda; Byrne, James; Donahue, Scott; Duquesnel, Janice; Fisher, Louis; Gilliam, David; Hendee, James; Johnson, Meaghan; Maxwell, Kerry; McDevitt, Erin; Monty, Jamie; Rueda, Digna; Ruzicka, Rob; Thanner, Sara			Severe 2010 Cold-Water Event Caused Unprecedented Mortality to Corals of the Florida Reef Tract and Reversed Previous Survivorship Patterns	PLOS ONE			English	Article							CALCIFICATION RATE; LOW-TEMPERATURES; STRESSORS; COMMUNITIES; TOLERANCE; SURVIVAL; IMPACTS; DISEASE; BAHAMAS; QUALITY	Background: Coral reefs are facing increasing pressure from natural and anthropogenic stressors that have already caused significant worldwide declines. In January 2010, coral reefs of Florida, United States, were impacted by an extreme cold-water anomaly that exposed corals to temperatures well below their reported thresholds (16 degrees C), causing rapid coral mortality unprecedented in spatial extent and severity. Methodology/Principal Findings: Reef surveys were conducted from Martin County to the Lower Florida Keys within weeks of the anomaly. The impacts recorded were catastrophic and exceeded those of any previous disturbances in the region. Coral mortality patterns were directly correlated to in-situ and satellite-derived cold-temperature metrics. These impacts rival, in spatial extent and intensity, the impacts of the well-publicized warm-water bleaching events around the globe. The mean percent coral mortality recorded for all species and subregions was 11.5% in the 2010 winter, compared to 0.5% recorded in the previous five summers, including years like 2005 where warm-water bleaching was prevalent. Highest mean mortality (15%-39%) was documented for inshore habitats where temperatures were < 11 degrees C for prolonged periods. Increases in mortality from previous years were significant for 21 of 25 coral species, and were 1-2 orders of magnitude higher for most species. Conclusions/Significance: The cold-water anomaly of January 2010 caused the worst coral mortality on record for the Florida Reef Tract, highlighting the potential catastrophic impacts that unusual but extreme climatic events can have on the persistence of coral reefs. Moreover, habitats and species most severely affected were those found in high-coral cover, inshore, shallow reef habitats previously considered the "oases" of the region, having escaped declining patterns observed for more offshore habitats. Thus, the 2010 cold-water anomaly not only caused widespread coral mortality but also reversed prior resistance and resilience patterns that will take decades to recover.	[Lirman, Diego; Schopmeyer, Stephanie] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Manzello, Derek; Gramer, Lewis J.; Hendee, James] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Precht, William F.] NOAA, Key Largo, FL USA; [Muller-Karger, Frank; Barnes, Brian; Rueda, Digna] Univ S Florida, Coll Marine Sci, Inst Marine Remote Sensing IMaRS, St Petersburg, FL 33701 USA; [Banks, Kenneth] Broward Cty Nat Resources Planning & Management D, Plantation, FL USA; [Bartels, Erich] Ctr Coral Reef Res, Mote Marine Lab, Summerland Key, FL USA; [Bourque, Amanda] Biscayne Natl Pk, Homestead, FL USA; [Byrne, James; Johnson, Meaghan] Nature Conservancy, Summerland Key, FL USA; [Donahue, Scott] NOAA, Key West, FL USA; [Duquesnel, Janice] Florida Pk Serv, Islamorada, FL USA; [Fisher, Louis] Broward Cty Environm Protect & Growth Management, Plantation, FL USA; [Gilliam, David] Nova SE Univ, Oceanog Ctr, Natl Coral Reef Inst, Dania, FL USA; [Maxwell, Kerry] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL USA; [McDevitt, Erin] Florida Fish & Wildlife Conservat Commiss, W Palm Beach, FL USA; [Monty, Jamie] Florida Gulf Coast Univ, Florida Dept Environm Protect, Coral Reef Conservat Program, Miami, FL USA; [Ruzicka, Rob] Fish & Wildlife Res Inst, St Petersburg, FL USA; [Thanner, Sara] Dept Environm Resources Management, Miami, FL USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA; Nova Southeastern University; Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; State University System of Florida; Florida Gulf Coast University; Florida Fish & Wildlife Conservation Commission	Lirman, D (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dlirman@rsmas.miami.edu	Rueda-Roa, Digna/AHD-3202-2022; Rueda, Digna/J-8045-2019; Manzello, Derek P/A-8661-2014; Hendee, James C/E-6358-2010; Gramer, Lewis James/A-5620-2010	Rueda-Roa, Digna/0000-0003-4621-009X; Manzello, Derek P/0000-0002-0720-3041; Hendee, James C/0000-0002-4799-5354; Gramer, Lewis James/0000-0003-4772-1991; Schopmeyer, Stephanie/0000-0003-4717-465X	NOAA; Nature Conservancy; ARRA program	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Nature Conservancy; ARRA program	This publication was made possible with support from NOAA's Coral Reef Conservation Program, The Nature Conservancy, and the ARRA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault JS, 2006, B MAR SCI, V78, P633; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barnes BB, 2011, IEEE GEOSCI REMOTE S, V8, P769, DOI 10.1109/LGRS.2011.2111353; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Dana F. D., 1843, AM J SCI, V45, P130; DAVIS GE, 1982, B MAR SCI, V32, P608; Dustan P., 1999, NAT RESOUR FORUM, V23, P147; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Ginsburg RN, 2001, B MAR SCI, V69, P1149; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; HENDEE JC, 2009, P 11 INT COR REEF S, P534; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hu CM, 2009, IEEE T GEOSCI REMOTE, V47, P2071, DOI 10.1109/TGRS.2009.2024992; HUDSON JH, 1976, GEOLOGY, V4, P361, DOI 10.1130/0091-7613(1976)4<361:SATFIP>2.0.CO;2; HUDSON JH, 1981, P 4 INT COR REEF S M, P444; IPCC, 2007, CLIM CHANG 2007; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 1999, AM ZOOL, V39, P146; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Kramer P.R., 2003, ATOLL RES B, V496, P611, DOI DOI 10.5479/SI.00775630.496-34.611; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MACINTYRE IG, 1969, SCIENCE, V166, P374, DOI 10.1126/science.166.3903.374; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Mayer A.G., 1915, YB CARNEGIE I WASH, V14, P212; MAYOR AG, 1914, CARNEGIE I PUB 183, V6, P1; Miller MW, 2000, CORAL REEFS, V19, P115, DOI 10.1007/s003380000079; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; OGDEN JC, 1994, B MAR SCI, V54, P1059; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Palandro D, 2003, CAN J REMOTE SENS, V29, P201, DOI 10.5589/m02-095; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Porter James W., 2002, P749; PORTER JW, 1992, AM ZOOL, V32, P625; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; PORTER JW, 1982, P NATL ACAD SCI-BIOL, V79, P1678, DOI 10.1073/pnas.79.5.1678; Precht William F., 2007, V192, P237, DOI 10.1007/978-0-387-33537-7_9; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; ROBERTS HH, 1982, J SEDIMENT PETROL, V52, P145; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; SHINN E. A., 1966, J PALEONTOL, V40, P233; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Hooidonk R, 2009, CORAL REEFS, V28, P579, DOI 10.1007/s00338-009-0502-z; Van Oppen MJH, 2009, CORAL BLEACHING PATT; VAUGHAN TW, 1918, CARNEGIE I WASHINGTO, V213, P321; VAUGHAN TW, 1919, ANN REP SMITHSON I, V17, P189; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Walker N.D., 1982, Coral Reefs, V1, P83, DOI 10.1007/BF00301689; WANG C, 2010, ATMOSPHERIC SCI LETT; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W	72	145	145	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23047	10.1371/journal.pone.0023047	http://dx.doi.org/10.1371/journal.pone.0023047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853066	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200037
J	Rochlin, I; Turbow, D; Gomez, F; Ninivaggi, DV; Campbell, SR				Rochlin, Ilia; Turbow, David; Gomez, Frank; Ninivaggi, Dominick V.; Campbell, Scott R.			Predictive Mapping of Human Risk for West Nile Virus (WNV) Based on Environmental and Socioeconomic Factors	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; ST-LOUIS ENCEPHALITIS; LAND-USE; SPATIAL AUTOCORRELATION; NEW-YORK; INFECTION; EPIDEMIOLOGY; SURVEILLANCE; DIPTERA; VECTOR	A West Nile virus (WNV) human risk map was developed for Suffolk County, New York utilizing a case-control approach to explore the association between the risk of vector-borne WNV and habitat, landscape, virus activity, and socioeconomic variables derived from publically available datasets. Results of logistic regression modeling for the time period between 2000 and 2004 revealed that higher proportion of population with college education, increased habitat fragmentation, and proximity to WNV positive mosquito pools were strongly associated with WNV human risk. Similar to previous investigations from north-central US, this study identified middle class suburban neighborhoods as the areas with the highest WNV human risk. These results contrast with similar studies from the southern and western US, where the highest WNV risk was associated with low income areas. This discrepancy may be due to regional differences in vector ecology, urban environment, or human behavior. Geographic Information Systems (GIS) analytical tools were used to integrate the risk factors in the 2000-2004 logistic regression model generating WNV human risk map. In 2005-2010, 41 out of 46 (89%) of WNV human cases occurred either inside of (30 cases) or in close proximity (11 cases) to the WNV high risk areas predicted by the 2000-2004 model. The novel approach employed by this study may be implemented by other municipal, local, or state public health agencies to improve geographic risk estimates for vector-borne diseases based on a small number of acute human cases.	[Rochlin, Ilia; Ninivaggi, Dominick V.] Suffolk Cty Vector Control, Yaphank, NY 11980 USA; [Turbow, David; Gomez, Frank] TUI Univ, Coll Hlth Sci, Cypress, CA USA; [Campbell, Scott R.] Suffolk Cty Arthropod Borne Dis Lab, Yaphank, NY USA		Rochlin, I (corresponding author), Suffolk Cty Vector Control, Yaphank, NY 11980 USA.	ilia.rochlin@suffolkcountyny.gov						Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Cooke William H 3rd, 2006, Int J Health Geogr, V5, P36, DOI 10.1186/1476-072X-5-36; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; ELDRIDGE BF, 1987, AM J TROP MED HYG, V37, pS77, DOI 10.4269/ajtmh.1987.37.77S; Grillet ME, 2010, AM J TROP MED HYG, V82, P194, DOI 10.4269/ajtmh.2010.09-0040; Gu WD, 2006, VECTOR-BORNE ZOONOT, V6, P91, DOI 10.1089/vbz.2006.6.91; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Haneuse S, 2008, STAT MED, V27, P864, DOI 10.1002/sim.2979; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; HAY SI, 2000, REMOTE SENSING GEOGR; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Johnson GD, 2006, AM J EPIDEMIOL, V163, P171, DOI 10.1093/aje/kwj023; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Konrad SK, 2009, VECTOR-BORNE ZOONOT, V9, P267, DOI 10.1089/vbz.2008.0084; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Liu A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-67; Liu H, 2009, ENVIRON MONIT ASSESS, V159, P143, DOI 10.1007/s10661-008-0618-6; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Meehan PJ, 2000, EPIDEMIOL INFECT, V125, P181, DOI 10.1017/S0950268899004227; Meyer TE, 2007, EMERG INFECT DIS, V13, P1500, DOI 10.3201/eid1310.070442; Moncayo AC, 2000, J MED ENTOMOL, V37, P701, DOI 10.1603/0022-2585-37.5.701; Patnaik JL, 2007, EMERG INFECT DIS, V13, P1788, DOI 10.3201/eid1311.070506; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Pradier S, 2008, VECTOR-BORNE ZOONOT, V8, P253, DOI 10.1089/vbz.2007.0178; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Rochlin I, 2010, THESIS; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Ward MR, 2006, J WILDLIFE DIS, V42, P92, DOI 10.7589/0090-3558-42.1.92	58	49	49	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23280	10.1371/journal.pone.0023280	http://dx.doi.org/10.1371/journal.pone.0023280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853103	Green Submitted, gold, Green Published			2022-12-25	WOS:000295454200063
J	Brisson, D; Baxamusa, N; Schwartz, I; Wormser, GP				Brisson, Dustin; Baxamusa, Nilofer; Schwartz, Ira; Wormser, Gary P.			Biodiversity of Borrelia burgdorferi Strains in Tissues of Lyme Disease Patients	PLOS ONE			English	Article							SENSU-STRICTO; GENETIC DIVERSITY; TICK VECTOR; ARTHRITIS; GENOTYPES; OSPC	Plant and animal biodiversity are essential to ecosystem health and can provide benefits to humans ranging from aesthetics to maintaining air quality. Although the importance of biodiversity to ecology and conservation biology is obvious, such measures have not been applied to strains of an invasive bacterium found in human tissues during infection. In this study, we compared the strain biodiversity of Borrelia burgdorferi found in tick populations with that found in skin, blood, synovial fluid or cerebrospinal fluid of Lyme disease patients. The biodiversity of B. burgdorferi strains is significantly greater in tick populations than in the skin of patients with erythema migrans. In turn, strains from skin are significantly more diverse than strains at any of the disseminated sites. The cerebrospinal fluid of patients with neurologic Lyme disease harbored the least pathogen biodiversity. These results suggest that human tissues act as niches that can allow entry to or maintain only a subset of the total pathogen population. These data help to explain prior clinical observations on the natural history of B. burgdorferi infection and raise several questions that may help to direct future research to better understand the pathogenesis of this infection.	[Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Baxamusa, Nilofer; Wormser, Gary P.] New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA; [Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	University of Pennsylvania; New York Medical College; New York Medical College	Brisson, D (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dbrisson@sas.upenn.edu	Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579	NIH [AR41511, AI076342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH grants AR41511 and AI076342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Hubalek Z, 2000, FOLIA ZOOL, V49, P241; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Jones KL, 2009, ARTHRITIS RHEUM-US, V60, P2174, DOI 10.1002/art.24812; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; LIVERIS D, 2011, J CLIN MICROBIOLOGY; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nowakowski J, 2009, CLIN INFECT DIS, V49, P1733, DOI 10.1086/648076; Qiu WG, 2002, GENETICS, V160, P833; REGINATO AJ, 1993, RHEUM DIS CLIN N AM, V19, P379; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	27	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22926	10.1371/journal.pone.0022926	http://dx.doi.org/10.1371/journal.pone.0022926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829670	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200039
J	de Lorgeril, J; Zenagui, R; Rosa, RD; Piquemal, D; Bachere, E				de Lorgeril, Julien; Zenagui, Reda; Rosa, Rafael D.; Piquemal, David; Bachere, Evelyne			Whole Transcriptome Profiling of Successful Immune Response to Vibrio Infections in the Oyster Crassostrea gigas by Digital Gene Expression Analysis	PLOS ONE			English	Article							TNF-ALPHA FACTOR; PACIFIC OYSTER; EXTRACELLULAR PRODUCTS; INNATE IMMUNITY; SEQUENCE TAGS; PATHOGEN; PROTEIN; BINDING; LETHALITY; HEMOCYTES	The cultivated Pacific oyster Crassostrea gigas has suffered for decades large scale summer mortality phenomenon resulting from the interaction between the environment parameters, the oyster physiological and/or genetic status and the presence of pathogenic microorganisms including Vibrio species. To obtain a general picture of the molecular mechanisms implicated in C. gigas immune responsiveness to circumvent Vibrio infections, we have developed the first deep sequencing study of the transcriptome of hemocytes, the immunocompetent cells. Using Digital Gene Expression (DGE), we generated a transcript catalog of up-regulated genes from oysters surviving infection with virulent Vibrio strains (Vibrio splendidus LGP32 and V. aestuarianus LPi 02/41) compared to an avirulent one, V. tasmaniensis LMG 20012 T. For that an original experimental infection protocol was developed in which only animals that were able to survive infections were considered for the DGE approach. We report the identification of cellular and immune functions that characterize the oyster capability to survive pathogenic Vibrio infections. Functional annotations highlight genes related to signal transduction of immune response, cell adhesion and communication as well as cellular processes and defence mechanisms of phagocytosis, actin cytosqueleton reorganization, cell trafficking and autophagy, but also antioxidant and anti-apoptotic reactions. In addition, quantitative PCR analysis reveals the first identification of pathogen-specific signatures in oyster gene regulation, which opens the way for in depth molecular studies of oyster-pathogen interaction and pathogenesis. This work is a prerequisite for the identification of those physiological traits controlling oyster capacity to survive a Vibrio infection and, subsequently, for a better understanding of the phenomenon of summer mortality.	[de Lorgeril, Julien; Zenagui, Reda; Rosa, Rafael D.; Bachere, Evelyne] IFREMER, Lab UMR Ecolag, F-34095 Montpellier, France; [Rosa, Rafael D.] Univ Montpellier 2, Montpellier, France; [Rosa, Rafael D.] Inst Rech Dev, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Piquemal, David] ZAC Euromed II, Skuld Tech, Cap Delta, Grabels, France	Ifremer; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	de Lorgeril, J (corresponding author), IFREMER, Lab UMR Ecolag, 2 Pl Eugene Batallion, F-34095 Montpellier, France.	ebachere@ifremer.fr	de Lorgeril, Julien/O-7488-2014; Bachere, Evelyne/O-6117-2014; Rosa, Rafael Diego/L-6944-2019	de Lorgeril, Julien/0000-0002-6400-5455; Rosa, Rafael Diego/0000-0002-4076-3163; Piquemal, David/0000-0002-5870-4276	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (Cnrs); ANR (Agence Nationale de la Recherche) [07/5210875/F]	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (Cnrs)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	Funding from the Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer) and the Centre National de la Recherche Scientifique (Cnrs) grant from ANR (Agence Nationale de la Recherche) Genanimal project Cg-Physiogene (No07/5210875/F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Bachere E., 1991, DEV COMP IMMUNOL, V15, pS102; Binesse J, 2008, APPL ENVIRON MICROB, V74, P7108, DOI 10.1128/AEM.01261-08; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gonzalez M, 2005, BIOCHEM BIOPH RES CO, V338, P1089, DOI 10.1016/j.bbrc.2005.10.075; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Guillou F, 2007, DEV COMP IMMUNOL, V31, P657, DOI 10.1016/j.dci.2006.10.001; Kanekiyo M, 2002, BIOCHEM J, V361, P363, DOI 10.1042/0264-6021:3610363; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Labreuche Y, 2010, FISH SHELLFISH IMMUN, V29, P753, DOI 10.1016/j.fsi.2010.07.007; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Montagnani C, 2008, DEV COMP IMMUNOL, V32, P182, DOI 10.1016/j.dci.2007.06.001; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Saulnier D, 2000, DIS AQUAT ORGAN, V40, P109, DOI 10.3354/dao040109; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Schwarz RS, 2007, IMMUNOGENETICS, V59, P233, DOI 10.1007/s00251-006-0179-1; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Terahara K, 2006, DEV COMP IMMUNOL, V30, P667, DOI 10.1016/j.dci.2005.09.009; Thompson FL, 2003, SYST APPL MICROBIOL, V26, P65, DOI 10.1078/072320203322337326; Travers MA, 2009, J CELL BIOCHEM, V106, P152, DOI 10.1002/jcb.21990; van Spriel AB, 2010, MICROBES INFECT, V12, P106, DOI 10.1016/j.micinf.2009.11.001; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	59	88	88	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23142	10.1371/journal.pone.0023142	http://dx.doi.org/10.1371/journal.pone.0023142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829707	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200049
J	Hecht, I; Levine, H; Rappel, WJ; Ben-Jacob, E				Hecht, Inbal; Levine, Herbert; Rappel, Wouter-Jan; Ben-Jacob, Eshel			"Self-Assisted" Amoeboid Navigation in Complex Environments	PLOS ONE			English	Article							TUMOR-CELL INVASION; EXTRACELLULAR-MATRIX; MIGRATION; CHEMOTAXIS; CANCER; EXPRESSION; DICTYOSTELIUM; ACTIVATION; MECHANISMS; MOVEMENT	Background: Living cells of many types need to move in response to external stimuli in order to accomplish their functional tasks; these tasks range from wound healing to immune response to fertilization. While the directional motion is typically dictated by an external signal, the actual motility is also restricted by physical constraints, such as the presence of other cells and the extracellular matrix. The ability to successfully navigate in the presence of obstacles is not only essential for organisms, but might prove relevant in the study of autonomous robotic motion. Methodology/Principal Findings: We study a computational model of amoeboid chemotactic navigation under differing conditions, from motion in an obstacle-free environment to navigation between obstacles and finally to moving in a maze. We use the maze as a simple stand-in for a motion task with severe constraints, as might be expected in dense extracellular matrix. Whereas agents using simple chemotaxis can successfully navigate around small obstacles, the presence of large barriers can often lead to agent trapping. We further show that employing a simple memory mechanism, namely secretion of a repulsive chemical by the agent, helps the agent escape from such trapping. Conclusions/Significance: Our main conclusion is that cells employing simple chemotactic strategies will often be unable to navigate through maze-like geometries, but a simple chemical marker mechanism ( which we refer to as "self-assistance") significantly improves success rates. This realization provides important insights into mechanisms that might be employed by real cells migrating in complex environments as well as clues for the design of robotic navigation strategies. The results can be extended to more complicated multi-cellular systems and can be used in the study of mammalian cell migration and cancer metastasis.	[Hecht, Inbal; Ben-Jacob, Eshel] Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Levine, Herbert; Rappel, Wouter-Jan; Ben-Jacob, Eshel] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Tel Aviv University; University of California System; University of California San Diego	Hecht, I (corresponding author), Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	inbal.hecht@gmail.com; eshelbj@gmail.com	Levine, Herbert/C-1704-2008	Levine, Herbert/0000-0002-8819-9055	European Community; Tauber Family Foundation; Tel Aviv University; National Institutes of Health [PO1 GM078586]; National Science Foundation [PHY-0822283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078586] Funding Source: NIH RePORTER	European Community(European Commission); Tauber Family Foundation; Tel Aviv University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I.H. acknowledges support by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme. E.B.J. acknowledges support by the Tauber Family Foundation and the Maguy-Glass chair in Physics of Complex Systems at Tel Aviv University. H.L. and W.-J.R. acknowledge support by the National Institutes of Health (PO1 GM078586) and by the National Science Foundation-sponsored Center for Theoretical Biological Physics (CTBP) at the University of California San Diego (grant no. PHY-0822283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; BUENEMANN M, BIOPHYS J, V99, P50; Choset HM., 2005, PRINCIPLES ROBOT MOT; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; FALCIONI R, 1994, EXP CELL RES, V210, P113, DOI 10.1006/excr.1994.1017; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Guy AG, 2008, ANIM BEHAV, V76, P585, DOI 10.1016/j.anbehav.2008.04.004; HECHT I, 2011, PLOS COMP B IN PRESS; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Jaspars LH, 1996, J PATHOL, V178, P36, DOI 10.1002/(SICI)1096-9896(199601)178:1<36::AID-PATH426>3.0.CO;2-S; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Latombe J.-C., 1991, ROBOT MOTION PLANNIN; Mineo R, 2004, ENDOCRINOLOGY, V145, P4355, DOI 10.1210/en.2003-1762; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Nishimura SI, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000310; OLGA I, 2011, PHYS BIOL, V8; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Reynolds AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.062901; Rintoul RC, 2001, LANCET ONCOL, V2, P437, DOI 10.1016/S1470-2045(00)00421-6; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Satulovsky J, 2008, BIOPHYS J, V94, P3671, DOI 10.1529/biophysj.107.117002; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SONG KT, 1991, ON LINE MOTION PLANN, V422, P423; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; VAIDYA U, 2008, MOTION PLANNING USIN, P850; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zhang S, 2008, CURR BIOL, V18, P1587, DOI 10.1016/j.cub.2008.08.069	48	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e21955	10.1371/journal.pone.0021955	http://dx.doi.org/10.1371/journal.pone.0021955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829602	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200005
J	Kim, S; Balakrishnan, K; Gross, DS				Kim, Sunyoung; Balakrishnan, Kripa; Gross, David S.			p53 Interacts with RNA Polymerase II through Its Core Domain and Impairs Pol II Processivity In Vivo	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; TUMOR-SUPPRESSOR; MUTANT P53; TRANSCRIPTION ELONGATION; CTD PHOSPHORYLATION; DNA-BINDING; GENE; ACTIVATION; COMPLEX; MUTATIONS	The tumor suppressor p53 principally functions as a gene-specific transcription factor. p53 triggers a variety of anti-proliferative programs by activating or repressing the transcription of effector genes in response to genotoxic stress. To date, much effort has been placed on understanding p53's ability to affect transcription in the context of its DNA-binding activity. How p53 regulates transcriptional output independent of DNA binding is less well understood. Here we provide evidence that human p53 can physically interact with the large subunit of RNA polymerase II (Pol II) both in in vitro interaction assays and in whole cell extracts, and that this interaction is mediated ( at least in part) through p53's core DNA-binding domain and the Ser5-phosphorylated CTD of Pol II. Ectopic expression of p53, combined with mutations in transcription elongation factors or exposure to drugs that inhibit Pol II elongation, elicit sickness or lethality in yeast cells. These phenotypes are suppressed by oncogenic point mutations within p53's core domain. The growth phenotypes raise the possibility that p53 impairs Pol II elongation. Consistent with this, a p53-dependent increase in Pol II density is seen at constitutively expressed genes without a concomitant increase in transcript accumulation. Additionally, p53-expressing yeast strains exhibit reduced transcriptional processivity at an episomal reporter gene; this inhibitory activity is abolished by a core domain point mutation. Our results suggest a novel mechanism by which p53 can regulate gene transcription, and a new biological function for its core domain that is susceptible to inactivation by oncogenic point mutations.	[Kim, Sunyoung; Balakrishnan, Kripa; Gross, David S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Kim, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0747227, MCB-025025]; Feist-Weiller Cancer Center	National Science Foundation(National Science Foundation (NSF)); Feist-Weiller Cancer Center	This work was supported by grants awarded to D.S.G. from the National Science Foundation (MCB-0747227, MCB-025025) and the Feist-Weiller Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Merrill GF, 1999, CANCER RES, V59, P3175; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Sigal A, 2000, CANCER RES, V60, P6788; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	40	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22183	10.1371/journal.pone.0022183	http://dx.doi.org/10.1371/journal.pone.0022183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829606	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200007
J	Laskar, S; Bhattacharyya, MK; Shankar, R; Bhattacharyya, S				Laskar, Shyamasree; Bhattacharyya, Mrinal K.; Shankar, Rama; Bhattacharyya, Sunanda			HSP90 Controls SIR2 Mediated Gene Silencing	PLOS ONE			English	Article							AFFECT TELOMERE LENGTH; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; PROTEIN-KINASE; YEAST; BINDING; P23; HETEROCHROMATIN; REQUIREMENT; EXPRESSION	In recent years, Hsp90 is found to interact with several telomeric proteins at various phases of cell cycle. The Hsp90 chaperone system controls assembly and disassembly of telomere structures and thus maintains the dynamic state of telomere. Here, for the first time we report that the activity of another telomeric protein Sir2p is modulated by Hsp82, the ortholog of Hsp90 from budding yeast (Saccharomyces cerevisiae). In a temperature sensitive Hsp90 deficient yeast strain (iG170Dhsp82), less abundant Sir2p is observed, resulting in de-repression of telomere silencing and a complete loss of mating type silencing. Intriguingly, over expression of Hsp90, either by exposing cells to heat shock or by introducing HSP82 overexpression plasmid also yields reduced level of Sir2p, with a consequential loss of telomere silencing. Thus, Hsp90 homeostasis maintains the cellular pool of Sir2p and thereby controls the reversible nature of telomere silencing. Interestingly, such regulation is independent of one of its major co-chaperones Sba1 (human ortholog of p23).	[Laskar, Shyamasree; Shankar, Rama; Bhattacharyya, Sunanda] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Bhattacharyya, Mrinal K.] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Laskar, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	sbtsl@uohyd.ernet.in		Laskar, Shyamasree/0000-0002-0497-0309	CSIR (Council for Scientific and Industrial Research), India [37/1343/08/EMR-II]; University of Hyderabad	CSIR (Council for Scientific and Industrial Research), India(Council of Scientific & Industrial Research (CSIR) - India); University of Hyderabad(University of Hyderabad)	This work was supported by a grant from CSIR (Council for Scientific and Industrial Research), India to MKB (Grant number 37/1343/08/EMR-II); and Purse grant from University of Hyderabad to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bhattacharyya MK, 2008, CHROMOSOMA, V117, P357, DOI 10.1007/s00412-008-0153-9; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Chiosis G, 2003, MOL CANCER THER, V2, P123; Cox MB, 2004, CELL STRESS CHAPERON, V9, P4, DOI 10.1379/1466-1268(2004)009<0004:COHSPA>2.0.CO;2; DeZwaan DC, 2010, TRENDS BIOCHEM SCI, V35, P384, DOI 10.1016/j.tibs.2010.02.005; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Grandin N, 2001, MOL GENET GENOMICS, V265, P126, DOI 10.1007/s004380000398; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hickman M, 2007, J MOL BIOL, V367, P1246, DOI 10.1016/j.jmb.2007.01.044; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; KIRK N, 1991, YEAST, V7, P539, DOI 10.1002/yea.320070602; Konieczny I, 1999, GENET ENG P, V21, P95; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Lustig AJ, 1996, MICROBIAL GENOME MET, P37; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; WILSON KL, 1984, MOL CELL BIOL, V4, P2420, DOI 10.1128/MCB.4.11.2420; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	38	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23406	10.1371/journal.pone.0023406	http://dx.doi.org/10.1371/journal.pone.0023406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829731	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200068
J	Schuldt, A; Both, S; Bruelheide, H; Hardtle, W; Schmid, B; Zhou, HZ; Assmann, T				Schuldt, Andreas; Both, Sabine; Bruelheide, Helge; Haerdtle, Werner; Schmid, Bernhard; Zhou, Hongzhang; Assmann, Thorsten			Predator Diversity and Abundance Provide Little Support for the Enemies Hypothesis in Forests of High Tree Diversity	PLOS ONE			English	Article							PLANT DIVERSITY; ARTHROPOD COMMUNITIES; FUNCTIONAL-ROLE; BIODIVERSITY; SPIDERS; LITTER; HERBIVORY; ASSEMBLAGES; RICHNESS; HABITAT	Predatory arthropods can exert strong top-down control on ecosystem functions. However, despite extensive theory and experimental manipulations of predator diversity, our knowledge about relationships between plant and predator diversity-and thus information on the relevance of experimental findings-for species-rich, natural ecosystems is limited. We studied activity abundance and species richness of epigeic spiders in a highly diverse forest ecosystem in subtropical China across 27 forest stands which formed a gradient in tree diversity of 25-69 species per plot. The enemies hypothesis predicts higher predator abundance and diversity, and concomitantly more effective top-down control of food webs, with increasing plant diversity. However, in our study, activity abundance and observed species richness of spiders decreased with increasing tree species richness. There was only a weak, non-significant relationship with tree richness when spider richness was rarefied, i.e. corrected for different total abundances of spiders. Only foraging guild richness (i.e. the diversity of hunting modes) of spiders was positively related to tree species richness. Plant species richness in the herb layer had no significant effects on spiders. Our results thus provide little support for the enemies hypothesis-derived from studies in less diverse ecosystems-of a positive relationship between predator and plant diversity. Our findings for an important group of generalist predators question whether stronger top-down control of food webs can be expected in the more plant diverse stands of our forest ecosystem. Biotic interactions could play important roles in mediating the observed relationships between spider and plant diversity, but further testing is required for a more detailed mechanistic understanding. Our findings have implications for evaluating the way in which theoretical predictions and experimental findings of functional predator effects apply to species-rich forest ecosystems, in which trophic interactions are often considered to be of crucial importance for the maintenance of high plant diversity.	[Schuldt, Andreas; Haerdtle, Werner; Assmann, Thorsten] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Both, Sabine; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany; [Both, Sabine; Bruelheide, Helge] Univ Halle Wittenberg, Bot Garden, Halle, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Zhou, Hongzhang] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Leuphana University Luneburg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Zurich; Chinese Academy of Sciences; Institute of Zoology, CAS	Schuldt, A (corresponding author), Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany.	schuldt@uni.leuphana.de	Assmann, Thorsten/Q-9304-2017; Schmid, Bernhard/C-8625-2009; Bruelheide, Helge/G-3907-2013; Schuldt, Andreas/J-9429-2013; Haerdtle, Werner/B-2568-2016; Both, Sabine/GRO-4210-2022	Assmann, Thorsten/0000-0002-9203-769X; Schmid, Bernhard/0000-0002-8430-3214; Bruelheide, Helge/0000-0003-3135-0356; Schuldt, Andreas/0000-0002-8761-0025; Hardtle, Werner/0000-0002-5599-5792; Both, Sabine/0000-0003-4437-5106	German Science Foundation (DFG) [FOR 891/1]; National Science Foundation of China (NSFC) [30710103907, 30930005]; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699]	German Science Foundation (DFG)(German Research Foundation (DFG)); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Sino-German Centre for Research Promotion in Beijing	The funding by the German Science Foundation (DFG FOR 891/1) and by the National Science Foundation of China (NSFC 30710103907 and 30930005), as well as various travel grants to prepare the project financed by DFG, NSFC and the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698 and 699) are highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2004, MODEL SELECTION MULT, V2nd; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Brose U, 2004, OIKOS, V105, P292, DOI 10.1111/j.0030-1299.2004.12884.x; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Garcia-Gunman G, 2003, J TROP ECOL, V19, P171, DOI 10.1017/S0266467403003195; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffiths GJK, 2008, ECOLOGY, V89, P2986, DOI 10.1890/08-0685.1; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jocque R, 2007, SPIDER FAMILIES WORL; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kapoor V, 2008, J INSECT CONSERV, V12, P53, DOI 10.1007/s10841-006-9062-5; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Lawrence KL, 2004, PEDOBIOLOGIA, V48, P149, DOI 10.1016/j.pedobi.2003.11.001; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Leuschner C, 2009, BASIC APPL ECOL, V10, P1, DOI 10.1016/j.baae.2008.06.001; Matern A, 2008, J INSECT CONSERV, V12, P591, DOI 10.1007/s10841-007-9096-3; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; OKSANEN E, 2008, VEGAN COMMUNITY ECOL; Pearce JL, 2004, BIODIVERS CONSERV, V13, P1305, DOI 10.1023/B:BIOC.0000019403.26948.55; Perner J, 2005, ECOGRAPHY, V28, P429, DOI 10.1111/j.0906-7590.2005.04119.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinol J, 2010, ECOL ENTOMOL, V35, P367, DOI 10.1111/j.1365-2311.2010.01190.x; Pringle RM, 2008, ECOL LETT, V11, P1328, DOI 10.1111/j.1461-0248.2008.01252.x; R Core Team, 2022, R LANG ENV STAT COMP; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Scherer-Lorenzen A, 2005, ECOL STUD-ANAL SYNTH, V176, P377; Scheu S, 2005, ECOL STUD-ANAL SYNTH, V176, P211; Schmid Bernhard, 2009, P14; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Schuldt A, 2008, BIODIVERS CONSERV, V17, P1267, DOI 10.1007/s10531-008-9330-7; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Southwood TRE, 2000, ECOLOGICAL METHODS; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stork NE, 2006, P ROY SOC B-BIOL SCI, V273, P1969, DOI 10.1098/rspb.2006.3521; Strong D.R., 1984, INSECTS PLANTS COMMU; Tanhuanpaa M, 1999, J ANIM ECOL, V68, P562, DOI 10.1046/j.1365-2656.1999.00305.x; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; Uetz GW, 1999, J ARACHNOL, V27, P270; Vehvilainen H, 2008, OIKOS, V117, P935, DOI 10.1111/j.2008.0030-1299.15972.x; Vila M, 2005, ECOL STU AN, V176, P65; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	68	59	62	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22905	10.1371/journal.pone.0022905	http://dx.doi.org/10.1371/journal.pone.0022905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829551	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600064
J	Brennan, D; Peltonen, S; Dowling, A; Medhat, W; Green, KJ; Wahl, JK; Del Galdo, F; Mahoney, MG				Brennan, D.; Peltonen, S.; Dowling, A.; Medhat, W.; Green, K. J.; Wahl, J. K., III; Del Galdo, F.; Mahoney, M. G.			A role for caveolin-1 in desmoglein binding and desmosome dynamics	ONCOGENE			English	Article						carcinogenesis; caveolin; caveolae; desmoglein; keratinocyte	PLASMA-MEMBRANE; LIPID RAFTS; SIGNAL-TRANSDUCTION; CELL-MIGRATION; BREAST-CANCER; GENE FAMILY; MOUSE SKIN; IN-VIVO; EXPRESSION; GROWTH	Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression. Oncogene (2012) 31, 1636-1648; doi:10.1038/onc.2011.346; published online 15 August 2011	[Mahoney, M. G.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Peltonen, S.] Univ Turku, Dept Dermatol, Turku, Finland; [Peltonen, S.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Green, K. J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Green, K. J.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wahl, J. K., III] Univ Nebraska Med Ctr, Dept Oral Biol, Lincoln, NE USA; [Del Galdo, F.] Univ Leeds, LMBU, Leeds Inst Mol Med, Scleroderma Res Ctr, Leeds, W Yorkshire, England	Jefferson University; University of Turku; University of Turku; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Leeds	Mahoney, MG (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 428 BLSB, Philadelphia, PA 19107 USA.	my.mahoney@jefferson.edu	Del+Galdo, Francesco/ABD-9872-2021; Peltonen, Sirkku/C-3133-2008	Del+Galdo, Francesco/0000-0002-8528-2283; Peltonen, Sirkku/0000-0003-0990-1430; Medhat, Walid/0000-0002-6704-2171	National Institutes of Health [R01 AR47938, R01 DE01905, R01 CA122151]; NATIONAL CANCER INSTITUTE [R01CA122151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr Abhilasha Gupta for critically reading the paper and insightful discussions. This work was supported by grants from the National Institutes of Health to M Mahoney (R01 AR47938), J Wahl (R01 DE01905) and K Green (R01 CA122151).	Allen E, 1996, J CELL BIOL, V133, P1367, DOI 10.1083/jcb.133.6.1367; Andl CD, 2001, J INVEST DERMATOL, V117, P1068, DOI 10.1046/j.0022-202x.2001.01528.x; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Chen ST, 2004, INT J MOL MED, V14, P577; Cheng X, 2004, J DERMATOL, V31, P171, DOI 10.1111/j.1346-8138.2004.tb00654.x; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Del Galdo F, 2008, CURR OPIN RHEUMATOL, V20, P713, DOI 10.1097/BOR.0b013e3283103d27; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Denault Jean-Bernard, 2008, V414, P191; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; FRA AM, 1994, J BIOL CHEM, V269, P30745; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gassmann MG, 2000, EXP CELL RES, V258, P23, DOI 10.1006/excr.2000.4904; Harada H, 1996, ACTA DERM-VENEREOL, V76, P417; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Laughlin RC, 2004, INFECT IMMUN, V72, P5349, DOI 10.1128/IAI.72.9.5349-5357.2004; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Mahoney MG, 2002, EXP DERMATOL, V11, P115, DOI 10.1034/j.1600-0625.2002.110203.x; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Okamoto CT, 1998, ADV DRUG DELIVER REV, V29, P215, DOI 10.1016/S0169-409X(97)00080-X; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schnitzer JE, 1996, AM J PHYSIOL-HEART C, V270, pH416, DOI 10.1152/ajpheart.1996.270.1.H416; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; SEVERS NJ, 1988, J CELL SCI, V90, P341; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song JP, 1996, BIOCHEMISTRY-US, V35, P14806, DOI 10.1021/bi961846b; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Trojan L, 2005, ANTICANCER RES, V25, P183; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Whittock NV, 2003, J INVEST DERMATOL, V120, P970, DOI 10.1046/j.1523-1747.2003.12257.x; Zheng XJ, 2003, BBA-MOL CELL RES, V1643, P25, DOI 10.1016/j.bbamcr.2003.08.006	61	51	51	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	13					1636	1648		10.1038/onc.2011.346	http://dx.doi.org/10.1038/onc.2011.346			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21841821	Green Accepted, Green Published			2022-12-25	WOS:000302231400003
J	Ren, HG; Fu, K; Wang, D; Mu, CC; Wang, GH				Ren, Haigang; Fu, Kai; Wang, Dan; Mu, Chenchen; Wang, Guanghui			Oxidized DJ-1 Interacts with the Mitochondrial Protein BCL-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED PROTEIN; CYSTEINE-SULFINIC ACID; NEURONAL CELL-DEATH; PARKINSONS-DISEASE; OXIDATIVE STRESS; CANCER-CELLS; APOPTOSIS; BAX; LOCALIZATION; INHIBITION	Parkinson disease (PD)- and cancer-associated protein, DJ-1, mediates cellular protection via many signaling pathways. Deletions or mutations in the DJ-1 gene are directly linked to autosomal recessive early-onset PD. DJ-1 has potential roles in mitochondria. Here, we show that DJ-1 increases its mitochondrial distribution in response to ultraviolet B (UVB) irradiation and binds to Bcl-X-L. The interactions between DJ-1 and Bcl-X-L are oxidation-dependent. DJ-1(C106A), a mutant form of DJ-1 that is unable to be oxidized, binds Bcl-X-L much less than DJ-1 does. Moreover, DJ-1 stabilizes Bcl-X-L protein level by inhibiting its ubiquitination and degradation through ubiquitin proteasome system (UPS) in response to UVB irradiation. Furthermore, under UVB irradiation, knockdown of DJ-1 leads to increases of Bcl-X-L ubiquitination and degradation upon UVB irradiation, thereby increasing mitochondrial Bax, caspase-3 activation and PARP cleavage. These data suggest that DJ-1 protects cells against UVB-induced cell death dependent on its oxidation and its association with mitochondrial Bcl-X-L.	[Fu, Kai; Mu, Chenchen; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci,Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Ren, Haigang; Wang, Dan] SW Univ Sci & Technol, Sch Life Sci & Engn, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southwest University of Science & Technology - China	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci,Chinese Acad Sci, Key Lab Brain Funct & Dis, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Ren, Haigang/U-6034-2017; Wang, Guanghui/U-3979-2017	Ren, Haigang/0000-0001-8844-4754; Wang, Guanghui/0000-0001-8551-6468	National Natural Sciences Foundation of China [30970921]; National High-tech Research and Development program of China [2011CB5004102]; Chinese Academy of Sciences [KSCX2-YW-R138]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech Research and Development program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the National Natural Sciences Foundation of China (No. 30970921), the National High-tech Research and Development program of China 973-Projects (2011CB5004102) and the Chinese Academy of Sciences Knowledge Innovation Project (KSCX2-YW-R138).	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Dietz G. P., 2008, J NEUROCHEM, V104, P757; Ethell DW, 2009, ANTIOXID REDOX SIGN, V11, P529, DOI [10.1089/ars.2008.2228, 10.1089/ARS.2008.2228]; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Feng Y, 2009, ARCH BIOCHEM BIOPHYS, V484, P46, DOI 10.1016/j.abb.2009.01.003; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Hong Z, 2006, INT J ONCOL, V28, P661; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kanli A., 2007, Experimental Oncology, V29, P314; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKeigan JP, 2003, CANCER RES, V63, P6928; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Park K, 2009, ONCOL REP, V21, P689, DOI 10.3892/or_00000272; Ren HG, 2010, CANCER LETT, V297, P101, DOI 10.1016/j.canlet.2010.05.001; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Ziv I, 1997, APOPTOSIS, V2, P149, DOI 10.1023/A:1026408313758	56	62	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35308	35317		10.1074/jbc.M110.207134	http://dx.doi.org/10.1074/jbc.M110.207134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852238	Green Published, hybrid			2022-12-25	WOS:000295406300084
J	Gulshan, K; Lee, SS; Moye-Rowley, WS				Gulshan, Kailash; Lee, Stella S.; Moye-Rowley, W. Scott			Differential Oxidant Tolerance Determined by the Key Transcription Factor Yap1 Is Controlled by Levels of the Yap1-binding Protein, Ybp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; CANDIDA-GLABRATA; DRUG-RESISTANCE; YEAST-CELLS; H2O2; ACTIVATION; LOCALIZATION; EXPRESSION	The Saccharomyces cerevisiae transcription factor Yap1 is a central determinant of oxidative stress tolerance. This protein is found primarily in the cytoplasm in the absence of oxidative stress but, upon exposure to oxidants, rapidly translocates to the nucleus and activates expression of target genes. Although both diamide and H2O2 have been used to impose oxidative stress on cells, these different oxidants trigger Yap1 nuclear localization in distinctly different ways. Diamide appears to oxidize particular cysteine residues on Yap1, leading to inhibition of association of Yap1 with the nuclear exportin Crm1. Crm1 would normally transport Yap1 out of the nucleus. H2O2 activation of Yap1 nuclear localization requires the participation of the glutathione peroxidase Gpx3 and the Yap1-binding protein Ybp1. H2O2 exposure triggers formation of a dual disulfide bonded Yap1 that is catalyzed by the presence of Gpx3 and Ybp1. In the current study, we have determined that two distinct pools of Yap1 exist in the cell. These pools are designated by the level of Ybp1. Ybp1 interacts directly with Yap1 and these proteins form a stable complex in vivo. Genetic and biochemical experiments indicate that Ybp1 is rate-limiting for Yap1 oxidative folding during H2O2 stress. The fungal pathogen Candida glabrata expresses a protein homologous to Ybp1 called CgYbp1. Overproduction of CgYbp1 elevated H2O2 tolerance in this pathogen indicating that the determinative role of Ybp1 in setting the level of H2O2 resistance has been evolutionarily conserved.	[Gulshan, Kailash; Moye-Rowley, W. Scott] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Lee, Stella S.] Univ Iowa, Program Mol Biol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Moye-Rowley, WS (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Lee, Stella/0000-0002-2629-2422	National Institutes of Health [GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49825.	BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Chen KH, 2007, GENE, V386, P63, DOI 10.1016/j.gene.2006.08.010; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; LEPPERT G, 1990, GENETICS, V125, P13; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ohkuni K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001617; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Takeuchi T, 1997, FEBS LETT, V416, P339, DOI 10.1016/S0014-5793(97)01233-7; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; WU AL, 1993, J BIOL CHEM, V268, P18850; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416	32	33	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34071	34081		10.1074/jbc.M111.251298	http://dx.doi.org/10.1074/jbc.M111.251298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21844193	Green Published, hybrid			2022-12-25	WOS:000295159200039
J	Li, CX; Han, JP; Ren, WY; Ji, AQ; Xu, XL; Hu, L				Li, Cai-xia; Han, Jun-ping; Ren, Wen-yan; Ji, An-quan; Xu, Xiu-lan; Hu, Lan			DNA Profiling of Spermatozoa by Laser Capture Microdissection and Low Volume-PCR	PLOS ONE			English	Article							CELLS; AMPLIFICATION; VALIDATION	Genetic profiling of sperm from complex biological mixtures such as sexual assault casework samples requires isolation of a pure sperm population and the ability to analyze low abundant samples. Current standard procedure for sperm isolation includes preferential lysis of epithelial contaminants followed by collection of intact sperm by centrifugation. While effective for samples where sperm are abundant, this method is less effective when samples contain few spermatozoa. Laser capture microdissection (LCM) is a proven method for the isolation of cells biological mixtures, even when found in low abundance. Here, we demonstrate the efficacy of LCM coupled with on-chip low volume PCR (LV-PCR) for the isolation and genotyping of low abundance sperm samples. Our results indicate that this method can obtain complete profiles (13-16 loci) from as few as 15 sperm cells with 80% reproducibility, whereas at least 40 sperm cells are required to profile 13-16 loci by standard 'in-tube' PCR. Further, LCM and LV-PCR of a sexual assault casework sample generated a DNA genotype that was consistent with that of the suspect. This method was unable, however, to analyze a casework sample from a gang rape case in which two or more sperm contributors were in a mixed population. The results indicate that LCM and LV-PCR is sensitive and effective for genotyping sperm from sperm/epithelial cell mixtures when epithelial lysis may be insufficient due to low abundance of sperm; LCM and LV-PCR, however, failed in a casework sample when spermatozoa from multiple donors was present, indicating that further study is necessitated.	[Li, Cai-xia; Ji, An-quan; Xu, Xiu-lan; Hu, Lan] Minist Publ Secur, Inst Forens Sci, Beijing, Peoples R China; [Li, Cai-xia; Ji, An-quan; Xu, Xiu-lan; Hu, Lan] Minist Publ Secur, Key Lab Forens Genet, Beijing, Peoples R China; [Han, Jun-ping; Ren, Wen-yan] Chinese Peoples Publ Secur Univ, Beijing, Peoples R China	Institute of Forensic Science Ministry of Justice PRC; Ministry of Public Security (China); Ministry of Public Security (China); People's Public Security University of China	Li, CX (corresponding author), Minist Publ Secur, Inst Forens Sci, Beijing, Peoples R China.	licaixia@tsinghua.org.cn; hulan328@yahoo.com			National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period [2006BAK07B01]	National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period	This study was supported by the National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period (No. 2006BAK07B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anslinger K, 2007, INT J LEGAL MED, V121, P54, DOI 10.1007/s00414-005-0065-7; Budimlija ZM, 2005, CROAT MED J, V46, P549; Budowle B, 2009, CROAT MED J, V50, P207, DOI 10.3325/cmj.2009.50.207; Caragine T, 2009, CROAT MED J, V50, P250, DOI 10.3325/cmj.2009.50.250; Di Martino D, 2004, FORENSIC SCI INT, V146, pS155, DOI 10.1016/j.forsciint.2004.09.047; Elliott K, 2003, FORENSIC SCI INT, V137, P28, DOI 10.1016/S0379-0738(03)00267-6; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; Li CX, 2009, FORENS SCI INT-GEN S, V2, P516, DOI 10.1016/j.fsigss.2009.08.016; Lutz-Bonengel S, 2007, INT J LEGAL MED, V121, P68, DOI 10.1007/s00414-006-0125-7; McAlister C, 2011, FORENSIC SCI INT-GEN, V5, P69, DOI 10.1016/j.fsigen.2010.04.008; Miyazaki T, 2008, FORENS SCI INT-GEN S, V1, P437, DOI 10.1016/j.fsigss.2007.10.074; Sanders CT, 2006, J FORENSIC SCI, V51, P748, DOI 10.1111/j.1556-4029.2006.00180.x; Schmidt U, 2006, INT J LEGAL MED, V120, P42, DOI 10.1007/s00414-005-0041-2; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P169, DOI 10.1007/s00414-008-0271-1	15	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22316	10.1371/journal.pone.0022316	http://dx.doi.org/10.1371/journal.pone.0022316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853031	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953400007
J	Liu, ZD; Xu, BB; Li, L; Sun, JH				Liu, Zhudong; Xu, Bingbing; Li, Li; Sun, Jianghua			Host-Size Mediated Trade-Off in a Parasitoid Sclerodermus harmandi	PLOS ONE			English	Article							SEX-RATIOS; STAGE SELECTION; HYMENOPTERA; WASPS; EVOLUTION; STRATEGIES; FITNESS; BRACONIDAE; BETHYLIDAE; APHIDIIDAE	Optimality models of host-parasitoid relationships have traditionally assumed that host quality increases as a function of host size at parasitism. However, trade-offs may play a crucial role in species evolution and should be found in host-parasitoid interactions where the host quality may differ between different sizes. Here, we investigated the effects of host size differences of Monochamus alternatus larva on foraging decisions, parasitism and related fitness in a gregarious ectoparasitoid, Sclerodermus harmandi. Two-choice and non-choice experiments were conducted with M. alternatus larvae to evaluate preference and performance of S. harmandi, respectively. Results from two-choice test showed that adult females prefer to attack large larvae rather than small larvae. In no-choice tests, adult females needed more time to paralyze large larvae than small larvae before laying eggs on the body surface of M. alternatus larvae and had lower survival and parasitism rate on those large larvae. Foraging decisions of S. harmandi led to the selection of the most profitable host size for parasitoid development, which showed more offspring gained on large M. alternatus larvae than on small larvae and got higher body weight on those large hosts. This study demonstrates the existence of trade-off occurring during host-parasitoids interactions according to host size related quality.	[Liu, Zhudong; Xu, Bingbing; Li, Li; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Li, Li] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Normal University	Liu, ZD (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Basic Research Program [2009CB119204]	National Basic Research Program(National Basic Research Program of China)	The research was supported by the National Basic Research Program (2009CB119204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; CHARNOV E L, 1982; CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CHARNOV EL, 1985, ENVIRON ENTOMOL, V14, P383, DOI 10.1093/ee/14.4.383; Chau A, 2001, CAN ENTOMOL, V133, P549, DOI 10.4039/Ent133549-4; Chong JH, 2006, ENTOMOL EXP APPL, V121, P39, DOI 10.1111/j.1570-8703.2006.00460.x; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Ding Y, 2001, CHIN J APPL ECOL, V12, P351; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld I. D., 1988, HYMENOPTERA; Gauld Ian D., 1995, P464; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Jervis M. A., 1996, P63; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KING BH, 1987, Q REV BIOL, V62, P367, DOI 10.1086/415618; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Lauziere I, 2001, BIOL CONTROL, V21, P128, DOI 10.1006/bcon.2000.0909; Li BP, 2004, ENTOMOL EXP APPL, V110, P249, DOI 10.1111/j.0013-8703.2004.00144.x; Li L, 2011, PLOS ONE, V6; Li L, 2010, BIOCONTROL, V55, P465, DOI 10.1007/s10526-010-9270-5; Li L, 2009, ECOL ENTOMOL, V34, P725, DOI 10.1111/j.1365-2311.2009.01120.x; Mackauer M., 1997, Ecological Studies, V130, P191; Mackauer M., 1993, PARASITES PATHOGENS, V1, P1; Nicol CMY, 1999, ENTOMOL EXP APPL, V90, P83, DOI 10.1023/A:1003546731081; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Pandey S, 1999, ENTOMOL EXP APPL, V90, P61, DOI 10.1023/A:1003558416329; Roitberg BD, 2001, CAN ENTOMOL, V133, P429, DOI 10.4039/Ent133429-3; SRIVASTAVA M, 1995, BIOL AGRIC HORTIC, V12, P15, DOI 10.1080/01448765.1995.9754720; STRAND MR, 1983, ENVIRON ENTOMOL, V12, P1114, DOI 10.1093/ee/12.4.1114; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Van Alphen J. J. M., 1996, P1; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Waage J.K., 1986, Symposia of the Royal Entomological Society of London, P63; Walker AM, 2003, J ECON ENTOMOL, V96, P1685, DOI 10.1603/0022-0493-96.6.1685; ZHANG WG, 2004, THESIS U SHANDONG AG; Zhou Zuji, 1997, Scientia Silvae Sinicae, V33, P475	40	35	54	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23260	10.1371/journal.pone.0023260	http://dx.doi.org/10.1371/journal.pone.0023260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853096	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953400035
J	Jiang, X; Barmada, MM; Cooper, GF; Becich, MJ				Jiang, Xia; Barmada, M. Michael; Cooper, Gregory F.; Becich, Michael J.			A Bayesian Method for Evaluating and Discovering Disease Loci Associations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; ALZHEIMER-DISEASE; AFRICAN-AMERICAN; FALSE; FGFR2; RISK; APOE; VARIANTS; ALLELES	Background: A genome-wide association study (GWAS) typically involves examining representative SNPs in individuals from some population. A GWAS data set can concern a million SNPs and may soon concern billions. Researchers investigate the association of each SNP individually with a disease, and it is becoming increasingly commonplace to also analyze multi-SNP associations. Techniques for handling so many hypotheses include the Bonferroni correction and recently developed Bayesian methods. These methods can encounter problems. Most importantly, they are not applicable to a complex multilocus hypothesis which has several competing hypotheses rather than only a null hypothesis. A method that computes the posterior probability of complex hypotheses is a pressing need. Methodology/Findings: We introduce the Bayesian network posterior probability (BNPP) method which addresses the difficulties. The method represents the relationship between a disease and SNPs using a directed acyclic graph (DAG) model, and computes the likelihood of such models using a Bayesian network scoring criterion. The posterior probability of a hypothesis is computed based on the likelihoods of all competing hypotheses. The BNPP can not only be used to evaluate a hypothesis that has previously been discovered or suspected, but also to discover new disease loci associations. The results of experiments using simulated and real data sets are presented. Our results concerning simulated data sets indicate that the BNPP exhibits both better evaluation and discovery performance than does a p-value based method. For the real data sets, previous findings in the literature are confirmed and additional findings are found. Conclusions/Significance: We conclude that the BNPP resolves a pressing problem by providing a way to compute the posterior probability of complex multi-locus hypotheses. A researcher can use the BNPP to determine the expected utility of investigating a hypothesis further. Furthermore, we conclude that the BNPP is a promising method for discovering disease loci associations.	[Jiang, Xia; Cooper, Gregory F.; Becich, Michael J.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Barmada, M. Michael] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Cooper, Gregory F.] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, X (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	xij6@pitt.edu		Barmada, M Michael/0000-0002-3604-6460	National Library of Medicine at the National Institutes of Health [1K99LM010822-01, R01-LM010020]; NATIONAL LIBRARY OF MEDICINE [K99LM010822, R01LM010020, R00LM010822] Funding Source: NIH RePORTER	National Library of Medicine at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by [grant number 1K99LM010822-01] and [grant number R01-LM010020] from the National Library of Medicine at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MINISTRY AGR; [Anonymous], 2008, POLICY SHARING DATA; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonifaci N, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-62; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fallin MD, 2010, NEUROGENETICS, V11, P335, DOI 10.1007/s10048-010-0234-9; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heckerman D, 1995, MSRTR9409; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang X, 2011, BMC BIOINFO IN PRESS; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Neapolitan RE, 2008, INNOVATIONS BAYESIAN; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sebastiani Paola, 2010, Science, V2010, DOI 10.1126/science.1190532; Shi H, 2010, INT J MOL EPIDEMIOL, V1, P53; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Visweswaran Shyam, 2009, AMIA Annu Symp Proc, V2009, P673; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	44	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22075	10.1371/journal.pone.0022075	http://dx.doi.org/10.1371/journal.pone.0022075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853025	Green Published, Green Accepted, gold			2022-12-25	WOS:000295454200006
J	Krumsiek, J; Marr, C; Schroeder, T; Theis, FJ				Krumsiek, Jan; Marr, Carsten; Schroeder, Timm; Theis, Fabian J.			Hierarchical Differentiation of Myeloid Progenitors Is Encoded in the Transcription Factor Network	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LINEAGE-COMMITMENT; FACTOR GATA-1; C/EBP-ALPHA; MICE LACKING; REGULATORY NETWORKS; LOGICAL ANALYSIS; MOUSE EMBRYOS; FETAL LIVER; FACTOR EKLF	Hematopoiesis is an ideal model system for stem cell biology with advanced experimental access. A systems view on the interactions of core transcription factors is important for understanding differentiation mechanisms and dynamics. In this manuscript, we construct a Boolean network to model myeloid differentiation, specifically from common myeloid progenitors to megakaryocytes, erythrocytes, granulocytes and monocytes. By interpreting the hematopoietic literature and translating experimental evidence into Boolean rules, we implement binary dynamics on the resulting 11-factor regulatory network. Our network contains interesting functional modules and a concatenation of mutual antagonistic pairs. The state space of our model is a hierarchical, acyclic graph, typifying the principles of myeloid differentiation. We observe excellent agreement between the steady states of our model and microarray expression profiles of two different studies. Moreover, perturbations of the network topology correctly reproduce reported knockout phenotypes in silico. We predict previously uncharacterized regulatory interactions and alterations of the differentiation process, and line out reprogramming strategies.	[Krumsiek, Jan; Marr, Carsten; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Munich, Germany; [Schroeder, Timm] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Krumsiek, J (corresponding author), Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Munich, Germany.	fabian.theis@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021; Schroeder, Timm/F-8448-2010; Marr, Carsten/B-3696-2013; Krumsiek, Jan/B-3961-2013	Theis, Fabian J/0000-0002-2419-1943; Schroeder, Timm/0000-0001-9320-0252; Marr, Carsten/0000-0003-2154-4552; 	Helmholtz Association within the Helmholtz Alliance on Systems Biology	Helmholtz Association within the Helmholtz Alliance on Systems Biology	This research was partially supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (project CoReNe). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barbeau B, 1999, ONCOGENE, V18, P5535, DOI 10.1038/sj.onc.1202913; BOCKAMP EO, 1995, BLOOD, V86, P1502, DOI 10.1182/blood.V86.4.1502.bloodjournal8641502; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; CLECH ML, 2006, J MOL BIOL, V355, P9; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Duan ZJ, 2005, TRENDS MOL MED, V11, P49, DOI 10.1016/j.molmed.2004.12.003; Elagib KE, 2007, CRIT REV EUKAR GENE, V17, P271, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.20; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kawada H, 2001, INT J HEMATOL, V73, P463, DOI 10.1007/BF02994008; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lim SK, 1997, BLOOD, V90, P1291, DOI 10.1182/blood.V90.3.1291.1291_1291_1299; MACKEY MC, MATH MODELS HEMATOPO, P149; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; McCormack MP, 2006, BLOOD, V108, P2248, DOI 10.1182/blood-2006-02-002188; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Moroni E, 2000, J BIOL CHEM, V275, P10567, DOI 10.1074/jbc.275.14.10567; MOUSSA O, 2010, MOL CELL BIOL; Narula J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000771; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; ORKIN SH, 1992, BLOOD, V80, P575; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; RADDE N, 2009, INT J SYST SCI; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rieger MA, 2009, J CELL BIOCHEM, V108, P343, DOI 10.1002/jcb.22273; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; TAOUDI S, 2011, GENES DEV; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Yamaguchi Y, 1998, BLOOD, V91, P450, DOI 10.1182/blood.V91.2.450.450_450_457; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang YJ, 2005, STEM CELLS, V23, P852, DOI 10.1634/stemcells.2004-0260	95	99	100	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22649	10.1371/journal.pone.0022649	http://dx.doi.org/10.1371/journal.pone.0022649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853041	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200017
J	Chen, S; Lai, CH; Wu, XX; Lu, YZ; Han, DS; Guo, WZ; Fu, LC; Andrieu, JM; Lu, W				Chen, Song; Lai, Chunhui; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Guo, Weizhong; Fu, Linchun; Andrieu, Jean-Marie; Lu, Wei			Variability of Bio-Clinical Parameters in Chinese-Origin Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Nonhuman Primate AIDS Model	PLOS ONE			English	Article							DISEASE PROGRESSION; HOMOSEXUAL-MEN; MACACA-MULATTA; HIV VACCINE; VIRAL LOAD; MONKEYS; REPLICATION; PATHOGENESIS; FREQUENCIES; SIVMAC239	Background: Although Chinese-origin Rhesus macaques (Ch RhMs) infected with simian immunodeficiency virus (SIV) have been used for many years to evaluate the efficacy of AIDS vaccines and therapeutics, the bio-clinical variability of such a nonhuman primate AIDS model was so far not established. Methodology/Principal Findings: By randomizing 150 (78 male and 72 female) Ch RhMs with diverse MHC class I alleles into 3 groups (50 animals per group) challenged with intrarectal (ir) SIVmac239, intravenous (iv) SIVmac239, or iv SIVmac251, we evaluated variability in bio-clinical endpoints for 118 weeks. All SIV-challenged Ch RhMs became seropositive for SIV during 1-2 weeks. Plasma viral load (VL) peaked at weeks 1-2 and then declined to set-point levels as from week 5. The set-point VL was 30 fold higher in SIVmac239 (ir or iv)-infected than in SIVmac251 (iv)-infected animals. This difference in plasma VL increased overtime (>100 fold as from week 68). The rates of progression to AIDS or death were more rapid in SIVmac239 (ir or iv)-infected than in SIVmac251 (iv)-infected animals. No significant difference in bio-clinical endpoints was observed in animals challenged with ir or iv SIVmac239. The variability (standard deviation) in peak/set-point VL was nearly one-half lower in animals infected with SIVmac239 (ir or iv) than in those infected with SIVmac251 (iv), allowing that the same treatment-related difference can be detected with one-half fewer animals using SIVmac239 than using SIVmac251. Conclusion/Significance: These results provide solid estimates of variability in bio-clinical endpoints needed when designing studies using the Ch RhM SIV model and contribute to the improving quality and standardization of preclinical studies.	[Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Peking Union Med Coll, Sinofrench Collaborat Ctr AIDS Res, Beijing 100021, Peoples R China; [Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Peking Union Med Coll, Dept Cell Biol, Beijing 100021, Peoples R China; [Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Tsinghua Univ, Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Chen, Song; Lai, Chunhui; Guo, Weizhong; Fu, Linchun; Lu, Wei] Guangzhou Univ Chinese Med, IRD China Branch Trop Med Inst UMI233, Guangzhou, Guangdong, Peoples R China; [Andrieu, Jean-Marie] Univ Paris 05, Inst Rech Vaccins & Immunotherapie Canc & Sida, St Peres Biomed Ctr, Paris, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Tsinghua University; Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite	Chen, S (corresponding author), Peking Union Med Coll, Sinofrench Collaborat Ctr AIDS Res, Beijing 100021, Peoples R China.	louis.luwei@ird.fr		CHEN, Song/0000-0003-2521-717X	Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Institut de Recherche pour le Developpement (IRD)	Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Institut de Recherche pour le Developpement (IRD)	This work was supported by the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS) and the Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AC NRCON, 2011, GUID CAR US LAB AN, P11601; Champoux M, 1997, DEV PSYCHOBIOL, V31, P49, DOI 10.1002/(SICI)1098-2302(199707)31:1<49::AID-DEV5>3.3.CO;2-A; Clarke MR, 1999, AM J PRIMATOL, V47, P335, DOI 10.1002/(SICI)1098-2345(1999)47:4<335::AID-AJP5>3.0.CO;2-Y; Doxiadis GGM, 2003, IMMUNOGENETICS, V55, P540, DOI 10.1007/s00251-003-0590-9; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Jiang Xuelong, 1991, Zoological Research, V12, P241; JOAG SV, 1994, VIROLOGY, V200, P436, DOI 10.1006/viro.1994.1207; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; LI J, 1992, J ACQ IMMUN DEF SYND, V5, P639; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Parker RA, 2001, J VIROL, V75, P11234, DOI 10.1128/JVI.75.22.11234-11238.2001; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; RERKSNGARM S, 2009, N ENGL J MED; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Robinson TM, 2007, J MED PRIMATOL, V36, P276, DOI 10.1111/j.1600-0684.2007.00245.x; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Trichel AM, 2002, J MED PRIMATOL, V31, P171, DOI 10.1034/j.1600-0684.2002.02003.x; TSAI CC, 1993, LAB ANIM SCI, V43, P411; Viray J, 2001, COMPARATIVE MED, V51, P555; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; WOLFS TFW, 1989, VOX SANG, V57, P127, DOI 10.1111/j.1423-0410.1989.tb01149.x; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; ZHANG R, 1991, Acta Theriologica Sinica, V11, P171	35	15	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23177	10.1371/journal.pone.0023177	http://dx.doi.org/10.1371/journal.pone.0023177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850259	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300044
J	Seta, F; Rahmani, M; Turner, PV; Funk, CD				Seta, Francesca; Rahmani, Mahboubeh; Turner, Patricia V.; Funk, Colin D.			Pulmonary Oxidative Stress Is Increased in Cyclooxygenase-2 Knockdown Mice with Mild Pulmonary Hypertension Induced by Monocrotaline	PLOS ONE			English	Article							BOVINE CORONARY-ARTERIES; CONGENITAL HEART-DISEASE; VASCULAR SMOOTH-MUSCLE; NADPH OXIDASE ACTIVITY; PROSTACYCLIN SYNTHASE; INTRAVASCULAR THROMBOSIS; PLATELET-AGGREGATION; ENDOTHELIAL INJURY; TRANSGENIC MICE; CELLS	The aim of this study was to examine the role of cyclooxygenase-2 (COX-2) and downstream signaling of prostanoids in the pathogenesis of pulmonary hypertension (PH) using mice with genetically manipulated COX-2 expression. COX-2 knockdown (KD) mice, characterized by 80-90% suppression of COX-2, and wild-type (WT) control mice were treated weekly with monocrotaline (MCT) over 10 weeks. Mice were examined for cardiac hypertrophy/function and right ventricular pressure. Lung histopathological analysis was performed and various assays were carried out to examine oxidative stress, as well as gene, protein, cytokine and prostanoid expression. We found that MCT increased right ventricular systolic and pulmonary arterial pressures in comparison to saline-treated mice, with no evidence of cardiac remodeling. Gene expression of endothelin receptor A and thromboxane synthesis, regulators of vasoconstriction, were increased in MCT-treated lungs. Bronchoalveolar lavage fluid and lung sections demonstrated mild inflammation and perivascular edema but activation of inflammatory cells was not predominant under the experimental conditions. Heme oxygenase-1 (HO-1) expression and indicators of oxidative stress in lungs were significantly increased, especially in COX-2 KD MCT-treated mice. Gene expression of NOX-4, but not NOX-2, two NADPH oxidase subunits crucial for superoxide generation, was induced by similar to 4-fold in both groups of mice by MCT. Vasodilatory and anti-aggregatory prostacyclin was reduced by similar to 85% only in MCT-treated COX-2 KD mice. This study suggests that increased oxidative stress-derived endothelial dysfunction, vasoconstriction and mild inflammation, exacerbated by the lack of COX-2, contribute to the pathogenesis of early stages of PH when mild hemodynamic changes are evident and not yet accompanied by vascular and cardiac remodeling.	[Seta, Francesca; Rahmani, Mahboubeh; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Turner, Patricia V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Queens University - Canada; University of Guelph	Seta, F (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Seta, Francesca/ABB-1566-2020	Funk, Colin/0000-0001-7029-4233; Seta, Francesca/0000-0001-7985-5615	CIHR [MOP-79459, MOP-93689]; Canadian Foundation for Innovation; Heart and Stroke Foundation of Ontario	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This research was supported by CIHR grants (MOP-79459 and MOP-93689) and a Canadian Foundation for Innovation Leading Opportunity Fund award. CDF holds a Tier I Canada Research Chair in Molecular, Cellular and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Aliotta JM, 2009, STEM CELLS DEV, V18, P773, DOI 10.1089/scd.2008.0237; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; BUTLER WH, 1970, J PATHOL, V102, P15, DOI 10.1002/path.1711020104; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; CELERMAJER DS, 1994, CIRCULATION, V89, P2041, DOI 10.1161/01.CIR.89.5.2041; CELERMAJER DS, 1993, CIRCULATION, V87, P440, DOI 10.1161/01.CIR.87.2.440; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; CZER GT, 1986, J APPL PHYSIOL, V60, P464, DOI 10.1152/jappl.1986.60.2.464; DEYO JA, 1994, TOXICOLOGY, V94, P209, DOI 10.1016/0300-483X(94)90039-6; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Dumitrascu Rio, 2008, BMC Pulm Med, V8, P25, DOI 10.1186/1471-2466-8-25; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Farber HW, 1999, J LAB CLIN MED, V134, P561, DOI 10.1016/S0022-2143(99)90094-X; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Fredenburgh LE, 2009, TRENDS CARDIOVAS MED, V19, P31, DOI 10.1016/j.tcm.2009.04.003; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Friedman R, 1997, CIRCULATION, V96, P2782, DOI 10.1161/01.CIR.96.9.2782; FUSE S, 1994, CIRCULATION, V90, P2952, DOI 10.1161/01.CIR.90.6.2952; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; GEORGE J, 2010, J HYPERTENS; Geraci M, 1998, CHEST, V114, p99S, DOI 10.1378/chest.114.1_Supplement.99S; Geraci MW, 1999, J CLIN INVEST, V103, P1509, DOI 10.1172/JCI5911; Goto J, 2002, ANTIOXID REDOX SIGN, V4, P563, DOI 10.1089/15230860260220058; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; GRYGLEWSKI RJ, 1978, NATURE, V273, P765, DOI 10.1038/273765a0; HASSOUN PM, 1992, P SOC EXP BIOL MED, V199, P165; Hoshikawa Y, 2001, AM J RESP CRIT CARE, V164, P314, DOI 10.1164/ajrccm.164.2.2010150; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3; Konduri GG, 2007, AM J PHYSIOL-HEART C, V292, pH1812, DOI 10.1152/ajpheart.00425.2006; Lee JD, 2005, CHEST, V128, p575S, DOI 10.1016/S0012-3692(15)30992-2; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MEYRICK B, 1980, AM J PHYSIOL, V239, pH692, DOI 10.1152/ajpheart.1980.239.5.H692; MIRANDA CL, 1981, CHEM-BIOL INTERACT, V37, P95, DOI 10.1016/0009-2797(81)90168-X; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukhopadhyay S, 2006, TOXICOL APPL PHARM, V211, P209, DOI 10.1016/j.taap.2005.06.004; Nishii Y, 2006, J THROMB HAEMOST, V4, P2331, DOI 10.1111/j.1538-7836.2006.02174.x; OHLSTEIN EH, 1992, EUR J PHARM-MOLEC PH, V225, P347, DOI 10.1016/0922-4106(92)90109-9; Pidgeon GP, 2004, CIRCULATION, V110, P2701, DOI 10.1161/01.CIR.0000145613.01188.0B; Qin L, 2010, J THROMB HAEMOST, V8, P808, DOI 10.1111/j.1538-7836.2010.03751.x; Raoul W, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-8; Reid MJ, 1998, J BIOCHEM MOL TOXIC, V12, P157; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Rudic RD, 2005, CIRC RES, V96, P1240, DOI 10.1161/01.RES.0000170888.11669.28; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Shah M, 2005, AM J PHYSIOL-CELL PH, V288, pC850, DOI 10.1152/ajpcell.00327.2004; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; TOPORSIAN M, ARTERIOSCLER THROMB, V30, P509; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Wunderlich C, 2008, PULM PHARMACOL THER, V21, P507, DOI 10.1016/j.pupt.2007.11.005; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Zanetti M, 2005, METH MOLEC MED, V108, P65; Zou MH, 1999, J EXP MED, V190, P135, DOI 10.1084/jem.190.1.135; Zou MH, 1999, BRIT J PHARMACOL, V126, P1283, DOI 10.1038/sj.bjp.0702434	69	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23439	10.1371/journal.pone.0023439	http://dx.doi.org/10.1371/journal.pone.0023439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850273	Green Published, gold			2022-12-25	WOS:000293563300058
J	Kim, TH; Lee, JY; Park, JS; Park, SW; Jang, AS; Lee, JY; Byun, JY; Uh, ST; Koh, ES; Chung, IY; Park, CS				Kim, Tae-Hoon; Lee, Ji-Yeon; Park, Jong-Sook; Park, Sung-Woo; Jang, An-Soo; Lee, Jae-Yong; Byun, Jang-Yul; Uh, Soo-Taek; Koh, Eun-Suk; Chung, Il Yup; Park, Choon-Sik			Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease	PLOS ONE			English	Article							INTOLERANT ASTHMA; ASSOCIATION ANALYSIS; GENE POLYMORPHISMS; CHRONIC SINUSITIS; ARACHIDONIC-ACID; HYPERSENSITIVITY; DIAGNOSIS; SUSCEPTIBILITY; IDENTIFICATION; PROTEOMICS	Background: Aspirin-exacerbated respiratory disease (AERD) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin. Although alterations in eicosanoid metabolites play a role in AERD, other immune or inflammatory mechanisms may be involved. We aimed to identify proteins that were differentially expressed in nasal polyps between patients with AERD and aspirin-tolerant asthma (ATA). Methodology/Principal Findings: Two-dimensional electrophoresis was adopted for differential display proteomics. Proteins were identified by liquid chromatography-tandem mass spectrometry (LC-MS). Western blotting and immunohistochemical staining were performed to compare the amount of fatty acid-binding protein 1 (FABP1) in the nasal polyps of patients with AERD and ATA. Fifteen proteins were significantly up-(seven spots) or down-regulated in the nasal polyps of patients with AERD (n = 5) compared to those with ATA (n = 8). LC-MS revealed an increase in seven proteins expression and a decrease in eight proteins expression in patients with AERD compared to those with ATA (P = 0.003-0.045). FABP1-expression based on immunoblotting and immunohistochemical analysis was significantly higher in the nasal polyps of patients with AERD compared to that in patients with ATA. FABP1 was observed in epithelial, eosinophils, macrophages, and the smooth-muscle cells of blood vessels in the polyps. Conclusions/Significance: Our results indicate that alterations in 15 proteins, including FABP1, may be related to the development of AERD.	[Kim, Tae-Hoon; Lee, Ji-Yeon; Park, Jong-Sook; Park, Sung-Woo; Jang, An-Soo; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyeonggi Do, South Korea; [Lee, Jae-Yong; Byun, Jang-Yul] Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Puchon, Gyeonggi Do, South Korea; [Uh, Soo-Taek] Soonchunhyang Univ Hosp, Div Allergy & Resp Med, Seoul, South Korea; [Koh, Eun-Suk] Soonchunhyang Univ, Bucheon Hosp, Dept Pathol, Puchon, Gyeonggi Do, South Korea; [Chung, Il Yup] Hanyang Univ, Div Mol & Life Sci, Coll Sci & Technol, Ansan, Gyeonggi Do, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University Hospital; Soonchunhyang University; Hanyang University	Kim, TH (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, 1174 Jung Dong, Puchon, Gyeonggi Do, South Korea.	mdcspark@unitel.co.kr	Gung, Amber/D-9842-2011	Park, Choon-Sik/0000-0003-2977-0255	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A010249]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Health 21 R&D project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A010249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Badaai Y, 2009, J OTOLARYNGOL-HEAD N, V38, P381, DOI 10.2310/7070.2009.080089; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; CHEONG HS, 2010, ALLERGY IN PRESS; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Cormican LJ, 2005, CLIN EXP ALLERGY, V35, P717, DOI 10.1111/j.1365-2222.2005.02261.x; Deroee AF, 2009, AM J RHINOL ALLERGY, V23, P480, DOI 10.2500/ajra.2009.23.3385; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kowalski Marek L, 2007, Clin Allergy Immunol, V19, P147; Lee SH, 2006, AM J RESP CRIT CARE, V173, P370, DOI 10.1164/rccm.200505-740OC; Meng M, 2009, PLANT CELL PHYSIOL, V50, P998, DOI 10.1093/pcp/pcp052; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Perez-G M, 2002, J IMMUNOL, V168, P1428, DOI 10.4049/jimmunol.168.3.1428; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Schachtrup C, 2004, BIOCHEM J, V382, P239, DOI 10.1042/BJ20031340; Sekigawa T, 2009, CLIN EXP ALLERGY, V39, P972, DOI 10.1111/j.1365-2222.2009.03229.x; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Wu MM, 2009, OTOLARYNG HEAD NECK, V141, P364, DOI 10.1016/j.otohns.2009.04.022; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zimmer JSD, 2004, J LIPID RES, V45, P2138, DOI 10.1194/jlr.M400240-JLR200	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22711	10.1371/journal.pone.0022711	http://dx.doi.org/10.1371/journal.pone.0022711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829647	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200027
J	Nelson, BR; Ueki, Y; Reardon, S; Karl, MO; Georgi, S; Hartman, BH; Lamba, DA; Reh, TA				Nelson, Branden R.; Ueki, Yumi; Reardon, Sara; Karl, Mike O.; Georgi, Sean; Hartman, Byron H.; Lamba, Deepak A.; Reh, Thomas A.			Genome-Wide Analysis of Muller Glial Differentiation Reveals a Requirement for Notch Signaling in Postmitotic Cells to Maintain the Glial Fate	PLOS ONE			English	Article							RETINAL PROGENITOR CELLS; MOUSE RETINA; GENE-EXPRESSION; DELTA-LIKE; PROLIFERATION; TRANSCRIPTOME; MECHANISMS; RECEPTOR; PROGRAM; SYSTEM	Previous studies have shown that Muller glia are closely related to retinal progenitors; these two cell types express many of the same genes and after damage to the retina, Muller glia can serve as a source for new neurons, particularly in non-mammalian vertebrates. We investigated the period of postnatal retinal development when progenitors are differentiating into Muller glia to better understand this transition. FACS purified retinal progenitors and Muller glia from various ages of Hes5-GFP mice were analyzed by Affymetrix cDNA microarrays. We found that genes known to be enriched/expressed by Muller glia steadily increase over the first three postnatal weeks, while genes associated with the mitotic cell cycle are rapidly downregulated from P0 to P7. Interestingly, progenitor genes not directly associated with the mitotic cell cycle, like the proneural genes Ascl1 and Neurog2, decline more slowly over the first 10-14 days of postnatal development, and there is a peak in Notch signaling several days after the presumptive Muller glia have been generated. To confirm that Notch signaling continues in the postmitotic Muller glia, we performed in situ hybridization, immunolocalization for the active form of Notch, and immunofluorescence for BrdU. Using genetic and pharmacological approaches, we found that sustained Notch signaling in the postmitotic Muller glia is necessary for their maturation and the stabilization of the glial identity for almost a week after the cells have exited the mitotic cell cycle.	[Nelson, Branden R.; Ueki, Yumi; Reardon, Sara; Karl, Mike O.; Georgi, Sean; Hartman, Byron H.; Lamba, Deepak A.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nelson, BR (corresponding author), Seattle Childrens Res Inst, Ctr Integrated Brain Res, Seattle, WA USA.	tomreh@u.washington.edu	Karl, Mike O./E-7246-2010	Karl, Mike O./0000-0002-0926-6556	NIH [R01 EY013475]; German Research Foundation (DFG) [KA 2794/1-1]; ProRetina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013475, P30EY001730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); ProRetina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH R01 EY013475 to TAR, by a Postdoctoral Fellowship by the German Research Foundation (DFG, KA 2794/1-1) and ProRetina Travel Grants to MOK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Brzezinski J., 2010, ENCY EYE, P73, DOI DOI 10.1016/B978-0-12-374203-2.00251-7; Burrows RT, 2000, DEV NEUROSCI-BASEL, V22, P7, DOI 10.1159/000017422; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Georgi SA, 2011, DEV NEUROBIOL, V71, P1153, DOI 10.1002/dneu.20899; Goureau O, 2004, DEV NEUROSCI-BASEL, V26, P359, DOI 10.1159/000082278; Hauck SM, 2003, GLIA, V44, P251, DOI 10.1002/glia.10292; Hojo M, 2000, DEVELOPMENT, V127, P2515; Jacobson M., 2013, DEV NEUROBIOL; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Lundkvist J, 2001, TRENDS NEUROSCI, V24, P492, DOI 10.1016/S0166-2236(00)01888-9; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Satow T, 2001, J NEUROSCI, V21, P1265; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	41	88	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22817	10.1371/journal.pone.0022817	http://dx.doi.org/10.1371/journal.pone.0022817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829655	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511900015
J	Lanteri, MC; Kaidarova, Z; Peterson, T; Cate, S; Custer, B; Wu, SQ; Agapova, M; Law, JP; Bielawny, T; Plummer, F; Tobler, LH; Loeb, M; Busch, MP; Bramson, J; Luo, M; Norris, PJ				Lanteri, Marion C.; Kaidarova, Zhanna; Peterson, Trevor; Cate, Steven; Custer, Brian; Wu, Shiquan; Agapova, Maria; Law, Jacqueline P.; Bielawny, Thomas; Plummer, Frank; Tobler, Leslie H.; Loeb, Mark; Busch, Michael P.; Bramson, Jonathan; Luo, Ma; Norris, Philip J.			Association between HLA Class I and Class II Alleles and the Outcome of West Nile Virus Infection: An Exploratory Study	PLOS ONE			English	Article							DENGUE HEMORRHAGIC-FEVER; GUILLAIN-BARRE-SYNDROME; T-CELL RESPONSES; BEHCETS-DISEASE; UNITED-STATES; HOST GENETICS; EXON-2 DNA; ENCEPHALITIS; FREQUENCIES; SEVERITY	Background: West Nile virus (WNV) infection is asymptomatic in most individuals, with a minority developing symptoms ranging from WNV fever to serious neuroinvasive disease. This study investigated the impact of host HLA on the outcome of WNV disease. Methods: A cohort of 210 non-Hispanic mostly white WNV+ subjects from Canada and the U. S. were typed for HLA-A, B, C, DP, DQ, and DR. The study subjects were divided into three WNV infection outcome groups: asymptomatic (AS), symptomatic (S), and neuroinvasive disease (ND). Allele frequency distribution was compared pair-wise between the AS, S, and ND groups using chi(2) and Fisher's exact tests and P values were corrected for multiple comparisons (Pc). Allele frequencies were compared between the groups and the North American population (NA) used as a control group. Logistic regression analysis was used to evaluate the potential synergistic effect of age and HLA allele phenotype on disease outcome. Results: The alleles HLA-A*68, C*08 and DQB*05 were more frequently associated with severe outcomes (ND vs. AS, P-A*68 = 0.013/Pc = 0.26, P-C*08 = 0.0075/Pc = 0.064, and P-DQB1*05 = 0.029/Pc = 0.68), However the apparent DQB1*05 association was driven by age. The alleles HLA-B*40 and C*03 were more frequently associated with asymptomatic outcome (AS vs. S, P-B*40 = 0.021/Pc = 0.58 and AS vs. ND P-C*03 = 0.039/Pc = 0.64) and their frequencies were lower within WNV+ subjects with neuroinvasive disease than within the North American population (NA vs. S, P-B*40 = 0.029 and NA vs. ND, P-C*03 = 0.032). Conclusions: Host HLA may be associated with the outcome of WNV disease; HLA-A*68 and C*08 might function as "susceptible" alleles, whereas HLA-B*40 and C*03 might function as "protective" alleles.	[Lanteri, Marion C.; Kaidarova, Zhanna; Custer, Brian; Wu, Shiquan; Agapova, Maria; Law, Jacqueline P.; Tobler, Leslie H.; Busch, Michael P.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA 94101 USA; [Peterson, Trevor; Bielawny, Thomas; Plummer, Frank; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cate, Steven] Univ Oklahoma, Hlth Sci Ctr, HLA Clin Lab, Oklahoma City, OK USA; [Loeb, Mark; Bramson, Jonathan] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Plummer, Frank; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Custer, Brian] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Custer, Brian; Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Vitalant; Vitalant Research Institute; Public Health Agency of Canada; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; University of Manitoba; McMaster University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanteri, MC (corresponding author), Blood Syst Res Inst, San Francisco, CA 94101 USA.	mlanteri@bloodsystems.org		Bramson, Jonathan/0000-0003-2874-6886	Centers for Disease Control and Prevention [R01-C1000214]; National Institutes of Health/National Heart Lung and Blood Institute [RC2HL101632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101632] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Centers for Disease Control and Prevention R01-C1000214, and National Institutes of Health/National Heart Lung and Blood Institute RC2HL101632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Axelsson-Robertson R, 2011, CLIN VACCINE IMMUNOL, V18, P125, DOI 10.1128/CVI.00302-10; BADEDOEDING C, 2010, HAEMATOLOGICA, V96, P110; Barzon L, 2009, EURO SURVEILL, V14, P19384; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Campbell GL, 2001, ANN NY ACAD SCI, V951, P94; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; *CONTR CFD, 2010, W NIL VIR ACT HUM DI; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; Depoortere E, 2004, TROP MED INT HEALTH, V9, P730, DOI 10.1111/j.1365-3156.2004.01253.x; deRezende PA, 1996, ARQ NEURO-PSIQUIAT, V54, P439, DOI 10.1590/S0004-282X1996000300013; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Elamin NE, 2010, TISSUE ANTIGENS, V76, P487, DOI 10.1111/j.1399-0039.2010.01547.x; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Healy BC, 2010, NEUROLOGY, V75, P634, DOI 10.1212/WNL.0b013e3181ed9c9c; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Koga M, 1998, J NEUROIMMUNOL, V88, P62, DOI 10.1016/S0165-5728(98)00072-1; Kuhn L, 2004, AIDS, V18, P1281, DOI 10.1097/00002030-200406180-00006; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Lee SI, 2007, VACCINE, V25, P7047, DOI 10.1016/j.vaccine.2007.07.062; LICHTMAN AKA, 2005, CELLULAR MOL IMMUNOL; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; Louie L, 1999, EMERG INFECT DIS, V5, P672, DOI 10.3201/eid0505.990508; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Ma JJ, 1998, NEUROLOGY, V51, P379, DOI 10.1212/WNL.51.2.379; Monini Marina, 2010, Open Virol J, V4, P42, DOI 10.2174/1874357901004020042; Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; *NCBI DBMHC, ANTHR DBMHC DAT DNA; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Palma MJC, 1996, MED CLIN-BARCELONA, V106, P121; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Polizel JR, 2004, MEM I OSWALDO CRUZ, V99, P559, DOI 10.1590/S0074-02762004000600003; Pollard K, 1999, Popul Today, V27, P7; Prydun M, 1983, J Neurosurg Nurs, V15, P27; ROMAN JS, 1992, MED CLIN-BARCELONA, V98, P366; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Schreuder GMT, 2001, EUR J IMMUNOGENET, V28, P565, DOI 10.1046/j.0960-7420.2001.00284.x; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; 't Hart BA, 2009, TRENDS MOL MED, V15, P235, DOI 10.1016/j.molmed.2009.04.001; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	66	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22948	10.1371/journal.pone.0022948	http://dx.doi.org/10.1371/journal.pone.0022948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829673	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200028
J	Vanaerschot, M; De Doncker, S; Rijal, S; Maes, L; Dujardin, JC; Decuypere, S				Vanaerschot, Manu; De Doncker, Simonne; Rijal, Suman; Maes, Louis; Dujardin, Jean-Claude; Decuypere, Saskia			Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; VITRO SUSCEPTIBILITY; MILTEFOSINE; GLUCONATE; TRANSPORTER; NEPAL; DRUG	Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). Antimonials (SSG) have long been the first-line treatment against VL, but have now been replaced by miltefosine (MIL) in the Indian subcontinent due to the emergence of SSG-resistance. Our previous study hypothesised that SSG-resistant L. donovani might have increased in vivo survival skills which could affect the efficacy of other treatments such as MIL. The present study attempts to validate these hypotheses. Fourteen strains derived from Nepalese clinical isolates with documented SSG-susceptibility were infected in BALB/c mice to study their survival capacity in drug free conditions (non-treated mice) and in MIL-treated mice. SSG-resistant parasites caused a significant higher in vivo parasite load compared to SSG-sensitive parasites. However, this did not seem to affect the strains' response to MIL-treatment since parasites from both phenotypes responded equally well to in vivo MIL exposure. We conclude that there is a positive association between SSG-resistance and in vivo survival skills in our sample of L. donovani strains which could suggest a higher virulence of SSG-R strains compared to SSG-S strains. These greater in vivo survival skills of SSG-R parasites do not seem to directly affect their susceptibility to MIL. However, it cannot be excluded that repeated MIL exposure will elicit different adaptations in these SSG-R parasites with superior survival skills compared to the SSG-S parasites. Our results therefore highlight the need to closely monitor drug efficacy in the field, especially in the context of the Kala-azar elimination programme ongoing in the Indian subcontinent.	[Vanaerschot, Manu; De Doncker, Simonne; Dujardin, Jean-Claude; Decuypere, Saskia] Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium; [Vanaerschot, Manu; Maes, Louis; Dujardin, Jean-Claude] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal	Institute of Tropical Medicine (ITM); University of Antwerp; B.P. Koirala Institute of Health Sciences	Vanaerschot, M (corresponding author), Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Maes, Louis JRM/A-2384-2017; Vanaerschot, Manu/B-6812-2013; Dujardin, Jean-Claude/AAO-1783-2021	Maes, Louis JRM/0000-0002-2324-9509; Vanaerschot, Manu/0000-0002-9141-2347; Decuypere, Saskia/0000-0001-5036-4601	LeishNatDrug-R [ICA4-CT-2001-10076]; FWO Flanders [G.0103.06]; EC [222895]; Agency for Innovation; Science and Technology in Flanders (IWT); Baillet-Latour Foundation	LeishNatDrug-R; FWO Flanders(FWO); EC(European CommissionEuropean Commission Joint Research Centre); Agency for Innovation; Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Baillet-Latour Foundation	This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001-10076), the FWO Flanders (contract G.0103.06) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC: http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Ouakad M, 2011, PARASITOLOGY, V138, P1392, DOI 10.1017/S0031182011001120; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P1898, DOI 10.1128/AAC.41.9.1898; Silva N, 2004, PARASITOLOGY, V128, P629, DOI 10.1017/S0031182004005098; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Vanaerschot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012211; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272	27	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23120	10.1371/journal.pone.0023120	http://dx.doi.org/10.1371/journal.pone.0023120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829701	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200040
J	Zou, LH; Sun, YM; Wang, MR; Zhan, QM				Zou, Lihui; Sun, Yimin; Wang, Mingrong; Zhan, Qimin			Aurora-A Interacts with AP-2 alpha and Down Regulates Its Transcription Activity	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; APOPTOSIS INDUCTION; GENE-EXPRESSION; FACTOR AP-2; KINASE; AP-2-GAMMA; PROTEIN; FAMILY; GROWTH	Aurora-A is a serine/threonine protein kinase and plays an important role in the control of mitotic progression. Dysregulated expression of Aurora-A impairs centrosome separation and maturation, which lead to disrupted cell cycle progression and tumorigenesis. However, the molecular mechanism by which Aurora-A causes cell malignant transformation remains to be further defined. In this report, using transcription factors array and mRNA expression profiling array, we found that overexpression of Aurora-A suppressed transcription activity of AP-2 alpha, a tumor suppressor that is often downregulated in variety of tumors, and inhibited expression of AP-2 alpha-regulated downstream genes. These array-based observations were further confirmed by microwell colorimetric TF assay and luciferase reporter assay. Downregulated transcription activity of AP-2 alpha by Aurora-A was found to be associated with reduced AP-2 alpha protein stability, which appeared to be mediated by Aurora-A enhanced ubiquitin-dependent proteasomal degradation of AP-2 alpha protein. Interestingly, Aurora-A-mediated AP-2 alpha degradation was likely dependent Aurora-A kinase activity since inhibition of Aurora-A kinase activity was able to rescue Aurora-A-induced degradation of AP-2 alpha. Moreover, we defined a physical interaction between Aurora-A and AP-2 alpha, and such interaction might bridge the suppressive effect of Aurora-A on AP-2 alpha protein stability. These findings provide new insights into molecular mechanism by which Aurora-A acts as an oncogenic molecule in tumor occurrence and malignant development.	[Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yimin] CapitalBio Corp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zou, LH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	ZhanQimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by funding from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Bosher JM, 1996, ONCOGENE, V13, P1701; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Friedrichs N, 2005, MODERN PATHOL, V18, P431, DOI 10.1038/modpathol.3800292; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Garcia MA, 1999, FEBS LETT, V444, P27, DOI 10.1016/S0014-5793(99)00021-6; Giet R, 1999, J CELL SCI, V112, P3591; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; HUNG L, 2006, INT J CANC, V118; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Li H, 2006, ONCOGENE, V25, P5405, DOI 10.1038/sj.onc.1209534; Li HL, 2006, NEOPLASIA, V8, P568, DOI 10.1593/neo.06367; Li QJ, 2004, J BIOL CHEM, V279, P45669, DOI 10.1074/jbc.M405025200; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Qiao JY, 2008, J PROTEOME RES, V7, P2769, DOI 10.1021/pr700883t; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Ruiz M, 2004, CANCER RES, V64, P631, DOI 10.1158/0008-5472.CAN-03-2751; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Shao W, 2005, J PROTEOME RES, V4, P1451, DOI 10.1021/pr050053l; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Turner BC, 1998, CANCER RES, V58, P5466; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Wang Y, 2008, BIOCHEM BIOPH RES CO, V370, P201, DOI 10.1016/j.bbrc.2008.03.031; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907	44	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23110	10.1371/journal.pone.0023110	http://dx.doi.org/10.1371/journal.pone.0023110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829699	gold, Green Published, Green Submitted			2022-12-25	WOS:000293511200039
J	Law, MR; Ystma, A; Morgan, SG				Law, Michael R.; Ystma, Alison; Morgan, Steven G.			The Short-Term Impact of Ontario's Generic Pricing Reforms	PLOS ONE			English	Article								Background: Canadians pay amongst the highest generic drug prices in the world. In July 2010, the province of Ontario enacted a policy that halved reimbursement for generic drugs from the public drug plan, and substantially lowered prices for private purchases. We quantified the impact of this policy on overall generic drug expenditures in the province, and projected the impact in other provinces had they mimicked this pricing change. Methods: We used quarterly prescription generic drug dispensing data from the IMS-Brogan CompuScript Audit. We used the price per unit in both the pre- and post-policy period and two economics price indexes to estimate the expenditure reduction in Ontario. Further, we used the post-policy Ontario prices to estimate the potential reduction in other provinces. Results: We estimate that total expenditure on generic drugs in Ontario during the second half of 2010 was between $ 181 and $ 194 million below what would be expected if prices had remained at pre-policy level. Over half of the reduction in spending was due to savings on just 10 generic ingredients. If other provinces had matched Ontario's prices, their expenditures over during the latter half of 2010 would have been $ 445 million lower. Discussion: We found that if Ontario's pricing scheme were adopted nationally, overall spending on generic drugs in Canada would drop at least $ 1.28 billion annually-a 5% decrease in total prescription drug expenditure. Other provinces should seriously consider both changes to their generic drug prices and the use of more competitive bulk purchasing policies.	[Law, Michael R.; Ystma, Alison; Morgan, Steven G.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Law, MR (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	mlaw@chspr.ubc.ca	Morgan, Steven/J-8814-2015	Morgan, Steven/0000-0002-7529-0028	Canadian Institutes of Health Researc; Peter Wall Institute	Canadian Institutes of Health Researc(Canadian Institutes of Health Research (CIHR)); Peter Wall Institute	Data access for this work was supported by an operating grant from the Canadian Institutes of Health Research ("For Whom the Bill Tolls: Private Drug Insurance in Canada", P. I.: Michael R. Law). Dr. Law receives salary support through a New Investigator Award from the Canadian Institutes of Health Research and an Early Career Scholar Award from the Peter Wall Institute for Advanced Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadian Cancer Society, 2009, CANC DRUG ACC CAN; Canadian Institute for Health Information, 2010, NAT HLTH EXP TRENDS; Competition Bureau Canada, 2007, GEN DRUG SECT STUD; Competition Bureau Canada, 2008, BEN GEN DRUG COMP CA; Diewert W., 1993, ESSAYS INDEX NUMBER; *GOV ONT, 2010, REF ONT DRUG SYST; Grootendorst P, 2011, MANAGING PHARM EXPEN; *HLTH CAN, 2006, NAT PHARM STRAT; Howlett K., 2010, GLOBE MAIL; *IMS BROG, 2009, RET PHARM PROV TERR; Law Michael R, 2011, Healthc Policy, V6, P36; MCCOMB G, 2010, PUBLIC DRUG PLAN PRO; Morgan Steve, 2007, Healthc Policy, V3, pe121; *PMPRB, 2010, GEN DRUGS CAN PRIC T; Statistics Canada, 2010, ANN DEM EST CAN PROV	15	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23030	10.1371/journal.pone.0023030	http://dx.doi.org/10.1371/journal.pone.0023030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829581	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600073
J	de la Cruz-Morcillo, MA; Valero, MLL; Callejas-Valera, JL; Arias-Gonzalez, L; Melgar-Rojas, P; Galan-Moya, EM; Garcia-Gil, E; Garcia-Cano, J; Sanchez-Prieto, R				de la Cruz-Morcillo, M. A.; Valero, M. L. L.; Callejas-Valera, J. L.; Arias-Gonzalez, L.; Melgar-Rojas, P.; Galan-Moya, E. M.; Garcia-Gil, E.; Garcia-Cano, J.; Sanchez-Prieto, R.			P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance	ONCOGENE			English	Article						5-fluorouracil; p38MAPK; autophagy; resistance; p53; apoptosis	ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; COLORECTAL-CANCER CELLS; CISPLATIN-BASED THERAPY; DNA-DAMAGE; GENE-EXPRESSION; COLON-CANCER; CHEMOTHERAPEUTIC-AGENTS; P53-DEPENDENT APOPTOSIS; THYMIDYLATE SYNTHASE	5-Fluorouracil (5-FU), together with other drugs such as oxaliplatin, is one of the most important pharmacological agents in the treatment of colorectal cancer. Although mitogen-activated protein kinases (MAPKs) have been extensively connected with resistance to platinum compounds, no role has been established in 5-FU resistance. Here we demonstrate that p38MAPK activation is a key determinant in the cellular response to 5-FU. Thus, inhibition of p38MAPK alpha by SB203580 compound or by short-hairpin RNA interference-specific knockdown correlates with a decrease in the 5-FU-associated apoptosis and chemical resistance in both HaCaT and HCT116 cells. Activation of p38MAPK by 5-FU was dependent on canonical MAP2K, MAPK kinase (MKK)-3 and MKK6. In addition, ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3 related (ATR) showed a redundancy of function for the final activation of p38MAPK. Resistance associated with p38MAPK inhibition correlates with an autophagic response that was mediated by a decrease in p53-driven apoptosis, without effect onto p53-dependent autophagy. Moreover, the results with colorectal cancer-derived cell lines with different p53 status and patterns of resistance to 5-FU suggest that de novo and acquired resistance was controlled by similar mechanisms. In summary, our data demonstrate a critical role for the p38MAPK signaling pathway in the cellular response to 5-FU by controlling the balance between apoptosis and autophagy. Oncogene (2012) 31, 1073-1085; doi:10.1038/onc.2011.321; published online 15 August 2011	[de la Cruz-Morcillo, M. A.; Valero, M. L. L.; Callejas-Valera, J. L.; Arias-Gonzalez, L.; Melgar-Rojas, P.; Galan-Moya, E. M.; Garcia-Gil, E.; Garcia-Cano, J.; Sanchez-Prieto, R.] UCLM, Oncol Mol Lab, CRIB, PCYTA, Albacete 02006, Spain	Universidad de Castilla-La Mancha	Sanchez-Prieto, R (corresponding author), UCLM, Oncol Mol Lab, CRIB, PCYTA, C Almansa 14, Albacete 02006, Spain.	ricardo.sanchez@uclm.es	Prieto, Ricardo/AAZ-7221-2021; Galan-Moya, Eva M/I-2912-2015; Sanchez-Prieto, Ricardo/AAY-4271-2021; Romo, José A./J-3024-2012; Garcia, Elena/GWR-0291-2022; García-Cano, Jesús/AAA-9257-2020; Sanchez-Prieto, Ricardo/B-6877-2008; Arias-González, Laura/D-9517-2016	Galan-Moya, Eva M/0000-0001-5758-7592; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Romo, José A./0000-0003-2907-580X; García-Cano, Jesús/0000-0002-8312-2622; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Arias-González, Laura/0000-0003-2132-9350; Garcia Gil, Elena/0000-0002-8952-0306; de la Cruz-Morcillo, Miguel Angel/0000-0002-6674-1333	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Innovacion [SAF2009-07329]; European Community	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Community(European Commission)	This work was supported by grants from Fundacion Leticia Castillejo Castillo and Ministerio de Ciencia e Innovacion (SAF2009-07329) to RSP. RSP Research Institute, and the work carried out in his laboratory, received support from the European Community through the regional development funding program (FEDER). We appreciate the comments and suggestions of Drs G Almazan, E de la Casa-Esperon, S Gutkind, D Arango, A Cuenda, A Vazquez, I Sanchez and D Garcia-Olmo.	Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Callejas-Valera JL, 2008, J BIOL CHEM, V283, P13450, DOI 10.1074/jbc.M709230200; Chan A, 2009, EUR J CANCER, V45, P2253, DOI 10.1016/j.ejca.2009.04.031; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Elsea CR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002355; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Ewald B, 2008, CANCER RES, V68, P7947, DOI 10.1158/0008-5472.CAN-08-0971; Fedier A, 2003, ANN ONCOL, V14, P938, DOI 10.1093/annonc/mdg240; Galan-Moya EM, 2008, INT J CANCER, V122, P289, DOI 10.1002/ijc.23063; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Habiro A, 2004, BIOCHEM BIOPH RES CO, V316, P71, DOI 10.1016/j.bbrc.2004.02.017; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Jardim MJ, 2009, MOL BIOL CELL, V20, P3801, DOI 10.1091/mbc.E09-04-0303; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kennedy AS, 2000, INT J CANCER, V90, P175, DOI 10.1002/1097-0215(20000820)90:4<175::AID-IJC1>3.0.CO;2-W; Koizumi K, 2005, ANTICANCER RES, V25, P3347; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Liu A, 2008, J CELL BIOCHEM, V105, P245, DOI 10.1002/jcb.21824; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Longley DB, 2002, CANCER RES, V62, P2644; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mariadason JM, 2003, CANCER RES, V63, P8791; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; McDonald GT, 2010, EXP CELL RES, V316, P3197, DOI 10.1016/j.yexcr.2010.08.007; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; NABEYA Y, 1995, INT J CANCER, V64, P37, DOI 10.1002/ijc.2910640109; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; OConnor PM, 1997, CANCER RES, V57, P4285; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Raftery L, 2008, SEMIN ONCOL, V35, P561, DOI 10.1053/j.seminoncol.2008.08.004; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Sanchez-Arevalo LV, 2005, BIOCH J 1, V387, P231; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Specenier P, 2010, CURR OPIN ONCOL, V22, P200, DOI 10.1097/CCO.0b013e3283376e15; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tominaga T, 2010, INT J CANCER, V126, P1691, DOI 10.1002/ijc.24929; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Xiong HY, 2010, CANCER LETT, V288, P68, DOI 10.1016/j.canlet.2009.06.039; Zeng XH, 2010, CELL RES, V20, P665, DOI 10.1038/cr.2010.40; Zhao HY, 2008, CANCER RES, V68, P7035, DOI 10.1158/0008-5472.CAN-07-6496; Zheng MH, 1999, J CANCER RES CLIN, V125, P357, DOI 10.1007/s004320050286	74	97	97	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1073	1085		10.1038/onc.2011.321	http://dx.doi.org/10.1038/onc.2011.321			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21841826				2022-12-25	WOS:000300945900001
J	Jung, J; Coe, H; Michalak, M				Jung, Joanna; Coe, Helen; Michalak, Marek			Specialization of endoplasmic reticulum chaperones for the folding and function of myelin glycoproteins P0 and PMP22	FASEB JOURNAL			English	Article						calreticulin; calnexin; ERp57; myelin disease; protein folding; quality control	PROTEIN-ZERO; CALNEXIN DEFICIENCY; QUALITY-CONTROL; DISULFIDE BOND; CALRETICULIN; DOMAIN; ER; NEUROPATHY; STRESS; VIVO	Peripheral myelin protein 22 (PMP22) and protein 0 (P0) are major peripheral myelin glycoproteins, and mutations in these two proteins are associated with hereditary demyelinating peripheral neuropathies. Calnexin, calreticulin, and ERp57 are critical components of protein quality control responsible for proper folding of newly synthesized glycoproteins. Here, using confocal microscopy, we show that cell surface targeting of P0 and PMP22 is not affected in the absence of the endoplasmic reticulum chaperones. However, the folding and function (adhesiveness) of PMP22 and P0, measured using the adhesion assay, are affected significantly in the absence of calnexin but not in the absence of calreticulin. Deficiency in oxidoreductase ERp57 results in impaired folding and function of P0, a disulfide bond-containing protein, but does not have any effect on folding or function of PMP22 (a protein that does not contain a disulfide bond). We concluded that calnexin and ERp57, but not calreticulin, play an important role in the biology of peripheral myelin proteins PMP22 and P0, and, consequently, these chaperones may contribute to the pathogenesis of peripheral neuropathies and the diversity of these neurological disorders.-Jung, J., Coe, H., Michalak, M. Specialization of endoplasmic reticulum chaperones for the folding and function of myelin glycoproteins P0 and PMP22. FASEB J. 25, 3929-3937 (2011). www.fasebj.org	[Jung, Joanna; Coe, Helen; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S7, Canada; [Coe, Helen; Michalak, Marek] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S7, Canada	University of Alberta; University of Alberta	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S7, Canada.	marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291]; Alberta Innovates-Health Solutions studentship awards	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions studentship awards	The authors thank Jody Groenendyk for technical help and valuable advice. The authors thank Monika Dabrowska, Alison Robinson, and Aleksandra Janowicz for superb technical help. The authors thank Dr. Lucia Notterpek (University of Florida, Gainesville, FL, USA) for anti-PMP22 antibodies. This work was supported by a grant to M.M. from the Canadian Institutes of Health Research (MOP-15291). J.J. and H.C. were supported by Alberta Innovates-Health Solutions studentship awards.	ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Ekici AB, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-29; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grandis M, 2008, HUM MOL GENET, V17, P1877, DOI 10.1093/hmg/ddn083; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Hasse B, 2004, MOL CELL NEUROSCI, V27, P370, DOI 10.1016/j.mcn.2004.06.009; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Keskanokwong T, 2007, J BIOL CHEM, V282, P23205, DOI 10.1074/jbc.M702139200; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; MARTINI R, 1995, J NEUROSCI, V15, P4488; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Mobley CK, 2007, BIOCHEMISTRY-US, V46, P11185, DOI 10.1021/bi700855j; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Pfend G, 2001, NEUROCHEM RES, V26, P503, DOI 10.1023/A:1010908828134; Plotkowski ML, 2007, BIOCHEMISTRY-US, V46, P12164, DOI 10.1021/bi701066h; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Shen Shuo, 2007, Methods Mol Biol, V379, P127; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang K, 1998, J NEUROSCI RES, V53, P1, DOI 10.1002/(SICI)1097-4547(19980701)53:1<1::AID-JNR1>3.0.CO;2-F; ZHANG KJ, 1994, J NEUROCHEM, V63, P367; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	40	17	17	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3929	3937		10.1096/fj.11-184911	http://dx.doi.org/10.1096/fj.11-184911			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21831887				2022-12-25	WOS:000296723100017
J	Ho, TC; Chen, SL; Shih, SC; Chang, SJ; Yang, SL; Hsieh, JW; Cheng, HC; Chen, LJ; Tsao, YP				Ho, Tsung-Chuan; Chen, Show-Li; Shih, Shou-Chuan; Chang, Shing-Jyh; Yang, Su-Lin; Hsieh, Jui-Wen; Cheng, Huey-Chuan; Chen, Lee-Jen; Tsao, Yeou-Ping			Pigment Epithelium-derived Factor (PEDF) Promotes Tumor Cell Death by Inducing Macrophage Membrane Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HUMAN DENDRITIC CELLS; NF-KAPPA-B; PPAR-GAMMA; CANCER; MICE; EXPRESSION; INHIBITION; CARCINOMA; BINDING	Pigment epithelium-derived factor (PEDF) is an intrinsic anti-angiogenic factor and a potential anti-tumor agent. The tumoricidal mechanism of PEDF, however, has not been fully elucidated. Here we report that PEDF induces the apoptosis of TC-1 and SK-Hep-1 tumor cells when they are cocultured with bone marrow-derived macrophages (BMDMs). This macrophage-mediated tumor killing is prevented by blockage of TNF-related apoptosis-inducing ligand (TRAIL) following treatment with the soluble TRAIL receptor. PEDF also increases the amount of membrane-bound TRAIL on cultured mouse BMDMs and on macrophages surrounding subcutaneous tumors. PEDF-induced tumor killing and TRAIL induction are abrogated by peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists or small interfering RNAs targeting PPAR gamma. PEDF also induces PPAR gamma in BMDMs. Furthermore, the activity of the TRAIL promoter in human macrophages is increased by PEDF stimulation. Chromatin immunoprecipitation and DNA pull-down assays confirmed that endogenous PPAR gamma binds to a functional PPAR-response element (PPRE) in the TRAIL promoter, and mutation of this PPRE abolishes the binding of the PPAR gamma-RXR alpha heterodimer. Also, PPAR gamma-dependent transactivation and PPAR gamma-RXR alpha binding to this PPRE are prevented by PPAR gamma antagonists. Our results provide a novel mechanism for the tumoricidal activity of PEDF, which involves tumor cell killing via PPAR gamma-mediated TRAIL induction in macrophages.	[Ho, Tsung-Chuan; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Med Res, Taipei 104, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Dept Gastroenterol, Taipei 104, Taiwan; [Chang, Shing-Jyh] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei 104, Taiwan; [Hsieh, Jui-Wen; Cheng, Huey-Chuan; Chen, Lee-Jen; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei 104, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei 100, Taiwan; [Shih, Shou-Chuan; Hsieh, Jui-Wen; Chen, Lee-Jen] Mackay Med Nursing & Management Coll, Taipei 112, Taiwan; [Chang, Shing-Jyh] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Yang, Su-Lin] Ctr Dis Control, Taipei 115, Taiwan; [Yang, Su-Lin; Tsao, Yeou-Ping] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei 114, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University; Mackay Junior College of Medicine, Nursing & Management; National Tsing Hua University; Centers For Disease Control - Taiwan; National Defense Medical Center	Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Med Res, 92 Sec 2,Chung Shan N Rd, Taipei 104, Taiwan.	yptsao@yahoo.com			National Science Council, Taiwan [NSC 97-2314-B-195-014-MY3]; Mackay Memorial Hospital [MMH-E-100-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by National Science Council, Taiwan, Grant NSC 97-2314-B-195-014-MY3 and Mackay Memorial Hospital Grant MMH-E-100-006.	Baetu TM, 2001, J IMMUNOL, V167, P3164, DOI 10.4049/jimmunol.167.6.3164; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chen PL, 2010, BIOCHEM BIOPH RES CO, V391, P936, DOI 10.1016/j.bbrc.2009.11.168; Cheung LWT, 2006, ENDOCRINOLOGY, V147, P4179, DOI 10.1210/en.2006-0168; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Galmbacher K, 2010, PLOS ONE, V5, pA93, DOI 10.1371/journal.pone.0009572; Gerard CM, 2001, CLIN CANCER RES, V7, p838S; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Guan M, 2004, CANCER GENE THER, V11, P325, DOI 10.1038/sj.cgt.7700675; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, MOL IMMUNOL, V45, P898, DOI 10.1016/j.molimm.2007.08.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Orgaz JL, 2009, ONCOGENE, V28, P4147, DOI 10.1038/onc.2009.284; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Taniguchi H, 2010, ANTICANCER RES, V30, P3159; Thompson PW, 2007, CYTOKINE, V39, P184, DOI 10.1016/j.cyto.2007.07.191; Tombran-Tink J, 1996, Mol Vis, V2, P11; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Van Ginderachter JA, 2006, BLOOD, V108, P525, DOI 10.1182/blood-2005-09-3777; Vishvakarma NK, 2010, IMMUNOL LETT, V134, P83, DOI 10.1016/j.imlet.2010.09.002; Watkins SK, 2009, EUR J IMMUNOL, V39, P2126, DOI 10.1002/eji.200839010; Yang SL, 2010, LIFE SCI, V87, P26, DOI 10.1016/j.lfs.2010.05.007; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yang YC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-216; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Zhang LJ, 2006, INT J MOL MED, V17, P937; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	56	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35943	35954		10.1074/jbc.M111.266064	http://dx.doi.org/10.1074/jbc.M111.266064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21846721	Green Published, hybrid			2022-12-25	WOS:000295927100068
J	Chertov, AO; Holzhausen, L; Kuok, IT; Couron, D; Parker, E; Linton, JD; Sadilek, M; Sweet, IR; Hurley, JB				Chertov, Andrei O.; Holzhausen, Lars; Kuok, Iok Teng; Couron, Drew; Parker, Ed; Linton, Jonathan D.; Sadilek, Martin; Sweet, Ian R.; Hurley, James B.			Roles of Glucose in Photoreceptor Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; RAT RETINA; PANCREATIC-ISLETS; OXIDATIVE STRESS; RABBIT RETINA; RD MOUSE; METABOLISM; APOPTOSIS; GLYCOSYLATION; AUTOPHAGY	Vertebrate photoreceptor neurons have a high demand for metabolic energy, and their viability is very sensitive to genetic and environmental perturbations. We investigated the relationship between energy metabolism and cell death by evaluating the metabolic effects of glucose deprivation on mouse photoreceptors. Oxygen consumption, lactate production, ATP, NADH/NAD(+), TCA cycle intermediates, morphological changes, autophagy, and viability were evaluated. We compared retinas incubated with glucose to retinas deprived of glucose or retinas treated with a mixture of mitochondrion-specific fuels. Rapid and slow phases of cell death were identified. The rapid phase is linked to reduced mitochondrial activity, and the slower phase reflects a need for substrates for cell maintenance and repair.	[Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kuok, Iok Teng; Couron, Drew; Sweet, Ian R.] Univ Washington, Dept Med, Obes Ctr Excellence, Seattle, WA 98195 USA; [Parker, Ed] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, POB 357350, Seattle, WA 98195 USA.	jbhhh@uw.edu			National Institutes of Health [RO1 EY017863, RO1 EY06641]; Diabetes Endocrine Research Center Islet Core [P30EY1730, DK17047]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY017863, R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrine Research Center Islet Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY017863 (to J. B. H.) and RO1 EY06641 (to J. B. H.), Core Grant for Vision Research P30EY1730, and Grant DK17047 from Diabetes Endocrine Research Center Islet Core (to I. R. S.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; ASANO T, 1991, J BIOL CHEM, V266, P24632; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; COHEN LH, 1960, J NEUROCHEM, V5, P253, DOI 10.1111/j.1471-4159.1960.tb13363.x; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; GIBLIN FJ, 1980, EXP EYE RES, V31, P601, DOI 10.1016/S0014-4835(80)80019-4; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kunchithapautham K, 2011, INVEST OPHTH VIS SCI, V52, P2967, DOI 10.1167/iovs.10-6278; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; Murray AR, 2009, OPHTHALMIC GENET, V30, P109, DOI 10.1080/13816810902962405; Mylvaganam GH, 2006, MOL VIS, V12, P1496; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Wang XD, 2001, GENE DEV, V15, P2922; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; WICK AN, 1957, J BIOL CHEM, V224, P963; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191; Yang S, 2010, J CHROMATOGR A, V1217, P7401, DOI 10.1016/j.chroma.2010.09.055; Ying H S, 2001, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0718s13; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	58	59	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34700	34711		10.1074/jbc.M111.279752	http://dx.doi.org/10.1074/jbc.M111.279752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840997	Green Published, hybrid			2022-12-25	WOS:000295406300024
J	Schwarz, F; Fan, YY; Schubert, M; Aebi, M				Schwarz, Flavio; Fan, Yao-Yun; Schubert, Mario; Aebi, Markus			Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZAE HMW1 ADHESIN; O-GLCNAC TRANSFERASE; IN-VIVO; BACTERIAL OLIGOSACCHARYLTRANSFERASE; GLYCOSYLATION; PROTEIN; NMR; GLYCOPROTEINS; SPECIFICITY; GLYCANS	N-Linked glycosylation is a frequent protein modification that occurs in all three domains of life. This process involves the transfer of a preassembled oligosaccharide from a lipid donor to asparagine side chains of polypeptides and is catalyzed by the membrane-bound oligosaccharyltransferase (OST). We characterized an alternative bacterial pathway wherein a cytoplasmic N-glycosyltransferase uses nucleotide-activated monosaccharides as donors to modify asparagine residues of peptides and proteins. N-Glycosyltransferase is an inverting glycosyltransferase and recognizes the NX(S/T) consensus sequence. It therefore exhibits similar acceptor site specificity as eukaryotic OST, despite the unrelated predicted structural architecture and the apparently different catalytic mechanism. The identification of an enzyme that integrates some of the features of OST in a cytoplasmic pathway defines a novel class of N-linked protein glycosylation found in pathogenic bacteria.	[Schubert, Mario] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Schwarz, Flavio; Fan, Yao-Yun; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schubert, M (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Schafmattstr 20, CH-8093 Zurich, Switzerland.	schubert@mol.biol.ethz.ch; aebi@micro.biol.ethz.ch	Schubert, Mario/B-3972-2008; Fan, YaoYun/AAS-5920-2020	Schubert, Mario/0000-0003-0278-4091; Schwarz, Flavio/0000-0002-1060-1585	Swiss National Science Foundation [3100AQ-105541]; Sinergia [CRSII3_127333]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grant 3100AQ-105541 (to M. A.), Sinergia Grant CRSII3_127333, and ETH Zurich.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Antoine T, 2003, CHEMBIOCHEM, V4, P406, DOI 10.1002/cbic.200200540; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; CLORE GM, 1988, FEBS LETT, V238, P17, DOI 10.1016/0014-5793(88)80216-3; Goddard TD, 2008, SPARKY VERSION 3; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hansen PI, 2008, BIOPOLYMERS, V89, P1179, DOI 10.1002/bip.21075; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Marshall R D, 1974, Biochem Soc Symp, P17; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; OGAWA T, 1983, AGR BIOL CHEM TOKYO, V47, P1213, DOI 10.1080/00021369.1983.10863384; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Simon B, 2000, THESIS FREE U BERLIN; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; TAKEDA T, 1980, CAN J CHEM, V58, P2600, DOI 10.1139/v80-415; Thijssen-van Zuylen CWEM, 1998, BIOCHEMISTRY-US, V37, P1933, DOI 10.1021/bi9718548; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; WILLIAMSON MP, 1995, CARBOHYD RES, V266, P229, DOI 10.1016/0008-6215(94)00273-I; Wood MJ, 2000, NAT STRUCT BIOL, V7, P200; Yamaguchi Y, 2000, J BIOMOL NMR, V18, P357, DOI 10.1023/A:1026776721348; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	39	61	65	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35267	35274		10.1074/jbc.M111.277160	http://dx.doi.org/10.1074/jbc.M111.277160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852240	hybrid, Green Published			2022-12-25	WOS:000295406300079
J	Zhou, BO; Zhou, JQ				Zhou, Bo O.; Zhou, Jin-Qiu			Recent Transcription-induced Histone H3 Lysine 4 (H3K4) Methylation Inhibits Gene Reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; S. CEREVISIAE; YEAST; MEMORY; UBIQUITINATION; COMPLEX; SET1; ACTIVATION; EXPRESSION	Recent transcription of GAL genes transiently leaves an H3K4 methylation mark at their promoters, providing an epigenetic memory for the recent transcriptional activity. However, the physiological significance of this mark is enigmatic. In our study, we show that the transient H3K4di- and trimethylation at recently transcribed GAL1 inhibited the reinduction of GAL1. The H3K4 methylation functioned by recruiting the Isw1 ATPase onto GAL1 and thereby limiting the action of RNA polymerase II during GAL1 reactivation. Strikingly, the H3K4 methylation was also observed at the promoters of inositol- and fatty acid-responsive genes after recent transcription and played a negative role in their reinduction. Taken together, our data present a new mechanism by which H3K4 methylation regulates gene transcription.	[Zhou, Bo O.; Zhou, Jin-Qiu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, JQ (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China.	jqzhou@sibs.ac.cn			National Natural Science Foundation of China [90919027]; Ministry of Science and Technology [2007CB914502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by National Natural Science Foundation of China Grant 90919027 and Ministry of Science and Technology Grant 2007CB914502.	Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Wang SS, 2011, MOL CELL BIOL, V31, P3171, DOI 10.1128/MCB.05017-11; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272; Zhou BO, 2010, MOL CELL BIOL, V30, P2391, DOI 10.1128/MCB.01106-09	34	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34770	34776		10.1074/jbc.M111.273128	http://dx.doi.org/10.1074/jbc.M111.273128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849496	Green Published, hybrid			2022-12-25	WOS:000295406300031
J	Martin, NK; Pitcher, AB; Vickerman, P; Vassall, A; Hickman, M				Martin, Natasha K.; Pitcher, Ashley B.; Vickerman, Peter; Vassall, Anna; Hickman, Matthew			Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users	PLOS ONE			English	Article							CANCER-CHEMOTHERAPY; ECONOMIC-EVALUATION; COST-EFFECTIVENESS; VIRUS; HIV; INFECTION; MODEL; HCV; PREVALENCE; THERAPY	In most developed countries, HCV is primarily transmitted by injecting drug users (IDUs). HCV antiviral treatment is effective, and deemed cost-effective for those with no re-infection risk. However, few active IDUs are currently treated. Previous modelling studies have shown antiviral treatment for active IDUs could reduce HCV prevalence, and there is emerging interest in developing targeted IDU treatment programmes. However, the optimal timing and scale-up of treatment is unknown, given the real-world constraints commonly existing for health programmes. We explore how the optimal programme is affected by a variety of policy objectives, budget constraints, and prevalence settings. We develop a model of HCV transmission and treatment amongst active IDUs, determine the optimal treatment programme strategy over 10 years for two baseline chronic HCV prevalence scenarios (30% and 45%), a range of maximum annual budgets (50,000-300,000 pound per 1,000 IDUs), and a variety of objectives: minimising health service costs and health utility losses; minimising prevalence at 10 years; minimising health service costs and health utility losses with a final time prevalence target; minimising health service costs with a final time prevalence target but neglecting health utility losses. The largest programme allowed for a given budget is the programme which minimises both prevalence at 10 years, and HCV health utility loss and heath service costs, with higher budgets resulting in greater cost-effectiveness (measured by cost per QALY gained compared to no treatment). However, if the objective is to achieve a 20% relative prevalence reduction at 10 years, while minimising both health service costs and losses in health utility, the optimal treatment strategy is an immediate expansion of coverage over 5-8 years, and is less cost-effective. By contrast, if the objective is only to minimise costs to the health service while attaining the 20% prevalence reduction, the programme is deferred until the final years of the decade, and is the least cost-effective of the scenarios.	[Martin, Natasha K.; Vickerman, Peter; Hickman, Matthew] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Martin, Natasha K.; Vickerman, Peter; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Pitcher, Ashley B.] Ecole Hautes Etud Sci Sociales, Ctr Anal & Math Sociales, Paris, France	University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Martin, NK (corresponding author), Univ Bristol, Dept Social Med, Bristol, Avon, England.	natasha.martin@bristol.ac.uk; ashley.pitcher@balliol.oxon.org	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Martin, Natasha/0000-0001-8344-1810; Vassall, Anna/0000-0002-2911-1375; Vickerman, Peter/0000-0002-8291-5890	Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs; Health Behaviour NIHR; French National Agency for Research [ANR-08-SYSC-008]; MRC; Medical Research Council [G0701627] Funding Source: researchfish; MRC [G0701627] Funding Source: UKRI	Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs; Health Behaviour NIHR; French National Agency for Research(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NKM is supported by the Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs and Health Behaviour NIHR Grant. ABP is supported by the 'DyXi' project of the SYSCOMM programme of the French National Agency for Research (grant number ANR-08-SYSC-008). PV is supported by a MRC New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACMD, 2009, PRIM PREV HEP C INJ; Alberti A, 2003, J HEPATOL, V38, pS104, DOI 10.1016/S0168-8278(03)00008-4; Ambruster B, 2010, MATH BIOSCI, V224, P35; Australian Goverment Department of Health, 2010, 3 NAT HEP C STRAT 20; Batt K, 2004, B WORLD HEALTH ORGAN, V82, P689; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Bryson A.E, 1969, APPL OPTIMAL CONTROL; Burden T, 2004, DISCRETE CONT DYN-B, V4, P135; Caetano MAL, 2001, OPTIM CONTR APPL MET, V22, P63, DOI 10.1002/oca.683; Chack E, 2010, CURRENT HEPATITIS RE, V9, P147; Corluka A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-81; Curtis L, 2019, UNIT COSTS HLTH SOCI; Davis GL, 1998, J VIRAL HEPATITIS, V5, P313, DOI 10.1046/j.1365-2893.1998.00119.x; De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306; ECMDDA, 2004, HEP C INJ DRUG US IM; Fister KR, 2000, SIAM J APPL MATH, V60, P1059, DOI 10.1137/S0036139998338509; Fleming W.H., 2012, DETERMINISTIC STOCHA; Grebely J, 2006, J HEPATOL, V44, pS214, DOI 10.1016/S0168-8278(06)80578-7; Grieve R, 2002, ACTA GASTRO-ENT BELG, V65, P104; Guinness L, 2005, B WORLD HEALTH ORGAN, V83, P747; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Health Protection Scotland, 2010, NEEDL EXCH SURV IN N; Hickman M, 2007, J VIRAL HEPATITIS, V14, P645, DOI 10.1111/j.1365-2893.2007.00855.x; Hickman M, 2009, J PUBLIC HEALTH-UK, V31, P374, DOI 10.1093/pubmed/fdp067; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobs P, 1999, COST EFFECTIVENESS S; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710; Judd A, 2005, BMJ-BRIT MED J, V330, P24, DOI 10.1136/bmj.38286.841227.7C; Jung E, 2002, DISCRETE CONT DYN-B, V2, P473; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; KOPP RE, 1965, AIAA J, V3, P1439, DOI 10.2514/3.3165; Kumaranayake L, 2008, AIDS, V22, pS23, DOI 10.1097/01.aids.0000327620.47103.1d; Ledzewicz U, 2007, MATH BIOSCI, V206, P320, DOI 10.1016/j.mbs.2005.03.013; Lenhart S., 2007, OPTIMAL CONTROL APPL; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; MCDANELL JP, 1971, SIAM J CONTROL, V9, P161, DOI 10.1137/0309014; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nanda S, 2007, MATH BIOSCI, V210, P143, DOI 10.1016/j.mbs.2007.05.003; National Institutes of Health, 2002, MAN HEP C 2002; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; NICE, 2009, GUID MAN 2009; NICE, 2004, GUID METH TECHN APPR; NICE, 2006, PEG ALF RIB TREATM M; NICE, 2000, INT ALF PEG NONP RIA; NICE, 2009, COST STAT NEEDL SYR; Noah N D, 1983, Community Med, V5, P140; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Public Health Wales, 2008, BLOOD BOURN VIR HEP; Seal KH, 2005, J GEN INTERN MED, V20, P171; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P809, DOI 10.1111/j.1365-2893.2008.01041.x; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; The London Joint Working Group for Substance Misuse and Hepatitis C, 2011, TACKL PROBL HEP C SU; The Scottish Government, 2008, HEP C ACT PLAN SCOTL; Vickerman P., 2008, ASSESSING COST EFFEC, P1; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Vincent TL., 1997, NONLINEAR OPTIMAL CO; World Bank, 2009, GROSS DOM PROD PPP; Zeiler I, 2010, DRUG ALCOHOL DEPEN, V110, P228, DOI 10.1016/j.drugalcdep.2010.03.006	74	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22309	10.1371/journal.pone.0022309	http://dx.doi.org/10.1371/journal.pone.0022309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853030	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000293953400006
J	Cai, X; Zhang, J; Chen, ML; Wu, Y; Wang, XQ; Chen, JY; Zhang, JQ; Shen, X; Qu, D; Jiang, HL				Cai, Xia; Zhang, Jian; Chen, Mingliang; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Shen, Xu; Qu, Di; Jiang, Hualiang			The Effect of the Potential PhoQ Histidine Kinase Inhibitors on Shigella flexneri Virulence	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; SMALL MOLECULES; SENSOR; ACTIVATION; COMMUNICATION; CONSTRUCTION; INVOLVEMENT; EXPRESSION; STRATEGIES; BACTERIA	PhoQ/PhoP is an important two-component system that regulates Shigella virulence. We explored whether the PhoQ/PhoP system is a promising target for new antibiotics against S. flexneri infection. By using a high-throughput screen and enzymatic activity coupled assay, four compounds were found as potential PhoQ inhibitors. These compounds not only inhibited the activity of SF-PhoQc autophosphorylation but also displayed high binding affinities to the SF-PhoQc protein in the Surface Plasmon Resonance response. A S. flexneri cell invasion assay showed that three of these potential PhoQ inhibitors inhibit the invasion of HeLa cells by S. flexneri 9380. In a Mouse Sereny test, mice inoculated with S. flexneri 9380 pre-treated with the potential PhoQ inhibitors 1, 2, 3 or 4 displayed no inflammation, whereas mice inoculated with S. flexneri 9380 alone displayed severe keratoconjunctival inflammation. All four potential PhoQ inhibitors showed no significant cytotoxicity or hemolytic activity. These data suggest that the four potential PhoQ inhibitors inhibited the virulence of S. flexneri and that PhoQ/PhoP is a promising target for the development of drugs against S. flexneri infection.	[Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Med Microbiol, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Med Microbiol, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Jian; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med,Grad Sch, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai, Peoples R China; [Chen, Mingliang] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Shanghai Center for Disease Control & Prevention	Cai, X (corresponding author), Fudan Univ, Inst Med Microbiol, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	dqu@fudan.edu.cn; hljiang@mail.shcnc.ac.cn	Chen, Jiayu/ABF-3722-2021; Zhang, Jian/GXA-1303-2022; Qu, Di/AAO-4590-2020	Chen, Jiayu/0000-0003-4755-8901; Zhang, Jian/0000-0002-6558-791X; 	Ministry of Science and Technology of China [2009ZX09303-005, 2008ZX10003-016, 2010DFA32100]; National Natural Science Foundation of China [30800036, J0730860]; Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602, 08JC1401600]; Fudan University [09FQ43]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Development Foundation of Shanghai; Fudan University	This work was supported by the Program of Ministry of Science and Technology of China (2009ZX09303-005, 2008ZX10003-016, 2010DFA32100), the National Natural Science Foundation of China (30800036, J0730860), the Scientific Technology Development Foundation of Shanghai (10410700600, 09DZ1908602, 08JC1401600), and the Research Initiation Grant for Young Faculty of Fudan University (09FQ43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg V, 2007, ORG BIOMOL CHEM, V5, P1827, DOI 10.1039/b702397a; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chu YW, 1998, ANTIMICROB AGENTS CH, V42, P440; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Giacometti A, 2005, PEPTIDES, V26, P169, DOI 10.1016/j.peptides.2004.09.018; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; HAUKKA K, 2007, EPIDEMIOLOGY INFECT, V136; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Kim SK, 1996, MOL MICROBIOL, V22, P135, DOI 10.1111/j.1365-2958.1996.tb02663.x; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lyon GJ, 2003, CHEM BIOL, V10, P1007, DOI 10.1016/j.chembiol.2003.11.003; Macielag MJ, 2000, EXPERT OPIN INV DRUG, V9, P2351, DOI 10.1517/13543784.9.10.2351; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Matsubara M, 1999, BIOSCI BIOTECH BIOCH, V63, P408, DOI 10.1271/bbb.63.408; MILLER SI, 1990, J BACTERIOL, V172, P6; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; Miyoshi SI, 1997, INFECT IMMUN, V65, P1830, DOI 10.1128/IAI.65.5.1830-1835.1997; Monsalveo JC, 2008, GAC SANIT, V22, P35, DOI 10.1157/13115108; Moss JE, 2000, CELL MICROBIOL, V2, P443, DOI 10.1046/j.1462-5822.2000.00065.x; Muller Simone, 2001, Expert Opin Ther Targets, V5, P327, DOI 10.1517/14728222.5.3.327; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; ROYCHOUDHURY S, 1993, P NATL ACAD SCI USA, V90, P965, DOI 10.1073/pnas.90.3.965; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Terajima J, 1999, MICROB PATHOGENESIS, V27, P223, DOI 10.1006/mpat.1999.0300; Venkatesan MM, 2002, INFECT IMMUN, V70, P2950, DOI 10.1128/IAI.70.6.2950-2958.2002; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Ward GE, 2002, CELL MICROBIOL, V4, P471, DOI 10.1046/j.1462-5822.2002.00205.x	50	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23100	10.1371/journal.pone.0023100	http://dx.doi.org/10.1371/journal.pone.0023100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853073	gold, Green Submitted, Green Published			2022-12-25	WOS:000295454200042
J	Franco, A; Hendriksen, RS; Lorenzetti, S; Onorati, R; Gentile, G; Dell'Omo, G; Aarestrup, FM; Battisti, A				Franco, Alessia; Hendriksen, Rene S.; Lorenzetti, Serena; Onorati, Roberta; Gentile, Gabriele; Dell'Omo, Giacomo; Aarestrup, Frank M.; Battisti, Antonio			Characterization of Salmonella Occurring at High Prevalence in a Population of the Land Iguana Conolophus subcristatus in Galapagos Islands, Ecuador	PLOS ONE			English	Article							SEROVARS; SUSCEPTIBILITY; RESISTANCE; INFECTION; REPTILES	The aim of the study was to elucidate the association between the zoonotic pathogen Salmonella and a population of land iguana, Colonophus subcristatus, endemic to Galapagos Islands in Ecuador. We assessed the presence of Salmonella subspecies and serovars and estimated the prevalence of the pathogen in that population. Additionally, we investigated the genetic relatedness among isolates and serovars utilising pulsed field gel electrophoresis (PFGE) on XbaI-digested DNA and determined the antimicrobial susceptibility to a panel of antimicrobials. The study was carried out by sampling cloacal swabs from animals (n = 63) in their natural environment on in the island of Santa Cruz. A high prevalence (62/63, 98.4%) was observed with heterogeneity of Salmonella subspecies and serovars, all known to be associated with reptiles and with reptile-associated salomonellosis in humans. Serotyping revealed 14 different serovars among four Salmonella enterica subspecies: S. enterica subsp. enterica (n = 48), S. enterica subsp. salamae (n = 2), S. enterica subsp. diarizonae (n = 1), and S. enterica subsp. houtenae (n = 7). Four serovars were predominant: S. Poona (n = 18), S. Pomona (n = 10), S. Abaetetuba (n = 8), and S. Newport (n = 5). The S. Poona isolates revealed nine unique XbaI PFGE patterns, with 15 isolates showing a similarity of 70%. Nine S. Pomona isolates had a similarity of 84%. One main cluster with seven (88%) indistinguishable isolates of S. Abaetetuba was observed. All the Salmonella isolates were pan-susceptible to antimicrobials representative of the most relevant therapeutic classes. The high prevalence and absence of clinical signs suggest a natural interaction of the different Salmonella serovars with the host species. The interaction may have been established before any possible exposure of the iguanas and the biocenosis to direct or indirect environmental factors influenced by the use of antimicrobials in agriculture, in human medicine or in veterinary medicine.	[Franco, Alessia; Lorenzetti, Serena; Onorati, Roberta; Battisti, Antonio] Ist Zooprofilatt Sperimentale Reg Lazio & Toscana, Rome, Italy; [Hendriksen, Rene S.; Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst DTU Food, DK-2800 Lyngby, Denmark; [Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Dell'Omo, Giacomo] Ornis Italica, Rome, Italy	IZS Lazio e Toscana; Technical University of Denmark; University of Rome Tor Vergata	Franco, A (corresponding author), Ist Zooprofilatt Sperimentale Reg Lazio & Toscana, Rome, Italy.	antonio.battisti@izslt.it	Gentile, Gabriele/E-8945-2013; Battisti, Antonio/AAQ-9243-2021; Hendriksen, Rene/A-5755-2013	Gentile, Gabriele/0000-0002-1045-6816; Battisti, Antonio/0000-0003-1308-199X; Hendriksen, Rene S./0000-0003-2934-8214; Aarestrup, Frank/0000-0002-7116-2723; Dell'Omo, Giacomo/0000-0002-9601-9675	Italian Ministry of Education, University and Research (MIUR); Ornis italica; Galapagos National Park	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ornis italica; Galapagos National Park	The research was supported by the Italian Ministry of Education, University and Research (MIUR), with a grant MIUR (2003) to Gabriele Gentile. Giacomo Dell'Omo was supported by Ornis italica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Ms. Cinzia Onorati, Ms. Carmela Buccella, Ms. Roberta Amoruso, Ms. Tamara Cerci (IZSLT), and Mrs. Christina Aaby Svendsen (DTU-Food) for outstanding technical assistance. Additionally, we would like to thank Dr. Karl Pedersen, Mrs. Gitte Sorensen and the zoonosis laboratorium (DTU-Food) for re-testing some of the isolates. We thank the Galapagos National Park for its support.	AIKEN AM, 2010, EUROSURVEILLANCE, P15; [Anonymous], 2002, MICROBIOLOGY FOOD AN; Bohme H, 2009, KLIN PADIATR, V221, P74, DOI 10.1055/s-0028-1112157; Burnham BR, 1998, J AM VET MED ASSOC, V213, P48; Chambers DL, 2006, APPL ENVIRON MICROB, V72, P3771, DOI 10.1128/AEM.72.5.3771-3773.2006; CHIODINI RJ, 1981, AM J EPIDEMIOL, V113, P494, DOI 10.1093/oxfordjournals.aje.a113124; Costantini D, 2005, COMP BIOCHEM PHYS B, V142, P239, DOI 10.1016/j.cbpb.2005.07.011; Cummings KJ, 2009, J DAIRY SCI, V92, P3766, DOI 10.3168/jds.2009-2093; Fabiani A, 2011, ANIM CONSERV, V14, P419, DOI 10.1111/j.1469-1795.2011.00442.x; Gaertner JP, 2008, J WILDLIFE DIS, V44, P519, DOI 10.7589/0090-3558-44.2.519; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hendriksen RS, 2009, J CLIN MICROBIOL, V47, P79, DOI 10.1128/JCM.00894-08; Hidalgo-Vila J, 2008, VET REC, V162, P218, DOI 10.1136/vr.162.7.218; Hidalgo-Vila J, 2007, VET MICROBIOL, V119, P311, DOI 10.1016/j.vetmic.2006.08.012; Hoag JB, 2005, SOUTH MED J, V98, P1123, DOI 10.1097/01.smj.0000177346.07719.00; Kitadai N, 2010, J VET MED SCI, V72, P939, DOI 10.1292/jvms.09-0576; Kodjo A, 1997, J VET MED B, V44, P625, DOI 10.1111/j.1439-0450.1997.tb01016.x; Lourenço Maria Cristina S., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P169, DOI 10.1590/S0036-46652004000300009; Maciel BM, 2010, ZOONOSES PUBLIC HLTH, V57, pE26, DOI 10.1111/j.1863-2378.2009.01283.x; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Milstone AM, 2006, OBSTET GYNECOL, V107, P516, DOI 10.1097/01.AOG.0000187950.37065.87; Molla W, 2006, TROP ANIM HEALTH PRO, V38, P455, DOI 10.1007/s11250-006-4325-4; OBOEGBULEM SI, 1990, J WILDLIFE DIS, V26, P119, DOI 10.7589/0090-3558-26.1.119; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; PIHIER N, 2005, EUROSURVEILLANCE, V11, P270; Popoff MY, 2001, GUIDELINES PREPARATI; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; TABARANI CM, 2010, J PEDIAT, V156, P22; TAUXE RV, 1985, JAMA-J AM MED ASSOC, V12, P237; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Warwick C, 2001, J ROY SOC MED, V94, P124, DOI 10.1177/014107680109400306; Wheeler E, 2011, ENV MICROBIOL REP, V3, P166, DOI 10.1111/j.1758-2229.2010.00203.x; Woodward DL, 1997, J CLIN MICROBIOL, V35, P2786, DOI 10.1128/JCM.35.11.2786-2790.1997	35	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23147	10.1371/journal.pone.0023147	http://dx.doi.org/10.1371/journal.pone.0023147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853080	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200047
J	Genet, F; Jourdan, C; Lautridou, C; Chehensse, C; Minooee, K; Denormandie, P; Schnitzler, A				Genet, Francois; Jourdan, Claire; Lautridou, Christine; Chehensse, Clement; Minooee, Kambiz; Denormandie, Philippe; Schnitzler, Alexis			The Impact of Preoperative Hip Heterotopic Ossification Extent on Recurrence in Patients with Head and Spinal Cord Injury: A Case Control Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BONE-FORMATION; EARLY EXCISION; RESECTION; ELBOW; HEMIPLEGIA; ANTIGENS; COMA; KNEE	Background: The preoperative Heterotopic Ossification (HO) extent is usually one of the main used criteria to predict the recurrence before excision. Brooker et al built a radiologic scale to assess this pre operative extent around the hip. The aim of this study is to investigate the relationship between the recurrence risk after hip HO excision in Traumatic Brain Injury (TBI) and Spinal Cord Injury (SCI) patients and the preoperative extent of HO. Methodology/Principal Findings: A case control study including TBI or SCI patients following surgery for troublesome hip HO with (case, n = 19) or without (control, n = 76) recurrence. Matching criteria were: sex, pathology (SCI or TBI) and age at the time of surgery (+/-4.5 years). For each etiology (TBI and SCI), the residual cognitive and functional status (Garland classification), the preoperative extent (Brooker status), the modified radiological and functional status (GCG-BD classification), HO localization, side, mean age at the CNS damage, mean delay for the first HO surgery, and for the case series, the mean operative delay for recurrence after the first surgical intervention were noted. Conclusions/Significance: The median delay for first HO surgery was 38.6 months (range 4.5 to 414.5;) for the case subgroup and 17.6 months (range 5.7 to 339.6) for the control group. No significant link was found between recurrence and operative delay (p = 0.51); the location around the joint (0.07); the Brooker (p = 0.52) or GCG-BD status (p = 0.79). Including all the matching factors, no significant relationship was found between the recurrence HO risk and the preoperative extent of troublesome hip HO using Brooker status (OR = 1.56(95% CI: 0.47-5.19)) or GCG-BD status (OR class 3 versus 2 = 0.67(95% CI: 0.11-4.24) and OR class 4 versus 2 = 0.79(95% CI: 0.09-6.91)). Until the pathophysiology of HO development is understood, it will be difficult to create tools which can predict HO recurrence.	[Genet, Francois; Jourdan, Claire; Chehensse, Clement; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France; [Minooee, Kambiz] CHU Erasme, Serv Rhumatol & Med Phys, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite Libre de Bruxelles	Genet, F (corresponding author), CHU R Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr						BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Denormandie P, 1999, Chir Main, V18, P99; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; ROSIN AJ, 1975, ANN RHEUM DIS, V34, P499, DOI 10.1136/ard.34.6.499; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Seegenschmiedt MH, 2008, MED RADIOL RADIAT ON, P333, DOI 10.1007/978-3-540-68943-0_18; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	33	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23129	10.1371/journal.pone.0023129	http://dx.doi.org/10.1371/journal.pone.0023129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853078	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200044
J	Ji, WD; Yang, JH; Wang, DM; Cao, L; Tan, WF; Qian, HH; Sun, B; Qian, QJ; Yin, ZF; Wu, MC; Su, CQ				Ji, Weidan; Yang, Jiahe; Wang, Duanming; Cao, Lu; Tan, Weifeng; Qian, Haihua; Sun, Bin; Qian, Qijun; Yin, Zhengfeng; Wu, Mengchao; Su, Changqing			hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers	PLOS ONE			English	Article							HEPARAN-SULFATE GLYCOSAMINOGLYCANS; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; BREAST-CANCER; OVARIAN-CANCER; TUMOR-GROWTH; IN-VIVO; CELLS; EXPRESSION; BINDING	Background: Human sulfatase 1 (hSulf-1) is a heparin-degrading endosulfatase that desulfates cell surface heparan sulfate proteoglycans (HSPGs) in extracellular matrix and negatively modulates heparin-binding growth factor and cytokine signaling in cell proliferation. But hSulf-1 function is more complicated, and its molecular mechanism has not been well known. Principal Findings: To further investigate the functions of hSulf-1 gene in regulating the vascular endothelial growth factor receptor (VEGFR) signaling, a series of vectors expressing hSulf-1, hSulf-1 small hairpin RNA (shRNA) and VEGFR-2 shRNA were generated. hSulf-1 re-expression could downregualte the VEGFR-2 phosphorylation and inhibit cancer cell proliferation both in ovarian and hepatocellular cancer cell lines. Knockdown of hSulf-1 expression by hSulf-1 shRNA enhanced the recovery of high levels of phosphorylated VEGFR-2, and knockdown of VEGFR-2 expression by VEGFR-2 shRNA inhibited the proliferation activity of cancer cells in vitro to some extent. In human cancer xenografts in nude mice, tumor growth was inhibited markedly after injections of adenovirus expressing hSulf-1, with the tumor inhibition rates of 46.19% and 49.56% in ovarian and hepatocellular tumor models, respectively. hSulf-1 expression significantly reduced tumor microvessel density. Conclusions: The results demonstrated that hSulf-1 re-expression both in ovarian and hepatocellular cancer cells induces antitumor efficacy by attenuating the phosphorylation of VEGFR-2 and suppressing angiogenesis. Therefore, hSulf-1-mediated antiproliferation and antiangiogenesis could be a reasonable approach for cancer therapy.	[Ji, Weidan; Yang, Jiahe; Cao, Lu; Tan, Weifeng; Qian, Haihua; Sun, Bin; Qian, Qijun; Yin, Zhengfeng; Wu, Mengchao; Su, Changqing] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp & Inst, Dept Mol Oncol, Shanghai, Peoples R China; [Ji, Weidan; Su, Changqing] Soochow Univ, Coll Med, Med Genet Lab, Suzhou, Peoples R China; [Wang, Duanming] Shihezi Univ, Coll Anim Sci & Technol, Xinjiang, Peoples R China	Naval Medical University; Soochow University - China; Shihezi University	Ji, WD (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp & Inst, Dept Mol Oncol, Shanghai, Peoples R China.	suchangqing@gmail.com	sun, bin/GLR-1711-2022	sun, bin/0000-0002-5082-3326; Su, Changqing/0000-0002-3396-7248	National Natural Scientific Foundation of China [81071866, 30872998]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Scientific Foundation of China (81071866, 30872998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2006, J CLIN PATHOL, V59, P1052, DOI 10.1136/jcp.2005.031716; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; Fang L, 2010, HEPATOL RES, V40, P216, DOI 10.1111/j.1872-034X.2009.00580.x; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Lai JP, 2006, GASTROENTEROLOGY, V130, P2130, DOI 10.1053/j.gastro.2006.02.056; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Liu P, 2009, CANCER RES, V69, P4843, DOI 10.1158/0008-5472.CAN-08-3065; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Perego P, 2010, BIOCHEM PHARMACOL, V80, P1459, DOI 10.1016/j.bcp.2010.07.030; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhao TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012563	35	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23274	10.1371/journal.pone.0023274	http://dx.doi.org/10.1371/journal.pone.0023274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853101	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200061
J	Yende, S; D'Angelo, G; Mayr, F; Kellum, JA; Weissfeld, L; Kaynar, AM; Young, T; Irani, K; Angus, DC				Yende, Sachin; D'Angelo, Gina; Mayr, Florian; Kellum, John A.; Weissfeld, Lisa; Kaynar, A. Murat; Young, Tammy; Irani, Kaikobad; Angus, Derek C.		GenIMS Investigators	Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; C-REACTIVE PROTEIN; OLD MANS FRIEND; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; TERM SURVIVAL; SEVERE SEPSIS; MORTALITY; DISEASE	Background: Acceleration of chronic diseases, particularly cardiovascular disease, may increase long-term mortality after community-acquired pneumonia (CAP), but underlying mechanisms are unknown. Persistence of the prothrombotic state that occurs during an acute infection may increase risk of subsequent atherothrombosis in patients with pre-existing cardiovascular disease and increase subsequent risk of death. We hypothesized that circulating hemostasis markers activated during CAP persist at hospital discharge, when patients appear to have recovered clinically, and are associated with higher mortality, particularly due to cardiovascular causes. Methods: In a cohort of survivors of CAP hospitalization from 28 US sites, we measured D-Dimer, thrombin-antithrombin complexes [TAT], Factor IX, antithrombin, and plasminogen activator inhibitor-1 at hospital discharge, and determined 1-year all-cause and cardiovascular mortality. Results: Of 893 subjects, most did not have severe pneumonia (70.6% never developed severe sepsis) and only 13.4% required intensive care unit admission. At discharge, 88.4% of subjects had normal vital signs and appeared to have clinically recovered. D-dimer and TAT levels were elevated at discharge in 78.8% and 30.1% of all subjects, and in 51.3% and 25.3% of those without severe sepsis. Higher D-dimer and TAT levels were associated with higher risk of all-cause mortality (range of hazard ratios were 1.66-1.17, p = 0.0001 and 1.46-1.04, p = 0.001 after adjusting for demographics and comorbid illnesses) and cardiovascular mortality (p = 0.009 and 0.003 in competing risk analyses). Conclusions: Elevations of TAT and D-dimer levels are common at hospital discharge in patients who appeared to have recovered clinically from pneumonia and are associated with higher risk of subsequent deaths, particularly due to cardiovascular disease.	[Yende, Sachin; Mayr, Florian; Kellum, John A.; Kaynar, A. Murat; Young, Tammy; Angus, Derek C.] Univ Pittsburgh, Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15260 USA; [D'Angelo, Gina] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Weissfeld, Lisa] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Irani, Kaikobad] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA 15261 USA; [Yende, Sachin; Mayr, Florian; Kellum, John A.; Weissfeld, Lisa; Kaynar, A. Murat; Young, Tammy; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yende, S (corresponding author), Univ Pittsburgh, Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15260 USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012; Kellum, John A/HCH-2944-2022; Kaynar, Ata Murat/ABI-6877-2020; Kellum, John/AAP-3072-2020	Kellum, John A/0000-0003-1995-2653; Kaynar, Ata Murat/0000-0001-8847-0450; Kellum, John/0000-0003-1995-2653; Irani, Kaikobad/0000-0001-9194-7387	National Institute of General Medical Sciences (NIGMS) [R01 GM61992, K23 GM083215]; GlaxoSmithKline; Diagnostic Products Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061992, K23GM083215] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); GlaxoSmithKline(GlaxoSmithKline); Diagnostic Products Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GenIMS was funded by National Institute of General Medical Sciences (NIGMS) [R01 GM61992] with additional support from GlaxoSmithKline for enrollment and clinical data collection, and Diagnostic Products Corporation for the cytokine assays. Dr. Yende is supported by NIGMS [K23 GM083215]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bordon J, 2010, CHEST, V138, P279, DOI 10.1378/chest.09-2702; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayton TC, 2008, EUR HEART J, V29, P96, DOI 10.1093/eurheartj/ehm516; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Epstein SE, 2009, CIRCULATION, V119, P3133, DOI 10.1161/CIRCULATIONAHA.109.849455; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Halm EA, 2002, NEW ENGL J MED, V347, P2039, DOI 10.1056/NEJMcp020499; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Hsu JL, 2011, INT J INFECT DIS, V15, pE382, DOI 10.1016/j.ijid.2011.02.002; Kannel WB, 2005, LIPIDS, V40, P1215, DOI 10.1007/s11745-005-1488-8; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kasal J, 2004, CRIT CARE MED, V32, P700, DOI 10.1097/01.CCM.0000114819.37569.4B; Keller TT, 2007, J THROMB HAEMOST, V5, P1567, DOI 10.1111/j.1538-7836.2007.02580.x; Keller TT, 2006, CIRC RES, V99, P1261, DOI 10.1161/01.RES.0000250834.29108.1a; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; TOSCHKE AM, 2008, AGE AGEING AFN232; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; NATL DEATH INDEX	41	72	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22847	10.1371/journal.pone.0022847	http://dx.doi.org/10.1371/journal.pone.0022847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853050	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000295454200023
J	Backer, JA; Nodelijk, G				Backer, Jantien A.; Nodelijk, Gonnie			Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS DIPTERA; BLUETONGUE VIRUS; SIMULATION; EPIDEMIC; EFFICACY	African horse sickness (AHS) is an equine viral disease that is spread by Culicoides spp. Since the closely related disease bluetongue established itself in The Netherlands in 2006, AHS is considered a potential threat for the Dutch horse population. A vector-host model that incorporates the current knowledge of the infection biology is used to explore the effect of different parameters on whether and how the disease will spread, and to assess the effect of control measures. The time of introduction is an important determinant whether and how the disease will spread, depending on temperature and vector season. Given an introduction in the most favourable and constant circumstances, our results identify the vector-to-host ratio as the most important factor, because of its high variability over the country. Furthermore, a higher temperature accelerates the epidemic, while a higher horse density increases the extent of the epidemic. Due to the short infectious period in horses, the obvious clinical signs and the presence of non-susceptible hosts, AHS is expected to invade and spread less easily than bluetongue. Moreover, detection is presumed to be earlier, which allows control measures to be targeted towards elimination of infection sources. We argue that recommended control measures are euthanasia of infected horses with severe clinical signs and vector control in infected herds, protecting horses from midge bites in neighbouring herds, and (prioritized) vaccination of herds farther away, provided that transport regulations are strictly applied. The largest lack of knowledge is the competence and host preference of the different Culicoides species present in temperate regions.	[Backer, Jantien A.; Nodelijk, Gonnie] Cent Vet Inst Wageningen UR, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands	Wageningen University & Research	Backer, JA (corresponding author), Cent Vet Inst Wageningen UR, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	jantien.backer@wur.nl			Dutch Ministry of Economic Affairs, Agriculture and Innovation [BO-08-010-021]	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This work was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (BO-08-010-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; Commission of the European Communities, 2001, OFFICIAL J EUROPEA L, V311, P1; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Gubbins S, 2010, EPIDEMICS, V2; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; HEESTERBEEK JAP, 1995, J BIOL SYST, V3, P779, DOI DOI 10.1016/JMBS.2004.10.013; HOUSE JA, 1994, VACCINE, V12, P142, DOI 10.1016/0264-410X(94)90052-3; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; Lord CC, 1996, J MED ENTOMOL, V33, P328, DOI 10.1093/jmedent/33.3.328; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; Lord CC, 1997, VACCINE, V15, P519, DOI 10.1016/S0264-410X(97)00220-X; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2008, PREV VET MED, V87, P98, DOI 10.1016/j.prevetmed.2008.06.013; MELLOR PS, 1990, EPIDEMIOL INFECT, V105, P447, DOI 10.1017/S0950268800048020; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MULLENS BA, 1991, J AM MOSQUITO CONTR, V7, P588; Rijksen C, 2005, INVENTARISATIE PAARD; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCOTTER DR, 1970, ECOLOGY, V52, P174; Sloet van Oldruitenborgh MM, 2009, INVENTARISATION PRES; Szmaragd C, 2010, EPIDEMICS, V2; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Wittmann EJ, 2002, VACCINE, V20, P1079	31	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23066	10.1371/journal.pone.0023066	http://dx.doi.org/10.1371/journal.pone.0023066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850252	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300037
J	Ma, Y; Jiang, WJ; Liu, QB; Ryuko, S; Kuno, T				Ma, Yan; Jiang, Weijuan; Liu, Qingbin; Ryuko, Sayomi; Kuno, Takayoshi			Genome-Wide Screening for Genes Associated with FK506 Sensitivity in Fission Yeast	PLOS ONE			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-D-GLUCAN SYNTHASE; SCHIZOSACCHAROMYCES-POMBE; CALCINEURIN PHOSPHATASE; DISTINCT PHENOTYPES; EXPRESSION; MEMBRANE; PATHWAY; STRESS	We have been studying calcineurin signal transduction pathway in fission yeast Schizosaccharomyces pombe (S. pombe) by developing a genetic screen for mutants that show hypersensitivity to the immunosuppressive calcineurin inhibitor FK506 (tacrolimus). In the present study, to identify nonessential genes that are functionally related to the calcineurin signaling pathway, we performed a genome-wide screen of 3004 haploid deletion strains and confirmed 72 deletion strains to be FK506 sensitive. These 72 genes are classified into nine functional groups to include membrane trafficking (16 genes), signal transduction (10 genes), ubiquitination (8 genes), chromatin remodeling (6 genes), cytokinesis (4 genes), ribosomal protein (3 genes), RNA binding protein (3 genes), and a variety of other known functions (17 genes) or still unknown functions (5 genes) in the biological system. In our previous screening of FK506-sensitive mutants we isolated several membrane-trafficking mutants showing defective cell wall integrity. Here, we further examined the vacuolar fusion, the v-SNARE synaptobrevin Syb1 localization, and the sensitivity to the beta-glucan synthase inhibitor micafungin in these 72 FK506-sensitive strains. Results showed that 25 deletion strains exhibited abnormal vacuole fusion, 19 deletion strains exhibited Syb1 mislocalization, and 14 deletion strains exhibited both abnormal vacuole fusion and Syb1 mislocalization, while 42 deletion strains showed both normal vacuole fusion and Syb1 localization. Likewise, 16 deletion strains showed sensitivity to micafungin. Altogether, our present study indicates that calcineurin mediates a plethora of physiological processes in fission yeast, and that calcineurin is extensively involved in cross-talk between signaling pathways.	[Ma, Yan; Jiang, Weijuan; Liu, Qingbin; Ryuko, Sayomi; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan	Kobe University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [22390048, 21790241]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by Grant-in-Aid for Scientific Research, on Scientific Research (B) to Takayoshi Kuno (No. 22390048) and on Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanapola SL, 2009, J CELL SCI, V122, P3856, DOI 10.1242/jcs.053959; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; EIDELMAN BH, 1991, TRANSPLANT P, V23, P3175; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fujita M, 2002, GENETICS, V161, P971; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; He Y, 2006, GENES CELLS, V11, P207, DOI 10.1111/j.1365-2443.2006.00935.x; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Iwaki T, 2004, YEAST, V21, P867, DOI 10.1002/yea.1134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Knoll GA, 2009, AM J KIDNEY DIS, V54, P1131, DOI 10.1053/j.ajkd.2009.06.031; Lu YB, 2002, GENES CELLS, V7, P1009, DOI 10.1046/j.1365-2443.2002.00582.x; Ma Y, 2006, GENETICS, V174, P1259, DOI 10.1534/genetics.106.064709; Ma Y, 2010, MOL GENET GENOMICS, V284, P161, DOI 10.1007/s00438-010-0550-7; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; McCourtie AS, 2010, ANN THORAC SURG, V89, P1766, DOI 10.1016/j.athoracsur.2010.02.068; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Park SY, 2001, J BIOL CHEM, V276, P28694, DOI 10.1074/jbc.M101185200; Parsons SA, 2007, J BIOL CHEM, V282, P10068, DOI 10.1074/jbc.M609368200; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; Webster AC, 2008, AM J TRANSPLANT, V8, P2185, DOI 10.1111/j.1600-6143.2008.02385.x; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	47	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23422	10.1371/journal.pone.0023422	http://dx.doi.org/10.1371/journal.pone.0023422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850271	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300056
J	Ruckert, IM; Heier, M; Rathmann, W; Baumeister, SE; Doring, A; Meisinger, C				Rueckert, Ina-Maria; Heier, Margit; Rathmann, Wolfgang; Baumeister, Sebastian E.; Doering, Angela; Meisinger, Christa			Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study	PLOS ONE			English	Article							CATALYTIC-ACTIVITY CONCENTRATIONS; GAMMA-GLUTAMYL-TRANSFERASE; APPROVED RECOMMENDATION 1985; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; 2-OXOGLUTARATE AMINOTRANSFERASE; METABOLIC SYNDROME; FASTING GLUCOSE; IFCC METHODS	Objective: To investigate whether the elevated liver enzymes gamma-glutamyltransferase (GGT), glutamate-pyruvate transaminase (GPT), glutamate-oxalacetate transaminase (GOT) and alkaline phosphatase (AP) and non-alcoholic fatty liver disease (NAFLD) respectively are independently associated with pre-diabetic states, namely impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) or known and newly diagnosed diabetes (NDD), in men and women from the general German population. Methods: The study was based on 3009 subjects (1556 females, 1453 males) aged 32 to 81 years who participated in the KORA-F4-Study in 2006/2008 in Augsburg, Southern Germany. All non-diabetic participants underwent an oral glucose tolerance test to assess disturbances in glucose metabolism. NAFLD was estimated by liver enzyme concentrations and the Bedogni Fatty Liver Index (FLI). Results: 229 participants (7.6%) reported known diabetes, 106 had NDD (3.5%), 107 (3.6%) had IFG, 309 (10.3%) had IGT, 69 (2.3%) were affected with both metabolic disorders (IFG/IGT) and 74 (2.5%) could not be classified. GGT and GPT were significantly elevated in persons with pre-diabetes and diabetes (GGT in diabetic persons OR = 1.76, [1.47-2.09], in IFG OR = 1.79 [1.50-2.13], GPT in diabetic persons OR = 1.51, [1.30-1.74], in NDD OR = 1.77 [1.52-2.06]), GOT and AP only inconsistently in some pre-diabetes groups. The effects were sharpened in models using an increase of two or three out of three enzymes as an estimate of fatty liver and especially in models using the FLI. Overall frequency of NAFLD applying the index was 39.8% (women: 27.3% and men: 53.2%). In participants with fatty liver disease, the OR for NDD adjusted for sex and age was 8.48 [5.13-14.00], 6.70 [3.74-12.01] for combined IFG and IGT and 4.78 [3.47-6.59] for known diabetes respectively. Conclusions: Elevated GGT and GPT-values as well as estimates of fatty liver disease are significantly associated with prediabetes and diabetes and thus very useful first indicators of a disturbed glucose metabolism.	[Rueckert, Ina-Maria; Heier, Margit; Doering, Angela; Meisinger, Christa] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Heier, Margit; Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Baumeister, Sebastian E.] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Doering, Angela] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ruckert, IM (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany.	ina-maria.rueckert@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Baumeister, Sebastian-Edgar/P-7894-2019	Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen; German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation [RA 459/2-1]; Nationales Aktionsforum Diabetes mellitus (NAFDM); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation; Nationales Aktionsforum Diabetes mellitus (NAFDM); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Diabetes Study was funded by a German Diabetes Foundation project grant to W. Rathmann (RA 459/2-1) and by a grant from the Nationales Aktionsforum Diabetes mellitus (NAFDM). The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alisi A, 2009, ANN HEPATOL, V8, pS44, DOI 10.1016/S1665-2681(19)31826-5; [Anonymous], 1995, PHYS STAT US INT ANT; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P497; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Caldwell SH, 2007, J GASTROEN HEPATOL, V22, pS11, DOI 10.1111/j.1440-1746.2006.04639.x; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Grant Lafaine M, 2004, Ann Hepatol, V3, P93; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Manco M, 2008, HEPATOLOGY, V48, P2087, DOI 10.1002/hep.22631; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P725, DOI 10.1515/CCLM.2002.125; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; Schumann G, 2006, CLIN CHEM LAB MED, V44, P1146, DOI 10.1515/CCLM.2006.212; Shin JY, 2009, DIABETES RES CLIN PR, V84, P152, DOI 10.1016/j.diabres.2009.02.004; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; THOMAS L, 2005, J LAB MED, V29, P301, DOI DOI 10.1515/JLM.2005.041; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yun JW, 2009, LIVER INT, V29, P525, DOI 10.1111/j.1478-3231.2008.01920.x	38	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22932	10.1371/journal.pone.0022932	http://dx.doi.org/10.1371/journal.pone.0022932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850244	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300029
J	Smaldino, PE; Lubell, M				Smaldino, Paul E.; Lubell, Mark			An Institutional Mechanism for Assortment in an Ecology of Games	PLOS ONE			English	Article							COOPERATION; PUNISHMENT; EVOLUTION; REPUTATION; EMERGENCE	Recent research has revived Long's "ecology of games" model to analyze how social actors cooperate in the context of multiple political and social games. However, there is still a paucity of theoretical work that considers the mechanisms by which large-scale cooperation can be promoted in a dynamic institutional landscape, in which actors can join new games and leave old ones. This paper develops an agent-based model of an ecology of games where agents participate in multiple public goods games. In addition to contribution decisions, the agents can leave and join different games, and these processes are de-coupled. We show that the payoff for cooperation is greater than for defection when limits to the number of actors per game ("capacity constraints") structure the population in ways that allow cooperators to cluster, independent of any complex individual-level mechanisms such as reputation or punishment. Our model suggests that capacity constraints are one effective mechanism for producing positive assortment and increasing cooperation in an ecology of games. The results suggest an important trade-off between the inclusiveness of policy processes and cooperation: Fully inclusive policy processes reduce the chances of cooperation.	[Smaldino, Paul E.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Lubell, Mark] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Smaldino, PE (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	pesmaldino@ucdavis.edu	Lubell, Mark/H-5018-2012	Smaldino, Paul/0000-0002-7133-5620; Lubell, Mark/0000-0001-5757-7116	National Science Foundation [0921904]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant 0921904 (to ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SWIMMING UPSTREAM CO, DOI DOI 10.7551/MITPRESS/6577.001.0001; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Giddens A, 1984, CONSTITUTION SOC OUT; Gigerenzer G., 2008, RATIONALITY MORTALS; Gintis H., 2000, GAME THEORY EVOLVING; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Li YX, 2010, PHYSICA A, V389, P1090, DOI 10.1016/j.physa.2009.11.010; LONG NE, 1958, AM J SOCIOL, V64, P251, DOI 10.1086/222468; Lubell M, 2010, AM J POLIT SCI, V54, P287, DOI 10.1111/j.1540-5907.2010.00431.x; McElreath R., 2007, MATH MODELS SOCIAL E; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; North D. C., 1990, I I CHANGE EC PERFOR; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; O'Leary R, 2006, PUBLIC ADMIN REV, V66, P6, DOI 10.1111/j.1540-6210.2006.00661.x; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; OLSON M., 1971, LOGIC COLLECTIVE ACT; Ostrom E., 1990, GOVERNING COMMONS EV; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Skyrms B, 2009, SPRINGER SER GAME TH, P105, DOI 10.1007/978-3-540-85436-4_6; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Williamson O.E., 1983, MARKETS HIERARCHIES; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006	40	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23019	10.1371/journal.pone.0023019	http://dx.doi.org/10.1371/journal.pone.0023019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850249	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300034
J	Laufer, I; Negishi, M; Lacadie, CM; Papademetris, X; Constable, RT				Laufer, Ilan; Negishi, Michiro; Lacadie, Cheryl M.; Papademetris, Xenophon; Constable, R. Todd			Dissociation between the Activity of the Right Middle Frontal Gyrus and the Middle Temporal Gyrus in Processing Semantic Priming	PLOS ONE			English	Article							REPETITION SUPPRESSION; COGNITIVE MECHANISMS; CONCEPTUAL RELATIONS; BRAIN ACTIVITY; FMRI; SPEECH; WORDS; NETWORK; ORGANIZATION; RECOGNITION	The aim of this event-related functional magnetic resonance imaging (fMRI) study was to test whether the right middle frontal gyrus (MFG) and middle temporal gyrus (MTG) would show differential sensitivity to the effect of prime-target association strength on repetition priming. In the experimental condition (RP), the target occurred after repetitive presentation of the prime within an oddball design. In the control condition (CTR), the target followed a single presentation of the prime with equal probability of the target as in RP. To manipulate semantic overlap between the prime and the target both conditions (RP and CTR) employed either the onomatopoeia "oink" as the prime and the referent "pig" as the target (OP) or vice-versa (PO) since semantic overlap was previously shown to be greater in OP. The results showed that the left MTG was sensitive to release of adaptation while both the right MTG and MFG were sensitive to sequence regularity extraction and its verification. However, dissociated activity between OP and PO was revealed in RP only in the right MFG. Specifically, target "pig" (OP) and the physically equivalent target in CTR elicited comparable deactivations whereas target "oink" (PO) elicited less inhibited response in RP than in CTR. This interaction in the right MFG was explained by integrating these effects into a competition model between perceptual and conceptual effects in priming processing.	[Laufer, Ilan; Negishi, Michiro; Lacadie, Cheryl M.; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Biomed Engn, New Haven, CT USA	Yale University; Yale University	Laufer, I (corresponding author), Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA.	ilan.laufer@yale.edu	Constable, R. Todd/ABE-8038-2021	Constable, R. Todd/0000-0001-5661-9521	NIH [R01 NS051622]; National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB) [1 R01 EB006494-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (http://www.nih.gov/) R01 NS051622. The authors acknowledge support for the Bioimagesuite software used in the fMRI analysis from the National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB) under grant 1 R01 EB006494-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Benoit MM, 2010, HUM BRAIN MAPP, V31, P526, DOI 10.1002/hbm.20884; Bubic A, 2009, J COGNITIVE NEUROSCI, V21, P155, DOI 10.1162/jocn.2009.21013; Buhler M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-30; Chang EF, 2011, J COGNITIVE NEUROSCI, V23, P1437, DOI 10.1162/jocn.2010.21466; Copland DA, 2003, NEUROIMAGE, V20, P302, DOI 10.1016/S1053-8119(03)00279-9; Copland DA, 2007, BRAIN RES, V1131, P163, DOI 10.1016/j.brainres.2006.11.016; De Lucia M, 2010, CEREB CORTEX, V20, P1676, DOI 10.1093/cercor/bhp230; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Friedman D, 2003, COGNITIVE BRAIN RES, V18, P58, DOI 10.1016/j.cogbrainres.2003.09.002; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Ghuman AS, 2008, P NATL ACAD SCI USA, V105, P8405, DOI 10.1073/pnas.0710674105; Giesbrecht B, 2004, CEREB CORTEX, V14, P521, DOI 10.1093/cercor/bhh014; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hill H, 2002, INT J PSYCHOPHYSIOL, V44, P197, DOI 10.1016/S0167-8760(01)00202-1; Huettel SA, 2004, NEUROIMAGE, V23, P402, DOI 10.1016/j.neuroimage.2004.04.031; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Kircher T, 2009, HUM BRAIN MAPP, V30, P4116, DOI 10.1002/hbm.20833; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Kreher DA, 2006, PSYCHOPHYSIOLOGY, V43, P550, DOI 10.1111/j.1469-8986.2006.00460.x; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Laufer I, 2008, BRAIN STRUCT FUNCT, V212, P427, DOI 10.1007/s00429-007-0167-8; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Matsumoto A, 2005, NEUROIMAGE, V24, P624, DOI 10.1016/j.neuroimage.2004.09.008; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Noppeney U, 2008, CEREB CORTEX, V18, P598, DOI 10.1093/cercor/bhm091; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Pariyadath V, 2008, NAT PREC; Peelle JE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00051; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Raposo A, 2006, NEUROPSYCHOLOGIA, V44, P2284, DOI 10.1016/j.neuropsychologia.2006.05.017; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sachs O, 2008, BRAIN RES, V1218, P194, DOI 10.1016/j.brainres.2008.03.045; Sachs O, 2011, J COGNITIVE NEUROSCI, V23, P1263, DOI 10.1162/jocn.2010.21483; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Talairach J., 1988, COPLANAR STEREOTAXIS; Tivarus ME, 2006, COGN BEHAV NEUROL, V19, P194; Vossel S, 2011, J COGNITIVE NEUROSCI, V23, P414, DOI 10.1162/jocn.2010.21441; Wheatley T, 2005, J COGNITIVE NEUROSCI, V17, P1871, DOI 10.1162/089892905775008689; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Whitney C, 2011, CEREB CORTEX, V21, P831, DOI 10.1093/cercor/bhq148; Wible CG, 2006, BRAIN LANG, V97, P294, DOI 10.1016/j.bandl.2005.11.006; Wig GS, 2009, J NEUROPHYSIOL, V101, P2632, DOI 10.1152/jn.91213.2008; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Zevin JD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-4	62	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22368	10.1371/journal.pone.0022368	http://dx.doi.org/10.1371/journal.pone.0022368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829619	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200016
J	Meskaldji, DE; Ottet, MC; Cammoun, L; Hagmann, P; Meuli, R; Eliez, S; Thiran, JP; Morgenthaler, S				Meskaldji, Djalel Eddine; Ottet, Marie-Christine; Cammoun, Leila; Hagmann, Patric; Meuli, Reto; Eliez, Stephan; Thiran, Jean Philippe; Morgenthaler, Stephan			Adaptive Strategy for the Statistical Analysis of Connectomes	PLOS ONE			English	Article							CARDIO-FACIAL-SYNDROME; FALSE DISCOVERY RATE; VELOCARDIOFACIAL SYNDROME; SYNDROME DELETION; BRAIN; CONNECTIVITY; ARCHITECTURE; ADOLESCENTS; CHILDREN; 22Q11.2	We study an adaptive statistical approach to analyze brain networks represented by brain connection matrices of interregional connectivity (connectomes). Our approach is at a middle level between a global analysis and single connections analysis by considering subnetworks of the global brain network. These subnetworks represent either the inter-connectivity between two brain anatomical regions or by the intra-connectivity within the same brain anatomical region. An appropriate summary statistic, that characterizes a meaningful feature of the subnetwork, is evaluated. Based on this summary statistic, a statistical test is performed to derive the corresponding p-value. The reformulation of the problem in this way reduces the number of statistical tests in an orderly fashion based on our understanding of the problem. Considering the global testing problem, the p-values are corrected to control the rate of false discoveries. Finally, the procedure is followed by a local investigation within the significant subnetworks. We contrast this strategy with the one based on the individual measures in terms of power. We show that this strategy has a great potential, in particular in cases where the subnetworks are well defined and the summary statistics are properly chosen. As an application example, we compare structural brain connection matrices of two groups of subjects with a 22q11.2 deletion syndrome, distinguished by their IQ scores.	[Meskaldji, Djalel Eddine; Cammoun, Leila; Thiran, Jean Philippe] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [Ottet, Marie-Christine; Eliez, Stephan] Off Medicopedag OMP, Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Lausanne CHUV UNIL, Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland; [Morgenthaler, Stephan] Ecole Polytech Fed Lausanne, Inst Math, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Meskaldji, DE (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland.	djalel.meskaldji@epfl.ch		Thiran, Jean-Philippe/0000-0003-2938-9657	Swiss National Science Foundation [205321-121945]; Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL),; Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaire de Geneve (HUG); Leenaards and the Jeantet Foundations; Swiss SNF SPUM [33CM30-124089]; Swiss National Research Funds [32473B-121996]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL),; Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaire de Geneve (HUG); Leenaards and the Jeantet Foundations; Swiss SNF SPUM; Swiss National Research Funds(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation under grant number 205321-121945, by the Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaire de Geneve (HUG), the Leenaards and the Jeantet Foundations, the Swiss SNF SPUM project number 33CM30-124089 and the Swiss National Research Funds to Dr. Stephan Eliez number 32473B-121996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2007, J AM STAT ASSOC, V102, P1272, DOI 10.1198/016214507000000941; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; BRILLINGER DR, 1990, SURV METHODOL, V16, P255; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; De Smedt B, 2007, J INTELL DISABIL RES, V51, P666, DOI 10.1111/j.1365-2788.2007.00955.x; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DUDOIT S, 2008, SPRINGER SER STAT; Dunnett C.W., 2004, LECT NOTES MONOGRAPH, V47, P48; EINOT I, 1975, J AM STAT ASSOC, V70, P574, DOI 10.2307/2285935; Eliez S, 2002, BIOL PSYCHIAT, V52, P68, DOI 10.1016/S0006-3223(02)01361-6; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Genovese CR, 1999, BAYESIAN STATISTICS 6, P255; Gothelf D, 2007, SCHIZOPHR RES, V96, P72, DOI 10.1016/j.schres.2007.07.021; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hochberg Y., 1987, WILEY SERIES PROBABI; Kates WR, 2004, J CHILD NEUROL, V19, P337, DOI 10.1177/088307380401900506; Kwong KS, 2002, J STAT PLAN INFER, V104, P351, DOI 10.1016/S0378-3758(01)00252-X; Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047; Penny W, 2003, IEEE T MED IMAGING, V22, P504, DOI 10.1109/TMI.2003.809140; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sarkar SK, 2008, TEST-SPAIN, V17, P450, DOI 10.1007/s11749-008-0129-3; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	34	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23009	10.1371/journal.pone.0023009	http://dx.doi.org/10.1371/journal.pone.0023009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829681	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200042
J	de Sousa, TN; Carvalho, LH; de Brito, CFA				de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira			Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; POPULATION-STRUCTURE; LIGAND DOMAIN; INHIBITORY ANTIBODIES; NATURAL-SELECTION; BLOOD-GROUP; ANTIGEN; INFECTION; POLYMORPHISMS; TRANSMISSION	The dependence of Plasmodium vivax on invasion mediated by Duffy binding protein (DBP) makes this protein a prime candidate for development of a vaccine. However, the development of a DBP-based vaccine might be hampered by the high variability of the protein ligand (DBPII), known to bias the immune response toward a specific DBP variant. Here, the hypothesis being investigated is that the analysis of the worldwide DBPII sequences will allow us to determine the minimum number of haplotypes (MNH) to be included in a DBP-based vaccine of broad coverage. For that, all DBPII sequences available were compiled and MNH was based on the most frequent nonsynonymous single nucleotide polymorphisms, the majority mapped on B and T cell epitopes. A preliminary analysis of DBPII genetic diversity from eight malaria-endemic countries estimated that a number between two to six DBP haplotypes (17 in total) would target at least 50% of parasite population circulating in each endemic region. Aiming to avoid region-specific haplotypes, we next analyzed the MNH that broadly cover worldwide parasite population. The results demonstrated that seven haplotypes would be required to cover around 60% of DBPII sequences available. Trying to validate these selected haplotypes per country, we found that five out of the eight countries will be covered by the MNH (67% of parasite populations, range 48-84%). In addition, to identify related subgroups of DBPII sequences we used a Bayesian clustering algorithm. The algorithm grouped all DBPII sequences in six populations that were independent of geographic origin, with ancestral populations present in different proportions in each country. In conclusion, in this first attempt to undertake a global analysis about DBPII variability, the results suggest that the development of DBP-based vaccine should consider multi-haplotype strategies; otherwise a putative P. vivax vaccine may not target some parasite populations.	[de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira] Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	de Sousa, TN (corresponding author), Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil.	cristiana@cpqrr.fiocruz.br	Carvalho, Luzia H/AAW-3461-2021; carvalho, luzia H/C-4087-2013; de Sousa, Tais Nobrega/AAG-6225-2019	de Sousa, Tais Nobrega/0000-0002-6874-9427	Research Foundation of Minas Gerais State (FAPEMIG); The Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ); CNPq (TNS, LHC and CFAB)	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); The Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (TNS, LHC and CFAB)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), The Brazilian National Research Council (CNPq), and Oswaldo Cruz Foundation (FIOCRUZ, PAPES V) and Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ). Scholarships from CNPq (TNS, LHC and CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Babaeekho L, 2009, AM J TROP MED HYG, V80, P112, DOI 10.4269/ajtmh.2009.80.112; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bolton MJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-45; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Cole-Tobian JL, 2007, AM J TROP MED HYG, V77, P955, DOI 10.4269/ajtmh.2007.77.955; Cole-Tobian JL, 2009, INFECT IMMUN, V77, P4009, DOI 10.1128/IAI.00158-09; Cole-Tobian JL, 2005, AM J TROP MED HYG, V73, P626, DOI 10.4269/ajtmh.2005.73.626; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gosi P, 2007, AM J TROP MED HYG, V77, P247; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2002, MOL BIOL EVOL, V19, P1128, DOI 10.1093/oxfordjournals.molbev.a004171; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MONS B, 1988, EXP PARASITOL, V66, P183, DOI 10.1016/0014-4894(88)90089-6; PREMARATNE PH, 2011, INFECT GENET EV 0428; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Pritchard JK, 2000, GENETICS, V155, P945; Rezende AM, 2010, TROP MED INT HEALTH, V15, P718, DOI 10.1111/j.1365-3156.2010.02535.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Saravia C, 2008, BIOCHEM BIOPH RES CO, V377, P1279, DOI 10.1016/j.bbrc.2008.10.153; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Sousa TN, 2007, VOX SANG, V92, P373, DOI 10.1111/j.1423-0410.2007.00902.x; Sousa TN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-334; Sousa TN, 2006, MOL BIOCHEM PARASIT, V146, P251, DOI 10.1016/j.molbiopara.2005.11.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; WELCH SG, 1977, T ROY SOC TROP MED H, V71, P295, DOI 10.1016/0035-9203(77)90102-X	63	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22944	10.1371/journal.pone.0022944	http://dx.doi.org/10.1371/journal.pone.0022944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829672	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511900017
J	Fiore-Donno, AM; Novozhilov, YK; Meyer, M; Schnittler, M				Fiore-Donno, Anna Maria; Novozhilov, Yuri K.; Meyer, Marianne; Schnittler, Martin			Genetic Structure of Two Protist Species (Myxogastria, Amoebozoa) Suggests Asexual Reproduction in Sexual Amoebae	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; PHYSARUM-POLYCEPHALUM; SLIME-MOLDS; DICTYOSTELIUM; REVEALS; SYSTEMS; DIVERSITY; EVOLUTION; HYPERAMOEBA; PHYLOGENY	Plasmodial slime molds (Myxogastria or Myxomycetes) are common and widespread unicellular organisms that are commonly assumed to have a sexual life cycle culminating with the formation of often macroscopic fruiting bodies that efficiently disseminate spores. However, laboratory studies based on mating compatibility revealed the coexistence of asexual as well as sexual strains. To test this hypothesis in natural populations, we investigated the genetic variability of two species of the genus Lamproderma. Detailed ecological releve's were carried out in 2007 and 2009 in several deep ravines in the Elbsandsteingebirge (Saxony, south-eastern Germany). Morphological characters of 93 specimens of Lamproderma were recorded and genetic analyses, based on the small subunit ribosomal gene, the internal transcribed spacer 1 and partial elongation factor 1 alpha sequences were carried out for 52 specimens. Genetic analyses showed the existence of two major clades, each composed of several discrete lineages. Most of these lineages were composed of several identical sequences (SSU, ITS 1 and EF-1 alpha) which is explained best by an asexual mode of reproduction. Detrended Correspondence Analysis of morphological characters revealed two morphospecies that corresponded to the two major clades, except for one genotype (Lc6), thus challenging the morphospecies concept. Genetic patterns were not related to the geographical distribution: specimens belonging to the same genotype were found in distinct ravines, suggesting effective long-distance dispersal via spores, except for the Lc6 genotype which was found only in one ravine. Implications for the morphological and biological species concept are discussed.	[Fiore-Donno, Anna Maria; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Novozhilov, Yuri K.] Russian Acad Sci, VL Komarov Bot Inst, Lab Systemat & Geog Fungi, St Petersburg 196140, Russia; [Meyer, Marianne] Le Bayet, Rognaix, France	Ernst Moritz Arndt Universitat Greifswald; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Fiore-Donno, AM (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	afiore-donno6@infomaniak.ch	Novozhilov, Yuri/H-5161-2013; Schnittler, Martin/A-8916-2013	Novozhilov, Yuri/0000-0001-8875-2263; Fiore-Donno, Anna Maria/0000-0001-6265-1907	Ernst Moritz Arndt University of Greifswald; Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia'' [P1300]; RFBR [10-04-00536a]; Deutsche Forschungsgemeinschaft [SCHN1080-2/1]	Ernst Moritz Arndt University of Greifswald; Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia''; RFBR(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by a travel grant of the Ernst Moritz Arndt University of Greifswald, the Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia'' (project P1300) and grant RFBR 10-04-00536a to the second author. Publication was supported by a grant of the Deutsche Forschungsgemeinschaft to the first and last authors (SCHN1080-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; BETTERLEY DA, 1983, MYCOLOGIA, V75, P1044, DOI 10.2307/3792661; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Clark J, 1997, MYCOLOGIA, V89, P241, DOI 10.2307/3761077; CLARK J, 1993, MYCOLOGIA, V85, P764, DOI 10.2307/3760607; Clark J, 2010, MYCOSPHERE, V1, P337; COLLINS O R, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P101; COLLINS OR, 1975, MYCOLOGIA, V67, P98, DOI 10.2307/3758232; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; de Meeus T, 2007, CELL MOL LIFE SCI, V64, P1355, DOI 10.1007/s00018-007-6515-2; Dunthorn M, 2010, TRENDS MICROBIOL, V18, P183, DOI 10.1016/j.tim.2010.02.005; ElHage N, 2000, MYCOLOGIA, V92, P54, DOI 10.2307/3761450; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Fiore-Donno AM, 2008, MOL PHYLOGENET EVOL, V46, P878, DOI 10.1016/j.ympev.2007.12.011; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Glockner G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-6; GREEN RF, 1995, J THEOR BIOL, V174, P87, DOI 10.1006/jtbi.1995.0081; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARKONEN M, 1978, Karstenia, V18, P20; Hood GM, 2009, POPTOOLS V 3 1 1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ING B, 1994, NEW PHYTOL, V126, P175, DOI 10.1111/j.1469-8137.1994.tb03937.x; ING B, 1983, J BIOGEOGR, V10, P299, DOI 10.2307/2844739; Ishida K, 2005, DEV GROWTH DIFFER, V47, P25; JOHANSEN T, 1988, CURR GENET, V14, P265, DOI 10.1007/BF00376747; Jolliffe I.T, 2002, PRINCIPAL COMPONENTS, V2nd, P487; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Lado C., 2001, CUADERNOS TRABAJO FL, V16, P1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; Martin MP, 2003, MYCOLOGIA, V95, P474, DOI 10.2307/3761889; McCune B., 2006, PC ORD MULTIVARIATE; Nassonova E, 2010, PROTIST, V161, P102, DOI 10.1016/j.protis.2009.07.003; Neubert H, 1990, BEITR KENNTN PILZE M, V6, P49; Neubert H, 2000, STEMONITALES, P391; Olive LS, 1975, MYCETOZOANS; Otto SP, 2006, BIOCHEM SOC T, V34, P519, DOI 10.1042/BST0340519; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Poulain M, 2011, MYXOMYCETES SEVRIER; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; Schnittler M, 2008, MYCOL RES, V112, P697, DOI 10.1016/j.mycres.2008.01.012; Schnittler M, 2010, NOVA HEDWIGIA, V90, P277, DOI 10.1127/0029-5035/2010/0090-0277; Song J, 2005, PLOS COMPUT BIOL, V1, P579, DOI 10.1371/journal.pcbi.0010071; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stephenson SL, 2008, BIODIVERS CONSERV, V17, P285, DOI 10.1007/s10531-007-9252-9; THERRIEN CD, 1977, AM J BOT, V64, P286, DOI 10.2307/2441972; Tsuchiya M, 2003, J FORAMIN RES, V33, P285, DOI 10.2113/0330285; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Watkins RF, 2008, PROTIST, V159, P269, DOI 10.1016/j.protis.2007.12.001; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698	58	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22872	10.1371/journal.pone.0022872	http://dx.doi.org/10.1371/journal.pone.0022872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829662	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511200024
J	Huang, L; Pan, CQ; Li, BW; Tucker-Kellogg, L; Tidor, B; Chen, YZ; Low, BC				Huang, Lu; Pan, Catherine Qiurong; Li, Baowen; Tucker-Kellogg, Lisa; Tidor, Bruce; Chen, Yuzong; Low, Boon Chuan			Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MAP KINASE CASCADE; FACTOR-RECEPTOR; RHO-KINASE; PC12 CELLS; IN-VIVO; DOWN-REGULATION; ACTIVATION; CANCER; PATHWAY	ERK activation is enhanced by the scaffolding proteins KSR and MP1, localized near the cell membrane and late endosomes respectively, but little is known about their dynamic interplay. We develop here a mathematical model with ordinary differential equations to describe the dynamic activation of EGFR-ERK signaling under a conventional pathway without scaffolds, a KSR-scaffolded pathway, and an MP1-scaffolded pathway, and their impacts were examined under the influence of the endosomal regulators, Cbl-CIN85 and Endophilin A1. This new integrated model, validated against experimental results and computational constraints, shows that changes of ERK activation and EGFR endocytosis in response to EGF concentrations (i. e ligand sensitivity) depend on these scaffold proteins and regulators. The KSR-scaffolded and the conventional pathways act synergistically and are sensitive to EGF stimulation. When the KSR level is high, the sensitivity of ERK activation from this combined pathway remains low when Cbl-CIN85 level is low. But, such sensitivity can be increased with increasing levels of Endophilin if Cbl-CIN85 level becomes high. However, reduced KSR levels already present high sensitivity independent of Endophilin levels. In contrast, ERK activation by MP1 is additive to that of KSR but it shows little ligand-sensitivity under high levels of EGF. This can be partly reversed by increasing level of Endophilin while keeping CblCIN85 level low. Further analyses showed that high levels of KSR affect ligand-sensitivity of EGFR endocytosis whereas MP1 ensures the robustness of endosomal ERK activation. These simulations constitute a multi-dimensional exploration of how EGF-dependent EGFR endocytosis and ERK activation are dynamically affected by scaffolds KSR and MP1, co-regulated by Cbl-CIN85 and Endophilin A1. Together, these results provide a detailed and quantitative demonstration of how regulators and scaffolds can collaborate to fine-tune the ligand-dependent sensitivity of EGFR endocytosis and ERK activation which could underlie differences during normal physiology, disease states and drug responses.	[Huang, Lu; Tucker-Kellogg, Lisa; Tidor, Bruce; Chen, Yuzong; Low, Boon Chuan] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore; [Chen, Yuzong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Tidor, Bruce] MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tidor, Bruce] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Pan, Catherine Qiurong; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Huang, Lu; Pan, Catherine Qiurong; Tucker-Kellogg, Lisa; Low, Boon Chuan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; National University of Singapore	Huang, L (corresponding author), Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore.	phacyz@nus.edu.sg; dbslowbc@nus.edu.sg	Huang, Lu/J-8841-2019; Low, Boon Chuan/AAU-7685-2021; Li, Baowen/G-3003-2011; Tucker-Kellogg, Lisa/G-3376-2012; Tucker-Kellogg, Lisa/AAD-9265-2022; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Li, Baowen/0000-0002-8728-520X; Tucker-Kellogg, Lisa/0000-0002-1301-7069; Low, Boon Chuan/0000-0003-0756-096X; Chen, Yu Zong/0000-0002-5473-8022; Huang, Lan/0000-0001-9594-4722; /0000-0002-3320-3969	National University of Singapore [R-148-000-081-112/101]; Singapore-MIT Alliance; Singapore National Research Foundation; Singapore National Research Foundation and the Ministry of Education, Singapore	National University of Singapore(National University of Singapore); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Singapore National Research Foundation(National Research Foundation, Singapore); Singapore National Research Foundation and the Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by Academic Research Fund (R-148-000-081-112/101) from the National University of Singapore, the Computation and Systems Biology Program of Singapore-MIT Alliance, the Singapore-MIT Alliance for Research and Technology (through funding from the Singapore National Research Foundation), and also from the Mechanobiology Institute of Singapore (co-funded by the Singapore National Research Foundation and the Ministry of Education, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; D'Alessio A, 2007, CELL SIGNAL, V19, P1193, DOI 10.1016/j.cellsig.2006.12.011; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Faried LS, 2006, ONCOL REP, V16, P57; Giurisato E, 2009, MOL CELL BIOL, V29, P1554, DOI 10.1128/MCB.01421-08; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kolesnick R, 2004, J CLIN INVEST, V114, P1233, DOI 10.1172/JCI200423441; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; KURACHI H, 1985, J ENDOCRINOL, V106, P197, DOI 10.1677/joe.0.1060197; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lazzara MJ, 2010, CANCER RES, V70, P3843, DOI 10.1158/0008-5472.CAN-09-3421; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu G, 2005, BIOINFORMATICS, V21, P1194, DOI 10.1093/bioinformatics/bti118; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Lozano J, 2003, CANCER RES, V63, P4232; Marshall CJ, 1998, NATURE, V392, P553, DOI 10.1038/33293; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; OKAMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6059, DOI 10.1073/pnas.81.19.6059; Pan CQ, 2010, J CELL SCI, V123, P903, DOI 10.1242/jcs.064162; Park ER, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-26; Peters SLM, 2006, TRENDS PHARMACOL SCI, V27, P492, DOI 10.1016/j.tips.2006.07.002; Price JT, 1996, EUR J CANCER, V32A, P1977, DOI 10.1016/0959-8049(96)00207-9; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SCOTT A, 1995, J BIOL CHEM, V270, P24540, DOI 10.1074/jbc.270.41.24540; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stoeger SM, 2009, CANCER CHEMOTH PHARM, V63, P807, DOI 10.1007/s00280-008-0794-7; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TOMMOY M, 1981, AM J ANAT, V160, P267, DOI 10.1002/aja.1001600305; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Ung CY, 2008, FEBS LETT, V582, P2283, DOI 10.1016/j.febslet.2008.05.026; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WOJCIK J, 2001, BIOINFORMATICS S1, V17, P296; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	83	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22933	10.1371/journal.pone.0022933	http://dx.doi.org/10.1371/journal.pone.0022933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829671	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200027
J	Medina, C; Camacho, EM; Flores, A; Mesa-Pereira, B; Santero, E				Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Mesa-Pereira, Beatriz; Santero, Eduardo			Improved Expression Systems for Regulated Expression in Salmonella Infecting Eukaryotic Cells	PLOS ONE			English	Article							RESPONSIVE TRANSCRIPTION ANTITERMINATION; GENE-EXPRESSION; III SECRETION; IN-VIVO; PROTEIN; NITRATE; OVEREXPRESSION; INDUCTION; NASR; SALICYLATE	In this work we describe a series of improvements to the Salmonella-based salicylate-inducible cascade expression system comprised of a plasmid-borne expression module, where target gene expression is driven by the Pm promoter governed by the XylS2 regulator, and a genome-integrated regulatory module controlled by the nahR/P-sal system. We have constructed a set of high and low-copy number plasmids bearing modified versions of the expression module with a more versatile multiple cloning site and different combinations of the following elements: (i) the nasF transcriptional attenuator, which reduces basal expression levels, (ii) a strong ribosome binding site, and (iii) the Type III Secretion System (TTSS) signal peptide from the effector protein SspH2 to deliver proteins directly to the eukaryotic cytosol following bacterial infection of animal cells. We show that different expression module versions can be used to direct a broad range of protein production levels. Furthermore, we demonstrate that the efficient reduction of basal expression by the nasF attenuator allows the cloning of genes encoding highly cytotoxic proteins such as colicin E3 even in the absence of its immunity protein. Additionally, we show that the Salmonella TTSS is able to translocate most of the protein produced by this regulatory cascade to the cytoplasm of infected HeLa cells. Our results indicate that these vectors represent useful tools for the regulated overproduction of heterologous proteins in bacterial culture or in animal cells, for the cloning and expression of genes encoding toxic proteins and for pathogenesis studies.	[Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Mesa-Pereira, Beatriz; Santero, Eduardo] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Medina, C (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	cmedmor@upo.es	Santero, Eduardo/K-6510-2014; Camacho, Eva/K-9839-2014; Medina Morillas, Carlos/L-1773-2014; Mesa, Beatriz/O-9895-2019; Flores, Amando/K-9283-2017	Camacho, Eva/0000-0002-6465-7381; Medina Morillas, Carlos/0000-0003-0069-7330; Flores, Amando/0000-0002-1887-0659; Santero, Eduardo/0000-0002-6111-7160	Spanish Ministry of Science and Innovation [BIO2008-01805, CSD2007-00005]; Andalusian government [P07-CVI-2518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian government	Work in the authors' laboratory was supported by the Spanish Ministry of Science and Innovation, grants BIO2008-01805 and CSD2007-00005, and by the Andalusian government, grant P07-CVI-2518 and a fellowship awarded to BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony LC, 2004, J MICROBIOL METH, V58, P243, DOI 10.1016/j.mimet.2004.04.003; Aune TEV, 2010, MICROB BIOTECHNOL, V3, P38, DOI 10.1111/j.1751-7915.2009.00126.x; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; CARLOMAGNO MS, 1985, J BACTERIOL, V163, P362, DOI 10.1128/JB.163.1.362-368.1985; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Chai WH, 1999, J MOL BIOL, V292, P203, DOI 10.1006/jmbi.1999.3084; Chai WH, 1998, J MOL BIOL, V283, P339, DOI 10.1006/jmbi.1998.2105; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIAZ E, 1994, MOL MICROBIOL, V13, P855, DOI 10.1111/j.1365-2958.1994.tb00477.x; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; Lin JT, 1996, J MOL BIOL, V256, P423, DOI 10.1006/jmbi.1996.0098; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miller JH, 1972, EXPT MOL GENETICS LA; Panthel K, 2005, INFECT IMMUN, V73, P334, DOI 10.1128/IAI.73.1.334-341.2005; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Royo JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni168; Royo JL, 2005, J BIOTECHNOL, V116, P113, DOI 10.1016/j.jbiotec.2004.10.006; Royo JL, 2007, NAT METHODS, V4, P937, DOI 10.1038/NMETH1107; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 2001, MOL CLONING LAB MANU; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; STRAGIER P, 1990, MOL MICROBIOL, V4, P1801, DOI 10.1111/j.1365-2958.1990.tb02028.x; Thone F, 2007, J MICROBIOL METH, V71, P220, DOI 10.1016/j.mimet.2007.08.016; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84; Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X; Wu SQT, 1999, J BACTERIOL, V181, P7274, DOI 10.1128/JB.181.23.7274-7284.1999	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23055	10.1371/journal.pone.0023055	http://dx.doi.org/10.1371/journal.pone.0023055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829692	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200036
J	Brittain, JM; Chen, L; Wilson, SM; Brustovetsky, T; Gao, X; Ashpole, NM; Molosh, AI; You, HT; Hudmon, A; Shekhar, A; White, FA; Zamponi, GW; Brustovetsky, N; Chen, JH; Khanna, R				Brittain, Joel M.; Chen, Liang; Wilson, Sarah M.; Brustovetsky, Tatiana; Gao, Xiang; Ashpole, Nicole M.; Molosh, Andrei I.; You, Haitao; Hudmon, Andy; Shekhar, Anantha; White, Fletcher A.; Zamponi, Gerald W.; Brustovetsky, Nickolay; Chen, Jinhui; Khanna, Rajesh			Neuroprotection against Traumatic Brain Injury by a Peptide Derived from the Collapsin Response Mediator Protein 2 (CRMP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTORS; CONTROLLED CORTICAL IMPACT; NEURONAL DEATH; MITOCHONDRIAL DYSFUNCTION; POSTSYNAPTIC DENSITY-95; CALPAIN CLEAVAGE; CLINICAL-TRIALS; NMDA-RECEPTORS; NR2B SUBUNIT; IN-VITRO	Background: CRMP2 is an axonal guidance protein that has been linked to NMDA receptor-mediated excitotoxicity. Results: A CRMP2 peptide protects against NMDA receptor-mediated excitotoxicity in vitro and in vivo following a traumatic brain injury. Conclusion: CRMP2 is a novel target for neuroprotection. Significance: Targeting CRMP2 could lead to development of neurotherapeutics against traumatic brain injury as well as other neuronal insults.	[Brittain, Joel M.; Wilson, Sarah M.; Ashpole, Nicole M.; Hudmon, Andy; White, Fletcher A.; Brustovetsky, Nickolay; Chen, Jinhui; Khanna, Rajesh] Indiana Univ, Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Chen, Liang; Gao, Xiang; Chen, Jinhui] Indiana Univ, Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Ashpole, Nicole M.; Hudmon, Andy] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Molosh, Andrei I.; Shekhar, Anantha] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [White, Fletcher A.] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Shekhar, Anantha] Indiana Univ, Sch Med, Indiana Clin & Translat Sci Inst, Indianapolis, IN 46202 USA; [White, Fletcher A.; Chen, Jinhui; Khanna, Rajesh] Indiana Univ, Sch Med, Indiana Spinal Cord & Brain Injury Grp, Indianapolis, IN 46202 USA; [You, Haitao; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Calgary	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu	White, Fletcher/F-3203-2015; White, Fletcher A/F-2895-2012	White, Fletcher/0000-0002-8408-9262; Khanna, Rajesh/0000-0002-9066-2969; Zamponi, Gerald W./0000-0002-0644-9066; Molosh, Andrei/0000-0001-6451-7912	National Institutes of Health [R01 NS050131]; Alberta Heritage Foundation for Medical Research (AHFMR); American Heart Association [SDG5280023]; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources [RR025761]; Ralph W. and Grace M. Showalter foundation [A70-0-079212, A70-9-079138]; Elwert Award in Medicine; Larry Kays Medical Neuroscience Fellowship; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072631, R01NS050131, R21NS075733, R01NS049136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); American Heart Association(American Heart Association); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ralph W. and Grace M. Showalter foundation; Elwert Award in Medicine; Larry Kays Medical Neuroscience Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS050131 (to N. B.). This work was also supported by a fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR) (to H. Y.), American Heart Association National Scientist Development Grant SDG5280023 (to R. K.), a grant from the Indiana Clinical and Translational Sciences Institute funded, in part by a Project Development Team Grant Number RR025761 from the National Institutes of Health, National Center for Research Resources, Clinical and Translational Sciences Award (Indiana State Department of Health, Indiana Spinal Cord and Brain Injury Research Fund, Grants A70-0-079212 (to N. B.) and A70-9-079138 (to R. K.)), grants from the Ralph W. and Grace M. Showalter foundation (to A. H., N. B., and R. K.), and the Elwert Award in Medicine (to R. K.).; Recipient of a Larry Kays Medical Neuroscience Fellowship.; An AHFMR Scientist and a Canada Research Chair, supported by the Canadian Institutes of Health Research.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; [Anonymous], 2003, COCHRANE DATABASE SY; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; CRUNELLI V, 1983, J PHYSIOL-LONDON, V341, P627, DOI 10.1113/jphysiol.1983.sp014829; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P1397, DOI 10.1517/13543784.9.6.1397; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molosh AI, 2010, NEUROPSYCHOPHARMACOL, V35, P1333, DOI 10.1038/npp.2010.2; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang Yuying, 2010, Commun Integr Biol, V3, P172; Wilson S. M., 2011, CHANNELS AU IN PRESS; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zhang Z, 2009, CELL MOL LIFE SCI, V66, P526, DOI 10.1007/s00018-008-8362-1; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078	72	75	80	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37778	37792		10.1074/jbc.M111.255455	http://dx.doi.org/10.1074/jbc.M111.255455			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21832084	Green Published, hybrid			2022-12-25	WOS:000296542400073
J	Chu, CS; Hsu, PH; Lo, PW; Scheer, E; Tora, L; Tsai, HJ; Tsai, MD; Juan, LJ				Chu, Chi-Shuen; Hsu, Pang-Hung; Lo, Pei-Wen; Scheer, Elisabeth; Tora, Laszlo; Tsai, Hang-Jen; Tsai, Ming-Daw; Juan, Li-Jung			Protein Kinase A-mediated Serine 35 Phosphorylation Dissociates Histone H1.4 from Mitotic Chromosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; COMPLEX; BINDING; MITOSIS; PKA; TRANSCRIPTION; CENTROSOMES; SIGNALS	Global histone H1 phosphorylation correlates with cell cycle progression. However, the function of site-specific H1 variant phosphorylation remains unclear. Our mass spectrometry analysis revealed a novel N-terminal phosphorylation of the major H1 variant H1.4 at serine 35 (H1.4S35ph), which accumulates at mitosis immediately after H3 phosphorylation at serine 10. Protein kinase A (PKA) was found to be a kinase for H1.4S35. Importantly, Ser-35-phosphorylated H1.4 dissociates from mitotic chromatin. Moreover, H1.4S35A substitution mutant cannot efficiently rescue the mitotic defect following H1.4 depletion, and inhibition of PKA activity increases the mitotic chromatin compaction depending on H1.4. Our results not only indicate that PKA-mediated H1.4S35 phosphorylation dissociates H1.4 from mitotic chromatin but also suggest that this phosphorylation is necessary for specific mitotic functions.	[Chu, Chi-Shuen; Hsu, Pang-Hung; Lo, Pei-Wen; Tsai, Hang-Jen; Tsai, Ming-Daw; Juan, Li-Jung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chu, Chi-Shuen; Juan, Li-Jung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung 20224, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 20224, Taiwan; [Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg, Program Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Graffenstaden, France; [Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan Ocean University; National Taiwan Ocean University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Academia Sinica - Taiwan	Juan, LJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ljjuan@gate.sinica.edu.tw	Tora, Laszlo/E-9999-2018; Juan, Li-Jung/H-6631-2015; Tsai, Ming-Daw/G-4689-2019; Hsu, Pang-Hung/C-5587-2018	Tora, Laszlo/0000-0001-7398-2250; Tsai, Ming-Daw/0000-0003-1374-0414; Hsu, Pang-Hung/0000-0001-6873-6434	National Science Council; Academia Sinica [NSC-96-2311-B-001-029, NSC-99-2320-B-001-017]; Agence Nationale de la Recherche [ANR-09-BLAN-0266]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by National Science Council and Academia Sinica Grants NSC-96-2311-B-001-029 and NSC-99-2320-B-001-017 (to L.-J. J.) and Agence Nationale de la Recherche Grant ANR-09-BLAN-0266 (to L. T.).	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Happel N, 2009, J MOL BIOL, V386, P339, DOI 10.1016/j.jmb.2008.12.047; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; JUAN LJ, 1994, EMBO J, V13, P6031, DOI 10.1002/j.1460-2075.1994.tb06949.x; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Lee CF, 2010, J CLIN INVEST, V120, P2920, DOI 10.1172/JCI42275; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; OTAEGUI PJ, 1994, MOL REPROD DEV, V39, P147, DOI 10.1002/mrd.1080390205; Padilla-Nash HM, 2007, EXP DERMATOL, V16, P98, DOI 10.1111/j.1600-0625.2006.00507.x; POCHRON SF, 1979, J BIOL CHEM, V254, P6352; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Wood C, 2009, FEBS J, V276, P4109, DOI 10.1111/j.1742-4658.2009.07079.x; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	33	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35843	35851		10.1074/jbc.M111.228064	http://dx.doi.org/10.1074/jbc.M111.228064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852232	Green Published, hybrid			2022-12-25	WOS:000295927100057
J	Asakuma, S; Hatakeyama, E; Urashima, T; Yoshida, E; Katayama, T; Yamamoto, K; Kumagai, H; Ashida, H; Hirose, J; Kitaoka, M				Asakuma, Sadaki; Hatakeyama, Emi; Urashima, Tadasu; Yoshida, Erina; Katayama, Takane; Yamamoto, Kenji; Kumagai, Hidehiko; Ashida, Hisashi; Hirose, Junko; Kitaoka, Motomitsu			Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BIOSE-I; LONGUM SUBSP INFANTIS; GENOME SEQUENCE; BINDING PROTEIN; BIFIDUM; DERIVATIZATION; DEGRADATION; MICROBIOTA; DIGESTION; CLONING	The bifidogenic effect of human milk oligosaccharides (HMOs) has long been known, yet the precise mechanism underlying it remains unresolved. Recent studies show that some species/subspecies of Bifidobacterium are equipped with genetic and enzymatic sets dedicated to the utilization of HMOs, and consequently they can grow on HMOs; however, the ability to metabolize HMOs has not been directly linked to the actual metabolic behavior of the bacteria. In this report, we clarify the fate of each HMO during cultivation of infant gut-associated bifidobacteria. Bifidobacterium bifidum JCM1254, Bifidobacterium longum subsp. infantis JCM1222, Bifidobacterium longum subsp. longum JCM1217, and Bifidobacterium breve JCM1192 were selected for this purpose and were grown on HMO media containing a main neutral oligosaccharide fraction. The mono-and oligosaccharides in the spent media were labeled with 2-anthranilic acid, and their concentrations were determined at various incubation times using normal phase high performance liquid chromatography. The results reflect the metabolic abilities of the respective bifidobacteria. B. bifidum used secretory glycosidases to degrade HMOs, whereas B. longum subsp. infantis assimilated all HMOs by incorporating them in their intact forms. B. longum subsp. longum and B. breve consumed lacto-N-tetraose only. Interestingly, B. bifidum left degraded HMO metabolites outside of the cell even when the cells initiate vegetative growth, which indicates that the different species/subspecies can share the produced sugars. The predominance of type 1 chains in HMOs and the preferential use of type 1 HMO by infant gut-associated bifidobacteria suggest the coevolution of the bacteria with humans.	[Yoshida, Erina; Katayama, Takane; Yamamoto, Kenji; Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Asakuma, Sadaki] Natl Agr Res Ctr Hokkaido Reg, Intens Grazing Res Team, Sapporo, Hokkaido 0628555, Japan; [Hatakeyama, Emi; Urashima, Tadasu] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido 0808555, Japan; [Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Hirose, Junko] Univ Shiga Prefecture, Dept Life Style Studies, Shiga 5228533, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Ishikawa Prefecture University; National Agriculture & Food Research Organization - Japan; Obihiro University of Agriculture & Veterinary Medicine; Kyoto University; University Shiga Prefecture; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Katayama, T (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan.	takane@ishikawa-pu.ac.jp	Ashida, Hisashi/HCI-0293-2022; Kitaoka, Motomitsu/R-1536-2019	Kitaoka, Motomitsu/0000-0002-0083-1838; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874	Ministry of Education, Culture, Sports, Science and Technology, Japan [22780072]; Urakami Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation)	This work was supported in part by a Grant-in-aid for Scientific Research by Young Scientists (B) 22780072 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grant-in-aid from The Urakami Foundation.	Amano J, 2009, GLYCOBIOLOGY, V19, P601, DOI 10.1093/glycob/cwp026; Anumula KR, 2006, ANAL BIOCHEM, V350, P1, DOI 10.1016/j.ab.2005.09.037; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Brand-Miller JC, 1998, J PEDIATR-US, V133, P95, DOI 10.1016/S0022-3476(98)70185-4; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Coppa GV, 1999, ACTA PAEDIATR, V88, P89, DOI 10.1080/080352599750029808; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Katayama T, 2000, APPL ENVIRON MICROB, V66, P4764, DOI 10.1128/AEM.66.11.4764-4771.2000; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Leo F, 2009, J CHROMATOGR A, V1216, P1520, DOI 10.1016/j.chroma.2009.01.015; Leo F, 2010, BIOSCI BIOTECH BIOCH, V74, P298, DOI 10.1271/bbb.90614; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Newburg D, 1995, HDB MILK COMPOSITION, P273; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Sakata S, 2005, FEMS MICROBIOL LETT, V243, P417, DOI 10.1016/j.femsle.2005.01.002; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Thurl S, 1996, ANAL BIOCHEM, V235, P202, DOI 10.1006/abio.1996.0113; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Urashima T, 2011, OLIGOSACCHARIDES SOU, P1; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	48	276	292	6	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34583	34592		10.1074/jbc.M111.248138	http://dx.doi.org/10.1074/jbc.M111.248138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832085	Green Published, hybrid			2022-12-25	WOS:000295406300013
J	Morishima, N; Nakanishi, K; Nakano, A				Morishima, Nobuhiro; Nakanishi, Keiko; Nakano, Akihiko			Activating Transcription Factor-6 (ATF6) Mediates Apoptosis with Reduction of Myeloid Cell Leukemia Sequence 1 (Mcl-1) Protein via Induction of WW Domain Binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL OUTER-MEMBRANE; NF-Y CBF; TRANSMEMBRANE PROTEIN; ER STRESS; DIABETES-MELLITUS; MAMMALIAN GENOME; OPTIC ATROPHY; BCL-2 FAMILY; DEATH	Endoplasmic reticulum (ER) stress is involved in both physiological and pathological apoptosis. ER stress triggers the unfolded protein response (UPR), which can then initiate apoptosis, when the cell fails to restore ER homeostasis. However, the mechanism employed by the UPR to lead cells into apoptosis is unknown. Among the three proximal sensors of ER stress, activating transcription factor-6 (ATF6) is specifically activated in apoptotic myoblasts during myoblast differentiation. This implies that active ATF6 has the ability to mediate apoptosis. Here, we demonstrate that overexpression of active ATF6 induced apoptosis in myoblast cells. Moreover, coexpression of a dominant negative form of ATF6 suppressed apoptosis. This suggested that apoptosis-related pathways depended on ATF6-mediated transcription activation. ATF6 caused up-regulation of the WBP1 (WW domain binding protein 1), probably via an indirect mechanism. Furthermore, WBP1 was also found to be proapoptotic. The silencing of WBP1 with small hairpin RNAs caused partial, but significant suppression of ATF6-induced apoptosis. Overexpression of active ATF6 or WBP1 caused a specific reduction in an anti-apoptotic protein, Mcl-1 (myeloid cell leukemia sequence 1). This suggested a molecular link between the UPR and an apoptosis regulator. Neither Bcl-2 nor Bcl-xL were reduced upon apoptosis induction in C2C12 cells that overexpressed ATF6 or WBP1. Cells treated with ER stressors underwent apoptosis concomitant with an up-regulation of WBP1 and suppression of Mcl-1. These results suggested that Mcl-1 is a determinant of cell fate, and ATF6 mediates apoptosis via specific suppression of Mcl-1 through up-regulation of WBP1.	[Morishima, Nobuhiro; Nakanishi, Keiko; Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; [Nakano, Akihiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Morishima, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	morishim@riken.jp	Morishima, Nobuhiro/D-3946-2017; Nakanishi, Keiko/B-9963-2013; Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X	Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the RIKEN Bioarchitect Research Project and by the Japan Society for the Promotion of Science (to N. M).; We thank Ron Prywes for providing human ATF6 cDNA, and Junying Yuan for providing the anti-caspase-12 monoclonal antibody. We also thank Rie Nakazawa and Yasue Ichikawa for DNA sequencing and Keisuke Fukumoto (the Support Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center) for assistance with GeneChip and real-time PCR analyses.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dominov JA, 2001, DEV DYNAM, V220, P18, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1088>3.0.CO;2-#; FIDZIANSKA A, 1991, ACTA NEUROPATHOL, V81, P572, DOI 10.1007/BF00310140; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kaba SA, 2002, PARASITOLOGY, V125, P497, DOI 10.1017/S003118200200241X; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Tsujii H, 2010, J BIOCHEM, V148, P157, DOI 10.1093/jb/mvq042; Wang Y, 2000, J BIOL CHEM, V275, P27013; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	44	74	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35227	35235		10.1074/jbc.M111.233502	http://dx.doi.org/10.1074/jbc.M111.233502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841196	Green Published, hybrid			2022-12-25	WOS:000295406300075
J	Regner, M; Pavlinovic, L; Young, N; Mullbacher, A				Regner, Matthias; Pavlinovic, Lisa; Young, Nicolie; Muellbacher, Arno			In Vivo Elimination of MHC-I-Deficient Lymphocytes by Activated Natural Killer Cells Is Independent of Granzymes A and B	PLOS ONE			English	Article							TARGET-CELLS; MEDIATED CYTOTOXICITY; CYTOLYTIC LEUKOCYTES; DNA FRAGMENTATION; VIRAL-INFECTION; CUTTING EDGE; A-DEFICIENT; T-CELLS; PERFORIN; MICE	NK cells kill target cells mainly via exocytosis of granules containing perforin (perf) and granzymes (gzm). In vitro, gzm delivery into the target cell cytosol results in apoptosis, and induction of apoptosis is severely impaired in the absence of gzm A and B. However, their importance for in vivo cytotoxicity by cytotoxic T cells has been questioned. We used an in vivo NK cytotoxicity assay, in which splenocytes from wild-type and beta(2)microglobulin-deficient (MHC-I(neg)) mice are co-injected into recipients whose NK cells were activated by virus infection or synthetic Toll-like receptor ligands. Elimination of adoptively transferred MHC-I(neg) splenocytes was unimpaired in the absence of gzmA and gzmB, but dependent on perforin. This target cell rejection was NK cell dependent, since NK cell depletion abrogated it. Furthermore, target cell elimination in vivo was equally rapid in both wild-type and gzmAxB-deficient recipients, with the majority of specific target cells lost from lymphoid tissue within less than one to two hours after transfer. Thus, similar to T cell cytotoxicity, the contribution of gzmA and B to in vivo target cell elimination remains unresolved.	[Regner, Matthias; Pavlinovic, Lisa; Young, Nicolie; Muellbacher, Arno] Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia; [Regner, Matthias] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Regner, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia.	Matthias.Regner@anu.edu.au			Australian National Health and Medical Research Council; government block	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); government block	This work was supported by the Australian National Health and Medical Research Council and by a government block grant to the John Curtin School of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharifi M, 2006, EUR J IMMUNOL, V36, P887, DOI 10.1002/eji.200535342; Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Davis JE, 2001, EUR J IMMUNOL, V31, P39, DOI 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Grundy MA, 2007, CANCER IMMUNOL IMMUN, V56, P1153, DOI 10.1007/s00262-006-0264-1; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hirst CE, 2001, MOL HUM REPROD, V7, P1133, DOI 10.1093/molehr/7.12.1133; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; MULLBACHER A, 1988, IMMUNOL CELL BIOL, V66, P153, DOI 10.1038/icb.1988.19; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; MULLBACHER A, 1989, SCAND J IMMUNOL, V30, P21, DOI 10.1111/j.1365-3083.1989.tb01184.x; MULLBACHER A, 1978, IMMUNOGENETICS, V7, P551, DOI 10.1007/BF01844044; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; Sedelies KA, 2008, CELL DEATH DIFFER, V15, P708, DOI 10.1038/sj.cdd.4402300; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smyth MJ, 2003, J IMMUNOL, V171, P515, DOI 10.4049/jimmunol.171.2.515; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; WONDERLICH J, 2006, INDUCTION MEASUREMEN	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23252	10.1371/journal.pone.0023252	http://dx.doi.org/10.1371/journal.pone.0023252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853094	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953400034
J	Menon, MB; Kotlyarov, A; Gaestel, M				Menon, Manoj B.; Kotlyarov, Alexey; Gaestel, Matthias			SB202190-Induced Cell Type-Specific Vacuole Formation and Defective Autophagy Do Not Depend on p38 MAP Kinase Inhibition	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELL; IN-VIVO; MATURATION STEP; SB 203580; P38-ALPHA; STRESS; GROWTH; SENSITIVITY; METABOLISM	SB202190, a widely used inhibitor of p38 MAPK alpha and beta, was recently described to induce autophagic vacuoles and cell death in colon and ovarian cancer cells lines and, therefore, this effect was supposed to be specific for transformed cells and to open therapeutic options. Here, we demonstrate that SB202190 and the structurally related inhibitor SB203580 induce pro-autophagic gene expression and vacuole formation in various cancer and non-cancer cell lines of human, rat, mouse and hamster origin. This effect seems to induce defective autophagy leading to the accumulation of acidic vacuoles, p62 protein and lipid conjugated LC3. Using further p38 inhibitors we show that p38 MAPK inhibition is not sufficient for the autophagic response. In line with these results, expression of a SB202190-resistant mutant of p38 alpha, which significantly increases activity of the p38 pathway under inhibitory conditions, does not block SB202190-dependent vacuole formation, indicating that lack of p38 alpha activity is not necessary for this effect. Obviously, the induction of autophagic vacuole formation by SB203580 and SB202190 is due to off-target effects of these inhibitors on post-translational protein modifications, such as phosphorylation of the MAPKs ERK1/2 and JNK1/2, ribosomal protein S6, and PKB/Akt. Interestingly, the PI3K-inhibitor wortmannin induces transient vacuole formation indicating that the PI3K-PKB/Akt-mTOR pathway is essential for preventing autophagy and that cross-inhibition of this pathway by SB202190 could be the reason for the early part of the effect observed.	[Menon, Manoj B.; Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany	Hannover Medical School	Menon, MB (corresponding author), Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany.	gaestel.matthias@mh-hannover.de	Menon, Manoj B./P-1543-2015; Gaestel, Matthias/A-6560-2013	Menon, Manoj B./0000-0001-5859-0347; Gaestel, Matthias/0000-0002-4944-4652	Deutsche Forschungsgemeinschaft; Hannover Medical School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Medical School	This work was supported by Deutsche Forschungsgemeinschaft and the PhD-Program of the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bawolak MT, 2010, CAN J ANAESTH, V57, P230, DOI 10.1007/s12630-009-9220-9; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P28766, DOI 10.1074/jbc.273.44.28766; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hsu MY, 2002, HUMAN CELL CULTURE, P259; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kametaka S, 2007, MOL BIOL CELL, V18, P2991, DOI 10.1091/mbc.E06-12-1162; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Laufer SA, 2003, J MED CHEM, V46, P3230, DOI 10.1021/jm030766k; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Matrone A, 2010, INT J GYNECOL CANCER, V20, P203, DOI 10.1111/IGC.0b013e3181c8ca12; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Menon MB, 2010, J BIOL CHEM, V285, P33242, DOI 10.1074/jbc.M110.132357; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Prick T, 2006, BIOCHEM J, V394, P153, DOI 10.1042/BJ20051243; RONKINA N, 2010, NUCL ACIDS RES; ROSS RA, 1983, J NATL CANCER I, V71, P741; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Simone C, 2007, AUTOPHAGY, V3, P468, DOI 10.4161/auto.4319; Singh AK, 2011, CELL MOL LIFE SCI, V68, P1041, DOI 10.1007/s00018-010-0503-7; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Son JK, 2010, CELL DEATH DIFFER, V17, P1288, DOI 10.1038/cdd.2010.9; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Szyniarowski P, 2011, AUTOPHAGY, V7, P892, DOI 10.4161/auto.7.8.15770; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	53	43	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23054	10.1371/journal.pone.0023054	http://dx.doi.org/10.1371/journal.pone.0023054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853067	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200038
J	Nel, A; Louw, C; Hellstrom, E; Braunstein, SL; Treadwell, I; Marais, M; de Villiers, M; Hugo, J; Paschke, I; Andersen, C; van de Wijgert, J				Nel, Annalene; Louw, Cheryl; Hellstrom, Elizabeth; Braunstein, Sarah L.; Treadwell, Ina; Marais, Melanie; de Villiers, Martie; Hugo, Jannie; Paschke, Inge; Andersen, Chrisna; van de Wijgert, Janneke			HIV Prevalence and Incidence among Sexually Active Females in Two Districts of South Africa to Determine Microbicide Trial Feasibility	PLOS ONE			English	Article								Background: The suitability of populations of sexually active women in Madibeng (North-West Province) and Mbekweni (Western Cape), South Africa, for a Phase III vaginal microbicide trial was evaluated. Methods: Sexually active women 18-35 years not known to be HIV-positive or pregnant were tested cross-sectionally to determine HIV and pregnancy prevalence (798 in Madibeng and 800 in Mbekweni). Out of these, 299 non-pregnant, HIV-negative women were subsequently enrolled at each clinical research center in a 12-month cohort study with quarterly study visits. Results: HIV prevalence was 24% in Madibeng and 22% in Mbekweni. HIV incidence rates based on seroconversions over 12 months were 6.0/100 person-years (PY) (95% CI 3.0, 9.0) in Madibeng and 4.5/100 PY (95% CI 1.8, 7.1) in Mbekweni and those estimated by cross-sectional BED testing were 7.1/100 PY (95% CI 2.8, 11.3) in Madibeng and 5.8/100 PY (95% CI 2.0, 9.6) in Mbekweni. The 12-month pregnancy incidence rates were 4.8/100 PY (95% CI 2.2, 7.5) in Madibeng and 7.0/100 PY (95% CI 3.7, 10.3) in Mbekweni; rates decreased over time in both districts. Genital symptoms were reported very frequently, with an incidence of 46.8/100 PY (95% CI 38.5, 55.2) in Madibeng and 21.5/100 PY (95% CI 15.8, 27.3) in Mbekweni. Almost all (>99%) participants said that they would be willing to participate in a microbicide trial. Conclusion: These populations might be suitable for Phase III microbicide trials provided that HIV incidence rates over time remain sufficiently high to support endpoint-driven trials.	[Nel, Annalene] Int Partnership Microbicides, Silver Spring, MD USA; [Louw, Cheryl; de Villiers, Martie; Hugo, Jannie] Madibeng Ctr Res, Brits, South Africa; [Hellstrom, Elizabeth; Treadwell, Ina; Marais, Melanie; Paschke, Inge; Andersen, Chrisna] Be Part Yoluntu Ctr, Mbekweni, South Africa; [Hellstrom, Elizabeth; Treadwell, Ina; Marais, Melanie; Paschke, Inge; Andersen, Chrisna] Be Part Yoluntu Ctr, Paarl, South Africa; [Braunstein, Sarah L.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	New York City Department of Health & Mental Hygiene; University of Amsterdam; Academic Medical Center Amsterdam	Nel, A (corresponding author), Int Partnership Microbicides, Silver Spring, MD USA.	j.vandewijgert@amc-cpcd.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	International Partnership for Microbicides	International Partnership for Microbicides	This study was funded by the International Partnership for Microbicides (a not-for-profit public-private partnership). The funders were involved in study design, data collection and preparation of the manuscript.	[Anonymous], 2011, US ASS REC INF EST H; Baldwin JI, 2000, ARCH SEX BEHAV, V29, P357, DOI 10.1023/A:1001918504344; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Braunstein SL, 2009, AIDS REV, V11, P140; Elias CJ, 1996, AIDS, V10, pS43; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; National Department of Health, 2008, 1 LIN COMPR MAN CONT, P1; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Raymond EG, 2007, SEX TRANSM DIS, V34, P1035, DOI 10.1097/OLQ.0b013e3180e90586; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van de Wijgert J, 2006, STUD FAMILY PLANN, V37, P123, DOI 10.1111/j.1728-4465.2006.00091.x; WHO Department of Reproductive Health, 2010, MED EL CRIT CONTR US; FORMULA SPREADSHEET	15	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21528	10.1371/journal.pone.0021528	http://dx.doi.org/10.1371/journal.pone.0021528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853020	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200002
J	Head, SI; Greenaway, B; Chan, S				Head, Stewart I.; Greenaway, Bronwen; Chan, Stephen			Incubating Isolated Mouse EDL Muscles with Creatine Improves Force Production and Twitch Kinetics in Fatigue Due to Reduction in Ionic Strength	PLOS ONE			English	Article							MAXIMUM SHORTENING VELOCITY; EXTENSOR DIGITORUM LONGUS; RAT SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; CELLULAR MECHANISMS; ENERGY-METABOLISM; BODY-COMPOSITION; SINGLE FIBERS; KINASE; SUPPLEMENTATION	Background: Creatine supplementation can improve performance during high intensity exercise in humans and improve muscle strength in certain myopathies. In this present study, we investigated the direct effects of acute creatine incubation on isolated mouse fast-twitch EDL muscles, and examined how these effects change with fatigue. Methods and Results: The extensor digitorum longus muscle from mice aged 12-14 weeks was isolated and stimulated with field electrodes to measure force characteristics in 3 different states: (i) before fatigue; (ii) immediately after a fatigue protocol; and (iii) after recovery. These served as the control measurements for the muscle. The muscle was then incubated in a creatine solution and washed. The measurement of force characteristics in the 3 different states was then repeated. In un-fatigued muscle, creatine incubation increased the maximal tetanic force. In fatigued muscle, creatine treatment increased the force produced at all frequencies of stimulation. Incubation also increased the rate of twitch relaxation and twitch contraction in fatigued muscle. During repetitive fatiguing stimulation, creatine-treated muscles took 55.1 +/- 9.5% longer than control muscles to lose half of their original force. Measurement of weight changes showed that creatine incubation increased EDL muscle mass by 7%. Conclusion: Acute creatine application improves force production in isolated fast-twitch EDL muscle, and these improvements are particularly apparent when the muscle is fatigued. One likely mechanism for this improvement is an increase in Ca2+ sensitivity of contractile proteins as a result of ionic strength decreases following creatine incubation.	[Head, Stewart I.; Greenaway, Bronwen; Chan, Stephen] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Head, SI (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	S.Head@unsw.edu.au	Head, Stewart/O-7016-2019; Head, Stewart I/F-4435-2010	Head, Stewart/0000-0002-6891-7590; 	National Health and Medical Research Council of Australia (NHMRC) [512254]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council of Australia (NHMRC Project Grant #512254, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; APRIL E, 1968, NATURE, V220, P182, DOI 10.1038/220182a0; ASHLEY CC, 1977, J PHYSIOL-LONDON, V270, P627, DOI 10.1113/jphysiol.1977.sp011972; Balsom P. D., 1993, Scandinavian Journal of Medicine and Science in Sports, V3, P143; Bassit RA, 2010, EUR J APPL PHYSIOL, V108, P945, DOI 10.1007/s00421-009-1305-1; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Boehm EA, 1996, BBA-BIOENERGETICS, V1274, P119, DOI 10.1016/0005-2728(96)00018-7; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; CANNELL MB, 1986, J PHYSIOL-LONDON, V376, P203, DOI 10.1113/jphysiol.1986.sp016149; Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE31, DOI 10.1152/ajpendo.1996.271.1.E31; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Chan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012345; Dahlstedt AJ, 2000, FASEB J, V14, P982, DOI 10.1096/fasebj.14.7.982; Dahlstedt AJ, 2003, J PHYSIOL-LONDON, V547, P395, DOI 10.1113/jphysiol.2002.034793; EARNEST CP, 1995, ACTA PHYSIOL SCAND, V153, P207, DOI 10.1111/j.1748-1716.1995.tb09854.x; Eijnde BO, 2004, MUSCLE NERVE, V29, P428, DOI 10.1002/mus.10568; FINK RHA, 1986, J PHYSIOL-LONDON, V370, P317, DOI 10.1113/jphysiol.1986.sp015937; FITCH CD, 1966, J BIOL CHEM, V241, P3611; FRYER MW, 1995, J PHYSIOL-LONDON, V482, P123, DOI 10.1113/jphysiol.1995.sp020504; Gagnon M, 2002, CLIN EXP PHARMACOL P, V29, P885, DOI 10.1046/j.1440-1681.2002.03745.x; Gallo M, 2006, PFLUG ARCH EUR J PHY, V452, P744, DOI 10.1007/s00424-006-0079-0; GILLIS JM, 1985, BIOCHIM BIOPHYS ACTA, V811, P97, DOI 10.1016/0304-4173(85)90016-3; HEAD SI, 1990, J PHYSIOL-LONDON, V422, P351, DOI 10.1113/jphysiol.1990.sp017988; HOMSHER E, 1978, ANNU REV PHYSIOL, V40, P93, DOI 10.1146/annurev.ph.40.030178.000521; HOMSHER E, 1987, ANNU REV PHYSIOL, V49, P673, DOI 10.1146/annurev.ph.49.030187.003325; HULTMAN E, 1991, SCI PROG, V75, P361; JACOBUS WE, 1985, BIOCHEM BIOPH RES CO, V133, P1035, DOI 10.1016/0006-291X(85)91240-9; Jones AM, 2009, AM J PHYSIOL-REG I, V296, pR1078, DOI 10.1152/ajpregu.90896.2008; Kley RA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004760.pub2; Levine S, 1996, AM J PHYSIOL-CELL PH, V271, pC1480, DOI 10.1152/ajpcell.1996.271.5.C1480; Macdonald WA, 2001, J PHYSIOL-LONDON, V532, P499, DOI 10.1111/j.1469-7793.2001.0499f.x; McGuire M, 2001, EXP PHYSIOL, V86, P185, DOI 10.1113/eph8602131; Motulsky H, 2003, PRACTICAL GUIDE CURV; Murphy RM, 2004, AM J PHYSIOL-CELL PH, V287, pC1589, DOI 10.1152/ajpcell.00276.2004; Odoom JE, 1996, MOL CELL BIOCHEM, V158, P179; Pulido SM, 1998, FEBS LETT, V439, P357, DOI 10.1016/S0014-5793(98)01399-4; Robinson DM, 2002, CLIN EXP PHARMACOL P, V29, P1105, DOI 10.1046/j.1440-1681.2002.03782.x; Roman BB, 1996, AM J PHYSIOL-CELL PH, V270, pC1236, DOI 10.1152/ajpcell.1996.270.4.C1236; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Terjung RL, 2000, MED SCI SPORT EXER, V32, P706, DOI 10.1097/00005768-200003000-00024; van Leemputte M, 1999, J APPL PHYSIOL, V86, P840, DOI 10.1152/jappl.1999.86.3.840; van Loon LJC, 2003, CLIN SCI, V104, P153, DOI 10.1042/CS20020159; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VENTURACLAPIER R, 1995, J BIOL CHEM, V270, P19914, DOI 10.1074/jbc.270.34.19914; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Wakatsuki T, 1995, JPN J PHYSIOL, V45, P979, DOI 10.2170/jjphysiol.45.979; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WESTERBLAD H, 1991, J PHYSIOL-LONDON, V434, P323, DOI 10.1113/jphysiol.1991.sp018472; WESTERBLAD H, 1995, J PHYSIOL-LONDON, V482, P383, DOI 10.1113/jphysiol.1995.sp020525; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Willott CA, 1999, ACTA PHYSIOL SCAND, V166, P99; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0167-4838(92)90506-9; Ziegenfuss T.N., 1998, J EXERC PHYSL ONLINE, V1, P1	57	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22742	10.1371/journal.pone.0022742	http://dx.doi.org/10.1371/journal.pone.0022742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850234	Green Submitted, Green Published, gold			2022-12-25	WOS:000293563300019
J	Kronhardt, A; Rolando, M; Beitzinger, C; Stefani, C; Leuber, M; Flatau, G; Popoff, MR; Benz, R; Lemichez, E				Kronhardt, Angelika; Rolando, Monica; Beitzinger, Christoph; Stefani, Caroline; Leuber, Michael; Flatau, Gilles; Popoff, Michel R.; Benz, Roland; Lemichez, Emmanuel			Cross-Reactivity of Anthrax and C2 Toxin: Protective Antigen Promotes the Uptake of Botulinum C2I Toxin into Human Endothelial Cells	PLOS ONE			English	Article							LIPID BILAYER-MEMBRANES; CURRENT NOISE-ANALYSIS; MATRIX PROTEIN PORIN; CLOSTRIDIUM-BOTULINUM; LETHAL FACTOR; EDEMA FACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ION-CHANNEL; PHENYLALANINE CLAMP	Binary toxins are among the most potent bacterial protein toxins performing a cooperative mode of translocation and exhibit fatal enzymatic activities in eukaryotic cells. Anthrax and C2 toxin are the most prominent examples for the AB(7/8) type of toxins. The B subunits bind both host cell receptors and the enzymatic A polypeptides to trigger their internalization and translocation into the host cell cytosol. C2 toxin is composed of an actin ADP-ribosyltransferase (C2I) and C2II binding subunits. Anthrax toxin is composed of adenylate cyclase (EF) and MAPKK protease (LF) enzymatic components associated to protective antigen (PA) binding subunit. The binding and translocation components anthrax protective antigen (PA(63)) and C2II of C2 toxin share a sequence homology of about 35%, suggesting that they might substitute for each other. Here we show by conducting in vitro measurements that PA(63) binds C2I and that C2II can bind both EF and LF. Anthrax edema factor (EF) and lethal factor (LF) have higher affinities to bind to channels formed by C2II than C2 toxin's C2I binds to anthrax protective antigen (PA(63)). Furthermore, we could demonstrate that PA in high concentration has the ability to transport the enzymatic moiety C2I into target cells, causing actin modification and cell rounding. In contrast, C2II does not show significant capacity to promote cell intoxication by EF and LF. Together, our data unveiled the remarkable flexibility of PA in promoting C2I heterologous polypeptide translocation into cells.	[Kronhardt, Angelika; Beitzinger, Christoph; Leuber, Michael; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Rolando, Monica; Stefani, Caroline; Flatau, Gilles; Lemichez, Emmanuel] Fac Med Nice, INSERM, U895, F-06034 Nice, France; [Rolando, Monica; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, Fac Med, Inst Federatif Rech 50, Nice, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Benz, Roland] Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Lemichez, Emmanuel] Ctr Hosp Univ Nice, Lab Cent Bacteriol, Nice, France	University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bremen; CHU Nice	Kronhardt, A (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany.	r.benz@jacobs-university.de; Emmanuel.Lemichez@unice.fr	Popoff, Michel/O-7719-2016; Lemichez, Emmanuel/G-3559-2013	Popoff, Michel/0000-0001-9305-8989; Lemichez, Emmanuel/0000-0001-9080-7761; Benz, Roland/0000-0002-9510-9265; stefani, caroline/0000-0003-3420-432X; Rolando, Monica/0000-0002-3710-0115	Deutsche Forschungsgemeinschaft [SFB 487, GRK 1141/1]; Association pour la Recherche sur le Cancer [ARC 3800]; L'Agence Nationale de la Recherche [Endotheltox R07113AS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); L'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Deutsche Forschungsgemeinschaft (project A5 of the SFB 487 and area 2B of GRK 1141/1 to RB), the Association pour la Recherche sur le Cancer (grant ARC 3800 to EL and a fellowship to MR), and L'Agence Nationale de la Recherche (Endotheltox R07113AS to EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Aktories K, 2004, ANAEROBE, V10, P101, DOI 10.1016/j.anaerobe.2003.10.003; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2002, N-S ARCH PHARMACOL, V366, P501, DOI 10.1007/s00210-002-0626-y; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 2002, J BIOL CHEM, V277, P5074, DOI 10.1074/jbc.M109167200; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; FINKELSTEIN A, 1994, TOXICOLOGY, V87, P29, DOI 10.1016/0300-483X(94)90153-8; Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2005, P NATL ACAD SCI USA, V102, P16409, DOI 10.1073/pnas.0508259102; Leppla SH, 1999, J APPL MICROBIOL, V87, P284, DOI 10.1046/j.1365-2672.1999.00890.x; Leuber M, 2008, BBA-BIOMEMBRANES, V1778, P1436, DOI 10.1016/j.bbamem.2008.01.007; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; Nguyen TL, 2004, J BIOMOL STRUCT DYN, V22, P253, DOI 10.1080/07391102.2004.10531226; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rolando M, 2010, CELL MICROBIOL, V12, P891, DOI 10.1111/j.1462-5822.2010.01438.x; Rolando M, 2009, INFECT IMMUN, V77, P3596, DOI 10.1128/IAI.00186-09; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23133	10.1371/journal.pone.0023133	http://dx.doi.org/10.1371/journal.pone.0023133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850257	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300042
J	Polacik, M; Reichard, M				Polacik, Matej; Reichard, Martin			Asymmetric Reproductive Isolation between Two Sympatric Annual Killifish with Extremely Short Lifespans	PLOS ONE			English	Article							AFRICAN ANNUAL KILLIFISH; NOTHOBRANCHIUS-FURZERI; SEXUAL COERCION; FISHES; VERTEBRATE; BARRIERS; BIOLOGY; SYSTEM	Background: Interspecific reproductive isolation is typically achieved by a combination of intrinsic and extrinsic barriers. Behavioural isolating barriers between sympatric, closely related species are often of primary importance and frequently aided by extrinsic factors causing spatial and temporal interspecific separation. Study systems with a severely limited role of extrinsic factors on reproductive isolation may provide valuable insights into how reproductive isolation between sympatric species is maintained. We used no-choice experimental set-up to study reproductive barriers between two closely related sympatric African killifish species, Nothobranchius furzeri and Nothobranchius orthonotus. These fish live in small temporary savannah pools and have complete spatial and temporal overlap in reproductive activities and share a similar ecology. Principal Findings: We found that the two species display largely incomplete and asymmetric reproductive isolation. Mating between N. furzeri males and N. orthonotus females was absent under standard experimental conditions and eggs were not viable when fish were forced to mate in a modified experimental setup. In contrast, male N. orthonotus indiscriminately mated with N. furzeri females, the eggs were viable, and offspring successfully hatched. Most spawnings, however, were achieved by male coercion and egg production and embryo survival were low. Behavioural asymmetry was likely facilitated by mating coercion from larger males of N. orthonotus and at relatively low cost to females. Interestingly, the direction of asymmetry was positively associated with asymmetry in post-mating reproductive barriers. Significance: We showed that, in fish species with a promiscuous mating system and multiple matings each day, selection for strong mate preferences was relaxed. This effect was likely due to the small proportion of resources allocated to each single mating and the high potential cost to females from mating refusal. We highlight and discuss the fact that males of rarer species may often coercively mate with females of a related, more abundant species.	[Polacik, Matej; Reichard, Martin] Acad Sci Czech Republ, Dept Fish Ecol, Inst Vertebrate Biol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Polacik, M (corresponding author), Acad Sci Czech Republ, Dept Fish Ecol, Inst Vertebrate Biol, Brno, Czech Republic.	polacik@ivb.cz	Polačik, Matej/A-8260-2010; Reichard, Martin/C-6563-2009	Polačik, Matej/0000-0003-1309-2146; Reichard, Martin/0000-0002-9306-0074	Czech Science Foundation [206/09/0815]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was funded by Czech Science Foundation grant No. 206/09/0815 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen JW, 2009, EVOLUTION, V63, P1191, DOI 10.1111/j.1558-5646.2009.00611.x; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cordingley JE, 2009, ANIM CONSERV, V12, P505, DOI 10.1111/j.1469-1795.2009.00294.x; Coyne JA, 2004, SPECIATION, V37; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Dorn A, 2011, MOL PHYLOGENET EVOL, V61, P739, DOI 10.1016/j.ympev.2011.06.010; EWULONU UK, 1985, COPEIA, P503; Genade T., 2005, LAB MANUAL CULTURING; Genner MJ, 2007, MOL ECOL, V16, P651, DOI 10.1111/j.1365-294X.2006.03173.x; HAAS R, 1976, COPEIA, P80; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Hettyey A, 2009, ANIM BEHAV, V78, P1365, DOI 10.1016/j.anbehav.2009.09.006; Immler S, 2011, J EVOLUTION BIOL, V24, P111, DOI 10.1111/j.1420-9101.2010.02142.x; PETERSON C, 1996, J AM KILLIFISH ASS, V29, P93; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Polacik M, 2011, J FISH BIOL, V78, P796, DOI 10.1111/j.1095-8649.2010.02893.x; Polacik M, 2010, J FISH BIOL, V77, P754, DOI 10.1111/j.1095-8649.2010.02717.x; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Reichard M, 2010, BIOL J LINN SOC, V100, P62, DOI 10.1111/j.1095-8312.2010.01406.x; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Rosenthal GG, 1996, ANIM BEHAV, V51, P811, DOI 10.1006/anbe.1996.0085; Ross CL, 2008, BIOL J LINN SOC, V94, P777, DOI 10.1111/j.1095-8312.2008.01018.x; Shine R, 2004, CAN J ZOOL, V82, P1091, DOI 10.1139/Z04-086; Strecker U, 1999, J EVOLUTION BIOL, V12, P927, DOI 10.1046/j.1420-9101.1999.00096.x; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670; Watters B.R., 2009, J AM KILLFISH ASSOC, V42, P37; Watters B.R., 2006, J AM KILLIFISH ASS, V39, P137; Wellenreuther M, 2007, MAR BIOL, V152, P619, DOI 10.1007/s00227-007-0713-1; Wildekamp RH., 2004, AWORLD KILLIES ATLAS; Wiwegweaw A, 2009, BIOL LETTERS, V5, P240, DOI 10.1098/rsbl.2008.0714; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310	36	31	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22684	10.1371/journal.pone.0022684	http://dx.doi.org/10.1371/journal.pone.0022684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850233	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300017
J	Hemelrijk, CK; Hildenbrandt, H				Hemelrijk, Charlotte K.; Hildenbrandt, Hanno			Some Causes of the Variable Shape of Flocks of Birds	PLOS ONE			English	Article							FISH SCHOOLS; STURNUS-VULGARIS; ANIMAL GROUPS; 3-DIMENSIONAL STRUCTURE; COLLECTIVE BEHAVIOR; STARLING FLOCKS; PATTERN; MODEL; INDIVIDUALS; SIMULATION	Flocks of birds are highly variable in shape in all contexts (while travelling, avoiding predation, wheeling above the roost). Particularly amazing in this respect are the aerial displays of huge flocks of starlings (Sturnus vulgaris) above the sleeping site at dawn. The causes of this variability are hardly known, however. Here we hypothesise that variability of shape increases when there are larger local differences in movement behaviour in the flock. We investigate this hypothesis with the help of a model of the self-organisation of travelling groups, called StarDisplay, since such a model has also increased our understanding of what causes the oblong shape of schools of fish. The flocking patterns in the model prove to resemble those of real birds, in particular of starlings and rock doves. As to shape, we measure the relative proportions of the flock in several ways, which either depend on the direction of movement or do not. We confirm that flock shape is usually more variable when local differences in movement in the flock are larger. This happens when a) flock size is larger, b) interacting partners are fewer, c) the flock turnings are stronger, and d) individuals roll into the turn. In contrast to our expectations, when variability of speed in the flock is higher, flock shape and the positions of members in the flock are more static. We explain this and indicate the adaptive value of low variability of speed and spatial restriction of interaction and develop testable hypotheses.	[Hemelrijk, Charlotte K.; Hildenbrandt, Hanno] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	c.k.hemelrijk@rug.nl	Hemelrijk, Charlotte K./E-4828-2013	Hemelrijk, Charlotte K./0000-0001-6160-077X	University of Groningen; STREP in the NEST [n12682]; NWO [051.07.006]	University of Groningen; STREP in the NEST; NWO(Netherlands Organization for Scientific Research (NWO))	The startup grant of the University of Groningen belonging to the Rosalind Franklin Fellowship of Hemelrijk, The 6th European framework under the STREP-project "Star-Flag" (n12682) in the NEST-programme of "Tackling Complexity in Science," The Cognitie Pilot project of NWO (051.07.006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Barequet G, 2001, J ALGORITHMS, V38, P91, DOI 10.1006/jagm.2000.1127; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Carere C, 2009, ANIM BEHAV, V77, P101, DOI 10.1016/j.anbehav.2008.08.034; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davis M. J., 1980, ANIM BEHAV, V28, P668, DOI [10.1016/S0003-3472(80)80127-8, DOI 10.1016/S0003-3472(80)80127-8]; Feare C.J., 1984, STARLING; Gerlotto F, 2003, AQUAT LIVING RESOUR, V16, P113, DOI 10.1016/S0990-7440(03)00027-5; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Helbing D, 1998, NATURE, V396, P738, DOI 10.1038/25499; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Hemelrijk CK, 2005, NEUROSCI BIOBEHAV R, V29, P125, DOI 10.1016/j.neubiorev.2004.07.003; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Huse G, 2002, J FISH BIOL, V60, P571, DOI 10.1006/jfbi.2002.1874; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Inada Y, 2002, J THEOR BIOL, V214, P371, DOI 10.1006/jtbi.2001.2449; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Lee SH, 2006, J THEOR BIOL, V240, P250, DOI 10.1016/j.jtbi.2005.09.009; MAJOR PF, 1978, BEHAV ECOL SOCIOBIOL, V4, P111, DOI 10.1007/BF00354974; Mirabet V, 2008, BEHAV ECOL SOCIOBIOL, V63, P159, DOI 10.1007/s00265-008-0647-8; Norberg U., 1990, VERTEBRATE FLIGHT ME; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; PITCHER TJ, 1980, FRESHWATER BIOL, V10, P539, DOI 10.1111/j.1365-2427.1980.tb01229.x; POMEROY H, 1992, AUK, V109, P256; POMEROY H, 1977, ANIM BEHAV, V25, P720, DOI 10.1016/0003-3472(77)90121-X; REUTER H, 1994, ECOL MODEL, V75, P147, DOI 10.1016/0304-3800(94)90014-0; REYNOLDS, 1987, COMPUTER GRAPHICS, V21, P25, DOI DOI 10.1145/37402.37406; Selous Edmund, 1931, THOUGHT TRANSFERENCE; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; van den Hout PJ, 2010, BEHAV ECOL, V21, P16, DOI 10.1093/beheco/arp146; Videler JJ., 2005, AVIAN FLIGHT; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Zheng M, 2005, J THEOR BIOL, V235, P153, DOI 10.1016/j.jtbi.2004.12.025	43	84	85	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22479	10.1371/journal.pone.0022479	http://dx.doi.org/10.1371/journal.pone.0022479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829627	gold, Green Submitted, Green Published			2022-12-25	WOS:000293561200020
J	Reino, DC; Pisarenko, V; Palange, D; Doucet, D; Bonitz, RP; Lu, Q; Colorado, I; Sheth, SU; Chandler, B; Kannan, KB; Ramanathan, M; Xu, DZ; Deitch, EA; Feinman, R				Reino, Diego C.; Pisarenko, Vadim; Palange, David; Doucet, Danielle; Bonitz, Robert P.; Lu, Qi; Colorado, Iriana; Sheth, Sharvil U.; Chandler, Benjamin; Kannan, Kolenkode B.; Ramanathan, Madhuri; Xu, Da Zhong; Deitch, Edwin A.; Feinman, Rena			Trauma Hemorrhagic Shock-Induced Lung Injury Involves a Gut-Lymph-Induced TLR4 Pathway in Mice	PLOS ONE			English	Article							INDUCED NITRIC-OXIDE; ISCHEMIA-REPERFUSION INJURY; ORGAN DYSFUNCTION SYNDROME; TOLL-LIKE RECEPTOR-4; MESENTERIC LYMPH; SYSTEMIC INFLAMMATION; INTESTINAL PERMEABILITY; IMMUNE-RESPONSES; OXIDATIVE STRESS; TOLL-LIKE-RECEPTOR-4	Background: Injurious non-microbial factors released from the stressed gut during shocked states contribute to the development of acute lung injury (ALI) and multiple organ dysfunction syndrome (MODS). Since Toll-like receptors (TLR) act as sensors of tissue injury as well as microbial invasion and TLR4 signaling occurs in both sepsis and noninfectious models of ischemia/reperfusion (I/R) injury, we hypothesized that factors in the intestinal mesenteric lymph after trauma hemorrhagic shock (T/HS) mediate gut-induced lung injury via TLR4 activation. Methods/Principal Findings: The concept that factors in T/HS lymph exiting the gut recreates ALI is evidenced by our findings that the infusion of porcine lymph, collected from animals subjected to global T/HS injury, into naive wildtype (WT) mice induced lung injury. Using C3H/HeJ mice that harbor a TLR4 mutation, we found that TLR4 activation was necessary for the development of T/HS porcine lymph-induced lung injury as determined by Evan's blue dye (EBD) lung permeability and myeloperoxidase (MPO) levels as well as the induction of the injurious pulmonary iNOS response. TRIF and Myd88 deficiency fully and partially attenuated T/HS lymph-induced increases in lung permeability respectively. Additional studies in TLR2 deficient mice showed that TLR2 activation was not involved in the pathology of T/HS lymph-induced lung injury. Lastly, the lymph samples were devoid of bacteria, endotoxin and bacterial DNA and passage of lymph through an endotoxin removal column did not abrogate the ability of T/HS lymph to cause lung injury in naive mice. Conclusions/Significance: Our findings suggest that non-microbial factors in the intestinal mesenteric lymph after T/HS are capable of recreating T/HS-induced lung injury via TLR4 activation.	[Reino, Diego C.; Pisarenko, Vadim; Palange, David; Doucet, Danielle; Bonitz, Robert P.; Lu, Qi; Colorado, Iriana; Sheth, Sharvil U.; Chandler, Benjamin; Kannan, Kolenkode B.; Ramanathan, Madhuri; Xu, Da Zhong; Deitch, Edwin A.; Feinman, Rena] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Reino, DC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	edeitch@umdnj.edu; feinmarr@umdnj.edu			NIH [R01-GM059841, 1P50GM069790, T32-GM069330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059841, P50GM069790, T32GM069330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01-GM059841 (EAD), 1P50GM069790 (to EAD and RF) and T32-GM069330 (to DCR, VP, DD and SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adams CA, 2001, SURGERY, V129, P351, DOI 10.1067/msy.2001.111698; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BORDER JR, 1987, ANN SURG, V206, P427, DOI 10.1097/00000658-198710000-00004; Breslin J, 2008, SHOCK, V29, P197; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; DEITCH EA, 1990, SURGERY, V107, P411; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Edwin A, 2006, J ORGAN DYSFUNCTION, V2, P70, DOI 10.1080/17471060600551772; Eswarappa SM, 2008, INNATE IMMUN-LONDON, V14, P13, DOI 10.1177/1753425907087349; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; Gonzalez RJ, 2000, SHOCK, V14, P404, DOI 10.1097/00024382-200014030-00028; Hierholzer C, 2004, AM J PHYSIOL-GASTR L, V286, pG225, DOI 10.1152/ajpgi.00447.2002; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ivatury RR, 1996, J AM COLL SURGEONS, V183, P145; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kaiser VL, 2005, SHOCK, V23, P417, DOI 10.1097/01.shk.0000160524.14235.6c; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koury J, 2004, SHOCK, V22, P270, DOI 10.1097/01.shk.0000135256.67441.3f; Leaphart CL, 2007, SURGERY, V141, P563, DOI 10.1016/j.surg.2007.01.021; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meng XZ, 2005, AM J PHYSIOL-REG I, V288, pR600, DOI 10.1152/ajpregu.00182.2004; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; Sambol JT, 2000, SHOCK, V14, P416, DOI 10.1097/00024382-200014030-00030; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sethi G, 2004, MOL IMMUNOL, V40, P1315, DOI 10.1016/j.molimm.2004.01.001; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	49	76	91	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e14829	10.1371/journal.pone.0014829	http://dx.doi.org/10.1371/journal.pone.0014829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829592	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200001
J	Souza-Smith, FM; Katz, PS; Trask, AJ; Stewart, JA; Lord, KC; Varner, KJ; Vassallo, DV; Lucchesi, PA				Souza-Smith, Flavia M.; Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lord, Kevin C.; Varner, Kurt J.; Vassallo, Dalton V.; Lucchesi, Pamela A.			Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE ACTIVITY; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR-MATRIX; VASCULAR STRUCTURE; RATS; HYPERTENSION; EXPRESSION; STIFFNESS; MELLITUS; ROLES	Objective: Resistance vessel remodeling is controlled by myriad of hemodynamic and neurohormonal factors. This study characterized structural and molecular remodeling in mesenteric resistance arteries (MRAs) in diabetic (db/db) and control (Db/db) mice. Methods: Structural properties were assessed in isolated MRAs from 12 and 16 wk-old db/db and Db/db mice by pressure myography. Matrix regulatory proteins were measured by Western blot analysis. Mean arterial pressure and superior mesenteric blood flow were measured in 12 wk-old mice by telemetry and a Doppler flow nanoprobe, respectively. Results: Blood pressure was similar between groups. Lumen diameter and medial cross-sectional area were significantly increased in 16 wk-old db/db MRA compared to control, indicating outward hypertrophic remodeling. Moreover, wall stress and cross-sectional compliance were significantly larger in diabetic arteries. These remodeling indices were associated with increased expression of matrix regulatory proteins matrix metalloproteinase (MMP)-9, MMP-12, tissue inhibitors of matrix metalloproteinase (TIMP)-1, TIMP-2, and plasminogen activator inhibitor-1 (PAI-1) in db/db arteries. Finally, superior mesenteric artery blood flow was increased by 46% in 12 wk-old db/db mice, a finding that preceded mesenteric resistance artery remodeling. Conclusions: These data suggest that flow-induced hemodynamic changes may supersede the local neurohormonal and metabolic milieu to culminate in hypertrophic outward remodeling of type 2 DM mesenteric resistance arteries.	[Souza-Smith, Flavia M.; Varner, Kurt J.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Souza-Smith, Flavia M.; Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Katz, Paige S.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Nationwide Childrens Hosp, Res Inst, Ctr Heart, Columbus, OH USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Lord, Kevin C.] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Universidade Federal do Espirito Santo; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Souza-Smith, FM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	pamela.lucchesi@nationwidechildrens.org	Lucchesi, Pamela A/E-3558-2011; Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174; Varner, Kurt/0000-0001-5460-8044	National Institutes of Health [COBRE P20RR18766, HL056046, T32HL098039]; Coordination for the Improvement of Higher Education Personnel; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098039, R29HL056046, R01HL056046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health COBRE P20RR18766 grant (LSUHSC), National Institutes of Health HL056046 grant (PAL), National Institutes of Health T32HL098039 grant (AJT), and Coordination for the Improvement of Higher Education Personnel (DVV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Brassard P, 2005, HYPERTENSION, V46, P598, DOI 10.1161/01.HYP.0000176744.15592.7d; Briones AM, 2003, J PHYSIOL-LONDON, V552, P185, DOI 10.1113/jphysiol.2003.046904; Briones AM, 2007, J GERONTOL A-BIOL, V62, P696, DOI 10.1093/gerona/62.7.696; Cooper ME, 2004, AM J HYPERTENS, V17, p16S, DOI 10.1016/j.amjhyper.2004.08.004; COOPER ME, 1994, DIABETES, V43, P1221, DOI 10.2337/diabetes.43.10.1221; COX JE, 1977, J COMP PHYSIOL PSYCH, V91, P347, DOI 10.1037/h0077322; Crijns FRL, 1999, AM J PHYSIOL-HEART C, V276, pH1672, DOI 10.1152/ajpheart.1999.276.5.H1672; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Dhalla NS, 1998, CARDIOVASC RES, V40, P239, DOI 10.1016/S0008-6363(98)00186-2; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; Dunn WR, 1997, HYPERTENSION, V29, P1140, DOI 10.1161/01.HYP.29.5.1140; FRIEDMAN MI, 1994, PHYSIOL BEHAV, V56, P373, DOI 10.1016/0031-9384(94)90209-7; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GLAGOV S, 1992, J HYPERTENS, V10, pS101; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goldsmith EC, 2002, J CARD FAIL, V8, pS314, DOI 10.1054/jcaf.2002.129258; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; Intengan HD, 1999, CIRCULATION, V100, P2267, DOI 10.1161/01.CIR.100.22.2267; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; LANGILLE BL, 1989, AM J PHYSIOL, V256, pH931, DOI 10.1152/ajpheart.1989.256.4.H931; Li Q, 2007, ACTA CARDIOL, V62, P485, DOI 10.2143/AC.62.5.2023412; McFarlane SI, 2003, AM J CARDIOL, V91, p30H, DOI 10.1016/S0002-9149(03)00432-6; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; QIU HY, 1995, J PHARMACOL TOXICOL, V33, P159, DOI 10.1016/1056-8719(94)00076-G; Rizzoni D, 2003, CIRCULATION, V108, P2230, DOI 10.1161/01.CIR.0000095031.51492.C5; Rizzoni D, 2001, J HYPERTENS, V19, P913, DOI 10.1097/00004872-200105000-00012; Rizzoni D, 2001, CIRCULATION, V103, P1238; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Stewart JA, 2003, J MOL CELL CARDIOL, V35, P311, DOI 10.1016/S0022-2828(03)00013-0; Stockklauser-Farber K, 2000, BBA-MOL BASIS DIS, V1535, P10, DOI 10.1016/S0925-4439(00)00078-8; Thrailkill KM, 2007, DIABETES CARE, V30, P2321, DOI 10.2337/dc07-0162; Tulis DA, 1998, AM J PHYSIOL-HEART C, V274, pH874, DOI 10.1152/ajpheart.1998.274.3.H874; Tuttle JL, 2001, AM J PHYSIOL-HEART C, V281, pH1380, DOI 10.1152/ajpheart.2001.281.3.H1380; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Unthank JL, 1996, CIRC RES, V79, P1015, DOI 10.1161/01.RES.79.5.1015; VANBORTEL LM, 1995, HYPERTENSION, V26, P531, DOI 10.1161/01.HYP.26.3.531; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wigg SJ, 2004, DIABETOLOGIA, V47, P1038, DOI 10.1007/s00125-004-1411-x; 2008, 2007 DIABETES CARE, V31, P596	45	36	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23337	10.1371/journal.pone.0023337	http://dx.doi.org/10.1371/journal.pone.0023337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829729	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200066
J	Sakaguchi, M; Murata, H; Yamamoto, K; Ono, T; Sakaguchi, Y; Motoyama, A; Hibino, T; Kataoka, K; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Yamamoto, Ken-ichi; Ono, Tomoyuki; Sakaguchi, Yoshihiko; Motoyama, Akira; Hibino, Toshihiko; Kataoka, Ken; Huh, Nam-ho			TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HUMAN KERATINOCYTES; RECEPTOR; GROWTH; INFLAMMATION; ACTIVATION; DOMAIN; AMPHOTERIN; DISEASE; CELLS	The receptor for advanced glycation end products (RAGE) is thought to be involved in the pathogenesis of a broad range of inflammatory, degenerative and hyperproliferative diseases. It binds to diverse ligands and activates multiple intracellular signaling pathways. Despite these pivotal functions, molecular events just downstream of ligand-activated RAGE have been surprisingly unknown. Here we show that the cytoplasmic domain of RAGE is phosphorylated at Ser391 by PKCf upon binding of ligands. TIRAP and MyD88, which are known to be adaptor proteins for Toll-like receptor-2 and -4 (TLR2/4), bound to the phosphorylated RAGE and transduced a signal to downstream molecules. Blocking of the function of TIRAP and MyD88 largely abrogated intracellular signaling from ligand-activated RAGE. Our findings indicate that functional interaction between RAGE and TLRs coordinately regulates inflammation, immune response and other cellular functions.	[Sakaguchi, Masakiyo; Murata, Hitoshi; Yamamoto, Ken-ichi; Ono, Tomoyuki; Kataoka, Ken; Huh, Nam-ho] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Kiyotake, Miyazaki, Japan; [Motoyama, Akira; Hibino, Toshihiko] Shiseido Res Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan	Okayama University; University of Miyazaki; Shiseido Company, Limited	Sakaguchi, M (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan.	namu@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; KATAOKA, Ken/B-1607-2011; MURATA, Hitoshi/B-2327-2011		Ministry of Health, Labor and Welfare (Research for Intractable Diseases); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23790479] Funding Source: KAKEN	Ministry of Health, Labor and Welfare (Research for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Health, Labor and Welfare (Research for Intractable Diseases) (N. Huh), from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Young Scientists (A)) (M. Sakaguchi), and from Takeda Science Foundation (M. Sakaguchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study. Akira Motoyama and Toshihiko Hibino are employees of the Shiseido Research Center who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Fages C, 2000, J CELL SCI, V113, P611; Fedorov YV, 2002, MOL CELL BIOL, V22, P1140, DOI 10.1128/MCB.22.4.1140-1149.2002; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, REV NEUROSCIENCE, V20, P95; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zhou YJ, 2006, BIOCHEM BIOPH RES CO, V344, P658, DOI 10.1016/j.bbrc.2006.03.167	36	154	158	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23132	10.1371/journal.pone.0023132	http://dx.doi.org/10.1371/journal.pone.0023132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829704	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511200041
J	Cui, H; Hung, AC; Klaver, DW; Suzuki, T; Freeman, C; Narkowicz, C; Jacobson, GA; Small, DH				Cui, Hao; Hung, Amos C.; Klaver, David W.; Suzuki, Toshiharu; Freeman, Craig; Narkowicz, Christian; Jacobson, Glenn A.; Small, David H.			Effects of Heparin and Enoxaparin on APP Processing and A beta Production in Primary Cortical Neurons from Tg2576 Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MOLECULAR-WEIGHT HEPARINS; ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; TRANSGENIC MICE; DYES ATTENUATE; MOUSE MODEL; PEPTIDE; BRAIN	Background: Alzheimer's disease (AD) is caused by accumulation of A beta, which is produced through sequential cleavage of beta-amyloid precursor protein (APP) by the beta-site APP cleaving enzyme (BACE1) and c-secretase. Enoxaparin, a low molecular weight form of the glycosaminoglycan (GAG) heparin, has been reported to lower A beta plaque deposition and improve cognitive function in AD transgenic mice. Methodology/Principal Findings: We examined whether heparin and enoxaparin influence APP processing and inhibit A beta production in primary cortical cell cultures. Heparin and enoxaparin were incubated with primary cortical cells derived from Tg2576 mice, and the level of APP and proteolytic products of APP (sAPPa, C99, C83 and A beta) was measured by western blotting. Treatment of the cells with heparin or enoxaparin had no significant effect on the level of total APP. However, both GAGs decreased the level of C99 and C83, and inhibited sAPPa and A beta secretion. Heparin also decreased the level of beta-secretase (BACE1) and alpha-secretase (ADAM10). In contrast, heparin had no effect on the level of ADAM17. Conclusions/Significance: The data indicate that heparin and enoxaparin decrease APP processing via both alpha- and beta-secretase pathways. The possibility that GAGs may be beneficial for the treatment of AD needs further study.	[Cui, Hao; Hung, Amos C.; Klaver, David W.; Small, David H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Cui, Hao; Narkowicz, Christian; Jacobson, Glenn A.] Univ Tasmania, Sch Pharm, Hobart, Tas 7001, Australia; [Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido, Japan; [Klaver, David W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Freeman, Craig] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia	University of Tasmania; University of Tasmania; Hokkaido University; Monash University; Australian National University; John Curtin School of Medical Research	Cui, H (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	d.h.small@menzies.utas.edu.au	Suzuki, Toshiharu/B-5342-2013; Jacobson, Glenn/J-7883-2014	Jacobson, Glenn/0000-0002-3409-8769; Hung, Chun-Tao/0000-0001-7572-8897	National Health and Medical Research Council of Australia [490031]; Grants-in-Aid for Scientific Research [23390017] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a project grant (490031) from the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Ando K, 1999, J NEUROSCI, V19, P4421; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Beckman M, 2006, BIOCHEMISTRY-US, V45, P6703, DOI 10.1021/bi052498t; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Endres K, 2011, CURR ALZHEIMER RES; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JOHNSTON J, 1994, NEUROCHEM INT, V25, P73, DOI 10.1016/0197-0186(94)90056-6; Kadusevicius E, 2010, INT J TECHNOL ASSESS, V26, P272, DOI 10.1017/S0266462310000310; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Klaver D, 2010, NEURODEGENER DIS, V7, P187, DOI 10.1159/000295661; Klaver DW, 2010, J NEUROCHEM, V112, P1552, DOI 10.1111/j.1471-4159.2010.06571.x; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Leveugle B, 1998, J NEUROCHEM, V70, P736; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; Ma Q, 2002, THROMB RES, V105, P447, DOI 10.1016/S0049-3848(02)00050-6; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McLaurin J, 2000, EUR J BIOCHEM, V267, P6353, DOI 10.1046/j.1432-1327.2000.01725.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mendelson K, 2010, J BIOL CHEM, V285, P25024, DOI 10.1074/jbc.M110.102566; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Racchi M, 2003, MOL PSYCHIATR, V8, P209, DOI 10.1038/sj.mp.4001204; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rose M, 2004, BRAIN RES, V1015, P96, DOI 10.1016/j.brainres.2004.04.048; Rose M, 2003, NEUROBIOL AGING, V24, P481, DOI 10.1016/S0197-4580(02)00093-3; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Small DH, 2004, IUBMB LIFE, V56, P203, DOI 10.1080/15216540410001709211; SMALL DH, 1994, J NEUROSCI, V14, P2117; TERRY RD, 1964, AM J PATHOL, V44, P269; Timmer NM, 2010, NEUROBIOL DIS, V40, P340, DOI 10.1016/j.nbd.2010.06.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhu H, 2001, MOL MED, V7, P517, DOI 10.1007/BF03401857	66	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23007	10.1371/journal.pone.0023007	http://dx.doi.org/10.1371/journal.pone.0023007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829577	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500068
J	Yim, SH; Kim, YJ; Oh, SY; Fujii, J; Zhang, Y; Gladyshev, VN; Rhee, SG				Yim, Sun Hee; Kim, Yoo-Jin; Oh, Sue Young; Fujii, Junichi; Zhang, Yan; Gladyshev, Vadim N.; Rhee, Sue Goo			Identification and Characterization of Alternatively Transcribed Form of Peroxiredoxin IV Gene That Is Specifically Expressed in Spermatids of Postpubertal Mouse Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; THIOL-DISULFIDE STATUS; NF-KAPPA-B; OXIDATIVE STRESS; MAMMALIAN SPERM; MATURATION; PROTEIN; GLUTATHIONE; ACTIVATION; REDUCTION	2-Cysteine (Cys) peroxiredoxins (Prxs), which include mammalian Prxs I-IV, possess two conserved Cys residues that are readily oxidized by H2O2 to form a disulfide. In the case of Prx I-III, the disulfide is reduced by thioredoxin, thus enabling these proteins to function as peroxidases. Prx IV was shown previously to be synthesized as a 31-kDa polypeptide with an NH2-terminal signal peptide that is subsequently cleaved to generate a 27-kDa form of the protein that is localized to the endoplasmic reticulum. A form of Prx IV, larger than 27 kDa revealed by immunoblot analysis was suggested to represent the unprocessed, 31-kDa form, but this larger form was detected only in spermatids of the postpubertal testis. We now show that the larger form of Prx IV (here designated Prx IV-L) detected in the testis is actually a product of alternative transcription of the Prx IV gene that is encoded by newly identified exon 1A together with exons 2-7 that are shared with the 27-kDa form (designated Prx IV-S). Prx IV-L was detected in spermatids but not in mature sperm, it could form disulfide-linked dimers but not higher order oligomers via oxidation, and it was resistant to hyperoxidation unless additional reductant was added, suggesting that its peroxidase activity is limited in vivo. Phylogenetic analysis showed that the Prx IV-S gene is present in all vertebrates examined, whereas the Prx IV-L gene was detected only in placental mammals. We suggest that Prx IV-L functions as an H2O2 sensor that mediates protein thiol oxidation required for the maturation of spermatozoa in placental mammals.	[Yim, Sun Hee; Kim, Yoo-Jin; Oh, Sue Young; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Gladyshev, Vadim N.; Rhee, Sue Goo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Fujii, Junichi] Yamagata Univ, Sch Med, Dept Biochem, Yamagata 9909585, Japan; [Zhang, Yan; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Zhang, Yan] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Ewha Womans University; Ewha Womans University; Yamagata University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yim, SH (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	shyim@rics.bwh.harvard.edu; rheesg@ewha.ac.kr	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016; Fujii, Junichi/0000-0003-2267-7357	National Research Foundation of Korea [2009-0052293, M10642040001-07N4204-00110]; World Class University [R31-2008-000-10010-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); World Class University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Research Foundation of Korea (National Honor Scientist Program Grant 2009-0052293 and Bio Research and Development Program Grant M10642040001-07N4204-00110 to S. G. R.) and World Class University Program Grant R31-2008-000-10010-0.	Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; BEDFORD JM, 1974, J EXP ZOOL, V187, P181, DOI 10.1002/jez.1401870202; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; de Lamirande E, 1998, FREE RADICAL BIO MED, V25, P803, DOI 10.1016/S0891-5849(98)00156-7; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; GROSSHANS K, 1985, BIOL REPROD, V33, P1197, DOI 10.1095/biolreprod33.5.1197; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Haridas V, 1998, J IMMUNOL, V161, P1; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; KOSOWER NS, 1992, J ANDROL, V13, P342; Lolis D, 1996, INT J ANDROL, V19, P23, DOI 10.1111/j.1365-2605.1996.tb00429.x; Maiorino M, 2002, BIOL CHEM, V383, P591, DOI 10.1515/BC.2002.061; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; NAGAO Y, 1989, IN VITRO CELL DEV B, V25, P1088, DOI 10.1007/BF02621259; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; RETIEF JD, 1995, P ROY SOC B-BIOL SCI, V259, P7, DOI 10.1098/rspb.1995.0002; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; ROUSSEAUX J, 1995, BIOL REPROD, V52, P1066, DOI 10.1095/biolreprod52.5.1066; RUFAS O, 1991, MOL REPROD DEV, V29, P282, DOI 10.1002/mrd.1080290311; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sutovsky P, 1997, BIOL REPROD, V56, P1503, DOI 10.1095/biolreprod56.6.1503; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zini A, 2001, UROLOGY, V58, P80, DOI 10.1016/S0090-4295(01)00997-9; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	48	15	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39002	39012		10.1074/jbc.M111.257220	http://dx.doi.org/10.1074/jbc.M111.257220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21835919	Green Published, hybrid			2022-12-25	WOS:000296759800019
J	Rawlings, ND; Barrett, AJ; Bateman, A				Rawlings, Neil David; Barrett, Alan John; Bateman, Alex			Asparagine Peptide Lyases A SEVENTH CATALYTIC TYPE OF PROTEOLYTIC ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; AUTOTRANSPORTER; VIRUS; CHYMOTRYPSIN; EXPRESSION; HYDROLASE; MECHANISM; CLEAVAGE; DOMAIN	The terms "proteolytic enzyme" and "peptidase" have been treated as synonymous, and all proteolytic enzymes have been considered to be hydrolases (EC 3.4). However, the recent discovery of proteins that cleave themselves at asparagine residues indicates that not all peptide bond cleavage occurs by hydrolysis. These self-cleaving proteins include the Tsh protein precursor of Escherichia coli, in which the large C-terminal propeptide acts as an autotransporter; certain viral coat proteins; and proteins containing inteins. Proteolysis is the action of an amidine lyase (EC 4.3.2). These proteolytic enzymes are also the first in which the nucleophile is an asparagine, defining the seventh proteolytic catalytic type and the first to be discovered since 2004. We have assembled ten families based on sequence similarity in which cleavage is thought to be catalyzed by an asparagine.	[Rawlings, Neil David; Barrett, Alan John; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Wellcome Trust Sanger Institute	Rawlings, ND (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	ndr@sanger.ac.uk	Rawlings, Neil D./I-4867-2012; Rawlings, Neil/M-5566-2013; Bateman, Alex/H-2861-2019; Barrett, Alan J/G-8970-2013	Rawlings, Neil/0000-0001-5557-7665; Bateman, Alex/0000-0002-6982-4660; Barrett, Alan J/0000-0002-6082-4437	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust Grant Number WT077044/Z/05/Z.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; De E, 2008, MOL MEMBR BIOL, V25, P192, DOI 10.1080/09687680701771925; Dehart MP, 2007, J PHARM SCI-US, V96, P2667, DOI 10.1002/jps.20905; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Duquerroy S, 2009, EMBO J, V28, P1655, DOI 10.1038/emboj.2009.109; Eckstein M, 2002, BIOTECHNOL LETT, V24, P867, DOI 10.1023/A:1015564608261; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hadfield AT, 1997, STRUCTURE, V5, P427, DOI 10.1016/S0969-2126(97)00199-8; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Lackner T, 2006, P NATL ACAD SCI USA, V103, P1510, DOI 10.1073/PNAS.0508247103; Li HM, 2002, J BIOL CHEM, V277, P24522, DOI 10.1074/jbc.M202020200; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; McDonough MA, 1999, PROTEIN SCI, V8, P1971, DOI 10.1110/ps.8.10.1971; Moure CM, 2002, NAT STRUCT BIOL, V9, P764, DOI 10.1038/nsb840; NC-IUBMB (Nomenclature Committee of the International Union of Biochemistry and Molecular Biology), 1992, ENZ NOM 1992 REC NOM; Raghavan R, 2009, J BACTERIOL, V191, P6193, DOI 10.1128/JB.00675-09; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Satani M, 2003, PROTEIN EXPRES PURIF, V28, P293, DOI 10.1016/S1046-5928(02)00684-8; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang Y, 2004, J VIROL, V78, P11061, DOI 10.1128/JVI.78.20.11061-11069.2004	48	56	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38321	38328		10.1074/jbc.M111.260026	http://dx.doi.org/10.1074/jbc.M111.260026			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21832066	hybrid, Green Published			2022-12-25	WOS:000296594200045
J	Huang, W; Andras, IE; Rha, GB; Hennig, B; Toborek, M				Huang, Wen; Andras, Ibolya E.; Rha, Geun Bae; Hennig, Bernhard; Toborek, Michal			PPAR alpha and PPAR gamma protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling	FASEB JOURNAL			English	Article						peroxisome proliferator-activated receptor; matrix metalloproteinase; human immunodeficiency virus-1; blood-brain barrier	HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BREAST-CANCER CELLS; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; MATRIX-METALLOPROTEINASE; OXIDATIVE STRESS; TRANSENDOTHELIAL MIGRATION; HIV-1-ASSOCIATED DEMENTIA	Activation of matrix metalloproteinase-9 (MMP-9) is involved in HIV-1-induced disruption of the blood-brain barrier (BBB). In the present study, we hypothesize that peroxisome proliferator-activated receptor (PPAR)-alpha or PPAR gamma can protect against HIV-1-induced MMP-9 overexpression in brain endothelial cells (hCMEC cell line) by attenuating cellular oxidative stress and down-regulation of caveolae-associated redox signaling. Exposure to HIV-1-infected monocytes induced phosphorylation of ERK1/2 and Akt in hCMEC by 2.5- and 3.6-fold, respectively; however, these effects were attenuated by overexpression of PPAR alpha or PPAR gamma and by silencing of caveolin-1 (cav-1). Coculture of hCMEC with HIV-1-infected monocytes significantly induced MMP-9 promoter and enzyme activity by 3- to 3.5-fold. Promoter mutation studies indicated that SP-1 (g1940t_g1941t) is an essential transcription factor involved in induction of MMP-9 promoter by HIV-1. In addition, HIV-1-stimulated activity of MMP-9 promoter was inhibited by mutation of AP-1 site 2 (c1918t_a1919g) and both (but not individual) NF-kappa B binding sites (g1389c and g1664c). PPAR overexpression, ERK1/2 or Akt inhibition, and silencing of cav-1 all effectively protected against HIV-1-induced MMP-9 promoter activity, indicating a close relationship among HIV-1-induced cerebrovascular toxicity, redox-regulated mechanisms, and functional caveolae. Such a link was further confirmed in MMP-9-deficient mice exposed to PPAR alpha or PPAR gamma agonist and injected with the HIV-1-specific protein Tat into cerebral vasculature. Overall, our results indicate that ERK1/2, Akt, and cav-1 are involved in the regulatory mechanisms of PPAR-mediated protection against HIV-1-induced MMP-9 expression in brain endothelial cells.-Huang, W., Andras, I. E., Rha, G. B., Hennig, B., Toborek, M. PPAR alpha and PPAR gamma protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling. FASEB J. 25, 3979-3988 (2011). www.fasebj.org	[Toborek, Michal] Univ Kentucky, Med Ctr, Dept Neurosurg, Mol Neurosci & Vasc Biol Lab, Lexington, KY 40536 USA; [Hennig, Bernhard] Univ Kentucky, Coll Agr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Toborek, M (corresponding author), Univ Kentucky, Med Ctr, Dept Neurosurg, Mol Neurosci & Vasc Biol Lab, 593 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	michal.toborek@uky.edu			U.S. National Institutes of Health [MH63022, MH072567, DA027569, ES07380, AHA09POST2060217]; National Center for Research Resources [P20 RR15592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063022, R01MH072567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027569] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health grants MH63022, MH072567, DA027569, ES07380, and AHA09POST2060217. Tat was produced and provided by support from the National Center for Research Resources (grant P20 RR15592).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Andersson LM, 2001, J NEUROVIROL, V7, P542, DOI 10.1080/135502801753248123; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Avison MJ, 2004, J NEUROIMMUNOL, V157, P140, DOI 10.1016/j.jneuroim.2004.08.025; Boven LA, 2000, NEUROPATH APPL NEURO, V26, P356, DOI 10.1046/j.1365-2990.2000.00255.x; Buttner A, 1996, ACTA NEUROPATHOL, V92, P35, DOI 10.1007/s004010050486; Byun HJ, 2006, J BIOL CHEM, V281, P34833, DOI 10.1074/jbc.M605483200; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Cho WJ, 2007, J CELL MOL MED, V11, P1069, DOI 10.1111/j.1582-4934.2007.00113.x; Ciborowski P, 2004, J NEUROIMMUNOL, V157, P11, DOI 10.1016/j.jneuroim.2004.08.033; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Dubuquoy L, 2009, PPAR RES, V2009, DOI 10.1155/2009/145124; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Hanley TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000981; Huang W, 2008, J NEUROCHEM, V107, P497, DOI 10.1111/j.1471-4159.2008.05626.x; Huang W, 2010, AM J PHYSIOL-HEART C, V298, pH1136, DOI 10.1152/ajpheart.01126.2009; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim HN, 2008, BMB REP, V41, P858, DOI 10.5483/BMBRep.2008.41.12.858; Kim J, 2009, CELL MOL LIFE SCI, V66, P1766, DOI 10.1007/s00018-009-9169-4; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Liuzzi GM, 2000, J NEUROVIROL, V6, P156, DOI 10.3109/13550280009013159; Lombardi A, 2008, ARTERIOSCL THROM VAS, V28, P718, DOI 10.1161/ATVBAHA.107.160713; Louboutin JP, 2010, J NEUROPATH EXP NEUR, V69, P801, DOI 10.1097/NEN.0b013e3181e8c96f; Lukes A, 1999, MOL NEUROBIOL, V19, P267, DOI 10.1007/BF02821717; McCoig C, 2004, PEDIATR INFECT DIS J, V23, P114, DOI 10.1097/01.inf.0000109247.67480.7a; Mcgee B, 2006, HIV CLIN TRIALS, V7, P142, DOI 10.1310/AW2H-TP5C-NP43-K6BY; Melendez MM, 2008, CLIN INFECT DIS, V46, P775, DOI 10.1086/527563; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Park SK, 2009, CARCINOGENESIS, V30, P1225, DOI 10.1093/carcin/bgp111; Pascale JM, 1997, CLIN DIAGN LAB IMMUN, V4, P474, DOI 10.1128/CDLI.4.4.474-477.1997; Persidsky Y, 2001, J NEUROIMMUNOL, V114, P57, DOI 10.1016/S0165-5728(00)00454-9; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Puyraimond A, 2001, EXP CELL RES, V262, P28, DOI 10.1006/excr.2000.5069; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; REDDY MM, 1989, J CLIN LAB ANAL, V3, P199, DOI 10.1002/jcla.1860030402; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sporer B, 2000, J NEUROIMMUNOL, V102, P125, DOI 10.1016/S0165-5728(99)00170-8; Sporer B, 1998, J INFECT DIS, V178, P854, DOI 10.1086/515342; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Toborek M., 2011, NEUROLOGY A IN PRESS, P207; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008	59	35	37	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3979	3988		10.1096/fj.11-188607	http://dx.doi.org/10.1096/fj.11-188607			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21840940	Green Published			2022-12-25	WOS:000296723100022
J	Jayaraman, S; Abe-Dohmae, S; Yokoyama, S; Cavigiolio, G				Jayaraman, Shobini; Abe-Dohmae, Sumiko; Yokoyama, Shinji; Cavigiolio, Giorgio			Impact of Self-association on Function of Apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; N-TERMINAL DOMAIN; LIPID-FREE; APOA-I; HUMAN-PLASMA; PRE-BETA; PROTEIN INTERACTIONS; STRUCTURAL-ANALYSIS; AQUEOUS-SOLUTIONS	Self-association is an inherent property of the lipid-free forms of several exchangeable apolipoproteins, including apolipoprotein A-I (apoA-I), the main protein component of high density lipoproteins (HDL) and an established anti-atherogenic factor. Monomeric lipid-free apoA-I is believed to be the biologically active species, but abnormal conditions, such as specific natural mutations or oxidation, produce an altered state of self-association that may contribute to apoA-I dysfunction. Replacement of the tryptophans of apoA-I with phenylalanines (Delta W-apoA-I) leads to unusually large and stable self-associated species. We took advantage of this unique solution property of Delta W-apoA-I to analyze the role of self-association in determining the structure and lipid-binding properties of apoA-I as well as ATP-binding cassette A1 (ABCA1)-mediated cellular lipid release, a relevant pathway in atherosclerosis. Monomeric Delta W-apoA-I and wild-type apoA-I activated ABCA1-mediated cellular lipid release with similar efficiencies, whereas the efficiency of high order self-associated species was reduced to less than 50%. Analysis of specific self-associated subclasses revealed that different factors influence the rate of HDL formation in vitro and ABCA1-mediated lipid release efficiency. The alpha-helix-forming ability of apoA-I is the main determinant of in vitro lipid solubilization rates, whereas loss of cellular lipid release efficiency is mainly caused by reduced structural flexibility by formation of stable quaternary interactions. Thus, stabilization of self-associated species impairs apoA-I biological activity through an ABCA1-mediated mechanism. These results afford mechanistic insights into the ABCA1 reaction and suggest self-association as a functional feature of apoA-I. Physiologic mechanisms may alter the native self-association state and contribute to apoA-I dysfunction.	[Cavigiolio, Giorgio] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Abe-Dohmae, Sumiko; Yokoyama, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Nagoya City University; Boston University	Cavigiolio, G (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org		/0000-0003-1616-5347; Cavigiolio, Giorgio/0000-0002-1622-0628	Tobacco-Related Disease Research Program of California [18KT-0021]; International Atherosclerosis Society; Ministry of Education, Culture, Sports, Science and Technology [21591164]; National Institutes of Health [GM067260, HL026355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067260] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program of California(University of California System); International Atherosclerosis Society; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a new investigator award from the Tobacco-Related Disease Research Program of California (Grant 18KT-0021) and an International Atherosclerosis Society Visiting Fellowship Award. Partial support was also provided by a Grant-in-Aid for Science Research in Japan from the Ministry of Education, Culture, Sports, Science and Technology (Grant 21591164) and by National Institutes of Health Grants GM067260 and HL026355.	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; BARBEAU DL, 1979, BIOCHEMISTRY-US, V18, P362, DOI 10.1021/bi00569a021; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Benjwal S, 2010, PROTEINS, V78, P1175, DOI 10.1002/prot.22637; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Gianazza E, 1997, BIOCHEMISTRY-US, V36, P7898, DOI 10.1021/bi962600+; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; GWYNNE J, 1974, J BIOL CHEM, V249, P2411; HARA H, 1992, BIOCHEMISTRY-US, V31, P2040, DOI 10.1021/bi00122a021; Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; MANTULIN WW, 1980, J BIOL CHEM, V255, P8185; MANTULIN WW, 1986, BIOCHEMISTRY-US, V25, P8034, DOI 10.1021/bi00372a036; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; MASSEY JB, 1981, BIOCHEM BIOPH RES CO, V99, P466, DOI 10.1016/0006-291X(81)91768-X; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; MONERA OD, 1993, J BIOL CHEM, V268, P19218; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Nanjee MN, 2000, CLIN CHEM, V46, P207; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Pyle LE, 1996, BIOCHEMISTRY-US, V35, P12046, DOI 10.1021/bi9609073; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Ren XF, 2005, BIOCHEMISTRY-US, V44, P14907, DOI 10.1021/bi0508385; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 2002, CURR TOP MEMBR, V52, P397; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sigalov AB, 2001, CHEM PHYS LIPIDS, V113, P133, DOI 10.1016/S0009-3084(01)00186-4; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Sparks DL, 1999, BIOCHEMISTRY-US, V38, P1727, DOI 10.1021/bi981945k; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Tanaka M, 2011, BBA-MOL CELL BIOL L, V1811, P25, DOI 10.1016/j.bbalip.2010.10.003; Teoh CL, 2011, PROTEIN CELL, V2, P116, DOI 10.1007/s13238-011-1013-6; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Tricerri MA, 2002, J LIPID RES, V43, P187; Tripet B, 1997, J BIOL CHEM, V272, P8946; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; VONECKARDSTEIN A, 1990, J BIOL CHEM, V265, P8610; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Weers PMM, 2011, J LIPID RES, V52, P35, DOI 10.1194/jlr.M007500; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375; Zhao YW, 1996, J BIOL CHEM, V271, P25145, DOI 10.1074/jbc.271.41.25145; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	90	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35610	35623		10.1074/jbc.M111.262485	http://dx.doi.org/10.1074/jbc.M111.262485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21835924	hybrid, Green Published			2022-12-25	WOS:000295927100033
J	Fu, CL; Tong, CF; Wang, ML; Gao, YX; Zhang, Y; Lu, SQ; Liang, SL; Dong, C; Long, MA				Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Liang, Shile; Dong, Cheng; Long, Mian			Determining beta(2)-Integrin and Intercellular Adhesion Molecule 1 Binding Kinetics in Tumor Cell Adhesion to Leukocytes and Endothelial Cells by a Gas-driven Micropipette Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY ADENOCARCINOMA CELLS; HYDRODYNAMIC SHEAR; MELANOMA ADHESION; 2-DIMENSIONAL KINETICS; HUMAN NEUTROPHILS; P-SELECTIN; METASTASIS DEVELOPMENT; LIGAND INTERACTIONS; CONCURRENT BINDING; CANCER METASTASIS	Interactions between polymorphonuclear neutrophils (PMNs) and tumor cells have been reported to facilitate the adhesion and subsequent extravasation of tumor cells through the endothelium under blood flow, both of which are mediated by binding beta(2)-integrin to intercellular adhesion molecule 1 (ICAM-1). Here the adhesions between humanWM9 metastatic melanoma cells, PMNs, and human pulmonary microvascular endothelial cells (HPMECs) were quantified by a gas-driven micropipette aspiration technique (GDMAT). Our data indicated that the cellular binding affinity of PMN-WM9 pair was 3.9-fold higher than that of the PMN-HPMEC pair. However, the effective binding affinities per molecular pair were comparable between the two cell pairs no matter whether WM9 cells or HPMECs were quiescent or cytokine-activated, indicating that the stronger adhesion between PMN-WM9 pair is mainly attributed to the high expression of ICAM-1 on WM9 cells. These results proposed an alternative mechanism, where WM9 melanoma cells adhere first with PMNs near vessel-wall regions and then bind to endothelial cells via PMNs under blood flow. In contrast, the adhesions between human MDA-MB-231 metastatic breast carcinoma cells and PMNs showed a comparable cellular binding affinity to PMN-HPMEC pair because the ICAM-1 expressions on MDA-MB-231 cells and HPMECs are similar. Furthermore, differences were observed in the intrinsic forward and reverse rates of the beta(2)-integrin-ICAM-1 bond between PMN-TC and PMN-EC pairs. This GDMAT assay enables us to quantify the binding kinetics of cell adhesion molecules physiologically expressed on nucleated cells. The findings also further the understanding of leukocyte-facilitated tumor cell adhesion from the viewpoint of molecular binding kinetics.	[Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China; [Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Inst Mech, Beijing 100190, Peoples R China; [Liang, Shile; Dong, Cheng] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China.	mlong@imech.ac.cn	Fu, Changliang/E-4779-2010		National Institutes of Health [CA-97306, CA-125707, M01-RR-010732, C06-RR-016499]; National Natural Science Foundation of China [30730032, 10702075, 10902117]; National Key Basic Research Foundation of China [2006CB910303, 2011CB710904]; Chinese Academy of Science [XDA01030102, XDA04020219, KJCX2-YW-L08]; National Science Foundation [BES-0138474, CBET-0729091]; NATIONAL CANCER INSTITUTE [R01CA125707, R01CA097306] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010732, C06RR016499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-97306, CA-125707, M01-RR-010732, and C06-RR-016499. This work was also supported by National Natural Science Foundation of China Grants 30730032, 10702075, and 10902117; National Key Basic Research Foundation of China Grants 2006CB910303 and 2011CB710904; Strategic Priority Research Program of Chinese Academy of Science grants XDA01030102 and XDA04020219, Knowledge Innovation Program of Chinese Academy of Science Grant KJCX2-YW-L08 (to M.L.), and National Science Foundation Grants BES-0138474 and CBET-0729091 (to C.D.).	AEED PA, 1988, INT J CANCER, V42, P748, DOI 10.1002/ijc.2910420521; BATEMAN J, 1993, CELL BIOCHEM FUNCT, V11, P87, DOI 10.1002/cbf.290110203; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Dong C, 2009, BIORHEOLOGY, V46, P265, DOI 10.3233/BIR-2009-0545; Fu CL, 2011, CELL MOL BIOENG, V4, P427, DOI 10.1007/s12195-011-0167-x; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Goetz DJ, 1996, INT J CANCER, V65, P192, DOI 10.1002/(SICI)1097-0215(19960117)65:2<192::AID-IJC11>3.0.CO;2-G; Hentzen ER, 2000, BLOOD, V95, P911, DOI 10.1182/blood.V95.3.911.003k36_911_920; Hoskins Meghan H., 2006, Molecular & Cellular Biomechanics, V3, P79; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jadhav S, 2002, AM J PHYSIOL-CELL PH, V283, pC1133, DOI 10.1152/ajpcell.00104.2002; Jadhav S, 2001, J IMMUNOL, V167, P5986, DOI 10.4049/jimmunol.167.10.5986; Jun CD, 2001, P NATL ACAD SCI USA, V98, P6830, DOI 10.1073/pnas.121186998; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Levin JD, 2001, BIOPHYS J, V80, P656, DOI 10.1016/S0006-3495(01)76046-8; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Liang SL, 2008, AM J PHYSIOL-CELL PH, V294, pC743, DOI 10.1152/ajpcell.00250.2007; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Lomakina EB, 2004, BIOPHYS J, V86, P1223, DOI 10.1016/S0006-3495(04)74196-X; Lomakina EB, 2009, BIOPHYS J, V96, P276, DOI 10.1016/j.bpj.2008.10.001; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Long M, 2006, CELL MOL IMMUNOL, V3, P79; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Ma YQ, 2000, J IMMUNOL, V165, P558, DOI 10.4049/jimmunol.165.1.558; MCCARTHY DA, 1994, CYTOMETRY, V17, P39, DOI 10.1002/cyto.990170106; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Neelamegham S, 1998, BLOOD, V92, P1626, DOI 10.1182/blood.V92.5.1626.417a02_1626_1638; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; REILLY PL, 1995, J IMMUNOL, V155, P529; Rinker KD, 2001, BIOPHYS J, V80, P1722, DOI 10.1016/S0006-3495(01)76143-7; Shao JY, 1996, BIOPHYS J, V71, P2892, DOI 10.1016/S0006-3495(96)79486-9; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Shao JY, 2002, J BIOMECH ENG-T ASME, V124, P388, DOI 10.1115/1.1486469; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sun GY, 2009, CELL MOL BIOENG, V2, P495, DOI 10.1007/s12195-009-0079-1; Sun GY, 2009, EUR BIOPHYS J BIOPHY, V38, P701, DOI 10.1007/s00249-009-0428-y; Vitte J, 2004, J LEUKOCYTE BIOL, V76, P594, DOI 10.1189/jlb.0204077; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814, DOI 10.1152/ajpcell.2001.280.4.C814; Yang HY, 2007, EXP CELL RES, V313, P3497, DOI 10.1016/j.yexcr.2007.08.001; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	62	25	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34777	34787		10.1074/jbc.M111.281642	http://dx.doi.org/10.1074/jbc.M111.281642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840991	Green Published, hybrid			2022-12-25	WOS:000295406300032
J	Dennis, MD; Schrufer, TL; Bronson, SK; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Schrufer, Tabitha L.; Bronson, Sarah K.; Kimball, Scot R.; Jefferson, Leonard S.			Hyperglycemia-Induced O-GlcNAcylation and Truncation of 4E-BP1 Protein in Liver of a Mouse Model of Type 1 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE LEVELS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MESSENGER-RNA; 3T3-L1 ADIPOCYTES; AMINO-ACIDS; RAT-LIVER; GLCNAC; PHOSPHORYLATION; GLYCOSYLATION	4E-BP1 is a protein that, in its hypophosphorylated state, binds the mRNA cap-binding protein eIF4E and represses cap-dependent mRNA translation. By doing so, it plays a major role in the regulation of gene expression by controlling the overall rate of mRNA translation as well as the selection of mRNAs for translation. Phosphorylation of 4E-BP1 causes it to release eIF4E to function in mRNA translation. 4E-BP1 is also subject to covalent addition of N-acetylglucosamine to Ser or Thr residues (O-GlcNAcylation) as well as to truncation. In the truncated form, it is both resistant to phosphorylation and able to bind eIF4E with high affinity. In the present study, Ins2(Akita/+) diabetic mice were used to test the hypothesis that hyperglycemia and elevated flux of glucose through the hexosamine biosynthetic pathway lead to increased O-GlcNAcylation and truncation of 4E-BP1 and consequently decreased eIF4E function in the liver. The amounts of both full-length and truncated 4E-BP1 bound to eIF4E were significantly elevated in the liver of diabetic as compared with non-diabetic mice. In addition, O-GlcNAcylation of both the full-length and truncated proteins was elevated by 2.5- and 5-fold, respectively. Phlorizin treatment of diabetic mice lowered blood glucose concentrations and reduced the expression and O-GlcNAcylation of 4E-BP1. Additionally, when livers were perfused in the absence of insulin, 4E-BP1 phosphorylation in the livers of diabetic mice was normalized to the control value, yet O-GlcNAcylation and the association of 4E-BP1 with eIF4E remained elevated in the liver of diabetic mice. These findings provide insight into the pathogenesis of metabolic abnormalities associated with diabetes.	[Dennis, Michael D.; Schrufer, Tabitha L.; Bronson, Sarah K.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Bronson, Sarah/0000-0002-5456-953X; Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, F32DK088416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416-01A1 (to M. D. D.).	Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bosch RR, 2004, ENDOCRINE, V23, P17, DOI 10.1385/ENDO:23:1:17; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Constantinou C, 2007, CELL DEATH DIFFER, V14, P576, DOI 10.1038/sj.cdd.4402045; Constantinou C, 2005, ONCOGENE, V24, P4839, DOI 10.1038/sj.onc.1208648; Constantinou C, 2008, BIOL CELL, V100, P279, DOI 10.1042/BC20070121; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Datta R, 2001, BIOCHIMIE, V83, P919, DOI 10.1016/S0300-9084(01)01344-X; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1996, AM J PHYSIOL-CELL PH, V270, pC705, DOI 10.1152/ajpcell.1996.270.2.C705; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Snow DM, 1998, INT REV CYTOL, V181, P43, DOI 10.1016/S0074-7696(08)60416-7; Sun HY, 2008, NAT PROTOC, V3, P1485, DOI 10.1038/nprot.2008.139; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; YkiJarvinen H, 1996, DIABETES, V45, P302, DOI 10.2337/diabetes.45.3.302; Yoshinaga T, 2005, BIOL CHEM, V386, P1077, DOI 10.1515/BC.2005.124; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zachara NE, 2002, CURR PROTOC MOL BIOL; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	50	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34286	34297		10.1074/jbc.M111.259457	http://dx.doi.org/10.1074/jbc.M111.259457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840999	hybrid, Green Published			2022-12-25	WOS:000295159200058
J	Fyfe, I; Schuh, AL; Edwardson, JM; Audhya, A				Fyfe, Ian; Schuh, Amber L.; Edwardson, J. Michael; Audhya, Anjon			Association of the Endosomal Sorting Complex ESCRT-II with the Vps20 Subunit of ESCRT-III Generates a Curvature-sensitive Complex Capable of Nucleating ESCRT-III Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; MECHANISM; TSG101; MODEL; RECONSTITUTION; SIMULATIONS; MACHINERY; SCISSION	The scission of membranes necessary for vesicle biogenesis and cytokinesis is mediated by cytoplasmic proteins, which include members of the ESCRT (endosomal sorting complex required for transport) machinery. During the formation of intralumenal vesicles that bud into multivesicular endosomes, the ESCRT-II complex initiates polymerization of ESCRT-III subunits essential for membrane fission. However, mechanisms underlying the spatial and temporal regulation of this process remain unclear. Here, we show that purified ESCRT-II binds to the ESCRT-III subunit Vps20 on chemically defined membranes in a curvature-dependent manner. Using a combination of liposome co-flotation assays, fluorescence-based liposome interaction studies, and high-resolution atomic force microscopy, we found that the interaction between ESCRT-II and Vps20 decreases the affinity of ESCRT-II for flat lipid bilayers. We additionally demonstrate that ESCRT-II and Vps20 nucleate flexible filaments of Vps32 that polymerize specifically along highly curved membranes as a single string of monomers. Strikingly, Vps32 filaments are shown to modulate membrane dynamics in vitro, a prerequisite for membrane scission events in cells. We propose that a curvature-dependent assembly pathway provides the spatial regulation of ESCRT-III to fuse juxtaposed bilayers of elevated curvature.	[Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin, Madison Med Sch, Dept Biomol Chem, Madison, WI 53706 USA; [Fyfe, Ian; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Audhya, A (corresponding author), Univ Wisconsin, Madison Med Sch, Dept Biomol Chem, Madison, WI 53706 USA.	audhya@wisc.edu		Fyfe, Ian/0000-0002-9362-0254	National Institutes of Health [1R01GM088151-01A1]; Greater Milwaukee Foundation; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greater Milwaukee Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM088151-01A1 (to A. A.). This work was also supported by a Shaw Scientist award (Greater Milwaukee Foundation; to A. A.) and a Biotechnology and Biological Sciences Research Council doctoral training award (to I. F.).	Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; de Joannis J, 2006, LANGMUIR, V22, P998, DOI 10.1021/la051278d; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jackson MB, 2009, J MEMBRANE BIOL, V231, P101, DOI 10.1007/s00232-009-9209-x; Jiang FY, 2004, BIOPHYS J, V87, P182, DOI 10.1529/biophysj.103.031054; Jiang Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2430714; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee MCS, 2004, SCIENCE, V303, P479, DOI 10.1126/science.1094231; LITSTER JD, 1975, PHYS LETT A, VA 53, P193, DOI 10.1016/0375-9601(75)90402-8; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wang H, 2008, BIOPHYS J, V95, P2647, DOI 10.1529/biophysj.108.131409; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	41	65	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34262	34270		10.1074/jbc.M111.266411	http://dx.doi.org/10.1074/jbc.M111.266411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835927	hybrid, Green Published			2022-12-25	WOS:000295159200056
J	Dexheimer, V; Mueller, S; Braatz, F; Richter, W				Dexheimer, Verena; Mueller, Sebastian; Braatz, Frank; Richter, Wiltrud			Reduced Reactivation from Dormancy but Maintained Lineage Choice of Human Mesenchymal Stem Cells with Donor Age	PLOS ONE			English	Article							HUMAN-BONE-MARROW; PROGENITOR CELLS; STROMAL CELLS; DIFFERENTIATION; SENESCENCE; EXPANSION; COLONIES; NUMBER	Mesenchymal stem cells (MSC) are promising for cell-based regeneration therapies but up to date it is still controversial whether their function is maintained throughout ageing. Aim of this study was to address whether frequency, activation in vitro, replicative function, and in vitro lineage choice of MSC is maintained throughout ageing to answer the question whether MSC-based regeneration strategies should be restricted to younger individuals. MSC from bone marrow aspirates of 28 donors (5-80 years) were characterized regarding colony-forming unit-fibroblast (CFU-F) numbers, single cell cloning efficiency (SSCE), osteogenic, adipogenic and chondrogenic differentiation capacity in vitro. Alkaline phosphatase (ALP) activity, mineralization, Oil Red O content, proteoglycan-and collagen type II deposition were quantified. While CFU-F frequency was maintained, SSCE and early proliferation rate decreased significantly with advanced donor age. MSC with higher proliferation rate before start of induction showed stronger osteogenic, adipogenic and chondrogenic differentiation. MSC with high osteogenic capacity underwent better chondrogenesis and showed a trend to better adipogenesis. Lineage choice was, however, unaltered with age. Conclusion: Ageing influenced activation from dormancy and replicative function of MSC in a way that it may be more demanding to mobilize MSC to fast cell growth at advanced age. Since fast proliferation came along with high multilineage capacity, the proliferation status of expanded MSC rather than donor age may provide an argument to restrict MSC-based therapies to certain individuals.	[Dexheimer, Verena; Richter, Wiltrud] Orthoped Univ Hosp Heidelberg, Res Ctr Expt Orthoped, Heidelberg, Germany; [Mueller, Sebastian; Braatz, Frank] Heidelberg Univ, Dept Orthoped Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dexheimer, V (corresponding author), Orthoped Univ Hosp Heidelberg, Res Ctr Expt Orthoped, Heidelberg, Germany.	Wiltrud.Richter@med.uni-heidelberg.de	Richter, Wiltrud/V-3217-2017	Richter, Wiltrud/0000-0003-4694-2768	Baden Wurttemberg Stiftung; Network Ageing Research, Heidelberg, Germany	Baden Wurttemberg Stiftung; Network Ageing Research, Heidelberg, Germany	This study was in part funded by the Baden Wurttemberg Stiftung and supported by the Network Ageing Research, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Carrington JL, 2005, BIOCHEM BIOPH RES CO, V328, P700, DOI 10.1016/j.bbrc.2004.12.041; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Claes L, 2002, LANGENBECK ARCH SURG, V387, P146, DOI 10.1007/s00423-002-0306-x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Fickert S, 2010, J BONE MINER METAB; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Mageed AS, 2007, TRANSPLANTATION, V83, P1019, DOI 10.1097/01.tp.0000259752.13304.0b; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402; Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007-0300; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	38	73	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22980	10.1371/journal.pone.0022980	http://dx.doi.org/10.1371/journal.pone.0022980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850247	gold, Green Submitted, Green Published			2022-12-25	WOS:000293563300032
J	Dong, WH; Wang, TY; Wang, F; Zhang, JH				Dong, Wei-Hua; Wang, Tian-Yun; Wang, Fang; Zhang, Jun-He			Simple, Time-Saving Dye Staining of Proteins for Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis Using Coomassie Blue	PLOS ONE			English	Article							GLYCAN-BINDING PROFILE; SENSITIVITY; LECTIN; G-250	A fixation-free and fast protein-staining method for sodium dodecyl sulfate-polyacrylamide gel electrophoresis using Coomassie blue is described. The protocol comprises staining and quick washing steps, which can be completed in 0.5 h. It has a sensitivity of 10 ng, comparable with that of conventional Coomassie Brilliant Blue G staining with phosphoric acid in the staining solution. In addition, the dye stain does not contain any amount of acid and methanol, such as phosphoric acid. Considering the speed, simplicity, and low cost, the dye stain may be of more practical value than other dye-based protein stains in routine proteomic research.	[Dong, Wei-Hua; Wang, Tian-Yun; Wang, Fang; Zhang, Jun-He] Xinxiang Med Univ, Dept Biochem & Mol Biol, Xinxiang, Henan, Peoples R China	Xinxiang Medical University	Dong, WH (corresponding author), Xinxiang Med Univ, Dept Biochem & Mol Biol, Xinxiang, Henan, Peoples R China.	wtianyuncn@126.com	Zhang, Junhe/HII-7839-2022	Zhang, Junhe/0000-0003-3109-1569	National Natural Science Foundation [30970055/C010202]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (30970055/C010202), http://159.226.244.28/portal/Proj_List.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT J, 1971, ANAL BIOCHEM, V43, P173, DOI 10.1016/0003-2697(71)90122-9; Berggren KN, 2002, PROTEOMICS, V2, P486, DOI 10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X; BERTOLINI MJ, 1976, ANAL BIOCHEM, V71, P6, DOI 10.1016/0003-2697(76)90003-8; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Choi JK, 2002, ARCH PHARM RES, V25, P704, DOI 10.1007/BF02976948; Choi JK, 1996, ANAL BIOCHEM, V236, P82, DOI 10.1006/abio.1996.0134; Divakar K, 2011, ANAL SCI, V27, P101, DOI 10.2116/analsci.27.101; DYBALLA N, 2009, J VIS EXP, V3; FAZEKAS SDS, 1963, BIOCHIM BIOPHYS ACTA, V71, P377; Kawsar SMA, 2008, COMP BIOCHEM PHYS B, V150, P349, DOI 10.1016/j.cbpb.2008.04.004; Kawsar SMA, 2009, COMP BIOCHEM PHYS B, V152, P382, DOI 10.1016/j.cbpb.2009.01.009; LAWRENCE AM, 2009, J VIS EXP, V14; Lin JF, 2008, ANAL BIOANAL CHEM, V390, P1765, DOI 10.1007/s00216-008-1910-6; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pink M, 2010, ELECTROPHORESIS, V31, P593, DOI 10.1002/elps.200900481; Shofuda K, 1998, LAB INVEST, V78, P915; Walker J. M., 2002, PROTEIN PROTOCOLS HD, V2nd, P61; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yasumitsu H, 2010, ELECTROPHORESIS, V31, P1913, DOI 10.1002/elps.200900524	21	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22394	10.1371/journal.pone.0022394	http://dx.doi.org/10.1371/journal.pone.0022394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850222	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300006
J	Burbelo, PD; Ching, KH; Esper, F; Iadarola, MJ; Delwart, E; Lipkin, WI; Kapoor, A				Burbelo, Peter D.; Ching, Kathryn H.; Esper, Frank; Iadarola, Michael J.; Delwart, Eric; Lipkin, W. Ian; Kapoor, Amit			Serological Studies Confirm the Novel Astrovirus HMOAstV-C as a Highly Prevalent Human Infectious Agent	PLOS ONE			English	Article							LUCIFERASE IMMUNOPRECIPITATION SYSTEMS; HUMAN STOOL; CHILDREN; DIARRHEA; GASTROENTERITIS; IDENTIFICATION; DIAGNOSIS; VIRUS; ASSAY; SEQUENCES	Molecular identification of a microbe is the first step in determining its prevalence of infection and pathogenic potential. Detection of specific adaptive immune responses can provide insights into whether a microbe is a human infectious agent and its epidemiology. Here we characterized human anti-IgG antibody responses by luciferase immunoprecipitation systems (LIPS) against two protein fragments derived from the capsid protein of the novel HMOAstV-C astrovirus. While antibodies to the N-terminal fragment were not informative, the C-terminal capsid fragment of HMOAstV-C showed a high frequency of immunoreactivity with serum from healthy blood donors. In contrast, a similar C-terminal capsid fragment from the related HMOAstV-A astrovirus failed to show immunoreactivity. Detailed analysis of adult serum from the United Sates using a standardized threshold demonstrated HMOAstV-C seropositivity in approximately 65% of the samples. Evaluation of serum samples from different pediatric age groups revealed that the prevalence of antibodies in 6-12 month, 1-2 year, 2-5 year and 5-10 year olds was 20%, 23%, 32% and 36%, respectively, indicating rising seroprevalence with age. Additionally, 50% (11/22) of the 0-6 month old children showed anti-HMOAstV-C antibody responses, likely reflecting maternal antibodies. Together these results document human humoral responses to HMOAstV-C and validate LIPS as a facile and effective approach for identifying humoral responses to novel infectious agents.	[Burbelo, Peter D.; Ching, Kathryn H.; Iadarola, Michael J.] Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, NIH, Bethesda, MD USA; [Esper, Frank] Case Western Reserve Univ Hosp, Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lipkin, W. Ian; Kapoor, Amit] Columbia Univ, Ctr Infect & Immun, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Columbia University	Burbelo, PD (corresponding author), Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, NIH, Bethesda, MD USA.	burbelop@nidcr.nih.gov	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Delwart, Eric/0000-0002-6296-4484	Division of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases [K23 AI065829, AI090196, AI57158]; Department of Defense; Blood Systems Research Institute; NIH [R01220 HL083254]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, K23AI065829, R21AI090196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Blood Systems Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research. This study is supported in part by the National Institute of Allergy and Infectious Diseases K23 AI065829 (F.E.), AI090196 (A.K.) and AI57158 (Northeast Biodefense Center - A.K., W.I.L), and the Department of Defense (A.K., W.I.L.) and the Blood Systems Research Institute and NIH R01220 HL083254 (E.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Burbelo PD, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-22; Burbelo PD, 2011, MOL BIOSYST; Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2011, MOL BIOSYST, V7, P1453, DOI 10.1039/c0mb00342e; Burbelo PD, 2010, EXPERT REV VACCINES, V9, P567, DOI [10.1586/erv.10.50, 10.1586/ERV.10.50]; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P621, DOI 10.1128/CVI.00474-08; Clark B, 2004, CURR OPIN INFECT DIS, V17, P461, DOI 10.1097/00001432-200410000-00011; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Fodha I, 2006, J MED VIROL, V78, P1198, DOI 10.1002/jmv.20681; Gabbay YB, 2007, VIRUS RES, V129, P166, DOI 10.1016/j.virusres.2007.07.006; Guix S, 2005, LETT APPL MICROBIOL, V41, P103, DOI 10.1111/j.1472-765X.2005.01759.x; Heininger U, 2006, VACCINE, V24, P3258, DOI 10.1016/j.vaccine.2006.01.026; Jin Y, 2009, J CLIN VIROL, V44, P238, DOI 10.1016/j.jcv.2008.12.010; Jonassen CM, 2003, VIRUS RES, V91, P195, DOI 10.1016/S0168-1702(02)00269-1; Jonassen CM, 2001, J GEN VIROL, V82, P1061, DOI 10.1099/0022-1317-82-5-1061; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Ramanathan R, 2008, J INFECT DIS, V198, P444, DOI 10.1086/589718; Tayeb HT, 2008, J MED VIROL, V80, P1919, DOI 10.1002/jmv.21291	32	53	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22576	10.1371/journal.pone.0022576	http://dx.doi.org/10.1371/journal.pone.0022576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829634	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200023
J	Birkenfeld, AL; Lee, HY; Majumdar, S; Jurczak, MJ; Camporez, JP; Jornayvaz, FR; Frederick, DW; Guigni, B; Kahn, M; Zhang, DY; Weismann, D; Arafat, AM; Pfeiffer, AF; Lieske, S; Oyadomari, S; Ron, D; Samuel, VT; Shulman, GI				Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie; Oyadomari, Seiichi; Ron, David; Samuel, Varman T.; Shulman, Gerald I.			Influence of the Hepatic Eukaryotic Initiation Factor 2 alpha (eIF2 alpha) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; RESISTANCE; DELETION; HOMEOSTASIS; OBESITY; MICE	Recent studies have implicated endoplasmic reticulum (ER) stress in insulin resistance associated with caloric excess. In mice placed on a 3-day high fat diet, we find augmented eIF2 alpha signaling, together with hepatic lipid accumulation and insulin resistance. To clarify the role of the liver ER stress-dependent phospho-eIF2 alpha (eIF2 alpha-P) pathway in response to acute caloric excess on liver and muscle glucose and lipid metabolism, we studied transgenic mice in which the hepatic ER stress-dependent eIF2 alpha-P pathway was inhibited by overexpressing a constitutively active C-terminal fragment of GADD34/PPP1R15a, a regulatory subunit of phosphatase that terminates ER stress signaling by phospho-eIF2 alpha. Inhibition of the eIF2 alpha-P signaling in liver led to a decrease in hepatic glucose production in the basal and clamped state, which could be attributed to reduced gluco-neogenic gene expression, resulting in reduced basal plasma glucose concentrations. Surprisingly, hepatic eIF2 alpha inhibition also impaired insulin-stimulated muscle and adipose tissue insulin sensitivity. This latter effect could be attributed at least in part by an increase in circulating IGFBP-3 levels in the transgenic animals. In addition, infusion of insulin during a hyperinsulinemic-euglycemic clamp induced conspicuous ER stress in the 3-day high fat diet-fed mice, which was aggravated through continuous dephosphorylation of eIF2 alpha. Together, these data imply that the hepatic ER stress eIF2 alpha signaling pathway affects hepatic glucose production without altering hepatic insulin sensitivity. Moreover, hepatic ER stress-dependent eIF2 alpha-P signaling is implicated in an unanticipated cross-talk between the liver and peripheral organs to influence insulin sensitivity, probably via IGFBP-3. Finally, eIF2 alpha is crucial for proper resolution of insulin-induced ER stress.	[Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA; [Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie] Charite Univ Sch Med, D-10117 Berlin, Germany; [Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Nuthetal, Germany; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Tokushima University; New York University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019; Pfeiffer, Andreas F.H./AAJ-2311-2020; Camporez, Joao Paulo G/B-9122-2015; Oyadomari, Seiichi/GZA-7157-2022; Oyadomari, Seiichi/GZA-7072-2022; Birkenfeld, Andreas L./U-3954-2019; Jornayvaz, François/AAL-2134-2020	Shulman, Gerald I./0000-0003-1529-5668; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Birkenfeld, Andreas L./0000-0003-1407-9023; Arafat, Ayman/0000-0003-3069-8385; Jurczak, Michael/0000-0002-6335-6915; Guigni, Blas/0000-0002-9667-8195; Lee, Hui-Young/0000-0002-3464-6382; Ron, David/0000-0002-3014-5636; Jornayvaz, Francois/0000-0001-9425-3137; /0000-0001-9732-4543; Camporez, Joao Paulo/0000-0003-3486-4301	United States Public Health Service [R01 DK-40936, U24 DK-059635, P30 DK-45735, P30 DK-034989]; Veterans Affaris Merit Award; American Diabetes Association; Deutsche Forschungsgemeinschaft [BI1292/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK040936, P30DK034989, U24DK059635] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Veterans Affaris Merit Award; American Diabetes Association(American Diabetes Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the United States Public Health Service Grants R01 DK-40936 (to G. I. S.), U24 DK-059635 (to V. T. S. and G. I. S.), P30 DK-45735, and P30 DK-034989, a Veterans Affaris Merit Award (to V. T. S.), and a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association (to G. I. S.).; Supported by Scholarship BI1292/2-1 from the Deutsche Forschungsgemeinschaft.	Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	30	57	58	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36163	36170		10.1074/jbc.M111.228817	http://dx.doi.org/10.1074/jbc.M111.228817			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832042	Green Published, hybrid			2022-12-25	WOS:000296538300001
J	Degousee, N; Kelvin, DJ; Geisslinger, G; Hwang, DM; Stefanski, E; Wang, XH; Danesh, A; Angioni, C; Schmidt, H; Lindsay, TF; Gelb, MH; Bollinger, J; Payre, C; Lambeau, G; Arm, JP; Keating, A; Rubin, BB				Degousee, Norbert; Kelvin, David J.; Geisslinger, Gerd; Hwang, David M.; Stefanski, Eva; Wang, Xing-Hua; Danesh, Ali; Angioni, Carlo; Schmidt, Helmut; Lindsay, Thomas F.; Gelb, Michael H.; Bollinger, James; Payre, Christine; Lambeau, Gerard; Arm, Jonathan P.; Keating, Armand; Rubin, Barry B.			Group V Phospholipase A(2) in Bone Marrow-derived Myeloid Cells and Bronchial Epithelial Cells Promotes Bacterial Clearance after Escherichia coli Pneumonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; GROUP-X; MAST-CELLS; EICOSANOID GENERATION; LEUKOCYTE RECRUITMENT; HUMAN NEUTROPHILS; IN-VITRO; LUNG; EXPRESSION; MICE	Group V-secreted phospholipase A(2) (GV sPLA(2)) hydrolyzes bacterial phospholipids and initiates eicosanoid biosynthesis. Here, we elucidate the role of GV sPLA(2) in the pathophysiology of Escherichia coli pneumonia. Inflammatory cells and bronchial epithelial cells both express GV sPLA(2) after pulmonary E. coli infection. GV(-/-) mice accumulate fewer polymorphonuclear leukocytes in alveoli, have higher levels of E. coli in bronchoalveolar lavage fluid and lung, and develop respiratory acidosis, more severe hypothermia, and higher IL-6, IL-10, and TNF-alpha levels than GV(+/+) mice after pulmonary E. coli infection. Eicosanoid levels in bronchoalveolar lavage are similar in GV(+/+) and GV(-/-) mice after lung E. coli infection. In contrast, GV(+/+) mice have higher levels of prostaglandin D-2 (PGD(2)), PGF(2 alpha), and 15-keto-PGE(2) in lung and express higher levels of ICAM-1 and PECAM-1 on pulmonary endothelial cells than GV(-/-) mice after lung infection with E. coli. Selective deletion of GV sPLA(2) in non-myeloid cells impairs leukocyte accumulation after pulmonary E. coli infection, and lack of GV sPLA(2) in either bone marrow-derived myeloid cells or non-myeloid cells attenuates E. coli clearance from the alveolar space and the lung parenchyma. These observations show that GV sPLA(2) in bone marrow-derived myeloid cells as well as non-myeloid cells, which are likely bronchial epithelial cells, participate in the regulation of the innate immune response to pulmonary infection with E. coli.	[Degousee, Norbert; Stefanski, Eva; Lindsay, Thomas F.; Rubin, Barry B.] Toronto Gen Hosp, Div Vasc Surg, Peter Munk Cardiac Ctr, Res Inst,Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Kelvin, David J.; Danesh, Ali] Toronto Gen Hosp, Div Expt Therapeut, Dept Med Oncol & Hematol, Res Inst,Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Hwang, David M.] Toronto Gen Hosp, Dept Pathol, Res Inst, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 2C4, Canada; [Arm, Jonathan P.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Arm, Jonathan P.] Brigham & Womens Hosp, Partners Asthma Ctr, Boston, MA 02115 USA; [Gelb, Michael H.; Bollinger, James] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.; Bollinger, James] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Payre, Christine; Lambeau, Gerard] Univ Nice, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Payre, Christine; Lambeau, Gerard] CNRS, F-06560 Valbonne, France; [Geisslinger, Gerd; Angioni, Carlo; Schmidt, Helmut] Inst Klin Pharmakol, D-60590 Frankfurt, Germany; [Kelvin, David J.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Div Immunol, Shantou 515041, Guangdong, Peoples R China	University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Shantou University	Rubin, BB (corresponding author), Toronto Gen Hosp, Div Vasc Surg, Peter Munk Cardiac Ctr, Res Inst,Univ Hlth Network, 200 Elizabeth St,EN6-222, Toronto, ON M5G 2C4, Canada.	barry.rubin@uhn.on.ca	Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X; Payre, Christine/0000-0003-3640-5061; gelb, michael/0000-0001-7000-5219	Canadian Institutes of Health Research [MOP-53297, MOP-97827, FRN-97827]; Physicians' Services Incorporated Foundation [98-049]; American Academy of Allergy Asthma and Immunology; Brigham and Women's Hospital Biomedical Research Institute; Deutsche Forschungsgemeinschaft; Li Ka Sing Foundation of Canada; National Institutes of Health [R01 HL070946, R37 HL36235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL070946] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation; American Academy of Allergy Asthma and Immunology; Brigham and Women's Hospital Biomedical Research Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Li Ka Sing Foundation of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-53297, MOP-97827, and FRN-97827 (to B. B. R.), Physicians of Ontario through the Physicians' Services Incorporated Foundation (98-049 to T. L.), bridge grants from the American Academy of Allergy Asthma and Immunology and the Brigham and Women's Hospital Biomedical Research Institute (to J. A.), the Deutsche Forschungsgemeinschaft, Excellence Cluster Cardio Pulmonary System (to G. G.), and the Li Ka Sing Foundation of Canada (to D. J. K.). This work was also supported, in whole or in part, by National Institutes of Health Grants R01 HL070946 (to J. A.) and R37 HL36235 (to M. H. G.).	ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Baughman RP, 1999, RESPIRATION, V66, P95, DOI 10.1159/000029349; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky B, 2009, ARTERIOSCL THROM VAS, V29, P532, DOI 10.1161/ATVBAHA.108.183038; Bubnic SJ, 2002, BONE MARROW TRANSPL, V30, P867, DOI 10.1038/sj.bmt.1703761; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; de Menezes GB, 2005, INFLAMMATION, V29, P163, DOI 10.1007/s10753-006-9013-z; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Degousee N, 2008, CIRCULATION, V117, P1701, DOI 10.1161/CIRCULATIONAHA.107.749739; Dudek SM, 2011, AM J RESP CELL MOL, V44, P361, DOI 10.1165/rcmb.2009-0446OC; ELSBACH P, 1991, METHOD ENZYMOL, V197, P24; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR23, DOI 10.1152/ajpregu.1995.269.1.R23; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lapointe S, 2010, J CELL PHYSIOL, V224, P127, DOI 10.1002/jcp.22106; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; Pryhuber GS, 2008, J IMMUNOL, V181, P1409, DOI 10.4049/jimmunol.181.2.1409; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Seeds MC, 2000, AM J RESP CELL MOL, V23, P37, DOI 10.1165/ajrcmb.23.1.4034; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Suckling KE, 2009, EXPERT OPIN INV DRUG, V18, P1425, DOI 10.1517/13543780903184583; Thommesen L, 1998, J IMMUNOL, V161, P3421; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	53	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35650	35662		10.1074/jbc.M111.262733	http://dx.doi.org/10.1074/jbc.M111.262733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849511	Green Published, hybrid			2022-12-25	WOS:000295927100037
J	Morina, K; Schulte, M; Hubrich, F; Dorner, K; Steimle, S; Stolpe, S; Friedrich, T				Morina, Klaudia; Schulte, Marius; Hubrich, Florian; Doerner, Katerina; Steimle, Stefan; Stolpe, Stefan; Friedrich, Thorsten			Engineering the Respiratory Complex I to Energy-converting NADPH:Ubiquinone Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; ESCHERICHIA-COLI NADH; QUINONE OXIDOREDUCTASE; NADHUBIQUINONE OXIDOREDUCTASE; CONFORMATIONAL-CHANGE; COENZYME SPECIFICITY; MODULAR EVOLUTION; PROTON PUMP; BEEF-HEART	The respiratory complex I couples the electron transfer from NADH to ubiquinone with a translocation of protons across the membrane. Its nucleotide-binding site is made up of a unique Rossmann fold to accommodate the binding of the substrate NADH and of the primary electron acceptor flavin mononucleotide. Binding of NADH includes interactions of the hydroxyl groups of the adenosine ribose with a conserved glutamic acid residue. Structural analysis revealed that due to steric hindrance and electrostatic repulsion, this residue most likely prevents the binding of NADPH, which is a poor substrate of the complex. We produced several variants with mutations at this position exhibiting up to 200-fold enhanced catalytic efficiency with NADPH. The reaction of the variants with NAD(P)H is coupled with proton translocation in an inhibitor-sensitive manner. Thus, we have created an energy-converting NADPH: ubiquinone oxidoreductase, an activity so far not found in nature. Remarkably, the oxidation of NAD(P) H by the variants leads to an enhanced production of reactive oxygen species.	[Morina, Klaudia; Schulte, Marius; Hubrich, Florian; Doerner, Katerina; Steimle, Stefan; Stolpe, Stefan; Friedrich, Thorsten] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Friedrich, T (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21,Chemiehochhaus, D-79104 Freiburg, Germany.	tfriedri@uni-freiburg.de		Hubrich, Florian/0000-0001-7093-8123	Volkswagen Stiftung; Deutsche Forschungsgemeinschaft	Volkswagen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Volkswagen Stiftung and the Deutsche Forschungsgemeinschaft.	Albracht SPJ, 1997, BBA-BIOENERGETICS, V1318, P92, DOI 10.1016/S0005-2728(96)00153-3; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brandt U, 2003, FEBS LETT, V545, P9, DOI 10.1016/S0014-5793(03)00387-9; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DJAVADIOHANIANCE L, 1975, J BIOL CHEM, V250, P9397; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Dupuis A, 2001, J BIOENERG BIOMEMBR, V33, P159, DOI 10.1023/A:1010770600418; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Glinn MA, 1997, BBA-BIOENERGETICS, V1318, P246, DOI 10.1016/S0005-2728(96)00142-9; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; HATEFI Y, 1973, BIOCHEMISTRY-US, V12, P3515, DOI 10.1021/bi00742a026; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Markham KA, 2004, ANAL BIOCHEM, V325, P62, DOI 10.1016/j.ab.2003.10.027; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MITTL PRE, 1994, PROTEIN SCI, V3, P1504, DOI 10.1002/pro.5560030916; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIS C, 1995, ACTA CRYSTALLOGR D, V51, P290, DOI 10.1107/S0907444994012229; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; RYDSTROM J, 1978, BIOCHIM BIOPHYS ACTA, V501, P370, DOI 10.1016/0005-2728(78)90105-6; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34627	34634		10.1074/jbc.M111.274571	http://dx.doi.org/10.1074/jbc.M111.274571			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832062	Green Published, hybrid			2022-12-25	WOS:000295406300017
J	Zhu, WL; Hossain, MS; Guo, DY; Liu, S; Tong, HL; Khakpoor, A; Casey, PJ; Wang, M				Zhu, Wan Long; Hossain, Mohammed S.; Guo, Dian Yan; Liu, Sen; Tong, Honglian; Khakpoor, Atefeh; Casey, Patrick J.; Wang, Mei			A Role for Rac3 GTPase in the Regulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; CANCER-CELLS; PROTEIN PRENYLATION; TUMOR-GROWTH; K-RAS; PATHWAY; DEATH; MTOR; RHO; DIFFERENTIATION	The process of autophagy is situated at the intersection of multiple cell signaling pathways, including cell metabolism, growth, and death, and hence is subject to multiple forms of regulation. We previously reported that inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step in the post-translational prenylation of so-called CAAX proteins, results in the induction of autophagy which enhances cell death in some cancer cells. In this study, using siRNA-mediated knockdown of a group of small GTPases that are predicted Icmt substrates, we identify Rac3 GTPase as a negative regulator of the process of autophagy. Knockdown of Rac3, but not the closely related isoforms Rac1 and Rac2, results in induction of autophagy. Ectopic expression of Rac3, significantly rescues cells from autophagy and cell death induced by Icmt inhibition, strengthening the notion of an isoform-specific autophagy regulatory function of Rac3. This role of Rac3 was observed in multiple cell lines with varying Rac subtype expression profiles, suggesting its broad involvement in the process. The identification of this less-studied Rac member as a novel regulator provides new insight into autophagy and opens opportunities in identifying additional regulatory inputs of the process.	[Casey, Patrick J.; Wang, Mei] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; Duke University	Wang, M (corresponding author), 07-15,8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg	Hossain, Mohammad Sorowar/AAX-2009-2020; Zhu, Wan Long/GYA-3382-2022	Hossain, Mohammad Sorowar/0000-0001-7143-2909; Casey, Patrick/0000-0002-7366-9309; zhu, Wanlong/0000-0003-0025-6674; Wang, Mei/0000-0001-6887-6840	Singapore National Medical Research Council; Agency for Science, Technology, and Research (A*STAR)	Singapore National Medical Research Council(National Medical Research Council, Singapore); Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by awards from the Singapore National Medical Research Council and A*STAR, the Agency for Science, Technology, and Research.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Joyce PL, 2003, CANCER RES, V63, P7959; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	43	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35291	35298		10.1074/jbc.M111.280990	http://dx.doi.org/10.1074/jbc.M111.280990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852230	hybrid, Green Published			2022-12-25	WOS:000295406300082
J	Saxena, R; Rozgaja, T; Grimwade, J; Crooke, E				Saxena, Rahul; Rozgaja, Tania; Grimwade, Julia; Crooke, Elliott			Remodeling of Nucleoprotein Complexes Is Independent of the Nucleotide State of a Mutant AAA plus Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION ORIGIN; ESCHERICHIA-COLI K-12; DNAA PROTEIN; SEQUENTIAL BINDING; INITIATOR PROTEIN; REQUIRES DNAA; ATP; SITES; GENE; OLIGOMERIZATION	DnaA protein, a member of the AAA+ (ATPase associated with various cellular activities) family, initiates DNA synthesis at the chromosomal origin of replication (oriC) and regulates the transcription of several genes, including its own. The assembly of DnaA complexes at chromosomal recognition sequences is affected by the tight binding of ATP or ADP by DnaA. DnaA with a point mutation in its membrane-binding amphipathic helix, DnaA(L366K), previously described for its ability to support growth in cells with altered phospholipid content, has biochemical characteristics similar to those of the wild-type protein. Yet DnaA(L366K) fails to initiate in vitro or in vivo replication from oriC. We found here, through in vitro dimethyl sulfate footprinting and gel mobility shift assays, that DnaA(L366K) in either nucleotide state was unable to assemble into productive prereplication complexes. In contrast, at the dnaA promoter, both the ATP and the ADP form of DnaA(L366K) generated active nucleoprotein complexes that efficiently repressed transcription in a manner similar to wildtype ATP-DnaA. Thus, it appears that unlike wild-type DnaA protein DnaA(L366K) can adopt architectures that are independent of its bound nucleotide, and instead the locus determines the functionality of the higher order DnaA(L366K)-DNA complexes.	[Saxena, Rahul; Crooke, Elliott] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Crooke, Elliott] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rozgaja, Tania; Grimwade, Julia] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Georgetown University; Georgetown University; Florida Institute of Technology	Crooke, E (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	crooke@georgetown.edu		Grimwade, Julia/0000-0002-8630-2696	National Institutes of Health [GM49700, GM54042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM049700, R01GM049700, R01GM054042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49700 and GM54042.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Crooke E, 1995, METHOD ENZYMOL, V262, P500; CROOKE E, 1992, J BIOL CHEM, V267, P16779; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Garner J, 1996, EMBO J, V15, P3477, DOI 10.1002/j.1460-2075.1996.tb00714.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Grimwade JE, 2000, MOL MICROBIOL, V35, P835, DOI 10.1046/j.1365-2958.2000.01755.x; HANSEN EB, 1986, P NATL ACAD SCI USA, V83, P4423, DOI 10.1073/pnas.83.12.4423; HEACOCK PN, 1989, J BIOL CHEM, V264, P14972; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Lee YS, 1997, J BIOL CHEM, V272, P83; Li ZY, 2005, J BIOL CHEM, V280, P9796, DOI 10.1074/jbc.M413923200; Li ZY, 1999, PROTEIN EXPRES PURIF, V17, P41, DOI 10.1006/prep.1999.1094; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Miller JH., 1972, EXPT MOL GENETICS; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; SAMITT CE, 1989, EMBO J, V8, P989, DOI 10.1002/j.1460-2075.1989.tb03462.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; WANG QP, 1987, MOL GEN GENET, V209, P518, DOI 10.1007/BF00331158	43	10	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33770	33777		10.1074/jbc.M111.223495	http://dx.doi.org/10.1074/jbc.M111.223495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832063	Green Published, hybrid			2022-12-25	WOS:000295159200007
J	Zhong, YW; Wang, Y; Yang, H; Ballar, P; Lee, JG; Ye, YH; Monteiro, MJ; Fang, SY				Zhong, Yongwang; Wang, Yang; Yang, Hui; Ballar, Petek; Lee, Jin-gu; Ye, Yihong; Monteiro, Mervyn J.; Fang, Shengyun			Importin beta Interacts with the Endoplasmic Reticulum-associated Degradation Machinery and Promotes Ubiquitination and Degradation of Mutant alpha 1-Antitrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; NUCLEAR-PORE COMPLEX; RETRO-TRANSLOCATION; MEMBRANE-PROTEIN; AAA-ATPASE; IN-VITRO; MISFOLDED GLYCOPROTEINS; DEUBIQUITINATING ENZYME; LIGASE	The mechanism by which misfolded proteins in the endoplasmic reticulum (ER) are retrotranslocated to the cytosol for proteasomal degradation is still poorly understood. Here, we show that importin beta, a well established nucleocytoplasmic transport protein, interacts with components of the retrotranslocation complex and promotes ER-associated degradation (ERAD). Knockdown of importin beta specifically inhibited the degradation of misfolded ERAD substrates but did not affect turnover of non-ERAD proteasome substrates. Genetic studies and in vitro reconstitution assays demonstrate that importin beta is critically required for ubiquitination of mutant beta 1-antitrypsin, a luminal ERAD substrate. Furthermore, we show that importin beta cooperates with Ran GTPase to promote ubiquitination and proteasomal degradation of mutant beta 1-antitrypsin. These results establish an unanticipated role for importin beta in ER protein quality control.	[Zhong, Yongwang; Wang, Yang; Fang, Shengyun] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Zhong, Yongwang; Wang, Yang; Yang, Hui; Ballar, Petek; Monteiro, Mervyn J.; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Lee, Jin-gu; Ye, Yihong] NIH, Mol Biol Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA	Zhong, YW (corresponding author), 725 W Lombard St,Rm N360, Baltimore, MD 21201 USA.	sfang@umaryland.edu	Fang, Shengyun/H-3802-2011; Monteiro, Mervyn J/H-3813-2011; Zhong, Yongwang/A-2527-2012; Kirmizibayrak, Petek Ballar/Y-6869-2018	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Fang, Shengyun/0000-0001-7280-5463; Lee, Jin-Gu/0000-0001-9477-6990	National Institutes of Health [GM06696, GM066287]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM06696 (to S. F.) and GM066287 (to M. J. M.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lonhienne TG, 2009, J BIOL CHEM, V284, P22549, DOI 10.1074/jbc.M109.019935; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang SY, 2008, NAT CELL BIOL, V10, P251, DOI 10.1038/ncb0308-251; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	69	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33921	33930		10.1074/jbc.M111.272906	http://dx.doi.org/10.1074/jbc.M111.272906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832065	Green Published, hybrid			2022-12-25	WOS:000295159200024
J	Dubrovsky, EB; Dubrovskaya, VA; Bernardo, T; Otte, V; DiFilippo, R; Bryan, H				Dubrovsky, Edward B.; Dubrovskaya, Veronica A.; Bernardo, Travis; Otte, Valerie; DiFilippo, Robert; Bryan, Heather			The Drosophila FTZ-F1 Nuclear Receptor Mediates Juvenile Hormone Activation of E75A Gene Expression through an Intracellular Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEETLE TRIBOLIUM-CASTANEUM; DNA-BINDING PROTEIN; BHLH-PAS FAMILY; METHOPRENE-TOLERANT; ECDYSONE RECEPTOR; INDEPENDENT ACTIVATION; FACTOR BETA-FTZ-F1; MOLECULAR ACTIONS; MANDUCA-SEXTA; KINASE-C	Juvenile hormone (JH) regulates a wide variety of biological activities in holometabolous insects, ranging from vitellogenesis and caste determination in adults to the timing of metamorphosis in larvae. The mechanism of JH signaling in such a diverse array of processes remains either unknown or contentious. We previously found that the nuclear receptor gene E75A is activated in S2 cells as a primary response to JH. Here, by expressing an intracellular form of JH esterase, we demonstrate that JH must enter the cell in order to activate E75A. To find intracellular receptors involved in the JH response, we performed an RNAi screen against nuclear receptor genes expressed in this cell line and identified the orphan receptor FTZ-F1. Removal of FTZ-F1 prevents JH activation of E75A, whereas overexpression enhances activation, implicating FTZ-F1 as a critical component of the JH response. FTZ-F1 is bound in vivo to multiple enhancers upstream of E75A, suggesting that it participates in direct JH-mediated gene activation. To better define the role of FTZ-F1 in JH signaling, we investigated interactions with candidate JH receptors and found that the bHLH-PAS proteins MET and GCE both interact with FTZ-F1 and can activate transcription through the FTZ-F1 response element. Removal of endogenous GCE, but not MET, prevents JH activation of E75A. We propose that FTZ-F1 functions as a competence factor by loading JH signaling components to the promoter, thus facilitating the direct regulation of E75A gene expression by JH.	[Dubrovsky, Edward B.; Dubrovskaya, Veronica A.; Bernardo, Travis; Otte, Valerie; DiFilippo, Robert; Bryan, Heather] Fordham Univ, Dept Biol, Bronx, NY 10458 USA; [Dubrovsky, Edward B.] Fordham Univ, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA	Fordham University; Fordham University	Dubrovsky, EB (corresponding author), Fordham Univ, Dept Biol, 441 E Fordham Rd, Bronx, NY 10458 USA.	dubrovsky@fordham.edu		Bernardo, Travis/0000-0003-4432-9724	National Science Foundation [0653567]; Fordham University	National Science Foundation(National Science Foundation (NSF)); Fordham University	This work was supported by National Science Foundation Grant 0653567 (to E. B. D.).; Supported by the summer research program at Fordham University.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Berger EM, 2005, VITAM HORM, V73, P175, DOI 10.1016/S0083-6729(05)73006-5; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P501, DOI 10.1016/S0965-1748(98)00037-X; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Davey KG, 1996, INVERTEBR REPROD DEV, V30, P249, DOI 10.1080/07924259.1996.9672551; Davey KG, 2000, INSECT BIOCHEM MOLEC, V30, P663, DOI 10.1016/S0965-1748(00)00037-0; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Fang F, 2005, FEBS J, V272, P1577, DOI 10.1111/j.1742-4658.2005.04578.x; Farkas R, 2001, BIOCHEM CELL BIOL, V79, P755, DOI 10.1139/bcb-79-6-755; GIORGI F, 1993, DEVELOPMENT, V117, P319; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P317, DOI 10.1016/S0965-1748(02)00246-1; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; JONES G, 1995, ANNU REV ENTOMOL, V40, P147, DOI 10.1146/annurev.en.40.010195.001051; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kawasaki H, 2002, DEV GROWTH DIFFER, V44, P419, DOI 10.1046/j.1440-169X.2002.00655.x; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Murata T, 1996, MOL CELL BIOL, V16, P6509; Palli SR, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P111, DOI 10.1007/978-90-481-2316-2_5; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pick L, 2006, AD DEV BIOL, V16, P255, DOI 10.1016/S1574-3349(06)16008-1; RICHARDS G, 1978, DEV BIOL, V66, P32, DOI 10.1016/0012-1606(78)90271-3; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; SPARKS TC, 1980, PESTIC BIOCHEM PHYS, V14, P290, DOI 10.1016/0048-3575(80)90037-1; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Thomas BA, 1999, PROTEINS, V34, P184, DOI 10.1002/(SICI)1097-0134(19990201)34:2<184::AID-PROT4>3.3.CO;2-#; UEDA H, 1991, NUCLEIC ACIDS RES, V19, P3689, DOI 10.1093/nar/19.13.3689; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; WARD VK, 1992, INT J BIOCHEM, V24, P1933, DOI 10.1016/0020-711X(92)90289-D; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Wogulis M, 2006, BIOCHEMISTRY-US, V45, P4045, DOI 10.1021/bi0521644; Wolfner MF, 1997, J INSECT PHYSL, V43, P1117; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Yamada M, 2000, DEVELOPMENT, V127, P5083; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Yoo JH, 2008, ACTA CRYSTALLOGR A, V64, pC241, DOI 10.1107/S0108767308092246; Zhou S, 2002, MOL CELL ENDOCRINOL, V190, P177, DOI 10.1016/S0303-7207(01)00602-5; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	68	37	40	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33689	33700		10.1074/jbc.M111.273458	http://dx.doi.org/10.1074/jbc.M111.273458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832074	Green Published, hybrid			2022-12-25	WOS:000294968800085
J	Magrini, E; Szabo, I; Doni, A; Cibella, J; Viola, A				Magrini, Elena; Szabo, Ildiko; Doni, Andrea; Cibella, Javier; Viola, Antonella			Serotonin-Mediated Tuning of Human Helper T Cell Responsiveness to the Chemokine CXCL12	PLOS ONE			English	Article							EXPERIMENTAL COLITIS; INTRACELLULAR PH; NA+/H+ EXCHANGE; RECEPTOR; LYMPHOCYTES; ACTIVATION; NETWORK; MOBILIZATION; NEUTROPHILS; CHEMOTAXIS	In addition to its role as neurotransmitter, serotonin (5-HT) is an important modulator of inflammation and immunity. Here, we report novel findings suggesting a 5-HT involvement in T cell migration. In particular, we show that 5-HT tunes the responsiveness of human T lymphocytes to the broadly expressed chemokine CXCL12 in transwell migration assays. By real-time PCR, western blot analysis and electrophysiological patch clamp experiments, we demonstrate that the type 3 5-HT receptor (5-HT3) is functionally expressed in human primary T cells. In addition, specific 5-HT3 receptor agonists selectively decrease T cell migration towards gradients of CXCL12 but not of inflammatory chemokines, such as CCL2 and CCL5. In transmigration experiments, 5-HT3 receptor stimulation reverts the inhibitory effect of endothelial-bound CXCL12 on T cell migration. Our data suggest that the reduced T cell responsiveness to CXCL12 induced by 5-HT may occur to facilitate T cell extravasation and migration into inflamed tissues.	[Magrini, Elena; Doni, Andrea; Cibella, Javier; Viola, Antonella] Humanitas Clin Inst IRCCS, Milan, Italy; [Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy; [Viola, Antonella] Univ Milan, Dept Translat Med, Milan, Italy	University of Padua; University of Milan	Magrini, E (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, Milan, Italy.	elena.magrini@ifom-ieo-campus.it	Agatea, Lisa/L-8267-2016; Magrini, Elena/K-2635-2018; Szabo, Ildiko/AAW-5972-2021; Padova, Ildiko/K-5344-2016; Cibella, Javier/AAB-8800-2020; Viola, Antonella/A-4321-2015	Magrini, Elena/0000-0003-1507-2325; Szabo, Ildiko/0000-0002-3637-3947; Doni, Andrea/0000-0001-9203-5814; Viola, Antonella/0000-0002-0125-9271	Italian Association for Cancer Research (AIRC) [5118, 5629, RG 6278]; European Community [FP7/2007-2013, 201106]; EMBO YIP	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); EMBO YIP(European Molecular Biology Organization (EMBO))	The research leading to these results has received funding from the Italian Association for Cancer Research (AIRC) to I.S. (IG grant no 5118) and to A.V. (IG grant no5629 and RG 6278), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no201106 and EMBO YIP to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes NM, 2008, SEMIN CANCER BIOL, V18, P218, DOI 10.1016/j.semcancer.2007.12.007; BIANCHI G, 1993, J IMMUNOL, V151, P5135; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; El-Nour H, 2007, EXP DERMATOL, V16, P644, DOI 10.1111/j.1600-0625.2007.00573.x; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P9, DOI 10.1080/03009740410006952; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Khan NA, 1999, J NEUROIMMUNOL, V99, P53, DOI 10.1016/S0165-5728(99)00101-0; Khan WI, 2010, CLIN EXP IMMUNOL, V161, P19, DOI 10.1111/j.1365-2249.2010.04150.x; Lai ZF, 2000, J IMMUNOL, V165, P83, DOI 10.4049/jimmunol.165.1.83; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Magro F, 2006, DIGEST DIS SCI, V51, P495, DOI 10.1007/s10620-006-3161-8; Menard G, 2007, CLIN EXP IMMUNOL, V150, P340, DOI 10.1111/j.1365-2249.2007.03492.x; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; SIMCHOWITZ L, 1985, J BIOL CHEM, V260, P3248; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Thorslund K, 2007, DRUG NEWS PERSPECT, V20, P521, DOI 10.1358/dnp.2007.20.8.1157614; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Yao L, 2003, BLOOD, V102, P3900, DOI 10.1182/blood-2003-02-0641; Yin J, 2006, J NEUROIMMUNOL, V181, P68, DOI 10.1016/j.jneuroim.2006.08.004	42	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22482	10.1371/journal.pone.0022482	http://dx.doi.org/10.1371/journal.pone.0022482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853036	Green Published, gold			2022-12-25	WOS:000295454200013
J	Hombrink, P; Hadrup, SR; Bakker, A; Kester, MGD; Falkenburg, JHF; Borne, PAV; Schumacher, TNM; Heemskerk, MHM				Hombrink, Pleun; Hadrup, Sine R.; Bakker, Arne; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Borne, Peter A. von Dem; Schumacher, Ton N. M.; Heemskerk, Mirjam H. M.			High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations	PLOS ONE			English	Article							T-CELL EPITOPES; HLA; IMMUNOTHERAPY; ASSOCIATION; PREDICTION; COMPLEXES; DATABASE; LIGANDS; BINDING	T-cell recognition of minor histocompatibility antigens (MiHA) plays an important role in the graft-versus-tumor (GVT) effect of allogeneic stem cell transplantation (allo-SCT). However, the number of MiHA identified to date remains limited, making clinical application of MiHA reactive T-cell infusion difficult. This study represents the first attempt of genome-wide prediction of MiHA, coupled to the isolation of T-cell populations that react with these antigens. In this unbiased high-throughput MiHA screen, both the possibilities and pitfalls of this approach were investigated. First, 973 polymorphic peptides expressed by hematopoietic stem cells were predicted and screened for HLA-A2 binding. Subsequently a set of 333 high affinity HLA-A2 ligands was identified and post transplantation samples from allo-SCT patients were screened for T-cell reactivity by a combination of pMHC-tetramer-based enrichment and multi-color flow cytometry. Using this approach, 71 peptide-reactive T-cell populations were generated. The isolation of a T-cell line specifically recognizing target cells expressing the MAP4K1(IMA) antigen demonstrates that identification of MiHA through this approach is in principle feasible. However, with the exception of the known MiHA HMHA1, none of the other T-cell populations that were generated demonstrated recognition of endogenously MiHA expressing target cells, even though recognition of peptide-loaded targets was often apparent. Collectively these results demonstrate the technical feasibility of high-throughput analysis of antigen-specific T-cell responses in small patient samples. However, the high-sensitivity of this approach requires the use of potential epitope sets that are not solely based on MHC binding, to prevent the frequent detection of T-cell responses that lack biological relevance.	[Hombrink, Pleun; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Borne, Peter A. von Dem; Heemskerk, Mirjam H. M.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Hadrup, Sine R.; Bakker, Arne; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	Hombrink, P (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	p.hombrink@lumc.nl	Heemskerk, Mirjam H.M./ABI-2336-2020; Hadrup, Sine Reker/P-3388-2014; Schumacher, Ton/Y-2432-2019	Heemskerk, Mirjam H.M./0000-0001-6320-9133; Hadrup, Sine Reker/0000-0002-5937-4344; Schumacher, Ton/0000-0003-0517-8804; Bakker, Arne/0000-0003-1944-6515	Dutch Cancer Society [07-3825]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society grant no. 07-3825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; DERIJKE RB, 2005, J CLIN INVEST, V115, P3506; Dierselhuis M, 2009, CURR OPIN ORGAN TRAN, V14, P419, DOI 10.1097/MOT.0b013e32832d399c; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eijsink C, 2006, J IMMUNOL METHODS, V315, P153, DOI 10.1016/j.jim.2006.07.020; Falkenburg JHF, 2003, EXP HEMATOL, V31, P743, DOI 10.1016/S0301-472X(03)00190-5; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Hadrup SR, 2010, CANCER IMMUNOL IMMUN, V59, P1425, DOI 10.1007/s00262-010-0824-2; Hadrup SR, 2009, METHODS MOL BIOL, V524, P383, DOI 10.1007/978-1-59745-450-6_28; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Kessler JH, 2007, LEUKEMIA, V21, P1859, DOI 10.1038/sj.leu.2404787; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; PARKER KC, 1994, J IMMUNOL, V152, P163; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Slager EH, 2006, BLOOD, V107, P4954, DOI 10.1182/blood-2005-09-3883; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Spierings E, 2005, J CLIN INVEST, V115, P3397, DOI 10.1172/JCI27094; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	35	27	29	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22523	10.1371/journal.pone.0022523	http://dx.doi.org/10.1371/journal.pone.0022523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850230	gold, Green Submitted, Green Published			2022-12-25	WOS:000293563300014
J	Jeudy, S; Wardrop, KE; Alessi, A; Dominov, JA				Jeudy, Sheila; Wardrop, Katherine E.; Alessi, Amy; Dominov, Janice A.			Bcl-2 Inhibits the Innate Immune Response during Early Pathogenesis of Murine Congenital Muscular Dystrophy	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SKELETAL-MUSCLE; INFLAMMATORY MYOPATHY; MEROSIN DEFICIENCY; GENE-EXPRESSION; LIMB-GIRDLE; ACTIVATION; DISEASE; ONSET	Laminin alpha 2 (LAMA2)-deficient congenital muscular dystrophy is a severe, early-onset disease caused by abnormal levels of laminin 211 in the basal lamina leading to muscle weakness, transient inflammation, muscle degeneration and impaired mobility. In a Lama2-deficient mouse model for this disease, animal survival is improved by muscle-specific expression of the apoptosis inhibitor Bcl-2, conferred by a MyoD-hBcl-2 transgene. Here we investigated early disease stages in this model to determine initial pathological events and effects of Bcl-2 on their progression. Using quantitative immunohistological and mRNA analyses we show that inflammation occurs very early in Lama2-deficient muscle, some aspects of which are reduced or delayed by the MyoD-hBcl-2 transgene. mRNAs for innate immune response regulators, including multiple Toll-like receptors (TLRs) and the inflammasome component NLRP3, are elevated in diseased muscle compared with age-matched controls expressing Lama2. MyoD-hBcl-2 inhibits induction of TLR4, TLR6, TLR7, TLR8 and TLR9 in Lama2-deficient muscle compared with non-transgenic controls, and leads to reduced infiltration of eosinophils, which are key death effector cells. This congenital disease model provides a new paradigm for investigating cell death mechanisms during early stages of pathogenesis, demonstrating that interactions exist between Bcl-2, a multifunctional regulator of cell survival, and the innate immune response.	[Jeudy, Sheila; Wardrop, Katherine E.; Alessi, Amy; Dominov, Janice A.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Jeudy, S (corresponding author), Boston Biomed Res Inst, Watertown, MA 02472 USA.	dominov@bbri.org		Dominov, Janice/0000-0002-5751-0955	NIH, NIAMS [R01AR051368, R21AR049306]; John W. Alden Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR049306, R01AR051368] Funding Source: NIH RePORTER	NIH, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); John W. Alden Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants to J.A.D. from the NIH, NIAMS (R01AR051368, R21AR049306) and from the John W. Alden Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; CARMIGNAC V, 2010, HUM MOL GENET; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Cheung PFY, 2008, INT IMMUNOL, V20, P353, DOI 10.1093/intimm/dxm146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Henriques-Pons A, 2009, CURR OPIN RHEUMATOL, V21, P581, DOI 10.1097/BOR.0b013e3283319265; Huang Qi-Quan, 2009, Curr Rheumatol Rep, V11, P357; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mrak RE, 1998, J CHILD NEUROL, V13, P513, DOI 10.1177/088307389801301009; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Pegoraro E, 1996, ANN NEUROL, V40, P782, DOI 10.1002/ana.410400515; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rocha CT, 2010, CURR NEUROL NEUROSCI, V10, P267, DOI 10.1007/s11910-010-0119-1; RODRIGUEZ D, 2010, BIOCH BIOPHYS ACTA; SCHAEFER L, 2009, CURR OPIN PHARM; Schreiner B, 2005, FASEB J, V19, P118, DOI 10.1096/fj.05-4342fje; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wardrop KE, 2011, J HISTOCHEM CYTOCHEM, V59, P167, DOI 10.1369/jhc.2010.956672	39	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22369	10.1371/journal.pone.0022369	http://dx.doi.org/10.1371/journal.pone.0022369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850221	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300005
J	Zou, F; Schafer, N; Palesch, D; Brucken, R; Beck, A; Sienczyk, M; Kalbacher, H; Sun, ZL; Boehm, BO; Burster, T				Zou, Fang; Schaefer, Nadja; Palesch, David; Bruecken, Ruth; Beck, Alexander; Sienczyk, Marcin; Kalbacher, Hubert; Sun, ZiLin; Boehm, Bernhard O.; Burster, Timo			Regulation of Cathepsin G Reduces the Activation of Proinsulin-Reactive T Cells from Type 1 Diabetes Patients	PLOS ONE			English	Article							LYSOSOMAL PROTEOLYSIS; INVARIANT CHAIN; DENDRITIC CELLS; VITAMIN-D; NOD MICE; INHIBITION; MELLITUS; PEPTIDE; INSULIN; INFLAMMATION	Autoantigenic peptides resulting from self-proteins such as proinsulin are important players in the development of type 1 diabetes mellitus (T1D). Self-proteins can be processed by cathepsins (Cats) within endocytic compartments and loaded to major histocompatibility complex (MHC) class II molecules for CD4(+) T cell inspection. However, the processing and presentation of proinsulin by antigen-presenting cells (APC) in humans is only partially understood. Here we demonstrate that the processing of proinsulin by B cell or myeloid dendritic cell (mDC1)-derived lysosomal cathepsins resulted in several proinsulin-derived intermediates. These intermediates were similar to those obtained using purified CatG and, to a lesser extent, CatD, S, and V in vitro. Some of these intermediates polarized T cell activation in peripheral blood mononuclear cells (PBMC) from T1D patients indicative for naturally processed T cell epitopes. Furthermore, CatG activity was found to be elevated in PBMC from T1D patients and abrogation of CatG activity resulted in functional inhibition of proinsulin-reactive T cells. Our data suggested the notion that CatG plays a critical role in proinsulin processing and is important in the activation process of diabetogenic T cells.	[Zou, Fang; Schaefer, Nadja; Palesch, David; Bruecken, Ruth; Boehm, Bernhard O.; Burster, Timo] Univ Med Ctr Ulm, Div Endocrinol & Diabet, Ctr Internal Med, Ulm, Germany; [Beck, Alexander] Panatecs, Tubingen, Germany; [Sienczyk, Marcin] Wroclaw Univ Technol, PL-50370 Wroclaw, Poland; [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, Tubingen, Germany; [Sun, ZiLin] Southeast Univ, Inst Diabet, Zhongda Hosp, Sch Med, Nanjing, Peoples R China	Ulm University; Wroclaw University of Science & Technology; Eberhard Karls University of Tubingen; Southeast University - China	Zou, F (corresponding author), Univ Med Ctr Ulm, Div Endocrinol & Diabet, Ctr Internal Med, Ulm, Germany.	timo.burster@uni-ulm.de	李, 伟/J-5211-2016; Sienczyk, Marcin/I-3869-2012; Boehm, Bernhard Otto/F-8750-2015	Burster, Timo/0000-0002-9596-6558	Deutsche Forschungsgemeinschaft [SFB 518, GRK 1041-2]; Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind" [226/06/10]; China Scholarship Council [2009609038]; State Committee for Scientific Research [N405 342633]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind"; China Scholarship Council(China Scholarship Council); State Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 518), GRK 1041-2 to BOB, Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind" 226/06/10 to TB, China Scholarship Council (No. 2009609038) to FZ, and State Committee for Scientific Research for financial support (grant N405 342633) MS. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AB was an employee of PANATecs GmbH when this study was conducted and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; Burster T, 2010, DIABETES-METAB RES, V26, P227, DOI 10.1002/dmrr.1090; Burster T, 2010, MOL IMMUNOL, V47, P658, DOI 10.1016/j.molimm.2009.10.003; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; COLBERT JD, 2009, EUR J IMMUNOL; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DELOVITCH TL, 1988, IMMUNOL REV, V106, P195, DOI 10.1111/j.1600-065X.1988.tb00780.x; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Ettinger RA, 1998, J IMMUNOL, V160, P2365; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lang Y, 1996, DIABETES, V45, P1711, DOI 10.2337/diabetes.45.12.1711; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Mathieu C, 2005, TRENDS ENDOCRIN MET, V16, P261, DOI 10.1016/j.tem.2005.06.004; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Miyata J, 2007, RHEUMATOL INT, V27, P375, DOI 10.1007/s00296-006-0210-8; OLEKSYSZYN J, 1991, BIOCHEMISTRY-US, V30, P485, DOI 10.1021/bi00216a026; Palesch D, 2011, ACTA BIOCHIM POL, V58, P39; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pitocco D, 2006, DIABETIC MED, V23, P920, DOI 10.1111/j.1464-5491.2006.01921.x; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; REICH M, 2011, CELL IMMUNOL; Reich M, 2009, MOL IMMUNOL, V46, P2994, DOI 10.1016/j.molimm.2009.06.017; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rudensky A, 2006, E SCHERING RES FDN W, V56, P81; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Shimoda N, 2007, AM J PATHOL, V170, P930, DOI 10.2353/ajpath.2007.060486; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tausch L, 2009, J IMMUNOL, V183, P3433, DOI 10.4049/jimmunol.0803574; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; van Endert P, 2007, CURR OPIN IMMUNOL, V19, P63, DOI 10.1016/j.coi.2006.11.015; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Zaidi N, 2007, BIOCHEM BIOPH RES CO, V364, P243, DOI 10.1016/j.bbrc.2007.09.114; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x	39	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22815	10.1371/journal.pone.0022815	http://dx.doi.org/10.1371/journal.pone.0022815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850236	Green Submitted, gold, Green Published			2022-12-25	WOS:000293563300021
J	Barboni, B; Bernabo, N; Palestini, P; Botto, L; Pistilli, MG; Chiarini, M; Tettamanti, E; Battista, N; Maccarrone, M; Mattioli, M				Barboni, Barbara; Bernabo, Nicola; Palestini, Paola; Botto, Laura; Pistilli, Maria Gabriella; Chiarini, Marco; Tettamanti, Enzo; Battista, Natalia; Maccarrone, Mauro; Mattioli, Mauro			Type-1 Cannabinoid Receptors Reduce Membrane Fluidity of Capacitated Boar Sperm by Impairing Their Activation by Bicarbonate	PLOS ONE			English	Article							EXPOSURE INFLUENCES NEUROENDOCRINE; ACROSOME REACTION; ENDOCANNABINOID SYSTEM; PLASMA-MEMBRANES; REPRODUCTIVE FUNCTIONS; MONOCLONAL-ANTIBODY; CHOLESTEROL EFFLUX; HUMAN SPERMATOZOA; IN-VITRO; FERTILIZATION	Background: Mammalian spermatozoa acquire their full fertilizing ability (so called capacitation) within the female genital tract, where they are progressively exposed to inverse gradients of inhibiting and stimulating molecules. Methodology/Principal Findings: In the present research, the effect on this process of anandamide, an endocannabinoid that can either activate or inhibit cannabinoid receptors depending on its concentration, and bicarbonate, an oviductal activatory molecule, was assessed, in order to study the role exerted by the type 1 cannabinoid receptor (CB1R) in the process of lipid membrane remodeling crucial to complete capacitation. To this aim, boar sperm were incubated in vitro under capacitating conditions (stimulated by bicarbonate) in the presence or in the absence of methanandamide (Met-AEA), a non-hydrolysable analogue of anandamide. The CB1R involvement was studied by using the specific inhibitor (SR141716) or mimicking its activation by adding a permeable cAMP analogue (8Br-cAMP). By an immunocytochemistry approach it was shown that the Met-AEA inhibits the bicarbonate-dependent translocation of CB1R from the post-equatorial to equatorial region of sperm head. In addition it was found that Met-AEA is able to prevent the bicarbonate-induced increase in membrane disorder and the cholesterol extraction, both preliminary to capacitation, acting through a CB1R-cAMP mediated pathway, as indicated by MC540 and filipin staining, EPR spectroscopy and biochemical analysis on whole membranes (CB1R activity) and on membrane enriched fraction (C/P content and anisotropy). Conclusions/Significance: Altogether, these data demonstrate that the endocannabinoid system strongly inhibits the process of sperm capacitation, acting as membrane stabilizing agent, thus increasing the basic knowledge on capacitation-related signaling and potentially opening new perspectives in diagnostics and therapeutics of male infertility.	[Barboni, Barbara; Bernabo, Nicola; Pistilli, Maria Gabriella; Tettamanti, Enzo; Maccarrone, Mauro; Mattioli, Mauro] Univ Teramo, Dept Biomed Comparat Sci, Teramo, Italy; [Palestini, Paola; Botto, Laura] Univ Milano Bicocca, Dept Expt Med, Milan, Italy; [Chiarini, Marco; Battista, Natalia] Univ Teramo, Dept Food Sci, Teramo, Italy; [Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; University of Milano-Bicocca; University of Teramo; IRCCS Santa Lucia	Barboni, B (corresponding author), Univ Teramo, Dept Biomed Comparat Sci, Teramo, Italy.	nbernabo@unite.it	Battista, Natalia/AAC-2529-2019; Palestini, PAOLA/AAD-9376-2019; Maccarrone, Mauro/K-5398-2012; Chiarini, Marco/B-9086-2008	Palestini, PAOLA/0000-0002-1045-8838; Maccarrone, Mauro/0000-0002-3990-2963; Chiarini, Marco/0000-0002-2298-5467; Bernabo, Nicola/0000-0001-5140-9656; Battista, Natalia/0000-0002-1936-6710				Abeydeera LR, 1997, THERIOGENOLOGY, V48, P537, DOI 10.1016/S0093-691X(97)00270-7; Abou-haila A, 2009, ARCH BIOCHEM BIOPHYS, V485, P72, DOI 10.1016/j.abb.2009.02.003; Barbonetti A, 2008, BIOL REPROD, V79, P649, DOI 10.1095/biolreprod.108.068254; Bari M, 2005, J NEUROSCI RES, V81, P275, DOI 10.1002/jnr.20546; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bernabo N, 2007, THERIOGENOLOGY, V67, P801, DOI 10.1016/j.theriogenology.2006.10.014; Bernabo N, 2010, MOL CELL ENDOCRINOL, V323, P224, DOI 10.1016/j.mce.2010.02.025; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Boni R, 2007, THERIOGENOLOGY, V68, pS156, DOI 10.1016/j.theriogenology.2007.05.048; Botto L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-7; Botto L, 2010, J MEMBRANE BIOL, V238, P33, DOI 10.1007/s00232-010-9316-8; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; CARMENA MJ, 1991, REGUL PEPTIDES, V33, P287, DOI 10.1016/0167-0115(91)90231-5; CASTELLANICERESA L, 1993, MOL REPROD DEV, V36, P203, DOI 10.1002/mrd.1080360211; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; DALTERIO S, 1984, PHARMACOL BIOCHEM BE, V20, P115, DOI 10.1016/0091-3057(84)90111-4; DALTERIO S, 1984, PHARMACOL BIOCHEM BE, V20, P107, DOI 10.1016/0091-3057(84)90110-2; Fasano S, 2009, ANN NY ACAD SCI, V1163, P112, DOI 10.1111/j.1749-6632.2009.04437.x; Flesch FM, 2001, J CELL SCI, V114, P3543; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gadella BM, 2008, ANIM REPROD SCI, V107, P229, DOI 10.1016/j.anireprosci.2008.05.006; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; HARRIS RA, 1982, J PHARMACOL EXP THER, V223, P424; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Laura B, 2008, J CELL BIOCHEM, V105, P503, DOI 10.1002/jcb.21850; Lewis SE, 2009, PHARMACOL RES, V60, P126, DOI 10.1016/j.phrs.2009.02.009; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Maccarrone M, 2009, PROG LIPID RES, V48, P344, DOI 10.1016/j.plipres.2009.07.001; MARQUANTLEGUIENNE B, 1986, J REPROD FERTIL, V77, P337, DOI 10.1530/jrf.0.0770337; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Nixon B, 2009, J REPROD IMMUNOL, V83, P8, DOI 10.1016/j.jri.2009.06.258; Ochsendorf FR, 2000, ANDROLOGIA, V32, P169, DOI 10.1046/j.1439-0272.2000.00360.x; OKABE M, 1986, J REPROD IMMUNOL, V9, P67, DOI 10.1016/0165-0378(86)90026-4; OKABE M, 1986, J PHARMACOBIO-DYNAM, V9, P55; Palestini P, 2002, AM J PHYSIOL-LUNG C, V282, pL1382, DOI 10.1152/ajplung.00447.2001; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; SHALGI R, 1990, MOL REPROD DEV, V25, P286, DOI 10.1002/mrd.1080250311; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Waterhouse KE, 2006, REPRODUCTION, V131, P887, DOI 10.1530/rep.1.01049; Wenger T, 1999, LIFE SCI, V65, P695, DOI 10.1016/S0024-3205(99)00292-1	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23038	10.1371/journal.pone.0023038	http://dx.doi.org/10.1371/journal.pone.0023038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829686	Green Submitted, Green Published, gold			2022-12-25	WOS:000293561200045
J	Chaudhury, S; Berrondo, M; Weitzner, BD; Muthu, P; Bergman, H; Gray, JJ				Chaudhury, Sidhartha; Berrondo, Monica; Weitzner, Brian D.; Muthu, Pravin; Bergman, Hannah; Gray, Jeffrey J.			Benchmarking and Analysis of Protein Docking Performance in Rosetta v3.2	PLOS ONE			English	Article							FERREDOXIN-NADP(+) REDUCTASE; BLIND PREDICTIONS	RosettaDock has been increasingly used in protein docking and design strategies in order to predict the structure of protein-protein interfaces. Here we test capabilities of RosettaDock 3.2, part of the newly developed Rosetta v3.2 modeling suite, against Docking Benchmark 3.0, and compare it with RosettaDock v2.3, the latest version of the previous Rosetta software package. The benchmark contains a diverse set of 116 docking targets including 22 antibody-antigen complexes, 33 enzyme-inhibitor complexes, and 60 'other' complexes. These targets were further classified by expected docking difficulty into 84 rigid-body targets, 17 medium targets, and 14 difficult targets. We carried out local docking perturbations for each target, using the unbound structures when available, in both RosettaDock v2.3 and v3.2. Overall the performances of RosettaDock v2.3 and v3.2 were similar. RosettaDock v3.2 achieved 56 docking funnels, compared to 49 in v2.3. A breakdown of docking performance by protein complex type shows that RosettaDock v3.2 achieved docking funnels for 63% of antibody-antigen targets, 62% of enzyme-inhibitor targets, and 35% of 'other' targets. In terms of docking difficulty, RosettaDock v3.2 achieved funnels for 58% of rigid-body targets, 30% of medium targets, and 14% of difficult targets. For targets that failed, we carry out additional analyses to identify the cause of failure, which showed that binding-induced backbone conformation changes account for a majority of failures. We also present a bootstrap statistical analysis that quantifies the reliability of the stochastic docking results. Finally, we demonstrate the additional functionality available in RosettaDock v3.2 by incorporating small-molecules and non-protein co-factors in docking of a smaller target set. This study marks the most extensive benchmarking of the RosettaDock module to date and establishes a baseline for future research in protein interface modeling and structure prediction.	[Chaudhury, Sidhartha] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Berrondo, Monica; Weitzner, Brian D.; Muthu, Pravin; Bergman, Hannah; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Chaudhury, S (corresponding author), Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA.	jgray@jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Weitzner, Brian/0000-0002-1909-0961	National Institutes of Health [R01 GM078221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM078221 (http://grants.nih.gov/grants/funding/r01.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; BAUGH EH, 2011, PLOS ONE IN PRESS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrondo M, 2010, J MOL BIOL, V398, P462, DOI 10.1016/j.jmb.2010.03.021; Bocik WE, 2011, J BIOL CHEM, V286, P3981, DOI 10.1074/jbc.M110.189050; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chaudhury S, 2009, STRUCTURE, V17, P1636, DOI 10.1016/j.str.2009.10.008; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Daily MD, 2005, PROTEINS, V60, P181, DOI 10.1002/prot.20555; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2010, PROTEINS, V78, P3212, DOI 10.1002/prot.22784; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hermoso JA, 2002, J MOL BIOL, V319, P1133, DOI 10.1016/S0022-2836(02)00388-1; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Morales R, 2000, ACTA CRYSTALLOGR D, V56, P1408, DOI 10.1107/S0907444900010052; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Sivasubramanian A, 2008, PROTEINS, V70, P218, DOI 10.1002/prot.21595; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747	35	196	197	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22477	10.1371/journal.pone.0022477	http://dx.doi.org/10.1371/journal.pone.0022477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829626	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511900007
J	Huang, YT; Lin, XH; Chirieac, LR; McGovern, R; Wain, JC; Heist, RS; Skaug, V; Zienolddiny, S; Haugen, A; Su, L; Christiani, DC				Huang, Yen-Tsung; Lin, Xihong; Chirieac, Lucian R.; McGovern, Ray; Wain, John C.; Heist, Rebecca S.; Skaug, Vidar; Zienolddiny, Shanbeh; Haugen, Aage; Su, Li; Christiani, David C.			Impact on Disease Development, Genomic Location and Biological Function of Copy Number Alterations in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							EXPRESSION PROFILES; GENETIC ALTERATIONS; CARCINOMA; CARCINOGENESIS; ADENOCARCINOMA; POLYMORPHISM; MUTATION; FREQUENT; EVENT; GAIN	Lung cancer, of which more than 80% is non-small cell, is the leading cause of cancer-related death in the United States. Copy number alterations (CNAs) in lung cancer have been shown to be positionally clustered in certain genomic regions. However, it remains unclear whether genes with copy number changes are functionally clustered. Using a dense single nucleotide polymorphism array, we performed genome-wide copy number analyses of a large collection of non-small cell lung tumors (n = 301). We proposed a formal statistical test for CNAs between different groups (e. g., non-involved lung vs. tumors, early vs. late stage tumors). We also customized the gene set enrichment analysis (GSEA) algorithm to investigate the overrepresentation of genes with CNAs in predefined biological pathways and gene sets (i.e., functional clustering). We found that CNAs events increase substantially from germline, early stage to late stage tumor. In addition to genomic position, CNAs tend to occur away from the gene locations, especially in germline, non-involved tissue and early stage tumors. Such tendency decreases from germline to early stage and then to late stage tumors, suggesting a relaxation of selection during tumor progression. Furthermore, genes with CNAs in non-small cell lung tumors were enriched in certain gene sets and biological pathways that play crucial roles in oncogenesis and cancer progression, demonstrating the functional aspect of CNAs in the context of biological pathways that were overlooked previously. We conclude that CNAs increase with disease progression and CNAs are both positionally and functionally clustered. The potential functional capabilities acquired via CNAs may be sufficient for normal cells to transform into malignant cells.	[Huang, Yen-Tsung; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Huang, Yen-Tsung; Lin, Xihong; McGovern, Ray] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Chirieac, Lucian R.] Massachusetts Gen Hosp, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02114 USA; [Wain, John C.; Heist, Rebecca S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Wain, John C.] Massachusetts Gen Hosp, Thorac Surg Unit, Boston, MA 02114 USA; [Heist, Rebecca S.; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Skaug, Vidar; Zienolddiny, Shanbeh; Haugen, Aage] Natl Inst Occupat Hlth, Dept Biol & Chem Working Environm, Oslo, Norway; [Christiani, David C.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Huang, YT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	dchris@hsph.harvard.edu	Huang, Yen-Tsung/AAQ-3919-2021; Zienolddiny, Shanbeh/O-7392-2015; Huang, Yen-Tsung/I-1003-2014; Pillay, Nischalan/F-9536-2012; Chirieac, Lucian R./AAD-2030-2019	Huang, Yen-Tsung/0000-0001-7657-0040; Zienolddiny, Shan/0000-0001-9747-9625	US National Institutes of Health [CA092824, CA074386, CA090578]; Norwegian Cancer Society; NATIONAL CANCER INSTITUTE [R01CA074386, P20CA090578, P50CA090578, R01CA092824] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by US National Institutes of Health (http://www.nih.gov/) grants no. CA092824 (D. C. C.), CA074386 (D. C. C.), CA090578 (D. C. C.); and Norwegian Cancer Society (http://www.kreftforeningen.no/english)(A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Duesberg P, 2005, CELL ONCOL, V27, P293; Duesberg P, 2005, SCIENCE, V307, P41; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang JU, 2008, CANCER GENET CYTOGEN, V184, P31, DOI 10.1016/j.cancergencyto.2008.03.002; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Panani AD, 2006, CANCER LETT, V239, P1, DOI 10.1016/j.canlet.2005.06.030; Sanchez-Cespedes M, 2003, LUNG CANCER, V40, P111, DOI 10.1016/S0169-5002(03)00033-3; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Smith MW, 2003, CANCER RES, V63, P859; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	28	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22961	10.1371/journal.pone.0022961	http://dx.doi.org/10.1371/journal.pone.0022961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829676	Green Submitted, Green Published, gold			2022-12-25	WOS:000293511900019
J	Borge-Holthoefer, J; Moreno, Y; Arenas, A				Borge-Holthoefer, Javier; Moreno, Yamir; Arenas, Alex			Modeling Abnormal Priming in Alzheimer's Patients with a Free Association Network	PLOS ONE			English	Article							SEMANTIC MEMORY IMPAIRMENT; DISEASE; SIMULATION; FLUENCY; TIME	Alzheimer's Disease irremediably alters the proficiency of word search and retrieval processes even at its early stages. Such disruption can sometimes be paradoxical in specific language tasks, for example semantic priming. Here we focus in the striking side-effect of hyperpriming in Alzheimer's Disease patients, which has been well-established in the literature for a long time. Previous studies have evidenced that modern network theory can become a powerful complementary tool to gain insight in cognitive phenomena. Here, we first show that network modeling is an appropriate approach to account for semantic priming in normal subjects. Then we turn to priming in degraded cognition: hyperpriming can be readily understood in the scope of a progressive degradation of the semantic network structure. We compare our simulation results with previous empirical observations in diseased patients finding a qualitative agreement. The network approach presented here can be used to accommodate current theories about impaired cognition, and towards a better understanding of lexical organization in healthy and diseased patients.	[Borge-Holthoefer, Javier; Moreno, Yamir; Arenas, Alex] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Moreno, Yamir] Inst Sci Interchange, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza; Universitat Rovira i Virgili	Borge-Holthoefer, J (corresponding author), Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	borge.holthoefer@gmail.com	Borge-Holthoefer, Javier/J-9187-2013; Moreno, Yamir/A-1076-2009; Arenas, Alex/A-5216-2009	Borge-Holthoefer, Javier/0000-0001-9036-8463; Moreno, Yamir/0000-0002-0895-1893; Arenas, Alex/0000-0003-0937-0334	Government of Aragon (DGA); Generalitat de Catalunya [SGR2009 838]; Spanish MICINN [FIS2008-01240, FIS2009- 13364-C02-01, FIS2009-13730-02-02]; Office of Science, Computational and Technology Research, United States Department of Energy [DE-AC02-05CH11231]	Government of Aragon (DGA)(Gobierno de Aragon); Generalitat de Catalunya(Generalitat de Catalunya); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Office of Science, Computational and Technology Research, United States Department of Energy(United States Department of Energy (DOE))	Y.M. and J.B.-H. are supported by the Government of Aragon (DGA) through a grant to FENOL. A. A. acknowledges financial support from Generalitat de Catalunya through project SGR2009 838. Y.M., J. B.-H. and A. A. are supported by the Spanish MICINN through projects FIS2008-01240, FIS2009- 13364-C02-01 and FIS2009-13730-02-02. A. A. acknowledges partial support by the Director, Office of Science, Computational and Technology Research, United States Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; Borge-Holthoefer J, 2009, P 31 ANN C COGN SCI; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; CHERTKOW H, 1989, BRAIN LANG, V36, P420, DOI 10.1016/0093-934X(89)90078-3; Cohen R, 2000, PHYS REV LETT, V85; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Cumming TB, 2006, BRAIN LANG, V98, P221, DOI 10.1016/j.bandl.2006.05.002; Giffard B, 2002, BRAIN, V125, P2044, DOI 10.1093/brain/awf209; Giffard B, 2001, BRAIN, V124, P1522, DOI 10.1093/brain/124.8.1522; Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Goni J, 2010, INT J BIFURCAT CHAOS, V20, P913, DOI 10.1142/S0218127410026204; Griffiths TL, 2007, PSYCHOL SCI, V18, P1069, DOI 10.1111/j.1467-9280.2007.02027.x; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Hills T, 2009, P 31 ANN C COGN SCI; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Hills TT, 2009, COGNITION, V112, P381, DOI 10.1016/j.cognition.2009.06.002; Hills TT, 2009, PSYCHOL SCI, V20, P729, DOI 10.1111/j.1467-9280.2009.02365.x; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Hutchison KA, 2003, PSYCHON B REV, V10, P785, DOI 10.3758/BF03196544; Hutchison KA, 2008, Q J EXP PSYCHOL, V61, P1036, DOI 10.1080/17470210701438111; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Laisney M, 2011, CORTEX, V47, P35, DOI 10.1016/j.cortex.2009.11.001; Leicht EA, 2006, PHYS REV E, V026120, P73; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mahon B, 2011, TRENDS COGNITIVE SCI; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; NEBES RD, 1989, PSYCHOL BULL, V106, P377, DOI 10.1037/0033-2909.106.3.377; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; QUILLIAN MR, 1967, BEHAV SCI, V12, P410, DOI 10.1002/bs.3830120511; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rogers SL, 2008, NEUROPSYCHOLOGIA, V46, P12, DOI 10.1016/j.neuropsychologia.2007.08.010; Salton G, 1983, INTRO MODERN INFORM; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	45	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22651	10.1371/journal.pone.0022651	http://dx.doi.org/10.1371/journal.pone.0022651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LA	21829639	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200014
J	Verma, K; Gu, JS; Werner, E				Verma, Kiran; Gu, Jingsheng; Werner, Erica			Tumor Endothelial Marker 8 Amplifies Canonical Wnt Signaling in Blood Vessels	PLOS ONE			English	Article							ANTHRAX LETHAL TOXIN; INTUSSUSCEPTIVE MICROVASCULAR GROWTH; CHORIOALLANTOIC MEMBRANE; PROTEIN LRP6; BETA-CATENIN; IN-VIVO; ANGIOGENESIS; PATHWAY; CELLS; INTERNALIZATION	Tumor Endothelial Marker 8/Anthrax Toxin Receptor 1 (TEM8/ANTXR1) expression is induced in the vascular compartment of multiple tumors and therefore, is a candidate molecule to target tumor therapies. This cell surface molecule mediates anthrax toxin internalization, however, its physiological function in blood vessels remains largely unknown. We identified the chicken chorioallantoic membrane (CAM) as a model system to study the endogenous function of TEM8 in blood vessels as we found that TEM8 expression was induced transiently between day 10 and 12 of embryonic development, when the vascular tree is undergoing final development and growth. We used the cell-binding component of anthrax toxin, Protective Antigen (PA), to engage endogenous TEM8 receptors and evaluate the effects of PA-TEM8 complexes on vascular development. PA applied at the time of highest TEM8 expression reduced vascular density and disrupted hierarchical branching as revealed by quantitative morphometric analysis of the vascular tree after 48h. PA-dependent reduced branching phenotype was partially mimicked by Wnt3a application and ameliorated by the Wnt antagonist, Dikkopf-1. These results implicate TEM8 expression in endothelial cells in regulating the canonical Wnt signaling pathway at this day of CAM development. Consistent with this model, PA increased beta catenin levels acutely in CAM blood vessels in vivo and in TEM8 transfected primary human endothelial cells in vitro. TEM8 expression in Hek293 cells, which neither express endogenous PA-binding receptors nor Wnt ligands, stabilized beta catenin levels and amplified beta catenin-dependent transcriptional activity induced by Wnt3a. This agonistic function is supported by findings in the CAM, where the increase in TEM8 expression from day 10 to day 12 and PA application correlated with Axin 2 induction, a universal reporter gene for canonical Wnt signaling. We postulate that the developmentally controlled expression of TEM8 modulates endothelial cell response to canonical Wnt signaling to regulate vessel patterning and density.	[Verma, Kiran; Gu, Jingsheng; Werner, Erica] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Werner, Erica] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University	Verma, K (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	ewerner@emory.edu		Werner, Erica/0000-0002-8183-1601	Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health [1K22CA12736]	Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant number 1K22CA12736 from the Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bell SE, 2001, J CELL SCI, V114, P2755; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bromberg-White JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006956; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CADUFF JH, 1986, ANAT RECORD, V216, P154, DOI 10.1002/ar.1092160207; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cui XZ, 2007, J INFECT DIS, V195, P572, DOI 10.1086/510856; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Dimitropoulou C, 1998, Angiogenesis, V2, P255, DOI 10.1023/A:1009210918738; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; Djonov VG, 2000, ANAT EMBRYOL, V202, P347, DOI 10.1007/s004290000126; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Kurz H, 2008, HISTOCHEM CELL BIOL, V130, P1027, DOI 10.1007/s00418-008-0478-8; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAHER MT, PLOS ONE, V5, pE184; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Patan S, 1996, MICROVASC RES, V51, P260, DOI 10.1006/mvre.1996.0025; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Ribatti D, 2005, ONCOL REP, V14, P81; Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rogers MS, 2007, CANCER RES, V67, P9980, DOI 10.1158/0008-5472.CAN-07-0829; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; St Croix B, 2000, SCIENCE, V289, P1197; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997; WILTING J, 1992, ANAT EMBRYOL, V186, P251; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	53	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22334	10.1371/journal.pone.0022334	http://dx.doi.org/10.1371/journal.pone.0022334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829615	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200007
J	Weyemi, U; Lagente-Chevallier, O; Boufraqech, M; Prenois, F; Courtin, F; Caillou, B; Talbot, M; Dardalhon, M; Al Ghuzlan, A; Bidart, JM; Schlumberger, M; Dupuy, C				Weyemi, U.; Lagente-Chevallier, O.; Boufraqech, M.; Prenois, F.; Courtin, F.; Caillou, B.; Talbot, M.; Dardalhon, M.; Al Ghuzlan, A.; Bidart, J-M; Schlumberger, M.; Dupuy, C.			ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence	ONCOGENE			English	Article						oncogenic H-RasV12; ROS; NADPH oxidase NOX4; DNA damage; senescence	SMOOTH-MUSCLE-CELLS; REACTIVE OXYGEN; PREMATURE SENESCENCE; GENOMIC INSTABILITY; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; MAMMALIAN-CELLS; NAD(P)H OXIDASE; TUMORIGENESIS	Activated Ras oncogene induces DNA-damage response by triggering reactive oxygen species (ROS) production and this is critical for oncogene-induced senescence. Until now, little connections between oncogene expression, ROS-generating NADPH oxidases and DNA-damage response have emerged from different studies. Here we report that H-RasV12 positively regulates the NADPH oxidase system NOX4-p22(phox) that produces H2O2. Knocking down the NADPH oxidase with small interference RNA decreases H-RasV12-induced DNA-damage response detected by gamma-H2A.X foci analysis. Using HyPer, a specific probe for H2O2, we detected an increase in H2O2 in the nucleus correlated with NOX4-p22(phox) perinuclear localization. DNA damage response can be caused not only by H-RasV12-driven accumulation of ROS but also by a replicative stress due to a sustained oncogenic signal. Interestingly, NOX4 downregulation by siRNA abrogated H-RasV12 regulation of CDC6 expression, an essential regulator of DNA replication. Moreover, senescence markers, such as senescence-associated heterochromatin foci, PML bodies, HP1 beta foci and p21 expression, induced under H-RasV12 activation were decreased with NOX4 inactivation. Taken together, our data indicate that NADPH oxidase NOX4 is a critical mediator in oncogenic H-RasV12-induced DNA-damage response and subsequent senescence. Oncogene (2012) 31, 1117-1129; doi:10.1038/onc.2011.327; published online 15 August 2011	[Weyemi, U.; Lagente-Chevallier, O.; Boufraqech, M.; Prenois, F.; Courtin, F.; Bidart, J-M; Schlumberger, M.; Dupuy, C.] CNRS, Inst Gustave Roussy, UMR8200, F-94805 Villejuif, France; [Weyemi, U.; Lagente-Chevallier, O.; Boufraqech, M.; Prenois, F.; Courtin, F.; Talbot, M.; Al Ghuzlan, A.; Bidart, J-M; Schlumberger, M.; Dupuy, C.] Univ Paris 11, Orsay, France; [Dardalhon, M.] CNRS, Inst Curie, Sect Rech, UMR 3348, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Dupuy, C (corresponding author), CNRS, Inst Gustave Roussy, UMR8200, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	dupuy@igr.fr	Weyemi, Urbain/E-2083-2016; Boufraqech, Myriem/E-4823-2016		Electricite de France (EDF); Association pour la Recherche sur le Cancer (ARC); Ligue Contre le Cancer (comite du Val-de Marne); Agence Nationale de la Recherche (ANR)	Electricite de France (EDF)(Electricite de France (EDF)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Contre le Cancer (comite du Val-de Marne); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Urbain Weyemi is the recipient of a grant from the Fondation pour la Recherche Medicale (FRM). We are indebted to Didier Methivier from Unite U848 INSERM, Villejuif, F-94805, France for his assistance in flow cytometry. This work was supported by grants from Electricite de France (EDF), Association pour la Recherche sur le Cancer (ARC), Ligue Contre le Cancer (comite du Val-de Marne) and Agence Nationale de la Recherche (ANR).	Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Boucher D, 2006, RADIAT ENVIRON BIOPH, V45, P267, DOI 10.1007/s00411-006-0070-3; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hemann MT, 2007, GENE DEV, V21, P1, DOI 10.1101/gad.1514207; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Johnson DG, 2006, CURR MOL MED, V6, P731; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Lener B, 2009, BIOCHEM J, V423, P363, DOI 10.1042/BJ20090666; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SUAREZ HG, 1990, ONCOGENE, V5, P565; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tallini G, 2002, ENDOCR PATHOL, V13, P271, DOI 10.1385/EP:13:4:271; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Weyemi U, 2010, ENDOCR-RELAT CANCER, V17, P27, DOI 10.1677/ERC-09-0175; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	47	207	211	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1117	1129		10.1038/onc.2011.327	http://dx.doi.org/10.1038/onc.2011.327			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21841825	Green Published, hybrid			2022-12-25	WOS:000300945900005
J	Jang, C; Choi, JK; Na, YJ; Jang, B; Wasco, W; Buxbaum, JD; Kim, YS; Choi, EK				Jang, Changhwan; Choi, Jin-Kyu; Na, Yeo-Jung; Jang, Byungki; Wasco, Wilma; Buxbaum, Joseph D.; Kim, Yong-Sun; Choi, Eun-Kyoung			Calsenilin regulates presenilin 1/gamma-secretase-mediated N-cadherin epsilon-cleavage and beta-catenin signaling	FASEB JOURNAL			English	Article						adhesion molecule; SH-SY5Y neuroblastoma cells	GAMMA-SECRETASE COMPLEX; CELL-CELL ADHESION; AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL REPRESSOR; NUCLEAR TRANSLOCATION; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE	Presenilin 1 (PS1) is a component of the gamma-secretase complex that cleaves a variety of type I membrane proteins, including the beta-amyloid precursor protein (beta-APP), Notch, and neuronal (N)- and epithelial (E)-cadherins. N-cadherin is an essential adhesion molecule that forms a complex with, and is cleaved by, PS1/gamma-secretase and beta-catenin in the plasma membrane. The purpose of this study was to determine whether calsenilin, a presenilin-interacting protein, has a functional role in PS1/gamma-secretase-mediated N-cadherin epsilon-cleavage using Western blot analysis, RT-PCR, immunoprecipitation, subcellular fractionation, biotinylation, and a luciferase reporter assay in SH-SY5Y neuroblastoma cells. Here, we demonstrate that the expression of calsenilin leads to a disruption of PS1/gamma-secretase-mediated epsilon-cleavage of N-cadherin, which results in the significant accumulation of N-cadherin C-terminal fragment 1 (Ncad/CTF1), the reduction of cytoplasmic Ncad/CTF2 release, and a deceleration of PS1-CTF delivery to the cell surface. Interestingly, we also found that the expression of calsenilin is associated with the redistribution of beta-catenin from the cell surface to a cytoplasmic pool, as well as with the negative regulation of genes that are targets of T-cell factor/beta-catenin nuclear signaling. Taken together, our findings suggest that calsenilin is a novel negative regulator of N-cadherin processing that plays an important role in beta-catenin signaling.-Jang, C., Choi, J.-K., Na, Y.-J., Jang, B., Wasco, W., Buxbaum, J. D., Kim, Y.-S., Choi, E.-K. Calsenilin regulates presenilin 1/gamma-secretase-mediated N-cadherin epsilon-cleavage and beta-catenin signaling. FASEB J. 25, 4174-4183 (2011). www.fasebj.org	[Choi, Eun-Kyoung] Hallym Univ, Ilsong Inst Life Sci, Lab Cellular Aging & Neurodegenerat, Anyang 431060, Gyeonggi Do, South Korea; [Jang, Changhwan; Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, South Korea; [Wasco, Wilma] Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Genet & Aging Res Unit,Dep, Charlestown, MA USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat & Neurobiol, Lab Mol Neuropsychiat, New York, NY USA	Hallym University; Hallym University; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Choi, EK (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Lab Cellular Aging & Neurodegenerat, 1605-4 Gwanyang Dong, Anyang 431060, Gyeonggi Do, South Korea.	ekchoi@hallym.ac.kr	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0006204]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors thank Dr. J. H. Boo (Seoul National University, Seoul, Korea) and Dr. H. G. Lee (Case Western Reserve University, Cleveland, OH, USA) for technical advice and helpful discussions. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0006204).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Caspi E, 2008, MOL BIOL CELL, V19, P4660, DOI 10.1091/mbc.E07-10-1046; Chen Q, 2005, J NEUROSCI, V25, P281, DOI 10.1523/JNEUROSCI.3692-04.2005; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fontan-Lozano A, 2009, CURR BIOL, V19, P54, DOI 10.1016/j.cub.2008.11.056; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Hong YM, 2003, NEUROSCI LETT, V340, P33, DOI 10.1016/S0304-3940(03)00067-3; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Jang C, 2011, BIOCHEM BIOPH RES CO, V405, P180, DOI 10.1016/j.bbrc.2010.12.137; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Jin JK, 2005, NEUROREPORT, V16, P451, DOI 10.1097/00001756-200504040-00007; Jo DG, 2005, NEUROSCI LETT, V378, P59, DOI 10.1016/j.neulet.2004.12.078; Jo DG, 2004, J NEUROCHEM, V88, P604, DOI 10.1046/j.1471-4159.2003.02159.x; Jo DG, 2001, FASEB J, V15, P589; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kiss A, 2008, MOL BIOL CELL, V19, P4042, DOI 10.1091/mbc.E08-04-0394; Kitagawa H, 2007, MOL CELL BIOL, V27, P7486, DOI 10.1128/MCB.00409-07; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Polakis P, 2000, GENE DEV, V14, P1837; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rubio ME, 2005, MOL CELL NEUROSCI, V30, P118, DOI 10.1016/j.mcn.2005.06.005; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zaidi NF, 2004, J NEUROCHEM, V89, P593, DOI 10.1046/j.1471-4159.2004.02362.x	67	22	22	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4174	4183		10.1096/fj.11-185926	http://dx.doi.org/10.1096/fj.11-185926			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21852538				2022-12-25	WOS:000298138100011
J	Dash, B; Bhakta, M; Chang, YC; Lukas, RJ				Dash, Bhagirathi; Bhakta, Minoti; Chang, Yongchang; Lukas, Ronald J.			Identification of N-terminal Extracellular Domain Determinants in Nicotinic Acetylcholine Receptor (nAChR) alpha 6 Subunits That Influence Effects of Wild-type or Mutant beta 3 Subunits on Function of alpha 6 beta 2*- or alpha 6 beta 4*-nAChR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPORTER MUTATION APPROACH; MIDBRAIN DOPAMINE NEURONS; XENOPUS OOCYTES; GENES; PHARMACOLOGY; DEPENDENCE; CONOTOXIN; RELEASE; ASSOCIATION; EXPRESSION	Despite the apparent function of naturally expressed mammalian alpha 6*-nicotinic acetylcholine receptors (alpha 6*-nAChR; where * indicates the known or possible presence of additional subunits), their functional and heterologous expression has been difficult. Here, we report that coexpression with wild-type beta 3 subunits abolishes the small amount of function typically seen for all-human or all-mouse alpha 6 beta 4*-nAChR expressed in Xenopus oocytes. However, levels of function and agonist potencies are markedly increased, and there is atropine-sensitive blockade of spontaneous channel opening upon coexpression of alpha 6 and beta 4 subunits with mutant beta 3 subunits harboring valine-to-serine mutations at 9'- or 13'-positions. There is no function when alpha 6 and beta 2 subunits are expressed alone or in the presence of wild-type or mutant beta 3 subunits. Interestingly, hybrid nAChR containing mouse alpha 6 and human (h) beta 4 subunits have function potentiated rather than suppressed by coexpression with wild-type h beta 3 subunits and potentiated further upon coexpression with h beta 3(V9)'(S) subunits. Studies using nAChR chimeric mouse/human alpha 6 subunits indicated that residues involved in effects seen with hybrid nAChR are located in the alpha 6 subunit N-terminal domain. More specifically, nAChR h alpha 6 subunit residues Asn-143 and Met-145 are important for dominant-negative effects of nAChR h beta 3 subunits on h alpha 6h beta 4-nAChR function. Asn-143 and additional residues in the N-terminal domain of nAChR h alpha 6 subunits are involved in the gain-of-function effects of nAChR h beta 3(V9)'(S) subunits on alpha 6 beta 2*-nAChR function. These studies illuminate the structural bases for effects of beta 3 subunits on alpha 6*-nAChR function and suggest that unique subunit interfaces involving the complementary rather than the primary face of alpha 6 subunits are involved.	[Dash, Bhagirathi; Bhakta, Minoti; Chang, Yongchang; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA015389]; Philip Morris U. S. A. Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris U. S. A. Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA015389. This work was also supported by the External Research Program of Philip Morris U. S. A. Inc. and Philip Morris International and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Zhang, J., Chang, Y., and Lukas, R. J. (2007) Soc. Neurosci. Abstr. 33, 39.19; Dash, B., Bhakta, M., Whiteaker, P., Stitzel, J. A., Chang, Y., and Lukas, R. J. (2009) Soc. Neurosci. Abstr. 35, 34.7).	Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bencherif M, 2002, CNS NEUROL DISORD-DR, V1, P349, DOI 10.2174/1568007023339094; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Boorman JP, 2003, J BIOL CHEM, V278, P44033, DOI 10.1074/jbc.M211719200; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Cui CH, 2003, J NEUROSCI, V23, P11045; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Greenbaum L, 2006, MOL PSYCHIATR, V11, P312, DOI 10.1038/sj.mp.4001774; Groot-Kormelink PJ, 1998, J BIOL CHEM, V273, P15317, DOI 10.1074/jbc.273.25.15317; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Palma E, 1999, J BIOL CHEM, V274, P18335, DOI 10.1074/jbc.274.26.18335; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37976	37989		10.1074/jbc.M111.263673	http://dx.doi.org/10.1074/jbc.M111.263673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21832048	Green Published, hybrid			2022-12-25	WOS:000296594200010
J	Norris, NC; Bingham, RJ; Harris, G; Speakman, A; Jones, RPO; Leech, A; Turkenburg, JP; Potts, JR				Norris, Nicole C.; Bingham, Richard J.; Harris, Gemma; Speakman, Adrian; Jones, Richard P. O.; Leech, Andrew; Turkenburg, Johan P.; Potts, Jennifer R.			Structural and Functional Analysis of the Tandem beta-Zipper Interaction of a Streptococcal Protein with Human Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC DISORDER; BINDING PROTEIN; BORRELIA-BURGDORFERI; HOT-SPOTS; RECOGNITION; IDENTIFICATION; PYOGENES; HORMONE; ENERGY; SERVER	Bacterial fibronectin-binding proteins (FnBPs) contain a large intrinsically disordered region (IDR) that mediates adhesion of bacteria to host tissues, and invasion of host cells, through binding to fibronectin (Fn). These FnBP IDRs consist of Fn-binding repeats (FnBRs) that form a highly extended tandem beta-zipper interaction on binding to the N-terminal domain of Fn. Several FnBR residues are highly conserved across bacterial species, and here we investigate their contribution to the interaction. Mutation of these residues to alanine in SfbI-5 (a disordered FnBR from the human pathogen Streptococcus pyogenes) reduced binding, but for each residue the change in free energy of binding was <2 kcal/mol. The structure of an SfbI-5 peptide in complex with the second and third F1 modules from Fn confirms that the conserved FnBR residues play equivalent functional roles across bacterial species. Thus, in SfbI-5, the binding energy for the tandem beta-zipper interaction with Fn is distributed across the interface rather than concentrated in a small number of "hot spot" residues that are frequently observed in the interactions of folded proteins. We propose that this might be a common feature of the interactions of IDRs and is likely to pose a challenge for the development of small molecule inhibitors of FnBP-mediated adhesion to and invasion of host cells.	[Norris, Nicole C.; Bingham, Richard J.; Harris, Gemma; Speakman, Adrian; Jones, Richard P. O.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Leech, Andrew] Univ York, Technol Facil, Dept Biol, Area 15, York YO10 5DD, N Yorkshire, England; [Turkenburg, Johan P.; Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jennifer.potts@york.ac.uk	Bingham, Richard J/H-6169-2019	Bingham, Richard J/0000-0003-3805-0364; Harris, Gemma/0000-0002-4587-4620; Turkenburg, Johan/0000-0001-6992-6838	British Heart Foundation; Overseas Research Students Awards Scheme Scholarship; University of Sydney; University of York; Biotechnology and Biological Sciences Research Council [D010608/1]; BBSRC [BB/D010608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010608/1, 1023651] Funding Source: researchfish; British Heart Foundation [FS/07/034/22969, PG/09/079/28008] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Overseas Research Students Awards Scheme Scholarship; University of Sydney(University of Sydney); University of York(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation Senior Basic Science Fellowship (to J. R. P.), an Overseas Research Students Awards Scheme Scholarship, scholarships from the Universities of Sydney and York (to N. N.), and by Biotechnology and Biological Sciences Research Council Grant D010608/1.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bright Jr, 2000, METH MOL B, V139, P59; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DESIMONE DW, 1992, DEV BIOL, V149, P357, DOI 10.1016/0012-1606(92)90291-N; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Penkett CJ, 2000, BIOCHEMISTRY-US, V39, P2887, DOI 10.1021/bi992267k; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pope B, 1996, NUCLEIC ACIDS RES, V24, P536, DOI 10.1093/nar/24.3.536; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553	64	31	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38311	38320		10.1074/jbc.M111.276592	http://dx.doi.org/10.1074/jbc.M111.276592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21840989	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000296594200044
J	Afrikanova, I; Yebra, M; Simpkinson, M; Xu, Y; Hayek, A; Montgomery, A				Afrikanova, Ivka; Yebra, Mayra; Simpkinson, Megan; Xu, Yang; Hayek, Alberto; Montgomery, Anthony			Inhibitors of Src and Focal Adhesion Kinase Promote Endocrine Specification IMPACT ON THE DERIVATION OF beta-CELLS FROM HUMAN PLURIPOTENT STEM CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-PRODUCING CELLS; TYROSINE KINASES; IN-VITRO; MESENCHYMAL TRANSITION; FAMILY KINASES; SELF-RENEWAL; CANCER-CELLS; DIFFERENTIATION; EXPRESSION; PANCREAS	Stepwise approaches for the derivation of beta-cells from human embryonic stem cells have been described. However, low levels of endocrine specification limit the final yield of insulin-producing beta-cells. In this study, we show that the pyrrolo-pyrimidine Src family kinase (SFK) inhibitor PP2 effectively promotes the endocrine specification of human embryonic stem cell derivatives based on its capacity to induce the expression of proendocrine transcription factors (NGN3, NEUROD1, NKX2.2, and PAX4) and to significantly increase the final yield of insulin-positive cells. We further demonstrate that PP2 inhibits the activation of focal adhesion kinase (FAK), and selective inhibition of this kinase is also sufficient to induce early endocrine commitment based on increased expression of NGN3, NEUROD1, and NKX2.2. Additional studies using dominant negative constructs and isolated human fetal pancreata suggest that c-Src is at least partially responsible for inhibiting early endocrine specification. Mechanistically, we propose that inhibition of SFK/FAK signaling can promote endocrine specification by limiting activation of the TGF beta R/Smad2/3 pathway. Moreover, we show that inhibition of SFK/FAK signaling suppresses cell growth, increases the expression of the beta-cell-associated cyclin-dependent kinase inhibitor p57kip2, and simultaneously suppresses the expression of Id1 and Id2. This study has important implications for the derivation of beta-cells for the cell-based therapy of diabetes and sheds new light on the signaling events that regulate early endocrine specification.	[Afrikanova, Ivka; Yebra, Mayra; Simpkinson, Megan; Hayek, Alberto; Montgomery, Anthony] Univ Calif San Diego, Pediat Diabet Res Ctr, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Pediat, San Diego, CA 92121 USA; [Xu, Yang] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Montgomery, A (corresponding author), Univ Calif San Diego, Pediat Diabet Res Ctr, 3525 John Hopkins Ct, San Diego, CA 92121 USA.	ammontgo@ucsd.edu		Xu, Yang/0000-0001-5574-921X	American Diabetes Association; Juvenile Diabetes Research Foundation; California Institute of Regenerative Medicine; Larry L. Hillblom Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Larry L. Hillblom Foundation	This work was supported by the American Diabetes Association (Innovation Award), by the Juvenile Diabetes Research Foundation (Regular Research Grant), by the California Institute of Regenerative Medicine (Early Translation Grant), and by the Larry L. Hillblom Foundation (network grant).	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; BEATTIE GM, 1994, J CLIN ENDOCR METAB, V78, P1232, DOI 10.1210/jc.78.5.1232; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Boretti MI, 2007, TISSUE ENG, V13, P775, DOI 10.1089/ten.2006.0258; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daoud G, 2006, J PHYSIOL-LONDON, V571, P537, DOI 10.1113/jphysiol.2005.102285; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Park MS, 2010, MATRIX BIOL, V29, P135, DOI 10.1016/j.matbio.2009.10.001; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Potikha T, 2005, LAB INVEST, V85, P364, DOI 10.1038/labinvest.3700229; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Theus MH, 2006, EXP CELL RES, V312, P3096, DOI 10.1016/j.yexcr.2006.06.022; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; VARDIMON L, 1991, MOL CELL BIOL, V11, P5275, DOI 10.1128/MCB.11.10.5275; Walker JL, 2007, INVEST OPHTH VIS SCI, V48, P2214, DOI 10.1167/iovs.06-1059; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	51	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36042	36052		10.1074/jbc.M111.290825	http://dx.doi.org/10.1074/jbc.M111.290825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852242	Green Published, hybrid			2022-12-25	WOS:000295927100077
J	Ardura, JA; Wang, B; Watkins, SC; Vilardaga, JP; Friedman, PA				Ardura, Juan A.; Wang, Bin; Watkins, Simon C.; Vilardaga, Jean-Pierre; Friedman, Peter A.			Dynamic Na+-H+ Exchanger Regulatory Factor-1 Association and Dissociation Regulate Parathyroid Hormone Receptor Trafficking at Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PDZ DOMAINS; BETA-ARRESTIN; BRUSH-BORDER; ERM PROTEINS; CELL CORTEX; NHERF1; INTERNALIZATION; ACTIVATION; COMPLEX	Na/H exchanger regulatory factor-1 (NHERF1) is a cytoplasmic PDZ (postsynaptic density 95/disc large/zona occludens) protein that assembles macromolecular complexes and determines the localization, trafficking, and signaling of select G protein-coupled receptors and other membrane-delimited proteins. The parathyroid hormone receptor (PTHR), which regulates mineral ion homeostasis and bone turnover, is a G protein-coupled receptor harboring a PDZ-binding motif that enables association with NHERF1 and tethering to the actin cytoskeleton. NHERF1 interactions with the PTHR modify its trafficking and signaling. Here, we characterized by live cell imaging the mechanism whereby NHERF1 coordinates the interactions of multiple proteins, as well as the fate of NHERF1 itself upon receptor activation. Upon PTHR stimulation, NHERF1 rapidly dissociates from the receptor and induces receptor aggregation in long lasting clusters that are enriched with the actin-binding protein ezrin and with clathrin. After NHERF1 dissociates from the PTHR, ezrin then directly interacts with the PTHR to stabilize the PTHR at the cell membrane. Recruitment of beta-arrestins to the PTHR is delayed until NHERF1 dissociates from the receptor, which is then trafficked to clathrin for internalization. The ability of NHERF to interact dynamically with the PTHR and cognate adapter proteins regulates receptor trafficking and signaling in a spatially and temporally coordinated manner.	[Ardura, Juan A.; Wang, Bin; Vilardaga, Jean-Pierre; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan/L-8139-2014; Watkins, Simon/ABG-2590-2021; Ardura, Juan Antonio/F-3378-2017	Ardura, Juan/0000-0002-8881-4775; Watkins, Simon/0000-0003-4092-1552; Ardura, Juan Antonio/0000-0002-2827-3364; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Wang, Bin/0000-0002-5396-6111	National Institutes of Health [R01DK06998, R01DK054171, U54RR022241, R01DK087688]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998, R01DK087688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK06998, R01DK054171 (to P. A. F.), U54RR022241 (to S. C. W.), and R01DK087688 (to J.-P.V.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chorev M, 2002, RECEPTOR CHANNEL, V8, P219, DOI 10.1080/10606820213685; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2001, J BIOL CHEM, V276, P33435, DOI 10.1074/jbc.M011495200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35020	35029		10.1074/jbc.M111.264978	http://dx.doi.org/10.1074/jbc.M111.264978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832055	hybrid, Green Published			2022-12-25	WOS:000295406300055
J	Eom, GH; Kim, KB; Kim, JH; Kim, JY; Kim, JR; Kee, HJ; Kim, DW; Choe, N; Park, HJ; Son, HJ; Choi, SY; Kook, H; Seo, SB				Eom, Gwang Hyeon; Kim, Kee-Beom; Kim, Jin Hee; Kim, Ji-Young; Kim, Ju-Ryung; Kee, Hae Jin; Kim, Dong-Wook; Choe, Nakwon; Park, Hye-Jeong; Son, Hye-Ju; Choi, Seok-Yong; Kook, Hyun; Seo, Sang-Beom			Histone Methyltransferase SETD3 Regulates Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; CHROMATIN MODIFICATIONS; LYSINE METHYLATION; GENE-EXPRESSION; TRANSCRIPTION; INHIBITION; MYOGENESIS; ZEBRAFISH; INTERACTS; PROTEIN	Histone lysine methylation, as one of the most important factors in transcriptional regulation, is associated with a various physiological conditions. Using a bioinformatics search, we identified and subsequently cloned mouse SET domain containing 3 (SETD3) with SET (Su(var) 3-9, Enhancer-of-zeste and Trithorax) and Rubis-subs-bind domains. SETD3 is a novel histone H3K4 and H3K36 methyltransferase with transcriptional activation activity. SETD3 is expressed abundantly in muscular tissues and, when overexpressed, activates transcription of muscle- related genes, myogenin, muscle creatine kinase (MCK), and myogenic factor 6 (Myf6), thereby inducing muscle cell differentiation. Conversely, knockdown of SETD3 by shRNA significantly retards muscle cell differentiation. In this study, SETD3 was recruited to the myogenin gene promoter along with MyoD where it activated transcription. Together, these data indicate that SETD3 is a H3K4/K36 methyltransferase and plays an important role in the transcriptional regulation of muscle cell differentiation.	[Eom, Gwang Hyeon; Kim, Ju-Ryung; Kee, Hae Jin; Choe, Nakwon; Seo, Sang-Beom] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea; [Eom, Gwang Hyeon; Kim, Ju-Ryung; Kee, Hae Jin; Choe, Nakwon; Seo, Sang-Beom] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Kwangju 501746, South Korea; [Kim, Jin Hee; Park, Hye-Jeong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju 501746, South Korea; [Kim, Kee-Beom; Kim, Ji-Young; Kim, Dong-Wook] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 156756, South Korea; [Park, Hye-Jeong] Chosun Univ, Dept Biol, Kwangju 501759, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chung Ang University; Chosun University	Kook, H (corresponding author), Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea.	kookhyun@chonnam.ac.kr; sangbs@cau.ac.kr	Kim, Kee-Beom/AFL-8804-2022; Kim, Kee-Beom/AAG-9225-2022; Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021	Kim, Kee-Beom/0000-0003-0132-8924; Kim, Kee-Beom/0000-0003-0132-8924; Kook, Hyun/0000-0002-0740-1806; Kee, Hae Jin/0000-0002-9774-4828	National Research Foundation of Korea, Ministry of Education, Science and Technology [R01-2008-000-20358-0, KRF-2007-313-E00126]	National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the Mid-career Researcher Program, National Research Foundation of Korea, Ministry of Education, Science and Technology Grants R01-2008-000-20358-0 and KRF-2007-313-E00126.	Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Cirillo L, 2004, SCIENCE, V304, P1607, DOI 10.1126/science.1099577; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Kim JR, 2009, J BIOL CHEM, V284, P16308, DOI 10.1074/jbc.M807725200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Qiao J, 2010, FERTIL STERIL, V93, P1628, DOI 10.1016/j.fertnstert.2009.03.002; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	28	65	71	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34733	34742		10.1074/jbc.M110.203307	http://dx.doi.org/10.1074/jbc.M110.203307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832073	hybrid, Green Published			2022-12-25	WOS:000295406300027
J	Shinozaki, S; Choi, CS; Shimizu, N; Yamada, M; Kim, M; Zhang, T; Dong, HH; Kim, YB; Kaneki, M				Shinozaki, Shohei; Choi, Cheol Soo; Shimizu, Nobuyuki; Yamada, Marina; Kim, Minhye; Zhang, Ting; Dong, H. Henry; Kim, Young-Bum; Kaneki, Masao			Liver-specific Inducible Nitric-oxide Synthase Expression Is Sufficient to Cause Hepatic Insulin Resistance and Mild Hyperglycemia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE CELLS; AKT/PROTEIN KINASE-B; S-NITROSYLATION; FASTING HYPERGLYCEMIA; RECEPTOR SUBSTRATE-1; POSSIBLE INVOLVEMENT; MAMMALIAN TARGET; GENE-EXPRESSION; OB/OB MICE	Inducible nitric-oxide synthase (iNOS), a major mediator of inflammation, plays an important role in obesity-induced insulin resistance. Inhibition of iNOS by gene disruption or pharmacological inhibitors reverses or ameliorates obesity-induced insulin resistance in skeletal muscle and liver in mice. It is unknown, however, whether increased expression of iNOS is sufficient to cause insulin resistance in vivo. To address this issue, we generated liver-specific iNOS transgenic (L-iNOS-Tg) mice, where expression of the transgene, iNOS, is regulated under mouse albumin promoter. L-iNOS-Tg mice exhibited mild hyperglycemia, hyperinsulinemia, insulin resistance, and impaired insulin-induced suppression of hepatic glucose output, as compared with wild type (WT) littermates. Insulin-stimulated phosphorylation of insulin receptor substrate-1 (IRS-1) and -2, and Akt was significantly attenuated in liver, but not in skeletal muscle, of L-iNOS-Tg mice relative to WT mice without changes in insulin receptor phosphorylation. Moreover, liver-specific iNOS expression abrogated insulin-stimulated phosphorylation of glycogen synthase kinase-3 beta, forkhead box O1, and mTOR (mammalian target of rapamycin), endogenous substrates of Akt, along with increased S-nitrosylation of Akt relative to WT mice. However, the expression of insulin receptor, IRS-1, IRS-2, Akt, glycogen synthase kinase-3 beta, forkhead box O1, protein-tyrosine phosphatase-1B, PTEN (phosphatase and tensin homolog), and p85 phosphatidylinositol 3-kinase was not altered by iNOS transgene. Hyperglycemia was associated with elevated glycogen phosphorylase activity and decreased glycogen synthase activity in the liver of L-iNOS-Tg mice, whereas phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and proliferator-activated receptor gamma coactivator-1 alpha expression were not altered. These results clearly indicate that selective expression of iNOS in liver causes hepatic insulin resistance along with deranged insulin signaling, leading to hyperglycemia and hyperinsulinemia. Our data highlight a critical role for iNOS in the development of hepatic insulin resistance and hyperglycemia.	[Shinozaki, Shohei; Shimizu, Nobuyuki; Yamada, Marina; Kim, Minhye; Kaneki, Masao] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp,Shriners Hosp Children, Charlestown, MA 02129 USA; [Choi, Cheol Soo] Gachon Univ Med & Sci, Dept Internal Med, Inchon 406840, South Korea; [Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Zhang, Ting; Dong, H. Henry] Univ Pittsburgh, Med Ctr, Div Immunogenet, Rangos Res Ctr,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Gachon University; Gachon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kaneki, M (corresponding author), 149 13th St,Rm 6604, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu	Shinozaki, Shohei/AAT-3018-2021; Zhang, Ting/J-5074-2015	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01DK05827, R01DK066301]; American Diabetes Association [7-08-RA-77, 109-RA-87]; Korea Healthcare Technology R&D Project, Republic of Korea [A084651]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Korea Healthcare Technology R&D Project, Republic of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK05827 (to M. K.) and R01DK066301 (to H. H. D.). This work was also supported by American Diabetes Association Grants 7-08-RA-77 (to Y.-B. K.) and 1-09-RA-87 (to H. H. D.), and Korea Healthcare Technology R&D Project, Republic of Korea Grant A084651 (to C. S. C.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Borgs M, 1996, HEPATOLOGY, V23, P1564, DOI 10.1053/jhep.1996.v23.pm0008675178; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Farghali H, 2008, PHYSIOL RES, V57, P569, DOI 10.33549/physiolres.931232; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodis J, 2007, PHYSIOL RES, V56, P419, DOI 10.33549/physiolres.931023; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Katta A, 2009, EXP DIABETES RES, DOI 10.1155/2009/384683; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kone BC, 1999, AM J PHYSIOL-RENAL, V276, pF614, DOI 10.1152/ajprenal.1999.276.4.F614; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Miller AM, 2008, AM J PHYSIOL-REG I, V295, pR1431, DOI 10.1152/ajpregu.90428.2008; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shinozaki S, 2007, HORM METAB RES, V39, P192, DOI 10.1055/s-2007-970417; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	50	53	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34959	34975		10.1074/jbc.M110.187666	http://dx.doi.org/10.1074/jbc.M110.187666			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846719	Green Published, hybrid			2022-12-25	WOS:000295406300050
J	Horn, DM; Mason, SL; Karbstein, K				Horn, Darryl M.; Mason, Saundra L.; Karbstein, Katrin			Rcl1 Protein, a Novel Nuclease for 18 S Ribosomal RNA Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; 3'-PHOSPHATE CYCLASE; PHOSPHATE CYCLASE; SITE A(2); YEAST; BIOGENESIS; DOMAIN	In all forms of life, rRNAs for the small and large ribosomal subunit are co-transcribed as a single transcript. Although this ensures the equimolar production of rRNAs, it requires the endonucleolytic separation of pre-rRNAs to initiate rRNA production. In yeast, processing of the primary transcript encoding 18 S, 5.8 S, and 25 S rRNAs has been studied extensively. Nevertheless, most nucleases remain to be identified. Here, we show that Rcl1, conserved in all eukaryotes, cleaves pre-rRNA at so-called site A(2), a co-transcriptional cleavage step that separates rRNAs destined for the small and large subunit. Recombinant Rcl1 cleaves pre-rRNA mimics at site A(2) in a reaction that is sensitive to nearby RNA mutations that inhibit cleavage in vivo. Furthermore, mutations in Rcl1 disrupt rRNA processing at site A(2) in vivo and in vitro. Together, these results demonstrate that the role of Rcl1 in eukaryotic pre-rRNA processing is identical to that of RNase III in bacteria: to co-transcriptionally separate the pre-rRNAs destined for the small and large subunit. Furthermore, because Rcl1 has no homology to other known endonucleases, these data also establish a novel class of nucleases.	[Horn, Darryl M.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Mason, Saundra L.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Karbstein, Katrin/0000-0002-4034-1331	National Science Foundation [MCB0845156]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB0845156.	AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Allmang C, 1996, RNA, V2, P51; Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; DEJONGE P, 1977, EUR J BIOCHEM, V72, P361; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; Karbstein K, 2006, J MOL BIOL, V356, P432, DOI 10.1016/j.jmb.2005.11.052; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Karbstein K, 2002, BIOCHEMISTRY-US, V41, P11171, DOI 10.1021/bi0202631; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; LINDAHL L, 1994, NUCLEIC ACIDS RES, V22, P5399, DOI 10.1093/nar/22.24.5399; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Tanaka N, 2011, RNA, V17, P595, DOI 10.1261/rna.2571811; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Torchet C, 1998, RNA, V4, P1636, DOI 10.1017/S1355838298981511; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Weaver PL, 1997, MOL CELL BIOL, V17, P1354, DOI 10.1128/MCB.17.3.1354; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Young CL, 2011, RNA, V17, P512, DOI 10.1261/rna.2458811	28	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34082	34087		10.1074/jbc.M111.268649	http://dx.doi.org/10.1074/jbc.M111.268649			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21849504	hybrid, Green Published			2022-12-25	WOS:000295159200040
J	Mandal, M; Wei, J; Zhong, P; Cheng, J; Duffney, LJ; Liu, WH; Yuen, EY; Twelvetrees, AE; Li, SH; Li, XJ; Kittler, JT; Yan, Z				Mandal, Madhuchhanda; Wei, Jing; Zhong, Ping; Cheng, Jia; Duffney, Lara J.; Liu, Wenhua; Yuen, Eunice Y.; Twelvetrees, Alison E.; Li, Shihua; Li, Xiao-Jiang; Kittler, Josef T.; Yan, Zhen			Impaired alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Trafficking and Function by Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST AXONAL-TRANSPORT; KINESIN LIGHT-CHAIN; NMDA RECEPTOR; MOUSE MODEL; INTRACELLULAR TRAFFICKING; SYNAPTIC-TRANSMISSION; TRANSGENIC MICE; PROTEIN-1 HAP1; DISEASE; NEURONS	Emerging evidence from studies of Huntington disease (HD) pathophysiology suggests that huntingtin (htt) and its associated protein HAP1 participate in intracellular trafficking and synaptic function. However, it is largely unknown whether AMPA receptor trafficking, which is crucial for controlling the efficacy of synaptic excitation, is affected by the mutant huntingtin with polyglutamine expansion (polyQ-htt). In this study, we found that expressing polyQ-htt in neuronal cultures significantly decreased the amplitude and frequency of AMPAR-mediated miniature excitatory postsynaptic current (mEPSC), while expressing wild-type huntingtin (WT-htt) increased mEPSC. AMPAR-mediated synaptic transmission was also impaired in a transgenic mouse model of HD expressing polyQ-htt. The effect of polyQ-htt on mEPSC was mimicked by knockdown of HAP1 and occluded by the dominant negative HAP1. Moreover, we found that huntingtin affected mESPC via a mechanism depending on the kinesin motor protein, KIF5, which controls the transport of GluR2-containing AMPARs along microtubules in dendrites. The GluR2/KIF5/HAP1 complex was disrupted and dissociated from microtubules in the HD mouse model. Together, these data suggest that AMPAR trafficking and function is impaired by mutant huntingtin, presumably due to the interference of KIF5-mediated microtubule-based transport of AMPA receptors. The diminished strength of glutamatergic transmission could contribute to the deficits in movement control and cognitive processes in HD conditions.	[Mandal, Madhuchhanda; Wei, Jing; Zhong, Ping; Cheng, Jia; Duffney, Lara J.; Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Twelvetrees, Alison E.; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of London; University College London; Emory University	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010; Twelvetrees, Alison/K-8712-2019	Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; Twelvetrees, Alison/0000-0002-1796-1508	National Institutes of Health [NS69929]; MRC [G0802377] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER; Medical Research Council [G0802377] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant NS69929 (to Z. Y.).	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Andre VM, 2006, J NEUROPHYSIOL, V95, P2108, DOI 10.1152/jn.01118.2005; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Guillaud L, 2003, J NEUROSCI, V23, P131; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lione LA, 1999, J NEUROSCI, V19, P10428; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Page KJ, 1998, EUR J NEUROSCI, V10, P1835, DOI 10.1046/j.1460-9568.1998.00185.x; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Yuen EY, 2011, J BIOL CHEM, V286, P24957, DOI 10.1074/jbc.M111.221416; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	53	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33719	33728		10.1074/jbc.M111.236521	http://dx.doi.org/10.1074/jbc.M111.236521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832090	hybrid, Green Published			2022-12-25	WOS:000295159200002
J	Ansari, MA; Zubair, S; Mahmood, A; Gupta, P; Khan, AA; Gupta, UD; Arora, A; Owais, M				Ansari, Mairaj Ahmed; Zubair, Swaleha; Mahmood, Anjum; Gupta, Pushpa; Khan, Aijaz A.; Gupta, Umesh D.; Arora, Ashish; Owais, Mohammad			RD Antigen Based Nanovaccine Imparts Long Term Protection by Inducing Memory Response against Experimental Murine Tuberculosis	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; VACCINES; SUBUNIT; ARCHAEOSOMES; DELIVERY; PROTEIN; BCG	Background: The absence of certain genomic loci that are present in most of the virulent strains of Mycobacterium tuberculosis as well as lack of lasting memory responses are some of the major causes attributed to the non effectiveness of Bacille Calmette-Gue'rin (BCG) vaccine. Immunization schedules addressing these issues can offer better strategy for protection against tuberculosis. Methods: The immunological responses evoked upon administration of archaeosome based antigen delivery system comprising T cell antigen, Rv3619c (an ESAT-6 family protein), has been assessed against experimental murine tuberculosis in BALB/c mice. Results: Archaeosome based subunit vaccine has been found to elicit type-1 cytokines in the immunized mice. Besides effective T cell memory response, the Rv3619c based vaccine was able to reduce mycobacterial burden in the animals challenged with Mycobacterium tuberculosis infection. Conclusion: The data of the present study suggest that archaeosome encapsulated RD gene products offer substantial protection against M. tuberculosis infection.	[Ansari, Mairaj Ahmed; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India; [Mahmood, Anjum; Arora, Ashish] CDRI, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Gupta, Pushpa; Gupta, Umesh D.] Natl JALMA Inst Leprosy & OMD, Agra, Uttar Pradesh, India; [Khan, Aijaz A.] JNMC, Dept Anat, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Aligarh Muslim University	Ansari, MA (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com		Mohammad, Owais/0000-0001-7377-7388; ANSARI, MAIRAJ/0000-0003-0040-4147	 [3/1/JRF/14/MPD/2006 (33644)]		A grant was received in the form of a fellowship and contingency of Mr. Mairaj Ahmed Ansari, 3/1/JRF/14/MPD/2006 (33644). Their website is www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Choquet CG, 1996, CAN J MICROBIOL, V42, P183, DOI 10.1139/m96-027; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Gareth JJ, 2010, INFECT IMMUN, V78, P1326; Grover A, 2006, PROTEIN EXPRES PURIF, V48, P274, DOI 10.1016/j.pep.2006.03.010; GUPTA RK, 1995, VACCINE DESIGN SUBUN; KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979; Krishnan L, 2000, J IMMUNOL, V165, P5177, DOI 10.4049/jimmunol.165.9.5177; Krishnan L, 2000, INFECT IMMUN, V68, P54, DOI 10.1128/IAI.68.1.54-63.2000; KUMAR A, 1983, NATURE, V303, P632, DOI 10.1038/303632a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; Petroff SA, 1928, AM J PUBLIC HEALTH N, V18, P843, DOI 10.2105/AJPH.18.7.843-b; Sable SB, 2005, EUR RESPIR J, V25, P902, DOI 10.1183/09031936.05.00105404; Sambrook J, 2001, MOL CLONING LAB MANU; Simmons CP, 1999, J IMMUNOL, V163, P6502; Sjolander A, 1998, J LEUKOCYTE BIOL, V64, P713; Sprott G. D., 1996, Cells and Materials, V6, P143; Sprott GD, 1997, FEMS MICROBIOL LETT, V154, P17, DOI 10.1016/S0378-1097(97)00294-2; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WHO, 2009, GLOB TUB CONTR EP ST, P6; World Health Organization, 2010, WHOHTMTB20103; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	35	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22889	10.1371/journal.pone.0022889	http://dx.doi.org/10.1371/journal.pone.0022889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853054	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400017
J	Keller, G; Cour, M; Hernu, R; Illinger, J; Robert, D; Argaud, L				Keller, Geoffray; Cour, Martin; Hernu, Romain; Illinger, Julien; Robert, Dominique; Argaud, Laurent			Management of Metformin-Associated Lactic Acidosis by Continuous Renal Replacement Therapy	PLOS ONE			English	Article							ACUTE PHYSIOLOGY; HEMODIALYSIS; HEMOFILTRATION; ABSENCE; SCORE	Background: Metformin-associated lactic acidosis (MALA) is a severe metabolic failure with high related mortality. Although its use is controversial, intermittent hemodialysis is reported to be the most frequently used treatment in conjunction with nonspecific supportive measures. Our aim was to report the evolution and outcome of cases managed by continuous renal replacement therapy (CRRT). Methodology and Principal Findings: Over a 3-year period, we retrospectively identified patients admitted to the intensive care unit for severe lactic acidosis caused by metformin. We included patients in our study who were treated with CRRT because of shock. We describe their clinical and biological features at admission and during renal support, as well as their evolution. We enrolled six patients with severe lactic acidosis; the mean pH and mean lactate was 6.92 +/- 0.20 and 14.4 +/- 5.1 mmol/l, respectively. Patients had high illness severity scores, including the Simplified Acute Physiology Score II (SAPS II) (average score 63 +/- 12 points). Early CRRT comprised either venovenous hemofiltration (n = 3) or hemodiafiltration (n = 3) with a mean effluent flow rate of 34 +/- 6 ml/kg/h. Metabolic acidosis control and metformin elimination was rapid and there was no rebound. Outcome was favorable in all cases. Conclusions and Significance: Standard use of CRRT efficiently treated MALA in association with symptomatic organ supportive therapies.	[Keller, Geoffray; Cour, Martin; Hernu, Romain; Illinger, Julien; Robert, Dominique; Argaud, Laurent] Groupement Hosp Edouard Herriot, Hosp Civils Lyon, Serv Reanimat Med, Lyon, France; [Keller, Geoffray; Cour, Martin; Robert, Dominique; Argaud, Laurent] Univ Lyon 1, Fac Med Lyon Est, F-69365 Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Keller, G (corresponding author), Groupement Hosp Edouard Herriot, Hosp Civils Lyon, Serv Reanimat Med, Lyon, France.	laurent.argaud@chu-lyon.fr	Cour, M/T-2525-2019	cour, martin/0000-0003-4909-9761				Arroyo AM, 2010, AM J THER, V17, P96, DOI 10.1097/MJT.0b013e318197eab6; Bruijstens LA, 2008, NETH J MED, V66, P185; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Galea M, 2007, BRIT J ANAESTH, V98, P213, DOI 10.1093/bja/ael347; Guo PYF, 2006, SEMIN DIALYSIS, V19, P80, DOI 10.1111/j.1525-139X.2006.00123.x; JACKSON GG, 1962, ARCH INTERN MED, V110, P663, DOI 10.1001/archinte.1962.03620230109016; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kruse JA, 2001, J EMERG MED, V20, P267, DOI 10.1016/S0736-4679(00)00320-6; Lalau JD, 1999, DRUG SAFETY, V20, P377, DOI 10.2165/00002018-199920040-00006; Lalau JD, 2003, DIABETES OBES METAB, V5, P93, DOI 10.1046/j.1463-1326.2003.00241.x; LALAU JD, 1987, INTENS CARE MED, V13, P383; Lalau JD, 2000, DIABETES OBES METAB, V2, P131, DOI 10.1046/j.1463-1326.2000.00053.x; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leverve XM, 2005, CRIT CARE, V9, P622, DOI 10.1186/cc3935; Levraut J, 1997, CRIT CARE MED, V25, P58, DOI 10.1097/00003246-199701000-00013; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Pan LTT, 2009, ANAESTH INTENS CARE, V37, P830, DOI 10.1177/0310057X0903700520; Panzer U, 2004, NEPHROL DIAL TRANSPL, V19, P2157, DOI 10.1093/ndt/gfh337; Peters N, 2008, CRIT CARE, V12, DOI 10.1186/cc7137; Ronco C, 2008, INTENS CARE MED, V34, P2139, DOI 10.1007/s00134-008-1258-6; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Uchino S, 2009, CRIT CARE MED, V37, P2576, DOI 10.1097/CCM.0b013e3181a38241; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	30	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23200	10.1371/journal.pone.0023200	http://dx.doi.org/10.1371/journal.pone.0023200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853087	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400031
J	Morishita, Y; Watanabe, M; Nakazawa, E; Ishibashi, K; Kusano, E				Morishita, Yoshiyuki; Watanabe, Minami; Nakazawa, Eiko; Ishibashi, Kenichi; Kusano, Eiji			The Interaction of LFA-1 on Mononuclear Cells and ICAM-1 on Tubular Epithelial Cells Accelerates TGF-beta 1-Induced Renal Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; UP-REGULATION; T-CELLS; TUBULOINTERSTITIAL NEPHRITIS; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; INTEGRIN AVIDITY; GENE-EXPRESSION; DENDRITIC CELLS; CC CHEMOKINES	The epithelial-mesenchymal transition (EMT) of renal epithelial cells (RTECs) has pivotal roles in the development of renal fibrosis. Although the interaction of lymphocyte function-associated antigen 1 (LFA-1) on leukocytes and its ligand, intracellular adhesion molecule 1 (ICAM-1), plays essential roles in most inflammatory reactions, its pathogenetic role in the EMT of RTECs remains to be clarified. In the present study, we investigated the effect of the interaction of LFA-1 on peripheral blood mononuclear cells (PBMCs) and ICAM-1 on HK-2 cells after stimulation with TGF-beta(1) on the EMT of RTECs. ICAM-1 was highly expressed in HK-2 cells. After TGF-beta(1) stimulation, the chemokines CCL3 and CXCL12 increased on HK-2 cells. After co-culture of PBMCs and HK-2 cells pre-stimulated with TGF-beta(1) (0.1 ng/ml) (HK-2-TGF-beta(1) (0.1)), the expression of the active form of LFA-1 increased on PBMCs; however, total LFA-1 expression did not change. The expression of the active form of LFA-1 on PBMCs did not increase after co-culture with not CCL3 but CXCL12 knockdown HK-2-TGF-beta(1) (0.1). The expression of epithelial cell junction markers (E-cadherin and occludin) further decreased and that of mesenchymal markers (vimentin and fibronectin) further increased in HK-2-TGF-beta(1) (0.1) after co-culture with PBMCs for 24 hrs (HK-2-TGF-beta(1) (0.1)PBMCs). The phosphorylation of ERK 1/2 but not smad2 and smad3 increased in HK-2-TGF-beta(1) (0.1)-PBMCs. The snail and slug signaling did not increase HK-2-TGF-beta(1) (0.1)-PBMCs. Although the migration and invasion of HK-2 cells induced full EMT by a high dose (10.0 ng/ml) and long-term (72-96 hrs) TGF-beta(1) stimulation increased, that of HK-2-TGF-beta(1) (0.1)-PBMCs did not increase. These results suggested that HK-2 cells stimulated with TGF-beta(1) induced conformational activation of LFA-1 on PBMCs by increased CXCL12. Then, the direct interaction of LFA-1 on PBMCs and ICAM-1 on HK-2 cells activated ERK1/2 signaling to accelerate the part of EMT of HK-2 cells induced by TGF-beta(1).	[Morishita, Yoshiyuki; Watanabe, Minami; Nakazawa, Eiko; Kusano, Eiji] Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan	Jichi Medical University; Meiji Pharmaceutical University	Morishita, Y (corresponding author), Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi, Japan.	ymori@jichi.ac.jp			Kidney Foundation, Japan [JFL 11-3]; Jichi Medical University	Kidney Foundation, Japan(Kidney Foundation, Japan); Jichi Medical University	This work was in part supported by grants from The Kidney Foundation, Japan (JFL 11-3), and Jichi Medical University Young Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 1997, TRANSPLANTATION, V64, P190, DOI 10.1097/00007890-199707270-00002; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; BUYON JP, 1988, J IMMUNOL, V140, P3156; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; CHIRATHAWORN C, 1995, J IMMUNOL, V155, P5479; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gardiner EE, 1999, J BIOL CHEM, V274, P11930, DOI 10.1074/jbc.274.17.11930; Gerritsma JSJ, 1998, KIDNEY INT, V53, P609, DOI 10.1046/j.1523-1755.1998.00799.x; Haberstroh U, 1998, J AM SOC NEPHROL, V9, P203; Hertig A, 2008, J AM SOC NEPHROL, V19, P1584, DOI 10.1681/ASN.2007101160; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Holland J, 1997, J BIOL CHEM, V272, P9108; HOOKE DH, 1987, KIDNEY INT, V31, P964, DOI 10.1038/ki.1987.93; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; KELLY KJ, 1994, P NATL ACAD SCI USA, V91, P812, DOI 10.1073/pnas.91.2.812; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kopp JB, 1996, LAB INVEST, V74, P991; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Lin Y, 2009, NEOPLASIA, V11, P864, DOI 10.1593/neo.09542; Lloyd AR, 1996, J IMMUNOL, V156, P932; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; MULLER GA, 1991, CLIN NEPHROL, V36, P203; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Ou ZL, 1999, J LAB CLIN MED, V133, P41, DOI 10.1053/lc.1999.v133.a94726; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Salahshor S, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-66; Schramek H, 2003, AM J PHYSIOL-CELL PH, V285, pC652, DOI 10.1152/ajpcell.00463.2002; Schramek H, 2002, NEWS PHYSIOL SCI, V17, P62, DOI 10.1152/nips.01365.2001; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TANG WW, 1994, LAB INVEST, V70, P631; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOMINO Y, 1994, NEPHRON, V67, P302, DOI 10.1159/000187984; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	54	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23267	10.1371/journal.pone.0023267	http://dx.doi.org/10.1371/journal.pone.0023267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850266	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300051
J	Mullick, A; Tremblay, J; Leon, Z; Gros, P				Mullick, Alaka; Tremblay, Jessy; Leon, Zully; Gros, Philippe			A Novel Role for the Fifth Component of Complement (C5) in Cardiac Physiology	PLOS ONE			English	Article							CANDIDA-ALBICANS; NATRIURETIC PEPTIDE; MICE; A/J; DEFICIENCY; RESPONSES; C57BL/6J; FAILURE	We have previously demonstrated that C5-deficient A/J and recombinant congenic BcA17 mice suffer from cardiac dysfunction when infected with C. albicans blastospores intravenously. During these studies we had observed that, even in the control un-infected state, BcA17 hearts displayed alterations in gene expression that have been associated with pathological cardiac hypertrophy in comparison to parental C5-sufficient C57Bl/6J (B6) mice. Of note was an increase in the expression of Nppb, a member of the fetal gene program and a decrease in the expression of Rgs2, an inhibitor of the hypertrophic response. We now report that C5-deletion has also affected the expression of other elements of the fetal gene program. Moreover deleting the C5a receptor, C5aR, has essentially the same effect as deleting C5, indicating a key role for C5a-C5aR signaling in the phenotype. Having noted a pathological phenotype in the un-infected state, we investigated the role of C5 in the response to cardiac stress. In previous studies, comparison of the expression profiles of C. albicans-infected BcA17 and similarly infected B6 hearts had revealed a paucity of cardioprotective genes in the C5-deficient heart. To determine whether this was also directly linked to C5-deficiency, we tested the expression of 5 such genes in the C. albicans-infected C5aR(-/-) mice. We found again that deletion of C5aR recapitulated the alterations in stress response of BcA17. To determine whether our observations were relevant to other forms of cardiac injury, we tested the effect of C5-deficiency on the response to isoproterenol-induced hypertrophic stimulation. Consistent with our hypothesis, A/J, BcA17 and C5aR(-/-) mice responded with higher levels of Nppa expression than B6 and BALB/c mice. In conclusion, our results suggest that an absence of functional C5a renders the heart in a state of distress, conferring a predisposition to cardiac dysfunction in the face of additional injury.	[Mullick, Alaka; Tremblay, Jessy; Leon, Zully] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Mullick, Alaka; Tremblay, Jessy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada	National Research Council Canada; Universite de Montreal; McGill University	Mullick, A (corresponding author), Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada.	alaka.mullick@cnrc-nrc.gc.ca			Canadian Institute of Health Research (CIHR) [CTP-79843]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a team grant on fungal pathogenesis from the Canadian Institute of Health Research (CIHR) to AM and PG (CTP-79843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN RB, 1993, IMMUNOL CELL BIOL, V71, P221, DOI 10.1038/icb.1993.25; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; EATON GJ, 1978, AM J PATHOL, V90, P173; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Hoit BD, 2002, GENOMICS, V79, P679, DOI 10.1006/geno.2002.6754; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Li F, 2008, BIOCHEM BIOPH RES CO, V370, P317, DOI 10.1016/j.bbrc.2008.03.096; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; Markiewski MM, 2009, J IMMUNOL, V182, P5412, DOI 10.4049/jimmunol.0804179; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; NILSSON UR, 1967, J EXP MED, V125, P1, DOI 10.1084/jem.125.1.1; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Papp S, 2010, AM J PATHOL, V176, P1113, DOI 10.2353/ajpath.2010.090392; Parekh N, 2009, CURR OPIN CARDIOL, V24, P155, DOI 10.1097/HCO.0b013e328320d82a; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Sawada T, 2010, J MOL CELL CARDIOL, V48, P1280, DOI 10.1016/j.yjmcc.2010.02.004; Scheuer J, 1999, AM J CARDIOL, V83, p70H; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; YASUNAGA I, 1988, EXP ANIM TOKYO, V37, P121, DOI 10.1538/expanim1978.37.2_121; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22919	10.1371/journal.pone.0022919	http://dx.doi.org/10.1371/journal.pone.0022919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829669	gold, Green Submitted, Green Published			2022-12-25	WOS:000293511200026
J	Chen, Z; Chen, YZ; Wang, XF; Wang, C; Yan, RX; Zhang, ZD				Chen, Zhen; Chen, Yong-Zi; Wang, Xiao-Feng; Wang, Chuan; Yan, Ren-Xiang; Zhang, Ziding			Prediction of Ubiquitination Sites by Using the Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							MEMBRANE-PROTEIN TYPES; COMPUTATIONAL IDENTIFICATION; PHOSPHORYLATION SITES; SEQUENCES; UBIQUITYLATION; RECOGNITION; COLLOCATION; DATABASE	As one of the most important reversible protein post-translation modifications, ubiquitination has been reported to be involved in lots of biological processes and closely implicated with various diseases. To fully decipher the molecular mechanisms of ubiquitination-related biological processes, an initial but crucial step is the recognition of ubiquitylated substrates and the corresponding ubiquitination sites. Here, a new bioinformatics tool named CKSAAP_UbSite was developed to predict ubiquitination sites from protein sequences. With the assistance of Support Vector Machine (SVM), the highlight of CKSAAP_UbSite is to employ the composition of k-spaced amino acid pairs surrounding a query site (i.e. any lysine in a query sequence) as input. When trained and tested in the dataset of yeast ubiquitination sites (Radivojac et al, Proteins, 2010, 78: 365-380), a 100-fold cross-validation on a 1: 1 ratio of positive and negative samples revealed that the accuracy and MCC of CKSAAP_UbSite reached 73.40% and 0.4694, respectively. The proposed CKSAAP_UbSite has also been intensively benchmarked to exhibit better performance than some existing predictors, suggesting that it can be served as a useful tool to the community. Currently, CKSAAP_UbSite is freely accessible at http://protein.cau.edu.cn/cksaap_ubsite/. Moreover, we also found that the sequence patterns around ubiquitination sites are not conserved across different species. To ensure a reasonable prediction performance, the application of the current CKSAAP_UbSite should be limited to the proteome of yeast.	[Chen, Zhen; Wang, Xiao-Feng; Wang, Chuan; Yan, Ren-Xiang; Zhang, Ziding] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Chen, Zhen; Wang, Xiao-Feng; Wang, Chuan; Yan, Ren-Xiang; Zhang, Ziding] China Agr Univ, Bioinformat Ctr, Coll Biol Sci, Beijing 100094, Peoples R China; [Chen, Yong-Zi] Tianjin Med Univ, Canc Inst & Hosp, Tianjin Canc Inst, Tianjin, Peoples R China	China Agricultural University; China Agricultural University; Tianjin Medical University	Chen, Z (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zidingzhang@cau.edu.cn	Wang, Chuan/B-7071-2012; , zidingzhang/E-9320-2011	Wang, Chuan/0000-0001-5143-1714; , zidingzhang/0000-0002-9296-571X; chen, yongzi/0000-0003-3396-7130; Chen, Zhen/0000-0002-9412-9774	National Key Basic Research Project of China [2009CB918802]; National Natural Science Foundation of China [31070259, 30830058]; State Education Ministry of China [20070019050]	National Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Education Ministry of China(Ministry of Education, China)	This work was supported by the National Key Basic Research Project of China (2009CB918802), the National Natural Science Foundation of China (31070259 and 30830058), and the State Education Ministry of China (20070019050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai Y., 2011, AMINO ACIDS; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Lee WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-440; Li H, 2009, MOL CELL PROTEOMICS, V8, P1839, DOI 10.1074/mcp.M900030-MCP200; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Si JN, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-73; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-124; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Tomlinson E, 2007, PROTEOMICS, V7, P1016, DOI 10.1002/pmic.200601008; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yang XG, 2002, J BIOMOL STRUCT DYN, V20, P163, DOI 10.1080/07391102.2002.10506832; Yang XG, 2007, BIOCHEM BIOPH RES CO, V353, P164, DOI 10.1016/j.bbrc.2006.12.004	39	112	115	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22930	10.1371/journal.pone.0022930	http://dx.doi.org/10.1371/journal.pone.0022930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829559	Green Published, gold			2022-12-25	WOS:000293286500055
J	Ferrao, PT; Bukczynska, EP; Johnstone, RW; McArthur, GA				Ferrao, P. T.; Bukczynska, E. P.; Johnstone, R. W.; McArthur, G. A.			Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells	ONCOGENE			English	Article						CHK inhibitors; DNA damage; p53; p19ARF; E mu-myc	DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; CHECKPOINT KINASE 1; C-MYC; CANCER-THERAPY; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; TRANSGENIC MICE; IN-VIVO; REPLICATION	CHK1 and CHK2 function as effectors of cell cycle checkpoint arrest following DNA damage. Small molecule inhibitors of CHK proteins are under clinical evaluation in combination with chemotherapeutic agents known to induce DNA damage. We examined whether CHK inhibitors could be effective as single agents in malignant cells with inherent DNA damage because of deregulated expression of the oncogene c-Myc. E mu-myc lymphoma cells showed a dramatic increase in the extent of DNA damage and DNA damage response (DDR) signalling within 1 h of treatment with CHK1 inhibitors followed by caspase-dependent apoptosis and cell death. In p53 wild-type/ARF null E mu-myc lymphoma cells, apoptotic cell death was preceded by accumulation of DNA damage and the amount of DNA damage correlated with the extent of cell death. This effect was not observed in normal B cells indicating that DNA damage accumulation following CHK inhibition was specific to E mu-myc lymphoma cells that exhibit inherent DNA damage because of MYC-induced replication stress. Similar results were obtained with another structurally distinct CHK-inhibitor. E mu-myc p53 null lymphoma cells were more sensitive to a dual CHK1/CHK2 inhibitor than to a CHK1-specific inhibitor. In all cases, the level of DNA damage following treatment was the most consistent indicator of drug sensitivity. Our results suggest that CHK inhibitors would be beneficial therapeutic agents in MYC-driven cancers. We propose that inhibitors of CHK can act in a synthetically lethal manner in cancers with replication stress as a result of these cancers being reliant on CHK proteins for an effective DDR and cell survival. Oncogene (2012) 31, 1661-1672; doi:10.1038/onc.2011.358; published online 15 August 2011	[Ferrao, P. T.; Bukczynska, E. P.; Johnstone, R. W.; McArthur, G. A.] Peter MacCallum Canc Inst, Div Res, Mol Oncol Lab, Melbourne, Vic 3002, Australia; [Ferrao, P. T.; Bukczynska, E. P.; Johnstone, R. W.; McArthur, G. A.] Peter MacCallum Canc Inst, Div Res, Canc Therapeut Program, Melbourne, Vic 3002, Australia; [Ferrao, P. T.; McArthur, G. A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Johnstone, R. W.; McArthur, G. A.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne	Ferrao, PT (corresponding author), Peter MacCallum Canc Inst, Div Res, Mol Oncol Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.	petranel.ferrao@petermac.org	Johnstone, Ricky w/H-3748-2014	Johnstone, Ricky w/0000-0001-7053-9237; McArthur, Grant/0000-0001-8908-6071	Pfizer Inc.; National Health and Medical Research Council of Australia; Cancer Council of Victoria	Pfizer Inc.(Pfizer); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	GAM, PTF and RWJ receive research support from Pfizer Inc.; This work was supported by grants from the National Health and Medical Research Council of Australia to GAM and to RWJ. GAM is a recipient of the Weary Dunlop Clinical Research Fellowship of the Cancer Council of Victoria. The statistical analysis and data presentation of dose response curves was performed by Dr Robert N Jorissen (LCCI, Ludwig Institute for Cancer Research). The MetaMorph Journal for measuring the Olive Tail Moment was provided by Cameron J Nowell of the Centre for Advanced Microscopy at the Ludwig Institute for Cancer Research. Pfizer Oncology, La Jolla, CA, USA provided PF-0477736 for this study. Dr Sreesha Srinivasa and Dr Wendy Levin (Pfizer Oncology) contributed to scientific discussion.	Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bertwistle D, 2007, BLOOD, V109, P792, DOI 10.1182/blood-2006-07-033985; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Giroux V, 2006, FASEB J, V20, P1982, DOI 10.1096/fj.06-6239com; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Janetka JW, 2007, CURR OPIN DRUG DISC, V10, P473; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104; Liu QH, 2000, GENE DEV, V14, P1448; Lord CJ, 2009, CLIN CANCER RES, V15, P3241, DOI 10.1158/1078-0432.CCR-09-0434; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mercurio Ciro, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P190; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Myers K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000324; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Newbold A, 2008, MOL CANCER THER, V7, P1066, DOI 10.1158/1535-7163.MCT-07-2256; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; R Development Core Team, 2009, R LANG ENV STAT COMP; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zenvirt S, 2010, ONCOGENE, V29, P6149, DOI 10.1038/onc.2010.343; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	50	101	105	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	13					1661	1672		10.1038/onc.2011.358	http://dx.doi.org/10.1038/onc.2011.358			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21841818				2022-12-25	WOS:000302231400005
J	Garstka, MA; Fritzsche, S; Lenart, I; Hein, Z; Jankevicius, G; Boyle, LH; Elliott, T; Trowsdale, J; Antoniou, AN; Zacharias, M; Springer, S				Garstka, Malgorzata Anna; Fritzsche, Susanne; Lenart, Izabela; Hein, Zeynep; Jankevicius, Gytis; Boyle, Louise H.; Elliott, Tim; Trowsdale, John; Antoniou, Antony N.; Zacharias, Martin; Springer, Sebastian			Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility	FASEB JOURNAL			English	Article						peptide binding; quality control; ligand binding; natively unstructured proteins	PEPTIDE-BINDING; ENDOPLASMIC-RETICULUM; TAP COMPLEX; HETERODIMER; DYNAMICS; PATHWAY; IMMUNODOMINANCE; TRANSPORTERS; ASSOCIATION; SIMULATION	Major histocompatibility complex (MHC) class I molecules present cell internally derived peptides at the plasma membrane for surveillance by cytotoxic T lymphocytes. The surface expression of most class I molecules at least partially depends on the endoplasmic reticulum protein, tapasin, which helps them to bind peptides of the right length and sequence. To determine what makes a class I molecule dependent on support by tapasin, we have conducted in silico molecular dynamics (MD) studies and laboratory experiments to assess the conformational state of tapasin-dependent and -independent class I molecules. We find that in the absence of peptide, the region around the F pocket of the peptide binding groove of the tapasin-dependent molecule HLA-B*44:02 is in a disordered conformational state and that it is converted to a conformationally stable state by tapasin. This novel chaperone function of tapasin has not been described previously. We demonstrate that the disordered state of class I is caused by the presence of two adjacent acidic residues in the bottom of the F pocket of class I, and we suggest that conformational disorder is a common feature of tapasin-dependent class I molecules, making them essentially unable to bind peptides on their own. MD simulations are a useful tool to predict such conformational disorder of class I molecules.-Garstka, M. A., Fritzsche, S., Lenart, I., Hein, Z., Jankevicius, G., Boyle, L. H., Elliott, T., Trowsdale, J., Antoniou, A. N., Zacharias, M., Springer, S. Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. FASEB J. 25, 3989-3998 (2011). www.fasebj.org	[Garstka, Malgorzata Anna; Fritzsche, Susanne; Hein, Zeynep; Jankevicius, Gytis; Springer, Sebastian] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Lenart, Izabela; Antoniou, Antony N.] UCL, Dept Immunol & Mol Pathol, London, England; [Boyle, Louise H.; Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Elliott, Tim] Univ Southampton, Sch Med, Southampton, Hants, England; [Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Munich, Germany	Jacobs University; University of London; University College London; University of Cambridge; University of Southampton; Technical University of Munich	Springer, S (corresponding author), Jacobs Univ Bremen, Campus Ring 1, D-28759 Bremen, Germany.	sebastian.springer@queens.oxon.org	Boyle, Louise/AFU-1885-2022; Jankevicius, Gytis/C-7126-2015; Springer, Sebastian/AAJ-7036-2021; Garstka, Malgorzata A./AAU-4401-2020	Jankevicius, Gytis/0000-0002-0212-3923; Springer, Sebastian/0000-0002-5527-6149; Garstka, Malgorzata A./0000-0003-2896-7275; Elliott, Tim/0000-0003-1097-0222; Boyle, Louise/0000-0002-3105-6555; Antoniou, Antony/0000-0002-6536-7781	Deutsche Forschungsgemeinschaft [SP583/2-3]; Fritz Thyssen Foundation; Arthritis Research UK [15293, 17868]; Wellcome Trust; Cancer Research UK; Versus Arthritis [18440] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Foundation; Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	The authors thank Tobias Dick and Lars Ellgaard for discussions; Peter van Endert (Universite Paris Descartes, Paris, France), Robert Tampe (Biocenter, Frankfurt University, Frankfurt, Germany), Ping Wang (University of London, London, UK), and David Williams (University of Toronto, Toronto, ON, Canada) for reagents; and Ute Claus and Ursula Wellbrock for technical assistance. The work was supported by the Deutsche Forschungsgemeinschaft (SP583/2-3 to S.S.), the Fritz Thyssen Foundation (Z.H.), Arthritis Research UK (fellowship 15293 to A.N.A. and studentship 17868 to I.L.), the Wellcome Trust (L.B. and J.T.), and Cancer Research UK (T.E.).	Boulanger DSM, 2010, J IMMUNOL, V184, P73, DOI 10.4049/jimmunol.0803489; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; CASE DA, 2004, AMBER 8; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; FRECH C, 1995, J MOL BIOL, V251, P135, DOI 10.1006/jmbi.1995.0421; Fussell H, 2008, ARTHRITIS RHEUM, V58, P3419, DOI 10.1002/art.23990; Garstka M, 2007, J BIOL CHEM, V282, P30680, DOI 10.1074/jbc.M701721200; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Neisig A, 1996, J IMMUNOL, V156, P3196; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Powis SJ, 2009, J IMMUNOL METHODS, V340, P81, DOI 10.1016/j.jim.2008.09.006; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Sandhu KS, 2007, PROTEINS, V68, P109, DOI 10.1002/prot.21328; Schneeweiss C, 2009, MOL IMMUNOL, V46, P2054, DOI 10.1016/j.molimm.2009.02.032; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; STAM NJ, 1986, J IMMUNOL, V137, P2299; Thammavongsa V, 2006, J IMMUNOL, V177, P3150, DOI 10.4049/jimmunol.177.5.3150; Thirdborough SM, 2008, EUR J IMMUNOL, V38, P364, DOI 10.1002/eji.200737832; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Van Hateren A, 2010, TISSUE ANTIGENS, V76, P428, DOI 10.1111/j.1399-0039.2010.01577.x; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yaneva R, 2010, MOL IMMUNOL, V47, P649, DOI 10.1016/j.molimm.2009.10.008; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	42	59	59	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3989	3998		10.1096/fj.11-190249	http://dx.doi.org/10.1096/fj.11-190249			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21836024	Bronze			2022-12-25	WOS:000296723100023
J	Hamdane, D; Argentini, M; Cornu, D; Myllykallio, H; Skouloubris, S; Hui-Bon-Hoa, G; Golinelli-Pimpaneau, B				Hamdane, Djemel; Argentini, Manuela; Cornu, David; Myllykallio, Hannu; Skouloubris, Stephane; Hui-Bon-Hoa, Gaston; Golinelli-Pimpaneau, Beatrice			Insights into Folate/FAD-dependent tRNA Methyltransferase Mechanism ROLE OF TWO HIGHLY CONSERVED CYSTEINES IN CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-PRESSURE CRYSTALLOGRAPHY; HYDROSTATIC-PRESSURE; THYMIDYLATE SYNTHASE; CYSTEINE RESIDUES; BACILLUS-SUBTILIS; NMR-SPECTROSCOPY; PROTEINS MNME; SUBSTRATE; GIDA; IDENTIFICATION	The flavoprotein TrmFO methylates specifically the C5 carbon of the highly conserved uridine 54 in tRNAs. Contrary to most methyltransferases, the 1- carbon unit transferred by TrmFO derives from 5,10-methylenetetrahydrofolate and not from S-adenosyl-L-methionine. The enzyme also employs the FAD hydroquinone as a reducing agent of the C5 methylene U54-tRNA intermediate in vitro. By analogy with the catalytic mechanism of thymidylate synthase ThyA, a conserved cysteine located near the FAD isoalloxazine ring was proposed to act as a nucleophile during catalysis. Here, we mutated this residue(Cys-53 in Bacillus subtilis TrmFO) to alanine and investigated its functional role. Biophysical characterization of this variant demonstrated the major structural role of Cys-53 in maintaining both the integrity and plasticity of the flavin binding site. Unexpectedly, gel mobility shift assays showed that, like the wild-type enzyme, the inactive C53A variant was capable of forming a covalent complex with a 5-fluorouridine-containing mini-RNA. This result confirms the existence of a covalent intermediate during catalysis but rules out a nucleophilic role for Cys-53. To identify the actual nucleophile, two other strictly conserved cysteines (Cys-192 and Cys-226) that are relatively far from the active site were replaced with alanine, and a double mutant C53A/C226A was generated. Interestingly, only mutations that target Cys-226 impeded TrmFO from forming a covalent complex and methylating tRNA. Altogether, we propose a revised mechanism for the m(5)U54 modification catalyzed by TrmFO, where Cys-226 attacks the C6 atom of the uridine, and Cys-53 plays the role of the general base abstracting the C5 proton.	[Golinelli-Pimpaneau, Beatrice] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Argentini, Manuela; Cornu, David] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; [Myllykallio, Hannu; Skouloubris, Stephane] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci, F-91128 Palaiseau, France; [Hui-Bon-Hoa, Gaston] INSERM, U779, F-94275 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)		hamdane@lebs.cnrs-gif.fr; beatrice.golinelli@lebs.cnrs-gif.fr	Golinelli, Beatrice/ABB-8347-2021; Myllykallio, Hannu/Y-5462-2019	Golinelli, Beatrice/0000-0001-8248-4704; Skouloubris, Stephane/0000-0001-6660-0023; Myllykallio, Hannu/0000-0002-0541-1197	Agence Nationale de la Recherche [PCV07_189094]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by THYMET Grant PCV07_189094 from the Agence Nationale de la Recherche and by CNRS.	Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d; Collins MD, 2007, J MOL BIOL, V367, P752, DOI 10.1016/j.jmb.2006.12.021; Collins MD, 2005, P NATL ACAD SCI USA, V102, P16668, DOI 10.1073/pnas.0508224102; Day R, 2008, PROTEINS, V70, P1175, DOI 10.1002/prot.21562; DELK AS, 1980, J BIOL CHEM, V255, P4387; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020; Geddes CD, 2001, ANAL BIOCHEM, V293, P60, DOI 10.1006/abio.2001.5103; Girard E, 2010, BIOPHYS J, V98, P2365, DOI 10.1016/j.bpj.2010.01.058; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; Guelorget A, 2011, STRUCTURE, V19, P282, DOI 10.1016/j.str.2011.01.005; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Hamdane D, 2011, BIOCHEMISTRY-US, V50, P5208, DOI 10.1021/bi1019463; Hamdane D, 2010, PROTEIN EXPRES PURIF, V73, P83, DOI 10.1016/j.pep.2010.04.013; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; JUNG C, 1995, EUR J BIOCHEM, V233, P600, DOI 10.1111/j.1432-1033.1995.600_2.x; Kamatari YO, 2001, EUR J BIOCHEM, V268, P1782, DOI 10.1046/j.1432-1327.2001.02050.x; KEALEY JT, 1995, BIOCHEMISTRY-US, V34, P2441, DOI 10.1021/bi00008a006; KEALEY JT, 1991, BIOCHEMISTRY-US, V30, P9724, DOI 10.1021/bi00104a022; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; Koehn EM, 2009, NATURE, V458, P919, DOI 10.1038/nature07973; KUNDROT CE, 1988, J MOL BIOL, V200, P401, DOI 10.1016/0022-2836(88)90249-5; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Liu YQ, 2000, P NATL ACAD SCI USA, V97, P8263, DOI 10.1073/pnas.97.15.8263; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nakanishi K, 2009, NATURE, V461, P1144, DOI 10.1038/nature08474; Nishimasu H, 2009, P NATL ACAD SCI USA, V106, P8180, DOI 10.1073/pnas.0901330106; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Phannachet K, 2004, NUCLEIC ACIDS RES, V32, P1422, DOI 10.1093/nar/gkh287; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Seif E, 2009, J BIOL CHEM, V284, P6600, DOI 10.1074/jbc.C800235200; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Urayama P, 2002, STRUCTURE, V10, P51, DOI 10.1016/S0969-2126(01)00699-2; Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703; von Ehrenstein G, 1967, METHOD ENZYMOL, V12, P588; Walbott H, 2007, RNA, V13, P967, DOI 10.1261/rna.515707; Wilton DJ, 2008, PROTEINS, V71, P1432, DOI 10.1002/prot.21832; Wilton DJ, 2009, BIOPHYS J, V97, P1482, DOI 10.1016/j.bpj.2009.06.022; Winter R, 2002, BBA-PROTEIN STRUCT M, V1595, P160, DOI 10.1016/S0167-4838(01)00342-9; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zhang HM, 2009, J BIOL CHEM, V284, P25678, DOI 10.1074/jbc.M109.032748	54	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36268	36280		10.1074/jbc.M111.256966	http://dx.doi.org/10.1074/jbc.M111.256966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846722	Green Published, hybrid			2022-12-25	WOS:000296538300011
J	Harper, CB; Martin, S; Nguyen, TH; Daniels, SJ; Lavidis, NA; Popoff, MR; Hadzic, G; Mariana, A; Chau, N; McCluskey, A; Robinson, PJ; Meunier, FA				Harper, Callista B.; Martin, Sally; Nguyen, Tam H.; Daniels, Shari J.; Lavidis, Nickolas A.; Popoff, Michel R.; Hadzic, Gordana; Mariana, Anna; Chau, Ngoc; McCluskey, Adam; Robinson, Phillip J.; Meunier, Frederic A.			Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILIZED CHROMAFFIN CELLS; SMALL-MOLECULE INHIBITORS; MOTOR-NERVE TERMINALS; TOXIN TYPE-A; SYNAPTIC VESICLES; PROTEIN-RECEPTOR; NEUROTRANSMITTER RELEASE; MULTIVESICULAR BODIES; MEDIATED ENDOCYTOSIS; BIOLOGICAL WEAPON	The botulinum neurotoxins (BoNTs) are di-chain bacterial proteins responsible for the paralytic disease botulism. Following binding to the plasma membrane of cholinergic motor nerve terminals, BoNTs are internalized into an endocytic compartment. Although several endocytic pathways have been characterized in neurons, the molecular mechanism underpinning the uptake of BoNTs at the presynaptic nerve terminal is still unclear. Here, a recombinant BoNT/A heavy chain binding domain (Hc) was used to unravel the internalization pathway by fluorescence and electron microscopy. BoNT/A-Hc initially enters cultured hippocampal neurons in an activity-dependent manner into synaptic vesicles and clathrin-coated vesicles before also entering endosomal structures and multivesicular bodies. We found that inhibiting dynamin with the novel potent Dynasore analog, Dyngo-4a (TM), was sufficient to abolish BoNT/A-Hc internalization and BoNT/A-induced SNAP25 cleavage in hippocampal neurons. Dyngo-4a also interfered with BoNT/A-Hc internalization into motor nerve terminals. Furthermore, Dyngo-4a afforded protection against BoNT/A-induced paralysis at the rat hemidiaphragm. A significant delay of >30% in the onset of botulism was observed in mice injected with Dyngo-4a. Dynamin inhibition therefore provides a therapeutic avenue for the treatment of botulism and other diseases caused by pathogens sharing dynamin-dependent uptake mechanisms.	[Harper, Callista B.; Martin, Sally; Nguyen, Tam H.; Daniels, Shari J.; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lavidis, Nickolas A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75724 Paris, France; [Hadzic, Gordana; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Mariana, Anna; Chau, Ngoc; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2145, Australia	University of Queensland; University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	f.meunier@uq.edu.au	Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011; Martin, Sally/A-7150-2010; Meunier, Frederic A/C-8161-2009; Nguyen, Tam/H-3423-2011; Popoff, Michel/O-7719-2016	Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X; Martin, Sally/0000-0001-9294-5404; Meunier, Frederic A/0000-0001-6400-1107; Popoff, Michel/0000-0001-9305-8989	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council. Dyngo-4a (TM) and Dyngo (TM) are trademarks of the authors' institutions and affiliates, the Children's Medical Research Institute and Newcastle Innovation, Ltd. (the commercial arm of the University of Newcastle), which have entered into a commercial license agreement with Ascent Scientific, Ltd. (Bristol, United Kingdom) to market and distribute Dyngo-4a as a research tool globally.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BLACK JD, 1986, J CELL BIOL, V103, P521, DOI 10.1083/jcb.103.2.521; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Chen S, 2011, J BIOL CHEM, V286, P15067, DOI 10.1074/jbc.M111.224493; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Couesnon A, 2009, CELL MICROBIOL, V11, P289, DOI 10.1111/j.1462-5822.2008.01253.x; Darios F, 2010, P NATL ACAD SCI USA, V107, P18197, DOI 10.1073/pnas.1007125107; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Foran PG, 2003, TRENDS MOL MED, V9, P291, DOI 10.1016/S1471-4914(03)00113-8; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Hill T, 2005, J MED CHEM, V48, P7781, DOI 10.1021/jm040208l; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2010, J MED CHEM, V53, P4094, DOI 10.1021/jm100119c; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Lawrence GW, 1996, EUR J BIOCHEM, V236, P877, DOI 10.1111/j.1432-1033.1996.00877.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meunier FA, 2000, J CELL SCI, V113, P1119; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Meunier FA, 2003, MOL CELL NEUROSCI, V22, P454, DOI 10.1016/S1044-7431(02)00016-7; Meunier FA, 1997, NEUROSCIENCE, V78, P883, DOI 10.1016/S0306-4522(96)00568-4; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Odell LR, 2010, J MED CHEM, V53, P5267, DOI 10.1021/jm100442u; Osborne SL, 2007, J NEUROSCI RES, V85, P1149, DOI 10.1002/jnr.21171; Pang YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010129; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Raciborska DA, 1999, CAN J PHYSIOL PHARM, V77, P679, DOI 10.1139/cjpp-77-9-679; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LL, 1973, NEUROPHARMACOLOGY, V12, P165, DOI 10.1016/0028-3908(73)90085-3; SIMPSON LL, 1971, J NEUROCHEM, V18, P1751, DOI 10.1111/j.1471-4159.1971.tb03750.x; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1981, J CELL BIOL, V90, P533, DOI 10.1083/jcb.90.2.533; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	71	113	119	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35966	35976		10.1074/jbc.M111.283879	http://dx.doi.org/10.1074/jbc.M111.283879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832053	Green Published, hybrid			2022-12-25	WOS:000295927100070
J	Lee, HJ; Lairson, LL; Rich, JR; Lameignere, E; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lee, Ho Jun; Lairson, Luke L.; Rich, Jamie R.; Lameignere, Emilie; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structural and Kinetic Analysis of Substrate Binding to the Sialyltransferase Cst-II from Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUILLAIN-BARRE-SYNDROME; SIALIC ACIDS; N-ACETYLGLUCOSAMINE; NEISSERIA-MENINGITIDIS; GANGLIOSIDE MIMICS; MECHANISM; ACCEPTOR; GLYCOSYLTRANSFERASE; BIOSYNTHESIS; SPECIFICITY	Background: The transfer of sialic acids is catalyzed by a set of sialyltransferases with defined specificities. Results: We solved the ternary complex of the sialyltransferase Cst-II and kinetically characterized its mechanism. Conclusion: Our analysis gives insights into the acceptor specificity and proposes the iso-ordered Bi Bi mechanism. Significance: This work improves our understanding of sialyltransferase structure/function.	[Lee, Ho Jun; Lameignere, Emilie; Withers, Stephen G.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lairson, Luke L.; Rich, Jamie R.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Lee, Ho Jun; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Strynadka, Natalie C. J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Withers, Stephen G.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Lairson, Luke/0000-0001-6701-996X	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; Canada Foundation for Innovation; B.C. Knowledge Development Fund; Kwanjeong Educational Foundation (Republic of Korea); University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); B.C. Knowledge Development Fund; Kwanjeong Educational Foundation (Republic of Korea); University of British Columbia	This work was supported in part by operating grants from the Canadian Institutes of Health Research (to N. C. J. S., W. W. W., and S. G. W.) and the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.), with infrastructure funding from the Michael Smith Foundation for Health Research, the Canada Foundation for Innovation, and the B.C. Knowledge Development Fund.; Supported by scholarships from the Kwanjeong Educational Foundation (Republic of Korea) and the University of British Columbia. Present address: Dept. of Molecular and Cell Biology, University of California, 356 Stanley Hall, Berkeley, CA 94720.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Chen L, 2002, BIOCHEMISTRY-US, V41, P6824, DOI 10.1021/bi0256678; Chiu CPC, 2007, BIOCHEMISTRY-US, V46, P7196, DOI 10.1021/bi602543d; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, P99; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Fromm H. G., 1975, INITIAL RATE ENZYME, P121; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Ohrui H., 1988, European Patent, Patent No. [EP0281067A3, 0281067]; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Piszkiewicz D., 1977, KINETICS CHEM ENZYME, P131; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; RUDOLPH FB, 1971, J BIOL CHEM, V246, P6611; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Segel I. H., 1975, ENZYME KINETICS, P560; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SIMON ES, 1988, J AM CHEM SOC, V110, P7159, DOI 10.1021/ja00229a033; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; WRAGG S, 1995, J BIOL CHEM, V270, P16947, DOI 10.1074/jbc.270.28.16947; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	56	25	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35922	35932		10.1074/jbc.M111.261172	http://dx.doi.org/10.1074/jbc.M111.261172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832050	hybrid, Green Published			2022-12-25	WOS:000295927100066
J	Marfori, M; Kobe, B; Forwood, JK				Marfori, Mary; Kobe, Bostjan; Forwood, Jade K.			Ligand-induced Conformational Changes within a Hexameric Acyl-CoA Thioesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Acyl-coenzyme A (acyl-CoA) thioesterases play a crucial role in the metabolism of activated fatty acids, coenzyme A, and other metabolic precursor molecules including arachidonic acid and palmitic acid. These enzymes hydrolyze coenzyme A from acyl-CoA esters to mediate a range of cellular functions including beta-oxidation, lipid biosynthesis, and signal transduction. Here, we present the crystal structure of a hexameric hot-dog domain-containing acyl-CoA thioesterase from Bacillus halodurans in the apo-form and provide structural and comparative analyses to the coenzyme A-bound form to identify key conformational changes induced upon ligand binding. We observed dramatic ligand-induced changes at both the hot-dog dimer and the trimer-of-dimer interfaces; the dimer interfaces in the apo-structure differ by over 20% and decrease to about half the size in the ligand-bound state. We also assessed the specificity of the enzyme against a range of fatty acyl-CoA substrates and have identified a preference for short-chain fatty acyl-CoAs. Coenzyme A was shown both to negatively regulate enzyme activity, representing a direct inhibitory feedback, and consistent with the structural data, to destabilize the quaternary structure of the enzyme. Coenzyme A-induced conformational changes in the C-terminal helices of enzyme were assessed through mutational analysis and shown to play a role in regulating enzyme activity. The conformational changes are likely to be conserved from bacteria through to humans and provide a greater understanding, particularly at a structural level, of thioesterase function and regulation.	[Marfori, Mary; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Marfori, Mary; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia	University of Queensland; University of Queensland; University of Queensland; Charles Sturt University	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au; jforwood@csu.edu.au	Kobe, Bostjan/D-1292-2009; Forwood, Jade K/K-4123-2014	Kobe, Bostjan/0000-0001-9413-9166; Forwood, Jade K/0000-0003-3267-9997; Christie, Mary/0000-0002-0955-665X	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded in part by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC).	Adams SH, 2001, BIOCHEM J, V360, P135, DOI 10.1042/bj3600135; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mandel CR, 2009, BIOCHEM BIOPH RES CO, V385, P630, DOI 10.1016/j.bbrc.2009.05.122; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Serek R, 2006, ACTA CRYSTALLOGR F, V62, P133, DOI 10.1107/S1744309106000030; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; WELSCH CW, 1992, CANCER RES, V52, pS2040; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V308, P118, DOI 10.1006/abbi.1994.1017; Yokoyama T, 2009, BBA-PROTEINS PROTEOM, V1794, P1073, DOI 10.1016/j.bbapap.2009.03.002	19	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35643	35649		10.1074/jbc.M111.225953	http://dx.doi.org/10.1074/jbc.M111.225953			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849495	hybrid, Green Published			2022-12-25	WOS:000295927100036
J	Ahmed, AH; Wang, S; Chuang, HH; Oswald, RE				Ahmed, Ahmed H.; Wang, Shu; Chuang, Huai-Hu; Oswald, Robert E.			Mechanism of AMPA Receptor Activation by Partial Agonists DISULFIDE TRAPPING OF CLOSED LOBE CONFORMATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; SUBUNIT; CHANNEL; COMPLEX; CORE; S1S2; ANTAGONISTS; DYNAMICS	The mechanism by which agonist binding to an ionotropic glutamate receptor leads to channel opening is a central issue in molecular neurobiology. Partial agonists are useful tools for studying the activation mechanism because they produce full channel activation with lower probability than full agonists. Structural transitions that determine the efficacy of partial agonists can provide information on the trigger that begins the channel-opening process. The ligand-binding domain of AMPA receptors is a bilobed structure, and the closure of the lobes is associated with channel activation. One possibility is that partial agonists sterically block full lobe closure but that partial degrees of closure trigger the channel with a lower probability. Alternatively, full lobe closure may be required for activation, and the stability of the fully closed state could determine efficacy with the fully closed state having a lower stability when bound to partial relative to full agonists. Disulfide-trapping experiments demonstrated that even extremely low efficacy ligands such as 6-cyano-7-nitroquinoxaline-2,3-dione can produce a full lobe closure, presumably with low probability. The results are consistent the hypothesis that the efficacy is determined at least in part by the stability of the state in which the lobes are fully closed.	[Ahmed, Ahmed H.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Wang, Shu; Chuang, Huai-Hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14850 USA.	reo1@cornell.edu			National Institutes of Health [R01-GM068935]; National Science Foundation [DMR 0225180]; National Institutes of Health through National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM068935. This work was also supported in part by research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by National Science Foundation Award DMR 0225180, and by using the Macromolecular Diffraction at the CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646, through its National Center for Research Resources.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Goddard T.D., SPARKY 3; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2003, BIOCHEMISTRY-US, V42, P5201, DOI 10.1021/bi020632t; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kussius CL, 2010, J NEUROSCI, V30, P12474, DOI 10.1523/JNEUROSCI.3337-10.2010; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35257	35266		10.1074/jbc.M111.269001	http://dx.doi.org/10.1074/jbc.M111.269001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846932	Green Published, hybrid			2022-12-25	WOS:000295406300078
J	Iozzo, RV; Buraschi, S; Genua, M; Xu, SQ; Solomides, CC; Peiper, SC; Gomella, LG; Owens, RC; Morrione, A				Iozzo, Renato V.; Buraschi, Simone; Genua, Marco; Xu, Shi-Qiong; Solomides, Charalambos C.; Peiper, Stephen C.; Gomella, Leonard G.; Owens, Rick C.; Morrione, Andrea			Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; LEUCINE-RICH PROTEOGLYCANS; CANCER-CELLS; TUMOR MICROENVIRONMENT; DOWN-REGULATION; INSULIN; BLADDER; PROTEINS; TRANSFORMATION; DEGRADATION	We have recently discovered that the insulin-like growth factor receptor I (IGF-IR) is up-regulated in human invasive bladder cancer and promotes migration and invasion of transformed urothelial cells. The proteoglycan decorin, a key component of the tumor stroma, can positively regulate the IGF-IR system in normal cells. However, there are no available data on the role of decorin in modulating IGF-IR activity in transformed cells or in tumor models. Here we show that the expression of decorin inversely correlated with IGF-IR expression in low and high grade bladder cancers (n = 20 each). Decorin bound with high affinity IGF-IR and IGF-I at distinct sites and negatively regulated IGF-IR activity in urothelial cancer cells. Nanomolar concentrations of decorin promoted down-regulation of IRS-1, one of the critical proteins of the IGF-IR pathway, and attenuated IGF-I-dependent activation of Akt and MAPK. This led to decorin-evoked inhibition of migration and invasion upon IGF-I stimulation. Notably, decorin did not cause down-regulation of the IGF-IR in bladder, breast, and squamous carcinoma cells. This indicates that decorin action on the IGF-IR differs from its known activity on other receptor tyrosine kinases such as the EGF receptor and Met. Our results provide a novel mechanism for decorin in negatively modulating both IGF-I and its receptor. Thus, decorin loss may contribute to increased IGF-IR activity in the progression of bladder cancer and perhaps other forms of cancer where IGF-IR plays a role.	[Iozzo, Renato V.; Buraschi, Simone; Solomides, Charalambos C.; Peiper, Stephen C.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.; Buraschi, Simone; Solomides, Charalambos C.; Peiper, Stephen C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Genua, Marco; Xu, Shi-Qiong; Gomella, Leonard G.; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol & Endocrine Mech, Philadelphia, PA 19107 USA; [Genua, Marco; Xu, Shi-Qiong; Gomella, Leonard G.; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Hormone Act Program, Philadelphia, PA 19107 USA; [Owens, Rick C.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org; andrea.morrione@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Genua, Marco/J-4159-2018	Genua, Marco/0000-0002-0764-8163; Buraschi, Simone/0000-0002-4233-7627; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 DK068419, RO1 CA39481, RO1 CA47282, RO1 CA120975]; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA039481, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK068419 (to A. M.) and RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R. V. I.). This work was also supported by the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund.	Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 1999, J CELL BIOCHEM, P68; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Doerr ME, 1996, J BIOL CHEM, V271, P2443, DOI 10.1074/jbc.271.5.2443; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Le Roith D, 2000, GROWTH HORM IGF RES, V10, pS12, DOI 10.1016/S1096-6374(00)90005-4; Le Roith D, 1999, ISR MED ASSOC J, V1, P25; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Mauro L, 1999, EXP CELL RES, V252, P439, DOI 10.1006/excr.1999.4639; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Miyake H, 2005, BJU INT, V95, P987, DOI 10.1111/j.1464-410X.2005.05453.x; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nash MA, 1999, CANCER RES, V59, P6192; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Salani B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014157; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; SCHER CD, 1979, NATURE, V281, P390, DOI 10.1038/281390a0; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shintani K, 2008, ONCOL REP, V19, P1533; STILES CD, 1979, J CELL PHYSIOL, V99, P395, DOI 10.1002/jcp.1040990314; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	77	117	122	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34712	34721		10.1074/jbc.M111.262766	http://dx.doi.org/10.1074/jbc.M111.262766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840990	Green Published, hybrid			2022-12-25	WOS:000295406300025
J	Wilkinson, K; Boyd, JD; Glicksman, M; Moore, KJ; El Khoury, J				Wilkinson, Kim; Boyd, Justin D.; Glicksman, Marcie; Moore, Kathryn J.; El Khoury, Joseph			A High Content Drug Screen Identifies Ursolic Acid as an Inhibitor of Amyloid beta Protein Interactions with Its Receptor CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SCAVENGER RECEPTOR; HUMAN BRAIN; CLASS-B; INFLAMMATION; MICROGLIA; ASTROCYTES; EXPRESSION; MIGRATION; FIBRILS	A pathological hallmark of Alzheimer disease (AD) is deposition of amyloid beta (A beta) in the brain. A beta binds to microglia via a receptor complex that includes CD36 leading to production of proinflammatory cytokines and neurotoxic reactive oxygen species and subsequent neurodegeneration. Interruption of A beta binding to CD36 is a potential therapeutic strategy for AD. To identify pharmacologic inhibitors of A beta binding to CD36, we developed a 384-well plate assay for binding of fluorescently labeled A beta to Chinese hamster ovary cells stably expressing human CD36 (CHO-CD36) and screened an Food and Drug Administration-approved compound library. The assay was optimized based on the cells' tolerance to dimethyl sulfoxide, A beta concentration, time required for A beta binding, reproducibility, and signal-to-background ratio. Using this assay, we identified four compounds as potential inhibitors of A beta binding to CD36. These compounds were ursolic acid, ellipticine, zoxazolamine, and homomoschatoline. Of these compounds, only ursolic acid, a naturally occurring pentacyclic triterpenoid, successfully inhibited binding of A beta to CHO-CD36 cells in a dose-dependent manner. The ursolic acid effect reached a plateau at similar to 20 mu M, with a maximal inhibition of 64%. Ursolic acid also blocked binding of A beta to microglial cells and subsequent ROS production. Our data indicate that cell-based high-content screening of small molecule libraries for their ability to block binding of A beta to its receptors is a useful tool to identify novel inhibitors of receptors involved in AD pathogenesis. Our data also suggest that ursolic acid is a potential therapeutic agent for AD via its ability to block A beta-CD36 interactions.	[Wilkinson, Kim; El Khoury, Joseph] Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Boyd, Justin D.; Glicksman, Marcie] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Boston, MA 02139 USA; [Moore, Kathryn J.] NYU, Leon H Charney Div Cardiol, Dept Med, Med Ctr, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; New York University	El Khoury, J (corresponding author), Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	jelkhoury@partners.org	Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Boyd, Justin/0000-0002-5197-4724	National Institutes of Health through NINDS [NS059005]; National Institutes of Health through NIAID [AI U24AI082660]; National Institutes of Health through NIA [AG032349, AG020255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255, R01AG032349] Funding Source: NIH RePORTER	National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through NIA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059005 through the NINDS and AI U24AI082660 through the NIAID (to J. E. K.), AG032349 through the NIA (to J. E. K. and K. J. M.), and AG020255 through the NIA (to K. J. M.).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Echeverria V, 2010, J BIOMOL SCREEN, V15, P1144, DOI 10.1177/1087057110378890; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; ElKhoury J, 1996, NATURE, V382, P716; Giuliano KA, 2003, ASSAY DRUG DEV TECHN, V1, P565, DOI 10.1089/154065803322302826; Grant WB, 2004, ARCH NEUROL-CHICAGO, V61, P802, DOI 10.1001/archneur.61.5.802-b; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hill JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012958; Huh HY, 1996, BLOOD, V87, P2020; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kang SY, 2008, J PHARM PHARMACOL, V60, P1347, DOI 10.1211/jpp/60.10.0011; Manez S, 1997, EUR J PHARMACOL, V334, P103, DOI 10.1016/S0014-2999(97)01187-4; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Oakley RH, 2002, ASSAY DRUG DEV TECHN, V1, P21, DOI 10.1089/154065802761001275; Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4	24	68	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34914	34922		10.1074/jbc.M111.232116	http://dx.doi.org/10.1074/jbc.M111.232116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835916	hybrid, Green Published			2022-12-25	WOS:000295406300045
J	Milcarek, C; Albring, M; Langer, C; Park, KS				Milcarek, Christine; Albring, Michael; Langer, Creityeka; Park, Kyung Soo			The Eleven-Nineteen Lysine-rich Leukemia Gene (ELL2) Influences the Histone H3 Protein Modifications Accompanying the Shift to Secretory Immunoglobulin Heavy Chain mRNA Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; TRANSCRIPTION ELONGATION; PLASMA-CELLS; TERMINAL DOMAIN; HIV-1 TAT; COMPLEX; ACTIVATION; FUSION; MLL; PHOSPHORYLATION	In plasma cells, immunoglobulin heavy chain (IgH) secretory-specific mRNA is made in high abundance as a result of both increased promoter proximal poly(A) site choice and weak splice-site skipping. Ell2, the eleven-nineteen lysine rich leukemia gene, is a transcription elongation factor that is induced similar to 6-fold in plasma cells and has been shown to drive secretory-specific mRNA production. Reducing ELL2 by siRNA, which reduced processing to the secretion-specific poly(A) site, also influenced the methylations of histone H3K4 and H3K79 on the IgH gene and impacted positive transcription factor b (pTEFb), Ser-2 carboxyl-terminal phosphorylation, and polyadenylation factor additions to RNA polymerase II. The multiple lineage leukemia gene (MLL) and Dot1L associations with the IgH gene were also impaired in the absence of ELL2. To investigate the link between histone modifications, transcription elongation, and alternative RNA processing in IgH mRNA production, we performed chromatin immunoprecipitation on cultured mouse B and plasma cells bearing the identical IgH gamma 2a gene. In the plasma cells, as compared with the B cells, the H3K4 and H3K79 methylations extended farther downstream, past the IgH enhancer to the end of the transcribed region. Thus the downstream H3K4 and H3K79 methylation of the IgH associated chromatin in plasma cells is associated with increased polyadenylation and exon skipping, resulting from the actions of ELL2 transcription elongation factor.	[Milcarek, Christine; Albring, Michael; Langer, Creityeka; Park, Kyung Soo] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Milcarek, C (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	milcarek@pitt.edu			National Science Foundation [MCB-0842725]; National Institutes of Health [5T32 CA82084-12]; Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine; NATIONAL CANCER INSTITUTE [T32CA082084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Science Foundation Grant MCB-0842725 (to C. M.), National Institutes of Health Grant 5T32 CA82084-12 (to K. S. P.), and the Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GROSSCHEDL R, 1988, CELL, V55, P645, DOI 10.1016/0092-8674(88)90223-1; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Milcarek C, 1996, MOL IMMUNOL, V33, P691, DOI 10.1016/0161-5890(96)00009-0; Milcarek C., 2011, RNA PROCESS IN PRESS; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sen R, 2010, GENE DEV, V24, P973, DOI 10.1101/gad.1930610; Shell SA, 2007, J IMMUNOL, V179, P7663, DOI 10.4049/jimmunol.179.11.7663; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Sugiura N, 2004, EUR J BIOCHEM, V271, P4629, DOI 10.1111/j.1432-1033.2004.04414.x; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024	36	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33795	33803		10.1074/jbc.M111.272096	http://dx.doi.org/10.1074/jbc.M111.272096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832080	Green Published, hybrid			2022-12-25	WOS:000295159200010
J	Crona, M; Torrents, E; Rohr, AK; Hofer, A; Furrer, E; Tomter, AB; Andersson, KK; Sahlin, M; Sjoberg, BM				Crona, Mikael; Torrents, Eduard; Rohr, Asmund K.; Hofer, Anders; Furrer, Ernst; Tomter, Ane B.; Andersson, K. Kristoffer; Sahlin, Margareta; Sjoberg, Britt-Marie			NrdH-Redoxin Protein Mediates High Enzyme Activity in Manganese-reconstituted Ribonucleotide Reductase from Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-AMMONIAGENES; CRYSTAL-STRUCTURE; COFACTOR; SUBUNIT; REVEALS; SYSTEM; GROWTH; GENES; SITE	Bacillus anthracis is a severe mammalian pathogen encoding a class Ib ribonucleotide reductase (RNR). RNR is a universal enzyme that provides the four essential deoxyribonucleotides needed for DNA replication and repair. Almost all Bacillus spp. encode both class Ib and class III RNR operons, but the B. anthracis class III operon was reported to encode a pseudogene, and conceivably class Ib RNR is necessary for spore germination and proliferation of B. anthracis upon infection. The class Ib RNR operon in B. anthracis encodes genes for the catalytic NrdE protein, the tyrosyl radical metalloprotein NrdF, and the flavodoxin protein NrdI. The tyrosyl radical in NrdF is stabilized by an adjacent Mn-2(III) site (Mn-NrdF) formed by the action of the NrdI protein or by a Fe-2(III) site (Fe-NrdF) formed spontaneously from Fe2+ and O-2. In this study, we show that the properties of B. anthracis Mn-NrdF and Fe-NrdF are in general similar for interaction with NrdE and NrdI. Intriguingly, the enzyme activity of Mn-NrdF was approximately an order of magnitude higher than that of Fe-NrdF in the presence of the class Ib-specific physiological reductant NrdH, strongly suggesting that the Mn-NrdF form is important in the life cycle of B. anthracis. Whether the Fe-NrdF form only exists in vitro or whether the NrdF protein in B. anthracis is a true cambialistic enzyme that can work with either manganese or iron remains to be established.	[Crona, Mikael; Torrents, Eduard; Furrer, Ernst; Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden; [Torrents, Eduard] Inst Bioengn Catalonia, ES-08080 Barcelona, Spain; [Rohr, Asmund K.; Tomter, Ane B.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Stockholm University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Oslo; Umea University	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, Arrhenius Labs Nat Sci, Svante Arrhenius Vag 20C, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@molbio.su.se	Torrents, Eduard/C-7184-2008; Johnson, Michael D. L./B-4352-2012; Kjendseth, Åsmund Røhr/O-2543-2016	Torrents, Eduard/0000-0002-3010-1609; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Crona, Mikael/0000-0002-6420-6097; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Foundation; Swedish Research Council; Spanish Ministerio de Ciencia e Innovacion [PI081062]; ERA-NET PathoGenoMics; Ramon y Cajal program; EMBIO/MLS at the University of Oslo; Carl Trygger Foundation; Research Council of Norway [177661/V30]; Norwegian Cancer Society	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ERA-NET PathoGenoMics; Ramon y Cajal program(Spanish Government); EMBIO/MLS at the University of Oslo; Carl Trygger Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Swedish Cancer Foundation and the Swedish Research Council (to B.-M. S.), from the Fondo de Investigacion Sanitaria from the Spanish Ministerio de Ciencia e Innovacion (Grant PI081062), the ERA-NET PathoGenoMics, and the Ramon y Cajal program (to E. T.), from the EMBIO/MLS at the University of Oslo to (to angstrom. K. R.), from the Carl Trygger Foundation (to A. H.), and from the Research Council of Norway (Grants 177661/V30) and Norwegian Cancer Society (to K. K. A.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2010, PROTEIN ENG DES SEL, V23, P633, DOI 10.1093/protein/gzq035; Fieschi F, 1998, J BIOL CHEM, V273, P4329, DOI 10.1074/jbc.273.8.4329; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Hartig E, 2006, APPL ENVIRON MICROB, V72, P5260, DOI 10.1128/AEM.00599-06; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P865, DOI 10.1002/bit.260180608; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nord D, 2007, J BACTERIOL, V189, P5293, DOI 10.1128/JB.00234-07; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rohr A. K., 2010, THESIS U OSLO OSLO N; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2010, SCIENCE, V329, P1475, DOI 10.1126/science.1196347; Thelander L, 1978, Methods Enzymol, V51, P227; Tomter A. B., 2010, THESIS U OSLO OSLO N; Tomter AB, 2008, BIOCHEMISTRY-US, V47, P11300, DOI 10.1021/bi801212f; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Torrents E, 2003, MICROBIOL-SGM, V149, P1011, DOI 10.1099/mic.0.26133-0; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Yang FD, 1997, J BACTERIOL, V179, P6408, DOI 10.1128/jb.179.20.6408-6415.1997; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	41	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33053	33060		10.1074/jbc.M111.278119	http://dx.doi.org/10.1074/jbc.M111.278119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832039	Green Published, hybrid			2022-12-25	WOS:000294968800024
J	Thomas, CJ; Briknarova, K; Hilmer, JK; Movahed, N; Bothner, B; Sumida, JP; Tall, GG; Sprang, SR				Thomas, Celestine J.; Briknarova, Klara; Hilmer, Jonathan K.; Movahed, Navid; Bothner, Brian; Sumida, John P.; Tall, Gregory G.; Sprang, Stephen R.			The Nucleotide Exchange Factor Ric-8A Is a Chaperone for the Conformationally Dynamic Nucleotide-Free State of G alpha i1	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; HETEROTRIMERIC G-PROTEINS; SECONDARY STRUCTURE; HYDROGEN-EXCHANGE; ACTIVATION; MECHANISM; RECEPTOR; BINDING; GTP; STABILIZATION	Heterotrimeric G protein alpha subunits are activated upon exchange of GDP for GTP at the nucleotide binding site of G alpha, catalyzed by guanine nucleotide exchange factors (GEFs). In addition to transmembrane G protein-coupled receptors (GPCRs), which act on G protein heterotrimers, members of the family cytosolic proteins typified by mammalian Ric-8A are GEFs for Gi/q/12/13-class G alpha subunits. Ric-8A binds to G alpha.GDP, resulting in the release of GDP. The Ric-8A complex with nucleotide-free G alpha i1 is stable, but dissociates upon binding of GTP to G alpha i1. To gain insight into the mechanism of Ric-8A-catalyzed GDP release from G alpha i1, experiments were conducted to characterize the physical state of nucleotide-free G alpha i1 (hereafter referred to as G alpha i1[]) in solution, both as a monomeric species, and in the complex with Ric-8A. We found that Ric-8A-bound, nucleotide-free G alpha i1 is more accessible to trypsinolysis than G alpha i1.GDP, but less so than G alpha i1[] alone. The TROSY-HSQC spectrum of [N-15]G alpha i1[] bound to Ric-8A shows considerable loss of peak intensity relative to that of [N-15]G alpha i1.GDP. Hydrogen-deuterium exchange in G alpha i1[] bound to Ric-8A is 1.5-fold more extensive than in G alpha i1.GDP. Differential scanning calorimetry shows that both Ric-8A and G alpha i1.GDP undergo cooperative, irreversible unfolding transitions at 47 degrees and 52 degrees, respectively, while nucleotide-free G alpha i1 shows a broad, weak transition near 35 degrees. The unfolding transition for Ric-8A: G alpha i1[] is complex, with a broad transition that peaks at 50 degrees, suggesting that both Ric-8A and G alpha i1[] are stabilized within the complex, relative to their respective free states. The C-terminus of G alpha i1 is shown to be a critical binding element for Ric-8A, as is also the case for GPCRs, suggesting that the two types of GEF might promote nucleotide exchange by similar mechanisms, by acting as chaperones for the unstable and dynamic nucleotide-free state of G alpha.	[Thomas, Celestine J.; Briknarova, Klara; Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Briknarova, Klara] Univ Montana, Dept Chem & Biochem, Missoula, MT 59812 USA; [Hilmer, Jonathan K.; Movahed, Navid; Bothner, Brian] Montana State Univ, Prote & Mass Spectrometry Facil, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Sumida, John P.] Univ Washington, Seattle, WA 98195 USA; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, Rochester, NY 14642 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; Montana State University System; Montana State University Bozeman; University of Washington; University of Washington Seattle; University of Rochester	Thomas, CJ (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	Stephen.sprang@umontana.edu		Hilmer, Jonathan/0000-0002-1494-6353	National Institutes of Health [DK46371, RR16455, RR020185, RR24237, GM088242]; The Murdock Charitable Trust; Washington State Life Science [2496490]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237, P20RR020185, P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Murdock Charitable Trust; Washington State Life Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants DK46371 (to S.R.S.), RR16455, RR020185 and RR24237 (to B.B.), GM088242 to (G.G.T.), and The Murdock Charitable Trust (B.B.). Funding for Bioanalytical Pharmacy Core at the University of Washington's Center for the Intracellular Delivery of Biologics is provided by the Washington State Life Science Discovery Fund (grant number 2496490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Abdulaev NG, 2005, J BIOMOL NMR, V32, P31, DOI 10.1007/s10858-005-3340-5; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Anderson LL, 2005, PROTEIN PEPTIDE LETT, V12, P783, DOI 10.2174/0929866054864175; Anderson LL, 2005, J BIOL CHEM, V280, P31019, DOI 10.1074/jbc.M503690200; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLEMAN DE, 1994, J MOL BIOL, V238, P630, DOI 10.1006/jmbi.1994.1320; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cooper Nutley Wadwood, 2000, DIFFERENTIAL SCANNIN; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FERGUSON KM, 1991, METHOD ENZYMOL, V195, P188; Figueroa M, 2009, PROTEIN SCI, V18, P1139, DOI 10.1002/pro.124; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; GRIKO YV, 1994, J MOL BIOL, V235, P1318, DOI 10.1006/jmbi.1994.1085; HIGASHIJIMA T, 1991, METHOD ENZYMOL, V195, P321; Holdeman TC, 2001, J BIOMOL NMR, V21, P383, DOI 10.1023/A:1013334608913; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Lonhienne TG, 2009, J BIOL CHEM, V284, P22549, DOI 10.1074/jbc.M109.019935; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Privalov P L, 1986, Methods Enzymol, V131, P4; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	51	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23197	10.1371/journal.pone.0023197	http://dx.doi.org/10.1371/journal.pone.0023197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853086	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400030
J	Bagher-Ebadian, H; Jafari-Khouzani, K; Mitsias, PD; Lu, M; Soltanian-Zadeh, H; Chopp, M; Ewing, JR				Bagher-Ebadian, Hassan; Jafari-Khouzani, Kourosh; Mitsias, Panayiotis D.; Lu, Mei; Soltanian-Zadeh, Hamid; Chopp, Michael; Ewing, James R.			Predicting Final Extent of Ischemic Infarction Using Artificial Neural Network Analysis of Multi-Parametric MRI in Patients with Stroke	PLOS ONE			English	Article							TISSUE VIABILITY; DIFFUSION; PERFUSION; ABCIXIMAB; ALGORITHMS; THERAPY; VOLUME	In hemispheric ischemic stroke, the final size of the ischemic lesion is the most important correlate of clinical functional outcome. Using a set of acute-phase MR images (Diffusion-weighted - DWI, T-1-weighted - T1WI, T-2-weighted-T2WI, and proton density weighted - PDWI) for inputs, and the chronic T2WI at 3 months as an outcome measure, an Artificial Neural Network (ANN) was trained to predict the 3-month outcome in the form of a voxel-by-voxel forecast of the chronic T2WI. The ANN was trained and tested using 12 subjects (with 83 slices and 140218 voxels) using a leave-one-out cross-validation method with calculation of the Area Under the Receiver Operator Characteristic Curve (AUROC) for training, testing and optimization of the ANN. After training and optimization, the ANN produced maps of predicted outcome that were well correlated (r = 0.80, p<0.0001) with the T2WI at 3 months for all 12 patients. This result implies that the trained ANN can provide an estimate of 3-month ischemic lesion on T2WI in a stable and accurate manner (AUROC = 0.89).	[Bagher-Ebadian, Hassan; Mitsias, Panayiotis D.; Chopp, Michael; Ewing, James R.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Bagher-Ebadian, Hassan; Chopp, Michael; Ewing, James R.] Oakland Univ, Dept Phys, Rochester, MI USA; [Jafari-Khouzani, Kourosh; Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Diagnost Radiol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, CIPCE, Tehran, Iran; [Ewing, James R.] Wayne State Univ, Dept Physiol, Detroit, MI USA; [Ewing, James R.] Wayne State Univ, Dept Neurol, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Tehran; Wayne State University; Wayne State University	Bagher-Ebadian, H (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	ebadian@neurnis.neuro.hfh.edu	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856	National Institutes of Health [1-R03-NS061170]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS061170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health grant 1-R03-NS061170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2005, STROKE, V36, P880, DOI 10.1161/01.STR.0000157668.39374.56; Adams HP, 2000, STROKE, V31, P601; Albers GW, 1999, STROKE, V30, P2230, DOI 10.1161/01.STR.30.10.2230; [Anonymous], 2002, LEARNING KERNELS; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Bagher-Ebadian H, 2004, IEEE T NUCL SCI, V51, P184, DOI 10.1109/TNS.2003.823047; Bagher-Ebadian H, 2007, MAGN RESON MED, V58, P290, DOI 10.1002/mrm.21332; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; BISHOP CM, 1997, NEURAL NETWORKS PATT; Buscema M, 2002, SUBST USE MISUSE, V37, P1093, DOI 10.1081/JA-120004171; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Eckert B, 2005, STROKE, V36, P1160, DOI 10.1161/01.STR.0000165918.80812.1e; Elisseeff A, 2005, J MACH LEARN RES, V6, P55; Freeman J. A., 1991, NEURAL NETWORK ALGOR; Goutte C, 1997, NEURAL COMPUT, V9, P1245, DOI 10.1162/neco.1997.9.6.1245; Grandin CB, 2002, RADIOLOGY, V223, P361, DOI 10.1148/radiol.2232010673; Gurney K., 2018, INTRO NEURAL NETWORK; Hosseini-Ashrafi ME, 1999, PHYS MED BIOL, V44, P1513, DOI 10.1088/0031-9155/44/6/306; Jacobs MA, 2001, STROKE, V32, P950, DOI 10.1161/01.STR.32.4.950; Koga M, 2005, STROKE, V36, P2132, DOI 10.1161/01.STR.0000181066.23213.8f; Looney C.G., 1997, PATTERN RECOGN; Lu M, 2005, J MAGN RESON IMAGING, V21, P495, DOI 10.1002/jmri.20313; Luby M, 2008, NEURAL NETWORK MODEL; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Mitsias PD, 2004, AM J NEURORADIOL, V25, P1499; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Nguyen Viet Ha, 2008, Program and Proceedings of PPIC '08, Tokyo: Pan-Pacific Imaging Conference '08, P238; Nguyen VH, 2008, IMAGING SOC JAPAN, P238; Oppenheim C, 2001, STROKE, V32, P2486, DOI 10.1161/hs1101.098331; SAS Institute, 2008, SAS STAT US GUID; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1336, DOI 10.1038/sj.jcbfm.9600126; Soltanian-Zadeh H, 2007, CEREBROVASC DIS, V23, P91, DOI 10.1159/000097044; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; WINDHAM JP, 1988, J COMPUT ASSIST TOMO, V12, P1, DOI 10.1097/00004728-198801000-00001; Wu O, 2007, J CEREBR BLOOD F MET, V27, P196, DOI 10.1038/sj.jcbfm.9600328	40	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22626	10.1371/journal.pone.0022626	http://dx.doi.org/10.1371/journal.pone.0022626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853039	Green Published, gold			2022-12-25	WOS:000295454200015
J	Frere, CH; Prentis, PJ; Gilding, EK; Mudge, AM; Cruickshank, A; Godwin, ID				Frere, Celine H.; Prentis, Peter J.; Gilding, Edward K.; Mudge, Agnieszka M.; Cruickshank, Alan; Godwin, Ian D.			Lack of Low Frequency Variants Masks Patterns of Non-Neutral Evolution following Domestication	PLOS ONE			English	Article							SORGHUM-BICOLOR; SEED BANKS; SELECTION; BOTTLENECK; DIVERSITY; PROTEIN; TESTS	Detecting artificial selection in the genome of domesticated species can not only shed light on human history but can also be beneficial to future breeding strategies. Evidence for selection has been documented in domesticated species including maize and rice, but few studies have to date detected signals of artificial selection in the Sorghum bicolor genome. Based on evidence that domesticated S. bicolor and its wild relatives show significant differences in endosperm structure and quality, we sequenced three candidate seed storage protein (kafirin) loci and three candidate starch biosynthesis loci to test whether these genes show non-neutral evolution resulting from the domestication process. We found strong evidence of non-neutral selection at the starch synthase IIa gene, while both starch branching enzyme I and the beta kafirin gene showed weaker evidence of non-neutral selection. We argue that the power to detect consistent signals of non-neutral selection in our dataset is confounded by the absence of low frequency variants at four of the six candidate genes. A future challenge in the detection of positive selection associated with domestication in sorghum is to develop models that can accommodate for skewed frequency spectrums.	[Frere, Celine H.; Prentis, Peter J.; Gilding, Edward K.; Mudge, Agnieszka M.; Godwin, Ian D.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Prentis, Peter J.] Queensland Univ Technol, Biogeosci Discipline, Brisbane, Qld 4001, Australia; [Cruickshank, Alan] Agri Sci Queensland, Dept Employment Econ Dev & Innovat, Warwick, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Queensland Department of Agriculture & Fisheries	Frere, CH (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	c.frere@uq.edu.au	Frere, Celine Henria/B-4905-2013; Cruickshank, Alan W/C-9654-2011; Gilding, Edward/A-8630-2011; Prentis, Peter/C-8729-2011; Godwin, Ian D/A-7498-2008; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; Cruickshank, Alan W/0000-0002-7982-1746; Gilding, Edward/0000-0003-1720-1282; Godwin, Ian D/0000-0002-4006-4426; Prentis, Peter/0000-0001-6587-8875	Pork CRC; Australian Research Council [DP0986043, LP0883808]	Pork CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council(Australian Research Council)	This study was funded by the Pork CRC and the Australian Research Council grant numbers DP0986043 and LP0883808. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Casa AM, 2006, CROP SCI, V46, pS27, DOI 10.2135/cropsci2006.0001tpg; CHANDRASHEKAR A, 1988, CEREAL CHEM, V65, P457; Darwin C., 1877, DIFFERENT FORMS FLOW; Dillon SL, 2007, PLANT SYST EVOL, V268, P29, DOI 10.1007/s00606-007-0571-9; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; Fay JC, 2000, GENETICS, V155, P1405; Figueiredo LFD, 2008, GENETICS, V179, P997, DOI 10.1534/genetics.108.087312; Guo JA, 2010, ANN BOT-LONDON, V106, P505, DOI 10.1093/aob/mcq125; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; HAMBLIN MT, 2007, PL GEN; Heidari Mostafa, 2009, Asian Journal of Plant Sciences, V8, P240, DOI 10.3923/ajps.2009.240.244; HOUSE LR, 1985, INT CROPS RES I SEMI; HOWARTH CJ, 1994, J EXP BOT, V45, P1353, DOI 10.1093/jxb/45.10.1353; HUDSON RR, 1987, GENETICS, V116, P153; Jordan DR, 1998, EUPHYTICA, V102, P1, DOI 10.1023/A:1018311908636; JORDAN DR, CROP SCI IN PRESS; Laidlaw HKC, 2010, THEOR APPL GENET, V121, P1227, DOI 10.1007/s00122-010-1383-9; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lindeboom N, 2004, STARCH-STARKE, V56, P89, DOI 10.1002/star.200300218; MARAMBE B, 1995, J AGRON CROP SCI, V174, P291, DOI 10.1111/j.1439-037X.1995.tb01115.x; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Nei M., 1987, MOL EVOLUTIONARY GEN; Prada D, 2009, J EXP BOT, V60, P2541, DOI 10.1093/jxb/erp130; Przeworski M, 2002, GENETICS, V160, P1179; REDDY BVS, 2006, GENETIC RESOURCES CH, P309; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Serna-Saldivar S., 1995, SORGHUM MILLETS CHEM, P69; Shapter F. M., 2008, Plant Genetic Resources Characterization and Utilization, V6, P85, DOI 10.1017/S1479262108986512; Sigmon B, 2010, MOL ECOL, V19, P1296, DOI 10.1111/j.1365-294X.2010.04562.x; TAJIMA F, 1989, GENETICS, V123; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tao YZ, 2000, THEOR APPL GENET, V100, P1225, DOI 10.1007/s001220051428; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; YI P, 2010, BMC EVOL BIOL; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231; Zhang GY, 1998, CEREAL CHEM, V75, P710, DOI 10.1094/CCHEM.1998.75.5.710	47	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23041	10.1371/journal.pone.0023041	http://dx.doi.org/10.1371/journal.pone.0023041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853065	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200036
J	Mongrain, V; Carrier, J; Paquet, J; Belanger-Nelson, E; Dumont, M				Mongrain, Valerie; Carrier, Julie; Paquet, Jean; Belanger-Nelson, Erika; Dumont, Marie			Morning and Evening-Type Differences in Slow Waves during NREM Sleep Reveal Both Trait and State-Dependent Phenotypes	PLOS ONE			English	Article							CORTICAL SYNCHRONIZATION; EEG; HOMEOSTASIS; OSCILLATIONS; PRESSURE; NIGHT; ADOLESCENTS; MODULATION; DENSITY; RHYTHMS	Brain recovery after prolonged wakefulness is characterized by increased density, amplitude and slope of slow waves (SW, < 4 Hz) during non-rapid eye movement (NREM) sleep. These SW comprise a negative phase, during which cortical neurons are mostly silent, and a positive phase, in which most neurons fire intensively. Previous work showed, using EEG spectral analysis as an index of cortical synchrony, that Morning-types (M-types) present faster dynamics of sleep pressure than Evening-types (E-types). We thus hypothesized that single SW properties will also show larger changes in M-types than in E-types in response to increased sleep pressure. SW density (number per minute) and characteristics (amplitude, slope between negative and positive peaks, frequency and duration of negative and positive phases) were compared between chronotypes for a baseline sleep episode (BL) and for recovery sleep (REC) after two nights of sleep fragmentation. While SW density did not differ between chronotypes, M-types showed higher SW amplitude and steeper slope than E-types, especially during REC. SW properties were also averaged for 3 NREM sleep periods selected for their decreasing level of sleep pressure (first cycle of REC [REC1], first cycle of BL [BL1] and fourth cycle of BL [BL4]). Slope was significantly steeper in M-types than in E-types in REC1 and BL1. SW frequency was consistently higher and duration of positive and negative phases constantly shorter in M-types than in E-types. Our data reveal that specific properties of cortical synchrony during sleep differ between M-types and E-types, although chronotypes show a similar capacity to generate SW. These differences may involve 1) stable trait characteristics independent of sleep pressure (i.e., frequency and durations) likely linked to the length of silent and burst-firing phases of individual neurons, and 2) specific responses to increased sleep pressure (i.e., slope and amplitude) expected to depend on the synchrony between neurons.	[Mongrain, Valerie; Carrier, Julie; Paquet, Jean; Belanger-Nelson, Erika; Dumont, Marie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Mongrain, Valerie; Dumont, Marie] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Carrier, Julie] Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Mongrain, V (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	valerie.mongrain@umontreal.ca	Mongrain, Valérie/A-3931-2012	Carrier, Julie/0000-0001-5311-2370	CIHR [MOP-68878, MOP-93733]; NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by CIHR grants to MD (MOP-68878) and JC (MOP-93733) (http://www.cihr-irsc.gc.ca/) and NSERC fellowships to VM (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2000, ACTA NEUROBIOL EXP, V60, P229; Bersagliere A, 2010, J SLEEP RES, V19, P228, DOI 10.1111/j.1365-2869.2009.00775.x; Brunner DP, 1996, J SLEEP RES, V5, P155, DOI 10.1046/j.1365-2869.1996.00009.x; Cajochen C, 1999, Sleep Res Online, V2, P65; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Feinberg I, 2003, SLEEP, V26, P192, DOI 10.1093/sleep/26.2.192; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Huber R, 2000, J NEUROPHYSIOL, V84, P1888, DOI 10.1152/jn.2000.84.4.1888; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Kurth S, 2010, SLEEP, V33, P475, DOI 10.1093/sleep/33.4.475; LANCEL M, 1991, PHYSIOL BEHAV, V49, P1195, DOI 10.1016/0031-9384(91)90351-N; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Misgeld U, 2007, PROG BRAIN RES, V160, P245, DOI 10.1016/S0079-6123(06)60014-9; Mongrain V, 2006, EUR J NEUROSCI, V23, P497, DOI 10.1111/j.1460-9568.2005.04561.x; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Mongrain V, 2007, SLEEP, V30, P773, DOI 10.1093/sleep/30.6.773; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Taillard J, 2003, J SLEEP RES, V12, P275, DOI 10.1046/j.0962-1105.2003.00369.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22679	10.1371/journal.pone.0022679	http://dx.doi.org/10.1371/journal.pone.0022679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829643	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200026
J	Sathuluri, RR; Yoshikawa, H; Shimizu, E; Saito, M; Tamiya, E				Sathuluri, Ramachandra Rao; Yoshikawa, Hiroyuki; Shimizu, Eiichi; Saito, Masato; Tamiya, Eiichi			Gold Nanoparticle-Based Surface-Enhanced Raman Scattering for Noninvasive Molecular Probing of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							SINGLE-MOLECULE; LIVE CELLS; SPECTROSCOPY; SERS; MITOCHONDRIA; DYNAMICS; FATE; PH	This study reports the use of gold nanoparticle-based surface-enhanced Raman scattering (SERS) for probing the differentiation of mouse embryonic stem (mES) cells, including undifferentiated single cells, embryoid bodies (EBs), and terminally differentiated cardiomyocytes. Gold nanoparticles (GNPs) were successfully delivered into all 3 mES cell differentiation stages without affecting cell viability or proliferation. Transmission electron microscopy (TEM) confirmed the localization of GNPs inside the following cell organelles: mitochondria, secondary lysosome, and endoplasmic reticulum. Using bright- and dark-field imaging, the bright scattering of GNPs and nanoaggregates in all 3 ES cell differentiation stages could be visualized. EB (an early differentiation stage) and terminally differentiated cardiomyocytes both showed SERS peaks specific to metabolic activity in the mitochondria and to protein translation (amide I, amide II, and amide III peaks). These peaks have been rarely identified in undifferentiated single ES cells. Spatiotemporal changes observed in the SERS spectra from terminally differentiated cardiomyocyte tissues revealed local and dynamic molecular interactions as well as transformations during ES cell differentiation.	[Sathuluri, Ramachandra Rao; Yoshikawa, Hiroyuki; Shimizu, Eiichi; Saito, Masato; Tamiya, Eiichi] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan; [Tamiya, Eiichi] Osaka Univ, Adv Photon Res Ctr, Grad Sch Engn, Suita, Osaka 565, Japan	Osaka University; Osaka University	Sathuluri, RR (corresponding author), Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan.	sathuluri@ap.eng.osaka-u.ac.jp; tamiya@ap.eng.osaka-u.ac.jp	Tamiya, Eiichi/M-6111-2018	Tamiya, Eiichi/0000-0002-7646-4827				Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bell SEJ, 2006, J AM CHEM SOC, V128, P15580, DOI 10.1021/ja066263w; Bizzarri AR, 2007, NANOMED-NANOTECHNOL, V3, P306, DOI 10.1016/j.nano.2007.09.005; Boheler KR, 2005, METH MOLEC MED, V108, P417; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Braun G, 2007, J AM CHEM SOC, V129, P6378, DOI 10.1021/ja070514z; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chiu L, 2010, J RAMAN SPECTROSC, V41, P2, DOI 10.1002/jrs.2425; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Esumi K, 2004, LANGMUIR, V20, P2536, DOI 10.1021/la036299r; Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6; Fujita K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3119242; Hossain MM, 2010, ANALYST, V135, P1624, DOI 10.1039/c0an00208a; Huh YS, 2009, MICROFLUID NANOFLUID, V6, P285, DOI 10.1007/s10404-008-0392-3; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Karatas OF, 2009, COLLOID SURFACE B, V71, P315, DOI 10.1016/j.colsurfb.2009.02.020; Khan I, 2006, ANAL CHEM, V78, P224, DOI 10.1021/ac051158a; Kim JH, 2006, ANAL CHEM, V78, P6967, DOI 10.1021/ac0607663; Kneipp J, 2006, NANO LETT, V6, P2225, DOI 10.1021/nl061517x; Kneipp J, 2010, J PHYS CHEM C, V114, P7421, DOI 10.1021/jp910034z; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kneipp K, 2002, APPL SPECTROSC, V56, P150, DOI 10.1366/0003702021954557; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Mandal D, 2009, J MATER SCI-MATER M, V20, P347, DOI 10.1007/s10856-008-3588-x; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720; Notingher I, 2007, SENSORS-BASEL, V7, P1343, DOI 10.3390/s7081343; Ochsenkuhn MA, 2009, ACS NANO, V3, P3613, DOI 10.1021/nn900681c; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Pallaoro A, 2010, SMALL, V6, P618, DOI 10.1002/smll.200901893; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Peticolas WL, 1996, J RAMAN SPECTROSC, V27, P571, DOI 10.1002/(SICI)1097-4555(199608)27:8<571::AID-JRS8>3.0.CO;2-5; Porter MD, 2008, CHEM SOC REV, V37, P1001, DOI 10.1039/b708461g; Qian XM, 2008, CHEM SOC REV, V37, P912, DOI 10.1039/b708839f; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schulze HG, 2010, ANAL CHEM, V82, P5020, DOI 10.1021/ac902697q; SEQUARIS JM, 1985, J COLLOID INTERF SCI, V105, P417, DOI 10.1016/0021-9797(85)90315-7; Sha MY, 2007, NANOMEDICINE-UK, V2, P725, DOI 10.2217/17435889.2.5.725; Shimizukawa R, 2005, GENESIS, V42, P47, DOI 10.1002/gene.20122; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1641, DOI 10.1016/S1386-1425(98)00294-7; Sujith A, 2009, ANAL BIOANAL CHEM, V394, P1803, DOI 10.1007/s00216-009-2883-9; Sun L, 2007, NANO LETT, V7, P351, DOI 10.1021/nl062453t; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935; Tran DN, 2007, FERTIL STERIL, V87, P965, DOI 10.1016/j.fertnstert.2006.07.1520; Willets KA, 2009, ANAL BIOANAL CHEM, V394, P85, DOI 10.1007/s00216-009-2682-3; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yakimovich NO, 2008, RUSS CHEM B+, V57, P520, DOI 10.1007/s11172-008-0080-1; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; Yamanaka S, 2008, CELL TISSUE RES, V331, P5, DOI 10.1007/s00441-007-0520-5; Yu KN, 2007, BIOCONJUGATE CHEM, V18, P1155, DOI 10.1021/bc070011i; Zhang XL, 2008, ANAL BIOANAL CHEM, V390, P833, DOI 10.1007/s00216-007-1564-9	63	62	63	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22802	10.1371/journal.pone.0022802	http://dx.doi.org/10.1371/journal.pone.0022802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829653	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200031
J	Pauwelyn, K; Roelandt, P; Notelaers, T; Sancho-Bru, P; Fevery, J; Verfaillie, CM				Pauwelyn, Karen; Roelandt, Philip; Notelaers, Tineke; Sancho-Bru, Pau; Fevery, Johan; Verfaillie, Catherine M.			Culture of Mouse Embryonic Stem Cells with Serum but without Exogenous Growth Factors Is Sufficient to Generate Functional Hepatocyte-Like Cells	PLOS ONE			English	Article							DEFINITIVE ENDODERM; LIVER DEVELOPMENT; IN-VITRO; PROGENITOR CELLS; TGF-BETA; DIFFERENTIATION; EXPRESSION; WNT; INTERFERENCE; MESENDODERM	Mouse embryonic stem cells (mESC) have been used to study lineage specification in vitro, including towards a hepatocyte-like fate, and such investigations guided lineage differentiation protocols for human (h)ESC. We recently described a four-step protocol to induce hepatocyte-like cells from hESC which also induced hepatocyte-like cell differentiation of mouse induced pluripotent stem cells. As ESC also spontaneously generate hepatocyte-like cells, we here tested whether the growth factors and serum used in this protocol are required to commit mESC and hESC to hepatocyte-like cells. Culture of mESC from two different mouse strains in the absence of serum and growth factors did not induce primitive streak/definitive endoderm genes but induced default differentiation to neuroectoderm on day 6. Although Activin-A and Wnt3 induced primitive streak/definitive endoderm transcripts most robustly in mESC, simple addition of serum also induced these transcripts. Expression of hepatoblast genes occurred earlier when growth factors were used for mESC differentiation. However, further maturation towards functional hepatocyte-like cells was similar in mESC progeny from cultures with serum, irrespective of the addition of growth factors, and irrespective of the mouse strain. This is in contrast to hESC, where growth factors are required for specification towards functional hepatocyte-like cells. Culture of mESC with serum but without growth factors did not induce preferential differentiation towards primitive endoderm or neuroectoderm. Thus, although induction of primitive streak/definitive endoderm specific genes and proteins is more robust when mESC are exposed to a combination of serum and exogenous growth factors, ultimate generation of hepatocyte-like cells from mESC occurs equally well in the presence or absence of exogenous growth factors. The latter is in contrast to what we observed for hESC. These results suggest that differences exist between lineage specific differentiation potential of mESC and hESC, requiring optimization of different protocols for ESC from either species.	[Pauwelyn, Karen; Roelandt, Philip; Notelaers, Tineke; Sancho-Bru, Pau; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cell Inst Leuven, Louvain, Belgium; [Pauwelyn, Karen; Roelandt, Philip; Fevery, Johan] Univ Hosp Leuven, Dept Hepatol, Louvain, Belgium; [Sancho-Bru, Pau] Hosp Clin Barcelona, Liver Unit, CIBERehd, IDIBAPS, Barcelona, Spain	KU Leuven; KU Leuven; University Hospital Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pauwelyn, K (corresponding author), Katholieke Univ Leuven, Stem Cell Inst Leuven, Louvain, Belgium.	Philip.roelandt@med.kuleuven.be	Sancho-Bru, Pau/D-4900-2014; Verfaillie, Catherine/H-5148-2013	Sancho-Bru, Pau/0000-0001-5569-9259; Verfaillie, Catherine/0000-0001-7564-4079	National Institutes of Health [RO1-DK58295, U19-DK61244]; Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders) [G.0667.07]; IWT-SBO (HepStem); K.U. Leuven SCIL Center of Excellence; K.U. Leuven OT [ETH-C0420-OT/09/053]; GOA [EME-C2161-GOA/11/012]; FWO [KAN 1.5163.09]; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); IWT (Agentschap voor Innovatie door Wetenschap en Technologie); Agencia de Gestio d'Ajuts Universitaris i de Recerca; Beatriu de Pinos [2006 BP-A 10104]; Juan de la Cierva [JCI-2009-03849]; Ministerio de Ciencia e Innovacion; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061244, R01DK058295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders)(FWO); IWT-SBO (HepStem)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); K.U. Leuven SCIL Center of Excellence; K.U. Leuven OT; GOA; FWO(FWO); BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); IWT (Agentschap voor Innovatie door Wetenschap en Technologie)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Beatriu de Pinos; Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to C. Verfaillie from the National Institutes of Health (RO1-DK58295 and U19-DK61244), the Alpha 1 Foundation, FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders, www.fwo.be) G.0667.07 Odysseus award, IWT-SBO grant (HepStem), a K.U. Leuven SCIL Center of Excellence/Program Financing Award, and a K.U. Leuven OT (ETH-C0420-OT/09/053) and GOA (EME-C2161-GOA/11/012) Award. K. Pauwelyn was funded by FWO, BAEF (Belgian American Education Foundation, www.baef.be), and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Roelandt was funded by IWT (Agentschap voor Innovatie door Wetenschap en Technologie) and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Sancho-Bru was funded by FWO (KAN 1.5163.09) and Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos (2006 BP-A 10104) and Postdoctoral contract Juan de la Cierva JCI-2009-03849, Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SL, 1996, DEVELOPMENT, V122, P243; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Dong XJ, 2009, WORLD J GASTROENTERO, V15, P5165, DOI 10.3748/wjg.15.5165; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Heo J, 2005, BIOCHEM BIOPH RES CO, V332, P1061, DOI 10.1016/j.bbrc.2005.04.173; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101; Roelandt P, 2010, NAT PROTOC, V5, P1324, DOI 10.1038/nprot.2010.80; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Sekhon SS, 2004, AM J PATHOL, V164, P2229, DOI 10.1016/S0002-9440(10)63779-0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhou MM, 2010, J CELL BIOCHEM, V109, P606, DOI 10.1002/jcb.22442	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23096	10.1371/journal.pone.0023096	http://dx.doi.org/10.1371/journal.pone.0023096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829697	Green Submitted, gold, Green Published			2022-12-25	WOS:000293511900025
J	Castillo, AF; Fan, JJ; Papadopoulos, V; Podesta, EJ				Fernanda Castillo, Ana; Fan, Jinjiang; Papadopoulos, Vassilios; Podesta, Ernesto J.			Hormone-Dependent Expression of a Steroidogenic Acute Regulatory Protein Natural Antisense Transcript in MA-10 Mouse Tumor Leydig Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; NITRIC-OXIDE SYNTHASE; MYOSIN HEAVY-CHAIN; MITOCHONDRIAL CHOLESTEROL TRANSPORT; GENE-EXPRESSION; STAR GENE; MEDIATED INHIBITION; ARACHIDONIC-ACID; MAMMALIAN-CELLS; NONCODING RNAS	Cholesterol transport is essential for many physiological processes, including steroidogenesis. In steroidogenic cells hormone-induced cholesterol transport is controlled by a protein complex that includes steroidogenic acute regulatory protein (StAR). Star is expressed as 3.5-, 2.8-, and 1.6-kb transcripts that differ only in their 3'-untranslated regions. Because these transcripts share the same promoter, mRNA stability may be involved in their differential regulation and expression. Recently, the identification of natural antisense transcripts (NATs) has added another level of regulation to eukaryotic gene expression. Here we identified a new NAT that is complementary to the spliced Star mRNA sequence. Using 59 and 39 RACE, strand-specific RT-PCR, and ribonuclease protection assays, we demonstrated that Star NAT is expressed in MA-10 Leydig cells and steroidogenic murine tissues. Furthermore, we established that human chorionic gonadotropin stimulates Star NAT expression via cAMP. Our results show that sense-antisense Star RNAs may be coordinately regulated since they are co-expressed in MA-10 cells. Overexpression of Star NAT had a differential effect on the expression of the different Star sense transcripts following cAMP stimulation. Meanwhile, the levels of StAR protein and progesterone production were downregulated in the presence of Star NAT. Our data identify antisense transcription as an additional mechanism involved in the regulation of steroid biosynthesis.	[Fernanda Castillo, Ana; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Mol Enfermedades Hormonales Neurodege, Buenos Aires, DF, Argentina; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ, Canada; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ, Canada	University of Buenos Aires; McGill University; McGill University	Castillo, AF (corresponding author), Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Mol Enfermedades Hormonales Neurodege, Buenos Aires, DF, Argentina.	ernestopodesta@yahoo.com.ar	Fan, Jinjiang/C-2010-2009; Papadopoulos, Vassilios/AAI-2613-2019	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568; Castillo, Ana Fernanda/0000-0002-1572-4728	University of Buenos Aires (UBA) [M059]; National Agency for Promotion of Science and Technology (ANPCyT) [PICT 2006-00819]; Bunge and Born Foundation; National Institutes of Health [R01 ES07747]; Canadian Institutes of Health Research [MOP102647]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	University of Buenos Aires (UBA)(University of Buenos Aires); National Agency for Promotion of Science and Technology (ANPCyT)(ANPCyT); Bunge and Born Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant M059 from the University of Buenos Aires (UBA, http://www.uba.ar/homepage.php) and grant PICT 2006-00819 from the National Agency for Promotion of Science and Technology (ANPCyT, http://www.agencia.mincyt.gov.ar) to E.J.P.; a fellowship from Bunge and Born Foundation (http://www.fundacionbyb.org/) to A. F. C.; grant R01 ES07747 from the National Institutes of Health (http://www.nih.gov/) and MOP102647 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to V. P. V. P. was also supported by a Canada Research Chair in Biochemical Pharmacology. The Research Institute of McGill University Health Centre (MUHC) is supported in part by a Center grant from Le Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Ariyoshi N, 1998, J BIOL CHEM, V273, P7610, DOI 10.1074/jbc.273.13.7610; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bartsch H, 2004, RNA, V10, P1215, DOI 10.1261/rna.5261204; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; CELANO P, 1993, BIOTECHNIQUES, V15, P26; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Delihas N, 1997, NAT BIOTECHNOL, V15, P751, DOI 10.1038/nbt0897-751; Duan HC, 2007, J MOL ENDOCRINOL, V38, P159, DOI 10.1677/jme.1.02153; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; EPSTEIN LF, 1991, MOL CELL ENDOCRINOL, V81, P113, DOI 10.1016/0303-7207(91)90210-J; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Ge XJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-27; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Haddad F, 2003, J BIOL CHEM, V278, P37132, DOI 10.1074/jbc.M305911200; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Haidan A, 2000, MOL CELL ENDOCRINOL, V165, P25, DOI 10.1016/S0303-7207(00)00267-7; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hiroi H, 2004, MOL CELL ENDOCRINOL, V215, P119, DOI 10.1016/j.mce.2003.11.014; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ivell R, 2000, J MOL ENDOCRINOL, V24, P109, DOI 10.1677/jme.0.0240109; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Korneev SA, 1999, J NEUROSCI, V19, P7711; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Kumar PA, 2010, J BIOL CHEM, V285, P31148, DOI 10.1074/jbc.M110.132332; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Luther HP, 2005, J CELL BIOCHEM, V94, P848, DOI 10.1002/jcb.20319; Luther HP, 2001, J CELL BIOCHEM, V80, P596, DOI 10.1002/1097-4644(20010315)80:4<596::AID-JCB1014>3.0.CO;2-Y; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merzendorfer H, 1997, FEBS LETT, V411, P239, DOI 10.1016/S0014-5793(97)00699-6; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Oeder S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-200; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Podlowski S, 2002, J CELL BIOCHEM, V85, P198, DOI 10.1002/jcb.10116; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Rusovici R, 2005, BIOL REPROD, V72, P862, DOI 10.1095/biolreprod.104.034298; Sambrook J., 2002, MOL CLONING LAB MANU; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shi MX, 2000, BRAIN RES BULL, V53, P317, DOI 10.1016/S0361-9230(00)00349-X; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Stocco DM, 1996, BIOCHEM PHARMACOL, V51, P197, DOI 10.1016/0006-2952(95)02093-4; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Tommasi S, 1999, J BIOL CHEM, V274, P27829, DOI 10.1074/jbc.274.39.27829; Tsuchiya M, 2003, LIFE SCI, V73, P2855, DOI 10.1016/S0024-3205(03)00698-2; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476; Werner A, 2007, PHYSIOL GENOMICS, V28, P294, DOI 10.1152/physiolgenomics.00127.2006; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Yamazaki T, 2006, BBA-PROTEINS PROTEOM, V1764, P1561, DOI 10.1016/j.bbapap.2006.08.016; Yeilding NM, 1998, J BIOL CHEM, V273, P15749, DOI 10.1074/jbc.273.25.15749; Zhang JX, 2006, BIOINFORMATICS, V22, P385, DOI 10.1093/bioinformatics/bti796; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhao D, 2005, J STEROID BIOCHEM, V96, P155, DOI 10.1016/j.jsbmb.2005.02.011	88	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22822	10.1371/journal.pone.0022822	http://dx.doi.org/10.1371/journal.pone.0022822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829656	Green Published, gold, Green Submitted			2022-12-25	WOS:000293511200020
J	Welsch, T; Zschabitz, S; Becker, V; Giese, T; Bergmann, F; Hinz, U; Keleg, S; Heller, A; Sipos, B; Klingmuller, U; Buchler, MW; Werner, J; Giese, NA				Welsch, Thilo; Zschaebitz, Stefanie; Becker, Verena; Giese, Thomas; Bergmann, Frank; Hinz, Ulf; Keleg, Shereen; Heller, Anette; Sipos, Bence; Klingmueller, Ursula; Buechler, Markus W.; Werner, Jens; Giese, Nathalia A.			Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; HUMAN TUMOR-CELLS; QUALITY-OF-LIFE; CANCER-PATIENTS; TRANSFERRIN RECEPTOR; STIMULATING AGENTS; EPOETIN-BETA; ANEMIA; EXPRESSION; CARCINOMA	Background: Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). Methodology: The clinico-pathological relevance of hemoglobin (Hb, n = 150), serum Epo (sEpo, n = 87) and tissue expression of Epo/Epo receptor (EpoR, n = 104) was analyzed in patients with PDAC. Epo/EpoR expression, signaling, growth, invasion and chemoresistance were studied in Epo-exposed PDAC cell lines. Results: Compared to donors, median preoperative Hb levels were reduced by 15% in both chronic pancreatitis (CP, p<0.05) and PDAC (p<0.001), reaching anemic grade in one third of patients. While inversely correlating to Hb (r = -0.46), 95% of sEPO values lay within the normal range. The individual levels of compensation were adequate in CP (observed to predicted ratio, O/P = 0.99) but not in PDAC (O/P = 0.85). Strikingly, lower sEPO values yielding inadequate Epo responses were prominent in non-metastatic M0-patients, whereas these parameters were restored in metastatic M1-group (8 vs. 13 mU/mL; O/P = 0.82 vs. 0.96; p<0.01)-although Hb levels and the prevalence of anemia were comparable. Higher sEpo values (upper quartile >= 16 mU/ml) were not significantly different in M0 (20%) and M1 (30%) groups, but were an independent prognostic factor for shorter survival (HR 2.20, 10 vs. 17 months, p<0.05). The pattern of Epo expression in pancreas and liver suggested ectopic release of Epo by capillaries/vasa vasorum and hepatocytes, regulated by but not emanating from tumor cells. Epo could initiate PI3K/Akt signaling via EpoR in PDAC cells but failed to alter their functions, probably due to co-expression of the soluble EpoR isoform, known to antagonize Epo. Conclusion/Significance: Higher sEPO levels counteract anemia but worsen outcome in PDAC patients. Further trials are required to clarify how overcoming a sEPO threshold $ 16 mU/ml by endogenous or exogenous means may predispose to or promote metastatic progression.	[Welsch, Thilo; Zschaebitz, Stefanie; Hinz, Ulf; Keleg, Shereen; Heller, Anette; Buechler, Markus W.; Werner, Jens; Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Becker, Verena; Klingmueller, Ursula] Univ Heidelberg, Div Syst Biol Signal Transduct, German Canc Res Ctr & Bioquant, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Bergmann, Frank] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Sipos, Bence] Univ Tubingen Hosp, Inst Pathol, Tubingen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Welsch, T (corresponding author), Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.	nathalia.giese@med.uni-heidelberg.de	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099	Heidelberger Stiftung Chirurgie; Helmholtz Alliance on Systems Biology (SBCancer); Dietmar-Hopp-Stiftung; German Ministry of Education and Research (NGFNnetwork) [PKB-01GS08178, PKB-01GS08114]	Heidelberger Stiftung Chirurgie; Helmholtz Alliance on Systems Biology (SBCancer); Dietmar-Hopp-Stiftung; German Ministry of Education and Research (NGFNnetwork)(Federal Ministry of Education & Research (BMBF))	The work was supported by the grants from the Heidelberger Stiftung Chirurgie to TW, the Helmholtz Alliance on Systems Biology (SBCancer) to VB and UK, the Dietmar-Hopp-Stiftung to NAG and by the German Ministry of Education and Research (NGFNnetwork grants PKB-01GS08178 to BS and PKB-01GS08114 to NAG, who is responsible for the contents of publication). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2008, BRIT J CANCER, V99, P14, DOI 10.1038/sj.bjc.6604408; Aapro MS, 2008, ONCOLOGIST, V13, P33, DOI 10.1634/theoncologist.13-S3-33; Acs G, 2004, CANCER-AM CANCER SOC, V100, P2376, DOI 10.1002/cncr.20244; Acs G, 2001, CANCER RES, V61, P3561; Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2; Arcasoy MO, 2008, CLIN CANCER RES, V14, P4685, DOI 10.1158/1078-0432.CCR-08-0264; BAROSI G, 1994, ANN HEMATOL, V68, P215, DOI 10.1007/BF01737420; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; BEGUIN Y, 1993, BLOOD, V81, P1067; Cao Yiting, 2010, Genes Cancer, V1, P50; Crawford J, 2002, CANCER-AM CANCER SOC, V95, P888, DOI 10.1002/cncr.10763; Dernedde U, 2007, CLIN ONCOL-UK, V19, P223, DOI 10.1016/j.clon.2006.11.011; Dunlop EA, 2007, STEM CELLS, V25, P380, DOI 10.1634/stemcells.2006-0452; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Glimelius B, 1998, J CLIN ONCOL, V16, P434, DOI 10.1200/JCO.1998.16.2.434; Hardee ME, 2006, MOL CANCER THER, V5, P356, DOI 10.1158/1535-7163.MCT-05-0196; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Juneja V, 2008, CLIN CANCER RES, V14, P3242, DOI 10.1158/1078-0432.CCR-07-1872; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; LEITGEB C, 1994, CANCER-AM CANCER SOC, V73, P2535, DOI 10.1002/1097-0142(19940515)73:10<2535::AID-CNCR2820731014>3.0.CO;2-5; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162; NOWROUSIAN MR, 1997, RECOMBINANT HUMAN ER, P149; Opasich C, 2005, EUR HEART J, V26, P2232, DOI 10.1093/eurheartj/ehi388; Pajonk F, 2004, ONCOGENE, V23, P8987, DOI 10.1038/sj.onc.1208140; Papworth K, 2009, TUMOR BIOL, V30, P86, DOI 10.1159/000216844; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Rades D, 2010, INT J RAD ONCOL BIOL; Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85; Ribatti D, 2007, HISTOPATHOLOGY, V50, P591, DOI 10.1111/j.1365-2559.2007.02654.x; Ribatti D, 2007, J NEURO-ONCOL, V82, P327, DOI 10.1007/s11060-006-9289-8; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rizzo JD, 2010, J CLIN ONCOL, V28, P4996, DOI 10.1200/JCO.2010.29.2201; Roque ME, 2001, CLIN LAB HAEMATOL, V23, P291, DOI 10.1046/j.1365-2257.2001.00413.x; Samyn I, 2004, J CLIN ONCOL, V22, P2240, DOI 10.1200/JCO.2004.10.031; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Szenajch J, 2010, BBA-REV CANCER, V1806, P82, DOI 10.1016/j.bbcan.2010.04.002; Talar-Wojnarowska R, 2009, DIGEST DIS SCI, V54, P683, DOI 10.1007/s10620-008-0390-z; van der Meer P, 2004, J AM COLL CARDIOL, V44, P63, DOI 10.1016/j.jacc.2004.03.052; Welsch T, 2011, LANGENBECK ARCH SURG, V396, P353, DOI 10.1007/s00423-010-0629-y; Welsch T, 2009, CLIN EXP METASTAS, V26, P701, DOI 10.1007/s10585-009-9269-4; Westphal G, 2002, CLIN EXP MED, V2, P45, DOI 10.1007/s102380200006; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Yin D, 2007, INT J ONCOL, V31, P1193; Zeh H. J., 2005, Cancer Biomarkers, V1, P259	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23151	10.1371/journal.pone.0023151	http://dx.doi.org/10.1371/journal.pone.0023151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829709	Green Published, Green Submitted, gold			2022-12-25	WOS:000293511200042
J	Erdner, DL; Richlen, M; McCauley, LAR; Anderson, DM				Erdner, Deana L.; Richlen, Mindy; McCauley, Linda A. R.; Anderson, Donald M.			Diversity and Dynamics of a Widespread Bloom of the Toxic Dinoflagellate Alexandrium fundyense	PLOS ONE			English	Article							DIATOM DITYLUM-BRIGHTWELLII; POPULATION GENETIC-STRUCTURE; MICROSATELLITE MARKERS; GONYAULAX-TAMARENSIS; CYST FORMATION; SPRING BLOOM; BACILLARIOPHYCEAE; SOFTWARE; DIFFERENTIATION; DINOPHYCEAE	Historically, cosmopolitan phytoplankton species were presumed to represent largely unstructured populations. However, the recent development of molecular tools to examine genetic diversity have revealed differences in phytoplankton taxa across geographic scales and provided insight into the physiology and ecology of blooms. Here we describe the genetic analysis of an extensive bloom of the toxic dinoflagellate Alexandrium fundyense that occurred in the Gulf of Maine in 2005. This bloom was notable for its intensity and duration, covering hundreds of kilometers and persisting for almost two months. Genotypic analyses based on microsatellite marker data indicate that the open waters of the northeastern U.S. harbor a single regional population of A. fundyense comprising two genetically distinct sub-populations. These subpopulations were characteristic of early-and late-bloom samples and were derived from the northern and southern areas of the bloom, respectively. The temporal changes observed during this study provide clear evidence of succession during a continuous bloom and show that selection can act on the timescale of weeks to significantly alter the representation of genotypes within a population. The effects of selection on population composition and turnover would be magnified if sexual reproduction were likewise influenced by environmental conditions. We hypothesize that the combined effects of differential growth and reproduction rates serves to reduce gene flow between the sub-populations, reinforcing population structure while maintaining the diversity of the overall regional population.	[Erdner, Deana L.] Univ Texas Marine Sci Inst, Port Aransas, TX USA; [Richlen, Mindy; McCauley, Linda A. R.; Anderson, Donald M.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Erdner, DL (corresponding author), Univ Texas Marine Sci Inst, Port Aransas, TX USA.	derdner@mail.utexas.edu	Erdner, Deana L/C-4981-2008	Erdner, Deana L/0000-0002-1736-8835	National Institute of Environmental Health Sciences [1-P50-ES012742]; National Science Foundation through the Woods Hole Center for Oceans and Human Health [OCE-0430724]; NOAA [NA06NOS4780245]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742] Funding Source: NIH RePORTER; Division Of Ocean Sciences [0911031] Funding Source: National Science Foundation	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation through the Woods Hole Center for Oceans and Human Health; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Institute of Environmental Health Sciences (1-P50-ES012742 to DMA and DLE), by the National Science Foundation through the Woods Hole Center for Oceans and Human Health (OCE-0430724), and by the ECOHAB program (NOAA Grant NA06NOS4780245). This is contribution number 660 from the ECOHAB program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Anderson D, 2005, DEEP-SEA RES PT II, V52, P2365, DOI 10.1016/j.dsr2.2005.08.001; Anderson D.M., 1998, PHYSL ECOLOGY HARMFU, V41, P29; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2856, DOI 10.1016/j.dsr2.2005.09.004; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; ANDERSON DM, 1985, J EXP MAR BIOL ECOL, V86, P1, DOI 10.1016/0022-0981(85)90039-5; ANDERSON DM, 1984, J PHYCOL, V20, P418, DOI 10.1111/j.0022-3646.1984.00418.x; [Anonymous], 1997, TFPGA TOOLS POPULATI; Balech E, 1995, GENUS ALEXANDRIUM HA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans KM, 2004, J PHYCOL, V40, P911, DOI 10.1111/j.1529-8817.2004.04027.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GALLAGHER JC, 1980, J PHYCOL, V16, P464; GOUDET J, 1999, PCAGEN VER 1 2; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HE R, 2008, J GEOPHYS RES OCEANS; Manning JP, 2009, CONT SHELF RES, V29, P835, DOI 10.1016/j.csr.2008.12.008; MARANDA L, 1985, ESTUAR COAST SHELF S, V21, P401, DOI 10.1016/0272-7714(85)90020-4; Masseret E, 2009, APPL ENVIRON MICROB, V75, P2037, DOI 10.1128/AEM.01686-08; Nagai S, 2004, MOL ECOL NOTES, V4, P83, DOI 10.1046/j.1471-8286.2003.00576.x; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	30	46	48	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22965	10.1371/journal.pone.0022965	http://dx.doi.org/10.1371/journal.pone.0022965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829565	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500058
J	Molenberghs, P; Sale, MV				Molenberghs, Pascal; Sale, Martin V.			Testing for Spatial Neglect with Line Bisection and Target Cancellation: Are Both Tasks Really Unrelated?	PLOS ONE			English	Article							VISUAL NEGLECT; HEMISPATIAL NEGLECT; VISUOSPATIAL NEGLECT; HEMISPHERE STROKE; PARIETAL CORTEX; BRAIN NETWORKS; ANATOMY; ATTENTION; AWARENESS; SENSITIVITY	Damage to the parietal lobe can induce a condition known as spatial neglect, characterized by a lack of awareness of the personal and/or extrapersonal space opposite the damaged brain region. Spatial neglect is commonly assessed clinically using either the line bisection or the target cancellation task. However, it is unclear whether poor performance on each of these two tasks is associated with the same or different lesion locations. To date, methodological limitations and differences have prevented a definitive link between task performance and lesion location to be made. Here we report findings from a voxel-based lesion symptom mapping (VLSM) analysis of an unbiased selection of 44 patients with a recent unifocal stroke. Patients performed both the line bisection and target cancellation task. For each of the two tasks a continuous score was incorporated into the VLSM analysis. Both tasks correlated highly with each other (r =.76) and VLSM analyses indicated that the angular gyrus was the critical lesion site for both tasks. The results suggest that both tasks probe the same underlying cortical deficits and although the cancellation task was more sensitive than the line bisection task, both can be used in a clinical setting to test for spatial neglect.	[Molenberghs, Pascal] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Sale, Martin V.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Molenberghs, P (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	p.molenberghs@uq.edu.au	Sale, Martin V/B-6621-2009; Molenberghs, Pascal/C-8176-2009	Sale, Martin V/0000-0002-2913-9212; Molenberghs, Pascal/0000-0003-0350-6659	University of Queensland; National Health and Medical Research Council (NHMRC)	University of Queensland(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a University of Queensland Postdoctoral Fellowship awarded to PM and a National Health and Medical Research Council (NHMRC) Postdoctoral Training Fellowship awarded to MVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; Bartolomeo P, 2007, CURR OPIN NEUROL, V20, P381, DOI 10.1097/WCO.0b013e32816aa3a3; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Coulthard EJ, 2008, NEURON, V58, P144, DOI 10.1016/j.neuron.2008.02.009; Doricchi F, 2008, CORTEX, V44, P983, DOI 10.1016/j.cortex.2008.03.006; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; HALLIGAN PW, 1989, LANCET, V2, P908; HALLIGAN PW, 1992, CORTEX, V28, P525, DOI 10.1016/S0010-9452(13)80225-0; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heilman K. M, 1983, LOCALIZATION NEUROPS, P471; Heilman KM., 1993, CLIN NEUROPSYCHOLOGY, P279; Hillis AE, 2005, J NEUROSCI, V25, P3161, DOI 10.1523/JNEUROSCI.4468-04.2005; Karnath HO, 2011, BRAIN, V134, P903, DOI 10.1093/brain/awq355; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kleinman JT, 2007, BRAIN COGNITION, V64, P50, DOI 10.1016/j.bandc.2006.10.005; McGlinchey-Berroth R, 1996, J Int Neuropsychol Soc, V2, P441; Molenberghs P, 2008, J NEUROSCI, V28, P3359, DOI 10.1523/JNEUROSCI.5247-07.2008; Molenberghs P, 2009, NEUROPSYCHOLOGIA, V47, P2866, DOI 10.1016/j.neuropsychologia.2009.06.012; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Rorden C, 2006, BRAIN RES, V1080, P17, DOI 10.1016/j.brainres.2004.10.071; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sarri M, 2009, NEUROPSYCHOLOGIA, V47, P91, DOI 10.1016/j.neuropsychologia.2008.08.020; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Talairach J., 1988, COPLANAR STEREOTAXIC; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P771, DOI 10.1016/j.neuropsychologia.2004.07.020; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Vallar G, 1993, UNILATERAL NEGLECT C, P27; Vandenberghe R, 2005, BRAIN, V128, P2843, DOI 10.1093/brain/awh522; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305	40	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23017	10.1371/journal.pone.0023017	http://dx.doi.org/10.1371/journal.pone.0023017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829578	gold, Green Published			2022-12-25	WOS:000293284600071
J	Staresincic, L; Walker, J; Dirac-Svejstrup, AB; Mitter, R; Svejstrup, JQ				Staresincic, Lidija; Walker, Jane; Dirac-Svejstrup, A. Barbara; Mitter, Richard; Svejstrup, Jesper Q.			GTP-dependent Binding and Nuclear Transport of RNA Polymerase II by Npa3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTION; LOCALIZATION; ELONGATION; IMPORT; YEAST; COMPONENT; CHROMATIN; SUBUNIT	We identified XAB1 in a proteomic screen for factors that interact with human RNA polymerase II (RNAPII). Because XAB1 has a conserved Saccharomyces cerevisiae homologue called Npa3, yeast genetics and biochemical analysis were used to dissect the significance of the interaction. Degron-dependent Npa3 depletion resulted in genome-wide transcription decreases, correlating with a loss of RNAPII from genes as measured by chromatin immunoprecipitation. Surprisingly, however, transcription in vitro was unaffected by Npa3, suggesting that it affects a process that is not required for transcription in yeast extracts. Indeed, Npa3 depletion in vivo affects nuclear localization of RNAPII; the polymerase accumulates in the cytoplasm. Npa3 is a member of the GPN-LOOP family of GTPases. Npa3 mutants that either cannot bind GTP or that bind but cannot hydrolyze it are inviable and unable to support nuclear transport of RNAPII. Surprisingly, we were unable to detect interactions between Npa3 and proteins in the classical importin alpha/beta pathway for nuclear import. Interestingly, Npa3-RNAPII binding is significantly increased by the addition of GTP or its slowly hydrolyzable analogue guanosine 5'-3-O-(thio)triphosphate (GTP gamma S). Moreover, the Npa3 mutant that binds GTP, but cannot hydrolyze it, binds RNAPII even in the absence of added GTP, whereas the mutant that cannot bind GTP is unable to bind the polymerase. Together, our data suggest that Npa3 defines an unconventional pathway for nuclear import of RNAPII, which involves GTP-dependent binding of Npa3 to the polymerase.	[Staresincic, Lidija; Walker, Jane; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Mitter, Richard] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Svejstrup, Jesper/0000-0003-4964-6147; Mitter, Richard/0000-0002-1279-3760	European Community [LSHG-CT-2005-512113]; Cancer Research UK; Cancer Research UK [11567] Funding Source: researchfish	European Community(European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a grant from the European Community (Integrated Project DNA Repair (LSHG-CT-2005-512113)) and by an in-house grant from Cancer Research UK (to J. Q. S.).	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; AYSCOUGH KR, 1998, IMMUNOFLUORESCENCE M; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CARRE C, 2011, MOL CELL BI IN PRESS; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Forget D, 2010, MOL CELL PROTEOMICS, V9, P2827, DOI 10.1074/mcp.M110.003616; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gras S, 2007, EMBO REP, V8, P569, DOI 10.1038/sj.embor.7400958; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kong SE, 2002, DNA REPAIR, V1, P731, DOI 10.1016/S1568-7864(02)00080-0; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lembo F, 2003, MOL CELL BIOL, V23, P1656, DOI 10.1128/MCB.23.5.1656-1665.2003; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x	33	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35553	35561		10.1074/jbc.M111.286161	http://dx.doi.org/10.1074/jbc.M111.286161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844196	Green Published, hybrid			2022-12-25	WOS:000295927100027
J	Eng, ET; Smagghe, BJ; Walz, T; Springer, TA				Eng, Edward T.; Smagghe, Benoit J.; Walz, Thomas; Springer, Timothy A.			Intact alpha(IIb)beta(3) Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB; STRUCTURAL BASIS; CONFORMATIONAL REGULATION; CRYSTAL-STRUCTURE; CELL-ADHESION; BINDING-SITE; OUTSIDE-IN; COMPLEX; LIGAND; DOMAIN	Integrins are bidirectional signaling molecules on the cell surface that have fundamental roles in regulating cell behavior and contribute to cell migration and adhesion. Understanding of the mechanism of integrin signaling and activation has been advanced with truncated ectodomain preparations; however, the nature of conformational change in the full-length intact integrin molecule remains an active area of research. Here we used small angle x-ray scattering and electron microscopy to study detergent-solubilized, intact platelet integrin alpha(IIb)beta(3). In the resting state, the intact alpha(IIb)beta(3) adopted a compact, bent conformation. Upon activation with Mn2+, the average integrin extension increased. Further activation by addition of ligand led to stabilization of the extended state and opening of the headpiece. The observed extension and conformational rearrangement upon activation are consistent with the extension and headpiece opening model of integrin activation.	[Eng, Edward T.; Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,CLSB, Boston, MA 02115 USA; [Eng, Edward T.; Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,CLSB, 3 Blackfan Circle,3rd Floor, Boston, MA 02115 USA.	springer@idi.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Eng, Edward/0000-0002-8014-7269	National Institutes of Health [HL103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103526.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki K, 2005, J STRUCT BIOL, V150, P259, DOI 10.1016/j.jsb.2005.03.005; Jennings LK, 2000, THROMB HAEMOSTASIS, V84, P1095; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nogales A, 2010, J BIOL CHEM, V285, P1023, DOI 10.1074/jbc.M109.050039; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS DR, 1988, BLOOD, V71, P831; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	50	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35218	35226		10.1074/jbc.M111.275107	http://dx.doi.org/10.1074/jbc.M111.275107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832081	Green Published, hybrid			2022-12-25	WOS:000295406300074
J	Preller, M; Bauer, S; Adamek, N; Fujita-Becker, S; Fedorov, R; Geeves, MA; Manstein, DJ				Preller, Matthias; Bauer, Stefanie; Adamek, Nancy; Fujita-Becker, Setsuko; Fedorov, Roman; Geeves, Michael A.; Manstein, Dietmar J.			Structural Basis for the Allosteric Interference of Myosin Function by Reactive Thiol Region Mutations G680A and G680V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; HEAVY-CHAIN; CRYSTAL-STRUCTURE; MOTOR DOMAINS; ACTIVE-SITE; DICTYOSTELIUM; NUCLEOTIDE; MUTANTS; FLUORESCENCE; SUPPRESSORS	The cold-sensitive single-residue mutation of glycine 680 in the reactive thiol region of Dictyostelium discoideum myosin-2 or the corresponding conserved glycine in other myosin isoforms has been reported to interfere with motor function. Here we present the x-ray structures of myosin motor domain mutants G680A in the absence and presence of nucleotide as well as the apo structure of mutant G680V. Our results show that the Gly-680 mutations lead to uncoupling of the reactive thiol region from the surrounding structural elements. Structural and functional data indicate that the mutations induce the preferential population of a state that resembles the ADP-bound state. Moreover, the Gly-680 mutants display greatly reduced dynamic properties, which appear to be related to the recovery of myosin motor function at elevated temperatures.	[Preller, Matthias; Bauer, Stefanie; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Fedorov, Roman; Manstein, Dietmar J.] Hannover Med Sch, Forsch Einrichtung Strukturanal, D-30625 Hannover, Germany; [Adamek, Nancy; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; [Fujita-Becker, Setsuko; Manstein, Dietmar J.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Hannover Medical School; Hannover Medical School; University of Kent; Max Planck Society	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Preller, Matthias/P-1176-2016; Manstein, Dietmar J./AAG-2640-2019; Geeves, Michael/F-7583-2011	Manstein, Dietmar J. J/0000-0003-0763-0147; Preller, Matthias/0000-0002-7784-4012; Manstein, Dietmar J./0000-0003-0763-0147; Geeves, Michael/0000-0002-9364-8898; Fedorov, Roman/0000-0002-5240-4205	Wellcome Trust [085309]; Deutsche Forschungsgemeinschaft [Ma 1081/16-1]; Cluster of Excellence "Rebirth"	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"	This work was supported in part by Wellcome Trust Grant 085309 (to M. A. G.) and grants from Deutsche Forschungsgemeinschaft Ma 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DALBEY RE, 1983, BIOCHEMISTRY-US, V22, P4696, DOI 10.1021/bi00289a014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELOZANNE A, 1985, P NATL ACAD SCI USA, V82, P6807, DOI 10.1073/pnas.82.20.6807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HUSTON EE, 1988, BIOCHEMISTRY-US, V27, P8945, DOI 10.1021/bi00425a011; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Liang WC, 1998, P NATL ACAD SCI USA, V95, P12844, DOI 10.1073/pnas.95.22.12844; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; PATTERSON B, 1995, GENETICS, V140, P505; Patterson B, 1998, GENETICS, V149, P1799; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Patterson B, 1996, GENETICS, V143, P801; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; TITUS MA, 1989, J MUSCLE RES CELL M, V10, P25, DOI 10.1007/BF01739854; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; WELLS JA, 1979, P NATL ACAD SCI USA, V76, P4966, DOI 10.1073/pnas.76.10.4966; WELLS JA, 1980, J BIOL CHEM, V255, P1598; Wu Y, 1999, GENETICS, V153, P107; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010	38	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35051	35060		10.1074/jbc.M111.265298	http://dx.doi.org/10.1074/jbc.M111.265298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841195	Green Published, hybrid			2022-12-25	WOS:000295406300058
J	Xiong, F; Leonov, S; Howard, AC; Xiong, S; Zhang, B; Mei, L; McNeil, P; Simon, S; Xiong, WC				Xiong, Fei; Leonov, Sergey; Howard, Amber Cyan; Xiong, Shan; Zhang, Bin; Mei, Lin; McNeil, Paul; Simon, Sylvia; Xiong, Wen-Cheng			Receptor for Advanced Glycation End Products (RAGE) Prevents Endothelial Cell Membrane Resealing and Regulates F-actin Remodeling in a beta-Catenin-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; MULTILIGAND RECEPTOR; PATTERN-RECOGNITION; PROGRESSION FACTOR; REPAIR; ACTIVATION; PERTURBATION; PATHOGENESIS; REQUIREMENT	Receptor for advanced glycation end products (RAGE), an immunoglobin superfamily cell surface receptor, contributes to the vascular pathology associated with multiple disorders, including Alzheimer disease (AD), diabetic complications, and inflammatory conditions. However, the underlying mechanisms remain largely unclear. Here, using the human umbilical vein endothelial cell line (ECV-304) expressing human RAGE, we report that RAGE expression leads to an altered F-actin organization and impaired membrane resealing. To investigate the underlying mechanisms, we showed that RAGE expression increases beta-catenin level, which decreases F-actin stress fibers and attenuates plasma membrane resealing. These results thus suggest a negative function for RAGE in endothelial cell membrane repair and reveal a new mechanism underlying RAGE regulation of F-actin remodeling and membrane resealing.	[Xiong, Fei; Xiong, Shan; Zhang, Bin; Mei, Lin; Xiong, Wen-Cheng] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Xiong, Fei; Xiong, Shan; Zhang, Bin; Mei, Lin; Xiong, Wen-Cheng] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Howard, Amber Cyan; McNeil, Paul] Georgia Hlth Sci Univ, Dept Cell Biol & Anat, Augusta, GA 30912 USA; [Xiong, Fei] Wuhan Univ, Sch Med, Wuhan 430071, Hubei, Peoples R China; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Dept Neurosci, S-15185 Sodertalje, Sweden; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Dept Translat Sci, CNS, S-15185 Sodertalje, Sweden; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Pain Innovat Med, S-15185 Sodertalje, Sweden	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; AstraZeneca; AstraZeneca; AstraZeneca	Xiong, WC (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA.	wxiong@georgiahealth.edu	Mei, Lin/G-8755-2012; Leonov, Sergey V/M-5514-2013	Leonov, Sergey V/0000-0002-3425-723X; Zhang, Bin/0000-0003-1323-8678	National Institutes of Health, NIAMS [AR048120]; AstraZeneca, Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048120] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000838] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AstraZeneca, Inc.(AstraZeneca); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR048120 (to W.-C.X.). This study was also supported by AstraZeneca, Inc.	Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen X, 2007, CURR MOL MED, V7, P735; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jeynes B, 2008, CURR ALZHEIMER RES, V5, P432, DOI 10.2174/156720508785908937; Kuchler-Bopp S, 1999, NEUROREPORT, V10, P1347, DOI 10.1097/00001756-199904260-00035; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil P. L., 2001, CURR PROTOC CELL BIO; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2002, J CELL SCI, V115, P873; Miyake K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000687; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; Schmidt AM, 2000, TRENDS ENDOCRIN MET, V11, P368, DOI 10.1016/S1043-2760(00)00311-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SD, 1998, RESTOR NEUROL NEUROS, V12, P167; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	43	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35061	35070		10.1074/jbc.M111.261073	http://dx.doi.org/10.1074/jbc.M111.261073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844192	hybrid, Green Published			2022-12-25	WOS:000295406300059
J	Nagashima, S; Fukuda, T; Kubota, Y; Sugiura, A; Nakao, M; Inatome, R; Yanagi, S				Nagashima, Shun; Fukuda, Toshifumi; Kubota, Yuka; Sugiura, Ayumu; Nakao, Mitsuyoshi; Inatome, Ryoko; Yanagi, Shigeru			CRMP5-associated GTPase (CRAG) Protein Protects Neuronal Cells against Cytotoxicity of Expanded Polyglutamine Protein Partially via c-Fos-dependent Activator Protein-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA PROTEIN; HUNTINGTONS-DISEASE; SERUM RESPONSE; SULFINIC ACID; MOUSE MODEL; BINDING; RICH; PML; PHOSPHORYLATION; IDENTIFICATION	We previously demonstrated that CRAM (CRMP5)-associated GTPase (CRAG), a short splicing variant of centaurin-gamma 3/AGAP3, facilitated degradation of expanded polyglutamine protein (polyQ) via the nuclear ubiquitin-proteasome pathway. Taking advantage of this feature, we also showed that lentivirus-mediated CRAG expression in the Purkinje cells of mice expressing polyQ resulted in clearance of the polyQ aggregates and rescue from ataxia. However, the molecular basis of the function of CRAG in cell survival against polyQ remains unclear. Here we report that CRAG, but not centaurin-gamma 3, induces transcriptional activation of c-Fos-dependent activator protein-1 (AP-1) via serum response factor (SRF). Mutation analysis indicated that the nuclear localization signal and both the N- and C-terminal regions of CRAG are critical for SRF-dependent c-Fos activation. CRAG knockdown by siRNA or expression of a dominant negative mutant of CRAG significantly attenuated the c-Fos activation triggered by either polyQ or the proteasome inhibitor MG132. Importantly, c-Fos expression partially rescued the enhanced cytotoxicity of CRAG knockdown in polyQ-expressing or MG132-treated cells. Finally, we suggest the possible involvement of CRAG in the sulfiredoxin-mediated antioxidant pathway via AP-1. Taken together, these results demonstrated that CRAG enhances the cell survival signal against the accumulation of unfolded proteins, including polyQ, through not only proteasome activation, but also the activation of c-Fos-dependent AP-1.	[Nagashima, Shun; Fukuda, Toshifumi; Kubota, Yuka; Sugiura, Ayumu; Inatome, Ryoko; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Tokyo 1920392, Japan; [Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan	Tokyo University of Pharmacy & Life Sciences; Kumamoto University	Yanagi, S (corresponding author), 1432-1 Horinouchi, Tokyo 1920392, Japan.	syanagi@toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020; Sugiura, Ayumu/G-3648-2018	Yanagi, Shigeru/0000-0002-1392-8663; Sugiura, Ayumu/0000-0002-4776-1478	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Naito Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (to T. F., R. I., and S. Y.), the Naito Foundation, the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Uehara Memorial Foundation.	BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; Garcia M, 2004, NEUROSCIENCE, V127, P859, DOI 10.1016/j.neuroscience.2004.05.054; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Inatome R, 2000, J BIOL CHEM, V275, P27291; Iwatsuki M, 2011, TOXICOL APPL PHARM, V251, P209, DOI 10.1016/j.taap.2010.12.015; Izzo A, 2008, NUCLEIC ACIDS RES, V36, P950, DOI 10.1093/nar/gkm1108; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Li F, 2005, MOL CELL BIOL, V25, P8913, DOI 10.1128/MCB.25.20.8913-8924.2005; Matsuzaki K, 2003, GENES CELLS, V8, P275, DOI 10.1046/j.1365-2443.2003.00632.x; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Meurer S, 2004, J BIOL CHEM, V279, P49346, DOI 10.1074/jbc.M410565200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Samaj J, 2002, EMBO J, V21, P3296, DOI 10.1093/emboj/cdf349; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	37	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33879	33889		10.1074/jbc.M111.234997	http://dx.doi.org/10.1074/jbc.M111.234997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832068	Green Published, hybrid			2022-12-25	WOS:000295159200020
J	Sales, KU; Hobson, JP; Wagenaar-Miller, R; Szabo, R; Rasmussen, AL; Bey, A; Shah, MF; Molinolo, AA; Bugge, TH				Sales, Katiuchia Uzzun; Hobson, John P.; Wagenaar-Miller, Rebecca; Szabo, Roman; Rasmussen, Amber L.; Bey, Alexandra; Shah, Maham F.; Molinolo, Alfredo A.; Bugge, Thomas H.			Expression and Genetic Loss of Function Analysis of the HAT/DESC Cluster Proteases TMPRSS11A and HAT	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASE; TRANSMEMBRANE SERINE PROTEASES; PROATRIAL NATRIURETIC PEPTIDE; AUTOSOMAL RECESSIVE DEAFNESS; SURFACE PROTEOLYTIC-ENZYMES; AIRWAY EPITHELIAL-CELLS; CONVERTING ENZYME; IRON-DEFICIENCY; MICE LACKING; HEARING-LOSS	Genome mining at the turn of the millennium uncovered a new family of type II transmembrane serine proteases (TTSPs) that comprises 17 members in humans and 19 in mice. TTSPs phylogenetically belong to one of four subfamilies: matriptase, hepsin/TMPRSS, corin and HAT/DESC. Whereas a wealth of information now has been gathered as to the physiological functions of members of the hepsin/TMPRSS, matriptase, and corin subfamilies of TTSPs, comparatively little is known about the functions of the HAT/DESC subfamily of proteases. Here we perform a combined expression and functional analysis of this TTSP subfamily. We show that the five human and seven murine HAT/DESC proteases are coordinately expressed, suggesting a level of functional redundancy. We also perform a comprehensive phenotypic analysis of mice deficient in two of the most widely expressed HAT/DESC proteases, TMPRSS11A and HAT, and show that the two proteases are dispensable for development, health, and long-term survival in the absence of external challenges or additional genetic deficits. Our comprehensive expression analysis and generation of TMPRSS11A- and HAT-deficient mutant mouse strains provide a valuable resource for the scientific community for further exploration of the HAT/DESC subfamily proteases in physiological and pathological processes.	[Sales, Katiuchia Uzzun; Hobson, John P.; Wagenaar-Miller, Rebecca; Szabo, Roman; Rasmussen, Amber L.; Bey, Alexandra; Shah, Maham F.; Molinolo, Alfredo A.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Wagenaar-Miller, Rebecca] Natl Inst Dent & Craniofacial Res, Div Extramural Act, NIH, Bethesda, MD USA; [Bey, Alexandra] Duke Univ, Sch Med, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Duke University	Sales, KU (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Wagenaar-Miller, Rebecca/0000-0002-5807-0111; sales, katiuchia/0000-0002-3768-5790	National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ANTALIS TM, PROG MOL BIOL TRANSL, V99, P1; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Diez-Roux G, PLOS BIOL, V9; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enshell-Seijffers D, 2008, DEVELOPMENT, V135, P217, DOI 10.1242/dev.011031; FASQUELLE L, J BIOL CHEM; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hansen IA, 2004, ENDOCRINOLOGY, V145, P1898, DOI 10.1210/en.2003-0930; HOBSON JP, 2004, J BIOL CHEM; Holzinger A, 2002, AM J HUM GENET, V70, P20, DOI 10.1086/338456; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Iwakiri K, 2004, J INVEST DERMATOL, V122, P937, DOI 10.1111/j.0022-202X.2004.22415.x; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Lang JC, 2001, BRIT J CANCER, V84, P237, DOI 10.1054/bjoc.2000.1586; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; Matsushima R, 2006, AM J PHYSIOL-LUNG C, V290, pL385, DOI 10.1152/ajplung.00098.2005; Meyer M., P NATL ACAD SCI US, V107, P15022; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Stallmach R, 2008, BIOCHEM J, V412, P81, DOI 10.1042/BJ20071432; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; SZABO R, 2011, ANN REV CEL IN PRESS; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77; Zheng X Long, 2009, Front Biosci (Elite Ed), V1, P242	45	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23261	10.1371/journal.pone.0023261	http://dx.doi.org/10.1371/journal.pone.0023261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853097	Green Submitted, gold, Green Published			2022-12-25	WOS:000295454200058
J	Garcia-Lazaro, JA; Ahmed, B; Schnupp, JWH				Garcia-Lazaro, Jose A.; Ahmed, Bashir; Schnupp, Jan W. H.			Emergence of Tuning to Natural Stimulus Statistics along the Central Auditory Pathway	PLOS ONE			English	Article							MECHANISMS UNDERLYING SELECTIVITY; FREQUENCY-MODULATED SWEEPS; INFERIOR COLLICULUS; 1/F NOISE; PALLID BAT; CORTEX; MUSIC; COMMUNICATION; FLUCTUATIONS; RESPONSES	We have previously shown that neurons in primary auditory cortex (A1) of anaesthetized (ketamine/medetomidine) ferrets respond more strongly and reliably to dynamic stimuli whose statistics follow "natural" 1/f dynamics than to stimuli exhibiting pitch and amplitude modulations that are faster (1/f(0.5)) or slower (1/f(2)) than 1/f. To investigate where along the central auditory pathway this 1/f-modulation tuning arises, we have now characterized responses of neurons in the central nucleus of the inferior colliculus (ICC) and the ventral division of the mediate geniculate nucleus of the thalamus (MGV) to 1/f(gamma) distributed stimuli with gamma varying between 0.5 and 2.8. We found that, while the great majority of neurons recorded from the ICC showed a strong preference for the most rapidly varying (1/f(0.5) distributed) stimuli, responses from MGV neurons did not exhibit marked or systematic preferences for any particular gamma exponent. Only in A1 did a majority of neurons respond with higher firing rates to stimuli in which gamma takes values near 1. These results indicate that 1/f tuning emerges at forebrain levels of the ascending auditory pathway.	[Garcia-Lazaro, Jose A.; Ahmed, Bashir; Schnupp, Jan W. H.] Dept Physiol Anat & Genet, Oxford, England		Garcia-Lazaro, JA (corresponding author), Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford, England.	jan.schnupp@dpag.ox.ac.uk		schnupp, jan w h/0000-0002-2604-0057	BBSRC (Biotechnology and Biological Sciences Research Council) [BB/D009758/1]; EPSRC (Engineering and Physical Sciences Research Council) [EP/C010841/1]; Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico); Deafness Research UK; BBSRC [BB/D009758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009758/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Deafness Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by BBSRC (Biotechnology and Biological Sciences Research Council) grant Nbr BB/D009758/1 and EPSRC (Engineering and Physical Sciences Research Council) grant Nbr EP/C010841/1 to JWHS, and studentships from Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico) and Deafness Research UK to JAGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1997, ADV NEUR IN, V9, P27; Bizzarri AR, 1999, PHYSICA A, V267, P257, DOI 10.1016/S0378-4371(98)00651-7; Caspary DM, 2002, HEARING RES, V168, P163, DOI 10.1016/S0378-5955(02)00363-5; De Coensel B, 2003, ACTA ACUST UNITED AC, V89, P287; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gilden DL, 1997, PSYCHOL SCI, V8, P296, DOI 10.1111/j.1467-9280.1997.tb00441.x; Irvine D. R., 1986, PROGR SENSORY PHYSL; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Nozaki D, 1998, PHYS LETT A, V243, P281, DOI 10.1016/S0375-9601(98)00247-3; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Scalas E, 1998, EUROPHYS LETT, V43, P101, DOI 10.1209/epl/i1998-00308-1; Shi Y, 1996, FRACTALS, V4, P547, DOI 10.1142/S0218348X96000662; Szendro P, 2001, EUR BIOPHYS J BIOPHY, V30, P227, DOI 10.1007/s002490100143; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; YAMAMOTO Y, 1994, AM J PHYSIOL, V266, pR40, DOI 10.1152/ajpregu.1994.266.1.R40	26	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22584	10.1371/journal.pone.0022584	http://dx.doi.org/10.1371/journal.pone.0022584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850231	Green Published, gold, Green Submitted			2022-12-25	WOS:000293563300015
J	Li, HY; Yeh, PA; Chiu, HC; Tang, CY; Tu, BPH				Li, Huei-Ying; Yeh, Po-An; Chiu, Hsiu-Chiang; Tang, Chiou-Yang; Tu, Benjamin Pang-hsien			Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; BINDING PROTEIN; PHOSPHORYLATED TDP-43; CELLULAR TOXICITY; DROSOPHILA MODEL; TARDBP MUTATIONS; LEWY BODIES; FTLD-U	Several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) are characterized by inclusion bodies formed by TDP-43 (TDP). We established cell and transgenic Drosophila models expressing TDP carboxyl terminal fragment (ND251 and ND207), which developed aggregates recapitulating important features of TDP inclusions in ALS/FTLD-U, including hyperphosphorylation at previously reported serine(403,404,409,410) residues, polyubiquitination and colocalization with optineurin. These models were used to address the pathogenic role of hyperphosphorylation in ALS/FTLD-U. We demonstrated that hyperphosphorylation and ubiquitination occurred temporally later than aggregation in cells. Expression of CK2 alpha which phosphorylated TDP decreased the aggregation propensity of ND251 or ND207; this effect could be blocked by CK2 inhibitor DMAT. Mutation of serines(379,403,404,409,410) to alanines (S5A) to eliminate phosphorylation increased the aggregation propensity and number of aggregates of TDP, but mutation to aspartic acids (S5D) or glutamic acids (S5E) to simulate hyperphosphorylation had the opposite effect. Functionally, ND251 or ND207 aggregates decreased the number of neurites of Neuro2a cells induced by retinoic acid or number of cells by MTT assay. S5A mutation aggravated, but S5E mutation alleviated these cytotoxic effects of aggregates. Finally, ND251 or ND251S5A developed aggregates in neurons, and salivary gland of transgenic Drosophila, but ND251S5E did not. Taken together, our data indicate that hyperphosphorylation may represent a compensatory defense mechanism to stop or prevent pathogenic TDP from aggregation. Therefore, enhancement of phosphorylation may serve as an effective therapeutic strategy against ALS/FTLD-U.	[Li, Huei-Ying; Tu, Benjamin Pang-hsien] Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei, Taiwan; [Li, Huei-Ying] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan; [Tang, Chiou-Yang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Li, HY (corresponding author), Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei, Taiwan.	btu@ibms.sinica.edu.tw		Tu, Pang-hsien/0000-0003-2821-7335	National Science Council and Academia Sinica, Taipei, Taiwan [TMIIBMTP2009091]	National Science Council and Academia Sinica, Taipei, Taiwan	Grant from National Science Council and Academia Sinica, Taipei, Taiwan (TMIIBMTP2009091) http://web1.nsc.gov.tw/mp.aspx?mp=7 and http://www.sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Braak H, 2010, ACTA NEUROPATHOL; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Ito K, 1997, DEVELOPMENT, V124, P761; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kametani F, 2009, BIOCH BIOPHYS RES CO; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI US; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WIGHTMAN G, 1992, NEUROSCI LETT, V139, P269, DOI 10.1016/0304-3940(92)90569-S; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, MOL NEURODEGENER, V5, P33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	58	75	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23075	10.1371/journal.pone.0023075	http://dx.doi.org/10.1371/journal.pone.0023075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850253	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300038
J	Ballouard, JM; Brischoux, F; Bonnet, X				Ballouard, Jean-Marie; Brischoux, Francois; Bonnet, Xavier			Children Prioritize Virtual Exotic Biodiversity over Local Biodiversity	PLOS ONE			English	Article							CONSERVATION; EDUCATION; TELEVISION; ATTITUDES; INTERNET; IMPACT	Environmental education is essential to stem current dramatic biodiversity loss, and childhood is considered as the key period for developing awareness and positive attitudes toward nature. Children are strongly influenced by the media, notably the internet, about biodiversity and conservation issues. However, most media focus on a few iconic, appealing, and usually exotic species. In addition, virtual activities are replacing field experiences. This situation may curb children knowledge and concerns about local biodiversity. Focusing our analyses on local versus exotic species, we examined the level of knowledge and the level of diversity of the animals that French schoolchildren are willing to protect, and whether these perceptions are mainly guided by information available in the internet. For that, we collected and compared two complementary data sets: 1) a questionnaire was administered to schoolchildren to assess their knowledge and consideration to protect animals, 2) an internet content analysis (i.e. Google searching sessions using keywords) was performed to assess which animals are the most often represented. Our results suggest that the knowledge of children and their consideration to protect animal are mainly limited to internet contents, represented by a few exotic and charismatic species. The identification rate of local animals by schoolchildren was meager, suggesting a worrying disconnection from their local environment. Schoolchildren were more prone to protect "virtual'' (unseen, exotic) rather than local animal species. Our results reinforce the message that environmental education must also focus on outdoor activities to develop conservation consciousness and concerns about local biodiversity.	[Ballouard, Jean-Marie; Bonnet, Xavier] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France; [Ballouard, Jean-Marie] SOPTOM, Ctr Rech & Conservat Cheloniens, Le Village Des Tortues, Gonfaron, France; [Brischoux, Francois] Univ Florida, Dept Biol, Gainesville, FL USA	Centre National de la Recherche Scientifique (CNRS); State University System of Florida; University of Florida	Ballouard, JM (corresponding author), CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France.	jmarie.ballouard@gmail.com		Bonnet, Xavier/0000-0001-6150-8199	Conseil General des Deux-Sevres; Region Poitou-Charentes; National Science Foundation [IOS-0926802]; Division Of Integrative Organismal Systems [0926802] Funding Source: National Science Foundation	Conseil General des Deux-Sevres(Region Nouvelle-Aquitaine); Region Poitou-Charentes(Region Nouvelle-Aquitaine); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a grant from the Conseil General des Deux-Sevres and the Region Poitou-Charentes. FB acknowledges funding by National Science Foundation grant IOS-0926802 to Harvey B. Lillywhite while working on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Archie M, 1993, PARTNERS ACTION ENV; Ballouard J-M, 2005, THESIS MUSEUM NATL H; Balmford A, 2002, SCIENCE, V295, P2367; Barker S, 2002, ENV ED, V71, P13; Barker S, 2002, ENV ED, V71, P9; Barney E.C., 2005, J ENVIRON EDUC, V36, P2, DOI [10.3200/JOEE.36.2.41-55, DOI 10.3200/JOEE.36.2.41-55]; BELL BF, 1981, J BIOL EDUC, V15, P213, DOI 10.1080/00219266.1981.9654381; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Brewer C, 2002, CONSERV BIOL, V16, P577, DOI 10.1046/j.1523-1739.2002.01633.x; CARO TM, 1994, CONSERV BIOL, V8, P846, DOI 10.1046/j.1523-1739.1994.08030846.x; Chawla L, 2006, BARN, V2, P57; CHIPENIUK R, 1995, ENVIRON BEHAV, V27, P490, DOI 10.1177/0013916595274003; Clark JA, 2002, SCIENCE, V297, P191; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Colwell RK., 2013, STAT ESTIMATION SPEC; Eagles P. F. J., 1999, J ENVIRON EDUC, V30, P33, DOI DOI 10.1080/00958969909601882; FEINSINGER P, 1987, TRENDS ECOL EVOL, V2, P51, DOI 10.1016/0169-5347(87)90100-5; Feldhamer G, 2002, J POP CULT, V36, P160, DOI 10.1111/1540-5931.00037; Feldman A, 2000, NETWORK SCI DECADE L, P179; Havick J, 2000, TECHNOL SOC, V22, P273, DOI 10.1016/S0160-791X(00)00008-7; Heerwagen JH, 2002, CHILDREN AND NATURE, P29; Hofferth SL, 2001, CHILDREN MILLENNIUM; Holbert RL, 2003, J BROADCAST ELECTRON, V47, P177, DOI 10.1207/s15506878jobem4702_2; Huston AC, 1999, DEV PSYCHOL, V35, P912, DOI 10.1037/0012-1649.35.4.912; Jacobson Susan K., 1998, P237, DOI 10.1002/9781444313499.ch12; Kaiser Family Foundation, 2006, ED HLTH, V24, P44; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Kellert SR, 2002, CHILDREN AND NATURE, P117; Lebo HJ, 2001, UCLA INTERNET REPORT; Levi D, 1999, ENVIRON BEHAV, V31, P203, DOI 10.1177/00139169921972065; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Lindemann-Matthies P, 2006, INT J SCI EDUC, V28, P895, DOI 10.1080/10670560500438396; Louv R., 2008, Last child in the woods: saving our children from nature-deficit disorder; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Mikami S, 1995, INT COMMUN GAZ, V54, P209, DOI DOI 10.1177/001654929505400302; Myers OE, 2002, CHILDREN AND NATURE, P153; Nie N., 2000, INTERNET SOC PRELIMI; Orr DW, 2002, CHILDREN AND NATURE, P279; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Pyle RM, 2002, CHILDREN AND NATURE, P305; Randler C., 2008, EURASIA J MATH SCI T, V4, P223, DOI [DOI 10.12973/ejmste/75344, 10.12973/ejmste/75344, DOI 10.12973/EJMSTE/75344]; Rivas JA, 1999, CONSERV BIOL, V13, P453, DOI 10.1046/j.1523-1739.1999.013002453.x; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; Van Rompaey V., 2002, Information Communication & Society, V5, P189, DOI 10.1080/13691180210130770; Vining J., 2003, HUM ECOL REV, V10, P87, DOI DOI 10.2307/3802153; Wells J., 2006, 2007020 NCES US DEP; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; White R, 2004, YOUNG CHILDRENS RELA; Williams TM, 1986, IMPACT TELEVISION NA, P143; Wilson, 1996, STARTING EARLY ENV E; Wilson C, 2005, DISCUSSION PAPERS EC, V188, P188; Young J, 2001, ENVIRON EDUC RES, V7, P439; Zaradic PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007367	61	124	130	5	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23152	10.1371/journal.pone.0023152	http://dx.doi.org/10.1371/journal.pone.0023152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829710	gold, Green Published, Green Submitted			2022-12-25	WOS:000293561200051
J	Blagovic, K; Kim, LLY; Voldman, J				Blagovic, Katarina; Kim, Lily Y.; Voldman, Joel			Microfluidic Perfusion for Regulating Diffusible Signaling in Stem Cells	PLOS ONE			English	Article							ON-A-CHIP; SELF-RENEWAL; DIFFERENTIATION; GROWTH; FGF; EXPRESSION; MODEL; TRANSITION; INDUCTION; PLATFORM	Background: Autocrine & paracrine signaling are widespread both in vivo and in vitro, and are particularly important in embryonic stem cell (ESC) pluripotency and lineage commitment. Although autocrine signaling via fibroblast growth factor-4 (FGF4) is known to be required in mouse ESC (mESC) neuroectodermal specification, the question of whether FGF4 autocrine signaling is sufficient, or whether other soluble ligands are also involved in fate specification, is unknown. The spatially confined and closed-loop nature of diffusible signaling makes its experimental control challenging; current experimental approaches typically require prior knowledge of the factor/receptor in order to modulate the loop. A new approach explored in this work is to leverage transport phenomena at cellular resolution to downregulate overall diffusible signaling through the physical removal of cell-secreted ligands. Methodology/Principal Findings: We develop a multiplex microfluidic platform to continuously remove cell-secreted (autocrine\paracrine) factors to downregulate diffusible signaling. By comparing cell growth and differentiation in side-by-side chambers with or without added cell-secreted factors, we isolate the effects of diffusible signaling from artifacts such as shear, nutrient depletion, and microsystem effects, and find that cell-secreted growth factor(s) are required during neuroectodermal specification. Then we induce FGF4 signaling in minimal chemically defined medium (N2B27) and inhibit FGF signaling in fully supplemented differentiation medium with cell-secreted factors to determine that the non-FGF cell-secreted factors are required to promote growth of differentiating mESCs. Conclusions/Significance: Our results demonstrate for the first time that flow can downregulate autocrine\paracrine signaling and examine sufficiency of extracellular factors. We show that autocrine\paracrine signaling drives neuroectodermal commitment of mESCs through both FGF4-dependent and -independent pathways. Overall, by uncovering autocrine\paracrine processes previously hidden in conventional culture systems, our results establish microfluidic perfusion as a technique to study and manipulate diffusible signaling in cell systems.	[Blagovic, Katarina; Kim, Lily Y.; Voldman, Joel] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Voldman, Joel] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Blagovic, K (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	voldman@mit.edu			NIH [EB007278]; SNSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH grant No. EB007278 and SNSF fellowship for prospective researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CATCHPOLE JP, 1966, IND ENG CHEM, V58, P46, DOI 10.1021/ie50675a012; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Domenech M, 2009, INTEGR BIOL-UK, V1, P267, DOI 10.1039/b823059e; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Gupta K, 2010, LAB CHIP, V10, P2019, DOI 10.1039/c004689b; Hall VJ, 2010, DEV DYNAM, V239, P2911, DOI 10.1002/dvdy.22424; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Irimia D, 2006, LAB CHIP, V6, P345, DOI 10.1039/b515983k; Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Mehta K, 2006, BIOTECHNOL BIOENG, V94, P596, DOI 10.1002/bit.20857; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; OLWIN BB, 1989, J CELL BIOCHEM, V39, P443, DOI 10.1002/jcb.240390410; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Skelley AM, 2008, LAB CHIP, V8, P1733, DOI 10.1039/b807037g; Squires TM, 2008, NAT BIOTECHNOL, V26, P417, DOI 10.1038/nbt1388; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tanford C., 1961, PHYS CHEM MACROMOLEC; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toh YC, 2010, INTEGR BIOL-UK, V2, P305, DOI 10.1039/c0ib00004c; Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Voorhoeve PM, 2003, TRENDS BIOTECHNOL, V21, P2, DOI 10.1016/S0167-7799(02)00002-1; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	51	68	70	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22892	10.1371/journal.pone.0022892	http://dx.doi.org/10.1371/journal.pone.0022892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829665	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200036
J	Dottorini, T; Sole, G; Nunziangeli, L; Baldracchini, F; Senin, N; Mazzoleni, G; Proietti, C; Balaci, L; Crisanti, A				Dottorini, Tania; Sole, Gabriella; Nunziangeli, Luisa; Baldracchini, Francesca; Senin, Nicola; Mazzoleni, Giorgio; Proietti, Carla; Balaci, Lenuta; Crisanti, Andrea			Serum IgE Reactivity Profiling in an Asthma Affected Cohort	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IGE; SENSITIZATION; AMPLIFICATION; ASSOCIATION; ENVIRONMENT; MICROARRAYS; CHILDHOOD; EXPOSURE; CHILDREN; ATOPY	Background: Epidemiological evidence indicates that atopic asthma correlates with high serum IgE levels though the contribution of allergen specific IgE to the pathogenesis and the severity of the disease is still unclear. Methods: We developed a microarray immunoassay containing 103 allergens to study the IgE reactivity profiles of 485 asthmatic and 342 non-asthmatic individuals belonging to families whose members have a documented history of asthma and atopy. We employed k-means clustering, to investigate whether a particular IgE reactivity profile correlated with asthma and other atopic conditions such as rhinitis, conjunctivitis and eczema. Results: Both case-control and parent-to-siblings analyses demonstrated that while the presence of specific IgE against individual allergens correlated poorly with pathological conditions, particular reactivity profiles were significantly associated with asthma (p<10E-09). An artificial neural network (ANN)-based algorithm, calibrated with the profile reactivity data, correctly classified as asthmatic or non-asthmatic 78% of the individual examined. Multivariate statistical analysis demonstrated that the familiar relationships of the study population did not affect the observed correlations. Conclusions: These findings indicate that asthma is a higher-order phenomenon related to patterns of IgE reactivity rather than to single antibody reactions. This notion sheds new light on the pathogenesis of the disease and can be readily employed to distinguish asthmatic and non-asthmatic individuals on the basis of their serum reactivity profile.	[Dottorini, Tania; Nunziangeli, Luisa; Proietti, Carla; Crisanti, Andrea] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Sole, Gabriella; Balaci, Lenuta] Natl Res Council Italy CNR, Inst Genet & Biomed Res IRGB, Cagliari, Italy; [Baldracchini, Francesca; Mazzoleni, Giorgio] Microtest Matrices LtD, London, England; [Senin, Nicola] Univ Perugia, Dept Ind Engn, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, London, England	University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Perugia; Imperial College London	Dottorini, T (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	a.crisanti@ic.ac.uk	Gung, Amber/D-9842-2011; Sole, Gabriella/I-4820-2013; Senin, Nicola/B-5292-2016	Sole, Gabriella/0000-0001-5292-5038; Dottorini, Tania/0000-0001-7733-906X; Senin, Nicola/0000-0002-9556-0363; Proietti, Carla/0000-0002-6290-0261; Crisanti, Andrea/0000-0002-2406-4426	Italian Ministery of Education (FIRB); European Union (FIGHTMAL)	Italian Ministery of Education (FIRB); European Union (FIGHTMAL)(European Commission)	Funding is provided by the Italian Ministery of Education (FIRB) and European Union (FIGHTMAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Bacarese-Hamilton T, 2004, J APPL MICROBIOL, V96, P10, DOI 10.1046/j.1365-2672.2003.02111.x; Bacarese-Hamilton T, 2002, CLIN CHEM, V48, P1367; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bishop C. M., 1995, NEURAL NETWORKS PATT; Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI 10.1016/j.jaci.2010.11.034; Bolshakova N, 2005, BIOINFORMATICS, V21, P451, DOI 10.1093/bioinformatics/bti190; Burney P, 1997, J ALLERGY CLIN IMMUN, V99, P314, DOI 10.1016/S0091-6749(97)70048-4; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Halonen M, 1999, AM J RESP CRIT CARE, V160, P564, DOI 10.1164/ajrccm.160.2.9809038; Jansson SA, 2007, RESP MED, V101, P2263, DOI 10.1016/j.rmed.2007.06.029; Ker J, 2009, ANN ALLERG ASTHMA IM, V103, P282, DOI 10.1016/S1081-1206(10)60526-1; Mandhane PJ, 2009, J ALLERGY CLIN IMMUN, V124, P745, DOI 10.1016/j.jaci.2009.06.038; Menz G, 1998, ALLERGY, V53, P15, DOI 10.1111/j.1398-9995.1998.tb04934.x; Mullenix MC, 2001, CLIN CHEM, V47, P1926; [National Institutes of Health/ National Heart Lung and Blood Institute (NHLBI) World Health Organization (WHO) Global initiative for asthma (GINA)], 2009, GLOB IN ASTHM GINA G, P112; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; Palacin A, 2008, ANN ALLERG ASTHMA IM, V101, P200, DOI 10.1016/S1081-1206(10)60210-4; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Platts-Mills TAE, 2009, AM J RESP CRIT CARE, V180, P109, DOI 10.1164/rccm.200811-1756PR; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; Prescott SL, 1998, J IMMUNOL, V160, P4730; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; Simirenko L, 2004, MAPLETREE; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Tovey ER, 2008, J ALLERGY CLIN IMMUN, V122, P114, DOI 10.1016/j.jaci.2008.05.010; Venables KM, 1997, LANCET, V349, P1465, DOI 10.1016/S0140-6736(96)07219-4; Wickman M, 2004, ALLERGY, V59, P30, DOI 10.1111/j.1398-9995.2004.00572.x; Wickman M, 2005, ALLERGY, V60, P650, DOI 10.1111/j.1398-9995.2004.00764.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22319	10.1371/journal.pone.0022319	http://dx.doi.org/10.1371/journal.pone.0022319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829614	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200013
J	Gahete, MD; Cordoba-Chacon, J; Hergueta-Redondo, M; Martinez-Fuentes, AJ; Kineman, RD; Moreno-Bueno, G; Luque, RM; Castano, JP				Gahete, Manuel D.; Cordoba-Chacon, Jose; Hergueta-Redondo, Marta; Martinez-Fuentes, Antonio J.; Kineman, Rhonda D.; Moreno-Bueno, Gema; Luque, Raul M.; Castano, Justo P.			A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PREPROGHRELIN ISOFORM; INTRON RETENTION; PROSTATE-CANCER; SPLICE VARIANTS; PROTEIN-KINASE; RECEPTOR; IDENTIFICATION; PEPTIDE; OBESTATIN	The human ghrelin gene, which encodes the ghrelin and obestatin peptides, contains 5 exons (Ex), with Ex1-Ex4 encoding a 117 amino-acid (aa) preproprotein that is known to be processed to yield a 28-aa (ghrelin) and/or a 23-aa (obestatin) mature peptides, which possess biological activities in multiple tissues. However, the ghrelin gene also encodes additional peptides through alternative splicing or post-translational modifications. Indeed, we previously identified a spliced mRNA ghrelin variant in mouse (In2-ghrelin-variant), which is regulated in a tissue-dependent manner by metabolic status and may thus be of biological relevance. Here, we have characterized a new human ghrelin variant that contains Ex0-1, intron (In) 1, and Ex2 and lacks Ex3-4. This human In1-ghrelin variant would encode a new prepropeptide that conserves the first 12aa of native-ghrelin (including the Ser3-potential octanoylation site) but has a different C-terminal tail. Expression of In1-variant was detected in 22 human tissues and its levels were positively correlated with those of ghrelin-O-acyltransferase (GOAT; p = 0.0001) but not with native-ghrelin expression, suggesting that In1-ghrelin could be a primary substrate for GOAT in human tissues. Interestingly, levels of In1-ghrelin variant expression in breast cancer samples were 8-times higher than those of normal mammary tissue, and showed a strong correlation in breast tumors with GOAT (p = 0.0001), ghrelin receptor-type 1b (GHSR1b; p = 0.049) and cyclin-D3 (a cell-cycle inducer/proliferation marker; p = 0.009), but not with native-ghrelin or GHSR1a expression. Interestingly, In1-ghrelin variant overexpression increased basal proliferation of MDA-MB-231 breast cancer cells. Taken together, our results provide evidence that In1-ghrelin is a novel element of the ghrelin family with a potential pathophysiological role in breast cancer.	[Gahete, Manuel D.; Cordoba-Chacon, Jose; Martinez-Fuentes, Antonio J.; Luque, Raul M.; Castano, Justo P.] Univ Cordoba, Hosp Univ Reina Sofia, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Gahete, Manuel D.; Cordoba-Chacon, Jose; Martinez-Fuentes, Antonio J.; Luque, Raul M.; Castano, Justo P.] CIBERobn Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Hergueta-Redondo, Marta; Moreno-Bueno, Gema] CSIC UAM, Dept Biochem, Inst Invest Biomed Alberto Sols, Inst Invest Sanitaria La Paz IdiPAZ, Madrid, Spain; [Hergueta-Redondo, Marta; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain; [Kineman, Rhonda D.] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Gahete, MD (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain.	raul.luque@uco.es; justo@uco.es	Cordoba-Chacon, Jose/AAH-5753-2019; Castaño, Justo P/A-7124-2010; Gahete, Manuel D./C-4969-2009; Martinez-Fuentes, Antonio J/F-8198-2016; Kineman, Rhonda D/H-2221-2011; Raul, Luque Huertas/M-6948-2018; Moreno-Bueno, Gema/K-9354-2016	Cordoba-Chacon, Jose/0000-0001-8787-2706; Castaño, Justo P/0000-0002-3145-7287; Gahete, Manuel D./0000-0002-4578-2179; Kineman, Rhonda D/0000-0001-7322-1152; Moreno-Bueno, Gema/0000-0002-5030-6687; Luque, Raul M./0000-0002-7585-1913	Ministerio de Ciencia e Innovacion [FPU-AP20052473, SAF2007-63075, SAF2007-63075/FMM07, RYC-2007-00186/BFU2008-01136-BFI, BIO-0139/CTS-01705/BFU2007-60180-BFI]; Instituto de Salud Carlos III [FI06-00804]; National Institutes of Health [NIDDK30677]; Jesse Brown VA Medical Center [NIDDK30677]; Ramon y Cajal [RYC-2007-00186/BFU2008-01136-BFI]; Junta de Andalucia [BIO-0139/CTS-01705/BFU2007-60180-BFI]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jesse Brown VA Medical Center(US Department of Veterans Affairs); Ramon y Cajal(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work has been supported by FPU-AP20052473 (Ministerio de Ciencia e Innovacion to Manuel D. Gahete), FI06-00804 (Instituto de Salud Carlos III to Jose Cordoba-Chacon), SAF2007-63075 (Ministerio de Ciencia e Innovacion to Marta Hergueta-Redondo), NIDDK30677/VA-Merit-Award (National Institutes of Health and Jesse Brown VA Medical Center to Rhonda D. Kineman), SAF2007-63075/FMM07 (Ministerio de Ciencia e Innovacion to Gema Moreno-Bueno), RYC-2007-00186/BFU2008-01136-BFI (Ramon y Cajal and Ministerio de Ciencia e Innovacion to Raul M. Luque), and BIO-0139/CTS-01705/BFU2007-60180-BFI (Ministerio de Ciencia e Innovacion and Junta de Andalucia to Justo P. Castano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzon L, 2005, ONCOLOGY-BASEL, V68, P414, DOI 10.1159/000086983; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Carraro G, 2004, INT J MOL MED, V13, P295; Cassoni P, 2001, J CLIN ENDOCR METAB, V86, P1738, DOI 10.1210/jc.86.4.1738; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Eisen SF, 2002, MOL PHARMACOL, V62, P911, DOI 10.1124/mol.62.4.911; Gahete MD, 2010, J ALZHEIMERS DIS, V22, P819, DOI 10.3233/JAD-2010-100873; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg A, 2007, J CLIN ENDOCR METAB, V92, P3396, DOI 10.1210/jc.2007-0999; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Jeffery PL, 2005, ENDOCRINOLOGY, V146, P432, DOI 10.1210/en.2003-1466; Jeffery PL, 2002, J ENDOCRINOL, V172, pR7, DOI 10.1677/joe.0.172R007; Jeffery PL, 2003, CYTOKINE GROWTH F R, V14, P113, DOI 10.1016/S1359-6101(02)00089-8; Karaoglu A, 2009, MOL CELL BIOCHEM, V323, P113, DOI 10.1007/s11010-008-9969-0; Kineman RD, 2007, J MOL ENDOCRINOL, V38, P511, DOI 10.1677/JME-06-0026; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lago F, 2005, VITAM HORM, V71, P405, DOI 10.1016/S0083-6729(05)71014-1; Lanfranco F, 2008, VITAM HORM, V77, P301, DOI 10.1016/S0083-6729(06)77013-3; Ledee DR, 2004, MOL VIS, V10, P663; Leontiou CA, 2007, PITUITARY, V10, P213, DOI 10.1007/s11102-007-0023-0; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Martinez-Fuentes AJ, 2006, J CLIN ENDOCR METAB, V91, P2225, DOI 10.1210/jc.2006-0235; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Nikolopoulos D, 2010, SURG ONCOL, V19, pE2, DOI 10.1016/j.suronc.2009.02.011; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; Seim I, 2010, CLIN EXP PHARMACOL P, V37, P125, DOI 10.1111/j.1440-1681.2009.05241.x; Seim Inge, 2009, BMC Res Notes, V2, P85, DOI 10.1186/1756-0500-2-85; Seim I, 2009, CYTOKINE GROWTH F R, V20, P297, DOI 10.1016/j.cytogfr.2009.07.006; Soares JB, 2008, PEPTIDES, V29, P1255, DOI 10.1016/j.peptides.2008.02.018; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Takahashi T, 2009, J BIOCHEM, V146, P675, DOI 10.1093/jb/mvp112; Tsolakis AV, 2009, EUR J ENDOCRINOL, V160, P941, DOI 10.1530/EJE-09-0001; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Volante M, 2009, J PATHOL, V218, P458, DOI 10.1002/path.2551; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yeh AH, 2005, CLIN CANCER RES, V11, P8295, DOI 10.1158/1078-0432.CCR-05-0443; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200	48	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23302	10.1371/journal.pone.0023302	http://dx.doi.org/10.1371/journal.pone.0023302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829727	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200064
J	Gutman, R; Dayan, T; Levy, O; Schubert, I; Kronfeld-Schor, N				Gutman, Roee; Dayan, Tamar; Levy, Ofir; Schubert, Iris; Kronfeld-Schor, Noga			The Effect of the Lunar Cycle on Fecal Cortisol Metabolite Levels and Foraging Ecology of Nocturnally and Diurnally Active Spiny Mice	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; MICROHABITAT USE; DESERT RODENT; ACTIVITY PATTERNS; HETEROMYID RODENTS; ACOMYS-CAHIRINUS; CHRONIC STRESS; OCTODON-DEGUS; OWL PREDATION; VULPES-CANA	We studied stress hormones and foraging of nocturnal Acomys cahirinus and diurnal A. russatus in field populations as well as in two field enclosures populated by both species and two field enclosures with individuals of A. russatus alone. When alone, A. russatus individuals become also nocturnally active. We asked whether nocturnally active A. russatus will respond to moon phase and whether this response will be obtained also in diurnally active individuals. We studied giving-up densities (GUDs) in artificial foraging patches and fecal cortisol metabolite levels. Both species exhibited elevated fecal cortisol metabolite levels and foraged to higher GUDs in full moon nights; thus A. russatus retains physiological response and behavioral patterns that correlate with full moon conditions, as can be expected in nocturnal rodents, in spite of its diurnal activity. The endocrinological and behavioral response of this diurnal species to moon phase reflects its evolutionary heritage.	[Gutman, Roee; Dayan, Tamar; Levy, Ofir; Schubert, Iris; Kronfeld-Schor, Noga] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Gutman, R (corresponding author), Tel Hai Coll, Dept Nutr Sci, Fac Sci & Technol, Upper Galilee, Israel.	DayanT@tauex.tau.ac.il	Callahan, Charles D/L-1641-2013; Levy, Ofir/H-6217-2013; Kronfeld-Schor, Noga/AAU-3792-2020	Levy, Ofir/0000-0003-0920-1207; Kronfeld-Schor, Noga/0000-0002-5224-3341; Gutman, Roee/0000-0002-3282-6558	National Geographic Society [6293-98]; ISF [04320021]	National Geographic Society(National Geographic Society); ISF(Israel Science Foundation)	This research was supported by a National Geographic Society grant (6293-98) to T. Dayan (http://www.nationalgeographic.com/) and an ISF grant (04320021) to T. Dayan and N. Kronfeld-Schor (http://www.isf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2004, CAN J ZOOL, V82, P464, DOI 10.1139/Z04-007; Abramsky Z, 2002, ECOLOGY, V83, P1330, DOI 10.2307/3071947; Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P1267, DOI 10.1037/0735-7044.120.6.1267; BLANCHARD RJ, 1995, ANTIPREDATOR BEHAV S; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BOWERS MA, 1988, J MAMMAL, V69, P201, DOI 10.2307/1381778; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Brown JS, 1999, EVOL ECOL RES, V1, P49; BROWN JS, 1989, ECOL MONOGR, V59, P1, DOI 10.2307/2937289; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; COCKREM JF, 2002, SIGHT PREDATOR CAN S; Cohen R, 2006, PHYSIOL BEHAV, V87, P563, DOI 10.1016/j.physbeh.2005.12.010; Cohen R, 2010, BRAIN BEHAV EVOLUT, V75, P9, DOI 10.1159/000282172; Cohen R, 2010, J BIOL RHYTHM, V25, P47, DOI 10.1177/0748730409351672; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Cowie R. J., 1979, POPULATION DYNAMICS, P183; Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; CRAWFORD LL, 1983, Z TIERPSYCHOL, V63, P283; Crawley M. J, 2002, STAT COMPUTING INTRO; Curio E., 1976, ETHOLOGY PREDATION; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; Eilam D, 1999, ANIM BEHAV, V58, P1085, DOI 10.1006/anbe.1999.1224; El Hage W, 2006, PHYSIOL BEHAV, V87, P45, DOI 10.1016/j.physbeh.2005.08.039; FENN MGP, 1995, J MAMMAL, V76, P130, DOI 10.2307/1382321; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; GEFFEN E, 1992, J MAMMAL, V73, P395, DOI 10.2307/1382074; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; Hagenauer MH, 2008, BIOL RHYTHM RES, V39, P269, DOI 10.1080/09291010701683425; HALLE S, 1995, J MAMMAL, V76, P88, DOI 10.2307/1382318; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hendrie CA, 1998, J ZOOL, V245, P439, DOI 10.1017/S0952836998008073; Hendrie CA, 1996, PHARMACOL BIOCHEM BE, V54, P13, DOI 10.1016/0091-3057(95)02176-0; HENDRIE CA, 1994, ETHOLOGY PSYCHOPHARM; JEDRZEJEWSKA B, 1990, ANN ZOOL FENN, V27, P321; Jones M, 2000, J CHEM ECOL, V26, P455, DOI 10.1023/A:1005417707588; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; KOTLER BP, 1994, OECOLOGIA, V100, P391, DOI 10.1007/BF00317860; Kotler BP, 1999, J MAMMAL, V80, P361, DOI 10.2307/1383285; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Kotler BP, 2002, EVOL ECOL RES, V4, P495; KOTLER BP, 1992, BEHAV ECOL SOCIOBIOL, V30, P239, DOI 10.1007/BF00166708; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2001, J THERM BIOL, V26, P139, DOI 10.1016/S0306-4565(00)00034-6; Kronfeld-Schor N, 2001, AM NAT, V158, P451, DOI 10.1086/321991; Kronfeld-Schor N, 2001, J MAMMAL, V82, P1016, DOI 10.1644/1545-1542(2001)082<1016:RSAFMU>2.0.CO;2; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; LAMERS WH, 1986, AM J PHYSIOL, V251, pE78, DOI 10.1152/ajpendo.1986.251.1.E78; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Mandelik Y, 2003, EVOL ECOL RES, V5, P501; Mandelik Y., 2000, Israel Journal of Zoology, V46, P167; MANDELIK Y, 1999, THESIS TEL AVIV U TE; MENDELSSOHN H, 1965, ISR J ZOOL, V14, P185; MENGERSEN K, 2000, SPATIAL EPIDEMIOLOGY, P393; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Mohawk JA, 2007, PHYSIOL BEHAV, V92, P800, DOI 10.1016/j.physbeh.2007.06.009; Monclus R, 2006, CHEMOECOLOGY, V16, P25, DOI 10.1007/s00049-005-0324-6; NELSON EH, 2004, PREDATORS REDUCE PRE; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1554/0014-3820(2002)056[0776:REOEAI]2.0.CO;2; Plummer M, 2009, CODA OUTPUT ANAL DIA; PLUMMER M, 2008, JAGS JUST ANOTHER GI; PRICE MV, 1984, J MAMMAL, V65, P353, DOI 10.2307/1381183; Redlin U, 2004, J BIOL RHYTHM, V19, P58, DOI 10.1177/0748730403260371; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roll U, 2006, EVOL ECOL, V20, P479, DOI 10.1007/s10682-006-0015-y; Rotics S, 2011, CHRONOBIOL INT, V28, P70, DOI 10.3109/07420528.2010.525674; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Shargal E, 1999, J ZOOL, V249, P187, DOI 10.1111/j.1469-7998.1999.tb00757.x; Shargal E, 2000, J MAMMAL, V81, P1046, DOI 10.1644/1545-1542(2000)081<1046:PBASRO>2.0.CO;2; SHKOLNIK A, 1971, International Journal of Biometeorology, V15, P115, DOI 10.1007/BF01803884; Sih A, 2000, TRENDS ECOL EVOL, V15, P3, DOI 10.1016/S0169-5347(99)01766-8; Skorzewska A, 2007, HORM BEHAV, V52, P317, DOI 10.1016/j.yhbeh.2007.05.007; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stoks R, 2003, EVOLUTION, V57, P574; Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x; Thaker M, 2009, HORM BEHAV, V56, P51, DOI 10.1016/j.yhbeh.2009.02.009; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Vivanco P, 2009, CHRONOBIOL INT, V26, P219, DOI 10.1080/07420520902768203; Volobouev V, 2007, BIOL J LINN SOC, V91, P203, DOI 10.1111/j.1095-8312.2007.00773.x; Weinert D, 2007, PHYSIOL BEHAV, V90, P325, DOI 10.1016/j.physbeh.2006.09.019; Weissenberg S, 1997, ISR J ZOOL, V43, P119	95	22	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23446	10.1371/journal.pone.0023446	http://dx.doi.org/10.1371/journal.pone.0023446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829733	Green Published, gold			2022-12-25	WOS:000293561200070
J	Hellen, EH; Volkov, E; Kurths, J; Dana, SK				Hellen, Edward H.; Volkov, Evgenii; Kurths, Jurgen; Dana, Syamal Kumar			An Electronic Analog of Synthetic Genetic Networks	PLOS ONE			English	Article							QUORUM; SYNCHRONIZATION	An electronic analog of a synthetic genetic network known as the repressilator is proposed. The repressilator is a synthetic biological clock consisting of a cyclic inhibitory network of three negative regulatory genes which produces oscillations in the expressed protein concentrations. Compared to previous circuit analogs of the repressilator, the circuit here takes into account more accurately the kinetics of gene expression, inhibition, and protein degradation. A good agreement between circuit measurements and numerical prediction is observed. The circuit allows for easy control of the kinetic parameters thereby aiding investigations of large varieties of potential dynamics.	[Hellen, Edward H.] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Volkov, Evgenii] PN Lebedev Phys Inst, Dept Theoret Phys, Moscow 117924, Russia; [Kurths, Jurgen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Dana, Syamal Kumar] Indian Inst Chem Biol, Council Sci & Ind Res, Kolkata, India	University of North Carolina; University of North Carolina Greensboro; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Potsdam Institut fur Klimafolgenforschung; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Hellen, EH (corresponding author), Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA.	ehhellen@uncg.edu	Hellen, Edward/AAN-7714-2021; Volkov, Evgeny I/K-9176-2015	Hellen, Edward/0000-0001-5060-7220; 	International Programs Center at the University of North Carolina Greensboro	International Programs Center at the University of North Carolina Greensboro	Travel funds to EHH were provided by the International Programs Center at the University of North Carolina Greensboro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Buldu JM, 2007, INT J BIFURCAT CHAOS, V17, P3507, DOI 10.1142/S0218127407019275; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lucks JB, 2011, IEEE SPECTRUM, V48, P38, DOI 10.1109/MSPEC.2011.5719724; Mason J, 2004, CHAOS, V14, P707, DOI 10.1063/1.1786683; Potapov I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031901; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Ullner E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031904; Wagemakers A, 2006, CHAOS, V16, DOI 10.1063/1.2173048; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	16	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23286	10.1371/journal.pone.0023286	http://dx.doi.org/10.1371/journal.pone.0023286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829723	Green Submitted, Green Published, gold			2022-12-25	WOS:000293561200061
J	Mossman, D; Scott, RJ				Mossman, David; Scott, Rodney J.			Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone Acetylation	PLOS ONE			English	Article							BREAST-CANCER; EARLY EVENT; PROMOTER DEMETHYLATION; ABERRANT METHYLATION; LUNG-CANCER; CHROMATIN; BINDING; IDENTIFICATION; PROGNOSIS; BIOMARKER	Epigenetic regulation of genes involves the coordination of DNA methylation and histone modifications to maintain transcriptional status. These two features are frequently disrupted in malignancy such that critical genes succumb to inactivation. 5-aza-2'-deoxycytidine (5-aza-dC) is an agent which inhibits DNA methyltransferase, and holds great potential as a treatment for cancer, yet the extent of its effectiveness varies greatly between tumour types. Previous evidence suggests expression status after 5-aza-dC exposure cannot be explained by the DNA methylation status alone. Aim: We sought to identify chromatin changes involved with short and long term gene reactivation following 5-aza-dC exposure. Two colorectal cancer cell lines, HCT116 and SW480, were treated with 5-aza-dC and then grown in drug-free media to allow DNA re-methylation. DNA methylation and chromatin modifications were assessed with bisulfite sequencing and Chromatin Immuno-Precipitation analysis. Results: Increased H3 acetylation, H3K4 tri-methylation and loss of H3K27 tri-methylation were associated with reactivation. Hypermethylated genes that did not show increased acetylation were transiently expressed with 5-aza-dC treatment before reverting to an inactive state. Three reactivated genes, CDO1, HSPC105 and MAGEA3, were still expressed 10 days post 5-aza-dC treatment and displayed localised hypomethylation at the transcriptional start site, and also an increased enrichment of histone H3 acetylation. Conclusions: These observations suggest that hypomethylation alone is insufficient to reactivate silenced genes and that increased Histone H3 acetylation in unison with localised hypomethylation allows long term reversion of these epigenetically silenced genes. This study suggests that combined DNA methyltransferase and histone deacetylase inhibitors may aid long term reactivation of silenced genes.	[Mossman, David; Scott, Rodney J.] Univ Newcastle, Discipline Med Genet, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia; [Mossman, David; Scott, Rodney J.] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Scott, Rodney J.] John Hunter Hosp, Div Genet, Hunter Area Pathol Serv, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital	Mossman, D (corresponding author), Univ Newcastle, Discipline Med Genet, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia.	rodney.scott@newcastle.edu.au	Scott, Rodney J/B-2827-2013	Scott, Rodney J/0000-0001-7724-3404	NBN Telethon; University of Newcastle; Hunter Medical Research Institute	NBN Telethon; University of Newcastle; Hunter Medical Research Institute	This study was supported by funds from the NBN Telethon, the University of Newcastle and the Hunter Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio Ana, 2002, Curr Opin Investig Drugs, V3, P627; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Deng GR, 2009, CLIN CANCER RES, V15, P1519, DOI 10.1158/1078-0432.CCR-08-1778; Dietrich D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-247; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Koga T, 2011, INT J CANCER, V128, P1009, DOI 10.1002/ijc.25447; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; KWON MJ, 2010, CARCINOGENESIS, V6, P6; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LIM HW, 2009, J REPROD DEVELOP, V9, P9; Litt MD, 1997, J BIOL CHEM, V272, P14921, DOI 10.1074/jbc.272.23.14921; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Marian A J, 2010, Methodist Debakey Cardiovasc J, V6, P13; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Menendez L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-10; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; Mittag F, 2006, CANCER LETT, V240, P69, DOI 10.1016/j.canlet.2005.08.034; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; NISHIOKA C, 2011, LEUK RES; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Qiu G, 2006, CLIN BIOCHEM, V39, P259, DOI 10.1016/j.clinbiochem.2006.01.014; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; You Y, 2010, MELANOMA RES, V20, P179, DOI 10.1097/CMR.0b013e32833413c0; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	38	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23127	10.1371/journal.pone.0023127	http://dx.doi.org/10.1371/journal.pone.0023127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829702	Green Published, Green Submitted, gold			2022-12-25	WOS:000293561200048
J	Vazquez-Cedeira, M; Barcia-Sanjurjo, I; Sanz-Garcia, M; Barcia, R; Lazo, PA				Vazquez-Cedeira, Marta; Barcia-Sanjurjo, Iria; Sanz-Garcia, Marta; Barcia, Ramiro; Lazo, Pedro A.			Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; VACCINIA-RELATED KINASE-1; PROTEIN-KINASE; BREAST-CANCER; ALZHEIMERS-DISEASE; CELL-DIVISION; GROWTH-FACTOR; BINDING-SITE; HUMAN GENOME; PHOSPHORYLATION	Human vaccinia-related kinases (VRK1 and VRK2) are atypical active Ser-Thr kinases implicated in control of cell cycle entry, apoptosis and autophagy, and affect signalling by mitogen activated protein kinases (MAPK). The specific structural differences in VRK catalytic sites make them suitable candidates for development of specific inhibitors. In this work we have determined the sensitivity of VRK1 and VRK2 to kinase inhibitors, currently used in biological assays or in preclinical studies, in order to discriminate between the two proteins as well as with respect to the vaccinia virus B1R kinase. Both VRK proteins and vaccinia B1R are poorly inhibited by inhibitors of different types targeting Src, MEK1, B-Raf, JNK, p38, CK1, ATM, CHK1/2 and DNA-PK, and most of them have no effect even at 100 mu M. Despite their low sensitivity, some of these inhibitors in the low micromolar range are able to discriminate between VRK1, VRK2 and B1R. VRK1 is more sensitive to staurosporine, RO-31-8220 and TDZD8. VRK2 is more sensitive to roscovitine, RO 31-8220, Cdk1 inhibitor, AZD7762, and IC261. Vaccinia virus B1R is more sensitive to staurosporine, KU55933, and RO 31-8220, but not to IC261. Thus, the three kinases present a different pattern of sensitivity to kinase inhibitors. This differential response to known inhibitors can provide a structural framework for VRK1 or VRK2 specific inhibitors with low or no cross-inhibition. The development of highly specific VRK1 inhibitors might be of potential clinical use in those cancers where these kinases identify a clinical subtype with a poorer prognosis, as is the case of VRK1 in breast cancer.	[Vazquez-Cedeira, Marta; Sanz-Garcia, Marta; Lazo, Pedro A.] Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain; [Barcia-Sanjurjo, Iria; Barcia, Ramiro] Univ Santiago de Compostela, Dept Bioquim & Biol Mol, Fac Vet, Lugo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidade de Santiago de Compostela	Vazquez-Cedeira, M (corresponding author), Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain.	pedro.lazo@csic.es	Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025	JAE/CSIC; Universidad de Santiago; Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon [CSI14A08, GR15]; Fundacion Sandra Ibarra; Kutxa-Fundacion INBIOMED; Xunta de Galicia	JAE/CSIC; Universidad de Santiago; Ministerio de Educacion, Ciencia e Innovacion; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Sandra Ibarra; Kutxa-Fundacion INBIOMED; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	M.V.-C. and M.S.-G. have predoctoral fellowships from JAE/CSIC. I.B.-S. has a predoctoral fellowship from Zymofeed project of the Universidad de Santiago. This work was funded by grants from Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935 and CSD2007-0017], Junta de Castilla y Leon [CSI14A08 and GR15], Fundacion Sandra Ibarra, and Kutxa-Fundacion INBIOMED to P. A. L.; and from the Zymofeed project from Xunta de Galicia to R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Andreani A, 2000, ANTI-CANCER DRUG DES, V15, P447; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BANHAM AH, 1992, VIROLOGY, V191, P803, DOI 10.1016/0042-6822(92)90256-O; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; CHEONG JK, 2011, ONCOGENE; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Eswaran J, 2010, BBA-PROTEINS PROTEOM, V1804, P429, DOI 10.1016/j.bbapap.2009.10.013; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KELLER HU, 1993, BIOCHEM BIOPH RES CO, V194, P1111, DOI 10.1006/bbrc.1993.1936; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; KOJIMA I, 1993, J BIOL CHEM, V268, P10003; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mahon TM, 1997, BIOCHEM J, V325, P39; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Mitchell JB, 2010, CLIN CANCER RES, V16, P2076, DOI 10.1158/1078-0432.CCR-09-3277; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nishijo K, 2009, CANCER RES, V69, P2902, DOI 10.1158/0008-5472.CAN-08-3723; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; Santos CR, 2004, VIROLOGY, V328, P254, DOI 10.1016/j.virol.2004.08.013; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Savage MJ, 2009, DRUG DEVELOP RES, V70, P125, DOI 10.1002/ddr.20287; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yeo EJ, 1997, BBA-MOL CELL RES, V1356, P308, DOI 10.1016/S0167-4889(97)00006-2; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23235	10.1371/journal.pone.0023235	http://dx.doi.org/10.1371/journal.pone.0023235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829721	Green Submitted, gold, Green Published			2022-12-25	WOS:000293561200059
J	Wang, J; Svendsen, A; Kmiecik, J; Immervol, H; Skaftnesmo, KO; Planaguma, J; Reed, RK; Bjerkvig, R; Miletic, H; Enger, PO; Rygh, CB; Chekenya, M				Wang, Jian; Svendsen, Agnete; Kmiecik, Justyna; Immervol, Heike; Skaftnesmo, Kai Ove; Planaguma, Jesus; Reed, Rolf Kare; Bjerkvig, Rolf; Miletic, Hrvoje; Enger, Per Oyvind; Rygh, Cecilie Brekke; Chekenya, Martha			Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; ACUTE MYELOID-LEUKEMIA; GLIOBLASTOMA-MULTIFORME; NG2 PROTEOGLYCAN; BRAIN-TUMORS; MONOCLONAL-ANTIBODY; GENETIC ALTERATIONS; FACTOR RECEPTOR-2; HUMAN HOMOLOG; IN-VIVO	Aberrant expression of the progenitor marker Neuron-glia 2 (NG2/CSPG4) or melanoma proteoglycan on cancer cells and angiogenic vasculature is associated with an aggressive disease course in several malignancies including glioblastoma multiforme (GBM) and melanoma. Thus, we investigated the mechanism of NG2 mediated malignant progression and its potential as a therapeutic target in clinically relevant GBM and melanoma animal models. Xenografting NG2 overexpressing GBM cell lines resulted in increased growth rate, angiogenesis and vascular permeability compared to control, NG2 negative tumours. The effect of abrogating NG2 function was investigated after intracerebral delivery of lentivirally encoded shRNAs targeting NG2 in patient GBM xenografts as well as in established subcutaneous A375 melanoma tumours. NG2 knockdown reduced melanoma proliferation and increased apoptosis and necrosis. Targeting NG2 in two heterogeneous GBM xenografts significantly reduced tumour growth and oedema levels, angiogenesis and normalised vascular function. Vascular normalisation resulted in increased tumour invasion and decreased apoptosis and necrosis. We conclude that NG2 promotes tumour progression by multiple mechanisms and represents an amenable target for cancer molecular therapy.	[Wang, Jian; Svendsen, Agnete; Kmiecik, Justyna; Skaftnesmo, Kai Ove; Planaguma, Jesus; Bjerkvig, Rolf; Miletic, Hrvoje; Enger, Per Oyvind; Rygh, Cecilie Brekke; Chekenya, Martha] Univ Bergen, Dept Biomed, Translat Canc Res Grp, Bergen, Norway; [Immervol, Heike; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Immervol, Heike] Univ Bergen, Gades Inst, Bergen, Norway; [Reed, Rolf Kare; Rygh, Cecilie Brekke] Haukeland Hosp, Heart & Circulatory Res Grp, N-5021 Bergen, Norway; [Bjerkvig, Rolf] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Enger, Per Oyvind] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health; University of Bergen; Haukeland University Hospital	Wang, J (corresponding author), Univ Bergen, Dept Biomed, Translat Canc Res Grp, Bergen, Norway.	martha.chekenya@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Reed, Rolf K./B-9422-2017; Engelsen, Agnete Svendsen Tenfjord/AAB-6652-2020	Reed, Rolf K./0000-0002-2633-6595; Engelsen, Agnete Svendsen Tenfjord/0000-0003-0375-3406; Chekenya, PhD, Dr Philos, Dr. Martha/0000-0001-7241-3451	Norwegian Cancer Society [PK01-2008-0093]; Meltzer Fond; Norges Forskningsrads FRIFORSK; Bergen Medical Research Foundation; Helse-Vest [911382, 911383]; Norwegian Research Council	Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Fond; Norges Forskningsrads FRIFORSK; Bergen Medical Research Foundation; Helse-Vest; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank The Norwegian Cancer Society (grant PK01-2008-0093), The Meltzer Fond, Norges Forskningsrads FRIFORSK, Bergen Medical Research Foundation and Helse-Vest (grants 911382 and 911383) that supported our work. The molecular imaging platform and MRI performed in Trondheim was supported by the National Program for Research in Functional Genomics (FUGE), funded by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm FG, 1996, BLOOD, V87, P1134, DOI 10.1182/blood.V87.3.1134.bloodjournal8731134; Benassi MS, 2009, J ORTHOP RES, V27, P135, DOI 10.1002/jor.20694; Brekke C, 2006, NEUROIMAGE, V29, P965, DOI 10.1016/j.neuroimage.2005.08.026; Burg MA, 1998, J CELL PHYSIOL, V177, P299, DOI 10.1002/(SICI)1097-4652(199811)177:2<299::AID-JCP12>3.3.CO;2-0; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chekenya M, 2002, NEUROPATH APPL NEURO, V28, P367, DOI 10.1046/j.1365-2990.2002.00412.x; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Engebraaten O, 1999, J NEUROSURG, V90, P125, DOI 10.3171/jns.1999.90.1.0125; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Folkman J, 2003, CANCER BIOL THER, V2, pS127; Gerstner ER, 2010, NEURO-ONCOLOGY, V12, P466, DOI 10.1093/neuonc/nop051; Goretzki L, 2000, J BIOL CHEM, V275, P28625, DOI 10.1074/jbc.M002290200; Hjortland GO, 2004, J NEUROSURG, V100, P320, DOI 10.3171/jns.2004.100.2.0320; Hovinga KE, 2005, J NEURO-ONCOL, V74, P99, DOI 10.1007/s11060-004-4204-7; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kunkel P, 2001, CANCER RES, V61, P6624; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lai A, 2008, INT J RADIAT ONCOL, V71, P1372, DOI 10.1016/j.ijrobp.2007.11.068; Lamszus K, 2005, CLIN CANCER RES, V11, P4934, DOI 10.1158/1078-0432.CCR-04-2270; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Li Y, 2003, BRIT J OPHTHALMOL, V87, P629, DOI 10.1136/bjo.87.5.629; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Mauvieux L, 1999, BRIT J HAEMATOL, V107, P674; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Peroulis I, 2002, INT J CANCER, V97, P839, DOI 10.1002/ijc.10115; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SU MY, 1994, MAGN RESON MED, V32, P714, DOI 10.1002/mrm.1910320606; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	39	61	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23062	10.1371/journal.pone.0023062	http://dx.doi.org/10.1371/journal.pone.0023062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829586	Green Published, gold			2022-12-25	WOS:000293286500073
J	Zhao, F; Bosserhoff, AK; Buettner, R; Moser, M				Zhao, Feng; Bosserhoff, Anja-Katrin; Buettner, Reinhard; Moser, Markus			A Heart-Hand Syndrome Gene: Tfap2b Plays a Critical Role in the Development and Remodeling of Mouse Ductus Arteriosus and Limb Patterning	PLOS ONE			English	Article							AP-2 TRANSCRIPTION FACTOR; CARDIAC OUTFLOW TRACT; CAUSE CHAR-SYNDROME; NEURAL CREST CELLS; FACTOR AP-2-BETA; MICE; MUTATIONS; CLONING; EXPRESSION; DEFECTS	Background: Patent ductus arteriosus (PDA) is one of the most common forms of congenital heart disease. Mutations in transcription factor TFAP2B cause Char syndrome, a human disorder characterized by PDA, facial dysmorphysm and hand anomalies. Animal research data are needed to understand the mechanisms. The aim of our study was to elucidate the pathogenesis of Char syndrome at the molecular level. Methodology/Principal Findings: Gene expression of Tfap2b during mouse development was studied, and newborns of Tfap2b-deficient mice were examined to identify phenotypes. Gel shift assays had been carried out to search for Tfap2 downstream genes. Promoters of candidate genes were cloned into a reporter construct and used to demonstrate their regulation by Tfap2b in cell transfection. In situ hybridizations showed that the murine transcription factor Tfap2b was expressed during the entire development of mouse ductus arteriosus. Histological examination of ductus arteriosus from Tfap2b knockout mice 6 hours after birth revealed that they were not closed. Consequently, the lungs of Tfap2b(-/-) mice demonstrated progressive congestion of the pulmonary capillaries, which was postulated to result secondarily from PDA. In addition, Tfap2b was expressed in the limb buds, particularly in the posterior limb field during development. Lack of Tfap2b resulted in bilateral postaxial accessory digits. Further study indicated that expressions of bone morphogenetic protein (Bmp) genes, which are reported to be involved in the limb patterning and ductal development, were altered in limb buds of Tfap2b-deficient embryos, due to direct control of Bmp2 and Bmp4 promoter activity by Tfap2b. Conclusions/Significance: Tfap2b plays important roles in the development of mouse ductus arteriosus and limb patterning. Loss of Tfap2b results in altered Bmp expression that may cause the heart-limb defects observed in Tfap2b mouse mutants and Char syndrome patients. The Tfap2b knockout mouse may add to the very limited available animal models of PDA.	[Zhao, Feng] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, Regensburg, Germany; [Moser, Markus] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Icahn School of Medicine at Mount Sinai; University of Regensburg; Max Planck Society; University of Cologne	Zhao, F (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	zhaof@mskcc.org	Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to R.B. and M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Brewer S, 2002, MECH DEVELOP, V110, P139, DOI 10.1016/S0925-4773(01)00579-2; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; DRAYTON MR, 1987, ARCH DIS CHILD, V62, P1030, DOI 10.1136/adc.62.10.1030; Feng W, 2009, MOL CELL NEUROSCI, V42, P161, DOI 10.1016/j.mcn.2009.06.010; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Khetyar M, 2008, GENET TEST, V12, P457, DOI 10.1089/gte.2008.0015; Mani A, 2005, P NATL ACAD SCI USA, V102, P2975, DOI 10.1073/pnas.0409852102; Monge I, 2001, DEVELOPMENT, V128, P1239; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Satoda M, 1999, CIRCULATION, V99, P3036, DOI 10.1161/01.CIR.99.23.3036; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Smith GCS, 1998, PHARMACOL REV, V50, P35; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Tummala R, 2003, GENE, V321, P93, DOI 10.1016/S0378-1119(03)00840-0; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; Wilson GN, 1998, AM J MED GENET, V76, P297, DOI 10.1002/(SICI)1096-8628(19980401)76:4<297::AID-AJMG4>3.0.CO;2-N; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	35	32	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22908	10.1371/journal.pone.0022908	http://dx.doi.org/10.1371/journal.pone.0022908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829553	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500049
J	Sylvius, N; Bonne, G; Straatman, K; Reddy, T; Gant, TW; Shackleton, S				Sylvius, Nicolas; Bonne, Gisele; Straatman, Kees; Reddy, Thimma; Gant, Timothy W.; Shackleton, Sue			MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy	FASEB JOURNAL			English	Article						cardiac and skeletal muscle; laminopathy; fetal genes	RNA-POLYMERASE-II; SKELETAL-MUSCLE DEVELOPMENT; CELL-CYCLE PROGRESSION; HEART-FAILURE; DILATED CARDIOMYOPATHY; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR-ENVELOPE; MIRNA EXPRESSION; IN-VIVO	Mutations in the lamin A/C gene (LMNA) cause several disorders referred to as laminopathies, which include premature aging syndromes, lipodystrophy, and striated muscle disorders. There is evidence that lamin A/C plays a role in gene expression. MicroRNAs (miRNAs) are short noncoding RNAs regulating mRNAs involved in various biological processes, including the pathophysiology of striated muscles. Here, we profiled the expression of the miRNA transcriptome in skeletal muscle from patients with LMNA-related muscular dystrophy. Results show that control and patient groups can be distinguished based on their miRNA expression profile. Sixteen miRNAs are significantly dysregulated in patients compared with controls. Pathway enrichment analysis in the predicted targets of these miRNAs revealed pathways involved in muscle repair, such as MAPK, transforming growth factor-beta, and Wnt signaling. Interestingly, 9 of these miRNAs (hsa-miR-100, -127-3p, -148a, -136*, -192, -335, -376c, -489, and -502-3p) are highly expressed in fetal muscle, suggesting that the fetal miRNA gene program mediates a regenerative process. Overexpression of these miRNAs in C2C12 mouse myoblasts revealed that 3 of them (miR-100, -192, and -335) participate in muscle proliferation and differentiation. We identified target genes that likely mediate this effect, which include the calcineurin gene PPP3CA. Our findings are the first to demonstrate that miRNA expression is affected in laminopathies.-Sylvius, N., Bonne, G., Straatman, K., Reddy, T., Gant, T. W., Shackleton, S. MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy. FASEB J. 25, 3966-3978 (2011). www.fasebj.org	[Sylvius, Nicolas; Gant, Timothy W.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Sylvius, Nicolas; Reddy, Thimma; Shackleton, Sue] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Straatman, Kees] Univ Leicester, Ctr Core Biotechnol Serv, Leicester LE1 7RH, Leics, England; [Bonne, Gisele] INSERM, U974, Paris, France; [Bonne, Gisele] Univ Paris 06, CNRS, UM 76, Inst Myol,UMR7215,IFR14, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Serv Biochim Metab, UF Cardiogenet & Myogenet, F-75634 Paris, France	University of Leicester; University of Leicester; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Sylvius, N (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ns249@le.ac.uk; ss115@le.ac.uk	Bonne, Gisèle/G-3121-2013	Bonne, Gisèle/0000-0002-2516-3258; Gant, Timothy/0000-0001-9057-4937; Sylvius, Nicolas/0000-0002-3470-3711; Straatman, Kornelis/0000-0002-9812-492X	Wellcome Trust; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie Paris 06; Universite de la Mediterranee; Centre National de la Recherche Scientifique; Association Francaise contre les Myopathies	Wellcome Trust(Wellcome TrustEuropean Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris 06; Universite de la Mediterranee; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by a Wellcome Trust Value in People grant (to N.S.), Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie Paris 06, Universite de la Mediterranee, Centre National de la Recherche Scientifique, and Association Francaise contre les Myopathies. The authors sincerely thank clinicians R. Ben Yaou (Institut de Myologie, Universite Pierre et Marie Curie, Paris, France), P. Laforet (Institut de Myologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France), and D. Duboc (Universite Paris Descartes, Hopital Cochin, Paris, France) for providing patient samples. The authors also acknowledge L. Demay and P. Richard for help in the LMNA mutation screening, M. Beuvin and N.B. Romero for help in the process of patient biopsies, N. Vignier (Institut de Myologie, Paris, France) for critical review of the manuscript, and Jinli Luo (Medical Research Council Toxicology Unit, Leicester, UK) for help in analyzing GO terms.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Astejada M N, 2007, Acta Myol, V26, P159; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Charniot JC, 2003, HUM MUTAT, V21, P473, DOI 10.1002/humu.10170; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Helbling-Leclerc A, 2002, EUR J HUM GENET, V10, P157, DOI 10.1038/sj.ejhg.5200744; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kaab S, 2004, J MOL MED, V82, P308, DOI 10.1007/s00109-004-0527-2; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12; Saenz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003750; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; SUNADOME K, DEV CELL, V20, P192; Sylvius N, 2005, J MED GENET, V42, P639, DOI 10.1136/jmg.2004.023283; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Berlo JH, 2004, EUR HEART J, V25, P812, DOI 10.1016/j.ehj.2004.03.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vytopil M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e132; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	55	34	38	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3966	3978		10.1096/fj.11-182915	http://dx.doi.org/10.1096/fj.11-182915			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21840938				2022-12-25	WOS:000296723100021
J	Leyn, SA; Li, XQ; Zheng, QX; Novichkov, PS; Reed, S; Romine, MF; Fredrickson, JK; Yang, C; Osterman, AL; Rodionov, DA				Leyn, Semen A.; Li, Xiaoqing; Zheng, Qingxiang; Novichkov, Pavel S.; Reed, Samantha; Romine, Margaret F.; Fredrickson, James K.; Yang, Chen; Osterman, Andrei L.; Rodionov, Dmitry A.			Control of Proteobacterial Central Carbon Metabolism by the HexR Transcriptional Regulator A CASE STUDY IN SHEWANELLA ONEIDENSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC RECONSTRUCTION; UTILIZATION PATHWAYS; PSEUDOMONAS-PUTIDA; GENE-EXPRESSION; PROTEIN; CATABOLISM; SEQUENCE; DOMAIN; NETWORKS; REGULON	Background: Different regulatory strategies are utilized by bacteria to control central carbohydrate metabolism. Results: Transcriptional factor HexR is a global regulator of the central carbohydrate metabolism genes in various groups of proteobacterial genomes. Conclusion: HexR in Shewanella is a repressor/activator of the glycolytic/gluconeogenic genes. Significance: Integration of the comparative genomics and experimental approaches is efficient for reconstruction of transcriptional regulons in bacteria.	[Osterman, Andrei L.; Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Leyn, Semen A.; Rodionov, Dmitry A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Zheng, Qingxiang; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Novichkov, Pavel S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Reed, Samantha; Romine, Margaret F.; Fredrickson, James K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rodionov, DA (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rodionov@sanfordburnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry/V-2688-2018	Leyn, Semen A/0000-0002-9886-9120; Romine, Margaret/0000-0002-0968-7641; Rodionov, Dmitry/0000-0002-0939-390X	United States Department of Energy, Office of Science [DE-AC05-76RLO]; Pacific Northwest National Laboratory; Sanford-Burnham Medical Research Institute; Lawrence Berkeley National Laboratory [DE-SC0004999]; National Science Foundation [DBI-0850546]; Russian Foundation for Basic Research [10-04-01768]; Russian Academy of Sciences; National Science Foundation of China [30970035, 31070033]; Chinese Academy of Sciences [KSCX2-EW-G-5]; Direct For Biological Sciences [0850546] Funding Source: National Science Foundation	United States Department of Energy, Office of Science(United States Department of Energy (DOE)); Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Sanford-Burnham Medical Research Institute; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the United States Department of Energy, Office of Science, as part of the Genomic Science Program under Contract DE-AC05-76RLO with Pacific Northwest National Laboratory (Genomic Science Program Foundational Scientific Focus Area), Sanford-Burnham Medical Research Institute, Lawrence Berkeley National Laboratory Grant DE-SC0004999, National Science Foundation Grant DBI-0850546, Russian Foundation for Basic Research Grant 10-04-01768, and the Russian Academy of Sciences Program Molecular and Cellular Biology.; Supported by National Science Foundation of China Grants 30970035 and 31070033 and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-G-5.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; Driscoll ME, 2007, GENOME INFORM SER, V18, P287; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; Johnston JW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-240; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Lin CT, 2006, PROTEIN EXPRES PURIF, V47, P16, DOI 10.1016/j.pep.2005.11.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; NIERSBACH M, 1992, MOL GEN GENET, V231, P332, DOI 10.1007/BF00279808; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Petruschka L, 2002, FEMS MICROBIOL LETT, V215, P89, DOI 10.1016/S0378-1097(02)00923-0; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Titolo S, 2003, J VIROL, V77, P5178, DOI 10.1128/JVI.77.9.5178-5191.2003; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	42	39	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35782	35794		10.1074/jbc.M111.267963	http://dx.doi.org/10.1074/jbc.M111.267963			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849503	hybrid, Green Published			2022-12-25	WOS:000295927100051
J	Xie, C; Li, N; Chen, ZJ; Li, BL; Song, BL				Xie, Chang; Li, Na; Chen, Zheng-Jun; Li, Bo-Liang; Song, Bao-Liang			The Small GTPase Cdc42 Interacts with Niemann-Pick C1-like 1 (NPC1L1) and Controls Its Movement from Endocytic Recycling Compartment to Plasma Membrane in a Cholesterol-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; PROTEIN; ABSORPTION; VARIANTS; CELLS; TRAFFICKING; HOMEOSTASIS; ACTIVATION; MORPHOLOGY; INSIG-1	Niemann-Pick C1-like 1 (NPC1L1) is a multi-transmembrane protein that mediates the absorption of dietary and biliary cholesterol through vesicular endocytosis. The subcellular localization of NPC1L1 is regulated by cholesterol. Cholesterol depletion induces the transport of NPC1L1 to plasma membrane (PM) from endocytic recycling compartment that requires MyoVb.Rab11a.Rab11-FIP2 triple complex, and cholesterol-replenishment renders the internalization of NPC1L1 together with cholesterol. Here, we find that GTP-bound Cdc42 interacts with NPC1L1. Cholesterol depletion regulates the activation of Cdc42 and enhances NPC1L1-Cdc42 interaction. Overexpression of constitutive GTP-bound Cdc42 mutant form or knockdown of Cdc42 inhibits the transport of NPC1L1 to the PM and disturbs the cholesterol-regulated binding of NPC1L1 to Rab11a, MyoVb, and actin. Knockdown of Cdc42 downstream effectors N-WASP or Arp3 also leads to the similar results. In liver-specific Cdc42 knock-out (Cdc42 LKO) mice, NPC1L1 fails to localize to bile canaliculi, and the biliary cholesterol cannot be efficiently reabsorbed. These results indicate that Cdc42 controls the cholesterol-regulated transport and localization of NPC1L1, and plays a role in cholesterol absorption.	[Xie, Chang; Li, Na; Chen, Zheng-Jun; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	Xie, Chang/V-7099-2019; Chen, Zhengjun/X-7133-2019; Xie, Chang/O-8270-2016	Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the grants from the Ministry of Science and Technology of China (2009CB919000 and 2011CB910900), National Natural Science Foundation of China (30925012), and Shanghai Science and Technology Committee (10QH1402900).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Weber M, 2005, FUNGAL GENET BIOL, V42, P624, DOI 10.1016/j.fgb.2005.03.012; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yamanashi Y, 2009, PHARMACOGENET GENOM, V19, P884, DOI 10.1097/FPC.0b013e3283327925; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yuan HX, 2009, HEPATOLOGY, V49, P240, DOI 10.1002/hep.22610; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	34	23	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35933	35942		10.1074/jbc.M111.270199	http://dx.doi.org/10.1074/jbc.M111.270199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844200	hybrid, Green Published			2022-12-25	WOS:000295927100067
J	Revert-Ros, F; Lopez-Pascual, E; Granero-Molto, F; Macias, J; Breyer, R; Zent, R; Hudson, BG; Saadeddin, A; Revert, F; Blasco, R; Navarro, C; Burks, D; Saus, J				Revert-Ros, Francisco; Lopez-Pascual, Ernesto; Granero-Molto, Froilan; Macias, Jesus; Breyer, Richard; Zent, Roy; Hudson, Billy G.; Saadeddin, Anas; Revert, Fernando; Blasco, Rauel; Navarro, Carmen; Burks, Deborah; Saus, Juan			Goodpasture Antigen-binding Protein (GPBP) Directs Myofibril Formation IDENTIFICATION OF INTRACELLULAR DOWNSTREAM EFFECTOR 130-kDa GPBP-INTERACTING PROTEIN (GIP130)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE TRANSFER PROTEIN; SKELETAL-MUSCLE DIFFERENTIATION; MYOBLAST DIFFERENTIATION; SARCOPLASMIC-RETICULUM; IV COLLAGEN; ENDOPLASMIC-RETICULUM; CELL-DIFFERENTIATION; C2C12 MYOBLASTS; SPLICED VARIANT; KINASE-ACTIVITY	Goodpasture antigen-binding protein-1 (GPBP-1) is an exportable non-conventional Ser/Thr kinase that regulates glomerular basement membrane collagen organization. Here we provide evidence that GPBP-1 accumulates in the cytoplasm of differentiating mouse myoblasts prior to myosin synthesis. Myoblasts deficient in GPBP-1 display defective myofibril formation, whereas myofibrils assemble with enhanced efficiency in those overexpressing GPBP-1. We also show that GPBP-1 targets the previously unidentified GIP130 (GPBP-interacting protein of 130 kDa), which binds to myosin and promotes its myofibrillar assembly. This report reveals that GPBP-1 directs myofibril formation, an observation that expands its reported role in supramolecular organization of structural proteins to the intracellular compartment.	[Revert-Ros, Francisco; Lopez-Pascual, Ernesto; Granero-Molto, Froilan; Macias, Jesus; Saadeddin, Anas; Revert, Fernando; Blasco, Rauel; Burks, Deborah; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Lopez-Pascual, Ernesto; Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain; [Granero-Molto, Froilan; Breyer, Richard; Zent, Roy; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Blasco, Rauel] Parc Cient Univ Valencia, Fibrostatin SL, Comunitat Valenciana, Paterna 46890, Spain; [Navarro, Carmen] Complejo Hosp Vigo, Serv Anat Patol, Vigo 36200, Spain	Prince Felipe Research Center; University of Valencia; Vanderbilt University; Complexo Hospitalario Universitario de Vigo	Saus, J (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16, Valencia 46012, Spain.	jsaus@cipf.es	Revert-Ros, Francisco/AAB-7055-2019; REVERT, FERNANDO/ABF-8171-2021; Granero-Moltó, Froilán/H-6975-2017; Navarro, Carmen/A-9210-2012	REVERT, FERNANDO/0000-0002-7304-5846; Granero-Moltó, Froilán/0000-0003-4817-5232; Saus, Juan/0000-0003-2082-1597; Hudson, Billy/0000-0002-5420-4100; Revert-Ros, Francisco/0000-0002-6162-3370	Ministerio de Ciencia e Innovacion (MICINN) [SAF2003-09772, SAF2006-12520, SAF2009-10703]; Generalitat Valenciana [GV04B-285, BM-001/2002, ACOMP07-188, Prometeo 2009/065]; MICINN [SAF2008-00011]; Fondo de Investigaciones Sanitarias (FIS) [07/1257, 07/90043]; MICINN (Spain); National Institutes of Health [DK 18381]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK018381] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2003-09772, SAF2006-12520, and SAF2009-10703 and Generalitat Valenciana Grants GV04B-285, BM-001/2002, ACOMP07-188, and Prometeo 2009/065 (to J.S.); MICINN Grant SAF2008-00011 (to D. B.); Fondo de Investigaciones Sanitarias (FIS) Grants 07/1257 and 07/90043 (to C.N.); and the Programa Torres Quevedo of MICINN (to R. B.) (Spain). This work was also supported in part by National Institutes of Health Grant DK 18381 (to B. G. H.). Juan Saus, Francisco Revert-Ros, and Fernando Revert are partners of Fibrostatin SL, a biotech company exploiting patents related to GPBP.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Calera MR, 1998, BIOCHEM BIOPH RES CO, V251, P835, DOI 10.1006/bbrc.1998.9566; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diel P, 2008, J MOL ENDOCRINOL, V40, P231, DOI 10.1677/JME-07-0175; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jo K, 2001, MOL CELL BIOL, V21, P1682, DOI 10.1128/MCB.21.5.1682-1687.2001; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; PENADES JR, 1995, EUR J BIOCHEM, V229, P754, DOI 10.1111/j.1432-1033.1995.tb20524.x; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; SAUS J, 1988, J BIOL CHEM, V263, P13374; Takekura H, 2001, DEV BIOL, V239, P204, DOI 10.1006/dbio.2001.0437; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973	46	7	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35030	35043		10.1074/jbc.M111.249458	http://dx.doi.org/10.1074/jbc.M111.249458			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832087	Green Published, hybrid			2022-12-25	WOS:000295406300056
J	Datta, M; Bhattacharyya, NP				Datta, Moumita; Bhattacharyya, Nitai P.			Regulation of RE1 Protein Silencing Transcription Factor (REST) Expression by HIP1 Protein Interactor (HIPPI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE PROMOTER SEQUENCE; HUNTINGTONS-DISEASE; MOLECULAR PARTNER; IN-VIVO; APOPTOSIS; CASPASE-1; REST/NRSF; PATHOGENESIS; AGGREGATION; MECHANISMS	Earlier we have shown that the proapoptotic protein HIPPI (huntingtin interacting protein 1 (HIP1) protein interactor) along with its molecular partner HIP1 could regulate transcription of the caspase-1 gene. Here we report that RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a new transcriptional target of HIPPI. HIPPI could bind to the promoter of REST and increased its expression in neuronal as well as non-neuronal cells. Such activation of REST down-regulated expression of REST target genes, such as brain-derived neurotrophic factor (BDNF) or proenkephalin (PENK). The ability of HIPPI to activate REST gene transcription was dependent on HIP1, the nuclear transporter of HIPPI. Using a Huntington disease cell model, we have demonstrated that feeble interaction of HIP1 with mutant huntingtin protein resulted in increased nuclear accumulation of HIPPI and HIP1, leading to higher occupancy of HIPPI at the REST promoter, triggering its transcriptional activation and consequent repression of REST target genes. This novel transcription regulatory mechanism of REST by HIPPI may contribute to the deregulation of transcription observed in the cell model of Huntington disease.	[Datta, Moumita; Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, W Bengal, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1 AF Bidhan Nagar, Kolkata 700064, W Bengal, India.	nitai_sinp@yahoo.com	Datta, Moumita/AAU-8006-2021		Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported by the Department of Atomic Energy, Government of India.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Banerjee M, 2010, NUCLEIC ACIDS RES, V38, P878, DOI 10.1093/nar/gkp1011; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Houde C, 2006, DEV BIOL, V300, P523, DOI 10.1016/j.ydbio.2006.09.001; Jiang LC, 2008, J NEUROSCI RES, V86, P1209, DOI 10.1002/jnr.21595; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Majumder P, 2007, FEBS J, V274, P3886, DOI 10.1111/j.1742-4658.2007.05922.x; Majumder P, 2007, BIOCHEM BIOPH RES CO, V353, P80, DOI 10.1016/j.bbrc.2006.11.138; Majumder P, 2006, NEUROBIOL DIS, V22, P242, DOI 10.1016/j.nbd.2005.11.003; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Nishihara S, 2003, BIOCHEM BIOPH RES CO, V311, P55, DOI 10.1016/j.bbrc.2003.09.158; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Shimojo M, 2008, J BIOL CHEM, V283, P34880, DOI 10.1074/jbc.M804183200; Sinha M, 2010, BIOCHEM BIOPH RES CO, V396, P742, DOI 10.1016/j.bbrc.2010.05.007; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33759	33769		10.1074/jbc.M111.265173	http://dx.doi.org/10.1074/jbc.M111.265173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832040	hybrid, Green Published			2022-12-25	WOS:000295159200006
J	Liao, JM; Lu, H				Liao, Jun-Ming; Lu, Hua			Autoregulatory Suppression of c-Myc by miR-185-3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L11; CANCER CELL-LINES; RNA-POLYMERASE-I; TRANSCRIPTIONAL ACTIVATION; CYCLE ARREST; GENES; EXPRESSION; ONCOGENE; BINDING; P53	The expression of the c-myc oncogene at both protein and mRNA levels is transient and begins to be turned off 3-6 h after growth stimulation of cultured cells. The exact mechanism(s) underlying this down-regulation of c-Myc remains incompletely understood. Here we report the identification of miR-185-3p as a novel feedback regulator of c-Myc. This microRNA (miRNA) was initially identified as one of the c-Myc target miRNA transcripts through analysis of RNA samples isolated from cells prior to and after serum stimulation and further verified by real-time PCR, luciferase reporter, and ChIP assays. Interestingly, overexpression of wild type, but not mutant, miR-185-3p decreased the protein, but not mRNA, level of c-Myc in a dose-dependent fashion and also drastically abated the serum induction of c-Myc level in human cancer cells by targeting the coding sequence of c-Myc mRNA, consequently suppressing c-Myc-mediated proliferation. A miR-185-3p inhibitor rescued the inhibition of c-Myc expression by endogenous miR-185-3p. Thus, our results unveil miR-185-3p as the first miRNA that monitors c-Myc levels via an autoregulatory feedback mechanism in response to serum stimulation.	[Lu, Hua] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lu, H (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Liao, Jun-Ming/G-3788-2012		National Institutes of Health, NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA127724, R01CA129828] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA127724, CA095441, and CA129828 (to H. L.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; PULVERER BJ, 1994, ONCOGENE, V9, P59; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	50	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33901	33909		10.1074/jbc.M111.262030	http://dx.doi.org/10.1074/jbc.M111.262030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832077	hybrid, Green Published			2022-12-25	WOS:000295159200022
J	Liu, ZM; Kanzawa, N; Ono, S				Liu, Zhongmei; Kanzawa, Nobuyuki; Ono, Shoichiro			Calcium-sensitive Activity and Conformation of Caenorhabditis elegans Gelsolin-like Protein 1 Are Altered by Mutations in the First Gelsolin-like Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR/COFILIN; C-TERMINAL TAIL; PLASMA GELSOLIN; BINDING DOMAIN; F-ACTIN; FILAMENTS; IDENTIFICATION; ACTIVATION; MECHANISM; COMPLEX	The gelsolin family of actin regulatory proteins is activated by Ca2+ to sever and cap actin filaments. Gelsolin has six homologous gelsolin-like domains (G1-G6), and Ca2+-dependent conformational changes regulate its accessibility to actin. Caenorhabditis elegans gelsolin-like protein-1 (GSNL-1) has only four gelsolin-like domains (G1-G4) and still exhibits Ca2+-dependent actin filament-severing and -capping activities. We found that acidic residues (Asp-83 and Asp-84) in G1 of GSNL-1 are important for its Ca2+ activation. These residues are conserved in GSNL-1 and gelsolin and previously implicated in actin-severing activity of the gelsolin family. We found that alanine mutations at Asp-83 and Asp-84 (D83A/D84A mutation) did not disrupt actin-severing or -capping activity. Instead, the mutants exhibited altered Ca2+ sensitivity when compared with wildtype GSNL-1. The D83A/D84A mutation enhanced Ca2+ sensitivity for actin severing and capping and its susceptibility to proteolytic digestion, suggesting a conformational change. Single mutations caused minimal changes in its activity, whereas Asp-83 and Asp-84 were required to stabilize Ca2+-free and Ca2+-bound conformations, respectively. On the other hand, the D83A/D84A mutation suppressed sensitivity of GSNL-1 to phosphatidylinositol 4,5-bisphosphate inhibition. The structure of an inactive form of gelsolin shows that the equivalent acidic residues are in close contact with G3, which may maintain an inactive conformation of the gelsolin family.	[Liu, Zhongmei; Ono, Shoichiro] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Kanzawa, Nobuyuki] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Tokyo 1028554, Japan; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Sophia University; Emory University	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398; Kanzawa, Nobuyuki/0000-0002-8703-6828	National Institutes of Health [R01 AR48615]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR48615 (to S. O.).	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; BRYAN J, 1986, J CELL BIOL, V102, P1439, DOI 10.1083/jcb.102.4.1439; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lin KM, 2000, J BIOL CHEM, V275, P27746; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; Lueck A, 2000, BIOCHEMISTRY-US, V39, P5274, DOI 10.1021/bi992871v; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	28	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34051	34059		10.1074/jbc.M111.237404	http://dx.doi.org/10.1074/jbc.M111.237404			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840993	Green Published, hybrid			2022-12-25	WOS:000295159200037
J	Olah, J; Vincze, O; Virok, D; Simon, D; Bozso, Z; Tokesi, N; Horvath, I; Hlavanda, E; Kovacs, J; Magyar, A; Szucs, M; Orosz, F; Penke, B; Ovadi, J				Olah, Judit; Vincze, Orsolya; Virok, Dezso; Simon, Dora; Bozso, Zsolt; Tokesi, Natalia; Horvath, Istvan; Hlavanda, Emma; Kovacs, Janos; Magyar, Anna; Szucs, Maria; Orosz, Ferenc; Penke, Botond; Ovadi, Judit			Interactions of Pathological Hallmark Proteins TUBULIN POLYMERIZATION PROMOTING PROTEIN/p25, beta-AMYLOID, AND alpha-SYNUCLEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIZATION-PROMOTING PROTEIN; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; PARKINSONS-DISEASES; PEPTIDE-SYNTHESIS; RAT-BRAIN; TUBULIN; TPPP/P25; IDENTIFICATION	The disordered tubulin polymerization promoting protein (TPPP/p25) was found to be co-enriched in neuronal and glial inclusions with alpha-synuclein in Parkinson disease and multiple system atrophy, respectively; however, co-occurrence of alpha-synuclein with beta-amyloid (A beta) in human brain inclusions has been recently reported, suggesting the existence of mixed type pathologies that could result in obstacles in the correct diagnosis and treatment. Here we identified TPPP/p25 as an interacting partner of the soluble A beta oligomers as major risk factors for Alzheimer disease using ProtoArray human protein microarray. The interactions of oligomeric A beta with proteins involved in the etiology of neurological disorders were characterized by ELISA, surface plasmon resonance, pelleting experiments, and tubulin polymerization assay. Weshowed that the A beta(42) tightly bound to TPPP/p25 (K-d = 85 nM) and caused aberrant protein aggregation by inhibiting the physiologically relevant TPPP/p25-derived microtubule assembly. The pair-wise interactions of A beta(42), alpha-synuclein, and tubulin were found to be relatively weak; however, these three components formed soluble ternary complex exclusively in the absence of TPPP/p25. The aggregation-facilitating activity of TPPP/p25 and its interaction with A beta was monitored by electron microscopy with purified proteins by pelleting experiments with cell-free extracts as well as by confocal microscopy with CHO cells expressing TPPP/p25 or amyloid. The finding that the interaction of TPPP/p25 with A beta can produce pathological-like aggregates is tightly coupled with unusual pathology of the Alzheimer disease revealed previously; that is, partial co-localization of A beta and TPPP/p25 in the case of diffuse Lewy body disease with Alzheimer disease.	[Olah, Judit; Vincze, Orsolya; Tokesi, Natalia; Horvath, Istvan; Hlavanda, Emma; Orosz, Ferenc; Ovadi, Judit] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Virok, Dezso] Univ Szeged, Inst Clin Microbiol, H-6725 Szeged, Hungary; [Simon, Dora; Bozso, Zsolt; Szucs, Maria; Penke, Botond] Univ Szeged, Dept Med Chem, H-6720 Szeged, Hungary; [Penke, Botond] Hungarian Acad Sci, Supramol & Nanostruct Mat Res Grp, H-6720 Szeged, Hungary; [Kovacs, Janos] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Hungarian Acad Sci, H-1117 Budapest, Hungary; [Magyar, Anna] Eotvos Lorand Univ, Res Grp Peptide Chem, Hungarian Acad Sci, H-1117 Budapest, Hungary; [Szucs, Maria] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Szeged University; Szeged University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Ovadi, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Karolina Ut 29, H-1113 Budapest, Hungary.	ovadi@enzim.hu	Horvath, Istvan/B-1889-2009	Horvath, Istvan/0000-0003-4262-1430; Olah, Judit/0000-0002-2470-8631; Ovadi, Judit/0000-0002-3420-682X	Hungarian National Scientific Research Fund (OTKA) [T-067963, PD 76793]; European Commission [DCI-ALA/19.09.01/10/21526/245-297/ALFA111(2010)29]; Hungarian Academy of Sciences; EC [201159]	Hungarian National Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); Hungarian Academy of Sciences(Hungarian Academy of Sciences); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Hungarian National Scientific Research Fund Grants OTKA T-067963 (to J. Ovadi) and PD 76793 (to J. Olah), the European Commission (DCI-ALA/19.09.01/10/21526/245-297/ALFA111(2010)29; to J. Ovadi), a Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to J. Olah), and EC-7 Health Grant 201159 ("Memoload").	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bozso Z, 2010, PEPTIDES, V31, P248, DOI 10.1016/j.peptides.2009.12.001; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Duce JA, 2006, J MOL BIOL, V361, P493, DOI 10.1016/j.jmb.2006.06.038; Fabian G, 2002, J PHARMACOL EXP THER, V302, P774, DOI 10.1124/jpet.102.036152; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hoftberger R, 2010, GLIA, V58, P1847, DOI 10.1002/glia.21054; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jensen PH, 2001, METH MOLEC MED, V62, P61; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; KRCHNAK V, 1988, INT J PEPT PROT RES, V32, P415; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; NA GC, 1986, BIOCHEMISTRY-US, V25, P6214, DOI 10.1021/bi00368a057; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orosz F, 2004, BIOL CELL, V96, P701, DOI 10.1016/j.biolcel.2004.08.002; Orosz Ferenc, 2009, V7, P225, DOI 10.1007/978-1-4020-9434-7_10; Ovadi J, 2008, IUBMB LIFE, V60, P637, DOI 10.1002/iub.112; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Tompa P, 2009, STRUCTURE FUNCTION I; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; Verdier Y, 2008, J PEPT SCI, V14, P755, DOI 10.1002/psc.998; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Virok DP, 2011, J PROTEOME RES, V10, P1538, DOI 10.1021/pr1009096; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	61	111	116	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34088	34100		10.1074/jbc.M111.243907	http://dx.doi.org/10.1074/jbc.M111.243907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832049	Green Published, hybrid			2022-12-25	WOS:000295159200041
J	Singh, BK; Sattler, JM; Chatterjee, M; Huttu, J; Schuler, H; Kursula, I				Singh, Bishal K.; Sattler, Julia M.; Chatterjee, Moon; Huttu, Jani; Schuler, Herwig; Kursula, Inari			Crystal Structures Explain Functional Differences in the Two Actin Depolymerization Factors of the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; FILAMENT TURNOVER; PROTEIN-STRUCTURE; BINDING PROTEIN; HUMAN COFILIN; ADF/COFILIN; ACTOPHORIN; MODEL; DYNAMICS; PROFILIN	Apicomplexan parasites, such as the malaria-causing Plasmodium, utilize an actin-based motor for motility and host cell invasion. The actin filaments of these parasites are unusually short, and actin polymerization is under strict control of a small set of regulatory proteins, which are poorly conserved with their mammalian orthologs. Actin depolymerization factors (ADFs) are among the most important actin regulators, affecting the rates of filament turnover in a multifaceted manner. Plasmodium has two ADFs that display low sequence homology with each other and with the higher eukaryotic family members. Here, we show that ADF2, like canonical ADF proteins but unlike ADF1, binds to both globular and filamentous actin, severing filaments and inducing nucleotide exchange on the actin monomer. The crystal structure of Plasmodium ADF1 shows major differences from the ADF consensus, explaining the lack of F-actin binding. Plasmodium ADF2 structurally resembles the canonical members of the ADF/cofilin family.	[Singh, Bishal K.; Huttu, Jani; Kursula, Inari] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Sattler, Julia M.; Schuler, Herwig] Heidelberg Univ, Fac Med, Dept Infect Dis Parasitol, D-69120 Heidelberg, Germany; [Chatterjee, Moon; Huttu, Jani; Kursula, Inari] Helmholtz Ctr Infect Res, Ctr Struct Syst Biol, D-22607 Hamburg, Germany; [Chatterjee, Moon; Huttu, Jani; Kursula, Inari] Univ Hamburg, Deutsch Elektronen Synchrotron, D-22607 Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, Scheeles Vag 2, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se; inari.kursula@helmholtz-hzi.de	Singh, Bishal/GPF-8900-2022; Kursula, Inari/F-7140-2013; Schuler, Herwig/E-5751-2011; Kursula, Inari/AHB-9980-2022	Singh, Bishal/0000-0001-5760-6765; Kursula, Inari/0000-0001-5236-7056; Schuler, Herwig/0000-0003-4059-3501; Kursula, Inari/0000-0001-5236-7056	European Community [FP7/2007-2013, 226716]; Academy of Finland; European Commission; Centre for International Mobility/Sitra; Sigrid Juselius Foundation; German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft [SCHU1561]; Hoffman-Berling International Graduate School of Molecular and Cellular Biology	European Community(European Commission); Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Centre for International Mobility/Sitra; Sigrid Juselius Foundation(Sigrid Juselius Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hoffman-Berling International Graduate School of Molecular and Cellular Biology	Data collection was supported by the European Community (FP7/2007-2013) under Grant Agreement 226716. This work was also supported by the Academy of Finland (to I. K.), the European Commission FP7 Marie Curie European Reintegration program (to I. K.), the Centre for International Mobility/Sitra (to B. K. S.), the Sigrid Juselius Foundation (to I. K.), the German Federal Ministry of Education and Research (to I. K.), Deutsche Forschungsgemeinschaft Grant SCHU1561 (to H. S.), and the Hartmut-Hoffman-Berling International Graduate School of Molecular and Cellular Biology (to J. M. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; COOPER JA, 1986, J BIOL CHEM, V261, P477; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Doi Y, 2010, BIOCHEM BIOPH RES CO, V397, P668, DOI 10.1016/j.bbrc.2010.05.155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Huttu J, 2010, ACTA CRYSTALLOGR F, V66, P583, DOI 10.1107/S1744309110011589; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard SA, 1997, NAT STRUCT BIOL, V4, P369, DOI 10.1038/nsb0597-369; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Sattler J. M., 2011, EUR J CELL IN PRESS; Schatten H, 2003, MICROSC MICROANAL, V9, P330, DOI 10.1017/S143192760030095; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	55	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28256	28264		10.1074/jbc.M111.211730	http://dx.doi.org/10.1074/jbc.M111.211730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21832095	Green Published, Bronze			2022-12-25	WOS:000293557800043
J	Juuti-Uusitalo, K; Klunder, LJ; Sjollema, KA; Mackovicova, K; Ohgaki, R; Hoekstra, D; Dekker, J; van Ijzendoorn, SCD				Juuti-Uusitalo, Kati; Klunder, Leon J.; Sjollema, Klaas A.; Mackovicova, Katarina; Ohgaki, Ryuichi; Hoekstra, Dick; Dekker, Jan; van Ijzendoorn, Sven C. D.			Differential Effects of TNF (TNFSF2) and IFN-gamma on Intestinal Epithelial Cell Morphogenesis and Barrier Function in Three-Dimensional Culture	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SPINDLE ORIENTATION; TIGHT JUNCTIONS; LUMEN FORMATION; APICAL SURFACE; MYOSIN-II; POLARITY; MECHANISMS; ALPHA; APOPTOSIS	Background: The cytokines TNF (TNFSF2) and IFN gamma are important mediators of inflammatory bowel diseases and contribute to enhanced intestinal epithelial permeability by stimulating apoptosis and/or disrupting tight junctions. Apoptosis and tight junctions are also important for epithelial tissue morphogenesis, but the effect of TNF and IFN gamma on the process of intestinal epithelial morphogenesis is unknown. Methods/Principal Findings: We have employed a three-dimensional cell culture system, reproducing in vivo-like multicellular organization of intestinal epithelial cells, to study the effect of TNF on intestinal epithelial morphogenesis and permeability. We show that human intestinal epithelial cells in three-dimensional culture assembled into luminal spheres consisting of a single layer of cells with structural, internal, and planar cell polarity. Exposure of preformed luminal spheres to TNF or IFN gamma enhanced paracellular permeability, but via distinctive mechanisms. Thus, while both TNF and IFN gamma, albeit in a distinguishable manner, induced the displacement of selected tight junction proteins, only TNF increased paracellular permeability via caspase-driven apoptosis and cell shedding. Infliximab and adalumimab inhibited these effects of TNF. Moreover, we demonstrate that TNF via its stimulatory effect on apoptosis fundamentally alters the process of intestinal epithelial morphogenesis, which contributes to the de novo generation of intestinal epithelial monolayers with increased permeability. Also IFN gamma contributes to the de novo formation of monolayers with increased permeability, but in a manner that does not involve apoptosis. Conclusions: Our study provides an optimized 3D model system for the integrated analysis of (real-time) intestinal epithelial paracellular permeability and morphogenesis, and reveals apoptosis as a pivotal mechanism underlying the enhanced permeability and altered morphogenesis in response to TNF, but not IFN gamma.	[Juuti-Uusitalo, Kati; Dekker, Jan; van Ijzendoorn, Sven C. D.] Top Inst Food & Nutr, Wageningen, Netherlands; [Juuti-Uusitalo, Kati; Klunder, Leon J.; Mackovicova, Katarina; Ohgaki, Ryuichi; Hoekstra, Dick; van Ijzendoorn, Sven C. D.] Univ Groningen, Dept Cell Biol, Sect Membrane Cell Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Sjollema, Klaas A.] Univ Groningen, Dept Cell Biol, Sect Mol Imaging & Electron Microscopy, Univ Med Ctr Groningen, Groningen, Netherlands; [Sjollema, Klaas A.] Univ Groningen, Univ Med Ctr Groningen, UMCG Microscopy & Imaging Ctr UMIC, Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen; University of Groningen	Juuti-Uusitalo, K (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	s.c.d.van.ijzendoorn@med.umcg.nl		Sjollema, Klaas/0000-0001-8840-2087; Ohgaki, Ryuichi/0000-0002-6894-7239; Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition; Grants-in-Aid for Scientific Research [23790334] Funding Source: KAKEN	Top Institute Food and Nutrition; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Top Institute Food and Nutrition (http://www.tifn.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Carpenter HA, 2000, AM J GASTROENTEROL, V95, P878; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Haouzi D, 2005, J CELL SCI, V118, P2763, DOI 10.1242/jcs.02403; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Melnick M, 2001, ANAT RECORD, V262, P318, DOI 10.1002/1097-0185(20010301)262:3<318::AID-AR1023>3.0.CO;2-3; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Sands BE, 2007, J CLIN PHARMACOL, V47, P930, DOI 10.1177/0091270007301623; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Toyli M, 2010, LAB INVEST, V90, P915, DOI 10.1038/labinvest.2010.63; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135	35	29	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22967	10.1371/journal.pone.0022967	http://dx.doi.org/10.1371/journal.pone.0022967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853060	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400021
J	Berry, N; Ham, C; Mee, ET; Rose, NJ; Mattiuzzo, G; Jenkins, A; Page, M; Elsley, W; Robinson, M; Smith, D; Ferguson, D; Towers, G; Almond, N; Stebbings, R				Berry, Neil; Ham, Claire; Mee, Edward T.; Rose, Nicola J.; Mattiuzzo, Giada; Jenkins, Adrian; Page, Mark; Elsley, William; Robinson, Mark; Smith, Deborah; Ferguson, Deborah; Towers, Greg; Almond, Neil; Stebbings, Richard			Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTE; MUCOSAL INFECTION; IMMUNE-RESPONSES; RHESUS MACAQUES; CELL DEPLETION; SHIV VACCINE; LONG-TERM; REPLICATION; SUPERINFECTION	Background: Live attenuated simian immunodeficiency virus (SIV) vaccines represent the most effective means of vaccinating macaques against pathogenic SIV challenge. However, thus far, protection has been demonstrated to be more effective against homologous than heterologous strains. Immune correlates of vaccine-induced protection have also been difficult to identify, particularly those measurable in the peripheral circulation. Methodology/Principal Findings: Here we describe potent protection in 6 out of 8 Mauritian-derived cynomolgus macaques (MCM) against heterologous virus challenge with the pathogenic, uncloned SIVsmE660 viral stock following vaccination with live attenuated SIVmac251/C8. MCM provided a characterised host genetic background with limited Major Histocompatibility Complex (MHC) and TRIM5 alpha allelic diversity. Early protection, observed as soon as 3 weeks post-vaccination, was comparable to that of 20 weeks vaccination. Recrudescence of vaccine virus was most pronounced in breakthrough cases where simultaneous identification of vaccine and challenge viruses by virus-specific PCR was indicative of active co-infection. Persistence of the vaccine virus in a range of lymphoid tissues was typified by a consistent level of SIV RNA positive cells in protected vaccinates. However, no association between MHC class I/II haplotype or TRIM5 alpha polymorphism and study outcome was identified. Conclusion/Significance: This SIV vaccine study, conducted in MHC-characterised MCM, demonstrated potent protection against the pathogenic, heterologous SIVsmE660 challenge stock after only 3 weeks vaccination. This level of protection against this viral stock by intravenous challenge has not been hitherto observed. The mechanism(s) of protection by vaccination with live attenuated SIV must account for the heterologous and early protection data described in this study, including those which relate to the innate immune system.	[Berry, Neil; Ham, Claire; Mee, Edward T.; Rose, Nicola J.; Mattiuzzo, Giada; Jenkins, Adrian; Page, Mark; Elsley, William; Robinson, Mark; Smith, Deborah; Ferguson, Deborah; Almond, Neil] HPA, NIBSC, Div Retrovirol, Potters Bar, Herts, England; [Stebbings, Richard] NIBSC HPA, Div Biotherapeut, Potters Bar, Herts, England; [Towers, Greg] UCL, MRC Ctr Med Mol Virol, Div Infect & Immun, London, England	Health Protection Agency; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; University of London; University College London	Berry, N (corresponding author), HPA, NIBSC, Div Retrovirol, Potters Bar, Herts, England.	neil.berry@nibsc.hpa.org.uk	Stebbings, Richard/E-2117-2013; Rose, Nicola/E-9366-2013; Towers, Greg J/H-8892-2012	Stebbings, Richard/0000-0001-9628-2708; Almond, Neil/0000-0001-6105-0616; Mee, Edward/0000-0003-3514-8067; Towers, Gregory/0000-0002-7707-0264; Rose, Nicola/0000-0003-1102-5062	UK Medical Research Council [G9025730, G9419998, G0600007, G0801172]; EU [037611]; National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency; UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Wellcome Trust [090940]; MRC [G0601201, G0801172, G9721629, G0900950, G0600007, G9025730] Funding Source: UKRI; Medical Research Council [G0801172, G0601201, G0900950B, G0900950, G9025730, G0600007, G9721629B, G9721629] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency(National Institute for Health Research (NIHR)); UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the UK Medical Research Council (G9025730, G9419998, G0600007 and G0801172), EUFP6 grant Europrise (037611), the National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency, and the UCL/UCLH NIHR Comprehensive Biomedical Research Centre. GT holds a Wellcome Trust senior fellowship (no 090940). This report is work commissioned by the National Institute for Health Research. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Ahmed RKS, 1999, J GEN VIROL, V80, P1569, DOI 10.1099/0022-1317-80-7-1569; Alexander L, 2003, J VIROL, V77, P6823, DOI 10.1128/JVI.77.12.6823-6835.2003; Almond N, 1997, J GEN VIROL, V78, P1919, DOI 10.1099/0022-1317-78-8-1919; ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Berry N, 2008, J GEN VIROL, V89, P2240, DOI 10.1099/vir.0.2008/001693-0; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Canto-Nogues C, 2001, J GEN VIROL, V82, P2225, DOI 10.1099/0022-1317-82-9-2225; Clarke S, 2003, VIROLOGY, V306, P100, DOI 10.1016/S0042-6822(02)00043-0; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das AT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-44; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384; Gundlach BR, 2000, J VIROL, V74, P3537, DOI 10.1128/JVI.74.8.3537-3542.2000; Ham C, 2010, J CLIN MICROBIOL, V48, P2582, DOI 10.1128/JCM.00082-10; HIRSCH VM, 1994, VIRUS RES, V32, P183, DOI 10.1016/0168-1702(94)90041-8; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Kumar A, 2008, VIROLOGY, V371, P238, DOI 10.1016/j.virol.2007.10.008; Li B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-8; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nilsson C, 1998, AIDS, V12, P2261, DOI 10.1097/00002030-199817000-00006; Norley S, 1996, VIROLOGY, V219, P195, DOI 10.1006/viro.1996.0237; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; RUD EW, 1994, J GEN VIROL, V75, P529, DOI 10.1099/0022-1317-75-3-529; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Sharpe SA, 1997, J GEN VIROL, V78, P1923, DOI 10.1099/0022-1317-78-8-1923; Sharpe SA, 2004, J GEN VIROL, V85, P2591, DOI 10.1099/vir.0.80050-0; Silvera P, 2001, J MED PRIMATOL, V30, P1, DOI 10.1111/j.1600-0684.2001.300101.x; StahlHennig C, 1996, J GEN VIROL, V77, P2969, DOI 10.1099/0022-1317-77-12-2969; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Stebbings R, 1998, AIDS RES HUM RETROV, V14, P1187, DOI 10.1089/aid.1998.14.1187; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Titti F, 1997, J GEN VIROL, V78, P2529, DOI 10.1099/0022-1317-78-10-2529; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Walther-Jallow L, 2001, J GEN VIROL, V82, P1601, DOI 10.1099/0022-1317-82-7-1601; WHATMORE AM, 1995, J VIROL, V69, P5117, DOI 10.1128/JVI.69.8.5117-5123.1995; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wodarz D, 2008, VIROLOGY, V378, P299, DOI 10.1016/j.virol.2008.05.017; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yankee TM, 2009, VIROLOGY, V383, P103, DOI 10.1016/j.virol.2008.09.038; Yeh WW, 2009, J VIROL, V83, P2686, DOI 10.1128/JVI.02237-08	68	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23092	10.1371/journal.pone.0023092	http://dx.doi.org/10.1371/journal.pone.0023092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853072	gold, Green Submitted, Green Published			2022-12-25	WOS:000295454200041
J	Dodla, MC; Young, A; Venable, A; Hasneen, K; Rao, RR; Machacek, DW; Stice, SL				Dodla, Mahesh C.; Young, Amber; Venable, Alison; Hasneen, Kowser; Rao, Raj R.; Machacek, David W.; Stice, Steven L.			Differing Lectin Binding Profiles among Human Embryonic Stem Cells and Derivatives Aid in the Isolation of Neural Progenitor Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; EXPRESSION; PLURIPOTENT; DIFFERENTIATION; PROLIFERATION; PROTEOGLYCANS; GALECTIN-1; MICROARRAY; PRECURSORS	Human embryonic stem cells (hESCs) and their differentiated progeny allow for investigation of important changes/events during normal embryonic development. Currently most of the research is focused on proteinacous changes occurring as a result of differentiation of stem cells and little is known about changes in cell surface glycosylation patterns. Identification of cell lineage specific glycans can help in understanding their role in maintenance, proliferation and differentiation. Furthermore, these glycans can serve as markers for isolation of homogenous populations of cells. Using a panel of eight biotinylated lectins, the glycan expression of hESCs, hESCs-derived human neural progenitors (hNP) cells, and hESCs-derived mesenchymal progenitor (hMP) cells was investigated. Our goal was to identify glycans that are unique for hNP cells and use the corresponding lectins for cell isolation. Flow cytometry and immunocytochemistry were used to determine expression and localization of glycans, respectively, in each cell type. These results show that the glycan expression changes upon differentiation of hESCs and is different for neural and mesenchymal lineage. For example, binding of PHA-L lectin is low in hESCs (14 +/- 4.4%) but significantly higher in differentiated hNP cells (99 +/- 0.4%) and hMP cells (90 +/- 3%). Three lectins: VVA, DBA and LTL have low binding in hESCs and hMP cells, but significantly higher binding in hNP cells. Finally, VVA lectin binding was used to isolate hNP cells from a mixed population of hESCs, hNP cells and hMP cells. This is the first report that compares glycan expression across these human stem cell lineages and identifies significant differences. Also, this is the first study that uses VVA lectin for isolation for human neural progenitor cells.	[Dodla, Mahesh C.; Young, Amber; Hasneen, Kowser; Stice, Steven L.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Venable, Alison] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Machacek, David W.; Stice, Steven L.] ArunA Biomed Inc, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Virginia Commonwealth University	Dodla, MC (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	sstice@uga.edu	Rao, Raj/AAW-4308-2021		Georgia Research Alliance endowment, Department of Defense; ArunA Biomedical Inc.	Georgia Research Alliance endowment, Department of Defense(United States Department of Defense); ArunA Biomedical Inc.	This work was supported by funding from Georgia Research Alliance endowment, Department of Defense grant to SLS, and ArunA Biomedical Inc. NP cells and some media were provided in part by ArunA Biomedical (NP cells: hNP1TM cells, AB2TM medium supplemented with ANSTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Hennig A., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P585; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kabos P, 2004, BIOCHEM BIOPH RES CO, V318, P955, DOI 10.1016/j.bbrc.2004.04.114; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; Mandai M, 2010, CELL TRANSPLANT, V19, P9, DOI 10.3727/096368909X476599; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Muraglia A, 2000, J CELL SCI, V113, P1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rao Raj R., 2007, V407, P51, DOI 10.1007/978-1-59745-536-7_5; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Varki A., 2009, ESSENTIALS GLYCOBIOL; Venable A, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-15; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; Wearne KA, 2008, GLYCOCONJUGATE J, V25, P121, DOI 10.1007/s10719-007-9064-x; Wearne KA, 2006, GLYCOBIOLOGY, V16, P981, DOI 10.1093/glycob/cwl019; Yamagata M, 2005, J NEUROSCI, V25, P8457, DOI 10.1523/JNEUROSCI.1976-05.2005; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018	31	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23266	10.1371/journal.pone.0023266	http://dx.doi.org/10.1371/journal.pone.0023266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850265	gold, Green Published, Green Submitted			2022-12-25	WOS:000293563300050
J	Ohka, F; Natsume, A; Motomura, K; Kishida, Y; Kondo, Y; Abe, T; Nakasu, Y; Namba, H; Wakai, K; Fukui, T; Momota, H; Iwami, K; Kinjo, S; Ito, M; Fujii, M; Wakabayashi, T				Ohka, Fumiharu; Natsume, Atsushi; Motomura, Kazuya; Kishida, Yugo; Kondo, Yutaka; Abe, Tatsuya; Nakasu, Yoko; Namba, Hiroki; Wakai, Kenji; Fukui, Takashi; Momota, Hiroyuki; Iwami, Kenichiro; Kinjo, Sayano; Ito, Maki; Fujii, Masazumi; Wakabayashi, Toshihiko			The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma	PLOS ONE			English	Article							CODON 132 MUTATION; IDH2 MUTATIONS; HUMAN GLIOBLASTOMA; COLORECTAL-CANCER; OLIGODENDROGLIAL TUMORS; DIFFUSE GLIOMAS; PHENOTYPE; HYPOMETHYLATION; BIOMARKER; HYPERMETHYLATION	Gliomas are the most frequently occurring primary brain tumor in the central nervous system of adults. Glioblastoma multiformes (GBMs, WHO grade 4) have a dismal prognosis despite the use of the alkylating agent, temozolomide (TMZ), and even low grade gliomas (LGGs, WHO grade 2) eventually transform to malignant secondary GBMs. Although GBM patients benefit from promoter hypermethylation of the O-6-methylguanine-DNA methyltransferase (MGMT) that is the main determinant of resistance to TMZ, recent studies suggested that MGMT promoter methylation is of prognostic as well as predictive significance for the efficacy of TMZ. Glioma-CpG island methylator phenotype (G-CIMP) in the global genome was shown to be a significant predictor of improved survival in patients with GBM. Collectively, we hypothesized that MGMT promoter methylation might reflect global DNA methylation. Additionally in LGGs, the significance of MGMT promoter methylation is still undetermined. In the current study, we aimed to determine the correlation between clinical, genetic, and epigenetic profiles including LINE-1 and different cancer-related genes and the clinical outcome in newly diagnosed 57 LGG and 54 GBM patients. Here, we demonstrated that (1) IDH1/2 mutation is closely correlated with MGMT promoter methylation and 1p/19q codeletion in LGGs, (2) LINE-1 methylation levels in primary and secondary GBMs are lower than those in LGGs and normal brain tissues, (3) LINE-1 methylation is proportional to MGMT promoter methylation in gliomas, and (4) higher LINE-1 methylation is a favorable prognostic factor in primary GBMs, even compared to MGMT promoter methylation. As a global DNA methylation marker, LINE-1 may be a promising marker in gliomas.	[Ohka, Fumiharu; Natsume, Atsushi; Motomura, Kazuya; Kishida, Yugo; Momota, Hiroyuki; Iwami, Kenichiro; Kinjo, Sayano; Ito, Maki; Fujii, Masazumi; Wakabayashi, Toshihiko] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Kishida, Yugo; Kondo, Yutaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Abe, Tatsuya] Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan; [Nakasu, Yoko] Shizuoka Canc Ctr, Dept Neurosurg, Shizuoka, Japan; [Namba, Hiroki] Hamamatsu Med Univ, Dept Neurosurg, Hamamatsu, Shizuoka, Japan; [Wakai, Kenji] Nagoya Univ, Sch Med, Dept Prevent Med, Nagoya, Aichi 466, Japan; [Fukui, Takashi] FALCO Biosyst, Kyoto, Japan	Nagoya University; Aichi Cancer Center; Oita University; Shizuoka Cancer Center; Hamamatsu University School of Medicine; Nagoya University	Ohka, F (corresponding author), Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan.	anatsume@med.nagoya-u.ac.jp	Ohka, Fumiharu/A-3420-2016; Wakai, Kenji/I-7248-2014; Natsume, Atsushi/I-7364-2014; Motomura, Kazuya/AAF-8776-2021; Wakabayashi, Toshihiko/I-3526-2012	Wakai, Kenji/0000-0001-7388-7157; Natsume, Atsushi/0000-0002-9113-0470; Motomura, Kazuya/0000-0002-4376-1104; Wakabayashi, Toshihiko/0000-0001-5254-2088; Ohka, Fumiharu/0000-0002-5569-5626	Ministry of Health, Labor, and Welfare, Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from a Grant-in-Aid (B) for Scientific Research from the Ministry of Health, Labor, and Welfare, Japan (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; DAY RS, 1980, NATURE, V288, P724, DOI 10.1038/288724a0; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; FULTS D, 1992, CANCER RES, V52, P674; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawakami K, 2011, CANCER SCI, V102, P166, DOI 10.1111/j.1349-7006.2010.01776.x; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Mollemann M, 2005, INT J CANCER, V113, P379, DOI 10.1002/ijc.20575; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Rodriguez FJ, 2008, APPL IMMUNOHISTO M M, V16, P59; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	38	81	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23332	10.1371/journal.pone.0023332	http://dx.doi.org/10.1371/journal.pone.0023332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829728	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200065
J	Skar, H; Gutenkunst, RN; Ramsay, KW; Alaeus, A; Albert, J; Leitner, T				Skar, Helena; Gutenkunst, Ryan N.; Ramsay, Karin Wilbe; Alaeus, Annette; Albert, Jan; Leitner, Thomas			Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FREQUENCY-DEPENDENT SELECTION; EFFECTIVE POPULATION-SIZE; GENETIC DRIFT; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; IN-VIVO; ANTIBODY NEUTRALIZATION; SEQUENCE DIVERSITY; EVOLUTIONARY RATE	The molecular evolution of HIV-1 is characterized by frequent substitutions, indels and recombination events. In addition, a HIV-1 population may adapt through frequency changes of its variants. To reveal such population dynamics we analyzed HIV-1 subpopulation frequencies in an untreated patient with stable, low plasma HIV-1 RNA levels and close to normal CD4+ T-cell levels. The patient was intensively sampled during a 32-day period as well as approximately 1.5 years before and after this period (days -664, 1, 2, 3, 11, 18, 25, 32 and 522). 77 sequences of HIV-1 env (approximately 3100 nucleotides) were obtained from plasma by limiting dilution with 7-11 sequences per time point, except day -664. Phylogenetic analysis using maximum likelihood methods showed that the sequences clustered in six distinct subpopulations. We devised a method that took into account the relatively coarse sampling of the population. Data from days 1 through 32 were consistent with constant within-patient subpopulation frequencies. However, over longer time periods, i.e. between days 1...32 and 522, there were significant changes in subpopulation frequencies, which were consistent with evolutionarily neutral fluctuations. We found no clear signal of natural selection within the subpopulations over the study period, but positive selection was evident on the long branches that connected the subpopulations, which corresponds to >3 years as the subpopulations already were established when we started the study. Thus, selective forces may have been involved when the subpopulations were established. Genetic drift within subpopulations caused by de novo substitutions could be resolved after approximately one month. Overall, we conclude that subpopulation frequencies within this patient changed significantly over a time period of 1.5 years, but that this does not imply directional or balancing selection. We show that the short-term evolution we study here is likely representative for many patients of slow and normal disease progression.	[Skar, Helena; Ramsay, Karin Wilbe; Albert, Jan] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Skar, Helena; Ramsay, Karin Wilbe; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Skar, Helena; Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Alaeus, Annette] Karolinska Inst, Dept Med, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Arizona; Karolinska Institutet	Skar, H (corresponding author), Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden.	tkl@lanl.gov		Wilbe Ramsay, Karin/0000-0001-6161-9032	National Institutes of Health (NIH) [1R01AI087520-01A1]; Swedish Research Council; Swedish International Development Cooperation Agency [SWE-2006-018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) [grant 1R01AI087520-01A1], the Swedish Research Council, and the Swedish International Development Cooperation Agency [grant no. SWE-2006-018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Allain JP, 2000, J VIROL, V74, P2541, DOI 10.1128/JVI.74.6.2541-2549.2000; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; BERRY IM, 2009, EPIDEMICS IN PRESS; Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Chen RX, 2005, J VIROL, V79, P12045, DOI 10.1128/JVI.79.18.12045-12057.2005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2010, VIROLOGY, V405, P492, DOI 10.1016/j.virol.2010.06.029; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Fay JC, 2000, GENETICS, V155, P1405; Forster R, 2007, PHYSICA A, V381, P255, DOI 10.1016/j.physa.2007.03.017; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; FU YX, 1993, GENETICS, V133, P693; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gao F, 2004, J VIROL, V78, P2426, DOI 10.1128/JVI.78.5.2426-2433.2004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Heath L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006949; Heeregrave EJ, 2009, VIROLOGY, V393, P24, DOI 10.1016/j.virol.2009.07.011; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ince WL, 2009, J VIROL, V83, P4068, DOI 10.1128/JVI.02486-08; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Kouyos RD, 2006, TRENDS MICROBIOL, V14, P507, DOI 10.1016/j.tim.2006.10.001; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; KUIKEN C, 2010, HIV SEQUENCE COMPEND, P10; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Lee SK, 2002, J CLIN INVEST, V110, P1339, DOI 10.1172/JCI0216028; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Liitsola K, 2000, AIDS RES HUM RETROV, V16, P1047, DOI 10.1089/08892220050075309; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nielsen R, 1998, GENETICS, V148, P929; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Poles MA, 2001, J INFECT DIS, V183, P143, DOI 10.1086/317640; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Reuter G, 2008, J CLIN VIROL, V42, P135, DOI 10.1016/j.jcv.2008.02.014; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Shriner D, 2006, EVOLUTION, V60, P1165, DOI 10.1554/05-473.1; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P585; Trotter MV, 2008, GENETICS, V180, P1547, DOI 10.1534/genetics.108.088880; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; van Rij RP, 2000, J CLIN INVEST, V106, P1039, DOI 10.1172/JCI7953; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Wang WK, 2002, VIROLOGY, V303, P181, DOI 10.1006/viro.2002.1635; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Yuste E, 2002, J GEN VIROL, V83, P103, DOI 10.1099/0022-1317-83-1-103; Zhang LQ, 2002, J VIROL, V76, P9465, DOI 10.1128/JVI.76.18.9465-9473.2002	78	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e21747	10.1371/journal.pone.0021747	http://dx.doi.org/10.1371/journal.pone.0021747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829600	gold, Green Submitted, Green Published			2022-12-25	WOS:000293511900003
J	Mindell, DP; Fisher, BL; Roopnarine, P; Eisen, J; Mace, GM; Page, RDM; Pyle, RL				Mindell, David P.; Fisher, Brian L.; Roopnarine, Peter; Eisen, Jonathan; Mace, Georgina M.; Page, Roderic D. M.; Pyle, Richard L.			Aggregating, Tagging and Integrating Biodiversity Research	PLOS ONE			English	Editorial Material							INFORMATICS		[Mindell, David P.; Fisher, Brian L.; Roopnarine, Peter] Calif Acad Sci, San Francisco, CA 94118 USA; [Eisen, Jonathan] Univ Calif Davis, Sect Evolut & Ecol, Dept Med Microbiol, Davis, CA 95616 USA; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Page, Roderic D. M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Pyle, Richard L.] Bernice P Bishop Museum, Dept Nat Sci, Honolulu, HI USA	California Academy of Sciences; University of California System; University of California Davis; Imperial College London; University of Glasgow	Mindell, DP (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	dmindell@calacademy.org	Fisher, Brian L./S-9374-2019; Mace, Georgina M/I-3072-2016; Eisen, Jonathan A./H-2706-2019; Page, Roderic/A-1375-2009	Mace, Georgina M/0000-0001-8965-5211; Eisen, Jonathan A./0000-0002-0159-2197; Fisher, Brian/0000-0002-4653-3270; Page, Roderic/0000-0002-7101-9767; Roopnarine, Peter/0000-0002-9811-1176	Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; C?lix M., 2018, EUROPEAN RED LIST SA; Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; Clark T, 2004, BRIEF BIOINFORM, V5, P59, DOI 10.1093/bib/5.1.59; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Johnson JA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-65; Miller Holly, 2009, BMC Res Notes, V2, P101, DOI 10.1186/1756-0500-2-101; Naeem S., 2009, BIODIVERSITY ECOSYST; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Sala OE, 2010, BIODIVERSITY CHANGE; Thomas C, 2009, SCIENCE, V324, P1632, DOI 10.1126/science.324_1632; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; *WORLD RES I, 2005, MILL EC ASS	15	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e19491	10.1371/journal.pone.0019491	http://dx.doi.org/10.1371/journal.pone.0019491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829594	Green Published, gold, Green Accepted			2022-12-25	WOS:000293511200001
J	Huang, WT; Chen, WC; Teng, HJ; Huang, WI; Huang, YW; Hsu, CW; Chuang, JH				Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Huang, Wei-I; Huang, Yu-Wen; Hsu, Chien-Wen; Chuang, Jen-Hsiang			Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women - Taiwan, November 2009-August 2010	PLOS ONE			English	Article							INFLUENZA VACCINATION; CAPTURE-RECAPTURE; SAFETY; SURVEILLANCE; SYSTEMS	Background: During the 2009 H1N1 pandemic, pregnant women were prioritized to receive the unadjuvanted or MF59 (R)-adjuvanted pandemic A (H1N1) 2009 monovalent vaccines ("2009 H1N1 vaccines") in Taiwan regardless of stage of pregnancy. Monitoring adverse events following 2009 H1N1 vaccination in pregnant women was a priority for the mass immunization campaign beginning November 2009. Methods/Findings: We characterized reports to the national passive surveillance from November 2009 through August 2010 involving adverse events following 2009 H1N1 vaccines among pregnant women. Reports from the passive surveillance were matched to a large-linked database on a unique identifier, date of vaccination, and date of diagnosis in a capture-recapture analysis to estimate the true number of spontaneous abortion after 2009 H1N1 vaccination. We verified 16 spontaneous abortions, 11 stillbirths, 4 neonatal deaths, 4 nonpregnancy-specific adverse events, and 2 inadvertent immunizations in recipients who were unaware of pregnancy at time of vaccination. The Chapman capture-recapture estimator of true number of spontaneous abortion after 2009 H1N1 vaccination was 329 (95% confidence interval [CI] 196-553). Of the 14,474 pregnant women who received the 2009 H1N1 vaccines, the estimated risk of spontaneous abortion was 2.3 (95% CI, 1.4-3.8) per 100 pregnancies, compared with a local background rate of 12.8 (95% CI, 12.8-12.9) per 100 pregnancies. Conclusions: The passive surveillance provided rapid initial assessment of adverse events after 2009 H1N1 vaccination among pregnant women. Its findings were reassuring for the safety of 2009 H1N1 vaccines in pregnancy.	[Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Taipei, Taiwan; [Huang, Wei-I] Taiwan Drug Relief Fdn, Taipei, Taiwan; [Huang, Yu-Wen; Hsu, Chien-Wen] Taiwan Food & Drug Adm, Taipei, Taiwan; [Huang, Yu-Wen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan	National Taiwan University	Huang, WT (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	muagi@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567; Weninger, Tim/0000-0003-3164-2615; , Heli/0000-0002-2765-6582; Chen, Wan-Chin/0000-0002-2278-6193	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	This work is funded by Taiwan Centers for Disease Control and Taiwan Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Carvajal A, 2011, VACCINE, V29, P519, DOI 10.1016/j.vaccine.2010.10.067; Chapman D. G., 1951, U CALIFORNIA PUBLICA, V1, P131; *DEP HLTH, PHARM TAIW, P11601; European Medicines Agency, CHMP REC PHARM PLAN; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; HARRIS JW, 1919, JAMA-J AM MED ASSOC, V72, P970; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; HUANG WT, 2011, EMER INFECT IN PRESS, P11601; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; Lim SH, 2010, VACCINE, V28, P7455, DOI 10.1016/j.vaccine.2010.08.087; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; SEBER GAF, 1970, BIOMETRICS, V26, P13, DOI 10.2307/2529040; SIMPSON JL, 1990, AM J MED GENET, V35, P165, DOI 10.1002/ajmg.1320350205; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Verstraeten T, 2001, AM J EPIDEMIOL, V154, P1006, DOI 10.1093/aje/154.11.1006; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	30	63	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23049	10.1371/journal.pone.0023049	http://dx.doi.org/10.1371/journal.pone.0023049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21887325	Green Published, gold			2022-12-25	WOS:000293563300035
